Citrus Sinensis ID: 016184
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 394 | 2.2.26 [Sep-21-2011] | |||||||
| Q39019 | 421 | Shaggy-related protein ki | yes | no | 0.992 | 0.928 | 0.880 | 0.0 | |
| Q9FVS6 | 420 | Shaggy-related protein ki | no | no | 0.984 | 0.923 | 0.868 | 0.0 | |
| P51138 | 411 | Glycogen synthase kinase- | N/A | no | 0.964 | 0.924 | 0.767 | 0.0 | |
| P51139 | 411 | Glycogen synthase kinase- | N/A | no | 0.964 | 0.924 | 0.772 | 0.0 | |
| Q8VZD5 | 410 | Shaggy-related protein ki | no | no | 0.959 | 0.921 | 0.765 | 1e-180 | |
| P43288 | 405 | Shaggy-related protein ki | no | no | 0.923 | 0.898 | 0.794 | 1e-179 | |
| Q40518 | 409 | Shaggy-related protein ki | N/A | no | 0.936 | 0.902 | 0.788 | 1e-179 | |
| P43289 | 409 | Shaggy-related protein ki | no | no | 0.967 | 0.931 | 0.754 | 1e-179 | |
| P51137 | 411 | Glycogen synthase kinase- | N/A | no | 0.969 | 0.929 | 0.763 | 1e-178 | |
| Q96287 | 472 | Shaggy-related protein ki | no | no | 0.921 | 0.769 | 0.769 | 1e-175 |
| >sp|Q39019|KSG10_ARATH Shaggy-related protein kinase kappa OS=Arabidopsis thaliana GN=ASK10 PE=2 SV=2 | Back alignment and function desciption |
|---|
Score = 736 bits (1900), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 345/392 (88%), Positives = 369/392 (94%), Gaps = 1/392 (0%)
Query: 1 MASASLGNGGVGSSRSVNGFKSSSSSVDWLGREMLEMRLRDQVDNDEDRDSEPDIIDGVG 60
MAS+ LGNG VG+SRS G KSSSSSVDWL R++ E R+RD+V+ D++RDSEPDIIDG G
Sbjct: 1 MASSGLGNG-VGTSRSAKGLKSSSSSVDWLTRDLAETRIRDKVETDDERDSEPDIIDGAG 59
Query: 61 AETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR 120
AE GHVIRTT+ GRNG S+Q VSYI+EHVVGTGSFG+VFQAKCRETGE+VAIKKVLQDKR
Sbjct: 60 AEPGHVIRTTLRGRNGQSRQTVSYISEHVVGTGSFGMVFQAKCRETGEVVAIKKVLQDKR 119
Query: 121 YKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRM 180
YKNRELQIMQMLDHPN VALKH FFS TD EE+YLNLVLE+VPETVNR+AR+YSR +Q M
Sbjct: 120 YKNRELQIMQMLDHPNAVALKHSFFSRTDNEEVYLNLVLEFVPETVNRVARSYSRTNQLM 179
Query: 181 PLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP 240
PLIYVKLYTYQICRALAYIHN G+CHRDIKPQNLLVNPHTHQLK+CDFGSAKVLVKGEP
Sbjct: 180 PLIYVKLYTYQICRALAYIHNSFGLCHRDIKPQNLLVNPHTHQLKICDFGSAKVLVKGEP 239
Query: 241 NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV 300
NVSYICSRYYRAPELIFGA+EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV
Sbjct: 240 NVSYICSRYYRAPELIFGASEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV 299
Query: 301 LGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTAL 360
LGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDL+CRFFQYSPNLRCTAL
Sbjct: 300 LGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLLCRFFQYSPNLRCTAL 359
Query: 361 EACVHPFFDELRDPNTRLPNGRPLPPLFNFKP 392
EAC+HP FDELRDPNTRLPNGRPLPPLFNFKP
Sbjct: 360 EACIHPLFDELRDPNTRLPNGRPLPPLFNFKP 391
|
May mediate extracellular signals to regulate transcription in differentiating cells. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9FVS6|KSG4_ARATH Shaggy-related protein kinase delta OS=Arabidopsis thaliana GN=ASK4 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 724 bits (1870), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 338/389 (86%), Positives = 366/389 (94%), Gaps = 1/389 (0%)
Query: 4 ASLGNGGVGSSRSVNGFKSSSSSVDWLGREMLEMRLRDQVDNDEDRDSEPDIIDGVGAET 63
+ LGNG VGSSRS K++SSSVDWL R+MLEM++RD+ + DE+RDSEPDIIDGVGAE
Sbjct: 3 SHLGNG-VGSSRSAKNTKNTSSSVDWLSRDMLEMKIRDKTEADEERDSEPDIIDGVGAEP 61
Query: 64 GHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN 123
GHVI TT+ GRNG S+Q VSYIAEHVVGTGSFG+VFQAKCRETGE+VAIKKVLQDKRYKN
Sbjct: 62 GHVITTTLPGRNGQSRQTVSYIAEHVVGTGSFGMVFQAKCRETGEVVAIKKVLQDKRYKN 121
Query: 124 RELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLI 183
RELQIMQMLDHPN+V LKH F+S T+ EE+YLNLVLE+VPETVNR AR+YSR++Q MPLI
Sbjct: 122 RELQIMQMLDHPNVVCLKHSFYSRTENEEVYLNLVLEFVPETVNRTARSYSRMNQLMPLI 181
Query: 184 YVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVS 243
YVKLYTYQICR LAY+HNC G+CHRDIKPQNLLVNPHTHQLK+CDFGSAKVLVKGEPN+S
Sbjct: 182 YVKLYTYQICRGLAYLHNCCGLCHRDIKPQNLLVNPHTHQLKICDFGSAKVLVKGEPNIS 241
Query: 244 YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGT 303
YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGT
Sbjct: 242 YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGT 301
Query: 304 PTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEAC 363
PTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDL+CRFFQYSPNLRCTA+EAC
Sbjct: 302 PTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLLCRFFQYSPNLRCTAVEAC 361
Query: 364 VHPFFDELRDPNTRLPNGRPLPPLFNFKP 392
+HPFFDELRDPN RLPNGRPLPPLFNFKP
Sbjct: 362 IHPFFDELRDPNARLPNGRPLPPLFNFKP 390
|
May mediate extracellular signals to regulate transcription in differentiating cells. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P51138|MSK2_MEDSA Glycogen synthase kinase-3 homolog MsK-2 OS=Medicago sativa GN=MSK-2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 635 bits (1639), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 297/387 (76%), Positives = 335/387 (86%), Gaps = 7/387 (1%)
Query: 6 LGNGGVGSSRSVNGFKSSSS-SVDWLGREMLEMRLRDQVDNDEDRDSEPDIIDGVGAETG 64
+ GV + + +SS+ +VD L E+L MR++D D++ E ++DG E G
Sbjct: 1 MATAGVAPASGIVDVNASSAIAVDKLPDEILGMRIKD------DKEMEAHVVDGNSTEAG 54
Query: 65 HVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR 124
HVI TTIGG+NG KQ +SY+AE VG GSFGVVFQAKC ETGE VAIKKVLQDKRYKNR
Sbjct: 55 HVIVTTIGGKNGQPKQTISYMAERAVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNR 114
Query: 125 ELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIY 184
ELQ M++LDHPN+V LKHCFFSTT+K+ELYLNLVLE+VPETV+R+ R+YS+++QRMPLIY
Sbjct: 115 ELQTMRLLDHPNVVTLKHCFFSTTEKDELYLNLVLEFVPETVHRVIRHYSKMNQRMPLIY 174
Query: 185 VKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY 244
VKLY+YQICR+LAYIHNC+G+ HRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN+SY
Sbjct: 175 VKLYSYQICRSLAYIHNCVGVSHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY 234
Query: 245 ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTP 304
ICSRYYRAPELIFGATEYT+AIDIWS GCV+ ELLLGQPLFPG SGVDQLVEIIKVLGTP
Sbjct: 235 ICSRYYRAPELIFGATEYTSAIDIWSAGCVLGELLLGQPLFPGASGVDQLVEIIKVLGTP 294
Query: 305 TREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV 364
TREEIKCMNPNYTEFKFPQIK HPWHK+F+KR+PPEAVDLV R QYSPNLR TALEA V
Sbjct: 295 TREEIKCMNPNYTEFKFPQIKAHPWHKIFRKRMPPEAVDLVSRLLQYSPNLRSTALEALV 354
Query: 365 HPFFDELRDPNTRLPNGRPLPPLFNFK 391
HPFFDELRDPNTRLPNGR LPPLFNFK
Sbjct: 355 HPFFDELRDPNTRLPNGRHLPPLFNFK 381
|
Medicago sativa (taxid: 3879) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P51139|MSK3_MEDSA Glycogen synthase kinase-3 homolog MsK-3 OS=Medicago sativa GN=MSK-3 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 635 bits (1637), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 299/387 (77%), Positives = 338/387 (87%), Gaps = 7/387 (1%)
Query: 6 LGNGGVGSSRSVNGFKSSSSSVDWLGREMLEMRLRDQVDNDEDRDSEP-DIIDGVGAETG 64
+ +GGV + +SS V+ L EM +M++RD D++ E I+DG G ETG
Sbjct: 1 MASGGVAPASGFIDKNASSVGVEKLPEEMNDMKIRD------DKEMEAATIVDGNGTETG 54
Query: 65 HVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR 124
H+I TTIGG+NG KQ +SY+AE VVG GSFGVVFQAKC ETGE VAIKKVLQDKRYKNR
Sbjct: 55 HIIVTTIGGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGETVAIKKVLQDKRYKNR 114
Query: 125 ELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIY 184
ELQ M++LDHPN+V+LKHCFFSTT+K+ELYLNLVLEYVPETV+R+ R+Y++++QRMP+IY
Sbjct: 115 ELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVSRVIRHYNKMNQRMPMIY 174
Query: 185 VKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY 244
VKLY+YQICRALAYIHN IG+CHRDIKPQNLLVNPHTHQLK+CDFGSAKVLVKGEPN+SY
Sbjct: 175 VKLYSYQICRALAYIHNSIGVCHRDIKPQNLLVNPHTHQLKICDFGSAKVLVKGEPNISY 234
Query: 245 ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTP 304
ICSRYYRAPELIFGATEYTTAIDIWS GCV+ ELLLGQPLFPGESGVDQLVEIIKVLGTP
Sbjct: 235 ICSRYYRAPELIFGATEYTTAIDIWSAGCVLGELLLGQPLFPGESGVDQLVEIIKVLGTP 294
Query: 305 TREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV 364
TREEIKCMNPNYTEFKFPQIK HPWHK+F KR+PPEAVDLV R QYSPNLR TALEA V
Sbjct: 295 TREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRSTALEALV 354
Query: 365 HPFFDELRDPNTRLPNGRPLPPLFNFK 391
HPF+D++RDPNTRLPNGR LPPLFNFK
Sbjct: 355 HPFYDDVRDPNTRLPNGRFLPPLFNFK 381
|
Medicago sativa (taxid: 3879) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8VZD5|KSG5_ARATH Shaggy-related protein kinase epsilon OS=Arabidopsis thaliana GN=ASK5 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 631 bits (1627), Expect = e-180, Method: Compositional matrix adjust.
Identities = 294/384 (76%), Positives = 332/384 (86%), Gaps = 6/384 (1%)
Query: 9 GGVGSSRSVNGFKSSSSSVDWLGREMLEMRLRDQVDNDEDRDSEPDIIDGVGAETGHVIR 68
G + +S ++S + L + EM+++D D++ E ++DG G ETGH+I
Sbjct: 5 GTLPASSMATKQSNASICAEKLPEGINEMKIKD------DKEMEAAVVDGNGTETGHIIV 58
Query: 69 TTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQI 128
TTIGG+NG KQ +SY+AE +VG GSFG+VFQAKC ETGE VAIKKVLQDKRYKNRELQ
Sbjct: 59 TTIGGKNGQPKQTISYMAERIVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQT 118
Query: 129 MQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLY 188
M++LDHPN+V+LKHCFFSTT+K+ELYLNLVLEYVPETV R++++YSR +QRMP+IYVKLY
Sbjct: 119 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVYRVSKHYSRANQRMPIIYVKLY 178
Query: 189 TYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR 248
TYQICRALAYIH +G+CHRDIKPQNLLVNPHTHQ+KLCDFGSAKVLVKGEPN+SYICSR
Sbjct: 179 TYQICRALAYIHGGVGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR 238
Query: 249 YYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 308
YYRAPELIFGATEYTT IDIWS GCV+AELLLGQPLFPGESGVDQLVEIIKVLGTPTREE
Sbjct: 239 YYRAPELIFGATEYTTTIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 298
Query: 309 IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368
IKCMNPNYTEFKFPQIK HPWHK+F KR PPEAVDLV R QYSPNLR TA+EA VHPFF
Sbjct: 299 IKCMNPNYTEFKFPQIKAHPWHKIFHKRTPPEAVDLVSRLLQYSPNLRSTAMEAIVHPFF 358
Query: 369 DELRDPNTRLPNGRPLPPLFNFKP 392
DELRDPNTRLPNGR LPPLFNFKP
Sbjct: 359 DELRDPNTRLPNGRALPPLFNFKP 382
|
May mediate extracellular signals to regulate transcription in differentiating cells. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P43288|KSG1_ARATH Shaggy-related protein kinase alpha OS=Arabidopsis thaliana GN=ASK1 PE=2 SV=3 | Back alignment and function description |
|---|
Score = 629 bits (1622), Expect = e-179, Method: Compositional matrix adjust.
Identities = 294/370 (79%), Positives = 329/370 (88%), Gaps = 6/370 (1%)
Query: 23 SSSSVDWLGREMLEMRLRDQVDNDEDRDSEPDIIDGVGAETGHVIRTTIGGRNGNSKQKV 82
S+ VD L EM +M++RD D++ E ++DG G ETGH+I TTIGGRNG KQ +
Sbjct: 14 DSTGVDKLPEEMNDMKIRD------DKEMEATVVDGNGTETGHIIVTTIGGRNGQPKQTI 67
Query: 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKH 142
SY+AE VVG GSFGVVFQAKC ETGE VAIKKVLQD+RYKNRELQ M++LDHPN+V+LKH
Sbjct: 68 SYMAERVVGHGSFGVVFQAKCLETGETVAIKKVLQDRRYKNRELQTMRLLDHPNVVSLKH 127
Query: 143 CFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
CFFSTT+K+ELYLNLVLEYVPETV+R+ ++Y++++QRMPLIYVKLYTYQI RAL+YIH C
Sbjct: 128 CFFSTTEKDELYLNLVLEYVPETVHRVIKHYNKLNQRMPLIYVKLYTYQIFRALSYIHRC 187
Query: 203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEY 262
IG+CHRDIKPQNLLVNPHTHQ+KLCDFGSAKVLVKGEPN+SYICSRYYRAPELIFGATEY
Sbjct: 188 IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEY 247
Query: 263 TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 322
TTAID+WS GCV+AELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP
Sbjct: 248 TTAIDVWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 307
Query: 323 QIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPNGR 382
QIK HPWHK+F KR+PPEAVDLV R QYSPNLR AL+ VHPFFDELRDPN RLPNGR
Sbjct: 308 QIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRSAALDTLVHPFFDELRDPNARLPNGR 367
Query: 383 PLPPLFNFKP 392
LPPLFNFKP
Sbjct: 368 FLPPLFNFKP 377
|
May mediate extracellular signals to regulate transcription in differentiating cells. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q40518|MSK1_TOBAC Shaggy-related protein kinase NtK-1 OS=Nicotiana tabacum GN=NTK-1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 629 bits (1621), Expect = e-179, Method: Compositional matrix adjust.
Identities = 298/378 (78%), Positives = 332/378 (87%), Gaps = 9/378 (2%)
Query: 17 VNGFKSSSS---SVDWLGREMLEMRLRDQVDNDEDRDSEPDIIDGVGAETGHVIRTTIGG 73
V+G + SSS VD L EM +MR+RD D++ E I+DG G ETGH+I TTIGG
Sbjct: 9 VSGLRESSSHSVGVDRLPEEMNDMRIRD------DKEIEAAIVDGNGTETGHIIVTTIGG 62
Query: 74 RNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLD 133
R+G KQ +SY+AE +VG GSFGVVFQAKC ETGE VAIKKVLQDKRYKNRELQ M++LD
Sbjct: 63 RHGQPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLD 122
Query: 134 HPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQIC 193
HPN+V LKHCFFSTT+K+E+YLNLVLEYVPETV+R+ ++Y++++QRMPLI VKLYTYQI
Sbjct: 123 HPNVVCLKHCFFSTTEKDEVYLNLVLEYVPETVHRVIKHYNKLNQRMPLILVKLYTYQIF 182
Query: 194 RALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAP 253
RAL+YIH+ IG+CHRDIKPQNLLVNPHTHQ+KLCDFGSAKVLVKGEPN+SYICSRYYRAP
Sbjct: 183 RALSYIHHTIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAP 242
Query: 254 ELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 313
ELIFGATEYTTAIDIWS GCV+AELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN
Sbjct: 243 ELIFGATEYTTAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 302
Query: 314 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD 373
PNY EFKFPQIK HPWHK+F KR+PPEAVDLV R QYSPNLRCTALEA H FFDELRD
Sbjct: 303 PNYNEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEAVTHAFFDELRD 362
Query: 374 PNTRLPNGRPLPPLFNFK 391
PNTRLPNGR LPPLFNFK
Sbjct: 363 PNTRLPNGRVLPPLFNFK 380
|
May mediate extracellular signals to regulate transcription in differentiating cells. Nicotiana tabacum (taxid: 4097) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P43289|KSG3_ARATH Shaggy-related protein kinase gamma OS=Arabidopsis thaliana GN=ASK3 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 628 bits (1619), Expect = e-179, Method: Compositional matrix adjust.
Identities = 292/387 (75%), Positives = 336/387 (86%), Gaps = 6/387 (1%)
Query: 6 LGNGGVGSSRSVNGFKSSSSSVDWLGREMLEMRLRDQVDNDEDRDSEPDIIDGVGAETGH 65
+ + G+ S +V + + D L EM +M+++D D++ E I++G ETGH
Sbjct: 1 MASVGIEPSAAVRESTGNVTDADRLPEEMKDMKIQD------DKEMEATIVNGNVTETGH 54
Query: 66 VIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRE 125
+I TTIGGRNG KQ +SY+AE VVG GSFGVVFQAKC ETGE VAIKKVLQD+RYKNRE
Sbjct: 55 IIVTTIGGRNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGETVAIKKVLQDRRYKNRE 114
Query: 126 LQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYV 185
LQ M++LDHPN+V+LKHCFFSTT+K+ELYLNLVLEYVPETV+R+ ++Y++++QRMPL+YV
Sbjct: 115 LQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHYNKLNQRMPLVYV 174
Query: 186 KLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYI 245
KLYTYQI R+L+YIH CIG+CHRDIKPQNLLVNPHTHQ+KLCDFGSAKVLVKGEPN+SYI
Sbjct: 175 KLYTYQIFRSLSYIHRCIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYI 234
Query: 246 CSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPT 305
CSRYYRAPELIFGATEYTTAID+WS GCV+AELLLGQPLFPGESGVDQLVEIIKVLGTPT
Sbjct: 235 CSRYYRAPELIFGATEYTTAIDVWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPT 294
Query: 306 REEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH 365
REEIKCMNPNYTEFKFPQIK HPWHK+F KR+PPEAVDLV R QYSPNLRC AL++ VH
Sbjct: 295 REEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCAALDSLVH 354
Query: 366 PFFDELRDPNTRLPNGRPLPPLFNFKP 392
PFFDELRDPN RLPNGR LPPLFNFKP
Sbjct: 355 PFFDELRDPNARLPNGRFLPPLFNFKP 381
|
May mediate extracellular signals to regulate transcription in differentiating cells. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P51137|MSK1_MEDSA Glycogen synthase kinase-3 homolog MsK-1 OS=Medicago sativa GN=MSK-1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 624 bits (1608), Expect = e-178, Method: Compositional matrix adjust.
Identities = 297/389 (76%), Positives = 330/389 (84%), Gaps = 7/389 (1%)
Query: 4 ASLGNGGVGSSRSVNGFKSSSSSVDWLGREMLEMRLRDQVDNDEDRDSEPDIIDGVGAET 63
AS+G R V G D L EM +M++RD DR+ E ++DG G ET
Sbjct: 2 ASVGVAPTSGFREVLG-DGEIGVDDILPEEMSDMKIRD------DREMEATVVDGNGTET 54
Query: 64 GHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN 123
GH+I TTIGGRNG KQ +SY+AE VVG GSFGVVFQAKC ETGE VAIKKVLQDKRYKN
Sbjct: 55 GHIIVTTIGGRNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGETVAIKKVLQDKRYKN 114
Query: 124 RELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLI 183
RELQ M++LDHPN+V+LKHCFFSTT+K+ELYLNLVLEYVPETV+R+ ++YS+++QRMP+I
Sbjct: 115 RELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHYSKLNQRMPMI 174
Query: 184 YVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVS 243
YVKLYTYQI RAL+YIH CIG+CHRDIKPQNLLVNPHTHQ+KLCDFGSAKVLVKGEPN+S
Sbjct: 175 YVKLYTYQIFRALSYIHRCIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNIS 234
Query: 244 YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGT 303
YICSRYYRAPELIFGATEYTTAID+WS GCV+AELLLGQPLFPGE GVDQLVEIIKVLGT
Sbjct: 235 YICSRYYRAPELIFGATEYTTAIDVWSVGCVLAELLLGQPLFPGERGVDQLVEIIKVLGT 294
Query: 304 PTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEAC 363
PTREEIKCMNPNYTEFKFPQIK HPWHK+F KR+P EAVDLV R QYSPNLRC AL+
Sbjct: 295 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPAEAVDLVSRLLQYSPNLRCQALDCL 354
Query: 364 VHPFFDELRDPNTRLPNGRPLPPLFNFKP 392
HPFFDELRDPN RLP GR LPPLFNFKP
Sbjct: 355 THPFFDELRDPNARLPTGRFLPPLFNFKP 383
|
Medicago sativa (taxid: 3879) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q96287|KSG8_ARATH Shaggy-related protein kinase theta OS=Arabidopsis thaliana GN=ASK8 PE=2 SV=3 | Back alignment and function description |
|---|
Score = 615 bits (1586), Expect = e-175, Method: Compositional matrix adjust.
Identities = 280/364 (76%), Positives = 322/364 (88%), Gaps = 1/364 (0%)
Query: 28 DWLGREMLEMRLRDQVD-NDEDRDSEPDIIDGVGAETGHVIRTTIGGRNGNSKQKVSYIA 86
D L M+EM++RD+ + N ED+D E +++G G ETG VI TT+GGR+G KQ +SY+A
Sbjct: 81 DQLPDVMIEMKIRDERNANREDKDMETTVVNGSGTETGQVITTTVGGRDGKPKQTISYMA 140
Query: 87 EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFS 146
+ VVGTGSFGVVFQAKC ETGE VAIKKVLQDKRYKNRELQIM++ DHPN+V L+H FFS
Sbjct: 141 QRVVGTGSFGVVFQAKCLETGEQVAIKKVLQDKRYKNRELQIMRLQDHPNVVRLRHSFFS 200
Query: 147 TTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGIC 206
TTDK+ELYLNLVLEYVPETV R +++Y++++Q MP+I+V+LYTYQICRAL Y+H +G+C
Sbjct: 201 TTDKDELYLNLVLEYVPETVYRASKHYTKMNQHMPIIFVQLYTYQICRALNYLHRVVGVC 260
Query: 207 HRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAI 266
HRDIKPQNLLVNP THQLK+CDFGSAK+LV GEPN+SYICSRYYRAPELIFGATEYT AI
Sbjct: 261 HRDIKPQNLLVNPQTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFGATEYTNAI 320
Query: 267 DIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKP 326
D+WS GCVMAELLLGQPLFPGESG+DQLVEIIK+LGTPTREEI+CMNPNYTEFKFPQIK
Sbjct: 321 DMWSGGCVMAELLLGQPLFPGESGIDQLVEIIKILGTPTREEIRCMNPNYTEFKFPQIKA 380
Query: 327 HPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPNGRPLPP 386
HPWHK+F KR+PPEAVDLV R QYSPNLRCTALEAC HPFFD+LRDPN LPNGR LPP
Sbjct: 381 HPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACAHPFFDDLRDPNVSLPNGRALPP 440
Query: 387 LFNF 390
LFNF
Sbjct: 441 LFNF 444
|
May mediate extracellular signals to regulate transcription in differentiating cells. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 394 | ||||||
| 449460309 | 428 | PREDICTED: shaggy-related protein kinase | 0.994 | 0.915 | 0.964 | 0.0 | |
| 224119932 | 422 | predicted protein [Populus trichocarpa] | 0.994 | 0.928 | 0.961 | 0.0 | |
| 224129720 | 422 | predicted protein [Populus trichocarpa] | 0.992 | 0.926 | 0.961 | 0.0 | |
| 225465185 | 422 | PREDICTED: shaggy-related protein kinase | 0.994 | 0.928 | 0.961 | 0.0 | |
| 359806970 | 420 | uncharacterized protein LOC100799387 [Gl | 0.941 | 0.883 | 0.957 | 0.0 | |
| 359806021 | 420 | uncharacterized protein LOC100820098 [Gl | 0.941 | 0.883 | 0.943 | 0.0 | |
| 116787454 | 424 | unknown [Picea sitchensis] | 0.994 | 0.924 | 0.888 | 0.0 | |
| 297849298 | 421 | hypothetical protein ARALYDRAFT_471093 [ | 0.992 | 0.928 | 0.877 | 0.0 | |
| 15218288 | 421 | Shaggy-related protein kinase kappa [Ara | 0.992 | 0.928 | 0.880 | 0.0 | |
| 357445263 | 428 | Glycogen synthase kinase-3-like protein | 0.994 | 0.915 | 0.912 | 0.0 |
| >gi|449460309|ref|XP_004147888.1| PREDICTED: shaggy-related protein kinase kappa-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 798 bits (2062), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 378/392 (96%), Positives = 385/392 (98%)
Query: 1 MASASLGNGGVGSSRSVNGFKSSSSSVDWLGREMLEMRLRDQVDNDEDRDSEPDIIDGVG 60
MASASLGNGGVGSSRS+NGFK SSSSVDWLGREMLEMRLRD+ D DEDRDSEPDIIDGVG
Sbjct: 7 MASASLGNGGVGSSRSINGFKGSSSSVDWLGREMLEMRLRDKTDTDEDRDSEPDIIDGVG 66
Query: 61 AETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR 120
AE GHVIRTTIGGRNG SKQ +SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR
Sbjct: 67 AEAGHVIRTTIGGRNGQSKQNISYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR 126
Query: 121 YKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRM 180
YKNRELQIMQMLDHPNIV+LKHCFFSTTDKEE+YLNLVLE+VPETVNRIARNYSRI QRM
Sbjct: 127 YKNRELQIMQMLDHPNIVSLKHCFFSTTDKEEVYLNLVLEFVPETVNRIARNYSRISQRM 186
Query: 181 PLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP 240
PLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP
Sbjct: 187 PLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP 246
Query: 241 NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV 300
NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLG+PLFPGESGVDQLVEIIKV
Sbjct: 247 NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGKPLFPGESGVDQLVEIIKV 306
Query: 301 LGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTAL 360
LGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTAL
Sbjct: 307 LGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTAL 366
Query: 361 EACVHPFFDELRDPNTRLPNGRPLPPLFNFKP 392
EACVHPFFDELRDPNTRLPNGRPLPPLFNFKP
Sbjct: 367 EACVHPFFDELRDPNTRLPNGRPLPPLFNFKP 398
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224119932|ref|XP_002331098.1| predicted protein [Populus trichocarpa] gi|222872826|gb|EEF09957.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 790 bits (2040), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 377/392 (96%), Positives = 384/392 (97%)
Query: 1 MASASLGNGGVGSSRSVNGFKSSSSSVDWLGREMLEMRLRDQVDNDEDRDSEPDIIDGVG 60
M+SASLGNGGVGSSRSVNGFKSSSSS+DWLGREMLEMRLRD+VD+DEDRDSEPDIIDGVG
Sbjct: 1 MSSASLGNGGVGSSRSVNGFKSSSSSMDWLGREMLEMRLRDKVDHDEDRDSEPDIIDGVG 60
Query: 61 AETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR 120
AE GHVIRTTIGGRNG S+Q VSYIAEHVVGTGSFGVV QAKCRETGEIVAIKKVLQDKR
Sbjct: 61 AEAGHVIRTTIGGRNGQSRQTVSYIAEHVVGTGSFGVVVQAKCRETGEIVAIKKVLQDKR 120
Query: 121 YKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRM 180
YKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSR + RM
Sbjct: 121 YKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRNNPRM 180
Query: 181 PLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP 240
PLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNP THQLKLCDFGSAKVLVKGEP
Sbjct: 181 PLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPSTHQLKLCDFGSAKVLVKGEP 240
Query: 241 NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV 300
NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV
Sbjct: 241 NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV 300
Query: 301 LGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTAL 360
LGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTAL
Sbjct: 301 LGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTAL 360
Query: 361 EACVHPFFDELRDPNTRLPNGRPLPPLFNFKP 392
EAC+HPFFDELRDP TRLPNGRPLPPLFNFKP
Sbjct: 361 EACIHPFFDELRDPATRLPNGRPLPPLFNFKP 392
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224129720|ref|XP_002328786.1| predicted protein [Populus trichocarpa] gi|222839084|gb|EEE77435.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 789 bits (2037), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 376/391 (96%), Positives = 382/391 (97%)
Query: 1 MASASLGNGGVGSSRSVNGFKSSSSSVDWLGREMLEMRLRDQVDNDEDRDSEPDIIDGVG 60
M+SASLGNGGVGSSRSVNGFKSSSSSVDWLGREMLEMRLRD+VD+DEDRDSEPDIIDGVG
Sbjct: 1 MSSASLGNGGVGSSRSVNGFKSSSSSVDWLGREMLEMRLRDKVDHDEDRDSEPDIIDGVG 60
Query: 61 AETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR 120
AE GHVIRTTIGGRNG S+Q +SYIAEHVVGTGSFGVV QAKCRETGEIVAIKKVLQDKR
Sbjct: 61 AEAGHVIRTTIGGRNGQSRQTISYIAEHVVGTGSFGVVVQAKCRETGEIVAIKKVLQDKR 120
Query: 121 YKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRM 180
YKNRELQIMQMLDHPNIVALKH FFSTTDKEELYLNLVLEYVP+TVNRIARNYSR QRM
Sbjct: 121 YKNRELQIMQMLDHPNIVALKHSFFSTTDKEELYLNLVLEYVPDTVNRIARNYSRNSQRM 180
Query: 181 PLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP 240
PLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNP THQLKLCDFGSAKVLVKGEP
Sbjct: 181 PLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPSTHQLKLCDFGSAKVLVKGEP 240
Query: 241 NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV 300
NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV
Sbjct: 241 NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV 300
Query: 301 LGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTAL 360
LGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTAL
Sbjct: 301 LGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTAL 360
Query: 361 EACVHPFFDELRDPNTRLPNGRPLPPLFNFK 391
EACVHPFFDELRDP TRLPNGRPLPPLFNFK
Sbjct: 361 EACVHPFFDELRDPTTRLPNGRPLPPLFNFK 391
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225465185|ref|XP_002263398.1| PREDICTED: shaggy-related protein kinase kappa [Vitis vinifera] gi|297739515|emb|CBI29697.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 768 bits (1982), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 377/392 (96%), Positives = 385/392 (98%)
Query: 1 MASASLGNGGVGSSRSVNGFKSSSSSVDWLGREMLEMRLRDQVDNDEDRDSEPDIIDGVG 60
MASASLG+GGVGSSR+ NGFK SSSSVDWLGREMLEMRLRD+VD D+DRDSEPDIIDGVG
Sbjct: 1 MASASLGHGGVGSSRTANGFKGSSSSVDWLGREMLEMRLRDRVDQDDDRDSEPDIIDGVG 60
Query: 61 AETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR 120
AE GHVIRTT GGRNG SKQ VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR
Sbjct: 61 AEAGHVIRTTFGGRNGQSKQTVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR 120
Query: 121 YKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRM 180
YKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLE+VPETVNRIARNYSRI+QRM
Sbjct: 121 YKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEFVPETVNRIARNYSRINQRM 180
Query: 181 PLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP 240
PLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP
Sbjct: 181 PLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP 240
Query: 241 NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV 300
NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV
Sbjct: 241 NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV 300
Query: 301 LGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTAL 360
LGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTAL
Sbjct: 301 LGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTAL 360
Query: 361 EACVHPFFDELRDPNTRLPNGRPLPPLFNFKP 392
EAC+HPFFDELRDP+TRLPNGRPLPPLFNFKP
Sbjct: 361 EACIHPFFDELRDPSTRLPNGRPLPPLFNFKP 392
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359806970|ref|NP_001241073.1| uncharacterized protein LOC100799387 [Glycine max] gi|255641011|gb|ACU20785.1| unknown [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 751 bits (1938), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 358/374 (95%), Positives = 365/374 (97%), Gaps = 3/374 (0%)
Query: 19 GFKSSSSSVDWLGREMLEMRLRDQVDNDEDRDSEPDIIDGVGAETGHVIRTTIGGRNGNS 78
GF+ SSSSVDWLGREMLEMRLRD D DRDSEPDIIDGVGAETGHVIRT+IGGRNG S
Sbjct: 20 GFRGSSSSVDWLGREMLEMRLRDHED---DRDSEPDIIDGVGAETGHVIRTSIGGRNGQS 76
Query: 79 KQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIV 138
KQ VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIV
Sbjct: 77 KQNVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIV 136
Query: 139 ALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
AL+HCFFSTTDKEE+YLNLVLEYVPETVNRIAR+YSRI+QRMPLIYVKLYTYQICRALAY
Sbjct: 137 ALRHCFFSTTDKEEVYLNLVLEYVPETVNRIARSYSRINQRMPLIYVKLYTYQICRALAY 196
Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFG 258
IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFG
Sbjct: 197 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFG 256
Query: 259 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 318
ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE
Sbjct: 257 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 316
Query: 319 FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRL 378
FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEAC+HPFFDELRDPNTRL
Sbjct: 317 FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACIHPFFDELRDPNTRL 376
Query: 379 PNGRPLPPLFNFKP 392
PN RPLPPLFNFKP
Sbjct: 377 PNARPLPPLFNFKP 390
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359806021|ref|NP_001240918.1| uncharacterized protein LOC100820098 [Glycine max] gi|255639602|gb|ACU20095.1| unknown [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 742 bits (1916), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 353/374 (94%), Positives = 364/374 (97%), Gaps = 3/374 (0%)
Query: 19 GFKSSSSSVDWLGREMLEMRLRDQVDNDEDRDSEPDIIDGVGAETGHVIRTTIGGRNGNS 78
GF+ SSSSVDWLGREMLEM LRD D RDSEPDIIDG+GAETGHVIRT++GGRNG S
Sbjct: 20 GFRGSSSSVDWLGREMLEMSLRDHEDV---RDSEPDIIDGLGAETGHVIRTSVGGRNGQS 76
Query: 79 KQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIV 138
KQ VSYI+EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIV
Sbjct: 77 KQNVSYISEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIV 136
Query: 139 ALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
AL+HCF+STTDKEE+YLNLVLEYVPETVNRIAR+YSRI+QRMPLIYVKLYTYQICRALAY
Sbjct: 137 ALRHCFYSTTDKEEVYLNLVLEYVPETVNRIARSYSRINQRMPLIYVKLYTYQICRALAY 196
Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFG 258
IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFG
Sbjct: 197 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFG 256
Query: 259 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 318
ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE
Sbjct: 257 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 316
Query: 319 FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRL 378
FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEAC+HPFFDELRDPNTRL
Sbjct: 317 FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACIHPFFDELRDPNTRL 376
Query: 379 PNGRPLPPLFNFKP 392
PNGRPLPPLFNFKP
Sbjct: 377 PNGRPLPPLFNFKP 390
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|116787454|gb|ABK24513.1| unknown [Picea sitchensis] | Back alignment and taxonomy information |
|---|
Score = 741 bits (1913), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 350/394 (88%), Positives = 375/394 (95%), Gaps = 2/394 (0%)
Query: 1 MASASLG-NGGVGSSRSVNGFKSSSSSVDWLGREMLEMRLRD-QVDNDEDRDSEPDIIDG 58
MASASLG +GGVGSSR++N K +SVDWLGREMLEMR+RD ++D D+++D EP I+DG
Sbjct: 1 MASASLGHSGGVGSSRTINRLKGPVNSVDWLGREMLEMRIRDNKLDVDDEKDIEPAIVDG 60
Query: 59 VGAETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD 118
+GAE+GH+I TTIGGRNG KQ +SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD
Sbjct: 61 MGAESGHIIATTIGGRNGQPKQTISYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD 120
Query: 119 KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQ 178
KRYKNRELQIM MLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIAR+Y+R++Q
Sbjct: 121 KRYKNRELQIMHMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARHYNRMNQ 180
Query: 179 RMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG 238
RMPLIYVKLY+YQICR+LAYIHNC+GICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG
Sbjct: 181 RMPLIYVKLYSYQICRSLAYIHNCVGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG 240
Query: 239 EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEII 298
EPN+SYICSRYYRAPELIFGATEYTTAID+WSTGCVMAELLLGQPLFPGESGVDQLVEII
Sbjct: 241 EPNISYICSRYYRAPELIFGATEYTTAIDMWSTGCVMAELLLGQPLFPGESGVDQLVEII 300
Query: 299 KVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCT 358
KVLGTPTREEIKCMNPNYTEFKFPQIK HPWHKVFQKRLPPEAVDLV R QYSPNLRCT
Sbjct: 301 KVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKVFQKRLPPEAVDLVSRLLQYSPNLRCT 360
Query: 359 ALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKP 392
ALEAC+HPFFDELRDPNTRLPNGRPLPPLFNFKP
Sbjct: 361 ALEACIHPFFDELRDPNTRLPNGRPLPPLFNFKP 394
|
Source: Picea sitchensis Species: Picea sitchensis Genus: Picea Family: Pinaceae Order: Coniferales Class: Coniferopsida Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297849298|ref|XP_002892530.1| hypothetical protein ARALYDRAFT_471093 [Arabidopsis lyrata subsp. lyrata] gi|297338372|gb|EFH68789.1| hypothetical protein ARALYDRAFT_471093 [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 736 bits (1901), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 344/392 (87%), Positives = 370/392 (94%), Gaps = 1/392 (0%)
Query: 1 MASASLGNGGVGSSRSVNGFKSSSSSVDWLGREMLEMRLRDQVDNDEDRDSEPDIIDGVG 60
MAS+ LGNG VG+SRS G KSSSSSVDWL R++ E R+RD+V+ D++RDSEPDIIDG G
Sbjct: 1 MASSGLGNG-VGTSRSAKGLKSSSSSVDWLTRDLAETRIRDKVETDDERDSEPDIIDGAG 59
Query: 61 AETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR 120
AE GHVIRTT+ GRNG S+Q VSYI+EHVVGTGSFG+VFQAKCRETGE+VAIKKVLQDKR
Sbjct: 60 AEPGHVIRTTLRGRNGQSRQTVSYISEHVVGTGSFGMVFQAKCRETGEVVAIKKVLQDKR 119
Query: 121 YKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRM 180
YKNRELQIMQMLDHPN+VALKH FFS TD EE+YLNLVLE+VPETVNR+AR+YSR +Q M
Sbjct: 120 YKNRELQIMQMLDHPNVVALKHSFFSRTDNEEVYLNLVLEFVPETVNRVARSYSRTNQLM 179
Query: 181 PLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP 240
PLIYVKLYTYQICRALAYIHN G+CHRDIKPQNLLVNPHTHQLK+CDFGSAKVLVKGEP
Sbjct: 180 PLIYVKLYTYQICRALAYIHNSFGLCHRDIKPQNLLVNPHTHQLKICDFGSAKVLVKGEP 239
Query: 241 NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV 300
NVSYICSRYYRAPELIFGA+EY+TAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV
Sbjct: 240 NVSYICSRYYRAPELIFGASEYSTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV 299
Query: 301 LGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTAL 360
LGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDL+CRFFQYSPNLRCTAL
Sbjct: 300 LGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLLCRFFQYSPNLRCTAL 359
Query: 361 EACVHPFFDELRDPNTRLPNGRPLPPLFNFKP 392
EAC+HP FDELRDPNTRLPNGRPLPPLFNFKP
Sbjct: 360 EACIHPLFDELRDPNTRLPNGRPLPPLFNFKP 391
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|15218288|ref|NP_172455.1| Shaggy-related protein kinase kappa [Arabidopsis thaliana] gi|30681397|ref|NP_849627.1| Shaggy-related protein kinase kappa [Arabidopsis thaliana] gi|42571421|ref|NP_973801.1| Shaggy-related protein kinase kappa [Arabidopsis thaliana] gi|79317477|ref|NP_001031013.1| Shaggy-related protein kinase kappa [Arabidopsis thaliana] gi|145323818|ref|NP_001077498.1| Shaggy-related protein kinase kappa [Arabidopsis thaliana] gi|145323820|ref|NP_001077499.1| Shaggy-related protein kinase kappa [Arabidopsis thaliana] gi|38503402|sp|Q39019.2|KSG10_ARATH RecName: Full=Shaggy-related protein kinase kappa; AltName: Full=ASK-kappa; Short=AtK-1 gi|20260176|gb|AAM12986.1| shaggy-like protien kinase, kappa [Arabidopsis thaliana] gi|23197848|gb|AAN15451.1| shaggy-like protien kinase, kappa [Arabidopsis thaliana] gi|332190380|gb|AEE28501.1| Shaggy-related protein kinase kappa [Arabidopsis thaliana] gi|332190381|gb|AEE28502.1| Shaggy-related protein kinase kappa [Arabidopsis thaliana] gi|332190382|gb|AEE28503.1| Shaggy-related protein kinase kappa [Arabidopsis thaliana] gi|332190383|gb|AEE28504.1| Shaggy-related protein kinase kappa [Arabidopsis thaliana] gi|332190384|gb|AEE28505.1| Shaggy-related protein kinase kappa [Arabidopsis thaliana] gi|332190385|gb|AEE28506.1| Shaggy-related protein kinase kappa [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 736 bits (1900), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 345/392 (88%), Positives = 369/392 (94%), Gaps = 1/392 (0%)
Query: 1 MASASLGNGGVGSSRSVNGFKSSSSSVDWLGREMLEMRLRDQVDNDEDRDSEPDIIDGVG 60
MAS+ LGNG VG+SRS G KSSSSSVDWL R++ E R+RD+V+ D++RDSEPDIIDG G
Sbjct: 1 MASSGLGNG-VGTSRSAKGLKSSSSSVDWLTRDLAETRIRDKVETDDERDSEPDIIDGAG 59
Query: 61 AETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR 120
AE GHVIRTT+ GRNG S+Q VSYI+EHVVGTGSFG+VFQAKCRETGE+VAIKKVLQDKR
Sbjct: 60 AEPGHVIRTTLRGRNGQSRQTVSYISEHVVGTGSFGMVFQAKCRETGEVVAIKKVLQDKR 119
Query: 121 YKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRM 180
YKNRELQIMQMLDHPN VALKH FFS TD EE+YLNLVLE+VPETVNR+AR+YSR +Q M
Sbjct: 120 YKNRELQIMQMLDHPNAVALKHSFFSRTDNEEVYLNLVLEFVPETVNRVARSYSRTNQLM 179
Query: 181 PLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP 240
PLIYVKLYTYQICRALAYIHN G+CHRDIKPQNLLVNPHTHQLK+CDFGSAKVLVKGEP
Sbjct: 180 PLIYVKLYTYQICRALAYIHNSFGLCHRDIKPQNLLVNPHTHQLKICDFGSAKVLVKGEP 239
Query: 241 NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV 300
NVSYICSRYYRAPELIFGA+EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV
Sbjct: 240 NVSYICSRYYRAPELIFGASEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV 299
Query: 301 LGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTAL 360
LGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDL+CRFFQYSPNLRCTAL
Sbjct: 300 LGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLLCRFFQYSPNLRCTAL 359
Query: 361 EACVHPFFDELRDPNTRLPNGRPLPPLFNFKP 392
EAC+HP FDELRDPNTRLPNGRPLPPLFNFKP
Sbjct: 360 EACIHPLFDELRDPNTRLPNGRPLPPLFNFKP 391
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357445263|ref|XP_003592909.1| Glycogen synthase kinase-3-like protein [Medicago truncatula] gi|92893880|gb|ABE91930.1| Protein kinase [Medicago truncatula] gi|355481957|gb|AES63160.1| Glycogen synthase kinase-3-like protein [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 734 bits (1896), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 363/398 (91%), Positives = 372/398 (93%), Gaps = 6/398 (1%)
Query: 1 MASASLGNGGVGSSRSVNGFKSSSSS-VDWLGREMLEMRLR-----DQVDNDEDRDSEPD 54
MASASLGNGG+GSS ++SS VDWLGREML M L D D D+ R+SEPD
Sbjct: 1 MASASLGNGGIGSSSRSAAALRAASSSVDWLGREMLHMNLNRDHDHDDDDEDDARESEPD 60
Query: 55 IIDGVGAETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKK 114
IIDGVGAETGHVIRT+I RNG SKQ VSYIAEHVVGTGSFG VFQAKCRETGEIVAIKK
Sbjct: 61 IIDGVGAETGHVIRTSIAARNGQSKQNVSYIAEHVVGTGSFGTVFQAKCRETGEIVAIKK 120
Query: 115 VLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYS 174
VLQDKRYKNRELQIMQMLDHPNIVAL+HCFFSTTDKEELYLNLVLEYVPETVNRIARNYS
Sbjct: 121 VLQDKRYKNRELQIMQMLDHPNIVALRHCFFSTTDKEELYLNLVLEYVPETVNRIARNYS 180
Query: 175 RIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV 234
RI+QRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV
Sbjct: 181 RINQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV 240
Query: 235 LVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQL 294
LVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQL
Sbjct: 241 LVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQL 300
Query: 295 VEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPN 354
VEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPN
Sbjct: 301 VEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPN 360
Query: 355 LRCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKP 392
LRCTALEAC+HPFFDELRDPNTRLPNGRPLPPLFNFKP
Sbjct: 361 LRCTALEACIHPFFDELRDPNTRLPNGRPLPPLFNFKP 398
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 394 | ||||||
| TAIR|locus:2024341 | 421 | SK41 "shaggy-like protein kina | 0.928 | 0.869 | 0.857 | 3.6e-176 | |
| TAIR|locus:2832141 | 405 | SK 11 "AT5G26751" [Arabidopsis | 0.913 | 0.888 | 0.765 | 1.3e-155 | |
| TAIR|locus:2222642 | 410 | SK13 "shaggy-like kinase 13" [ | 0.890 | 0.856 | 0.775 | 4.4e-155 | |
| TAIR|locus:2074464 | 409 | ATSK12 [Arabidopsis thaliana ( | 0.911 | 0.877 | 0.756 | 3.1e-154 | |
| TAIR|locus:2126993 | 472 | SK32 "shaggy-like protein kina | 0.921 | 0.769 | 0.733 | 9.8e-151 | |
| TAIR|locus:2202255 | 407 | GSK1 "GSK3/SHAGGY-like protein | 0.895 | 0.867 | 0.722 | 2.5e-145 | |
| TAIR|locus:2052861 | 412 | SKdZeta "SHAGGY-related protei | 0.895 | 0.856 | 0.722 | 5.1e-145 | |
| TAIR|locus:2124082 | 380 | BIN2 "BRASSINOSTEROID-INSENSIT | 0.875 | 0.907 | 0.718 | 6.8e-143 | |
| TAIR|locus:2098896 | 438 | AT3G61160 [Arabidopsis thalian | 0.906 | 0.815 | 0.663 | 7.9e-133 | |
| UNIPROTKB|Q91757 | 420 | gsk3b "Glycogen synthase kinas | 0.840 | 0.788 | 0.653 | 5.6e-116 |
| TAIR|locus:2024341 SK41 "shaggy-like protein kinase 41" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1711 (607.4 bits), Expect = 3.6e-176, P = 3.6e-176
Identities = 314/366 (85%), Positives = 334/366 (91%)
Query: 27 VDWLGREMLEMRLRDQVDNDEDRDSEPDIIDGVGAETGHVIRTTIGGRNGNSKQKVSYIA 86
VDWL R++ E R+RD+V+ D++RDSEPDIIDG GAE GHVIRTT+ GRNG S+Q VSYI+
Sbjct: 26 VDWLTRDLAETRIRDKVETDDERDSEPDIIDGAGAEPGHVIRTTLRGRNGQSRQTVSYIS 85
Query: 87 EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFS 146
EHVVGTGSFG+VFQAKCRETGE+VAIKKVLQDKRYKNRELQIMQMLDHPN VALKH FFS
Sbjct: 86 EHVVGTGSFGMVFQAKCRETGEVVAIKKVLQDKRYKNRELQIMQMLDHPNAVALKHSFFS 145
Query: 147 TTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGIC 206
TD TVNR+AR+YSR +Q MPLIYVKLYTYQICRALAYIHN G+C
Sbjct: 146 RTDNEEVYLNLVLEFVPETVNRVARSYSRTNQLMPLIYVKLYTYQICRALAYIHNSFGLC 205
Query: 207 HRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAI 266
HRDIKPQNLLVNPHTHQLK+CDFGSAKVLVKGEPNVSYICSRYYRAPELIFGA+EYTTAI
Sbjct: 206 HRDIKPQNLLVNPHTHQLKICDFGSAKVLVKGEPNVSYICSRYYRAPELIFGASEYTTAI 265
Query: 267 DIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKP 326
DIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKP
Sbjct: 266 DIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKP 325
Query: 327 HPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPNGRPLPP 386
HPWHKVFQKRLPPEAVDL+CRFFQYSPNLRCTALEAC+HP FDELRDPNTRLPNGRPLPP
Sbjct: 326 HPWHKVFQKRLPPEAVDLLCRFFQYSPNLRCTALEACIHPLFDELRDPNTRLPNGRPLPP 385
Query: 387 LFNFKP 392
LFNFKP
Sbjct: 386 LFNFKP 391
|
|
| TAIR|locus:2832141 SK 11 "AT5G26751" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1517 (539.1 bits), Expect = 1.3e-155, P = 1.3e-155
Identities = 280/366 (76%), Positives = 313/366 (85%)
Query: 27 VDWLGREMLEMRLRDQVDNDEDRDSEPDIIDGVGAETGHVIRTTIGGRNGNSKQKVSYIA 86
VD L EM +M++RD D++ E ++DG G ETGH+I TTIGGRNG KQ +SY+A
Sbjct: 18 VDKLPEEMNDMKIRD------DKEMEATVVDGNGTETGHIIVTTIGGRNGQPKQTISYMA 71
Query: 87 EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFS 146
E VVG GSFGVVFQAKC ETGE VAIKKVLQD+RYKNRELQ M++LDHPN+V+LKHCFFS
Sbjct: 72 ERVVGHGSFGVVFQAKCLETGETVAIKKVLQDRRYKNRELQTMRLLDHPNVVSLKHCFFS 131
Query: 147 TTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGIC 206
TT+K TV+R+ ++Y++++QRMPLIYVKLYTYQI RAL+YIH CIG+C
Sbjct: 132 TTEKDELYLNLVLEYVPETVHRVIKHYNKLNQRMPLIYVKLYTYQIFRALSYIHRCIGVC 191
Query: 207 HRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAI 266
HRDIKPQNLLVNPHTHQ+KLCDFGSAKVLVKGEPN+SYICSRYYRAPELIFGATEYTTAI
Sbjct: 192 HRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAI 251
Query: 267 DIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKP 326
D+WS GCV+AELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIK
Sbjct: 252 DVWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKA 311
Query: 327 HPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPNGRPLPP 386
HPWHK+F KR+PPEAVDLV R QYSPNLR AL+ VHPFFDELRDPN RLPNGR LPP
Sbjct: 312 HPWHKIFHKRMPPEAVDLVSRLLQYSPNLRSAALDTLVHPFFDELRDPNARLPNGRFLPP 371
Query: 387 LFNFKP 392
LFNFKP
Sbjct: 372 LFNFKP 377
|
|
| TAIR|locus:2222642 SK13 "shaggy-like kinase 13" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1512 (537.3 bits), Expect = 4.4e-155, P = 4.4e-155
Identities = 277/357 (77%), Positives = 308/357 (86%)
Query: 36 EMRLRDQVDNDEDRDSEPDIIDGVGAETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSF 95
EM+++D D++ E ++DG G ETGH+I TTIGG+NG KQ +SY+AE +VG GSF
Sbjct: 32 EMKIKD------DKEMEAAVVDGNGTETGHIIVTTIGGKNGQPKQTISYMAERIVGQGSF 85
Query: 96 GVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKXXXXX 155
G+VFQAKC ETGE VAIKKVLQDKRYKNRELQ M++LDHPN+V+LKHCFFSTT+K
Sbjct: 86 GIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYL 145
Query: 156 XXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNL 215
TV R++++YSR +QRMP+IYVKLYTYQICRALAYIH +G+CHRDIKPQNL
Sbjct: 146 NLVLEYVPETVYRVSKHYSRANQRMPIIYVKLYTYQICRALAYIHGGVGVCHRDIKPQNL 205
Query: 216 LVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVM 275
LVNPHTHQ+KLCDFGSAKVLVKGEPN+SYICSRYYRAPELIFGATEYTT IDIWS GCV+
Sbjct: 206 LVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTTIDIWSAGCVL 265
Query: 276 AELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQK 335
AELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIK HPWHK+F K
Sbjct: 266 AELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHK 325
Query: 336 RLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKP 392
R PPEAVDLV R QYSPNLR TA+EA VHPFFDELRDPNTRLPNGR LPPLFNFKP
Sbjct: 326 RTPPEAVDLVSRLLQYSPNLRSTAMEAIVHPFFDELRDPNTRLPNGRALPPLFNFKP 382
|
|
| TAIR|locus:2074464 ATSK12 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1504 (534.5 bits), Expect = 3.1e-154, P = 3.1e-154
Identities = 276/365 (75%), Positives = 313/365 (85%)
Query: 28 DWLGREMLEMRLRDQVDNDEDRDSEPDIIDGVGAETGHVIRTTIGGRNGNSKQKVSYIAE 87
D L EM +M+++D D++ E I++G ETGH+I TTIGGRNG KQ +SY+AE
Sbjct: 23 DRLPEEMKDMKIQD------DKEMEATIVNGNVTETGHIIVTTIGGRNGQPKQTISYMAE 76
Query: 88 HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFST 147
VVG GSFGVVFQAKC ETGE VAIKKVLQD+RYKNRELQ M++LDHPN+V+LKHCFFST
Sbjct: 77 RVVGHGSFGVVFQAKCLETGETVAIKKVLQDRRYKNRELQTMRLLDHPNVVSLKHCFFST 136
Query: 148 TDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICH 207
T+K TV+R+ ++Y++++QRMPL+YVKLYTYQI R+L+YIH CIG+CH
Sbjct: 137 TEKDELYLNLVLEYVPETVHRVIKHYNKLNQRMPLVYVKLYTYQIFRSLSYIHRCIGVCH 196
Query: 208 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAID 267
RDIKPQNLLVNPHTHQ+KLCDFGSAKVLVKGEPN+SYICSRYYRAPELIFGATEYTTAID
Sbjct: 197 RDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAID 256
Query: 268 IWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPH 327
+WS GCV+AELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIK H
Sbjct: 257 VWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAH 316
Query: 328 PWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPNGRPLPPL 387
PWHK+F KR+PPEAVDLV R QYSPNLRC AL++ VHPFFDELRDPN RLPNGR LPPL
Sbjct: 317 PWHKIFHKRMPPEAVDLVSRLLQYSPNLRCAALDSLVHPFFDELRDPNARLPNGRFLPPL 376
Query: 388 FNFKP 392
FNFKP
Sbjct: 377 FNFKP 381
|
|
| TAIR|locus:2126993 SK32 "shaggy-like protein kinase 32" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1471 (522.9 bits), Expect = 9.8e-151, P = 9.8e-151
Identities = 267/364 (73%), Positives = 308/364 (84%)
Query: 28 DWLGREMLEMRLRDQVD-NDEDRDSEPDIIDGVGAETGHVIRTTIGGRNGNSKQKVSYIA 86
D L M+EM++RD+ + N ED+D E +++G G ETG VI TT+GGR+G KQ +SY+A
Sbjct: 81 DQLPDVMIEMKIRDERNANREDKDMETTVVNGSGTETGQVITTTVGGRDGKPKQTISYMA 140
Query: 87 EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFS 146
+ VVGTGSFGVVFQAKC ETGE VAIKKVLQDKRYKNRELQIM++ DHPN+V L+H FFS
Sbjct: 141 QRVVGTGSFGVVFQAKCLETGEQVAIKKVLQDKRYKNRELQIMRLQDHPNVVRLRHSFFS 200
Query: 147 TTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGIC 206
TTDK TV R +++Y++++Q MP+I+V+LYTYQICRAL Y+H +G+C
Sbjct: 201 TTDKDELYLNLVLEYVPETVYRASKHYTKMNQHMPIIFVQLYTYQICRALNYLHRVVGVC 260
Query: 207 HRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAI 266
HRDIKPQNLLVNP THQLK+CDFGSAK+LV GEPN+SYICSRYYRAPELIFGATEYT AI
Sbjct: 261 HRDIKPQNLLVNPQTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFGATEYTNAI 320
Query: 267 DIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKP 326
D+WS GCVMAELLLGQPLFPGESG+DQLVEIIK+LGTPTREEI+CMNPNYTEFKFPQIK
Sbjct: 321 DMWSGGCVMAELLLGQPLFPGESGIDQLVEIIKILGTPTREEIRCMNPNYTEFKFPQIKA 380
Query: 327 HPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPNGRPLPP 386
HPWHK+F KR+PPEAVDLV R QYSPNLRCTALEAC HPFFD+LRDPN LPNGR LPP
Sbjct: 381 HPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACAHPFFDDLRDPNVSLPNGRALPP 440
Query: 387 LFNF 390
LFNF
Sbjct: 441 LFNF 444
|
|
| TAIR|locus:2202255 GSK1 "GSK3/SHAGGY-like protein kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1420 (504.9 bits), Expect = 2.5e-145, P = 2.5e-145
Identities = 255/353 (72%), Positives = 297/353 (84%)
Query: 39 LRDQVDNDEDRDSEPDIIDGVGAETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVV 98
L+ + + D D++ +I+G A TGH+I TTIGG+NG KQ +SY+AE VVGTGSFG+V
Sbjct: 25 LKRRPELDSDKEMSAAVIEGNDAVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIV 84
Query: 99 FQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKXXXXXXXX 158
FQAKC ETGE VAIKKVLQD+RYKNRELQ+M+ +DHPN+++LKHCFFSTT +
Sbjct: 85 FQAKCLETGESVAIKKVLQDRRYKNRELQLMRPMDHPNVISLKHCFFSTTSRDELFLNLV 144
Query: 159 XXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVN 218
T+ R+ R+Y+ +QRMP+ YVKLYTYQI R LAYIH G+CHRD+KPQNLLV+
Sbjct: 145 MEYVPETLYRVLRHYTSSNQRMPIFYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVD 204
Query: 219 PHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAEL 278
P THQ+KLCDFGSAKVLVKGEPN+SYICSRYYRAPELIFGATEYT +IDIWS GCV+AEL
Sbjct: 205 PLTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTASIDIWSAGCVLAEL 264
Query: 279 LLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLP 338
LLGQPLFPGE+ VDQLVEIIKVLGTPTREEI+CMNPNYT+F+FPQIK HPWHKVF KR+P
Sbjct: 265 LLGQPLFPGENSVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMP 324
Query: 339 PEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFK 391
PEA+DL R QYSP+LRCTALEAC HPFF+ELR+PN RLPNGRPLPPLFNFK
Sbjct: 325 PEAIDLASRLLQYSPSLRCTALEACAHPFFNELREPNARLPNGRPLPPLFNFK 377
|
|
| TAIR|locus:2052861 SKdZeta "SHAGGY-related protein kinase dZeta" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1417 (503.9 bits), Expect = 5.1e-145, P = 5.1e-145
Identities = 255/353 (72%), Positives = 297/353 (84%)
Query: 39 LRDQVDNDEDRDSEPDIIDGVGAETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVV 98
L+ + D D D++ +I+G A TGH+I TTIGG+NG KQ +SY+AE VVGTGSFG+V
Sbjct: 27 LKRRPDIDNDKEMSAAVIEGNDAVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIV 86
Query: 99 FQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKXXXXXXXX 158
FQAKC ETGE VAIKKVLQD+RYKNRELQ+M+++DHPN+V+LKHCFFSTT +
Sbjct: 87 FQAKCLETGESVAIKKVLQDRRYKNRELQLMRLMDHPNVVSLKHCFFSTTTRDELFLNLV 146
Query: 159 XXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVN 218
T+ R+ ++Y+ +QRMP+ YVKLYTYQI R LAYIH G+CHRD+KPQNLLV+
Sbjct: 147 MEYVPETLYRVLKHYTSSNQRMPIFYVKLYTYQIFRGLAYIHTAPGVCHRDVKPQNLLVD 206
Query: 219 PHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAEL 278
P THQ KLCDFGSAKVLVKGE N+SYICSRYYRAPELIFGATEYT++IDIWS GCV+AEL
Sbjct: 207 PLTHQCKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTSSIDIWSAGCVLAEL 266
Query: 279 LLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLP 338
LLGQPLFPGE+ VDQLVEIIKVLGTPTREEI+CMNPNYT+F+FPQIK HPWHKVF KR+P
Sbjct: 267 LLGQPLFPGENSVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMP 326
Query: 339 PEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFK 391
PEA+DL R QYSP+LRCTALEAC HPFF+ELR+PN RLPNGRPLPPLFNFK
Sbjct: 327 PEAIDLASRLLQYSPSLRCTALEACAHPFFNELREPNARLPNGRPLPPLFNFK 379
|
|
| TAIR|locus:2124082 BIN2 "BRASSINOSTEROID-INSENSITIVE 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1397 (496.8 bits), Expect = 6.8e-143, P = 6.8e-143
Identities = 248/345 (71%), Positives = 290/345 (84%)
Query: 47 EDRDSEPDIIDGVGAETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRET 106
+D++ ++DG TGH+I TTIGG+NG KQ +SY+AE VVGTGSFG+VFQAKC ET
Sbjct: 3 DDKEMPAAVVDGHDQVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLET 62
Query: 107 GEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTV 166
GE VAIKKVLQD+RYKNRELQ+M+++DHPN+V LKHCFFSTT K ++
Sbjct: 63 GETVAIKKVLQDRRYKNRELQLMRVMDHPNVVCLKHCFFSTTSKDELFLNLVMEYVPESL 122
Query: 167 NRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKL 226
R+ ++YS +QRMPL+YVKLY YQI R LAYIHN G+CHRD+KPQNLLV+P THQ+K+
Sbjct: 123 YRVLKHYSSANQRMPLVYVKLYMYQIFRGLAYIHNVAGVCHRDLKPQNLLVDPLTHQVKI 182
Query: 227 CDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFP 286
CDFGSAK LVKGE N+SYICSR+YRAPELIFGATEYTT+IDIWS GCV+AELLLGQPLFP
Sbjct: 183 CDFGSAKQLVKGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFP 242
Query: 287 GESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVC 346
GE+ VDQLVEIIKVLGTPTREEI+CMNP+YT+F+FPQIK HPWHK+F KR+PPEA+D
Sbjct: 243 GENAVDQLVEIIKVLGTPTREEIRCMNPHYTDFRFPQIKAHPWHKIFHKRMPPEAIDFAS 302
Query: 347 RFFQYSPNLRCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFK 391
R QYSP+LRCTALEAC HPFFDELR+PN RLPNGRP PPLFNFK
Sbjct: 303 RLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPFPPLFNFK 347
|
|
| TAIR|locus:2098896 AT3G61160 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1302 (463.4 bits), Expect = 7.9e-133, P = 7.9e-133
Identities = 241/363 (66%), Positives = 286/363 (78%)
Query: 28 DWLGREMLEMRLRDQVDNDEDRDSEPDIIDGVGAETGHVIRTTIGGRNGNSKQKVSYIAE 87
D L +E+ E+ L D D+D + II G G E+G +I T G N + +SY AE
Sbjct: 59 DHLPKEIREVGLGD------DKDMDCGIIKGNGTESGRIITTKKKGLNDQKDKTISYRAE 112
Query: 88 HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFST 147
HV+GTGSFGVVFQAKC ET E VAIKKVLQDKRYKNRELQIM+MLDHPN+V LKH FFST
Sbjct: 113 HVIGTGSFGVVFQAKCLETEEKVAIKKVLQDKRYKNRELQIMRMLDHPNVVELKHSFFST 172
Query: 148 TDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICH 207
T+K T+ R +R+Y++++Q MPLIY++LYTYQICRA+ Y+H +G+CH
Sbjct: 173 TEKDELYLNLVLEYVPETIYRASRSYTKMNQHMPLIYIQLYTYQICRAMNYLHQVVGVCH 232
Query: 208 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAID 267
RDIKPQNLLVN TH++K+CDFGSAK+L+ GEPN+SYICSRYYRAPELIFGATEYT+AID
Sbjct: 233 RDIKPQNLLVNNVTHEVKICDFGSAKMLIPGEPNISYICSRYYRAPELIFGATEYTSAID 292
Query: 268 IWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPH 327
+WS GCVMAEL LG PLFPGE+ VDQLVEIIK+LGTP REEIK MNP Y +FKFPQIK
Sbjct: 293 MWSVGCVMAELFLGHPLFPGETSVDQLVEIIKILGTPAREEIKNMNPRYNDFKFPQIKAQ 352
Query: 328 PWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPNGRPLPPL 387
PWHK+F++++ PEA+DL R QYSPNLRCTALEAC HPFFD+LRDP LPNGR LPPL
Sbjct: 353 PWHKIFRRQVSPEAMDLASRLLQYSPNLRCTALEACAHPFFDDLRDPRASLPNGRALPPL 412
Query: 388 FNF 390
F+F
Sbjct: 413 FDF 415
|
|
| UNIPROTKB|Q91757 gsk3b "Glycogen synthase kinase-3 beta" [Xenopus laevis (taxid:8355)] | Back alignment and assigned GO terms |
|---|
Score = 1143 (407.4 bits), Expect = 5.6e-116, P = 5.6e-116
Identities = 219/335 (65%), Positives = 263/335 (78%)
Query: 57 DGVGAETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVL 116
D G++ V+ T G+ + +Q+V+Y V+G GSFGVV+QAK +TGE+VAIKKVL
Sbjct: 31 DKDGSKVTTVVATP--GQGPDRQQEVTYTDTKVIGNGSFGVVYQAKLCDTGELVAIKKVL 88
Query: 117 QDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXX-XTVNRIARNYSR 175
QDKR+KNRELQIM+ LDH NIV L++ F+S+ +K TV R+AR+YSR
Sbjct: 89 QDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSR 148
Query: 176 IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL 235
Q +P+IYVKLY YQ+ R+LAYIH+ GICHRDIKPQNLL++P T LKLCDFGSAK L
Sbjct: 149 AKQALPIIYVKLYMYQLFRSLAYIHS-FGICHRDIKPQNLLLDPETAVLKLCDFGSAKQL 207
Query: 236 VKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLV 295
V+GEPNVSYICSRYYRAPELIFGAT+YT++ID+WS GCV+AELLLGQP+FPG+SGVDQLV
Sbjct: 208 VRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 267
Query: 296 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNL 355
EIIKVLGTPTRE+I+ MNPNYTEFKFPQIK HPW KVF+ R PPEA+ L R +Y+P
Sbjct: 268 EIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRARTPPEAIALCSRLLEYTPTS 327
Query: 356 RCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNF 390
R T L+AC H FFDELRDPN +LPNGR P LFNF
Sbjct: 328 RLTPLDACAHSFFDELRDPNLKLPNGREFPALFNF 362
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| P43289 | KSG3_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.7545 | 0.9670 | 0.9315 | no | no |
| P43288 | KSG1_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.7945 | 0.9238 | 0.8987 | no | no |
| Q10452 | GSK3_SCHPO | 2, ., 7, ., 1, 1, ., 1 | 0.6355 | 0.8172 | 0.8320 | yes | no |
| Q39012 | KSG9_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.7535 | 0.8959 | 0.8673 | no | no |
| A8X5H5 | GSK3_CAEBR | 2, ., 7, ., 1, 1, ., 2, 6 | 0.6687 | 0.8147 | 0.8941 | N/A | no |
| Q39010 | KSG6_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.7535 | 0.8959 | 0.8567 | no | no |
| Q39011 | KSG7_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.7507 | 0.8756 | 0.9078 | no | no |
| Q388M1 | GSK3B_TRYB2 | 2, ., 7, ., 1, 1, ., 2, 6 | 0.5209 | 0.8248 | 0.9232 | N/A | no |
| Q39019 | KSG10_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.8801 | 0.9923 | 0.9287 | yes | no |
| P38615 | RIM11_YEAST | 2, ., 7, ., 1, 1, ., 1 | 0.5872 | 0.7436 | 0.7918 | yes | no |
| Q9U2Q9 | GSK3_CAEEL | 2, ., 7, ., 1, 1, ., 2, 6 | 0.6687 | 0.8147 | 0.8867 | yes | no |
| Q9FVS6 | KSG4_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.8688 | 0.9847 | 0.9238 | no | no |
| Q40518 | MSK1_TOBAC | 2, ., 7, ., 1, 1, ., 1 | 0.7883 | 0.9365 | 0.9022 | N/A | no |
| Q9WV60 | GSK3B_MOUSE | 2, ., 7, ., 1, 1, ., 1 | 0.6895 | 0.8401 | 0.7880 | yes | no |
| P51136 | GSK3_DICDI | 2, ., 7, ., 1, 1, ., 2, 6 | 0.6774 | 0.7791 | 0.6573 | yes | no |
| P51137 | MSK1_MEDSA | 2, ., 7, ., 1, 1, ., 1 | 0.7634 | 0.9695 | 0.9294 | N/A | no |
| P51138 | MSK2_MEDSA | 2, ., 7, ., 1, 1, ., 1 | 0.7674 | 0.9644 | 0.9245 | N/A | no |
| P51139 | MSK3_MEDSA | 2, ., 7, ., 1, 1, ., 1 | 0.7726 | 0.9644 | 0.9245 | N/A | no |
| O04160 | KSGT_BRANA | 2, ., 7, ., 1, 1, ., 1 | 0.7369 | 0.9644 | 0.8119 | N/A | no |
| P18266 | GSK3B_RAT | 2, ., 7, ., 1, 1, ., 1 | 0.6895 | 0.8401 | 0.7880 | yes | no |
| Q8VZD5 | KSG5_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.7656 | 0.9593 | 0.9219 | no | no |
| P49841 | GSK3B_HUMAN | 2, ., 7, ., 1, 1, ., 1 | 0.6895 | 0.8401 | 0.7880 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.994 |
| 3rd Layer | 2.7.11 | 0.998 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 394 | |||
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 1e-135 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 1e-91 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 8e-88 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 4e-87 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 1e-84 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 1e-82 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 4e-82 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 3e-79 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 5e-79 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 3e-77 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 3e-74 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 3e-73 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 9e-69 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 1e-66 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 5e-66 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 7e-66 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 8e-66 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 5e-64 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 2e-63 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 7e-63 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 1e-62 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 2e-62 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 2e-60 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 6e-60 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 4e-59 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 4e-59 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 1e-58 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 9e-58 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 1e-57 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 2e-57 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 5e-57 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 4e-55 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 4e-55 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 3e-54 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 4e-54 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 4e-54 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 7e-53 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 5e-52 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 6e-52 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 4e-51 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 4e-51 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 1e-50 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 5e-50 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 5e-50 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 1e-49 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 2e-49 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 2e-49 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 2e-49 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 9e-49 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 9e-49 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 2e-48 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 4e-48 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 8e-46 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 1e-43 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 1e-41 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 5e-40 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 9e-40 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 2e-39 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 6e-39 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 1e-37 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 2e-37 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 5e-37 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 8e-36 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 9e-36 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 1e-35 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 4e-35 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 1e-34 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 2e-34 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 8e-34 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 1e-33 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 2e-32 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 4e-32 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 1e-31 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 5e-31 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 1e-30 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 2e-30 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 4e-30 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 6e-30 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 4e-29 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 7e-29 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 7e-29 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 2e-28 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 5e-28 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 9e-28 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 9e-28 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 1e-27 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 2e-27 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 1e-26 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 6e-26 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 9e-25 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 5e-24 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 7e-24 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 9e-24 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 1e-23 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 1e-23 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 2e-23 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 8e-23 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 1e-22 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 1e-22 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 2e-22 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 3e-22 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 7e-22 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 8e-22 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 1e-21 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 2e-21 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 3e-21 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 3e-21 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 3e-21 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 4e-21 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 6e-21 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 6e-21 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 6e-21 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 7e-21 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 7e-21 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 1e-20 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 1e-20 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 1e-20 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 2e-20 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 3e-20 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 4e-20 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 4e-20 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 5e-20 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 5e-20 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 9e-20 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 1e-19 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 1e-19 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 2e-19 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 3e-19 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 3e-19 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 9e-19 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 1e-18 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 1e-18 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 2e-18 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 2e-18 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 4e-18 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 5e-18 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 5e-18 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 5e-18 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 6e-18 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 9e-18 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 2e-17 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 2e-17 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 2e-17 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 2e-17 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 3e-17 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 4e-17 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 5e-17 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 5e-17 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 5e-17 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 6e-17 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 6e-17 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 7e-17 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 7e-17 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 8e-17 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 8e-17 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 1e-16 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 2e-16 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 2e-16 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 3e-16 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 3e-16 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 3e-16 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 3e-16 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 3e-16 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 5e-16 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 5e-16 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 8e-16 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 9e-16 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 1e-15 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 1e-15 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 1e-15 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 3e-15 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 5e-15 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 7e-15 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 7e-15 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 8e-15 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 1e-14 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 1e-14 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 2e-14 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 2e-14 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 2e-14 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 3e-14 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 3e-14 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 4e-14 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 4e-14 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 5e-14 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 2e-13 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 3e-13 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 3e-13 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 4e-13 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 4e-13 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 4e-13 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 5e-13 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 7e-13 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 7e-13 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 7e-13 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 8e-13 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 1e-12 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 3e-12 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 3e-12 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 5e-12 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 6e-12 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 6e-12 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 8e-12 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 9e-12 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 9e-12 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 1e-11 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 2e-11 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 2e-11 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 2e-11 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 2e-11 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 2e-11 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 2e-11 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 3e-11 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 3e-11 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 3e-11 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 4e-11 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 8e-11 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 9e-11 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 1e-10 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 2e-10 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 2e-10 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 2e-10 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 3e-10 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 3e-10 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 3e-10 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 6e-10 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 7e-10 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 8e-10 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 1e-09 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 2e-09 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 2e-09 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 3e-09 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 3e-09 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 4e-09 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 5e-09 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 8e-09 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 1e-08 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 1e-08 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 1e-08 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 2e-08 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 2e-08 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 2e-08 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 3e-08 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 4e-08 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 7e-08 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 9e-08 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 1e-07 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 1e-07 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 1e-07 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 1e-07 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 1e-07 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 2e-07 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 3e-07 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 3e-07 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 4e-07 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 4e-07 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 6e-07 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 7e-07 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 7e-07 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 1e-06 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 1e-06 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 1e-06 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 1e-06 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 2e-06 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 3e-06 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 3e-06 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 4e-06 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 4e-06 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 4e-06 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 6e-06 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 1e-05 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 2e-05 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 3e-05 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 4e-05 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 5e-05 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 5e-05 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 6e-05 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 8e-05 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 2e-04 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 2e-04 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 3e-04 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 9e-04 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 0.001 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 0.001 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 0.001 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 0.002 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 0.002 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 0.002 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 0.002 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 0.003 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 393 bits (1011), Expect = e-135
Identities = 173/318 (54%), Positives = 237/318 (74%), Gaps = 5/318 (1%)
Query: 77 NSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPN 136
N SY +++G GSFGVV++A C +T E VAIKKVLQD +YKNREL IM+ L+H N
Sbjct: 61 NRSPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRELLIMKNLNHIN 120
Query: 137 IVALKHCFFSTT---DKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQIC 193
I+ LK +++ +++ ++LN+V+E++P+TV++ ++Y+R + +PL VKLY+YQ+C
Sbjct: 121 IIFLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLC 180
Query: 194 RALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAP 253
RALAYIH+ ICHRD+KPQNLL++P+TH LKLCDFGSAK L+ G+ +VSYICSR+YRAP
Sbjct: 181 RALAYIHSKF-ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSRFYRAP 239
Query: 254 ELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 313
EL+ GAT YTT ID+WS GC++AE++LG P+F G+S VDQLV II+VLGTPT +++K MN
Sbjct: 240 ELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMN 299
Query: 314 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD 373
PNY + KFP +KP KVF K P +A++ + +F +Y P R +EA PFFD+LRD
Sbjct: 300 PNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLRD 359
Query: 374 PNTRLPNG-RPLPPLFNF 390
P +LP LP LFNF
Sbjct: 360 PCIKLPKYIDKLPDLFNF 377
|
Length = 440 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 278 bits (714), Expect = 1e-91
Identities = 113/309 (36%), Positives = 171/309 (55%), Gaps = 28/309 (9%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV------LQDKRYKNRELQIMQMLDHPNI 137
Y +G+G++GVV A + TG VAIKK+ L D + RE+++++ L H NI
Sbjct: 2 YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENI 61
Query: 138 VALKHCF--FSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPL--IYVKLYTYQIC 193
+ L S D ++Y+ V E + ++++ I PL +++ + YQI
Sbjct: 62 IGLLDILRPPSPEDFNDVYI--VTELMETDLHKV------IKSPQPLTDDHIQYFLYQIL 113
Query: 194 RALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVS----YICSRY 249
R L Y+H+ + HRD+KP N+LVN LK+CDFG A+ + E Y+ +R+
Sbjct: 114 RGLKYLHSA-NVIHRDLKPSNILVN-SNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRW 171
Query: 250 YRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI 309
YRAPEL+ ++ YT AIDIWS GC+ AELL +PLFPG +DQL I++VLGTP+ E++
Sbjct: 172 YRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDL 231
Query: 310 KCM-NPNYTEF--KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHP 366
K + + + P+ P K+F PEA+DL+ + + P R TA EA HP
Sbjct: 232 KFITSEKARNYLKSLPKKPKKPLSKLFPG-ASPEAIDLLEKMLVFDPKKRITADEALAHP 290
Query: 367 FFDELRDPN 375
+ +L DP
Sbjct: 291 YLAQLHDPE 299
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 267 bits (684), Expect = 8e-88
Identities = 117/302 (38%), Positives = 171/302 (56%), Gaps = 37/302 (12%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN--------RELQIMQMLDHP 135
Y +G G++GVV++A+ ++TGEIVA+KK+ D + RE+ +++ L HP
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLD--NEEEGIPSTALREISLLKELKHP 58
Query: 136 NIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNY-SRIHQRMPLIYVKLYTYQICR 194
NIV L + + +LYL V EY + + Y + + +K YQ+ R
Sbjct: 59 NIVKLLDVIHT---ERKLYL--VFEYCDMDL----KKYLDKRPGPLSPNLIKSIMYQLLR 109
Query: 195 ALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSRYYR 251
LAY H I HRD+KPQN+L+N LKL DFG A+ G P +Y + + +YR
Sbjct: 110 GLAYCH-SHRILHRDLKPQNILIN-RDGVLKLADFGLARAF--GIPLRTYTHEVVTLWYR 165
Query: 252 APELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 311
APE++ G+ Y+TA+DIWS GC+ AE++ G+PLFPG+S +DQL +I ++LGTPT E
Sbjct: 166 APEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESW-- 223
Query: 312 MNPNYTEFK-----FPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHP 366
P T+ FP+ P KV RL PE +DL+ + QY+P R +A EA HP
Sbjct: 224 --PGVTKLPDYKPTFPKFPPKDLEKVL-PRLDPEGIDLLSKMLQYNPAKRISAKEALKHP 280
Query: 367 FF 368
+F
Sbjct: 281 YF 282
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 265 bits (679), Expect = 4e-87
Identities = 116/298 (38%), Positives = 171/298 (57%), Gaps = 25/298 (8%)
Query: 80 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR---YKN---RELQIMQMLD 133
QK+ I G G++GVV++A+ + TGEIVAIKK+ RE+++++ L+
Sbjct: 2 QKLGKI-----GEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELN 56
Query: 134 HPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQIC 193
HPNI+ L F K +LYL V E++ + ++ ++ R +P +K Y YQ+
Sbjct: 57 HPNIIKLLDVFR---HKGDLYL--VFEFMDTDLYKLIKDRQRG---LPESLIKSYLYQLL 108
Query: 194 RALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL-VKGEPNVSYICSRYYRA 252
+ LA+ H+ GI HRD+KP+NLL+N LKL DFG A+ P Y+ +R+YRA
Sbjct: 109 QGLAFCHSH-GILHRDLKPENLLINTEG-VLKLADFGLARSFGSPVRPYTHYVVTRWYRA 166
Query: 253 PELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 312
PEL+ G Y+T +DIWS GC+ AELL +PLFPG+S +DQL +I + LGTP E
Sbjct: 167 PELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKF 226
Query: 313 NPN--YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368
+F FP+ P K+F P+A+DL+ + Y P+ R TA +A HP+F
Sbjct: 227 TSLARNYKFSFPKKAGMPLPKLFPN-ASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 259 bits (663), Expect = 1e-84
Identities = 111/290 (38%), Positives = 167/290 (57%), Gaps = 23/290 (7%)
Query: 90 VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 143
+G G+ G+VF+AK RETGE VA+KKV + RE++ +Q HP +V L
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDV 67
Query: 144 FFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203
F L V+EY+P ++ + R+ R +P VK Y + + +AY+H
Sbjct: 68 F---PHGSGFVL--VMEYMPSDLSEVLRDEER---PLPEAQVKSYMRMLLKGVAYMHA-N 118
Query: 204 GICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY--ICSRYYRAPELIFGATE 261
GI HRD+KP NLL++ LK+ DFG A++ + EP + + +R+YRAPEL++GA +
Sbjct: 119 GIMHRDLKPANLLISADGV-LKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARK 177
Query: 262 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE---EIKCMNPNYTE 318
Y +D+W+ GC+ AELL G PLFPGE+ ++QL + + LGTP E + + P+Y +
Sbjct: 178 YDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSL-PDYNK 236
Query: 319 FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368
FP+ KP P ++F PEA+DL+ Y P+ R +A EA HP+F
Sbjct: 237 ITFPESKPIPLEEIFPD-ASPEALDLLKGLLVYDPSKRLSAAEALRHPYF 285
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 252 bits (647), Expect = 1e-82
Identities = 105/292 (35%), Positives = 155/292 (53%), Gaps = 45/292 (15%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV-----LQDKRYKNRELQIMQMLDHPNIV 138
Y +G GSFG V+ A+ ++TG++VAIK + +D+ RE++I++ L HPNIV
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60
Query: 139 ALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
L F D+++LYL V+EY + + + + R+ + Y QI AL
Sbjct: 61 RLYDVF---EDEDKLYL--VMEYCEGGDLFDLLKK-----RGRLSEDEARFYLRQILSAL 110
Query: 197 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELI 256
Y+H+ GI HRD+KP+N+L++ H +KL DFG A+ L GE +++ + Y APE++
Sbjct: 111 EYLHSK-GIVHRDLKPENILLDEDGH-VKLADFGLARQLDPGEKLTTFVGTPEYMAPEVL 168
Query: 257 FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 316
G Y A+DIWS G ++ ELL G+P FPG+ DQL+E+ K +G P
Sbjct: 169 LG-KGYGKAVDIWSLGVILYELLTGKPPFPGD---DQLLELFKKIGKPK----------- 213
Query: 317 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368
P P W + PEA DL+ + P R TA EA HPFF
Sbjct: 214 -----PPFPPPEW------DISPEAKDLIRKLLVKDPEKRLTAEEALQHPFF 254
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 252 bits (647), Expect = 4e-82
Identities = 112/299 (37%), Positives = 162/299 (54%), Gaps = 29/299 (9%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---------RELQIMQMLDH 134
Y +G G++ VV++A+ +ETG IVAIKK+ +R + RE++++Q L H
Sbjct: 2 YEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKH 61
Query: 135 PNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICR 194
PNI+ L F +NLV E++ + ++ ++ S + +K Y R
Sbjct: 62 PNIIGLLDVF--GHKS---NINLVFEFMETDLEKVIKDKSIVLT---PADIKSYMLMTLR 113
Query: 195 ALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYIC---SRYYR 251
L Y+H+ I HRD+KP NLL+ LKL DFG A+ G PN +R+YR
Sbjct: 114 GLEYLHSN-WILHRDLKPNNLLIASDG-VLKLADFGLARSF--GSPNRKMTHQVVTRWYR 169
Query: 252 APELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 311
APEL+FGA Y +D+WS GC+ AELLL P PG+S +DQL +I + LGTPT E
Sbjct: 170 APELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPG 229
Query: 312 MN--PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368
+ P+Y EFK P P ++F +A+DL+ R +PN R TA +A HP+F
Sbjct: 230 VTSLPDYVEFKP--FPPTPLKQIF-PAASDDALDLLQRLLTLNPNKRITARQALEHPYF 285
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 245 bits (627), Expect = 3e-79
Identities = 115/292 (39%), Positives = 164/292 (56%), Gaps = 21/292 (7%)
Query: 88 HVVGTGSFGVVFQAKCRETGEIVAIKKVLQ---DKRYKN---RELQIMQMLDHPNIVALK 141
VVG G++GVV + + + TGEIVAIKK + D+ K RE+++++ L H NIV LK
Sbjct: 7 GVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLK 66
Query: 142 HCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
F K LYL V EYV T+ + +P V+ Y +Q+ +A+AY H+
Sbjct: 67 EAFRR---KGRLYL--VFEYVERTLLELLEASPG---GLPPDAVRSYIWQLLQAIAYCHS 118
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV--KGEPNVSYICSRYYRAPELIFGA 259
I HRDIKP+N+LV+ LKLCDFG A+ L P Y+ +R+YRAPEL+ G
Sbjct: 119 -HNIIHRDIKPENILVSESG-VLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGD 176
Query: 260 TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLG--TPTREEIKCMNPNYT 317
T Y +D+W+ GC+MAELL G+PLFPG+S +DQL I K LG P+ +E+ NP +
Sbjct: 177 TNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFA 236
Query: 318 EFKFPQIK-PHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368
FP+ P + + ++ A+D + + P R T E HP+F
Sbjct: 237 GVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 243 bits (623), Expect = 5e-79
Identities = 98/292 (33%), Positives = 147/292 (50%), Gaps = 39/292 (13%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNI 137
Y +G+GSFG V++AK + TG+IVA+K + + RE++I++ L HPNI
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNI 60
Query: 138 VALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALA 197
V L F DK+ LYL V+EY +Y + K QI R L
Sbjct: 61 VRLIDAF---EDKDHLYL--VMEYCEGGDLF---DYLSRGGPLSEDEAKKIALQILRGLE 112
Query: 198 YIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK-GEPNVSYICSRYYRAPELI 256
Y+H+ GI HRD+KP+N+L++ +K+ DFG AK L+K +++ + +Y APE++
Sbjct: 113 YLHSN-GIIHRDLKPENILLD-ENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVL 170
Query: 257 FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 316
G Y +D+WS G ++ ELL G+P F GE+ +DQL I ++LG P
Sbjct: 171 LGGNGYGPKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPL----------- 219
Query: 317 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368
+F + K EA DL+ + P+ R TA E HP+F
Sbjct: 220 ---EFDEPKWSS--------GSEEAKDLIKKCLNKDPSKRPTAEEILQHPWF 260
|
Length = 260 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 239 bits (613), Expect = 3e-77
Identities = 109/291 (37%), Positives = 172/291 (59%), Gaps = 26/291 (8%)
Query: 90 VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-------RELQ-IMQMLDHPNIVALK 141
+G G+FG V+ A+ +ETGE+VAIKK+ + ++ + RE++ + ++ +HPNIV LK
Sbjct: 7 LGDGTFGSVYLARNKETGELVAIKKMKK--KFYSWEECMNLREVKSLRKLNEHPNIVKLK 64
Query: 142 HCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
F + +ELY V EY+ + ++ + R + ++ YQI + LA+IH
Sbjct: 65 EVF---RENDELYF--VFEYMEGNLYQLMK--DRKGKPFSESVIRSIIYQILQGLAHIHK 117
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 261
G HRD+KP+NLLV+ +K+ DFG A+ + P Y+ +R+YRAPE++ +T
Sbjct: 118 H-GFFHRDLKPENLLVSGPE-VVKIADFGLAREIRSRPPYTDYVSTRWYRAPEILLRSTS 175
Query: 262 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE----IKCMNPNYT 317
Y++ +DIW+ GC+MAEL +PLFPG S +DQL +I VLGTPT+++ K +
Sbjct: 176 YSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASK--L 233
Query: 318 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368
F+FPQ P H++ PEA+DL+ ++ P R TA +A HP+F
Sbjct: 234 GFRFPQFAPTSLHQLIP-NASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 232 bits (594), Expect = 3e-74
Identities = 97/292 (33%), Positives = 158/292 (54%), Gaps = 24/292 (8%)
Query: 90 VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-------RELQIMQMLDHPNIVALKH 142
+G G++G V++A+ ++TGE+VA+KK+ + K RE++++Q L HPNIV LK
Sbjct: 7 IGEGTYGQVYKARNKKTGELVALKKIRME-NEKEGFPITAIREIKLLQKLRHPNIVRLKE 65
Query: 143 CFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
S K +Y+ V EY+ + + + + +K Y Q+ L Y+H+
Sbjct: 66 IVTSK-GKGSIYM--VFEYMDHDLTGLLDSPE---VKFTESQIKCYMKQLLEGLQYLHSN 119
Query: 203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSRYYRAPELIFGA 259
GI HRDIK N+L+N LKL DFG A+ K + Y + + +YR PEL+ GA
Sbjct: 120 -GILHRDIKGSNILINNDGV-LKLADFGLARPYTK-RNSADYTNRVITLWYRPPELLLGA 176
Query: 260 TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE---EIKCMNPNY 316
T Y +D+WS GC++AEL LG+P+F G + ++QL +I ++ G+PT E + + P +
Sbjct: 177 TRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKL-PWF 235
Query: 317 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368
K + + F+ + P A+DL+ + P R +A +A H +F
Sbjct: 236 ENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 231 bits (591), Expect = 3e-73
Identities = 109/305 (35%), Positives = 176/305 (57%), Gaps = 35/305 (11%)
Query: 90 VGTGSFGVVFQAKCRETGEIVAIKKVL------QDKRYKNRELQIM---QMLDHPNIVAL 140
+G G++G+V++A R T E+VA+KK+ D + RE IM ++ DHPNIV L
Sbjct: 15 LGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFRE--IMFLQELGDHPNIVKL 72
Query: 141 KHCFFSTTDKEELYLNLVLEYVPETVNRIARN--YSRIHQRMPLIYVKLYTYQICRALAY 198
+ + DK+ +YL V EY+ ++ + R +H+R Y+ YQ+ +AL Y
Sbjct: 73 LNVIKAENDKD-IYL--VFEYMETDLHAVIRANILEDVHKR----YI---MYQLLKALKY 122
Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVS------YICSRYYRA 252
IH+ + HRD+KP N+L+N +KL DFG A+ L + E N Y+ +R+YRA
Sbjct: 123 IHSG-NVIHRDLKPSNILLNSDCR-VKLADFGLARSLSELEENPENPVLTDYVATRWYRA 180
Query: 253 PELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 312
PE++ G+T YT +D+WS GC++ E+LLG+PLFPG S ++QL +II+V+G P+ E+I+ +
Sbjct: 181 PEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESI 240
Query: 313 NPNYTEF---KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFD 369
+ P P ++ + +A+DL+ + ++PN R TA EA HP+
Sbjct: 241 KSPFAATMLDSLPSRPRKPLDELL-PKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVA 299
Query: 370 ELRDP 374
+ +P
Sbjct: 300 QFHNP 304
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 219 bits (561), Expect = 9e-69
Identities = 109/309 (35%), Positives = 166/309 (53%), Gaps = 28/309 (9%)
Query: 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKK------VLQDKRYKNRELQIMQMLDHPN 136
Y +G+G++GVV A +G+ VAIKK V + REL+I++ H N
Sbjct: 6 RYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDN 65
Query: 137 IVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLI--YVKLYTYQICR 194
I+A++ + + +V++ + ++ I IH PL +++ + YQ+ R
Sbjct: 66 IIAIRD-ILRPPGADFKDVYVVMDLMESDLHHI------IHSDQPLTEEHIRYFLYQLLR 118
Query: 195 ALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVS-----YICSRY 249
L YIH+ + HRD+KP NLLVN L++ DFG A+ L Y+ +R+
Sbjct: 119 GLKYIHSA-NVIHRDLKPSNLLVNEDCE-LRIGDFGMARGLSSSPTEHKYFMTEYVATRW 176
Query: 250 YRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI 309
YRAPEL+ EYTTAID+WS GC+ AE+L + LFPG++ V QL I+ VLG+P+ E +
Sbjct: 177 YRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVL 236
Query: 310 KCMNP----NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH 365
+ Y + P+ +P PW K+F K PEA+DL+ + Q+ P R T +A H
Sbjct: 237 NRIGSDRVRKYIQ-NLPRKQPVPWSKIFPKA-SPEALDLLSQMLQFDPEERITVEQALQH 294
Query: 366 PFFDELRDP 374
PF + DP
Sbjct: 295 PFLAQYHDP 303
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 212 bits (542), Expect = 1e-66
Identities = 104/293 (35%), Positives = 164/293 (55%), Gaps = 30/293 (10%)
Query: 90 VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 143
+G G++GVV++A+ + TGEIVA+KK+ + + RE+ +++ L+HPNIV L
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDV 66
Query: 144 FFSTTDKEELYLNLVLEYVPETVNRIARNY--SRIHQRMPLIYVKLYTYQICRALAYIHN 201
S +LYL V E++ + + Y S + +K Y YQ+ + +AY H+
Sbjct: 67 VHSEN---KLYL--VFEFL----DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHS 117
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSRYYRAPELIFG 258
+ HRD+KPQNLL++ LKL DFG A+ G P +Y + + +YRAPE++ G
Sbjct: 118 H-RVLHRDLKPQNLLID-REGALKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEILLG 173
Query: 259 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE---EIKCMNPN 315
+ +Y+T +DIWS GC+ AE++ +PLFPG+S +DQL I + LGTP + + + P+
Sbjct: 174 SRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSL-PD 232
Query: 316 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368
Y FP+ KV L + +DL+ + Y P R +A A HP+F
Sbjct: 233 YKP-TFPKWARQDLSKVVP-NLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 211 bits (539), Expect = 5e-66
Identities = 115/306 (37%), Positives = 170/306 (55%), Gaps = 37/306 (12%)
Query: 80 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLD 133
+K++ I E G++GVV++A+ ++TGEIVA+KK+ +K + RE+ I+ L
Sbjct: 8 EKLNRIEE-----GTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQ 62
Query: 134 HPNIVALKHCFF-STTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQI 192
HPNIV +K S DK +Y+ V+EYV + + + Q VK Q+
Sbjct: 63 HPNIVTVKEVVVGSNLDK--IYM--VMEYVEHDLKSL---METMKQPFLQSEVKCLMLQL 115
Query: 193 CRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSRY 249
+A++H+ I HRD+K NLL+N + LK+CDFG A+ G P Y + + +
Sbjct: 116 LSGVAHLHD-NWILHRDLKTSNLLLN-NRGILKICDFGLAREY--GSPLKPYTQLVVTLW 171
Query: 250 YRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI 309
YRAPEL+ GA EY+TAID+WS GC+ AELL +PLFPG+S +DQL +I K+LGTPT +
Sbjct: 172 YRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIW 231
Query: 310 KCMNPNYTEFKFPQIKPHPWHKVFQ--KRLPP-----EAVDLVCRFFQYSPNLRCTALEA 362
P ++E + K + Q K+ P DL+ R Y P R +A +A
Sbjct: 232 ----PGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDA 287
Query: 363 CVHPFF 368
HP+F
Sbjct: 288 LKHPYF 293
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 212 bits (542), Expect = 7e-66
Identities = 108/305 (35%), Positives = 164/305 (53%), Gaps = 26/305 (8%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KR-YKNRELQIMQMLDHP 135
Y VG+G++G V A +TG VAIKK+ + KR Y REL++++ +DH
Sbjct: 17 YQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTY--RELRLLKHMDHE 74
Query: 136 NIVALKHCFFSTTDKEELY-LNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICR 194
N++ L F + E+ + LV + +N I + Q++ +++ YQI R
Sbjct: 75 NVIGLLDVFTPASSLEDFQDVYLVTHLMGADLNNIVK-----CQKLSDDHIQFLVYQILR 129
Query: 195 ALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPE 254
L YIH+ GI HRD+KP N+ VN +LK+ DFG A+ + Y+ +R+YRAPE
Sbjct: 130 GLKYIHSA-GIIHRDLKPSNIAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPE 185
Query: 255 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 314
++ Y +DIWS GC+MAELL G+ LFPG +DQL I+ ++GTP E ++ ++
Sbjct: 186 IMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISS 245
Query: 315 ----NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE 370
NY + PQ+ + +VF P A+DL+ + P+ R TA EA HP+ E
Sbjct: 246 ESARNYIQ-SLPQMPKKDFKEVFS-GANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAE 303
Query: 371 LRDPN 375
DP
Sbjct: 304 YHDPE 308
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 212 bits (541), Expect = 8e-66
Identities = 106/325 (32%), Positives = 175/325 (53%), Gaps = 28/325 (8%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV------LQDKRYKNRELQIMQMLDHPNI 137
Y +G G++G+V A + TG VAIKK+ +R RE++I++ H NI
Sbjct: 7 YQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQR-TLREIKILRRFKHENI 65
Query: 138 VALKHCFFSTTDKE--ELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRA 195
+ + + + ++Y+ V E + + ++ + Q + +++ + YQI R
Sbjct: 66 IGILDIIRPPSFESFNDVYI--VQELMETDLYKLIKT-----QHLSNDHIQYFLYQILRG 118
Query: 196 LAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN----VSYICSRYYR 251
L YIH+ + HRD+KP NLL+N LK+CDFG A++ + Y+ +R+YR
Sbjct: 119 LKYIHSA-NVLHRDLKPSNLLLN-TNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYR 176
Query: 252 APELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 311
APE++ + YT AIDIWS GC++AE+L +PLFPG+ + QL I+ VLGTP++E++ C
Sbjct: 177 APEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNC 236
Query: 312 M-NP---NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 367
+ + NY + P PW+K+F P+A+DL+ + ++P+ R T EA HP+
Sbjct: 237 IISLRARNYIK-SLPFKPKVPWNKLFPN-ADPKALDLLDKMLTFNPHKRITVEEALAHPY 294
Query: 368 FDELRDPNTRLPNGRPLPPLFNFKP 392
++ DP+ P P F
Sbjct: 295 LEQYHDPSDEPVAEEPFPFDFELFD 319
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 206 bits (525), Expect = 5e-64
Identities = 109/292 (37%), Positives = 164/292 (56%), Gaps = 27/292 (9%)
Query: 90 VGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHC 143
+G GS+GVVF+ + RETG+IVAIKK ++ K+ RE+++++ L HPN+V L
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEV 68
Query: 144 FFSTTDKEELYLNLVLEYVPETV-NRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH-- 200
F + + L+LV EY TV N + +N + +P +K +Q +A+ + H
Sbjct: 69 F-----RRKRKLHLVFEYCDHTVLNELEKN----PRGVPEHLIKKIIWQTLQAVNFCHKH 119
Query: 201 NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVS-YICSRYYRAPELIFGA 259
NCI HRD+KP+N+L+ Q+KLCDFG A++L + + Y+ +R+YRAPEL+ G
Sbjct: 120 NCI---HRDVKPENILITKQ-GQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVGD 175
Query: 260 TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLG--TPTREEIKCMNPNYT 317
T+Y +D+W+ GCV AELL GQPL+PG+S VDQL I K LG P ++I N +
Sbjct: 176 TQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFK 235
Query: 318 EFKFPQIKP-HPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368
P+ + P F + A+ + Q P R + E HP+F
Sbjct: 236 GLSIPEPETREPLESKFPN-ISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 204 bits (521), Expect = 2e-63
Identities = 116/291 (39%), Positives = 173/291 (59%), Gaps = 23/291 (7%)
Query: 89 VVGTGSFGVVFQAKCRETGEIVAIKKVLQ---DKRYKN---RELQIMQMLDHPNIVALKH 142
+VG GS+G+V + K +ETG+IVAIKK L+ DK K RE+++++ L H N+V L
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIE 67
Query: 143 CFFSTTDKEELYLNLVLEYVPETV-NRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
F K+ LYL V E+V TV + + + + + + V+ Y +QI R + + H+
Sbjct: 68 VF---RRKKRLYL--VFEFVDHTVLDDLEKYPNGLDESR----VRKYLFQILRGIEFCHS 118
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK-GEPNVSYICSRYYRAPELIFGAT 260
I HRDIKP+N+LV+ + +KLCDFG A+ L GE Y+ +R+YRAPEL+ G T
Sbjct: 119 H-NIIHRDIKPENILVSQ-SGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVGDT 176
Query: 261 EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGT--PTREEIKCMNPNYTE 318
+Y A+DIW+ GC++ E+L G+PLFPG+S +DQL IIK LG P +EI NP +
Sbjct: 177 KYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAG 236
Query: 319 FKFPQIK-PHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368
+ P++K P K F K L +DL + + P+ R ++ + H FF
Sbjct: 237 MRLPEVKEIEPLEKRFPK-LSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 203 bits (518), Expect = 7e-63
Identities = 103/295 (34%), Positives = 160/295 (54%), Gaps = 23/295 (7%)
Query: 90 VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDH-PNIVALKH 142
+G G++G V++A+ + TG++VA+KK + + RE+ ++QML IV L
Sbjct: 9 IGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLD 68
Query: 143 CFFSTTDKEELYLNLVLEYVPETVNR-IARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
+ L LV EY+ + + + N + +P +K + YQ+ + +A+ H
Sbjct: 69 VEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHK 128
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSRYYRAPELIFG 258
G+ HRD+KPQNLLV+ LK+ D G + P SY I + +YRAPE++ G
Sbjct: 129 -HGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSI--PVKSYTHEIVTLWYRAPEVLLG 185
Query: 259 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 318
+T Y+T +DIWS GC+ AE+ QPLFPG+S + QL+ I K+LGTPT + P ++
Sbjct: 186 STHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVW----PGVSK 241
Query: 319 FK----FPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFD 369
+ FPQ KP + L PE +DL+ + +Y P R +A A HP+FD
Sbjct: 242 LRDWHEFPQWKPQDLSRAVPD-LSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD 295
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 204 bits (520), Expect = 1e-62
Identities = 112/316 (35%), Positives = 177/316 (56%), Gaps = 31/316 (9%)
Query: 90 VGTGSFGVVFQAKCRETGEIVAIKKV------LQDKRYKNRELQIMQMLDHPNIVALKHC 143
+G G++G+V AK ET E VAIKK+ D + RE+++++ LDH N++A+K
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDI 72
Query: 144 FFSTTDK--EELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
+ ++Y+ V E + +++I R+ Q + + + + YQ+ R L YIH+
Sbjct: 73 MPPPHREAFNDVYI--VYELMDTDLHQIIRS----SQTLSDDHCQYFLYQLLRGLKYIHS 126
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV-LVKGEPNVSYICSRYYRAPELIFGAT 260
+ HRD+KP NLL+N + LK+CDFG A+ KG+ Y+ +R+YRAPEL+ +
Sbjct: 127 A-NVLHRDLKPSNLLLNANC-DLKICDFGLARTTSEKGDFMTEYVVTRWYRAPELLLNCS 184
Query: 261 EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM-NPNYTEF 319
EYTTAID+WS GC+ AELL +PLFPG+ V QL I ++LG+P+ E++ + N +
Sbjct: 185 EYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKARRY 244
Query: 320 KFPQIK--PHPWHKVFQKRLP---PEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP 374
I+ P+ + F + P P A+DL+ + + P+ R T EA HP+ L DP
Sbjct: 245 ----IRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHDP 300
Query: 375 NTRLPNGRPLPPLFNF 390
+ P F+F
Sbjct: 301 SDEPVCQTP----FSF 312
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 201 bits (514), Expect = 2e-62
Identities = 102/287 (35%), Positives = 152/287 (52%), Gaps = 21/287 (7%)
Query: 91 GTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-------RELQIMQML-DHPNIVALKH 142
G G+F V +A+ R+TG+ AIK + K +K+ RE+Q ++ L HPNI+ L
Sbjct: 8 GEGTFSEVLKAQSRKTGKYYAIKCM--KKHFKSLEQVNNLREIQALRRLSPHPNILRLIE 65
Query: 143 CFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
F D++ L LV E + + + + + +P VK Y YQ+ ++L ++H
Sbjct: 66 VLF---DRKTGRLALVFELMDMNLYELIKGR---KRPLPEKRVKSYMYQLLKSLDHMHRN 119
Query: 203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEY 262
GI HRDIKP+N+L+ LKL DFGS + + P YI +R+YRAPE + Y
Sbjct: 120 -GIFHRDIKPENILIKDDI--LKLADFGSCRGIYSKPPYTEYISTRWYRAPECLLTDGYY 176
Query: 263 TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP-NYTEFKF 321
+DIW+ GCV E+L PLFPG + +DQ+ +I VLGTP E +K + + F
Sbjct: 177 GPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNF 236
Query: 322 PQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368
P K K+ E +DL+ + Y P+ R TA +A HP+F
Sbjct: 237 PSKKGTGLRKLLPN-ASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 196 bits (501), Expect = 2e-60
Identities = 107/292 (36%), Positives = 168/292 (57%), Gaps = 28/292 (9%)
Query: 90 VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-----RELQIMQMLDHPNIVALKHCF 144
+G G++ V++ + R TGEIVA+K++ D RE+ +M+ L H NIV L H
Sbjct: 8 LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRL-HDV 66
Query: 145 FSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQR---MPLIYVKLYTYQICRALAYIHN 201
T +K L LV EY+ + + + Y H + VK +TYQ+ + +A+ H
Sbjct: 67 IHTENK----LMLVFEYMDKDLKK----YMDTHGVRGALDPNTVKSFTYQLLKGIAFCHE 118
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSRYYRAPELIFG 258
+ HRD+KPQNLL+N +LKL DFG A+ G P ++ + + +YRAP+++ G
Sbjct: 119 N-RVLHRDLKPQNLLINKRG-ELKLADFGLARAF--GIPVNTFSNEVVTLWYRAPDVLLG 174
Query: 259 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--PNY 316
+ Y+T+IDIWS GC+MAE++ G+PLFPG + DQL++I +++GTPT ++ P Y
Sbjct: 175 SRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEY 234
Query: 317 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368
+ FP+ P ++F P +DL+ R Q +P LR +A +A HP+F
Sbjct: 235 -KPTFPRYPPQDLQQLF-PHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 195 bits (498), Expect = 6e-60
Identities = 103/298 (34%), Positives = 162/298 (54%), Gaps = 24/298 (8%)
Query: 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV-LQDKR----YKNRELQIMQMLDHPNI 137
+Y +G GS+ V++ + + TG++VA+K++ L+ + RE +++ L H NI
Sbjct: 6 TYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANI 65
Query: 138 VALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALA 197
V L H T L LV EY+ + + + + + V+L+ +Q+ R LA
Sbjct: 66 VTL-HDIIHTKKT----LTLVFEYLDTDLKQYMDDCGGG---LSMHNVRLFLFQLLRGLA 117
Query: 198 YIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSRYYRAPE 254
Y H + HRD+KPQNLL++ +LKL DFG A+ K P+ +Y + + +YR P+
Sbjct: 118 YCHQ-RRVLHRDLKPQNLLIS-ERGELKLADFGLARA--KSVPSKTYSNEVVTLWYRPPD 173
Query: 255 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGV-DQLVEIIKVLGTPTREEIK--C 311
++ G+TEY+T++D+W GC+ E+ G+PLFPG + V DQL +I +VLGTPT E
Sbjct: 174 VLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVS 233
Query: 312 MNPNYTEFKFPQIKPHPWHKVFQK-RLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368
NP + + FP P P + P +L +F QY P R +A EA HP+F
Sbjct: 234 SNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 194 bits (495), Expect = 4e-59
Identities = 104/295 (35%), Positives = 171/295 (57%), Gaps = 25/295 (8%)
Query: 90 VGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHC 143
VG G+FG+V A+ + TG+ VAIKK+++ + REL++++ L H NI++L
Sbjct: 18 VGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDI 77
Query: 144 FFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203
F S E++Y V E + ++R+ + + + +++ + YQI R L Y+H+
Sbjct: 78 FISP--LEDIYF--VTELLGTDLHRLLTS-----RPLEKQFIQYFLYQILRGLKYVHSA- 127
Query: 204 GICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVS-YICSRYYRAPELIFGATEY 262
G+ HRD+KP N+L+N + LK+CDFG A++ +P ++ Y+ +RYYRAPE++ +Y
Sbjct: 128 GVVHRDLKPSNILINENC-DLKICDFGLARI---QDPQMTGYVSTRYYRAPEIMLTWQKY 183
Query: 263 TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM-NPNYTEF-- 319
+DIWS GC+ AE+L G+PLFPG+ V+Q I +LGTP + I + + N F
Sbjct: 184 DVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFVQ 243
Query: 320 KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP 374
P+ +P P+ + F+ P A+DL+ + + P R +A EA HP+ DP
Sbjct: 244 SLPKREPVPFSEKFKN-ADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYHDP 297
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 194 bits (494), Expect = 4e-59
Identities = 105/301 (34%), Positives = 150/301 (49%), Gaps = 36/301 (11%)
Query: 88 HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALK 141
+ +G G++G+V++A+ +GEIVA+KKV D RE+ ++ L HPNIV LK
Sbjct: 13 NRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELK 72
Query: 142 HCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH- 200
K + LV+EY + + + N VK Q+ R L Y+H
Sbjct: 73 EV---VVGKHLDSIFLVMEYCEQDLASLLDNMPT---PFSESQVKCLMLQLLRGLQYLHE 126
Query: 201 NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSRYYRAPELIF 257
N I HRD+K NLL+ LK+ DFG A+ G P + + +YRAPEL+
Sbjct: 127 NFI--IHRDLKVSNLLLTDKGC-LKIADFGLARTY--GLPAKPMTPKVVTLWYRAPELLL 181
Query: 258 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--PN 315
G T YTTAID+W+ GC++AELL +PL PG+S ++QL II++LGTP + P
Sbjct: 182 GCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPL 241
Query: 316 YTEFKFPQ-----IKPH-PWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFD 369
+F P+ +K PW L + L+ Y P R TA EA +F
Sbjct: 242 VGKFTLPKQPYNNLKHKFPW-------LSEAGLRLLNFLLMYDPKKRATAEEALESSYFK 294
Query: 370 E 370
E
Sbjct: 295 E 295
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 191 bits (488), Expect = 1e-58
Identities = 110/306 (35%), Positives = 166/306 (54%), Gaps = 41/306 (13%)
Query: 80 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLD 133
QKV I E G++GVV++A+ + TGE+VA+KK+ D + RE+ +++ L+
Sbjct: 3 QKVEKIGE-----GTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 57
Query: 134 HPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQIC 193
HPNIV L + + +LYL V E++ + + + +PLI K Y +Q+
Sbjct: 58 HPNIVKLLDVIHT---ENKLYL--VFEFLHQDLKKFMDASPLSGIPLPLI--KSYLFQLL 110
Query: 194 RALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSRYY 250
+ LA+ H+ + HRD+KPQNLL+N +KL DFG A+ G P +Y + + +Y
Sbjct: 111 QGLAFCHSH-RVLHRDLKPQNLLINTEGA-IKLADFGLARAF--GVPVRTYTHEVVTLWY 166
Query: 251 RAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 310
RAPE++ G Y+TA+DIWS GC+ AE++ + LFPG+S +DQL I + LGTP
Sbjct: 167 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEV--- 223
Query: 311 CMNPNYTEFK-----FPQIKPHPWHKVFQKRLPP---EAVDLVCRFFQYSPNLRCTALEA 362
+ P T FP+ F K +PP + DL+ + Y PN R +A A
Sbjct: 224 -VWPGVTSLPDYKPSFPKWARQD----FSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAA 278
Query: 363 CVHPFF 368
HPFF
Sbjct: 279 LAHPFF 284
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 191 bits (487), Expect = 9e-58
Identities = 118/328 (35%), Positives = 178/328 (54%), Gaps = 33/328 (10%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV------LQDKRYKNRELQIMQMLDHPNI 137
Y + V+G GS+GVV A TGE VAIKK+ + D RE++++++L HP+I
Sbjct: 2 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDI 61
Query: 138 VALKHCFFSTTDKEELYLNLVLEYVPETVNRIAR---NYSRIHQRMPLIYVKLYTYQICR 194
V +KH + +E + +V E + ++++ + + + H + + YQ+ R
Sbjct: 62 VEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHH-------QFFLYQLLR 114
Query: 195 ALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN----VSYICSRYY 250
AL YIH + HRD+KP+N+L N +LK+CDFG A+V P Y+ +R+Y
Sbjct: 115 ALKYIHTA-NVFHRDLKPKNILANADC-KLKICDFGLARVAFNDTPTAIFWTDYVATRWY 172
Query: 251 RAPELIFGA--TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 308
RAPEL G+ ++YT AIDIWS GC+ AE+L G+PLFPG++ V QL I +LGTP+ E
Sbjct: 173 RAPELC-GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPET 231
Query: 309 I-KCMNPNYTEFKFPQIKPHPWHKVFQKRLP---PEAVDLVCRFFQYSPNLRCTALEACV 364
I + N + K P F ++ P P A+ L+ R + P R TA EA
Sbjct: 232 ISRVRNEKARRYLSSMRKKQP--VPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALA 289
Query: 365 HPFFDELRDPNTRLPNGRPLPPL-FNFK 391
P+F L R P+ +P+ L F F+
Sbjct: 290 DPYFKGLAKVE-REPSAQPITKLEFEFE 316
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 188 bits (480), Expect = 1e-57
Identities = 97/291 (33%), Positives = 142/291 (48%), Gaps = 46/291 (15%)
Query: 88 HVVGTGSFGVVFQAKCRETGEIVAIKKV-LQDKRYKN-----RELQIMQMLDHPNIVALK 141
++G GSFG V+ A ++TGE++A+K V L + RE++I+ L HPNIV
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIV--- 62
Query: 142 HCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 200
+ S D+E+ LN+ LEYV +++ + + + ++ + + ++ YT QI LAY+H
Sbjct: 63 RYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPV----IRKYTRQILEGLAYLH 118
Query: 201 NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL---VKGEPNVSYICSRYYRAPELIF 257
+ GI HRDIK N+LV+ +KL DFG AK L GE S + Y+ APE+I
Sbjct: 119 SN-GIVHRDIKGANILVDS-DGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIR 176
Query: 258 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 317
G EY A DIWS GC + E+ G+P + + I G P
Sbjct: 177 G-EEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEP------------- 222
Query: 318 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368
P+I H L EA D + + + P R TA E HPF
Sbjct: 223 ----PEIPEH---------LSEEAKDFLRKCLRRDPKKRPTADELLQHPFL 260
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 188 bits (480), Expect = 2e-57
Identities = 105/298 (35%), Positives = 171/298 (57%), Gaps = 29/298 (9%)
Query: 90 VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 143
+G G++GVV++A+ R T E +A+KK+ ++ + RE+ +++ + H NIV L+
Sbjct: 10 IGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDV 69
Query: 144 FFSTTDKEELYLNLVLEYVPETVNR---IARNYSRIHQRMPLIYVKLYTYQICRALAYIH 200
S E L LV EY+ + + + ++++ + R+ +K Y YQI R +AY H
Sbjct: 70 VHS-----EKRLYLVFEYLDLDLKKHMDSSPDFAK-NPRL----IKTYLYQILRGIAYCH 119
Query: 201 NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSRYYRAPELIF 257
+ + HRD+KPQNLL++ T+ LKL DFG A+ G P ++ + + +YRAPE++
Sbjct: 120 SH-RVLHRDLKPQNLLIDRRTNALKLADFGLARAF--GIPVRTFTHEVVTLWYRAPEILL 176
Query: 258 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--PN 315
G+ Y+T +DIWS GC+ AE++ +PLFPG+S +D+L +I ++LGTP E + P+
Sbjct: 177 GSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPD 236
Query: 316 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD 373
Y FP+ P V L P VDL+ + + P+ R TA A H +F +L D
Sbjct: 237 YKS-AFPKWPPKDLATVVPT-LEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDLGD 292
|
Length = 294 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 187 bits (477), Expect = 5e-57
Identities = 110/296 (37%), Positives = 160/296 (54%), Gaps = 36/296 (12%)
Query: 90 VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 143
+G G++G VF+AK RET EIVA+K+V D + RE+ +++ L H NIV L
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDV 67
Query: 144 FFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203
S DK+ L LV EY + + + + + + VK + +Q+ + LA+ H+
Sbjct: 68 LHS--DKK---LTLVFEYCDQDLKKY---FDSCNGDIDPEIVKSFMFQLLKGLAFCHSH- 118
Query: 204 GICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSRYYRAPELIFGAT 260
+ HRD+KPQNLL+N + +LKL DFG A+ G P Y + + +YR P+++FGA
Sbjct: 119 NVLHRDLKPQNLLINKNG-ELKLADFGLARAF--GIPVRCYSAEVVTLWYRPPDVLFGAK 175
Query: 261 EYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 319
Y+T+ID+WS GC+ AEL G+PLFPG DQL I ++LGTPT E P +
Sbjct: 176 LYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESW----PGVS-- 229
Query: 320 KFPQIKPHP-------WHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368
K P KP+P V +L DL+ +P R +A EA HP+F
Sbjct: 230 KLPDYKPYPMYPATTSLVNVV-PKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 184 bits (469), Expect = 4e-55
Identities = 107/313 (34%), Positives = 159/313 (50%), Gaps = 45/313 (14%)
Query: 90 VGTGSFGVVFQAKCRET--GEIVAIKKV-------LQDKRYKNRELQIMQML-DHPNIVA 139
+G G++G+V A+ ET E VAIKK+ + KR REL++++ H NI
Sbjct: 8 LGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKR-ALRELKLLRHFRGHKNITC 66
Query: 140 LKHCFFSTTDK-EELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
L ELYL E + +++I R+ Q + + + + YQI L Y
Sbjct: 67 LYDMDIVFPGNFNELYL--YEELMEADLHQIIRS----GQPLTDAHFQSFIYQILCGLKY 120
Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK----VLVKGEPNVS-YICSRYYRAP 253
IH+ + HRD+KP NLLVN +LK+CDFG A+ + ++ Y+ +R+YRAP
Sbjct: 121 IHSA-NVLHRDLKPGNLLVNADC-ELKICDFGLARGFSENPGENAGFMTEYVATRWYRAP 178
Query: 254 ELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE------ 307
E++ YT AID+WS GC++AELL +P+F G+ VDQL +I++VLGTP E
Sbjct: 179 EIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIG 238
Query: 308 EIKCMN-----PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEA 362
K N PN + F I P+ P A+DL+ + + P R + EA
Sbjct: 239 SPKAQNYIRSLPNIPKKPFESIFPNA---------NPLALDLLEKLLAFDPTKRISVEEA 289
Query: 363 CVHPFFDELRDPN 375
HP+ DP+
Sbjct: 290 LEHPYLAIWHDPD 302
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 183 bits (467), Expect = 4e-55
Identities = 99/304 (32%), Positives = 146/304 (48%), Gaps = 35/304 (11%)
Query: 91 GTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-------RELQIMQMLDHPNIVALKHC 143
G G+FG V++A+ +TG +VA+KK+L K+ RE++I++ L HPN+V L
Sbjct: 17 GEGTFGEVYKARQIKTGRVVALKKILM-HNEKDGFPITALREIKILKKLKHPNVVPLIDM 75
Query: 144 FFSTTDKE-----ELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
DK +Y+ V Y+ ++ + N + I K Y Q+ + Y
Sbjct: 76 AVERPDKSKRKRGSVYM--VTPYMDHDLSGLLEN-PSVKLTESQI--KCYMLQLLEGINY 130
Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY------------IC 246
+H I HRDIK N+L++ + LK+ DFG A+ PN +
Sbjct: 131 LH-ENHILHRDIKAANILID-NQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVV 188
Query: 247 SRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTR 306
+R+YR PEL+ G YTTA+DIW GCV AE+ +P+ G+S +DQL I K+ GTPT
Sbjct: 189 TRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCGTPTE 248
Query: 307 EEIKCMN--PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV 364
E P P + F K PE +DL+ + P R TA +A
Sbjct: 249 ETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLG-PEGLDLLSKLLSLDPYKRLTASDALE 307
Query: 365 HPFF 368
HP+F
Sbjct: 308 HPYF 311
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 182 bits (463), Expect = 3e-54
Identities = 108/301 (35%), Positives = 165/301 (54%), Gaps = 30/301 (9%)
Query: 90 VGTGSFGVVFQAKCRETGEIVAIKKV-------LQDKRYKNRELQIMQMLDHPNIVALKH 142
VG+G++G V A R TG VAIKK+ L KR REL++++ + H N++ L
Sbjct: 23 VGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKR-AYRELRLLKHMKHENVIGLLD 81
Query: 143 CFFSTTDKEELY-LNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
F + + LV+ ++ + ++ + H+++ ++ YQ+ + L YIH
Sbjct: 82 VFTPDLSLDRFHDFYLVMPFMGTDLGKLMK-----HEKLSEDRIQFLVYQMLKGLKYIHA 136
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 261
GI HRD+KP NL VN +LK+ DFG A+ Y+ +R+YRAPE+I
Sbjct: 137 A-GIIHRDLKPGNLAVNEDC-ELKILDFGLARQ--TDSEMTGYVVTRWYRAPEVILNWMH 192
Query: 262 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 317
YT +DIWS GC+MAE+L G+PLF G +DQL+EI+KV GTP++E ++ + NY
Sbjct: 193 YTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDAKNYV 252
Query: 318 EFKFPQIKPHPWHKVFQKRLP---PEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP 374
+ K P+ + K F+ LP P AV+++ + R TA EA HP+F+E DP
Sbjct: 253 K-KLPRFR----KKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHDP 307
Query: 375 N 375
Sbjct: 308 E 308
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 177 bits (452), Expect = 4e-54
Identities = 69/247 (27%), Positives = 121/247 (48%), Gaps = 40/247 (16%)
Query: 90 VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-----RELQIMQMLDHPNIVALKHCF 144
+G G FG V+ A+ ++TG+ VAIK + ++ RE++I++ L+HPNIV L F
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 145 FSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203
++E +L LV+EY ++ + + ++ + QI L Y+H+
Sbjct: 61 -----EDENHLYLVMEYCEGGSLKDLLKENEG---KLSEDEILRILLQILEGLEYLHSN- 111
Query: 204 GICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYIC-SRYYRAPELIFGATEY 262
GI HRD+KP+N+L++ ++KL DFG +K+L + + I + Y APE++ G Y
Sbjct: 112 GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYY 171
Query: 263 TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE-FKF 321
+ DIWS G ++ EL +L ++I+ K + + +
Sbjct: 172 SEKSDIWSLGVILYEL-------------PELKDLIR----------KMLQKDPEKRPSA 208
Query: 322 PQIKPHP 328
+I H
Sbjct: 209 KEILEHL 215
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 180 bits (458), Expect = 4e-54
Identities = 99/294 (33%), Positives = 162/294 (55%), Gaps = 31/294 (10%)
Query: 90 VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN----------RELQIMQMLDHPNIVA 139
+G G++GVV++ + ++TG+IVA+KK+ R ++ RE+ +++ L HPNIV
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKI----RLESEEEGVPSTAIREISLLKELQHPNIVC 63
Query: 140 LKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 199
L+ +E L L+ E++ + + + Q M VK Y YQI + + +
Sbjct: 64 LQDVLM-----QESRLYLIFEFLSMDLKKYL-DSLPKGQYMDAELVKSYLYQILQGILFC 117
Query: 200 HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSRYYRAPELI 256
H+ + HRD+KPQNLL++ + +KL DFG A+ G P Y + + +YRAPE++
Sbjct: 118 HS-RRVLHRDLKPQNLLID-NKGVIKLADFGLARAF--GIPVRVYTHEVVTLWYRAPEVL 173
Query: 257 FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--P 314
G+ Y+T +DIWS G + AE+ +PLF G+S +DQL I ++LGTPT + + P
Sbjct: 174 LGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLP 233
Query: 315 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368
+Y FP+ K + K L + +DL+ + Y P R +A +A HP+F
Sbjct: 234 DYKN-TFPKWKK-GSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 177 bits (450), Expect = 7e-53
Identities = 97/295 (32%), Positives = 150/295 (50%), Gaps = 30/295 (10%)
Query: 90 VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN----------RELQIMQMLD---HPN 136
+G G++G V++A+ TG VA+KKV R RE+ +++ L+ HPN
Sbjct: 7 IGEGAYGTVYKARDLNTGRFVALKKV----RVPLSEEGIPLSTLREIALLKQLESFEHPN 62
Query: 137 IVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
IV L EL L LV E+V + + + +P +K Q+ R +
Sbjct: 63 IVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPK--PGLPPETIKDLMRQLLRGV 120
Query: 197 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELI 256
++H I HRD+KPQN+LV Q+K+ DFG A++ S + + +YRAPE++
Sbjct: 121 DFLH-SHRIVHRDLKPQNILVT-SDGQVKIADFGLARIYSFEMALTSVVVTLWYRAPEVL 178
Query: 257 FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 316
++ Y T +D+WS GC+ AEL +PLF G S DQL +I V+G P+ EE N +
Sbjct: 179 LQSS-YATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWP-RNVSL 236
Query: 317 TEFKFPQIKPHPWHKVFQKRLP---PEAVDLVCRFFQYSPNLRCTALEACVHPFF 368
FP P F+ +P E +DL+ + ++P+ R +A EA HP+F
Sbjct: 237 PRSSFPSYTPRS----FKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 176 bits (448), Expect = 5e-52
Identities = 104/303 (34%), Positives = 160/303 (52%), Gaps = 23/303 (7%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKNR---ELQIMQMLDHPNI 137
Y + VG+G++G V A + TGE VAIKK+ Q + + R EL +++ + H N+
Sbjct: 17 YTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENV 76
Query: 138 VALKHCFFSTTDKEELY-LNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
+ L F S +E LV+ Y+ + +I + + V+ YQ+ L
Sbjct: 77 IGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKI------MGHPLSEDKVQYLVYQMLCGL 130
Query: 197 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELI 256
YIH+ GI HRD+KP NL VN +LK+ DFG A+ Y+ +R+YRAPE+I
Sbjct: 131 KYIHSA-GIIHRDLKPGNLAVNEDC-ELKILDFGLARH--ADAEMTGYVVTRWYRAPEVI 186
Query: 257 FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--- 313
Y +DIWS GC+MAE+L G+ LF G+ +DQL +I+KV G P E ++ +
Sbjct: 187 LNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKA 246
Query: 314 -PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR 372
+Y + P+ + +F + P+AVDL+ + + + R TA EA HP+FD R
Sbjct: 247 AKSYIK-SLPKYPRKDFSTLF-PKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFR 304
Query: 373 DPN 375
D +
Sbjct: 305 DAD 307
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 177 bits (449), Expect = 6e-52
Identities = 90/321 (28%), Positives = 135/321 (42%), Gaps = 48/321 (14%)
Query: 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-------RELQIMQMLDHP 135
SY +G GSFG V+ A+ R+ +VA+K + + K+ RE+QI+ L+HP
Sbjct: 1 SYRILRKLGEGSFGEVYLARDRK---LVALKVLAKKLESKSKEVERFLREIQILASLNHP 57
Query: 136 -NIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICR 194
NIV L F ++E L LV+EYV + QI
Sbjct: 58 PNIVKLYDFF-----QDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILS 112
Query: 195 ALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNV-------SYICS 247
AL Y+H+ GI HRDIKP+N+L++ +KL DFG AK+L + + +
Sbjct: 113 ALEYLHSK-GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGT 171
Query: 248 RYYRAPELIFGATE--YTTAIDIWSTGCVMAELLLGQPLFPGESG---VDQLVEIIKVLG 302
Y APE++ G + +++ DIWS G + ELL G P F GE Q ++II L
Sbjct: 172 PGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELP 231
Query: 303 TPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEA 362
TP P + + A DL+ + P R ++
Sbjct: 232 TP-------------------SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSD 272
Query: 363 CVHPFFDELRDPNTRLPNGRP 383
H L+ + L +
Sbjct: 273 LSHDLLAHLKLKESDLSDLLK 293
|
Length = 384 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 172 bits (438), Expect = 4e-51
Identities = 114/295 (38%), Positives = 160/295 (54%), Gaps = 30/295 (10%)
Query: 89 VVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKH 142
VVG G++GVV + + +ET EIVAIKK K REL++++ L NIV LK
Sbjct: 8 VVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKE 67
Query: 143 CFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPL----IYVKLYTYQICRALAY 198
F + +LYL V EYV +N + + MP V+ Y YQ+ +A+ +
Sbjct: 68 AF---RRRGKLYL--VFEYV-------EKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHW 115
Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN--VSYICSRYYRAPELI 256
H I HRDIKP+NLL++ H LKLCDFG A+ L +G Y+ +R+YR+PEL+
Sbjct: 116 CHKN-DIVHRDIKPENLLIS-HNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELL 173
Query: 257 FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM--NP 314
GA Y A+D+WS GC++ EL GQPLFPGES +DQL I KVLG E++K NP
Sbjct: 174 LGAP-YGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNP 232
Query: 315 NYTEFKFPQIK-PHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368
+ +FP + P + + L +DL+ + +P R + HP F
Sbjct: 233 RFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF 287
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 173 bits (440), Expect = 4e-51
Identities = 106/299 (35%), Positives = 164/299 (54%), Gaps = 23/299 (7%)
Query: 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-----RELQIMQMLDHPNI 137
+YI +G G++ VF+ + + T +VA+K++ + RE+ +++ L H NI
Sbjct: 7 TYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANI 66
Query: 138 VALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALA 197
V L TDK L LV EY+ + + + + I M + VK++ YQI R LA
Sbjct: 67 VTLHDIVH--TDKS---LTLVFEYLDKDLKQYMDDCGNI---MSMHNVKIFLYQILRGLA 118
Query: 198 YIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSRYYRAPE 254
Y H + HRD+KPQNLL+N +LKL DFG A+ K P +Y + + +YR P+
Sbjct: 119 YCHR-RKVLHRDLKPQNLLINERG-ELKLADFGLARA--KSVPTKTYSNEVVTLWYRPPD 174
Query: 255 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 314
++ G++EY+T ID+W GC+ E+ G+PLFPG + D+L I ++LGTPT E ++
Sbjct: 175 VLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISS 234
Query: 315 N--YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL 371
N + + FP+ KP P RL E ++L+ +F QY R +A EA H +F L
Sbjct: 235 NDEFKNYNFPKYKPQPLIN-HAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSL 292
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 174 bits (442), Expect = 1e-50
Identities = 109/307 (35%), Positives = 158/307 (51%), Gaps = 43/307 (14%)
Query: 90 VGTGSFGVVFQAKCRETGEIVAIKK---VLQD----KRYKNRELQIMQMLDHPNIV---- 138
+G G+FGVV+ G+ VA+KK V Q+ KR REL+++ H N++
Sbjct: 8 IGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVF-RELKMLCFFKHDNVLSALD 66
Query: 139 ----ALKHCFFSTTDKEELYLNLVLEYVPETVNR-IARNYSRIHQRMPLIYVKLYTYQIC 193
F EE+Y+ V E + +++ I Q + +VK++ YQI
Sbjct: 67 ILQPPHIDPF------EEIYV--VTELMQSDLHKIIVSP-----QPLSSDHVKVFLYQIL 113
Query: 194 RALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY-----ICSR 248
R L Y+H+ GI HRDIKP NLLVN + LK+CDFG A+V EP+ S + ++
Sbjct: 114 RGLKYLHSA-GILHRDIKPGNLLVNSNC-VLKICDFGLARV---EEPDESKHMTQEVVTQ 168
Query: 249 YYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 308
YYRAPE++ G+ YT+A+DIWS GC+ AELL + LF +S + QL I +LGTP+ E
Sbjct: 169 YYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEA 228
Query: 309 IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPP---EAVDLVCRFFQYSPNLRCTALEACVH 365
++ P V EAV L+CR + P+ R +A +A H
Sbjct: 229 MRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288
Query: 366 PFFDELR 372
P+ DE R
Sbjct: 289 PYLDEGR 295
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 171 bits (435), Expect = 5e-50
Identities = 102/329 (31%), Positives = 154/329 (46%), Gaps = 54/329 (16%)
Query: 77 NSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------------- 123
+ ++ H+ G G++G V +A TG+IVAIKKV + N
Sbjct: 5 SISERYIQKGAHL-GEGTYGKVEKAYDTLTGKIVAIKKV-KIIEISNDVTKDRQLVGMCG 62
Query: 124 ------RELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIH 177
REL+IM + H NI+ L + E ++NLV++ + + ++ +I
Sbjct: 63 IHFTTLRELKIMNEIKHENIMGLVDVYV-----EGDFINLVMDIMASDLKKVVD--RKI- 114
Query: 178 QRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK---- 233
R+ VK QI L +H HRD+ P N+ +N K+ DFG A+
Sbjct: 115 -RLTESQVKCILLQILNGLNVLHKWY-FMHRDLSPANIFINSKG-ICKIADFGLARRYGY 171
Query: 234 -VLVKGEPNVSYICSR----------YYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQ 282
+ R +YRAPEL+ GA +Y A+D+WS GC+ AELL G+
Sbjct: 172 PPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231
Query: 283 PLFPGESGVDQLVEIIKVLGTPTRE---EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPP 339
PLFPGE+ +DQL I ++LGTP + + K + P YTEF KP +F
Sbjct: 232 PLFPGENEIDQLGRIFELLGTPNEDNWPQAKKL-PLYTEFTP--RKPKDLKTIFPNA-SD 287
Query: 340 EAVDLVCRFFQYSPNLRCTALEACVHPFF 368
+A+DL+ + +P R +A EA H +F
Sbjct: 288 DAIDLLQSLLKLNPLERISAKEALKHEYF 316
|
Length = 335 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 170 bits (433), Expect = 5e-50
Identities = 106/322 (32%), Positives = 151/322 (46%), Gaps = 56/322 (17%)
Query: 90 VGTGSFGVVFQAKCRE--TGEIVAIKKVLQDKRYKN-------RELQIMQMLDHPNIVAL 140
+G G++G V++AK + G+ AIKK DK RE+ +++ L H N+V+L
Sbjct: 8 IGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSL 67
Query: 141 KHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSR-----IHQRMPLIYVKLYTYQICRA 195
F DK + L+ +Y + +I + + + I M VK +QI
Sbjct: 68 VEVFLEHADKS---VYLLFDYAEHDLWQIIKFHRQAKRVSIPPSM----VKSLLWQILNG 120
Query: 196 LAYIH-NCIGICHRDIKPQNLLV---NPHTHQLKLCDFGSA-------KVLVKGEPNVSY 244
+ Y+H N + HRD+KP N+LV P +K+ D G A K L +P V
Sbjct: 121 VHYLHSNWV--LHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVT 178
Query: 245 ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESG---------VDQLV 295
I +YRAPEL+ GA YT AIDIW+ GC+ AELL +P+F G DQL
Sbjct: 179 I---WYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLE 235
Query: 296 EIIKVLGTPTREE---IKCMNPNYTEFKFPQIKPHPW----HKVFQKRLP--PEAVDLVC 346
I +VLGTPT ++ IK M P Y K +K + DL+
Sbjct: 236 RIFEVLGTPTEKDWPDIKKM-PEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLR 294
Query: 347 RFFQYSPNLRCTALEACVHPFF 368
+ +Y P R TA EA HP+F
Sbjct: 295 KLLEYDPTKRITAEEALEHPYF 316
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 168 bits (427), Expect = 1e-49
Identities = 110/301 (36%), Positives = 166/301 (55%), Gaps = 30/301 (9%)
Query: 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPN 136
SY+ +G GS+ V++ R G++VA+K V+ K + RE +++ L H N
Sbjct: 6 SYLNLEKLGEGSYATVYKGISRINGQLVALK-VISMKTEEGVPFTAIREASLLKGLKHAN 64
Query: 137 IVALKHCFFSTTDKEELYLNLVLEYV-PETVNRIARNYSRIHQRMPLIYVKLYTYQICRA 195
IV L H T + L V EY+ + + ++ +H V+L+ +Q+ R
Sbjct: 65 IVLL-HDIIHTKET----LTFVFEYMHTDLAQYMIQHPGGLHPY----NVRLFMFQLLRG 115
Query: 196 LAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSRYYRA 252
LAYIH I HRD+KPQNLL++ + +LKL DFG A+ K P+ +Y + + +YR
Sbjct: 116 LAYIHG-QHILHRDLKPQNLLIS-YLGELKLADFGLARA--KSIPSQTYSSEVVTLWYRP 171
Query: 253 PELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGV-DQLVEIIKVLGTPTREEIKC 311
P+++ GAT+Y++A+DIW GC+ E+L GQP FPG S V +QL +I VLG PT +
Sbjct: 172 PDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPG 231
Query: 312 MN--PNYTEFKFPQIKPHPWHKVFQKRL--PPEAVDLVCRFFQYSPNLRCTALEACVHPF 367
++ PNY F KP V+ KRL PP+A DL + P R +A +A +HP+
Sbjct: 232 VSKLPNYKPEWFLPCKPQQLRVVW-KRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPY 290
Query: 368 F 368
F
Sbjct: 291 F 291
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 170 bits (431), Expect = 2e-49
Identities = 101/304 (33%), Positives = 158/304 (51%), Gaps = 21/304 (6%)
Query: 90 VGTGSFGVVFQAKCRETGEIVAIKKV------LQDKRYKNRELQIMQMLDHPNIVALKHC 143
VG+G++G V A + VA+KK+ L R REL++++ + H N++ L
Sbjct: 23 VGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDV 82
Query: 144 FFSTTDKEELY-LNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
F T E + LV + +N I + Q++ +V+ YQ+ R L YIH+
Sbjct: 83 FTPATSIENFNEVYLVTNLMGADLNNIVK-----CQKLSDEHVQFLIYQLLRGLKYIHSA 137
Query: 203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEY 262
GI HRD+KP N+ VN +L++ DFG A+ + Y+ +R+YRAPE++ Y
Sbjct: 138 -GIIHRDLKPSNVAVNEDC-ELRILDFGLARQ--ADDEMTGYVATRWYRAPEIMLNWMHY 193
Query: 263 TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 322
+DIWS GC+MAELL G+ LFPG +DQL I++V+GTP+ E +K ++ +
Sbjct: 194 NQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEHARKYIQ 253
Query: 323 QIKPHPWH---KVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLP 379
+ P K+F + P A+DL+ + + R +A EA HP+F + DP P
Sbjct: 254 SLPHMPQQDLKKIF-RGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQYHDPEDE-P 311
Query: 380 NGRP 383
P
Sbjct: 312 EAEP 315
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 168 bits (427), Expect = 2e-49
Identities = 98/308 (31%), Positives = 164/308 (53%), Gaps = 23/308 (7%)
Query: 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-----RELQIMQMLDHPNI 137
+YI +G G++ V++ + + T +VA+K++ + RE+ +++ L H NI
Sbjct: 7 TYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANI 66
Query: 138 VALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALA 197
V L H T E L LV EY+ + + + + + + VKL+ +Q+ R L
Sbjct: 67 VTL-HDIIHT----EKSLTLVFEYLDKDLKQYLDDCGNS---INMHNVKLFLFQLLRGLN 118
Query: 198 YIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSRYYRAPE 254
Y H + HRD+KPQNLL+N +LKL DFG A+ K P +Y + + +YR P+
Sbjct: 119 YCHR-RKVLHRDLKPQNLLINERG-ELKLADFGLARA--KSIPTKTYSNEVVTLWYRPPD 174
Query: 255 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM-- 312
++ G+T+Y+T ID+W GC+ E+ G+PLFPG + +QL I ++LGTPT E +
Sbjct: 175 ILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILS 234
Query: 313 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR 372
N + + +P+ + H RL + +L+ + Q+ R +A EA HP+F L
Sbjct: 235 NEEFKSYNYPKYRADCLHN-HAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLG 293
Query: 373 DPNTRLPN 380
+ +LP+
Sbjct: 294 ERIHKLPD 301
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 169 bits (430), Expect = 2e-49
Identities = 92/307 (29%), Positives = 158/307 (51%), Gaps = 44/307 (14%)
Query: 90 VGTGSFGVVFQAKCRETGEIVAIKK-VLQDKR---YKNRELQIMQMLDHPNIVALKHCFF 145
+G GS G+VF A + + VA+KK VL D + + RE++I++ LDH NIV +
Sbjct: 13 LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLG 72
Query: 146 S-----TTDKEELY----LNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
T D L + +V EY+ + + + + +L+ YQ+ R L
Sbjct: 73 PSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLE-----QGPLSEEHARLFMYQLLRGL 127
Query: 197 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY-------ICSRY 249
YIH+ + HRD+KP N+ +N LK+ DFG A+++ +P+ S+ + +++
Sbjct: 128 KYIHSA-NVLHRDLKPANVFINTEDLVLKIGDFGLARIV---DPHYSHKGYLSEGLVTKW 183
Query: 250 YRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQL---VEIIKVLGTPTR 306
YR+P L+ YT AID+W+ GC+ AE+L G+PLF G ++Q+ +E + V+ R
Sbjct: 184 YRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVREEDR 243
Query: 307 EEIKCMNPNYTEFKFPQIKPHPW--HKVFQKRLP---PEAVDLVCRFFQYSPNLRCTALE 361
E+ + P++ ++ + + LP PEA+D + + ++P R TA E
Sbjct: 244 NELLNVIPSF-------VRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEE 296
Query: 362 ACVHPFF 368
A +HP+
Sbjct: 297 ALMHPYM 303
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 168 bits (426), Expect = 9e-49
Identities = 104/298 (34%), Positives = 158/298 (53%), Gaps = 24/298 (8%)
Query: 90 VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 142
VG+G++G V A +TG VA+KK ++ KR REL++++ + H N++ L
Sbjct: 25 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 83
Query: 143 CFFSTTDKEELY-LNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
F EE + LV + +N I + Q++ +V+ YQI R L YIH+
Sbjct: 84 VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 138
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 261
I HRD+KP NL VN +LK+ DFG A+ + Y+ +R+YRAPE++
Sbjct: 139 A-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 194
Query: 262 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 317
Y +DIWS GC+MAELL G+ LFPG +DQL I++++GTP E +K ++ NY
Sbjct: 195 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 254
Query: 318 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 375
+ Q+ + VF P AVDL+ + + R TA +A H +F + DP+
Sbjct: 255 Q-SLTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 310
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 165 bits (420), Expect = 9e-49
Identities = 79/285 (27%), Positives = 128/285 (44%), Gaps = 42/285 (14%)
Query: 88 HVVGTGSFGVVFQAKCRETGEIVAIKKV-LQDKRYKN---RELQIMQMLDHPNIVALKHC 143
+G G FG V++A+ + TG+ VAIK + L+ K K E+QI++ HPNIV
Sbjct: 6 EKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGS 65
Query: 144 FFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
+ K+EL+ +V+E+ ++ + ++ +Q + + ++ + L Y+H+
Sbjct: 66 YL---KKDELW--IVMEFCSGGSLKDLLKST---NQTLTESQIAYVCKELLKGLEYLHS- 116
Query: 203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEY 262
GI HRDIK N+L+ ++KL DFG + L + + + + Y+ APE+I G Y
Sbjct: 117 NGIIHRDIKAANILLT-SDGEVKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVING-KPY 174
Query: 263 TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 322
DIWS G EL G+P + E + + I G P
Sbjct: 175 DYKADIWSLGITAIELAEGKPPY-SELPPMKALFKIATNGPP---------------GLR 218
Query: 323 QIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 367
P W E D + + Q +P R TA + HPF
Sbjct: 219 --NPEKW--------SDEFKDFLKKCLQKNPEKRPTAEQLLKHPF 253
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 164 bits (417), Expect = 2e-48
Identities = 91/292 (31%), Positives = 137/292 (46%), Gaps = 55/292 (18%)
Query: 90 VGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKR--YKNRELQIMQMLDHPNIVALKH 142
+G GSFG V + ++TG++ A+K K+++ K + E I+ ++HP IV L H
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKL-H 59
Query: 143 CFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 200
F T +K L LVLEY P E + +++ R + Y +I AL Y+H
Sbjct: 60 YAFQTEEK----LYLVLEYAPGGELFSHLSK-----EGRFSEERARFYAAEIVLALEYLH 110
Query: 201 NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYIC-SRYYRAPELIFGA 259
+ GI +RD+KP+N+L++ H +KL DFG AK L + C + Y APE++ G
Sbjct: 111 SL-GIIYRDLKPENILLDADGH-IKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGK 168
Query: 260 TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 319
Y A+D WS G ++ E+L G+P F E ++ E I
Sbjct: 169 -GYGKAVDWWSLGVLLYEMLTGKPPFYAED-RKEIYEKIL----------------KDPL 210
Query: 320 KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEA-CV--HPFF 368
+FP + L PEA DL+ Q P R + A + HPFF
Sbjct: 211 RFP------------EFLSPEARDLISGLLQKDPTKRLGSGGAEEIKAHPFF 250
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 164 bits (417), Expect = 4e-48
Identities = 97/296 (32%), Positives = 156/296 (52%), Gaps = 23/296 (7%)
Query: 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-----RELQIMQMLDHPNI 137
+Y+ +G G++ VF+ + + T +VA+K++ + RE+ +++ L H NI
Sbjct: 6 TYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANI 65
Query: 138 VALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALA 197
V L H T E L LV EY+ + + N + M + VK++ +Q+ R L+
Sbjct: 66 VTL-HDIIHT----ERCLTLVFEYLDSDLKQYLDNCGNL---MSMHNVKIFMFQLLRGLS 117
Query: 198 YIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSRYYRAPE 254
Y H I HRD+KPQNLL+N +LKL DFG A+ K P +Y + + +YR P+
Sbjct: 118 YCHK-RKILHRDLKPQNLLINEKG-ELKLADFGLARA--KSVPTKTYSNEVVTLWYRPPD 173
Query: 255 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK--CM 312
++ G+TEY+T ID+W GC++ E+ G+P+FPG + ++L I ++LGTPT E
Sbjct: 174 VLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITS 233
Query: 313 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368
N + + FPQ + P RL + +DL+ Y R +A A H +F
Sbjct: 234 NEEFRSYLFPQYRAQPL-INHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 159 bits (403), Expect = 8e-46
Identities = 97/310 (31%), Positives = 150/310 (48%), Gaps = 53/310 (17%)
Query: 89 VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKH 142
+G G++G V++A+ ++TGE+VA+KKV D + RE++I++ L+H NIV LK
Sbjct: 14 QIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKE 73
Query: 143 CFFSTTD-----KEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTY------- 190
D K++ LV EY+ H M L+ L +
Sbjct: 74 IVTDKQDALDFKKDKGAFYLVFEYMD-------------HDLMGLLESGLVHFSEDHIKS 120
Query: 191 ---QICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE--PNVSYI 245
Q+ L Y H HRDIK N+L+N + Q+KL DFG A++ E P + +
Sbjct: 121 FMKQLLEGLNYCHK-KNFLHRDIKCSNILLN-NKGQIKLADFGLARLYNSEESRPYTNKV 178
Query: 246 CSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPT 305
+ +YR PEL+ G Y AID+WS GC++ EL +P+F + QL I ++ G+P
Sbjct: 179 ITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPC 238
Query: 306 REEIKCMNPNYTEFK-FPQIKPHPWHKVFQKRL-------PPEAVDLVCRFFQYSPNLRC 357
+ P+ + F +KP K +++RL P A+DL+ P+ RC
Sbjct: 239 ----PAVWPDVIKLPYFNTMKP---KKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRC 291
Query: 358 TALEACVHPF 367
TA EA P+
Sbjct: 292 TAEEALNSPW 301
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 154 bits (392), Expect = 1e-43
Identities = 103/319 (32%), Positives = 161/319 (50%), Gaps = 44/319 (13%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKR-YKNRELQIMQMLDHP 135
Y +G+G+ G+V A TG+ VAIKK V KR Y REL +M++++H
Sbjct: 18 YQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAY--RELVLMKLVNHK 75
Query: 136 NIVALKHCFFSTTDK-----EELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTY 190
NI+ L + F T K +++YL V+E + + ++ H+RM + Y
Sbjct: 76 NIIGLLNVF--TPQKSLEEFQDVYL--VMELMDANLCQVI-QMDLDHERMSYL-----LY 125
Query: 191 QICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYY 250
Q+ + ++H+ GI HRD+KP N++V LK+ DFG A+ Y+ +RYY
Sbjct: 126 QMLCGIKHLHSA-GIIHRDLKPSNIVVK-SDCTLKILDFGLARTAGTSFMMTPYVVTRYY 183
Query: 251 RAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 310
RAPE+I G Y +DIWS GC+M E++ G LFPG +DQ +II+ LGTP+ E +
Sbjct: 184 RAPEVILGMG-YKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMS 242
Query: 311 CMNP---NYTEFKFPQIKPHPWHKVF------------QKRLPPEAVDLVCRFFQYSPNL 355
+ P NY E + P+ + + ++F K +A DL+ + P
Sbjct: 243 RLQPTVRNYVENR-PKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEK 301
Query: 356 RCTALEACVHPFFDELRDP 374
R + +A HP+ + DP
Sbjct: 302 RISVDDALQHPYINVWYDP 320
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 148 bits (375), Expect = 1e-41
Identities = 93/302 (30%), Positives = 141/302 (46%), Gaps = 34/302 (11%)
Query: 90 VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKH- 142
+G G+FG VF+A+ ++T +IVA+KKVL + + RE++I+Q+L H N+V L
Sbjct: 20 IGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 79
Query: 143 CFFSTT----DKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
C T K YL V E+ + +A S + + L +K + L Y
Sbjct: 80 CRTKATPYNRYKGSFYL--VFEFCE---HDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYY 134
Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV---KGEPN--VSYICSRYYRAP 253
IH I HRD+K N+L+ LKL DFG A+ +PN + + + +YR P
Sbjct: 135 IHRN-KILHRDMKAANILITKDG-ILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPP 192
Query: 254 ELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI-KCM 312
EL+ G +Y ID+W GC+MAE+ P+ G + QL I ++ G+ T E
Sbjct: 193 ELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEVWPGVD 252
Query: 313 N-PNYTEFKFPQ-----IKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHP 366
+ + + PQ +K V P A+DL+ + P R A A H
Sbjct: 253 KLELFKKMELPQGQKRKVKERLKPYVKD----PHALDLIDKLLVLDPAKRIDADTALNHD 308
Query: 367 FF 368
FF
Sbjct: 309 FF 310
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 143 bits (362), Expect = 5e-40
Identities = 94/296 (31%), Positives = 147/296 (49%), Gaps = 32/296 (10%)
Query: 90 VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRE-------------LQIMQMLDHPN 136
+G G++G V++A+ +G VA+K V R + E L+ ++ DHPN
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSV----RVQTNEDGLPLSTVREVALLKRLEAFDHPN 63
Query: 137 IVALKH-CFFSTTDKEELYLNLVLEYVPETVNRIARNY-SRIHQR-MPLIYVKLYTYQIC 193
IV L C S TD+E + LV E+V + + R Y ++ +P +K Q
Sbjct: 64 IVRLMDVCATSRTDRE-TKVTLVFEHVDQDL----RTYLDKVPPPGLPAETIKDLMRQFL 118
Query: 194 RALAYIH-NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRA 252
R L ++H NCI HRD+KP+N+LV Q+KL DFG A++ + + +YRA
Sbjct: 119 RGLDFLHANCI--VHRDLKPENILVTSGG-QVKLADFGLARIYSCQMALTPVVVTLWYRA 175
Query: 253 PELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 312
PE++ +T Y T +D+WS GC+ AE+ +PLF G S DQL +I ++G P ++
Sbjct: 176 PEVLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWP-R 233
Query: 313 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368
+ F P P V + + L+ ++P+ R +A A HPFF
Sbjct: 234 DVTLPRGAFSPRGPRPVQSVVPE-IEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 141 bits (359), Expect = 9e-40
Identities = 65/217 (29%), Positives = 107/217 (49%), Gaps = 22/217 (10%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV------LQDKRYKNRELQIMQMLDHPNI 137
Y +G GSFG V+ + + G++ +K++ +++ E++I++ L+HPNI
Sbjct: 2 YEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNI 61
Query: 138 VALKHCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
+ F +E+ L +V+EY +++ + + + P + + Q+C AL
Sbjct: 62 IKYYESF-----EEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLAL 116
Query: 197 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR----YYRA 252
Y+H+ I HRDIKPQN+ + +KL DFG +KVL V + YY +
Sbjct: 117 KYLHS-RKILHRDIKPQNIFLT-SNGLVKLGDFGISKVL---SSTVDLAKTVVGTPYYLS 171
Query: 253 PELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGES 289
PEL Y DIWS GCV+ EL + F GE+
Sbjct: 172 PELCQNK-PYNYKSDIWSLGCVLYELCTLKHPFEGEN 207
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 141 bits (356), Expect = 2e-39
Identities = 90/287 (31%), Positives = 134/287 (46%), Gaps = 46/287 (16%)
Query: 90 VGTGSFGVVFQAKCRETGEIVAIKKVL---QDKRYK------NRELQIMQMLDHPNIVAL 140
+G+GSFG V++ + G+ A+K+V + + +E+ ++ L HPNIV
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQ- 66
Query: 141 KHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 200
+ T++EE L + LE VP +A+ + + P ++LYT QI L Y+H
Sbjct: 67 ----YLGTEREEDNLYIFLELVPG--GSLAKLLKK-YGSFPEPVIRLYTRQILLGLEYLH 119
Query: 201 NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGAT 260
+ HRDIK N+LV+ +KL DFG AK +V+ S+ S Y+ APE+I
Sbjct: 120 D-RNTVHRDIKGANILVDT-NGVVKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIAQQG 177
Query: 261 EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 320
Y A DIWS GC + E+ G+P + GV + +I + P
Sbjct: 178 GYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELP---------------- 221
Query: 321 FPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 367
P P H L EA D + + Q P+LR TA E HPF
Sbjct: 222 -----PIPDH------LSDEAKDFILKCLQRDPSLRPTAAELLEHPF 257
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 140 bits (355), Expect = 6e-39
Identities = 101/302 (33%), Positives = 158/302 (52%), Gaps = 26/302 (8%)
Query: 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV-LQDKR----YKNRELQIMQMLDHPNI 137
SY +G GS+ V++ K + G++VA+K + LQ++ RE +++ L H NI
Sbjct: 6 SYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANI 65
Query: 138 VALKHCFFSTTDKEELYLNLVLEYV-PETVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
V L H T + L LV EYV + + ++ +H VKL+ +Q+ R L
Sbjct: 66 VLL-HDIIHTKET----LTLVFEYVHTDLCQYMDKHPGGLHPE----NVKLFLFQLLRGL 116
Query: 197 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSRYYRAP 253
+YIH I HRD+KPQNLL++ T +LKL DFG A+ K P+ +Y + + +YR P
Sbjct: 117 SYIHQRY-ILHRDLKPQNLLIS-DTGELKLADFGLARA--KSVPSHTYSNEVVTLWYRPP 172
Query: 254 ELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGV-DQLVEIIKVLGTPTREEIKCM 312
+++ G+TEY+T +D+W GC+ E++ G FPG + DQL I VLGTP + +
Sbjct: 173 DVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGV 232
Query: 313 N--PNYTEFKFPQIKPHPWHKVFQK-RLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFD 369
+ P++ +F P + + K A DL + Q P R +A A H +F
Sbjct: 233 HSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFS 292
Query: 370 EL 371
+L
Sbjct: 293 DL 294
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 136 bits (344), Expect = 1e-37
Identities = 86/294 (29%), Positives = 137/294 (46%), Gaps = 50/294 (17%)
Query: 88 HVVGTGSFGVVFQAKCRETGEIVAIKKV-LQDKRYKN-----RELQIMQMLDHPNIVALK 141
+ +G G+FG V+ A +TGE++A+K++ +QD K E++++++L HPN+V
Sbjct: 6 NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVK-- 63
Query: 142 HCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 200
+ +E++Y+ +EY T+ + + RI + +++YT Q+ LAY+H
Sbjct: 64 -YYGVEVHREKVYI--FMEYCSGGTLEELLE-HGRI---LDEHVIRVYTLQLLEGLAYLH 116
Query: 201 NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK-----GEPNVSYICSRYYRAPEL 255
+ GI HRDIKP N+ ++ H +KL DFG A L GE S + Y APE+
Sbjct: 117 SH-GIVHRDIKPANIFLD-HNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEV 174
Query: 256 IFGAT--EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 313
I G + A DIWS GCV+ E+ G+ + Q++ + P
Sbjct: 175 ITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPP-------- 226
Query: 314 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 367
P +L PE D + R + P R TA E HPF
Sbjct: 227 -------IPDS----------LQLSPEGKDFLDRCLESDPKKRPTASELLQHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 136 bits (344), Expect = 2e-37
Identities = 88/320 (27%), Positives = 138/320 (43%), Gaps = 77/320 (24%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKR--YKNRELQIMQMLD-HP 135
+ ++G GSF V AK +ET + AIK +++++K+ Y E +++ L+ HP
Sbjct: 3 FKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHP 62
Query: 136 NIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRA 195
I+ L + F D+E LY VLEY P N Y R + + + Y +I A
Sbjct: 63 GIIKLYYTF---QDEENLY--FVLEYAP---NGELLQYIRKYGSLDEKCTRFYAAEILLA 114
Query: 196 LAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL----VKGEPNVSYICSRY-- 249
L Y+H+ GI HRD+KP+N+L++ H +K+ DFG+AKVL
Sbjct: 115 LEYLHSK-GIIHRDLKPENILLDKDMH-IKITDFGTAKVLDPNSSPESNKGDATNIDSQI 172
Query: 250 ---------------YRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQL 294
Y +PEL+ + D+W+ GC++ ++L G+P F G + + L
Sbjct: 173 EKNRRRFASFVGTAEYVSPELL-NEKPAGKSSDLWALGCIIYQMLTGKPPFRGSN--EYL 229
Query: 295 V--EIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYS 352
+I+K E+ FP PP+A DL+ +
Sbjct: 230 TFQKILK-----------------LEYSFPPN------------FPPDAKDLIEKLLVLD 260
Query: 353 PNLRCTALEACV----HPFF 368
P R E HPFF
Sbjct: 261 PQDRLGVNEGYDELKAHPFF 280
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 134 bits (339), Expect = 5e-37
Identities = 87/288 (30%), Positives = 139/288 (48%), Gaps = 48/288 (16%)
Query: 89 VVGTGSFGVVFQAKCRETGEIVAIKKV-LQDKRYKN-----RELQIMQMLDHPNIVALKH 142
++G G+FGVV++ ETG+ VAIK++ L+ + + +E+ +++ L HPNIV
Sbjct: 7 LIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIG 66
Query: 143 CFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
+ L ++LEY ++ +I + + + + V +Y YQ+ + LAY+H
Sbjct: 67 SI-----ETSDSLYIILEYAENGSLRQIIKKFGPFPESL----VAVYVYQVLQGLAYLHE 117
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSA-KVLVKGEPNVSYICSRYYRAPELIFGAT 260
G+ HRDIK N+L +KL DFG A K+ + + S + + Y+ APE+I +
Sbjct: 118 -QGVIHRDIKAANILTTKDGV-VKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEM-S 174
Query: 261 EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 320
+TA DIWS GC + ELL G P + +NP F+
Sbjct: 175 GASTASDIWSLGCTVIELLTGNPPYYD------------------------LNPMAALFR 210
Query: 321 FPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368
Q HP + + PE D + + FQ PNLR TA + HP+
Sbjct: 211 IVQ-DDHP---PLPEGISPELKDFLMQCFQKDPNLRPTAKQLLKHPWI 254
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 131 bits (332), Expect = 8e-36
Identities = 83/271 (30%), Positives = 135/271 (49%), Gaps = 45/271 (16%)
Query: 93 GSFGVVFQAKCRETGEIVAIKKV-LQDKRYKNR------ELQIMQMLDHPNIVALKHCFF 145
G++G VF AK + TG+I AIK + D KN+ E I+ P +V L ++
Sbjct: 4 GAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKL---YY 60
Query: 146 STTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG 204
S K+ LYL V+EY+P + + N + + + ++Y +I AL Y+H+ G
Sbjct: 61 SFQGKKNLYL--VMEYLPGGDLASLLENVGSLDEDV----ARIYIAEIVLALEYLHSN-G 113
Query: 205 ICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE---------PNVSYICSRYYRAPEL 255
I HRD+KP N+L++ + H LKL DFG +KV + + + + Y APE+
Sbjct: 114 IIHRDLKPDNILIDSNGH-LKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEV 172
Query: 256 IFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEII--KVLGTPTREEI---- 309
I G ++ +D WS GC++ E L+G P F GE+ +++ + I + P E+
Sbjct: 173 ILGQG-HSKTVDWWSLGCILYEFLVGIPPFHGET-PEEIFQNILNGKIEWPEDVEVSDEA 230
Query: 310 -----KCMNPNYTE---FK-FPQIKPHPWHK 331
K + P+ + K +IK HP+ K
Sbjct: 231 IDLISKLLVPDPEKRLGAKSIEEIKNHPFFK 261
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 134 bits (337), Expect = 9e-36
Identities = 98/305 (32%), Positives = 154/305 (50%), Gaps = 29/305 (9%)
Query: 90 VGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKNR---ELQIMQMLDHPNIVALKHC 143
+G+G+ G+V A VAIKK+ Q++ + R EL +M+ ++H NI++L +
Sbjct: 25 IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 84
Query: 144 FFSTTDKEELY-LNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
F EE + LV+E + + ++ + H+RM + YQ+ + ++H+
Sbjct: 85 FTPQKSLEEFQDVYLVMELMDANLCQVIQ-MELDHERMSYLL-----YQMLCGIKHLHSA 138
Query: 203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEY 262
GI HRD+KP N++V LK+ DFG A+ Y+ +RYYRAPE+I G Y
Sbjct: 139 -GIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-Y 195
Query: 263 TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP---NYTE- 318
+DIWS GC+M E++ + LFPG +DQ ++I+ LGTP E +K + P NY E
Sbjct: 196 KENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVEN 255
Query: 319 ------FKFPQIKPH---PWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFD 369
FP++ P P K +A DL+ + P R + EA HP+ +
Sbjct: 256 RPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYIN 315
Query: 370 ELRDP 374
DP
Sbjct: 316 VWYDP 320
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 134 bits (337), Expect = 1e-35
Identities = 95/305 (31%), Positives = 154/305 (50%), Gaps = 29/305 (9%)
Query: 90 VGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKNR---ELQIMQMLDHPNIVALKHC 143
+G+G+ G+V A G VA+KK+ Q++ + R EL +++ ++H NI++L +
Sbjct: 29 IGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNV 88
Query: 144 FFSTTDKEELY-LNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
F EE + LV+E + + ++ + H+RM + YQ+ + ++H+
Sbjct: 89 FTPQKSLEEFQDVYLVMELMDANLCQVI-HMELDHERMSYLL-----YQMLCGIKHLHSA 142
Query: 203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEY 262
GI HRD+KP N++V LK+ DFG A+ Y+ +RYYRAPE+I G Y
Sbjct: 143 -GIIHRDLKPSNIVVKSDC-TLKILDFGLARTACTNFMMTPYVVTRYYRAPEVILG-MGY 199
Query: 263 TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP---NYTEF 319
+DIWS GC+M EL+ G +F G +DQ ++I+ LGTP+ E + + P NY E
Sbjct: 200 KENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTVRNYVEN 259
Query: 320 K-------FPQIKPH---PWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFD 369
+ F ++ P P K +A DL+ + P+ R + EA HP+
Sbjct: 260 RPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYIT 319
Query: 370 ELRDP 374
DP
Sbjct: 320 VWYDP 324
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 129 bits (327), Expect = 4e-35
Identities = 74/241 (30%), Positives = 127/241 (52%), Gaps = 21/241 (8%)
Query: 88 HVVGTGSFGVVFQAKCRETGEIVAIKKVL----QDKRYK-NRELQIMQMLDHPNIVALKH 142
V+G GS GVV++ + + TG+I A+KK+ ++ R + REL+ ++ + P +V
Sbjct: 7 KVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYG 66
Query: 143 CFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
F+ E +++VLEY+ ++ + + ++P + QI + L Y+H
Sbjct: 67 AFYK-----EGEISIVLEYMDGGSLADLLK----KVGKIPEPVLAYIARQILKGLDYLHT 117
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-EPNVSYICSRYYRAPELIFGAT 260
I HRDIKP NLL+N ++K+ DFG +KVL + +++ + Y +PE I G +
Sbjct: 118 KRHIIHRDIKPSNLLIN-SKGEVKIADFGISKVLENTLDQCNTFVGTVTYMSPERIQGES 176
Query: 261 EYTTAIDIWSTGCVMAELLLGQ-P-LFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 318
Y+ A DIWS G + E LG+ P L PG+ +L++ I G P + +P + +
Sbjct: 177 -YSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAI-CDGPPPSLPAEEFSPEFRD 234
Query: 319 F 319
F
Sbjct: 235 F 235
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 130 bits (329), Expect = 1e-34
Identities = 96/306 (31%), Positives = 155/306 (50%), Gaps = 31/306 (10%)
Query: 90 VGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKNR---ELQIMQMLDHPNIVALKHC 143
+G+G+ G+V A VAIKK+ Q++ + R EL +M+ ++H NI+ L +
Sbjct: 32 IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV 91
Query: 144 FFSTTDKEELY-LNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
F EE + +V+E + + ++ + H+RM + YQ+ + ++H+
Sbjct: 92 FTPQKSLEEFQDVYIVMELMDANLCQVIQ-MELDHERMSYLL-----YQMLCGIKHLHSA 145
Query: 203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEY 262
GI HRD+KP N++V LK+ DFG A+ Y+ +RYYRAPE+I G Y
Sbjct: 146 -GIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-Y 202
Query: 263 TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP---NYTEF 319
+DIWS GC+M E++ G LFPG +DQ ++I+ LGTP E +K + P Y E
Sbjct: 203 KENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVEN 262
Query: 320 KFPQIKPHPWHKVFQKRLPP-----------EAVDLVCRFFQYSPNLRCTALEACVHPFF 368
+ P+ + + K+F L P +A DL+ + + R + EA HP+
Sbjct: 263 R-PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYI 321
Query: 369 DELRDP 374
+ DP
Sbjct: 322 NVWYDP 327
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 128 bits (323), Expect = 2e-34
Identities = 76/290 (26%), Positives = 124/290 (42%), Gaps = 47/290 (16%)
Query: 89 VVGTGSFGVVFQAKCRETGEIVAIKKVL--QDKRYKN---RELQIMQMLDHPNIVALKHC 143
+G G+ GVV + R TG+I+A+K + ++ + REL I+ + P IV
Sbjct: 8 ELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGA 67
Query: 144 FFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203
F++ D +++ +EY+ + + + R+P + + + L Y+H
Sbjct: 68 FYNNGD-----ISICMEYMDGG--SLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKH 120
Query: 204 GICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYT 263
I HRD+KP N+LVN Q+KLCDFG + LV +++ + Y APE I G +Y+
Sbjct: 121 KIIHRDVKPSNILVN-SRGQIKLCDFGVSGQLVNSLAK-TFVGTSSYMAPERIQG-NDYS 177
Query: 264 TAIDIWSTGCVMAELLLGQPLFPGESG-----VDQLVEIIKVLGTPTREEIKCMNPNYTE 318
DIWS G + EL G+ +P E+ + L I+ P
Sbjct: 178 VKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVN------------EPP---- 221
Query: 319 FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368
P++ + P+ D V P R + E HPF
Sbjct: 222 ---PRLPSGKF--------SPDFQDFVNLCLIKDPRERPSYKELLEHPFI 260
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 127 bits (319), Expect = 8e-34
Identities = 93/304 (30%), Positives = 154/304 (50%), Gaps = 29/304 (9%)
Query: 80 QKVSYIAEHVVGTGSFGVVFQAK-CRETGEIVAIKKVLQDKRYKN------RELQIMQML 132
Q+ +AE +G G++G VF+A+ + G VA+K+V + RE+ +++ L
Sbjct: 1 QQYECVAE--IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 58
Query: 133 D---HPNIVAL-KHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLY 188
+ HPN+V L C S TD+E L LV E+V + + +P +K
Sbjct: 59 ETFEHPNVVRLFDVCTVSRTDRET-KLTLVFEHVDQDLTTYLDKVP--EPGVPTETIKDM 115
Query: 189 TYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR 248
+Q+ R L ++H+ + HRD+KPQN+LV + Q+KL DFG A++ S + +
Sbjct: 116 MFQLLRGLDFLHSH-RVVHRDLKPQNILVTS-SGQIKLADFGLARIYSFQMALTSVVVTL 173
Query: 249 YYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 308
+YRAPE++ ++ Y T +D+WS GC+ AE+ +PLF G S VDQL +I+ V+G P E+
Sbjct: 174 WYRAPEVLLQSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED 232
Query: 309 IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPE----AVDLVCRFFQYSPNLRCTALEACV 364
P + ++ + DL+ + ++P R +A A
Sbjct: 233 W----PRDVALPRQAFHSKSAQPI--EKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286
Query: 365 HPFF 368
HP+F
Sbjct: 287 HPYF 290
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 126 bits (319), Expect = 1e-33
Identities = 66/207 (31%), Positives = 111/207 (53%), Gaps = 26/207 (12%)
Query: 89 VVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKRYK--NRELQIMQMLDHPNIVALK 141
+GTGSFG V + + +G+ A+K K+++ K+ + E +I+Q + HP +V L
Sbjct: 8 TLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLY 67
Query: 142 HCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 199
F +++ L LV+EYVP E + + ++ R P + Y Q+ AL Y+
Sbjct: 68 GSF-----QDDSNLYLVMEYVPGGELFSHLRKS-----GRFPEPVARFYAAQVVLALEYL 117
Query: 200 HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYIC-SRYYRAPELIFG 258
H+ I +RD+KP+NLL++ + +K+ DFG AK + + +C + Y APE+I
Sbjct: 118 HSL-DIVYRDLKPENLLLDSDGY-IKITDFGFAKRV---KGRTYTLCGTPEYLAPEIILS 172
Query: 259 ATEYTTAIDIWSTGCVMAELLLGQPLF 285
Y A+D W+ G ++ E+L G P F
Sbjct: 173 -KGYGKAVDWWALGILIYEMLAGYPPF 198
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 2e-32
Identities = 67/238 (28%), Positives = 111/238 (46%), Gaps = 48/238 (20%)
Query: 87 EHVVGTGSFGVVFQAKCR----ETGEIVAIKKVLQDKRYKN-----RELQIMQMLDHPNI 137
+G G+FG V++ + VA+K + +D + RE +IM+ LDHPNI
Sbjct: 4 GKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNI 63
Query: 138 VALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKL--YTYQICRA 195
V L T++E L +V+EY+P +Y R ++ L L + QI R
Sbjct: 64 VKLLGV---CTEEEPLM--IVMEYMP---GGDLLDYLRKNRPKELSLSDLLSFALQIARG 115
Query: 196 LAYIH--NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR-- 251
+ Y+ N I HRD+ +N LV +K+ DFG ++ L + YY+
Sbjct: 116 MEYLESKNFI---HRDLAARNCLVG-ENLVVKISDFGLSRDLYDDD---------YYKVK 162
Query: 252 ---------APELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQLVEIIK 299
APE + ++T+ D+WS G ++ E+ LG+ +PG S +++E +K
Sbjct: 163 GGKLPIRWMAPESLK-EGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMS-NAEVLEYLK 218
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 121 bits (306), Expect = 4e-32
Identities = 67/237 (28%), Positives = 115/237 (48%), Gaps = 47/237 (19%)
Query: 87 EHVVGTGSFGVVFQAKCRE----TGEIVAIKKVLQDKRYKN-----RELQIMQMLDHPNI 137
+G G+FG V++ K + VA+K + +D + RE +IM+ LDHPN+
Sbjct: 4 GKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNV 63
Query: 138 VALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQ-RMPLIYVKLYTYQICRAL 196
V L T++E LY +V+EY+ +Y R ++ ++ L + + QI R +
Sbjct: 64 VKLLGV---CTEEEPLY--IVMEYME---GGDLLSYLRKNRPKLSLSDLLSFALQIARGM 115
Query: 197 AYIH--NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR--- 251
Y+ N I HRD+ +N LV +K+ DFG ++ L + YYR
Sbjct: 116 EYLESKNFI---HRDLAARNCLVG-ENLVVKISDFGLSRDLYDDD---------YYRKRG 162
Query: 252 --------APELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQLVEIIK 299
APE + ++T+ D+WS G ++ E+ LG+ +PG S ++++E +K
Sbjct: 163 GKLPIRWMAPESLK-EGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMS-NEEVLEYLK 217
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 122 bits (309), Expect = 1e-31
Identities = 90/320 (28%), Positives = 138/320 (43%), Gaps = 79/320 (24%)
Query: 89 VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 141
V+G G+FG V+ + ++TG++ A+K + + K ++ I+ D P IV L
Sbjct: 8 VIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKL- 66
Query: 142 HCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 199
++S D+E LY LV+EY+P + +N + R P + Y ++ AL +
Sbjct: 67 --YYSFQDEEHLY--LVMEYMPGGDLMNLLIR-----KDVFPEETARFYIAELVLALDSV 117
Query: 200 HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK-----------------------VLV 236
H +G HRDIKP N+L++ H +KL DFG K VLV
Sbjct: 118 HK-LGFIHRDIKPDNILIDADGH-IKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLV 175
Query: 237 KGEPNVSYICSRY-------YRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGES 289
+ + Y APE++ G T Y D WS G ++ E+L G P F ++
Sbjct: 176 RRRDHKQRRVRANSTVGTPDYIAPEVLRG-TPYGLECDWWSLGVILYEMLYGFPPFYSDT 234
Query: 290 GVDQLVEIIKVLGTPTREEIKCMNPNYTE-FKFPQIKPHPWHKVFQKRLPPEAVDLVCRF 348
L E T +I N+ E +FP P + PEA+DL+CR
Sbjct: 235 ----LQE--------TYNKII----NWKESLRFPPDPP----------VSPEAIDLICRL 268
Query: 349 FQYSPNLRCTALEACVHPFF 368
+ + E HPFF
Sbjct: 269 LCDPEDRLGSFEEIKSHPFF 288
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 5e-31
Identities = 83/287 (28%), Positives = 128/287 (44%), Gaps = 47/287 (16%)
Query: 89 VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN--RELQIMQMLDHPNIVALKHCFFS 146
+G GS+G V++A +ETG++VAIK V ++ + +E+ I++ D P IV +F
Sbjct: 10 KLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIKEISILKQCDSPYIVKYYGSYFK 69
Query: 147 TTDKEELYLNLVLEY-VPETVNRI--ARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203
TD L +V+EY +V+ I N + + + I YQ + L Y+H+
Sbjct: 70 NTD-----LWIVMEYCGAGSVSDIMKITNKTLTEEEIAAI-----LYQTLKGLEYLHS-N 118
Query: 204 GICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK--GEPNVSYICSRYYRAPELIFGATE 261
HRDIK N+L+N Q KL DFG + L + N + I + ++ APE+I
Sbjct: 119 KKIHRDIKAGNILLN-EEGQAKLADFGVSGQLTDTMAKRN-TVIGTPFWMAPEVIQE-IG 175
Query: 262 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF 321
Y DIWS G E+ G+P P + ++P F
Sbjct: 176 YNNKADIWSLGITAIEMAEGKP--------------------PYSD----IHPMRAIFMI 211
Query: 322 PQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368
P KP P ++ PE D V + P R +A++ HPF
Sbjct: 212 PN-KPPPTLSD-PEKWSPEFNDFVKKCLVKDPEERPSAIQLLQHPFI 256
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 1e-30
Identities = 63/225 (28%), Positives = 107/225 (47%), Gaps = 22/225 (9%)
Query: 89 VVGTGSFGVVFQAKCRETGEIVAIKKV------LQDKRYKNRELQIMQMLDHPNIVALKH 142
+G GSFG V + + + G+I+ K++ ++K+ E+ I++ L HPNIV
Sbjct: 7 TIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYD 66
Query: 143 CFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
D+ L +V+EY + ++ + + + + ++ Q+ AL HN
Sbjct: 67 RII---DRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHN 123
Query: 202 CIG----ICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNV---SYICSRYYRAPE 254
+ HRD+KP N+ ++ + +KL DFG AK+L G + +Y+ + YY +PE
Sbjct: 124 RSDPGNTVLHRDLKPANIFLD-ANNNVKLGDFGLAKIL--GHDSSFAKTYVGTPYYMSPE 180
Query: 255 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIK 299
+ + Y DIWS GC++ EL P F QL IK
Sbjct: 181 QLNHMS-YDEKSDIWSLGCLIYELCALSPPFTA-RNQLQLASKIK 223
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 2e-30
Identities = 93/308 (30%), Positives = 141/308 (45%), Gaps = 67/308 (21%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVL-------QDKRYKN------RELQIMQ 130
+I ++G+GSFG V+ +GE++A+K+V R ++ RE+ +++
Sbjct: 2 WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLK 61
Query: 131 MLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYT 189
L H NIV +LN+ LEYVP +V + NY + + V+ +
Sbjct: 62 ELQHENIVQYLGSSLDAD-----HLNIFLEYVPGGSVAALLNNYGAFEETL----VRNFV 112
Query: 190 YQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNV------- 242
QI + L Y+HN GI HRDIK N+LV+ + +K+ DFG +K K E N
Sbjct: 113 RQILKGLNYLHN-RGIIHRDIKGANILVD-NKGGIKISDFGISK---KLEANSLSTKTNG 167
Query: 243 ---SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIK 299
S S ++ APE++ T YT DIWS GC++ E+L G+ FP QL I K
Sbjct: 168 ARPSLQGSVFWMAPEVV-KQTSYTRKADIWSLGCLVVEMLTGKHPFP---DCTQLQAIFK 223
Query: 300 VLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTA 359
+ E P+I + + EA+D + + F+ N R TA
Sbjct: 224 I----------------GENASPEIPSN---------ISSEAIDFLEKTFEIDHNKRPTA 258
Query: 360 LEACVHPF 367
E HPF
Sbjct: 259 AELLKHPF 266
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 4e-30
Identities = 91/305 (29%), Positives = 142/305 (46%), Gaps = 53/305 (17%)
Query: 82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV--------LQDKRYK------NRELQ 127
++ ++G G++G V+ A TGE++A+K+V D R K E++
Sbjct: 1 FKWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIE 60
Query: 128 IMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVK 186
++ LDH NIV + E YL++ LEYVP ++ R Y R +++ V+
Sbjct: 61 TLKDLDHLNIVQYLGF-----ETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQL----VR 111
Query: 187 LYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV---LVKGEPNVS 243
+T Q+ LAY+H+ GI HRD+K NLLV+ K+ DFG +K + + N+S
Sbjct: 112 FFTEQVLEGLAYLHS-KGILHRDLKADNLLVD-ADGICKISDFGISKKSDDIYDNDQNMS 169
Query: 244 YICSRYYRAPELIFGATE-YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLG 302
S ++ APE+I ++ Y+ +DIWS GCV+ E+ G+ + E
Sbjct: 170 MQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDE-------------- 215
Query: 303 TPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEA 362
E I M + P I P L P A+D + F +P+ R TA E
Sbjct: 216 ----EAIAAMFKLGNKRSAPPIPPD-----VSMNLSPVALDFLNACFTINPDNRPTAREL 266
Query: 363 CVHPF 367
HPF
Sbjct: 267 LQHPF 271
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 6e-30
Identities = 85/294 (28%), Positives = 129/294 (43%), Gaps = 58/294 (19%)
Query: 88 HVVGTGSFGVVFQAKCRETGEIVAIKKV-LQDKRYKN--RELQIMQMLDHPNIVALKHCF 144
+G G+ G V++A R TG+ VAIKK+ L+ + + E+ IM+ HPNIV +
Sbjct: 25 EKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYDSY 84
Query: 145 FSTTDKEELYLNLVLEYVPE-------TVNRIARNYSRIHQRMPLIYVKLYTYQICRALA 197
+EL++ V+EY+ T N + N +I YV ++ + L
Sbjct: 85 L---VGDELWV--VMEYMDGGSLTDIITQNFVRMNEPQI------AYVCR---EVLQGLE 130
Query: 198 YIH--NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-VSYICSRYYRAPE 254
Y+H N I HRDIK N+L++ +KL DFG A L K + S + + Y+ APE
Sbjct: 131 YLHSQNVI---HRDIKSDNILLS-KDGSVKLADFGFAAQLTKEKSKRNSVVGTPYWMAPE 186
Query: 255 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 314
+I +Y +DIWS G + E+ G+P + E + L I G P +K
Sbjct: 187 VIKR-KDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITT-KGIP---PLK---- 237
Query: 315 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368
P W F+ D + + P R +A E HPF
Sbjct: 238 ----------NPEKWSPEFK--------DFLNKCLVKDPEKRPSAEELLQHPFL 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 4e-29
Identities = 62/229 (27%), Positives = 104/229 (45%), Gaps = 47/229 (20%)
Query: 89 VVGTGSFGVVFQAKCRETGE----IVAIKKVLQDKRYKN-----RELQIMQMLDHPNIVA 139
+G G+FG V++ + GE VA+K + + + E IM+ L HPNIV
Sbjct: 6 KLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVR 65
Query: 140 LKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIH-QRMPLIYVKLYTYQICRALAY 198
L T E LY +V EY+P ++ R H +++ L + QI + + Y
Sbjct: 66 LLGVC---TQGEPLY--IVTEYMP---GGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEY 117
Query: 199 IH--NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR----- 251
+ N + HRD+ +N LV +K+ DFG ++ + + + YYR
Sbjct: 118 LESKNFV---HRDLAARNCLVT-ENLVVKISDFGLSRDIYEDD---------YYRKRGGG 164
Query: 252 -------APELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVD 292
APE + ++T+ D+WS G ++ E+ LG+ +PG S +
Sbjct: 165 KLPIKWMAPESLK-DGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEE 212
|
Length = 258 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 7e-29
Identities = 85/290 (29%), Positives = 128/290 (44%), Gaps = 56/290 (19%)
Query: 93 GSFGVVFQAKCRETGEIVAIK-----KVLQDKRYKNRELQ---IMQMLDHPNIVALKHCF 144
G+FG V+ AK R TG+ AIK ++ + N + + +M + P + L +
Sbjct: 7 GAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKL---Y 63
Query: 145 FSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRM---PLIYVKLYTYQICRALAYIHN 201
+S K+ YL LV+EY+ + + + + + P + K Y ++ + +H
Sbjct: 64 YSFQSKD--YLYLVMEYLN------GGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQ 115
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 261
GI HRDIKP+NLL++ H LKL DFG ++ G N ++ + Y APE I G +
Sbjct: 116 -RGIIHRDIKPENLLIDQTGH-LKLTDFGLSRN---GLENKKFVGTPDYLAPETILGVGD 170
Query: 262 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF 321
D WS GCV+ E L G P F E+ D + + I I
Sbjct: 171 -DKMSDWWSLGCVIFEFLFGYPPFHAET-PDAVFDNI------LSRRIN----------- 211
Query: 322 PQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTA---LEACVHPFF 368
W + ++ PEAVDL+ R P R A E HPFF
Sbjct: 212 -------WPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHPFF 254
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 7e-29
Identities = 76/295 (25%), Positives = 126/295 (42%), Gaps = 48/295 (16%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKRYKN--RELQIMQMLDHPN 136
+ V+G G+FG V + R+T ++ A+K K ++ +N E +I+Q L+HP
Sbjct: 2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPF 61
Query: 137 IVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQ-RMPLIYVKLYTYQICRA 195
+V L ++S D+E +YL V++ + R Y + + VK + +I A
Sbjct: 62 LVNL---WYSFQDEENMYL--VVDLLLGGDLR----YHLSQKVKFSEEQVKFWICEIVLA 112
Query: 196 LAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPEL 255
L Y+H+ GI HRDIKP N+L++ H + + DF A + S + Y APE+
Sbjct: 113 LEYLHS-KGIIHRDIKPDNILLDEQGH-VHITDFNIATKVTPDTLTTSTSGTPGYMAPEV 170
Query: 256 IFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 315
+ Y+ A+D WS G E L G+ + G S R++I
Sbjct: 171 LCRQG-YSVAVDWWSLGVTAYECLRGKRPYRGHS-------------RTIRDQI------ 210
Query: 316 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLR--CTALEACVHPFF 368
K + EA+D + + + P R + HP+F
Sbjct: 211 --RAKQETADVL-----YPATWSTEAIDAINKLLERDPQKRLGDNLKDLKNHPYF 258
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 2e-28
Identities = 78/296 (26%), Positives = 126/296 (42%), Gaps = 56/296 (18%)
Query: 90 VGTGSFGVVFQAKCRETGEIVAIKKV-------LQDKRYKNRELQIMQMLDHPNIVALKH 142
+G G FG V K + A+K V + + E +I++ +HP IV L +
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKL-Y 59
Query: 143 CFFSTTDKEELYLNLVLEYVPE----TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
F K++ Y+ +++EY T+ R + R Y + A Y
Sbjct: 60 RTF----KDKKYIYMLMEYCLGGELWTILRDRGLFDEYTAR-------FYIACVVLAFEY 108
Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFG 258
+HN GI +RD+KP+NLL++ +KL DFG AK L G+ ++ + Y APE+I
Sbjct: 109 LHN-RGIIYRDLKPENLLLD-SNGYVKLVDFGFAKKLKSGQKTWTFCGTPEYVAPEIILN 166
Query: 259 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 318
Y ++D WS G ++ ELL G+P F GE D + +I N
Sbjct: 167 KG-YDFSVDYWSLGILLYELLTGRPPF-GEDDEDPME---------IYNDILKGNGKL-- 213
Query: 319 FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV-----HPFFD 369
+FP + A DL+ + + +P R L+ + H +F+
Sbjct: 214 -EFPNY------------IDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKWFN 256
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (278), Expect = 5e-28
Identities = 61/228 (26%), Positives = 101/228 (44%), Gaps = 48/228 (21%)
Query: 89 VVGTGSFGVVFQAKCR---ETGEIVAIKKVLQDKRYKNR-----ELQIMQMLDHPNIVAL 140
+G G+FG V++ K + VA+K + +D + R E ++M+ L HPN+V L
Sbjct: 2 KLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRL 61
Query: 141 KHCFFSTTDKEELYLNLVLEYVPE----TVNRIARNYSRIHQRMPLIYVKL--YTYQICR 194
T++E LY LVLEY+ R +R ++ L L + QI +
Sbjct: 62 LGV---CTEEEPLY--LVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAK 116
Query: 195 ALAYIH--NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR- 251
+ Y+ + HRD+ +N LV +K+ DFG ++ + + YYR
Sbjct: 117 GMEYLASKKFV---HRDLAARNCLVG-EDLVVKISDFGLSRDVYDDD---------YYRK 163
Query: 252 -----------APELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPG 287
APE + +T+ D+WS G ++ E+ LG +PG
Sbjct: 164 KTGGKLPIRWMAPESLKDGI-FTSKSDVWSFGVLLWEIFTLGATPYPG 210
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 9e-28
Identities = 67/214 (31%), Positives = 108/214 (50%), Gaps = 17/214 (7%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV----LQDKRYKNR---ELQIMQMLDHPN 136
+ E +G G F VV++A C G +VA+KKV + D + + E+ +++ LDHPN
Sbjct: 4 FKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPN 63
Query: 137 IVALKHCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRA 195
++ F E LN+VLE ++R+ +++ + + +P + Y Q+C A
Sbjct: 64 VIKYLASFI-----ENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSA 118
Query: 196 LAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV-KGEPNVSYICSRYYRAPE 254
L ++H+ I HRDIKP N+ + T +KL D G + K S + + YY +PE
Sbjct: 119 LEHMHS-KRIMHRDIKPANVFITA-TGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPE 176
Query: 255 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGE 288
I Y DIWS GC++ E+ Q F G+
Sbjct: 177 RIHENG-YNFKSDIWSLGCLLYEMAALQSPFYGD 209
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 111 bits (278), Expect = 9e-28
Identities = 95/318 (29%), Positives = 156/318 (49%), Gaps = 48/318 (15%)
Query: 90 VGTGSFGVVFQAKCRETGEI---VAIKKVLQD--KRYKNRELQIMQMLDHPNIVALKHCF 144
VG G++G V++AK R+ G+ A+K++ RE+ +++ L HPN++AL+ F
Sbjct: 9 VGRGTYGHVYKAK-RKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVF 67
Query: 145 FSTTDKEELYLNLVLEYVPETVNRI-----ARNYSRIHQRMPLIYVKLYTYQICRALAYI 199
S +D++ + L+ +Y + I A ++ ++P VK YQI + Y+
Sbjct: 68 LSHSDRK---VWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYL 124
Query: 200 HNCIGICHRDIKPQNLLV---NPHTHQLKLCDFGSAKV-------LVKGEPNVSYICSRY 249
H + HRD+KP N+LV P ++K+ D G A++ L +P + + +
Sbjct: 125 H-ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDP---VVVTFW 180
Query: 250 YRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLF---------PGESGVDQLVEIIKV 300
YRAPEL+ GA YT AIDIW+ GC+ AELL +P+F DQL I V
Sbjct: 181 YRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSV 240
Query: 301 LGTPTR---EEIKCMNPNY----TEFKFPQIKPHPWHKVFQK-RLPPEA--VDLVCRFFQ 350
+G P E+I+ M P Y +F+ K +K ++ P++ L+ +
Sbjct: 241 MGFPADKDWEDIRKM-PEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLT 299
Query: 351 YSPNLRCTALEACVHPFF 368
P R T+ +A P+F
Sbjct: 300 MDPTKRITSEQALQDPYF 317
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 111 bits (278), Expect = 1e-27
Identities = 98/320 (30%), Positives = 158/320 (49%), Gaps = 52/320 (16%)
Query: 90 VGTGSFGVVFQAKCRETGEI---VAIKKVLQD--KRYKNRELQIMQMLDHPNIVALKHCF 144
VG G++G V++AK R+ G+ A+K++ RE+ +++ L HPN+++L+ F
Sbjct: 9 VGRGTYGHVYKAK-RKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVF 67
Query: 145 FSTTDKEELYLNLVLEYVPETVNRIARNY--SRIHQR---MPLIYVKLYTYQICRALAYI 199
S D++ + L+ +Y + I + + S+ +++ +P VK YQI + Y+
Sbjct: 68 LSHADRK---VWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYL 124
Query: 200 HNCIGICHRDIKPQNLLV---NPHTHQLKLCDFGSAKV-------LVKGEPNVSYICSRY 249
H + HRD+KP N+LV P ++K+ D G A++ L +P + + +
Sbjct: 125 H-ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDP---VVVTFW 180
Query: 250 YRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLF---------PGESGVDQLVEIIKV 300
YRAPEL+ GA YT AIDIW+ GC+ AELL +P+F DQL I V
Sbjct: 181 YRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNV 240
Query: 301 LGTPTR---EEIKCMNPNYTEFK-FPQ--------IKPHPWHKVFQKRLPPEAVDLVCRF 348
+G P E+IK M + T K F + IK HKV + +A L+ +
Sbjct: 241 MGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKV---KPDSKAFHLLQKL 297
Query: 349 FQYSPNLRCTALEACVHPFF 368
P R T+ +A P+F
Sbjct: 298 LTMDPIKRITSEQAMQDPYF 317
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 2e-27
Identities = 79/296 (26%), Positives = 136/296 (45%), Gaps = 51/296 (17%)
Query: 89 VVGTGSFGVVFQAKCRETGEIVAIKKV--------LQDKRYKN--RELQIMQMLDHPNIV 138
+GTG+F +QA+ +TG ++A+K+V Q++ + +E+++M L+HP+I+
Sbjct: 7 QLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHII 66
Query: 139 ALKHCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALA 197
+T E+ + NL +E++ +V+ + Y + + + YT Q+ R L+
Sbjct: 67 ---RMLGAT--CEDSHFNLFVEWMAGGSVSHLLSKYGAFKEA---VIIN-YTEQLLRGLS 117
Query: 198 YIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK-----GEPNVSYICSRYYRA 252
Y+H I HRD+K NLL++ +L++ DFG+A L GE + + + A
Sbjct: 118 YLHEN-QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMA 176
Query: 253 PELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 312
PE++ G +Y + D+WS GCV+ E+ +P + E + L I K I
Sbjct: 177 PEVLRG-EQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFK---------IASA 226
Query: 313 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368
P I H L P D+ R + P R + E HP F
Sbjct: 227 TTA------PSIPEH---------LSPGLRDVTLRCLELQPEDRPPSRELLKHPVF 267
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 1e-26
Identities = 86/298 (28%), Positives = 126/298 (42%), Gaps = 59/298 (19%)
Query: 90 VGTGSFGVVFQAKCRETGEIVAI----KKVLQDKRYKNRELQ---IMQMLDHPNIVALKH 142
VG G +G VF AK ++TGEIVA+ K +L L I+ +V L +
Sbjct: 9 VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLY 68
Query: 143 CFFSTTDKEELYLNLVLEYVPETVNRIARNYSRI-HQRMPLIYVKLYTYQICRALAYIHN 201
F D E LY L +EYVP R N + + + + Y ++ A+ +H
Sbjct: 69 AF---QDDEYLY--LAMEYVPGGDFRTLLNNLGVLSED----HARFYMAEMFEAVDALHE 119
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 261
+G HRD+KP+N L++ H +KL DFG +K +V S + S Y APE++ G
Sbjct: 120 -LGYIHRDLKPENFLIDASGH-IKLTDFGLSKGIV--TYANSVVGSPDYMAPEVLRG-KG 174
Query: 262 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF 321
Y +D WS GC++ E L G P F G PN T +
Sbjct: 175 YDFTVDYWSLGCMLYEFLCGFPPFSGS------------------------TPNET---W 207
Query: 322 PQIKPHPWHKVFQK--------RLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL 371
+K W + Q+ L EA DL+ + + + HPFF E+
Sbjct: 208 ENLK--YWKETLQRPVYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNHPFFKEV 263
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 6e-26
Identities = 65/215 (30%), Positives = 103/215 (47%), Gaps = 23/215 (10%)
Query: 89 VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-----RELQIMQMLDH---PNIVAL 140
++G G++G V++ K TG +VA+K + D + RE+ ++ L PNI
Sbjct: 8 LIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKY 67
Query: 141 KHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 200
+ L +++EY R I ++ Y+ + ++ AL YIH
Sbjct: 68 YGSYLKGPR-----LWIIMEYAEGGSVRTLMKAGPIAEK----YISVIIREVLVALKYIH 118
Query: 201 NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVS-YICSRYYRAPELIFGA 259
+G+ HRDIK N+LV +T +KLCDFG A +L + S ++ + Y+ APE+I
Sbjct: 119 K-VGVIHRDIKAANILVT-NTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEG 176
Query: 260 TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQL 294
Y T DIWS G + E+ G P + S VD
Sbjct: 177 KYYDTKADIWSLGITIYEMATGNPPY---SDVDAF 208
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 9e-25
Identities = 70/210 (33%), Positives = 107/210 (50%), Gaps = 27/210 (12%)
Query: 88 HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-------RELQIMQMLDHPNIVAL 140
+G GSFG V+ A+ T E+VAIKK+ + N +E++ +Q L HPN +
Sbjct: 21 REIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEY 80
Query: 141 KHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKL--YTYQICRALAY 198
K C+ E LV+EY + A + +H++ PL V++ + + LAY
Sbjct: 81 KGCYL-----REHTAWLVMEYCLGS----ASDILEVHKK-PLQEVEIAAICHGALQGLAY 130
Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFG 258
+H+ I HRDIK N+L+ +KL DFGSA ++ P S++ + Y+ APE+I
Sbjct: 131 LHSHERI-HRDIKAGNILLTEPG-TVKLADFGSASLV---SPANSFVGTPYWMAPEVILA 185
Query: 259 ATE--YTTAIDIWSTGCVMAELLLGQ-PLF 285
E Y +D+WS G EL + PLF
Sbjct: 186 MDEGQYDGKVDVWSLGITCIELAERKPPLF 215
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 5e-24
Identities = 84/290 (28%), Positives = 126/290 (43%), Gaps = 61/290 (21%)
Query: 89 VVGTGSFGVVFQAKCRETGEIVAIKKVLQDK--RYKNRELQIM-------QMLDHPNIVA 139
V+G GSFG V AK + G+ A+ KVLQ K K + IM + + HP +V
Sbjct: 2 VIGKGSFGKVLLAKHKADGKFYAV-KVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVG 60
Query: 140 LKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALA 197
L H F T DK LY VL+YV E + R + P + Y +I AL
Sbjct: 61 L-HYSFQTADK--LY--FVLDYVNGGELFFHLQR-----ERSFPEPRARFYAAEIASALG 110
Query: 198 YIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYIC-SRYYRAPELI 256
Y+H+ + I +RD+KP+N+L++ H + L DFG K ++ S C + Y APE++
Sbjct: 111 YLHS-LNIIYRDLKPENILLDSQGH-VVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVL 168
Query: 257 FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 316
Y +D W G V+ E+L G P F ++ + +L P R + PN
Sbjct: 169 R-KQPYDRTVDWWCLGAVLYEMLYGLPPFYSRD-TAEMYD--NILNKPLR-----LKPNI 219
Query: 317 T---------------------EFKFPQIKPHP------WHKVFQKRLPP 339
+ + F +IK H W + K++ P
Sbjct: 220 SVSARHLLEGLLQKDRTKRLGAKDDFLEIKNHVFFSSINWDDLVNKKITP 269
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 7e-24
Identities = 95/319 (29%), Positives = 141/319 (44%), Gaps = 59/319 (18%)
Query: 90 VGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKRYK--NRELQIMQMLDHPNIVALKH 142
+GTGSFG V AK + TGE AIK ++L+ K+ + +E I+ L HP IV +
Sbjct: 26 LGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMC 85
Query: 143 CFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
F D+ +Y +LE+V V + R R P K Y ++ A Y+H+
Sbjct: 86 SF---QDENRVY--FLLEFV---VGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSK 137
Query: 203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY-IC-SRYYRAPELIFGAT 260
I +RD+KP+NLL++ H +K+ DFG AK + P+ ++ +C + Y APE+I +
Sbjct: 138 -DIIYRDLKPENLLLDNKGH-VKVTDFGFAKKV----PDRTFTLCGTPEYLAPEVI-QSK 190
Query: 261 EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 320
+ A+D W+ G ++ E + G P F + TP R K + K
Sbjct: 191 GHGKAVDWWTMGVLLYEFIAGYPPFFDD--------------TPFRIYEKILA---GRLK 233
Query: 321 FPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV-----HPFFDELRDPN 375
FP W F R A DLV Q R L+ V HP+F + +
Sbjct: 234 FPN-----W---FDGR----ARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFHGA-NWD 280
Query: 376 TRLPNGRPLPPLFNFKPPG 394
P P K PG
Sbjct: 281 KLYARYYPAPIPVRVKSPG 299
|
Length = 329 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 99.1 bits (247), Expect = 9e-24
Identities = 84/287 (29%), Positives = 133/287 (46%), Gaps = 42/287 (14%)
Query: 89 VVGTGSFGVVFQAKCRETGEIVAIKKV-LQDKRYK---NRELQIMQMLDHPNIVALKHCF 144
V+G G++G+V+ A+ T +AIK++ +D RY + E+ + L H NIV
Sbjct: 15 VLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQ----- 69
Query: 145 FSTTDKEELYLNLVLEYVPE-TVNRIARN-YSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
+ +D E + + +E VP +++ + R+ + + I YT QI L Y+H+
Sbjct: 70 YLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTI--IFYTKQILEGLKYLHD- 126
Query: 203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNV-SYICSRYYRAPELI-FGAT 260
I HRDIK N+LVN ++ +K+ DFG++K L P ++ + Y APE+I G
Sbjct: 127 NQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDKGPR 186
Query: 261 EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 320
Y DIWS GC + E+ G+P F I+ P FK
Sbjct: 187 GYGAPADIWSLGCTIVEMATGKPPF-----------------------IELGEPQAAMFK 223
Query: 321 FPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 367
K HP + L EA + + R F+ P+ R +A + PF
Sbjct: 224 VGMFKIHP---EIPESLSAEAKNFILRCFEPDPDKRASAHDLLQDPF 267
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 99.7 bits (248), Expect = 1e-23
Identities = 84/285 (29%), Positives = 135/285 (47%), Gaps = 37/285 (12%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-------RELQIMQMLDHPN 136
++ H +G GSFG V+ A T E+VA+KK+ + N +E++ +Q L HPN
Sbjct: 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPN 82
Query: 137 IVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKL--YTYQICR 194
+ K C+ +E LV+EY + A + +H++ PL V++ T+ +
Sbjct: 83 TIEYKGCYL-----KEHTAWLVMEYCLGS----ASDLLEVHKK-PLQEVEIAAITHGALQ 132
Query: 195 ALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPE 254
LAY+H+ I HRDIK N+L+ Q+KL DFGSA P S++ + Y+ APE
Sbjct: 133 GLAYLHSHNMI-HRDIKAGNILLT-EPGQVKLADFGSASKS---SPANSFVGTPYWMAPE 187
Query: 255 LIFGATE--YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 312
+I E Y +D+WS G EL +P + + L I + +PT + +
Sbjct: 188 VILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN-DSPTLQSNEWT 246
Query: 313 NP-----NYTEFKFPQIKPHPW----HKVFQKRLPPEA-VDLVCR 347
+ +Y K PQ +P H ++ P +DL+ R
Sbjct: 247 DSFRGFVDYCLQKIPQERPASAELLRHDFVRRDRPARVLIDLIQR 291
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 98.5 bits (246), Expect = 1e-23
Identities = 80/293 (27%), Positives = 123/293 (41%), Gaps = 52/293 (17%)
Query: 88 HVVGTGSFGVVFQAKCRETGEIVAIKKV-LQDK---RYKNRELQIMQMLDHPNIVALKHC 143
+G+G++G V++A+ TGE+VAIK + L+ +E+ +++ HPNIVA
Sbjct: 9 QRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGS 68
Query: 144 FFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLI-YVKLYTYQICRALAYIHNC 202
+ L +V+EY + +R I YV T + LAY+H
Sbjct: 69 YLRRD-----KLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLK---GLAYLHE- 119
Query: 203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK--GEPNVSYICSRYYRAPELIFGAT 260
G HRDIK N+L+ +KL DFG + L + S+I + Y+ APE+ A
Sbjct: 120 TGKIHRDIKGANILLTEDGD-VKLADFGVSAQLTATIAKRK-SFIGTPYWMAPEVA--AV 175
Query: 261 E----YTTAIDIWSTGCVMAELLLGQ-PLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 315
E Y DIW+ G EL Q P+F + ++ L ++
Sbjct: 176 ERKGGYDGKCDIWALGITAIELAELQPPMFD--------LHPMRALFLISKS-------- 219
Query: 316 YTEFKFPQIK-PHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 367
F P++K W VF D + + P R TA + HPF
Sbjct: 220 --NFPPPKLKDKEKWSPVFH--------DFIKKCLTKDPKKRPTATKLLQHPF 262
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 98.7 bits (246), Expect = 2e-23
Identities = 67/215 (31%), Positives = 112/215 (52%), Gaps = 36/215 (16%)
Query: 90 VGTGSFGVVFQAKCRETGEIVAIKKV-------LQDKRYKNRELQIMQMLDHPNIVALKH 142
VGTG+FG V + R + A+K + L+ +++ + E ++++ + HP I+ L
Sbjct: 9 VGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRL-- 66
Query: 143 CFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 200
F++ D+ LY+ ++EYVP E + + RN R L Y +I AL Y+H
Sbjct: 67 -FWTEHDQRFLYM--LMEYVPGGELFSYL-RNSGRFSNSTGL----FYASEIVCALEYLH 118
Query: 201 NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK------GEPNVSYICSRYYRAPE 254
+ I +RD+KP+N+L++ H +KL DFG AK L G P Y APE
Sbjct: 119 S-KEIVYRDLKPENILLDKEGH-IKLTDFGFAKKLRDRTWTLCGTPE--------YLAPE 168
Query: 255 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGES 289
+I + + A+D W+ G ++ E+L+G P F ++
Sbjct: 169 VI-QSKGHNKAVDWWALGILIYEMLVGYPPFFDDN 202
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 96.1 bits (239), Expect = 8e-23
Identities = 62/208 (29%), Positives = 106/208 (50%), Gaps = 16/208 (7%)
Query: 89 VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR------ELQIMQMLDHPNIVALKH 142
VVG G+FG+V + + ++V IK++ ++ K+ E Q++++L HPNI+
Sbjct: 7 VVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYE 66
Query: 143 CFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
F E+ L +V+EY P T+ + R + + + + QI AL ++H
Sbjct: 67 NFL-----EDKALMIVMEYAPGGTLAEYIQK--RCNSLLDEDTILHFFVQILLALHHVHT 119
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 261
+ I HRD+K QN+L++ H +K+ DFG +K+L + + + Y +PEL G
Sbjct: 120 KL-ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVVGTPCYISPELCEG-KP 177
Query: 262 YTTAIDIWSTGCVMAELLLGQPLFPGES 289
Y DIW+ GCV+ EL + F +
Sbjct: 178 YNQKSDIWALGCVLYELASLKRAFEAAN 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.6 bits (238), Expect = 1e-22
Identities = 77/292 (26%), Positives = 126/292 (43%), Gaps = 51/292 (17%)
Query: 90 VGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKNR------ELQIMQMLDHPNIVAL 140
+G G+FG V+ +TG +A+K+V K E+Q+++ L H IV
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQY 69
Query: 141 KHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 200
C D E L + +EY+P ++ + + + + YT QI + Y+H
Sbjct: 70 YGCL---RDDETLSI--FMEYMP---GGSVKDQLKAYGALTETVTRKYTRQILEGVEYLH 121
Query: 201 NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL----VKGEPNVSYICSRYYRAPELI 256
+ + I HRDIK N+L + +KL DFG++K L G S + Y+ +PE+I
Sbjct: 122 SNM-IVHRDIKGANILRDS-AGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVI 179
Query: 257 FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 316
G Y D+WS GC + E+L +P + + + + I K+ PT
Sbjct: 180 SGEG-YGRKADVWSVGCTVVEMLTEKPPW---AEFEAMAAIFKIATQPTN---------- 225
Query: 317 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368
PQ+ H + P+A + + R F + R +A E H F
Sbjct: 226 -----PQLPSH---------VSPDARNFLRRTFVENAKKRPSAEELLRHFFV 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 95.6 bits (238), Expect = 1e-22
Identities = 71/213 (33%), Positives = 100/213 (46%), Gaps = 36/213 (16%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV-LQDKRYKNR-----ELQIMQMLDHPNI 137
YI V+G G+FG + E +V K+V L K R E+ I+ +L HPNI
Sbjct: 2 YIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNI 61
Query: 138 VALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRA 195
+A + F ++ L + +EY ++I R + Q V Y +QI A
Sbjct: 62 IAYYNHFM-----DDNTLLIEMEYANGGTLYDKIVR---QKGQLFEEEMVLWYLFQIVSA 113
Query: 196 LAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL---------VKGEPNVSYIC 246
++YIH GI HRDIK N+ + +KL DFG +K+L V G P
Sbjct: 114 VSYIHK-AGILHRDIKTLNIFLT-KAGLIKLGDFGISKILGSEYSMAETVVGTP------ 165
Query: 247 SRYYRAPELIFGATEYTTAIDIWSTGCVMAELL 279
YY +PEL G +Y DIW+ GCV+ ELL
Sbjct: 166 --YYMSPELCQGV-KYNFKSDIWALGCVLYELL 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.4 bits (238), Expect = 2e-22
Identities = 63/214 (29%), Positives = 106/214 (49%), Gaps = 29/214 (13%)
Query: 89 VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR-----ELQIMQML-DHPNIVALKH 142
V+G G++G V++A+ ++TG++VAIK + D E I++ +HPNI
Sbjct: 13 VIGEGTYGKVYKARHKKTGQLVAIK--IMDIIEDEEEEIKEEYNILRKYSNHPNIATFYG 70
Query: 143 CFF---STTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
F + ++L+ LV+E +V + + + +R+ ++ + R LAY
Sbjct: 71 AFIKKNPPGNDDQLW--LVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAY 128
Query: 199 IH--NCIGICHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPNVSYICSRYYRAPEL 255
+H I HRDIK QN+L+ ++KL DFG SA++ ++I + Y+ APE+
Sbjct: 129 LHENKVI---HRDIKGQNILLT-KNAEVKLVDFGVSAQLDSTLGRRNTFIGTPYWMAPEV 184
Query: 256 IFGATE------YTTAIDIWSTGCVMAELLLGQP 283
I A + Y D+WS G EL G+P
Sbjct: 185 I--ACDEQPDASYDARSDVWSLGITAIELADGKP 216
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 95.2 bits (237), Expect = 3e-22
Identities = 85/298 (28%), Positives = 137/298 (45%), Gaps = 49/298 (16%)
Query: 90 VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR------ELQIMQMLDHPNIVALKHC 143
+G GS G+V A + TG VA+KK+ D R + R E+ IM+ HPNIV +
Sbjct: 27 IGEGSTGIVCIATDKSTGRQVAVKKM--DLRKQQRRELLFNEVVIMRDYQHPNIVEM--- 81
Query: 144 FFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
+ S +EL++ V+E++ + I H RM + + +AL+++H
Sbjct: 82 YSSYLVGDELWV--VMEFLEGGALTDIV-----THTRMNEEQIATVCLAVLKALSFLHA- 133
Query: 203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-VSYICSRYYRAPELIFGATE 261
G+ HRDIK ++L+ ++KL DFG + K P S + + Y+ APE+I
Sbjct: 134 QGVIHRDIKSDSILLT-SDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVI-SRLP 191
Query: 262 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF 321
Y T +DIWS G ++ E++ G+P + E + + + I+ P
Sbjct: 192 YGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAM------------KRIRDNLP------- 232
Query: 322 PQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLP 379
P++K HKV P + R P R TA E HPF + P++ +P
Sbjct: 233 PKLKNL--HKV-----SPRLRSFLDRMLVRDPAQRATAAELLNHPFLAKAGPPSSIVP 283
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.8 bits (234), Expect = 7e-22
Identities = 73/296 (24%), Positives = 117/296 (39%), Gaps = 57/296 (19%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV-----LQDKRYKNRELQIMQMLDHPNIV 138
+ +G GSFG V++A + T ++VAIK + + +E+Q + P I
Sbjct: 3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYIT 62
Query: 139 ALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
F + L +++EY + + ++ Y+ ++ L Y
Sbjct: 63 KYYGSFLKGSK-----LWIIMEYCG---GGSCLDLLKP-GKLDETYIAFILREVLLGLEY 113
Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-------YYR 251
+H G HRDIK N+L++ +KL DFG V G+ S + R ++
Sbjct: 114 LHE-EGKIHRDIKAANILLSEEG-DVKLADFG-----VSGQLT-STMSKRNTFVGTPFWM 165
Query: 252 APELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 311
APE+I + Y DIWS G EL G+P P S + + +VL K
Sbjct: 166 APEVIKQ-SGYDEKADIWSLGITAIELAKGEP--P-LSDLHPM----RVL----FLIPKN 213
Query: 312 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 367
NP P ++ + + K F+ D V P R +A E H F
Sbjct: 214 -NP-------PSLEGNKFSKPFK--------DFVSLCLNKDPKERPSAKELLKHKF 253
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.6 bits (235), Expect = 8e-22
Identities = 90/314 (28%), Positives = 137/314 (43%), Gaps = 56/314 (17%)
Query: 90 VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALKH 142
+G GSFG V Q + R+T I A+K + + E+ ++ ++ P IV LK
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLK- 59
Query: 143 CFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
FS E+LYL L E + + R R L + YT ++ AL +H
Sbjct: 60 --FSFQSPEKLYLVLAFINGGELFHHLQR-----EGRFDLSRARFYTAELLCALENLHK- 111
Query: 203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYIC-SRYYRAPELIFGATE 261
+ +RD+KP+N+L++ + + LCDFG K+ +K + + C + Y APEL+ G
Sbjct: 112 FNVIYRDLKPENILLD-YQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHG- 169
Query: 262 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF 321
YT A+D W+ G ++ E+L G P F E+ V+++ K+L P R
Sbjct: 170 YTKAVDWWTLGVLLYEMLTGLPPFYDEN-VNEMYR--KILQEPLR--------------- 211
Query: 322 PQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC---TALEACVHPFFDELRDPNTRL 378
F +A DL+ P R A E HPFF +L +L
Sbjct: 212 -----------FPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFFSQLS--WKKL 258
Query: 379 PNGRPLPPLFNFKP 392
PP FKP
Sbjct: 259 LMKGIQPP---FKP 269
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 93.3 bits (232), Expect = 1e-21
Identities = 86/321 (26%), Positives = 134/321 (41%), Gaps = 61/321 (19%)
Query: 90 VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR--------ELQIMQMLDHPNIVALK 141
+G G FG V + + TG++ A KK L KR K R E +I++ + IV+L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKK-LDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLA 59
Query: 142 HCFFSTTDKEELYLNLV----LEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALA 197
+ F T D L + L+ L+Y V +R Y QI L
Sbjct: 60 YAF-ETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEAR---------AIFYAAQIICGLE 109
Query: 198 YIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIF 257
++H I +RD+KP+N+L++ H + +++ D G A L G+ + Y APE++
Sbjct: 110 HLHQ-RRIVYRDLKPENVLLDDHGN-VRISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQ 167
Query: 258 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 317
G Y ++D ++ GC + E++ G+ F Q E ++ +EE+K
Sbjct: 168 GE-VYDFSVDWFALGCTLYEMIAGRSPF------RQRKEKVE------KEELKRRTLE-M 213
Query: 318 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-----TALEACVHPFFDELR 372
++P + PEA DL Q P R +A E HP F +L
Sbjct: 214 AVEYPD------------KFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFKDLN 261
Query: 373 DPNTRLPNGRPLPPLFNFKPP 393
RL G PP F P
Sbjct: 262 WR--RLEAGMLEPP---FIPD 277
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 93.2 bits (232), Expect = 2e-21
Identities = 81/299 (27%), Positives = 127/299 (42%), Gaps = 58/299 (19%)
Query: 89 VVGTGSFGVVFQAKCRETGEIVAIKK-----VLQDKRYK--NRELQIMQML-DHPNIVAL 140
V+G GSFG V A+ + T E+ A+K +LQD + E +++ + HP + L
Sbjct: 2 VLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQL 61
Query: 141 KHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQ--RMPLIYVKLYTYQICRALAY 198
H F T D+ L V+EYV N + I + R + Y +I L +
Sbjct: 62 -HSCFQTKDR----LFFVMEYV----NGGDLMF-HIQRSGRFDEPRARFYAAEIVLGLQF 111
Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYIC-SRYYRAPELIF 257
+H GI +RD+K N+L++ H +K+ DFG K + G S C + Y APE++
Sbjct: 112 LHE-RGIIYRDLKLDNVLLDSEGH-IKIADFGMCKEGILGGVTTSTFCGTPDYIAPEILS 169
Query: 258 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 317
Y A+D W+ G ++ E+L GQ F G+ D+L + I +
Sbjct: 170 Y-QPYGPAVDWWALGVLLYEMLAGQSPFEGD-DEDELFQSI-------------LEDEV- 213
Query: 318 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV-----HPFFDEL 371
+ + L EA ++ F +P R L HPFF E+
Sbjct: 214 --------------RYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFFREI 258
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 92.8 bits (230), Expect = 3e-21
Identities = 61/203 (30%), Positives = 102/203 (50%), Gaps = 22/203 (10%)
Query: 90 VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-------RELQIMQMLDHPNIVALKH 142
+G GSFG V+ A+ E+VAIKK+ + N +E++ +Q L HPN + +
Sbjct: 23 IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 82
Query: 143 CFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
C+ E LV+EY + + + + + Q + + V T+ + LAY+H+
Sbjct: 83 CYL-----REHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAV---THGALQGLAYLHSH 134
Query: 203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE- 261
+ HRD+K N+L++ +KL DFGSA ++ P ++ + Y+ APE+I E
Sbjct: 135 -NMIHRDVKAGNILLS-EPGLVKLGDFGSASIM---APANXFVGTPYWMAPEVILAMDEG 189
Query: 262 -YTTAIDIWSTGCVMAELLLGQP 283
Y +D+WS G EL +P
Sbjct: 190 QYDGKVDVWSLGITCIELAERKP 212
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 92.1 bits (229), Expect = 3e-21
Identities = 79/303 (26%), Positives = 127/303 (41%), Gaps = 51/303 (16%)
Query: 91 GTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKN--RELQI-MQMLDHPNIVALKHCF 144
G G++GVV + + TG I+A+K++ + + K +L I M+ +D P V
Sbjct: 10 GRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGAL 69
Query: 145 FSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG 204
F D + + +E + ++++ + +P + I +AL Y+H+ +
Sbjct: 70 FREGD-----VWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS 124
Query: 205 ICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE--- 261
+ HRD+KP N+L+N Q+KLCDFG + LV + Y APE I
Sbjct: 125 VIHRDVKPSNVLIN-RNGQVKLCDFGISGYLVDSVAKTIDAGCKPYMAPERINPELNQKG 183
Query: 262 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF 321
Y D+WS G M EL G+ FP +S TP F
Sbjct: 184 YDVKSDVWSLGITMIELATGR--FPYDS-----------WKTP----------------F 214
Query: 322 PQIK-----PHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNT 376
Q+K P P ++ ++ PE D V + + + R E HPFF+ NT
Sbjct: 215 QQLKQVVEEPSP--QLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELHLSKNT 272
Query: 377 RLP 379
+
Sbjct: 273 DVA 275
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 92.8 bits (230), Expect = 3e-21
Identities = 68/205 (33%), Positives = 105/205 (51%), Gaps = 26/205 (12%)
Query: 90 VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-------RELQIMQMLDHPNIVALKH 142
+G GSFG V+ A+ T E+VAIKK+ + N +E++ +Q + HPN + K
Sbjct: 33 IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKG 92
Query: 143 CFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPL--IYVKLYTYQICRALAYIH 200
C+ E LV+EY + A + +H++ PL + + T+ + LAY+H
Sbjct: 93 CYL-----REHTAWLVMEYCLGS----ASDLLEVHKK-PLQEVEIAAITHGALQGLAYLH 142
Query: 201 NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGAT 260
+ I HRDIK N+L+ Q+KL DFGSA + P S++ + Y+ APE+I
Sbjct: 143 SHNMI-HRDIKAGNILLT-EPGQVKLADFGSASIA---SPANSFVGTPYWMAPEVILAMD 197
Query: 261 E--YTTAIDIWSTGCVMAELLLGQP 283
E Y +D+WS G EL +P
Sbjct: 198 EGQYDGKVDVWSLGITCIELAERKP 222
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 91.4 bits (227), Expect = 4e-21
Identities = 66/220 (30%), Positives = 108/220 (49%), Gaps = 24/220 (10%)
Query: 91 GTGSFGVVFQAKCRETGEIVAIKKV-LQDKRYKNR-----ELQIMQMLDHPNIVALKHCF 144
G GS+G V++ K + A+K+V L K R E++I+ ++HPNI++ K F
Sbjct: 9 GKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAF 68
Query: 145 FSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTY--QICRALAYIH 200
D +L + V+EY P + I++ R +R + +++ Q+ R L +H
Sbjct: 69 L---DGNKLCI--VMEYAPFGDLSKAISK---RKKKRKLIPEQEIWRIFIQLLRGLQALH 120
Query: 201 NCIGICHRDIKPQN-LLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGA 259
I HRD+K N LLV +K+ D G +KVL K + I + +Y APE ++
Sbjct: 121 E-QKILHRDLKSANILLVAND--LVKIGDLGISKVLKKNMAK-TQIGTPHYMAPE-VWKG 175
Query: 260 TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIK 299
Y+ DIWS GC++ E+ P F S D ++ +
Sbjct: 176 RPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQR 215
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 91.3 bits (227), Expect = 6e-21
Identities = 74/296 (25%), Positives = 122/296 (41%), Gaps = 52/296 (17%)
Query: 89 VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-----RELQIMQMLDHPNIVALKHC 143
V+G G+ VV+ A C E VAIK++ +K + +E+Q M +HPN+V +
Sbjct: 8 VIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKY-YT 66
Query: 144 FFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
F +EL+ LV+ Y+ ++ + +Y R +I L ++ + L Y+H+
Sbjct: 67 SF--VVGDELW--LVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVL--KEVLKGLEYLHS 120
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVS-----YICSRYYRAPELI 256
G HRDIK N+L+ +K+ DFG + L G ++ + + APE++
Sbjct: 121 N-GQIHRDIKAGNILLGEDG-SVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVM 178
Query: 257 FGATEYTTAIDIWSTGCVMAELLLGQP----LFPGESGVDQLVEIIKVLGTPTREEIKCM 312
Y DIWS G EL G P + L+ ++
Sbjct: 179 EQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKV----LMLTLQ------------- 221
Query: 313 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368
N P ++ +K + K ++ Q P+ R TA E H FF
Sbjct: 222 ND------PPSLETGADYKKYSKSFR----KMISLCLQKDPSKRPTAEELLKHKFF 267
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 91.1 bits (226), Expect = 6e-21
Identities = 63/213 (29%), Positives = 107/213 (50%), Gaps = 31/213 (14%)
Query: 89 VVGTGSFGVVFQAKCRETGEIVAIKKVLQD--------KRYK--NRELQIMQMLDHPNIV 138
V+G G++G V+ G+++A+K+V D K Y+ E+ +++ L H NIV
Sbjct: 7 VLGKGAYGTVY-CGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65
Query: 139 ALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
+ T ++ +++ +E+VP I+ +R ++ K YT QI +AY
Sbjct: 66 Q-----YLGTCLDDNTISIFMEFVPG--GSISSILNRFGPLPEPVFCK-YTKQILDGVAY 117
Query: 199 IH-NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYI-------CSRYY 250
+H NC+ HRDIK N+++ P +KL DFG A+ L + ++ + Y+
Sbjct: 118 LHNNCV--VHRDIKGNNVMLMP-NGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYW 174
Query: 251 RAPELIFGATEYTTAIDIWSTGCVMAELLLGQP 283
APE+I + Y DIWS GC + E+ G+P
Sbjct: 175 MAPEVI-NESGYGRKSDIWSIGCTVFEMATGKP 206
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 91.4 bits (227), Expect = 6e-21
Identities = 77/286 (26%), Positives = 121/286 (42%), Gaps = 36/286 (12%)
Query: 90 VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-----RELQIMQMLDHPNIVALKHCF 144
+G G+ G V + K TG ++A K V + RELQIM P IV+ F
Sbjct: 13 LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAF 72
Query: 145 FSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203
+ + + + +E++ +++RI + I P+ + + L Y++N
Sbjct: 73 LNENN-----ICMCMEFMDCGSLDRIYKKGGPI----PVEILGKIAVAVVEGLTYLYNVH 123
Query: 204 GICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYT 263
I HRDIKP N+LVN Q+KLCDFG + L+ + +++ + Y +PE I G +YT
Sbjct: 124 RIMHRDIKPSNILVNSRG-QIKLCDFGVSGELINSIAD-TFVGTSTYMSPERIQGG-KYT 180
Query: 264 TAIDIWSTGCVMAELLLGQ-PLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 322
D+WS G + EL LG+ P D + + +L
Sbjct: 181 VKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDL-----------------LQ 223
Query: 323 QIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368
QI P ++ P + D V P R T + C P F
Sbjct: 224 QIVQEPPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPF 269
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 91.8 bits (228), Expect = 7e-21
Identities = 82/310 (26%), Positives = 139/310 (44%), Gaps = 65/310 (20%)
Query: 89 VVGTGSFGVVFQAKCRETGEIVAIKKV-LQDKRYKNR------ELQIMQMLDHPNIVALK 141
++ G++G V+ + +ET + A+KK+ Q+ +N+ E I+ ++P +V++
Sbjct: 8 LISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSM- 66
Query: 142 HCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 200
C F T + +L +V+EYV + +N +P+ ++Y + AL Y+H
Sbjct: 67 FCSFET----KRHLCMVMEYVEGGDCATLLKNIGA----LPVDMARMYFAETVLALEYLH 118
Query: 201 NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV-LVKGEPNV--------------SYI 245
N GI HRD+KP NLL+ H +KL DFG +K+ L+ N+ +
Sbjct: 119 N-YGIVHRDLKPDNLLITSMGH-IKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQV 176
Query: 246 C-SRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTP 304
C + Y APE+I Y +D W+ G ++ E L+G F G++ + ++I
Sbjct: 177 CGTPEYIAPEVIL-RQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVIS----- 230
Query: 305 TREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC---TALE 361
++I P E LP +A DL+ R + +P R A E
Sbjct: 231 --DDI--EWPEGDE-----------------ALPADAQDLISRLLRQNPLERLGTGGAFE 269
Query: 362 ACVHPFFDEL 371
H FF L
Sbjct: 270 VKQHRFFLGL 279
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 91.7 bits (228), Expect = 7e-21
Identities = 84/301 (27%), Positives = 138/301 (45%), Gaps = 39/301 (12%)
Query: 89 VVGTGSFGVVFQAKCRETGEIVAIKKV-LQDK-RYKN---RELQIMQMLDHPNIVALKHC 143
+G G+ GVV + R +G I+A K + L+ K +N REL+++ + P IV
Sbjct: 8 ELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGA 67
Query: 144 FFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
F+S D E +++ +E++ +++++ + RI P + + + R L Y+
Sbjct: 68 FYS--DGE---ISICMEHMDGGSLDQVLKKAGRI----PENILGKISIAVLRGLTYLREK 118
Query: 203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEY 262
I HRD+KP N+LVN ++KLCDFG + L+ N S++ +R Y +PE + G T Y
Sbjct: 119 HKIMHRDVKPSNILVNSRG-EIKLCDFGVSGQLIDSMAN-SFVGTRSYMSPERLQG-THY 175
Query: 263 TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 322
T DIWS G + E+ +G+ P E+ + G P E + + P
Sbjct: 176 TVQSDIWSLGLSLVEMAIGRYPIPPPDA----KELEAMFGRPV-SEGEAKESHRPVSGHP 230
Query: 323 QIKPHPWHKVFQ----------KRLP-----PEAVDLVCRFFQYSPNLRCTALEACVHPF 367
P P +F+ +LP E D V + + +P R E HPF
Sbjct: 231 PDSPRPM-AIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPF 289
Query: 368 F 368
Sbjct: 290 I 290
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 90.5 bits (224), Expect = 1e-20
Identities = 66/211 (31%), Positives = 107/211 (50%), Gaps = 17/211 (8%)
Query: 87 EHVVGTGSFGVVFQAKCRETGEIVAIKKV----LQDKRYKN---RELQIMQMLDHPNIVA 139
E +G G F V++A C G VA+KKV L D + + +E+ +++ L+HPN++
Sbjct: 7 EKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIK 66
Query: 140 LKHCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
F E+ LN+VLE ++R+ +++ + + +P V Y Q+C AL +
Sbjct: 67 YYASFI-----EDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEH 121
Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL-VKGEPNVSYICSRYYRAPELIF 257
+H+ + HRDIKP N+ + T +KL D G + K S + + YY +PE I
Sbjct: 122 MHS-RRVMHRDIKPANVFITA-TGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIH 179
Query: 258 GATEYTTAIDIWSTGCVMAELLLGQPLFPGE 288
Y DIWS GC++ E+ Q F G+
Sbjct: 180 -ENGYNFKSDIWSLGCLLYEMAALQSPFYGD 209
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 90.6 bits (225), Expect = 1e-20
Identities = 69/210 (32%), Positives = 104/210 (49%), Gaps = 38/210 (18%)
Query: 90 VGTGSFGVVFQAKCR------ETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVA 139
+G G+FG V CR TGE+VA+KK+ R RE++I++ L H NIV
Sbjct: 12 LGKGNFGSV--ELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVK 69
Query: 140 LKHCFFSTTDKEELYLNLVLEYVPETVNR--IARNYSRIHQRMPLIYVKLYTYQICRALA 197
K +S + L LV+EY+P R + ++ R+ R L LY QIC+ +
Sbjct: 70 YKGVCYSAGRRN---LRLVMEYLPYGSLRDYLQKHRERLDHRKLL----LYASQICKGME 122
Query: 198 YI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL-------VKGEPNVSYICSR 248
Y+ + HRD+ +N+LV +K+ DFG KVL EP S I
Sbjct: 123 YLGSKRYV---HRDLATRNILVESENR-VKIGDFGLTKVLPQDKEYYKVREPGESPI--- 175
Query: 249 YYRAPELIFGATEYTTAIDIWSTGCVMAEL 278
++ APE + ++++ A D+WS G V+ EL
Sbjct: 176 FWYAPESL-TESKFSVASDVWSFGVVLYEL 204
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 91.8 bits (228), Expect = 1e-20
Identities = 86/311 (27%), Positives = 136/311 (43%), Gaps = 67/311 (21%)
Query: 89 VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-------RELQIMQMLDHPNIVALK 141
V+G G+FG V + + + ++ A+K + + + K E IM + IV L
Sbjct: 50 VIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQL- 108
Query: 142 HCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 199
H F +++ YL +V+EY+P + VN ++ NY +P + + YT ++ AL I
Sbjct: 109 HYAF----QDDKYLYMVMEYMPGGDLVNLMS-NYD-----IPEKWARFYTAEVVLALDAI 158
Query: 200 HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY-----YRAPE 254
H+ +G HRD+KP N+L++ H LKL DFG+ +K + N C Y +PE
Sbjct: 159 HS-MGFIHRDVKPDNMLLDKSGH-LKLADFGTC---MKMDANGMVRCDTAVGTPDYISPE 213
Query: 255 LIF---GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 311
++ G Y D WS G + E+L+G F +S V GT + K
Sbjct: 214 VLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV----------GTYS----KI 259
Query: 312 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNL--RCTALEACVHPFF- 368
M+ + FP + +A DL+C F R E HPFF
Sbjct: 260 MD-HKNSLTFPD----------DIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFK 308
Query: 369 ------DELRD 373
D +R+
Sbjct: 309 NDQWTFDNIRE 319
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 90.2 bits (224), Expect = 2e-20
Identities = 67/209 (32%), Positives = 102/209 (48%), Gaps = 33/209 (15%)
Query: 90 VGTGSFGVVFQAKCR------ETGEIVAIKK-----VLQDKRYKNRELQIMQMLDHPNIV 138
+G G FG V CR TGE VA+K Q + RE++I++ LDH NIV
Sbjct: 12 LGEGHFGKVE--LCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIV 69
Query: 139 ALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQ-RMPLIYVKLYTYQICRALA 197
K L L++EY+P R Y + H+ ++ L + L++ QIC+ +
Sbjct: 70 KYKGV---CEKPGGRSLRLIMEYLPSGSLRD---YLQRHRDQINLKRLLLFSSQICKGMD 123
Query: 198 YIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-------EPNVSYICSRYY 250
Y+ + HRD+ +N+LV +K+ DFG AKVL + EP S I +Y
Sbjct: 124 YLGS-QRYIHRDLAARNILVE-SEDLVKISDFGLAKVLPEDKDYYYVKEPGESPI--FWY 179
Query: 251 RAPELIFGATEYTTAIDIWSTGCVMAELL 279
APE + + +++A D+WS G + EL
Sbjct: 180 -APECLRTSK-FSSASDVWSFGVTLYELF 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 90.2 bits (224), Expect = 3e-20
Identities = 85/310 (27%), Positives = 137/310 (44%), Gaps = 47/310 (15%)
Query: 89 VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCF---- 144
V+G GSFG V A+ + T E AIK + +D ++ +++ + +A +H F
Sbjct: 2 VLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHL 61
Query: 145 FSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG 204
F T +E +L V+EY+ + + R + Y +I L ++H G
Sbjct: 62 FCTFQTKE-HLFFVMEYL--NGGDLMFHIQSSG-RFDEARARFYAAEIICGLQFLHKK-G 116
Query: 205 ICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYIC-SRYYRAPELIFGATEYT 263
I +RD+K N+L++ H +K+ DFG K + GE S C + Y APE++ G +Y
Sbjct: 117 IIYRDLKLDNVLLDKDGH-IKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKG-QKYN 174
Query: 264 TAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQ 323
++D WS G ++ E+L+GQ F GE D+L + I +
Sbjct: 175 ESVDWWSFGVLLYEMLIGQSPFHGE-DEDELFDSI-------LNDR-------------- 212
Query: 324 IKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-TALEACVHPFFDELRDPNTRLPNGR 382
P F + + EA D + + F+ P R + HPFF R + R
Sbjct: 213 ----PH---FPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQHPFF---RGIDWERLEKR 262
Query: 383 PLPPLFNFKP 392
+PP FKP
Sbjct: 263 EIPP--PFKP 270
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 89.9 bits (223), Expect = 4e-20
Identities = 86/285 (30%), Positives = 135/285 (47%), Gaps = 49/285 (17%)
Query: 89 VVGTGSFGVVF---QAKCRETGEIVAIK-------KVLQDKRYKNRELQIMQMLDHPNIV 138
V+G GSFG VF + + G++ A+K KV R K E I+ ++HP IV
Sbjct: 3 VLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKM-ERDILAEVNHPFIV 61
Query: 139 ALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIY--VKLYTYQICRAL 196
L H F T K L L+L+++ R ++R+ + + VK Y ++ AL
Sbjct: 62 KL-HYAFQTEGK----LYLILDFL-----RGGDLFTRLSKEVMFTEEDVKFYLAELALAL 111
Query: 197 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY-YRAPEL 255
++H+ +GI +RD+KP+N+L++ H +KL DFG +K + E C Y APE+
Sbjct: 112 DHLHS-LGIIYRDLKPENILLDEEGH-IKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEV 169
Query: 256 IFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV-LGTPT--------- 305
+ +T + D WS G +M E+L G F G+ + + I+K LG P
Sbjct: 170 V-NRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSL 228
Query: 306 -REEIKCMNPNYTEFKFPQ----IKPHP------WHKVFQKRLPP 339
R K NP P IK HP W+K++++ + P
Sbjct: 229 LRALFK-RNPANRLGAGPDGVEEIKRHPFFSTIDWNKLYRREIKP 272
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 88.5 bits (219), Expect = 4e-20
Identities = 69/217 (31%), Positives = 109/217 (50%), Gaps = 22/217 (10%)
Query: 89 VVGTGSFGVVFQAKCRETGEIVAIKKV------LQDKRYKNRELQIMQMLDHPNIVALKH 142
+G GSFG ++ AK + E IK++ +++K +E+ ++ + HPNIV
Sbjct: 7 KIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVT--- 63
Query: 143 CFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 200
FF++ +E L +V+EY + + RI R + ++ + QI L +IH
Sbjct: 64 -FFASF-QENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQIL---SWFVQISLGLKHIH 118
Query: 201 NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYIC--SRYYRAPELIFG 258
+ I HRDIK QN+ ++ + KL DFG A+ L ++Y C + YY +PE I
Sbjct: 119 D-RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQL-NDSMELAYTCVGTPYYLSPE-ICQ 175
Query: 259 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLV 295
Y DIWS GCV+ EL + F G + + QLV
Sbjct: 176 NRPYNNKTDIWSLGCVLYELCTLKHPFEGNN-LHQLV 211
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 89.0 bits (221), Expect = 5e-20
Identities = 77/281 (27%), Positives = 121/281 (43%), Gaps = 50/281 (17%)
Query: 91 GTGSFGVVFQAKCRETGEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFF 145
G G+ G V + + + TG I A+K + D ++ REL+I + P IV F
Sbjct: 10 GEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAF- 68
Query: 146 STTDKEELYLNLVLEY-----VPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 200
D+ + + +EY + ++ + RI ++ L + + + L+Y+H
Sbjct: 69 --LDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEK-VLGKI---AESVLKGLSYLH 122
Query: 201 NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVS----YICSRYYRAPELI 256
+ I HRDIKP N+L+ Q+KLCDFG V GE S + + +Y APE I
Sbjct: 123 S-RKIIHRDIKPSNILLTRKG-QVKLCDFG-----VSGELVNSLAGTFTGTSFYMAPERI 175
Query: 257 FGATEYTTAIDIWSTGCVMAELLLGQPLFPGES----GVDQLVEIIKVLGTPT------- 305
G Y+ D+WS G + E+ + FP E G +L+ I + P
Sbjct: 176 QGKP-YSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGN 234
Query: 306 ----REEIK-----CMNPNYTEFKFP-QIKPHPWHKVFQKR 336
EE K C+ + T P + HPW K K+
Sbjct: 235 GIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQMKK 275
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.6 bits (220), Expect = 5e-20
Identities = 78/304 (25%), Positives = 120/304 (39%), Gaps = 68/304 (22%)
Query: 91 GTGSFGVVFQAKCRETGEIVAIKKV-------LQDKRYKNRELQIMQMLDHPNIVALKHC 143
G G+FG V++A+ +ETG A K + L+D E+ I+ HPNIV L
Sbjct: 14 GDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMV---EIDILSECKHPNIVGLYEA 70
Query: 144 FFSTTDKEELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLI--YVKLYTYQICRALAYIH 200
+F L +++E+ ++ I R L ++ Q+ AL ++H
Sbjct: 71 YFYENK-----LWILIEFCDGGALDSIMLELER-----GLTEPQIRYVCRQMLEALNFLH 120
Query: 201 NCIGICHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPNVSYICSRYYRAPELI--- 256
+ + HRD+K N+L+ +KL DFG SAK + ++I + Y+ APE++
Sbjct: 121 SHK-VIHRDLKAGNILLTLDG-DVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACE 178
Query: 257 -FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 315
F Y DIWS G + EL +P P E +NP
Sbjct: 179 TFKDNPYDYKADIWSLGITLIELAQMEP--------------------PHHE----LNPM 214
Query: 316 YTEFKFPQ------IKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFD 369
K + +P W F D + P+ R TA E HPF
Sbjct: 215 RVLLKILKSEPPTLDQPSKWSSSFN--------DFLKSCLVKDPDDRPTAAELLKHPFVS 266
Query: 370 ELRD 373
+ D
Sbjct: 267 DQSD 270
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 88.7 bits (220), Expect = 9e-20
Identities = 78/295 (26%), Positives = 128/295 (43%), Gaps = 57/295 (19%)
Query: 89 VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNREL-------QIMQMLDHPNIVALK 141
++G G+FG V + + TG+ A+K + ++ E+ +++Q HP + ALK
Sbjct: 2 LLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALK 61
Query: 142 HCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 199
+ F T D L V+EY E ++R R + Y +I AL Y+
Sbjct: 62 YSF-QTHD----RLCFVMEYANGGELFFHLSRERVFSEDR-----ARFYGAEIVSALGYL 111
Query: 200 HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYIC-SRYYRAPELIFG 258
H+C + +RD+K +NL+++ H +K+ DFG K + + C + Y APE +
Sbjct: 112 HSC-DVVYRDLKLENLMLDKDGH-IKITDFGLCKEGISDGATMKTFCGTPEYLAPE-VLE 168
Query: 259 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 318
+Y A+D W G VM E++ G+ F + ++L E+I + EEI+
Sbjct: 169 DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-EKLFELILM------EEIR-------- 213
Query: 319 FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-----TALEACVHPFF 368
F + L PEA L+ + P R A E H FF
Sbjct: 214 --------------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFF 254
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 88.0 bits (218), Expect = 1e-19
Identities = 76/300 (25%), Positives = 130/300 (43%), Gaps = 50/300 (16%)
Query: 90 VGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKN--RELQIMQMLDHPNIVALKHCF 144
+G G++G V++ R TG +A+K++ L + ++ EL I+ P IV F
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAF 68
Query: 145 FSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203
F E + + +EY+ +++++ + +P ++ TY + + L ++
Sbjct: 69 F-----IEGAVYMCMEYMDAGSLDKLYAGGVAT-EGIPEDVLRRITYAVVKGLKFLKEEH 122
Query: 204 GICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELI-----FG 258
I HRD+KP N+LVN + Q+KLCDFG + LV + C Y APE I
Sbjct: 123 NIIHRDVKPTNVLVNGNG-QVKLCDFGVSGNLVASLAKTNIGCQSYM-APERIKSGGPNQ 180
Query: 259 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVD---QLVEIIKVLGTPTREEIKCMNPN 315
YT D+WS G + E+ LG+ +P E+ + QL I+ G P +
Sbjct: 181 NPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVD--GDPPT-----LPSG 233
Query: 316 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 375
Y+ +A D V + PN R T + HP+ + ++ +
Sbjct: 234 YS---------------------DDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYKNAD 272
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 88.5 bits (219), Expect = 1e-19
Identities = 87/282 (30%), Positives = 128/282 (45%), Gaps = 45/282 (15%)
Query: 89 VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ---------IMQMLDHPNIVA 139
V+G GSFG V AK + G+ A+ KVLQ K NR+ Q +++ + HP +V
Sbjct: 2 VIGKGSFGKVLLAKRKLDGKCYAV-KVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVG 60
Query: 140 LKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALA 197
L H F TT+K L VL++V E + R S P + Y +I AL
Sbjct: 61 L-HYSFQTTEK----LYFVLDFVNGGELFFHLQRERS-----FPEPRARFYAAEIASALG 110
Query: 198 YIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYIC-SRYYRAPELI 256
Y+H+ I I +RD+KP+N+L++ H + L DFG K + + C + Y APE+I
Sbjct: 111 YLHS-INIVYRDLKPENILLDSQGH-VVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVI 168
Query: 257 FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEII-KVL----GTPT------ 305
Y +D W G V+ E+L G P F + I+ K L G
Sbjct: 169 -RKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLRPGASLTAWSIL 227
Query: 306 REEIKCMNPNYTEFK--FPQIKPHP------WHKVFQKRLPP 339
E ++ K F +I+ HP W + QK++PP
Sbjct: 228 EELLEKDRQRRLGAKEDFLEIQEHPFFESLSWTDLEQKKIPP 269
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 87.2 bits (216), Expect = 2e-19
Identities = 85/303 (28%), Positives = 133/303 (43%), Gaps = 57/303 (18%)
Query: 89 VVGTGSFGVVFQAKCR---ETGEIVAIK-----KVLQDKRYKNRELQIMQMLDH----PN 136
V+GTG++G VF + + G++ A+K ++Q + Q+L+ P
Sbjct: 7 VLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPF 66
Query: 137 IVALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICR 194
+V L H F T K L+L+L+YV E + Y R + V++Y +I
Sbjct: 67 LVTL-HYAFQTDTK----LHLILDYVNGGELFTHL---YQR--EHFTESEVRVYIAEIVL 116
Query: 195 ALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY-ICSRY-YRA 252
AL ++H +GI +RDIK +N+L++ H + L DFG +K + E +Y C Y A
Sbjct: 117 ALDHLHQ-LGIIYRDIKLENILLDSEGH-VVLTDFGLSKEFLAEEEERAYSFCGTIEYMA 174
Query: 253 PELIFGATE-YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 311
PE+I G + + A+D WS G + ELL G F + + EI +R +K
Sbjct: 175 PEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEI-------SRRILKS 227
Query: 312 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC---TALEACVHPFF 368
P F K + EA D + + + P R A E HPFF
Sbjct: 228 KPP------------------FPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFF 269
Query: 369 DEL 371
+
Sbjct: 270 QGI 272
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 87.5 bits (217), Expect = 3e-19
Identities = 89/300 (29%), Positives = 130/300 (43%), Gaps = 63/300 (21%)
Query: 89 VVGTGSFGVVFQAK---CRETGEIVAIKKVLQ---------DKRYKNRELQIMQMLDHPN 136
V+G G +G VFQ + +TG+I A+K VL+ D + E I++ + HP
Sbjct: 3 VLGKGGYGKVFQVRKVTGADTGKIFAMK-VLKKATIVRNQKDTAHTKAERNILEAVKHPF 61
Query: 137 IVALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICR 194
IV L F T K LYL +LEY+ E + R + Y +I
Sbjct: 62 IVDL-IYAFQTGGK--LYL--ILEYLSGGELFMHLEREGIFMEDT-----ACFYLSEISL 111
Query: 195 ALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY-YRAP 253
AL ++H GI +RD+KP+N+L++ H +KL DFG K + C Y AP
Sbjct: 112 ALEHLHQ-QGIIYRDLKPENILLDAQGH-VKLTDFGLCKESIHEGTVTHTFCGTIEYMAP 169
Query: 254 ELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 313
E I + + A+D WS G +M ++L G P F E+ + +I+K K
Sbjct: 170 E-ILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKG---------KLNL 219
Query: 314 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-----TALEACVHPFF 368
P Y L PEA DL+ + + +P+ R A E HPFF
Sbjct: 220 PPY--------------------LTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFF 259
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 86.0 bits (213), Expect = 3e-19
Identities = 59/227 (25%), Positives = 110/227 (48%), Gaps = 24/227 (10%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV-LQ--DKRYKN---RELQIMQMLDHPNI 137
+ + +G GSFGVVF+ + + A+K++ L ++R + E +++ LD I
Sbjct: 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYI 61
Query: 138 VALKHCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
+ F ++ LN+V+EY ++++ + + +P V + QI L
Sbjct: 62 IRYYESFL-----DKGKLNIVMEYAENGDLHKLLKMQRG--RPLPEDQVWRFFIQILLGL 114
Query: 197 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY----ICSRYYRA 252
A++H+ I HRDIK NL ++ + +K+ D G AK+L N ++ + + YY +
Sbjct: 115 AHLHS-KKILHRDIKSLNLFLDAYD-NVKIGDLGVAKLL---SDNTNFANTIVGTPYYLS 169
Query: 253 PELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIK 299
PEL Y D+W+ G V+ E G+ F + +++II+
Sbjct: 170 PELC-EDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIR 215
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 9e-19
Identities = 85/314 (27%), Positives = 139/314 (44%), Gaps = 55/314 (17%)
Query: 89 VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQM--------LDHPNIVAL 140
++G GSFG VF A+ + T + AIK + +D + +++ + +HP + L
Sbjct: 2 MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHL 61
Query: 141 KHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 200
+C F T KE L+ V+EY+ + + H + L Y +I L ++H
Sbjct: 62 -YCTFQT--KENLFF--VMEYL--NGGDLMFHIQSCH-KFDLPRATFYAAEIICGLQFLH 113
Query: 201 NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYIC-SRYYRAPELIFGA 259
+ GI +RD+K N+L++ H +K+ DFG K + G+ C + Y APE++ G
Sbjct: 114 S-KGIVYRDLKLDNILLDTDGH-IKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLG- 170
Query: 260 TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 319
+Y T++D WS G ++ E+L+GQ F G + + I+ NP Y +
Sbjct: 171 QKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELF------------QSIRMDNPCYPRW 218
Query: 320 KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTAL-EACVHPFFDELRDPNTRL 378
L EA D++ + F P R + HPFF E+ + L
Sbjct: 219 -----------------LTREAKDILVKLFVREPERRLGVKGDIRQHPFFREID--WSAL 259
Query: 379 PNGRPLPPLFNFKP 392
PP FKP
Sbjct: 260 EEREIEPP---FKP 270
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.3 bits (214), Expect = 1e-18
Identities = 80/308 (25%), Positives = 125/308 (40%), Gaps = 86/308 (27%)
Query: 89 VVGTGSFGVVFQAKCRETGEIVAIKKVLQ-DKRYKNR------ELQIMQMLDHPNIVALK 141
V+G G+FG V + ++TG I A+KK+ + + K + E I+ D+P +V L
Sbjct: 8 VIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLY 67
Query: 142 HCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 199
+ F ++E YL L++EY+P + + + + + Y+ + A+ I
Sbjct: 68 YSF-----QDENYLYLIMEYLPGGDMMTLLMK-KDTFTEEETRFYIA----ETILAIDSI 117
Query: 200 HNCIGICHRDIKPQNLLVNPHTHQLKLCDFG------------SAKVLVKGEPN--VSYI 245
H +G HRDIKP NLL++ H +KL DFG ++L P+ + +I
Sbjct: 118 HK-LGYIHRDIKPDNLLLDAKGH-IKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFI 175
Query: 246 CSRY-------------------------YRAPELIFGATEYTTAIDIWSTGCVMAELLL 280
Y APE +F T Y D WS G +M E+L+
Sbjct: 176 SKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPE-VFLQTGYNKECDWWSLGVIMYEMLV 234
Query: 281 GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPE 340
G P F + P K +N T +FP + L PE
Sbjct: 235 GYPPFCSD--------------NPQETYRKIINWKET-LQFPD----------EVPLSPE 269
Query: 341 AVDLVCRF 348
A DL+ R
Sbjct: 270 AKDLIKRL 277
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 1e-18
Identities = 92/305 (30%), Positives = 140/305 (45%), Gaps = 60/305 (19%)
Query: 89 VVGTGSFGVVF---QAKCRETGEIVAIKKVLQD----KRYKNRELQIM--QMLDH----P 135
V+GTG++G VF + +TG++ A+K VLQ ++ K E +L+H P
Sbjct: 7 VLGTGAYGKVFLVRKVTGHDTGKLYAMK-VLQKAALVQKAKTVEHTRTERNVLEHVRQSP 65
Query: 136 NIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQR--MPLIYVKLYTYQIC 193
+V L H F T K L+L+L+YV ++ ++QR V+ Y+ +I
Sbjct: 66 FLVTL-HYAFQTEAK----LHLILDYVSG-----GEMFTHLYQRDNFSEDEVRFYSGEII 115
Query: 194 RALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY-ICSRY-YR 251
AL ++H +GI +RDIK +N+L++ H + L DFG +K + E +Y C Y
Sbjct: 116 LALEHLHK-LGIVYRDIKLENILLDSEGH-VVLTDFGLSKEFLSEEKERTYSFCGTIEYM 173
Query: 252 APELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 311
APE+I G + A+D WS G ++ ELL G F E + E+ +R +KC
Sbjct: 174 APEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEV-------SRRILKC 226
Query: 312 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-----TALEACVHP 366
P F + PEA DL+ + + P R A E HP
Sbjct: 227 DPP------------------FPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHP 268
Query: 367 FFDEL 371
FF L
Sbjct: 269 FFKGL 273
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 84.3 bits (209), Expect = 2e-18
Identities = 65/233 (27%), Positives = 108/233 (46%), Gaps = 30/233 (12%)
Query: 90 VGTGSFGVVFQAKCRETGEIVAIKKV--LQDKRYKNRELQ----IMQMLDHPNIVALKHC 143
+G G+FG V + + +G I+A+K++ D++ + R L +M+ D P IV
Sbjct: 12 IGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVK---- 67
Query: 144 FFSTTDKE-------ELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
F+ +E EL +++ L+ + V Y + +P + +AL
Sbjct: 68 FYGALFREGDCWICMEL-MDISLDKFYKYV------YEVLKSVIPEEILGKIAVATVKAL 120
Query: 197 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELI 256
Y+ + I HRD+KP N+L++ + + +KLCDFG + LV R Y APE I
Sbjct: 121 NYLKEELKIIHRDVKPSNILLDRNGN-IKLCDFGISGQLVDSIAKTRDAGCRPYMAPERI 179
Query: 257 --FGATEYTTAIDIWSTGCVMAELLLGQPLFPG-ESGVDQLVEIIKVLGTPTR 306
Y D+WS G + E+ G+ +P S DQL +++K G P
Sbjct: 180 DPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVK--GDPPI 230
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 84.5 bits (209), Expect = 2e-18
Identities = 90/301 (29%), Positives = 137/301 (45%), Gaps = 60/301 (19%)
Query: 89 VVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKRYKNR--ELQIMQM-LDHPNIVAL 140
V+G GSFG V A+ + T E+ AIK +LQD E +I+ + HP + AL
Sbjct: 2 VLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTAL 61
Query: 141 KHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
HC F T D+ L V+EYV + + +I R+ R + Y ++ AL +
Sbjct: 62 -HCCFQTKDR----LFFVMEYVNGGDLMFQIQRSRKFDEPR-----SRFYAAEVTLALMF 111
Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV-LVKGEPNVSYICSRYYRAPELIF 257
+H G+ +RD+K N+L++ H KL DFG K ++ G ++ + Y APE I
Sbjct: 112 LHRH-GVIYRDLKLDNILLDAEGH-CKLADFGMCKEGILNGVTTTTFCGTPDYIAPE-IL 168
Query: 258 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 317
EY ++D W+ G +M E++ GQP F ++ D L E I +
Sbjct: 169 QELEYGPSVDWWALGVLMYEMMAGQPPFEADNE-DDLFESIL----------------HD 211
Query: 318 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLR--CTALEAC-----VHPFFDE 370
+ +P W L EAV ++ F +PN R C A + HPFF E
Sbjct: 212 DVLYPV-----W-------LSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHPFFKE 259
Query: 371 L 371
+
Sbjct: 260 I 260
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 4e-18
Identities = 67/224 (29%), Positives = 120/224 (53%), Gaps = 28/224 (12%)
Query: 90 VGTGSFGVVFQAKCRETGEIVA-------IKKVLQDKRYKNRELQIMQMLDHPNIVALKH 142
+G G+ GVV + + + +G I+A IK ++++ RELQ++ + P IV
Sbjct: 13 LGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQII--RELQVLHECNSPYIVGFYG 70
Query: 143 CFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
F+S D E +++ +E++ +++++ + RI + + + + + R LAY+
Sbjct: 71 AFYS--DGE---ISICMEHMDGGSLDQVLKEAKRIPEEI----LGKVSIAVLRGLAYLRE 121
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 261
I HRD+KP N+LVN ++KLCDFG + L+ N S++ +R Y +PE + G T
Sbjct: 122 KHQIMHRDVKPSNILVNSRG-EIKLCDFGVSGQLIDSMAN-SFVGTRSYMSPERLQG-TH 178
Query: 262 YTTAIDIWSTGCVMAELLLGQ-PLFPGESGVDQLVEIIKVLGTP 304
Y+ DIWS G + EL +G+ P+ P ++ E+ + G P
Sbjct: 179 YSVQSDIWSMGLSLVELAIGRYPIPPPDAK-----ELEAIFGRP 217
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 5e-18
Identities = 67/229 (29%), Positives = 122/229 (53%), Gaps = 23/229 (10%)
Query: 90 VGTGSFGVVFQAKCRETGEIVA-------IKKVLQDKRYKNRELQIMQMLDHPNIVALKH 142
+G G+ GVVF+ + +G I+A IK ++++ RELQ++ + P IV
Sbjct: 13 LGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQII--RELQVLHECNSPYIVGFYG 70
Query: 143 CFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
F+S D E +++ +E++ +++++ + RI +++ + + + + L Y+
Sbjct: 71 AFYS--DGE---ISICMEHMDGGSLDQVLKKAGRIPEQI----LGKVSIAVIKGLTYLRE 121
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 261
I HRD+KP N+LVN ++KLCDFG + L+ N S++ +R Y +PE + G T
Sbjct: 122 KHKIMHRDVKPSNILVNSRG-EIKLCDFGVSGQLIDSMAN-SFVGTRSYMSPERLQG-TH 178
Query: 262 YTTAIDIWSTGCVMAELLLGQ-PLFPGESGVDQLVEIIKVLGTPTREEI 309
Y+ DIWS G + E+ +G+ P+ P ++ +L+ V G P E
Sbjct: 179 YSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESET 227
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 83.8 bits (207), Expect = 5e-18
Identities = 84/316 (26%), Positives = 142/316 (44%), Gaps = 59/316 (18%)
Query: 89 VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQM--------LDHPNIVAL 140
V+G GSFG V A+ + GE A+K + +D + +++ + ++P + L
Sbjct: 2 VLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHL 61
Query: 141 KHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
+C F T + +L V+E++ + + I R L Y +I L +
Sbjct: 62 -YCTFQTKE----HLFFVMEFLNGGDLMFHIQDK-----GRFDLYRATFYAAEIVCGLQF 111
Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYIC-SRYYRAPELIF 257
+H+ GI +RD+K N++++ H +K+ DFG K V G+ S C + Y APE++
Sbjct: 112 LHS-KGIIYRDLKLDNVMLDRDGH-IKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQ 169
Query: 258 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 317
G +YT ++D WS G ++ E+L+GQ F G+ D+L E I+V
Sbjct: 170 G-LKYTFSVDWWSFGVLLYEMLIGQSPFHGDDE-DELFESIRV----------------- 210
Query: 318 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTAL-EACVHPFFDELRDPNT 376
PH + + + E+ D++ + F+ P R + HPFF + N
Sbjct: 211 ------DTPH-----YPRWITKESKDILEKLFERDPTRRLGVVGNIRGHPFFKTI---NW 256
Query: 377 RLPNGRPLPPLFNFKP 392
R L P FKP
Sbjct: 257 TALEKRELDP--PFKP 270
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 5e-18
Identities = 61/215 (28%), Positives = 107/215 (49%), Gaps = 17/215 (7%)
Query: 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV----LQDKRYKN---RELQIMQMLDHP 135
++ E +G G F V++A C + VA+KKV + D + + +E+ +++ L+HP
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62
Query: 136 NIVALKHCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICR 194
N++ F + LN+VLE ++++ + + + + +P V Y Q+C
Sbjct: 63 NVIKYLDSFIEDNE-----LNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCS 117
Query: 195 ALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL-VKGEPNVSYICSRYYRAP 253
A+ ++H+ + HRDIKP N+ + T +KL D G + K S + + YY +P
Sbjct: 118 AVEHMHS-RRVMHRDIKPANVFITA-TGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSP 175
Query: 254 ELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGE 288
E I Y DIWS GC++ E+ Q F G+
Sbjct: 176 ERIH-ENGYNFKSDIWSLGCLLYEMAALQSPFYGD 209
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 82.6 bits (204), Expect = 6e-18
Identities = 62/207 (29%), Positives = 101/207 (48%), Gaps = 24/207 (11%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV----LQDKRYKN--RELQIMQMLDHPNI 137
Y+ +G GSFG K +E G+ IK++ + K + +E+ ++ + HPNI
Sbjct: 2 YVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNI 61
Query: 138 VALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIY----VKLYTYQIC 193
V + F +E L +V++Y Y +I+ + +++ + + QIC
Sbjct: 62 VQYQESF-----EENGNLYIVMDYCEG-----GDLYKKINAQRGVLFPEDQILDWFVQIC 111
Query: 194 RALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-EPNVSYICSRYYRA 252
AL ++H+ I HRDIK QN+ + +KL DFG A+VL E + I + YY +
Sbjct: 112 LALKHVHD-RKILHRDIKSQNIFLTKDG-TIKLGDFGIARVLNSTVELARTCIGTPYYLS 169
Query: 253 PELIFGATEYTTAIDIWSTGCVMAELL 279
PE I Y DIW+ GCV+ E+
Sbjct: 170 PE-ICENRPYNNKSDIWALGCVLYEMC 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 9e-18
Identities = 82/297 (27%), Positives = 133/297 (44%), Gaps = 61/297 (20%)
Query: 89 VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR---------ELQIMQMLDHPNIVA 139
++G G+FG V+ +TG +A+K+V D E+Q+++ L H IV
Sbjct: 9 LLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQ 68
Query: 140 LKHCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
C D E L++ +E++P ++ ++Y + + + + YT QI ++Y
Sbjct: 69 YYGCL---RDPMERTLSIFMEHMPGGSIKDQLKSYGALTENV----TRKYTRQILEGVSY 121
Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL----VKGEPNVSYICSRYYRAPE 254
+H+ + I HRDIK N+L + +KL DFG++K L + G S + Y+ +PE
Sbjct: 122 LHSNM-IVHRDIKGANILRDS-VGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPE 179
Query: 255 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 314
+I G Y DIWS GC + E+L +P + + + + I K+ PT NP
Sbjct: 180 VISGEG-YGRKADIWSVGCTVVEMLTEKPPW---AEFEAMAAIFKIATQPT-------NP 228
Query: 315 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL 371
LPP D CR F L+ +EA + P DEL
Sbjct: 229 ---------------------VLPPHVSDH-CRDF-----LKRIFVEAKLRPSADEL 258
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 2e-17
Identities = 69/209 (33%), Positives = 101/209 (48%), Gaps = 26/209 (12%)
Query: 89 VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRY--KNRELQIM-------QMLDHPNIVA 139
V+G GSFG V A+ + + A+K VLQ K K E IM + + HP +V
Sbjct: 2 VIGKGSFGKVLLARHKAEEKFYAVK-VLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 60
Query: 140 LKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALA 197
L H F T DK L VL+Y+ E + R + R + Y +I AL
Sbjct: 61 L-HFSFQTADK----LYFVLDYINGGELFYHLQRERCFLEPR-----ARFYAAEIASALG 110
Query: 198 YIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYIC-SRYYRAPELI 256
Y+H+ + I +RD+KP+N+L++ H + L DFG K ++ S C + Y APE++
Sbjct: 111 YLHS-LNIVYRDLKPENILLDSQGH-IVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVL 168
Query: 257 FGATEYTTAIDIWSTGCVMAELLLGQPLF 285
Y +D W G V+ E+L G P F
Sbjct: 169 H-KQPYDRTVDWWCLGAVLYEMLYGLPPF 196
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 82.2 bits (203), Expect = 2e-17
Identities = 86/321 (26%), Positives = 138/321 (42%), Gaps = 71/321 (22%)
Query: 89 VVGTGSFGVVFQAKCRETGEIVAIKK----VLQDKR---YKNRELQIMQMLDHPNIVALK 141
+VG G FG V + + TG+I A+K VL + + E I+ + + P I L+
Sbjct: 8 LVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQ 67
Query: 142 HCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 199
+ F DK+ LYL V+EY P + ++ + R + + M + Y ++ A+ +
Sbjct: 68 YAF---QDKDNLYL--VMEYQPGGDLLSLLNRYEDQFDEDM----AQFYLAELVLAIHSV 118
Query: 200 HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY--ICSRYYRAPELI- 256
H +G HRDIKP+N+L++ H +KL DFGSA L + S + + Y APE++
Sbjct: 119 HQ-MGYVHRDIKPENVLIDRTGH-IKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLT 176
Query: 257 ----FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 312
G Y D WS G + E++ G+ F + I+
Sbjct: 177 TMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIM-------------- 222
Query: 313 NPNYTEF-KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEA------CVH 365
N+ F KFP+ ++ + +DL+ +L C E C H
Sbjct: 223 --NFQRFLKFPE----------DPKVSSDFLDLI-------QSLLCGQKERLGYEGLCCH 263
Query: 366 PFFDELRDPNTRLPNGRPLPP 386
PFF ++ N R LPP
Sbjct: 264 PFFSKIDWNNIR----NSLPP 280
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 81.9 bits (202), Expect = 2e-17
Identities = 68/209 (32%), Positives = 103/209 (49%), Gaps = 26/209 (12%)
Query: 89 VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ---------IMQMLDHPNIVA 139
V+G GSFG V AK + G A+ KVLQ K ++ Q +++ L HP +V
Sbjct: 2 VIGKGSFGKVLLAKRKSDGSFYAV-KVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVG 60
Query: 140 LKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALA 197
L + F + E+LY VL+YV E + R + R + Y ++ A+
Sbjct: 61 LHYSFQTA---EKLY--FVLDYVNGGELFFHLQRERCFLEPR-----ARFYAAEVASAIG 110
Query: 198 YIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYIC-SRYYRAPELI 256
Y+H+ + I +RD+KP+N+L++ H + L DFG K V+ E S C + Y APE +
Sbjct: 111 YLHS-LNIIYRDLKPENILLDSQGHVV-LTDFGLCKEGVEPEETTSTFCGTPEYLAPE-V 167
Query: 257 FGATEYTTAIDIWSTGCVMAELLLGQPLF 285
Y +D W G V+ E+L G P F
Sbjct: 168 LRKEPYDRTVDWWCLGAVLYEMLYGLPPF 196
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.9 bits (202), Expect = 2e-17
Identities = 73/284 (25%), Positives = 125/284 (44%), Gaps = 47/284 (16%)
Query: 90 VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRE----------LQIMQMLDHPNIVA 139
+G G+FG V+Q + ++T I A+K + + + +E L + + P IV
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 140 LKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALA 197
LK F + +D L LV +Y+ E + + R K Y ++ AL
Sbjct: 61 LKFSFQTDSD-----LYLVTDYMSGGELFWHLQKE-----GRFSEDRAKFYIAELVLALE 110
Query: 198 YIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV-LVKGEPNVSYICSRYYRAPELI 256
++H I +RD+KP+N+L++ H + LCDFG +K L + ++ + Y APE++
Sbjct: 111 HLHK-YDIVYRDLKPENILLDATGH-IALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVL 168
Query: 257 FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEII---------KVLGTPTRE 307
YT +D WS G ++ E+ G F E Q+ I VL R+
Sbjct: 169 LDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAED-TQQMYRNIAFGKVRFPKNVLSDEGRQ 227
Query: 308 EIKCM---NPNY---TEFKFPQIKPHP------WHKVFQKRLPP 339
+K + NP + ++K HP W + +K++ P
Sbjct: 228 FVKGLLNRNPQHRLGAHRDAVELKEHPFFADIDWDLLSKKQITP 271
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 3e-17
Identities = 60/203 (29%), Positives = 99/203 (48%), Gaps = 19/203 (9%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-----RELQIMQMLDHPNIV 138
Y VVG GSFG + + + A+K++ K +E ++ + HPNIV
Sbjct: 2 YNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIV 61
Query: 139 ALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
A K F + + +L +V+EY + + +I ++ P + + Q+C +
Sbjct: 62 AFKESF-----EADGHLYIVMEYCDGGDLMQKIKLQRGKL---FPEDTILQWFVQMCLGV 113
Query: 197 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK-GEPNVSYICSRYYRAPEL 255
+IH + HRDIK +N+ + ++KL DFGSA++L G +Y+ + YY PE
Sbjct: 114 QHIHE-KRVLHRDIKSKNIFLT-QNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPE- 170
Query: 256 IFGATEYTTAIDIWSTGCVMAEL 278
I+ Y DIWS GC++ EL
Sbjct: 171 IWENMPYNNKSDIWSLGCILYEL 193
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.5 bits (198), Expect = 4e-17
Identities = 65/235 (27%), Positives = 117/235 (49%), Gaps = 27/235 (11%)
Query: 89 VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR---------ELQIMQMLDHPNIVA 139
++G G+FG V+ +TG +A+K+V D + E+Q+++ L H IV
Sbjct: 9 LLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQ 68
Query: 140 LKHCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
C D EE L++ +EY+P ++ + Y + + + + YT QI + ++Y
Sbjct: 69 YYGCL---RDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENV----TRRYTRQILQGVSY 121
Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK----VLVKGEPNVSYICSRYYRAPE 254
+H+ + I HRDIK N+L + +KL DFG++K + + G S + Y+ +PE
Sbjct: 122 LHSNM-IVHRDIKGANILRDS-AGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPE 179
Query: 255 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI 309
+I G Y D+WS C + E+L +P + + + + I K+ PT+ +
Sbjct: 180 VISGEG-YGRKADVWSVACTVVEMLTEKPPW---AEYEAMAAIFKIATQPTKPML 230
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 80.5 bits (199), Expect = 5e-17
Identities = 59/209 (28%), Positives = 107/209 (51%), Gaps = 22/209 (10%)
Query: 90 VGTGSFGVVFQAKCRETGEIVAIKKVLQ-DKRYKN----RELQIMQM-LDHPNIVALKHC 143
+G+G+ G V++ + ++TG ++A+K++ + + +N +L ++ D P IV
Sbjct: 23 IGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGY 82
Query: 144 FFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMP-LIYVKLYTYQICRALAYIHNC 202
F + +D + + +E + ++++ + RI +P I K+ T I +AL Y+
Sbjct: 83 FITDSD-----VFICMELMSTCLDKLLK---RIQGPIPEDILGKM-TVAIVKALHYLKEK 133
Query: 203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNV-SYICSRYYRAPELIFGAT- 260
G+ HRD+KP N+L++ + +KLCDFG + LV + S C+ Y APE I
Sbjct: 134 HGVIHRDVKPSNILLD-ASGNVKLCDFGISGRLVDSKAKTRSAGCAAYM-APERIDPPDP 191
Query: 261 --EYTTAIDIWSTGCVMAELLLGQPLFPG 287
+Y D+WS G + EL GQ +
Sbjct: 192 NPKYDIRADVWSLGISLVELATGQFPYKN 220
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 80.5 bits (198), Expect = 5e-17
Identities = 83/297 (27%), Positives = 135/297 (45%), Gaps = 47/297 (15%)
Query: 90 VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR------ELQIMQMLDHPNIVALKHC 143
+G GS G+V A + +G++VA+KK+ D R + R E+ IM+ H N+V + +
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKM--DLRKQQRRELLFNEVVIMRDYQHENVVEMYNS 85
Query: 144 FFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203
+ +EL+ +V+E++ A H RM + + +AL+ +H
Sbjct: 86 YLV---GDELW--VVMEFLEGG----ALTDIVTHTRMNEEQIAAVCLAVLKALSVLH-AQ 135
Query: 204 GICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP-NVSYICSRYYRAPELIFGATEY 262
G+ HRDIK ++L+ H ++KL DFG + K P S + + Y+ APELI Y
Sbjct: 136 GVIHRDIKSDSILLT-HDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELI-SRLPY 193
Query: 263 TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 322
+DIWS G ++ E++ G+P + E P + +K + N P
Sbjct: 194 GPEVDIWSLGIMVIEMVDGEPPYFNE---------------PPLKAMKMIRDNLP----P 234
Query: 323 QIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLP 379
++K HKV P + R P R TA E HPF + P+ +P
Sbjct: 235 KLK--NLHKV-----SPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGPPSCIVP 284
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 80.5 bits (198), Expect = 5e-17
Identities = 82/302 (27%), Positives = 135/302 (44%), Gaps = 57/302 (18%)
Query: 90 VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR------ELQIMQMLDHPNIVALKHC 143
+G GS G+V A+ + +G VA+K + D R + R E+ IM+ H N+V +
Sbjct: 29 IGEGSTGIVCIAREKHSGRQVAVK--MMDLRKQQRRELLFNEVVIMRDYQHQNVVEM--- 83
Query: 144 FFSTTDKEELYLNLVLEYV-----PETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
+ S EEL++ ++E++ + V++ N +I + +AL Y
Sbjct: 84 YKSYLVGEELWV--LMEFLQGGALTDIVSQTRLNEEQI---------ATVCESVLQALCY 132
Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-VSYICSRYYRAPELIF 257
+H+ G+ HRDIK ++L+ ++KL DFG + K P S + + Y+ APE+I
Sbjct: 133 LHS-QGVIHRDIKSDSILLTLDG-RVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVI- 189
Query: 258 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 317
T Y T +DIWS G ++ E++ G+P + +S V + + R+
Sbjct: 190 SRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRL--------RDS--------- 232
Query: 318 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTR 377
P P K K + P D + R P R TA E HPF + P
Sbjct: 233 --------PPPKLKNAHK-ISPVLRDFLERMLTREPQERATAQELLDHPFLLQTGLPECL 283
Query: 378 LP 379
+P
Sbjct: 284 VP 285
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 80.0 bits (197), Expect = 6e-17
Identities = 81/305 (26%), Positives = 138/305 (45%), Gaps = 59/305 (19%)
Query: 89 VVGTGSFGVVF---QAKCRETGEIVAIK-----KVLQDKRYKNRELQIMQMLDH----PN 136
V+GTG++G VF + ++G++ A+K ++Q + Q+L+H P
Sbjct: 7 VLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPF 66
Query: 137 IVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIY--VKLYTYQICR 194
+V L + F + T L+L+L+Y+ ++ + QR V++Y+ +I
Sbjct: 67 LVTLHYAFQTDTK-----LHLILDYING-----GELFTHLSQRERFKEQEVQIYSGEIVL 116
Query: 195 ALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY-ICSRY-YRA 252
AL ++H +GI +RDIK +N+L++ + H + L DFG +K + E +Y C Y A
Sbjct: 117 ALEHLHK-LGIIYRDIKLENILLDSNGH-VVLTDFGLSKEFHEDEVERAYSFCGTIEYMA 174
Query: 253 PELIFGA-TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 311
P+++ G + A+D WS G +M ELL G F + + EI +R +K
Sbjct: 175 PDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEI-------SRRILKS 227
Query: 312 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-----TALEACVHP 366
P +PQ + A D++ R P R A E HP
Sbjct: 228 EPP------YPQ------------EMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHP 269
Query: 367 FFDEL 371
FF ++
Sbjct: 270 FFQKI 274
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 6e-17
Identities = 80/293 (27%), Positives = 129/293 (44%), Gaps = 52/293 (17%)
Query: 89 VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR---------ELQIMQMLDHPNIVA 139
++G G+FG V+ +TG +A K+V D E+Q+++ L H IV
Sbjct: 9 LLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQ 68
Query: 140 LKHCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
C D+ E L + +EY+P +V + Y + + + + YT QI ++Y
Sbjct: 69 YYGCL---RDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESV----TRKYTRQILEGMSY 121
Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL----VKGEPNVSYICSRYYRAPE 254
+H+ + I HRDIK N+L + +KL DFG++K L + G S + Y+ +PE
Sbjct: 122 LHSNM-IVHRDIKGANILRDS-AGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPE 179
Query: 255 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 314
+I G Y D+WS GC + E+L +P + + + + I K+ PT NP
Sbjct: 180 VISGEG-YGRKADVWSLGCTVVEMLTEKPPW---AEYEAMAAIFKIATQPT-------NP 228
Query: 315 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 367
P H R D + F + + R +A E HPF
Sbjct: 229 -----------QLPSHISEHAR------DFLGCIFVEARH-RPSAEELLRHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 7e-17
Identities = 70/237 (29%), Positives = 116/237 (48%), Gaps = 43/237 (18%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQ-------DKRYKNRELQIMQMLDHPN 136
Y V+G G+FG V + + + ++ A+K + + D + E IM + P
Sbjct: 45 YDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPW 104
Query: 137 IVALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICR 194
+V L C F +++ YL +V+EY+P + VN ++ NY +P + K YT ++
Sbjct: 105 VVQL-FCAF----QDDKYLYMVMEYMPGGDLVNLMS-NYD-----VPEKWAKFYTAEVVL 153
Query: 195 ALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK----------GEPNVSY 244
AL IH+ +G+ HRD+KP N+L++ H H LKL DFG+ + + G P+
Sbjct: 154 ALDAIHS-MGLIHRDVKPDNMLLDKHGH-LKLADFGTCMKMDETGMVRCDTAVGTPD--- 208
Query: 245 ICSRYYRAPELIF---GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEII 298
Y +PE++ G Y D WS G + E+L+G F +S V +I+
Sbjct: 209 -----YISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIM 260
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 7e-17
Identities = 75/293 (25%), Positives = 137/293 (46%), Gaps = 55/293 (18%)
Query: 89 VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQM--------LDHPNIVAL 140
V+G GS+ V + ++T I A+K + ++ + ++ +Q +HP +V L
Sbjct: 2 VIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGL 61
Query: 141 KHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
CF + E L V+E+V + + + R +++P + + Y+ +I AL +
Sbjct: 62 HSCF-----QTESRLFFVIEFVSGGDLMFHMQR-----QRKLPEEHARFYSAEISLALNF 111
Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV-LVKGEPNVSYICSRYYRAPELIF 257
+H GI +RD+K N+L++ H +KL D+G K + G+ ++ + Y APE++
Sbjct: 112 LHE-RGIIYRDLKLDNVLLDAEGH-IKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILR 169
Query: 258 GATEYTTAIDIWSTGCVMAELLLGQPLF--------PGESGVDQLVEII--KVLGTPTRE 307
G +Y ++D W+ G +M E++ G+ F P ++ D L ++I K + P
Sbjct: 170 G-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPRSL 228
Query: 308 EIKC-------MNPNYTE-------FKFPQIKPHP------WHKVFQKR-LPP 339
+K +N + E F IK HP W + QK+ LPP
Sbjct: 229 SVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRNIDWDLLEQKQVLPP 281
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.0 bits (198), Expect = 8e-17
Identities = 65/239 (27%), Positives = 110/239 (46%), Gaps = 48/239 (20%)
Query: 89 VVGTGSFGVVFQAKCRETGEIVAIK---KVLQDKRYKNR----ELQIMQMLDHPNIVALK 141
++G G G VF + + TG++ A+K K KR K + E +I+ LDHP + L
Sbjct: 8 LLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLY 67
Query: 142 HCFFSTTDKEELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 200
F + T YL LV++Y P + R+ + + + + + Y ++ AL Y+H
Sbjct: 68 ASFQTET-----YLCLVMDYCPGGELFRLLQ--RQPGKCLSEEVARFYAAEVLLALEYLH 120
Query: 201 NCIGICHRDIKPQNLLVNPHTHQLKLCDF-------------------GSAKVLVKGEPN 241
+GI +RD+KP+N+L++ H + L DF GS + V P+
Sbjct: 121 -LLGIVYRDLKPENILLHESGH-IMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPS 178
Query: 242 VSYICS-----------RYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGES 289
++ Y APE+I G + +A+D W+ G ++ E+L G F G +
Sbjct: 179 ETFSEEPSFRSNSFVGTEEYIAPEVISGDG-HGSAVDWWTLGILLYEMLYGTTPFKGSN 236
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 79.3 bits (196), Expect = 8e-17
Identities = 66/242 (27%), Positives = 102/242 (42%), Gaps = 47/242 (19%)
Query: 90 VGTGSFGVVFQAKCRETG--EI-VAIK-----KVLQDKRYKNRELQIMQMLDHPNIVALK 141
+G G+FG V + E+ VA+K + K+ RE +M LDHP IV L
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRL- 61
Query: 142 HCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 200
E L LV+E P + + Y + + +P+ +K +Q+ +AY+
Sbjct: 62 ---IGVCKGEPLM--LVMELAPLGPLLK----YLKKRREIPVSDLKELAHQVAMGMAYLE 112
Query: 201 NCIGICHRDIKPQN-LLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR-------- 251
+ HRD+ +N LLVN HQ K+ DFG ++ L G S YYR
Sbjct: 113 SK-HFVHRDLAARNVLLVN--RHQAKISDFGMSRALGAG--------SDYYRATTAGRWP 161
Query: 252 ----APELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVD--QLVEIIKVLGTP 304
APE I +++ D+WS G + E G + G + ++E + L P
Sbjct: 162 LKWYAPECINYGK-FSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERLPRP 220
Query: 305 TR 306
Sbjct: 221 EE 222
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 1e-16
Identities = 65/205 (31%), Positives = 105/205 (51%), Gaps = 22/205 (10%)
Query: 90 VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR-----ELQIMQMLDHPNIVALKHCF 144
+G G+FG V++AK +ETG +A KV++ K + E++I+ +HP IV L F
Sbjct: 20 LGDGAFGKVYKAKNKETG-ALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAF 78
Query: 145 FSTTDKEELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203
+ + L +++E+ P V+ I R P I ++ Q+ AL Y+H+ +
Sbjct: 79 Y-----WDGKLWIMIEFCPGGAVDAIMLELDRGLTE-PQI--QVICRQMLEALQYLHS-M 129
Query: 204 GICHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPNVSYICSRYYRAPELIFGAT-- 260
I HRD+K N+L+ +KL DFG SAK + + S+I + Y+ APE++ T
Sbjct: 130 KIIHRDLKAGNVLLT-LDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCETMK 188
Query: 261 --EYTTAIDIWSTGCVMAELLLGQP 283
Y DIWS G + E+ +P
Sbjct: 189 DTPYDYKADIWSLGITLIEMAQIEP 213
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 78.8 bits (194), Expect = 2e-16
Identities = 66/211 (31%), Positives = 106/211 (50%), Gaps = 37/211 (17%)
Query: 89 VVGTGSFGVV----FQAKCRETGEIVAIKKVLQDKRYKNR-----ELQIMQMLDHPNIVA 139
V+G G FG V + TGE+VA+K + ++ +N E+ I++ L H NIV
Sbjct: 11 VLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVK 70
Query: 140 LKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 199
K C +++ L L++EYVP R+Y H ++ L + L+ QIC +AY+
Sbjct: 71 YKGC---CSEQGGKGLQLIMEYVPLGS---LRDYLPKH-KLNLAQLLLFAQQICEGMAYL 123
Query: 200 HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPE----- 254
H+ I HRD+ +N+L++ + +K+ DFG AK + +G YYR E
Sbjct: 124 HSQHYI-HRDLAARNVLLD-NDRLVKIGDFGLAKAVPEGH--------EYYRVREDGDSP 173
Query: 255 LIFGATE------YTTAIDIWSTGCVMAELL 279
+ + A E ++ A D+WS G + ELL
Sbjct: 174 VFWYAVECLKENKFSYASDVWSFGVTLYELL 204
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 2e-16
Identities = 67/219 (30%), Positives = 110/219 (50%), Gaps = 21/219 (9%)
Query: 89 VVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKRYKNR--ELQIMQMLDHPNIVALK 141
V+G GSFG V A+ + T E+ AIK V+QD + E +++ + D P +
Sbjct: 7 VLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQL 66
Query: 142 HCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQ-RMPLIYVKLYTYQICRALAYIH 200
H F T D+ L V+EYV + + ++ + + P Y +I L ++H
Sbjct: 67 HSCFQTVDR----LYFVMEYV--NGGDLMYHIQQVGKFKEP--QAVFYAAEISVGLFFLH 118
Query: 201 NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV-LVKGEPNVSYICSRYYRAPELIFGA 259
GI +RD+K N++++ H +K+ DFG K +V G ++ + Y APE+I
Sbjct: 119 R-RGIIYRDLKLDNVMLDSEGH-IKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEII-AY 175
Query: 260 TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEII 298
Y ++D W+ G ++ E+L GQP F GE D+L + I
Sbjct: 176 QPYGKSVDWWAYGVLLYEMLAGQPPFDGEDE-DELFQSI 213
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 78.8 bits (194), Expect = 3e-16
Identities = 91/315 (28%), Positives = 138/315 (43%), Gaps = 58/315 (18%)
Query: 89 VVGTGSFGVVFQAKCRETGEIVAIKK-----VLQDKRYK--NRELQIMQML-DHPNIVAL 140
V+G GSFG V A+ +E+G + A+K +LQD + E +I+ + +HP + L
Sbjct: 2 VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQL 61
Query: 141 KHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 200
+C F T D+ L V+E+V SR R + Y +I AL ++H
Sbjct: 62 -YCCFQTPDR----LFFVMEFVNGGDLMFHIQKSR---RFDEARARFYAAEITSALMFLH 113
Query: 201 NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYIC-SRYYRAPELIFGA 259
+ GI +RD+K N+L++ H KL DFG K + S C + Y APE I
Sbjct: 114 D-KGIIYRDLKLDNVLLD-HEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPE-ILQE 170
Query: 260 TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 319
Y ++D W+ G ++ E+L G F E+ D L E I +E+
Sbjct: 171 MLYGPSVDWWAMGVLLYEMLCGHAPFEAENE-DDLFEAI------LNDEV---------- 213
Query: 320 KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLR--CTAL--EACV--HPFFDELRD 373
V+ L +AVD++ F +P +R L E + HPFF EL
Sbjct: 214 ------------VYPTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPFFKEL-- 259
Query: 374 PNTRLPNGRPLPPLF 388
+ N R + P F
Sbjct: 260 -DWEKLNRRQIEPPF 273
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 3e-16
Identities = 66/245 (26%), Positives = 112/245 (45%), Gaps = 37/245 (15%)
Query: 90 VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR--------ELQIMQMLDHPNIVALK 141
+G G FG V + + TG++ A KK L KR K + E +I++ ++ P IV L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKK-LDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLA 59
Query: 142 HCFFSTTDKEELYLNLV--------LEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQIC 193
+ F S T +L LV L+Y V R+ I+ Y+ QI
Sbjct: 60 YAFESKT-----HLCLVMSLMNGGDLKYHIYNVGERGLEMERV------IH---YSAQIT 105
Query: 194 RALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAP 253
+ ++H+ + I +RD+KP+N+L++ +L D G A L G+ + Y AP
Sbjct: 106 CGILHLHS-MDIVYRDMKPENVLLDDQG-NCRLSDLGLAVELKDGKTITQRAGTNGYMAP 163
Query: 254 ELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 313
E I Y+ +D ++ GC + E++ G+ F + V ++ +E+K +
Sbjct: 164 E-ILKEEPYSYPVDWFAMGCSIYEMVAGRTPF---KDHKEKVAKEELKRRTLEDEVKFEH 219
Query: 314 PNYTE 318
N+TE
Sbjct: 220 QNFTE 224
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 78.0 bits (192), Expect = 3e-16
Identities = 71/293 (24%), Positives = 123/293 (41%), Gaps = 41/293 (13%)
Query: 89 VVGTGSFGVVFQAKCRETGEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHC 143
++G G+ G V++A T I+A+K + D ++ EL+I+ D P I+
Sbjct: 8 ILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGA 67
Query: 144 FFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203
FF E +++ E++ +++++P + + + L Y+ + +
Sbjct: 68 FFV-----ENRISICTEFMDG-------GSLDVYRKIPEHVLGRIAVAVVKGLTYLWS-L 114
Query: 204 GICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYT 263
I HRD+KP N+LVN Q+KLCDFG + LV +Y+ + Y APE I G +Y
Sbjct: 115 KILHRDVKPSNMLVNTRG-QVKLCDFGVSTQLVNSIAK-TYVGTNAYMAPERISG-EQYG 171
Query: 264 TAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQ 323
D+WS G EL LG+ +P + +++L E+ P
Sbjct: 172 IHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDP------------PV 219
Query: 324 IKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNT 376
+ + + F V + + + P R HPF + D N
Sbjct: 220 LPVGQFSEKF--------VHFITQCMRKQPKERPAPENLMDHPFIVQYNDGNA 264
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 3e-16
Identities = 67/235 (28%), Positives = 119/235 (50%), Gaps = 32/235 (13%)
Query: 89 VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDH--------PNIVAL 140
V+G GS+ V + ++ +I A+K V ++ + + ++ +Q H P +V L
Sbjct: 2 VIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGL 61
Query: 141 KHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
CF +T+ L LV+EYV + + + R +++P + + Y +IC AL +
Sbjct: 62 HSCFQTTSR-----LFLVIEYVNGGDLMFHMQR-----QRKLPEEHARFYAAEICIALNF 111
Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV-LVKGEPNVSYICSRYYRAPELIF 257
+H GI +RD+K N+L++ H +KL D+G K L G+ ++ + Y APE++
Sbjct: 112 LHE-RGIIYRDLKLDNVLLDADGH-IKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILR 169
Query: 258 GATEYTTAIDIWSTGCVMAELLLGQPLF------PGESGVDQLVEIIKVLGTPTR 306
G EY ++D W+ G +M E++ G+ F P + D L ++I L P R
Sbjct: 170 GE-EYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVI--LEKPIR 221
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 3e-16
Identities = 68/232 (29%), Positives = 113/232 (48%), Gaps = 43/232 (18%)
Query: 89 VVGTGSFGVVFQAKCRETGEIVAIKKVLQ-------DKRYKNRELQIMQMLDHPNIVALK 141
V+G G+FG V + + T ++ A+K + + D + E IM + P +V L
Sbjct: 50 VIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF 109
Query: 142 HCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 199
+ F +++ YL +V+EY+P + VN ++ NY +P + + YT ++ AL I
Sbjct: 110 YAF-----QDDRYLYMVMEYMPGGDLVNLMS-NYD-----VPEKWARFYTAEVVLALDAI 158
Query: 200 HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK----------GEPNVSYICSRY 249
H+ +G HRD+KP N+L++ H LKL DFG+ + K G P+
Sbjct: 159 HS-MGFIHRDVKPDNMLLDKSGH-LKLADFGTCMKMNKEGMVRCDTAVGTPD-------- 208
Query: 250 YRAPELIF---GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEII 298
Y +PE++ G Y D WS G + E+L+G F +S V +I+
Sbjct: 209 YISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIM 260
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 78.2 bits (192), Expect = 5e-16
Identities = 76/296 (25%), Positives = 131/296 (44%), Gaps = 62/296 (20%)
Query: 89 VVGTGSFGVVFQAKCRETGEIVAIKKVL-------QDKRYKNRELQIM-QMLDHPNIVAL 140
V+G GS+ V + ++T I A+K V +D + E + Q +HP +V L
Sbjct: 2 VIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 61
Query: 141 KHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
CF + E L V+EYV + + + R +++P + + Y+ +I AL Y
Sbjct: 62 HSCF-----QTESRLFFVIEYVNGGDLMFHMQR-----QRKLPEEHARFYSAEISLALNY 111
Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYIC-SRYYRAPELIF 257
+H GI +RD+K N+L++ H +KL D+G K ++ S C + Y APE++
Sbjct: 112 LHE-RGIIYRDLKLDNVLLDSEGH-IKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILR 169
Query: 258 GATEYTTAIDIWSTGCVMAELLLGQPLF--------PGESGVDQLVEII----------- 298
G +Y ++D W+ G +M E++ G+ F P ++ D L ++I
Sbjct: 170 GE-DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSL 228
Query: 299 ---------KVLGTPTREEIKCMNPNYTEFKFPQIKPHP------WHKVFQKRLPP 339
L +E + C + F I+ HP W + QK++ P
Sbjct: 229 SVKAASVLKSFLNKDPKERLGCH----PQTGFADIQGHPFFRNVDWDLMEQKQVVP 280
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 5e-16
Identities = 62/210 (29%), Positives = 102/210 (48%), Gaps = 22/210 (10%)
Query: 89 VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 141
V+G GSFG V A+ + T E+ AIK + +D ++ +++ ++ + P +
Sbjct: 7 VLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQL 66
Query: 142 HCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQ--RMPLIYVKLYTYQICRALAYI 199
H F T D+ L +V E VN Y I Q + + Y +I L ++
Sbjct: 67 HSCFQTMDR--------LYFVMEYVNGGDLMY-HIQQVGKFKEPHAVFYAAEIAIGLFFL 117
Query: 200 HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYIC-SRYYRAPELIFG 258
H+ GI +RD+K N++++ H +K+ DFG K + G C + Y APE+I
Sbjct: 118 HS-KGIIYRDLKLDNVMLDAEGH-IKIADFGMCKENIFGGKTTRTFCGTPDYIAPEII-A 174
Query: 259 ATEYTTAIDIWSTGCVMAELLLGQPLFPGE 288
Y ++D W+ G ++ E+L GQP F GE
Sbjct: 175 YQPYGKSVDWWAFGVLLYEMLAGQPPFDGE 204
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 76.5 bits (188), Expect = 8e-16
Identities = 69/289 (23%), Positives = 122/289 (42%), Gaps = 54/289 (18%)
Query: 89 VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRE-----------LQIMQMLDHPNI 137
++G G FG V+ + +TG++ A+K L KR K ++ L ++ D P I
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMK-CLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI 59
Query: 138 VALKHCFFSTTDKEELYLNLV----LEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQIC 193
V + + F T DK L+L+ L Y ++++ M + Y +I
Sbjct: 60 VCMSYAF-HTPDKLSFILDLMNGGDLHY------HLSQHGVFSEAEM-----RFYAAEII 107
Query: 194 RALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAP 253
L ++HN + +RD+KP N+L++ H H +++ D G A K +P+ S + + Y AP
Sbjct: 108 LGLEHMHN-RFVVYRDLKPANILLDEHGH-VRISDLGLACDFSKKKPHAS-VGTHGYMAP 164
Query: 254 ELIFGATEYTTAIDIWSTGCVMAELLLGQ----------------------PLFPGESGV 291
E++ Y ++ D +S GC++ +LL G P
Sbjct: 165 EVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSP 224
Query: 292 DQLVEIIKVLGTPTREEIKCMNPNYTEFK-FPQIKPHPWHKVFQKRLPP 339
+ + +L + C+ E K P + W VF ++ PP
Sbjct: 225 ELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRSLDWQMVFLQKYPP 273
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 9e-16
Identities = 84/326 (25%), Positives = 134/326 (41%), Gaps = 71/326 (21%)
Query: 89 VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR--------ELQIMQMLDHPNIVAL 140
V+G G FG V + R TG++ A KK L+ KR K R E QI++ ++ +V+L
Sbjct: 7 VLGKGGFGEVCACQVRATGKMYACKK-LEKKRIKKRKGEAMALNEKQILEKVNSRFVVSL 65
Query: 141 KHCFFSTTDKEELYLNLV----LEYVPETVNRIARNYSRIHQRMPLIY----VKLYTYQI 192
+ + T D L L L+ L++ I+ + Y +I
Sbjct: 66 AYAY-ETKDALCLVLTLMNGGDLKF-------------HIYNMGNPGFDEERAVFYAAEI 111
Query: 193 CRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRA 252
L +H I +RD+KP+N+L++ + H +++ D G A + +GE + + Y A
Sbjct: 112 TCGLEDLHR-ERIVYRDLKPENILLDDYGH-IRISDLGLAVEIPEGETIRGRVGTVGYMA 169
Query: 253 PELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 312
PE++ YT + D W GC++ E++ G+ F E +K REE++
Sbjct: 170 PEVV-KNERYTFSPDWWGLGCLIYEMIEGKSPFRQRK------EKVK------REEVERR 216
Query: 313 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLR--C---TALEACVHPF 367
E + ++ A + + P R C A E HPF
Sbjct: 217 VKEDQE-------------EYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPF 263
Query: 368 FDELRDPN-TRLPNGRPLPPLFNFKP 392
F R N RL G PP F P
Sbjct: 264 F---RTANFKRLEAGMLEPP---FCP 283
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 1e-15
Identities = 66/206 (32%), Positives = 107/206 (51%), Gaps = 21/206 (10%)
Query: 90 VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR------ELQIMQMLDHPNIVALKHC 143
+G GS G+V A + TG+ VA+KK+ D R + R E+ IM+ H N+V + +
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVKKM--DLRKQQRRELLFNEVVIMRDYHHENVVDMYNS 87
Query: 144 FFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203
+ +EL++ V+E++ A H RM + + RAL+Y+HN
Sbjct: 88 YLV---GDELWV--VMEFLEGG----ALTDIVTHTRMNEEQIATVCLSVLRALSYLHN-Q 137
Query: 204 GICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-VSYICSRYYRAPELIFGATEY 262
G+ HRDIK ++L+ ++KL DFG + K P S + + Y+ APE+I Y
Sbjct: 138 GVIHRDIKSDSILLTSDG-RIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVI-SRLPY 195
Query: 263 TTAIDIWSTGCVMAELLLGQPLFPGE 288
T +DIWS G ++ E++ G+P + E
Sbjct: 196 GTEVDIWSLGIMVIEMIDGEPPYFNE 221
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 1e-15
Identities = 62/203 (30%), Positives = 101/203 (49%), Gaps = 15/203 (7%)
Query: 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV------LQDKRYKNRELQIMQMLDHPN 136
+Y VVG GS+G V + R G+ IKK+ ++++ +E Q++ L HPN
Sbjct: 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPN 60
Query: 137 IVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
IVA + + + E+ L +V+ + E + + + + +P V + QI AL
Sbjct: 61 IVAYRESW----EGEDGLLYIVMGFC-EGGDLYHKLKEQKGKLLPENQVVEWFVQIAMAL 115
Query: 197 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVS-YICSRYYRAPEL 255
Y+H I HRD+K QN+ + T+ +K+ D G A+VL S I + YY +PEL
Sbjct: 116 QYLHE-KHILHRDLKTQNVFLT-RTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPEL 173
Query: 256 IFGATEYTTAIDIWSTGCVMAEL 278
F Y D+W+ GC + E+
Sbjct: 174 -FSNKPYNYKSDVWALGCCVYEM 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 1e-15
Identities = 91/348 (26%), Positives = 145/348 (41%), Gaps = 99/348 (28%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR--------ELQIMQMLDHP 135
++ +G G+FG V A +T + A+K L+ K NR E I+ D+
Sbjct: 3 FVKIKTLGIGAFGEVCLACKVDTHALYAMK-TLRKKDVLNRNQVAHVKAERDILAEADNE 61
Query: 136 NIVALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQIC 193
+V L ++S DK+ LY V++Y+P + ++ + R + P + + Y ++
Sbjct: 62 WVVKL---YYSFQDKDNLYF--VMDYIPGGDMMSLLIR-----MEVFPEVLARFYIAELT 111
Query: 194 RALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFG---------SAKVLVKG------ 238
A+ +H +G HRDIKP N+L++ H +KL DFG ++K KG
Sbjct: 112 LAIESVHK-MGFIHRDIKPDNILIDLDGH-IKLTDFGLCTGFRWTHNSKYYQKGSHIRQD 169
Query: 239 --EPN-------------------------------VSYICSRYYRAPELIFGATEYTTA 265
EP+ S + + Y APE++ YT
Sbjct: 170 SMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLL-RKGYTQL 228
Query: 266 IDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIK 325
D WS G ++ E+L+GQP F + TPT ++K +N T PQ+K
Sbjct: 229 CDWWSVGVILFEMLVGQPPF--------------LAPTPTETQLKVINWENTLHIPPQVK 274
Query: 326 PHPWHKVFQKRLPPEAVDLVCRFFQYSPNL--RCTALEACVHPFFDEL 371
L PEAVDL+ + + R A + HPFF E+
Sbjct: 275 -----------LSPEAVDLITKLCCSAEERLGRNGADDIKAHPFFSEV 311
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 75.5 bits (186), Expect = 3e-15
Identities = 74/285 (25%), Positives = 119/285 (41%), Gaps = 49/285 (17%)
Query: 89 VVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----------RYKNRELQIMQMLDHPNI 137
V+G G FG V A+ ++TGE+ AIK L+ + R + HP +
Sbjct: 6 VLGRGHFGKVLLAEYKKTGELYAIK-ALKKGDIIARDEVESLMCEKRIFETANSERHPFL 64
Query: 138 VALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRA 195
V L CF + E ++ V+EY + + I + Y +
Sbjct: 65 VNLFACF-----QTEDHVCFVMEYAAGGDLMMHIHTD------VFSEPRAVFYAACVVLG 113
Query: 196 LAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYIC-SRYYRAPE 254
L Y+H I +RD+K NLL++ +K+ DFG K + S C + + APE
Sbjct: 114 LQYLHEN-KIVYRDLKLDNLLLDTEGF-VKIADFGLCKEGMGFGDRTSTFCGTPEFLAPE 171
Query: 255 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPG---ESGVDQLV-EIIKVLGTPTREEIK 310
++ T YT A+D W G ++ E+L+G+ FPG E D +V + ++ +RE I
Sbjct: 172 VLTE-TSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSREAIS 230
Query: 311 CM------NPN----YTEFKFPQIKPHP------WHKVFQKRLPP 339
M NP E +K P W + +++ P
Sbjct: 231 IMRRLLRRNPERRLGSGEKDAEDVKKQPFFRDINWDDLLARKIKP 275
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 5e-15
Identities = 87/308 (28%), Positives = 133/308 (43%), Gaps = 56/308 (18%)
Query: 89 VVGTGSFGVVFQAKCRETGEIVAIK---KVLQDKRYKN----RELQIMQMLDHPNIVALK 141
V+G G+FG V K + TG++ A+K K KR + E ++ D I L
Sbjct: 8 VIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLH 67
Query: 142 HCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
+ F ++E L LV++Y + S+ R+P + Y ++ A+ +H
Sbjct: 68 YAF-----QDENNLYLVMDYY--VGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQ 120
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSA-KVLVKG--EPNVS-----YICSRYYRAP 253
+G HRDIKP N+L++ + H ++L DFGS ++L G + NV+ YI +A
Sbjct: 121 -LGYVHRDIKPDNVLLDKNGH-IRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAM 178
Query: 254 ELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 313
E G Y D WS G M E+L G+ F ES V+ +I+
Sbjct: 179 E--DGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM--------------- 221
Query: 314 PNYTE-FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC---TALEACVHPFFD 369
N+ E F+FP + EA DL+ R SP R + HPFF+
Sbjct: 222 -NHKEHFQFPPDVTD---------VSEEAKDLIRRLI-CSPETRLGRNGLQDFKDHPFFE 270
Query: 370 ELRDPNTR 377
+ N R
Sbjct: 271 GIDWDNIR 278
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 74.2 bits (182), Expect = 7e-15
Identities = 70/258 (27%), Positives = 123/258 (47%), Gaps = 38/258 (14%)
Query: 76 GNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV-LQDKRYKN---RELQIMQM 131
G+ K+K Y +G G+ G V+ A TG+ VAIK++ LQ + K E+ +M+
Sbjct: 15 GDPKKK--YTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRE 72
Query: 132 LDHPNIVALKHCFFSTTDKEELYLNLVLEYVP-----ETVNRIARNYSRIHQRMPLIYVK 186
HPNIV + +EL++ V+EY+ + V + +I
Sbjct: 73 NKHPNIVNYLDSYLVG---DELWV--VMEYLAGGSLTDVVTETCMDEGQIAA-------- 119
Query: 187 LYTYQICR----ALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPN 241
+CR AL ++H+ + HRDIK N+L+ +KL DFG A++ +
Sbjct: 120 -----VCRECLQALEFLHSN-QVIHRDIKSDNILLG-MDGSVKLTDFGFCAQITPEQSKR 172
Query: 242 VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVL 301
+ + + Y+ APE++ Y +DIWS G + E++ G+P + E+ + L +I
Sbjct: 173 STMVGTPYWMAPEVV-TRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY-LIATN 230
Query: 302 GTPTREEIKCMNPNYTEF 319
GTP + + ++ + +F
Sbjct: 231 GTPELQNPEKLSAIFRDF 248
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 7e-15
Identities = 63/245 (25%), Positives = 117/245 (47%), Gaps = 31/245 (12%)
Query: 85 IAEHVVGTGSFGVVFQAKCRETGE-IVAIKKVL-------QDKRYKNRELQ--------I 128
+ EH+ G+G+FG V++ + + G+ ++A+K++ +DKR +++ + I
Sbjct: 4 VLEHL-GSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTII 62
Query: 129 MQMLDHPNIVALKHCFFSTTDKEELYLNLVL-EYVP--ETVNRIARNYSRI-HQRMPLIY 184
+ L HPNIV F + + LY+ + L E P E N + R +R+ I+
Sbjct: 63 KEQLRHPNIVRYYKTF---LENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIF 119
Query: 185 VKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY 244
V Q+ AL Y+H I HRD+ P N+++ ++ + DFG AK S
Sbjct: 120 V-----QMVLALRYLHKEKRIVHRDLTPNNIMLG-EDDKVTITDFGLAKQKQPESKLTSV 173
Query: 245 ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTP 304
+ + Y PE++ Y D+W+ GC++ ++ QP F + + +I++ + P
Sbjct: 174 VGTILYSCPEIVKN-EPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEP 232
Query: 305 TREEI 309
E +
Sbjct: 233 LPEGM 237
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 8e-15
Identities = 67/205 (32%), Positives = 103/205 (50%), Gaps = 23/205 (11%)
Query: 90 VGTGSFGVVFQAKCR-ETGEIVAIKKVLQDKRYKNR-------ELQIMQMLDHPNIVALK 141
+GTGSFG V A + E VAIK+ + K K + E +I+ ++HP V L
Sbjct: 38 LGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLY 97
Query: 142 HCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
F K+E YL LVLE+V + + R ++R P Y QI Y+ +
Sbjct: 98 GSF-----KDESYLYLVLEFV---IGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQS 149
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYIC-SRYYRAPELIFGAT 260
+ I +RD+KP+NLL++ +K+ DFG AKV+ + +C + Y APE++
Sbjct: 150 -LNIVYRDLKPENLLLDKDGF-IKMTDFGFAKVV---DTRTYTLCGTPEYIAPEILLNVG 204
Query: 261 EYTTAIDIWSTGCVMAELLLGQPLF 285
+ A D W+ G + E+L+G P F
Sbjct: 205 -HGKAADWWTLGIFIYEILVGCPPF 228
|
Length = 340 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 1e-14
Identities = 79/295 (26%), Positives = 128/295 (43%), Gaps = 56/295 (18%)
Query: 89 VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNREL-------QIMQMLDHPNIVALK 141
++G G+FG V K + TG A+K + ++ E+ +++Q HP + ALK
Sbjct: 2 LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK 61
Query: 142 HCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 199
+ F T D+ L V+EY E ++R R + Y +I AL Y+
Sbjct: 62 YSF-QTHDR----LCFVMEYANGGELFFHLSRERVFSEDR-----ARFYGAEIVSALDYL 111
Query: 200 HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYIC-SRYYRAPELIFG 258
H+ + +RD+K +NL+++ H +K+ DFG K +K + C + Y APE +
Sbjct: 112 HSEKNVVYRDLKLENLMLDKDGH-IKITDFGLCKEGIKDGATMKTFCGTPEYLAPE-VLE 169
Query: 259 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 318
+Y A+D W G VM E++ G+ F + ++L E+I + EEI+
Sbjct: 170 DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-EKLFELILM------EEIR-------- 214
Query: 319 FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-----TALEACVHPFF 368
F + L PEA L+ + P R A E H FF
Sbjct: 215 --------------FPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFF 255
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 1e-14
Identities = 86/339 (25%), Positives = 136/339 (40%), Gaps = 97/339 (28%)
Query: 89 VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNREL-------QIMQMLDHPNIVALK 141
V+G G+FG V + ++TG+I A+K +L+ + +K +L ++ D P +V+L
Sbjct: 8 VIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLY 67
Query: 142 HCFFSTTDKEELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 200
+ F ++ YL L++E++P + + Y + + + Y + A+ +H
Sbjct: 68 YSF-----QDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDV----TRFYMAECVLAIEAVH 118
Query: 201 NCIGICHRDIKPQNLLVNPHTHQLKLCDFG------------SAKVLVKGEPNVSYICSR 248
+G HRDIKP N+L++ H +KL DFG + L++G+ N + I +R
Sbjct: 119 K-LGFIHRDIKPDNILIDRGGH-IKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNR 176
Query: 249 Y------------------------------------YRAPELIFGATEYTTAIDIWSTG 272
Y APE IF Y D WS G
Sbjct: 177 NSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPE-IFLQQGYGQECDWWSLG 235
Query: 273 CVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE-FKFPQIKPHPWHK 331
+M E L+G P F E+ + +II N+ E FP
Sbjct: 236 AIMFECLIGWPPFCSENSHETYRKII----------------NWRETLYFPD-------- 271
Query: 332 VFQKRLPPEAVDLVCRFFQYSPNL--RCTALEACVHPFF 368
L EA DL+ R + N R A E HPFF
Sbjct: 272 --DIHLSVEAEDLIRRLITNAENRLGRGGAHEIKSHPFF 308
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 2e-14
Identities = 86/317 (27%), Positives = 136/317 (42%), Gaps = 53/317 (16%)
Query: 89 VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR--------ELQIMQMLDHPNIVAL 140
V+G G FG V + R TG++ A KK L+ KR K R E QI++ ++ +V+L
Sbjct: 7 VLGKGGFGEVCACQVRATGKMYACKK-LEKKRIKKRKGESMALNEKQILEKVNSRFVVSL 65
Query: 141 KHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 200
+ + + K+ L L L L + I Y Y +IC L +H
Sbjct: 66 AYAYET---KDALCLVLTLMNGGDLKFHI---YHMGEAGFEEGRAVFYAAEICCGLEDLH 119
Query: 201 NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGAT 260
I +RD+KP+N+L++ H H +++ D G A + +G+ + + Y APE++
Sbjct: 120 Q-ERIVYRDLKPENILLDDHGH-IRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVV-KNE 176
Query: 261 EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 320
YT + D W+ GC++ E++ GQ F Q + IK REE++ + E
Sbjct: 177 RYTFSPDWWALGCLLYEMIAGQSPF------QQRKKKIK------REEVERLVKEVQE-- 222
Query: 321 FPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-----TALEACVHPFFDELRDPN 375
+ ++ P+A L P R A E HP F ++
Sbjct: 223 -----------EYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQIN--F 269
Query: 376 TRLPNGRPLPPLFNFKP 392
RL G PP FKP
Sbjct: 270 KRLEAGMLEPP---FKP 283
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 2e-14
Identities = 64/206 (31%), Positives = 103/206 (50%), Gaps = 22/206 (10%)
Query: 90 VGTGSFGVVFQAKCRETGEIVAIKKVL----QDKRYKNRELQIMQMLDHPNIVALKHCFF 145
+G+G++G V++A+ TGE+ AIK + +D +E+ +M+ H NIVA F
Sbjct: 17 IGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAY---FG 73
Query: 146 STTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGI 205
S +++L++ +E+ + + + + YV T Q L Y+H+ G
Sbjct: 74 SYLRRDKLWIC--MEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQ---GLYYLHS-KGK 127
Query: 206 CHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPNVSYICSRYYRAPELIFGATE--- 261
HRDIK N+L+ + H +KL DFG SA++ S+I + Y+ APE+ A E
Sbjct: 128 MHRDIKGANILLTDNGH-VKLADFGVSAQITATIAKRKSFIGTPYWMAPEV--AAVERKG 184
Query: 262 -YTTAIDIWSTGCVMAELL-LGQPLF 285
Y DIW+ G EL L P+F
Sbjct: 185 GYNQLCDIWAVGITAIELAELQPPMF 210
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 2e-14
Identities = 64/208 (30%), Positives = 106/208 (50%), Gaps = 28/208 (13%)
Query: 90 VGTGSFGVVFQAKCRETGEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCF 144
+G+G+ G V++ R TG + A+K + + +R RE++I++ ++HPN+V H
Sbjct: 82 IGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKC-HDM 140
Query: 145 FSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG 204
F + + ++LE++ + + + I L V QI +AY+H
Sbjct: 141 FDHNGE----IQVLLEFM----DGGSLEGTHIADEQFLADV---ARQILSGIAYLHR-RH 188
Query: 205 ICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-EPNVSYICSRYYRAPELI-----FG 258
I HRDIKP NLL+N +K+ DFG +++L + +P S + + Y +PE I G
Sbjct: 189 IVHRDIKPSNLLINS-AKNVKIADFGVSRILAQTMDPCNSSVGTIAYMSPERINTDLNHG 247
Query: 259 ATEYTTAIDIWSTGCVMAELLLGQPLFP 286
A + A DIWS G + E LG+ FP
Sbjct: 248 AYD-GYAGDIWSLGVSILEFYLGR--FP 272
|
Length = 353 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 3e-14
Identities = 84/319 (26%), Positives = 138/319 (43%), Gaps = 62/319 (19%)
Query: 89 VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNREL-------QIMQMLDHPNIVALK 141
++G G+FG V + + TG A+K + ++ E+ +++Q HP + ALK
Sbjct: 2 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 61
Query: 142 HCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 199
+ F T D+ L V+EY E ++R +R + Y +I AL Y+
Sbjct: 62 YAF-QTHDR----LCFVMEYANGGELFFHLSRERVFTEER-----ARFYGAEIVSALEYL 111
Query: 200 HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYIC-SRYYRAPELIFG 258
H+ + +RDIK +NL+++ H +K+ DFG K + + C + Y APE +
Sbjct: 112 HS-RDVVYRDIKLENLMLDKDGH-IKITDFGLCKEGISDGATMKTFCGTPEYLAPE-VLE 168
Query: 259 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 318
+Y A+D W G VM E++ G+ F + ++L E+I + EEI+
Sbjct: 169 DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-ERLFELILM------EEIR-------- 213
Query: 319 FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-----TALEACVHPFFDELRD 373
F + L PEA L+ + P R A E H FF +
Sbjct: 214 --------------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINW 259
Query: 374 PNTRLPNGRPLPPLFNFKP 392
+ + + LPP FKP
Sbjct: 260 QD--VVQKKLLPP---FKP 273
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 3e-14
Identities = 72/258 (27%), Positives = 124/258 (48%), Gaps = 38/258 (14%)
Query: 76 GNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR----ELQIMQM 131
G+ K+K Y +G G+ G VF A TG+ VAIK++ K+ K E+ +M+
Sbjct: 15 GDPKKK--YTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKE 72
Query: 132 LDHPNIVALKHCFFSTTDKEELYLNLVLEYVP-----ETVNRIARNYSRIHQRMPLIYVK 186
L +PNIV F +EL++ V+EY+ + V + ++I
Sbjct: 73 LKNPNIVNFLDSFLV---GDELFV--VMEYLAGGSLTDVVTETCMDEAQIAA-------- 119
Query: 187 LYTYQICR----ALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPN 241
+CR AL ++H + HRDIK N+L+ +KL DFG A++ +
Sbjct: 120 -----VCRECLQALEFLH-ANQVIHRDIKSDNVLLGMDG-SVKLTDFGFCAQITPEQSKR 172
Query: 242 VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVL 301
+ + + Y+ APE++ Y +DIWS G + E++ G+P + E+ + L +I
Sbjct: 173 STMVGTPYWMAPEVV-TRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY-LIATN 230
Query: 302 GTPTREEIKCMNPNYTEF 319
GTP + + ++P + +F
Sbjct: 231 GTPELQNPEKLSPIFRDF 248
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 4e-14
Identities = 60/212 (28%), Positives = 103/212 (48%), Gaps = 31/212 (14%)
Query: 89 VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRE-----------LQIMQMLDHPNI 137
++G G FG V+ + +TG++ A+K L KR K ++ L ++ D P I
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMK-CLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI 59
Query: 138 VALKHCFFSTTDKEELYLNLV----LEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQIC 193
V + + F T DK L+L+ L Y + H ++ Y +I
Sbjct: 60 VCMTYAF-HTPDKLCFILDLMNGGDLHY-----------HLSQHGVFSEKEMRFYATEII 107
Query: 194 RALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAP 253
L ++HN + +RD+KP N+L++ H H +++ D G A K +P+ S + + Y AP
Sbjct: 108 LGLEHMHNRF-VVYRDLKPANILLDEHGH-VRISDLGLACDFSKKKPHAS-VGTHGYMAP 164
Query: 254 ELIFGATEYTTAIDIWSTGCVMAELLLGQPLF 285
E++ T Y ++ D +S GC++ +LL G F
Sbjct: 165 EVLQKGTAYDSSADWFSLGCMLFKLLRGHSPF 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 4e-14
Identities = 69/243 (28%), Positives = 114/243 (46%), Gaps = 27/243 (11%)
Query: 90 VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR-----ELQIMQMLDHPNIVALKHCF 144
+G G+FG V++A+ +ETG ++A KV+ K + E+ I+ DHPNIV L F
Sbjct: 13 LGDGAFGKVYKAQNKETG-VLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 71
Query: 145 FSTTDKEELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLI--YVKLYTYQICRALAYIHN 201
+ + L +++E+ V+ + R PL +++ Q AL Y+H
Sbjct: 72 YYENN-----LWILIEFCAGGAVDAVMLELER-----PLTEPQIRVVCKQTLEALNYLHE 121
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPNVSYICSRYYRAPELIFGAT 260
I HRD+K N+L +KL DFG SAK + S+I + Y+ APE++ T
Sbjct: 122 N-KIIHRDLKAGNILFTLDG-DIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCET 179
Query: 261 E----YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 316
Y D+WS G + E+ +P + + L++I K PT + + +
Sbjct: 180 SKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKS-EPPTLAQPSRWSSEF 238
Query: 317 TEF 319
+F
Sbjct: 239 KDF 241
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 71.3 bits (175), Expect = 5e-14
Identities = 65/208 (31%), Positives = 97/208 (46%), Gaps = 35/208 (16%)
Query: 89 VVGTGSFGVVFQA--KCRETGEI-VAIKKVLQDKRYKNREL-----QIMQMLDHPNIVAL 140
+G G FG V+Q E +I VA+K RE IM+ DHP+IV L
Sbjct: 13 CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKL 72
Query: 141 KHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQ-RMPLIYVKLYTYQICRALAYI 199
E + +V+E P R+Y ++++ + L + LY+YQ+ ALAY+
Sbjct: 73 IGVI------TENPVWIVMELAPLGE---LRSYLQVNKYSLDLASLILYSYQLSTALAYL 123
Query: 200 H--NCIGICHRDIKPQNLLV-NPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-----YYR 251
+ HRDI +N+LV +P +KL DFG ++ L E Y S+ +
Sbjct: 124 ESKRFV---HRDIAARNVLVSSPDC--VKLGDFGLSRYL---EDESYYKASKGKLPIKWM 175
Query: 252 APELIFGATEYTTAIDIWSTGCVMAELL 279
APE I +T+A D+W G M E+L
Sbjct: 176 APESI-NFRRFTSASDVWMFGVCMWEIL 202
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 2e-13
Identities = 58/207 (28%), Positives = 100/207 (48%), Gaps = 18/207 (8%)
Query: 89 VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR--------ELQIMQMLDHPNIVAL 140
V+G G FG V + R TG++ A K+ L+ KR K R E QI++ ++ +V L
Sbjct: 7 VLGKGGFGEVCACQVRATGKMYACKR-LEKKRIKKRKGESMALNEKQILEKVNSQFVVNL 65
Query: 141 KHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 200
+ + + K+ L L L + + I Y+ + Y +I L +H
Sbjct: 66 AYAYET---KDALCLVLTIMNGGDLKFHI---YNMGNPGFEEERALFYAAEILCGLEDLH 119
Query: 201 NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGAT 260
+RD+KP+N+L++ + H +++ D G A + +GE + + Y APE++
Sbjct: 120 R-ENTVYRDLKPENILLDDYGH-IRISDLGLAVKIPEGESIRGRVGTVGYMAPEVL-NNQ 176
Query: 261 EYTTAIDIWSTGCVMAELLLGQPLFPG 287
YT + D W GC++ E++ GQ F G
Sbjct: 177 RYTLSPDYWGLGCLIYEMIEGQSPFRG 203
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 3e-13
Identities = 69/295 (23%), Positives = 122/295 (41%), Gaps = 30/295 (10%)
Query: 93 GSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE 152
GS G VF A + + K+ Q K E ++Q ++HP+++ +K S
Sbjct: 77 GSEGRVFVAT-KPGQPDPVVLKIGQ-KGTTLIEAMLLQNVNHPSVIRMKDTLVS----GA 130
Query: 153 LYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKP 212
+ ++ Y + + + + LI K QI L Y+H I HRD+K
Sbjct: 131 ITCMVLPHYSSDLYTYLTKRSRPLPIDQALIIEK----QILEGLRYLHA-QRIIHRDVKT 185
Query: 213 QNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTG 272
+N+ +N Q+ + D G+A+ V + + APE + +Y + DIWS G
Sbjct: 186 ENIFIN-DVDQVCIGDLGAAQFPVVAPAFLGLAGTVETNAPE-VLARDKYNSKADIWSAG 243
Query: 273 CVMAELLL----------GQPLFPGESGVDQLVEIIKVLGT-----PTREEIKCMNPNYT 317
V+ E+L P +S L++II L P + + +
Sbjct: 244 IVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRDPGSR-LVRGFI 302
Query: 318 EFKFPQIKPHPWHKVFQK-RLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL 371
E+ + +P+ + FQ+ LP + LV + + +R +A E +P F +L
Sbjct: 303 EYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQL 357
|
Length = 357 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 3e-13
Identities = 64/203 (31%), Positives = 101/203 (49%), Gaps = 21/203 (10%)
Query: 90 VGTGSFGVVFQAKCRETGEIVAIKKVL----QDKRYKNRELQIMQMLDHPNIVALKHCFF 145
VG+G++G V++A+ TGE+ A+K + D +E+ +++ H NIVA F
Sbjct: 17 VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAY---FG 73
Query: 146 STTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGI 205
S +E+L+ + +EY + + + + + YV T Q LAY+H+ G
Sbjct: 74 SYLSREKLW--ICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQ---GLAYLHS-KGK 127
Query: 206 CHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPNVSYICSRYYRAPELIFGATE--- 261
HRDIK N+L+ + +KL DFG +AK+ S+I + Y+ APE+ A E
Sbjct: 128 MHRDIKGANILLTDNG-DVKLADFGVAAKITATIAKRKSFIGTPYWMAPEV--AAVEKNG 184
Query: 262 -YTTAIDIWSTGCVMAELLLGQP 283
Y DIW+ G EL QP
Sbjct: 185 GYNQLCDIWAVGITAIELAELQP 207
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 4e-13
Identities = 81/344 (23%), Positives = 122/344 (35%), Gaps = 113/344 (32%)
Query: 90 VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR--------ELQIMQMLDHPNIVALK 141
+G G+FG V + +T + A+K L+ R E I+ D+ +V L
Sbjct: 9 IGIGAFGEVCLVRKVDTNALYAMKT-LRKADVLMRNQAAHVKAERDILAEADNEWVVKL- 66
Query: 142 HCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRM---PLIYVKLYTYQICRALAY 198
++S DK+ LY V++Y+P + + R+ + Y ++ A+
Sbjct: 67 --YYSFQDKDNLYF--VMDYIP------GGDMMSLLIRLGIFEEDLARFYIAELTCAIES 116
Query: 199 IHNCIGICHRDIKPQNLLVNPH----------------THQLKL---------------- 226
+H +G HRDIKP N+L++ TH K
Sbjct: 117 VHK-MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSE 175
Query: 227 -------CDFGSAKVLVK------------GEPNVSYICSRYYRAPELIFGATEYTTAID 267
C + K G PN Y APE++ T YT D
Sbjct: 176 EWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPN--------YIAPEVLL-RTGYTQLCD 226
Query: 268 IWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPH 327
WS G ++ E+L+GQP F + TP ++K +N T P
Sbjct: 227 WWSVGVILYEMLVGQPPFLAD--------------TPAETQLKVINWE-TTLHIP----- 266
Query: 328 PWHKVFQKRLPPEAVDLVCRFFQYSPNLRC---TALEACVHPFF 368
Q +L EA DL+ R R A E HPFF
Sbjct: 267 -----SQAKLSREASDLILRLCC-GAEDRLGKNGADEIKAHPFF 304
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 68.7 bits (169), Expect = 4e-13
Identities = 69/283 (24%), Positives = 118/283 (41%), Gaps = 51/283 (18%)
Query: 93 GSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQ-MLDHPNIVALKHCFFSTTDKE 151
G FG V K + T + + ++K+++ K + E + Q M D+PN + L + TT K
Sbjct: 27 GKFGKVSVLKHKPTQK-LFVQKIIKAKNFNAIEPMVHQLMKDNPNFIKLYYSV--TTLKG 83
Query: 152 ELYLNLVLEYVP-----ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGIC 206
+ L+++Y+ + + + ++ VK Q+ AL +H I
Sbjct: 84 HV---LIMDYIKDGDLFDLL--------KKEGKLSEAEVKKIIRQLVEALNDLHK-HNII 131
Query: 207 HRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAI 266
H DIK +N+L + ++ LCD+G K + G P+ Y + Y +PE I G Y +
Sbjct: 132 HNDIKLENVLYDRAKDRIYLCDYGLCK--IIGTPSC-YDGTLDYFSPEKIKGHN-YDVSF 187
Query: 267 DIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKP 326
D W+ G + ELL G+ P + D E + +++ +
Sbjct: 188 DWWAVGVLTYELLTGK--HPFKEDED---EEL---------DLESLLKRQQ--------- 224
Query: 327 HPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV-HPFF 368
F K + A D V +Y+ N R T + HPF
Sbjct: 225 --KKLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKHPFL 265
|
Length = 267 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 70.9 bits (173), Expect = 4e-13
Identities = 65/244 (26%), Positives = 114/244 (46%), Gaps = 41/244 (16%)
Query: 90 VGTGSFGVVFQAKCRETGEIVAIKKVLQ---DKRYKNR---ELQIMQMLDHPNIVALKHC 143
+G G FG VF K + T E K + +R K++ E+ +M+ L H NIV
Sbjct: 21 IGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDR 80
Query: 144 FFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLI---YVKLYTYQICRALAYIH 200
F + +++ L +++E+ ++RN + ++ I + T Q+ ALAY H
Sbjct: 81 FLNKANQK---LYILMEFC--DAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCH 135
Query: 201 NCIG------ICHRDIKPQNLLVNPHTHQL----------------KLCDFGSAKVLVKG 238
N + HRD+KPQN+ ++ + K+ DFG +K + G
Sbjct: 136 NLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNI--G 193
Query: 239 EPNVSYIC--SRYYRAPELIFGATE-YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLV 295
++++ C + YY +PEL+ T+ Y D+W+ GC++ EL G+ F + QL+
Sbjct: 194 IESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNFSQLI 253
Query: 296 EIIK 299
+K
Sbjct: 254 SELK 257
|
Length = 1021 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 5e-13
Identities = 86/327 (26%), Positives = 131/327 (40%), Gaps = 83/327 (25%)
Query: 89 VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVA------LKH 142
V+G G+FG V + ++TG I A+K +L+ +E Q+ + +I+ +
Sbjct: 8 VIGRGAFGEVRLVQKKDTGHIYAMK-ILRKADMLEKE-QVAHIRAERDILVEADGAWVVK 65
Query: 143 CFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 200
F+S DK LYL ++E++P + + + + + + + Y + A+ IH
Sbjct: 66 MFYSFQDKRNLYL--IMEFLPGGDMMTLLMKKDTLSEEA-----TQFYIAETVLAIDAIH 118
Query: 201 NCIGICHRDIKPQNLLVNPHTHQLKLCDFG------------------------------ 230
+G HRDIKP NLL++ H +KL DFG
Sbjct: 119 Q-LGFIHRDIKPDNLLLDAKGH-VKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNM 176
Query: 231 ----SAKVLVKGEPNVSY--ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPL 284
A+ K ++Y + + Y APE +F T Y D WS G +M E+L+G P
Sbjct: 177 NSKRKAETWKKNRRQLAYSTVGTPDYIAPE-VFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235
Query: 285 FPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDL 344
F E TP K MN T FP P + +A DL
Sbjct: 236 FCSE--------------TPQETYRKVMNWKET-LVFPPEVP----------ISEKAKDL 270
Query: 345 VCRFFQYSPNL--RCTALEACVHPFFD 369
+ RF S N E HPFF+
Sbjct: 271 ILRFCTDSENRIGSNGVEEIKSHPFFE 297
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 7e-13
Identities = 70/264 (26%), Positives = 113/264 (42%), Gaps = 54/264 (20%)
Query: 90 VGTGSFGVVFQAKCRETGEIVAIKK-----VLQDKRYKNRELQIMQMLDHPNIVALKHCF 144
+G G+FG V++ + E VA+K KR +E +I++ DHPNIV L
Sbjct: 3 IGKGNFGDVYKGVLKGNTE-VAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKL---I 58
Query: 145 FSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH-- 200
K+ +Y +V+E VP + + + + R+ + + + + Y+
Sbjct: 59 GVCVQKQPIY--IVMELVPGGSLLTFLRKKKN----RLTVKKLLQMSLDAAAGMEYLESK 112
Query: 201 NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR-------AP 253
NCI HRD+ +N LV + LK+ DFG + + E Y S + AP
Sbjct: 113 NCI---HRDLAARNCLVG-ENNVLKISDFG----MSREEEGGIYTVSDGLKQIPIKWTAP 164
Query: 254 E-LIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 311
E L +G YT+ D+WS G ++ E LG +PG S TRE I+
Sbjct: 165 EALNYG--RYTSESDVWSYGILLWETFSLGDTPYPGMSNQQ------------TRERIE- 209
Query: 312 MNPNYTEFKFPQIKPHPWHKVFQK 335
Y PQ+ P +++ +
Sbjct: 210 --SGY-RMPAPQLCPEEIYRLMLQ 230
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 7e-13
Identities = 65/206 (31%), Positives = 90/206 (43%), Gaps = 34/206 (16%)
Query: 105 ETGEIVAIKKVLQD--------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN 156
TG VAIK + D R++ RE + L HPNIVAL + + L
Sbjct: 1 MTGHEVAIKLLRTDAPEEEHQRARFR-RETALCARLYHPNIVAL----LDSGEAPPGLLF 55
Query: 157 LVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLL 216
V EYVP R R +P Q+ ALA HN GI HRD+KPQN++
Sbjct: 56 AVFEYVP---GRTLREVLAADGALPAGETGRLMLQVLDALACAHNQ-GIVHRDLKPQNIM 111
Query: 217 VN-----PHTHQLKLCDFGSAKVLVK-GEPNVS-------YICSRYYRAPELIFGATEYT 263
V+ PH K+ DFG +L + +V+ + + Y APE + G T
Sbjct: 112 VSQTGVRPHA---KVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPV-T 167
Query: 264 TAIDIWSTGCVMAELLLGQPLFPGES 289
D+++ G + E L GQ + G S
Sbjct: 168 PNSDLYAWGLIFLECLTGQRVVQGAS 193
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 7e-13
Identities = 67/220 (30%), Positives = 107/220 (48%), Gaps = 23/220 (10%)
Query: 89 VVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKRYKNR--ELQIMQMLDHPNIVALK 141
V+G GSFG V A+ + T E+ AIK V+QD + E +++ + P +
Sbjct: 7 VLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQL 66
Query: 142 HCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQ--RMPLIYVKLYTYQICRALAYI 199
H F T D+ L +V E VN Y +I Q R + Y +I L ++
Sbjct: 67 HSCFQTMDR--------LYFVMEYVNGGDLMY-QIQQVGRFKEPHAVFYAAEIAIGLFFL 117
Query: 200 HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV-LVKGEPNVSYICSRYYRAPELIFG 258
H+ GI +RD+K N++++ H +K+ DFG K + G ++ + Y APE+I
Sbjct: 118 HS-KGIIYRDLKLDNVMLDSEGH-IKIADFGMCKENMWDGVTTKTFCGTPDYIAPEII-A 174
Query: 259 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEII 298
Y ++D W+ G ++ E+L GQ F GE D+L + I
Sbjct: 175 YQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE-DELFQSI 213
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 8e-13
Identities = 65/220 (29%), Positives = 107/220 (48%), Gaps = 16/220 (7%)
Query: 89 VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTT 148
V+G G+FG V K + T I A+K + + + K E + + N++ C + TT
Sbjct: 8 VIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFR--EERNVLVNGDCQWITT 65
Query: 149 ----DKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG 204
++E YL LV++Y + S+ R+P + Y ++ A+ IH +
Sbjct: 66 LHYAFQDENYLYLVMDYY--VGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQ-LH 122
Query: 205 ICHRDIKPQNLLVNPHTHQLKLCDFGSA-KVLVKGEPNVSY-ICSRYYRAPELIF----G 258
HRDIKP N+L++ + H ++L DFGS K+ G S + + Y +PE++ G
Sbjct: 123 YVHRDIKPDNVLLDMNGH-IRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDG 181
Query: 259 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEII 298
+Y D WS G M E+L G+ F ES V+ +I+
Sbjct: 182 MGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM 221
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 67.4 bits (165), Expect = 1e-12
Identities = 60/234 (25%), Positives = 99/234 (42%), Gaps = 48/234 (20%)
Query: 89 VVGTGSFGVVFQAKCRETGE----IVAIKKVLQDKRYKN-----RELQIMQMLDHPNIVA 139
V+G+G+FG V++ GE VAIK + ++ K E +M +DHP++V
Sbjct: 14 VLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVR 73
Query: 140 L-------KHCFFSTTDKEELYLNLVLEYVPETVNRIAR----NYSRIHQRMPLIYVKLY 188
L + + + + L +L+YV + I N+
Sbjct: 74 LLGICLSSQVQLIT----QLMPLGCLLDYVRNHKDNIGSQYLLNWCV------------- 116
Query: 189 TYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR 248
QI + ++Y+ + HRD+ +N+LV H +K+ DFG AK+L E +
Sbjct: 117 --QIAKGMSYLEE-KRLVHRDLAARNVLVKTPQH-VKITDFGLAKLLDVDEKEYHAEGGK 172
Query: 249 Y---YRAPELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVD--QLVE 296
+ A E I YT D+WS G + EL+ G + G V+ L+E
Sbjct: 173 VPIKWMALESIL-HRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLE 225
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 3e-12
Identities = 60/220 (27%), Positives = 108/220 (49%), Gaps = 24/220 (10%)
Query: 89 VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNREL-------QIMQMLDHPNIVALK 141
++G G+FG V + + +G+ A+K + ++ E+ ++++ HP + +LK
Sbjct: 2 LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLK 61
Query: 142 HCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 199
+ F T D+ L V+EYV E ++R R + Y +I AL Y+
Sbjct: 62 YSF-QTKDR----LCFVMEYVNGGELFFHLSRERVFSEDR-----TRFYGAEIVSALDYL 111
Query: 200 HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYIC-SRYYRAPELIFG 258
H+ I +RD+K +NL+++ H +K+ DFG K + + C + Y APE +
Sbjct: 112 HSG-KIVYRDLKLENLMLDKDGH-IKITDFGLCKEGITDAATMKTFCGTPEYLAPE-VLE 168
Query: 259 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEII 298
+Y A+D W G VM E++ G+ F + ++L E+I
Sbjct: 169 DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-EKLFELI 207
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 3e-12
Identities = 58/229 (25%), Positives = 99/229 (43%), Gaps = 39/229 (17%)
Query: 90 VGTGSFGVVFQAKCRE-TGEI--VAIKKVLQDKRYKN-----RELQIMQMLDHPNIVALK 141
+G GSFGVV + + G++ VA+K + DK +E IM LDH N++ L
Sbjct: 3 LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLY 62
Query: 142 HCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQR----MPLIYVKLYTYQICRALA 197
+ L +V E P + R+ + + + Y QI +
Sbjct: 63 GVVLTHP------LMMVTELAP-----LGSLLDRLRKDALGHFLISTLCDYAVQIANGMR 111
Query: 198 YIH--NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR---- 251
Y+ I HRD+ +N+L+ ++K+ DFG + L + E + Y+ + +
Sbjct: 112 YLESKRFI---HRDLAARNILL-ASDDKVKIGDFGLMRALPQNEDH--YVMEEHLKVPFA 165
Query: 252 --APELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQLVEI 297
APE + T ++ A D+W G + E+ G+ + G SG L +I
Sbjct: 166 WCAPESLRTRT-FSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKI 213
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 5e-12
Identities = 67/251 (26%), Positives = 108/251 (43%), Gaps = 59/251 (23%)
Query: 88 HVVGTGSFGVVFQAK-----CRETGEIVAIKKVLQDKRYKN-----RELQIMQML-DHPN 136
+G G+FG V +A+ VA+K + D K+ E+++M+M+ H N
Sbjct: 18 KPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 77
Query: 137 IVALKHCFFSTTDKEELYLNLVLEYVPE-------TVNR-IARNYSRIHQRMPLIYVKLY 188
I+ L T + LY +V+EY R S R P +
Sbjct: 78 IINLLGV---CTQEGPLY--VVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQK 132
Query: 189 -----TYQICRALAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN 241
YQ+ R + ++ CI HRD+ +N+LV H +K+ DFG A+ +
Sbjct: 133 DLVSFAYQVARGMEFLASKKCI---HRDLAARNVLVT-EDHVMKIADFGLAR-------D 181
Query: 242 VSYICSRYYR------------APELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGE 288
+ +I YYR APE +F YT D+WS G ++ E+ LG +PG
Sbjct: 182 IHHI--DYYRKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLLWEIFTLGGSPYPGI 238
Query: 289 SGVDQLVEIIK 299
V++L +++K
Sbjct: 239 P-VEELFKLLK 248
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 6e-12
Identities = 85/343 (24%), Positives = 152/343 (44%), Gaps = 60/343 (17%)
Query: 89 VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR---ELQIMQML------DHPNIVA 139
++G G+FG V +A R+ E A+K V +Y E+Q M+ + D ++
Sbjct: 136 LLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMK 195
Query: 140 LKHCFFSTTDKEELYLNLVL-EYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
++ F E ++ +V+ +Y P ++ I ++ H+ + I +Q AL Y
Sbjct: 196 IQRYF----QNETGHMCIVMPKYGPCLLDWIMKHGPFSHRHLAQI-----IFQTGVALDY 246
Query: 199 IHNCIGICHRDIKPQNLL-------VNPHTHQ--------LKLCDFGSAKVLVKGEPNVS 243
H + + H D+KP+N+L V+P T++ +++CD G + +
Sbjct: 247 FHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGGC--CDERHSRTA 304
Query: 244 YICSRYYRAPELIFG-ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLG 302
+ +R+YR+PE++ G Y+T D+WS GC++ EL G+ L+ ++ L + K LG
Sbjct: 305 IVSTRHYRSPEVVLGLGWMYST--DMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEKTLG 362
Query: 303 T-PTREEIKCMNPNYTEF--KFPQIKP--HPWH--KVFQKRLPPEAV------DLVCRFF 349
P+ +C Q++P P H ++ + R E + DL+
Sbjct: 363 RLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLL 422
Query: 350 QYSPNLRCTALEACVHP----FFDELRD-PNTRLPNGRP-LPP 386
Y R A + HP ++ E R PN P+ R L P
Sbjct: 423 HYDRQKRLNARQMTTHPYVLKYYPECRQHPNY--PDNRSMLRP 463
|
Length = 467 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 6e-12
Identities = 59/208 (28%), Positives = 102/208 (49%), Gaps = 31/208 (14%)
Query: 90 VGTGSFGVV----FQAKCRETGEIVAIKKVLQDKRYKN-----RELQIMQMLDHPNIVAL 140
+G G FG V + + TGE VA+K + + + +E++I++ L H NIV
Sbjct: 12 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 71
Query: 141 KHCFFSTTDKEELYLNLVLEYVPETVNR--IARNYSRIHQRMPLIYVKLYTYQICRALAY 198
K T+ + L++E++P + + RN ++I+ + L Y QIC+ + Y
Sbjct: 72 KGI---CTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQL----KYAVQICKGMDY 124
Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-------YYR 251
+ + + HRD+ +N+LV HQ+K+ DFG K + E + Y + ++
Sbjct: 125 LGSRQYV-HRDLAARNVLVE-SEHQVKIGDFGLTKAI---ETDKEYYTVKDDLDSPVFWY 179
Query: 252 APELIFGATEYTTAIDIWSTGCVMAELL 279
APE + + Y A D+WS G + ELL
Sbjct: 180 APECLIQSKFYI-ASDVWSFGVTLYELL 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 8e-12
Identities = 59/221 (26%), Positives = 106/221 (47%), Gaps = 30/221 (13%)
Query: 90 VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPNIVALKHCFFS 146
+G+G FGVV K R + VAIK + + + E ++M L HP +V L +
Sbjct: 12 LGSGQFGVVHLGKWRAQIK-VAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQL---YGV 67
Query: 147 TTDKEELYLNLVLEYVPE--TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG 204
T ++ LY+ V E++ +N + + ++ + M L + +C + Y+
Sbjct: 68 CTQQKPLYI--VTEFMENGCLLNYLRQRQGKLSKDMLLSMCQ----DVCEGMEYLERN-S 120
Query: 205 ICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR------YYRAPELIFG 258
HRD+ +N LV+ T +K+ DFG + ++ E Y S + PE +F
Sbjct: 121 FIHRDLAARNCLVS-STGVVKVSDFGMTRYVLDDE----YTSSSGAKFPVKWSPPE-VFN 174
Query: 259 ATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEII 298
++Y++ D+WS G +M E+ G+ F +S ++VE+I
Sbjct: 175 FSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNY-EVVEMI 214
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 9e-12
Identities = 77/307 (25%), Positives = 122/307 (39%), Gaps = 49/307 (15%)
Query: 93 GSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE 152
G+ G F +T E V IK + E I++ ++HP+I+ LK F
Sbjct: 103 GAEGFAFACIDNKTCEHVVIKA--GQRGGTATEAHILRAINHPSIIQLKGTF-------- 152
Query: 153 LYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKP 212
Y +P + Y + + + + + RA+ Y+H I HRDIK
Sbjct: 153 TYNKFTCLILPRYKTDL-YCYLAAKRNIAICDILAIERSVLRAIQYLHEN-RIIHRDIKA 210
Query: 213 QNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYY--------RAPELIFGATEYTT 264
+N+ +N H + L DFG+A V N +YY APEL+ Y
Sbjct: 211 ENIFIN-HPGDVCLGDFGAACFPVDINAN------KYYGWAGTIATNAPELL-ARDPYGP 262
Query: 265 AIDIWSTGCVMAELLLGQPLFPGESGVD-------QLVEIIKVLGTPTRE---------- 307
A+DIWS G V+ E+ + G+D Q+ II+ GT E
Sbjct: 263 AVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQANLD 322
Query: 308 EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 367
EI + K P +P W +++ LP + L+C+ + + R +A
Sbjct: 323 EIYIGLAKKSSRK-PGSRP-LWTNLYE--LPIDLEYLICKMLAFDAHHRPSAEALLDFAA 378
Query: 368 FDELRDP 374
F ++ DP
Sbjct: 379 FQDIPDP 385
|
Length = 391 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 9e-12
Identities = 72/225 (32%), Positives = 106/225 (47%), Gaps = 23/225 (10%)
Query: 77 NSKQKVSYIAEHVVGTGSFGVVFQA-KCRETGEIVAIKKV-LQDKR---YKNRELQIMQM 131
N+ ++ Y+ +VG F A + + E V K V L D+R Y EL +
Sbjct: 62 NNPREHMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAA 121
Query: 132 LDHPNIVALKHCF-FSTTDKEELYLNLVLEY-VPETVNRIARNYSRIHQRMPL--IYVKL 187
DH IV KH F + DK L L++EY +N+ + R+ + +P V L
Sbjct: 122 CDHFGIV--KHFDDFKSDDK----LLLIMEYGSGGDLNKQIKQ--RLKEHLPFQEYEVGL 173
Query: 188 YTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL---VKGEPNVSY 244
YQI AL +H+ + HRD+K N+ + P T +KL DFG +K V + S+
Sbjct: 174 LFYQIVLALDEVHS-RKMMHRDLKSANIFLMP-TGIIKLGDFGFSKQYSDSVSLDVASSF 231
Query: 245 ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGES 289
+ YY APEL + Y+ D+WS G ++ ELL F G S
Sbjct: 232 CGTPYYLAPEL-WERKRYSKKADMWSLGVILYELLTLHRPFKGPS 275
|
Length = 478 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 1e-11
Identities = 57/202 (28%), Positives = 100/202 (49%), Gaps = 22/202 (10%)
Query: 90 VGTGSFGVVFQAKCRETGEIVAIKKV-LQDKRYK----NRELQIMQMLDHPNIVALKHCF 144
+G GSFG VF+ T ++VAIK + L++ + +E+ ++ D P + +
Sbjct: 12 IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 71
Query: 145 FSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTY--QICRALAYIHNC 202
T L +++EY+ + + + PL ++ T +I + L Y+H+
Sbjct: 72 LKDTK-----LWIIMEYLG------GGSALDLLEPGPLDETQIATILREILKGLDYLHSE 120
Query: 203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVS-YICSRYYRAPELIFGATE 261
I HRDIK N+L++ H ++KL DFG A L + + ++ + ++ APE+I +
Sbjct: 121 KKI-HRDIKAANVLLSEHG-EVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVI-KQSA 177
Query: 262 YTTAIDIWSTGCVMAELLLGQP 283
Y + DIWS G EL G+P
Sbjct: 178 YDSKADIWSLGITAIELAKGEP 199
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 2e-11
Identities = 60/207 (28%), Positives = 101/207 (48%), Gaps = 22/207 (10%)
Query: 89 VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR--------ELQIMQMLDHPNIVAL 140
V+G G FG V + R TG++ A KK L+ KR K R E +I++ ++ +V+L
Sbjct: 7 VLGKGGFGEVCACQVRATGKMYACKK-LEKKRIKKRKGEAMALNEKRILEKVNSRFVVSL 65
Query: 141 KHCFFSTTDKEELYLNLVLEYVPETVNRIAR--NYSRIHQRMPLIYVKLYTYQICRALAY 198
+ + + K+ L L L + + I N QR Y ++C L
Sbjct: 66 AYAYET---KDALCLVLTIMNGGDLKFHIYNMGNPGFDEQR-----AIFYAAELCCGLED 117
Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFG 258
+ I +RD+KP+N+L++ H +++ D G A + +GE + + Y APE+I
Sbjct: 118 LQR-ERIVYRDLKPENILLDDRGH-IRISDLGLAVQIPEGETVRGRVGTVGYMAPEVI-N 174
Query: 259 ATEYTTAIDIWSTGCVMAELLLGQPLF 285
+YT + D W GC++ E++ GQ F
Sbjct: 175 NEKYTFSPDWWGLGCLIYEMIQGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 2e-11
Identities = 62/218 (28%), Positives = 102/218 (46%), Gaps = 32/218 (14%)
Query: 89 VVGTGSFGVVFQAKC----RETGEI-VAIKKVLQDKRYKNR-----ELQIMQML-DHPNI 137
+G G+FG V +A + + VA+K + R EL+IM L +H NI
Sbjct: 42 TLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENI 101
Query: 138 VALKHCFFSTTDKEELYLNLVLEYV--PETVNRIARNYSRIHQRMPLIYVKLYTYQICRA 195
V L + T + + + EY + +N + R L+ ++YQ+ +
Sbjct: 102 VNL---LGACTIGGPILV--ITEYCCYGDLLNFLRRKRESFLTLEDLLS---FSYQVAKG 153
Query: 196 LAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---Y 250
+A++ NCI HRD+ +N+L+ H +K+CDFG A+ ++ V +R +
Sbjct: 154 MAFLASKNCI---HRDLAARNVLLT-HGKIVKICDFGLARDIMNDSNYVVKGNARLPVKW 209
Query: 251 RAPELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPG 287
APE IF YT D+WS G ++ E+ LG +PG
Sbjct: 210 MAPESIFNCV-YTFESDVWSYGILLWEIFSLGSNPYPG 246
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 2e-11
Identities = 55/202 (27%), Positives = 97/202 (48%), Gaps = 22/202 (10%)
Query: 90 VGTGSFGVVFQAKCRETGEIVAIKKV-LQDKRYK----NRELQIMQMLDHPNIVALKHCF 144
+G GSFG VF+ T ++VAIK + L++ + +E+ ++ D P + +
Sbjct: 12 IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 71
Query: 145 FSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTY--QICRALAYIHNC 202
T L +++EY+ + + + P ++ T +I + L Y+H+
Sbjct: 72 LKGTK-----LWIIMEYLG------GGSALDLLRAGPFDEFQIATMLKEILKGLDYLHSE 120
Query: 203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE-PNVSYICSRYYRAPELIFGATE 261
I HRDIK N+L++ +KL DFG A L + +++ + ++ APE+I +
Sbjct: 121 KKI-HRDIKAANVLLSEQG-DVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVI-QQSA 177
Query: 262 YTTAIDIWSTGCVMAELLLGQP 283
Y + DIWS G EL G+P
Sbjct: 178 YDSKADIWSLGITAIELAKGEP 199
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 63.6 bits (154), Expect = 2e-11
Identities = 80/307 (26%), Positives = 134/307 (43%), Gaps = 63/307 (20%)
Query: 76 GNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV-LQDKRYKN---RELQIMQM 131
G+ K+K Y +G G+ G V+ A TG+ VAIK++ LQ + K E+ +M+
Sbjct: 15 GDPKKK--YTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRE 72
Query: 132 LDHPNIVALKHCFFSTTDKEELYLNLVLEYVP-----ETVNRIARNYSRIHQRMPLIYVK 186
+PNIV + +EL++ V+EY+ + V + +I
Sbjct: 73 NKNPNIVNYLDSYLV---GDELWV--VMEYLAGGSLTDVVTETCMDEGQIAA-------- 119
Query: 187 LYTYQICR----ALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPN 241
+CR AL ++H+ + HRDIK N+L+ +KL DFG A++ +
Sbjct: 120 -----VCRECLQALDFLHSN-QVIHRDIKSDNILLG-MDGSVKLTDFGFCAQITPEQSKR 172
Query: 242 VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVL 301
+ + + Y+ APE++ Y +DIWS G + E++ G+P + E+ + L +I
Sbjct: 173 STMVGTPYWMAPEVV-TRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY-LIATN 230
Query: 302 GTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALE 361
GTP + NP +RL D + R + + R +A E
Sbjct: 231 GTP-----ELQNP--------------------ERLSAVFRDFLNRCLEMDVDRRGSAKE 265
Query: 362 ACVHPFF 368
HPF
Sbjct: 266 LLQHPFL 272
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 2e-11
Identities = 62/223 (27%), Positives = 106/223 (47%), Gaps = 22/223 (9%)
Query: 89 VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-------RELQIMQMLDHPNIVALK 141
V+G G+FG V K + ++ A+K + + + K E ++ D+ I L
Sbjct: 8 VIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLH 67
Query: 142 HCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
+ F D+ LYL V++Y + S+ R+P + Y ++ A+ +H
Sbjct: 68 YAF---QDENNLYL--VMDYY--VGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQ 120
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSA-KVLVKGEPNVSY-ICSRYYRAPELIF-- 257
+ HRDIKP N+L++ + H ++L DFGS K++ G S + + Y +PE++
Sbjct: 121 -LHYVHRDIKPDNILMDMNGH-IRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAM 178
Query: 258 --GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEII 298
G +Y D WS G M E+L G+ F ES V+ +I+
Sbjct: 179 EDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM 221
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 63.9 bits (156), Expect = 2e-11
Identities = 70/322 (21%), Positives = 118/322 (36%), Gaps = 62/322 (19%)
Query: 96 GVVFQAKCRETGEIVAIKKVLQDKRYKNR------ELQIMQMLDHPNIVALKHCFFSTTD 149
+V AK + T +VA+KK+ D K E+ + L HPNI+ F
Sbjct: 14 MIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSF---IV 70
Query: 150 KEELYL-----------NLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
ELY+ +L+ + PE +P + + + AL Y
Sbjct: 71 DSELYVVSPLMAYGSCEDLLKTHFPEG--------------LPELAIAFILKDVLNALDY 116
Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG--------EPNVSYICSRYY 250
IH+ G HR +K ++L++ + L + ++K + S + + +
Sbjct: 117 IHS-KGFIHRSVKASHILLSGDGK-VVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPW 174
Query: 251 RAPELIFGATE-YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTR--- 306
+PE++ + Y DI+S G EL G F L+E KV GT
Sbjct: 175 LSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLE--KVRGTVPCLLD 232
Query: 307 -----EEIKCMNPNYTEFKFPQIK---PHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCT 358
M+ + + + P + HP+ + F V Q P R +
Sbjct: 233 KSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFS----EHFHQFVELCLQRDPESRPS 288
Query: 359 ALEACVHPFFDELRDPNTRLPN 380
A + H FF + + NT L +
Sbjct: 289 ASQLLNHSFFKQCKRRNTSLLD 310
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 3e-11
Identities = 67/242 (27%), Positives = 107/242 (44%), Gaps = 58/242 (23%)
Query: 90 VGTGSFGVVFQAKCRE-----TGEI-VAIKK-----VLQDKRYKNRELQIMQMLDHPNIV 138
+G+G+FG V++ + +G I VA+K Q+K+ +E +M +HPNIV
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIV 62
Query: 139 A-LKHCFFSTTDKEELYLNL-------VLEYVPETVNRIARNYSRIHQRMPLIYVKLYTY 190
L C E Y+ + +L Y+ + R+ R + L+ + L
Sbjct: 63 KLLGVCL----LNEPQYIIMELMEGGDLLSYLRDA--RVERFGPPLLTLKELLDICLDVA 116
Query: 191 QICRALAYIHNCIGICHRDIKPQNLLVNPHTHQ----LKLCDFGSAKVLVKGEPNVSYIC 246
+ C L +H HRD+ +N LV+ + +K+ DFG A+ + K
Sbjct: 117 KGCVYLEQMH----FIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYK--------- 163
Query: 247 SRYYR------------APE-LIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVD 292
S YYR APE L+ G +TT D+WS G +M E+L LGQ +P + +
Sbjct: 164 SDYYRKEGEGLLPVRWMAPESLLDGK--FTTQSDVWSFGVLMWEILTLGQQPYPALNNQE 221
Query: 293 QL 294
L
Sbjct: 222 VL 223
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 3e-11
Identities = 79/305 (25%), Positives = 121/305 (39%), Gaps = 83/305 (27%)
Query: 89 VVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKR--YKNRELQIMQMLDHPNIVALK 141
V+G G+FG V + ++TG + A+K +L+ ++ + E I+ D +V +
Sbjct: 8 VIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKM- 66
Query: 142 HCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 199
F+S DK LYL ++E++P + + + + + + + Y + A+ I
Sbjct: 67 --FYSFQDKLNLYL--IMEFLPGGDMMTLLMKKDTLTEEE-----TQFYIAETVLAIDSI 117
Query: 200 HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY--------------- 244
H +G HRDIKP NLL++ H +KL DFG L K Y
Sbjct: 118 HQ-LGFIHRDIKPDNLLLDSKGH-VKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQN 175
Query: 245 ---------------------ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQP 283
+ + Y APE +F T Y D WS G +M E+L+G P
Sbjct: 176 MNSKRKAETWKRNRRQLAFSTVGTPDYIAPE-VFMQTGYNKLCDWWSLGVIMYEMLIGYP 234
Query: 284 LFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVD 343
F E TP K MN T FP P + +A D
Sbjct: 235 PFCSE--------------TPQETYKKVMNWKET-LIFPPEVP----------ISEKAKD 269
Query: 344 LVCRF 348
L+ RF
Sbjct: 270 LILRF 274
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 63.6 bits (154), Expect = 3e-11
Identities = 68/258 (26%), Positives = 123/258 (47%), Gaps = 38/258 (14%)
Query: 76 GNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV-LQDKRYKN---RELQIMQM 131
G+ K+K Y +G G+ G V+ A TG+ VAI+++ LQ + K E+ +M+
Sbjct: 16 GDPKKK--YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRE 73
Query: 132 LDHPNIVALKHCFFSTTDKEELYLNLVLEYVP-----ETVNRIARNYSRIHQRMPLIYVK 186
+PNIV + +EL++ V+EY+ + V + +I
Sbjct: 74 NKNPNIVNYLDSYLV---GDELWV--VMEYLAGGSLTDVVTETCMDEGQIAA-------- 120
Query: 187 LYTYQICR----ALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPN 241
+CR AL ++H+ + HRDIK N+L+ +KL DFG A++ +
Sbjct: 121 -----VCRECLQALEFLHSN-QVIHRDIKSDNILLG-MDGSVKLTDFGFCAQITPEQSKR 173
Query: 242 VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVL 301
+ + + Y+ APE++ Y +DIWS G + E++ G+P + E+ + L +I
Sbjct: 174 STMVGTPYWMAPEVV-TRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY-LIATN 231
Query: 302 GTPTREEIKCMNPNYTEF 319
GTP + + ++ + +F
Sbjct: 232 GTPELQNPEKLSAIFRDF 249
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 4e-11
Identities = 64/207 (30%), Positives = 102/207 (49%), Gaps = 26/207 (12%)
Query: 87 EHVVGTGSFGVVFQAKCRETG--EI-VAIKKV---LQDKRYKN--RELQIMQMLDHPNIV 138
E V+G G FG V + + G EI VAIK + +K+ ++ E IM DHPNI+
Sbjct: 9 EKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNII 68
Query: 139 ALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQ-RMPLIYVKLYTYQICRALA 197
L+ T K + +V EY+ N + R H + +I + I +
Sbjct: 69 HLEGVV--TKSKPVM---IVTEYME---NGSLDAFLRKHDGQFTVIQLVGMLRGIASGMK 120
Query: 198 YIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-----YYRA 252
Y+ + +G HRD+ +N+LVN + K+ DFG ++VL + +P +Y + A
Sbjct: 121 YLSD-MGYVHRDLAARNILVNSNL-VCKVSDFGLSRVL-EDDPEAAYTTRGGKIPIRWTA 177
Query: 253 PELIFGATEYTTAIDIWSTGCVMAELL 279
PE I ++T+A D+WS G VM E++
Sbjct: 178 PEAI-AYRKFTSASDVWSYGIVMWEVM 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 8e-11
Identities = 56/205 (27%), Positives = 95/205 (46%), Gaps = 14/205 (6%)
Query: 90 VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ----IMQML-DHPNIVALKHCF 144
+G G++G V++ ++ G + A+ K+L + E++ I+Q L +HPN+V F
Sbjct: 30 IGKGTYGKVYKVTNKKDGSLAAV-KILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMF 88
Query: 145 FSTTDKEELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203
+ L LVLE +V + + QR+ + Y L ++HN
Sbjct: 89 YKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN- 147
Query: 204 GICHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPNVSYICSRYYRAPELIFGATEY 262
I HRD+K N+L+ +KL DFG SA++ + + + ++ APE+I +Y
Sbjct: 148 RIIHRDVKGNNILLTTEG-GVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQY 206
Query: 263 TTA----IDIWSTGCVMAELLLGQP 283
+ D+WS G EL G P
Sbjct: 207 DYSYDARCDVWSLGITAIELGDGDP 231
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 9e-11
Identities = 57/199 (28%), Positives = 97/199 (48%), Gaps = 26/199 (13%)
Query: 90 VGTGSFGVVFQAKCRETGEI-VAIKKVLQDKRYKN---RELQIMQMLDHPNIVALKHCFF 145
+G+G FGVV K R G+I VAIK + + ++ E ++M L HPN+V L +
Sbjct: 12 LGSGQFGVVHLGKWR--GKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQL---YG 66
Query: 146 STTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKL-YTYQICRALAYIHNCIG 204
T + +++ V EY+ N NY R + L +C A+ Y+ + G
Sbjct: 67 VCTKQRPIFI--VTEYM---ANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESN-G 120
Query: 205 ICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR-----APELIFGA 259
HRD+ +N LV + +K+ DFG A+ ++ + Y S+ + AP +F
Sbjct: 121 FIHRDLAARNCLVG-EDNVVKVSDFGLARYVLDDQ----YTSSQGTKFPVKWAPPEVFDY 175
Query: 260 TEYTTAIDIWSTGCVMAEL 278
+ +++ D+WS G +M E+
Sbjct: 176 SRFSSKSDVWSFGVLMWEV 194
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 1e-10
Identities = 54/227 (23%), Positives = 102/227 (44%), Gaps = 20/227 (8%)
Query: 84 YIAEHVVGTGSFGVVF---QAKCRETGEIVAIKKVL------QDKRYKNRELQIMQMLDH 134
YI + +G GSFG V+ K + +K++ + N+E Q++ LDH
Sbjct: 2 YILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDH 61
Query: 135 PNIVALKHCFFSTTDKEELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQIC 193
P IV F E ++ EY ++ + + V + Q+
Sbjct: 62 PAIVKFHASFL-----ERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLL 116
Query: 194 RALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-EPNVSYICSRYYRA 252
+ Y+H I HRD+K +N+ + + LK+ DFG +++L+ + ++ + YY +
Sbjct: 117 LGVHYMHQ-RRILHRDLKAKNIFLK--NNLLKIGDFGVSRLLMGSCDLATTFTGTPYYMS 173
Query: 253 PELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIK 299
PE + Y + DIWS GC++ E+ F G++ + ++ I++
Sbjct: 174 PEAL-KHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVE 219
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 2e-10
Identities = 59/207 (28%), Positives = 103/207 (49%), Gaps = 17/207 (8%)
Query: 89 VVGTGSFGVVFQAKCRETGEIVAIK--KVLQDKRYK-NRELQIMQMLDHPNIVALKHCFF 145
VVG G++G V++ + +TG++ AIK V +D+ + E+ +++ H +A + F
Sbjct: 23 VVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAF 82
Query: 146 --STTDKEELYLNLVLEYV-PETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
+ + L LV+E+ +V + +N + ++ +I R LA++H
Sbjct: 83 IKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTK--GNALKEDWIAYICREILRGLAHLH-A 139
Query: 203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK--GEPNVSYICSRYYRAPELIF--- 257
+ HRDIK QN+L+ + ++KL DFG + L + G N ++I + Y+ APE+I
Sbjct: 140 HKVIHRDIKGQNVLLTENA-EVKLVDFGVSAQLDRTVGRRN-TFIGTPYWMAPEVIACDE 197
Query: 258 -GATEYTTAIDIWSTGCVMAELLLGQP 283
Y DIWS G E+ G P
Sbjct: 198 NPDATYDYRSDIWSLGITAIEMAEGAP 224
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 60.4 bits (147), Expect = 2e-10
Identities = 58/209 (27%), Positives = 96/209 (45%), Gaps = 31/209 (14%)
Query: 87 EHVVGTGSFGVVFQAKCRETGE---IVAIKKV---LQDKRYKN--RELQIMQMLDHPNIV 138
E V+G G FG V + + + G+ VAIK + DK+ + E IM DHPNI+
Sbjct: 9 EKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNII 68
Query: 139 ALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIH--QRMPLIYVKLYTYQICRAL 196
L+ + + ++ EY+ N + R + + V + I +
Sbjct: 69 RLEGVVTKSRP-----VMIITEYM---ENGSLDKFLRENDGKFTVGQLVGM-LRGIASGM 119
Query: 197 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY------ICSRYY 250
Y+ + HRD+ +N+LVN + K+ DFG ++ L + +Y I R+
Sbjct: 120 KYLSE-MNYVHRDLAARNILVNSNL-VCKVSDFGLSRRL--EDSEATYTTKGGKIPIRW- 174
Query: 251 RAPELIFGATEYTTAIDIWSTGCVMAELL 279
APE I ++T+A D+WS G VM E++
Sbjct: 175 TAPEAI-AYRKFTSASDVWSFGIVMWEVM 202
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 2e-10
Identities = 57/202 (28%), Positives = 96/202 (47%), Gaps = 22/202 (10%)
Query: 90 VGTGSFGVVFQAKCRETGEIVAIKKV-LQDKRYK----NRELQIMQMLDHPNIVALKHCF 144
+G GSFG V++ T E+VAIK + L++ + +E+ ++ D P I +
Sbjct: 12 IGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSY 71
Query: 145 FSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPL--IYVKLYTYQICRALAYIHNC 202
T L +++EY+ + + + PL Y+ +I + L Y+H+
Sbjct: 72 LKGTK-----LWIIMEYLG------GGSALDLLKPGPLEETYIATILREILKGLDYLHSE 120
Query: 203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE-PNVSYICSRYYRAPELIFGATE 261
I HRDIK N+L++ +KL DFG A L + +++ + ++ APE+I +
Sbjct: 121 RKI-HRDIKAANVLLSEQG-DVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVI-KQSA 177
Query: 262 YTTAIDIWSTGCVMAELLLGQP 283
Y DIWS G EL G+P
Sbjct: 178 YDFKADIWSLGITAIELAKGEP 199
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 3e-10
Identities = 55/205 (26%), Positives = 96/205 (46%), Gaps = 14/205 (6%)
Query: 90 VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ----IMQML-DHPNIVALKHCF 144
+G G++G VF+ ++ G A+K +L + E++ I++ L DHPN+V +
Sbjct: 26 IGKGTYGKVFKVLNKKNGSKAAVK-ILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMY 84
Query: 145 FSTTDKEELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203
+ K L LVLE +V + + + + +RM + ++ L ++H
Sbjct: 85 YKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK 144
Query: 204 GICHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPNVSYICSRYYRAPELIFGA--- 259
I HRD+K N+L+ +KL DFG SA++ + + + ++ APE+I
Sbjct: 145 TI-HRDVKGNNILLTTEG-GVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQL 202
Query: 260 -TEYTTAIDIWSTGCVMAELLLGQP 283
+ Y D+WS G EL G P
Sbjct: 203 DSTYDARCDVWSLGITAIELGDGDP 227
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 60.0 bits (146), Expect = 3e-10
Identities = 56/209 (26%), Positives = 102/209 (48%), Gaps = 28/209 (13%)
Query: 91 GTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPNIVALKHCFFST 147
G G FG V+ T + VA+K + +E QIM+ L H +V L +
Sbjct: 15 GAGQFGEVWMGTWNGTTK-VAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQL---YAVC 70
Query: 148 TDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMP-LIYVKLYTYQICRALAYIH--NCI 203
+++E +Y +V EY+ + ++ ++ R+P L+ + QI +AY+ N I
Sbjct: 71 SEEEPIY--IVTEYMSKGSLLDFLKSGEGKKLRLPQLVDM---AAQIAEGMAYLESRNYI 125
Query: 204 GICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAPELI-FGA 259
HRD+ +N+LV + K+ DFG A+++ E + +++ + APE +G
Sbjct: 126 ---HRDLAARNILVGEN-LVCKIADFGLARLIEDDE-YTAREGAKFPIKWTAPEAANYG- 179
Query: 260 TEYTTAIDIWSTGCVMAELL-LGQPLFPG 287
+T D+WS G ++ E++ G+ +PG
Sbjct: 180 -RFTIKSDVWSFGILLTEIVTYGRVPYPG 207
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 3e-10
Identities = 54/196 (27%), Positives = 96/196 (48%), Gaps = 20/196 (10%)
Query: 90 VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPNIVALKHCFFS 146
+GTG FGVV K R + VAIK + + ++ E ++M L H +V L +
Sbjct: 12 LGTGQFGVVKYGKWRGQYD-VAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQL---YGV 67
Query: 147 TTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKL-YTYQICRALAYIHNCIGI 205
T + +Y +V EY+ N NY R H + L +C +AY+ + I
Sbjct: 68 CTKQRPIY--IVTEYMS---NGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFI 122
Query: 206 CHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAPELIFGATEY 262
HRD+ +N LV+ +K+ DFG ++ ++ E S + S++ + PE + +++
Sbjct: 123 -HRDLAARNCLVDDQG-CVKVSDFGLSRYVLDDE-YTSSVGSKFPVRWSPPE-VLLYSKF 178
Query: 263 TTAIDIWSTGCVMAEL 278
++ D+W+ G +M E+
Sbjct: 179 SSKSDVWAFGVLMWEV 194
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 6e-10
Identities = 46/160 (28%), Positives = 81/160 (50%), Gaps = 17/160 (10%)
Query: 93 GSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALK------HCFFS 146
G+FG V+ + + ++ A+K V++ N+ + + Q+ + +AL H ++S
Sbjct: 15 GAFGKVYLGRKKNNSKLYAVK-VVKKADMINKNM-VHQVQAERDALALSKSPFIVHLYYS 72
Query: 147 TTDKEELYLNLVLEY-VPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGI 205
+YL V+EY + V + Y + M + Y+ ++ AL Y+H GI
Sbjct: 73 LQSANNVYL--VMEYLIGGDVKSLLHIYGYFDEEMAVKYIS----EVALALDYLHRH-GI 125
Query: 206 CHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYI 245
HRD+KP N+L++ H +KL DFG +KV + E N+ I
Sbjct: 126 IHRDLKPDNMLISNEGH-IKLTDFGLSKVTLNRELNMMDI 164
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 7e-10
Identities = 59/200 (29%), Positives = 95/200 (47%), Gaps = 19/200 (9%)
Query: 90 VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR--------ELQIMQMLDHPNIVALK 141
+G G FG V + R TG++ A KK L KR K R E +I+ + IV+L
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKK-LNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLA 59
Query: 142 HCFFSTTDKEELYLNLVLEYVPETVNRI-ARNYSRIHQRMPLIYVKLYTYQICRALAYIH 200
+ F + TD L LV+ + R N + P YT QI L ++H
Sbjct: 60 YAFQTKTD-----LCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLH 114
Query: 201 NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNV-SYICSRYYRAPELIFGA 259
I +RD+KP+N+L++ + +++ D G A L G+ Y + + APEL+ G
Sbjct: 115 Q-RRIIYRDLKPENVLLDNDGN-VRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQG- 171
Query: 260 TEYTTAIDIWSTGCVMAELL 279
EY ++D ++ G + E++
Sbjct: 172 EEYDFSVDYFALGVTLYEMI 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 8e-10
Identities = 64/228 (28%), Positives = 102/228 (44%), Gaps = 26/228 (11%)
Query: 80 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV------LQDKRYKNRELQIMQMLD 133
Q Y V+G+G+ G V AK GE A+K V DK E+ + D
Sbjct: 30 QAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCD 89
Query: 134 HPNIVALKHCFFSTTDKEE---LYLNLVLEYV------PETVNRIARNYSRIHQRMPLIY 184
+IV F + L + LVL+Y E +R N + L++
Sbjct: 90 FFSIVKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLF 149
Query: 185 VKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL---VKGEPN 241
+ Q+ A+ ++H+ I HRDIK N+L+ + +KL DFG +K+ V +
Sbjct: 150 I-----QVLLAVHHVHSKHMI-HRDIKSANILLCSNG-LVKLGDFGFSKMYAATVSDDVG 202
Query: 242 VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGES 289
++ + YY APE I+ Y+ D++S G ++ ELL + F GE+
Sbjct: 203 RTFCGTPYYVAPE-IWRRKPYSKKADMFSLGVLLYELLTLKRPFDGEN 249
|
Length = 496 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 58.6 bits (141), Expect = 1e-09
Identities = 56/207 (27%), Positives = 103/207 (49%), Gaps = 17/207 (8%)
Query: 89 VVGTGSFGVVFQAKCRETGEIVAIK--KVLQDKRYK-NRELQIMQMLDHPNIVALKHCFF 145
+VG G++G V++ + +TG++ AIK V D+ + +E+ +++ H +A + F
Sbjct: 13 LVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAF 72
Query: 146 STTDKEEL--YLNLVLEYV-PETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
+ + L LV+E+ +V + +N + ++ +I R L+++H
Sbjct: 73 IKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTK--GNTLKEEWIAYICREILRGLSHLHQH 130
Query: 203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK--GEPNVSYICSRYYRAPELIF--- 257
+ HRDIK QN+L+ + ++KL DFG + L + G N ++I + Y+ APE+I
Sbjct: 131 -KVIHRDIKGQNVLLTENA-EVKLVDFGVSAQLDRTVGRRN-TFIGTPYWMAPEVIACDE 187
Query: 258 -GATEYTTAIDIWSTGCVMAELLLGQP 283
Y D+WS G E+ G P
Sbjct: 188 NPDATYDFKSDLWSLGITAIEMAEGAP 214
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 2e-09
Identities = 59/214 (27%), Positives = 97/214 (45%), Gaps = 27/214 (12%)
Query: 82 VSYIA-EHVVGTGSFGVVFQAKCRETGE---IVAIKKVLQDKRYKNR-----ELQIMQML 132
VS + E V+G G FG V + + + G+ VAIK + K R E IM
Sbjct: 3 VSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQF 62
Query: 133 DHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQ-RMPLIYVKLYTYQ 191
DHPNI+ L+ T + + + +E N ++ R + + +I +
Sbjct: 63 DHPNIIHLEGVV--TKSRPVMIITEFME------NGALDSFLRQNDGQFTVIQLVGMLRG 114
Query: 192 ICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR--- 248
I + Y+ + HRD+ +N+LVN + K+ DFG ++ L + +Y S
Sbjct: 115 IAAGMKYLSE-MNYVHRDLAARNILVNSNL-VCKVSDFGLSRFLEDDTSDPTYTSSLGGK 172
Query: 249 ---YYRAPELIFGATEYTTAIDIWSTGCVMAELL 279
+ APE I ++T+A D+WS G VM E++
Sbjct: 173 IPIRWTAPEAI-AYRKFTSASDVWSYGIVMWEVM 205
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 2e-09
Identities = 59/208 (28%), Positives = 92/208 (44%), Gaps = 28/208 (13%)
Query: 87 EHVVGTGSFGVVFQAKCRETGE---IVAIKKVLQDKRYKNR-----ELQIMQMLDHPNIV 138
+ V+G G FG VF+ + G VAIK + K R E IM H NI+
Sbjct: 10 QKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNII 69
Query: 139 ALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIH--QRMPLIYVKLYTYQICRAL 196
L+ ++ EY+ N Y R H + V + I +
Sbjct: 70 RLEGVVTKFKP-----AMIITEYME---NGALDKYLRDHDGEFSSYQLVGMLR-GIAAGM 120
Query: 197 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-----YYR 251
Y+ + + HRD+ +N+LVN + K+ DFG ++VL + +P +Y S +
Sbjct: 121 KYLSD-MNYVHRDLAARNILVN-SNLECKVSDFGLSRVL-EDDPEGTYTTSGGKIPIRWT 177
Query: 252 APELIFGATEYTTAIDIWSTGCVMAELL 279
APE I ++T+A D+WS G VM E++
Sbjct: 178 APEAI-AYRKFTSASDVWSFGIVMWEVM 204
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 3e-09
Identities = 57/236 (24%), Positives = 94/236 (39%), Gaps = 60/236 (25%)
Query: 89 VVGTGSFGVVFQAKCR-----ETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNI 137
+G G+FG VF +C E+VA+ K L++ ++ RE +++ H NI
Sbjct: 12 ELGEGAFGKVFLGECYHLEPENDKELVAV-KTLKETASNDARKDFEREAELLTNFQHENI 70
Query: 138 VALKHCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRM--------PLIYVKLY 188
V T+ + +V EY+ +N+ R++ + L +L
Sbjct: 71 VKFYGV---CTEGDPPI--MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLL 125
Query: 189 --TYQICRALAYI---HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVS 243
QI + Y+ H HRD+ +N LV + +K+ DFG ++ +
Sbjct: 126 QIAVQIASGMVYLASQH----FVHRDLATRNCLVG-YDLVVKIGDFGMSRDV-------- 172
Query: 244 YICSRYYR------------APELIFGATEYTTAIDIWSTGCVMAELLL--GQPLF 285
Y YYR PE I +TT D+WS G V+ E+ QP +
Sbjct: 173 YTTD-YYRVGGHTMLPIRWMPPESIMYRK-FTTESDVWSFGVVLWEIFTYGKQPWY 226
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 57.2 bits (138), Expect = 3e-09
Identities = 55/216 (25%), Positives = 105/216 (48%), Gaps = 29/216 (13%)
Query: 85 IAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPNIVAL- 140
+H +G G +G V++ ++ VA+K + +D +E +M+ + HPN+V L
Sbjct: 9 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLL 68
Query: 141 -----KHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRA 195
+ F+ T+ Y NL L+Y+ E NR Q + + + QI A
Sbjct: 69 GVCTREPPFYIITEFMT-YGNL-LDYLREC-NR---------QEVNAVVLLYMATQISSA 116
Query: 196 LAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRA 252
+ Y+ I HRD+ +N LV + H +K+ DFG ++ L+ G+ ++ +++ + A
Sbjct: 117 MEYLEKKNFI-HRDLAARNCLVGEN-HLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTA 173
Query: 253 PELIFGATEYTTAIDIWSTGCVMAEL-LLGQPLFPG 287
PE + +++ D+W+ G ++ E+ G +PG
Sbjct: 174 PESL-AYNKFSIKSDVWAFGVLLWEIATYGMSPYPG 208
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 4e-09
Identities = 43/149 (28%), Positives = 73/149 (48%), Gaps = 18/149 (12%)
Query: 188 YTYQICRALAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYI 245
Y++Q+ + + ++ CI HRD+ +N+L++ + +K+CDFG A+ + K V
Sbjct: 184 YSFQVAKGMEFLASRKCI---HRDLAARNILLS-ENNVVKICDFGLARDIYKDPDYVRKG 239
Query: 246 CSRY---YRAPELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQLVEIIKVL 301
+R + APE IF YT D+WS G ++ E+ LG +PG V+I +
Sbjct: 240 DARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG-------VKIDEEF 291
Query: 302 GTPTREEIKCMNPNYTEFKFPQIKPHPWH 330
+E + P+YT + Q WH
Sbjct: 292 CRRLKEGTRMRAPDYTTPEMYQTMLDCWH 320
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 5e-09
Identities = 57/217 (26%), Positives = 89/217 (41%), Gaps = 44/217 (20%)
Query: 89 VVGTGSFGVVFQAK----CRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIV 138
+G G FG VF AK E GE + + K LQ + +N REL + + L H N+V
Sbjct: 12 TLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVV 71
Query: 139 ALKHCFFSTTDKEELYLNLVLEYVP----ETVNRIARNYSRIHQRMPLIYVKLYT--YQI 192
L + E Y+ +LEY + R ++ + PL + QI
Sbjct: 72 RL---LGLCREAEPHYM--ILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQI 126
Query: 193 CRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR- 251
+ ++ N HRD+ +N LV + Q + KV + Y S YY+
Sbjct: 127 ALGMDHLSN-ARFVHRDLAARNCLV---SSQRE------VKVSLLSLSKDVY-NSEYYKL 175
Query: 252 ----------APELIFGATEYTTAIDIWSTGCVMAEL 278
APE + +++T D+WS G +M E+
Sbjct: 176 RNALIPLRWLAPEAVQ-EDDFSTKSDVWSFGVLMWEV 211
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 55.5 bits (134), Expect = 8e-09
Identities = 56/225 (24%), Positives = 102/225 (45%), Gaps = 38/225 (16%)
Query: 90 VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPNIVALKHCFFS 146
+G G FG V++ T VA+K + E QIM+ L HP ++ L +
Sbjct: 14 LGAGQFGEVWEGLWNNTTP-VAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQL---YAV 69
Query: 147 TTDKEELYL-------NLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 199
T +E +Y+ +LEY + A ++ Q + + Q+ +AY+
Sbjct: 70 CTLEEPIYIVTELMKYGSLLEY----LQGGAGRALKLPQLIDM------AAQVASGMAYL 119
Query: 200 --HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAPE 254
N I HRD+ +N+LV + + K+ DFG A+V+ + + +++ + APE
Sbjct: 120 EAQNYI---HRDLAARNVLVGEN-NICKVADFGLARVIKEDIYE-AREGAKFPIKWTAPE 174
Query: 255 LIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESG--VDQLVE 296
++ D+WS G ++ E++ G+ +PG + V Q V+
Sbjct: 175 AAL-YNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVD 218
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 55.1 bits (133), Expect = 1e-08
Identities = 52/197 (26%), Positives = 83/197 (42%), Gaps = 26/197 (13%)
Query: 90 VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR---ELQIMQMLDHPNIVALKHCFFS 146
+G G FG V R G+ VA+K + D E +M L HPN+V L
Sbjct: 14 IGKGEFGDVMLGDYR--GQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVL- 70
Query: 147 TTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGIC 206
LY +V EY+ + + SR + L + +C + Y+
Sbjct: 71 --QGNPLY--IVTEYM-AKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEE-KNFV 124
Query: 207 HRDIKPQNLLVNPHTHQL--KLCDFGSAKVLVKGEPNVSYICSRY---YRAPELIFGATE 261
HRD+ +N+LV + L K+ DFG AK E + + + APE + +
Sbjct: 125 HRDLAARNVLV---SEDLVAKVSDFGLAK-----EASQGQDSGKLPVKWTAPEAL-REKK 175
Query: 262 YTTAIDIWSTGCVMAEL 278
++T D+WS G ++ E+
Sbjct: 176 FSTKSDVWSFGILLWEI 192
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 1e-08
Identities = 36/106 (33%), Positives = 57/106 (53%), Gaps = 11/106 (10%)
Query: 188 YTYQICRALAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVS-- 243
+TYQ+ R + ++ NC+ HRD+ +N+L+ +K+CDFG A+ ++ VS
Sbjct: 242 FTYQVARGMEFLASKNCV---HRDLAARNVLLA-QGKIVKICDFGLARDIMHDSNYVSKG 297
Query: 244 -YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPG 287
+ APE IF YTT D+WS G ++ E+ LG +PG
Sbjct: 298 STFLPVKWMAPESIFDNL-YTTLSDVWSYGILLWEIFSLGGTPYPG 342
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 1e-08
Identities = 37/95 (38%), Positives = 51/95 (53%), Gaps = 16/95 (16%)
Query: 191 QICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYY 250
Q+ A+ YIH GI HRDIK +N+LVN + L DFG+A +G S+ +Y
Sbjct: 268 QLLSAIDYIH-GEGIIHRDIKTENVLVNG-PEDICLGDFGAA-CFARG----SWSTPFHY 320
Query: 251 --------RAPELIFGATEYTTAIDIWSTGCVMAE 277
APE++ G YT ++DIWS G V+ E
Sbjct: 321 GIAGTVDTNAPEVLAG-DPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 2e-08
Identities = 36/106 (33%), Positives = 59/106 (55%), Gaps = 11/106 (10%)
Query: 188 YTYQICRALAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYI 245
Y++Q+ R + ++ CI HRD+ +N+L++ + +K+CDFG A+ + K V
Sbjct: 179 YSFQVARGMEFLASRKCI---HRDLAARNILLS-ENNVVKICDFGLARDIYKDPDYVRKG 234
Query: 246 CSRY---YRAPELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPG 287
+R + APE IF YTT D+WS G ++ E+ LG +PG
Sbjct: 235 SARLPLKWMAPESIFDKV-YTTQSDVWSFGVLLWEIFSLGASPYPG 279
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 2e-08
Identities = 34/110 (30%), Positives = 56/110 (50%), Gaps = 19/110 (17%)
Query: 188 YTYQICRALAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK-------VLVKG 238
++ Q+ + + ++ NCI HRD+ +N+L+ K+CDFG A+ +VKG
Sbjct: 217 FSSQVAQGMDFLASKNCI---HRDVAARNVLLT-DGRVAKICDFGLARDIMNDSNYVVKG 272
Query: 239 EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPG 287
+ + APE IF YT D+WS G ++ E+ LG+ +PG
Sbjct: 273 NARLPV----KWMAPESIFDCV-YTVQSDVWSYGILLWEIFSLGKSPYPG 317
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 2e-08
Identities = 54/237 (22%), Positives = 104/237 (43%), Gaps = 49/237 (20%)
Query: 89 VVGTGSFGVV-----FQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIV 138
+G G FG V F+ K R VA+K + ++ R E +++ ++HP+++
Sbjct: 7 TLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVI 66
Query: 139 ALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKL----------- 187
L + + + L L ++EY R++ R +++ Y+
Sbjct: 67 KL---YGACSQDGPLLL--IVEYAKYGS---LRSFLRESRKVGPSYLGSDGNRNSSYLDN 118
Query: 188 -------------YTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV 234
+ +QI R + Y+ + + HRD+ +N+LV ++K+ DFG ++
Sbjct: 119 PDERALTMGDLISFAWQISRGMQYLAE-MKLVHRDLAARNVLV-AEGRKMKISDFGLSRD 176
Query: 235 LVKGEPNVSYICSRY---YRAPELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPG 287
+ + + V R + A E +F YTT D+WS G ++ E++ LG +PG
Sbjct: 177 VYEEDSYVKRSKGRIPVKWMAIESLFDHI-YTTQSDVWSFGVLLWEIVTLGGNPYPG 232
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 3e-08
Identities = 75/283 (26%), Positives = 120/283 (42%), Gaps = 58/283 (20%)
Query: 90 VGTGSFGVVFQAKC-------RETGEIVAIKKVLQDKRYKN-----RELQIMQML-DHPN 136
+G G FG V A+ + VA+K + D K+ E+++M+M+ H N
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82
Query: 137 IVALKHCFFSTTDKEELYLNLVLEYVPETVNR--------IARNYSRIHQRMP---LIYV 185
I+ L + T LY+ ++EY + R YS R+P + +
Sbjct: 83 IINL---LGACTQDGPLYV--IVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFK 137
Query: 186 KLY--TYQICRALAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN 241
L TYQ+ R + Y+ CI HRD+ +N+LV + +K+ DFG L + N
Sbjct: 138 DLVSCTYQVARGMEYLASQKCI---HRDLAARNVLVT-ENNVMKIADFG----LARDVNN 189
Query: 242 VSYICSRY-------YRAPELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQ 293
+ Y + APE +F YT D+WS G +M E+ LG +PG V++
Sbjct: 190 IDYYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFTLGGSPYPGIP-VEE 247
Query: 294 LVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKR 336
L +++K G + C N Y + WH + R
Sbjct: 248 LFKLLKE-GHRMDKPANCTNELYMMMR------DCWHAIPSHR 283
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 53.9 bits (130), Expect = 4e-08
Identities = 67/311 (21%), Positives = 119/311 (38%), Gaps = 93/311 (29%)
Query: 90 VGTGSFGVVFQ--AKCRETGEI---VAIKKVLQDKRYKNR-----ELQIMQMLDHPNIVA 139
+G GSFG+V++ AK GE VAIK V ++ + R E +M+ + ++V
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 140 LKHCFFSTTDKEELYLNLVLEYVPETV--NRIA----RNYSRIHQ--------RMPLIYV 185
L L +V P V +A ++Y R + P
Sbjct: 74 L--------------LGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQ 119
Query: 186 KLYTY--QICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVS 243
K +I +AY+ HRD+ +N +V +K+ DFG + + + +
Sbjct: 120 KFIQMAAEIADGMAYLAA-KKFVHRDLAARNCMVA-EDLTVKIGDFGMTRDIYETD---- 173
Query: 244 YICSRYYR------------APELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESG 290
YYR APE + +TT D+WS G V+ E+ L + + G S
Sbjct: 174 -----YYRKGGKGLLPVRWMAPESLKDGV-FTTKSDVWSFGVVLWEMATLAEQPYQGLSN 227
Query: 291 VDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQ 350
+++++ + + ++ P+ P ++ + +Q
Sbjct: 228 -EEVLKFVI--------DGGHLDL-------PENCPDKLLELMR------------MCWQ 259
Query: 351 YSPNLRCTALE 361
Y+P +R T LE
Sbjct: 260 YNPKMRPTFLE 270
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 52.8 bits (127), Expect = 7e-08
Identities = 61/243 (25%), Positives = 94/243 (38%), Gaps = 68/243 (27%)
Query: 78 SKQKVSYIAEHVVGTGSFGVV-----FQAKCRETGEIVAIK--------KVLQDKRYKNR 124
V ++ E +G G+FG V R + VAIK KV Q+ R +
Sbjct: 3 PLSAVRFLEE--LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFR---Q 57
Query: 125 ELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVP--------------ETVNRIA 170
E ++M L HPNIV C KE+ L EY+ V +
Sbjct: 58 EAELMSDLQHPNIV----CLLGVCTKEQPTCML-FEYLAHGDLHEFLVRNSPHSDVGAES 112
Query: 171 RNYSRIHQRMPLIYVKLYTYQICRALAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCD 228
+ + ++ + QI + Y+ H+ HRD+ +N LV +K+ D
Sbjct: 113 GDETVKSSLDCSDFLHI-AIQIAAGMEYLSSHH---FVHRDLAARNCLVGEG-LTVKISD 167
Query: 229 FGSAKVLVKGEPNVSYICSRYYR------------APELI-FGATEYTTAIDIWSTGCVM 275
FG ++ + + YYR PE I +G ++TT DIWS G V+
Sbjct: 168 FGLSRDIYSAD---------YYRVQSKSLLPVRWMPPEAILYG--KFTTESDIWSFGVVL 216
Query: 276 AEL 278
E+
Sbjct: 217 WEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 9e-08
Identities = 36/110 (32%), Positives = 58/110 (52%), Gaps = 19/110 (17%)
Query: 188 YTYQICRALAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK-------VLVKG 238
++YQ+ + ++++ NCI HRD+ +N+L+ H K+CDFG A+ +VKG
Sbjct: 219 FSYQVAKGMSFLASKNCI---HRDLAARNILLT-HGRITKICDFGLARDIRNDSNYVVKG 274
Query: 239 EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPG 287
+ + APE IF YT D+WS G ++ E+ LG +PG
Sbjct: 275 NARLPV----KWMAPESIFNCV-YTFESDVWSYGILLWEIFSLGSSPYPG 319
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 1e-07
Identities = 57/206 (27%), Positives = 94/206 (45%), Gaps = 29/206 (14%)
Query: 89 VVGTGSFGVVFQAKCRETGE----IVAIKKVLQDKRYK-NREL----QIMQMLDHPNIVA 139
V+G+G+FG V++ GE VAIK++ + K N+E+ +M +D+P++
Sbjct: 14 VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 73
Query: 140 LKH-CFFSTTD--KEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
L C ST + + +L+YV E + I Y+ + QI + +
Sbjct: 74 LLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQ-----------YLLNWCVQIAKGM 122
Query: 197 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAP 253
Y+ + HRD+ +N+LV H +K+ DFG AK+L E + + A
Sbjct: 123 NYLEE-RRLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGADEKEYHAEGGKVPIKWMAL 180
Query: 254 ELIFGATEYTTAIDIWSTGCVMAELL 279
E I YT D+WS G + EL+
Sbjct: 181 ESILHRI-YTHQSDVWSYGVTVWELM 205
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 1e-07
Identities = 51/198 (25%), Positives = 94/198 (47%), Gaps = 24/198 (12%)
Query: 90 VGTGSFGVVFQAKCRETGEIVAIKKV----LQDKRYKNRELQIMQMLDHPNIVALKHCFF 145
+G+G FG+V+ E + VAIK + + ++ + E Q+M L HP +V L
Sbjct: 12 IGSGQFGLVWLGYWLEKRK-VAIKTIREGAMSEEDFI-EEAQVMMKLSHPKLVQLYGVCT 69
Query: 146 STTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKL--YTYQICRALAYIHNCI 203
+ + LV E++ + +Y R QR L +C +AY+ +
Sbjct: 70 ERSP-----ICLVFEFME---HGCLSDYLR-AQRGKFSQETLLGMCLDVCEGMAYLESSN 120
Query: 204 GICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAPELIFGAT 260
I HRD+ +N LV +K+ DFG + ++ + S +++ + +PE +F +
Sbjct: 121 VI-HRDLAARNCLVG-ENQVVKVSDFGMTRFVLDDQYTSST-GTKFPVKWSSPE-VFSFS 176
Query: 261 EYTTAIDIWSTGCVMAEL 278
+Y++ D+WS G +M E+
Sbjct: 177 KYSSKSDVWSFGVLMWEV 194
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 1e-07
Identities = 36/106 (33%), Positives = 59/106 (55%), Gaps = 11/106 (10%)
Query: 188 YTYQICRALAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYI 245
Y++Q+ R + ++ CI HRD+ +N+L++ + +K+CDFG A+ + K V
Sbjct: 178 YSFQVARGMEFLASRKCI---HRDLAARNILLS-ENNVVKICDFGLARDIYKDPDYVRKG 233
Query: 246 CSRY---YRAPELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPG 287
+R + APE IF YTT D+WS G ++ E+ LG +PG
Sbjct: 234 DARLPLKWMAPESIFDKV-YTTQSDVWSFGVLLWEIFSLGASPYPG 278
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 1e-07
Identities = 62/270 (22%), Positives = 110/270 (40%), Gaps = 27/270 (10%)
Query: 112 IKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIAR 171
I K + + RE+ I++ + H I+ L H + + + V +P+ +
Sbjct: 123 IVKAVTGGKTPGREIDILKTISHRAIINLIHAY--------RWKSTVCMVMPKYKCDLF- 173
Query: 172 NYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS 231
Y +PL ++ ALAY+H GI HRD+K +N+ ++ + + L DFG+
Sbjct: 174 TYVDRSGPLPLEQAITIQRRLLEALAYLHG-RGIIHRDVKTENIFLDEPENAV-LGDFGA 231
Query: 232 AKVLVKGEPNVSYICSRY-----YRAPELIFGATEYTTAIDIWSTGCVMAELLLGQ-PLF 285
A L + C + +PEL+ Y DIWS G V+ E+ + LF
Sbjct: 232 ACKL--DAHPDTPQCYGWSGTLETNSPELL-ALDPYCAKTDIWSAGLVLFEMSVKNVTLF 288
Query: 286 PGE--SGVDQLVEIIKVLGTPTREEIKCMNPN----YTEFKFPQIKPHPWHKVFQKRLPP 339
+ S QL II+ + E + + N + ++ P+ V +K
Sbjct: 289 GKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMH 348
Query: 340 EAVD-LVCRFFQYSPNLRCTALEACVHPFF 368
V+ L+ + + R +A + P F
Sbjct: 349 MDVEYLIAKMLTFDQEFRPSAQDILSLPLF 378
|
Length = 392 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 1e-07
Identities = 59/213 (27%), Positives = 98/213 (46%), Gaps = 35/213 (16%)
Query: 90 VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPNIVALKHCFFS 146
+G G FG V+ + VAIK + Q E +M+ L HP +V L ++
Sbjct: 14 LGAGQFGEVWMGYYNGHTK-VAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRL----YA 68
Query: 147 TTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKL--YTYQICRALAYIH--NC 202
+E +Y+ + EY+ N ++ + + + L KL QI +A+I N
Sbjct: 69 VVTQEPIYI--ITEYM---ENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNY 123
Query: 203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR------YYRAPELI 256
I HRD++ N+LV+ T K+ DFG A+++ E Y + APE I
Sbjct: 124 I---HRDLRAANILVS-ETLCCKIADFGLARLIEDNE----YTAREGAKFPIKWTAPEAI 175
Query: 257 -FGATEYTTAIDIWSTGCVMAELL-LGQPLFPG 287
+G +T D+WS G ++ E++ G+ +PG
Sbjct: 176 NYGT--FTIKSDVWSFGILLTEIVTYGRIPYPG 206
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 2e-07
Identities = 62/218 (28%), Positives = 103/218 (47%), Gaps = 41/218 (18%)
Query: 89 VVGTGSFGVVFQAKCRETGEIVAIKKVLQD--KRYKNR---ELQIMQMLDHPNIVALKHC 143
++G G+FG VF+ ++ VA+K +D + K + E +I++ DHPNIV L
Sbjct: 2 LLGKGNFGEVFKGTLKDKTP-VAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKL--- 57
Query: 144 FFSTTDKEELYLNLVLEYVPE----TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 199
T ++ +Y +V+E VP + R ++ + Q + + +AY+
Sbjct: 58 IGVCTQRQPIY--IVMELVPGGDFLSFLRKKKDELKTKQLVK------FALDAAAGMAYL 109
Query: 200 H--NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY------YR 251
NCI HRD+ +N LV + LK+ DFG + + E + Y S +
Sbjct: 110 ESKNCI---HRDLAARNCLVG-ENNVLKISDFG----MSRQEDDGIYSSSGLKQIPIKWT 161
Query: 252 APE-LIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPG 287
APE L +G Y++ D+WS G ++ E LG +PG
Sbjct: 162 APEALNYG--RYSSESDVWSYGILLWETFSLGVCPYPG 197
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 3e-07
Identities = 60/206 (29%), Positives = 94/206 (45%), Gaps = 32/206 (15%)
Query: 90 VGTGSFGVVFQA--KCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALK 141
+G+G+FG V + K R+ VAIK VL+++ K+ RE +IM LD+P IV +
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIK-VLKNENEKSVRDEMMREAEIMHQLDNPYIVRM- 60
Query: 142 HCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
+ E L LV+E + + S + + V +Q+ + Y+
Sbjct: 61 ---IGVCEAEALM--LVMEMASG--GPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEG 113
Query: 202 CIGICHRDIKPQN-LLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY-------YRAP 253
HRD+ +N LLVN H K+ DFG +K L + SY +R + AP
Sbjct: 114 -KNFVHRDLAARNVLLVN--QHYAKISDFGLSKALGADD---SYYKARSAGKWPLKWYAP 167
Query: 254 ELIFGATEYTTAIDIWSTGCVMAELL 279
E I ++++ D+WS G M E
Sbjct: 168 ECI-NFRKFSSRSDVWSYGITMWEAF 192
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 3e-07
Identities = 45/151 (29%), Positives = 76/151 (50%), Gaps = 23/151 (15%)
Query: 90 VGTGSFGVVFQAKCRETGEIVAIKKVLQ-DKRYKNR------ELQIMQMLDHPNIVALKH 142
+G G+FG V A+ +T + A+K + + D +N+ E I+ D+ +V L
Sbjct: 9 LGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRL-- 66
Query: 143 CFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRM---PLIYVKLYTYQICRALAYI 199
++S DK+ LY V++Y+P + + RM P + Y ++ A+ +
Sbjct: 67 -YYSFQDKDNLYF--VMDYIP------GGDMMSLLIRMGIFPEDLARFYIAELTCAVESV 117
Query: 200 HNCIGICHRDIKPQNLLVNPHTHQLKLCDFG 230
H +G HRDIKP N+L++ H +KL DFG
Sbjct: 118 HK-MGFIHRDIKPDNILIDRDGH-IKLTDFG 146
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 4e-07
Identities = 79/317 (24%), Positives = 124/317 (39%), Gaps = 81/317 (25%)
Query: 89 VVGTGSFGVVFQAKCRETGEIVAIK---KVLQDKRYKNRELQ------IMQMLDHPNIVA 139
V+G+G+FG V++ GE V I K+L + ++ IM +DHP++V
Sbjct: 14 VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVR 73
Query: 140 LKHCFFSTTDKEELYL---NLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
L S T + L +L+YV E + I + + QI + +
Sbjct: 74 LLGVCLSPTIQLVTQLMPHGCLLDYVHEHKDNIGSQ-----------LLLNWCVQIAKGM 122
Query: 197 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAP 253
Y+ + HRD+ +N+LV H +K+ DFG A++L E + + + A
Sbjct: 123 MYLEE-RRLVHRDLAARNVLVKSPNH-VKITDFGLARLLEGDEKEYNADGGKMPIKWMAL 180
Query: 254 ELIFGATEYTTAIDIWSTGCVMAELLL--GQPLFPGESGVDQLVEIIKVLGTPTREEIKC 311
E I ++T D+WS G + EL+ G+P G PTRE
Sbjct: 181 ECIH-YRKFTHQSDVWSYGVTIWELMTFGGKPYD----------------GIPTREI--- 220
Query: 312 MNPNYTEF--KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFD 369
P+ E + PQ PP +C Y ++C ++A P F
Sbjct: 221 --PDLLEKGERLPQ--------------PP-----ICTIDVYMVMVKCWMIDADSRPKFK 259
Query: 370 EL--------RDPNTRL 378
EL RDP L
Sbjct: 260 ELAAEFSRMARDPQRYL 276
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 4e-07
Identities = 56/236 (23%), Positives = 93/236 (39%), Gaps = 50/236 (21%)
Query: 79 KQKVSYIAEHVVGTGSFGVVFQAKC-----RETGEIVAIKKV-----LQDKRYKNRELQI 128
+ + Y+ + +G G+FG VFQA+ E +VA+K + + RE +
Sbjct: 4 RNNIEYVRD--IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAAL 61
Query: 129 MQMLDHPNIVAL--------KHC----FFSTTDKEELYLNLVLEYVPETVNRIARNYSRI 176
M DHPNIV L C + + D E + + +
Sbjct: 62 MAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCG 121
Query: 177 HQRMPLIYVKLY--TYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV 234
+PL + Q+ +AY+ + HRD+ +N LV + +K+ DFG ++
Sbjct: 122 LNPLPLSCTEQLCIAKQVAAGMAYLSERKFV-HRDLATRNCLVGENM-VVKIADFGLSRN 179
Query: 235 LVKGEPNVSYICSRYYRA------------PELIFGATEYTTAIDIWSTGCVMAEL 278
+ + YY+A PE IF YTT D+W+ G V+ E+
Sbjct: 180 IYSAD---------YYKASENDAIPIRWMPPESIFYN-RYTTESDVWAYGVVLWEI 225
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 50.4 bits (121), Expect = 6e-07
Identities = 48/191 (25%), Positives = 75/191 (39%), Gaps = 44/191 (23%)
Query: 111 AIKKVLQDKRYKNRELQIMQMLDHPNIVAL-------KHCFFSTTDKEELYLNLVL-EYV 162
A +D +E++I+ L PNI L E LN L ++V
Sbjct: 58 ASDNAREDFL---KEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHV 114
Query: 163 PETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI--HNCIGICHRDIKPQNLLVNPH 220
ET S+ L+Y+ QI + Y+ N + HRD+ +N LV
Sbjct: 115 AETSG--LACNSKSLSFSTLLYMAT---QIASGMRYLESLNFV---HRDLATRNCLVGK- 165
Query: 221 THQLKLCDFGSAKVLVKGEPNVSYICSRYY----RAP--------ELIFGATEYTTAIDI 268
+ +K+ DFG ++ L Y YY RAP E + ++TT D+
Sbjct: 166 NYTIKIADFGMSRNL--------YSSD-YYRVQGRAPLPIRWMAWESVLL-GKFTTKSDV 215
Query: 269 WSTGCVMAELL 279
W+ G + E+L
Sbjct: 216 WAFGVTLWEIL 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 7e-07
Identities = 55/226 (24%), Positives = 97/226 (42%), Gaps = 40/226 (17%)
Query: 89 VVGTGSFGVVFQAKCR-ETGEI--VAIKKVLQDKRYKN------RELQIMQMLDHPNIVA 139
++G G FG V + + + G VA+K + D + E M+ DHPN++
Sbjct: 6 ILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMK 65
Query: 140 LKHCFFSTTDKEELYLNLV-LEYVPETVNRIARNYSRIH---QRMPLIYVKLYTYQICRA 195
L F + +++ +V L ++ YSR+ +++PL + + I
Sbjct: 66 LIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALG 125
Query: 196 LAYIHNCIGICHRDIKPQNLLVNPHTHQLKLC--DFGSAKVLVKGEPNVSYICSRYYRAP 253
+ Y+ N I HRD+ +N ++ + +C DFG +K + G+ YYR
Sbjct: 126 MEYLSNRNFI-HRDLAARNCMLR---EDMTVCVADFGLSKKIYSGD---------YYRQG 172
Query: 254 ELI-----FGATE------YTTAIDIWSTGCVMAELL-LGQPLFPG 287
+ + A E YT+ D+W+ G M E+ GQ +PG
Sbjct: 173 RIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPG 218
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 7e-07
Identities = 61/243 (25%), Positives = 105/243 (43%), Gaps = 49/243 (20%)
Query: 90 VGTGSFGVVFQA--KCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALK 141
+G+G+FG V + K +++ + VA+K + D K RE +MQ LD+P IV +
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRM- 61
Query: 142 HCFFSTTDKEELYLNLVLEYVPETVNRIARN-YSRIHQRMPLIYVKLYTYQICRALAYI- 199
+ E L + L + + +N + L+ +Q+ + Y+
Sbjct: 62 ---IGICEAESWMLVMELAELGPLNKFLQKNKHVTEKNITELV------HQVSMGMKYLE 112
Query: 200 -HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR------- 251
N + HRD+ +N+L+ H K+ DFG +K L E YY+
Sbjct: 113 ETNFV---HRDLAARNVLLVTQ-HYAKISDFGLSKALGADE--------NYYKAKTHGKW 160
Query: 252 -----APELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESG--VDQLVEIIKVLGT 303
APE + ++++ D+WS G +M E GQ + G G V Q++E + +
Sbjct: 161 PVKWYAPECM-NYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERMEC 219
Query: 304 PTR 306
P R
Sbjct: 220 PQR 222
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 1e-06
Identities = 55/218 (25%), Positives = 97/218 (44%), Gaps = 44/218 (20%)
Query: 90 VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR----ELQIMQMLDHPNIVALKHCFF 145
+G+G FG V++ + VAIK + D K + E+Q ++ L H ++++L F
Sbjct: 14 LGSGYFGEVWEGLWKNRVR-VAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISL---FA 69
Query: 146 STTDKEELYL--------NLVLEYV--PETVNRIARNYSRIHQRMPLIYVKLYTYQICRA 195
+ E +Y+ +L L ++ PE ++ LI + Q+
Sbjct: 70 VCSVGEPVYIITELMEKGSL-LAFLRSPE---------GQVLPVASLIDM---ACQVAEG 116
Query: 196 LAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY-----Y 250
+AY+ HRD+ +N+LV K+ DFG A+++ E Y+ S +
Sbjct: 117 MAYLEE-QNSIHRDLAARNILVGEDL-VCKVADFGLARLI--KED--VYLSSDKKIPYKW 170
Query: 251 RAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPG 287
APE ++T D+WS G ++ E+ GQ +PG
Sbjct: 171 TAPEAA-SHGTFSTKSDVWSFGILLYEMFTYGQVPYPG 207
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 1e-06
Identities = 48/187 (25%), Positives = 86/187 (45%), Gaps = 21/187 (11%)
Query: 160 EYVPETVNRIARNYSRIHQRMPLIYVKL--YTYQICRALAYI--HNCIGICHRDIKPQNL 215
+Y+P R R+ + I++ L Y+ L ++YQ+ + ++ NC+ HRD+ +N+
Sbjct: 215 QYLPSAPERTRRD-TLINESPALSYMDLVGFSYQVANGMEFLASKNCV---HRDLAARNV 270
Query: 216 LVNPHTHQLKLCDFGSAKVLVKGEPNVS---YICSRYYRAPELIFGATEYTTAIDIWSTG 272
L+ +K+CDFG A+ +++ +S + APE IF YTT D+WS G
Sbjct: 271 LIC-EGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNL-YTTLSDVWSFG 328
Query: 273 CVMAELL-LGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHK 331
++ E+ LG +P +Q IK + P + + +I W +
Sbjct: 329 ILLWEIFTLGGTPYPELPMNEQFYNAIK-------RGYRMAKPAHASDEIYEIMQKCWEE 381
Query: 332 VFQKRLP 338
F+ R
Sbjct: 382 KFEIRPD 388
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 1e-06
Identities = 26/69 (37%), Positives = 38/69 (55%), Gaps = 9/69 (13%)
Query: 191 QICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY- 249
QI AL +H+ GI HRD+KPQN++ + + K+ D G+A L G ++YI +
Sbjct: 263 QILFALDGLHS-TGIVHRDVKPQNIIFSEGSGSFKIIDLGAAADLRVG---INYIPKEFL 318
Query: 250 ----YRAPE 254
Y APE
Sbjct: 319 LDPRYAAPE 327
|
Length = 566 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 1e-06
Identities = 62/243 (25%), Positives = 96/243 (39%), Gaps = 59/243 (24%)
Query: 135 PNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQ--RMPLIYVKLYTYQI 192
PN+V L S E + LVL++ + +S I + +P VK + ++
Sbjct: 45 PNMVCLHKYIVS-----EDSVFLVLQHAEG-----GKLWSHISKFLNIPEECVKRWAAEM 94
Query: 193 CRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNV-SYICSRYYR 251
AL +H GI RD+ P N+L++ H ++L F + E + Y
Sbjct: 95 VVALDALHR-EGIVCRDLNPNNILLDDRGH-IQLTYFSR---WSEVEDSCDGEAVENMYC 149
Query: 252 APELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGE-SGVDQLVEIIKVLGTPTREEIK 310
APE + G +E T A D WS G ++ ELL G+ L SG++
Sbjct: 150 APE-VGGISEETEACDWWSLGAILFELLTGKTLVECHPSGINT----------------- 191
Query: 311 CMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV-----H 365
+T P+ + EA L+ + Q++P R A A V H
Sbjct: 192 -----HTTLNIPEW------------VSEEARSLLQQLLQFNPTERLGAGVAGVEDIKSH 234
Query: 366 PFF 368
PFF
Sbjct: 235 PFF 237
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 2e-06
Identities = 54/223 (24%), Positives = 92/223 (41%), Gaps = 50/223 (22%)
Query: 90 VGTGSFGVVFQAKC--------RETGEIVAIKKVLQDKRYK-NRELQIMQMLDHPNIVAL 140
+G G+FG VF A+C + + A+K+ + R RE +++ +L H +IV
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVR- 71
Query: 141 KHCFFSTTDKEELYLNLVLEYVPE-TVNRIARNY---------SRIHQRMPLIYVKLY-- 188
F+ + L +V EY+ +NR R++ L ++
Sbjct: 72 ---FYGVCTEGRP-LLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAI 127
Query: 189 TYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR 248
QI + Y+ + + HRD+ +N LV +K+ DFG ++ + +
Sbjct: 128 ASQIASGMVYLAS-LHFVHRDLATRNCLVGQGL-VVKIGDFGMSRDIYSTD--------- 176
Query: 249 YYRA------------PELIFGATEYTTAIDIWSTGCVMAELL 279
YYR PE I ++TT DIWS G V+ E+
Sbjct: 177 YYRVGGRTMLPIRWMPPESIL-YRKFTTESDIWSFGVVLWEIF 218
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 3e-06
Identities = 56/231 (24%), Positives = 99/231 (42%), Gaps = 56/231 (24%)
Query: 90 VGTGSFGVVFQAKCRETGEIVAIKKVLQD----KRYKNR---ELQIMQMLDHPNIVALKH 142
+G G G V+ A VA+KK+ +D K R E +I L HP IV +
Sbjct: 10 IGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPV-- 67
Query: 143 CFFSTTDKEELYLNLVLEYVP-ETVNRIARNY-------SRIHQRMPL-----IYVKLYT 189
+ +D + +Y + Y+ T+ + ++ + ++ + I+ K
Sbjct: 68 -YSICSDGDPVYYTM--PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHK--- 121
Query: 190 YQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK-------VLVKGEPNV 242
IC + Y+H+ G+ HRD+KP N+L+ + L D+G+A L+ + +
Sbjct: 122 --ICATIEYVHS-KGVLHRDLKPDNILLGLFGEVVIL-DWGAAIFKKLEEEDLLDIDVDE 177
Query: 243 SYICSRY------------YRAPELIFG--ATEYTTAIDIWSTGCVMAELL 279
IC Y APE + G A+E T DI++ G ++ ++L
Sbjct: 178 RNICYSSMTIPGKIVGTPDYMAPERLLGVPASEST---DIYALGVILYQML 225
|
Length = 932 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 3e-06
Identities = 51/206 (24%), Positives = 88/206 (42%), Gaps = 29/206 (14%)
Query: 89 VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVA--------- 139
V+G+G+FG V++ GE V I ++ R ++LD ++A
Sbjct: 14 VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCR 73
Query: 140 -LKHCFFSTTD--KEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
L C ST + + +L+YV E +RI + + QI + +
Sbjct: 74 LLGICLTSTVQLVTQLMPYGCLLDYVRENKDRIGSQ-----------DLLNWCVQIAKGM 122
Query: 197 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAP 253
+Y+ + + HRD+ +N+LV H +K+ DFG A++L E + + A
Sbjct: 123 SYLEE-VRLVHRDLAARNVLVKSPNH-VKITDFGLARLLDIDETEYHADGGKVPIKWMAL 180
Query: 254 ELIFGATEYTTAIDIWSTGCVMAELL 279
E I +T D+WS G + EL+
Sbjct: 181 ESIL-HRRFTHQSDVWSYGVTVWELM 205
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 4e-06
Identities = 83/317 (26%), Positives = 131/317 (41%), Gaps = 75/317 (23%)
Query: 90 VGTGSFGVVFQAKC-------RETGEIVAIKKVLQDKRYKN-----RELQIMQML-DHPN 136
+G G FG V A+ VA+K + D K+ E+++M+M+ H N
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79
Query: 137 IVALKHCFFSTTDKEELYLNLVLEYVPETVNR---IAR-----NYSRIHQRMP---LIYV 185
I+ L + T LY+ ++EY + R AR +YS ++P L +
Sbjct: 80 IINL---LGACTQDGPLYV--LVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFK 134
Query: 186 KLYT--YQICRALAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN 241
L + YQ+ R + Y+ CI HRD+ +N+LV + +K+ DFG L + N
Sbjct: 135 DLVSCAYQVARGMEYLASQKCI---HRDLAARNVLVT-EDNVMKIADFG----LARDVHN 186
Query: 242 VSYICSRY-------YRAPELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQ 293
+ Y + APE +F YT D+WS G ++ E+ LG +PG V++
Sbjct: 187 IDYYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLLWEIFTLGGSPYPGIP-VEE 244
Query: 294 LVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKR----------------- 336
L +++K E + P + I WH V +R
Sbjct: 245 LFKLLK-------EGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVT 297
Query: 337 LPPEAVDLVCRFFQYSP 353
E +DL F QYSP
Sbjct: 298 STDEYLDLSVPFEQYSP 314
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 4e-06
Identities = 58/217 (26%), Positives = 96/217 (44%), Gaps = 25/217 (11%)
Query: 90 VGTGSFGVVFQAKCRETGEI--VAIK--KVLQDKRYKN----RELQIMQMLDHPNIVALK 141
+G G FG V + + + I VA+K K+ R + E M+ DHPN++ L
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 142 HCFFSTTDKEELYLNLV-LEYVPETVNRIARNYSRIH---QRMPLIYVKLYTYQICRALA 197
T + E +V L ++ YSR+ Q +P + + I +
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126
Query: 198 YIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIF 257
Y+ + I HRD+ +N ++N + + + + DFG +K + G+ Y R + P + +
Sbjct: 127 YLSSKSFI-HRDLAARNCMLNENMN-VCVADFGLSKKIYNGD---YYRQGRIAKMP-VKW 180
Query: 258 GATE------YTTAIDIWSTGCVMAELLL-GQPLFPG 287
A E YTT D+WS G M E+ GQ +PG
Sbjct: 181 IAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPG 217
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 4e-06
Identities = 77/318 (24%), Positives = 134/318 (42%), Gaps = 76/318 (23%)
Query: 90 VGTGSFGVVFQAKC-------RETGEIVAIKKVLQDKRYKN-----RELQIMQMLD-HPN 136
+G G FG V +A+ + VA+K + + K+ E+++M+++ H N
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79
Query: 137 IVALKHCFFSTTDKEELYLNLVLEYVPETVNR------------IARNYSRIHQRMPLIY 184
I+ L T + LY+ ++EY + R + +++ + L +
Sbjct: 80 IINL---LGVCTQEGPLYV--IVEYAAKGNLREFLRARRPPGPDYTFDITKVPEE-QLSF 133
Query: 185 VKLYT--YQICRALAYIHN--CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP 240
L + YQ+ R + Y+ + CI HRD+ +N+LV + +K+ DFG L +G
Sbjct: 134 KDLVSCAYQVARGMEYLESRRCI---HRDLAARNVLVT-EDNVMKIADFG----LARGVH 185
Query: 241 NVSYICSRY-------YRAPELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVD 292
++ Y + APE +F YT D+WS G +M E+ LG +PG
Sbjct: 186 DIDYYKKTSNGRLPVKWMAPEALFDRV-YTHQSDVWSFGILMWEIFTLGGSPYPGIP--- 241
Query: 293 QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKR---------------- 336
+ E+ K+L RE + P+ + + WH V +R
Sbjct: 242 -VEELFKLL----REGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAA 296
Query: 337 LPPEAVDLVCRFFQYSPN 354
+ E +DL F QYSP+
Sbjct: 297 VSEEYLDLSMPFEQYSPS 314
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 47.0 bits (112), Expect = 6e-06
Identities = 53/226 (23%), Positives = 91/226 (40%), Gaps = 53/226 (23%)
Query: 89 VVGTGSFGVVFQAKCRETG----EIVAIKKVLQDKRYKNRELQIMQML---------DHP 135
++ G+FG +F + E V +K V E+Q+ +L H
Sbjct: 13 LLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHAS----EIQVTLLLQESCLLYGLSHQ 68
Query: 136 NIVALKH-CFFSTTDKEELY-------LNLVLE---YVPETVNRIARNYSRIHQRMPLIY 184
NI+ + H C LY L L L+ + +H M +
Sbjct: 69 NILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVH--MAI-- 124
Query: 185 VKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY 244
QI ++Y+H G+ H+DI +N +++ Q+K+ D ++ L + Y
Sbjct: 125 ------QIACGMSYLHK-RGVIHKDIAARNCVID-EELQVKITDNALSRDLFPMD----Y 172
Query: 245 IC-----SRYYR--APELIFGATEYTTAIDIWSTGCVMAELL-LGQ 282
C +R + A E + EY++A D+WS G ++ EL+ LGQ
Sbjct: 173 HCLGDNENRPVKWMALESLVN-KEYSSASDVWSFGVLLWELMTLGQ 217
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 1e-05
Identities = 58/226 (25%), Positives = 98/226 (43%), Gaps = 40/226 (17%)
Query: 89 VVGTGSFGVVFQAKCRE---TGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVA 139
++G G FG V +A+ + + + VA+K + D + RE M+ DHPN++
Sbjct: 6 MLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIK 65
Query: 140 LKHCFFSTTDKEELYLNLV-LEYVPETVNRIARNYSRIHQR---MPLIYVKLYTYQICRA 195
L + K L + +V L ++ SRI + +PL + + I
Sbjct: 66 LIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASG 125
Query: 196 LAYIHNCIGICHRDIKPQNLLVNPHTHQLKLC--DFGSAKVLVKGEPNVSYICSRYYR-- 251
+ Y+ + HRD+ +N ++N + +C DFG +K + G+ YYR
Sbjct: 126 MEYLSS-KNFIHRDLAARNCMLN---ENMTVCVADFGLSKKIYSGD---------YYRQG 172
Query: 252 -APELIFG--ATE------YTTAIDIWSTGCVMAELL-LGQPLFPG 287
A +L A E YTT D+W+ G M E++ GQ + G
Sbjct: 173 CASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAG 218
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 2e-05
Identities = 57/218 (26%), Positives = 97/218 (44%), Gaps = 37/218 (16%)
Query: 87 EHVVGTGSFGVVFQAKCRETGEIV--AIKKVLQ-----DKRYKNRELQIMQML-DHPNIV 138
+ V+G G+FG V +A+ ++ G + AIK++ + D R EL+++ L HPNI+
Sbjct: 12 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 71
Query: 139 -ALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVK----------- 186
L C + YL L +EY P SR+ + P +
Sbjct: 72 NLLGAC------EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQ 125
Query: 187 --LYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK---VLVKGEPN 241
+ + R + Y+ I HRD+ +N+LV + K+ DFG ++ V VK
Sbjct: 126 LLHFAADVARGMDYLSQKQFI-HRDLAARNILVG-ENYVAKIADFGLSRGQEVYVK--KT 181
Query: 242 VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELL 279
+ + R+ L + YTT D+WS G ++ E++
Sbjct: 182 MGRLPVRWMAIESLNYSV--YTTNSDVWSYGVLLWEIV 217
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 3e-05
Identities = 61/249 (24%), Positives = 107/249 (42%), Gaps = 39/249 (15%)
Query: 89 VVGTGSFGVVFQAKCRETGEI---VAIKKV-----LQDKRYKNRELQIMQMLDHPNIVAL 140
V+G G FG V+ ++ A+K + L++ +E IM+ HPN+++L
Sbjct: 2 VIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSL 61
Query: 141 KHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMP----LIYVKLYTYQICRAL 196
E L +VL Y+ + RN+ R P LI L Q+ + +
Sbjct: 62 LGICL---PSEGSPL-VVLPYM---KHGDLRNFIRSETHNPTVKDLIGFGL---QVAKGM 111
Query: 197 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPEL- 255
Y+ + HRD+ +N +++ + +K+ DFG A+ + E Y + +L
Sbjct: 112 EYLAS-KKFVHRDLAARNCMLD-ESFTVKVADFGLARDIYDKE----YYSVHNHTGAKLP 165
Query: 256 -IFGATE------YTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTRE 307
+ A E +TT D+WS G ++ EL+ G P +P D V +++ G +
Sbjct: 166 VKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQ--GRRLLQ 223
Query: 308 EIKCMNPNY 316
C +P Y
Sbjct: 224 PEYCPDPLY 232
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 4e-05
Identities = 72/288 (25%), Positives = 121/288 (42%), Gaps = 68/288 (23%)
Query: 90 VGTGSFGVVFQAKC-----RETGEI--VAIKKVLQDKRYKN-----RELQIMQML-DHPN 136
+G G FG V A+ + + VA+K + D K+ E+++M+M+ H N
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85
Query: 137 IVALKHCFFSTTDKEELYLNLVLEYVPETVNR----------IARNYSRIHQRMPLIYVK 186
I+ L + T LY+ ++EY + R + Y+ + K
Sbjct: 86 IINL---LGACTQDGPLYV--IVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFK 140
Query: 187 LY---TYQICRALAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN 241
YQ+ R + Y+ CI HRD+ +N+LV + +K+ DFG A+ +
Sbjct: 141 DLVSCAYQVARGMEYLASKKCI---HRDLAARNVLVT-EDNVMKIADFGLAR-------D 189
Query: 242 VSYICSRYYR------------APELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGE 288
+ +I YY+ APE +F YT D+WS G ++ E+ LG +PG
Sbjct: 190 IHHI--DYYKKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEIFTLGGSPYPGV 246
Query: 289 SGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKR 336
V++L +++K G + C N Y + WH V +R
Sbjct: 247 P-VEELFKLLKE-GHRMDKPSNCTNELYMMMR------DCWHAVPSQR 286
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 5e-05
Identities = 57/204 (27%), Positives = 92/204 (45%), Gaps = 34/204 (16%)
Query: 90 VGTGSFGVVFQAKCRETGEIVAIKKV-------LQDKRYKNRELQIMQMLDHPNIVALKH 142
+G G+FG VF + R VA+K L+ K + E +I++ HPNIV L
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQ--EARILKQYSHPNIVRL-- 58
Query: 143 CFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALA---YI 199
T K+ +Y +V+E V + + + P + VK + A A Y+
Sbjct: 59 -IGVCTQKQPIY--IVMELV-----QGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYL 110
Query: 200 HN--CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAPE 254
+ CI HRD+ +N LV + LK+ DFG ++ G + + + APE
Sbjct: 111 ESKHCI---HRDLAARNCLVT-EKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPE 166
Query: 255 -LIFGATEYTTAIDIWSTGCVMAE 277
L +G Y++ D+WS G ++ E
Sbjct: 167 ALNYG--RYSSESDVWSFGILLWE 188
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 5e-05
Identities = 77/347 (22%), Positives = 131/347 (37%), Gaps = 85/347 (24%)
Query: 89 VVGTG--SFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVAL 140
V+G G V A+ + TGE V ++++ + + EL + ++ +HPNIV
Sbjct: 5 VIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPY 64
Query: 141 KHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 200
+ F D E + + Y + I ++ + + Y+ + +AL YIH
Sbjct: 65 RATFI--ADNELWVVTSFMAY-GSAKDLICTHFMDGMSELAIAYILQ---GVLKALDYIH 118
Query: 201 NCIGICHRDIKPQNLLVN-----------------PHTHQLKLC-DFG--SAKVLVKGEP 240
+ +G HR +K ++L++ H +L++ DF S KVL P
Sbjct: 119 H-MGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVL----P 173
Query: 241 NVSYICSRYYRAPELIFGATE-YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIK 299
+S PE++ + Y DI+S G EL G F L+E K
Sbjct: 174 WLS---------PEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLE--K 222
Query: 300 VLGT------------------PTR--------EEIKCMNPNYTEFKFPQIKPHPWHKVF 333
+ GT P+R E P + + HP+++ F
Sbjct: 223 LNGTVPCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSN---GESSSHPYNRTF 279
Query: 334 QKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL-RDPNTRLP 379
P V + Q +P+ R +A H FF ++ R + LP
Sbjct: 280 S----PHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIKRRASEALP 322
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 6e-05
Identities = 55/207 (26%), Positives = 102/207 (49%), Gaps = 23/207 (11%)
Query: 90 VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPNIVALKHCFFS 146
+G G FG V+ T + VAIK + +E QIM+ L H +V L ++
Sbjct: 14 LGQGCFGEVWMGTWNGTTK-VAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPL----YA 68
Query: 147 TTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGI 205
+E +Y+ V E++ + ++ + + ++P + V + QI +AYI +
Sbjct: 69 VVSEEPIYI--VTEFMGKGSLLDFLKEGDGKYLKLPQL-VDMAA-QIADGMAYIER-MNY 123
Query: 206 CHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAPEL-IFGATE 261
HRD++ N+LV + K+ DFG A+ L++ + +++ + APE ++G
Sbjct: 124 IHRDLRAANILVGDNL-VCKIADFGLAR-LIEDNEYTARQGAKFPIKWTAPEAALYG--R 179
Query: 262 YTTAIDIWSTGCVMAELLL-GQPLFPG 287
+T D+WS G ++ EL+ G+ +PG
Sbjct: 180 FTIKSDVWSFGILLTELVTKGRVPYPG 206
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 8e-05
Identities = 46/189 (24%), Positives = 86/189 (45%), Gaps = 27/189 (14%)
Query: 109 IVAIKKVLQD--KRYKN---RELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVP 163
+VA+K + D K +N +E++IM L +PNI+ L + D L ++ EY+
Sbjct: 46 LVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL-GVCVSDDP----LCMITEYME 100
Query: 164 E------TVNRIARNYSRIHQRMPLIYVKLYTY---QICRALAYIHNCIGICHRDIKPQN 214
R + +P + + Y QI + Y+ + + HRD+ +N
Sbjct: 101 NGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLAS-LNFVHRDLATRN 159
Query: 215 LLVNPHTHQLKLCDFGSAKVLVKGE----PNVSYICSRYYRAPELIFGATEYTTAIDIWS 270
LV H + +K+ DFG ++ L G+ + + R+ ++ G ++TTA D+W+
Sbjct: 160 CLVGNH-YTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLG--KFTTASDVWA 216
Query: 271 TGCVMAELL 279
G + E+
Sbjct: 217 FGVTLWEMF 225
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 2e-04
Identities = 32/90 (35%), Positives = 44/90 (48%), Gaps = 10/90 (11%)
Query: 175 RIHQRMP-----LIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDF 229
+I MP + +K Q+ L +H IGI HRDIKP+NLLV Q+K+ DF
Sbjct: 296 KIPDNMPQDKRDINVIKGVMRQVLTGLRKLHR-IGIVHRDIKPENLLVTVDG-QVKIIDF 353
Query: 230 GSAKVLVKG---EPNVSYICSRYYRAPELI 256
G+A + G P + RY EL+
Sbjct: 354 GAAVDMCTGINFNPLYGMLDPRYSPPEELV 383
|
Length = 507 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 2e-04
Identities = 53/207 (25%), Positives = 99/207 (47%), Gaps = 23/207 (11%)
Query: 90 VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPNIVALKHCFFS 146
+G G FG V+ + VA+K + E QIM+ L H +V L ++
Sbjct: 14 LGNGQFGEVWMGTWNGNTK-VAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQL----YA 68
Query: 147 TTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGI 205
+E +Y+ V EY+ + ++ ++ ++P + V + Q+ +AYI +
Sbjct: 69 VVSEEPIYI--VTEYMSKGSLLDFLKDGEGRALKLPNL-VDMAA-QVAAGMAYIER-MNY 123
Query: 206 CHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAPEL-IFGATE 261
HRD++ N+LV K+ DFG A+ L++ + +++ + APE ++G
Sbjct: 124 IHRDLRSANILVG-DGLVCKIADFGLAR-LIEDNEYTARQGAKFPIKWTAPEAALYG--R 179
Query: 262 YTTAIDIWSTGCVMAELLL-GQPLFPG 287
+T D+WS G ++ EL+ G+ +PG
Sbjct: 180 FTIKSDVWSFGILLTELVTKGRVPYPG 206
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 3e-04
Identities = 60/225 (26%), Positives = 100/225 (44%), Gaps = 51/225 (22%)
Query: 87 EHVVGTGSFGVVFQAKCRETG-EIVAIKKVLQDKRYKNR------ELQIMQML-DHPNIV 138
E V+G G+FG V +A ++ G ++ A K+L++ +N EL+++ L HPNI+
Sbjct: 7 EDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNII 66
Query: 139 AL-KHCFFSTTDKEELYLNLVLEYVP--------------ETVNRIARNY---SRIHQRM 180
L C + YL + +EY P ET A+ + S + +
Sbjct: 67 NLLGAC------ENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQ 120
Query: 181 PLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP 240
L + + + Y+ I HRD+ +N+LV + K+ DFG L +GE
Sbjct: 121 LL----QFASDVATGMQYLSEKQFI-HRDLAARNVLVGENLAS-KIADFG----LSRGEE 170
Query: 241 NVSYICSRYYRAPELIFGATE------YTTAIDIWSTGCVMAELL 279
Y+ R P + + A E YTT D+WS G ++ E++
Sbjct: 171 --VYVKKTMGRLP-VRWMAIESLNYSVYTTKSDVWSFGVLLWEIV 212
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 9e-04
Identities = 35/121 (28%), Positives = 57/121 (47%), Gaps = 29/121 (23%)
Query: 191 QICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYY 250
QI + Y+ + + HRD+ +N LV + +K+ DFG ++ L G+ YY
Sbjct: 146 QIASGMKYLSS-LNFVHRDLATRNCLVGENLT-IKIADFGMSRNLYAGD---------YY 194
Query: 251 R------------APELIFGATEYTTAIDIWSTGCVMAELLL---GQPLFPGESGVDQLV 295
R A E I ++TTA D+W+ G + E+L+ QP GE +Q++
Sbjct: 195 RIQGRAVLPIRWMAWECILMG-KFTTASDVWAFGVTLWEILMLCKEQPY--GELTDEQVI 251
Query: 296 E 296
E
Sbjct: 252 E 252
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 0.001
Identities = 48/218 (22%), Positives = 82/218 (37%), Gaps = 48/218 (22%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRE----TGEIVA----------------------IKKVLQ 117
+ + ++G G FG V++ +C + VA I K+
Sbjct: 14 WKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIAL 73
Query: 118 DKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIH 177
K N +DH I C + Y ++LE + E I + RI
Sbjct: 74 WKNIHN--------IDHLGIPKYYGCGSFKRCRM-YYRFILLEKLVENTKEI---FKRIK 121
Query: 178 QR-MPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV 236
+ LI K + L YIH GI H DIKP+N++V+ + ++ + D+G A +
Sbjct: 122 CKNKKLI--KNIMKDMLTTLEYIHE-HGISHGDIKPENIMVDGN-NRGYIIDYGIASHFI 177
Query: 237 KGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCV 274
++ Y + + + T Y +D + CV
Sbjct: 178 IHGKHI-----EYSKEQKDLHRGTLYYAGLDAHNGACV 210
|
Length = 294 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 40.1 bits (94), Expect = 0.001
Identities = 52/232 (22%), Positives = 89/232 (38%), Gaps = 49/232 (21%)
Query: 89 VVGTGSFGVVFQAKCR-----ETGEIVAIKKVLQDKRYKNR-----ELQIMQMLDHPNIV 138
+G G+FG V++ R VA+K + + ++ E IM +H NIV
Sbjct: 13 ALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIV 72
Query: 139 ALKHCFFSTTDKEELYLNLVL-------EYVPETVNRIARNYSRIHQRMPLIYVKLYTYQ 191
+ ++ ++ L L ++ E R R S + L++ +
Sbjct: 73 ---RLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKD--LLFCARDVAK 127
Query: 192 ICRALAYIHNCIGICHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNVSYICSRY 249
C+ L H HRDI +N L+ K+ DFG A+ + + + Y
Sbjct: 128 GCKYLEENH----FIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYR---------ASY 174
Query: 250 YR-----------APELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGES 289
YR P F +T+ D+WS G ++ E+ LG +PG +
Sbjct: 175 YRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRT 226
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.001
Identities = 36/116 (31%), Positives = 58/116 (50%), Gaps = 8/116 (6%)
Query: 191 QICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY--ICSR 248
Q+ A+ YIH+ + HRDIK +N+ +N ++ L DFG+A K Y + +
Sbjct: 275 QLLCAVEYIHDKK-LIHRDIKLENIFLNCDG-KIVLGDFGTAMPFEKEREAFDYGWVGTV 332
Query: 249 YYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVD---QLVEIIKVL 301
+PE++ G Y DIWS G ++ ++L G+ G QL++II L
Sbjct: 333 ATNSPEILAGDG-YCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKIIDSL 387
|
Length = 501 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 39.7 bits (92), Expect = 0.002
Identities = 58/223 (26%), Positives = 98/223 (43%), Gaps = 51/223 (22%)
Query: 89 VVGTGSFGVVFQAKCRETG-EIVAIKKVLQDKRYKNR------ELQIM-QMLDHPNIV-A 139
V+G G+FG V +A+ ++ G + A K +++ K+ EL+++ ++ HPNI+
Sbjct: 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 61
Query: 140 LKHCFFSTTDKEELYLNLVLEYVP--------------ETVNRIARNY---SRIHQRMPL 182
L C + YL L +EY P ET A S + + L
Sbjct: 62 LGAC------EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL 115
Query: 183 IYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNV 242
+ + R + Y+ I HRD+ +N+LV + K+ DFG L +G+
Sbjct: 116 HFAA----DVARGMDYLSQKQFI-HRDLAARNILVGENYVA-KIADFG----LSRGQE-- 163
Query: 243 SYICSRYYRAPELIFGATE------YTTAIDIWSTGCVMAELL 279
Y+ R P + + A E YTT D+WS G ++ E++
Sbjct: 164 VYVKKTMGRLP-VRWMAIESLNYSVYTTNSDVWSYGVLLWEIV 205
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 39.5 bits (92), Expect = 0.002
Identities = 48/201 (23%), Positives = 85/201 (42%), Gaps = 52/201 (25%)
Query: 109 IVAIKKVLQD--KRYKN---RELQIMQMLDHPNIVAL--------KHC----FFSTTDKE 151
+VA+K + +D K +N +E++IM L PNI+ L C + D
Sbjct: 48 LVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLN 107
Query: 152 ELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIK 211
+ + E + + +YS LI++ QI + Y+ + + HRD+
Sbjct: 108 QFLSRHEPQEAAEKADVVTISYST------LIFMAT---QIASGMKYLSS-LNFVHRDLA 157
Query: 212 PQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRA-------------PELIFG 258
+N LV + +K+ DFG ++ L G+ YYR ++ G
Sbjct: 158 TRNCLVG-KNYTIKIADFGMSRNLYSGD---------YYRIQGRAVLPIRWMSWESILLG 207
Query: 259 ATEYTTAIDIWSTGCVMAELL 279
++TTA D+W+ G + E+L
Sbjct: 208 --KFTTASDVWAFGVTLWEIL 226
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 39.2 bits (91), Expect = 0.002
Identities = 46/207 (22%), Positives = 90/207 (43%), Gaps = 31/207 (14%)
Query: 89 VVGTGSFGVVFQAKCRETGEIVAIK---KVLQDKRYKNRELQI------MQMLDHPNIVA 139
++G+G FG V + G+ + I K +QD+ + +I M LDH IV
Sbjct: 14 LLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVR 73
Query: 140 LKH-CFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
L C ++ L LV + P ++ + ++ + + L + QI + +
Sbjct: 74 LLGICPGAS-------LQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNW----CVQIAKGM 122
Query: 197 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY----ICSRYYRA 252
Y+ + HR++ +N+L+ + +++ DFG A +L + Y ++
Sbjct: 123 YYLEEH-RMVHRNLAARNILLKSDS-IVQIADFGVADLLYPDDKKYFYSEHKTPIKWMAL 180
Query: 253 PELIFGATEYTTAIDIWSTGCVMAELL 279
++FG YT D+WS G + E++
Sbjct: 181 ESILFG--RYTHQSDVWSYGVTVWEMM 205
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 39.2 bits (91), Expect = 0.002
Identities = 78/331 (23%), Positives = 138/331 (41%), Gaps = 85/331 (25%)
Query: 78 SKQKVSYIAEHVVGTGSFGVVFQAKCRE--TGEI---VAIKKVLQDKRYKNR-----ELQ 127
S++K++ + E +G GSFG+V++ R+ GE VA+K V + + R E
Sbjct: 4 SREKITLLRE--LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEAS 61
Query: 128 IMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVP----ETVNRIARNYSRIHQRMPLI 183
+M+ ++V L K + L +V+E + ++ R R + + P
Sbjct: 62 VMKGFTCHHVVRL----LGVVSKGQPTL-VVMELMAHGDLKSYLRSLRPEAENNPGRPPP 116
Query: 184 YVK---LYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP 240
++ +I +AY+ N HRD+ +N +V H +K+ DFG + + + +
Sbjct: 117 TLQEMIQMAAEIADGMAYL-NAKKFVHRDLAARNCMV-AHDFTVKIGDFGMTRDIYETD- 173
Query: 241 NVSYICSRYYR------------APELIFGATEYTTAIDIWSTGCVMAEL--LLGQPLFP 286
YYR APE + +TT+ D+WS G V+ E+ L QP +
Sbjct: 174 --------YYRKGGKGLLPVRWMAPESLKDGV-FTTSSDMWSFGVVLWEITSLAEQP-YQ 223
Query: 287 GESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVC 346
G S +Q+++ + M+ Y + P P DL+
Sbjct: 224 GLSN-EQVLKFV-------------MDGGYLD--------QP------DNCPERVTDLMR 255
Query: 347 RFFQYSPNLRCTALEAC------VHPFFDEL 371
+Q++P +R T LE +HP F E+
Sbjct: 256 MCWQFNPKMRPTFLEIVNLLKDDLHPSFPEV 286
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 38.9 bits (90), Expect = 0.003
Identities = 55/224 (24%), Positives = 93/224 (41%), Gaps = 54/224 (24%)
Query: 90 VGTGSFGVVFQAKCR----ETGEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVAL 140
+G G+FG VF A+C E +I+ K L+D ++ +RE +++ L H +IV
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVK- 71
Query: 141 KHCFFSTTDKEELYLNLVLEYV-------------PETVNRIARNYSRIHQRMPLIYVKL 187
F E L +V EY+ P+ V N + ++++
Sbjct: 72 ----FYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHI-- 125
Query: 188 YTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICS 247
QI + Y+ + HRD+ +N LV + +K+ DFG ++ + +
Sbjct: 126 -AQQIAAGMVYLAS-QHFVHRDLATRNCLVGENL-LVKIGDFGMSRDVYSTD-------- 174
Query: 248 RYYRA------------PELIFGATEYTTAIDIWSTGCVMAELL 279
YYR PE I ++TT D+WS G V+ E+
Sbjct: 175 -YYRVGGHTMLPIRWMPPESIM-YRKFTTESDVWSLGVVLWEIF 216
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 394 | |||
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 100.0 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.98 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.97 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.97 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.97 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.96 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.96 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.96 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.95 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.95 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.95 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.94 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.93 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.92 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.92 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.91 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.91 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.91 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.9 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.89 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.88 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.87 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.87 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.86 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.83 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.82 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.81 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.81 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.74 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.74 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.73 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.72 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.71 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.69 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.67 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.66 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.66 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.65 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.6 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.48 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.43 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.41 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.4 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.4 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.4 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.39 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.38 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.28 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.17 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 99.16 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.15 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.13 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.08 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.03 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.89 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.85 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.79 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.75 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.71 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.66 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.55 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 98.55 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.45 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.29 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.28 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.27 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 98.19 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.05 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.0 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.97 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 97.93 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.8 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 97.72 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.69 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.6 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.58 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.57 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.55 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.51 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.47 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.37 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 97.31 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.18 | |
| PLN02236 | 344 | choline kinase | 97.17 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 97.15 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 97.03 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 96.99 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 96.97 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 96.9 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 96.84 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.8 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 96.68 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 96.59 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 96.46 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 96.34 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 95.97 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 95.97 | |
| PTZ00384 | 383 | choline kinase; Provisional | 95.79 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 95.41 | |
| PF07914 | 414 | DUF1679: Protein of unknown function (DUF1679); In | 95.36 | |
| PF05445 | 434 | Pox_ser-thr_kin: Poxvirus serine/threonine protein | 95.03 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 94.64 | |
| KOG2269 | 531 | consensus Serine/threonine protein kinase [Signal | 94.62 |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-69 Score=472.94 Aligned_cols=327 Identities=76% Similarity=1.240 Sum_probs=309.6
Q ss_pred ceeeeccCCCCCCCccceeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccchhhhHHHHHHHHHcCCCCeeeeceEE
Q 016184 65 HVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCF 144 (394)
Q Consensus 65 ~~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 144 (394)
..................+|+-.+++|.|+||.||+|....+++.||||++..+.+...+|+++|+.+.|||||++..+|
T Consensus 7 ~~~~~~~~~~~~~~~~~i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~knrEl~im~~l~HpNIV~L~~~f 86 (364)
T KOG0658|consen 7 HVIQTVAEGRNDGKKVEISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYKNRELQIMRKLDHPNIVRLLYFF 86 (364)
T ss_pred eEEEEEeecCCCCcceEEEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCcCcHHHHHHHhcCCcCeeeEEEEE
Confidence 34444555555666677789999999999999999999999999999999999999999999999999999999999998
Q ss_pred EecCCCceeEEEEEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcE
Q 016184 145 FSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQL 224 (394)
Q Consensus 145 ~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~v 224 (394)
....+.+..+..+||||++.+|.+.++.+......++...++-+.+||++||.|||+ .||+||||||.|+|+|.+.+.+
T Consensus 87 ~~~~~~d~~~lnlVleymP~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~-~~IcHRDIKPqNlLvD~~tg~L 165 (364)
T KOG0658|consen 87 SSSTESDEVYLNLVLEYMPETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHS-HGICHRDIKPQNLLVDPDTGVL 165 (364)
T ss_pred EecCCCchhHHHHHHHhchHHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHh-cCcccCCCChheEEEcCCCCeE
Confidence 877766667889999999999999999888888999999999999999999999999 9999999999999999997799
Q ss_pred EEEeecCccccccCCCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCC
Q 016184 225 KLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTP 304 (394)
Q Consensus 225 kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~ 304 (394)
||||||+|+....++++.++.+|..|+|||.+.+...|+.+.||||.||++.||+-|++.|+|.+..+++..|++.+|.|
T Consensus 166 KicDFGSAK~L~~~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~P 245 (364)
T KOG0658|consen 166 KICDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTP 245 (364)
T ss_pred EeccCCcceeeccCCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCC
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ChhhhhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCCCCCCCCCC
Q 016184 305 TREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPNGRPL 384 (394)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~~~~~~~~~ 384 (394)
..+.+.++++++.+..+++....+|...+....++++.+|+.++|+.+|.+|.++.|+|.||||.++++++.+++++.+.
T Consensus 246 t~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~~~~~l~~g~~l 325 (364)
T KOG0658|consen 246 TREDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRDPNTKLPNGRPL 325 (364)
T ss_pred CHHHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhCcCccCcCCCcC
Confidence 99999999999999999999999999988899999999999999999999999999999999999999999999999999
Q ss_pred CCCCCCCC
Q 016184 385 PPLFNFKP 392 (394)
Q Consensus 385 ~~~~~~~~ 392 (394)
||+|+|++
T Consensus 326 p~lf~f~~ 333 (364)
T KOG0658|consen 326 PPLFNFKR 333 (364)
T ss_pred CCccCchH
Confidence 99999975
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-59 Score=420.59 Aligned_cols=285 Identities=35% Similarity=0.652 Sum_probs=254.0
Q ss_pred eeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccch-----hhhHHHHHHHHHcC-CCCeeeeceEEEecCCCceeEE
Q 016184 82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLD-HPNIVALKHCFFSTTDKEELYL 155 (394)
Q Consensus 82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~ 155 (394)
++|.++++||.|.||.||+|+.+.+|+.||||.+++.- ....||+..|++|+ ||||+++.+++.+.. ..+
T Consensus 10 ~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~----~~L 85 (538)
T KOG0661|consen 10 DRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDND----RIL 85 (538)
T ss_pred HHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccC----ceE
Confidence 46999999999999999999999999999999886543 33348999999998 999999999884322 268
Q ss_pred EEEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCcccc
Q 016184 156 NLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL 235 (394)
Q Consensus 156 ~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~ 235 (394)
++|||||..+|+++++.. ...+++..++.|+.||+.||+|+|+ +|+.||||||||||+.... .+||+|||+|+.+
T Consensus 86 ~fVfE~Md~NLYqLmK~R---~r~fse~~irnim~QilqGL~hiHk-~GfFHRDlKPENiLi~~~~-~iKiaDFGLARev 160 (538)
T KOG0661|consen 86 YFVFEFMDCNLYQLMKDR---NRLFSESDIRNIMYQILQGLAHIHK-HGFFHRDLKPENILISGND-VIKIADFGLAREV 160 (538)
T ss_pred eeeHHhhhhhHHHHHhhc---CCcCCHHHHHHHHHHHHHHHHHHHh-cCcccccCChhheEecccc-eeEeccccccccc
Confidence 999999999999999875 5899999999999999999999999 8999999999999999655 7999999999999
Q ss_pred ccCCCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhcc--C
Q 016184 236 VKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM--N 313 (394)
Q Consensus 236 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~--~ 313 (394)
....+...++.|..|+|||++.....|+.+.||||+|||++|+.+-++.|+|.++.+++.+|.+++|.|....|... -
T Consensus 161 ~SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~L 240 (538)
T KOG0661|consen 161 RSKPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNL 240 (538)
T ss_pred ccCCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHH
Confidence 88888889999999999999998888999999999999999999999999999999999999999999998777532 1
Q ss_pred CCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCC
Q 016184 314 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNT 376 (394)
Q Consensus 314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~ 376 (394)
.+.-.+.+|+....+...+++. .+.++.+||.+||.+||.+||||.++|+||||+.......
T Consensus 241 a~~mnf~~P~~~~~~l~~L~p~-~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~~~~~~ 302 (538)
T KOG0661|consen 241 ASAMNFRFPQVKPSPLKDLLPN-ASSEAASLIERLLAWDPDKRPTASQALQHPFFQVGRASGS 302 (538)
T ss_pred HHHhccCCCcCCCCChHHhCcc-cCHHHHHHHHHHhcCCCccCccHHHHhcCccccccccccc
Confidence 1223467788888888888866 9999999999999999999999999999999998765544
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-58 Score=392.91 Aligned_cols=280 Identities=36% Similarity=0.681 Sum_probs=242.7
Q ss_pred eEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccchh------hhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEEE
Q 016184 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR------YKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN 156 (394)
Q Consensus 83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 156 (394)
.|+.+.++|+|+||+||+|+++.||+.||||++..+.. ...+|+++|++|+|+|+|.++++| .....++
T Consensus 3 kYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVF-----rrkrklh 77 (396)
T KOG0593|consen 3 KYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVF-----RRKRKLH 77 (396)
T ss_pred HHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHH-----HhcceeE
Confidence 58899999999999999999999999999999865432 234799999999999999999999 6666688
Q ss_pred EEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCccccc
Q 016184 157 LVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV 236 (394)
Q Consensus 157 lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~ 236 (394)
+|+|||..++.+.+.. ....++...++.+++|++.|+.|+|+ ++++||||||+||||+.++ .+||||||+|+...
T Consensus 78 LVFE~~dhTvL~eLe~---~p~G~~~~~vk~~l~Q~l~ai~~cHk-~n~IHRDIKPENILit~~g-vvKLCDFGFAR~L~ 152 (396)
T KOG0593|consen 78 LVFEYCDHTVLHELER---YPNGVPSELVKKYLYQLLKAIHFCHK-NNCIHRDIKPENILITQNG-VVKLCDFGFARTLS 152 (396)
T ss_pred EEeeecchHHHHHHHh---ccCCCCHHHHHHHHHHHHHHhhhhhh-cCeecccCChhheEEecCC-cEEeccchhhHhhc
Confidence 9999999877555554 45789999999999999999999999 8999999999999999988 89999999999886
Q ss_pred -cCCCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhcc--C
Q 016184 237 -KGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM--N 313 (394)
Q Consensus 237 -~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~--~ 313 (394)
.++.-..++.|..|+|||.+.++..|+..+||||+||++.||++|.+.|++.++.+++..|...+|...+....-+ +
T Consensus 153 ~pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N 232 (396)
T KOG0593|consen 153 APGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSN 232 (396)
T ss_pred CCcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccC
Confidence 4555567788999999999999888999999999999999999999999999999999999999999887766543 4
Q ss_pred CCCcccCCCCCCCC-CcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q 016184 314 PNYTEFKFPQIKPH-PWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD 373 (394)
Q Consensus 314 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~ 373 (394)
+-+....+|..... +.+.-+ ..++..+.+|++.||..||.+|++.+++|.||+|.++.+
T Consensus 233 ~~F~Gv~lP~~~~~epLe~k~-p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd~~~e 292 (396)
T KOG0593|consen 233 PFFHGVRLPEPEHPEPLERKY-PKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFDGFIE 292 (396)
T ss_pred CceeeeecCCCCCccchhhhc-ccchHHHHHHHHHHhcCCccccccHHHHhcChHHHHHHH
Confidence 55666777766533 333333 456778999999999999999999999999999976543
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-56 Score=415.21 Aligned_cols=267 Identities=30% Similarity=0.501 Sum_probs=231.7
Q ss_pred eeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccc-------hhhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeE
Q 016184 82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY 154 (394)
Q Consensus 82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 154 (394)
.+|...++||+|||+.||++++..+|+.||+|++.+. .....+|+++.+.|+|||||+++++| .+..+
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~F-----EDs~n 92 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFF-----EDSNN 92 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEe-----ecCCc
Confidence 4699999999999999999999999999999998652 34456799999999999999999999 55666
Q ss_pred EEEEEeccc-ccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCcc
Q 016184 155 LNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK 233 (394)
Q Consensus 155 ~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~ 233 (394)
+|||.|+|. ++|.++++ ..+.++|.+++.+++||+.||.|||+ ++|+|||||..|+|++++. +|||+|||+|+
T Consensus 93 VYivLELC~~~sL~el~K----rrk~ltEpEary~l~QIv~GlkYLH~-~~IiHRDLKLGNlfL~~~~-~VKIgDFGLAt 166 (592)
T KOG0575|consen 93 VYIVLELCHRGSLMELLK----RRKPLTEPEARYFLRQIVEGLKYLHS-LGIIHRDLKLGNLFLNENM-NVKIGDFGLAT 166 (592)
T ss_pred eEEEEEecCCccHHHHHH----hcCCCCcHHHHHHHHHHHHHHHHHHh-cCceecccchhheeecCcC-cEEecccceee
Confidence 999999999 46666655 34899999999999999999999999 8999999999999999988 69999999999
Q ss_pred ccccC-CCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhcc
Q 016184 234 VLVKG-EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 312 (394)
Q Consensus 234 ~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 312 (394)
.+... +...+.+|||.|.|||++.... .+..+||||+||+||.|++|++||...+-.+.+..|..
T Consensus 167 ~le~~~Erk~TlCGTPNYIAPEVl~k~g-HsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~------------- 232 (592)
T KOG0575|consen 167 QLEYDGERKKTLCGTPNYIAPEVLNKSG-HSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKL------------- 232 (592)
T ss_pred eecCcccccceecCCCcccChhHhccCC-CCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHh-------------
Confidence 88744 6778899999999999997544 89999999999999999999999998877777777765
Q ss_pred CCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCCCCCCCCCCCCCCC
Q 016184 313 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPNGRPLPPLFN 389 (394)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~~~~~~~~~~~~~~ 389 (394)
.++.+| ..++.++++||.++|+.||.+|||++++|.|+||+.-.-+..-....-+..|.|.
T Consensus 233 ----~~Y~~P------------~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff~~g~~p~~lp~~~l~~~p~~~ 293 (592)
T KOG0575|consen 233 ----NEYSMP------------SHLSAEAKDLIRKLLRPNPSERPSLDEVLDHPFFKSGFTPARLPSSCLTMVPRFG 293 (592)
T ss_pred ----cCcccc------------cccCHHHHHHHHHHhcCCcccCCCHHHHhcCHhhhCCCcCCCCCccccccCCcCC
Confidence 334443 5789999999999999999999999999999999766666655555555666665
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-57 Score=404.97 Aligned_cols=259 Identities=34% Similarity=0.481 Sum_probs=213.4
Q ss_pred cceeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccch-----------hhhHHHHHHHHHcCCCCeeeeceEEEecC
Q 016184 80 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----------RYKNRELQIMQMLDHPNIVALKHCFFSTT 148 (394)
Q Consensus 80 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 148 (394)
....|.+.+.||+|+||.|-+|..+.||+.||||++.+.. ....+|+++|++|+|||||+++++|
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f---- 245 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFF---- 245 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeee----
Confidence 4456999999999999999999999999999999986432 1235899999999999999999999
Q ss_pred CCceeEEEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCC--CCcEE
Q 016184 149 DKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPH--THQLK 225 (394)
Q Consensus 149 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~--~~~vk 225 (394)
....+.||||||++| .|.+.+- .++.+.+..-+.++.|++.|+.|||+ .||+||||||+|||+..+ ...+|
T Consensus 246 -~~~ds~YmVlE~v~GGeLfd~vv----~nk~l~ed~~K~~f~Qll~avkYLH~-~GI~HRDiKPeNILl~~~~e~~llK 319 (475)
T KOG0615|consen 246 -EVPDSSYMVLEYVEGGELFDKVV----ANKYLREDLGKLLFKQLLTAVKYLHS-QGIIHRDIKPENILLSNDAEDCLLK 319 (475)
T ss_pred -ecCCceEEEEEEecCccHHHHHH----hccccccchhHHHHHHHHHHHHHHHH-cCcccccCCcceEEeccCCcceEEE
Confidence 444457899999996 4433322 24778888889999999999999999 899999999999999765 22699
Q ss_pred EEeecCccccccCCCcccccccccccccccccCC--CCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHH-HHHHHHHHhC
Q 016184 226 LCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGA--TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVD-QLVEIIKVLG 302 (394)
Q Consensus 226 l~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~-~~~~i~~~~~ 302 (394)
|+|||+|+...+.....+.+|||.|.|||++... ..+..+.|+|||||+||-+++|.+||.+..... ...+|.+.-
T Consensus 320 ItDFGlAK~~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~- 398 (475)
T KOG0615|consen 320 ITDFGLAKVSGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGR- 398 (475)
T ss_pred ecccchhhccccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCc-
Confidence 9999999998877777889999999999999543 235568999999999999999999999876655 445544421
Q ss_pred CCChhhhhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q 016184 303 TPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD 373 (394)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~ 373 (394)
+ .+....+..+++++++||.+||..||++|||++|+|+||||+....
T Consensus 399 ----------------y--------~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~~~ 445 (475)
T KOG0615|consen 399 ----------------Y--------AFGPLQWDRISEEALDLINWMLVVDPENRPSADEALNHPWFKDAPC 445 (475)
T ss_pred ----------------c--------cccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhcccc
Confidence 0 0111123578999999999999999999999999999999997653
|
|
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-55 Score=425.23 Aligned_cols=309 Identities=56% Similarity=1.033 Sum_probs=271.8
Q ss_pred eeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccchhhhHHHHHHHHHcCCCCeeeeceEEEecC---CCceeEEEEE
Q 016184 82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTT---DKEELYLNLV 158 (394)
Q Consensus 82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~---~~~~~~~~lv 158 (394)
.+|++.++||+|+||.||+|.+..+++.||||++........+|+.+++.++|+||++++++++... .....++++|
T Consensus 66 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l~lv 145 (440)
T PTZ00036 66 KSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVV 145 (440)
T ss_pred CeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCcchHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEEEEE
Confidence 4699999999999999999999999999999998777666778999999999999999988875432 2334568899
Q ss_pred EecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCccccccC
Q 016184 159 LEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG 238 (394)
Q Consensus 159 ~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~~ 238 (394)
|||+++++..++..+......+++..++.++.||+.||+|||+ .||+||||||+|||++.++..+||+|||+|+.....
T Consensus 146 mE~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~-~~IiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~ 224 (440)
T PTZ00036 146 MEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHS-KFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAG 224 (440)
T ss_pred EecCCccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCEecCCcCHHHEEEcCCCCceeeeccccchhccCC
Confidence 9999999888877766667889999999999999999999999 899999999999999977657999999999877655
Q ss_pred CCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCCCcc
Q 016184 239 EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 318 (394)
Q Consensus 239 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 318 (394)
.......+|+.|+|||++.+...++.++|||||||++|+|++|.+||.+....+.+..+.+.++.+..+.+..+++.+..
T Consensus 225 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~ 304 (440)
T PTZ00036 225 QRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMNPNYAD 304 (440)
T ss_pred CCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhchhhhc
Confidence 55556788999999999877666899999999999999999999999999989999999999999999888888888888
Q ss_pred cCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCCCCCC-CCCCCCCCCCC
Q 016184 319 FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPN-GRPLPPLFNFK 391 (394)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~~~~~-~~~~~~~~~~~ 391 (394)
..++......+...++...++++.+||.+||++||.+|||+.|+|+||||++++++...++. ....|++|+|+
T Consensus 305 ~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~~~~~~~~~~~~~~~~~~~~~~ 378 (440)
T PTZ00036 305 IKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLRDPCIKLPKYIDKLPDLFNFC 378 (440)
T ss_pred ccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhhhcccccCCCCCCCCCCCcCCC
Confidence 88888777778888888899999999999999999999999999999999999988776655 35677788774
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-56 Score=390.90 Aligned_cols=260 Identities=30% Similarity=0.546 Sum_probs=217.3
Q ss_pred eEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccc-----hhhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEEEE
Q 016184 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL 157 (394)
Q Consensus 83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 157 (394)
..+.++.||+|..|+||+++|+.|++.+|+|++... .+.+.+|+++++..+|||||.++++|+.... .+.|
T Consensus 80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~----~isI 155 (364)
T KOG0581|consen 80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGE----EISI 155 (364)
T ss_pred HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCc----eEEe
Confidence 467788999999999999999999999999998432 3445689999999999999999999965542 3789
Q ss_pred EEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCccccc
Q 016184 158 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV 236 (394)
Q Consensus 158 v~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~ 236 (394)
+||||++ +|..++.. .+++++..+..++.+|++||.|||+.++||||||||+||||+..| .|||||||.+..+.
T Consensus 156 ~mEYMDgGSLd~~~k~----~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskG-eVKicDFGVS~~lv 230 (364)
T KOG0581|consen 156 CMEYMDGGSLDDILKR----VGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKG-EVKICDFGVSGILV 230 (364)
T ss_pred ehhhcCCCCHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCC-CEEeccccccHHhh
Confidence 9999995 77666654 378999999999999999999999548999999999999999998 79999999998876
Q ss_pred cCCCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCC-C-cHHHHHHHHHHhCCCChhhhhccCC
Q 016184 237 KGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGE-S-GVDQLVEIIKVLGTPTREEIKCMNP 314 (394)
Q Consensus 237 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~-~-~~~~~~~i~~~~~~~~~~~~~~~~~ 314 (394)
.. ...+..||..|||||.+.+.. |+.++||||||+.++|+++|+.||... . ....+..+..+...+++.
T Consensus 231 nS-~a~tfvGT~~YMsPERi~g~~-Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~------- 301 (364)
T KOG0581|consen 231 NS-IANTFVGTSAYMSPERISGES-YSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPR------- 301 (364)
T ss_pred hh-hcccccccccccChhhhcCCc-CCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCC-------
Confidence 65 556889999999999997765 999999999999999999999999874 1 222333333333222221
Q ss_pred CCcccCCCCCCCCCcchhccc-cCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCCCC
Q 016184 315 NYTEFKFPQIKPHPWHKVFQK-RLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRL 378 (394)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~~~ 378 (394)
++. .+|+++++||..||++||.+|||+.||++|||+++...+...+
T Consensus 302 ------------------lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~~~~~vd~ 348 (364)
T KOG0581|consen 302 ------------------LPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQHPFIKKFEDPNVDM 348 (364)
T ss_pred ------------------CCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcCHHHhhcccccccH
Confidence 123 3799999999999999999999999999999999988877653
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-55 Score=378.80 Aligned_cols=287 Identities=34% Similarity=0.553 Sum_probs=246.6
Q ss_pred ccceeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccchhh------hHHHHHHHHHcCCCCeeeeceEEEecCCCce
Q 016184 79 KQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRY------KNRELQIMQMLDHPNIVALKHCFFSTTDKEE 152 (394)
Q Consensus 79 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~------~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 152 (394)
+....|+.+..|++|+||.||+|+++.|++.||+|+++.+... ..+|+.+|.+++|||||.+.+++.... -
T Consensus 73 rsv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~---~ 149 (419)
T KOG0663|consen 73 RSVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSN---M 149 (419)
T ss_pred ccHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccc---c
Confidence 3445699999999999999999999999999999998754421 248999999999999999999875332 2
Q ss_pred eEEEEEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCc
Q 016184 153 LYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA 232 (394)
Q Consensus 153 ~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a 232 (394)
.-+|||||||+.+|..++.... +++...+++.++.|++.||+|||. +.|+||||||+|+|++..| .+||+|||+|
T Consensus 150 d~iy~VMe~~EhDLksl~d~m~---q~F~~~evK~L~~QlL~glk~lH~-~wilHRDLK~SNLLm~~~G-~lKiaDFGLA 224 (419)
T KOG0663|consen 150 DKIYIVMEYVEHDLKSLMETMK---QPFLPGEVKTLMLQLLRGLKHLHD-NWILHRDLKTSNLLLSHKG-ILKIADFGLA 224 (419)
T ss_pred ceeeeeHHHHHhhHHHHHHhcc---CCCchHHHHHHHHHHHHHHHHHhh-ceeEecccchhheeeccCC-cEEecccchh
Confidence 2378999999999988888754 789999999999999999999999 8999999999999999888 7999999999
Q ss_pred cccccCCC-cccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhc
Q 016184 233 KVLVKGEP-NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 311 (394)
Q Consensus 233 ~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 311 (394)
+.+..... ....+.|..|+|||.+.+...|+++.|+||+|||+.||+++++.|++....+++..|++.+|.|....|..
T Consensus 225 R~ygsp~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg 304 (419)
T KOG0663|consen 225 REYGSPLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPG 304 (419)
T ss_pred hhhcCCcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCC
Confidence 98765533 34567799999999999999999999999999999999999999999999999999999999999988875
Q ss_pred cC--CCCcccCCCCCCCCCcchhcccc-CChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q 016184 312 MN--PNYTEFKFPQIKPHPWHKVFQKR-LPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD 373 (394)
Q Consensus 312 ~~--~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~ 373 (394)
+. +.+..+.++......++..|.-. +++...+|+..+|.+||.+|.||+|.|+|+||.+...
T Consensus 305 ~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~P~ 369 (419)
T KOG0663|consen 305 YSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRETPL 369 (419)
T ss_pred ccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccCCC
Confidence 54 23334455555555555555444 7899999999999999999999999999999999543
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-55 Score=368.36 Aligned_cols=280 Identities=38% Similarity=0.707 Sum_probs=239.7
Q ss_pred eEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccch------hhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEEE
Q 016184 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN 156 (394)
Q Consensus 83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 156 (394)
+|..+++||+|.||.||+|++..+|+.||||++.... ...-+|++.|+.++|+||+.++++|. ....+.
T Consensus 3 rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~-----~~~~l~ 77 (318)
T KOG0659|consen 3 RYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFP-----HKSNLS 77 (318)
T ss_pred hhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhcc-----CCCceE
Confidence 5889999999999999999999999999999986442 22358999999999999999999993 333377
Q ss_pred EEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCccccc
Q 016184 157 LVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV 236 (394)
Q Consensus 157 lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~ 236 (394)
+|+||++.+|...++.. ...++...++.++.+++.||+|||+ +.|+||||||.|+||+.+| .+||+|||+|+...
T Consensus 78 lVfEfm~tdLe~vIkd~---~i~l~pa~iK~y~~m~LkGl~y~H~-~~IlHRDlKPnNLLis~~g-~lKiADFGLAr~f~ 152 (318)
T KOG0659|consen 78 LVFEFMPTDLEVVIKDK---NIILSPADIKSYMLMTLKGLAYCHS-KWILHRDLKPNNLLISSDG-QLKIADFGLARFFG 152 (318)
T ss_pred EEEEeccccHHHHhccc---ccccCHHHHHHHHHHHHHHHHHHHh-hhhhcccCCccceEEcCCC-cEEeecccchhccC
Confidence 99999999988777753 3678999999999999999999999 8999999999999999998 79999999999876
Q ss_pred cCCCccc-ccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccC--
Q 016184 237 KGEPNVS-YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN-- 313 (394)
Q Consensus 237 ~~~~~~~-~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~-- 313 (394)
....... .+.|..|+|||.+.|...|+...||||.|||+.||+-|.+.|+|.++.+++..|++.+|.|.++.|..+.
T Consensus 153 ~p~~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~l 232 (318)
T KOG0659|consen 153 SPNRIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSL 232 (318)
T ss_pred CCCcccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCcccccc
Confidence 5444332 3679999999999999999999999999999999999999999999999999999999999999998765
Q ss_pred CCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCC
Q 016184 314 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 375 (394)
Q Consensus 314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~ 375 (394)
+++..+. .....+....| ...+.++.+|+.+||..||.+|+|+.|+|+|+||+...-++
T Consensus 233 pdY~~~~--~~P~~~~~~lf-~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~P~pt 291 (318)
T KOG0659|consen 233 PDYVKIQ--QFPKPPLNNLF-PAASSDALDLLSKMLTYNPKKRITASQALKHPYFKSLPLPT 291 (318)
T ss_pred ccHHHHh--cCCCCcccccc-ccccHHHHHHHHhhhccCchhcccHHHHhcchhhhcCCCCC
Confidence 3333332 23333333344 45688889999999999999999999999999999854443
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-54 Score=393.78 Aligned_cols=282 Identities=34% Similarity=0.581 Sum_probs=236.8
Q ss_pred ccceeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccch------hhhHHHHHHHHHcCCCCeeeeceEEEecCCCce
Q 016184 79 KQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE 152 (394)
Q Consensus 79 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 152 (394)
+....|+.+++||+|.||.||+|++..+|+.||+|+++-+. ....+|+.||++|+||||+++.+.+... ..
T Consensus 114 r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~---~~ 190 (560)
T KOG0600|consen 114 RRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSK---LS 190 (560)
T ss_pred cchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEec---CC
Confidence 34456999999999999999999999999999999986543 2335899999999999999999988554 23
Q ss_pred eEEEEEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCc
Q 016184 153 LYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA 232 (394)
Q Consensus 153 ~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a 232 (394)
..+|||+|||+.+|..++.. ..-.|++.+++.++.||+.||+|+|. +||+|||||..|||||.+| .+||+|||+|
T Consensus 191 ~siYlVFeYMdhDL~GLl~~---p~vkft~~qIKc~mkQLl~Gl~~cH~-~gvlHRDIK~SNiLidn~G-~LKiaDFGLA 265 (560)
T KOG0600|consen 191 GSIYLVFEYMDHDLSGLLSS---PGVKFTEPQIKCYMKQLLEGLEYCHS-RGVLHRDIKGSNILIDNNG-VLKIADFGLA 265 (560)
T ss_pred ceEEEEEecccchhhhhhcC---CCcccChHHHHHHHHHHHHHHHHHhh-cCeeeccccccceEEcCCC-CEEeccccce
Confidence 45889999999988887765 23589999999999999999999999 8999999999999999988 7999999999
Q ss_pred cccccCC--CcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhh
Q 016184 233 KVLVKGE--PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 310 (394)
Q Consensus 233 ~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 310 (394)
+.+.... .....+.|..|+|||.+.|...|+.+.|+||.||||.||++|+++|++.++.+++..|++..|.|.+..|.
T Consensus 266 r~y~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~ 345 (560)
T KOG0600|consen 266 RFYTPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWP 345 (560)
T ss_pred eeccCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccc
Confidence 9765443 34567789999999999999999999999999999999999999999999999999999999999998886
Q ss_pred ccCCCCcccCCCCCC-CCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCC
Q 016184 311 CMNPNYTEFKFPQIK-PHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFD 369 (394)
Q Consensus 311 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~ 369 (394)
...--+....-+... .....+. -..+++.+.+|+..||..||.+|.||.++|+|+||.
T Consensus 346 ~~kLP~~~~~kp~~~y~r~l~E~-~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~ 404 (560)
T KOG0600|consen 346 VSKLPHATIFKPQQPYKRRLRET-FKDFPASALDLLEKLLSLDPDKRGTASSALQSEYFT 404 (560)
T ss_pred cccCCcccccCCCCcccchHHHH-hccCCHHHHHHHHHHhccCccccccHHHHhcCcccc
Confidence 222111111111111 1112222 356899999999999999999999999999999993
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-54 Score=381.33 Aligned_cols=256 Identities=34% Similarity=0.515 Sum_probs=219.4
Q ss_pred ceeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccch-------hhhHHHHHHHHHcCCCCeeeeceEEEecCCCcee
Q 016184 81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL 153 (394)
Q Consensus 81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 153 (394)
...|+++++||+|+||+||+++.+.+++.+|+|++++.. .....|..+|..++||.||+++-.| +...
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysF-----Qt~~ 98 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSF-----QTEE 98 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEec-----ccCC
Confidence 446999999999999999999999999999999986543 3345799999999999999998888 5566
Q ss_pred EEEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCc
Q 016184 154 YLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA 232 (394)
Q Consensus 154 ~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a 232 (394)
.+|+|+||+.| .|...+. ..+.+++..++.++..|+.||.|||+ +|||||||||+|||+|.+|| ++|+|||+|
T Consensus 99 kLylVld~~~GGeLf~hL~----~eg~F~E~~arfYlaEi~lAL~~LH~-~gIiyRDlKPENILLd~~GH-i~LtDFgL~ 172 (357)
T KOG0598|consen 99 KLYLVLDYLNGGELFYHLQ----REGRFSEDRARFYLAEIVLALGYLHS-KGIIYRDLKPENILLDEQGH-IKLTDFGLC 172 (357)
T ss_pred eEEEEEeccCCccHHHHHH----hcCCcchhHHHHHHHHHHHHHHHHHh-CCeeeccCCHHHeeecCCCc-EEEeccccc
Confidence 69999999997 4433333 35889999999999999999999999 99999999999999999995 999999999
Q ss_pred ccccc-CCCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhc
Q 016184 233 KVLVK-GEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 311 (394)
Q Consensus 233 ~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 311 (394)
+.... +....+.+||+.|||||++.+.. |+.++|+||||+++|+|++|.+||.+.+....+..|...-.
T Consensus 173 k~~~~~~~~t~tfcGT~eYmAPEil~~~g-y~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~--------- 242 (357)
T KOG0598|consen 173 KEDLKDGDATRTFCGTPEYMAPEILLGKG-YDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKL--------- 242 (357)
T ss_pred hhcccCCCccccccCCccccChHHHhcCC-CCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcC---------
Confidence 85544 34555679999999999998764 99999999999999999999999999988877777766310
Q ss_pred cCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCC----CHHHHhcCCCCCCCCCCCC
Q 016184 312 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC----TALEACVHPFFDELRDPNT 376 (394)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp----t~~ell~hp~f~~~~~~~~ 376 (394)
...+..++.++++||+++|++||++|. .+.++-+||||+.+....+
T Consensus 243 -------------------~~~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~HpfF~~inW~~l 292 (357)
T KOG0598|consen 243 -------------------PLPPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRHPFFKGINWEKL 292 (357)
T ss_pred -------------------CCCCccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhcCcccccCCHHHH
Confidence 011234899999999999999999996 7889999999999976655
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-54 Score=379.90 Aligned_cols=289 Identities=39% Similarity=0.702 Sum_probs=252.3
Q ss_pred eEEEeeEEeecCceEEEEEEECCCCcEEEEEEecc------chhhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEEE
Q 016184 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQ------DKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN 156 (394)
Q Consensus 83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~------~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 156 (394)
.|..++.||.|+||.|..|.++.+|+.||||++.. .....-+|+++|+.++|+||+.+.+++.........-+|
T Consensus 23 ~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvY 102 (359)
T KOG0660|consen 23 YYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVY 102 (359)
T ss_pred eecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeE
Confidence 36668999999999999999999999999998863 223445899999999999999999998664444455688
Q ss_pred EEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCccccc
Q 016184 157 LVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV 236 (394)
Q Consensus 157 lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~ 236 (394)
+|+|+|+.+|.++++. ++.++...+..+++|++.||+|+|+ .+|+||||||.|+|++.+. .+||+|||+|+...
T Consensus 103 iV~elMetDL~~iik~----~~~L~d~H~q~f~YQiLrgLKyiHS-AnViHRDLKPsNll~n~~c-~lKI~DFGLAR~~~ 176 (359)
T KOG0660|consen 103 LVFELMETDLHQIIKS----QQDLTDDHAQYFLYQILRGLKYIHS-ANVIHRDLKPSNLLLNADC-DLKICDFGLARYLD 176 (359)
T ss_pred EehhHHhhHHHHHHHc----CccccHHHHHHHHHHHHHhcchhhc-ccccccccchhheeeccCC-CEEeccccceeecc
Confidence 9999999888888876 3449999999999999999999999 9999999999999999987 79999999999875
Q ss_pred c---CCCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccC
Q 016184 237 K---GEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 313 (394)
Q Consensus 237 ~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 313 (394)
. ......++.|..|.|||++.....|+.+.||||+|||+.||++|++.|+|.+..+++..|...+|.|..+.+....
T Consensus 177 ~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~ 256 (359)
T KOG0660|consen 177 KFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIR 256 (359)
T ss_pred ccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhc
Confidence 4 3344567789999999999888889999999999999999999999999999999999999999999998887654
Q ss_pred CCC---cccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCCCC
Q 016184 314 PNY---TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRL 378 (394)
Q Consensus 314 ~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~~~ 378 (394)
+.. .-.+.+.....+|...|+ +.++.+.+|+.+||.+||.+|+|++|+|.||||..+.++.-.+
T Consensus 257 s~~ar~yi~slp~~p~~~f~~~fp-~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hdp~dEP 323 (359)
T KOG0660|consen 257 SEKARPYIKSLPQIPKQPFSSIFP-NANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHDPEDEP 323 (359)
T ss_pred cHHHHHHHHhCCCCCCCCHHHHcC-CCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcCCccCC
Confidence 221 123567777888888886 8999999999999999999999999999999999999888764
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-53 Score=389.72 Aligned_cols=257 Identities=31% Similarity=0.574 Sum_probs=224.1
Q ss_pred ccceeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccc-------hhhhHHHHHHHHHc-CCCCeeeeceEEEecCCC
Q 016184 79 KQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQML-DHPNIVALKHCFFSTTDK 150 (394)
Q Consensus 79 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~ 150 (394)
+...+|..++.||+|+|++|++|+.+.+++.||||++.+. ..+..+|-.+|.+| .||.|++++..| +
T Consensus 70 k~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TF-----Q 144 (604)
T KOG0592|consen 70 KTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTF-----Q 144 (604)
T ss_pred CChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEe-----e
Confidence 3445799999999999999999999999999999988543 34556799999999 899999999888 5
Q ss_pred ceeEEEEEEeccc-ccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEee
Q 016184 151 EELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDF 229 (394)
Q Consensus 151 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Df 229 (394)
+...+|+|+||++ |.|.+++..+ +.+++..++.++.+|+.||+|||+ +|||||||||+|||+|.|+ .++|+||
T Consensus 145 D~~sLYFvLe~A~nGdll~~i~K~----Gsfde~caR~YAAeIldAleylH~-~GIIHRDlKPENILLd~dm-hikITDF 218 (604)
T KOG0592|consen 145 DEESLYFVLEYAPNGDLLDLIKKY----GSFDETCARFYAAEILDALEYLHS-NGIIHRDLKPENILLDKDG-HIKITDF 218 (604)
T ss_pred cccceEEEEEecCCCcHHHHHHHh----CcchHHHHHHHHHHHHHHHHHHHh-cCceeccCChhheeEcCCC-cEEEeec
Confidence 5555889999999 4677766654 789999999999999999999999 8999999999999999999 5999999
Q ss_pred cCccccccCCC--------------cccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHH
Q 016184 230 GSAKVLVKGEP--------------NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLV 295 (394)
Q Consensus 230 g~a~~~~~~~~--------------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~ 295 (394)
|.|+.+..... ..+++||..|.+||++.. ...+..+|+|+||||||.|+.|.+||.+.++...++
T Consensus 219 GsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~-~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFq 297 (604)
T KOG0592|consen 219 GSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLND-SPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQ 297 (604)
T ss_pred cccccCChhhccccCccCcccccCcccceeeeecccCHHHhcC-CCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHH
Confidence 99987743211 145789999999999954 458999999999999999999999999999999999
Q ss_pred HHHHHhCCCChhhhhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCC
Q 016184 296 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 375 (394)
Q Consensus 296 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~ 375 (394)
+|+.+ ++. |++++++.+++||+++|..||.+|+|+.+|.+||||.++...+
T Consensus 298 kI~~l-----------------~y~------------fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~Vdw~n 348 (604)
T KOG0592|consen 298 KIQAL-----------------DYE------------FPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGVDWEN 348 (604)
T ss_pred HHHHh-----------------ccc------------CCCCCCHHHHHHHHHHHccCccccccHHHHhhCcccccCChhh
Confidence 99884 233 3367899999999999999999999999999999999998877
Q ss_pred C
Q 016184 376 T 376 (394)
Q Consensus 376 ~ 376 (394)
+
T Consensus 349 l 349 (604)
T KOG0592|consen 349 L 349 (604)
T ss_pred h
Confidence 4
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-52 Score=357.76 Aligned_cols=253 Identities=29% Similarity=0.481 Sum_probs=219.8
Q ss_pred ceeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccch-------hhhHHHHHHHHHcCCCCeeeeceEEEecCCCcee
Q 016184 81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL 153 (394)
Q Consensus 81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 153 (394)
..+|++++.||.|+||.|.+++++.+|..+|+|++.+.. ....+|..+|+.+.||+++++++.+ .+..
T Consensus 43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~-----~d~~ 117 (355)
T KOG0616|consen 43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTF-----KDNS 117 (355)
T ss_pred hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEee-----ccCC
Confidence 346999999999999999999999999999999986543 2234699999999999999999888 6666
Q ss_pred EEEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCc
Q 016184 154 YLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA 232 (394)
Q Consensus 154 ~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a 232 (394)
+++|||||++| .+..+++ ..+++++..++.++.||+.||+|||+ ++|++|||||||||+|.+|+ +||+|||+|
T Consensus 118 ~lymvmeyv~GGElFS~Lr----k~~rF~e~~arFYAAeivlAleylH~-~~iiYRDLKPENiLlD~~G~-iKitDFGFA 191 (355)
T KOG0616|consen 118 NLYMVMEYVPGGELFSYLR----KSGRFSEPHARFYAAEIVLALEYLHS-LDIIYRDLKPENLLLDQNGH-IKITDFGFA 191 (355)
T ss_pred eEEEEEeccCCccHHHHHH----hcCCCCchhHHHHHHHHHHHHHHHHh-cCeeeccCChHHeeeccCCc-EEEEeccce
Confidence 79999999997 3434333 35789999999999999999999999 89999999999999999995 999999999
Q ss_pred cccccCCCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhcc
Q 016184 233 KVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 312 (394)
Q Consensus 233 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 312 (394)
+.... ...+.+|||.|+|||++... .++.++|.|||||++|||+.|.+||.+.+....+.+|...
T Consensus 192 K~v~~--rT~TlCGTPeYLAPEii~sk-~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~------------ 256 (355)
T KOG0616|consen 192 KRVSG--RTWTLCGTPEYLAPEIIQSK-GYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEG------------ 256 (355)
T ss_pred EEecC--cEEEecCCccccChHHhhcC-CCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhC------------
Confidence 87643 36788999999999999654 5999999999999999999999999999998888888773
Q ss_pred CCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCC-----CHHHHhcCCCCCCCCCCCC
Q 016184 313 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-----TALEACVHPFFDELRDPNT 376 (394)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----t~~ell~hp~f~~~~~~~~ 376 (394)
.+. ++..++.++++||+++|++|-.+|. ...++.+||||+++....+
T Consensus 257 -----~v~------------fP~~fs~~~kdLl~~LL~vD~t~R~gnlknG~~dIk~H~wF~~v~W~~i 308 (355)
T KOG0616|consen 257 -----KVK------------FPSYFSSDAKDLLKKLLQVDLTKRFGNLKNGVEDIKNHPWFKGVDWEAI 308 (355)
T ss_pred -----ccc------------CCcccCHHHHHHHHHHHhhhhHhhhcCcCCCccccccCcccccccHHHH
Confidence 222 3357899999999999999999994 5679999999999876655
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-52 Score=381.74 Aligned_cols=272 Identities=32% Similarity=0.513 Sum_probs=226.7
Q ss_pred cceeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccchh-------hhHHHHHHHHHcCCCCeeeeceEEEecCCCce
Q 016184 80 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-------YKNRELQIMQMLDHPNIVALKHCFFSTTDKEE 152 (394)
Q Consensus 80 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 152 (394)
..+.|.++++||+|+||.||+|+-+.||..+|+|++++..- ....|..+|....+++||+++-.| ++.
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsF-----QD~ 213 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSF-----QDK 213 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEe-----cCC
Confidence 45679999999999999999999999999999999876542 234588899999999999999988 777
Q ss_pred eEEEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecC
Q 016184 153 LYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS 231 (394)
Q Consensus 153 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~ 231 (394)
.++||||||++| ++..++.. ...+++..++.++.+++.|++.||+ .|+|||||||+|+|||..|| +||+|||+
T Consensus 214 ~~LYLiMEylPGGD~mTLL~~----~~~L~e~~arfYiaE~vlAI~~iH~-~gyIHRDIKPdNlLiD~~GH-iKLSDFGL 287 (550)
T KOG0605|consen 214 EYLYLIMEYLPGGDMMTLLMR----KDTLTEDWARFYIAETVLAIESIHQ-LGYIHRDIKPDNLLIDAKGH-IKLSDFGL 287 (550)
T ss_pred CeeEEEEEecCCccHHHHHHh----cCcCchHHHHHHHHHHHHHHHHHHH-cCcccccCChhheeecCCCC-Eeeccccc
Confidence 789999999996 55555554 4789999999999999999999999 99999999999999999995 99999999
Q ss_pred cccccc------------------------CC------------------------CcccccccccccccccccCCCCCC
Q 016184 232 AKVLVK------------------------GE------------------------PNVSYICSRYYRAPELIFGATEYT 263 (394)
Q Consensus 232 a~~~~~------------------------~~------------------------~~~~~~~t~~y~aPE~~~~~~~~~ 263 (394)
+..... .. ...+.+|||.|+|||++.+.. |+
T Consensus 288 s~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kg-Y~ 366 (550)
T KOG0605|consen 288 STGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKG-YG 366 (550)
T ss_pred cchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCC-CC
Confidence 853311 00 002356899999999998766 99
Q ss_pred ChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCCCcccCCCCCCCCCcchhccccCChHHHH
Q 016184 264 TAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVD 343 (394)
Q Consensus 264 ~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 343 (394)
..+|+||||||+||||.|.+||.+.++.+...+|+..-. -+.+|. ...++++++|
T Consensus 367 ~~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~---------------~l~fP~----------~~~~s~eA~D 421 (550)
T KOG0605|consen 367 KECDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRE---------------TLKFPE----------EVDLSDEAKD 421 (550)
T ss_pred ccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhh---------------hccCCC----------cCcccHHHHH
Confidence 999999999999999999999999999988888876321 111111 1357899999
Q ss_pred HHHHhcccCCCCCCC---HHHHhcCCCCCCCCCCCCCCCCCCCCCCCCC
Q 016184 344 LVCRFFQYSPNLRCT---ALEACVHPFFDELRDPNTRLPNGRPLPPLFN 389 (394)
Q Consensus 344 li~~~L~~dP~~Rpt---~~ell~hp~f~~~~~~~~~~~~~~~~~~~~~ 389 (394)
||++||. ||++|.. ++||.+||||+++...+++-..++..|.+.+
T Consensus 422 LI~rll~-d~~~RLG~~G~~EIK~HPfF~~v~W~~l~~~~apfvP~v~~ 469 (550)
T KOG0605|consen 422 LITRLLC-DPENRLGSKGAEEIKKHPFFKGVDWDHLREMPAPFVPQVNS 469 (550)
T ss_pred HHHHHhc-CHHHhcCcccHHHHhcCCccccCCcchhhcCCCCCCCCCCC
Confidence 9999999 9999995 8999999999999999997555555555443
|
|
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-52 Score=390.50 Aligned_cols=279 Identities=36% Similarity=0.596 Sum_probs=231.1
Q ss_pred eEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccchhhhH---HHHHHHHHcC-C-----CCeeeeceEEEecCCCcee
Q 016184 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLD-H-----PNIVALKHCFFSTTDKEEL 153 (394)
Q Consensus 83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~---~E~~~l~~l~-h-----~~iv~~~~~~~~~~~~~~~ 153 (394)
+|.|+++||+|+||.|.+|.+..|++.||||+++....... .|+.+|..|+ | -|+|+++++| ....
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F-----~fr~ 261 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYF-----YFRN 261 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecc-----cccc
Confidence 79999999999999999999999999999999988776654 4888888886 3 4899999999 5556
Q ss_pred EEEEEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCC-CCcEEEEeecCc
Q 016184 154 YLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPH-THQLKLCDFGSA 232 (394)
Q Consensus 154 ~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~-~~~vkl~Dfg~a 232 (394)
++|||+|.+..+|+++++.... .+++...++.++.||+.||.+||+ .||||+||||||||+... ...|||+|||+|
T Consensus 262 HlciVfELL~~NLYellK~n~f--~Glsl~~ir~~~~Qil~~L~~L~~-l~IIHcDLKPENILL~~~~r~~vKVIDFGSS 338 (586)
T KOG0667|consen 262 HLCIVFELLSTNLYELLKNNKF--RGLSLPLVRKFAQQILTALLFLHE-LGIIHCDLKPENILLKDPKRSRIKVIDFGSS 338 (586)
T ss_pred ceeeeehhhhhhHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHh-CCeeeccCChhheeeccCCcCceeEEecccc
Confidence 6999999999999999997554 679999999999999999999999 999999999999999643 337999999999
Q ss_pred cccccCCCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhcc
Q 016184 233 KVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 312 (394)
Q Consensus 233 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 312 (394)
+... .....++.+..|+|||++.|.+ |+.+.||||||||++||++|.+.|+|.+..+++..|++.+|.|+..++...
T Consensus 339 c~~~--q~vytYiQSRfYRAPEVILGlp-Y~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~ 415 (586)
T KOG0667|consen 339 CFES--QRVYTYIQSRFYRAPEVILGLP-YDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTA 415 (586)
T ss_pred cccC--CcceeeeeccccccchhhccCC-CCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhc
Confidence 7643 3334788899999999998766 999999999999999999999999999999999999999999998887543
Q ss_pred CCCCcccCC------------------------------CCC----CCCCcchhccccCChHHHHHHHHhcccCCCCCCC
Q 016184 313 NPNYTEFKF------------------------------PQI----KPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCT 358 (394)
Q Consensus 313 ~~~~~~~~~------------------------------~~~----~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt 358 (394)
......+.- ... ....+...........+.+||++||.+||.+|+|
T Consensus 416 ~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~t 495 (586)
T KOG0667|consen 416 KKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERIT 495 (586)
T ss_pred cccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCC
Confidence 221111100 000 1111222222233456899999999999999999
Q ss_pred HHHHhcCCCCCCCC
Q 016184 359 ALEACVHPFFDELR 372 (394)
Q Consensus 359 ~~ell~hp~f~~~~ 372 (394)
+.++|+||||+...
T Consensus 496 p~qal~Hpfl~~~~ 509 (586)
T KOG0667|consen 496 PAQALNHPFLTGTS 509 (586)
T ss_pred HHHHhcCccccccc
Confidence 99999999999643
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-52 Score=389.54 Aligned_cols=255 Identities=31% Similarity=0.504 Sum_probs=226.3
Q ss_pred eEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccc-------hhhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEE
Q 016184 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL 155 (394)
Q Consensus 83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 155 (394)
-|.+++.||.|+-|.|-+|++..||+.+|||++.+. ...+++|+.+|+.+.||||+.+++++ .+..++
T Consensus 13 pwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVw-----e~~~~l 87 (786)
T KOG0588|consen 13 PWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVW-----ENKQHL 87 (786)
T ss_pred ceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeee-----ccCceE
Confidence 499999999999999999999999999999999766 56678999999999999999999999 555568
Q ss_pred EEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCccc
Q 016184 156 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV 234 (394)
Q Consensus 156 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~ 234 (394)
|+|.||+++ .|.++ ....+++++.++.++++||+.|+.|+|. .+|+||||||+|+|+|.+++ +||+|||+|..
T Consensus 88 ylvlEyv~gGELFdy----lv~kG~l~e~eaa~ff~QIi~gv~yCH~-~~icHRDLKpENlLLd~~~n-IKIADFGMAsL 161 (786)
T KOG0588|consen 88 YLVLEYVPGGELFDY----LVRKGPLPEREAAHFFRQILDGVSYCHA-FNICHRDLKPENLLLDVKNN-IKIADFGMASL 161 (786)
T ss_pred EEEEEecCCchhHHH----HHhhCCCCCHHHHHHHHHHHHHHHHHhh-hcceeccCCchhhhhhcccC-Eeeeccceeec
Confidence 999999996 33332 2335899999999999999999999999 89999999999999999885 99999999998
Q ss_pred cccCCCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCC
Q 016184 235 LVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 314 (394)
Q Consensus 235 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 314 (394)
...+.-..+.+|+|.|.|||++.+.++.+.++||||.|||||.|+||+.||.+.+-...+.++.+
T Consensus 162 e~~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~--------------- 226 (786)
T KOG0588|consen 162 EVPGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQR--------------- 226 (786)
T ss_pred ccCCccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHc---------------
Confidence 77777778899999999999999999889999999999999999999999997776666666655
Q ss_pred CCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCCC
Q 016184 315 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTR 377 (394)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~~ 377 (394)
..+.+| ..++.++++||++||.+||++|.|.+|+++|||+.+.......
T Consensus 227 --G~f~MP------------s~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g~~~~~~~ 275 (786)
T KOG0588|consen 227 --GVFEMP------------SNISSEAQDLLRRMLDVDPSTRITTEEILKHPFLSGYTSLPSS 275 (786)
T ss_pred --CcccCC------------CcCCHHHHHHHHHHhccCccccccHHHHhhCchhhcCCCCChh
Confidence 334444 4689999999999999999999999999999999998776654
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-51 Score=379.89 Aligned_cols=252 Identities=35% Similarity=0.510 Sum_probs=216.0
Q ss_pred cceeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccc---------hhhhHHHHHHHHHcC-CCCeeeeceEEEecCC
Q 016184 80 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD---------KRYKNRELQIMQMLD-HPNIVALKHCFFSTTD 149 (394)
Q Consensus 80 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---------~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~ 149 (394)
..+.|.+.+.||+|+||+|++|.+..+|..||+|++.+. .....+|+.+++.+. ||||+++++++....
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~- 93 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT- 93 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC-
Confidence 344699999999999999999999999999999977553 223457999999999 999999999984333
Q ss_pred CceeEEEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCC-CCcEEEE
Q 016184 150 KEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPH-THQLKLC 227 (394)
Q Consensus 150 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~-~~~vkl~ 227 (394)
.+++||||+.| .|.+.+.. .+++.+..++.+++|++.|++|+|+ +||+||||||+|||++.+ + ++||+
T Consensus 94 ----~~~ivmEy~~gGdL~~~i~~----~g~l~E~~ar~~F~Qlisav~y~H~-~gi~HRDLK~ENilld~~~~-~~Kl~ 163 (370)
T KOG0583|consen 94 ----KIYIVMEYCSGGDLFDYIVN----KGRLKEDEARKYFRQLISAVAYCHS-RGIVHRDLKPENILLDGNEG-NLKLS 163 (370)
T ss_pred ----eEEEEEEecCCccHHHHHHH----cCCCChHHHHHHHHHHHHHHHHHHh-CCEeeCCCCHHHEEecCCCC-CEEEe
Confidence 38899999997 55555443 5889999999999999999999999 899999999999999998 6 79999
Q ss_pred eecCcccc-ccCCCcccccccccccccccccCCC-CCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCC
Q 016184 228 DFGSAKVL-VKGEPNVSYICSRYYRAPELIFGAT-EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPT 305 (394)
Q Consensus 228 Dfg~a~~~-~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~ 305 (394)
|||++... .........+||+.|+|||++.+.. +.+.++||||+||+||.|++|+.||...+....+..+..
T Consensus 164 DFG~s~~~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~------ 237 (370)
T KOG0583|consen 164 DFGLSAISPGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRK------ 237 (370)
T ss_pred ccccccccCCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhc------
Confidence 99999887 4566677889999999999998766 557899999999999999999999998776666666544
Q ss_pred hhhhhccCCCCcccCCCCCCCCCcchhccccC-ChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 016184 306 REEIKCMNPNYTEFKFPQIKPHPWHKVFQKRL-PPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL 371 (394)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 371 (394)
..+.+| ..+ |+++++||++||..||.+|+|+.++++||||+..
T Consensus 238 -----------~~~~~p------------~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~~ 281 (370)
T KOG0583|consen 238 -----------GEFKIP------------SYLLSPEARSLIEKMLVPDPSTRITLLEILEHPWFQKE 281 (370)
T ss_pred -----------CCccCC------------CCcCCHHHHHHHHHHcCCCcccCCCHHHHhhChhhccC
Confidence 223333 345 9999999999999999999999999999999983
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-51 Score=366.60 Aligned_cols=255 Identities=31% Similarity=0.528 Sum_probs=217.7
Q ss_pred ceeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccch------hhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeE
Q 016184 81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY 154 (394)
Q Consensus 81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 154 (394)
..+|.+.+.||+|+||+||+|+++.++..||||.+.+.. .....|+.+|+.++|||||.+++++ ....+
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~-----~~~~~ 83 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCI-----EDDDF 83 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEE-----ecCCe
Confidence 446999999999999999999999999999999986552 3345799999999999999999998 44446
Q ss_pred EEEEEeccc-ccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCC-C----CcEEEEe
Q 016184 155 LNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPH-T----HQLKLCD 228 (394)
Q Consensus 155 ~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~-~----~~vkl~D 228 (394)
+|+|||||. |+|..++.. .+.+++..++.++.||+.||++||+ ++||||||||.|||++.. . ..+||+|
T Consensus 84 i~lVMEyC~gGDLs~yi~~----~~~l~e~t~r~Fm~QLA~alq~L~~-~~IiHRDLKPQNiLLs~~~~~~~~~~LKIAD 158 (429)
T KOG0595|consen 84 IYLVMEYCNGGDLSDYIRR----RGRLPEATARHFMQQLASALQFLHE-NNIIHRDLKPQNILLSTTARNDTSPVLKIAD 158 (429)
T ss_pred EEEEEEeCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeccCCcceEEeccCCCCCCCceEEecc
Confidence 999999999 577777665 4689999999999999999999999 899999999999999864 1 2599999
Q ss_pred ecCccccccCCCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhh
Q 016184 229 FGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 308 (394)
Q Consensus 229 fg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~ 308 (394)
||+|+.+.++.-..+.+|+|.|||||++... .|+.|+|+||+|+|+|++++|+.||...+..+.+..+.+.-...
T Consensus 159 FGfAR~L~~~~~a~tlcGSplYMAPEV~~~~-~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~---- 233 (429)
T KOG0595|consen 159 FGFARFLQPGSMAETLCGSPLYMAPEVIMSQ-QYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIV---- 233 (429)
T ss_pred cchhhhCCchhHHHHhhCCccccCHHHHHhc-cccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcccccc----
Confidence 9999999888878889999999999999644 59999999999999999999999999988888777554421111
Q ss_pred hhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 016184 309 IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR 372 (394)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 372 (394)
..++..++..+.+|+..+|+++|..|.+..+-+.|+++....
T Consensus 234 ----------------------~~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~~p 275 (429)
T KOG0595|consen 234 ----------------------PVLPAELSNPLRELLISLLQRNPKDRISFEDFFDHPFLAANP 275 (429)
T ss_pred ----------------------CchhhhccCchhhhhhHHHhcCccccCchHHhhhhhhcccCc
Confidence 112245677788999999999999999999999999987653
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-51 Score=358.43 Aligned_cols=291 Identities=35% Similarity=0.698 Sum_probs=243.0
Q ss_pred eEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccchh------hhHHHHHHHHHcCCCC-eeeeceEEEecCC-CceeE
Q 016184 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR------YKNRELQIMQMLDHPN-IVALKHCFFSTTD-KEELY 154 (394)
Q Consensus 83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~------~~~~E~~~l~~l~h~~-iv~~~~~~~~~~~-~~~~~ 154 (394)
.|..+++||+|+||+||+|+.+.+|+.||+|++..+.. ...+|+.+++.++|+| |+.+++++..... .....
T Consensus 12 ~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~ 91 (323)
T KOG0594|consen 12 DYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGK 91 (323)
T ss_pred HHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccce
Confidence 47788889999999999999999999999999865433 2358999999999999 9999999865442 33346
Q ss_pred EEEEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCccc
Q 016184 155 LNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV 234 (394)
Q Consensus 155 ~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~ 234 (394)
+++|+||+.-.+...+.........++...++.+++||+.||+|||+ +||+||||||.||||++.| .+||+|||+|+.
T Consensus 92 l~lvfe~~d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~-~~IlHRDLKPQNlLi~~~G-~lKlaDFGlAra 169 (323)
T KOG0594|consen 92 LYLVFEFLDRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHS-HGILHRDLKPQNLLISSSG-VLKLADFGLARA 169 (323)
T ss_pred EEEEEEeecccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHh-CCeecccCCcceEEECCCC-cEeeeccchHHH
Confidence 88999999998888887755443578889999999999999999999 8999999999999999988 799999999986
Q ss_pred cc-cCCCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccC
Q 016184 235 LV-KGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 313 (394)
Q Consensus 235 ~~-~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 313 (394)
.. .........+|..|+|||++.+...|+...||||+|||++||++++..|++..+.+++..|.+.+|.|..+.|....
T Consensus 170 ~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~v~ 249 (323)
T KOG0594|consen 170 FSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPGVS 249 (323)
T ss_pred hcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCCcc
Confidence 65 33335567789999999999999889999999999999999999999999999999999999999999998886443
Q ss_pred --CCCcccCCCCCC-CCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCCC
Q 016184 314 --PNYTEFKFPQIK-PHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTR 377 (394)
Q Consensus 314 --~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~~ 377 (394)
+++.. .++... ...+.... +..+++..+++.+||+.||.+|.||+.+|.||||+++......
T Consensus 250 ~~~~~k~-~f~~~~~~~~l~~~~-~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~~~~~~ 314 (323)
T KOG0594|consen 250 SLPDYKA-PFPKWPGPKDLSSIL-PKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELPEKSSQ 314 (323)
T ss_pred ccccccc-cCcCCCCccchHHhc-cccCccHHHHHHHHhccCcccCcCHHHHhcChhhcccccchhh
Confidence 22222 333333 22333322 3455799999999999999999999999999999998666553
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-51 Score=361.91 Aligned_cols=275 Identities=27% Similarity=0.459 Sum_probs=233.5
Q ss_pred ceeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccchh-------hhHHHHHHHHHcCCCCeeeeceEEEecCCCcee
Q 016184 81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-------YKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL 153 (394)
Q Consensus 81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 153 (394)
-..|++++.||.|.-|+||+|+.+.++..+|+|++.+..- ..+.|.+||+.+.||.++.++..| ....
T Consensus 76 l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~f-----et~~ 150 (459)
T KOG0610|consen 76 LRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASF-----ETDK 150 (459)
T ss_pred HHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhhee-----eccc
Confidence 3458999999999999999999999999999999976432 223589999999999999999999 6777
Q ss_pred EEEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCc
Q 016184 154 YLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA 232 (394)
Q Consensus 154 ~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a 232 (394)
|.|++||||+| +|..+.+. ..++.+++..++.++..|+.||+|||- .|||+||||||||||.++|| |.|+||.++
T Consensus 151 ~~cl~meyCpGGdL~~Lrqk--Qp~~~fse~~aRFYaAEvl~ALEYLHm-lGivYRDLKPENILvredGH-IMLsDFDLS 226 (459)
T KOG0610|consen 151 YSCLVMEYCPGGDLHSLRQK--QPGKRFSESAARFYAAEVLLALEYLHM-LGIVYRDLKPENILVREDGH-IMLSDFDLS 226 (459)
T ss_pred eeEEEEecCCCccHHHHHhh--CCCCccchhhHHHHHHHHHHHHHHHHh-hceeeccCCcceeEEecCCc-EEeeecccc
Confidence 89999999996 66665554 345889999999999999999999999 99999999999999999995 999999987
Q ss_pred ccccc---------------------------------C-C-----------------------Cccccccccccccccc
Q 016184 233 KVLVK---------------------------------G-E-----------------------PNVSYICSRYYRAPEL 255 (394)
Q Consensus 233 ~~~~~---------------------------------~-~-----------------------~~~~~~~t~~y~aPE~ 255 (394)
..... . . ...+.+||-.|.|||+
T Consensus 227 ~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEv 306 (459)
T KOG0610|consen 227 LRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEV 306 (459)
T ss_pred ccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCcccccccccccccccee
Confidence 43210 0 0 0123567999999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCCCcccCCCCCCCCCcchhccc
Q 016184 256 IFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQK 335 (394)
Q Consensus 256 ~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 335 (394)
+.+.. .+.++|+|+||+++|||+.|..||.+.+..+.+.+++. .+..+|.. .
T Consensus 307 I~G~G-HgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~-----------------~~l~Fp~~----------~ 358 (459)
T KOG0610|consen 307 IRGEG-HGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVG-----------------QPLKFPEE----------P 358 (459)
T ss_pred eecCC-CCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhc-----------------CCCcCCCC----------C
Confidence 98776 79999999999999999999999999999988888865 23333331 2
Q ss_pred cCChHHHHHHHHhcccCCCCCCC----HHHHhcCCCCCCCCCCCCCCCCCCCCCCCCCCCC
Q 016184 336 RLPPEAVDLVCRFFQYSPNLRCT----ALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKP 392 (394)
Q Consensus 336 ~~~~~~~~li~~~L~~dP~~Rpt----~~ell~hp~f~~~~~~~~~~~~~~~~~~~~~~~~ 392 (394)
.++..++|||+++|.+||.+|.. |.||.+||||+++++.-++...++-+|.++....
T Consensus 359 ~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~HpFF~gVnWaLir~~~PP~iP~~~d~~~ 419 (459)
T KOG0610|consen 359 EVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKRHPFFEGVNWALIRCARPPEIPKPVDGGL 419 (459)
T ss_pred cchhHHHHHHHHHhccChhhhhccccchHHhhcCccccCCChhheeccCCCcCCCccccCc
Confidence 57889999999999999999998 9999999999999999989888888888777643
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-50 Score=364.64 Aligned_cols=266 Identities=29% Similarity=0.456 Sum_probs=220.2
Q ss_pred CCCCCCccceeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccch------------------hhhHHHHHHHHHcCC
Q 016184 73 GRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------------------RYKNRELQIMQMLDH 134 (394)
Q Consensus 73 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------------------~~~~~E~~~l~~l~h 134 (394)
......++.++|++.+.||+|.||.|-+|++..+++.||||++.+.. ....+|+.+|+++.|
T Consensus 88 ~~~~~~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H 167 (576)
T KOG0585|consen 88 DDDQDRKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHH 167 (576)
T ss_pred cCcccceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCC
Confidence 34444566789999999999999999999999999999999985422 234579999999999
Q ss_pred CCeeeeceEEEecCCCceeEEEEEEecccccHHHHHHHhhhhcCC-CCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCC
Q 016184 135 PNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQR-MPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQ 213 (394)
Q Consensus 135 ~~iv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~-l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~ 213 (394)
+|||+++++. ++.+...+|||+|||..+-.. . ....+. +.+.+++.|+++++.||+|||. +|||||||||.
T Consensus 168 ~nVV~LiEvL---DDP~s~~~YlVley~s~G~v~--w--~p~d~~els~~~Ar~ylrDvv~GLEYLH~-QgiiHRDIKPs 239 (576)
T KOG0585|consen 168 PNVVKLIEVL---DDPESDKLYLVLEYCSKGEVK--W--CPPDKPELSEQQARKYLRDVVLGLEYLHY-QGIIHRDIKPS 239 (576)
T ss_pred cCeeEEEEee---cCcccCceEEEEEeccCCccc--c--CCCCcccccHHHHHHHHHHHHHHHHHHHh-cCeeccccchh
Confidence 9999999988 566677799999999843211 1 122244 8999999999999999999999 89999999999
Q ss_pred ceEEeCCCCcEEEEeecCccccccC------CCcccccccccccccccccC---CCCCCChhhHHHHHHHHHHHHhCCCC
Q 016184 214 NLLVNPHTHQLKLCDFGSAKVLVKG------EPNVSYICSRYYRAPELIFG---ATEYTTAIDIWSTGCVMAELLLGQPL 284 (394)
Q Consensus 214 Nil~~~~~~~vkl~Dfg~a~~~~~~------~~~~~~~~t~~y~aPE~~~~---~~~~~~~~DiwslG~il~~lltg~~p 284 (394)
|+||+.+| +|||+|||.+.....+ .......|||.|+|||.+.+ ....+.+.||||+||+||.|+.|+.|
T Consensus 240 NLLl~~~g-~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~P 318 (576)
T KOG0585|consen 240 NLLLSSDG-TVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLP 318 (576)
T ss_pred heEEcCCC-cEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCC
Confidence 99999998 7999999998765222 22345789999999999976 23357799999999999999999999
Q ss_pred CCCCCcHHHHHHHHHHhCCCChhhhhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 016184 285 FPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV 364 (394)
Q Consensus 285 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 364 (394)
|.+....+.+.+|+. ....+|.. +.+.+++++||.+||++||++|+++.++..
T Consensus 319 F~~~~~~~l~~KIvn-----------------~pL~fP~~----------pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~ 371 (576)
T KOG0585|consen 319 FFDDFELELFDKIVN-----------------DPLEFPEN----------PEINEDLKDLIKRLLEKDPEQRITLPDIKL 371 (576)
T ss_pred cccchHHHHHHHHhc-----------------CcccCCCc----------ccccHHHHHHHHHHhhcChhheeehhhhee
Confidence 999988888888876 23333331 347899999999999999999999999999
Q ss_pred CCCCCCCCCC
Q 016184 365 HPFFDELRDP 374 (394)
Q Consensus 365 hp~f~~~~~~ 374 (394)
|||...-.+.
T Consensus 372 Hpwvt~~g~~ 381 (576)
T KOG0585|consen 372 HPWVTRDGDS 381 (576)
T ss_pred cceeccCCCC
Confidence 9999886443
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-49 Score=363.40 Aligned_cols=276 Identities=33% Similarity=0.645 Sum_probs=226.7
Q ss_pred eeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccch-----hhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEEE
Q 016184 82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN 156 (394)
Q Consensus 82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 156 (394)
.+|++.++||.|+||.||+|++..+++.||+|++.... ....+|+.+++.++|+||+++++++ ....+.+
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~-----~~~~~~~ 79 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDII-----HTERCLT 79 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEE-----cCCCeEE
Confidence 45999999999999999999999999999999885322 2345799999999999999999987 3334588
Q ss_pred EEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCccccc
Q 016184 157 LVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV 236 (394)
Q Consensus 157 lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~ 236 (394)
+||||+++++.+.+... ...+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+++...
T Consensus 80 lv~e~~~~~l~~~l~~~---~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivH~dlkp~Nil~~~~~-~~kl~DfG~~~~~~ 154 (288)
T cd07871 80 LVFEYLDSDLKQYLDNC---GNLMSMHNVKIFMFQLLRGLSYCHK-RKILHRDLKPQNLLINEKG-ELKLADFGLARAKS 154 (288)
T ss_pred EEEeCCCcCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHHEEECCCC-CEEECcCcceeecc
Confidence 99999998887665532 3457899999999999999999999 8999999999999999887 69999999987543
Q ss_pred cCC-CcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCC
Q 016184 237 KGE-PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 315 (394)
Q Consensus 237 ~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 315 (394)
... ......+++.|+|||.+.+...++.++||||+||++|+|++|+.||.+.+..+.+..+.+..+.++.+.+......
T Consensus 155 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (288)
T cd07871 155 VPTKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSN 234 (288)
T ss_pred CCCccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccc
Confidence 322 2234567899999999876666899999999999999999999999998888889999999999888877654322
Q ss_pred --CcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 016184 316 --YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368 (394)
Q Consensus 316 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f 368 (394)
+....++.....++... ...++.++++||++||++||.+|||++|+|+||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f 288 (288)
T cd07871 235 EEFRSYLFPQYRAQPLINH-APRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288 (288)
T ss_pred hhhhccccCccCCCchHHh-CCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence 22223333333333322 24678999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-50 Score=381.42 Aligned_cols=267 Identities=28% Similarity=0.479 Sum_probs=225.4
Q ss_pred cceeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccch-------hhhHHHHHHHHHc-CCCCeeeeceEEEecCCCc
Q 016184 80 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQML-DHPNIVALKHCFFSTTDKE 151 (394)
Q Consensus 80 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~ 151 (394)
...+|+++++||+|+||+|++|..+.+++.+|||++++.. .....|.+|+... +||.++.++.+| +.
T Consensus 366 ~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~f-----QT 440 (694)
T KOG0694|consen 366 TLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCF-----QT 440 (694)
T ss_pred cccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeeccccc-----cc
Confidence 3457999999999999999999999999999999987643 2334577777777 599999999999 66
Q ss_pred eeEEEEEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecC
Q 016184 152 ELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS 231 (394)
Q Consensus 152 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~ 231 (394)
..++|+||||+.|+. +.. ......+++..++.|+..|+.||.|||+ +||||||||.+|||+|.+|+ +||+|||+
T Consensus 441 ~~~l~fvmey~~Ggd--m~~--~~~~~~F~e~rarfyaAev~l~L~fLH~-~~IIYRDlKLdNiLLD~eGh-~kiADFGl 514 (694)
T KOG0694|consen 441 KEHLFFVMEYVAGGD--LMH--HIHTDVFSEPRARFYAAEVVLGLQFLHE-NGIIYRDLKLDNLLLDTEGH-VKIADFGL 514 (694)
T ss_pred CCeEEEEEEecCCCc--EEE--EEecccccHHHHHHHHHHHHHHHHHHHh-cCceeeecchhheEEcccCc-EEeccccc
Confidence 667999999999754 221 2223789999999999999999999999 89999999999999999995 99999999
Q ss_pred ccccc-cCCCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhh
Q 016184 232 AKVLV-KGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 310 (394)
Q Consensus 232 a~~~~-~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 310 (394)
++... .+....+.+|||.|||||++.+.. |+.++|+|||||+|||||.|..||++.+..+....|...
T Consensus 515 cKe~m~~g~~TsTfCGTpey~aPEil~e~~-Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d---------- 583 (694)
T KOG0694|consen 515 CKEGMGQGDRTSTFCGTPEFLAPEVLTEQS-YTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVND---------- 583 (694)
T ss_pred ccccCCCCCccccccCChhhcChhhhccCc-ccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcC----------
Confidence 98765 556677889999999999997655 999999999999999999999999999999999888762
Q ss_pred ccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCC-----HHHHhcCCCCCCCCCCCCCCCCCCCCC
Q 016184 311 CMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCT-----ALEACVHPFFDELRDPNTRLPNGRPLP 385 (394)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt-----~~ell~hp~f~~~~~~~~~~~~~~~~~ 385 (394)
+.. ++..+|.++..+++++|++||++|.. +++|..||||+.+..... ..+.++
T Consensus 584 -------~~~------------yP~~ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i~w~~L---~~r~i~ 641 (694)
T KOG0694|consen 584 -------EVR------------YPRFLSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKKHPFFRSIDWDDL---LNRRIK 641 (694)
T ss_pred -------CCC------------CCCcccHHHHHHHHHHhccCcccccCCCCCCchhhhhCCccccCCHHHH---hhccCC
Confidence 222 33568999999999999999999995 579999999999974433 344455
Q ss_pred CCCCC
Q 016184 386 PLFNF 390 (394)
Q Consensus 386 ~~~~~ 390 (394)
|+|.+
T Consensus 642 PPf~P 646 (694)
T KOG0694|consen 642 PPFVP 646 (694)
T ss_pred CCCCc
Confidence 66655
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-50 Score=363.31 Aligned_cols=257 Identities=34% Similarity=0.566 Sum_probs=209.1
Q ss_pred eeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccc----hhhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEEEE
Q 016184 82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL 157 (394)
Q Consensus 82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 157 (394)
.+|...+.||+|+||+||++.+..+|..+|||.+... ...+.+|+.+|+.++|||||++++......+ ..+++
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~---~~~~i 93 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSREN---DEYNI 93 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccC---eeeEe
Confidence 3588899999999999999999999999999988765 4556899999999999999999886422221 46789
Q ss_pred EEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeC-CCCcEEEEeecCcccc
Q 016184 158 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNP-HTHQLKLCDFGSAKVL 235 (394)
Q Consensus 158 v~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~-~~~~vkl~Dfg~a~~~ 235 (394)
+|||+++ ++.+++..+. ..+++..++.+..||+.||+|||+ +|||||||||+|||++. ++ .+||+|||++...
T Consensus 94 ~mEy~~~GsL~~~~~~~g---~~l~E~~v~~ytr~iL~GL~ylHs-~g~vH~DiK~~NiLl~~~~~-~~KlaDFG~a~~~ 168 (313)
T KOG0198|consen 94 FMEYAPGGSLSDLIKRYG---GKLPEPLVRRYTRQILEGLAYLHS-KGIVHCDIKPANILLDPSNG-DVKLADFGLAKKL 168 (313)
T ss_pred eeeccCCCcHHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHHh-CCEeccCcccceEEEeCCCC-eEEeccCcccccc
Confidence 9999995 7777776532 269999999999999999999999 89999999999999998 56 7999999999876
Q ss_pred cc----CCCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCC-CcHHHHHHHHHHhCCCChhhhh
Q 016184 236 VK----GEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGE-SGVDQLVEIIKVLGTPTREEIK 310 (394)
Q Consensus 236 ~~----~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~-~~~~~~~~i~~~~~~~~~~~~~ 310 (394)
.. ........||+.|||||++........++|||||||++.||+||..||... .....+..+... .
T Consensus 169 ~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~---~------ 239 (313)
T KOG0198|consen 169 ESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGRE---D------ 239 (313)
T ss_pred ccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhcc---C------
Confidence 53 223446789999999999974322345999999999999999999999873 333323222211 0
Q ss_pred ccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q 016184 311 CMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD 373 (394)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~ 373 (394)
..| .++..+|.++++||.+||.+||++||||+++|+|||.+....
T Consensus 240 ---------~~P---------~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~~ 284 (313)
T KOG0198|consen 240 ---------SLP---------EIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQNSI 284 (313)
T ss_pred ---------CCC---------CCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhcccc
Confidence 011 244679999999999999999999999999999999988655
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-52 Score=346.48 Aligned_cols=254 Identities=32% Similarity=0.461 Sum_probs=217.1
Q ss_pred ceeEEEeeEEeecCceEEEEEEECCCCcEEEEEEecc------chhhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeE
Q 016184 81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQ------DKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY 154 (394)
Q Consensus 81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~------~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 154 (394)
.++|.+.++||+|.|+.||++.+..+|+.+|+|++.. +...+++|+.+.+.|+||||+++.+.+ .+..+
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti-----~~~~~ 84 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSI-----QEESF 84 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhh-----cccce
Confidence 3459999999999999999999999999999998743 345567899999999999999998887 67778
Q ss_pred EEEEEeccccc--HHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeC--CCCcEEEEeec
Q 016184 155 LNLVLEYVPET--VNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNP--HTHQLKLCDFG 230 (394)
Q Consensus 155 ~~lv~e~~~~~--l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~--~~~~vkl~Dfg 230 (394)
.|+|+|++.|. ..+++.. .-.++..+-.+++||+.||.|+|. +||||||+||+|+|+-. .+.-+||+|||
T Consensus 85 ~ylvFe~m~G~dl~~eIV~R-----~~ySEa~aSH~~rQiLeal~yCH~-n~IvHRDvkP~nllLASK~~~A~vKL~~FG 158 (355)
T KOG0033|consen 85 HYLVFDLVTGGELFEDIVAR-----EFYSEADASHCIQQILEALAYCHS-NGIVHRDLKPENLLLASKAKGAAVKLADFG 158 (355)
T ss_pred eEEEEecccchHHHHHHHHH-----HHHHHHHHHHHHHHHHHHHHHHHh-cCceeccCChhheeeeeccCCCceeecccc
Confidence 89999999973 2333332 457888999999999999999999 89999999999999954 33369999999
Q ss_pred CccccccCCCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhh
Q 016184 231 SAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 310 (394)
Q Consensus 231 ~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 310 (394)
+|.....+.......|||.|||||++...+ |+..+|||+.||+||-|+.|++||.+.+....++.|++.-
T Consensus 159 vAi~l~~g~~~~G~~GtP~fmaPEvvrkdp-y~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~--------- 228 (355)
T KOG0033|consen 159 LAIEVNDGEAWHGFAGTPGYLSPEVLKKDP-YSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGA--------- 228 (355)
T ss_pred eEEEeCCccccccccCCCcccCHHHhhcCC-CCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccc---------
Confidence 999888666777889999999999997655 9999999999999999999999999988888888887732
Q ss_pred ccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 016184 311 CMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL 371 (394)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 371 (394)
+.++. . .++++++++++|+++||..||.+|.|+.|.|+|||+++-
T Consensus 229 --------yd~~~---~-----~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~HpWi~~r 273 (355)
T KOG0033|consen 229 --------YDYPS---P-----EWDTVTPEAKSLIRRMLTVNPKKRITADEALKHPWICNR 273 (355)
T ss_pred --------cCCCC---c-----ccCcCCHHHHHHHHHHhccChhhhccHHHHhCCchhcch
Confidence 11111 1 126789999999999999999999999999999999863
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-52 Score=353.90 Aligned_cols=246 Identities=28% Similarity=0.487 Sum_probs=206.6
Q ss_pred eeEEEeeEEeecCceEEEEEEECCCCcEEEEEEec------cchhhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEE
Q 016184 82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVL------QDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL 155 (394)
Q Consensus 82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~------~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 155 (394)
..|+|+++||+|+||.||++.+..+|+.||.|.+. +.....-.|+.+|++|+|||||++++.-+. .+...+
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~---~~~evl 95 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFI---EDNEVL 95 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhh---ccchhh
Confidence 35999999999999999999999999999999874 233444579999999999999999873321 333447
Q ss_pred EEEEeccc-ccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhC---CCceeccCCCCceEEeCCCCcEEEEeecC
Q 016184 156 NLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC---IGICHRDIKPQNLLVNPHTHQLKLCDFGS 231 (394)
Q Consensus 156 ~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---~givH~Dlkp~Nil~~~~~~~vkl~Dfg~ 231 (394)
+||||||. |+|.++++.+....+.+++..+|+++.|++.||..+|.. .-|+||||||.||+++.+| .|||+|||+
T Consensus 96 nivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~g-vvKLGDfGL 174 (375)
T KOG0591|consen 96 NIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANG-VVKLGDFGL 174 (375)
T ss_pred HHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCC-ceeeccchh
Confidence 89999998 699999999999999999999999999999999999972 1389999999999999888 799999999
Q ss_pred ccccccCCCc-ccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhh
Q 016184 232 AKVLVKGEPN-VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 310 (394)
Q Consensus 232 a~~~~~~~~~-~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 310 (394)
++.+...... .+.+|||+||+||.+.+.+ |+.++||||+||++|||+.-++||.+.+-.+.-.+|.++- .++.
T Consensus 175 ~r~l~s~~tfA~S~VGTPyYMSPE~i~~~~-Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd-~~~~---- 248 (375)
T KOG0591|consen 175 GRFLSSKTTFAHSLVGTPYYMSPERIHESG-YNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGD-YPPL---- 248 (375)
T ss_pred HhHhcchhHHHHhhcCCCcccCHHHHhcCC-CCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCC-CCCC----
Confidence 9987655433 4678999999999997665 9999999999999999999999999986555555555431 1110
Q ss_pred ccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCH
Q 016184 311 CMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTA 359 (394)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~ 359 (394)
| ...+|.++..||..|+..||+.||+.
T Consensus 249 -----------p-----------~~~YS~~l~~li~~ci~vd~~~RP~t 275 (375)
T KOG0591|consen 249 -----------P-----------DEHYSTDLRELINMCIAVDPEQRPDT 275 (375)
T ss_pred -----------c-----------HHHhhhHHHHHHHHHccCCcccCCCc
Confidence 0 14578999999999999999999985
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-50 Score=373.50 Aligned_cols=250 Identities=31% Similarity=0.493 Sum_probs=215.4
Q ss_pred eeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccch------hhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEE
Q 016184 82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL 155 (394)
Q Consensus 82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 155 (394)
++|.+.+.||+|+||.||+|+.+.+.+.||+|.+.+.. ....+|+++++.++||||+.++++| .....+
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esf-----Et~~~~ 76 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESF-----ETSAHL 76 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhh-----cccceE
Confidence 35899999999999999999999999999999986543 2356899999999999999999999 455559
Q ss_pred EEEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCcccc
Q 016184 156 NLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL 235 (394)
Q Consensus 156 ~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~ 235 (394)
++|+||+.|+|..++.. .+.++++.++.++.+++.||.|||+ ++|.|||+||.|||++..+ .+|+||||+|+.+
T Consensus 77 ~vVte~a~g~L~~il~~----d~~lpEe~v~~~a~~LVsaL~yLhs-~rilhrd~kPqniLl~~~~-~~KlcdFg~Ar~m 150 (808)
T KOG0597|consen 77 WVVTEYAVGDLFTILEQ----DGKLPEEQVRAIAYDLVSALYYLHS-NRILHRDMKPQNILLEKGG-TLKLCDFGLARAM 150 (808)
T ss_pred EEEehhhhhhHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHh-cCcccccCCcceeeecCCC-ceeechhhhhhhc
Confidence 99999999988877765 4789999999999999999999999 8999999999999999888 6999999999987
Q ss_pred ccCCC-cccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCC
Q 016184 236 VKGEP-NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 314 (394)
Q Consensus 236 ~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 314 (394)
..... ..+.-|||.|||||.+.+. .|+..+|+||||||+||+++|++||....-......|...--.
T Consensus 151 ~~~t~vltsikGtPlYmAPElv~e~-pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~v~----------- 218 (808)
T KOG0597|consen 151 STNTSVLTSIKGTPLYMAPELVEEQ-PYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKDPVK----------- 218 (808)
T ss_pred ccCceeeeeccCcccccCHHHHcCC-CccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCCCC-----------
Confidence 65443 3456789999999999755 4999999999999999999999999877655555555441111
Q ss_pred CCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 016184 315 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR 372 (394)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 372 (394)
| +..++..+..||..+|.+||.+|.|..+++.|||+++..
T Consensus 219 --------------~----p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~HpF~k~~~ 258 (808)
T KOG0597|consen 219 --------------P----PSTASSSFVNFLQGLLIKDPAQRLTWTDLLGHPFWKGKI 258 (808)
T ss_pred --------------C----cccccHHHHHHHHHHhhcChhhcccHHHHhcChHHhhhh
Confidence 1 136789999999999999999999999999999998753
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-49 Score=354.83 Aligned_cols=269 Identities=26% Similarity=0.430 Sum_probs=221.3
Q ss_pred cceeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccch-----hhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeE
Q 016184 80 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY 154 (394)
Q Consensus 80 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 154 (394)
....|++..+||.|..++||+|++..+++.||||++.-++ ..+.+|+..++.++||||++++.+|.... .
T Consensus 24 n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~-----~ 98 (516)
T KOG0582|consen 24 NAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDS-----E 98 (516)
T ss_pred CccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecc-----e
Confidence 3446999999999999999999999999999999986432 45678999999999999999999884433 3
Q ss_pred EEEEEeccc-ccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCcc
Q 016184 155 LNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK 233 (394)
Q Consensus 155 ~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~ 233 (394)
+++||.||. |++.++++.+.. ..+.+..+..++++++.||.|||. +|.||||||+.||||+.+| .|||+|||.+.
T Consensus 99 LWvVmpfMa~GS~ldIik~~~~--~Gl~E~~Ia~iLre~LkaL~YLH~-~G~IHRdvKAgnILi~~dG-~VkLadFgvsa 174 (516)
T KOG0582|consen 99 LWVVMPFMAGGSLLDIIKTYYP--DGLEEASIATILREVLKALDYLHQ-NGHIHRDVKAGNILIDSDG-TVKLADFGVSA 174 (516)
T ss_pred eEEeehhhcCCcHHHHHHHHcc--ccccHHHHHHHHHHHHHHHHHHHh-cCceecccccccEEEcCCC-cEEEcCceeee
Confidence 899999998 589999988776 669999999999999999999999 8999999999999999999 79999999876
Q ss_pred ccccCCCc-----ccccccccccccccc-cCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChh
Q 016184 234 VLVKGEPN-----VSYICSRYYRAPELI-FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 307 (394)
Q Consensus 234 ~~~~~~~~-----~~~~~t~~y~aPE~~-~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~ 307 (394)
.+...... ....||++|||||++ .....|+.|+||||||++..||++|..||....++..+..-. .+.|+..
T Consensus 175 ~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tL--qn~pp~~ 252 (516)
T KOG0582|consen 175 SLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTL--QNDPPTL 252 (516)
T ss_pred eecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHh--cCCCCCc
Confidence 66544321 345789999999995 334459999999999999999999999999887776654433 3444422
Q ss_pred hhhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCC
Q 016184 308 EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNT 376 (394)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~ 376 (394)
.....+. .-...++..++.+|..||+.||.+||||+++|+|+||+..+...-
T Consensus 253 ~t~~~~~-----------------d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k~~~~ 304 (516)
T KOG0582|consen 253 LTSGLDK-----------------DEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAKSKEY 304 (516)
T ss_pred ccccCCh-----------------HHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhccchhh
Confidence 2111100 011346789999999999999999999999999999999876554
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-48 Score=367.14 Aligned_cols=288 Identities=37% Similarity=0.669 Sum_probs=226.7
Q ss_pred eEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccc------hhhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEEE
Q 016184 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN 156 (394)
Q Consensus 83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 156 (394)
+|++.++||+|+||.||+|++..+|+.||||++... .....+|+++++.++||||+++++++..........++
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 499999999999999999999999999999987532 12345799999999999999999988655444445678
Q ss_pred EEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCccccc
Q 016184 157 LVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV 236 (394)
Q Consensus 157 lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~ 236 (394)
+||||+++++.+.+.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||+++...
T Consensus 81 lv~e~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~dlkp~NIll~~~~-~~kL~Dfg~~~~~~ 154 (338)
T cd07859 81 VVFELMESDLHQVIKA----NDDLTPEHHQFFLYQLLRALKYIHT-ANVFHRDLKPKNILANADC-KLKICDFGLARVAF 154 (338)
T ss_pred EEEecCCCCHHHHHHh----cccCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHeEECCCC-cEEEccCccccccc
Confidence 9999999888766653 3568999999999999999999999 8999999999999999888 79999999987543
Q ss_pred cCCC----cccccccccccccccccCC-CCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhc
Q 016184 237 KGEP----NVSYICSRYYRAPELIFGA-TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 311 (394)
Q Consensus 237 ~~~~----~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 311 (394)
.... .....+|+.|+|||++.+. ..++.++|||||||++|+|++|+.||.+.+....+..+....+.++......
T Consensus 155 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (338)
T cd07859 155 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISR 234 (338)
T ss_pred cccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHH
Confidence 2221 1235689999999998542 4589999999999999999999999999888888888888888877665543
Q ss_pred cCCCCcc-c--CCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCCC
Q 016184 312 MNPNYTE-F--KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTR 377 (394)
Q Consensus 312 ~~~~~~~-~--~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~~ 377 (394)
....... + .+......+....+ ..+++++.+||.+||+.||++|||++++|+||||+++......
T Consensus 235 i~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~~~~~~ 302 (338)
T cd07859 235 VRNEKARRYLSSMRKKQPVPFSQKF-PNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLAKVERE 302 (338)
T ss_pred hhhhhHHHHHHhhcccCCCchHHhc-CCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhcCccccc
Confidence 2211000 0 00001111111112 3468889999999999999999999999999999988775543
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-48 Score=359.17 Aligned_cols=282 Identities=32% Similarity=0.560 Sum_probs=217.6
Q ss_pred ceeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccch-----hhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEE
Q 016184 81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL 155 (394)
Q Consensus 81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 155 (394)
.++|++.+.||+|+||.||+|++..+++.||||++.... ....+|+.+++.++||||+++++++. .....
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~-----~~~~~ 78 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIH-----TKETL 78 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEe-----cCCeE
Confidence 356999999999999999999999999999999886432 23457999999999999999999883 33458
Q ss_pred EEEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCcccc
Q 016184 156 NLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL 235 (394)
Q Consensus 156 ~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~ 235 (394)
++||||+++++.+.+.. ....+++..++.++.|++.||+|||+ .||+||||||+|||++.++ .+||+|||++...
T Consensus 79 ~lv~e~~~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~-~~ivH~dlkp~Nill~~~~-~~kl~Dfg~~~~~ 153 (303)
T cd07869 79 TLVFEYVHTDLCQYMDK---HPGGLHPENVKLFLFQLLRGLSYIHQ-RYILHRDLKPQNLLISDTG-ELKLADFGLARAK 153 (303)
T ss_pred EEEEECCCcCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEECCCC-CEEECCCCcceec
Confidence 89999999888666553 23568999999999999999999999 8999999999999999887 6999999998654
Q ss_pred ccC-CCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcH-HHHHHHHHHhCCCChhhhhccC
Q 016184 236 VKG-EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGV-DQLVEIIKVLGTPTREEIKCMN 313 (394)
Q Consensus 236 ~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~~ 313 (394)
... .......+++.|+|||++.+...++.++|||||||++|+|++|..||.+..+. +.+..+....+.+....+....
T Consensus 154 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (303)
T cd07869 154 SVPSHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVH 233 (303)
T ss_pred cCCCccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchh
Confidence 322 22234567899999999876666899999999999999999999999876543 5566666666666554443221
Q ss_pred C--CCcccCCCCCCCCCcchhc-cccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 016184 314 P--NYTEFKFPQIKPHPWHKVF-QKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR 372 (394)
Q Consensus 314 ~--~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 372 (394)
. .+....+.......+.... ....+..+.+||.+||+.||++|||+.++|+||||+++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~~ 295 (303)
T cd07869 234 SLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDLP 295 (303)
T ss_pred hccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccCC
Confidence 1 0000001111111111111 123567899999999999999999999999999998874
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-50 Score=369.40 Aligned_cols=251 Identities=29% Similarity=0.480 Sum_probs=215.7
Q ss_pred eEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccc----hhhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEEEEE
Q 016184 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLV 158 (394)
Q Consensus 83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv 158 (394)
.|....+||+|+.|.||.|+...+++.||||.+... +..+-+|+.+|+...|+|||.+++.|+..++ +++|
T Consensus 274 ~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~de-----LWVV 348 (550)
T KOG0578|consen 274 KYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDE-----LWVV 348 (550)
T ss_pred hhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccce-----eEEE
Confidence 588888999999999999999999999999998644 3444589999999999999999999865533 8899
Q ss_pred Eecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCcccccc
Q 016184 159 LEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK 237 (394)
Q Consensus 159 ~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~ 237 (394)
|||++| +|.+++.. ..+++.++..++++++.||+|||. +||+|||||.+|||++.+| .+||+|||+|..+..
T Consensus 349 MEym~ggsLTDvVt~-----~~~~E~qIA~Icre~l~aL~fLH~-~gIiHrDIKSDnILL~~~g-~vKltDFGFcaqi~~ 421 (550)
T KOG0578|consen 349 MEYMEGGSLTDVVTK-----TRMTEGQIAAICREILQGLKFLHA-RGIIHRDIKSDNILLTMDG-SVKLTDFGFCAQISE 421 (550)
T ss_pred EeecCCCchhhhhhc-----ccccHHHHHHHHHHHHHHHHHHHh-cceeeeccccceeEeccCC-cEEEeeeeeeecccc
Confidence 999996 66666665 569999999999999999999999 8999999999999999998 699999999987765
Q ss_pred CC-CcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCCC
Q 016184 238 GE-PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 316 (394)
Q Consensus 238 ~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 316 (394)
.. ...+.+|||+|||||++. ...|+.+.||||||++++||+-|.+||-..+....++.|... |.|...
T Consensus 422 ~~~KR~TmVGTPYWMAPEVvt-rk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~n-g~P~lk--------- 490 (550)
T KOG0578|consen 422 EQSKRSTMVGTPYWMAPEVVT-RKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATN-GTPKLK--------- 490 (550)
T ss_pred ccCccccccCCCCccchhhhh-hcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhc-CCCCcC---------
Confidence 54 456778999999999995 455999999999999999999999999887777777666553 333221
Q ss_pred cccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 016184 317 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR 372 (394)
Q Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 372 (394)
.+..+|+.+++||.+||+.|+.+|++|.|||+||||+...
T Consensus 491 ----------------~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~HpFl~~a~ 530 (550)
T KOG0578|consen 491 ----------------NPEKLSPELKDFLDRCLVVDVEQRASAKELLEHPFLKMAK 530 (550)
T ss_pred ----------------CccccCHHHHHHHHHHhhcchhcCCCHHHHhcChhhhhcC
Confidence 1257899999999999999999999999999999995543
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-48 Score=356.44 Aligned_cols=271 Identities=23% Similarity=0.378 Sum_probs=215.6
Q ss_pred EEEeeEEeecCceEEEEEEECCCCcEEEEEEeccch-------hhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEEE
Q 016184 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN 156 (394)
Q Consensus 84 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 156 (394)
|++.+.||+|+||.||+|.+..+|+.||+|.+.... ....+|+.+++.++|+||+.+.+++ ....+.+
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~-----~~~~~~~ 76 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAY-----ETKDALC 76 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEE-----ccCCeEE
Confidence 889999999999999999999999999999875432 2234699999999999999998887 3334588
Q ss_pred EEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCcccc
Q 016184 157 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL 235 (394)
Q Consensus 157 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~ 235 (394)
++|||+++ +|...+... ....+++..+..++.|++.||+|||+ .||+||||||+|||++.++ .++|+|||++...
T Consensus 77 lv~e~~~~g~L~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~-~~iiH~dikp~Nill~~~~-~~kl~Dfg~~~~~ 152 (285)
T cd05631 77 LVLTIMNGGDLKFHIYNM--GNPGFDEQRAIFYAAELCCGLEDLQR-ERIVYRDLKPENILLDDRG-HIRISDLGLAVQI 152 (285)
T ss_pred EEEEecCCCcHHHHHHhh--CCCCCCHHHHHHHHHHHHHHHHHHHh-CCEEeCCCCHHHEEECCCC-CEEEeeCCCcEEc
Confidence 99999985 565544332 23468999999999999999999999 8999999999999999887 6999999999876
Q ss_pred ccCCCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCC
Q 016184 236 VKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 315 (394)
Q Consensus 236 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 315 (394)
..........||+.|+|||++.+. .++.++|||||||++|+|++|+.||...........+........
T Consensus 153 ~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~---------- 221 (285)
T cd05631 153 PEGETVRGRVGTVGYMAPEVINNE-KYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQ---------- 221 (285)
T ss_pred CCCCeecCCCCCCCccCHhhhcCC-CCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhccc----------
Confidence 444444456789999999999654 489999999999999999999999987654333333322211100
Q ss_pred CcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCC-----HHHHhcCCCCCCCCCCCCCCCCCCCCCCCCCC
Q 016184 316 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCT-----ALEACVHPFFDELRDPNTRLPNGRPLPPLFNF 390 (394)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt-----~~ell~hp~f~~~~~~~~~~~~~~~~~~~~~~ 390 (394)
..++..++.++.+||++||+.||.+||+ ++++++||||+++..... .....+|+|.+
T Consensus 222 ---------------~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~~~~~~---~~~~~~~~~~~ 283 (285)
T cd05631 222 ---------------EEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIFKNINFKRL---EANMLEPPFCP 283 (285)
T ss_pred ---------------ccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcCHhhcCCCHHHH---HhCcCCcCCCC
Confidence 0122457899999999999999999997 899999999999854333 34566688888
Q ss_pred CC
Q 016184 391 KP 392 (394)
Q Consensus 391 ~~ 392 (394)
||
T Consensus 284 ~~ 285 (285)
T cd05631 284 DP 285 (285)
T ss_pred CC
Confidence 75
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-48 Score=353.49 Aligned_cols=279 Identities=32% Similarity=0.570 Sum_probs=219.1
Q ss_pred eEEEeeEEeecCceEEEEEEECC-CCcEEEEEEeccch------hhhHHHHHHHHHc---CCCCeeeeceEEEecCCCce
Q 016184 83 SYIAEHVVGTGSFGVVFQAKCRE-TGEIVAIKKVLQDK------RYKNRELQIMQML---DHPNIVALKHCFFSTTDKEE 152 (394)
Q Consensus 83 ~y~~~~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~~~------~~~~~E~~~l~~l---~h~~iv~~~~~~~~~~~~~~ 152 (394)
+|++.+.||+|+||.||+|++.. +++.||+|++.... ....+|+.+++.+ .||||+++++++........
T Consensus 2 ~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~ 81 (290)
T cd07862 2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE 81 (290)
T ss_pred CcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCC
Confidence 59999999999999999999854 46889999875321 2334677777665 69999999998854443444
Q ss_pred eEEEEEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCc
Q 016184 153 LYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA 232 (394)
Q Consensus 153 ~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a 232 (394)
..++++|||+++++.+++.... ...+++..++.++.|++.||.|||+ .||+||||||+|||++.++ .+||+|||++
T Consensus 82 ~~~~lv~e~~~~~l~~~~~~~~--~~~~~~~~~~~i~~qi~~aL~~lH~-~~iiH~dlkp~Nil~~~~~-~~kl~Dfg~~ 157 (290)
T cd07862 82 TKLTLVFEHVDQDLTTYLDKVP--EPGVPTETIKDMMFQLLRGLDFLHS-HRVVHRDLKPQNILVTSSG-QIKLADFGLA 157 (290)
T ss_pred CcEEEEEccCCCCHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeCCCCHHHEEEcCCC-CEEEccccce
Confidence 5678999999998877765432 2568999999999999999999999 8999999999999999887 7999999999
Q ss_pred cccccCCCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhcc
Q 016184 233 KVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 312 (394)
Q Consensus 233 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 312 (394)
.............+++.|+|||.+.+. .++.++|||||||++|+|++|++||.+....+.+..+....+.+....+...
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~ 236 (290)
T cd07862 158 RIYSFQMALTSVVVTLWYRAPEVLLQS-SYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRD 236 (290)
T ss_pred EeccCCcccccccccccccChHHHhCC-CCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhh
Confidence 766544444456789999999998654 4899999999999999999999999999888889898888777665544321
Q ss_pred CCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 016184 313 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368 (394)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f 368 (394)
.. .....+......+... +...++..+.+||.+||+.||++|||+.++|+||||
T Consensus 237 ~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f 290 (290)
T cd07862 237 VA-LPRQAFHSKSAQPIEK-FVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 290 (290)
T ss_pred hc-ccchhccCCCCCCHHH-HccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence 10 0011111111112222 234578899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-47 Score=362.19 Aligned_cols=288 Identities=31% Similarity=0.532 Sum_probs=226.7
Q ss_pred eeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccc------hhhhHHHHHHHHHcCCCCeeeeceEEEecCC-CceeE
Q 016184 82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTD-KEELY 154 (394)
Q Consensus 82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~~~~~ 154 (394)
.+|++.+.||+|+||.||+|.+..+++.||||++... .....+|+.+++.++|+||+++++++..... .....
T Consensus 24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~~ 103 (364)
T cd07875 24 KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQD 103 (364)
T ss_pred cceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccCe
Confidence 4699999999999999999999999999999988642 1234578999999999999999988743321 22345
Q ss_pred EEEEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCccc
Q 016184 155 LNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV 234 (394)
Q Consensus 155 ~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~ 234 (394)
.++||||+++++...+. ..+++..++.++.|++.||.|||+ +||+||||||+|||++.++ .+||+|||+++.
T Consensus 104 ~~lv~e~~~~~l~~~~~------~~~~~~~~~~~~~qi~~aL~~LH~-~~ivH~Dlkp~NIll~~~~-~~kL~DfG~a~~ 175 (364)
T cd07875 104 VYIVMELMDANLCQVIQ------MELDHERMSYLLYQMLCGIKHLHS-AGIIHRDLKPSNIVVKSDC-TLKILDFGLART 175 (364)
T ss_pred EEEEEeCCCCCHHHHHH------hcCCHHHHHHHHHHHHHHHHHHhh-CCeecCCCCHHHEEECCCC-cEEEEeCCCccc
Confidence 78999999988766553 357888999999999999999999 8999999999999999888 799999999986
Q ss_pred cccCCCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCC
Q 016184 235 LVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 314 (394)
Q Consensus 235 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 314 (394)
...........+|+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+.+..+....+.+..+.+..+..
T Consensus 176 ~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (364)
T cd07875 176 AGTSFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQP 254 (364)
T ss_pred cCCCCcccCCcccCCcCCHHHHhCC-CCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhH
Confidence 6444344456789999999999654 489999999999999999999999999988888888888888777665443322
Q ss_pred C----------CcccCCCCCC---CCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCCCC
Q 016184 315 N----------YTEFKFPQIK---PHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRL 378 (394)
Q Consensus 315 ~----------~~~~~~~~~~---~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~~~ 378 (394)
. +..+.+.... ..++........+..+++||.+||+.||.+|||+.++|+||||....++....
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~~~~~~~~~ 331 (364)
T cd07875 255 TVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDPSEAE 331 (364)
T ss_pred HHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCcccccccCcccCC
Confidence 1 1111100000 00111111223467899999999999999999999999999999887776643
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-47 Score=351.92 Aligned_cols=275 Identities=40% Similarity=0.713 Sum_probs=218.5
Q ss_pred eEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccc------hhhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEEE
Q 016184 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN 156 (394)
Q Consensus 83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 156 (394)
+|++.+.||+|+||.||+|+++.+++.||+|++... .....+|+++++.++|+||+++++++ ......+
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~~ 76 (287)
T cd07848 2 KFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAF-----RRRGKLY 76 (287)
T ss_pred CceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhE-----ecCCEEE
Confidence 599999999999999999999999999999988643 22345799999999999999999988 3344588
Q ss_pred EEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCccccc
Q 016184 157 LVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV 236 (394)
Q Consensus 157 lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~ 236 (394)
+||||+++++...+.. ....+++..++.++.|++.||.|||+ .||+||||||+||+++.++ .+||+|||++....
T Consensus 77 lv~e~~~~~~l~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~-~~i~H~dlkp~Nill~~~~-~~kl~Dfg~~~~~~ 151 (287)
T cd07848 77 LVFEYVEKNMLELLEE---MPNGVPPEKVRSYIYQLIKAIHWCHK-NDIVHRDIKPENLLISHND-VLKLCDFGFARNLS 151 (287)
T ss_pred EEEecCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEEcCCC-cEEEeeccCccccc
Confidence 9999999876554432 23578999999999999999999999 8999999999999999887 79999999997654
Q ss_pred cCC--CcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccC-
Q 016184 237 KGE--PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN- 313 (394)
Q Consensus 237 ~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~- 313 (394)
... ......+++.|+|||++.+.. ++.++|+|||||++|+|++|+.||.+.+..+.+..+....+..+...+....
T Consensus 152 ~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (287)
T cd07848 152 EGSNANYTEYVATRWYRSPELLLGAP-YGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYS 230 (287)
T ss_pred ccccccccccccccccCCcHHHcCCC-CCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhc
Confidence 322 222356799999999996554 8999999999999999999999999888777777777777766655543221
Q ss_pred -CCCcccCCCCCC-CCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 016184 314 -PNYTEFKFPQIK-PHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368 (394)
Q Consensus 314 -~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f 368 (394)
+.+.....+... ...+.......++.++.+||++||++||++|||++++|+||||
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f 287 (287)
T cd07848 231 NPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF 287 (287)
T ss_pred cchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 111111111111 1112222334578999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-47 Score=355.14 Aligned_cols=286 Identities=35% Similarity=0.656 Sum_probs=229.7
Q ss_pred eeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccch-----hhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEEE
Q 016184 82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN 156 (394)
Q Consensus 82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 156 (394)
.+|++.+.||+|+||.||+|++..+++.||+|.+.... ....+|+++++.++|+||+++++++.. ....+
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~~ 80 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHT-----DKSLT 80 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEee-----CCeEE
Confidence 45999999999999999999999999999999875332 234579999999999999999998833 33478
Q ss_pred EEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCccccc
Q 016184 157 LVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV 236 (394)
Q Consensus 157 lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~ 236 (394)
+||||+++++.+.+... ...+++..++.++.|++.||+|||+ .||+||||||+|||++.++ .+||+|||++....
T Consensus 81 lv~e~~~~~l~~~~~~~---~~~~~~~~~~~~~~qi~~aL~~lH~-~~ivH~dlkp~Nill~~~~-~~kl~Dfg~~~~~~ 155 (309)
T cd07872 81 LVFEYLDKDLKQYMDDC---GNIMSMHNVKIFLYQILRGLAYCHR-RKVLHRDLKPQNLLINERG-ELKLADFGLARAKS 155 (309)
T ss_pred EEEeCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEECCCC-CEEECccccceecC
Confidence 99999998876665432 3568899999999999999999999 8999999999999999887 69999999987543
Q ss_pred cCC-CcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCC
Q 016184 237 KGE-PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 315 (394)
Q Consensus 237 ~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 315 (394)
... ......+++.|+|||.+.+...++.++|||||||++|+|+||+.||.+.+..+.+..+....+.+....+......
T Consensus 156 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (309)
T cd07872 156 VPTKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSN 235 (309)
T ss_pred CCccccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcch
Confidence 322 2223456889999999876666899999999999999999999999998888888888888888888776544322
Q ss_pred --CcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCCCC
Q 016184 316 --YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRL 378 (394)
Q Consensus 316 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~~~ 378 (394)
+....++......+... ...+++++++||.+||+.||.+|||+.|+|+||||+.+.....+.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~~~~~~ 299 (309)
T cd07872 236 DEFKNYNFPKYKPQPLINH-APRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSLGTRIHSL 299 (309)
T ss_pred hhhhhhhcCccCCCchhhh-ccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhcccccccC
Confidence 11222333222222222 245789999999999999999999999999999999885444433
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-47 Score=370.00 Aligned_cols=291 Identities=22% Similarity=0.366 Sum_probs=217.0
Q ss_pred ceeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccc---hhhhHHHHHHHHHcCCC------CeeeeceEEEecCCCc
Q 016184 81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD---KRYKNRELQIMQMLDHP------NIVALKHCFFSTTDKE 151 (394)
Q Consensus 81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~E~~~l~~l~h~------~iv~~~~~~~~~~~~~ 151 (394)
..+|++.++||+|+||+||+|.+..+++.||||++... ......|+++++.+.|. +++.+++++.. +
T Consensus 128 ~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~----~ 203 (467)
T PTZ00284 128 TQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQN----E 203 (467)
T ss_pred CCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEc----C
Confidence 35799999999999999999999999999999998643 22345688888877554 47778777632 2
Q ss_pred eeEEEEEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCC---------
Q 016184 152 ELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTH--------- 222 (394)
Q Consensus 152 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~--------- 222 (394)
..++|+||+++++++.+++.. ...+++..++.++.||+.||+|||+..|||||||||+|||++.++.
T Consensus 204 ~~~~~iv~~~~g~~l~~~l~~----~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~ 279 (467)
T PTZ00284 204 TGHMCIVMPKYGPCLLDWIMK----HGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRA 279 (467)
T ss_pred CceEEEEEeccCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccc
Confidence 345789999998887776653 3578999999999999999999997249999999999999986542
Q ss_pred ------cEEEEeecCccccccCCCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHH
Q 016184 223 ------QLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVE 296 (394)
Q Consensus 223 ------~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~ 296 (394)
.+||+|||.+... ........||+.|+|||++.+. .++.++|||||||++|||++|+.||.+.+..+.+..
T Consensus 280 ~~~~~~~vkl~DfG~~~~~--~~~~~~~~gt~~Y~APE~~~~~-~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~ 356 (467)
T PTZ00284 280 LPPDPCRVRICDLGGCCDE--RHSRTAIVSTRHYRSPEVVLGL-GWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHL 356 (467)
T ss_pred cCCCCceEEECCCCccccC--ccccccccCCccccCcHHhhcC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Confidence 4999999987543 2233456789999999999765 489999999999999999999999999888888888
Q ss_pred HHHHhCCCChhhhhccCCCC-ccc-C-----CCCCCCCCcchh------ccccCChHHHHHHHHhcccCCCCCCCHHHHh
Q 016184 297 IIKVLGTPTREEIKCMNPNY-TEF-K-----FPQIKPHPWHKV------FQKRLPPEAVDLVCRFFQYSPNLRCTALEAC 363 (394)
Q Consensus 297 i~~~~~~~~~~~~~~~~~~~-~~~-~-----~~~~~~~~~~~~------~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell 363 (394)
+...++.++........... ..+ . .+......+... ......+.+.+||.+||++||.+|||++|+|
T Consensus 357 i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L 436 (467)
T PTZ00284 357 MEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMT 436 (467)
T ss_pred HHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHh
Confidence 88888887765443211000 000 0 000000000000 0001246688999999999999999999999
Q ss_pred cCCCCCCCCCCCCCCCCCC
Q 016184 364 VHPFFDELRDPNTRLPNGR 382 (394)
Q Consensus 364 ~hp~f~~~~~~~~~~~~~~ 382 (394)
+||||++....-..++.-+
T Consensus 437 ~Hp~~~~~~~~~~~~~~~~ 455 (467)
T PTZ00284 437 THPYVLKYYPECRQHPNYP 455 (467)
T ss_pred cCccccccCCccccCCCCC
Confidence 9999998655443334333
|
|
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-47 Score=362.47 Aligned_cols=286 Identities=31% Similarity=0.548 Sum_probs=222.8
Q ss_pred eeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccc------hhhhHHHHHHHHHcCCCCeeeeceEEEecCC-CceeE
Q 016184 82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTD-KEELY 154 (394)
Q Consensus 82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~~~~~ 154 (394)
.+|++.+.||+|+||.||+|++..+|+.||||++... .....+|+.+++.++||||+++++++..... .....
T Consensus 21 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 100 (359)
T cd07876 21 KRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQD 100 (359)
T ss_pred hceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccce
Confidence 4699999999999999999999999999999988542 2234579999999999999999998743322 12345
Q ss_pred EEEEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCccc
Q 016184 155 LNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV 234 (394)
Q Consensus 155 ~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~ 234 (394)
.++||||+++++...+. ..+++..+..++.|++.||.|||+ +||+||||||+|||++.++ .+||+|||++..
T Consensus 101 ~~lv~e~~~~~l~~~~~------~~~~~~~~~~~~~qi~~~L~~LH~-~~ivHrDlkp~NIl~~~~~-~~kl~Dfg~a~~ 172 (359)
T cd07876 101 VYLVMELMDANLCQVIH------MELDHERMSYLLYQMLCGIKHLHS-AGIIHRDLKPSNIVVKSDC-TLKILDFGLART 172 (359)
T ss_pred eEEEEeCCCcCHHHHHh------ccCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHHEEECCCC-CEEEecCCCccc
Confidence 78999999988765543 458889999999999999999999 8999999999999999888 799999999976
Q ss_pred cccCCCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccC-
Q 016184 235 LVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN- 313 (394)
Q Consensus 235 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~- 313 (394)
...........+|+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+.+..+...++.+....+....
T Consensus 173 ~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (359)
T cd07876 173 ACTNFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQP 251 (359)
T ss_pred cccCccCCCCcccCCCCCchhccCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHH
Confidence 5444444456789999999999654 48999999999999999999999999988888888888877777665432211
Q ss_pred ---------CCCcccCCCCCCC---CCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCC
Q 016184 314 ---------PNYTEFKFPQIKP---HPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNT 376 (394)
Q Consensus 314 ---------~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~ 376 (394)
+.+....+..... .+.........++.+++||.+||+.||++|||+.|+|+||||+...++..
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~~~~~ 326 (359)
T cd07876 252 TVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITVWYDPAE 326 (359)
T ss_pred HHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhhhcCccc
Confidence 1111111000000 00001112335788999999999999999999999999999998766543
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-47 Score=348.63 Aligned_cols=279 Identities=30% Similarity=0.547 Sum_probs=220.1
Q ss_pred eEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccch------hhhHHHHHHHHHc---CCCCeeeeceEEEecCCCcee
Q 016184 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQML---DHPNIVALKHCFFSTTDKEEL 153 (394)
Q Consensus 83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l---~h~~iv~~~~~~~~~~~~~~~ 153 (394)
+|++.+.||+|+||.||+|+++.+|+.||+|.+.... ....+|+++++.+ +||||+++++++.........
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 4999999999999999999999999999999876421 2234677777665 799999999988654444456
Q ss_pred EEEEEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCcc
Q 016184 154 YLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK 233 (394)
Q Consensus 154 ~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~ 233 (394)
..+++|||+.+++..++.... ...+++..++.++.|++.||.|||+ .||+||||||+|||++.++ .+||+|||++.
T Consensus 81 ~~~lv~e~~~~~l~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH~-~~ivH~dikp~Nili~~~~-~~kl~dfg~~~ 156 (288)
T cd07863 81 KVTLVFEHVDQDLRTYLDKVP--PPGLPAETIKDLMRQFLRGLDFLHA-NCIVHRDLKPENILVTSGG-QVKLADFGLAR 156 (288)
T ss_pred eEEEEEcccccCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEECCCC-CEEECccCccc
Confidence 688999999988877665432 2458999999999999999999999 8999999999999999887 69999999998
Q ss_pred ccccCCCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccC
Q 016184 234 VLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 313 (394)
Q Consensus 234 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 313 (394)
............+++.|+|||++.+. .++.++|||||||++|+|++|++||.+....+.+..+....+.+....+....
T Consensus 157 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (288)
T cd07863 157 IYSCQMALTPVVVTLWYRAPEVLLQS-TYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDV 235 (288)
T ss_pred cccCcccCCCccccccccCchHhhCC-CCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcccc
Confidence 66544444456778999999998654 48999999999999999999999999888888888888877766654443210
Q ss_pred CCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 016184 314 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368 (394)
Q Consensus 314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f 368 (394)
......+.......+.. ....++..+.+||.+||+.||.+|||+.+++.||||
T Consensus 236 -~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f 288 (288)
T cd07863 236 -TLPRGAFSPRGPRPVQS-VVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288 (288)
T ss_pred -cccccccCCCCCCchHH-hCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 00011111111112222 224578899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-47 Score=348.59 Aligned_cols=288 Identities=32% Similarity=0.618 Sum_probs=230.0
Q ss_pred ceeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccch-----hhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEE
Q 016184 81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL 155 (394)
Q Consensus 81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 155 (394)
..+|++.+.||.|+||.||+|++..+++.||+|.+.... ....+|+.+++.++|+||+++++++. ...+.
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~-----~~~~~ 79 (301)
T cd07873 5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIH-----TEKSL 79 (301)
T ss_pred ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEe-----cCCeE
Confidence 346999999999999999999999999999999875332 23457999999999999999999883 33458
Q ss_pred EEEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCcccc
Q 016184 156 NLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL 235 (394)
Q Consensus 156 ~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~ 235 (394)
++||||+++++...+... ...+++..++.++.|++.||+|||+ .||+|+||||+|||++.++ .++|+|||++...
T Consensus 80 ~lv~e~~~~~l~~~l~~~---~~~~~~~~~~~~~~qi~~aL~~lH~-~~i~H~dlkp~Nil~~~~~-~~kl~dfg~~~~~ 154 (301)
T cd07873 80 TLVFEYLDKDLKQYLDDC---GNSINMHNVKLFLFQLLRGLNYCHR-RKVLHRDLKPQNLLINERG-ELKLADFGLARAK 154 (301)
T ss_pred EEEEeccccCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHh-CCeeCCCCCHHHEEECCCC-cEEECcCcchhcc
Confidence 899999998876665532 3568899999999999999999999 8999999999999999887 7999999998754
Q ss_pred ccCC-CcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCC
Q 016184 236 VKGE-PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 314 (394)
Q Consensus 236 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 314 (394)
.... ......+++.|+|||.+.+...++.++|||||||++|+|++|+.||.+.+..+.+..+...++.+....+..+..
T Consensus 155 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (301)
T cd07873 155 SIPTKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILS 234 (301)
T ss_pred CCCCCcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhc
Confidence 3322 222345688999999987666688999999999999999999999998888888888888888777766543321
Q ss_pred C--CcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCCCCC
Q 016184 315 N--YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLP 379 (394)
Q Consensus 315 ~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~~~~ 379 (394)
. +....++....... ......+++++++||.+||+.||.+|||++++|+||||+.+.+...++|
T Consensus 235 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~~~~~~~~~ 300 (301)
T cd07873 235 NEEFKSYNYPKYRADCL-HNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLGERIHKLP 300 (301)
T ss_pred cccccccccCccccccH-HhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccccchhhcCC
Confidence 1 11222222211111 1223467899999999999999999999999999999999987666554
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-47 Score=363.09 Aligned_cols=278 Identities=24% Similarity=0.350 Sum_probs=212.7
Q ss_pred cceeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccchhhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEEEEEE
Q 016184 80 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVL 159 (394)
Q Consensus 80 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~ 159 (394)
...+|.+.+.||+|+||.||+|++..+++.||+|.... ....+|+++++.++||||+++++++. ...+.++++
T Consensus 90 ~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~--~~~~~E~~il~~l~HpnIv~~~~~~~-----~~~~~~lv~ 162 (391)
T PHA03212 90 EKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR--GGTATEAHILRAINHPSIIQLKGTFT-----YNKFTCLIL 162 (391)
T ss_pred ccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh--hhhHHHHHHHHhCCCCCCCCEeEEEE-----ECCeeEEEE
Confidence 34569999999999999999999999999999997543 34568999999999999999999883 334578999
Q ss_pred ecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCccccccC-
Q 016184 160 EYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG- 238 (394)
Q Consensus 160 e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~~- 238 (394)
|++.+++...+.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||++......
T Consensus 163 e~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~ylH~-~~IvHrDiKP~NIll~~~~-~vkL~DFG~a~~~~~~~ 236 (391)
T PHA03212 163 PRYKTDLYCYLAA----KRNIAICDILAIERSVLRAIQYLHE-NRIIHRDIKAENIFINHPG-DVCLGDFGAACFPVDIN 236 (391)
T ss_pred ecCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCChHhEEEcCCC-CEEEEeCCccccccccc
Confidence 9999887665543 3568999999999999999999999 8999999999999999887 6999999998653222
Q ss_pred -CCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCC-------cHHHHHHHHHHhCCCChhhhh
Q 016184 239 -EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGES-------GVDQLVEIIKVLGTPTREEIK 310 (394)
Q Consensus 239 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~-------~~~~~~~i~~~~~~~~~~~~~ 310 (394)
.......||+.|+|||++.+. .++.++|||||||++|+|++|..||.... ....+..+....+.++.+...
T Consensus 237 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~ 315 (391)
T PHA03212 237 ANKYYGWAGTIATNAPELLARD-PYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPI 315 (391)
T ss_pred ccccccccCccCCCChhhhcCC-CCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCc
Confidence 222345789999999998654 48999999999999999999998775432 234566666666665433211
Q ss_pred ccCCCCc---------ccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCC
Q 016184 311 CMNPNYT---------EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP 374 (394)
Q Consensus 311 ~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~ 374 (394)
....... ....+. ....|... ..++.++.+||++||++||.+|||++|+|+||||+++..+
T Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~--~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~~~ 385 (391)
T PHA03212 316 DAQANLDEIYIGLAKKSSRKPG-SRPLWTNL--YELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDIPDP 385 (391)
T ss_pred chhHHHHHHHHHHHhccCCCCC-CCCCHHHH--hhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhccCCCC
Confidence 0000000 000000 00112111 2357789999999999999999999999999999886443
|
|
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-47 Score=356.95 Aligned_cols=284 Identities=32% Similarity=0.557 Sum_probs=223.5
Q ss_pred eeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccch------hhhHHHHHHHHHcCCCCeeeeceEEEecCC-CceeE
Q 016184 82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTD-KEELY 154 (394)
Q Consensus 82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~~~~~ 154 (394)
.+|++.+.||+|+||.||+|.+..+++.||||++.... ....+|+.+++.++|+||+++++++..... .....
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 96 (355)
T cd07874 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQD 96 (355)
T ss_pred hceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccce
Confidence 46999999999999999999999999999999886421 233468999999999999999998754332 22345
Q ss_pred EEEEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCccc
Q 016184 155 LNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV 234 (394)
Q Consensus 155 ~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~ 234 (394)
.+++|||+++++.+.+. ..+++..++.++.|++.||.|||+ .||+||||||+|||++.++ .+||+|||+++.
T Consensus 97 ~~lv~e~~~~~l~~~~~------~~l~~~~~~~~~~qi~~aL~~LH~-~givHrDikp~Nill~~~~-~~kl~Dfg~~~~ 168 (355)
T cd07874 97 VYLVMELMDANLCQVIQ------MELDHERMSYLLYQMLCGIKHLHS-AGIIHRDLKPSNIVVKSDC-TLKILDFGLART 168 (355)
T ss_pred eEEEhhhhcccHHHHHh------hcCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCChHHEEECCCC-CEEEeeCccccc
Confidence 78999999988765543 358889999999999999999999 8999999999999999888 799999999986
Q ss_pred cccCCCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCC
Q 016184 235 LVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 314 (394)
Q Consensus 235 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 314 (394)
...........+|+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+.+..+...++.+..+.+..+.+
T Consensus 169 ~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (355)
T cd07874 169 AGTSFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP 247 (355)
T ss_pred CCCccccCCccccCCccCHHHHcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcH
Confidence 6544444556789999999999654 489999999999999999999999999888888888888777776655443321
Q ss_pred C----------CcccCCCCCCCC---CcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCC
Q 016184 315 N----------YTEFKFPQIKPH---PWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP 374 (394)
Q Consensus 315 ~----------~~~~~~~~~~~~---~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~ 374 (394)
. +....++..... +.........+..+++||.+||+.||++|||+.|+|+||||....++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~~~~~ 320 (355)
T cd07874 248 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINVWYDP 320 (355)
T ss_pred HHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhcccCh
Confidence 1 111111111000 01111223356789999999999999999999999999999877654
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-47 Score=361.02 Aligned_cols=283 Identities=35% Similarity=0.574 Sum_probs=222.9
Q ss_pred EEEeeEEeecCceEEEEEEECCCCcEEEEEEeccc------hhhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEEEE
Q 016184 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL 157 (394)
Q Consensus 84 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 157 (394)
|++.+.||+|+||.||+|.+..+|+.||||++... .....+|+++++.++|+||+++++++...........++
T Consensus 2 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 81 (372)
T cd07853 2 VEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYV 81 (372)
T ss_pred CcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEEE
Confidence 78899999999999999999999999999987542 123457999999999999999999885433222336789
Q ss_pred EEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCcccccc
Q 016184 158 VLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK 237 (394)
Q Consensus 158 v~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~ 237 (394)
||||+.+++...+.. ...+++..++.++.||+.||.|||+ .||+||||||+|||++.++ .+||+|||++.....
T Consensus 82 v~e~~~~~l~~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~-~~ivH~dlkp~Nili~~~~-~~kL~Dfg~a~~~~~ 155 (372)
T cd07853 82 VTELMQSDLHKIIVS----PQPLSSDHVKVFLYQILRGLKYLHS-AGILHRDIKPGNLLVNSNC-VLKICDFGLARVEEP 155 (372)
T ss_pred EeeccccCHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHh-CCeeCCCCChHHEEECCCC-CEEeccccceeeccc
Confidence 999999877665532 3678999999999999999999999 8999999999999999887 799999999875432
Q ss_pred CC--CcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCC
Q 016184 238 GE--PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 315 (394)
Q Consensus 238 ~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 315 (394)
.. ......+++.|+|||.+.+...++.++|||||||++|+|++|+.||.+.+..+.+..+.+.++.++.+.+......
T Consensus 156 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~ 235 (372)
T cd07853 156 DESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEG 235 (372)
T ss_pred CccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHH
Confidence 22 1223457889999999977666899999999999999999999999999988999999998888877655322111
Q ss_pred CcccCCCCCC-CCCcch--hccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 016184 316 YTEFKFPQIK-PHPWHK--VFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR 372 (394)
Q Consensus 316 ~~~~~~~~~~-~~~~~~--~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 372 (394)
.......... ...... .+....++++.+||.+||+.||.+|||+.++|+||||++.+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~ 295 (372)
T cd07853 236 ARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEGR 295 (372)
T ss_pred HHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCCc
Confidence 0000000000 000000 12345688999999999999999999999999999999854
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-47 Score=353.59 Aligned_cols=257 Identities=32% Similarity=0.544 Sum_probs=217.0
Q ss_pred eeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccch-------hhhHHHHHHHHHcC-CCCeeeeceEEEecCCCcee
Q 016184 82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLD-HPNIVALKHCFFSTTDKEEL 153 (394)
Q Consensus 82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~ 153 (394)
..|.+.+.||.|.||.||+|+.+.+|+.+|+|++.+.. ....+|+.+|+++. ||||+.+.+.|. ...
T Consensus 35 ~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e-----~~~ 109 (382)
T KOG0032|consen 35 EKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFE-----DPD 109 (382)
T ss_pred ccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEE-----cCC
Confidence 35999999999999999999999999999999986543 35678999999998 999999999993 333
Q ss_pred EEEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCC---CcEEEEee
Q 016184 154 YLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHT---HQLKLCDF 229 (394)
Q Consensus 154 ~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~---~~vkl~Df 229 (394)
.+++|||++.| .|.+.+... .+++..+..++.|++.|++|||+ .||+||||||+|+|+.... ..+|++||
T Consensus 110 ~~~lvmEL~~GGeLfd~i~~~-----~~sE~da~~~~~~il~av~~lH~-~gvvHrDlKpEN~L~~~~~~~~~~ik~~DF 183 (382)
T KOG0032|consen 110 SVYLVMELCEGGELFDRIVKK-----HYSERDAAGIIRQILEAVKYLHS-LGVVHRDLKPENLLLASKDEGSGRIKLIDF 183 (382)
T ss_pred eEEEEEEecCCchHHHHHHHc-----cCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCHHHeeeccccCCCCcEEEeeC
Confidence 58899999995 454444432 39999999999999999999999 8999999999999996542 26999999
Q ss_pred cCccccccCCCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhh
Q 016184 230 GSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI 309 (394)
Q Consensus 230 g~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 309 (394)
|++.....+......+||+.|+|||++.. ..|+..+||||+|+++|.|++|.+||.+.+.......+...-
T Consensus 184 Gla~~~~~~~~~~~~~Gtp~y~APEvl~~-~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~-------- 254 (382)
T KOG0032|consen 184 GLAKFIKPGERLHTIVGTPEYVAPEVLGG-RPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGD-------- 254 (382)
T ss_pred CCceEccCCceEeeecCCccccCchhhcC-CCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCC--------
Confidence 99998877666778899999999999954 459999999999999999999999999988777777665521
Q ss_pred hccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCC
Q 016184 310 KCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 375 (394)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~ 375 (394)
+ .....+| ..++..+++||+.||..||.+|+|+.++|+|||++......
T Consensus 255 ---------~---~f~~~~w-----~~is~~akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~~~~~ 303 (382)
T KOG0032|consen 255 ---------F---DFTSEPW-----DDISESAKDFIRKLLEFDPRKRLTAAQALQHPWIKSIGEAT 303 (382)
T ss_pred ---------C---CCCCCCc-----cccCHHHHHHHHHhcccCcccCCCHHHHhcCccccCCcccc
Confidence 1 1112223 56899999999999999999999999999999998874444
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-47 Score=353.52 Aligned_cols=252 Identities=29% Similarity=0.426 Sum_probs=207.4
Q ss_pred cceeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccch-------hhhHHHHHHHHHcCCCCeeeeceEEEecCCCce
Q 016184 80 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE 152 (394)
Q Consensus 80 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 152 (394)
...+|++.+.||+|+||.||+|++..+++.||+|++.... ....+|+.+++.++||||+++++++. ..
T Consensus 16 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-----~~ 90 (329)
T PTZ00263 16 KLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQ-----DE 90 (329)
T ss_pred CchheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEE-----cC
Confidence 3456999999999999999999999999999999886432 23457999999999999999999883 33
Q ss_pred eEEEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecC
Q 016184 153 LYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS 231 (394)
Q Consensus 153 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~ 231 (394)
...+++|||+.+ +|.+.+.. ...+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+
T Consensus 91 ~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivH~dlkp~NIll~~~~-~~kl~Dfg~ 164 (329)
T PTZ00263 91 NRVYFLLEFVVGGELFTHLRK----AGRFPNDVAKFYHAELVLAFEYLHS-KDIIYRDLKPENLLLDNKG-HVKVTDFGF 164 (329)
T ss_pred CEEEEEEcCCCCChHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCCHHHEEECCCC-CEEEeeccC
Confidence 458899999985 66555543 3678999999999999999999999 8999999999999999888 699999999
Q ss_pred ccccccCCCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhc
Q 016184 232 AKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 311 (394)
Q Consensus 232 a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 311 (394)
+..... ......||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+.......+...
T Consensus 165 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~----------- 230 (329)
T PTZ00263 165 AKKVPD--RTFTLCGTPEYLAPEVIQSKG-HGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAG----------- 230 (329)
T ss_pred ceEcCC--CcceecCChhhcCHHHHcCCC-CCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcC-----------
Confidence 976533 223457899999999996544 799999999999999999999999877665554444321
Q ss_pred cCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCC-----HHHHhcCCCCCCCCCC
Q 016184 312 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCT-----ALEACVHPFFDELRDP 374 (394)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt-----~~ell~hp~f~~~~~~ 374 (394)
... ++..++..+++||++||+.||.+|++ ++++++||||++....
T Consensus 231 ------~~~------------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~~~~~ 280 (329)
T PTZ00263 231 ------RLK------------FPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFHGANWD 280 (329)
T ss_pred ------CcC------------CCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCccCCCCHH
Confidence 001 12346889999999999999999997 7999999999985433
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-47 Score=348.38 Aligned_cols=249 Identities=27% Similarity=0.409 Sum_probs=207.0
Q ss_pred eEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccc-------hhhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEE
Q 016184 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL 155 (394)
Q Consensus 83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 155 (394)
+|++.+.||+|+||.||+|.+..+|+.||+|++... .....+|+++++.++||||+++++++ .+..+.
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~~~~ 76 (291)
T cd05612 2 DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTE-----HDQRFL 76 (291)
T ss_pred CceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhh-----ccCCeE
Confidence 599999999999999999999999999999988542 22345799999999999999998877 344568
Q ss_pred EEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCccc
Q 016184 156 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV 234 (394)
Q Consensus 156 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~ 234 (394)
++||||+++ +|.+++.. ...+++..++.++.|++.||+|||+ +||+||||||+|||++.++ .+||+|||++..
T Consensus 77 ~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~NIli~~~~-~~kl~Dfg~~~~ 150 (291)
T cd05612 77 YMLMEYVPGGELFSYLRN----SGRFSNSTGLFYASEIVCALEYLHS-KEIVYRDLKPENILLDKEG-HIKLTDFGFAKK 150 (291)
T ss_pred EEEEeCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCCHHHeEECCCC-CEEEEecCcchh
Confidence 899999985 66665543 3578999999999999999999999 8999999999999999887 699999999876
Q ss_pred cccCCCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCC
Q 016184 235 LVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 314 (394)
Q Consensus 235 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 314 (394)
... ......|++.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+.......+....
T Consensus 151 ~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~------------- 214 (291)
T cd05612 151 LRD--RTWTLCGTPEYLAPEVIQSK-GHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGK------------- 214 (291)
T ss_pred ccC--CcccccCChhhcCHHHHcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-------------
Confidence 533 22345689999999998654 48999999999999999999999998877665555544310
Q ss_pred CCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCC-----HHHHhcCCCCCCCCCC
Q 016184 315 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCT-----ALEACVHPFFDELRDP 374 (394)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt-----~~ell~hp~f~~~~~~ 374 (394)
.. ++..++..+++||++||+.||.+|++ ++++++||||+.+...
T Consensus 215 ----~~------------~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~~~ 263 (291)
T cd05612 215 ----LE------------FPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWFKSVDWD 263 (291)
T ss_pred ----cC------------CCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCccccCCCHH
Confidence 00 12456889999999999999999995 9999999999986544
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-48 Score=321.66 Aligned_cols=254 Identities=29% Similarity=0.449 Sum_probs=218.1
Q ss_pred CccceeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccch-------hhhHHHHHHHHHcCCCCeeeeceEEEecCCC
Q 016184 78 SKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDK 150 (394)
Q Consensus 78 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 150 (394)
....++|.+++.||.|-||.||+|+.+.++-.||+|++.++. ....+|+++-..|+||||++++++| .
T Consensus 18 ~~~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~f-----h 92 (281)
T KOG0580|consen 18 TWTLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYF-----H 92 (281)
T ss_pred ccchhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhhe-----e
Confidence 344567999999999999999999999999999999986543 4456899999999999999999999 4
Q ss_pred ceeEEEEEEeccc-ccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEee
Q 016184 151 EELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDF 229 (394)
Q Consensus 151 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Df 229 (394)
+...+|+++||.+ |.+...+... ...++++...+.++.|++.||.|+|. ++|+||||||+|+|++.++ .+||+||
T Consensus 93 d~~riyLilEya~~gel~k~L~~~--~~~~f~e~~~a~Yi~q~A~Al~y~h~-k~VIhRdiKpenlLlg~~~-~lkiAdf 168 (281)
T KOG0580|consen 93 DSKRIYLILEYAPRGELYKDLQEG--RMKRFDEQRAATYIKQLANALLYCHL-KRVIHRDIKPENLLLGSAG-ELKIADF 168 (281)
T ss_pred ccceeEEEEEecCCchHHHHHHhc--ccccccccchhHHHHHHHHHHHHhcc-CCcccCCCCHHHhccCCCC-CeeccCC
Confidence 4445899999998 4565555432 34779999999999999999999999 8999999999999999998 6999999
Q ss_pred cCccccccCCCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhh
Q 016184 230 GSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI 309 (394)
Q Consensus 230 g~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 309 (394)
|-+-... .....+.+||..|.+||...+.. .+...|+|++|++.||++.|.+||......+.+..|.+.
T Consensus 169 GwsV~~p-~~kR~tlcgt~dyl~pEmv~~~~-hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~--------- 237 (281)
T KOG0580|consen 169 GWSVHAP-SNKRKTLCGTLDYLPPEMVEGRG-HDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKV--------- 237 (281)
T ss_pred CceeecC-CCCceeeecccccCCHhhcCCCC-ccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHc---------
Confidence 9886544 44556789999999999996554 899999999999999999999999998877888887763
Q ss_pred hccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 016184 310 KCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL 371 (394)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 371 (394)
++. ++..++.+++|||.+||.++|.+|.+..|++.|||+...
T Consensus 238 --------~~~------------~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpwI~a~ 279 (281)
T KOG0580|consen 238 --------DLK------------FPSTISGGAADLISRLLVKNPIERLALTEVMDHPWIVAN 279 (281)
T ss_pred --------ccc------------CCcccChhHHHHHHHHhccCccccccHHHHhhhHHHHhc
Confidence 222 235789999999999999999999999999999999765
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-46 Score=337.78 Aligned_cols=306 Identities=26% Similarity=0.429 Sum_probs=251.9
Q ss_pred CCCCcCceeeeccCCCCCCCccceeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccchhhhH---HHHHHHHHcC--
Q 016184 59 VGAETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLD-- 133 (394)
Q Consensus 59 ~~~~~~~~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~---~E~~~l~~l~-- 133 (394)
..+..|...+..+|+.+.. .+|.+.++||.|.|++||+|.+....+.||+|+++....+.+ .|+++|++++
T Consensus 59 ~dY~kGGYHpV~IGD~F~~----gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhYtEaAlDEIklL~~v~~~ 134 (590)
T KOG1290|consen 59 EDYRKGGYHPVRIGDVFNG----GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHYTEAALDEIKLLQQVREG 134 (590)
T ss_pred hhhhcCCCceeeccccccC----ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhHHHHHHHHHHHHHHHHHhc
Confidence 3566777888888877654 359999999999999999999999999999999987766554 5999999882
Q ss_pred ---C---CCeeeeceEEEecCCCceeEEEEEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcee
Q 016184 134 ---H---PNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICH 207 (394)
Q Consensus 134 ---h---~~iv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH 207 (394)
| .+||++++.|- ..+.++.++|||+|+++.+|..++..... +.+++..++.|++||+.||.|||+..||||
T Consensus 135 Dp~~~~~~~VV~LlD~Fk-hsGpNG~HVCMVfEvLGdnLLklI~~s~Y--rGlpl~~VK~I~~qvL~GLdYLH~ecgIIH 211 (590)
T KOG1290|consen 135 DPNDPGKKCVVQLLDHFK-HSGPNGQHVCMVFEVLGDNLLKLIKYSNY--RGLPLSCVKEICRQVLTGLDYLHRECGIIH 211 (590)
T ss_pred CCCCCCCceeeeeeccce-ecCCCCcEEEEEehhhhhHHHHHHHHhCC--CCCcHHHHHHHHHHHHHHHHHHHHhcCccc
Confidence 2 47999999874 34478889999999999999888886554 889999999999999999999999889999
Q ss_pred ccCCCCceEEe---------------------------------------------------------------------
Q 016184 208 RDIKPQNLLVN--------------------------------------------------------------------- 218 (394)
Q Consensus 208 ~Dlkp~Nil~~--------------------------------------------------------------------- 218 (394)
.||||+|||+.
T Consensus 212 TDlKPENvLl~~~e~~~~~~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~ 291 (590)
T KOG1290|consen 212 TDLKPENVLLCSTEIDPAKDAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGL 291 (590)
T ss_pred cCCCcceeeeeccccchhhhhhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhccc
Confidence 99999999982
Q ss_pred ---------------------------------------------CC---------------------------C-----
Q 016184 219 ---------------------------------------------PH---------------------------T----- 221 (394)
Q Consensus 219 ---------------------------------------------~~---------------------------~----- 221 (394)
.. .
T Consensus 292 ~~~~~~~~~~s~n~~~~~n~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~ 371 (590)
T KOG1290|consen 292 EGIEEEPNQESYNNEPRINGNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSP 371 (590)
T ss_pred ccccccccccccccccCCCccccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCc
Confidence 00 0
Q ss_pred -------------------CcEEEEeecCccccccCCCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCC
Q 016184 222 -------------------HQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQ 282 (394)
Q Consensus 222 -------------------~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~ 282 (394)
-.|||+|||-|+... ........|..|+|||++.+.. |+..+||||++|++|||+||.
T Consensus 372 ~~~~~n~~v~p~~~~~~~di~vKIaDlGNACW~~--khFT~DIQTRQYRapEVllGsg-Y~~~ADiWS~AC~~FELaTGD 448 (590)
T KOG1290|consen 372 GTIASNPLVNPDIPLPECDIRVKIADLGNACWVH--KHFTEDIQTRQYRAPEVLLGSG-YSTSADIWSTACMAFELATGD 448 (590)
T ss_pred cccccccccCCCCCCCccceeEEEeeccchhhhh--hhhchhhhhhhccCcceeecCC-CCCchhHHHHHHHHHHhhcCc
Confidence 036888888887642 3344556799999999998876 999999999999999999999
Q ss_pred CCCCCC------CcHHHHHHHHHHhCCCChhhhh-------ccCCCCcccCCCCCCCCCcchhcccc------CChHHHH
Q 016184 283 PLFPGE------SGVDQLVEIIKVLGTPTREEIK-------CMNPNYTEFKFPQIKPHPWHKVFQKR------LPPEAVD 343 (394)
Q Consensus 283 ~pf~~~------~~~~~~~~i~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~ 343 (394)
..|... .+.++++.|+..+|..|..... .++.......+..+++.++.+++.+. ...++.+
T Consensus 449 yLFePhsG~~Y~rDEDHiA~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsd 528 (590)
T KOG1290|consen 449 YLFEPHSGENYSRDEDHIALIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSD 528 (590)
T ss_pred eeecCCCCCCCCccHHHHHHHHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHH
Confidence 998643 4678999999999999987764 44555556677777888776665443 2356889
Q ss_pred HHHHhcccCCCCCCCHHHHhcCCCCCCCCCC
Q 016184 344 LVCRFFQYSPNLRCTALEACVHPFFDELRDP 374 (394)
Q Consensus 344 li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~ 374 (394)
||.-||+++|++||||.+.|+|||+..+-.+
T Consensus 529 FL~PmLef~PeKR~tA~~cl~hPwLn~~~~~ 559 (590)
T KOG1290|consen 529 FLSPMLEFDPEKRPTAAQCLKHPWLNPVAGP 559 (590)
T ss_pred HHHHHHhcCccccccHHHHhcCccccCCCCC
Confidence 9999999999999999999999999877655
|
|
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-46 Score=354.16 Aligned_cols=285 Identities=34% Similarity=0.615 Sum_probs=226.1
Q ss_pred eeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccch------hhhHHHHHHHHHcCCCCeeeeceEEEecCC-CceeE
Q 016184 82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTD-KEELY 154 (394)
Q Consensus 82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~~~~~ 154 (394)
.+|++.+.||.|+||.||+|.+..+++.||||++.... ....+|+.+++.++|+||+++++++..... .....
T Consensus 15 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 94 (343)
T cd07878 15 ERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNE 94 (343)
T ss_pred hhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccCc
Confidence 35999999999999999999999999999999886432 234479999999999999999988743221 22344
Q ss_pred EEEEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCccc
Q 016184 155 LNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV 234 (394)
Q Consensus 155 ~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~ 234 (394)
.+++++++++++..++.. ..+++..++.++.||+.||.|||+ .||+||||||+|||++.++ .+||+|||++..
T Consensus 95 ~~~~~~~~~~~l~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~-~~ivHrdikp~Nil~~~~~-~~kl~Dfg~~~~ 167 (343)
T cd07878 95 VYLVTNLMGADLNNIVKC-----QKLSDEHVQFLIYQLLRGLKYIHS-AGIIHRDLKPSNVAVNEDC-ELRILDFGLARQ 167 (343)
T ss_pred EEEEeecCCCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH-CCeecccCChhhEEECCCC-CEEEcCCcccee
Confidence 689999998888776643 579999999999999999999999 8999999999999999887 699999999976
Q ss_pred cccCCCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCC
Q 016184 235 LVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 314 (394)
Q Consensus 235 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 314 (394)
... ......+|+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+.+..+....+.+..+.......
T Consensus 168 ~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (343)
T cd07878 168 ADD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISS 245 (343)
T ss_pred cCC--CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcch
Confidence 533 234457899999999987656689999999999999999999999998888888888888777776655433222
Q ss_pred CCccc---CCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCC
Q 016184 315 NYTEF---KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNT 376 (394)
Q Consensus 315 ~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~ 376 (394)
..... .++......+...+ ...++.+.+||.+||+.||.+|||+.++|+||||....++..
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~~~~~~ 309 (343)
T cd07878 246 EHARKYIQSLPHMPQQDLKKIF-RGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQYHDPED 309 (343)
T ss_pred hhHHHHhhccccccchhHHHhc-cCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhccCCCcc
Confidence 11100 11111111122222 346788999999999999999999999999999999876654
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-48 Score=329.68 Aligned_cols=253 Identities=28% Similarity=0.489 Sum_probs=215.1
Q ss_pred eEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccc------------hhhhHHHHHHHHHc-CCCCeeeeceEEEecCC
Q 016184 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------------KRYKNRELQIMQML-DHPNIVALKHCFFSTTD 149 (394)
Q Consensus 83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------------~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~ 149 (394)
.|.-.+.||.|..++|.++.++.+|+.+|+|++... .....+|+.+|+++ .||+|+++.+.|
T Consensus 18 ~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~y----- 92 (411)
T KOG0599|consen 18 KYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVY----- 92 (411)
T ss_pred hcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeec-----
Confidence 377788999999999999999999999999987421 12234689999998 799999999998
Q ss_pred CceeEEEEEEeccc-ccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEe
Q 016184 150 KEELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCD 228 (394)
Q Consensus 150 ~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~D 228 (394)
....++++|+|.|+ |.|.+.+.. ...++++..+.+++|++.|++|||. ++||||||||+|||++++. ++||+|
T Consensus 93 es~sF~FlVFdl~prGELFDyLts----~VtlSEK~tR~iMrqlfegVeylHa-~~IVHRDLKpENILlddn~-~i~isD 166 (411)
T KOG0599|consen 93 ESDAFVFLVFDLMPRGELFDYLTS----KVTLSEKETRRIMRQLFEGVEYLHA-RNIVHRDLKPENILLDDNM-NIKISD 166 (411)
T ss_pred cCcchhhhhhhhcccchHHHHhhh----heeecHHHHHHHHHHHHHHHHHHHH-hhhhhcccChhheeecccc-ceEEec
Confidence 66667889999998 455555443 4779999999999999999999999 8999999999999999877 699999
Q ss_pred ecCccccccCCCcccccccccccccccccC-----CCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCC
Q 016184 229 FGSAKVLVKGEPNVSYICSRYYRAPELIFG-----ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGT 303 (394)
Q Consensus 229 fg~a~~~~~~~~~~~~~~t~~y~aPE~~~~-----~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~ 303 (394)
||+|+.+..++.....+|||+|.|||.+.. .+.|+...|+||+|||+|.|+.|.+||.-..+..++..|++..
T Consensus 167 FGFa~~l~~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGk-- 244 (411)
T KOG0599|consen 167 FGFACQLEPGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGK-- 244 (411)
T ss_pred cceeeccCCchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcc--
Confidence 999999999999999999999999999843 3458889999999999999999999998877777777776632
Q ss_pred CChhhhhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 016184 304 PTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL 371 (394)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 371 (394)
+.+ ....| .+++.+.++||.+||+.||.+|.|++|+|.||||..+
T Consensus 245 ---------------yqF---~speW-----adis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q~ 289 (411)
T KOG0599|consen 245 ---------------YQF---RSPEW-----ADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQI 289 (411)
T ss_pred ---------------ccc---CCcch-----hhccccHHHHHHHHHeeCchhcccHHHHhcChHHHHH
Confidence 111 11122 5689999999999999999999999999999999554
|
|
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-46 Score=352.70 Aligned_cols=277 Identities=23% Similarity=0.333 Sum_probs=206.6
Q ss_pred eeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccchhhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEEEEEEec
Q 016184 82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEY 161 (394)
Q Consensus 82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~ 161 (394)
.+|++.+.||+|+||.||+|++..+++.||+|+.... ....|+.+++.++|+||+++++++.. ..+.++|||+
T Consensus 66 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~--~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~~lv~e~ 138 (357)
T PHA03209 66 LGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG--TTLIEAMLLQNVNHPSVIRMKDTLVS-----GAITCMVLPH 138 (357)
T ss_pred cCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc--ccHHHHHHHHhCCCCCCcChhheEEe-----CCeeEEEEEc
Confidence 3699999999999999999999999999999975433 33569999999999999999998843 3457899999
Q ss_pred ccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCccccccCCCc
Q 016184 162 VPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN 241 (394)
Q Consensus 162 ~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~~~~~ 241 (394)
+.+++...+.. ....+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||++.........
T Consensus 139 ~~~~l~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlkp~Nill~~~~-~~kl~DfG~a~~~~~~~~~ 213 (357)
T PHA03209 139 YSSDLYTYLTK---RSRPLPIDQALIIEKQILEGLRYLHA-QRIIHRDVKTENIFINDVD-QVCIGDLGAAQFPVVAPAF 213 (357)
T ss_pred cCCcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEECCCC-CEEEecCccccccccCccc
Confidence 99888776653 23678999999999999999999999 8999999999999999887 6999999999754443344
Q ss_pred ccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCC-CCCCCCc---------HHHHHHHHHHhCCCChhhhhc
Q 016184 242 VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQP-LFPGESG---------VDQLVEIIKVLGTPTREEIKC 311 (394)
Q Consensus 242 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~-pf~~~~~---------~~~~~~i~~~~~~~~~~~~~~ 311 (394)
....||+.|+|||++.+. .++.++|||||||++|+|+++.. +|..... ...+..+...++..+......
T Consensus 214 ~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 292 (357)
T PHA03209 214 LGLAGTVETNAPEVLARD-KYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRD 292 (357)
T ss_pred ccccccccccCCeecCCC-CCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCCC
Confidence 456789999999999654 48999999999999999998654 4443211 123344444444333221100
Q ss_pred cCCCCc--ccCCCCCC---CCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 016184 312 MNPNYT--EFKFPQIK---PHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL 371 (394)
Q Consensus 312 ~~~~~~--~~~~~~~~---~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 371 (394)
...... ........ ...+.......++.++.+||.+||++||.+|||+.|+|+||||+++
T Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~~ 357 (357)
T PHA03209 293 PGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQL 357 (357)
T ss_pred CccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhccC
Confidence 000000 00000000 0011111123568889999999999999999999999999999874
|
|
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-46 Score=342.85 Aligned_cols=271 Identities=24% Similarity=0.373 Sum_probs=215.0
Q ss_pred EEEeeEEeecCceEEEEEEECCCCcEEEEEEeccch-------hhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEEE
Q 016184 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN 156 (394)
Q Consensus 84 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 156 (394)
|++.++||+|+||.||++.+..+++.||+|++.... ....+|+.+++.++|+||+++++++ ....+.+
T Consensus 2 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~~ 76 (285)
T cd05605 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAY-----ETKDALC 76 (285)
T ss_pred ceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeee-----cCCCeEE
Confidence 899999999999999999999999999999885432 2234699999999999999998887 3334588
Q ss_pred EEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCcccc
Q 016184 157 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL 235 (394)
Q Consensus 157 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~ 235 (394)
+||||+.+ +|...+... ....+++..+..++.|++.||.|||+ .|++||||||+||+++.++ .++|+|||++...
T Consensus 77 lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~dlkp~Nil~~~~~-~~~l~Dfg~~~~~ 152 (285)
T cd05605 77 LVLTLMNGGDLKFHIYNM--GNPGFDEERAVFYAAEITCGLEDLHR-ERIVYRDLKPENILLDDYG-HIRISDLGLAVEI 152 (285)
T ss_pred EEEeccCCCcHHHHHHhc--CcCCCCHHHHHHHHHHHHHHHHHHHH-CCcEecCCCHHHEEECCCC-CEEEeeCCCceec
Confidence 99999985 665544432 23568999999999999999999999 8999999999999999887 6999999999766
Q ss_pred ccCCCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCC
Q 016184 236 VKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 315 (394)
Q Consensus 236 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 315 (394)
..........+++.|+|||++.+. .++.++||||+||++|+|++|+.||.+.........+...+....
T Consensus 153 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~---------- 221 (285)
T cd05605 153 PEGETIRGRVGTVGYMAPEVVKNE-RYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQ---------- 221 (285)
T ss_pred CCCCccccccCCCCccCcHHhcCC-CCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcc----------
Confidence 444433445789999999998654 489999999999999999999999987665444333333211100
Q ss_pred CcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCC-----CHHHHhcCCCCCCCCCCCCCCCCCCCCCCCCCC
Q 016184 316 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-----TALEACVHPFFDELRDPNTRLPNGRPLPPLFNF 390 (394)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----t~~ell~hp~f~~~~~~~~~~~~~~~~~~~~~~ 390 (394)
..++..++..+.+||.+||+.||.+|| +++++++||||.+...... +....+|++.+
T Consensus 222 ---------------~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~~~~---~~~~~~~~~~~ 283 (285)
T cd05605 222 ---------------EEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTANFKRL---EAGMLEPPFCP 283 (285)
T ss_pred ---------------cccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcCcCccCCCHHHH---hhCCCCCCCCC
Confidence 001245788999999999999999999 9999999999998644433 23444577777
Q ss_pred CC
Q 016184 391 KP 392 (394)
Q Consensus 391 ~~ 392 (394)
+|
T Consensus 284 ~~ 285 (285)
T cd05605 284 DP 285 (285)
T ss_pred CC
Confidence 76
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-47 Score=352.07 Aligned_cols=244 Identities=27% Similarity=0.457 Sum_probs=199.4
Q ss_pred eEEeecCceEEEEEEECCCCcEEEEEEeccch-------hhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEEEEEEe
Q 016184 88 HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLE 160 (394)
Q Consensus 88 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e 160 (394)
+.||+|+||.||+|++..+|+.||||++.+.. ....+|+.+++.++||||+++++++ ....+.++|||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~-----~~~~~~~lv~e 75 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSF-----QTHDRLCFVME 75 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEE-----EcCCEEEEEEe
Confidence 46999999999999999999999999886432 2234688999999999999998887 33445889999
Q ss_pred cccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCcccccc-C
Q 016184 161 YVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK-G 238 (394)
Q Consensus 161 ~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~-~ 238 (394)
|+++ +|...+.. ...+++..++.++.||+.||+|||+ .||+||||||+|||++.++ .+||+|||+++.... .
T Consensus 76 ~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~L~~lH~-~~ivHrDlkp~NIll~~~~-~~kl~DfG~a~~~~~~~ 149 (323)
T cd05571 76 YANGGELFFHLSR----ERVFSEDRARFYGAEIVSALGYLHS-CDVVYRDLKLENLMLDKDG-HIKITDFGLCKEGISDG 149 (323)
T ss_pred CCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeEeCCCCHHHEEECCCC-CEEEeeCCCCcccccCC
Confidence 9986 55444432 4678999999999999999999999 8999999999999999887 699999999875422 2
Q ss_pred CCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCCCcc
Q 016184 239 EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 318 (394)
Q Consensus 239 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 318 (394)
.......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+.......+... .
T Consensus 150 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~-----------------~ 211 (323)
T cd05571 150 ATMKTFCGTPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME-----------------E 211 (323)
T ss_pred CcccceecCccccChhhhcCC-CCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcC-----------------C
Confidence 233345789999999998654 4899999999999999999999999876654444433221 0
Q ss_pred cCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCC-----CHHHHhcCCCCCCCC
Q 016184 319 FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-----TALEACVHPFFDELR 372 (394)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----t~~ell~hp~f~~~~ 372 (394)
.. ++..+++++.+||++||+.||++|| ++.++++||||+.+.
T Consensus 212 ~~------------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h~~f~~~~ 258 (323)
T cd05571 212 IR------------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFFASIN 258 (323)
T ss_pred CC------------CCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcCCCcCCCC
Confidence 11 2245789999999999999999999 899999999998853
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-46 Score=346.27 Aligned_cols=245 Identities=31% Similarity=0.471 Sum_probs=201.8
Q ss_pred EEEeeEEeecCceEEEEEEECCCCcE-EEEEEeccc------hhhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEEE
Q 016184 84 YIAEHVVGTGSFGVVFQAKCRETGEI-VAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN 156 (394)
Q Consensus 84 y~~~~~lg~G~~g~V~~~~~~~~~~~-vaiK~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 156 (394)
..+...||.|+||+||+|.++ |+. ||||++... ...+.+|+.+|.+++|||||++++++..... .++
T Consensus 43 l~~~~~iG~G~~g~V~~~~~~--g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~----~~~ 116 (362)
T KOG0192|consen 43 LPIEEVLGSGSFGTVYKGKWR--GTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPG----SLC 116 (362)
T ss_pred hhhhhhcccCCceeEEEEEeC--CceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC----ceE
Confidence 445566999999999999997 556 999998653 2467789999999999999999999943321 488
Q ss_pred EEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCC-ceeccCCCCceEEeCCCCcEEEEeecCccc
Q 016184 157 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG-ICHRDIKPQNLLVNPHTHQLKLCDFGSAKV 234 (394)
Q Consensus 157 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~g-ivH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~ 234 (394)
+||||+++ +|.+++... ....++...+..++.||+.||+|||+ .+ ||||||||+|||++.++.++||+|||+++.
T Consensus 117 iVtEy~~~GsL~~~l~~~--~~~~l~~~~~l~~aldiArGm~YLH~-~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~ 193 (362)
T KOG0192|consen 117 IVTEYMPGGSLSVLLHKK--RKRKLPLKVRLRIALDIARGMEYLHS-EGPIIHRDLKSDNILVDLKGKTLKIADFGLSRE 193 (362)
T ss_pred EEEEeCCCCcHHHHHhhc--ccCCCCHHHHHHHHHHHHHHHHHHhc-CCCeeecccChhhEEEcCCCCEEEECCCcccee
Confidence 99999994 777777654 35789999999999999999999999 79 999999999999998864699999999987
Q ss_pred cccC-CCcccccccccccccccccC-CCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhcc
Q 016184 235 LVKG-EPNVSYICSRYYRAPELIFG-ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 312 (394)
Q Consensus 235 ~~~~-~~~~~~~~t~~y~aPE~~~~-~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 312 (394)
.... .......||+.|||||++.+ ...|+.|+||||||+++|||+||+.||.+.........+.....+|.
T Consensus 194 ~~~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~------- 266 (362)
T KOG0192|consen 194 KVISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPP------- 266 (362)
T ss_pred eccccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCC-------
Confidence 6544 33344789999999999974 34599999999999999999999999999887555555544322222
Q ss_pred CCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 016184 313 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV 364 (394)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 364 (394)
++..+++.+..|+.+||..||.+||+..+++.
T Consensus 267 --------------------~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~ 298 (362)
T KOG0192|consen 267 --------------------IPKECPPHLSSLMERCWLVDPSRRPSFLEIVS 298 (362)
T ss_pred --------------------CCccCCHHHHHHHHHhCCCCCCcCCCHHHHHH
Confidence 22457899999999999999999999988763
|
|
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-47 Score=345.63 Aligned_cols=254 Identities=28% Similarity=0.414 Sum_probs=225.6
Q ss_pred eEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccch------hhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEEE
Q 016184 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN 156 (394)
Q Consensus 83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 156 (394)
-|.+.+.||+|.|..|-+|++..+|+.||||++.+.+ ..+.+|++.|+.++|||||+++++. .....+|
T Consensus 19 LYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEVi-----DTQTKly 93 (864)
T KOG4717|consen 19 LYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVI-----DTQTKLY 93 (864)
T ss_pred eehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehh-----cccceEE
Confidence 4999999999999999999999999999999997643 3345799999999999999999987 3344488
Q ss_pred EEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCcccc
Q 016184 157 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL 235 (394)
Q Consensus 157 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~ 235 (394)
+|+|+-.+ +|.+++..+ ...+.+..+++++.||+.|+.|+|+ ..+|||||||+||.+.+.-+-|||.|||++..+
T Consensus 94 LiLELGD~GDl~DyImKH---e~Gl~E~La~kYF~QI~~AI~YCHq-LHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf 169 (864)
T KOG4717|consen 94 LILELGDGGDLFDYIMKH---EEGLNEDLAKKYFAQIVHAISYCHQ-LHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKF 169 (864)
T ss_pred EEEEecCCchHHHHHHhh---hccccHHHHHHHHHHHHHHHHHHhh-hhhhcccCCcceeEEeeecCceEeeeccccccC
Confidence 99998875 777666554 4789999999999999999999999 999999999999988776558999999999999
Q ss_pred ccCCCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCC
Q 016184 236 VKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 315 (394)
Q Consensus 236 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 315 (394)
..+....+.+|+..|.|||++.+..+...+.||||||||||-|++|++||...++.+.+..|+++-
T Consensus 170 ~PG~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCK-------------- 235 (864)
T KOG4717|consen 170 QPGKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCK-------------- 235 (864)
T ss_pred CCcchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhccc--------------
Confidence 999999999999999999999999877889999999999999999999999999999999988752
Q ss_pred CcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCC
Q 016184 316 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP 374 (394)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~ 374 (394)
+. ++..++.++++||..||..||.+|.|.++|..|+|+|..-.+
T Consensus 236 ---Yt------------vPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq~~D~~ 279 (864)
T KOG4717|consen 236 ---YT------------VPSHVSKECRDLIQSMLVRDPKKRASLEEIVSTSWLQAGDRG 279 (864)
T ss_pred ---cc------------CchhhhHHHHHHHHHHHhcCchhhccHHHHhccccccCCCCC
Confidence 22 235789999999999999999999999999999999987544
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-46 Score=352.88 Aligned_cols=255 Identities=27% Similarity=0.442 Sum_probs=203.7
Q ss_pred eEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccch-------hhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEE
Q 016184 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL 155 (394)
Q Consensus 83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 155 (394)
+|++.+.||+|+||+||+|++..+++.||||++.+.. ....+|+.++..++|+||+++++++ .....+
T Consensus 2 ~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~-----~~~~~~ 76 (363)
T cd05628 2 DFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSF-----QDKLNL 76 (363)
T ss_pred CceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEE-----ecCCeE
Confidence 5999999999999999999999999999999986532 2345689999999999999999888 334458
Q ss_pred EEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCccc
Q 016184 156 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV 234 (394)
Q Consensus 156 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~ 234 (394)
++||||+++ +|.+++.. ...+++..++.++.|++.||+|||+ +||+||||||+|||++.++ .+||+|||+++.
T Consensus 77 ~lv~E~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~-~givHrDlKp~NILi~~~~-~vkL~DFGla~~ 150 (363)
T cd05628 77 YLIMEFLPGGDMMTLLMK----KDTLTEEETQFYIAETVLAIDSIHQ-LGFIHRDIKPDNLLLDSKG-HVKLSDFGLCTG 150 (363)
T ss_pred EEEEcCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeEecCCCHHHeEECCCC-CEEEeeccCccc
Confidence 899999985 66665543 3679999999999999999999999 8999999999999999888 699999999875
Q ss_pred cccCC------------------------------------CcccccccccccccccccCCCCCCChhhHHHHHHHHHHH
Q 016184 235 LVKGE------------------------------------PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAEL 278 (394)
Q Consensus 235 ~~~~~------------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l 278 (394)
..... ......||+.|+|||++.+. .++.++|||||||++|+|
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~~~~~DvwSlGvil~el 229 (363)
T cd05628 151 LKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQT-GYNKLCDWWSLGVIMYEM 229 (363)
T ss_pred ccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCC-CCCCchhhhhhHHHHHHH
Confidence 42211 01234789999999999655 489999999999999999
Q ss_pred HhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCC---C
Q 016184 279 LLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPN---L 355 (394)
Q Consensus 279 ltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~---~ 355 (394)
++|+.||.+.+..+.+..+...... ..++. ...+++++++||.+|+. +|. .
T Consensus 230 l~G~~Pf~~~~~~~~~~~i~~~~~~---------------~~~p~----------~~~~s~~~~~li~~l~~-~~~~r~~ 283 (363)
T cd05628 230 LIGYPPFCSETPQETYKKVMNWKET---------------LIFPP----------EVPISEKAKDLILRFCC-EWEHRIG 283 (363)
T ss_pred HhCCCCCCCCCHHHHHHHHHcCcCc---------------ccCCC----------cCCCCHHHHHHHHHHcC-ChhhcCC
Confidence 9999999887766666555432110 01110 02368899999999775 444 4
Q ss_pred CCCHHHHhcCCCCCCCCCCC
Q 016184 356 RCTALEACVHPFFDELRDPN 375 (394)
Q Consensus 356 Rpt~~ell~hp~f~~~~~~~ 375 (394)
||+++++++||||+++....
T Consensus 284 r~~~~ei~~hp~f~~~~~~~ 303 (363)
T cd05628 284 APGVEEIKTNPFFEGVDWEH 303 (363)
T ss_pred CCCHHHHhCCCCCCCCCHHH
Confidence 68999999999999875443
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-46 Score=344.36 Aligned_cols=277 Identities=29% Similarity=0.496 Sum_probs=207.1
Q ss_pred eeEEeecCceEEEEEEEC--CCCcEEEEEEeccch--hhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEEEEEEecc
Q 016184 87 EHVVGTGSFGVVFQAKCR--ETGEIVAIKKVLQDK--RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYV 162 (394)
Q Consensus 87 ~~~lg~G~~g~V~~~~~~--~~~~~vaiK~~~~~~--~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~ 162 (394)
.++||+|+||.||+|+++ .+++.||+|.+.... ....+|+++++.++||||+++++++... ....++++|||+
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~---~~~~~~lv~e~~ 82 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFLSH---ADRKVWLLFDYA 82 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCCcHHHHHHHHHHHhcCCCCCcceeeeEecC---CCcEEEEEEecc
Confidence 357999999999999975 467899999886532 3456899999999999999999887432 234578999999
Q ss_pred cccHHHHHHHhhh-----hcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEe----CCCCcEEEEeecCcc
Q 016184 163 PETVNRIARNYSR-----IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVN----PHTHQLKLCDFGSAK 233 (394)
Q Consensus 163 ~~~l~~~~~~~~~-----~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~----~~~~~vkl~Dfg~a~ 233 (394)
++++..++..... ....+++..++.++.||+.||+|||+ .||+||||||+|||++ ..+ .+||+|||+++
T Consensus 83 ~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~-~~ivHrDlkp~Nil~~~~~~~~~-~~kl~DfG~a~ 160 (317)
T cd07868 83 EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA-NWVLHRDLKPANILVMGEGPERG-RVKIADMGFAR 160 (317)
T ss_pred CCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHh-CCEEcCCCCHHHEEEecCCCCcC-cEEEeecCcee
Confidence 9988777654321 12358999999999999999999999 8999999999999994 334 69999999997
Q ss_pred ccccCC----CcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCc---------HHHHHHHHHH
Q 016184 234 VLVKGE----PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESG---------VDQLVEIIKV 300 (394)
Q Consensus 234 ~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~---------~~~~~~i~~~ 300 (394)
...... ......+|+.|+|||++.+...++.++||||+||++|+|++|++||..... ...+..+...
T Consensus 161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~ 240 (317)
T cd07868 161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNV 240 (317)
T ss_pred ccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHHh
Confidence 654322 123456799999999997766689999999999999999999999975432 3556677777
Q ss_pred hCCCChhhhhccCCCCc---------ccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 016184 301 LGTPTREEIKCMNPNYT---------EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368 (394)
Q Consensus 301 ~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f 368 (394)
++.+....+.....-.. ...........+........+..+.+||++||++||.+|||++|+|+||||
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07868 241 MGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF 317 (317)
T ss_pred cCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 77776655433211000 000000000000011112345679999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-46 Score=339.04 Aligned_cols=265 Identities=24% Similarity=0.365 Sum_probs=205.1
Q ss_pred EeecCceEEEEEEECCCCcEEEEEEeccch-------hhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEEEEEEecc
Q 016184 90 VGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYV 162 (394)
Q Consensus 90 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~ 162 (394)
||+|+||+||+|.+..+|+.||+|.+.... .....|+++++.++|+||+++.+++ ......++||||+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~-----~~~~~~~lv~e~~ 75 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAF-----QTKTDLCLVMTIM 75 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEE-----cCCCeEEEEEeCC
Confidence 699999999999999999999999886432 2234689999999999999998877 3334578999999
Q ss_pred cc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCccccccCCC-
Q 016184 163 PE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP- 240 (394)
Q Consensus 163 ~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~~~~- 240 (394)
++ +|...+.........+++..++.++.||+.||+|||+ +||+||||||+||+++.++ .++|+|||++........
T Consensus 76 ~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~Nili~~~~-~~~l~dfg~~~~~~~~~~~ 153 (280)
T cd05608 76 NGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQ-RRIIYRDLKPENVLLDNDG-NVRISDLGLAVELKDGQSK 153 (280)
T ss_pred CCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEECCCC-CEEEeeCccceecCCCCcc
Confidence 85 6665554433445679999999999999999999999 8999999999999999877 699999999876543322
Q ss_pred cccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCCCcccC
Q 016184 241 NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 320 (394)
Q Consensus 241 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 320 (394)
.....+|+.|+|||++.+. .++.++|+|||||++|+|++|+.||...........+.......+
T Consensus 154 ~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~--------------- 217 (280)
T cd05608 154 TKGYAGTPGFMAPELLQGE-EYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDS--------------- 217 (280)
T ss_pred ccccCCCcCccCHHHhcCC-CCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccC---------------
Confidence 2235678999999999655 489999999999999999999999986543322222222110000
Q ss_pred CCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCC-----CHHHHhcCCCCCCCCCCCCCCCCCCCCCCCCCC
Q 016184 321 FPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-----TALEACVHPFFDELRDPNTRLPNGRPLPPLFNF 390 (394)
Q Consensus 321 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----t~~ell~hp~f~~~~~~~~~~~~~~~~~~~~~~ 390 (394)
..++..++..+.+|+.+||+.||++|| |++++++||||+....... .. ...|++|++
T Consensus 218 ----------~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h~~~~~~~~~~~--~~-~~~~~~~~~ 279 (280)
T cd05608 218 ----------VTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPLFRDLNWRQL--EA-GMLPPPFVP 279 (280)
T ss_pred ----------CCCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcChhhhcCCHhHH--hh-ccCCCCCCC
Confidence 012245789999999999999999999 8899999999998754432 22 233456654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-46 Score=348.88 Aligned_cols=258 Identities=30% Similarity=0.471 Sum_probs=209.5
Q ss_pred eEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccch-------hhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEE
Q 016184 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL 155 (394)
Q Consensus 83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 155 (394)
+|++.+.||+|+||.||+|++..+++.||||++.+.. ....+|++++..++||||+++++++ ....+.
T Consensus 2 ~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~-----~~~~~~ 76 (333)
T cd05600 2 DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAF-----QDDEYL 76 (333)
T ss_pred CcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEE-----EcCCEE
Confidence 5999999999999999999999999999999986432 2345689999999999999999887 334468
Q ss_pred EEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCccc
Q 016184 156 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV 234 (394)
Q Consensus 156 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~ 234 (394)
++||||+++ +|.+++.. ...+++..++.++.||+.||.|||+ .||+||||||+|||++.++ .+||+|||++..
T Consensus 77 ~lv~e~~~g~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~-~~ivH~dlkp~Nil~~~~~-~~kL~Dfg~a~~ 150 (333)
T cd05600 77 YLAMEYVPGGDFRTLLNN----LGVLSEDHARFYMAEMFEAVDALHE-LGYIHRDLKPENFLIDASG-HIKLTDFGLSKG 150 (333)
T ss_pred EEEEeCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCHHHEEECCCC-CEEEEeCcCCcc
Confidence 899999975 77666643 3578999999999999999999999 8999999999999999888 699999999975
Q ss_pred cccCCCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCC
Q 016184 235 LVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 314 (394)
Q Consensus 235 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 314 (394)
... ......||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+....+........
T Consensus 151 ~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~--------- 218 (333)
T cd05600 151 IVT--YANSVVGSPDYMAPEVLRGK-GYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQ--------- 218 (333)
T ss_pred ccc--ccCCcccCccccChhHhcCC-CCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhcccccc---------
Confidence 533 33456789999999999665 589999999999999999999999988776665555443211000
Q ss_pred CCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCC
Q 016184 315 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 375 (394)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~ 375 (394)
.+... .....++.++.+||.+||..+|.+||++.++++||||++.....
T Consensus 219 ------~~~~~------~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h~~~~~~~~~~ 267 (333)
T cd05600 219 ------RPVYD------DPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNHPFFKEVDWNE 267 (333)
T ss_pred ------CCCCC------ccccccCHHHHHHHHHHhhChhhhcCCHHHHHhCcccCCCCHHH
Confidence 00000 00024689999999999999999999999999999999875433
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-46 Score=354.29 Aligned_cols=253 Identities=32% Similarity=0.515 Sum_probs=204.6
Q ss_pred eEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccch-------hhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEE
Q 016184 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL 155 (394)
Q Consensus 83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 155 (394)
+|++.+.||+|+||.||+|++..+|+.||||++.... ....+|+.+++.++|+||+++++++ ....++
T Consensus 2 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~-----~~~~~~ 76 (364)
T cd05599 2 DFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSF-----QDENYL 76 (364)
T ss_pred CceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEE-----EcCCeE
Confidence 5999999999999999999999999999999986432 2345799999999999999999988 344568
Q ss_pred EEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCccc
Q 016184 156 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV 234 (394)
Q Consensus 156 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~ 234 (394)
++||||+++ +|.+++.. ...+++..++.++.|++.||+|||+ .||+||||||+|||++.++ .++|+|||++..
T Consensus 77 ~lv~E~~~~g~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~-~~ivH~Dlkp~NIl~~~~~-~~kl~Dfg~~~~ 150 (364)
T cd05599 77 YLIMEYLPGGDMMTLLMK----KDTFTEEETRFYIAETILAIDSIHK-LGYIHRDIKPDNLLLDAKG-HIKLSDFGLCTG 150 (364)
T ss_pred EEEECCCCCcHHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeEeccCCHHHeEECCCC-CEEEeeccccee
Confidence 899999975 56555543 3578999999999999999999999 8999999999999999888 699999999865
Q ss_pred cccCCC---------------------------------------cccccccccccccccccCCCCCCChhhHHHHHHHH
Q 016184 235 LVKGEP---------------------------------------NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVM 275 (394)
Q Consensus 235 ~~~~~~---------------------------------------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il 275 (394)
...... .....||+.|+|||++.+. .++.++|||||||++
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il 229 (364)
T cd05599 151 LKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQT-GYNKECDWWSLGVIM 229 (364)
T ss_pred ccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCC-CCCCeeeeecchhHH
Confidence 422110 0124589999999998654 489999999999999
Q ss_pred HHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCC
Q 016184 276 AELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNL 355 (394)
Q Consensus 276 ~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 355 (394)
|+|++|..||.+.+..+....+..... ...++. ...+++++.+||++||. ||.+
T Consensus 230 ~el~~G~~Pf~~~~~~~~~~~i~~~~~---------------~~~~~~----------~~~~s~~~~~li~~ll~-~p~~ 283 (364)
T cd05599 230 YEMLVGYPPFCSDNPQETYRKIINWKE---------------TLQFPD----------EVPLSPEAKDLIKRLCC-EAER 283 (364)
T ss_pred HHhhcCCCCCCCCCHHHHHHHHHcCCC---------------ccCCCC----------CCCCCHHHHHHHHHHcc-CHhh
Confidence 999999999988776655555433110 001110 02468899999999997 9999
Q ss_pred CCC---HHHHhcCCCCCCCCC
Q 016184 356 RCT---ALEACVHPFFDELRD 373 (394)
Q Consensus 356 Rpt---~~ell~hp~f~~~~~ 373 (394)
|++ +.++++||||++...
T Consensus 284 R~~~~~~~~ll~h~~~~~~~~ 304 (364)
T cd05599 284 RLGNNGVNEIKSHPFFKGVDW 304 (364)
T ss_pred cCCCCCHHHHhcCCCcCCCCH
Confidence 998 999999999998754
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-46 Score=352.52 Aligned_cols=256 Identities=32% Similarity=0.547 Sum_probs=209.1
Q ss_pred eEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccch-------hhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEE
Q 016184 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL 155 (394)
Q Consensus 83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 155 (394)
+|++.+.||+|+||.||+|++..+|+.||||++.... ....+|++++..++|+||+++++++ ....+.
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~~ 76 (350)
T cd05573 2 DFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSF-----QDEEHL 76 (350)
T ss_pred CceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhhe-----ecCCeE
Confidence 5999999999999999999999999999999986432 2345799999999999999999887 344468
Q ss_pred EEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCccc
Q 016184 156 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV 234 (394)
Q Consensus 156 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~ 234 (394)
++||||+++ +|.+++.. ...+++..++.++.||+.||+|||+ .||+||||||+|||++.++ .+||+|||++..
T Consensus 77 ~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~-~giiH~Dlkp~NIll~~~~-~~kL~Dfg~~~~ 150 (350)
T cd05573 77 YLVMEYMPGGDLMNLLIR----KDVFPEETARFYIAELVLALDSVHK-LGFIHRDIKPDNILIDADG-HIKLADFGLCKK 150 (350)
T ss_pred EEEEcCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCCHHHeEECCCC-CEEeecCCCCcc
Confidence 899999975 67666554 2678999999999999999999999 8999999999999999888 699999999876
Q ss_pred cccCC------------------------------CcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCC
Q 016184 235 LVKGE------------------------------PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPL 284 (394)
Q Consensus 235 ~~~~~------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~p 284 (394)
..... ......||+.|+|||++.+. .++.++|||||||++|+|++|+.|
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~ell~g~~P 229 (350)
T cd05573 151 MNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGT-PYGLECDWWSLGVILYEMLYGFPP 229 (350)
T ss_pred CcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCC-CCCCceeeEecchhhhhhccCCCC
Confidence 54332 22345689999999999665 589999999999999999999999
Q ss_pred CCCCCcHHHHHHHHHHhCCCChhhhhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCC-HHHHh
Q 016184 285 FPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCT-ALEAC 363 (394)
Q Consensus 285 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt-~~ell 363 (394)
|...+.......+...... ..++. ...+++++.+||.+||. ||.+|++ +++++
T Consensus 230 f~~~~~~~~~~~i~~~~~~---------------~~~p~----------~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll 283 (350)
T cd05573 230 FYSDTLQETYNKIINWKES---------------LRFPP----------DPPVSPEAIDLICRLLC-DPEDRLGSFEEIK 283 (350)
T ss_pred CCCCCHHHHHHHHhccCCc---------------ccCCC----------CCCCCHHHHHHHHHHcc-ChhhcCCCHHHHh
Confidence 9887765555554431100 01111 12368999999999998 9999999 99999
Q ss_pred cCCCCCCCCCCCC
Q 016184 364 VHPFFDELRDPNT 376 (394)
Q Consensus 364 ~hp~f~~~~~~~~ 376 (394)
+||||+++.....
T Consensus 284 ~hp~~~~~~~~~~ 296 (350)
T cd05573 284 SHPFFKGIDWENL 296 (350)
T ss_pred cCCCcCCCCHHHH
Confidence 9999998755433
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-45 Score=350.71 Aligned_cols=278 Identities=23% Similarity=0.328 Sum_probs=211.7
Q ss_pred ceeEEEeeEEeecCceEEEEEEEC--CCCcEEEEEEeccchhhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEEEEE
Q 016184 81 KVSYIAEHVVGTGSFGVVFQAKCR--ETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLV 158 (394)
Q Consensus 81 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~~~vaiK~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv 158 (394)
..+|.+++.||.|+||.||+|... .+++.||+|.+... ....+|+++++.++|+||+++++++ ......|++
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-~~~~~E~~il~~l~h~~iv~~~~~~-----~~~~~~~lv 164 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-KTPGREIDILKTISHRAIINLIHAY-----RWKSTVCMV 164 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-ccHHHHHHHHHhcCCCCccceeeeE-----eeCCEEEEE
Confidence 346999999999999999999764 35678999987654 3446899999999999999999887 334458899
Q ss_pred EecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCccccccC
Q 016184 159 LEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG 238 (394)
Q Consensus 159 ~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~~ 238 (394)
||++.+++..++. ....+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .++|+|||++......
T Consensus 165 ~e~~~~~l~~~l~----~~~~l~~~~~~~i~~ql~~aL~~LH~-~givHrDlkp~Nill~~~~-~~~l~DfG~a~~~~~~ 238 (392)
T PHA03207 165 MPKYKCDLFTYVD----RSGPLPLEQAITIQRRLLEALAYLHG-RGIIHRDVKTENIFLDEPE-NAVLGDFGAACKLDAH 238 (392)
T ss_pred ehhcCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCHHHEEEcCCC-CEEEccCccccccCcc
Confidence 9999988776663 24679999999999999999999999 8999999999999999888 6999999998765433
Q ss_pred CC---cccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCC---cHHHHHHHHHHhCCCChhhhhcc
Q 016184 239 EP---NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGES---GVDQLVEIIKVLGTPTREEIKCM 312 (394)
Q Consensus 239 ~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~---~~~~~~~i~~~~~~~~~~~~~~~ 312 (394)
.. .....||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.. ....+..+.+.++..+.+.....
T Consensus 239 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~ 317 (392)
T PHA03207 239 PDTPQCYGWSGTLETNSPELLALD-PYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNG 317 (392)
T ss_pred cccccccccccccCccCHhHhcCC-CCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCcc
Confidence 22 2245689999999999654 48999999999999999999999997654 34556666666665443322110
Q ss_pred CCC----CcccCCCCCCCCCcchh-ccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 016184 313 NPN----YTEFKFPQIKPHPWHKV-FQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL 371 (394)
Q Consensus 313 ~~~----~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 371 (394)
... +..+............. ....++.++.+||++||+.||.+|||+.++|+||||++.
T Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~ 381 (392)
T PHA03207 318 STNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKE 381 (392)
T ss_pred chhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhcc
Confidence 000 00011000000011111 123467889999999999999999999999999999774
|
|
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-45 Score=336.70 Aligned_cols=276 Identities=34% Similarity=0.552 Sum_probs=214.9
Q ss_pred eEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccch------hhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEEE
Q 016184 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN 156 (394)
Q Consensus 83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 156 (394)
+|++.+.||.|+||.||+|++..+|+.||+|.+.... ....+|+++++.++|+||+++++++. .....+
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~-----~~~~~~ 75 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLH-----SDKKLT 75 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhc-----cCCceE
Confidence 4899999999999999999999999999999885421 23457999999999999999999883 334578
Q ss_pred EEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCccccc
Q 016184 157 LVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV 236 (394)
Q Consensus 157 lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~ 236 (394)
+++||+++++...+.. ....+++..++.++.||+.||.|||+ .||+|+||||+||+++.++ .++|+|||++....
T Consensus 76 lv~e~~~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~al~~LH~-~~i~H~dl~~~nil~~~~~-~~~l~dfg~~~~~~ 150 (284)
T cd07839 76 LVFEYCDQDLKKYFDS---CNGDIDPEIVKSFMFQLLKGLAFCHS-HNVLHRDLKPQNLLINKNG-ELKLADFGLARAFG 150 (284)
T ss_pred EEEecCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCEecCCCCHHHEEEcCCC-cEEECccchhhccC
Confidence 9999999887665543 23568999999999999999999999 8999999999999999887 79999999987553
Q ss_pred cCC-CcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCC-CCCCcHHHHHHHHHHhCCCChhhhhccCC
Q 016184 237 KGE-PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLF-PGESGVDQLVEIIKVLGTPTREEIKCMNP 314 (394)
Q Consensus 237 ~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf-~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 314 (394)
... ......+++.|+|||.+.+...++.++|||||||++|+|++|..|| .+.+....+..+.+..+.+....+.....
T Consensus 151 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (284)
T cd07839 151 IPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSK 230 (284)
T ss_pred CCCCCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhh
Confidence 322 1223456888999999876666799999999999999999998774 55555666777777777666655433221
Q ss_pred CCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 016184 315 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368 (394)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f 368 (394)
......++..............+++++.+||.+||+.||.+|||++++++||||
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f 284 (284)
T cd07839 231 LPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284 (284)
T ss_pred cccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence 111111111111111111224578999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-46 Score=354.86 Aligned_cols=253 Identities=30% Similarity=0.492 Sum_probs=202.2
Q ss_pred eEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccch-------hhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEE
Q 016184 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL 155 (394)
Q Consensus 83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 155 (394)
+|++.+.||+|+||.||+|++..+++.||||++.+.. ....+|+++++.++||||+++++++ ....++
T Consensus 2 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~-----~~~~~~ 76 (377)
T cd05629 2 DFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSF-----QDAQYL 76 (377)
T ss_pred CceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEE-----EcCCee
Confidence 5999999999999999999999999999999885432 2345699999999999999999988 344568
Q ss_pred EEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCccc
Q 016184 156 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV 234 (394)
Q Consensus 156 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~ 234 (394)
|+||||+++ +|.+++.. ...+++..++.++.|++.||+|||+ .||+||||||+|||++.++ .+||+|||+++.
T Consensus 77 ~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~ql~~aL~~LH~-~givHrDlkp~NIll~~~~-~~kl~DfGla~~ 150 (377)
T cd05629 77 YLIMEFLPGGDLMTMLIK----YDTFSEDVTRFYMAECVLAIEAVHK-LGFIHRDIKPDNILIDRGG-HIKLSDFGLSTG 150 (377)
T ss_pred EEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCHHHEEECCCC-CEEEeecccccc
Confidence 899999974 66665543 3678999999999999999999999 8999999999999999887 699999999863
Q ss_pred cccCCC------------------------------------------------cccccccccccccccccCCCCCCChh
Q 016184 235 LVKGEP------------------------------------------------NVSYICSRYYRAPELIFGATEYTTAI 266 (394)
Q Consensus 235 ~~~~~~------------------------------------------------~~~~~~t~~y~aPE~~~~~~~~~~~~ 266 (394)
...... .....||+.|+|||++.+. .++.++
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~ 229 (377)
T cd05629 151 FHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQ-GYGQEC 229 (377)
T ss_pred cccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccC-CCCCce
Confidence 211000 0124689999999998654 489999
Q ss_pred hHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHH
Q 016184 267 DIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVC 346 (394)
Q Consensus 267 DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 346 (394)
|||||||++|+|++|..||.+.+..+.+..+..... ...++. ...++.++.+||.
T Consensus 230 DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~---------------~~~~p~----------~~~~s~~~~dli~ 284 (377)
T cd05629 230 DWWSLGAIMFECLIGWPPFCSENSHETYRKIINWRE---------------TLYFPD----------DIHLSVEAEDLIR 284 (377)
T ss_pred eeEecchhhhhhhcCCCCCCCCCHHHHHHHHHccCC---------------ccCCCC----------CCCCCHHHHHHHH
Confidence 999999999999999999988776655555443110 011111 0246889999999
Q ss_pred HhcccCCCCC---CCHHHHhcCCCCCCCCC
Q 016184 347 RFFQYSPNLR---CTALEACVHPFFDELRD 373 (394)
Q Consensus 347 ~~L~~dP~~R---pt~~ell~hp~f~~~~~ 373 (394)
+||. +|.+| +|+.++++||||++...
T Consensus 285 ~lL~-~~~~r~~r~~~~~~l~hp~~~~~~~ 313 (377)
T cd05629 285 RLIT-NAENRLGRGGAHEIKSHPFFRGVDW 313 (377)
T ss_pred HHhc-CHhhcCCCCCHHHHhcCCCcCCCCH
Confidence 9998 67765 59999999999997643
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-46 Score=346.93 Aligned_cols=250 Identities=30% Similarity=0.435 Sum_probs=205.5
Q ss_pred ceeEEEeeEEeecCceEEEEEEECCCC-cEEEEEEeccch-------hhhHHHHHHHHHcCCCCeeeeceEEEecCCCce
Q 016184 81 KVSYIAEHVVGTGSFGVVFQAKCRETG-EIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE 152 (394)
Q Consensus 81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~-~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 152 (394)
..+|++.+.||+|+||.||+|.+..++ ..||+|++.... ....+|+.+++.++||||+++++++ ...
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~-----~~~ 103 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSF-----KDE 103 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEE-----EeC
Confidence 346999999999999999999976654 689999885432 2344699999999999999999988 334
Q ss_pred eEEEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecC
Q 016184 153 LYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS 231 (394)
Q Consensus 153 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~ 231 (394)
.+.++||||+.+ +|.+++.. ...+++..+..++.|++.||.|||+ .||+||||||+|||++.++ .+||+|||+
T Consensus 104 ~~~~lv~Ey~~~g~L~~~i~~----~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivHrDLkp~NILl~~~~-~ikL~DFG~ 177 (340)
T PTZ00426 104 SYLYLVLEFVIGGEFFTFLRR----NKRFPNDVGCFYAAQIVLIFEYLQS-LNIVYRDLKPENLLLDKDG-FIKMTDFGF 177 (340)
T ss_pred CEEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeEccCCCHHHEEECCCC-CEEEecCCC
Confidence 458899999975 66665543 3678999999999999999999999 8999999999999999887 799999999
Q ss_pred ccccccCCCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhc
Q 016184 232 AKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 311 (394)
Q Consensus 232 a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 311 (394)
+..... ......||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+.......+....
T Consensus 178 a~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~---------- 244 (340)
T PTZ00426 178 AKVVDT--RTYTLCGTPEYIAPEILLNV-GHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGI---------- 244 (340)
T ss_pred CeecCC--CcceecCChhhcCHHHHhCC-CCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCC----------
Confidence 976532 23456789999999999654 48999999999999999999999998877655555544311
Q ss_pred cCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCC-----CHHHHhcCCCCCCCCC
Q 016184 312 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-----TALEACVHPFFDELRD 373 (394)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----t~~ell~hp~f~~~~~ 373 (394)
.. ++..+++.+.++|++||+.||.+|+ |++++++||||+++..
T Consensus 245 -------~~------------~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~~~~ 292 (340)
T PTZ00426 245 -------IY------------FPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNIDW 292 (340)
T ss_pred -------CC------------CCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCCcCCCCH
Confidence 01 1245788999999999999999995 8999999999998653
|
|
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-45 Score=351.68 Aligned_cols=254 Identities=28% Similarity=0.469 Sum_probs=201.0
Q ss_pred eEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccch-------hhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEE
Q 016184 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL 155 (394)
Q Consensus 83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 155 (394)
.|++++.||+|+||+||+|++..+++.||||++.+.. ....+|+++++.++|+||+++++++. ...++
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~-----~~~~~ 76 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQ-----DKDNL 76 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEe-----cCCEE
Confidence 4899999999999999999999999999999986432 23457999999999999999999883 34458
Q ss_pred EEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCccc
Q 016184 156 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV 234 (394)
Q Consensus 156 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~ 234 (394)
++||||+++ +|.+++.. ...+++..++.++.||+.||+|||+ .||+||||||+|||++.++ .+||+|||++..
T Consensus 77 ~lv~E~~~gg~L~~~l~~----~~~~~e~~~~~~~~qi~~aL~~LH~-~givHrDlKp~Nili~~~~-~~kL~DFGl~~~ 150 (381)
T cd05626 77 YFVMDYIPGGDMMSLLIR----MEVFPEVLARFYIAELTLAIESVHK-MGFIHRDIKPDNILIDLDG-HIKLTDFGLCTG 150 (381)
T ss_pred EEEEecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeeecCCcHHHEEECCCC-CEEEeeCcCCcc
Confidence 899999975 66665543 3568999999999999999999999 8999999999999999887 699999998753
Q ss_pred cccCC------------------------------------------------CcccccccccccccccccCCCCCCChh
Q 016184 235 LVKGE------------------------------------------------PNVSYICSRYYRAPELIFGATEYTTAI 266 (394)
Q Consensus 235 ~~~~~------------------------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~ 266 (394)
..... ......||+.|+|||++.+. .++.++
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~~ 229 (381)
T cd05626 151 FRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRK-GYTQLC 229 (381)
T ss_pred cccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCC-CCCCcc
Confidence 21000 01234689999999998654 489999
Q ss_pred hHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHH
Q 016184 267 DIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVC 346 (394)
Q Consensus 267 DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 346 (394)
|||||||++|+|++|..||...+..+....+...... ..++. ...+++++.+||.
T Consensus 230 DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~---------------~~~~~----------~~~~s~~~~dli~ 284 (381)
T cd05626 230 DWWSVGVILFEMLVGQPPFLAPTPTETQLKVINWENT---------------LHIPP----------QVKLSPEAVDLIT 284 (381)
T ss_pred ceeehhhHHHHHHhCCCCCcCCCHHHHHHHHHccccc---------------cCCCC----------CCCCCHHHHHHHH
Confidence 9999999999999999999887655544444321100 01110 1247899999999
Q ss_pred Hhcc--cCCCCCCCHHHHhcCCCCCCCCC
Q 016184 347 RFFQ--YSPNLRCTALEACVHPFFDELRD 373 (394)
Q Consensus 347 ~~L~--~dP~~Rpt~~ell~hp~f~~~~~ 373 (394)
+|+. .+|..|++++++++||||+++..
T Consensus 285 ~ll~~~~~~~~R~~~~~~l~hp~f~~~~~ 313 (381)
T cd05626 285 KLCCSAEERLGRNGADDIKAHPFFSEVDF 313 (381)
T ss_pred HHccCcccccCCCCHHHHhcCcccCCCCh
Confidence 9654 45556999999999999998644
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-45 Score=335.33 Aligned_cols=276 Identities=34% Similarity=0.628 Sum_probs=215.5
Q ss_pred eEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccc------hhhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEEE
Q 016184 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN 156 (394)
Q Consensus 83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 156 (394)
.|++.+.||+|++|.||+|++..+++.||+|++... .....+|+.+++.++|+||+++++++. .....+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~ 75 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLM-----QESRLY 75 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEe-----eCCeEE
Confidence 389999999999999999999999999999987532 133567999999999999999999884 334578
Q ss_pred EEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCccccc
Q 016184 157 LVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV 236 (394)
Q Consensus 157 lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~ 236 (394)
+||||+.+++...+.... ....+++..++.++.|++.||.|||+ .|++|+||||+||+++.++ .++|+|||++....
T Consensus 76 ~v~e~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~qi~~~L~~lH~-~~i~H~dl~p~nil~~~~~-~~~l~dfg~~~~~~ 152 (285)
T cd07861 76 LIFEFLSMDLKKYLDSLP-KGQYMDAELVKSYLYQILQGILFCHS-RRVLHRDLKPQNLLIDNKG-VIKLADFGLARAFG 152 (285)
T ss_pred EEEecCCCCHHHHHhcCC-CCCcCCHHHHHHHHHHHHHHHHHHHh-CCeeecCCCHHHEEEcCCC-cEEECcccceeecC
Confidence 999999988776665422 23568999999999999999999999 8999999999999999888 69999999987543
Q ss_pred cCC-CcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCC
Q 016184 237 KGE-PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 315 (394)
Q Consensus 237 ~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 315 (394)
... ......+++.|+|||.+.+...++.++|+||||+++|+|+||+.||.+....+....+....+.+....+.....-
T Consensus 153 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (285)
T cd07861 153 IPVRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSL 232 (285)
T ss_pred CCcccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhh
Confidence 221 1123456888999999866656789999999999999999999999988877777777776666554443221100
Q ss_pred Cccc--CCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 016184 316 YTEF--KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368 (394)
Q Consensus 316 ~~~~--~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f 368 (394)
..+ .++..... ........+++++.+||++||+.||.+|||+.++++||||
T Consensus 233 -~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~ 285 (285)
T cd07861 233 -PDYKNTFPKWKKG-SLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285 (285)
T ss_pred -HHHHhhccccCcc-hhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence 000 00110000 1111124578999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-45 Score=342.53 Aligned_cols=287 Identities=34% Similarity=0.646 Sum_probs=225.8
Q ss_pred eeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccc-----hhhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEEE
Q 016184 82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN 156 (394)
Q Consensus 82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 156 (394)
.+|++.+.||+|+||.||+|++..+|+.||||++... .....+|+.+++.++|+||+++++++...........+
T Consensus 5 ~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 84 (336)
T cd07849 5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVY 84 (336)
T ss_pred cceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceEE
Confidence 4599999999999999999999999999999987532 12244699999999999999999887544434445678
Q ss_pred EEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCccccc
Q 016184 157 LVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV 236 (394)
Q Consensus 157 lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~ 236 (394)
+++||+++++.+.+.. ..+++..++.++.|++.||.|||+ .||+||||||+|||++.++ .++|+|||++....
T Consensus 85 lv~e~~~~~l~~~~~~-----~~l~~~~~~~i~~ql~~aL~~LH~-~~ivH~dlkp~Nill~~~~-~~kl~dfg~~~~~~ 157 (336)
T cd07849 85 IVQELMETDLYKLIKT-----QHLSNDHIQYFLYQILRGLKYIHS-ANVLHRDLKPSNLLLNTNC-DLKICDFGLARIAD 157 (336)
T ss_pred EEehhcccCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCHHHEEECCCC-CEEECcccceeecc
Confidence 9999999887666543 679999999999999999999999 8999999999999999887 69999999987653
Q ss_pred cCCCc----ccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhcc
Q 016184 237 KGEPN----VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 312 (394)
Q Consensus 237 ~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 312 (394)
..... ....+++.|+|||.+.+...++.++|||||||++|+|++|+.||.+.+.......+...++.+..+.+...
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (336)
T cd07849 158 PEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCI 237 (336)
T ss_pred ccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHh
Confidence 32211 23467889999998765556899999999999999999999999988877777778887777766555322
Q ss_pred CCCCcc---cCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCC
Q 016184 313 NPNYTE---FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNT 376 (394)
Q Consensus 313 ~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~ 376 (394)
...... ...+.....++... ...+++++.+||.+||+.||++|||+.++++||||+.+.++..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~~~~ 303 (336)
T cd07849 238 ISLRARNYIKSLPFKPKVPWNKL-FPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHDPSD 303 (336)
T ss_pred hchhhhhHHhhcCcCCcccHHHH-hcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCCCCC
Confidence 211000 00111111112111 2346888999999999999999999999999999999988644
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-45 Score=348.90 Aligned_cols=256 Identities=29% Similarity=0.495 Sum_probs=206.2
Q ss_pred ceeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccc-------hhhhHHHHHHHHHcCCCCeeeeceEEEecCCCcee
Q 016184 81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL 153 (394)
Q Consensus 81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 153 (394)
..+|++.+.||+|+||.||+|++..+++.||+|++.+. .....+|+.+++.++||||+++++++ ....
T Consensus 42 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~-----~~~~ 116 (370)
T cd05621 42 AEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAF-----QDDK 116 (370)
T ss_pred HHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEE-----EcCC
Confidence 34699999999999999999999999999999988542 22345799999999999999999988 3445
Q ss_pred EEEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCc
Q 016184 154 YLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA 232 (394)
Q Consensus 154 ~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a 232 (394)
++++||||+++ +|.+++.. ..+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||++
T Consensus 117 ~~~lv~Ey~~gg~L~~~l~~-----~~~~~~~~~~~~~qil~aL~~LH~-~~IvHrDLKp~NILl~~~~-~~kL~DFG~a 189 (370)
T cd05621 117 YLYMVMEYMPGGDLVNLMSN-----YDVPEKWAKFYTAEVVLALDAIHS-MGLIHRDVKPDNMLLDKHG-HLKLADFGTC 189 (370)
T ss_pred EEEEEEcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHH-CCeEecCCCHHHEEECCCC-CEEEEecccc
Confidence 68899999975 77776653 468999999999999999999999 8999999999999999888 6999999999
Q ss_pred cccccCCC--cccccccccccccccccCCC---CCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChh
Q 016184 233 KVLVKGEP--NVSYICSRYYRAPELIFGAT---EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 307 (394)
Q Consensus 233 ~~~~~~~~--~~~~~~t~~y~aPE~~~~~~---~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~ 307 (394)
........ .....||+.|+|||++.+.. .++.++|+|||||++|+|++|+.||.+.+....+..+......
T Consensus 190 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~---- 265 (370)
T cd05621 190 MKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNS---- 265 (370)
T ss_pred eecccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcc----
Confidence 76533221 23456899999999985432 3788999999999999999999999887766665555432110
Q ss_pred hhhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCC--CCCHHHHhcCCCCCCCCC
Q 016184 308 EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNL--RCTALEACVHPFFDELRD 373 (394)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~--Rpt~~ell~hp~f~~~~~ 373 (394)
..++. ...++..+++||.+||+.++.+ |+|+.++++||||+....
T Consensus 266 -----------~~~p~----------~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~~~~ 312 (370)
T cd05621 266 -----------LNFPE----------DVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKNDQW 312 (370)
T ss_pred -----------cCCCC----------cccCCHHHHHHHHHHccCchhccCCCCHHHHhcCcccCCCCc
Confidence 11110 1246889999999999865544 899999999999998543
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-46 Score=297.28 Aligned_cols=277 Identities=35% Similarity=0.674 Sum_probs=231.2
Q ss_pred EEEeeEEeecCceEEEEEEECCCCcEEEEEEeccch------hhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEEEE
Q 016184 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL 157 (394)
Q Consensus 84 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 157 (394)
|.-.++||+|.||+||+|+++.+++.||+|.++.+. ....+|+.+++.++|.|||++++.. ..+..+-+
T Consensus 4 ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvl-----hsdkkltl 78 (292)
T KOG0662|consen 4 YDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVL-----HSDKKLTL 78 (292)
T ss_pred hHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhh-----ccCceeEE
Confidence 666678999999999999999999999999986543 2335899999999999999999988 44444789
Q ss_pred EEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCcccccc
Q 016184 158 VLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK 237 (394)
Q Consensus 158 v~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~ 237 (394)
|+|||...| .+.+...++.++...++.++.|+++||.|.|+ +++.||||||.|.||+.+| ++||+|||+++.+.-
T Consensus 79 vfe~cdqdl---kkyfdslng~~d~~~~rsfmlqllrgl~fchs-hnvlhrdlkpqnllin~ng-elkladfglarafgi 153 (292)
T KOG0662|consen 79 VFEFCDQDL---KKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHS-HNVLHRDLKPQNLLINRNG-ELKLADFGLARAFGI 153 (292)
T ss_pred eHHHhhHHH---HHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhh-hhhhhccCCcceEEeccCC-cEEecccchhhhcCC
Confidence 999999665 44444566889999999999999999999999 8999999999999999998 799999999986643
Q ss_pred CC-CcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCChhhhhccC--
Q 016184 238 GE-PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN-- 313 (394)
Q Consensus 238 ~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~-- 313 (394)
.- -......|..|.+|.++.+..-|++..|+||.|||+.|+.. |++.|++.+-.+++..|+..+|.|.++.|..+.
T Consensus 154 pvrcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~l 233 (292)
T KOG0662|consen 154 PVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKL 233 (292)
T ss_pred ceEeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccC
Confidence 32 22334568999999999999889999999999999999985 899999999999999999999999998887554
Q ss_pred CCCcccCCCCCCCC-CcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q 016184 314 PNYTEFKFPQIKPH-PWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD 373 (394)
Q Consensus 314 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~ 373 (394)
+++.. +|..... .|..+. +.++..-++|++++|.-+|.+|.+|++.++||+|.+...
T Consensus 234 pdyk~--yp~ypattswsqiv-p~lns~grdllqkll~cnp~qrisaeaalqhpyf~d~s~ 291 (292)
T KOG0662|consen 234 PDYKP--YPIYPATTSWSQIV-PKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSDFSP 291 (292)
T ss_pred CCCcc--cCCccccchHHHHh-hhhcchhHHHHHHHhccCcccccCHHHHhcCccccccCC
Confidence 22222 2222222 344433 567888999999999999999999999999999987643
|
|
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-45 Score=349.54 Aligned_cols=255 Identities=28% Similarity=0.482 Sum_probs=207.3
Q ss_pred ceeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccch-------hhhHHHHHHHHHcCCCCeeeeceEEEecCCCcee
Q 016184 81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL 153 (394)
Q Consensus 81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 153 (394)
..+|++.+.||+|+||.||+|++..+++.||+|++.+.. ....+|+.+++.++||||+++++++ ....
T Consensus 42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~-----~~~~ 116 (370)
T cd05596 42 AEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAF-----QDDK 116 (370)
T ss_pred HHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEE-----ecCC
Confidence 346999999999999999999999999999999985421 2345789999999999999999887 3445
Q ss_pred EEEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCc
Q 016184 154 YLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA 232 (394)
Q Consensus 154 ~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a 232 (394)
++++||||+++ +|..++.. ..+++..+..++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||++
T Consensus 117 ~~~lv~Ey~~gg~L~~~l~~-----~~l~~~~~~~~~~qi~~aL~~LH~-~~ivHrDLkp~NILl~~~~-~~kL~DfG~~ 189 (370)
T cd05596 117 YLYMVMEYMPGGDLVNLMSN-----YDIPEKWARFYTAEVVLALDAIHS-MGFIHRDVKPDNMLLDKSG-HLKLADFGTC 189 (370)
T ss_pred EEEEEEcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCCHHHEEEcCCC-CEEEEeccce
Confidence 68899999975 67666653 468899999999999999999999 8999999999999999888 6999999998
Q ss_pred cccccCCC--cccccccccccccccccCC---CCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChh
Q 016184 233 KVLVKGEP--NVSYICSRYYRAPELIFGA---TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 307 (394)
Q Consensus 233 ~~~~~~~~--~~~~~~t~~y~aPE~~~~~---~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~ 307 (394)
........ .....||+.|+|||++.+. ..++.++|||||||++|+|++|+.||.+.+....+..+.....
T Consensus 190 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~----- 264 (370)
T cd05596 190 MKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKN----- 264 (370)
T ss_pred eeccCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCC-----
Confidence 76543221 2345689999999998543 2378899999999999999999999988776655555543110
Q ss_pred hhhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCC--CCCHHHHhcCCCCCCCC
Q 016184 308 EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNL--RCTALEACVHPFFDELR 372 (394)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~--Rpt~~ell~hp~f~~~~ 372 (394)
...++. ...++.++.+||++||+.+|.+ |+|++++++||||++..
T Consensus 265 ----------~~~~~~----------~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~~~ 311 (370)
T cd05596 265 ----------SLTFPD----------DIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFKNDQ 311 (370)
T ss_pred ----------cCCCCC----------cCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCcccCCCC
Confidence 011111 1247899999999999999988 99999999999998743
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-46 Score=347.09 Aligned_cols=258 Identities=27% Similarity=0.475 Sum_probs=208.5
Q ss_pred eEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccch-------hhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEE
Q 016184 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL 155 (394)
Q Consensus 83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 155 (394)
+|.+.+.||+|+||.||+|++..+|+.||+|++.... ....+|+.+++.++|+||+++++++ ....+.
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~-----~~~~~~ 76 (330)
T cd05601 2 DFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAF-----QDKDNL 76 (330)
T ss_pred CceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEE-----ecCCeE
Confidence 5999999999999999999999999999999986532 2345788999999999999998887 333458
Q ss_pred EEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCccc
Q 016184 156 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV 234 (394)
Q Consensus 156 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~ 234 (394)
++||||+++ +|.+++... ...+++..++.++.|++.||+|||+ .||+||||||+|||++.++ .+||+|||++..
T Consensus 77 ~lv~e~~~~~~L~~~l~~~---~~~l~~~~~~~~~~qi~~aL~~lH~-~~i~H~Dlkp~NIll~~~~-~~kL~Dfg~a~~ 151 (330)
T cd05601 77 YLVMEYQPGGDLLSLLNRY---EDQFDEDMAQFYLAELVLAIHSVHQ-MGYVHRDIKPENVLIDRTG-HIKLADFGSAAR 151 (330)
T ss_pred EEEECCCCCCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH-CCeEcccCchHheEECCCC-CEEeccCCCCeE
Confidence 899999974 776666542 2578999999999999999999999 8999999999999999888 699999999976
Q ss_pred cccCCCc--ccccccccccccccccC-----CCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChh
Q 016184 235 LVKGEPN--VSYICSRYYRAPELIFG-----ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 307 (394)
Q Consensus 235 ~~~~~~~--~~~~~t~~y~aPE~~~~-----~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~ 307 (394)
....... ....+|+.|+|||++.. ...++.++|||||||++|+|++|+.||........+..+.....
T Consensus 152 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~----- 226 (330)
T cd05601 152 LTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQR----- 226 (330)
T ss_pred CCCCCceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCC-----
Confidence 5433322 23467999999999852 33478899999999999999999999988776665555443210
Q ss_pred hhhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCC
Q 016184 308 EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNT 376 (394)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~ 376 (394)
...++. ...++.++.+||..||+ ||.+|||++++++||||+++.....
T Consensus 227 ----------~~~~~~----------~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h~~~~~~~~~~~ 274 (330)
T cd05601 227 ----------FLKFPE----------DPKVSSDFLDLIQSLLC-GQKERLGYEGLCCHPFFSKIDWNNI 274 (330)
T ss_pred ----------ccCCCC----------CCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCCCCcCCCCHHHH
Confidence 001110 12478999999999998 9999999999999999998765544
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-46 Score=334.05 Aligned_cols=250 Identities=25% Similarity=0.435 Sum_probs=218.5
Q ss_pred ccceeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccch-------hhhHHHHHHHHHcCCCCeeeeceEEEecCCCc
Q 016184 79 KQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKE 151 (394)
Q Consensus 79 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 151 (394)
+.+.+|++.+.||+|.||+|-+|.....|+.||||.++++. ..+++|+++|..|+||||+.++++| .+
T Consensus 50 nlkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVF-----EN 124 (668)
T KOG0611|consen 50 NLKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVF-----EN 124 (668)
T ss_pred chhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhh-----cC
Confidence 34557999999999999999999999999999999887643 3346899999999999999999998 44
Q ss_pred eeEEEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeec
Q 016184 152 ELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFG 230 (394)
Q Consensus 152 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg 230 (394)
...+.|||||..+ .|++++.. .+.+++.+++.+++||+.|+.|+|. ++++|||||.+|||+|.++ ++||+|||
T Consensus 125 kdKIvivMEYaS~GeLYDYiSe----r~~LsErEaRhfFRQIvSAVhYCHk-nrVvHRDLKLENILLD~N~-NiKIADFG 198 (668)
T KOG0611|consen 125 KDKIVIVMEYASGGELYDYISE----RGSLSEREARHFFRQIVSAVHYCHK-NRVVHRDLKLENILLDQNN-NIKIADFG 198 (668)
T ss_pred CceEEEEEEecCCccHHHHHHH----hccccHHHHHHHHHHHHHHHHHHhh-ccceecccchhheeecCCC-Ceeeeccc
Confidence 4448899999984 77777665 4789999999999999999999999 8999999999999999888 69999999
Q ss_pred CccccccCCCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhh
Q 016184 231 SAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 310 (394)
Q Consensus 231 ~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 310 (394)
++..+.......+++|+|.|.+||++.+.++-+...|.|||||+||.|+.|..||.+.+....+.+|.+.-
T Consensus 199 LSNly~~~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~Ga--------- 269 (668)
T KOG0611|consen 199 LSNLYADKKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGA--------- 269 (668)
T ss_pred hhhhhccccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhccc---------
Confidence 99988877778889999999999999888877899999999999999999999999988777776665521
Q ss_pred ccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCC
Q 016184 311 CMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFD 369 (394)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~ 369 (394)
+. .+.-+.++.-||++||-+||++|.|++++.+|=|+.
T Consensus 270 --------Yr-------------EP~~PSdA~gLIRwmLmVNP~RRATieDiAsHWWvN 307 (668)
T KOG0611|consen 270 --------YR-------------EPETPSDASGLIRWMLMVNPERRATIEDIASHWWVN 307 (668)
T ss_pred --------cc-------------CCCCCchHHHHHHHHHhcCcccchhHHHHhhhheee
Confidence 11 123477899999999999999999999999997763
|
|
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-45 Score=342.28 Aligned_cols=247 Identities=27% Similarity=0.455 Sum_probs=199.8
Q ss_pred EEEeeEEeecCceEEEEEEECCCCcEEEEEEeccch-------hhhHHHHHHH---HHcCCCCeeeeceEEEecCCCcee
Q 016184 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIM---QMLDHPNIVALKHCFFSTTDKEEL 153 (394)
Q Consensus 84 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l---~~l~h~~iv~~~~~~~~~~~~~~~ 153 (394)
|++.+.||+|+||.||+|.+..+|+.||||++.+.. ....+|.+++ +.++||||+++++++. ...
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~-----~~~ 75 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQ-----TED 75 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEE-----cCC
Confidence 678999999999999999999999999999986432 2233455544 4568999999999883 334
Q ss_pred EEEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCc
Q 016184 154 YLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA 232 (394)
Q Consensus 154 ~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a 232 (394)
..|+||||+++ +|...+. ...+++..++.++.||+.||+|||+ .||+||||||+|||++.++ .+||+|||++
T Consensus 76 ~~~lv~E~~~~~~L~~~~~-----~~~l~~~~~~~~~~qi~~al~~lH~-~~ivHrdlkp~Nill~~~~-~~kL~Dfg~~ 148 (324)
T cd05589 76 HVCFVMEYAAGGDLMMHIH-----TDVFSEPRAVFYAACVVLGLQYLHE-NKIVYRDLKLDNLLLDTEG-FVKIADFGLC 148 (324)
T ss_pred EEEEEEcCCCCCcHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeEecCCCHHHeEECCCC-cEEeCcccCC
Confidence 58899999986 4544332 2579999999999999999999999 8999999999999999888 7999999998
Q ss_pred cccccC-CCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhc
Q 016184 233 KVLVKG-EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 311 (394)
Q Consensus 233 ~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 311 (394)
...... .......|++.|+|||.+.+. .++.++|||||||++|+|++|+.||.+.+..+.+..+....
T Consensus 149 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~---------- 217 (324)
T cd05589 149 KEGMGFGDRTSTFCGTPEFLAPEVLTET-SYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDE---------- 217 (324)
T ss_pred ccCCCCCCcccccccCccccCHhHhcCC-CCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC----------
Confidence 653222 223345789999999998654 48999999999999999999999998877665555443310
Q ss_pred cCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCC-----CHHHHhcCCCCCCCC
Q 016184 312 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-----TALEACVHPFFDELR 372 (394)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----t~~ell~hp~f~~~~ 372 (394)
. .++..++..+.+||.+||+.||.+|| ++.++++||||+++.
T Consensus 218 -------~------------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~~~f~~~~ 264 (324)
T cd05589 218 -------V------------RYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQPFFRDIN 264 (324)
T ss_pred -------C------------CCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhCCCcCCCC
Confidence 0 01245789999999999999999999 799999999998864
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-45 Score=351.67 Aligned_cols=253 Identities=28% Similarity=0.476 Sum_probs=202.2
Q ss_pred eEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccch-------hhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEE
Q 016184 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL 155 (394)
Q Consensus 83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 155 (394)
.|+++++||+|+||.||+|++..+++.||+|++.+.. ....+|+.+++.++|+||+++++++. ...++
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~-----~~~~~ 76 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQ-----DKDNL 76 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEE-----eCCEE
Confidence 4899999999999999999999999999999986532 23457999999999999999999883 33458
Q ss_pred EEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCccc
Q 016184 156 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV 234 (394)
Q Consensus 156 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~ 234 (394)
++||||+++ +|..++.. ...+++..++.++.||+.||+|||+ .||+||||||+|||++.++ .+||+|||++..
T Consensus 77 ~lv~E~~~gg~L~~~l~~----~~~~~e~~~~~~~~qi~~al~~lH~-~~ivHrDlKp~NILl~~~g-~~kL~DFGla~~ 150 (382)
T cd05625 77 YFVMDYIPGGDMMSLLIR----MGIFPEDLARFYIAELTCAVESVHK-MGFIHRDIKPDNILIDRDG-HIKLTDFGLCTG 150 (382)
T ss_pred EEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEECCCC-CEEEeECCCCcc
Confidence 899999985 66655543 3568999999999999999999999 8999999999999999888 699999999753
Q ss_pred cccC------------------------------------------------CCcccccccccccccccccCCCCCCChh
Q 016184 235 LVKG------------------------------------------------EPNVSYICSRYYRAPELIFGATEYTTAI 266 (394)
Q Consensus 235 ~~~~------------------------------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~ 266 (394)
.... .......||+.|+|||++.+. .++.++
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~~ 229 (382)
T cd05625 151 FRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRT-GYTQLC 229 (382)
T ss_pred ccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCC-CCCCee
Confidence 2100 001124689999999999654 489999
Q ss_pred hHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHH
Q 016184 267 DIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVC 346 (394)
Q Consensus 267 DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 346 (394)
|||||||++|+|++|+.||.+.+..+....+...... ..++ ....+++++.+||.
T Consensus 230 DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~---------------~~~p----------~~~~~s~~~~~li~ 284 (382)
T cd05625 230 DWWSVGVILYEMLVGQPPFLAQTPLETQMKVINWQTS---------------LHIP----------PQAKLSPEASDLII 284 (382)
T ss_pred eEEechHHHHHHHhCCCCCCCCCHHHHHHHHHccCCC---------------cCCC----------CcccCCHHHHHHHH
Confidence 9999999999999999999887765555444331100 0011 01357899999999
Q ss_pred HhcccCCCCCCC---HHHHhcCCCCCCCCC
Q 016184 347 RFFQYSPNLRCT---ALEACVHPFFDELRD 373 (394)
Q Consensus 347 ~~L~~dP~~Rpt---~~ell~hp~f~~~~~ 373 (394)
+|+ .||.+|++ ++++++||||+.+..
T Consensus 285 ~l~-~~p~~R~~~~~~~ei~~hp~f~~~~~ 313 (382)
T cd05625 285 KLC-RGPEDRLGKNGADEIKAHPFFKTIDF 313 (382)
T ss_pred HHc-cCHhHcCCCCCHHHHhcCCCcCCcCh
Confidence 976 59999997 999999999998643
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-45 Score=343.78 Aligned_cols=244 Identities=26% Similarity=0.427 Sum_probs=197.6
Q ss_pred eEEeecCceEEEEEEECCCCcEEEEEEeccch-------hhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEEEEEEe
Q 016184 88 HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLE 160 (394)
Q Consensus 88 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e 160 (394)
+.||+|+||.||+|++..+|+.||+|++.+.. ....+|+.+++.+.||||+++.+++ .....+++|||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~~~~~lv~E 75 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSF-----QTKDRLCFVME 75 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEE-----EcCCEEEEEEe
Confidence 46999999999999999999999999986432 2334688999999999999998887 33445889999
Q ss_pred cccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCccccccC-
Q 016184 161 YVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG- 238 (394)
Q Consensus 161 ~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~~- 238 (394)
|+++ ++...+. ....+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+++.....
T Consensus 76 y~~~g~L~~~l~----~~~~l~~~~~~~~~~qi~~aL~~LH~-~~ivHrDikp~NIll~~~~-~~kL~DfG~~~~~~~~~ 149 (328)
T cd05593 76 YVNGGELFFHLS----RERVFSEDRTRFYGAEIVSALDYLHS-GKIVYRDLKLENLMLDKDG-HIKITDFGLCKEGITDA 149 (328)
T ss_pred CCCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHh-CCeEecccCHHHeEECCCC-cEEEecCcCCccCCCcc
Confidence 9986 5544433 24678999999999999999999999 8999999999999999887 6999999998754222
Q ss_pred CCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCCCcc
Q 016184 239 EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 318 (394)
Q Consensus 239 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 318 (394)
.......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+.......+.. ..
T Consensus 150 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~-----------------~~ 211 (328)
T cd05593 150 ATMKTFCGTPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM-----------------ED 211 (328)
T ss_pred cccccccCCcCccChhhhcCC-CCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhcc-----------------CC
Confidence 222345689999999998654 489999999999999999999999987665444333221 00
Q ss_pred cCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCC-----CHHHHhcCCCCCCCC
Q 016184 319 FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-----TALEACVHPFFDELR 372 (394)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----t~~ell~hp~f~~~~ 372 (394)
.. ++..+++++.+||++||+.||++|+ ++.++++||||....
T Consensus 212 ~~------------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~~ 258 (328)
T cd05593 212 IK------------FPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSFFTGVN 258 (328)
T ss_pred cc------------CCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcCCCcCCCC
Confidence 11 2245789999999999999999997 899999999998753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-45 Score=342.33 Aligned_cols=244 Identities=27% Similarity=0.435 Sum_probs=198.9
Q ss_pred eEEeecCceEEEEEEECCCCcEEEEEEeccch-------hhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEEEEEEe
Q 016184 88 HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLE 160 (394)
Q Consensus 88 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e 160 (394)
+.||+|+||.||+|++..+|+.||+|++.... ....+|+.+++.++||||+++++++. ....+++|||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~-----~~~~~~lv~E 75 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQ-----THDRLCFVME 75 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEe-----cCCEEEEEEe
Confidence 46999999999999999999999999986432 22346889999999999999998883 3345889999
Q ss_pred cccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCccccccC-
Q 016184 161 YVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG- 238 (394)
Q Consensus 161 ~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~~- 238 (394)
|+++ +|...+. ....+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||++......
T Consensus 76 ~~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivH~Dlkp~NIll~~~~-~~kL~Dfg~~~~~~~~~ 149 (323)
T cd05595 76 YANGGELFFHLS----RERVFTEERARFYGAEIVSALEYLHS-RDVVYRDIKLENLMLDKDG-HIKITDFGLCKEGISDG 149 (323)
T ss_pred CCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEecCCCHHHEEEcCCC-CEEecccHHhccccCCC
Confidence 9986 5544443 23578999999999999999999999 8999999999999999887 6999999998754222
Q ss_pred CCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCCCcc
Q 016184 239 EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 318 (394)
Q Consensus 239 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 318 (394)
.......||+.|+|||++.+. .++.++|||||||++|+|++|+.||...+.......+... .
T Consensus 150 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~-----------------~ 211 (323)
T cd05595 150 ATMKTFCGTPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME-----------------E 211 (323)
T ss_pred CccccccCCcCcCCcccccCC-CCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcC-----------------C
Confidence 222345689999999998654 4899999999999999999999999877655544443321 0
Q ss_pred cCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCC-----CHHHHhcCCCCCCCC
Q 016184 319 FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-----TALEACVHPFFDELR 372 (394)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----t~~ell~hp~f~~~~ 372 (394)
.. ++..+++++.+||.+||+.||.+|+ ++.++++||||.+..
T Consensus 212 ~~------------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h~~~~~~~ 258 (323)
T cd05595 212 IR------------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSIN 258 (323)
T ss_pred CC------------CCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcCCCcCCCC
Confidence 11 1245789999999999999999998 899999999998864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-45 Score=341.74 Aligned_cols=242 Identities=31% Similarity=0.535 Sum_probs=197.6
Q ss_pred EeecCceEEEEEEECCCCcEEEEEEeccch-------hhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEEEEEEecc
Q 016184 90 VGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYV 162 (394)
Q Consensus 90 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~ 162 (394)
||+|+||.||+|++..+++.||+|++.+.. ....+|+.+++.++||||+++++++. .....++||||+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~~lv~e~~ 75 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQ-----SPEKLYLVLAFI 75 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEe-----cCCeEEEEEcCC
Confidence 699999999999999999999999886432 22346899999999999999988873 334578999999
Q ss_pred cc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCccccccC-CC
Q 016184 163 PE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-EP 240 (394)
Q Consensus 163 ~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~~-~~ 240 (394)
++ +|...+.. ...+++..++.++.|++.||.|||+ +||+||||||+|||++.++ .++|+|||+++..... ..
T Consensus 76 ~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~HrDlkp~Nili~~~~-~~kl~Dfg~~~~~~~~~~~ 149 (312)
T cd05585 76 NGGELFHHLQR----EGRFDLSRARFYTAELLCALENLHK-FNVIYRDLKPENILLDYQG-HIALCDFGLCKLNMKDDDK 149 (312)
T ss_pred CCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeEeCCCCHHHeEECCCC-cEEEEECcccccCccCCCc
Confidence 85 56555543 3678999999999999999999999 8999999999999999888 6999999998754322 22
Q ss_pred cccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCCCcccC
Q 016184 241 NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 320 (394)
Q Consensus 241 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 320 (394)
.....||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+....+..+... ...
T Consensus 150 ~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~-----------------~~~ 211 (312)
T cd05585 150 TNTFCGTPEYLAPELLLGH-GYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQE-----------------PLR 211 (312)
T ss_pred cccccCCcccCCHHHHcCC-CCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcC-----------------CCC
Confidence 3345689999999999654 4899999999999999999999999877655544443321 001
Q ss_pred CCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCC---CHHHHhcCCCCCCCC
Q 016184 321 FPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC---TALEACVHPFFDELR 372 (394)
Q Consensus 321 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp---t~~ell~hp~f~~~~ 372 (394)
++..+++++.+||.+||+.||.+|| ++.++|+||||++..
T Consensus 212 ------------~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~hp~~~~~~ 254 (312)
T cd05585 212 ------------FPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFFSQLS 254 (312)
T ss_pred ------------CCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcCCCcCCCC
Confidence 2245789999999999999999997 589999999999863
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-48 Score=345.14 Aligned_cols=250 Identities=27% Similarity=0.449 Sum_probs=208.2
Q ss_pred eEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccch-----hhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEEEE
Q 016184 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL 157 (394)
Q Consensus 83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 157 (394)
.|+...+||+|+||.||+|.+..+++.||||++..+. ..+++|+.+|..++++||.++++.|+.... +++
T Consensus 14 ~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~-----Lwi 88 (467)
T KOG0201|consen 14 LYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTK-----LWI 88 (467)
T ss_pred ccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeeccc-----HHH
Confidence 4888899999999999999999999999999986443 345689999999999999999999965444 889
Q ss_pred EEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCccccc
Q 016184 158 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV 236 (394)
Q Consensus 158 v~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~ 236 (394)
+||||.| ++.++++. ...+.+..+..++++++.||.|||. .+.+|||||+.|||+..+| .|||+|||.+....
T Consensus 89 iMey~~gGsv~~lL~~----~~~~~E~~i~~ilre~l~~l~ylH~-~~kiHrDIKaanil~s~~g-~vkl~DfgVa~ql~ 162 (467)
T KOG0201|consen 89 IMEYCGGGSVLDLLKS----GNILDEFEIAVILREVLKGLDYLHS-EKKIHRDIKAANILLSESG-DVKLADFGVAGQLT 162 (467)
T ss_pred HHHHhcCcchhhhhcc----CCCCccceeeeehHHHHHHhhhhhh-cceecccccccceeEeccC-cEEEEecceeeeee
Confidence 9999986 66665554 3445888888899999999999999 8999999999999999997 79999999987664
Q ss_pred cCCC-cccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCC
Q 016184 237 KGEP-NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 315 (394)
Q Consensus 237 ~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 315 (394)
.... ..+++|||.|||||++.+. .|+.++||||||++.+||++|.+|+....++..+..|
T Consensus 163 ~~~~rr~tfvGTPfwMAPEVI~~~-~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflI------------------ 223 (467)
T KOG0201|consen 163 NTVKRRKTFVGTPFWMAPEVIKQS-GYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLI------------------ 223 (467)
T ss_pred chhhccccccccccccchhhhccc-cccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEec------------------
Confidence 4332 3678999999999999744 5999999999999999999999999887663322222
Q ss_pred CcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 016184 316 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR 372 (394)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 372 (394)
++..+.. +...+++.+++|+..||.+||+.||||.+||+|+|++...
T Consensus 224 ------pk~~PP~----L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh~FIk~a~ 270 (467)
T KOG0201|consen 224 ------PKSAPPR----LDGDFSPPFKEFVEACLDKNPEFRPSAKELLKHKFIKRAK 270 (467)
T ss_pred ------cCCCCCc----cccccCHHHHHHHHHHhhcCcccCcCHHHHhhhHHHHhcC
Confidence 2111111 2246789999999999999999999999999999999844
|
|
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-44 Score=340.41 Aligned_cols=268 Identities=25% Similarity=0.352 Sum_probs=203.5
Q ss_pred ceeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccc-----hhhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEE
Q 016184 81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL 155 (394)
Q Consensus 81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 155 (394)
...|++.+.||+|+||.||+|++..+++.||||++... ...+.+|+++++.++|+||+++++++ .....+
T Consensus 73 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~ 147 (353)
T PLN00034 73 LSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMF-----DHNGEI 147 (353)
T ss_pred HHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEe-----ccCCeE
Confidence 44688999999999999999999999999999998543 23456799999999999999999988 334457
Q ss_pred EEEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCcccc
Q 016184 156 NLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL 235 (394)
Q Consensus 156 ~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~ 235 (394)
++||||+.+... .. .....+..+..++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||++...
T Consensus 148 ~lv~e~~~~~~L---~~----~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlkp~NIll~~~~-~~kL~DfG~~~~~ 218 (353)
T PLN00034 148 QVLLEFMDGGSL---EG----THIADEQFLADVARQILSGIAYLHR-RHIVHRDIKPSNLLINSAK-NVKIADFGVSRIL 218 (353)
T ss_pred EEEEecCCCCcc---cc----cccCCHHHHHHHHHHHHHHHHHHHH-CCEeecCCCHHHEEEcCCC-CEEEcccccceec
Confidence 899999986421 11 1345677888999999999999999 8999999999999999887 7999999998765
Q ss_pred ccCC-CcccccccccccccccccCC----CCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhh
Q 016184 236 VKGE-PNVSYICSRYYRAPELIFGA----TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 310 (394)
Q Consensus 236 ~~~~-~~~~~~~t~~y~aPE~~~~~----~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 310 (394)
.... ......||..|+|||++... ...+.++|||||||++|+|++|+.||......+....+........
T Consensus 219 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~----- 293 (353)
T PLN00034 219 AQTMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQP----- 293 (353)
T ss_pred ccccccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccCC-----
Confidence 4322 22345789999999987432 2245689999999999999999999974332222111111100000
Q ss_pred ccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCCCCCCCCCCCCCCCC
Q 016184 311 CMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNF 390 (394)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~~~~~~~~~~~~~~~ 390 (394)
......++.++++||.+||+.||++|||+.|+|+||||.+.... ..++....+++.+
T Consensus 294 --------------------~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~~~~---~~~~~~~~~~~~~ 350 (353)
T PLN00034 294 --------------------PEAPATASREFRHFISCCLQREPAKRWSAMQLLQHPFILRAQPG---QGQGGPNLHQLLP 350 (353)
T ss_pred --------------------CCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcCcccccCCcc---cccCCCCccCCCC
Confidence 00124578899999999999999999999999999999986433 2334444444444
|
|
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-45 Score=342.34 Aligned_cols=301 Identities=35% Similarity=0.629 Sum_probs=232.4
Q ss_pred eEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccc------hhhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEEE
Q 016184 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN 156 (394)
Q Consensus 83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 156 (394)
+|.+.+.||+|+||.||+|++..+++.||||.+... .....+|+.+++.++|+||+++++++...........+
T Consensus 6 ~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~ 85 (337)
T cd07858 6 KYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDVY 85 (337)
T ss_pred ceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcEE
Confidence 599999999999999999999999999999987532 22334699999999999999999987544333334578
Q ss_pred EEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCccccc
Q 016184 157 LVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV 236 (394)
Q Consensus 157 lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~ 236 (394)
+++||+++++.+.+.. ...+++..++.++.|++.||.|||+ +|++|+||||+||+++.++ .+||+|||++....
T Consensus 86 lv~e~~~~~L~~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~-~~i~H~dlkp~Nil~~~~~-~~kL~Dfg~~~~~~ 159 (337)
T cd07858 86 IVYELMDTDLHQIIRS----SQTLSDDHCQYFLYQLLRGLKYIHS-ANVLHRDLKPSNLLLNANC-DLKICDFGLARTTS 159 (337)
T ss_pred EEEeCCCCCHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHh-CCEecCCCCHHHEEEcCCC-CEEECcCccccccC
Confidence 9999999887665543 3679999999999999999999999 8999999999999999887 69999999997654
Q ss_pred cC-CCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCC
Q 016184 237 KG-EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 315 (394)
Q Consensus 237 ~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 315 (394)
.. .......++..|+|||.+.....++.++|+|||||++|+|++|+.||.+.+....+..+....+.+..+.+......
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (337)
T cd07858 160 EKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNE 239 (337)
T ss_pred CCcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCch
Confidence 33 22234467888999999865445899999999999999999999999988777777777777777666554322111
Q ss_pred Cccc---CCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCCCCCCCCCCCCCCCCCC
Q 016184 316 YTEF---KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKP 392 (394)
Q Consensus 316 ~~~~---~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~~~~~~~~~~~~~~~~~ 392 (394)
.... ..+........ .....+++++.+||++||+.||++|||+.++++||||+.++++..-.. ...|..|+|+.
T Consensus 240 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~~~~~~~--~~~~~~~~~~~ 316 (337)
T cd07858 240 KARRYIRSLPYTPRQSFA-RLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHDPSDEPV--CQTPFSFDFEE 316 (337)
T ss_pred hhhHHHHhcCcccccCHH-HHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcCcccCcc--CCCccchhhhh
Confidence 0000 01111111111 122468899999999999999999999999999999999988876322 23445555543
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-45 Score=341.52 Aligned_cols=245 Identities=29% Similarity=0.504 Sum_probs=198.0
Q ss_pred eEEeecCceEEEEEEECCCCcEEEEEEeccch-------hhhHHHHHHHHHc-CCCCeeeeceEEEecCCCceeEEEEEE
Q 016184 88 HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQML-DHPNIVALKHCFFSTTDKEELYLNLVL 159 (394)
Q Consensus 88 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~lv~ 159 (394)
+.||+|+||.||+|+++.+++.||||++.+.. .....|..++..+ .||||+++++++ .....+++||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~-----~~~~~~~iv~ 75 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCF-----QTPDRLFFVM 75 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEE-----EcCCEEEEEE
Confidence 46999999999999999999999999986432 2233577777766 799999999988 3334578999
Q ss_pred ecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCcccccc-
Q 016184 160 EYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK- 237 (394)
Q Consensus 160 e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~- 237 (394)
||+++ +|...+.. ...+++..++.++.|++.||+|||+ +||+||||||+|||++.++ .+||+|||++.....
T Consensus 76 Ey~~~g~L~~~i~~----~~~l~~~~~~~~~~ql~~~L~~lH~-~~ivH~dlkp~NIli~~~~-~~kL~DfG~~~~~~~~ 149 (320)
T cd05590 76 EFVNGGDLMFHIQK----SRRFDEARARFYAAEITSALMFLHD-KGIIYRDLKLDNVLLDHEG-HCKLADFGMCKEGIFN 149 (320)
T ss_pred cCCCCchHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeEeCCCCHHHeEECCCC-cEEEeeCCCCeecCcC
Confidence 99986 55444432 4678999999999999999999999 8999999999999999888 699999999875422
Q ss_pred CCCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCCCc
Q 016184 238 GEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 317 (394)
Q Consensus 238 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 317 (394)
........||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+....+..+....
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~---------------- 212 (320)
T cd05590 150 GKTTSTFCGTPDYIAPEILQEM-LYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDE---------------- 212 (320)
T ss_pred CCcccccccCccccCHHHHcCC-CCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCC----------------
Confidence 2233345689999999998654 48999999999999999999999998877665555443310
Q ss_pred ccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCH------HHHhcCCCCCCCCC
Q 016184 318 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTA------LEACVHPFFDELRD 373 (394)
Q Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~------~ell~hp~f~~~~~ 373 (394)
.. ++..++.++.+||++||+.||.+|+++ +++++||||+.+..
T Consensus 213 -~~------------~~~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h~~f~~~~~ 261 (320)
T cd05590 213 -VV------------YPTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPFFKELDW 261 (320)
T ss_pred -CC------------CCCCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcCCCcCCCCH
Confidence 00 123478899999999999999999998 89999999998753
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-45 Score=334.45 Aligned_cols=271 Identities=25% Similarity=0.407 Sum_probs=211.0
Q ss_pred EEEeeEEeecCceEEEEEEECCCCcEEEEEEeccch-------hhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEEE
Q 016184 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN 156 (394)
Q Consensus 84 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 156 (394)
|++.+.||+|+||.||+|.+..+++.||+|.+.... ....+|+.+++.++|++++.+.+.+. ...+.+
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~-----~~~~~~ 76 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYE-----TKDALC 76 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEe-----cCCEEE
Confidence 788899999999999999999999999999875431 22346999999999999999988873 334588
Q ss_pred EEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCcccc
Q 016184 157 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL 235 (394)
Q Consensus 157 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~ 235 (394)
++|||+++ +|...+... ....+++..+..++.|++.||.|||+ .||+||||||+||+++.++ .++|+|||++...
T Consensus 77 lv~e~~~g~~L~~~l~~~--~~~~l~~~~~~~~~~qi~~~l~~lH~-~~iiH~dikp~Nil~~~~~-~~~l~Dfg~~~~~ 152 (285)
T cd05630 77 LVLTLMNGGDLKFHIYHM--GEAGFEEGRAVFYAAEICCGLEDLHQ-ERIVYRDLKPENILLDDHG-HIRISDLGLAVHV 152 (285)
T ss_pred EEEEecCCCcHHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHh-CCEEeCCCCHHHEEECCCC-CEEEeeccceeec
Confidence 99999975 676655432 22568999999999999999999999 8999999999999999887 6999999998765
Q ss_pred ccCCCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCC
Q 016184 236 VKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 315 (394)
Q Consensus 236 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 315 (394)
..........+++.|+|||++.+. .++.++|+||+|+++|+|++|+.||...................
T Consensus 153 ~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~----------- 220 (285)
T cd05630 153 PEGQTIKGRVGTVGYMAPEVVKNE-RYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEV----------- 220 (285)
T ss_pred CCCccccCCCCCccccChHHHcCC-CCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhh-----------
Confidence 444333445789999999999654 48999999999999999999999998654322111111110000
Q ss_pred CcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCC-----HHHHhcCCCCCCCCCCCCCCCCCCCCCCCCCC
Q 016184 316 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCT-----ALEACVHPFFDELRDPNTRLPNGRPLPPLFNF 390 (394)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt-----~~ell~hp~f~~~~~~~~~~~~~~~~~~~~~~ 390 (394)
...+...+++++.+||++||+.||.+||| ++++++||||+++... .... ...+|++.+
T Consensus 221 --------------~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~~~~~--~~~~-~~~~~~~~~ 283 (285)
T cd05630 221 --------------QEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQINFK--RLEA-GMLEPPFKP 283 (285)
T ss_pred --------------hhhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcChhhhccCHH--HHhc-CCCCCCCCC
Confidence 00122457889999999999999999999 9999999999986333 2223 344477777
Q ss_pred CC
Q 016184 391 KP 392 (394)
Q Consensus 391 ~~ 392 (394)
+|
T Consensus 284 ~~ 285 (285)
T cd05630 284 DP 285 (285)
T ss_pred CC
Confidence 65
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-45 Score=351.27 Aligned_cols=252 Identities=27% Similarity=0.460 Sum_probs=201.6
Q ss_pred eEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccc-------hhhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEE
Q 016184 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL 155 (394)
Q Consensus 83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 155 (394)
.|++++.||+|+||.||+|++..+++.||||++.+. .....+|+++++.++|+||+++++.+ ....++
T Consensus 2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~-----~~~~~~ 76 (376)
T cd05598 2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSF-----QDKDNL 76 (376)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEE-----EcCCEE
Confidence 499999999999999999999999999999998542 22345799999999999999999888 334468
Q ss_pred EEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCccc
Q 016184 156 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV 234 (394)
Q Consensus 156 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~ 234 (394)
++||||+++ +|.+++.. ...+++..++.++.||+.||+|||+ .||+||||||+|||++.++ .+||+|||+|..
T Consensus 77 ~lv~E~~~~g~L~~~i~~----~~~~~~~~~~~~~~qi~~al~~lH~-~~ivHrDlkp~Nill~~~~-~ikL~DFG~a~~ 150 (376)
T cd05598 77 YFVMDYIPGGDMMSLLIR----LGIFEEDLARFYIAELTCAIESVHK-MGFIHRDIKPDNILIDRDG-HIKLTDFGLCTG 150 (376)
T ss_pred EEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeEeCCCCHHHEEECCCC-CEEEEeCCCCcc
Confidence 899999975 67666543 3568999999999999999999999 8999999999999999888 699999999742
Q ss_pred cccC--------------------------------------------CCcccccccccccccccccCCCCCCChhhHHH
Q 016184 235 LVKG--------------------------------------------EPNVSYICSRYYRAPELIFGATEYTTAIDIWS 270 (394)
Q Consensus 235 ~~~~--------------------------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diws 270 (394)
.... .......||+.|+|||++.+. .++.++||||
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwS 229 (376)
T cd05598 151 FRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRT-GYTQLCDWWS 229 (376)
T ss_pred ccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCC-CCCcceeeee
Confidence 2100 001124689999999999654 4899999999
Q ss_pred HHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcc
Q 016184 271 TGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQ 350 (394)
Q Consensus 271 lG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~ 350 (394)
|||++|+|++|+.||.+....+....+...... ..++ ....+++++.+||.+|+
T Consensus 230 lGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~---------------~~~~----------~~~~~s~~~~~li~~l~- 283 (376)
T cd05598 230 VGVILYEMLVGQPPFLADTPAETQLKVINWETT---------------LHIP----------SQAKLSREASDLILRLC- 283 (376)
T ss_pred ccceeeehhhCCCCCCCCCHHHHHHHHhccCcc---------------ccCC----------CCCCCCHHHHHHHHHHh-
Confidence 999999999999999887765554443321100 0000 01357889999999976
Q ss_pred cCCCCCC---CHHHHhcCCCCCCCC
Q 016184 351 YSPNLRC---TALEACVHPFFDELR 372 (394)
Q Consensus 351 ~dP~~Rp---t~~ell~hp~f~~~~ 372 (394)
.+|.+|+ |+.++++||||+.+.
T Consensus 284 ~~p~~R~~~~t~~ell~h~~~~~~~ 308 (376)
T cd05598 284 CGAEDRLGKNGADEIKAHPFFKGID 308 (376)
T ss_pred cCHhhcCCCCCHHHHhCCCCcCCCC
Confidence 5999999 999999999999864
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=341.62 Aligned_cols=285 Identities=32% Similarity=0.569 Sum_probs=223.0
Q ss_pred eeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccc------hhhhHHHHHHHHHcCCCCeeeeceEEEecCC-CceeE
Q 016184 82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTD-KEELY 154 (394)
Q Consensus 82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~~~~~ 154 (394)
.+|++.+.||+|+||.||+|++..+|+.||||.+.+. .....+|+.+++.++|+||+++++++..... .+..+
T Consensus 16 ~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 95 (353)
T cd07850 16 KRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQD 95 (353)
T ss_pred cceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccCc
Confidence 4599999999999999999999999999999987542 1233469999999999999999998753322 22345
Q ss_pred EEEEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCccc
Q 016184 155 LNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV 234 (394)
Q Consensus 155 ~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~ 234 (394)
.++||||+.+++.+.+.. .+++..+..++.|++.||+|||+ .||+||||||+||+++.++ .+||+|||++..
T Consensus 96 ~~lv~e~~~~~l~~~~~~------~l~~~~~~~~~~ql~~aL~~LH~-~gi~H~dlkp~Nil~~~~~-~~kL~Dfg~~~~ 167 (353)
T cd07850 96 VYLVMELMDANLCQVIQM------DLDHERMSYLLYQMLCGIKHLHS-AGIIHRDLKPSNIVVKSDC-TLKILDFGLART 167 (353)
T ss_pred EEEEEeccCCCHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHh-CCeeeCCCCHHHEEECCCC-CEEEccCcccee
Confidence 789999999887766542 38889999999999999999999 8999999999999999888 699999999986
Q ss_pred cccCCCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCC
Q 016184 235 LVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 314 (394)
Q Consensus 235 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 314 (394)
...........+++.|+|||.+.+. .++.++|||||||++|+|++|+.||...+.......+...++.++.+....+..
T Consensus 168 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (353)
T cd07850 168 AGTSFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQP 246 (353)
T ss_pred CCCCCCCCCCcccccccCHHHHhCC-CCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhh
Confidence 6444333445678899999999654 489999999999999999999999998888888888888888887655443322
Q ss_pred CCcccC--CCCCCCCCcchhc------------cccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCC
Q 016184 315 NYTEFK--FPQIKPHPWHKVF------------QKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 375 (394)
Q Consensus 315 ~~~~~~--~~~~~~~~~~~~~------------~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~ 375 (394)
....+. .+.....++...+ ....++.+++||.+||+.||++|||+.++|+||||+...++.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~~~~~~ 321 (353)
T cd07850 247 TVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINVWYDPS 321 (353)
T ss_pred hhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhhccCCc
Confidence 111110 0000001111111 123567789999999999999999999999999999766543
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-44 Score=333.07 Aligned_cols=285 Identities=35% Similarity=0.552 Sum_probs=223.3
Q ss_pred ceeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccch------hhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeE
Q 016184 81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY 154 (394)
Q Consensus 81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 154 (394)
..+|++.+.||.|+||.||+|.+..+|+.||+|++.... ....+|+.+++.++|+||+++++++... ....
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~---~~~~ 82 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGK---HLDS 82 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecC---CCCe
Confidence 346999999999999999999999999999999875332 1234799999999999999999987432 2234
Q ss_pred EEEEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCccc
Q 016184 155 LNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV 234 (394)
Q Consensus 155 ~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~ 234 (394)
.++||||+.+++..++... ...+++..++.++.|++.||.|||+ .|++||||||+||+++.++ .+||+|||.+..
T Consensus 83 ~~lv~e~~~~~l~~~l~~~---~~~l~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~p~nil~~~~~-~~kL~dfg~~~~ 157 (309)
T cd07845 83 IFLVMEYCEQDLASLLDNM---PTPFSESQVKCLMLQLLRGLQYLHE-NFIIHRDLKVSNLLLTDKG-CLKIADFGLART 157 (309)
T ss_pred EEEEEecCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEECCCC-CEEECccceeee
Confidence 6899999998887766543 2678999999999999999999999 8999999999999999887 799999999876
Q ss_pred cccCC-CcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccC
Q 016184 235 LVKGE-PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 313 (394)
Q Consensus 235 ~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 313 (394)
..... ......+++.|+|||.+.+...++.++|+|||||++|+|++|+.||...+..+.+..+.+..+.+....+....
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (309)
T cd07845 158 YGLPAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFS 237 (309)
T ss_pred cCCccCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhh
Confidence 64332 22233457889999998765668999999999999999999999999988888888888888777665543221
Q ss_pred C--CCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCC
Q 016184 314 P--NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP 374 (394)
Q Consensus 314 ~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~ 374 (394)
. ....+.++......+... ....++.+.+||++||++||++|||+.++++||||++...+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~~~~ 299 (309)
T cd07845 238 DLPLVGKFTLPKQPYNNLKHK-FPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEKPLP 299 (309)
T ss_pred cccccccccccCCCCCchHHh-ccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccCCCC
Confidence 1 111111111111111111 12368899999999999999999999999999999866444
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-44 Score=338.85 Aligned_cols=278 Identities=26% Similarity=0.433 Sum_probs=206.6
Q ss_pred eeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccc-----hhhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEEE
Q 016184 82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN 156 (394)
Q Consensus 82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 156 (394)
++|++.+.||+|+||.||+|++..+|..||+|++... ...+.+|+++++.++|+||+++++++.. ....+
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~~ 79 (331)
T cd06649 5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS-----DGEIS 79 (331)
T ss_pred ccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE-----CCEEE
Confidence 4699999999999999999999999999999988643 2345679999999999999999998843 33478
Q ss_pred EEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCcccc
Q 016184 157 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL 235 (394)
Q Consensus 157 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~ 235 (394)
+||||+++ +|.+++.. ...+++..+..++.|++.||.|||+..+|+||||||+|||++.++ .+||+|||++...
T Consensus 80 lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~-~~kl~Dfg~~~~~ 154 (331)
T cd06649 80 ICMEHMDGGSLDQVLKE----AKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRG-EIKLCDFGVSGQL 154 (331)
T ss_pred EEeecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCC-cEEEccCcccccc
Confidence 99999986 77666543 356899999999999999999999833699999999999999888 6999999998765
Q ss_pred ccCCCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhc----
Q 016184 236 VKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC---- 311 (394)
Q Consensus 236 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~---- 311 (394)
... ......+++.|+|||++.+. .++.++|||||||++|+|++|+.||...+..+.. .+ ++.+.......
T Consensus 155 ~~~-~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~-~~---~~~~~~~~~~~~~~~ 228 (331)
T cd06649 155 IDS-MANSFVGTRSYMSPERLQGT-HYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELE-AI---FGRPVVDGEEGEPHS 228 (331)
T ss_pred ccc-ccccCCCCcCcCCHhHhcCC-CCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHH-HH---hcccccccccCCccc
Confidence 332 23345689999999999654 4899999999999999999999999766543322 21 22111100000
Q ss_pred cCCC----------CcccCCCC---------CCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 016184 312 MNPN----------YTEFKFPQ---------IKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR 372 (394)
Q Consensus 312 ~~~~----------~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 372 (394)
..+. ......+. .............+++++++||.+||++||++|||+.++++||||+...
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~ 308 (331)
T cd06649 229 ISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKRSE 308 (331)
T ss_pred cCcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhhcc
Confidence 0000 00000000 0000000001124688999999999999999999999999999998865
Q ss_pred CCC
Q 016184 373 DPN 375 (394)
Q Consensus 373 ~~~ 375 (394)
...
T Consensus 309 ~~~ 311 (331)
T cd06649 309 VEE 311 (331)
T ss_pred ccc
Confidence 443
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-44 Score=331.29 Aligned_cols=285 Identities=35% Similarity=0.613 Sum_probs=220.3
Q ss_pred eEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccch------hhhHHHHHHHHHcC-CCCeeeeceEEEecCCCceeEE
Q 016184 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLD-HPNIVALKHCFFSTTDKEELYL 155 (394)
Q Consensus 83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~ 155 (394)
+|++.+.||+|+||.||+|.+..+++.||||.+.... ....+|+.+++.+. |+||+++++++...........
T Consensus 2 ~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~ 81 (295)
T cd07837 2 AYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSL 81 (295)
T ss_pred CceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceE
Confidence 5999999999999999999999999999999875432 23457999999995 6999999988855444344567
Q ss_pred EEEEecccccHHHHHHHhhhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCccc
Q 016184 156 NLVLEYVPETVNRIARNYSRI-HQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV 234 (394)
Q Consensus 156 ~lv~e~~~~~l~~~~~~~~~~-~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~ 234 (394)
+++|||+++++.+++...... ...+++..++.++.||+.||.|||+ +||+||||||+||+++.+...+||+|||++..
T Consensus 82 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~-~~i~H~dl~~~nil~~~~~~~~kl~dfg~~~~ 160 (295)
T cd07837 82 YLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHK-HGVMHRDLKPQNLLVDKQKGLLKIADLGLGRA 160 (295)
T ss_pred EEEeeccCcCHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCChHHEEEecCCCeEEEeeccccee
Confidence 899999999887776654332 4568999999999999999999999 89999999999999998344799999999875
Q ss_pred cccC-CCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccC
Q 016184 235 LVKG-EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 313 (394)
Q Consensus 235 ~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 313 (394)
.... .......+++.|+|||.+.+...++.++|+||||+++|+|++|..||.+.+....+..+...++.+....+....
T Consensus 161 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (295)
T cd07837 161 FSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGVS 240 (295)
T ss_pred cCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhCcchh
Confidence 4322 112223557889999998665567999999999999999999999999988888888887777666554432211
Q ss_pred CCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCC
Q 016184 314 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFD 369 (394)
Q Consensus 314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~ 369 (394)
.......++....... ....+.++..+.+||.+||..||.+|||+.+++.||||+
T Consensus 241 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~ 295 (295)
T cd07837 241 KLRDWHEFPQWKPQDL-SRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD 295 (295)
T ss_pred hccchhhcCcccchhH-HHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence 1111111111111111 111245789999999999999999999999999999995
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-45 Score=338.49 Aligned_cols=250 Identities=27% Similarity=0.435 Sum_probs=201.3
Q ss_pred eEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccch-------hhhHHHHHHHHHcCCC-CeeeeceEEEecCCCceeE
Q 016184 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHP-NIVALKHCFFSTTDKEELY 154 (394)
Q Consensus 83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~-~iv~~~~~~~~~~~~~~~~ 154 (394)
+|++.+.||+|+||.||+|++..+++.||||++.+.. .....|.+++..+.|+ +|+.+++++. ....
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~-----~~~~ 75 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQ-----TMDR 75 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEE-----cCCE
Confidence 3899999999999999999999999999999986432 2234688888888775 5777777762 2335
Q ss_pred EEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCcc
Q 016184 155 LNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK 233 (394)
Q Consensus 155 ~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~ 233 (394)
+++||||+++ +|...+.. ...+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||++.
T Consensus 76 ~~lv~E~~~~g~L~~~~~~----~~~~~~~~~~~~~~qi~~al~~lH~-~~ivH~dlkp~Nill~~~~-~~kL~Dfg~~~ 149 (324)
T cd05587 76 LYFVMEYVNGGDLMYHIQQ----VGKFKEPHAVFYAAEIAIGLFFLHS-KGIIYRDLKLDNVMLDAEG-HIKIADFGMCK 149 (324)
T ss_pred EEEEEcCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeEecCCCHHHeEEcCCC-CEEEeecCcce
Confidence 7899999985 66554433 3568999999999999999999999 8999999999999999887 69999999986
Q ss_pred cccc-CCCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhcc
Q 016184 234 VLVK-GEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 312 (394)
Q Consensus 234 ~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 312 (394)
.... ........||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+.+..+....
T Consensus 150 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~----------- 217 (324)
T cd05587 150 ENIFGGKTTRTFCGTPDYIAPEIIAYQ-PYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHN----------- 217 (324)
T ss_pred ecCCCCCceeeecCCccccChhhhcCC-CCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC-----------
Confidence 4322 2223345689999999999654 48999999999999999999999998877666555544310
Q ss_pred CCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCH-----HHHhcCCCCCCCCC
Q 016184 313 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTA-----LEACVHPFFDELRD 373 (394)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~-----~ell~hp~f~~~~~ 373 (394)
. .++..++.++.+||++||+.||.+|++. +++++||||+.+..
T Consensus 218 ------~------------~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~hp~~~~~~~ 265 (324)
T cd05587 218 ------V------------SYPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREHAFFRRIDW 265 (324)
T ss_pred ------C------------CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCCcCCCCH
Confidence 0 0124578999999999999999999976 89999999998643
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-45 Score=338.98 Aligned_cols=249 Identities=27% Similarity=0.425 Sum_probs=201.2
Q ss_pred eEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccchh-------hhHHHHHHHHHc-CCCCeeeeceEEEecCCCceeE
Q 016184 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-------YKNRELQIMQML-DHPNIVALKHCFFSTTDKEELY 154 (394)
Q Consensus 83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-------~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~ 154 (394)
+|.+.+.||+|+||.||+|++..+++.||+|++.+... ....|..++..+ .|++|+++++++ .....
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~-----~~~~~ 75 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCF-----QTMDR 75 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEE-----ecCCE
Confidence 38899999999999999999999999999999865321 223466777766 578888888887 33345
Q ss_pred EEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCcc
Q 016184 155 LNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK 233 (394)
Q Consensus 155 ~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~ 233 (394)
+++||||+++ +|...+.. ...+++..+..++.||+.||+|||+ .||+||||||+|||++.++ .+||+|||+++
T Consensus 76 ~~lv~E~~~~g~L~~~~~~----~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivHrDlkp~Nill~~~~-~~kL~DfG~~~ 149 (323)
T cd05616 76 LYFVMEYVNGGDLMYQIQQ----VGRFKEPHAVFYAAEIAIGLFFLHS-KGIIYRDLKLDNVMLDSEG-HIKIADFGMCK 149 (323)
T ss_pred EEEEEcCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCEEecCCCHHHeEECCCC-cEEEccCCCce
Confidence 8899999985 56544432 3578999999999999999999999 8999999999999999888 69999999987
Q ss_pred cccc-CCCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhcc
Q 016184 234 VLVK-GEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 312 (394)
Q Consensus 234 ~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 312 (394)
.... ........||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+....+..+....
T Consensus 150 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~----------- 217 (323)
T cd05616 150 ENMWDGVTTKTFCGTPDYIAPEIIAYQ-PYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHN----------- 217 (323)
T ss_pred ecCCCCCccccCCCChhhcCHHHhcCC-CCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-----------
Confidence 5432 2223345689999999999654 48999999999999999999999998877666655554311
Q ss_pred CCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCC-----HHHHhcCCCCCCCC
Q 016184 313 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCT-----ALEACVHPFFDELR 372 (394)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt-----~~ell~hp~f~~~~ 372 (394)
.. ++..++.++.+||.+||+.||.+|++ ..++++||||+.+.
T Consensus 218 ------~~------------~p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~~~~~~ 264 (323)
T cd05616 218 ------VA------------YPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYID 264 (323)
T ss_pred ------CC------------CCCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcCCCcCCCC
Confidence 00 12457899999999999999999998 48999999999864
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-44 Score=335.59 Aligned_cols=276 Identities=29% Similarity=0.526 Sum_probs=204.2
Q ss_pred eEEeecCceEEEEEEECC--CCcEEEEEEeccch--hhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEEEEEEeccc
Q 016184 88 HVVGTGSFGVVFQAKCRE--TGEIVAIKKVLQDK--RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVP 163 (394)
Q Consensus 88 ~~lg~G~~g~V~~~~~~~--~~~~vaiK~~~~~~--~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~ 163 (394)
.+||+|+||.||+|++.. ++..||+|.+.... ....+|+++++.++||||+++++++... .....+++|||++
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~---~~~~~~lv~e~~~ 83 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVFLSH---SDRKVWLLFDYAE 83 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCCCcHHHHHHHHHHHhCCCCCeeeEEEEEecc---CCCeEEEEEeeeC
Confidence 579999999999999754 56889999886542 3456799999999999999999988543 2345789999999
Q ss_pred ccHHHHHHHhhh-----hcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEe----CCCCcEEEEeecCccc
Q 016184 164 ETVNRIARNYSR-----IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVN----PHTHQLKLCDFGSAKV 234 (394)
Q Consensus 164 ~~l~~~~~~~~~-----~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~----~~~~~vkl~Dfg~a~~ 234 (394)
+++...+..... ....+++..++.++.||+.||.|||+ .||+||||||+|||+. .++ .+||+|||+++.
T Consensus 84 ~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~-~~ivH~Dlkp~Nil~~~~~~~~~-~~kl~DfG~a~~ 161 (317)
T cd07867 84 HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHA-NWVLHRDLKPANILVMGEGPERG-RVKIADMGFARL 161 (317)
T ss_pred CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHh-CCEEcCCCCHHHEEEccCCCCCC-cEEEeeccceec
Confidence 988777654321 12358899999999999999999999 8999999999999994 334 799999999976
Q ss_pred cccCCC----cccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCc---------HHHHHHHHHHh
Q 016184 235 LVKGEP----NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESG---------VDQLVEIIKVL 301 (394)
Q Consensus 235 ~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~---------~~~~~~i~~~~ 301 (394)
...... .....+|+.|+|||++.+...++.++|||||||++|+|+||++||..... ...+..+...+
T Consensus 162 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (317)
T cd07867 162 FNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVM 241 (317)
T ss_pred cCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHHhc
Confidence 543221 22346789999999987656689999999999999999999999975432 24456666666
Q ss_pred CCCChhhhhccCCC--Ccc----c---CCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 016184 302 GTPTREEIKCMNPN--YTE----F---KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368 (394)
Q Consensus 302 ~~~~~~~~~~~~~~--~~~----~---~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f 368 (394)
+.+....+...... +.. + ..................+..+.+||.+||+.||.+|||+.|+|+||||
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07867 242 GFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF 317 (317)
T ss_pred CCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 66655544322110 000 0 0000000000011112346679999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-45 Score=341.77 Aligned_cols=254 Identities=30% Similarity=0.466 Sum_probs=199.4
Q ss_pred eEEEeeEEeecCceEEEEEEEC---CCCcEEEEEEeccch--------hhhHHHHHHHHHc-CCCCeeeeceEEEecCCC
Q 016184 83 SYIAEHVVGTGSFGVVFQAKCR---ETGEIVAIKKVLQDK--------RYKNRELQIMQML-DHPNIVALKHCFFSTTDK 150 (394)
Q Consensus 83 ~y~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~--------~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~ 150 (394)
+|++.+.||+|+||.||+|++. .+++.||+|++.+.. ....+|+.+++.+ .|+||+++++++ .
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~-----~ 75 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAF-----Q 75 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEE-----e
Confidence 3899999999999999999874 478999999886421 2234688999999 589999998887 3
Q ss_pred ceeEEEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEee
Q 016184 151 EELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDF 229 (394)
Q Consensus 151 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Df 229 (394)
....+++||||+.+ +|...+.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+||
T Consensus 76 ~~~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivHrDlkp~Nili~~~~-~~kl~Df 149 (332)
T cd05614 76 TEAKLHLILDYVSGGEMFTHLYQ----RDNFSEDEVRFYSGEIILALEHLHK-LGIVYRDIKLENILLDSEG-HVVLTDF 149 (332)
T ss_pred cCCEEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCcEecCCCHHHeEECCCC-CEEEeeC
Confidence 34457899999985 66555433 3678999999999999999999999 8999999999999999888 7999999
Q ss_pred cCccccccCC--CcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChh
Q 016184 230 GSAKVLVKGE--PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 307 (394)
Q Consensus 230 g~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~ 307 (394)
|+++...... ......||+.|+|||++.+...++.++|||||||++|+|++|..||...........+.......
T Consensus 150 G~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~--- 226 (332)
T cd05614 150 GLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKC--- 226 (332)
T ss_pred cCCccccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcC---
Confidence 9987653322 22345689999999999765557899999999999999999999997543221111121111000
Q ss_pred hhhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCC-----CHHHHhcCCCCCCCC
Q 016184 308 EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-----TALEACVHPFFDELR 372 (394)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----t~~ell~hp~f~~~~ 372 (394)
...++..++..+.+||.+||+.||++|| +++++++||||++..
T Consensus 227 ----------------------~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~ 274 (332)
T cd05614 227 ----------------------DPPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGLD 274 (332)
T ss_pred ----------------------CCCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCCC
Confidence 0012245789999999999999999999 889999999999753
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-45 Score=342.35 Aligned_cols=245 Identities=28% Similarity=0.434 Sum_probs=197.5
Q ss_pred eEEeecCceEEEEEEECCCCcEEEEEEeccch-------hhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEEEEEEe
Q 016184 88 HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLE 160 (394)
Q Consensus 88 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e 160 (394)
+.||+|+||.||+|++..+|+.||+|++.... ....+|+++++.++||||+++.+++ .....+++|||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~-----~~~~~~~lv~E 75 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSF-----QTHDRLCFVME 75 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEE-----EcCCEEEEEEe
Confidence 46999999999999999999999999986432 2234688899999999999998887 33345889999
Q ss_pred cccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCccccccC-
Q 016184 161 YVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG- 238 (394)
Q Consensus 161 ~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~~- 238 (394)
|+++ +|...+. ....+++..++.++.||+.||+|||+..||+||||||+|||++.++ .+||+|||++......
T Consensus 76 ~~~~~~L~~~l~----~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~-~~kL~Dfg~~~~~~~~~ 150 (325)
T cd05594 76 YANGGELFFHLS----RERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDG-HIKITDFGLCKEGIKDG 150 (325)
T ss_pred CCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCC-CEEEecCCCCeecCCCC
Confidence 9986 4544333 2467899999999999999999999635999999999999999888 6999999998754322
Q ss_pred CCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCCCcc
Q 016184 239 EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 318 (394)
Q Consensus 239 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 318 (394)
.......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+.......+... .
T Consensus 151 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~-----------------~ 212 (325)
T cd05594 151 ATMKTFCGTPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME-----------------E 212 (325)
T ss_pred cccccccCCcccCCHHHHccC-CCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcC-----------------C
Confidence 222345689999999998654 4899999999999999999999999876654444333221 0
Q ss_pred cCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCC-----CHHHHhcCCCCCCCC
Q 016184 319 FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-----TALEACVHPFFDELR 372 (394)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----t~~ell~hp~f~~~~ 372 (394)
.. ++..+++++.+||.+||+.||++|+ ++.++++||||++..
T Consensus 213 ~~------------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~~ 259 (325)
T cd05594 213 IR------------FPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFFAGIV 259 (325)
T ss_pred CC------------CCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcCCCcCCCC
Confidence 11 2245789999999999999999997 999999999999864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-44 Score=328.55 Aligned_cols=276 Identities=40% Similarity=0.756 Sum_probs=223.9
Q ss_pred eEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccch------hhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEEE
Q 016184 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN 156 (394)
Q Consensus 83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 156 (394)
+|++.+.||.|++|.||+|.+..+|+.||+|++.... ....+|+.+++.++|+||+++++++. ...+.+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-----~~~~~~ 75 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFP-----HGSGFV 75 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEe-----cCCeeE
Confidence 4899999999999999999999999999999886432 34567999999999999999999883 344578
Q ss_pred EEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCccccc
Q 016184 157 LVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV 236 (394)
Q Consensus 157 lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~ 236 (394)
+|+||++++|.+++.... ..+++..++.++.|++.||+|||+ .|++|+||||+||+++.++ .++|+|||++....
T Consensus 76 ~v~e~~~~~L~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dl~p~ni~~~~~~-~~~l~dfg~~~~~~ 150 (286)
T cd07832 76 LVMEYMPSDLSEVLRDEE---RPLPEAQVKSYMRMLLKGVAYMHA-NGIMHRDLKPANLLISADG-VLKIADFGLARLFS 150 (286)
T ss_pred EEecccCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCcCHHHEEEcCCC-cEEEeeeeeccccc
Confidence 999999778877765432 668999999999999999999999 8999999999999999887 69999999987664
Q ss_pred cCCC--cccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccC-
Q 016184 237 KGEP--NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN- 313 (394)
Q Consensus 237 ~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~- 313 (394)
.... .....++..|+|||.+.+...++.++||||||+++|+|++|.+||.+..+...+..+....+.+....+....
T Consensus 151 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (286)
T cd07832 151 EEEPRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTS 230 (286)
T ss_pred CCCCCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccC
Confidence 4331 2345678899999998766657899999999999999999999998888888888888888777665554322
Q ss_pred -CCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCC
Q 016184 314 -PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFD 369 (394)
Q Consensus 314 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~ 369 (394)
..+....++.....++...+ ...+.++.+||.+||+.||++|||++++|+||||.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~ 286 (286)
T cd07832 231 LPDYNKITFPESKPIPLEEIF-PDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT 286 (286)
T ss_pred cchhhcccCCCCCcchHHHhC-CCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence 12223333333333333322 45678999999999999999999999999999994
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-45 Score=313.11 Aligned_cols=259 Identities=25% Similarity=0.422 Sum_probs=209.3
Q ss_pred ccceeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccchhhh--H---HHHHHHHH-cCCCCeeeeceEEEecCCCce
Q 016184 79 KQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK--N---RELQIMQM-LDHPNIVALKHCFFSTTDKEE 152 (394)
Q Consensus 79 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--~---~E~~~l~~-l~h~~iv~~~~~~~~~~~~~~ 152 (394)
...+..+++..||.|+.|+||+++++.+|..+|||.+.+..... + ..+.++.. ...|+||+.+++|....+
T Consensus 89 ~dindl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~d--- 165 (391)
T KOG0983|consen 89 ADINDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTD--- 165 (391)
T ss_pred cChHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCch---
Confidence 33445677889999999999999999999999999997643322 1 23333322 357999999999977665
Q ss_pred eEEEEEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCc
Q 016184 153 LYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA 232 (394)
Q Consensus 153 ~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a 232 (394)
+++-||.|..-+..+++. ..+++++..+-++...++.||.||.+.+||+|||+||+|||+|..| ++||||||.+
T Consensus 166 --V~IcMelMs~C~ekLlkr---ik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~G-niKlCDFGIs 239 (391)
T KOG0983|consen 166 --VFICMELMSTCAEKLLKR---IKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERG-NIKLCDFGIS 239 (391)
T ss_pred --HHHHHHHHHHHHHHHHHH---hcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCC-CEEeeccccc
Confidence 567889887655555543 3478999999999999999999999878999999999999999988 6999999999
Q ss_pred cccccCCCcccccccccccccccccC--CCCCCChhhHHHHHHHHHHHHhCCCCCCCCC-cHHHHHHHHHHhCCCChhhh
Q 016184 233 KVLVKGEPNVSYICSRYYRAPELIFG--ATEYTTAIDIWSTGCVMAELLLGQPLFPGES-GVDQLVEIIKVLGTPTREEI 309 (394)
Q Consensus 233 ~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~~DiwslG~il~~lltg~~pf~~~~-~~~~~~~i~~~~~~~~~~~~ 309 (394)
.++.+........|.+.|||||.+.. ...|+.++||||||++++||+||+.||.+.+ +.+.+..+.+. .|+.-
T Consensus 240 GrlvdSkAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~--ePP~L-- 315 (391)
T KOG0983|consen 240 GRLVDSKAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNE--EPPLL-- 315 (391)
T ss_pred ceeecccccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhc--CCCCC--
Confidence 99988888888899999999999843 3458999999999999999999999999864 45666666552 11110
Q ss_pred hccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 016184 310 KCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR 372 (394)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 372 (394)
+ -...+|+.+++|+..||++|+.+||.-.+||+|||++.+.
T Consensus 316 ------------~----------~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~ye 356 (391)
T KOG0983|consen 316 ------------P----------GHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEHPFIKRYE 356 (391)
T ss_pred ------------C----------cccCcCHHHHHHHHHHhhcCcccCcchHHHhcCcceeecc
Confidence 0 0134799999999999999999999999999999887654
|
|
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=330.25 Aligned_cols=264 Identities=25% Similarity=0.392 Sum_probs=201.8
Q ss_pred EeecCceEEEEEEECCCCcEEEEEEeccch-------hhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEEEEEEecc
Q 016184 90 VGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYV 162 (394)
Q Consensus 90 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~ 162 (394)
||+|+||.||+++++.+|+.||+|.+.... .....|+++++.++||||+++.+++ ....+.++||||+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~-----~~~~~~~lv~e~~ 75 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAF-----ESKTHLCLVMSLM 75 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEE-----ecCCeEEEEEecC
Confidence 699999999999999999999999885321 1223589999999999999998887 3344588999999
Q ss_pred cc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCccccccCCCc
Q 016184 163 PE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN 241 (394)
Q Consensus 163 ~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~~~~~ 241 (394)
++ +|...+... ....+++..+..++.|++.||+|||+ .||+||||||+||+++.++ .++|+|||++.........
T Consensus 76 ~g~~L~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~-~~ivH~dikp~Nili~~~~-~~~l~Dfg~~~~~~~~~~~ 151 (277)
T cd05607 76 NGGDLKYHIYNV--GERGLEMERVIHYSAQITCGILHLHS-MDIVYRDMKPENVLLDDQG-NCRLSDLGLAVELKDGKTI 151 (277)
T ss_pred CCCCHHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHH-CCEEEccCChHhEEEcCCC-CEEEeeceeeeecCCCcee
Confidence 75 665555432 23458889999999999999999999 8999999999999999887 6999999998766544443
Q ss_pred ccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCCCcccCC
Q 016184 242 VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF 321 (394)
Q Consensus 242 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 321 (394)
....+++.|+|||++.+.. ++.++|+|||||++|+|++|+.||...........+....... ....
T Consensus 152 ~~~~~~~~y~aPE~~~~~~-~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~-------------~~~~ 217 (277)
T cd05607 152 TQRAGTNGYMAPEILKEEP-YSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLED-------------EVKF 217 (277)
T ss_pred eccCCCCCccCHHHHccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhcc-------------cccc
Confidence 4456889999999986655 8999999999999999999999997654322222221111000 0000
Q ss_pred CCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCH----HHHhcCCCCCCCCCCCCCCCCCCCCCCCCCC
Q 016184 322 PQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTA----LEACVHPFFDELRDPNTRLPNGRPLPPLFNF 390 (394)
Q Consensus 322 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~----~ell~hp~f~~~~~~~~~~~~~~~~~~~~~~ 390 (394)
....++.++++||.+||+.||.+||++ +++++||||+.+..+... ....||+|.+
T Consensus 218 -----------~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~~h~~f~~~~~~~~~---~~~~~~~~~~ 276 (277)
T cd05607 218 -----------EHQNFTEESKDICRLFLAKKPEDRLGSREKNDDPRKHEFFKTINFPRLE---AGLIPPPFVP 276 (277)
T ss_pred -----------ccccCCHHHHHHHHHHhccCHhhCCCCccchhhhhcChhhcCCCHHHHh---cCcCCCCCCC
Confidence 013578899999999999999999999 678899999987544332 2333455544
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-46 Score=341.02 Aligned_cols=253 Identities=26% Similarity=0.448 Sum_probs=222.5
Q ss_pred eeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccc------hhhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEE
Q 016184 82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL 155 (394)
Q Consensus 82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 155 (394)
.+|..++++|+|+||.+++++++.+++.+++|.+.-. ++...+|+.+++++.|||||.+.+.|. .++.++
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~----~~~~~l 79 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFE----EDGQLL 79 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchh----cCCceE
Confidence 3599999999999999999999999999999988532 234457999999999999999999883 344568
Q ss_pred EEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCccc
Q 016184 156 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV 234 (394)
Q Consensus 156 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~ 234 (394)
+|+|+||+| ++.+.+.... ...++++.+..|+.|++.|+.|||+ ++|+|||||+.||+++.++ .|+|+|||+|+.
T Consensus 80 ~Ivm~Y~eGg~l~~~i~~~k--~~~f~E~~i~~~~~Q~~~av~ylH~-~~iLHRDlK~~Nifltk~~-~VkLgDfGlaK~ 155 (426)
T KOG0589|consen 80 CIVMEYCEGGDLAQLIKEQK--GVLFPEERILKWFVQILLAVNYLHE-NRVLHRDLKCANIFLTKDK-KVKLGDFGLAKI 155 (426)
T ss_pred EEEEeecCCCCHHHHHHHHh--hccccHHHHHHHHHHHHHHHHHHHh-hhhhcccchhhhhhccccC-ceeecchhhhhh
Confidence 999999996 7777777655 5789999999999999999999998 8999999999999999998 589999999999
Q ss_pred cccCC-CcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccC
Q 016184 235 LVKGE-PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 313 (394)
Q Consensus 235 ~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 313 (394)
+.... ...+..||+.||+||.+.+ .+|+.|+|||||||++|||++-+++|.+.+-...+.++.+....|.
T Consensus 156 l~~~~~~a~tvvGTp~YmcPEil~d-~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~Pl-------- 226 (426)
T KOG0589|consen 156 LNPEDSLASTVVGTPYYMCPEILSD-IPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYSPL-------- 226 (426)
T ss_pred cCCchhhhheecCCCcccCHHHhCC-CCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCCCC--------
Confidence 87776 6678899999999999965 4599999999999999999999999999988888888887653332
Q ss_pred CCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 016184 314 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL 371 (394)
Q Consensus 314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 371 (394)
+...+.+++.||+.||..+|..||++.+||.+|.++..
T Consensus 227 --------------------p~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~P~l~~~ 264 (426)
T KOG0589|consen 227 --------------------PSMYSSELRSLVKSMLRKNPEHRPSALELLRRPHLLRY 264 (426)
T ss_pred --------------------CccccHHHHHHHHHHhhcCCccCCCHHHHhhChhhhhH
Confidence 25678999999999999999999999999999999854
|
|
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-44 Score=342.55 Aligned_cols=256 Identities=29% Similarity=0.481 Sum_probs=205.1
Q ss_pred ceeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccc-------hhhhHHHHHHHHHcCCCCeeeeceEEEecCCCcee
Q 016184 81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL 153 (394)
Q Consensus 81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 153 (394)
..+|++.+.||+|+||.||+|++..+++.||+|++.+. .....+|+.+++.++||||+++++++ ....
T Consensus 42 ~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~-----~~~~ 116 (371)
T cd05622 42 AEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAF-----QDDR 116 (371)
T ss_pred hhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEE-----EcCC
Confidence 35699999999999999999999999999999988542 12345789999999999999999888 3445
Q ss_pred EEEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCc
Q 016184 154 YLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA 232 (394)
Q Consensus 154 ~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a 232 (394)
+.++||||+++ +|..++.. ..+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||++
T Consensus 117 ~~~lv~Ey~~gg~L~~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~-~~ivHrDLkp~NIll~~~~-~ikL~DfG~a 189 (371)
T cd05622 117 YLYMVMEYMPGGDLVNLMSN-----YDVPEKWARFYTAEVVLALDAIHS-MGFIHRDVKPDNMLLDKSG-HLKLADFGTC 189 (371)
T ss_pred EEEEEEcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHH-CCEEeCCCCHHHEEECCCC-CEEEEeCCce
Confidence 68899999975 67666653 468999999999999999999999 8999999999999999888 6999999999
Q ss_pred cccccCCC--cccccccccccccccccCCC---CCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChh
Q 016184 233 KVLVKGEP--NVSYICSRYYRAPELIFGAT---EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 307 (394)
Q Consensus 233 ~~~~~~~~--~~~~~~t~~y~aPE~~~~~~---~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~ 307 (394)
........ .....||+.|+|||++.... .++.++|||||||++|+|++|+.||.+.+.......+......
T Consensus 190 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~---- 265 (371)
T cd05622 190 MKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNS---- 265 (371)
T ss_pred eEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCc----
Confidence 76543221 23456899999999985432 3788999999999999999999999887765555555431110
Q ss_pred hhhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCC--CCCHHHHhcCCCCCCCCC
Q 016184 308 EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNL--RCTALEACVHPFFDELRD 373 (394)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~--Rpt~~ell~hp~f~~~~~ 373 (394)
..++. ...++..+++||..||..++.+ |++++++++||||++...
T Consensus 266 -----------~~~~~----------~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~~~~ 312 (371)
T cd05622 266 -----------LTFPD----------DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQW 312 (371)
T ss_pred -----------ccCCC----------cCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcccCCCCh
Confidence 11111 1357899999999999844433 789999999999988543
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-44 Score=329.15 Aligned_cols=283 Identities=37% Similarity=0.646 Sum_probs=222.6
Q ss_pred eEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccchh---------hhHHHHHHHHHcCCCCeeeeceEEEecCCCcee
Q 016184 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR---------YKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL 153 (394)
Q Consensus 83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 153 (394)
+|++.+.||.|++|.||+|.+..+|+.||||.+..... ....|+++++.++|+||+++++++.. ..
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-----~~ 75 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGH-----KS 75 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeec-----CC
Confidence 38899999999999999999998999999999864322 23468999999999999999998833 44
Q ss_pred EEEEEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCcc
Q 016184 154 YLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK 233 (394)
Q Consensus 154 ~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~ 233 (394)
+.++||||+.++|.+++.... ..+++..++.++.||+.||.|||+ +||+|+||||+||+++.++ .++|+|||++.
T Consensus 76 ~~~lv~e~~~~~L~~~i~~~~---~~~~~~~~~~~~~qi~~al~~lH~-~~i~H~dl~p~nill~~~~-~~~l~dfg~~~ 150 (298)
T cd07841 76 NINLVFEFMETDLEKVIKDKS---IVLTPADIKSYMLMTLRGLEYLHS-NWILHRDLKPNNLLIASDG-VLKLADFGLAR 150 (298)
T ss_pred EEEEEEcccCCCHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHh-CCeeecCCChhhEEEcCCC-CEEEccceeee
Confidence 588999999778877765421 368999999999999999999999 8999999999999999887 79999999997
Q ss_pred ccccCC-CcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhcc
Q 016184 234 VLVKGE-PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 312 (394)
Q Consensus 234 ~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 312 (394)
...... ......+++.|+|||.+.+...++.++|+|||||++|+|++|.+||.+....+.+..+....+.+....+...
T Consensus 151 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (298)
T cd07841 151 SFGSPNRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGV 230 (298)
T ss_pred eccCCCccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhc
Confidence 664432 2223456788999999866556899999999999999999999999888888888887777776665554322
Q ss_pred CCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCC
Q 016184 313 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNT 376 (394)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~ 376 (394)
...............+... .....+..+.+||.+||+.||.+|||+.++++||||++...++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~~~~~ 293 (298)
T cd07841 231 TSLPDYVEFKPFPPTPLKQ-IFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDPAPTP 293 (298)
T ss_pred ccccccccccccCCcchhh-hcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCCCCCC
Confidence 1111111111111111111 22456889999999999999999999999999999999877664
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-45 Score=338.26 Aligned_cols=244 Identities=30% Similarity=0.488 Sum_probs=198.1
Q ss_pred eEEeecCceEEEEEEECCCCcEEEEEEeccch-------hhhHHHHHHHHHc-CCCCeeeeceEEEecCCCceeEEEEEE
Q 016184 88 HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQML-DHPNIVALKHCFFSTTDKEELYLNLVL 159 (394)
Q Consensus 88 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~lv~ 159 (394)
++||+|+||.||+|++..+++.||||++.+.. .....|.+++..+ +||||+++++++. ....+++||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~-----~~~~~~lv~ 75 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQ-----TKDRLFFVM 75 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEE-----cCCeEEEEE
Confidence 36999999999999999999999999986532 1233577788765 8999999999883 334588999
Q ss_pred ecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCccccccC
Q 016184 160 EYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG 238 (394)
Q Consensus 160 e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~~ 238 (394)
||+++ +|...+.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||++......
T Consensus 76 E~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivHrDikp~Nill~~~~-~~kL~Dfg~~~~~~~~ 149 (321)
T cd05591 76 EYVNGGDLMFQIQR----SRKFDEPRSRFYAAEVTLALMFLHR-HGVIYRDLKLDNILLDAEG-HCKLADFGMCKEGILN 149 (321)
T ss_pred eCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCCHHHeEECCCC-CEEEeecccceecccC
Confidence 99986 55444432 3678999999999999999999999 8999999999999999888 6999999998754322
Q ss_pred -CCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCCCc
Q 016184 239 -EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 317 (394)
Q Consensus 239 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 317 (394)
.......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+.+..+....
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~---------------- 212 (321)
T cd05591 150 GVTTTTFCGTPDYIAPEILQEL-EYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDD---------------- 212 (321)
T ss_pred CccccccccCccccCHHHHcCC-CCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCC----------------
Confidence 223345689999999998654 48999999999999999999999998877666665554310
Q ss_pred ccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCC-------CHHHHhcCCCCCCCC
Q 016184 318 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-------TALEACVHPFFDELR 372 (394)
Q Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-------t~~ell~hp~f~~~~ 372 (394)
.. ++..++.++.+||.+||+.||++|+ ++.++++||||+.+.
T Consensus 213 -~~------------~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~hp~~~~~~ 261 (321)
T cd05591 213 -VL------------YPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHPFFKEID 261 (321)
T ss_pred -CC------------CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcCCccCCCC
Confidence 00 1234688999999999999999999 999999999998753
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-46 Score=330.07 Aligned_cols=282 Identities=28% Similarity=0.499 Sum_probs=221.8
Q ss_pred ceeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccchhhh---HHHHHHHHHcCC--C----CeeeeceEEEecCCCc
Q 016184 81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK---NRELQIMQMLDH--P----NIVALKHCFFSTTDKE 151 (394)
Q Consensus 81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~---~~E~~~l~~l~h--~----~iv~~~~~~~~~~~~~ 151 (394)
..+|.|.+.+|+|.||.|-++.+..++..||||+++.-..+. .-|+++|.++.+ | -++++.++| +.
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wF-----dy 162 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWF-----DY 162 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhh-----hc
Confidence 456999999999999999999999999999999886544443 348999999943 2 366777777 66
Q ss_pred eeEEEEEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCC-----------
Q 016184 152 ELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPH----------- 220 (394)
Q Consensus 152 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~----------- 220 (394)
..++|+|+|.++-++.+.+.... ..+++...++.+++|++.+++|||+ .+++|.||||+|||+...
T Consensus 163 rghiCivfellG~S~~dFlk~N~--y~~fpi~~ir~m~~QL~~sv~fLh~-~kl~HTDLKPENILfvss~~~~~~~~k~~ 239 (415)
T KOG0671|consen 163 RGHICIVFELLGLSTFDFLKENN--YIPFPIDHIRHMGYQLLESVAFLHD-LKLTHTDLKPENILFVSSEYFKTYNPKKK 239 (415)
T ss_pred cCceEEEEeccChhHHHHhccCC--ccccchHHHHHHHHHHHHHHHHHHh-cceeecCCChheEEEeccceEEEeccCCc
Confidence 67799999999988888777533 3779999999999999999999999 899999999999998311
Q ss_pred --------CCcEEEEeecCccccccCCCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHH
Q 016184 221 --------THQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVD 292 (394)
Q Consensus 221 --------~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~ 292 (394)
...|+|+|||.|+.. .+.....+.|..|.|||++.+-+ ++.++||||+||||+|+.||...|++.++.+
T Consensus 240 ~~~~r~~ks~~I~vIDFGsAtf~--~e~hs~iVsTRHYRAPEViLgLG-wS~pCDvWSiGCIL~ElytG~~LFqtHen~E 316 (415)
T KOG0671|consen 240 VCFIRPLKSTAIKVIDFGSATFD--HEHHSTIVSTRHYRAPEVILGLG-WSQPCDVWSIGCILVELYTGETLFQTHENLE 316 (415)
T ss_pred cceeccCCCcceEEEecCCccee--ccCcceeeeccccCCchheeccC-cCCccCceeeeeEEEEeeccceecccCCcHH
Confidence 125999999999764 34446778899999999998765 9999999999999999999999999999999
Q ss_pred HHHHHHHHhCCCChhhhhccC---------CCCcccCCCC------CCCCCcchhcc--ccCChHHHHHHHHhcccCCCC
Q 016184 293 QLVEIIKVLGTPTREEIKCMN---------PNYTEFKFPQ------IKPHPWHKVFQ--KRLPPEAVDLVCRFFQYSPNL 355 (394)
Q Consensus 293 ~~~~i~~~~~~~~~~~~~~~~---------~~~~~~~~~~------~~~~~~~~~~~--~~~~~~~~~li~~~L~~dP~~ 355 (394)
+++.|..++|+.|...+.... -+|.+..... ..+.+...... +..-..+.|||++||.+||.+
T Consensus 317 HLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~ 396 (415)
T KOG0671|consen 317 HLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPAR 396 (415)
T ss_pred HHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccc
Confidence 999999999988876664331 1111111111 00111111111 111235899999999999999
Q ss_pred CCCHHHHhcCCCCCCCCC
Q 016184 356 RCTALEACVHPFFDELRD 373 (394)
Q Consensus 356 Rpt~~ell~hp~f~~~~~ 373 (394)
|+|+.|+|.||||+....
T Consensus 397 RiTl~EAL~HpFF~~~~~ 414 (415)
T KOG0671|consen 397 RITLREALSHPFFARLTP 414 (415)
T ss_pred cccHHHHhcCHHhhcCCC
Confidence 999999999999987653
|
|
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-44 Score=347.18 Aligned_cols=274 Identities=25% Similarity=0.327 Sum_probs=204.5
Q ss_pred eeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccchhhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEEEEEEec
Q 016184 82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEY 161 (394)
Q Consensus 82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~ 161 (394)
..|.+.+.||+|+||.||+|.+..+++.||||.... ....+|++++++++|+||+++++++.. ....+++||+
T Consensus 169 ~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~--~~~~~E~~iL~~L~HpnIv~l~~~~~~-----~~~~~lv~e~ 241 (461)
T PHA03211 169 LGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY--ASSVHEARLLRRLSHPAVLALLDVRVV-----GGLTCLVLPK 241 (461)
T ss_pred CCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc--cCHHHHHHHHHHCCCCCCCcEEEEEEE-----CCEEEEEEEc
Confidence 469999999999999999999999999999996432 345689999999999999999998733 3347789999
Q ss_pred ccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCccccccCCC-
Q 016184 162 VPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP- 240 (394)
Q Consensus 162 ~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~~~~- 240 (394)
+.+++...+... ...+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||+++.......
T Consensus 242 ~~~~L~~~l~~~---~~~l~~~~~~~i~~qi~~aL~yLH~-~gIvHrDLKP~NILl~~~~-~vkL~DFGla~~~~~~~~~ 316 (461)
T PHA03211 242 YRSDLYTYLGAR---LRPLGLAQVTAVARQLLSAIDYIHG-EGIIHRDIKTENVLVNGPE-DICLGDFGAACFARGSWST 316 (461)
T ss_pred cCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHH-CCEEECcCCHHHEEECCCC-CEEEcccCCceeccccccc
Confidence 988887666532 2468999999999999999999999 8999999999999999887 699999999976533221
Q ss_pred --cccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCC-------cHHHHHHHHHHhCCCChhhhhc
Q 016184 241 --NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGES-------GVDQLVEIIKVLGTPTREEIKC 311 (394)
Q Consensus 241 --~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~-------~~~~~~~i~~~~~~~~~~~~~~ 311 (394)
.....||+.|+|||++.+. .++.++|||||||++|||++|..++.... ....+..+++..+....+....
T Consensus 317 ~~~~~~~GT~~Y~APE~~~~~-~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~ 395 (461)
T PHA03211 317 PFHYGIAGTVDTNAPEVLAGD-PYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQH 395 (461)
T ss_pred ccccccCCCcCCcCHHHHcCC-CCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCC
Confidence 1234689999999999665 48999999999999999999876543321 1234455544433221111000
Q ss_pred --------cCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 016184 312 --------MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE 370 (394)
Q Consensus 312 --------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~ 370 (394)
..........+......|... ..++.++.+||++||+.||.+|||+.|+|+||||+.
T Consensus 396 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~ 460 (461)
T PHA03211 396 AGSRLVSQYRHRAARNRRPAYTRPAWTRY--YKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQS 460 (461)
T ss_pred cchHHHHHHHhhhhcccCCccCCcchhhh--ccccchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence 000000001111112223222 146778999999999999999999999999999974
|
|
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-44 Score=328.71 Aligned_cols=282 Identities=35% Similarity=0.618 Sum_probs=219.8
Q ss_pred eEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccch------hhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEEE
Q 016184 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN 156 (394)
Q Consensus 83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 156 (394)
+|++.+.||.|++|.||+|.+..+|+.||+|.+.... ....+|+++++.++|+||+++++++. ...+.+
T Consensus 3 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~ 77 (294)
T PLN00009 3 QYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVH-----SEKRLY 77 (294)
T ss_pred ceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEe-----cCCeEE
Confidence 5999999999999999999999999999999875431 23457999999999999999999883 334588
Q ss_pred EEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCccccc
Q 016184 157 LVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV 236 (394)
Q Consensus 157 lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~ 236 (394)
+||||+++++...+.... ...+++..++.++.||+.||+|||+ +|++|+||+|+||+++.++..+||+|||++....
T Consensus 78 lv~e~~~~~l~~~~~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~-~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~ 154 (294)
T PLN00009 78 LVFEYLDLDLKKHMDSSP--DFAKNPRLIKTYLYQILRGIAYCHS-HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFG 154 (294)
T ss_pred EEEecccccHHHHHHhCC--CCCcCHHHHHHHHHHHHHHHHHHHh-CCeeCCCCCcceEEEECCCCEEEEcccccccccC
Confidence 999999987766654322 2346788899999999999999999 8999999999999999665579999999987543
Q ss_pred cCCC-cccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCC
Q 016184 237 KGEP-NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 315 (394)
Q Consensus 237 ~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 315 (394)
.... .....+++.|+|||.+.+...++.++||||||+++|+|+||+.||...+..+.+..+....+.+....+.....-
T Consensus 155 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (294)
T PLN00009 155 IPVRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSL 234 (294)
T ss_pred CCccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccc
Confidence 3221 223456788999999866556889999999999999999999999988888888888887777766555422110
Q ss_pred Cc-ccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q 016184 316 YT-EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD 373 (394)
Q Consensus 316 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~ 373 (394)
.. ...++.... .........+++++.++|.+||+.||++||++.++++||||+++.+
T Consensus 235 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~~~~ 292 (294)
T PLN00009 235 PDYKSAFPKWPP-KDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDLGD 292 (294)
T ss_pred hhhhhhcccCCC-CCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhHHhc
Confidence 00 000111000 1111123457889999999999999999999999999999998753
|
|
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-44 Score=325.36 Aligned_cols=276 Identities=36% Similarity=0.642 Sum_probs=213.2
Q ss_pred eEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccch------hhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEEE
Q 016184 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN 156 (394)
Q Consensus 83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 156 (394)
+|++.+.||+|++|.||+|++..+|+.||+|++.... ....+|+.+++.++|+|++++++++. .....+
T Consensus 2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~-----~~~~~~ 76 (286)
T cd07847 2 KYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFR-----RKRKLH 76 (286)
T ss_pred ceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEe-----eCCEEE
Confidence 5999999999999999999999999999999875332 23457999999999999999999883 334578
Q ss_pred EEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCccccc
Q 016184 157 LVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV 236 (394)
Q Consensus 157 lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~ 236 (394)
++|||+++++...+ ......+++..++.++.|++.||+|||+ .|++|+||||+||+++.++ .++|+|||++....
T Consensus 77 ~v~e~~~~~~l~~~---~~~~~~~~~~~~~~~~~ql~~~l~~LH~-~~i~H~dl~p~nil~~~~~-~~~l~dfg~~~~~~ 151 (286)
T cd07847 77 LVFEYCDHTVLNEL---EKNPRGVPEHLIKKIIWQTLQAVNFCHK-HNCIHRDVKPENILITKQG-QIKLCDFGFARILT 151 (286)
T ss_pred EEEeccCccHHHHH---HhCCCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCChhhEEEcCCC-cEEECccccceecC
Confidence 99999997654333 2233568999999999999999999999 8999999999999999887 79999999997664
Q ss_pred cCC-CcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCC
Q 016184 237 KGE-PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 315 (394)
Q Consensus 237 ~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 315 (394)
... ......++..|+|||.+.+...++.++|+||||+++|+|++|..||.+....+.+..+....+.............
T Consensus 152 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (286)
T cd07847 152 GPGDDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTN 231 (286)
T ss_pred CCcccccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccc
Confidence 433 2223456788999999876566889999999999999999999999988877777776665554433222211111
Q ss_pred --CcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 016184 316 --YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368 (394)
Q Consensus 316 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f 368 (394)
+.....+......-.......++..+.+||.+||+.||++|||+.+++.||||
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f 286 (286)
T cd07847 232 QFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286 (286)
T ss_pred cccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence 01111111111111111124578999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-45 Score=332.32 Aligned_cols=274 Identities=26% Similarity=0.387 Sum_probs=222.7
Q ss_pred ceeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccchh-------hhHHHHHHHHHcCCCCeeeeceEEEecCCCcee
Q 016184 81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-------YKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL 153 (394)
Q Consensus 81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 153 (394)
.+.|+.-++||+|+||.||-++.+.||+-+|+|.+.+..- ...+|..+|.+++.+.||.+--.|.+.+
T Consensus 184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd----- 258 (591)
T KOG0986|consen 184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKD----- 258 (591)
T ss_pred ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCC-----
Confidence 3468899999999999999999999999999998754321 2236889999999999999876663333
Q ss_pred EEEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCc
Q 016184 154 YLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA 232 (394)
Q Consensus 154 ~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a 232 (394)
.+|+|+..|.| +|.-.+. ......+++..++.++.+|+.||++||+ .+||+|||||+|||+|++|| |+|+|+|+|
T Consensus 259 ~LClVLtlMNGGDLkfHiy--n~g~~gF~e~ra~FYAAEi~cGLehlH~-~~iVYRDLKPeNILLDd~Gh-vRISDLGLA 334 (591)
T KOG0986|consen 259 ALCLVLTLMNGGDLKFHIY--NHGNPGFDEQRARFYAAEIICGLEHLHR-RRIVYRDLKPENILLDDHGH-VRISDLGLA 334 (591)
T ss_pred ceEEEEEeecCCceeEEee--ccCCCCCchHHHHHHHHHHHhhHHHHHh-cceeeccCChhheeeccCCC-eEeeccceE
Confidence 38999999996 4332222 2233589999999999999999999999 89999999999999999995 999999999
Q ss_pred cccccCCCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhcc
Q 016184 233 KVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 312 (394)
Q Consensus 233 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 312 (394)
..+..+......+||.+|||||++.+.. |+...|+|||||+||+|+.|+.||........-.++-+.....+.
T Consensus 335 vei~~g~~~~~rvGT~GYMAPEvl~ne~-Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~~------ 407 (591)
T KOG0986|consen 335 VEIPEGKPIRGRVGTVGYMAPEVLQNEV-YDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDPE------ 407 (591)
T ss_pred EecCCCCccccccCcccccCHHHHcCCc-ccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcchh------
Confidence 9998888888889999999999997665 999999999999999999999999876544433333332211111
Q ss_pred CCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCC-----CHHHHhcCCCCCCCCCCCCCCCCCCCCCCC
Q 016184 313 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-----TALEACVHPFFDELRDPNTRLPNGRPLPPL 387 (394)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----t~~ell~hp~f~~~~~~~~~~~~~~~~~~~ 387 (394)
.+++.+|+++++|++.+|++||.+|. +++++.+||||+.++..... ..-.+|+
T Consensus 408 -------------------ey~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~lnw~rle---agml~PP 465 (591)
T KOG0986|consen 408 -------------------EYSDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDLNWRRLE---AGMLEPP 465 (591)
T ss_pred -------------------hcccccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhCcccccCCHhHHh---ccCCCCC
Confidence 13467899999999999999999998 57899999999998766553 3345677
Q ss_pred CCCCC
Q 016184 388 FNFKP 392 (394)
Q Consensus 388 ~~~~~ 392 (394)
|-+||
T Consensus 466 fiPdp 470 (591)
T KOG0986|consen 466 FIPDP 470 (591)
T ss_pred CCCCc
Confidence 87766
|
|
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-44 Score=328.34 Aligned_cols=271 Identities=25% Similarity=0.375 Sum_probs=213.7
Q ss_pred EEEeeEEeecCceEEEEEEECCCCcEEEEEEeccch-------hhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEEE
Q 016184 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN 156 (394)
Q Consensus 84 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 156 (394)
|++.+.||+|+||+||+|.+..+++.||+|.+.... ....+|+++++.++|+||+.+.+++ ......+
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~-----~~~~~~~ 76 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAY-----ETKDALC 76 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEE-----ecCCEEE
Confidence 788899999999999999999999999999875431 2245699999999999999998887 3334588
Q ss_pred EEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCcccc
Q 016184 157 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL 235 (394)
Q Consensus 157 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~ 235 (394)
++|||+.+ ++...+... ....+++..+..++.|++.||.|||+ .||+||||||+||+++.++ .++|+|||++...
T Consensus 77 lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~ql~~~l~~lH~-~~iiH~dikp~Nili~~~~-~~kl~Dfg~~~~~ 152 (285)
T cd05632 77 LVLTIMNGGDLKFHIYNM--GNPGFEEERALFYAAEILCGLEDLHR-ENTVYRDLKPENILLDDYG-HIRISDLGLAVKI 152 (285)
T ss_pred EEEEeccCccHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeecCCCHHHEEECCCC-CEEEecCCcceec
Confidence 99999986 555444321 23469999999999999999999999 8999999999999999887 6999999998765
Q ss_pred ccCCCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCC
Q 016184 236 VKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 315 (394)
Q Consensus 236 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 315 (394)
..........++..|+|||.+.+. .++.++|+||||+++|+|++|..||.+.........+.........
T Consensus 153 ~~~~~~~~~~g~~~~~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~--------- 222 (285)
T cd05632 153 PEGESIRGRVGTVGYMAPEVLNNQ-RYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEE--------- 222 (285)
T ss_pred CCCCcccCCCCCcCccChHHhcCC-CCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhcccc---------
Confidence 444333456789999999998654 4899999999999999999999999876654444443322111100
Q ss_pred CcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCC-----HHHHhcCCCCCCCCCCCCCCCCCCCCCCCCCC
Q 016184 316 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCT-----ALEACVHPFFDELRDPNTRLPNGRPLPPLFNF 390 (394)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt-----~~ell~hp~f~~~~~~~~~~~~~~~~~~~~~~ 390 (394)
.+...++.++.+|+..||+.||.+||| +.++++||||+....... . .....|.|.+
T Consensus 223 ----------------~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~~~~--~-~~~~~~~~~~ 283 (285)
T cd05632 223 ----------------VYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNMNFKRL--E-AGMLDPPFVP 283 (285)
T ss_pred ----------------ccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcChhhhcCCHHHH--h-cCcCCCCCCC
Confidence 112457889999999999999999999 899999999999844432 2 3334477776
Q ss_pred CC
Q 016184 391 KP 392 (394)
Q Consensus 391 ~~ 392 (394)
+|
T Consensus 284 ~~ 285 (285)
T cd05632 284 DP 285 (285)
T ss_pred CC
Confidence 54
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-45 Score=343.69 Aligned_cols=256 Identities=28% Similarity=0.456 Sum_probs=204.5
Q ss_pred eEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccch-------hhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEE
Q 016184 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL 155 (394)
Q Consensus 83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 155 (394)
.|++.+.||+|+||.||+|++..+++.||+|++.... ....+|+.++..++|++|+++++.+ ....++
T Consensus 2 ~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~-----~~~~~~ 76 (360)
T cd05627 2 DFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSF-----QDKRNL 76 (360)
T ss_pred CceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEE-----EcCCEE
Confidence 4899999999999999999999999999999986422 2345689999999999999999887 334458
Q ss_pred EEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCccc
Q 016184 156 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV 234 (394)
Q Consensus 156 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~ 234 (394)
++||||+++ +|.+++.. ...+++..++.++.|++.||+|||+ +||+||||||+|||++.++ .++|+|||++..
T Consensus 77 ~lv~E~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~~L~~lH~-~givHrDLkp~NIli~~~~-~vkL~DfG~~~~ 150 (360)
T cd05627 77 YLIMEFLPGGDMMTLLMK----KDTLSEEATQFYIAETVLAIDAIHQ-LGFIHRDIKPDNLLLDAKG-HVKLSDFGLCTG 150 (360)
T ss_pred EEEEeCCCCccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeEccCCCHHHEEECCCC-CEEEeeccCCcc
Confidence 899999985 66665543 3678999999999999999999999 8999999999999999888 699999999864
Q ss_pred cccCC------------------------------------CcccccccccccccccccCCCCCCChhhHHHHHHHHHHH
Q 016184 235 LVKGE------------------------------------PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAEL 278 (394)
Q Consensus 235 ~~~~~------------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l 278 (394)
..... ......||+.|+|||++.+. .++.++|||||||++|+|
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~-~~~~~~DiwSlGvilyel 229 (360)
T cd05627 151 LKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQT-GYNKLCDWWSLGVIMYEM 229 (360)
T ss_pred cccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCC-CCCCcceeccccceeeec
Confidence 42110 01134689999999998654 489999999999999999
Q ss_pred HhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCC-
Q 016184 279 LLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC- 357 (394)
Q Consensus 279 ltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp- 357 (394)
++|+.||.+.+....+..+..... ...++. ...+++++++||.+|+. ||.+|+
T Consensus 230 ~tG~~Pf~~~~~~~~~~~i~~~~~---------------~~~~p~----------~~~~s~~~~~li~~l~~-~p~~R~~ 283 (360)
T cd05627 230 LIGYPPFCSETPQETYRKVMNWKE---------------TLVFPP----------EVPISEKAKDLILRFCT-DSENRIG 283 (360)
T ss_pred ccCCCCCCCCCHHHHHHHHHcCCC---------------ceecCC----------CCCCCHHHHHHHHHhcc-ChhhcCC
Confidence 999999988776665555443110 000110 02368899999999874 999998
Q ss_pred --CHHHHhcCCCCCCCCCCCC
Q 016184 358 --TALEACVHPFFDELRDPNT 376 (394)
Q Consensus 358 --t~~ell~hp~f~~~~~~~~ 376 (394)
+++++++||||+++.....
T Consensus 284 ~~~~~ei~~hp~f~~~~~~~~ 304 (360)
T cd05627 284 SNGVEEIKSHPFFEGVDWGHI 304 (360)
T ss_pred CCCHHHHhcCCCCCCCCHHHH
Confidence 4899999999999755443
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-44 Score=336.22 Aligned_cols=257 Identities=28% Similarity=0.434 Sum_probs=203.4
Q ss_pred eEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccc-------hhhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEE
Q 016184 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL 155 (394)
Q Consensus 83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 155 (394)
+|++.+.||+|+||.||++++..+++.||+|++.+. ...+.+|+.++..++|+||+++++++ ....++
T Consensus 2 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~~ 76 (331)
T cd05597 2 DFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAF-----QDENNL 76 (331)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEE-----ecCCeE
Confidence 599999999999999999999999999999998642 12345788999999999999999988 334468
Q ss_pred EEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCccc
Q 016184 156 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV 234 (394)
Q Consensus 156 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~ 234 (394)
++||||+.+ +|.+++.. ....+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||++..
T Consensus 77 ~lv~e~~~g~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~dlkp~Nill~~~~-~~kl~Dfg~~~~ 151 (331)
T cd05597 77 YLVMDYYVGGDLLTLLSK---FEDRLPEDMARFYLAEMVLAIDSVHQ-LGYVHRDIKPDNVLLDKNG-HIRLADFGSCLR 151 (331)
T ss_pred EEEEecCCCCcHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHh-CCeEECCCCHHHEEECCCC-CEEEEECCceee
Confidence 899999975 77666643 23578999999999999999999999 8999999999999999888 699999999876
Q ss_pred cccCCCc--ccccccccccccccccC----CCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhh
Q 016184 235 LVKGEPN--VSYICSRYYRAPELIFG----ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 308 (394)
Q Consensus 235 ~~~~~~~--~~~~~t~~y~aPE~~~~----~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~ 308 (394)
....... ....||+.|+|||++.. ...++.++|||||||++|+|++|+.||.+.+..+....+.....
T Consensus 152 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~------ 225 (331)
T cd05597 152 LLADGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKE------ 225 (331)
T ss_pred cCCCCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCC------
Confidence 5433222 22468999999999853 23478899999999999999999999987766555554433110
Q ss_pred hhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCC--CCCHHHHhcCCCCCCCCC
Q 016184 309 IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNL--RCTALEACVHPFFDELRD 373 (394)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~--Rpt~~ell~hp~f~~~~~ 373 (394)
...++. ....++..+++||++||..++.+ |++++++++||||.++..
T Consensus 226 ---------~~~~~~---------~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~~~~ 274 (331)
T cd05597 226 ---------HFQFPP---------DVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHPFFEGIDW 274 (331)
T ss_pred ---------cccCCC---------ccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCCCCCCCCH
Confidence 000110 01347899999999999765544 889999999999988643
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-44 Score=335.39 Aligned_cols=244 Identities=29% Similarity=0.497 Sum_probs=195.2
Q ss_pred eEEeecCceEEEEEEECCCCcEEEEEEeccch-------hhhHHHHHHHHH-cCCCCeeeeceEEEecCCCceeEEEEEE
Q 016184 88 HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQM-LDHPNIVALKHCFFSTTDKEELYLNLVL 159 (394)
Q Consensus 88 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~-l~h~~iv~~~~~~~~~~~~~~~~~~lv~ 159 (394)
++||+|+||.||+|++..+++.||||++.... .....|..++.. ..||||+++++++ ....++++||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~-----~~~~~~~lv~ 75 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTF-----QTKEHLFFVM 75 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEE-----EcCCEEEEEE
Confidence 46999999999999999999999999886532 112345556654 4899999999887 3334588999
Q ss_pred ecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCccccccC
Q 016184 160 EYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG 238 (394)
Q Consensus 160 e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~~ 238 (394)
||+++ +|...+.. ...+++..++.++.|++.||+|||+ .||+||||||+|||++.++ .+||+|||++......
T Consensus 76 e~~~gg~L~~~~~~----~~~~~~~~~~~~~~qi~~al~~LH~-~~ivH~dlkp~Nill~~~~-~~kL~Dfg~a~~~~~~ 149 (316)
T cd05592 76 EYLNGGDLMFHIQS----SGRFDEARARFYAAEIICGLQFLHK-KGIIYRDLKLDNVLLDKDG-HIKIADFGMCKENMNG 149 (316)
T ss_pred cCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCEEeCCCCHHHeEECCCC-CEEEccCcCCeECCCC
Confidence 99975 56554433 3578999999999999999999999 8999999999999999887 6999999998754332
Q ss_pred -CCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCCCc
Q 016184 239 -EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 317 (394)
Q Consensus 239 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 317 (394)
.......||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+..+.+..+....
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~---------------- 212 (316)
T cd05592 150 EGKASTFCGTPDYIAPEILKGQK-YNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDR---------------- 212 (316)
T ss_pred CCccccccCCccccCHHHHcCCC-CCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC----------------
Confidence 2233456899999999996554 8999999999999999999999998877655554433210
Q ss_pred ccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCH-HHHhcCCCCCCCC
Q 016184 318 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTA-LEACVHPFFDELR 372 (394)
Q Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~-~ell~hp~f~~~~ 372 (394)
..++..++.++.+||.+||+.||.+||++ .++++||||+.+.
T Consensus 213 -------------~~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~h~~~~~~~ 255 (316)
T cd05592 213 -------------PHFPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQHPFFRGID 255 (316)
T ss_pred -------------CCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCcccCCCC
Confidence 01124578899999999999999999986 5899999999864
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-44 Score=335.70 Aligned_cols=244 Identities=29% Similarity=0.496 Sum_probs=197.8
Q ss_pred eEEeecCceEEEEEEECCCCcEEEEEEeccch-------hhhHHHHHHHHHc-CCCCeeeeceEEEecCCCceeEEEEEE
Q 016184 88 HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQML-DHPNIVALKHCFFSTTDKEELYLNLVL 159 (394)
Q Consensus 88 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~lv~ 159 (394)
+.||+|+||.||+|++..+++.||||++.+.. ....+|.++++.+ .||||+++++++. ....+++||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~-----~~~~~~lv~ 75 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQ-----TKDRLFFVM 75 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEE-----cCCEEEEEE
Confidence 46999999999999999999999999986532 2234677888877 7999999999883 334588999
Q ss_pred ecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCcccccc-
Q 016184 160 EYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK- 237 (394)
Q Consensus 160 e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~- 237 (394)
||+++ +|...+.. ...+++..+..++.|++.||.|||+ .||+||||||+|||++.++ .+||+|||++.....
T Consensus 76 e~~~~~~L~~~~~~----~~~l~~~~~~~~~~qi~~~l~~LH~-~~ivH~dlkp~Nill~~~~-~~kl~Dfg~~~~~~~~ 149 (318)
T cd05570 76 EYVNGGDLMFHIQR----SGRFDEPRARFYAAEIVLGLQFLHE-RGIIYRDLKLDNVLLDSEG-HIKIADFGMCKEGILG 149 (318)
T ss_pred cCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeEccCCCHHHeEECCCC-cEEecccCCCeecCcC
Confidence 99985 55444432 3579999999999999999999999 8999999999999999888 799999999865322
Q ss_pred CCCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCCCc
Q 016184 238 GEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 317 (394)
Q Consensus 238 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 317 (394)
........+++.|+|||++.+. .++.++|+|||||++|+|++|+.||.+.+.......+...
T Consensus 150 ~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~----------------- 211 (318)
T cd05570 150 GVTTSTFCGTPDYIAPEILSYQ-PYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILED----------------- 211 (318)
T ss_pred CCcccceecCccccCHHHhcCC-CCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcC-----------------
Confidence 2223345689999999999654 4899999999999999999999999877655544443321
Q ss_pred ccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCH-----HHHhcCCCCCCCC
Q 016184 318 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTA-----LEACVHPFFDELR 372 (394)
Q Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~-----~ell~hp~f~~~~ 372 (394)
.. .++..++..+.+||++||+.||.+|||+ .++++||||+...
T Consensus 212 ~~------------~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~~~~~~~~ 259 (318)
T cd05570 212 EV------------RYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFFREID 259 (318)
T ss_pred CC------------CCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcCCCcCCCC
Confidence 00 1224578999999999999999999999 9999999998864
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-44 Score=335.99 Aligned_cols=244 Identities=31% Similarity=0.487 Sum_probs=197.4
Q ss_pred eEEeecCceEEEEEEEC---CCCcEEEEEEeccch--------hhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEEE
Q 016184 88 HVVGTGSFGVVFQAKCR---ETGEIVAIKKVLQDK--------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN 156 (394)
Q Consensus 88 ~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~--------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 156 (394)
+.||+|+||.||+|++. .+++.||+|++.... ....+|+.+++.++||||+++++++. .....+
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~-----~~~~~~ 76 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQ-----TGGKLY 76 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEe-----cCCeEE
Confidence 67999999999999874 468899999886432 22346999999999999999998883 334578
Q ss_pred EEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCcccc
Q 016184 157 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL 235 (394)
Q Consensus 157 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~ 235 (394)
+||||+.+ +|...+.. ...+++..+..++.|++.||+|||+ +||+||||||+|||++.++ .+||+|||+++..
T Consensus 77 lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~dlkp~Nil~~~~~-~~kl~Dfg~~~~~ 150 (323)
T cd05584 77 LILEYLSGGELFMHLER----EGIFMEDTACFYLSEISLALEHLHQ-QGIIYRDLKPENILLDAQG-HVKLTDFGLCKES 150 (323)
T ss_pred EEEeCCCCchHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHeEECCCC-CEEEeeCcCCeec
Confidence 99999986 55554432 4668889999999999999999999 8999999999999999888 7999999998754
Q ss_pred ccC-CCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCC
Q 016184 236 VKG-EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 314 (394)
Q Consensus 236 ~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 314 (394)
... .......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+....+..+....
T Consensus 151 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~------------- 216 (323)
T cd05584 151 IHEGTVTHTFCGTIEYMAPEILMRS-GHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGK------------- 216 (323)
T ss_pred ccCCCcccccCCCccccChhhccCC-CCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC-------------
Confidence 322 223345689999999998654 47899999999999999999999998877655554443310
Q ss_pred CCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCC-----CHHHHhcCCCCCCCC
Q 016184 315 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-----TALEACVHPFFDELR 372 (394)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----t~~ell~hp~f~~~~ 372 (394)
.. ++..+++.+.+||++||+.||++|| +++++++||||+...
T Consensus 217 ----~~------------~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h~~~~~~~ 263 (323)
T cd05584 217 ----LN------------LPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFFRHVN 263 (323)
T ss_pred ----CC------------CCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcCCCcCCCC
Confidence 01 1245788999999999999999999 899999999998753
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-44 Score=327.70 Aligned_cols=276 Identities=36% Similarity=0.644 Sum_probs=215.9
Q ss_pred eEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccch------hhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEEE
Q 016184 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN 156 (394)
Q Consensus 83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 156 (394)
+|++.+.||.|++|.||+|++..+|+.||||.+.... ....+|+++++.++|+||+++++++. .....+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~~~~~ 75 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIH-----TENKLY 75 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcc-----cCCcEE
Confidence 3899999999999999999999999999999875432 24567999999999999999999873 334578
Q ss_pred EEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCccccc
Q 016184 157 LVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV 236 (394)
Q Consensus 157 lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~ 236 (394)
++|||+.+++...+.... ...+++..++.++.|++.||+|||+ .|++|+||+|+||+++.++ .+||+|||++....
T Consensus 76 ~v~e~~~~~l~~~~~~~~--~~~l~~~~~~~~~~~i~~~l~~lh~-~~i~H~~l~p~nill~~~~-~~~l~dfg~~~~~~ 151 (284)
T cd07860 76 LVFEFLHQDLKKFMDASP--LSGIPLPLIKSYLFQLLQGLAFCHS-HRVLHRDLKPQNLLINTEG-AIKLADFGLARAFG 151 (284)
T ss_pred EEeeccccCHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEECCCC-CEEEeeccchhhcc
Confidence 999999887766654322 3568999999999999999999999 8999999999999999888 79999999987553
Q ss_pred cCCC-cccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCC
Q 016184 237 KGEP-NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 315 (394)
Q Consensus 237 ~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 315 (394)
.... .....+++.|+|||.+.+...++.++|+||||+++|+|+||+.||.+.+..+.+..+.+..+.+....+.....-
T Consensus 152 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (284)
T cd07860 152 VPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSL 231 (284)
T ss_pred cCccccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHH
Confidence 3221 223345788999999876555788999999999999999999999988888888888877777665433211100
Q ss_pred C-cccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 016184 316 Y-TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368 (394)
Q Consensus 316 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f 368 (394)
- ....++......... ....++++++++|.+||+.||.+|||++++++||||
T Consensus 232 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f 284 (284)
T cd07860 232 PDYKPSFPKWARQDFSK-VVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284 (284)
T ss_pred HHHHhhcccccccCHHH-HcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence 0 000111111111111 124578899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-44 Score=350.68 Aligned_cols=261 Identities=24% Similarity=0.330 Sum_probs=211.6
Q ss_pred eeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccc------hhhhHHHHHHHHHcCCCCeeeeceEEEecCC---Cce
Q 016184 82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTD---KEE 152 (394)
Q Consensus 82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~---~~~ 152 (394)
.+|++.+.||+|+||+||+|++..+|+.||||++... .....+|+.++..++|+|+++++..+..... ...
T Consensus 32 ~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~~ 111 (496)
T PTZ00283 32 KKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENV 111 (496)
T ss_pred CCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcccc
Confidence 4699999999999999999999999999999988543 2334568899999999999998877643322 223
Q ss_pred eEEEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecC
Q 016184 153 LYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS 231 (394)
Q Consensus 153 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~ 231 (394)
.++++||||+.+ +|.+.+.........+++..++.++.|++.||.|||+ .||+||||||+|||++.++ .+||+|||+
T Consensus 112 ~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~-~~IiHrDLKP~NILl~~~~-~vkL~DFGl 189 (496)
T PTZ00283 112 LMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHS-KHMIHRDIKSANILLCSNG-LVKLGDFGF 189 (496)
T ss_pred eEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHh-CCEecCCCCHHHEEEeCCC-CEEEEeccc
Confidence 357899999984 7888777655556789999999999999999999999 8999999999999999887 699999999
Q ss_pred ccccccC---CCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhh
Q 016184 232 AKVLVKG---EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 308 (394)
Q Consensus 232 a~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~ 308 (394)
++..... .......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+.+..+.....
T Consensus 190 s~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~~~------ 262 (496)
T PTZ00283 190 SKMYAATVSDDVGRTFCGTPYYVAPEIWRRK-PYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRY------ 262 (496)
T ss_pred CeeccccccccccccccCCcceeCHHHhCCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCC------
Confidence 8765322 122345689999999999654 489999999999999999999999987665544444332100
Q ss_pred hhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q 016184 309 IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD 373 (394)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~ 373 (394)
..++..+++++.+||.+||+.||.+||++.++++|||++....
T Consensus 263 ----------------------~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~~~~ 305 (496)
T PTZ00283 263 ----------------------DPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKLFIS 305 (496)
T ss_pred ----------------------CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHHhhh
Confidence 0122467899999999999999999999999999999987544
|
|
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-44 Score=334.28 Aligned_cols=245 Identities=27% Similarity=0.477 Sum_probs=196.0
Q ss_pred eEEeecCceEEEEEEECCCCcEEEEEEeccch-------hhhHHHHHHHHH-cCCCCeeeeceEEEecCCCceeEEEEEE
Q 016184 88 HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQM-LDHPNIVALKHCFFSTTDKEELYLNLVL 159 (394)
Q Consensus 88 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~-l~h~~iv~~~~~~~~~~~~~~~~~~lv~ 159 (394)
++||+|+||.||+|+++.+|+.||+|++.... .....|..++.. +.|+||+++++++ ....++++||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~-----~~~~~~~lv~ 75 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTF-----QTKEHLFFVM 75 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEE-----EeCCEEEEEE
Confidence 46999999999999999999999999986532 223456677765 4899999999988 3344688999
Q ss_pred ecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCcccccc-
Q 016184 160 EYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK- 237 (394)
Q Consensus 160 e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~- 237 (394)
||+.+ +|...+.. ...+++..+..++.|++.||+|||+ +||+||||||+|||++.++ .++|+|||++.....
T Consensus 76 E~~~~g~L~~~i~~----~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivHrDlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~ 149 (316)
T cd05620 76 EFLNGGDLMFHIQD----KGRFDLYRATFYAAEIVCGLQFLHS-KGIIYRDLKLDNVMLDRDG-HIKIADFGMCKENVFG 149 (316)
T ss_pred CCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeEecCCCHHHeEECCCC-CEEeCccCCCeecccC
Confidence 99985 55544432 3678999999999999999999999 8999999999999999888 699999999864322
Q ss_pred CCCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCCCc
Q 016184 238 GEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 317 (394)
Q Consensus 238 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 317 (394)
........||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+.......+.... +
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~~--~------------- 213 (316)
T cd05620 150 DNRASTFCGTPDYIAPEILQGL-KYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDT--P------------- 213 (316)
T ss_pred CCceeccCCCcCccCHHHHcCC-CCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC--C-------------
Confidence 2223345689999999999654 48999999999999999999999998776554444332210 0
Q ss_pred ccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCH-HHHhcCCCCCCCCC
Q 016184 318 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTA-LEACVHPFFDELRD 373 (394)
Q Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~-~ell~hp~f~~~~~ 373 (394)
.++..++.++++||++||+.||++|+++ +++++||||+....
T Consensus 214 --------------~~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~~h~~f~~~~~ 256 (316)
T cd05620 214 --------------HYPRWITKESKDILEKLFERDPTRRLGVVGNIRGHPFFKTINW 256 (316)
T ss_pred --------------CCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCCCcCCCCH
Confidence 0123478899999999999999999998 58999999998753
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-44 Score=325.33 Aligned_cols=275 Identities=36% Similarity=0.628 Sum_probs=216.5
Q ss_pred EEEeeEEeecCceEEEEEEECCCCcEEEEEEeccchh-----hhHHHHHHHHHcC-CCCeeeeceEEEecCCCceeEEEE
Q 016184 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-----YKNRELQIMQMLD-HPNIVALKHCFFSTTDKEELYLNL 157 (394)
Q Consensus 84 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-----~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~~l 157 (394)
|++.+.||+|+||.||+|.+..+++.||+|++..... ...+|+.+++++. |+|++++++++... ...+.++
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~---~~~~~~l 77 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDR---KTGRLAL 77 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecC---CCCcEEE
Confidence 6788999999999999999999999999998764321 1235888888885 99999999988433 1234789
Q ss_pred EEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCcccccc
Q 016184 158 VLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK 237 (394)
Q Consensus 158 v~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~ 237 (394)
||||+++++.+.+... ...+++..++.++.|++.||+|||+ .|++|+||||+||+++. + .+||+|||++.....
T Consensus 78 v~e~~~~~l~~~l~~~---~~~~~~~~~~~~~~qi~~~L~~LH~-~~i~H~dl~p~ni~l~~-~-~~kl~dfg~~~~~~~ 151 (282)
T cd07831 78 VFELMDMNLYELIKGR---KRPLPEKRVKSYMYQLLKSLDHMHR-NGIFHRDIKPENILIKD-D-ILKLADFGSCRGIYS 151 (282)
T ss_pred EEecCCccHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHH-CCceecccCHHHEEEcC-C-CeEEEeccccccccc
Confidence 9999998877665542 2568999999999999999999999 89999999999999998 6 799999999987654
Q ss_pred CCCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCC-C
Q 016184 238 GEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN-Y 316 (394)
Q Consensus 238 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~-~ 316 (394)
........+++.|+|||.+.....++.++|+|||||++|+|++|..||.+.+..+.+..+....+.+........... .
T Consensus 152 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (282)
T cd07831 152 KPPYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRH 231 (282)
T ss_pred CCCcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhccccc
Confidence 444445567889999998755555789999999999999999999999998888888888887777776553322211 1
Q ss_pred cccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 016184 317 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368 (394)
Q Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f 368 (394)
..+.++....... ..+...++.++.+||.+||+.||++|||++++++||||
T Consensus 232 ~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~ 282 (282)
T cd07831 232 MNYNFPSKKGTGL-RKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282 (282)
T ss_pred ccccCcccccccH-HHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence 1112222111111 11224578999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-46 Score=317.05 Aligned_cols=262 Identities=29% Similarity=0.468 Sum_probs=207.0
Q ss_pred eEEEe-eEEeecCceEEEEEEECCCCcEEEEEEeccchhhhHHHHHHHHHc-CCCCeeeeceEEEecCCCceeEEEEEEe
Q 016184 83 SYIAE-HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQML-DHPNIVALKHCFFSTTDKEELYLNLVLE 160 (394)
Q Consensus 83 ~y~~~-~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~lv~e 160 (394)
+|.|. ++||-|-.|.|..+.++.||+.+|+|++... ...++|+++--.. .|+|||.++++|.... .....+.+|||
T Consensus 62 dY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-~KARrEVeLHw~~s~h~~iV~IidVyeNs~-~~rkcLLiVmE 139 (400)
T KOG0604|consen 62 DYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-PKARREVELHWMASGHPHIVSIIDVYENSY-QGRKCLLIVME 139 (400)
T ss_pred hheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-HHHHhHhhhhhhhcCCCceEEeehhhhhhc-cCceeeEeeee
Confidence 46664 6799999999999999999999999976544 3445788875444 7999999999884333 44566889999
Q ss_pred cccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCC--CcEEEEeecCcccccc
Q 016184 161 YVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHT--HQLKLCDFGSAKVLVK 237 (394)
Q Consensus 161 ~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~--~~vkl~Dfg~a~~~~~ 237 (394)
.++| .|...+.. +....+.+.++..|+.||..|+.|||+ .+|.||||||+|+|....+ ..+||+|||+|+....
T Consensus 140 ~meGGeLfsriq~--~g~~afTErea~eI~~qI~~Av~~lH~-~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~ 216 (400)
T KOG0604|consen 140 CMEGGELFSRIQD--RGDQAFTEREASEIMKQIGLAVRYLHS-MNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQE 216 (400)
T ss_pred cccchHHHHHHHH--cccccchHHHHHHHHHHHHHHHHHHHh-cchhhccCChhheeeecCCCCcceEecccccccccCC
Confidence 9997 34333333 334779999999999999999999999 9999999999999997532 2699999999998776
Q ss_pred CCCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCCCc
Q 016184 238 GEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 317 (394)
Q Consensus 238 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 317 (394)
.....+.+.||+|.|||++ +...|+..+|+||+||++|.|++|.+||.+......-..+.+.+. ..
T Consensus 217 ~~~L~TPc~TPyYvaPevl-g~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~-------------~g 282 (400)
T KOG0604|consen 217 PGDLMTPCFTPYYVAPEVL-GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIR-------------TG 282 (400)
T ss_pred CccccCCcccccccCHHHh-CchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhh-------------cc
Confidence 6667777889999999998 566699999999999999999999999987654322111211110 01
Q ss_pred ccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 016184 318 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL 371 (394)
Q Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 371 (394)
.+.||+ ..| ..+|++++++|+.+|..+|.+|.|+++++.|||+...
T Consensus 283 qy~FP~---pEW-----s~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~ 328 (400)
T KOG0604|consen 283 QYEFPE---PEW-----SCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQY 328 (400)
T ss_pred CccCCC---hhH-----hHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhccc
Confidence 222322 112 4589999999999999999999999999999999764
|
|
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-44 Score=329.02 Aligned_cols=279 Identities=38% Similarity=0.624 Sum_probs=221.9
Q ss_pred eeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccch------hhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEE
Q 016184 82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL 155 (394)
Q Consensus 82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 155 (394)
.+|++.+.||.|+||.||+|.+..+++.+|+|.+.... ....+|+.+++.++||||+++++++.... ..+.
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~---~~~~ 81 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSN---LDKI 81 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecC---CCcE
Confidence 35999999999999999999999999999999885432 12346999999999999999999874331 2458
Q ss_pred EEEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCcccc
Q 016184 156 NLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL 235 (394)
Q Consensus 156 ~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~ 235 (394)
+++|||+++++.+++.... ..+++..++.++.|++.||+|||+ .|++|+||||+||+++.++ .++|+|||++...
T Consensus 82 ~lv~e~~~~~L~~~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~-~~i~H~dl~p~nili~~~~-~~~l~d~g~~~~~ 156 (293)
T cd07843 82 YMVMEYVEHDLKSLMETMK---QPFLQSEVKCLMLQLLSGVAHLHD-NWILHRDLKTSNLLLNNRG-ILKICDFGLAREY 156 (293)
T ss_pred EEEehhcCcCHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHH-CCeeeccCCHHHEEECCCC-cEEEeecCceeec
Confidence 8999999988877665422 468999999999999999999999 8999999999999999887 6999999998766
Q ss_pred ccC-CCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCC
Q 016184 236 VKG-EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 314 (394)
Q Consensus 236 ~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 314 (394)
... .......+++.|+|||.+.+...++.++|+||||+++|+|++|..||......+.+..+....+.+....+.....
T Consensus 157 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (293)
T cd07843 157 GSPLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSE 236 (293)
T ss_pred cCCccccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhc
Confidence 543 2223455688899999987665578999999999999999999999999888888888888877777665543211
Q ss_pred --CCcccCCCCCCCCCcchhcccc-CChHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 016184 315 --NYTEFKFPQIKPHPWHKVFQKR-LPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368 (394)
Q Consensus 315 --~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f 368 (394)
..............+...++.. +++.+.+||++||+.||++|||+.|+|+||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f 293 (293)
T cd07843 237 LPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293 (293)
T ss_pred cchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence 0011111111222223334343 68899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-44 Score=335.86 Aligned_cols=245 Identities=27% Similarity=0.505 Sum_probs=193.8
Q ss_pred eEEeecCceEEEEEEECCCCcEEEEEEeccch-------hhhHHHHHHHHHc-CCCCeeeeceEEEecCCCceeEEEEEE
Q 016184 88 HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQML-DHPNIVALKHCFFSTTDKEELYLNLVL 159 (394)
Q Consensus 88 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~lv~ 159 (394)
++||+|+||.||+|++..+++.||||++.+.. ....+|..+++.+ +||||+++++++ .....+++||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~-----~~~~~~~lv~ 75 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCF-----QTESRLFFVI 75 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEE-----EcCCEEEEEE
Confidence 46999999999999999999999999986432 2245688888888 799999999988 3334588999
Q ss_pred ecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCccccc-c
Q 016184 160 EYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV-K 237 (394)
Q Consensus 160 e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~-~ 237 (394)
||+++ +|...+. ....+++..++.++.|++.||+|||+ +||+||||||+|||++.++ .+||+|||+++... .
T Consensus 76 e~~~~g~L~~~~~----~~~~l~~~~~~~~~~qi~~~l~~lH~-~~ivH~dlkp~Nili~~~~-~~kL~Dfg~~~~~~~~ 149 (329)
T cd05588 76 EFVSGGDLMFHMQ----RQRKLPEEHARFYSAEISLALNFLHE-RGIIYRDLKLDNVLLDAEG-HIKLTDYGMCKEGIRP 149 (329)
T ss_pred eCCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEecCCCHHHeEECCCC-CEEECcCccccccccC
Confidence 99986 5544443 24679999999999999999999999 8999999999999999887 69999999987532 2
Q ss_pred CCCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCc--------HHHHHHHHHHhCCCChhhh
Q 016184 238 GEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESG--------VDQLVEIIKVLGTPTREEI 309 (394)
Q Consensus 238 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~--------~~~~~~i~~~~~~~~~~~~ 309 (394)
........||+.|+|||++.+. .++.++|+|||||++|+|++|+.||..... .+.+...+..
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~--------- 219 (329)
T cd05588 150 GDTTSTFCGTPNYIAPEILRGE-DYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILE--------- 219 (329)
T ss_pred CCccccccCCccccCHHHHcCC-CCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHc---------
Confidence 2333456789999999999654 489999999999999999999999963211 1111111110
Q ss_pred hccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCC------HHHHhcCCCCCCCC
Q 016184 310 KCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCT------ALEACVHPFFDELR 372 (394)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt------~~ell~hp~f~~~~ 372 (394)
.... ++..++..+.+||++||+.||.+|+| ++++++||||+.+.
T Consensus 220 -------~~~~------------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~~~ 269 (329)
T cd05588 220 -------KQIR------------IPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRNID 269 (329)
T ss_pred -------CCCC------------CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcCCCCCCCC
Confidence 0001 22457889999999999999999997 78999999998754
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-44 Score=323.83 Aligned_cols=252 Identities=35% Similarity=0.564 Sum_probs=204.1
Q ss_pred EEEeeEEeecCceEEEEEEECCCCcEEEEEEeccchhh------hHHHHHHHHHcCCCCeeeeceEEEecCCCceeEEEE
Q 016184 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRY------KNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL 157 (394)
Q Consensus 84 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~------~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 157 (394)
|++.+.||+|+||+||+|++..+++.||+|++...... ..+|+.+++.++|+||+++++++.. ....++
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~-----~~~~~~ 75 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQD-----DNYLYI 75 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEE-----SSEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhccccccccccccccccccc-----cccccc
Confidence 88999999999999999999999999999998654322 1248899999999999999998844 445779
Q ss_pred EEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCcccc-
Q 016184 158 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL- 235 (394)
Q Consensus 158 v~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~- 235 (394)
+||++.+ ++.+++. ....+++..++.++.|++.||++||+ .|++|+||||+||+++.++ .++|+|||.+...
T Consensus 76 v~~~~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~~L~~Lh~-~~i~H~dikp~NIl~~~~~-~~~l~Dfg~~~~~~ 149 (260)
T PF00069_consen 76 VMEYCPGGSLQDYLQ----KNKPLSEEEILKIAYQILEALAYLHS-KGIVHRDIKPENILLDENG-EVKLIDFGSSVKLS 149 (260)
T ss_dssp EEEEETTEBHHHHHH----HHSSBBHHHHHHHHHHHHHHHHHHHH-TTEEESSBSGGGEEESTTS-EEEESSGTTTEEST
T ss_pred ccccccccccccccc----cccccccccccccccccccccccccc-ccccccccccccccccccc-cccccccccccccc
Confidence 9999998 8877776 34788999999999999999999999 8999999999999999877 7999999998753
Q ss_pred ccCCCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCC
Q 016184 236 VKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 315 (394)
Q Consensus 236 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 315 (394)
..........++..|+|||++.....++.++|+||||+++|+|++|..||......+....+.+............
T Consensus 150 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~---- 225 (260)
T PF00069_consen 150 ENNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQ---- 225 (260)
T ss_dssp STTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTS----
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccccc----
Confidence 2233344567799999999986345689999999999999999999999988744444444433322111111000
Q ss_pred CcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 016184 316 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368 (394)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f 368 (394)
....+..+.++|++||+.||++|||+.++++||||
T Consensus 226 ------------------~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~~~~ 260 (260)
T PF00069_consen 226 ------------------SREKSEELRDLIKKMLSKDPEQRPSAEELLKHPWF 260 (260)
T ss_dssp ------------------HTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTSGGG
T ss_pred ------------------cchhHHHHHHHHHHHccCChhHCcCHHHHhcCCCC
Confidence 01123789999999999999999999999999998
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-44 Score=359.54 Aligned_cols=262 Identities=27% Similarity=0.420 Sum_probs=211.3
Q ss_pred ceeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccc------hhhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeE
Q 016184 81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY 154 (394)
Q Consensus 81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 154 (394)
..+|++++.||.|+||+||+|++..+++.||+|++... ...+..|+.+++.|.||||++++++|... ....
T Consensus 12 l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de---~~~~ 88 (1021)
T PTZ00266 12 LNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNK---ANQK 88 (1021)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEec---CCCE
Confidence 34699999999999999999999999999999987532 23345799999999999999999988543 2345
Q ss_pred EEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCC-------ceeccCCCCceEEeCCC-----
Q 016184 155 LNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG-------ICHRDIKPQNLLVNPHT----- 221 (394)
Q Consensus 155 ~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~g-------ivH~Dlkp~Nil~~~~~----- 221 (394)
++|||||+++ +|..++.........+++..++.|+.||+.||.|||+ .+ ||||||||+||||+.+.
T Consensus 89 lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs-~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~ 167 (1021)
T PTZ00266 89 LYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHN-LKDGPNGERVLHRDLKPQNIFLSTGIRHIGK 167 (1021)
T ss_pred EEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHh-cccccccCCceeccCcHHHeEeecCcccccc
Confidence 7899999985 8888877655555789999999999999999999998 44 99999999999996421
Q ss_pred -----------CcEEEEeecCccccccCCCcccccccccccccccccCC-CCCCChhhHHHHHHHHHHHHhCCCCCCCCC
Q 016184 222 -----------HQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGA-TEYTTAIDIWSTGCVMAELLLGQPLFPGES 289 (394)
Q Consensus 222 -----------~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~lltg~~pf~~~~ 289 (394)
..+||+|||++.............+|+.|+|||++.+. ..++.++|||||||+||+|+||..||....
T Consensus 168 i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~ 247 (1021)
T PTZ00266 168 ITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKAN 247 (1021)
T ss_pred ccccccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCC
Confidence 14899999999766444444456789999999998543 347899999999999999999999998766
Q ss_pred cHHHHHHHHHHhCCCChhhhhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCC
Q 016184 290 GVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFD 369 (394)
Q Consensus 290 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~ 369 (394)
....+...+... +. ++ ....+.++.+||..||+.||.+||++.++|.||||+
T Consensus 248 ~~~qli~~lk~~--p~---------------lp-----------i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik 299 (1021)
T PTZ00266 248 NFSQLISELKRG--PD---------------LP-----------IKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIK 299 (1021)
T ss_pred cHHHHHHHHhcC--CC---------------CC-----------cCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHh
Confidence 554443332211 00 00 024688999999999999999999999999999999
Q ss_pred CCCCC
Q 016184 370 ELRDP 374 (394)
Q Consensus 370 ~~~~~ 374 (394)
.+..+
T Consensus 300 ~i~~p 304 (1021)
T PTZ00266 300 NVGPP 304 (1021)
T ss_pred hcCCC
Confidence 87654
|
|
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-44 Score=332.47 Aligned_cols=245 Identities=29% Similarity=0.521 Sum_probs=196.5
Q ss_pred eEEeecCceEEEEEEECCCCcEEEEEEeccch-------hhhHHHHHHHHH-cCCCCeeeeceEEEecCCCceeEEEEEE
Q 016184 88 HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQM-LDHPNIVALKHCFFSTTDKEELYLNLVL 159 (394)
Q Consensus 88 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~-l~h~~iv~~~~~~~~~~~~~~~~~~lv~ 159 (394)
+.||+|+||.||+|++..+++.||||++.... .....|..++.. +.||||+++++++. ....+++||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~-----~~~~~~lv~ 75 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQ-----TKENLFFVM 75 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEE-----eCCEEEEEE
Confidence 46999999999999999999999999886532 223356677765 49999999998883 334588999
Q ss_pred ecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCccccccC
Q 016184 160 EYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG 238 (394)
Q Consensus 160 e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~~ 238 (394)
||+++ +|...+.. ...+++..+..++.|++.||+|||+ .||+||||||+|||++.++ .+||+|||++......
T Consensus 76 ey~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~LH~-~~ivHrdikp~Nil~~~~~-~~kl~Dfg~~~~~~~~ 149 (316)
T cd05619 76 EYLNGGDLMFHIQS----CHKFDLPRATFYAAEIICGLQFLHS-KGIVYRDLKLDNILLDTDG-HIKIADFGMCKENMLG 149 (316)
T ss_pred eCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeEeCCCCHHHEEECCCC-CEEEccCCcceECCCC
Confidence 99975 66555543 3578999999999999999999999 8999999999999999887 6999999998754222
Q ss_pred -CCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCCCc
Q 016184 239 -EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 317 (394)
Q Consensus 239 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 317 (394)
.......||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+.+..+... .+
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~--~~------------- 213 (316)
T cd05619 150 DAKTCTFCGTPDYIAPEILLGQ-KYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMD--NP------------- 213 (316)
T ss_pred CCceeeecCCccccCHHHHcCC-CCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--CC-------------
Confidence 223345689999999998654 4899999999999999999999999877655444443221 00
Q ss_pred ccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHH-HHhcCCCCCCCCC
Q 016184 318 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTAL-EACVHPFFDELRD 373 (394)
Q Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~-ell~hp~f~~~~~ 373 (394)
.++..++.++++||.+||+.||.+||++. ++++||||+++..
T Consensus 214 --------------~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~h~~~~~~~~ 256 (316)
T cd05619 214 --------------CYPRWLTREAKDILVKLFVREPERRLGVKGDIRQHPFFREIDW 256 (316)
T ss_pred --------------CCCccCCHHHHHHHHHHhccCHhhcCCChHHHHcCcccCCCCH
Confidence 01234688999999999999999999996 9999999999753
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-44 Score=336.11 Aligned_cols=245 Identities=27% Similarity=0.451 Sum_probs=195.3
Q ss_pred eEEeecCceEEEEEEECCCCcEEEEEEeccchh-------hhHHHH-HHHHHcCCCCeeeeceEEEecCCCceeEEEEEE
Q 016184 88 HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-------YKNREL-QIMQMLDHPNIVALKHCFFSTTDKEELYLNLVL 159 (394)
Q Consensus 88 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-------~~~~E~-~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~ 159 (394)
+.||+|+||+||+|++..+|+.||||++..... ...+|. .+++.++||||+++++++. .....++||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~-----~~~~~~lv~ 75 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQ-----TADKLYFVL 75 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEE-----eCCEEEEEE
Confidence 469999999999999999999999999864321 112233 3567899999999988873 334578999
Q ss_pred ecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCccccccC
Q 016184 160 EYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG 238 (394)
Q Consensus 160 e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~~ 238 (394)
||+.+ +|...+.. ...+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||++......
T Consensus 76 e~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~-~givH~dikp~NIll~~~~-~~kl~Dfg~~~~~~~~ 149 (323)
T cd05575 76 DYVNGGELFFHLQR----ERSFPEPRARFYAAEIASALGYLHS-LNIIYRDLKPENILLDSQG-HVVLTDFGLCKEGIEH 149 (323)
T ss_pred cCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeEeCCCCHHHeEECCCC-cEEEeccCCCcccccC
Confidence 99986 55444432 4678999999999999999999999 8999999999999999888 6999999998754322
Q ss_pred -CCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCCCc
Q 016184 239 -EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 317 (394)
Q Consensus 239 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 317 (394)
.......||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+....+....
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~---------------- 212 (323)
T cd05575 150 SKTTSTFCGTPEYLAPEVLRKQ-PYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKP---------------- 212 (323)
T ss_pred CCccccccCChhhcChhhhcCC-CCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCC----------------
Confidence 223345689999999998654 48999999999999999999999998776555544443210
Q ss_pred ccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCH----HHHhcCCCCCCCCC
Q 016184 318 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTA----LEACVHPFFDELRD 373 (394)
Q Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~----~ell~hp~f~~~~~ 373 (394)
.. +...++..+.+||++||+.||.+||++ .++++||||.....
T Consensus 213 -~~------------~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~il~~~~~~~~~~ 259 (323)
T cd05575 213 -LR------------LKPNISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNHVFFSSINW 259 (323)
T ss_pred -CC------------CCCCCCHHHHHHHHHHhhcCHHhCCCCCCCHHHHHcCCCcCCCCH
Confidence 00 123578999999999999999999998 69999999987643
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=332.96 Aligned_cols=286 Identities=29% Similarity=0.522 Sum_probs=214.4
Q ss_pred eeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccch----hhhHHHHHHHHHcCCCCeeeeceEEEecCCC-------
Q 016184 82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVALKHCFFSTTDK------- 150 (394)
Q Consensus 82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~------- 150 (394)
.+|.+.+.||.|+||.||+|.+..+|+.||+|.+.... ....+|+++++.++|+||+++++++......
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 84 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGS 84 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccc
Confidence 46999999999999999999999999999999875432 3345799999999999999998876432211
Q ss_pred --ceeEEEEEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEe
Q 016184 151 --EELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCD 228 (394)
Q Consensus 151 --~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~D 228 (394)
+....+++|||+++++.+.+.. ..+++..++.++.||+.||.|||+ .||+||||||+||+++.++..++|+|
T Consensus 85 ~~~~~~~~lv~e~~~~~L~~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~-~givH~dikp~Nili~~~~~~~kl~d 158 (342)
T cd07854 85 LTELNSVYIVQEYMETDLANVLEQ-----GPLSEEHARLFMYQLLRGLKYIHS-ANVLHRDLKPANVFINTEDLVLKIGD 158 (342)
T ss_pred ccccceEEEEeecccccHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHHEEEcCCCceEEECC
Confidence 1235789999999877665542 568999999999999999999999 89999999999999986655799999
Q ss_pred ecCccccccCCC----cccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCC
Q 016184 229 FGSAKVLVKGEP----NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTP 304 (394)
Q Consensus 229 fg~a~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~ 304 (394)
||.+........ .....++..|+|||.+.....++.++|||||||++|+|++|+.||.+.........+.......
T Consensus 159 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 238 (342)
T cd07854 159 FGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVV 238 (342)
T ss_pred cccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence 999875532211 1223568889999987655568899999999999999999999998887766666655544333
Q ss_pred ChhhhhccCCCCcccCC--CCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCC
Q 016184 305 TREEIKCMNPNYTEFKF--PQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP 374 (394)
Q Consensus 305 ~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~ 374 (394)
................. ......+... +...++.++.+||++||+.||.+|||+.++++||||+.+..+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~~~~ 309 (342)
T cd07854 239 REEDRNELLNVIPSFVRNDGGEPRRPLRD-LLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSCYSCP 309 (342)
T ss_pred ChHHhhhhhhhhhhhhhhcccccCCCHHH-HccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCccccccCC
Confidence 33222111100000000 0001111111 224578899999999999999999999999999999876443
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-43 Score=323.45 Aligned_cols=276 Identities=35% Similarity=0.669 Sum_probs=213.3
Q ss_pred eeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccch-----hhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEEE
Q 016184 82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN 156 (394)
Q Consensus 82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 156 (394)
.+|++.+.||.|++|.||+|.++.+++.||||.+.... ....+|+++++.++|+||+++++++ ....+.+
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~~~~ 79 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDII-----HTKKTLT 79 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEE-----ecCCeEE
Confidence 46999999999999999999999899999999875432 2345799999999999999999987 3334588
Q ss_pred EEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCccccc
Q 016184 157 LVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV 236 (394)
Q Consensus 157 lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~ 236 (394)
+||||+++++.+++... ...+++..++.++.|++.||.|||+ .||+|+||||+||+++.++ .+||+|||++....
T Consensus 80 lv~e~~~~~L~~~~~~~---~~~~~~~~~~~~~~ql~~al~~lH~-~~i~H~dl~p~nil~~~~~-~~kl~dfg~~~~~~ 154 (291)
T cd07844 80 LVFEYLDTDLKQYMDDC---GGGLSMHNVRLFLFQLLRGLAYCHQ-RRVLHRDLKPQNLLISERG-ELKLADFGLARAKS 154 (291)
T ss_pred EEEecCCCCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHh-CCeecccCCHHHEEEcCCC-CEEECccccccccC
Confidence 99999998877765532 2468899999999999999999999 8999999999999999888 69999999986542
Q ss_pred cCCC-cccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCC-cHHHHHHHHHHhCCCChhhhhccCC
Q 016184 237 KGEP-NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGES-GVDQLVEIIKVLGTPTREEIKCMNP 314 (394)
Q Consensus 237 ~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~~~ 314 (394)
.... .....++..|+|||.+.+...++.++||||+|+++|+|++|+.||.+.. ..+.+..+.+..+.+....+.....
T Consensus 155 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (291)
T cd07844 155 VPSKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSS 234 (291)
T ss_pred CCCccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhh
Confidence 2211 1223457889999998765568999999999999999999999998765 4566666667777766655533221
Q ss_pred C--CcccCCCCCCCCCcchhccccCC--hHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 016184 315 N--YTEFKFPQIKPHPWHKVFQKRLP--PEAVDLVCRFFQYSPNLRCTALEACVHPFF 368 (394)
Q Consensus 315 ~--~~~~~~~~~~~~~~~~~~~~~~~--~~~~~li~~~L~~dP~~Rpt~~ell~hp~f 368 (394)
. +................+ ..++ .++.++|.+||+.||.+|||+.++++||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f 291 (291)
T cd07844 235 NPEFKPYSFPFYPPRPLINHA-PRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291 (291)
T ss_pred ccccccccccccCChhHHHhC-cCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 1 111111111111111111 1234 789999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=329.00 Aligned_cols=281 Identities=34% Similarity=0.590 Sum_probs=213.8
Q ss_pred eEEEeeEEeecCceEEEEEEECC--CCcEEEEEEeccch-------hhhHHHHHHHHHcCCCCeeeeceEEEecCCCcee
Q 016184 83 SYIAEHVVGTGSFGVVFQAKCRE--TGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL 153 (394)
Q Consensus 83 ~y~~~~~lg~G~~g~V~~~~~~~--~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 153 (394)
+|.+.++||+|+||.||+|.+.. +++.||+|.+.... ....+|+.+++.++||||+++++++... ...
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~~~ 77 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEH---ADK 77 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCC---CCc
Confidence 38999999999999999999988 89999999887632 3345799999999999999999988432 234
Q ss_pred EEEEEEecccccHHHHHHHhhhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeC----CCCcEEEEe
Q 016184 154 YLNLVLEYVPETVNRIARNYSRIH-QRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNP----HTHQLKLCD 228 (394)
Q Consensus 154 ~~~lv~e~~~~~l~~~~~~~~~~~-~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~----~~~~vkl~D 228 (394)
..++||||+++++.+++....... ..+++..++.++.|++.||.|||+ .+|+||||||+||+++. ++ .+||+|
T Consensus 78 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~h~dlkp~Nil~~~~~~~~~-~~kl~D 155 (316)
T cd07842 78 SVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHS-NWVLHRDLKPANILVMGEGPERG-VVKIGD 155 (316)
T ss_pred eEEEEEeCCCcCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHh-CCEeeCCCCHHHEEEcCCCCccc-eEEECC
Confidence 688999999988877766544433 378999999999999999999999 89999999999999998 66 799999
Q ss_pred ecCccccccCCC----cccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcH---------HHHH
Q 016184 229 FGSAKVLVKGEP----NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGV---------DQLV 295 (394)
Q Consensus 229 fg~a~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~---------~~~~ 295 (394)
||++........ .....++..|+|||.+.+...++.++||||||+++|+|++|+.||.+.... ..+.
T Consensus 156 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (316)
T cd07842 156 LGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLE 235 (316)
T ss_pred CccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHH
Confidence 999876533222 123456888999999876666899999999999999999999999865432 3455
Q ss_pred HHHHHhCCCChhhhhccCC--CCcc----cCCCCCCCCCcchhccc--cCChHHHHHHHHhcccCCCCCCCHHHHhcCCC
Q 016184 296 EIIKVLGTPTREEIKCMNP--NYTE----FKFPQIKPHPWHKVFQK--RLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 367 (394)
Q Consensus 296 ~i~~~~~~~~~~~~~~~~~--~~~~----~~~~~~~~~~~~~~~~~--~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~ 367 (394)
.+...++.+....+..... .+.. ..............+.. ..+..+.++|.+||+.||++|||+.++++|||
T Consensus 236 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~ 315 (316)
T cd07842 236 RIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPY 315 (316)
T ss_pred HHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCC
Confidence 5566666555543321110 0000 00000000111111222 57788999999999999999999999999999
Q ss_pred C
Q 016184 368 F 368 (394)
Q Consensus 368 f 368 (394)
|
T Consensus 316 f 316 (316)
T cd07842 316 F 316 (316)
T ss_pred C
Confidence 8
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-44 Score=332.84 Aligned_cols=294 Identities=36% Similarity=0.649 Sum_probs=233.5
Q ss_pred eEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccch------hhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEEE
Q 016184 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN 156 (394)
Q Consensus 83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 156 (394)
+|++.+.||.|++|.||+|++..+++.||||++.... ....+|+.+++.++|+||+++.+++..........++
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 4899999999999999999999889999999875432 3455799999999999999999987554433344678
Q ss_pred EEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCccccc
Q 016184 157 LVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV 236 (394)
Q Consensus 157 lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~ 236 (394)
++|||+++++.+.+.. ...+++..++.++.|++.||+|||+ .||+|+||||+|||++.++ .++|+|||++....
T Consensus 81 lv~e~~~~~l~~~l~~----~~~l~~~~~~~i~~~l~~~l~~LH~-~gi~H~dlkp~nili~~~~-~~~L~dfg~~~~~~ 154 (330)
T cd07834 81 IVTELMETDLHKVIKS----PQPLTDDHIQYFLYQILRGLKYLHS-ANVIHRDLKPSNILVNSNC-DLKICDFGLARGVD 154 (330)
T ss_pred EEecchhhhHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEcCCC-CEEEcccCceEeec
Confidence 9999999877665543 3478999999999999999999999 8999999999999999887 79999999998765
Q ss_pred cCC----CcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhcc
Q 016184 237 KGE----PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 312 (394)
Q Consensus 237 ~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 312 (394)
... ......+++.|+|||.+.+...++.++|+||||+++|+|++|+.||.+.+..+.+..+....+.++...+...
T Consensus 155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 234 (330)
T cd07834 155 PDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFI 234 (330)
T ss_pred ccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhc
Confidence 443 2334567889999999976646899999999999999999999999999888888888888888877655422
Q ss_pred CCCCcc-c--CCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCCCCCCCCC
Q 016184 313 NPNYTE-F--KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPNGRP 383 (394)
Q Consensus 313 ~~~~~~-~--~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~~~~~~~~ 383 (394)
...... + ........++... ...++.++.+||.+||++||.+|||++++++||||++++++....+...+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~~~~~~~~~~ 307 (330)
T cd07834 235 TSEKARNYLKSLPKKPKKPLSKL-FPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDPEDEPVAKPP 307 (330)
T ss_pred cccchhhHHhhcccCCcchhHHh-cccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcccccCCCCCCc
Confidence 111100 0 0111111122222 24478999999999999999999999999999999999887665444433
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-44 Score=333.22 Aligned_cols=257 Identities=26% Similarity=0.425 Sum_probs=204.0
Q ss_pred eEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccch-------hhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEE
Q 016184 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL 155 (394)
Q Consensus 83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 155 (394)
+|++.++||+|+||.||+++++.+++.||+|++.+.. ..+.+|+.++..+.|++|+++++++ ......
T Consensus 2 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~~ 76 (332)
T cd05623 2 DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAF-----QDENNL 76 (332)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEE-----ecCCEE
Confidence 5999999999999999999999999999999985421 2245688899999999999999887 333458
Q ss_pred EEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCccc
Q 016184 156 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV 234 (394)
Q Consensus 156 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~ 234 (394)
++||||+.+ +|.+++... ...+++..++.++.||+.||+|||+ .||+||||||+|||++.++ .+||+|||++..
T Consensus 77 ~lv~ey~~~g~L~~~l~~~---~~~l~~~~~~~~~~qi~~al~~lH~-~~iiHrDlkp~Nili~~~~-~~kL~DfG~a~~ 151 (332)
T cd05623 77 YLVMDYYVGGDLLTLLSKF---EDRLPEDMARFYLAEMVIAIDSVHQ-LHYVHRDIKPDNILMDMNG-HIRLADFGSCLK 151 (332)
T ss_pred EEEEeccCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH-CCeEecCCCHHHEEECCCC-CEEEeecchhee
Confidence 899999974 776666532 3578999999999999999999999 8999999999999999887 699999999875
Q ss_pred cccCCC--cccccccccccccccccC----CCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhh
Q 016184 235 LVKGEP--NVSYICSRYYRAPELIFG----ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 308 (394)
Q Consensus 235 ~~~~~~--~~~~~~t~~y~aPE~~~~----~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~ 308 (394)
...... .....||+.|+|||++.. ...++.++|||||||++|+|++|+.||...+..+.+..+.....
T Consensus 152 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~------ 225 (332)
T cd05623 152 LMEDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKE------ 225 (332)
T ss_pred cccCCcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCc------
Confidence 533322 123568999999999852 33478899999999999999999999988776666555543110
Q ss_pred hhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCC--CCCHHHHhcCCCCCCCCC
Q 016184 309 IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNL--RCTALEACVHPFFDELRD 373 (394)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~--Rpt~~ell~hp~f~~~~~ 373 (394)
...++. ....++.++++||++||..++.+ |++++++++||||+++..
T Consensus 226 ---------~~~~p~---------~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~~~~ 274 (332)
T cd05623 226 ---------RFQFPA---------QVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQHPFFTGIDW 274 (332)
T ss_pred ---------cccCCC---------ccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCCCCcCCCCH
Confidence 001111 11357899999999999765554 789999999999998653
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-45 Score=315.57 Aligned_cols=286 Identities=34% Similarity=0.579 Sum_probs=227.7
Q ss_pred eeEEEeeEEeecCceEEEEEEECCCC----cEEEEEEeccchh------hhHHHHHHHHHcCCCCeeeeceEEEecCCCc
Q 016184 82 VSYIAEHVVGTGSFGVVFQAKCRETG----EIVAIKKVLQDKR------YKNRELQIMQMLDHPNIVALKHCFFSTTDKE 151 (394)
Q Consensus 82 ~~y~~~~~lg~G~~g~V~~~~~~~~~----~~vaiK~~~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 151 (394)
..|++.+.||+|.||.||+|..+.++ +.+|||.+..++. ..-+|+.+++.++|+|++.+..+|+..
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~---- 99 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSH---- 99 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhcc----
Confidence 45999999999999999999765553 3689998865532 223799999999999999999988643
Q ss_pred eeEEEEEEecccccHHHHHHHhhhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCC----CCcEEE
Q 016184 152 ELYLNLVLEYVPETVNRIARNYSRI-HQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPH----THQLKL 226 (394)
Q Consensus 152 ~~~~~lv~e~~~~~l~~~~~~~~~~-~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~----~~~vkl 226 (394)
+..+++++||.+.+|.++++.+... .+.++...++.+++||+.|+.|||+ +-|+||||||.||||..+ | .|||
T Consensus 100 d~~v~l~fdYAEhDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~-NWvlHRDLKPaNIlvmgdgperG-~VKI 177 (438)
T KOG0666|consen 100 DKKVWLLFDYAEHDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHS-NWVLHRDLKPANILVMGDGPERG-RVKI 177 (438)
T ss_pred CceEEEEehhhhhhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhh-hheeeccCCcceEEEeccCCccC-eeEe
Confidence 3458899999999999998876653 3568999999999999999999999 799999999999999877 5 7999
Q ss_pred EeecCccccccCCCc----ccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCC---------CcHHH
Q 016184 227 CDFGSAKVLVKGEPN----VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGE---------SGVDQ 293 (394)
Q Consensus 227 ~Dfg~a~~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~---------~~~~~ 293 (394)
+|||+++.+...-.. ...+.|..|+|||.+.+...|+.+.||||+|||+.||+|-.+.|.+. ...++
T Consensus 178 aDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQ 257 (438)
T KOG0666|consen 178 ADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQ 257 (438)
T ss_pred ecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHH
Confidence 999999877543222 24566999999999999999999999999999999999999999764 23578
Q ss_pred HHHHHHHhCCCChhhhhccCC--CCcccCCCCCCCCCcc-----hhc--cccCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 016184 294 LVEIIKVLGTPTREEIKCMNP--NYTEFKFPQIKPHPWH-----KVF--QKRLPPEAVDLVCRFFQYSPNLRCTALEACV 364 (394)
Q Consensus 294 ~~~i~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~-----~~~--~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 364 (394)
+..|+..+|.|....|..+.. .+.. .+.......|. ..+ ...-++...+|+.+||+.||-+|.|++++|+
T Consensus 258 l~rIf~vLG~Pt~~~Wp~lkk~Pe~q~-~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAle 336 (438)
T KOG0666|consen 258 LDRIFEVLGTPTDKDWPDLKKMPEYQT-LLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALE 336 (438)
T ss_pred HHHHHHHcCCCccccchhhhhCcchHH-HHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhc
Confidence 899999999999988865431 1100 00000111111 111 1223556999999999999999999999999
Q ss_pred CCCCCCCCCC
Q 016184 365 HPFFDELRDP 374 (394)
Q Consensus 365 hp~f~~~~~~ 374 (394)
|+||++-.-+
T Consensus 337 h~yF~~d~lp 346 (438)
T KOG0666|consen 337 HPYFTEDPLP 346 (438)
T ss_pred ccccccCCCC
Confidence 9999887544
|
|
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-44 Score=347.40 Aligned_cols=253 Identities=27% Similarity=0.356 Sum_probs=207.4
Q ss_pred eEEEeeEEeecCceEEEEEEECCC-CcEEEEEEeccc----hhhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEEEE
Q 016184 83 SYIAEHVVGTGSFGVVFQAKCRET-GEIVAIKKVLQD----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL 157 (394)
Q Consensus 83 ~y~~~~~lg~G~~g~V~~~~~~~~-~~~vaiK~~~~~----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 157 (394)
.|.+.+.||+|+||.||+|....+ ++.||+|.+... .....+|+.+++.++||||+++++++. .....++
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~-----~~~~~~l 142 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFK-----SDDKLLL 142 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEE-----ECCEEEE
Confidence 499999999999999999998877 788999976432 233457999999999999999999883 3345889
Q ss_pred EEeccc-ccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCccccc
Q 016184 158 VLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV 236 (394)
Q Consensus 158 v~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~ 236 (394)
||||++ ++|.+.+.........+++..+..++.|++.||+|||+ .||+||||||+|||++.++ .+||+|||+++...
T Consensus 143 v~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~-~~ivHrDlkp~NIll~~~~-~~kL~DFgla~~~~ 220 (478)
T PTZ00267 143 IMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHS-RKMMHRDLKSANIFLMPTG-IIKLGDFGFSKQYS 220 (478)
T ss_pred EEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh-CCEEECCcCHHhEEECCCC-cEEEEeCcCceecC
Confidence 999997 47877776555555678999999999999999999999 8999999999999999887 79999999998654
Q ss_pred cCCC---cccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccC
Q 016184 237 KGEP---NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 313 (394)
Q Consensus 237 ~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 313 (394)
.... .....||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+.+..+......
T Consensus 221 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~---------- 289 (478)
T PTZ00267 221 DSVSLDVASSFCGTPYYLAPELWERK-RYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYD---------- 289 (478)
T ss_pred CccccccccccCCCccccCHhHhCCC-CCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC----------
Confidence 3321 2345689999999998654 4899999999999999999999999877665555444331100
Q ss_pred CCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 016184 314 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL 371 (394)
Q Consensus 314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 371 (394)
.++..++.++.+||.+||+.||++|||+.+++.|||++.+
T Consensus 290 ------------------~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~~~~~~~ 329 (478)
T PTZ00267 290 ------------------PFPCPVSSGMKALLDPLLSKNPALRPTTQQLLHTEFLKYV 329 (478)
T ss_pred ------------------CCCccCCHHHHHHHHHHhccChhhCcCHHHHHhCHHHHHH
Confidence 0123578899999999999999999999999999998753
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-45 Score=318.13 Aligned_cols=255 Identities=29% Similarity=0.450 Sum_probs=213.6
Q ss_pred ceeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccchhhhH-------HHHHHHHHcCCCCeeeeceEEEecCCCcee
Q 016184 81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-------RELQIMQMLDHPNIVALKHCFFSTTDKEEL 153 (394)
Q Consensus 81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~-------~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 153 (394)
.++|..+++||+|.||+|-+++.+.+|+.+|+|+++++.-..+ .|-++|+..+||.+..+.-.| +...
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsF-----Qt~d 241 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSF-----QTQD 241 (516)
T ss_pred cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhh-----ccCc
Confidence 3468899999999999999999999999999998876543222 467899999999998886666 4444
Q ss_pred EEEEEEeccccc-HHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCc
Q 016184 154 YLNLVLEYVPET-VNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA 232 (394)
Q Consensus 154 ~~~lv~e~~~~~-l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a 232 (394)
.+|+||||+.|+ |...+ .....+++...+.+...|+.||.|||+ .+||+||||.+|+|+|.+|+ +||+|||++
T Consensus 242 rlCFVMeyanGGeLf~HL----srer~FsE~RtRFYGaEIvsAL~YLHs-~~ivYRDlKLENLlLDkDGH-IKitDFGLC 315 (516)
T KOG0690|consen 242 RLCFVMEYANGGELFFHL----SRERVFSEDRTRFYGAEIVSALGYLHS-RNIVYRDLKLENLLLDKDGH-IKITDFGLC 315 (516)
T ss_pred eEEEEEEEccCceEeeeh----hhhhcccchhhhhhhHHHHHHhhhhhh-CCeeeeechhhhheeccCCc-eEeeecccc
Confidence 589999999863 32222 224779999999999999999999999 89999999999999999995 999999999
Q ss_pred ccccc-CCCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhc
Q 016184 233 KVLVK-GEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 311 (394)
Q Consensus 233 ~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 311 (394)
+.-.. +......+|||.|.|||++. ...|+.+.|+|.+||++|||++|+.||...+....+..|.-.
T Consensus 316 KE~I~~g~t~kTFCGTPEYLAPEVle-DnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~e----------- 383 (516)
T KOG0690|consen 316 KEEIKYGDTTKTFCGTPEYLAPEVLE-DNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILME----------- 383 (516)
T ss_pred hhcccccceeccccCChhhcCchhhc-cccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhh-----------
Confidence 86543 44556789999999999995 455999999999999999999999999988877776666542
Q ss_pred cCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCC-----CHHHHhcCCCCCCCCCCCC
Q 016184 312 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-----TALEACVHPFFDELRDPNT 376 (394)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----t~~ell~hp~f~~~~~~~~ 376 (394)
+.. |+..++++++.|+..+|.+||.+|. .|.|+.+|+||..+....+
T Consensus 384 ------d~k------------FPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~v~W~~~ 435 (516)
T KOG0690|consen 384 ------DLK------------FPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRFFASVDWEAT 435 (516)
T ss_pred ------hcc------------CCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhhhhhccCCHHHH
Confidence 222 3468999999999999999999998 4789999999999887665
|
|
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-44 Score=332.83 Aligned_cols=288 Identities=35% Similarity=0.661 Sum_probs=228.1
Q ss_pred eeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccch------hhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEE
Q 016184 82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL 155 (394)
Q Consensus 82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 155 (394)
.+|++.+.||.|+||.||+|.+..+|+.||+|++.... ....+|+.+++.++|+||+++++++.... ......
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~~~~ 83 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPG-ADFKDV 83 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccC-CCCceE
Confidence 45999999999999999999999999999999876432 23346999999999999999998764333 334567
Q ss_pred EEEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCcccc
Q 016184 156 NLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL 235 (394)
Q Consensus 156 ~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~ 235 (394)
++||||+++++.+.+.. ...+++..++.++.||+.||.|||+ .||+||||||+||+++.++ .+||+|||++...
T Consensus 84 ~lv~e~~~~~l~~~~~~----~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~dlkp~Nil~~~~~-~~kl~dfg~~~~~ 157 (334)
T cd07855 84 YVVMDLMESDLHHIIHS----DQPLTEEHIRYFLYQLLRGLKYIHS-ANVIHRDLKPSNLLVNEDC-ELRIGDFGMARGL 157 (334)
T ss_pred EEEEehhhhhHHHHhcc----CCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEEcCCC-cEEecccccceee
Confidence 89999998877665532 3568999999999999999999999 8999999999999999888 6999999998765
Q ss_pred ccCCCc-----ccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhh
Q 016184 236 VKGEPN-----VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 310 (394)
Q Consensus 236 ~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 310 (394)
...... ....++..|+|||.+.+...++.++|||||||++|+|++|+.||.+.+....+..+....|.++...+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~ 237 (334)
T cd07855 158 SSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLN 237 (334)
T ss_pred cccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhh
Confidence 332211 234678889999998654558999999999999999999999999888888888888888888776654
Q ss_pred ccCCCCcc---cCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCCC
Q 016184 311 CMNPNYTE---FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTR 377 (394)
Q Consensus 311 ~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~~ 377 (394)
......-. ..++.....+|.. +....+.++.++|++||+.||.+|||+.+++.||||++...+...
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~~~~~~ 306 (334)
T cd07855 238 RIGSDRVRKYIQNLPRKQPVPWSK-IFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYHDPDDE 306 (334)
T ss_pred hhchhhHHHHHhhcccCCCCCHHH-HcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhccCCccc
Confidence 32211100 0111112222222 224578999999999999999999999999999999988777664
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-43 Score=321.62 Aligned_cols=276 Identities=36% Similarity=0.661 Sum_probs=218.2
Q ss_pred eEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccc-----hhhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEEEE
Q 016184 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL 157 (394)
Q Consensus 83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 157 (394)
+|++.+.||.|++|.||+|++..+|+.||||++... .....+|+.+++.++|+||+++++++.. ....++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----~~~~~l 75 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHT-----ENKLML 75 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEee-----CCcEEE
Confidence 489999999999999999999999999999987643 2334579999999999999999998843 334789
Q ss_pred EEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCcccccc
Q 016184 158 VLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK 237 (394)
Q Consensus 158 v~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~ 237 (394)
||||+++++.+++..... ...+++..+..++.|++.||.|||+ .|++|+||||+||+++.++ .++|+|||++.....
T Consensus 76 v~e~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~h~dl~p~ni~~~~~~-~~~l~d~g~~~~~~~ 152 (284)
T cd07836 76 VFEYMDKDLKKYMDTHGV-RGALDPNTVKSFTYQLLKGIAFCHE-NRVLHRDLKPQNLLINKRG-ELKLADFGLARAFGI 152 (284)
T ss_pred EEecCCccHHHHHHhcCC-CCCcCHHHHHHHHHHHHHHHHHHHH-CCeeeCCCCHHHEEECCCC-cEEEeecchhhhhcC
Confidence 999999988776654321 3468999999999999999999999 8999999999999999887 699999999875433
Q ss_pred CC-CcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCCC
Q 016184 238 GE-PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 316 (394)
Q Consensus 238 ~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 316 (394)
.. ......++..|++||.+.+...++.++|+||||+++|+|++|+.||.+.+..+....+.+....+....+..+. ..
T Consensus 153 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~ 231 (284)
T cd07836 153 PVNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGIS-QL 231 (284)
T ss_pred CccccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHh-cC
Confidence 21 12234568889999998665567899999999999999999999999888888888887777777665543322 11
Q ss_pred cc--cCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 016184 317 TE--FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368 (394)
Q Consensus 317 ~~--~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f 368 (394)
.. ..++....... ..+...++..+.++|.+||+.||.+||++.++++||||
T Consensus 232 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f 284 (284)
T cd07836 232 PEYKPTFPRYPPQDL-QQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284 (284)
T ss_pred chhcccccCCChHHH-HHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 11 11111111111 11223568899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-44 Score=332.89 Aligned_cols=257 Identities=27% Similarity=0.418 Sum_probs=203.7
Q ss_pred eEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccch-------hhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEE
Q 016184 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL 155 (394)
Q Consensus 83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 155 (394)
+|++.+.||+|+||.||++++..+++.||+|++.+.. ....+|..++..+.|++|+.+++++ ....+.
T Consensus 2 ~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~-----~~~~~~ 76 (331)
T cd05624 2 DFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAF-----QDENYL 76 (331)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEE-----EcCCEE
Confidence 5999999999999999999999999999999886421 2245688899999999999999888 334568
Q ss_pred EEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCccc
Q 016184 156 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV 234 (394)
Q Consensus 156 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~ 234 (394)
++||||+.+ +|..++... ...+++..++.++.|++.||+|||+ +||+||||||+|||++.++ .+||+|||++..
T Consensus 77 ~lv~Ey~~gg~L~~~l~~~---~~~l~~~~~~~~~~qi~~~L~~lH~-~~iiHrDlkp~Nill~~~~-~~kl~DfG~a~~ 151 (331)
T cd05624 77 YLVMDYYVGGDLLTLLSKF---EDRLPEDMARFYIAEMVLAIHSIHQ-LHYVHRDIKPDNVLLDMNG-HIRLADFGSCLK 151 (331)
T ss_pred EEEEeCCCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeccCchHHEEEcCCC-CEEEEeccceee
Confidence 899999975 676666532 3578999999999999999999999 8999999999999999887 699999999876
Q ss_pred cccCCCc--ccccccccccccccccCC----CCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhh
Q 016184 235 LVKGEPN--VSYICSRYYRAPELIFGA----TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 308 (394)
Q Consensus 235 ~~~~~~~--~~~~~t~~y~aPE~~~~~----~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~ 308 (394)
....... ....||+.|+|||++.+. ..++.++|||||||++|+|++|+.||...+..+.+..+......
T Consensus 152 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~----- 226 (331)
T cd05624 152 MNQDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEER----- 226 (331)
T ss_pred ccCCCceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCc-----
Confidence 5433221 234689999999998542 34788999999999999999999999887765555544331100
Q ss_pred hhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCC--CCCHHHHhcCCCCCCCCC
Q 016184 309 IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNL--RCTALEACVHPFFDELRD 373 (394)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~--Rpt~~ell~hp~f~~~~~ 373 (394)
..++. ....+++++++||.+||..++.+ |++++++++||||+....
T Consensus 227 ----------~~~p~---------~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~~~~ 274 (331)
T cd05624 227 ----------FQFPS---------HITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEGIDW 274 (331)
T ss_pred ----------ccCCC---------ccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcCCCcCCCCH
Confidence 00110 01346899999999999976655 569999999999998643
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-44 Score=332.48 Aligned_cols=245 Identities=28% Similarity=0.509 Sum_probs=192.4
Q ss_pred eEEeecCceEEEEEEECCCCcEEEEEEeccch-------hhhHHHHHHHHHc-CCCCeeeeceEEEecCCCceeEEEEEE
Q 016184 88 HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQML-DHPNIVALKHCFFSTTDKEELYLNLVL 159 (394)
Q Consensus 88 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~lv~ 159 (394)
+.||+|+||.||+|++..+++.||+|++.+.. ....+|..++..+ +||||+++++++. .....++||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~-----~~~~~~lv~ 75 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQ-----TESRLFFVI 75 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEE-----eCCEEEEEE
Confidence 46999999999999999999999999986532 2234677777766 8999999999883 334578999
Q ss_pred ecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCcccccc-
Q 016184 160 EYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK- 237 (394)
Q Consensus 160 e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~- 237 (394)
||+++ +|...+. ....+++..++.++.|++.||+|||+ +||+||||||+|||++.++ .+||+|||+++....
T Consensus 76 E~~~~~~L~~~~~----~~~~l~~~~~~~i~~qi~~~l~~lH~-~~ivH~Dikp~Nili~~~~-~~kL~DfG~~~~~~~~ 149 (329)
T cd05618 76 EYVNGGDLMFHMQ----RQRKLPEEHARFYSAEISLALNYLHE-RGIIYRDLKLDNVLLDSEG-HIKLTDYGMCKEGLRP 149 (329)
T ss_pred eCCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeCCCCHHHEEECCCC-CEEEeeCCccccccCC
Confidence 99986 5544333 24679999999999999999999999 8999999999999999888 699999999875322
Q ss_pred CCCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCc--------HHHHHHHHHHhCCCChhhh
Q 016184 238 GEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESG--------VDQLVEIIKVLGTPTREEI 309 (394)
Q Consensus 238 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~--------~~~~~~i~~~~~~~~~~~~ 309 (394)
........||+.|+|||++.+. .++.++|||||||++|+|++|+.||..... ...+......
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~--------- 219 (329)
T cd05618 150 GDTTSTFCGTPNYIAPEILRGE-DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILE--------- 219 (329)
T ss_pred CCccccccCCccccCHHHHcCC-CCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhc---------
Confidence 2233446789999999999654 489999999999999999999999953111 1111111110
Q ss_pred hccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCC------HHHHhcCCCCCCCC
Q 016184 310 KCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCT------ALEACVHPFFDELR 372 (394)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt------~~ell~hp~f~~~~ 372 (394)
... .++..++..+.+||++||+.||.+||| +.++++||||+++.
T Consensus 220 -------~~~------------~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~~~ 269 (329)
T cd05618 220 -------KQI------------RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVD 269 (329)
T ss_pred -------CCC------------CCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcCCCCCCCC
Confidence 000 123457889999999999999999998 57999999998864
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-43 Score=332.23 Aligned_cols=278 Identities=26% Similarity=0.429 Sum_probs=203.6
Q ss_pred eeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccch-----hhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEEE
Q 016184 82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN 156 (394)
Q Consensus 82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 156 (394)
++|++.+.||.|+||.||+|.+..++..+|+|.+.... ..+.+|+++++.++|+||+++++++.. ..+.+
T Consensus 5 ~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~~ 79 (333)
T cd06650 5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS-----DGEIS 79 (333)
T ss_pred hhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEE-----CCEEE
Confidence 46999999999999999999999999999999875431 335679999999999999999998843 33588
Q ss_pred EEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCcccc
Q 016184 157 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL 235 (394)
Q Consensus 157 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~ 235 (394)
+||||+.+ +|.+++.. ...+++..+..++.|++.||.|||+..+|+|+||||+|||++.++ .+||+|||++...
T Consensus 80 lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~-~~kL~Dfg~~~~~ 154 (333)
T cd06650 80 ICMEHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRG-EIKLCDFGVSGQL 154 (333)
T ss_pred EEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCC-CEEEeeCCcchhh
Confidence 99999975 77776653 356899999999999999999999734799999999999999887 6999999998755
Q ss_pred ccCCCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHH--hCCCChhhhhcc-
Q 016184 236 VKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV--LGTPTREEIKCM- 312 (394)
Q Consensus 236 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~- 312 (394)
... ......+++.|+|||++.+. .++.++|+|||||++|+|++|+.||......... .+... .+.+........
T Consensus 155 ~~~-~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 231 (333)
T cd06650 155 IDS-MANSFVGTRSYMSPERLQGT-HYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELE-LMFGCPVEGDPAESETSPRP 231 (333)
T ss_pred hhh-ccccCCCCccccCHHHhcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHH-HHhcCcccCCccccccCccc
Confidence 322 22345688999999999654 4899999999999999999999999765543222 11110 011100000000
Q ss_pred C------CCCcccCCCCC---------CCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 016184 313 N------PNYTEFKFPQI---------KPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR 372 (394)
Q Consensus 313 ~------~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 372 (394)
. ..+.....+.. ........-...++.++++||.+||++||++|||+.|+++||||+...
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~ 306 (333)
T cd06650 232 RPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSE 306 (333)
T ss_pred CCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcCc
Confidence 0 00000000000 000000000123678899999999999999999999999999998764
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-44 Score=334.87 Aligned_cols=244 Identities=30% Similarity=0.478 Sum_probs=198.4
Q ss_pred eEEeecCceEEEEEEE---CCCCcEEEEEEeccch------hhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEEEEE
Q 016184 88 HVVGTGSFGVVFQAKC---RETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLV 158 (394)
Q Consensus 88 ~~lg~G~~g~V~~~~~---~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv 158 (394)
+.||+|+||.||++++ ..+|+.||+|++.... ....+|+++++.++||||+++++++. .....++|
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~-----~~~~~~lv 76 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQ-----TEGKLYLI 76 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEE-----cCCEEEEE
Confidence 5799999999999986 3578999999986432 22346899999999999999998883 33457899
Q ss_pred Eecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCcccccc
Q 016184 159 LEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK 237 (394)
Q Consensus 159 ~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~ 237 (394)
|||+.+ +|.+.+.. ...+++..++.++.||+.||+|||+ .||+||||||+|||++.++ .+||+|||++.....
T Consensus 77 ~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~Nil~~~~~-~~kL~Dfg~~~~~~~ 150 (318)
T cd05582 77 LDFLRGGDLFTRLSK----EVMFTEEDVKFYLAELALALDHLHS-LGIIYRDLKPENILLDEEG-HIKLTDFGLSKESID 150 (318)
T ss_pred EcCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCEecCCCCHHHeEECCCC-cEEEeeccCCcccCC
Confidence 999975 66555432 3568999999999999999999999 8999999999999999887 699999999876543
Q ss_pred C-CCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCCC
Q 016184 238 G-EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 316 (394)
Q Consensus 238 ~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 316 (394)
. .......|++.|+|||.+.+. .++.++|||||||++|+|++|+.||.+.+....+..+....
T Consensus 151 ~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~--------------- 214 (318)
T cd05582 151 HEKKAYSFCGTVEYMAPEVVNRR-GHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAK--------------- 214 (318)
T ss_pred CCCceecccCChhhcCHHHHcCC-CCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCC---------------
Confidence 3 223345789999999998654 47899999999999999999999998877655555443310
Q ss_pred cccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCC-----HHHHhcCCCCCCCC
Q 016184 317 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCT-----ALEACVHPFFDELR 372 (394)
Q Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt-----~~ell~hp~f~~~~ 372 (394)
.. ++..+++++.+||++||+.||.+||| +.++++||||+.+.
T Consensus 215 --~~------------~p~~~~~~~~~li~~~l~~~P~~R~~a~~~~~~~~~~~~~~~~~~ 261 (318)
T cd05582 215 --LG------------MPQFLSPEAQSLLRALFKRNPANRLGAGPDGVEEIKRHPFFSTID 261 (318)
T ss_pred --CC------------CCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhCCCCcCCCC
Confidence 01 12357899999999999999999999 77899999998753
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=329.21 Aligned_cols=248 Identities=27% Similarity=0.446 Sum_probs=199.8
Q ss_pred EEEeeEEeecCceEEEEEEECCCCcEEEEEEeccch-------hhhHHHHHHHHHcCC-CCeeeeceEEEecCCCceeEE
Q 016184 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDH-PNIVALKHCFFSTTDKEELYL 155 (394)
Q Consensus 84 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~~~~~~~ 155 (394)
|.+.+.||+|+||.||+|+++.+|+.||+|++.+.. .....|..+++.+.| ++|+++.+++ .....+
T Consensus 2 f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~-----~~~~~~ 76 (323)
T cd05615 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCF-----QTVDRL 76 (323)
T ss_pred ceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEE-----ecCCEE
Confidence 788899999999999999999999999999886532 123457788888765 6677787776 233358
Q ss_pred EEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCccc
Q 016184 156 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV 234 (394)
Q Consensus 156 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~ 234 (394)
++||||+++ +|...+. ....+++..++.++.|++.||+|||+ +||+||||||+|||++.++ .+||+|||++..
T Consensus 77 ~lv~Ey~~~g~L~~~i~----~~~~l~~~~~~~i~~qi~~al~~lH~-~~ivHrDikp~Nill~~~~-~ikL~Dfg~~~~ 150 (323)
T cd05615 77 YFVMEYVNGGDLMYHIQ----QVGKFKEPQAVFYAAEISVGLFFLHR-RGIIYRDLKLDNVMLDSEG-HIKIADFGMCKE 150 (323)
T ss_pred EEEEcCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCCHHHeEECCCC-CEEEeccccccc
Confidence 899999985 5655443 23679999999999999999999999 8999999999999999888 699999999875
Q ss_pred cccCC-CcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccC
Q 016184 235 LVKGE-PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 313 (394)
Q Consensus 235 ~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 313 (394)
..... ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+.......+....
T Consensus 151 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~------------ 217 (323)
T cd05615 151 HMVDGVTTRTFCGTPDYIAPEIIAYQ-PYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHN------------ 217 (323)
T ss_pred cCCCCccccCccCCccccCHHHHcCC-CCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC------------
Confidence 43222 22345689999999998654 48999999999999999999999998877665555554311
Q ss_pred CCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCC-----HHHHhcCCCCCCCC
Q 016184 314 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCT-----ALEACVHPFFDELR 372 (394)
Q Consensus 314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt-----~~ell~hp~f~~~~ 372 (394)
.. ++..++.++.+|+.+||+.||.+|++ .+++++||||+.+.
T Consensus 218 -----~~------------~p~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~f~~~~ 264 (323)
T cd05615 218 -----VS------------YPKSLSKEAVSICKGLMTKHPSKRLGCGPEGERDIREHAFFRRID 264 (323)
T ss_pred -----CC------------CCccCCHHHHHHHHHHcccCHhhCCCCCCCCHHHHhcCcccCCCC
Confidence 01 12457889999999999999999997 57999999999874
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-43 Score=326.85 Aligned_cols=259 Identities=29% Similarity=0.496 Sum_probs=210.5
Q ss_pred eEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccch-------hhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEE
Q 016184 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL 155 (394)
Q Consensus 83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 155 (394)
+|++.+.||+|++|.||+|.+..+++.||+|.+.... ....+|+++++.++|+||+++++.+ ....+.
T Consensus 2 ~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~ 76 (316)
T cd05574 2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASF-----QTETYL 76 (316)
T ss_pred ceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeee-----ecCCEE
Confidence 5999999999999999999999999999999886432 2345689999999999999999887 334468
Q ss_pred EEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCccc
Q 016184 156 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV 234 (394)
Q Consensus 156 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~ 234 (394)
+++|||+.+ +|.+++... ....+++..++.++.|++.||+|||+ .|++|+||||+||+++.++ .++|+|||++..
T Consensus 77 ~lv~e~~~~~~L~~~~~~~--~~~~l~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~Nili~~~~-~~~l~dfg~~~~ 152 (316)
T cd05574 77 CLVMDYCPGGELFRLLQRQ--PGKCLSEEVARFYAAEVLLALEYLHL-LGIVYRDLKPENILLHESG-HIMLSDFDLSKQ 152 (316)
T ss_pred EEEEEecCCCCHHHHHHhC--CCCccCHHHHHHHHHHHHHHHHHHHH-CCeeccCCChHHeEEcCCC-CEEEeecchhhc
Confidence 899999875 777766532 23678999999999999999999999 8999999999999999887 699999999865
Q ss_pred cccCCC------------------------------cccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCC
Q 016184 235 LVKGEP------------------------------NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPL 284 (394)
Q Consensus 235 ~~~~~~------------------------------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~p 284 (394)
...... .....|+..|+|||++.+. .++.++||||||+++|+|++|..|
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Di~slG~ll~~l~~g~~p 231 (316)
T cd05574 153 SDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGD-GHGSAVDWWTLGILLYEMLYGTTP 231 (316)
T ss_pred ccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCC-CCCchHHHHHHHHHHHHHhhCCCC
Confidence 432211 1123568889999999654 479999999999999999999999
Q ss_pred CCCCCcHHHHHHHHHHhCCCChhhhhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCC----HH
Q 016184 285 FPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCT----AL 360 (394)
Q Consensus 285 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt----~~ 360 (394)
|.+.+....+..+.... ..++. ...++..++++|.+||+.||++||| ++
T Consensus 232 f~~~~~~~~~~~~~~~~-----------------~~~~~----------~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~ 284 (316)
T cd05574 232 FKGSNRDETFSNILKKE-----------------VTFPG----------SPPVSSSARDLIRKLLVKDPSKRLGSKRGAA 284 (316)
T ss_pred CCCCchHHHHHHHhcCC-----------------ccCCC----------ccccCHHHHHHHHHHccCCHhHCCCchhhHH
Confidence 98777665554443210 00000 0236899999999999999999999 99
Q ss_pred HHhcCCCCCCCCCCCCCC
Q 016184 361 EACVHPFFDELRDPNTRL 378 (394)
Q Consensus 361 ell~hp~f~~~~~~~~~~ 378 (394)
++|+||||+....+..++
T Consensus 285 ~ll~~~~~~~~~~~~~~~ 302 (316)
T cd05574 285 EIKQHPFFRGVNWALIRH 302 (316)
T ss_pred HHHcCchhhcCChhhccc
Confidence 999999999998888876
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-44 Score=333.77 Aligned_cols=244 Identities=28% Similarity=0.462 Sum_probs=194.1
Q ss_pred eEEeecCceEEEEEEECCCCcEEEEEEeccch-------hhhHHHH-HHHHHcCCCCeeeeceEEEecCCCceeEEEEEE
Q 016184 88 HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNREL-QIMQMLDHPNIVALKHCFFSTTDKEELYLNLVL 159 (394)
Q Consensus 88 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~-~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~ 159 (394)
+.||+|+||.||+|++..+|+.||+|++.+.. .....|. .+++.++||||+++++++. .....++||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~-----~~~~~~lv~ 75 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQ-----TTEKLYFVL 75 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEe-----cCCEEEEEE
Confidence 46999999999999999999999999986432 1122333 3567789999999988873 334578999
Q ss_pred ecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCcccccc-
Q 016184 160 EYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK- 237 (394)
Q Consensus 160 e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~- 237 (394)
||+++ ++...+. ....+++..++.++.||+.||+|||+ .||+||||||+|||++.++ .+||+|||++.....
T Consensus 76 e~~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~al~~lH~-~givH~Dlkp~NIll~~~~-~~kL~DfG~~~~~~~~ 149 (325)
T cd05604 76 DFVNGGELFFHLQ----RERSFPEPRARFYAAEIASALGYLHS-INIVYRDLKPENILLDSQG-HVVLTDFGLCKEGIAQ 149 (325)
T ss_pred cCCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCCHHHeEECCCC-CEEEeecCCcccCCCC
Confidence 99986 5544333 24678999999999999999999999 8999999999999999888 699999999875322
Q ss_pred CCCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCCCc
Q 016184 238 GEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 317 (394)
Q Consensus 238 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 317 (394)
........||+.|+|||++.+. .++.++|||||||++|+|++|..||...+..+....+....
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~---------------- 212 (325)
T cd05604 150 SDTTTTFCGTPEYLAPEVIRKQ-PYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKP---------------- 212 (325)
T ss_pred CCCcccccCChhhCCHHHHcCC-CCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCC----------------
Confidence 2223445689999999999654 48999999999999999999999998876555544443210
Q ss_pred ccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCH----HHHhcCCCCCCCC
Q 016184 318 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTA----LEACVHPFFDELR 372 (394)
Q Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~----~ell~hp~f~~~~ 372 (394)
. .+....+..+.++|++||+.||.+||++ .++++||||+...
T Consensus 213 -~------------~~~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i~~h~~f~~~~ 258 (325)
T cd05604 213 -L------------VLRPGASLTAWSILEELLEKDRQRRLGAKEDFLEIQEHPFFESLS 258 (325)
T ss_pred -c------------cCCCCCCHHHHHHHHHHhccCHHhcCCCCCCHHHHhcCCCcCCCC
Confidence 0 0113578899999999999999999977 5999999998764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=319.14 Aligned_cols=277 Identities=36% Similarity=0.621 Sum_probs=209.6
Q ss_pred eeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccch-----hhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEEE
Q 016184 82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN 156 (394)
Q Consensus 82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 156 (394)
.+|++.+.||+|+||.||+|.+..+|+.||+|++.... ....+|+.+++.++|+||+++.+++. .....+
T Consensus 5 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~-----~~~~~~ 79 (291)
T cd07870 5 TSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIH-----TKETLT 79 (291)
T ss_pred ceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEe-----cCCeEE
Confidence 46999999999999999999999999999999885432 23457999999999999999999873 334578
Q ss_pred EEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCccccc
Q 016184 157 LVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV 236 (394)
Q Consensus 157 lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~ 236 (394)
+||||+.+++...+.. ....+++..++.++.|++.||+|||+ .||+|+||||+|||++.++ .++|+|||+++...
T Consensus 80 lv~e~~~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~-~~i~H~dlkp~Nil~~~~~-~~~l~Dfg~~~~~~ 154 (291)
T cd07870 80 FVFEYMHTDLAQYMIQ---HPGGLHPYNVRLFMFQLLRGLAYIHG-QHILHRDLKPQNLLISYLG-ELKLADFGLARAKS 154 (291)
T ss_pred EEEecccCCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCChHHEEEcCCC-cEEEeccccccccC
Confidence 9999999877655432 22457888899999999999999999 8999999999999999887 79999999987543
Q ss_pred cCC-CcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCc-HHHHHHHHHHhCCCChhhhhccC-
Q 016184 237 KGE-PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESG-VDQLVEIIKVLGTPTREEIKCMN- 313 (394)
Q Consensus 237 ~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~~- 313 (394)
... ......+++.|+|||.+.+...++.++|+||||+++|+|++|..||.+... .+.+..+....+.+.........
T Consensus 155 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (291)
T cd07870 155 IPSQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSK 234 (291)
T ss_pred CCCCCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhh
Confidence 221 223345688999999986655578899999999999999999999986543 35566666666666655433221
Q ss_pred -CCCcccCCCCCCCCCcchhcc-ccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 016184 314 -PNYTEFKFPQIKPHPWHKVFQ-KRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368 (394)
Q Consensus 314 -~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f 368 (394)
+.+.................. -..+..+.+++.+||+.||.+|||+.+++.||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~ 291 (291)
T cd07870 235 LPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291 (291)
T ss_pred cccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence 111111111110111100000 1236789999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=331.73 Aligned_cols=298 Identities=35% Similarity=0.661 Sum_probs=232.5
Q ss_pred eeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccc------hhhhHHHHHHHHHc-CCCCeeeeceEEEecCCCceeE
Q 016184 82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQML-DHPNIVALKHCFFSTTDKEELY 154 (394)
Q Consensus 82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~ 154 (394)
.+|++.+.||+|+||.||+|.+..+|+.+|+|++... .....+|+.+++.+ +|+||+++++++.. .....
T Consensus 7 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~---~~~~~ 83 (337)
T cd07852 7 RKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKA---ENDKD 83 (337)
T ss_pred hHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeecc---CCCce
Confidence 4599999999999999999999989999999987432 22344699999999 99999999998732 22345
Q ss_pred EEEEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCccc
Q 016184 155 LNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV 234 (394)
Q Consensus 155 ~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~ 234 (394)
.++||||+++++...+.. ..+++..++.++.|++.||.|||+ .||+|+||||+||+++.++ .+||+|||.+..
T Consensus 84 ~~lv~e~~~~~L~~~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~-~~i~H~dl~p~nill~~~~-~~kl~d~g~~~~ 156 (337)
T cd07852 84 IYLVFEYMETDLHAVIRA-----NILEDVHKRYIMYQLLKALKYIHS-GNVIHRDLKPSNILLNSDC-RVKLADFGLARS 156 (337)
T ss_pred EEEEecccccCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEEcCCC-cEEEeeccchhc
Confidence 789999999877665543 367888889999999999999999 8999999999999999988 699999999876
Q ss_pred cccCC------CcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhh
Q 016184 235 LVKGE------PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 308 (394)
Q Consensus 235 ~~~~~------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~ 308 (394)
..... ......+++.|+|||.+.+...++.++|+||||+++|+|++|+.||.+....+....+....+.+....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 236 (337)
T cd07852 157 LSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAED 236 (337)
T ss_pred cccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Confidence 54332 122345788999999886656688999999999999999999999998888888888888777766654
Q ss_pred hhccCCCCcccC---CCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCCCCCCCCCCC
Q 016184 309 IKCMNPNYTEFK---FPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPNGRPLP 385 (394)
Q Consensus 309 ~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~~~~~~~~~~ 385 (394)
+..+........ ............+ ..++.++.+||.+||+.||++|||+.++++||||+....++.......+..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~~~~~~~~~~~~~~~ 315 (337)
T cd07852 237 IESIKSPFAATMLDSLPSRPRKPLDELL-PKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQFHNPSDEPVLPYPIT 315 (337)
T ss_pred HHHHHhhhHHHhhhhcccccccchhhhc-cCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhhccCCCCCCCCCCcc
Confidence 443321111100 1111111111222 347899999999999999999999999999999999988877766666655
Q ss_pred CCCCC
Q 016184 386 PLFNF 390 (394)
Q Consensus 386 ~~~~~ 390 (394)
++|..
T Consensus 316 ~~~~~ 320 (337)
T cd07852 316 IPLDD 320 (337)
T ss_pred CCccc
Confidence 66653
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-43 Score=328.04 Aligned_cols=297 Identities=34% Similarity=0.575 Sum_probs=229.3
Q ss_pred eEEEeeEEeecCceEEEEEEECCC--CcEEEEEEeccc------hhhhHHHHHHHHHc-CCCCeeeeceEEEecCCCcee
Q 016184 83 SYIAEHVVGTGSFGVVFQAKCRET--GEIVAIKKVLQD------KRYKNRELQIMQML-DHPNIVALKHCFFSTTDKEEL 153 (394)
Q Consensus 83 ~y~~~~~lg~G~~g~V~~~~~~~~--~~~vaiK~~~~~------~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~ 153 (394)
+|++.+.||+|+||.||+|++..+ +..||+|.+... .....+|+++++.+ .|+||+++++...... ....
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~-~~~~ 79 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFP-GNFN 79 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeecc-ccCC
Confidence 489999999999999999999888 899999987542 12345689999998 5999999988654322 2234
Q ss_pred EEEEEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCcc
Q 016184 154 YLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK 233 (394)
Q Consensus 154 ~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~ 233 (394)
..++++++++++|...+.. ...+++..++.++.||+.||+|||+ .||+||||||+||+++.++ .++|+|||.+.
T Consensus 80 ~~~~~~e~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~-~givH~dlkp~Nili~~~~-~~kl~Dfg~a~ 153 (332)
T cd07857 80 ELYLYEELMEADLHQIIRS----GQPLTDAHFQSFIYQILCGLKYIHS-ANVLHRDLKPGNLLVNADC-ELKICDFGLAR 153 (332)
T ss_pred cEEEEEecccCCHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHHeEEcCCC-CEEeCcCCCce
Confidence 4678999999887766543 4678999999999999999999999 8999999999999999887 69999999987
Q ss_pred ccccCCC-----cccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhh
Q 016184 234 VLVKGEP-----NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 308 (394)
Q Consensus 234 ~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~ 308 (394)
....... .....+++.|+|||.+.+...++.++|+||||+++|+|++|..||.+.+....+..+...++.++.+.
T Consensus 154 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 233 (332)
T cd07857 154 GFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEET 233 (332)
T ss_pred ecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 6532211 22346788999999886655589999999999999999999999998888888899999888877765
Q ss_pred hhccCCCCcc---cCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCCCCCCCCCCC
Q 016184 309 IKCMNPNYTE---FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPNGRPLP 385 (394)
Q Consensus 309 ~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~~~~~~~~~~ 385 (394)
+..+...... ..........+.. .....+..+.+|+.+||+.||.+|||+.+++.||||++.+++....-+..+-+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~~~~~~~~~~~~~~~ 312 (332)
T cd07857 234 LSRIGSPKAQNYIRSLPNIPKKPFES-IFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIWHDPDDEPVCQKPFD 312 (332)
T ss_pred HHhhhhhhHHHHHHhccccCCcchHh-hCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhhcCcccccccccccc
Confidence 4433211000 0011111111111 12346889999999999999999999999999999999988766555544443
Q ss_pred CC
Q 016184 386 PL 387 (394)
Q Consensus 386 ~~ 387 (394)
+.
T Consensus 313 ~~ 314 (332)
T cd07857 313 FS 314 (332)
T ss_pred CC
Confidence 33
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-43 Score=320.59 Aligned_cols=275 Identities=35% Similarity=0.628 Sum_probs=215.2
Q ss_pred EEEeeEEeecCceEEEEEEECCCCcEEEEEEeccch------hhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEEEE
Q 016184 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL 157 (394)
Q Consensus 84 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 157 (394)
|++.+.||.|++|.||+|.+..+|+.||+|++.... ....+|+++++.++|+|++++++++. ...+.++
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~-----~~~~~~i 75 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVH-----SENKLYL 75 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheec-----cCCeEEE
Confidence 677899999999999999999999999999875432 23457999999999999999999883 3356889
Q ss_pred EEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCcccccc
Q 016184 158 VLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK 237 (394)
Q Consensus 158 v~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~ 237 (394)
+|||+++++..++..... ..+++..+..++.|++.||+|||+ .+++|+||+|+||+++.++ .++|+|||++.....
T Consensus 76 v~e~~~~~l~~~~~~~~~--~~~~~~~~~~~~~~i~~~L~~lH~-~~~~H~dl~p~nil~~~~~-~~~l~df~~~~~~~~ 151 (283)
T cd07835 76 VFEFLDLDLKKYMDSSPL--TGLDPPLIKSYLYQLLQGIAYCHS-HRVLHRDLKPQNLLIDREG-ALKLADFGLARAFGV 151 (283)
T ss_pred EEeccCcCHHHHHhhCCC--CCCCHHHHHHHHHHHHHHHHHHHH-CCeeCCCCCHHHEEEcCCC-cEEEeecccccccCC
Confidence 999998887776654221 468999999999999999999999 8999999999999999877 799999999875432
Q ss_pred CC-CcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCCC
Q 016184 238 GE-PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 316 (394)
Q Consensus 238 ~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 316 (394)
.. ......+++.|+|||++.+...++.++|+||||+++|+|++|+.||...+....+..+.+..+.+....+.......
T Consensus 152 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (283)
T cd07835 152 PVRTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLP 231 (283)
T ss_pred CccccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhch
Confidence 22 11233457889999988665557899999999999999999999999888877777887777776655442211000
Q ss_pred c-ccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 016184 317 T-EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368 (394)
Q Consensus 317 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f 368 (394)
. ...++....... ......++.++.++|.+||+.||.+|||+++++.||||
T Consensus 232 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~ 283 (283)
T cd07835 232 DYKPTFPKWARQDL-SKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283 (283)
T ss_pred hhhhhcccccccch-hhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence 0 001111111111 11234678899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-45 Score=341.67 Aligned_cols=255 Identities=24% Similarity=0.375 Sum_probs=210.9
Q ss_pred eEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccc-hh---hhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEEEEE
Q 016184 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-KR---YKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLV 158 (394)
Q Consensus 83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~---~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv 158 (394)
-|.|+..||.|+||.||+|..+.++-..|.|++... .. ...-|++||..+.||+||++++.|+..+. ++|+
T Consensus 33 ~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enk-----Lwil 107 (1187)
T KOG0579|consen 33 HWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENK-----LWIL 107 (1187)
T ss_pred HHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCc-----eEEE
Confidence 489999999999999999999999988999987532 22 22358999999999999999999865444 8899
Q ss_pred EecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCccccc-c
Q 016184 159 LEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV-K 237 (394)
Q Consensus 159 ~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~-~ 237 (394)
.|||+|+..+.+. ......+.+..+..+++|++.||.|||+ ++|||||||..|||++.+| .++|+|||.+.... .
T Consensus 108 iEFC~GGAVDaim--lEL~r~LtE~QIqvvc~q~ldALn~LHs-~~iIHRDLKAGNiL~TldG-dirLADFGVSAKn~~t 183 (1187)
T KOG0579|consen 108 IEFCGGGAVDAIM--LELGRVLTEDQIQVVCYQVLDALNWLHS-QNIIHRDLKAGNILLTLDG-DIRLADFGVSAKNKST 183 (1187)
T ss_pred EeecCCchHhHHH--HHhccccchHHHHHHHHHHHHHHHHHhh-cchhhhhccccceEEEecC-cEeeecccccccchhH
Confidence 9999986544433 2345889999999999999999999999 8999999999999999999 69999999875432 2
Q ss_pred CCCccccccccccccccccc----CCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccC
Q 016184 238 GEPNVSYICSRYYRAPELIF----GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 313 (394)
Q Consensus 238 ~~~~~~~~~t~~y~aPE~~~----~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 313 (394)
.....++.|||+|||||++. ...+|+.++||||||++|.+|..+.+|-...+.+..+..+... .|
T Consensus 184 ~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKS--eP--------- 252 (1187)
T KOG0579|consen 184 RQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKS--EP--------- 252 (1187)
T ss_pred HhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhc--CC---------
Confidence 23345789999999999974 3456999999999999999999999999988888777766541 11
Q ss_pred CCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 016184 314 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR 372 (394)
Q Consensus 314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 372 (394)
-.-+.+...+..+.||+.+||.+||..||++.+||+||||+++.
T Consensus 253 ---------------PTLlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~~~~ 296 (1187)
T KOG0579|consen 253 ---------------PTLLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKHPFVQNAP 296 (1187)
T ss_pred ---------------CcccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhCcccccCC
Confidence 11112345678899999999999999999999999999998753
|
|
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-44 Score=334.62 Aligned_cols=244 Identities=28% Similarity=0.485 Sum_probs=193.7
Q ss_pred EeecCceEEEEEEECCCCcEEEEEEeccchhh-------hHHHHHHHHHc---CCCCeeeeceEEEecCCCceeEEEEEE
Q 016184 90 VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRY-------KNRELQIMQML---DHPNIVALKHCFFSTTDKEELYLNLVL 159 (394)
Q Consensus 90 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-------~~~E~~~l~~l---~h~~iv~~~~~~~~~~~~~~~~~~lv~ 159 (394)
||+|+||+||+|++..+|+.||||++.+.... ...|..++..+ .||||+.++.++ ......++||
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~-----~~~~~~~lv~ 75 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSF-----QTDSDLYLVT 75 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEE-----ecCCeEEEEE
Confidence 69999999999999999999999998643211 12355566554 799999999888 3334588999
Q ss_pred ecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCccccccC
Q 016184 160 EYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG 238 (394)
Q Consensus 160 e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~~ 238 (394)
||+.+ +|...+.. ...+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .++|+|||++......
T Consensus 76 e~~~~g~L~~~l~~----~~~~~~~~~~~~~~qil~al~~LH~-~~ivHrDlkp~Nili~~~~-~~kl~Dfg~a~~~~~~ 149 (330)
T cd05586 76 DYMSGGELFWHLQK----EGRFSEDRAKFYIAELVLALEHLHK-YDIVYRDLKPENILLDATG-HIALCDFGLSKANLTD 149 (330)
T ss_pred cCCCCChHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeEeccCCHHHeEECCCC-CEEEecCCcCcCCCCC
Confidence 99985 55544432 4678999999999999999999999 8999999999999999887 6999999998754332
Q ss_pred -CCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCCCc
Q 016184 239 -EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 317 (394)
Q Consensus 239 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 317 (394)
.......||+.|+|||++.+...++.++|||||||++|+|++|..||.+.+..+.+..+...
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~----------------- 212 (330)
T cd05586 150 NKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFG----------------- 212 (330)
T ss_pred CCCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcC-----------------
Confidence 22334568999999999876555899999999999999999999999877655544443221
Q ss_pred ccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCC----CHHHHhcCCCCCCCC
Q 016184 318 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC----TALEACVHPFFDELR 372 (394)
Q Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp----t~~ell~hp~f~~~~ 372 (394)
...++ ...+++++.+||++||+.||.+|| ++.++++||||++..
T Consensus 213 ~~~~~-----------~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h~~~~~~~ 260 (330)
T cd05586 213 KVRFP-----------KNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEHPFFADID 260 (330)
T ss_pred CCCCC-----------CccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcCccccCCC
Confidence 01111 124688999999999999999998 799999999998754
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-43 Score=321.58 Aligned_cols=260 Identities=26% Similarity=0.395 Sum_probs=204.9
Q ss_pred eEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccch-----hhhHHHHH-HHHHcCCCCeeeeceEEEecCCCceeEEE
Q 016184 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQ-IMQMLDHPNIVALKHCFFSTTDKEELYLN 156 (394)
Q Consensus 83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~-~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 156 (394)
+|++.+.||+|+||.||+|++..+|+.||||++.... .....|.. .++.+.|+||+++++++... ...+
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~-----~~~~ 76 (283)
T cd06617 2 DLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFRE-----GDVW 76 (283)
T ss_pred CceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecC-----CcEE
Confidence 5999999999999999999999999999999886432 12223444 46677999999999988432 3378
Q ss_pred EEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC-CceeccCCCCceEEeCCCCcEEEEeecCcccc
Q 016184 157 LVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI-GICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL 235 (394)
Q Consensus 157 lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~-givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~ 235 (394)
++|||+++++.+++.........+++..++.++.|++.||+|||+ + +++||||||+||+++.++ .+||+|||++...
T Consensus 77 lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~~i~h~dlkp~nil~~~~~-~~kl~dfg~~~~~ 154 (283)
T cd06617 77 ICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHS-KLSVIHRDVKPSNVLINRNG-QVKLCDFGISGYL 154 (283)
T ss_pred EEhhhhcccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhh-cCCeecCCCCHHHEEECCCC-CEEEeeccccccc
Confidence 999999998888877655445679999999999999999999998 6 999999999999999887 7999999998765
Q ss_pred ccCCCcccccccccccccccccCC---CCCCChhhHHHHHHHHHHHHhCCCCCCCCC-cHHHHHHHHHHhCCCChhhhhc
Q 016184 236 VKGEPNVSYICSRYYRAPELIFGA---TEYTTAIDIWSTGCVMAELLLGQPLFPGES-GVDQLVEIIKVLGTPTREEIKC 311 (394)
Q Consensus 236 ~~~~~~~~~~~t~~y~aPE~~~~~---~~~~~~~DiwslG~il~~lltg~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~ 311 (394)
..........++..|+|||.+.+. ..++.++|+|||||++|+|++|+.||.... ..+.+..+.... .
T Consensus 155 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~---~------ 225 (283)
T cd06617 155 VDSVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEP---S------ 225 (283)
T ss_pred ccccccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcC---C------
Confidence 433333335678889999988542 336889999999999999999999996532 223333322210 0
Q ss_pred cCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCC
Q 016184 312 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNT 376 (394)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~ 376 (394)
..+ ....++.++.+||.+||..||.+||++.++++||||++......
T Consensus 226 -------~~~-----------~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~~~ 272 (283)
T cd06617 226 -------PQL-----------PAEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELHLSKNT 272 (283)
T ss_pred -------CCC-----------CccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhhhcccccH
Confidence 000 01346889999999999999999999999999999999865543
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=330.22 Aligned_cols=245 Identities=28% Similarity=0.444 Sum_probs=193.6
Q ss_pred eEEeecCceEEEEEEECCCCcEEEEEEeccchh-------hhHHHH-HHHHHcCCCCeeeeceEEEecCCCceeEEEEEE
Q 016184 88 HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-------YKNREL-QIMQMLDHPNIVALKHCFFSTTDKEELYLNLVL 159 (394)
Q Consensus 88 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-------~~~~E~-~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~ 159 (394)
++||+|+||.||+|++..+|+.||+|++.+... ...+|. .+++.++||||+++++++ ......++||
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~-----~~~~~~~lv~ 75 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSF-----QTAEKLYFVL 75 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEE-----EcCCEEEEEE
Confidence 469999999999999999999999999864321 122333 467889999999998887 3334578999
Q ss_pred ecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCcccccc-
Q 016184 160 EYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK- 237 (394)
Q Consensus 160 e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~- 237 (394)
||+++ +|...+. ....+++..++.++.||+.||.|||+ .||+||||||+|||++.++ .+||+|||++.....
T Consensus 76 e~~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~~L~~lH~-~~ivH~Dlkp~NIll~~~~-~~kl~Dfg~~~~~~~~ 149 (321)
T cd05603 76 DYVNGGELFFHLQ----RERCFLEPRARFYAAEVASAIGYLHS-LNIIYRDLKPENILLDSQG-HVVLTDFGLCKEGVEP 149 (321)
T ss_pred cCCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEeccCCHHHeEECCCC-CEEEccCCCCccCCCC
Confidence 99986 5544333 24678999999999999999999999 8999999999999999888 699999999875322
Q ss_pred CCCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCCCc
Q 016184 238 GEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 317 (394)
Q Consensus 238 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 317 (394)
........+|+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+.......+... +
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~---~------------- 212 (321)
T cd05603 150 EETTSTFCGTPEYLAPEVLRKE-PYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHK---P------------- 212 (321)
T ss_pred CCccccccCCcccCCHHHhcCC-CCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcC---C-------------
Confidence 2223345689999999998654 4899999999999999999999999887655444443321 0
Q ss_pred ccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCH----HHHhcCCCCCCCCC
Q 016184 318 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTA----LEACVHPFFDELRD 373 (394)
Q Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~----~ell~hp~f~~~~~ 373 (394)
.. ++...+..+.++|.+||+.||.+|+++ .++++||||..+..
T Consensus 213 -~~------------~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~~~~~~~~~ 259 (321)
T cd05603 213 -LQ------------LPGGKTVAACDLLVGLLHKDQRRRLGAKADFLEIKNHVFFSPINW 259 (321)
T ss_pred -CC------------CCCCCCHHHHHHHHHHccCCHhhcCCCCCCHHHHhCCCCcCCCCH
Confidence 00 123568899999999999999999976 49999999987543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=330.43 Aligned_cols=244 Identities=25% Similarity=0.431 Sum_probs=194.9
Q ss_pred eEEeecCceEEEEEEECCCCcEEEEEEeccchh-------hhHHH-HHHHHHcCCCCeeeeceEEEecCCCceeEEEEEE
Q 016184 88 HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-------YKNRE-LQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVL 159 (394)
Q Consensus 88 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-------~~~~E-~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~ 159 (394)
+.||+|+||.||+|++..+++.||+|++.+... ...+| ..+++.++|+||+++++++. .....++||
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~-----~~~~~~lv~ 75 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQ-----TADKLYFVL 75 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEE-----cCCeEEEEE
Confidence 369999999999999999999999999864321 11123 33567789999999988873 334578999
Q ss_pred ecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCcccccc-
Q 016184 160 EYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK- 237 (394)
Q Consensus 160 e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~- 237 (394)
||+.+ ++...+.. ...+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||++.....
T Consensus 76 e~~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~L~~lH~-~giiHrDlkp~Nili~~~~-~~kl~DfG~a~~~~~~ 149 (325)
T cd05602 76 DYINGGELFYHLQR----ERCFLEPRARFYAAEIASALGYLHS-LNIVYRDLKPENILLDSQG-HIVLTDFGLCKENIEH 149 (325)
T ss_pred eCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeEecCCCHHHeEECCCC-CEEEccCCCCcccccC
Confidence 99986 56554443 3668899999999999999999999 8999999999999999888 699999999875432
Q ss_pred CCCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCCCc
Q 016184 238 GEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 317 (394)
Q Consensus 238 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 317 (394)
........||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+.+..+....
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~---------------- 212 (325)
T cd05602 150 NGTTSTFCGTPEYLAPEVLHKQ-PYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKP---------------- 212 (325)
T ss_pred CCCcccccCCccccCHHHHcCC-CCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCC----------------
Confidence 2223445789999999999654 48999999999999999999999998877655555443310
Q ss_pred ccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHH----HHhcCCCCCCCC
Q 016184 318 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTAL----EACVHPFFDELR 372 (394)
Q Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~----ell~hp~f~~~~ 372 (394)
. .+...++..+.++|.+||+.||.+|+++. ++++|+||....
T Consensus 213 -~------------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i~~~~~~~~~~ 258 (325)
T cd05602 213 -L------------QLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKNHIFFSPIN 258 (325)
T ss_pred -c------------CCCCCCCHHHHHHHHHHcccCHHHCCCCCCCHHHHhcCcccCCCC
Confidence 0 01245789999999999999999999876 899999997753
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-44 Score=310.27 Aligned_cols=270 Identities=24% Similarity=0.432 Sum_probs=210.4
Q ss_pred eEEE-eeEEeecCceEEEEEEECCCCcEEEEEEeccc----hhhhHHHHHHHHHc-CCCCeeeeceEEEecCCCceeEEE
Q 016184 83 SYIA-EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD----KRYKNRELQIMQML-DHPNIVALKHCFFSTTDKEELYLN 156 (394)
Q Consensus 83 ~y~~-~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~ 156 (394)
-|.+ .+.||+|+|+.|--+....+|..||||++.+. +....+|++++.+. .|+||++++++| .++..+|
T Consensus 78 ~YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefF-----Edd~~FY 152 (463)
T KOG0607|consen 78 MYKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFF-----EDDTRFY 152 (463)
T ss_pred HHHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHh-----cccceEE
Confidence 3554 46799999999999999999999999999764 33445899999888 699999999998 4444478
Q ss_pred EEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCC--cEEEEeecCcc
Q 016184 157 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTH--QLKLCDFGSAK 233 (394)
Q Consensus 157 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~--~vkl~Dfg~a~ 233 (394)
+|||-|.| .+...+. ..+.+++.++.++..+|+.||.|||. +||.||||||+|||...... -||||||.+..
T Consensus 153 LVfEKm~GGplLshI~----~~~~F~E~EAs~vvkdia~aLdFlH~-kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgS 227 (463)
T KOG0607|consen 153 LVFEKMRGGPLLSHIQ----KRKHFNEREASRVVKDIASALDFLHT-KGIAHRDLKPENILCESPNKVSPVKICDFDLGS 227 (463)
T ss_pred EEEecccCchHHHHHH----HhhhccHHHHHHHHHHHHHHHHHHhh-cCcccccCCccceeecCCCCcCceeeecccccc
Confidence 99999986 4433333 24789999999999999999999999 99999999999999864322 49999999875
Q ss_pred ccccC--------CCccccccccccccccccc----CCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcH----------
Q 016184 234 VLVKG--------EPNVSYICSRYYRAPELIF----GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGV---------- 291 (394)
Q Consensus 234 ~~~~~--------~~~~~~~~t~~y~aPE~~~----~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~---------- 291 (394)
-+... ....+.+|+..|||||++. ....|+.++|.||||||+|.|++|.+||.+..+.
T Consensus 228 g~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~C 307 (463)
T KOG0607|consen 228 GIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVC 307 (463)
T ss_pred ccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCcc
Confidence 44222 1223456788899999972 2334899999999999999999999999875321
Q ss_pred -----HHHHHHHHHhCCCChhhhhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCC
Q 016184 292 -----DQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHP 366 (394)
Q Consensus 292 -----~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp 366 (394)
..+..|.. ..+.+|. ..| ..+|.++++||+.+|.+|+..|.++.++++||
T Consensus 308 r~CQ~~LFesIQE-----------------GkYeFPd---kdW-----ahIS~eakdlisnLlvrda~~rlsa~~vlnhP 362 (463)
T KOG0607|consen 308 RVCQNKLFESIQE-----------------GKYEFPD---KDW-----AHISSEAKDLISNLLVRDAKQRLSAAQVLNHP 362 (463)
T ss_pred HHHHHHHHHHHhc-----------------cCCcCCh---hhh-----HHhhHHHHHHHHHHHhccHHhhhhhhhccCCc
Confidence 12223322 2233332 122 46899999999999999999999999999999
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCC
Q 016184 367 FFDELRDPNTRLPNGRPLPPLFNFKP 392 (394)
Q Consensus 367 ~f~~~~~~~~~~~~~~~~~~~~~~~~ 392 (394)
|++..... ++.++|+.++..+
T Consensus 363 w~~~~~~e-----kalptp~v~~r~~ 383 (463)
T KOG0607|consen 363 WVQRCAPE-----KALPTPQVLQRNS 383 (463)
T ss_pred cccccchh-----ccCCCCcccccCc
Confidence 99887544 7788888887754
|
|
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-45 Score=338.37 Aligned_cols=253 Identities=28% Similarity=0.448 Sum_probs=217.5
Q ss_pred eEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccch-------hhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEE
Q 016184 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL 155 (394)
Q Consensus 83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 155 (394)
.|.=++.||.|+||.||.|++..+.+.||||++.-.. ..+-+|+..|+++.|||++.+.+||+.... .
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~T-----a 101 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHT-----A 101 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccch-----H
Confidence 3777889999999999999999999999999985321 234479999999999999999999965554 7
Q ss_pred EEEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCcccc
Q 016184 156 NLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL 235 (394)
Q Consensus 156 ~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~ 235 (394)
++|||||-|+-.+++..+. +++.+.++..|+.+.+.||+|||+ ++.||||||..|||++..| .|||+|||.|...
T Consensus 102 WLVMEYClGSAsDlleVhk---KplqEvEIAAi~~gaL~gLaYLHS-~~~IHRDiKAGNILLse~g-~VKLaDFGSAsi~ 176 (948)
T KOG0577|consen 102 WLVMEYCLGSASDLLEVHK---KPLQEVEIAAITHGALQGLAYLHS-HNRIHRDIKAGNILLSEPG-LVKLADFGSASIM 176 (948)
T ss_pred HHHHHHHhccHHHHHHHHh---ccchHHHHHHHHHHHHHHHHHHHH-hhHHhhhccccceEecCCC-eeeeccccchhhc
Confidence 8999999999999888765 789999999999999999999999 9999999999999999888 7999999999765
Q ss_pred ccCCCcccccccccccccccccC--CCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccC
Q 016184 236 VKGEPNVSYICSRYYRAPELIFG--ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 313 (394)
Q Consensus 236 ~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 313 (394)
. +..+++|||+|||||++.. ...|+-++||||||++..||.-.++|+...+.+..+..|.+.-.
T Consensus 177 ~---PAnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNes----------- 242 (948)
T KOG0577|consen 177 A---PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNES----------- 242 (948)
T ss_pred C---chhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCC-----------
Confidence 3 4457899999999999853 44599999999999999999999999999999988888876321
Q ss_pred CCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCC
Q 016184 314 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 375 (394)
Q Consensus 314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~ 375 (394)
|.+. ....|..++.|+..||++-|.+|||.+++|+|+|...-+-++
T Consensus 243 --------PtLq--------s~eWS~~F~~Fvd~CLqKipqeRptse~ll~H~fv~R~Rp~t 288 (948)
T KOG0577|consen 243 --------PTLQ--------SNEWSDYFRNFVDSCLQKIPQERPTSEELLKHRFVLRERPPT 288 (948)
T ss_pred --------CCCC--------CchhHHHHHHHHHHHHhhCcccCCcHHHHhhcchhccCCCch
Confidence 1111 133477899999999999999999999999999998765544
|
|
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-43 Score=326.96 Aligned_cols=276 Identities=36% Similarity=0.576 Sum_probs=216.1
Q ss_pred eEE-EeeEEeecCceEEEEEEECCCCcEEEEEEeccchh------------------hhHHHHHHHHHcCCCCeeeeceE
Q 016184 83 SYI-AEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR------------------YKNRELQIMQMLDHPNIVALKHC 143 (394)
Q Consensus 83 ~y~-~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~------------------~~~~E~~~l~~l~h~~iv~~~~~ 143 (394)
+|. +.+.||.|+||.||+|++..+++.||||++..... ...+|+++++.++|+||++++++
T Consensus 9 ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 88 (335)
T PTZ00024 9 RYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDV 88 (335)
T ss_pred chhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEE
Confidence 465 45789999999999999999999999998754321 24579999999999999999998
Q ss_pred EEecCCCceeEEEEEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCc
Q 016184 144 FFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQ 223 (394)
Q Consensus 144 ~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~ 223 (394)
+. ...+.+++|||+.+++.+.+.. ...+++..+..++.|++.||+|||+ .|++|+||+|+||+++.++ .
T Consensus 89 ~~-----~~~~~~lv~e~~~~~l~~~l~~----~~~~~~~~~~~~~~ql~~aL~~LH~-~~i~H~dl~~~nill~~~~-~ 157 (335)
T PTZ00024 89 YV-----EGDFINLVMDIMASDLKKVVDR----KIRLTESQVKCILLQILNGLNVLHK-WYFMHRDLSPANIFINSKG-I 157 (335)
T ss_pred Ee-----cCCcEEEEEeccccCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeecccccHHHeEECCCC-C
Confidence 83 3345889999999888776653 3568999999999999999999999 8999999999999999887 7
Q ss_pred EEEEeecCccccccC---------------CCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 016184 224 LKLCDFGSAKVLVKG---------------EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGE 288 (394)
Q Consensus 224 vkl~Dfg~a~~~~~~---------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~ 288 (394)
++|+|||++...... .......+++.|+|||.+.+...++.++|+|||||++|+|++|..||.+.
T Consensus 158 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~ 237 (335)
T PTZ00024 158 CKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGE 237 (335)
T ss_pred EEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 999999998765411 11122345778999999876555799999999999999999999999998
Q ss_pred CcHHHHHHHHHHhCCCChhhhhccCC--CCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCC
Q 016184 289 SGVDQLVEIIKVLGTPTREEIKCMNP--NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHP 366 (394)
Q Consensus 289 ~~~~~~~~i~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp 366 (394)
++.+.+..+....+.+....+..... .+..+ ......... ......+.++.+||.+||+.||++|||++++|.||
T Consensus 238 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~ 314 (335)
T PTZ00024 238 NEIDQLGRIFELLGTPNEDNWPQAKKLPLYTEF--TPRKPKDLK-TIFPNASDDAIDLLQSLLKLNPLERISAKEALKHE 314 (335)
T ss_pred CHHHHHHHHHHHhCCCchhhCcchhhccccccc--CcCCcccHH-HhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCc
Confidence 88888888888777766544332110 00000 000011111 11245688999999999999999999999999999
Q ss_pred CCCCCC
Q 016184 367 FFDELR 372 (394)
Q Consensus 367 ~f~~~~ 372 (394)
||+...
T Consensus 315 ~~~~~~ 320 (335)
T PTZ00024 315 YFKSDP 320 (335)
T ss_pred ccCCCC
Confidence 998663
|
|
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=318.79 Aligned_cols=276 Identities=39% Similarity=0.693 Sum_probs=218.2
Q ss_pred eEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccc------hhhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEEE
Q 016184 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN 156 (394)
Q Consensus 83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 156 (394)
+|++.+.||+|+||.||+|.+..+++.||+|++... .....+|+++++.++|+||+++++++.. ....+
T Consensus 2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~~ 76 (288)
T cd07833 2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRR-----KGRLY 76 (288)
T ss_pred ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEE-----CCEEE
Confidence 599999999999999999999999999999987532 2345679999999999999999998843 33478
Q ss_pred EEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCccccc
Q 016184 157 LVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV 236 (394)
Q Consensus 157 lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~ 236 (394)
++|||+++++...+.. ....+++..++.++.|++.||.|||+ .|++|+||+|+||+++.++ .+||+|||++....
T Consensus 77 iv~e~~~~~~l~~~~~---~~~~~~~~~~~~~~~~i~~~l~~LH~-~~i~H~dl~~~ni~~~~~~-~~kl~d~g~~~~~~ 151 (288)
T cd07833 77 LVFEYVERTLLELLEA---SPGGLPPDAVRSYIWQLLQAIAYCHS-HNIIHRDIKPENILVSESG-VLKLCDFGFARALR 151 (288)
T ss_pred EEEecCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHeEECCCC-CEEEEeeecccccC
Confidence 9999999876544332 23568999999999999999999999 8999999999999999887 69999999987665
Q ss_pred cCC--CcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCC
Q 016184 237 KGE--PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 314 (394)
Q Consensus 237 ~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 314 (394)
... ......++..|+|||++.+...++.++|+||||+++|+|++|+.||.+....+.+..+....+..+......+..
T Consensus 152 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (288)
T cd07833 152 ARPASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSS 231 (288)
T ss_pred CCccccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhccc
Confidence 443 223456688899999997664689999999999999999999999998877777777777766655544332221
Q ss_pred --CCcccCCCCCC-CCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 016184 315 --NYTEFKFPQIK-PHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368 (394)
Q Consensus 315 --~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f 368 (394)
.+....++... ...+...++..++.++.+||++||..||++|||++++++||||
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f 288 (288)
T cd07833 232 NPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288 (288)
T ss_pred CccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence 11111111111 1112223344568999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-43 Score=319.90 Aligned_cols=276 Identities=37% Similarity=0.655 Sum_probs=211.8
Q ss_pred eEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccch------hhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEEE
Q 016184 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN 156 (394)
Q Consensus 83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 156 (394)
+|++.+.||+|+||.||+|.+..+++.||+|++.... ....+|+++++.++|+||+++++++ ......+
T Consensus 2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~ 76 (286)
T cd07846 2 KYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVF-----RRKKRLY 76 (286)
T ss_pred ceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhc-----ccCCeEE
Confidence 5999999999999999999999899999999875422 2345799999999999999999988 3445588
Q ss_pred EEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCccccc
Q 016184 157 LVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV 236 (394)
Q Consensus 157 lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~ 236 (394)
+||||+.++....+ ......+++..++.++.|++.||.|||+ .|++|+||+|+||+++.++ .++|+|||++....
T Consensus 77 lv~e~~~~~~l~~~---~~~~~~~~~~~~~~~~~~i~~~l~~LH~-~~i~h~~l~p~ni~~~~~~-~~~l~dfg~~~~~~ 151 (286)
T cd07846 77 LVFEFVDHTVLDDL---EKYPNGLDESRVRKYLFQILRGIEFCHS-HNIIHRDIKPENILVSQSG-VVKLCDFGFARTLA 151 (286)
T ss_pred EEEecCCccHHHHH---HhccCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCHHHEEECCCC-cEEEEeeeeeeecc
Confidence 99999997543322 2223468999999999999999999999 8999999999999999887 79999999987654
Q ss_pred cCCC-cccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCC
Q 016184 237 KGEP-NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 315 (394)
Q Consensus 237 ~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 315 (394)
.... .....++..|+|||.+.+...++.++||||||+++|+|++|++||......+....+....+.........+...
T Consensus 152 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (286)
T cd07846 152 APGEVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKN 231 (286)
T ss_pred CCccccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccc
Confidence 3322 223457888999999866555789999999999999999999999887777777777666554433221111100
Q ss_pred --CcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 016184 316 --YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368 (394)
Q Consensus 316 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f 368 (394)
......+..............++..+.+|+++||+.||++||++.++++||||
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 286 (286)
T cd07846 232 PLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286 (286)
T ss_pred hHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence 01111111111111111234678999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=321.51 Aligned_cols=283 Identities=30% Similarity=0.501 Sum_probs=214.2
Q ss_pred ceeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccch------hhhHHHHHHHHHcCCCCeeeeceEEEecCC---Cc
Q 016184 81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTD---KE 151 (394)
Q Consensus 81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~---~~ 151 (394)
.++|++.+.||+|+||.||+|.+..+++.||||.+.... ....+|+++++.++||||+++++++..... ..
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 90 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY 90 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence 346999999999999999999999999999999875321 123469999999999999999998754332 22
Q ss_pred eeEEEEEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecC
Q 016184 152 ELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS 231 (394)
Q Consensus 152 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~ 231 (394)
....++||||+++++...+.. ....+++..++.++.|++.||+|||+ .|++|+||||+||+++.++ .+||+|||+
T Consensus 91 ~~~~~lv~e~~~~~l~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~-~~i~H~dl~p~nil~~~~~-~~kl~dfg~ 165 (310)
T cd07865 91 KGSFYLVFEFCEHDLAGLLSN---KNVKFTLSEIKKVMKMLLNGLYYIHR-NKILHRDMKAANILITKDG-ILKLADFGL 165 (310)
T ss_pred CceEEEEEcCCCcCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCCHHHEEECCCC-cEEECcCCC
Confidence 345789999999887666543 22468999999999999999999999 8999999999999999887 799999999
Q ss_pred ccccccCCCc-----ccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCh
Q 016184 232 AKVLVKGEPN-----VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTR 306 (394)
Q Consensus 232 a~~~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~ 306 (394)
+......... ....++..|+|||.+.+...++.++|+||||+++|+|++|+.||.+.+.......+....+..+.
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (310)
T cd07865 166 ARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITP 245 (310)
T ss_pred cccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCh
Confidence 8765332211 23356788999999866555788999999999999999999999888777766666666665554
Q ss_pred hhhhccCC--CCcccCCCCCCCCCcch-hccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 016184 307 EEIKCMNP--NYTEFKFPQIKPHPWHK-VFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368 (394)
Q Consensus 307 ~~~~~~~~--~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f 368 (394)
+.+..... .+....++......... ......+..+.+||.+||..||.+|||++++|+||||
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f 310 (310)
T cd07865 246 EVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF 310 (310)
T ss_pred hhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence 43322210 00111111111111100 0111246778999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-43 Score=327.52 Aligned_cols=247 Identities=27% Similarity=0.490 Sum_probs=194.9
Q ss_pred eEEeecCceEEEEEEECCCCcEEEEEEeccch-------hhhHHHHHHHHHc-CCCCeeeeceEEEecCCCceeEEEEEE
Q 016184 88 HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQML-DHPNIVALKHCFFSTTDKEELYLNLVL 159 (394)
Q Consensus 88 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~lv~ 159 (394)
+.||+|+||.||+|++..+++.||+|++.+.. ....+|..++..+ .|++|+.+++++ .....+++||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~-----~~~~~~~lv~ 75 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCF-----QTTSRLFLVI 75 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEE-----EeCCEEEEEE
Confidence 46999999999999999999999999986532 2244688888877 699999999988 3334588999
Q ss_pred ecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCcccccc-
Q 016184 160 EYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK- 237 (394)
Q Consensus 160 e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~- 237 (394)
||+++ +|...+.. ...+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+++....
T Consensus 76 e~~~~~~L~~~~~~----~~~l~~~~~~~~~~qi~~al~~lH~-~~ivHrDlkp~Nili~~~~-~~kl~Dfg~~~~~~~~ 149 (327)
T cd05617 76 EYVNGGDLMFHMQR----QRKLPEEHARFYAAEICIALNFLHE-RGIIYRDLKLDNVLLDADG-HIKLTDYGMCKEGLGP 149 (327)
T ss_pred eCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCCHHHEEEeCCC-CEEEeccccceeccCC
Confidence 99985 55444432 3679999999999999999999999 8999999999999999888 699999999875322
Q ss_pred CCCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCc------HHHHHHHHHHhCCCChhhhhc
Q 016184 238 GEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESG------VDQLVEIIKVLGTPTREEIKC 311 (394)
Q Consensus 238 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~------~~~~~~i~~~~~~~~~~~~~~ 311 (394)
........||+.|+|||++.+. .++.++|||||||++|+|++|+.||..... .+.+...... .
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~--~-------- 218 (327)
T cd05617 150 GDTTSTFCGTPNYIAPEILRGE-EYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILE--K-------- 218 (327)
T ss_pred CCceecccCCcccCCHHHHCCC-CCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHh--C--------
Confidence 2333456789999999999654 489999999999999999999999964321 1122221110 0
Q ss_pred cCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCC------HHHHhcCCCCCCCCCC
Q 016184 312 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCT------ALEACVHPFFDELRDP 374 (394)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt------~~ell~hp~f~~~~~~ 374 (394)
... ++..++..+.++|++||+.||.+|++ .+++++||||+.+...
T Consensus 219 ------~~~------------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h~~f~~~~~~ 269 (327)
T cd05617 219 ------PIR------------IPRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSHTFFRSIDWD 269 (327)
T ss_pred ------CCC------------CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcCCCCCCCCHH
Confidence 000 22457889999999999999999998 5799999999987533
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-45 Score=357.73 Aligned_cols=269 Identities=29% Similarity=0.476 Sum_probs=226.6
Q ss_pred cceeEEEeeEEeecCceEEEEEEECCCCcEEEEEEecc-------chhhhHHHHHHHHHcCCCCeeeeceEEEecCCCce
Q 016184 80 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQ-------DKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE 152 (394)
Q Consensus 80 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-------~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 152 (394)
...+|.|+++||+|+||.|.+++++.+++.||.|++.+ +...+..|..+|...+.+-|++++-.| .+.
T Consensus 73 ~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAF-----QD~ 147 (1317)
T KOG0612|consen 73 KAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAF-----QDE 147 (1317)
T ss_pred CHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHh-----cCc
Confidence 34579999999999999999999999999999998865 234566789999999999999998888 778
Q ss_pred eEEEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecC
Q 016184 153 LYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS 231 (394)
Q Consensus 153 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~ 231 (394)
.|+|+||||++| +|..++..+ ..+|+.+++.|+..|+.||..||+ .|+|||||||+|||+|..|| +||+|||.
T Consensus 148 ~~LYlVMdY~pGGDlltLlSk~----~~~pE~~ArFY~aEiVlAldslH~-mgyVHRDiKPDNvLld~~GH-ikLADFGs 221 (1317)
T KOG0612|consen 148 RYLYLVMDYMPGGDLLTLLSKF----DRLPEDWARFYTAEIVLALDSLHS-MGYVHRDIKPDNVLLDKSGH-IKLADFGS 221 (1317)
T ss_pred cceEEEEecccCchHHHHHhhc----CCChHHHHHHHHHHHHHHHHHHHh-ccceeccCCcceeEecccCc-Eeeccchh
Confidence 889999999986 676766653 379999999999999999999999 99999999999999999995 99999999
Q ss_pred ccccccCCCc--ccccccccccccccccC----CCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCC
Q 016184 232 AKVLVKGEPN--VSYICSRYYRAPELIFG----ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPT 305 (394)
Q Consensus 232 a~~~~~~~~~--~~~~~t~~y~aPE~~~~----~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~ 305 (394)
|-.+..++.. ...+|||.|++||++.. ...|+..+|+||+||++|||+.|..||....-.+.+.+|+..-
T Consensus 222 Clkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk---- 297 (1317)
T KOG0612|consen 222 CLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHK---- 297 (1317)
T ss_pred HHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchh----
Confidence 9777644432 35689999999999842 2458999999999999999999999999998888888887631
Q ss_pred hhhhhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCC---HHHHhcCCCCCCCCCCCCCCCCCC
Q 016184 306 REEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCT---ALEACVHPFFDELRDPNTRLPNGR 382 (394)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt---~~ell~hp~f~~~~~~~~~~~~~~ 382 (394)
..+.||.. ..+|+++++||++++. +|+.|.. ++++.+||||.++.+.+++-..++
T Consensus 298 -----------~~l~FP~~----------~~VSeeakdLI~~ll~-~~e~RLgrngiedik~HpFF~g~~W~~iR~~~pP 355 (1317)
T KOG0612|consen 298 -----------ESLSFPDE----------TDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHPFFEGIDWDNIRESVPP 355 (1317)
T ss_pred -----------hhcCCCcc----------cccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCccccCCChhhhhhcCCC
Confidence 12333311 3489999999999886 4778888 999999999999988888755544
Q ss_pred CCC
Q 016184 383 PLP 385 (394)
Q Consensus 383 ~~~ 385 (394)
-+|
T Consensus 356 ~vP 358 (1317)
T KOG0612|consen 356 VVP 358 (1317)
T ss_pred CCC
Confidence 453
|
|
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=318.11 Aligned_cols=261 Identities=24% Similarity=0.366 Sum_probs=208.0
Q ss_pred ceeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccc---hhhhHHHHHHHHHc-CCCCeeeeceEEEecCCCceeEEE
Q 016184 81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD---KRYKNRELQIMQML-DHPNIVALKHCFFSTTDKEELYLN 156 (394)
Q Consensus 81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~ 156 (394)
.++|.+.+.||+|+||.||+|....+++.+|+|++... .....+|+.+++.+ +|+|++++++++...........+
T Consensus 21 ~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~~ 100 (291)
T cd06639 21 TDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLW 100 (291)
T ss_pred CCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCeeE
Confidence 45699999999999999999999999999999988543 23445788899988 899999999988655433345678
Q ss_pred EEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCcccc
Q 016184 157 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL 235 (394)
Q Consensus 157 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~ 235 (394)
+||||+++ +|.+++.........+++..++.++.|++.||+|||+ .|++|+||||+||+++.++ .+||+|||++...
T Consensus 101 lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~-~~ivH~dlkp~nili~~~~-~~kl~dfg~~~~~ 178 (291)
T cd06639 101 LVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHN-NRIIHRDVKGNNILLTTEG-GVKLVDFGVSAQL 178 (291)
T ss_pred EEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCHHHEEEcCCC-CEEEeecccchhc
Confidence 99999975 7777776554455778999999999999999999999 8999999999999999887 6999999998765
Q ss_pred ccCC-CcccccccccccccccccCCC----CCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhh
Q 016184 236 VKGE-PNVSYICSRYYRAPELIFGAT----EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 310 (394)
Q Consensus 236 ~~~~-~~~~~~~t~~y~aPE~~~~~~----~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 310 (394)
.... ......++..|+|||.+.... .++.++|+|||||++|+|++|+.||........+..+.... ++
T Consensus 179 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~--~~----- 251 (291)
T cd06639 179 TSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNP--PP----- 251 (291)
T ss_pred ccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcCC--CC-----
Confidence 4322 122345788899999875332 26889999999999999999999998766554444332210 00
Q ss_pred ccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCC
Q 016184 311 CMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFD 369 (394)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~ 369 (394)
.+ ......+..+.+||.+||+.||++||++.++++||||+
T Consensus 252 ---------~~----------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~ 291 (291)
T cd06639 252 ---------TL----------LHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK 291 (291)
T ss_pred ---------CC----------CcccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence 00 01134567899999999999999999999999999995
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=322.03 Aligned_cols=282 Identities=33% Similarity=0.575 Sum_probs=218.3
Q ss_pred ceeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccch------hhhHHHHHHHHHcCCCCeeeeceEEEecCC---Cc
Q 016184 81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTD---KE 151 (394)
Q Consensus 81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~---~~ 151 (394)
.++|++.+.||.|+||.||+|++..+++.||||++.... ....+|+++++.++|+||+++++++..... ..
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 457999999999999999999999999999999875321 234679999999999999999987754332 23
Q ss_pred eeEEEEEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecC
Q 016184 152 ELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS 231 (394)
Q Consensus 152 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~ 231 (394)
...++++|||+.+++...+.. ....+++..++.++.|++.||.|||+ .||+|+||||+||+++.++ .++|+|||+
T Consensus 87 ~~~~~lv~~~~~~~l~~~~~~---~~~~~~~~~~~~i~~~l~~al~~lH~-~~i~H~dl~p~nil~~~~~-~~~l~dfg~ 161 (311)
T cd07866 87 RGSVYMVTPYMDHDLSGLLEN---PSVKLTESQIKCYMLQLLEGINYLHE-NHILHRDIKAANILIDNQG-ILKIADFGL 161 (311)
T ss_pred CceEEEEEecCCcCHHHHHhc---cccCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEECCCC-CEEECcCcc
Confidence 446789999999877655543 23579999999999999999999999 8999999999999999888 699999999
Q ss_pred ccccccCCCc------------ccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHH
Q 016184 232 AKVLVKGEPN------------VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIK 299 (394)
Q Consensus 232 a~~~~~~~~~------------~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~ 299 (394)
+......... ....+++.|+|||.+.+...++.++||||||+++|+|++|+.||.+.+.......+..
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~ 241 (311)
T cd07866 162 ARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFK 241 (311)
T ss_pred chhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 8755332211 1234578899999986655689999999999999999999999998888888888887
Q ss_pred HhCCCChhhhhccCC--CCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 016184 300 VLGTPTREEIKCMNP--NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368 (394)
Q Consensus 300 ~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f 368 (394)
..+.+....+..+.. ................. ....+++.+.+||.+||+.||.+|||+.++++||||
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f 311 (311)
T cd07866 242 LCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEE-RFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF 311 (311)
T ss_pred HhCCCChhhchhhhhcccccccccCCCCCccHHH-HcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence 777666554432211 00000000001111111 113456889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-43 Score=315.12 Aligned_cols=247 Identities=28% Similarity=0.457 Sum_probs=200.5
Q ss_pred eEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccch---------hhhHHHHHHHHHcCCCCeeeeceEEEecCCCcee
Q 016184 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL 153 (394)
Q Consensus 83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 153 (394)
+|.+.+.||+|++|.||+|.+..+++.||+|.+.... ....+|+++++.++||||+++++++. ...
T Consensus 3 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~ 77 (263)
T cd06625 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLR-----DDE 77 (263)
T ss_pred cccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEc-----cCC
Confidence 4999999999999999999999999999999875321 23457999999999999999999883 333
Q ss_pred EEEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCc
Q 016184 154 YLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA 232 (394)
Q Consensus 154 ~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a 232 (394)
..++++||+++ ++.+.+.. ...+++..++.++.|++.||.|||+ .|++|+||+|+||+++.++ .++|+|||++
T Consensus 78 ~~~~v~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lH~-~~i~H~dl~p~nilv~~~~-~~~l~dfg~~ 151 (263)
T cd06625 78 TLSIFMEYMPGGSVKDQLKA----YGALTETVTRKYTRQILEGVEYLHS-NMIVHRDIKGANILRDSAG-NVKLGDFGAS 151 (263)
T ss_pred eEEEEEEECCCCcHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEcCCC-CEEEeecccc
Confidence 68899999975 66555543 3568899999999999999999999 8999999999999999887 6999999998
Q ss_pred cccccCCCc----ccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhh
Q 016184 233 KVLVKGEPN----VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 308 (394)
Q Consensus 233 ~~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~ 308 (394)
......... ....++..|+|||.+.+.. ++.++||||||+++|+|++|+.||...+.......+.....
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~------ 224 (263)
T cd06625 152 KRLQTICSSGTGMKSVTGTPYWMSPEVISGEG-YGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPT------ 224 (263)
T ss_pred eeccccccccccccCCCcCccccCcceeccCC-CCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCC------
Confidence 755332111 2345678899999997654 89999999999999999999999987655544433322100
Q ss_pred hhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 016184 309 IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368 (394)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f 368 (394)
...++..++..+.++|++||..||.+|||+.++++||||
T Consensus 225 ---------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~ 263 (263)
T cd06625 225 ---------------------NPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRHFFV 263 (263)
T ss_pred ---------------------CCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhCCCC
Confidence 011234578899999999999999999999999999998
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-43 Score=328.38 Aligned_cols=285 Identities=35% Similarity=0.638 Sum_probs=224.6
Q ss_pred eeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccc------hhhhHHHHHHHHHcCCCCeeeeceEEEecCC-CceeE
Q 016184 82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTD-KEELY 154 (394)
Q Consensus 82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~~~~~ 154 (394)
++|++.+.||.|++|.||+|++..+++.||+|++... .....+|+.+++.+.|+|++++.+++..... .....
T Consensus 15 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 94 (343)
T cd07851 15 DRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQD 94 (343)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccccc
Confidence 3599999999999999999999999999999987542 1223469999999999999999887743322 23345
Q ss_pred EEEEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCccc
Q 016184 155 LNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV 234 (394)
Q Consensus 155 ~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~ 234 (394)
.++|+||++++|.+++.. ..+++..++.++.|++.||.|||+ .||+|+||||+||+++.++ .++|+|||++..
T Consensus 95 ~~lv~e~~~~~L~~~~~~-----~~l~~~~~~~~~~ql~~aL~~LH~-~gi~H~dlkp~Nill~~~~-~~kL~dfg~~~~ 167 (343)
T cd07851 95 VYLVTHLMGADLNNIVKC-----QKLSDDHIQFLVYQILRGLKYIHS-AGIIHRDLKPSNIAVNEDC-ELKILDFGLARH 167 (343)
T ss_pred EEEEEecCCCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHeEECCCC-CEEEcccccccc
Confidence 789999998888777654 579999999999999999999999 8999999999999999887 699999999876
Q ss_pred cccCCCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCC
Q 016184 235 LVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 314 (394)
Q Consensus 235 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 314 (394)
.... .....++..|+|||.+.+...++.++||||||+++|+|++|+.||.+......+..+.+..+.++...+.....
T Consensus 168 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 245 (343)
T cd07851 168 TDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISS 245 (343)
T ss_pred cccc--ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhccc
Confidence 5332 33456788899999986555678999999999999999999999998888888888888777766655433221
Q ss_pred CCc-cc--CCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCC
Q 016184 315 NYT-EF--KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNT 376 (394)
Q Consensus 315 ~~~-~~--~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~ 376 (394)
... .+ ..+......+... ...+++.+.+||++||+.||.+|||+.++++||||++..++..
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~-~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~~~~~~ 309 (343)
T cd07851 246 ESARNYIQSLPQMPKKDFKEV-FSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYHDPED 309 (343)
T ss_pred hhHHHHHHhccccCCCCHHHH-hccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccccCCCcc
Confidence 100 00 0111111111111 1346889999999999999999999999999999999877754
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=325.14 Aligned_cols=283 Identities=36% Similarity=0.627 Sum_probs=219.9
Q ss_pred eeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccc------hhhhHHHHHHHHHcCCCCeeeeceEEEecCC-CceeE
Q 016184 82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTD-KEELY 154 (394)
Q Consensus 82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~~~~~ 154 (394)
.+|.+.+.||+|+||.||+|++..+|+.||||++... .....+|+.+++.+.|+||+++++++..... .....
T Consensus 15 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 94 (342)
T cd07879 15 ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQD 94 (342)
T ss_pred cceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCce
Confidence 3599999999999999999999989999999988542 1234579999999999999999998744322 12234
Q ss_pred EEEEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCccc
Q 016184 155 LNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV 234 (394)
Q Consensus 155 ~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~ 234 (394)
.++++||+..++.... ...+++..++.++.|++.||+|||+ .|++||||||+||+++.++ .++|+|||++..
T Consensus 95 ~~lv~e~~~~~l~~~~------~~~~~~~~~~~~~~qi~~aL~~LH~-~~i~H~dlkp~NIll~~~~-~~kL~dfg~~~~ 166 (342)
T cd07879 95 FYLVMPYMQTDLQKIM------GHPLSEDKVQYLVYQMLCGLKYIHS-AGIIHRDLKPGNLAVNEDC-ELKILDFGLARH 166 (342)
T ss_pred EEEEecccccCHHHHH------cCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEECCCC-CEEEeeCCCCcC
Confidence 6799999987654432 2468999999999999999999999 8999999999999999887 799999999875
Q ss_pred cccCCCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCC
Q 016184 235 LVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 314 (394)
Q Consensus 235 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 314 (394)
... ......+++.|+|||.+.+...++.++|+|||||++|+|++|+.||.+.+....+..+....+.+..........
T Consensus 167 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (342)
T cd07879 167 ADA--EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLED 244 (342)
T ss_pred CCC--CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhcc
Confidence 422 223456788899999986655588999999999999999999999998887777777777777666655443321
Q ss_pred CCcc---cCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCC
Q 016184 315 NYTE---FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 375 (394)
Q Consensus 315 ~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~ 375 (394)
.... ...+......+...+ ...+.++.+||.+||+.||.+||++.+++.||||+.+++..
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~~~ 307 (342)
T cd07879 245 KAAKSYIKSLPKYPRKDFSTLF-PKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRDAD 307 (342)
T ss_pred cchHHHHhhcCCcccchHHHHh-cCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccccc
Confidence 1000 001111111111111 34688899999999999999999999999999999997643
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-44 Score=329.94 Aligned_cols=243 Identities=26% Similarity=0.364 Sum_probs=201.5
Q ss_pred eEEEeeEEeecCceEEEEEEECCCCcEEEEEEecc---chhhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEEEEEE
Q 016184 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQ---DKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVL 159 (394)
Q Consensus 83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~---~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~ 159 (394)
.++.++.||+|.||.||+|.+.. ...||+|.+.. ....+.+|+++|++|+|++||++++++.... -++|||
T Consensus 207 ~l~l~~~LG~G~FG~V~~g~~~~-~~~vavk~ik~~~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~-----piyIVt 280 (468)
T KOG0197|consen 207 ELKLIRELGSGQFGEVWLGKWNG-STKVAVKTIKEGSMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQE-----PIYIVT 280 (468)
T ss_pred HHHHHHHhcCCccceEEEEEEcC-CCcccceEEeccccChhHHHHHHHHHHhCcccCeEEEEEEEecCC-----ceEEEE
Confidence 35567789999999999999964 34799998764 3355668999999999999999999994322 488999
Q ss_pred eccc-ccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCccccccC
Q 016184 160 EYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG 238 (394)
Q Consensus 160 e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~~ 238 (394)
|||+ |+|.++++. ..+..+.......++.|||.|++||.+ +++|||||...||||+.+. .+||+|||+|+...++
T Consensus 281 E~m~~GsLl~yLr~--~~~~~l~~~~Ll~~a~qIaeGM~YLes-~~~IHRDLAARNiLV~~~~-~vKIsDFGLAr~~~d~ 356 (468)
T KOG0197|consen 281 EYMPKGSLLDYLRT--REGGLLNLPQLLDFAAQIAEGMAYLES-KNYIHRDLAARNILVDEDL-VVKISDFGLARLIGDD 356 (468)
T ss_pred EecccCcHHHHhhh--cCCCccchHHHHHHHHHHHHHHHHHHh-CCccchhhhhhheeeccCc-eEEEcccccccccCCC
Confidence 9999 678888776 345789999999999999999999999 8999999999999999887 7999999999954433
Q ss_pred CCccccc--ccccccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCC
Q 016184 239 EPNVSYI--CSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 315 (394)
Q Consensus 239 ~~~~~~~--~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 315 (394)
.-....- -...|.|||.+... .++.+||||||||+||||+| |+.||.+.+..+.+..+.+...-|.
T Consensus 357 ~Y~~~~~~kfPIkWtAPEa~~~~-~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRlp~---------- 425 (468)
T KOG0197|consen 357 EYTASEGGKFPIKWTAPEALNYG-KFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRLPR---------- 425 (468)
T ss_pred ceeecCCCCCCceecCHHHHhhC-CcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcCCC----------
Confidence 3222222 25569999999644 59999999999999999998 9999999998888888776433222
Q ss_pred CcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 016184 316 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV 364 (394)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 364 (394)
+..+|+++.+++..||..+|++|||.+.+..
T Consensus 426 ------------------P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~ 456 (468)
T KOG0197|consen 426 ------------------PEGCPDEVYELMKSCWHEDPEDRPTFETLRE 456 (468)
T ss_pred ------------------CCCCCHHHHHHHHHHhhCCcccCCCHHHHHH
Confidence 2578999999999999999999999997653
|
|
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=325.98 Aligned_cols=286 Identities=35% Similarity=0.574 Sum_probs=223.0
Q ss_pred eeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccch------hhhHHHHHHHHHcCCCCeeeeceEEEecCC-CceeE
Q 016184 82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTD-KEELY 154 (394)
Q Consensus 82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~~~~~ 154 (394)
++|++.+.||+|+||.||+|.+..+|+.||+|++.... ....+|+.+++.++|+||+++++++..... .....
T Consensus 17 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 96 (345)
T cd07877 17 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND 96 (345)
T ss_pred CceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeeccccccccc
Confidence 46999999999999999999999999999999886432 234469999999999999999988743322 22334
Q ss_pred EEEEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCccc
Q 016184 155 LNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV 234 (394)
Q Consensus 155 ~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~ 234 (394)
.+++++++++++.+++.. ..+++..++.++.|++.||+|||+ .||+||||||+||+++.++ .+||+|||++..
T Consensus 97 ~~lv~~~~~~~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~-~~ivH~dlkp~NIll~~~~-~~kl~dfg~~~~ 169 (345)
T cd07877 97 VYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS-ADIIHRDLKPSNLAVNEDC-ELKILDFGLARH 169 (345)
T ss_pred EEEEehhcccCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCChHHEEEcCCC-CEEEeccccccc
Confidence 678999998888766543 568999999999999999999999 8999999999999999888 699999999875
Q ss_pred cccCCCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCC
Q 016184 235 LVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 314 (394)
Q Consensus 235 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 314 (394)
... ......+++.|+|||.+.+...++.++|||||||++|+|++|+.||...+....+..+.+..+.++.........
T Consensus 170 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (345)
T cd07877 170 TDD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 247 (345)
T ss_pred ccc--cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhccc
Confidence 432 233456788999999986655588999999999999999999999988877777777777777666655443322
Q ss_pred CCccc---CCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCCC
Q 016184 315 NYTEF---KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTR 377 (394)
Q Consensus 315 ~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~~ 377 (394)
..... ..+......+... ....++++.+||.+||+.||.+|||+.++++||||++...+...
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~~~~~~~ 312 (345)
T cd07877 248 ESARNYIQSLTQMPKMNFANV-FIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE 312 (345)
T ss_pred HhHHHHHHHhcccCCcchhhh-cCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhcCCCCcc
Confidence 11000 0011111111111 12468889999999999999999999999999999998776654
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-43 Score=326.19 Aligned_cols=278 Identities=21% Similarity=0.336 Sum_probs=199.3
Q ss_pred EeeEEeec--CceEEEEEEECCCCcEEEEEEeccch------hhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEEEE
Q 016184 86 AEHVVGTG--SFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL 157 (394)
Q Consensus 86 ~~~~lg~G--~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 157 (394)
++++||+| +|++||+++++.+|+.||+|++.... ....+|+++++.++||||+++++++.. ....++
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~-----~~~~~l 76 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIA-----DNELWV 76 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEE-----CCEEEE
Confidence 46789999 78999999999999999999986432 345579999999999999999998843 334789
Q ss_pred EEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCccccc
Q 016184 158 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV 236 (394)
Q Consensus 158 v~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~ 236 (394)
||||+++ ++.+++.... ...+++..++.++.|++.||+|||+ +||+||||||+|||++.++ .++++||+.+....
T Consensus 77 v~e~~~~~~l~~~~~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~-~~iiH~dlkp~Nil~~~~~-~~~l~~~~~~~~~~ 152 (327)
T cd08227 77 VTSFMAYGSAKDLICTHF--MDGMSELAIAYILQGVLKALDYIHH-MGYVHRSVKASHILISVDG-KVYLSGLRSNLSMI 152 (327)
T ss_pred EEeccCCCcHHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHH-CCEecCCCChhhEEEecCC-cEEEcccchhhccc
Confidence 9999985 6766665432 2458999999999999999999999 8999999999999999887 79999998654332
Q ss_pred cCCC--------cccccccccccccccccCC-CCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCC----
Q 016184 237 KGEP--------NVSYICSRYYRAPELIFGA-TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGT---- 303 (394)
Q Consensus 237 ~~~~--------~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~---- 303 (394)
.... .....++..|+|||++.+. ..++.++|||||||++|+|++|+.||..................
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 232 (327)
T cd08227 153 NHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLD 232 (327)
T ss_pred cccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCcccccc
Confidence 1111 1123456779999998653 34889999999999999999999999865544433332211000
Q ss_pred ---CChhhhhcc------CCCCcccCC----CCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 016184 304 ---PTREEIKCM------NPNYTEFKF----PQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE 370 (394)
Q Consensus 304 ---~~~~~~~~~------~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~ 370 (394)
.+.+..... ......... ...............+++++.+||++||+.||++|||++++++||||++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~ 312 (327)
T cd08227 233 TTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQ 312 (327)
T ss_pred ccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhh
Confidence 000100000 000000000 0000000011123456789999999999999999999999999999998
Q ss_pred CC
Q 016184 371 LR 372 (394)
Q Consensus 371 ~~ 372 (394)
+.
T Consensus 313 ~~ 314 (327)
T cd08227 313 IK 314 (327)
T ss_pred cc
Confidence 65
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-46 Score=318.80 Aligned_cols=253 Identities=29% Similarity=0.454 Sum_probs=211.9
Q ss_pred eEEEeeEEeecCceEEEEEEECCCCcEEEEEEecc--chhhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEEEEEEe
Q 016184 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQ--DKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLE 160 (394)
Q Consensus 83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e 160 (394)
-|.++.+||+|+||.||+|.++.+|..+|||.+.- +...+-+|+.+++++..+++|++++.|+...+ +++|||
T Consensus 34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sD-----LWIVME 108 (502)
T KOG0574|consen 34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSD-----LWIVME 108 (502)
T ss_pred HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccchHHHHHHHHHHHHHcCCchhhhhhhhhccCCc-----eEeehh
Confidence 38899999999999999999999999999998754 44566689999999999999999999988777 899999
Q ss_pred ccc-ccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCccccccC-
Q 016184 161 YVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG- 238 (394)
Q Consensus 161 ~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~~- 238 (394)
||+ |+..++++.. .+.+.+.++..++...+.||+|||. ..-+|||||..|||++.+| ..||+|||.|..+.+.
T Consensus 109 YCGAGSiSDI~R~R---~K~L~E~EIs~iL~~TLKGL~YLH~-~~KIHRDIKAGNILLNT~G-~AKLADFGVAGQLTDTM 183 (502)
T KOG0574|consen 109 YCGAGSISDIMRAR---RKPLSEQEISAVLRDTLKGLQYLHD-LKKIHRDIKAGNILLNTDG-IAKLADFGVAGQLTDTM 183 (502)
T ss_pred hcCCCcHHHHHHHh---cCCccHHHHHHHHHHHHhHHHHHHH-HHHHHhhcccccEEEcccc-hhhhhhccccchhhhhH
Confidence 998 6777777653 4899999999999999999999999 8999999999999999999 5999999998655332
Q ss_pred CCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCCCcc
Q 016184 239 EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 318 (394)
Q Consensus 239 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 318 (394)
....+..|||.|||||++..-. |+.++||||||++..||.-|++||.+..++..+..
T Consensus 184 AKRNTVIGTPFWMAPEVI~EIG-Y~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFM---------------------- 240 (502)
T KOG0574|consen 184 AKRNTVIGTPFWMAPEVIEEIG-YDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFM---------------------- 240 (502)
T ss_pred HhhCccccCcccccHHHHHHhc-cchhhhHhhhcchhhhhhcCCCCcccccccceeEe----------------------
Confidence 2334678999999999996544 99999999999999999999999987655433222
Q ss_pred cCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 016184 319 FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR 372 (394)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 372 (394)
+|...+..+.. ++..|.++.+||+.||.+.|++|.||.+|++|||+++..
T Consensus 241 --IPT~PPPTF~K--PE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H~FiknA~ 290 (502)
T KOG0574|consen 241 --IPTKPPPTFKK--PEEWSSEFNDFIRSCLIKKPEERKTALRLCEHTFIKNAP 290 (502)
T ss_pred --ccCCCCCCCCC--hHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhhhhhcCCC
Confidence 12111111111 134578899999999999999999999999999998763
|
|
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-42 Score=320.86 Aligned_cols=283 Identities=36% Similarity=0.714 Sum_probs=224.0
Q ss_pred ceeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccc------hhhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeE
Q 016184 81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY 154 (394)
Q Consensus 81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 154 (394)
.++|++.+.||.|+||.||+|.+..+++.||||++.+. .....+|+++++.++||||+++.+++.... ..
T Consensus 9 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~----~~ 84 (328)
T cd07856 9 TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPL----ED 84 (328)
T ss_pred ccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCC----Cc
Confidence 34699999999999999999999999999999987432 234457999999999999999999874322 23
Q ss_pred EEEEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCccc
Q 016184 155 LNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV 234 (394)
Q Consensus 155 ~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~ 234 (394)
.++++||+++++..++.. ..+++..+..++.|++.||.|||+ .||+|+||+|.||+++.++ .++|+|||.+..
T Consensus 85 ~~lv~e~~~~~L~~~~~~-----~~~~~~~~~~~~~ql~~aL~~LH~-~~iiH~dl~p~Nili~~~~-~~~l~dfg~~~~ 157 (328)
T cd07856 85 IYFVTELLGTDLHRLLTS-----RPLEKQFIQYFLYQILRGLKYVHS-AGVVHRDLKPSNILINENC-DLKICDFGLARI 157 (328)
T ss_pred EEEEeehhccCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHHEeECCCC-CEEeCccccccc
Confidence 678999998887766543 568888899999999999999999 8999999999999999887 699999999875
Q ss_pred cccCCCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCC
Q 016184 235 LVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 314 (394)
Q Consensus 235 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 314 (394)
... ......+++.|+|||.+.+...++.++|+||||+++|+|++|+.||...........+.+.++.++.+.......
T Consensus 158 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (328)
T cd07856 158 QDP--QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICS 235 (328)
T ss_pred cCC--CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccc
Confidence 422 223456688899999886545689999999999999999999999998888777788888888877665543211
Q ss_pred CCc-cc--CCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCCC
Q 016184 315 NYT-EF--KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTR 377 (394)
Q Consensus 315 ~~~-~~--~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~~ 377 (394)
.-. .+ ..+.....+.... ...++..+.++|++||+.||++|||+++++.||||+....+...
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~~~~~~~ 300 (328)
T cd07856 236 ENTLRFVQSLPKREPVPFSEK-FKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYHDPTDE 300 (328)
T ss_pred hhhHHHHhhccccCCCcHHHH-cCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccccccCCccc
Confidence 100 00 0111111112111 23578899999999999999999999999999999998887664
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=316.80 Aligned_cols=277 Identities=34% Similarity=0.611 Sum_probs=216.2
Q ss_pred EEEeeEEeecCceEEEEEEECCCCcEEEEEEeccch------hhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEEEE
Q 016184 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL 157 (394)
Q Consensus 84 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 157 (394)
|++.+.||.|++|.||+|++..+++.+|+|++.... ....+|+++++.++|+|++++++++.... ....++
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~---~~~~~l 77 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKG---KGSIYM 77 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCC---CCcEEE
Confidence 678899999999999999999999999999986542 23457999999999999999999884321 245789
Q ss_pred EEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCcccccc
Q 016184 158 VLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK 237 (394)
Q Consensus 158 v~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~ 237 (394)
|+||+++++..++... ...+++..++.++.|++.||+|||+ .|++|+||||+||+++.++ .++|+|||++.....
T Consensus 78 v~e~~~~~l~~~~~~~---~~~~~~~~~~~i~~~i~~al~~LH~-~~~~h~dl~p~nil~~~~~-~~~l~d~g~~~~~~~ 152 (287)
T cd07840 78 VFEYMDHDLTGLLDSP---EVKFTESQIKCYMKQLLEGLQYLHS-NGILHRDIKGSNILINNDG-VLKLADFGLARPYTK 152 (287)
T ss_pred EeccccccHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCcHHHeEEcCCC-CEEEccccceeeccC
Confidence 9999998776665432 2578999999999999999999999 8999999999999999888 799999999876644
Q ss_pred CCC--cccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCC
Q 016184 238 GEP--NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 315 (394)
Q Consensus 238 ~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 315 (394)
... .....++..|+|||.+.+...++.++||||||+++|+|++|+.||...+....+..+....+.+....+.....-
T Consensus 153 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (287)
T cd07840 153 RNSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKL 232 (287)
T ss_pred CCcccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccc
Confidence 331 223456788999998866555899999999999999999999999988877777777777766665544322110
Q ss_pred --CcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 016184 316 --YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368 (394)
Q Consensus 316 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f 368 (394)
.................+...++..+.++|++||+.||.+||++.++++||||
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~ 287 (287)
T cd07840 233 PWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287 (287)
T ss_pred hhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence 00000000001111122223358999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-42 Score=323.85 Aligned_cols=286 Identities=35% Similarity=0.633 Sum_probs=222.3
Q ss_pred ceeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccch------hhhHHHHHHHHHcCCCCeeeeceEEEecCCC-cee
Q 016184 81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDK-EEL 153 (394)
Q Consensus 81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~-~~~ 153 (394)
.++|++.+.||+|+||.||+|.+..+|..||||++.... ....+|+++++.++|+||+++++++...... ...
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 93 (343)
T cd07880 14 PDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFH 93 (343)
T ss_pred ccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccc
Confidence 345999999999999999999999999999999875321 2345799999999999999999987433221 223
Q ss_pred EEEEEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCcc
Q 016184 154 YLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK 233 (394)
Q Consensus 154 ~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~ 233 (394)
.+++||||+++++..++.. ..+++..++.++.|++.||+|||+ .||+||||||+||+++.++ .++|+|||++.
T Consensus 94 ~~~lv~e~~~~~l~~~~~~-----~~l~~~~~~~i~~qi~~al~~LH~-~gi~H~dlkp~Nill~~~~-~~kl~dfg~~~ 166 (343)
T cd07880 94 DFYLVMPFMGTDLGKLMKH-----EKLSEDRIQFLVYQMLKGLKYIHA-AGIIHRDLKPGNLAVNEDC-ELKILDFGLAR 166 (343)
T ss_pred eEEEEEecCCCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEcCCC-CEEEeeccccc
Confidence 4689999998887666543 578999999999999999999999 8999999999999999887 69999999987
Q ss_pred ccccCCCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccC
Q 016184 234 VLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 313 (394)
Q Consensus 234 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 313 (394)
.... ......+++.|+|||.+.+...++.++|+||||+++|+|++|..||.+.+....+..+....+.++.+......
T Consensus 167 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (343)
T cd07880 167 QTDS--EMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQ 244 (343)
T ss_pred cccc--CccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhc
Confidence 6532 22334568889999998654558899999999999999999999999888777777777766665554433222
Q ss_pred CCCcc---cCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCC
Q 016184 314 PNYTE---FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNT 376 (394)
Q Consensus 314 ~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~ 376 (394)
..... ...+....... ..+...++.++.++|.+||+.||.+|||+.+++.||||+..++...
T Consensus 245 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~~~~~ 309 (343)
T cd07880 245 SEDAKNYVKKLPRFRKKDF-RSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHDPED 309 (343)
T ss_pred chhHHHHHHhccccCcchH-HHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhcCccc
Confidence 11000 00111111111 1123567889999999999999999999999999999999877544
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=315.77 Aligned_cols=256 Identities=24% Similarity=0.385 Sum_probs=202.0
Q ss_pred eeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccc---hhhhHHHHHHHHHc-CCCCeeeeceEEEecCCC-ceeEEE
Q 016184 82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD---KRYKNRELQIMQML-DHPNIVALKHCFFSTTDK-EELYLN 156 (394)
Q Consensus 82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~-~~~~~~ 156 (394)
+.|++.+.||+|+||.||+|.+..+++.||+|++... .....+|+.+++.+ +|+||+++++++...... ....++
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~ 85 (272)
T cd06637 6 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLW 85 (272)
T ss_pred hhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEEE
Confidence 3589999999999999999999999999999988543 33456788899988 799999999988654322 234678
Q ss_pred EEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCcccc
Q 016184 157 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL 235 (394)
Q Consensus 157 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~ 235 (394)
++|||+++ ++.+++... ....+++..+..++.|++.||.|||+ .+|+|+||||+||+++.++ .++|+|||++...
T Consensus 86 iv~e~~~~~~L~~~l~~~--~~~~l~~~~~~~~~~qi~~~l~~LH~-~~ivh~dl~~~nili~~~~-~~~l~Dfg~~~~~ 161 (272)
T cd06637 86 LVMEFCGAGSVTDLIKNT--KGNTLKEEWIAYICREILRGLSHLHQ-HKVIHRDIKGQNVLLTENA-EVKLVDFGVSAQL 161 (272)
T ss_pred EEEEcCCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHH-CCCccCCCCHHHEEECCCC-CEEEccCCCceec
Confidence 99999985 776666542 23568999999999999999999999 8999999999999999887 6999999998755
Q ss_pred ccC-CCcccccccccccccccccC----CCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhh
Q 016184 236 VKG-EPNVSYICSRYYRAPELIFG----ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 310 (394)
Q Consensus 236 ~~~-~~~~~~~~t~~y~aPE~~~~----~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 310 (394)
... .......+++.|+|||++.+ ...++.++|+|||||++|+|++|..||............... +
T Consensus 162 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~---~------ 232 (272)
T cd06637 162 DRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRN---P------ 232 (272)
T ss_pred ccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcC---C------
Confidence 322 22234567889999999853 224788999999999999999999999765443322222110 0
Q ss_pred ccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 016184 311 CMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368 (394)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f 368 (394)
........++.++.+||.+||..||.+|||+.++++||||
T Consensus 233 ------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~ 272 (272)
T cd06637 233 ------------------APRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI 272 (272)
T ss_pred ------------------CCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence 0001113467899999999999999999999999999998
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-44 Score=334.58 Aligned_cols=248 Identities=31% Similarity=0.474 Sum_probs=205.4
Q ss_pred EEeecCceEEEEEEECCCCcEEEEEEeccc----hhhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEEEEEEecccc
Q 016184 89 VVGTGSFGVVFQAKCRETGEIVAIKKVLQD----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPE 164 (394)
Q Consensus 89 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~~ 164 (394)
+||+|.||+||-|++..+...+|||.+... ..-..+|+.+-++|+|.|||++++++ .+..++-|+||-++|
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~-----senGf~kIFMEqVPG 656 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSV-----SENGFFKIFMEQVPG 656 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhcc-----CCCCeEEEEeecCCC
Confidence 699999999999999999999999988543 23446899999999999999999998 556678899999985
Q ss_pred -cHHHHHHHhhhhcCCC--CHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCccccccCC-C
Q 016184 165 -TVNRIARNYSRIHQRM--PLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE-P 240 (394)
Q Consensus 165 -~l~~~~~~~~~~~~~l--~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~~~-~ 240 (394)
+|..+++.-+ +++ .+..+-.+..||+.||.|||+ +.|||||||-+||||+...+.+||+|||-+++...-. -
T Consensus 657 GSLSsLLrskW---GPlKDNEstm~fYtkQILeGLkYLHe-n~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~ 732 (1226)
T KOG4279|consen 657 GSLSSLLRSKW---GPLKDNESTMNFYTKQILEGLKYLHE-NKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPC 732 (1226)
T ss_pred CcHHHHHHhcc---CCCccchhHHHHHHHHHHHHhhhhhh-cceeeccccCCcEEEeeccceEEecccccchhhccCCcc
Confidence 7888777643 455 788899999999999999999 8999999999999999887799999999998764433 3
Q ss_pred cccccccccccccccccC-CCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCCCccc
Q 016184 241 NVSYICSRYYRAPELIFG-ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 319 (394)
Q Consensus 241 ~~~~~~t~~y~aPE~~~~-~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 319 (394)
..++.||..|||||++.. ...|+.++|||||||++.||.||++||....... +.+++... +
T Consensus 733 TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgspq--AAMFkVGm----------------y 794 (1226)
T KOG4279|consen 733 TETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQ--AAMFKVGM----------------Y 794 (1226)
T ss_pred ccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChh--Hhhhhhcc----------------e
Confidence 446789999999999943 3459999999999999999999999997654332 22333211 0
Q ss_pred CCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 016184 320 KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL 371 (394)
Q Consensus 320 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 371 (394)
.....++..++.+++.||.+|+..||..||+|.+||..||++..
T Consensus 795 --------KvHP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~DpFlq~~ 838 (1226)
T KOG4279|consen 795 --------KVHPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQDPFLQHN 838 (1226)
T ss_pred --------ecCCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhccCcccccC
Confidence 01112446789999999999999999999999999999999987
|
|
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-42 Score=315.61 Aligned_cols=261 Identities=23% Similarity=0.342 Sum_probs=206.5
Q ss_pred cceeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccc---hhhhHHHHHHHHHc-CCCCeeeeceEEEecCCCceeEE
Q 016184 80 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD---KRYKNRELQIMQML-DHPNIVALKHCFFSTTDKEELYL 155 (394)
Q Consensus 80 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~ 155 (394)
...+|++.+.||+|+||.||+|.+..+++.+|+|++... .....+|+.+++.+ +|+||+++++++.........+.
T Consensus 16 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~ 95 (286)
T cd06638 16 PSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQL 95 (286)
T ss_pred cccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccchHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeE
Confidence 345699999999999999999999999999999987542 23456789999998 79999999998865544455678
Q ss_pred EEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCccc
Q 016184 156 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV 234 (394)
Q Consensus 156 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~ 234 (394)
+++|||+++ +|.+++.........+++..++.++.|++.||.|||+ .+++||||||+||+++.++ .++|+|||++..
T Consensus 96 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dlkp~nili~~~~-~~kl~dfg~~~~ 173 (286)
T cd06638 96 WLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHV-NKTIHRDVKGNNILLTTEG-GVKLVDFGVSAQ 173 (286)
T ss_pred EEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHh-CCccccCCCHHhEEECCCC-CEEEccCCceee
Confidence 899999975 7777766554445678999999999999999999999 8999999999999999888 699999999876
Q ss_pred cccCC-CcccccccccccccccccC----CCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhh
Q 016184 235 LVKGE-PNVSYICSRYYRAPELIFG----ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI 309 (394)
Q Consensus 235 ~~~~~-~~~~~~~t~~y~aPE~~~~----~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 309 (394)
..... ......+++.|+|||++.. ...++.++|||||||++|+|++|+.||........+..+... .++
T Consensus 174 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~--~~~---- 247 (286)
T cd06638 174 LTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRN--PPP---- 247 (286)
T ss_pred cccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhcccc--CCC----
Confidence 54322 2233467899999998742 233788999999999999999999999766543333221110 000
Q ss_pred hccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 016184 310 KCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368 (394)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f 368 (394)
....+...+..+.+||.+||+.||++|||+.++++||||
T Consensus 248 --------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~ 286 (286)
T cd06638 248 --------------------TLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286 (286)
T ss_pred --------------------cccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence 000113357789999999999999999999999999997
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-42 Score=316.37 Aligned_cols=248 Identities=30% Similarity=0.495 Sum_probs=205.2
Q ss_pred eEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccc-------hhhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEE
Q 016184 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL 155 (394)
Q Consensus 83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 155 (394)
+|++.+.||+|+||.||+|.+..+++.||+|++... .....+|+++++.+.||||+++++++. .....
T Consensus 2 ~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~ 76 (290)
T cd05580 2 DFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQ-----DDSNL 76 (290)
T ss_pred ceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEE-----cCCeE
Confidence 599999999999999999999999999999988542 233457999999999999999999883 34458
Q ss_pred EEEEeccc-ccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCccc
Q 016184 156 NLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV 234 (394)
Q Consensus 156 ~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~ 234 (394)
+++|||++ ++|.+.+.. ...+++..+..++.|++.||.|||+ .|++|+||+|.|||++.++ .+||+|||++..
T Consensus 77 ~~v~e~~~~~~L~~~~~~----~~~l~~~~~~~~~~qil~~l~~lH~-~~i~H~dl~p~nili~~~~-~~kl~dfg~~~~ 150 (290)
T cd05580 77 YLVMEYVPGGELFSHLRK----SGRFPEPVARFYAAQVVLALEYLHS-LDIVYRDLKPENLLLDSDG-YIKITDFGFAKR 150 (290)
T ss_pred EEEEecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCEecCCCCHHHEEECCCC-CEEEeeCCCccc
Confidence 89999995 577666543 3678999999999999999999999 8999999999999999887 699999999876
Q ss_pred cccCCCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCC
Q 016184 235 LVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 314 (394)
Q Consensus 235 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 314 (394)
.... .....+++.|+|||.+.+. ..+.++|+||||+++|+|++|..||...+.......+... .
T Consensus 151 ~~~~--~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~--~----------- 214 (290)
T cd05580 151 VKGR--TYTLCGTPEYLAPEIILSK-GYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEG--K----------- 214 (290)
T ss_pred cCCC--CCCCCCCccccChhhhcCC-CCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC--C-----------
Confidence 5443 3345678899999998654 4789999999999999999999999876644444433321 0
Q ss_pred CCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCC-----CHHHHhcCCCCCCCCC
Q 016184 315 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-----TALEACVHPFFDELRD 373 (394)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----t~~ell~hp~f~~~~~ 373 (394)
.. ++..++..++++|.+||+.||.+|+ +++++++||||+.+..
T Consensus 215 ----~~------------~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~ 262 (290)
T cd05580 215 ----VR------------FPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWFAGIDW 262 (290)
T ss_pred ----cc------------CCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcCcccccCCH
Confidence 00 1234688999999999999999999 9999999999988763
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=316.39 Aligned_cols=274 Identities=40% Similarity=0.727 Sum_probs=219.4
Q ss_pred EEEeeEEeecCceEEEEEEECCCCcEEEEEEeccch------hhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEEEE
Q 016184 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL 157 (394)
Q Consensus 84 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 157 (394)
|.+.+.||.|++|.||+|.+..+++.+|+|.+.... ....+|+++++.++|+||+++++++.. ....++
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~~~ 75 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRH-----KGDLYL 75 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhcc-----CCCEEE
Confidence 567889999999999999999899999999875432 234578999999999999999998733 345789
Q ss_pred EEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCcccccc
Q 016184 158 VLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK 237 (394)
Q Consensus 158 v~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~ 237 (394)
++||+++++...+... ...+++..+..++.|++.||.|||+ .||+|+||||+||+++.++ .++|+|||.+.....
T Consensus 76 v~e~~~~~l~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~LH~-~~i~H~dl~p~nili~~~~-~~~l~df~~~~~~~~ 150 (283)
T cd05118 76 VFEFMDTDLYKLIKDR---QRGLPESLIKSYLYQLLQGLAFCHS-HGILHRDLKPENLLINTEG-VLKLADFGLARSFGS 150 (283)
T ss_pred EEeccCCCHHHHHHhh---cccCCHHHHHHHHHHHHHHHHHHHH-CCeeecCcCHHHEEECCCC-cEEEeeeeeeEecCC
Confidence 9999998876665542 2578999999999999999999999 8999999999999999887 699999999876644
Q ss_pred CC-CcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCC--
Q 016184 238 GE-PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP-- 314 (394)
Q Consensus 238 ~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~-- 314 (394)
.. ......++..|+|||.+.+...++.++|+||||+++|+|++|+.||...+..+.+..+...++.+....+.....
T Consensus 151 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (283)
T cd05118 151 PVRPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLA 230 (283)
T ss_pred CcccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhh
Confidence 33 222345778899999987654689999999999999999999999998888888888888777776665544332
Q ss_pred CCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 016184 315 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368 (394)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f 368 (394)
......++........ .....++.++++||.+||+.||.+||++.++++||||
T Consensus 231 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~ 283 (283)
T cd05118 231 RNYKFSFPKKAGMPLP-KLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283 (283)
T ss_pred hhhhhhhccccccCHH-HhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence 1111222222222221 1234578999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=325.84 Aligned_cols=250 Identities=24% Similarity=0.369 Sum_probs=192.0
Q ss_pred ceeEEEeeEEeecCceEEEEEEEC-----CCCcEEEEEEeccc-----hhhhHHHHHHHHHc-CCCCeeeeceEEEecCC
Q 016184 81 KVSYIAEHVVGTGSFGVVFQAKCR-----ETGEIVAIKKVLQD-----KRYKNRELQIMQML-DHPNIVALKHCFFSTTD 149 (394)
Q Consensus 81 ~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~ 149 (394)
+++|++.++||.|+||.||+|.+. .+++.||||++... .....+|+.+++.+ +||||+++++++...
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~-- 83 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKP-- 83 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCC--
Confidence 346999999999999999999852 34578999988642 23355799999999 899999999987422
Q ss_pred CceeEEEEEEecccc-cHHHHHHHhhh-----------------------------------------------------
Q 016184 150 KEELYLNLVLEYVPE-TVNRIARNYSR----------------------------------------------------- 175 (394)
Q Consensus 150 ~~~~~~~lv~e~~~~-~l~~~~~~~~~----------------------------------------------------- 175 (394)
...++++|||+++ +|.+++.....
T Consensus 84 --~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (338)
T cd05102 84 --NGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQ 161 (338)
T ss_pred --CCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccch
Confidence 2346789999984 77777654221
Q ss_pred -----hcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCccccccCCC---ccccccc
Q 016184 176 -----IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP---NVSYICS 247 (394)
Q Consensus 176 -----~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~~t 247 (394)
....+++..+..++.||+.||+|||+ .||+||||||+|||++.++ .+||+|||+++....... .....++
T Consensus 162 ~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~-~~ivHrDiKp~Nil~~~~~-~~kl~DfG~a~~~~~~~~~~~~~~~~~~ 239 (338)
T cd05102 162 ETDDLWKSPLTMEDLICYSFQVARGMEFLAS-RKCIHRDLAARNILLSENN-VVKICDFGLARDIYKDPDYVRKGSARLP 239 (338)
T ss_pred hccccccCCCCHHHHHHHHHHHHHHHHHHHH-CCEECCCCccceEEEcCCC-cEEEeecccccccccCcchhcccCCCCC
Confidence 02357788899999999999999999 8999999999999999887 799999999976533221 1123446
Q ss_pred ccccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCCCcccCCCCCCC
Q 016184 248 RYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKP 326 (394)
Q Consensus 248 ~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (394)
+.|+|||++.+. .++.++|||||||++|+|++ |..||.+......+......... .
T Consensus 240 ~~y~aPE~~~~~-~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~---------------~------- 296 (338)
T cd05102 240 LKWMAPESIFDK-VYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTR---------------M------- 296 (338)
T ss_pred ccccCcHHhhcC-CCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCC---------------C-------
Confidence 789999998654 48999999999999999997 99999876543333332221000 0
Q ss_pred CCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 016184 327 HPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV 364 (394)
Q Consensus 327 ~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 364 (394)
..+..+++++.+||.+||+.||.+|||+.++++
T Consensus 297 -----~~~~~~~~~l~~li~~cl~~dp~~RPs~~el~~ 329 (338)
T cd05102 297 -----RAPENATPEIYRIMLACWQGDPKERPTFSALVE 329 (338)
T ss_pred -----CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 012457889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=316.36 Aligned_cols=255 Identities=26% Similarity=0.436 Sum_probs=199.6
Q ss_pred eEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccc-----hhhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEEEE
Q 016184 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL 157 (394)
Q Consensus 83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 157 (394)
+|++.++||+|+||.||+|++..+++.||+|++... ...+.+|++++++++||||+++++.+... ...++
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~~l 76 (279)
T cd06619 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVE-----NRISI 76 (279)
T ss_pred cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEEC-----CEEEE
Confidence 488899999999999999999999999999987543 12345799999999999999999988432 34679
Q ss_pred EEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCcccccc
Q 016184 158 VLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK 237 (394)
Q Consensus 158 v~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~ 237 (394)
+|||+++...... ..+++..+..++.|++.||.|||+ .||+|+||||+|||++.++ .++|+|||++.....
T Consensus 77 v~e~~~~~~l~~~-------~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~Nill~~~~-~~~l~dfg~~~~~~~ 147 (279)
T cd06619 77 CTEFMDGGSLDVY-------RKIPEHVLGRIAVAVVKGLTYLWS-LKILHRDVKPSNMLVNTRG-QVKLCDFGVSTQLVN 147 (279)
T ss_pred EEecCCCCChHHh-------hcCCHHHHHHHHHHHHHHHHHHHH-CCEeeCCCCHHHEEECCCC-CEEEeeCCcceeccc
Confidence 9999997543211 357888999999999999999999 8999999999999999988 699999999876533
Q ss_pred CCCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHH---HHHHHHHhCCCChhhhhccCC
Q 016184 238 GEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQ---LVEIIKVLGTPTREEIKCMNP 314 (394)
Q Consensus 238 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~---~~~i~~~~~~~~~~~~~~~~~ 314 (394)
. ......++..|+|||.+.+. .++.++|+||||+++|+|++|+.||........ .............
T Consensus 148 ~-~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~-------- 217 (279)
T cd06619 148 S-IAKTYVGTNAYMAPERISGE-QYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDP-------- 217 (279)
T ss_pred c-cccCCCCChhhcCceeecCC-CCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCC--------
Confidence 2 23345788999999998654 489999999999999999999999965322110 1111111100000
Q ss_pred CCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCC
Q 016184 315 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNT 376 (394)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~ 376 (394)
. .......++++.+||.+||+.||++||+++++++||||+...+...
T Consensus 218 ----~-----------~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~~~~~~~~~~~ 264 (279)
T cd06619 218 ----P-----------VLPVGQFSEKFVHFITQCMRKQPKERPAPENLMDHPFIVQYNDGNA 264 (279)
T ss_pred ----C-----------CCCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCcccccccCccH
Confidence 0 0011346789999999999999999999999999999998865543
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=340.80 Aligned_cols=287 Identities=21% Similarity=0.280 Sum_probs=198.8
Q ss_pred ceeEEEeeEEeecCceEEEEEEECCCC-cEEEEE------------------Eecc---chhhhHHHHHHHHHcCCCCee
Q 016184 81 KVSYIAEHVVGTGSFGVVFQAKCRETG-EIVAIK------------------KVLQ---DKRYKNRELQIMQMLDHPNIV 138 (394)
Q Consensus 81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~-~~vaiK------------------~~~~---~~~~~~~E~~~l~~l~h~~iv 138 (394)
..+|++++.||+|+||+||+|..+... ..+++| .+.. ....+.+|+.+++.++|+||+
T Consensus 147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv 226 (501)
T PHA03210 147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL 226 (501)
T ss_pred hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence 357999999999999999998765332 112222 1111 122346799999999999999
Q ss_pred eeceEEEecCCCceeEEEEEEecccccHHHHHHHhh-hhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEE
Q 016184 139 ALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYS-RIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLV 217 (394)
Q Consensus 139 ~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~-~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~ 217 (394)
++++++.. ....+++++++.+++...+.... ..........++.++.||+.||+|||+ +||+||||||+|||+
T Consensus 227 ~l~~~~~~-----~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~-~gIiHrDLKP~NILl 300 (501)
T PHA03210 227 KIEEILRS-----EANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHD-KKLIHRDIKLENIFL 300 (501)
T ss_pred cEeEEEEE-----CCeeEEEEeccccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEE
Confidence 99998833 33477899999887766554321 112334466788899999999999999 899999999999999
Q ss_pred eCCCCcEEEEeecCccccccCCC--cccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCC-CCCC--CcHH
Q 016184 218 NPHTHQLKLCDFGSAKVLVKGEP--NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPL-FPGE--SGVD 292 (394)
Q Consensus 218 ~~~~~~vkl~Dfg~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~p-f~~~--~~~~ 292 (394)
+.++ .+||+|||++........ .....||+.|+|||++.+. .++.++|||||||++|+|++|..+ |... ....
T Consensus 301 ~~~~-~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~ 378 (501)
T PHA03210 301 NCDG-KIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGD-GYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGK 378 (501)
T ss_pred CCCC-CEEEEeCCCceecCcccccccccccCCcCCCCchhhcCC-CCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHH
Confidence 9888 699999999976643322 2345789999999999665 489999999999999999998754 4332 3345
Q ss_pred HHHHHHHHhCCCChhhhhccC---CCCcccCCCCCCCCCcchhc-cccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 016184 293 QLVEIIKVLGTPTREEIKCMN---PNYTEFKFPQIKPHPWHKVF-QKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368 (394)
Q Consensus 293 ~~~~i~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f 368 (394)
.+.+++..++....+...... .......+... .......+ ...++.++.++|.+||++||.+|||+.|+|.||||
T Consensus 379 ~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f 457 (501)
T PHA03210 379 QLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHA-GHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPLF 457 (501)
T ss_pred HHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccC-ccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChhh
Confidence 555555554433222110000 00000000000 00111111 12467889999999999999999999999999999
Q ss_pred CCCCCCCC
Q 016184 369 DELRDPNT 376 (394)
Q Consensus 369 ~~~~~~~~ 376 (394)
........
T Consensus 458 ~~~~~~~~ 465 (501)
T PHA03210 458 SAEEEEEI 465 (501)
T ss_pred hcCCchHH
Confidence 87654443
|
|
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-42 Score=315.19 Aligned_cols=275 Identities=39% Similarity=0.692 Sum_probs=218.9
Q ss_pred EEEeeEEeecCceEEEEEEECCCCcEEEEEEeccch-----hhhHHHHHHHHHcC-CCCeeeeceEEEecCCCceeEEEE
Q 016184 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLD-HPNIVALKHCFFSTTDKEELYLNL 157 (394)
Q Consensus 84 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~~l 157 (394)
|++.+.||.|++|.||+|+...+++.||||.+.... ....+|+..++.+. |+|++++++++.. ....++
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~-----~~~~~l 75 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRE-----NDELYF 75 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhc-----CCcEEE
Confidence 678899999999999999998889999999875432 22346888999998 9999999998833 345789
Q ss_pred EEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCcccccc
Q 016184 158 VLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK 237 (394)
Q Consensus 158 v~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~ 237 (394)
||||+++++.+.+.... ...+++..+..++.|++.||.|||+ +|++|+||+|+||+++.++ .++|+|||.+.....
T Consensus 76 v~e~~~~~l~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~Lh~-~~i~H~dl~~~ni~i~~~~-~~~l~d~~~~~~~~~ 151 (283)
T cd07830 76 VFEYMEGNLYQLMKDRK--GKPFSESVIRSIIYQILQGLAHIHK-HGFFHRDLKPENLLVSGPE-VVKIADFGLAREIRS 151 (283)
T ss_pred EEecCCCCHHHHHHhcc--cccCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCChhhEEEcCCC-CEEEeecccceeccC
Confidence 99999888877665422 2478999999999999999999999 8999999999999999887 799999999987655
Q ss_pred CCCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCC--
Q 016184 238 GEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN-- 315 (394)
Q Consensus 238 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~-- 315 (394)
........++..|+|||++.....++.++|+||||+++|+|++|+.||......+.+..+...++.+....+......
T Consensus 152 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (283)
T cd07830 152 RPPYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLAS 231 (283)
T ss_pred CCCcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhc
Confidence 444445667889999998866556899999999999999999999999998888888888888887776544321110
Q ss_pred CcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 016184 316 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368 (394)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f 368 (394)
.....++..........+ ...+.++.+||++||+.||++|||+.|++.||||
T Consensus 232 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~ 283 (283)
T cd07830 232 KLGFRFPQFAPTSLHQLI-PNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283 (283)
T ss_pred cccccccccccccHHHHc-ccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence 011111211111112222 2337889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-42 Score=307.98 Aligned_cols=249 Identities=28% Similarity=0.433 Sum_probs=200.5
Q ss_pred eEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccch------hhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEEE
Q 016184 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN 156 (394)
Q Consensus 83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 156 (394)
+|++.+.||.|++|.||++.+..+++.||+|.+.... ....+|+++++.++|+|++++.+.+. ....+.+
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~----~~~~~~~ 76 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWE----GEDGLLY 76 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeec----CCCCEEE
Confidence 3999999999999999999999999999999875321 23456899999999999999987662 2234578
Q ss_pred EEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCcccc
Q 016184 157 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL 235 (394)
Q Consensus 157 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~ 235 (394)
++|||+++ ++.+.+... ....+++..++.++.|++.||++||+ .|++|+||||+||+++.++ .++|+|||++...
T Consensus 77 lv~e~~~~~~l~~~l~~~--~~~~l~~~~~~~~~~~l~~~l~~lH~-~~i~H~di~p~nil~~~~~-~~~l~df~~~~~~ 152 (257)
T cd08223 77 IVMGFCEGGDLYHKLKEQ--KGKLLPENQVVEWFVQIAMALQYLHE-KHILHRDLKTQNVFLTRTN-IIKVGDLGIARVL 152 (257)
T ss_pred EEecccCCCcHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCchhEEEecCC-cEEEecccceEEe
Confidence 99999985 676666542 23568999999999999999999999 8999999999999999887 6999999998765
Q ss_pred ccCCC-cccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCC
Q 016184 236 VKGEP-NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 314 (394)
Q Consensus 236 ~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 314 (394)
..... .....+++.|+|||++.+. .++.++|+||||+++|+|++|+.||...+.......+.... .
T Consensus 153 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~--~---------- 219 (257)
T cd08223 153 ENQCDMASTLIGTPYYMSPELFSNK-PYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGK--L---------- 219 (257)
T ss_pred cccCCccccccCCcCccChhHhcCC-CCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcC--C----------
Confidence 43222 2234578899999998654 48899999999999999999999998766444433332210 0
Q ss_pred CCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 016184 315 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368 (394)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f 368 (394)
+ ..+..+++.+.+||.+||+.||++|||+.++++||||
T Consensus 220 -------~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~ 257 (257)
T cd08223 220 -------P---------PMPKDYSPELGELIATMLSKRPEKRPSVKSILRQPYI 257 (257)
T ss_pred -------C---------CCccccCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 0 0123578899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=325.97 Aligned_cols=257 Identities=27% Similarity=0.427 Sum_probs=197.3
Q ss_pred eeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccc------hhhhHHHHHHHHHc-CCCCeeeeceEEEecCCCceeE
Q 016184 82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQML-DHPNIVALKHCFFSTTDKEELY 154 (394)
Q Consensus 82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~ 154 (394)
..|+++++||.||.+.||++... +.+.||+|.+... ...+.+|++.|.+| .|.+|++++++- -.+.+
T Consensus 361 ~~Yeilk~iG~GGSSkV~kV~~s-~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYE-----v~d~~ 434 (677)
T KOG0596|consen 361 REYEILKQIGSGGSSKVFKVLNS-DKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYE-----VTDGY 434 (677)
T ss_pred chhhHHHhhcCCCcceeeeeecC-CCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeee-----ccCce
Confidence 35999999999999999999974 4566777765322 23456899999999 689999999976 34667
Q ss_pred EEEEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCccc
Q 016184 155 LNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV 234 (394)
Q Consensus 155 ~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~ 234 (394)
+||||||-..+|..++.... ..++.-.++.+..||+.|+.++|. .||||.||||.|+|+- .| .+||+|||.|..
T Consensus 435 lYmvmE~Gd~DL~kiL~k~~---~~~~~~~lk~ywkqML~aV~~IH~-~gIVHSDLKPANFLlV-kG-~LKLIDFGIA~a 508 (677)
T KOG0596|consen 435 LYMVMECGDIDLNKILKKKK---SIDPDWFLKFYWKQMLLAVKTIHQ-HGIVHSDLKPANFLLV-KG-RLKLIDFGIANA 508 (677)
T ss_pred EEEEeecccccHHHHHHhcc---CCCchHHHHHHHHHHHHHHHHHHH-hceeecCCCcccEEEE-ee-eEEeeeechhcc
Confidence 99999999999999888743 234434888999999999999999 8999999999999988 35 699999999987
Q ss_pred cccCCCc---ccccccccccccccccCCC----------CCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHh
Q 016184 235 LVKGEPN---VSYICSRYYRAPELIFGAT----------EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVL 301 (394)
Q Consensus 235 ~~~~~~~---~~~~~t~~y~aPE~~~~~~----------~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~ 301 (394)
+..+... .+.+||+.||+||.+.... ..++++||||||||||+|+.|++||.... ..++++..+
T Consensus 509 I~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~--n~~aKl~aI- 585 (677)
T KOG0596|consen 509 IQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQII--NQIAKLHAI- 585 (677)
T ss_pred cCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHH--HHHHHHHhh-
Confidence 7655433 3578999999999984321 15679999999999999999999996532 122222221
Q ss_pred CCCChhhhhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCC
Q 016184 302 GTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 375 (394)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~ 375 (394)
..| + ..+.++.. .-..++.++++.||++||.+|||+.+||+|||++-..-+.
T Consensus 586 ~~P----------~-~~Iefp~~-----------~~~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~~~i~~ 637 (677)
T KOG0596|consen 586 TDP----------N-HEIEFPDI-----------PENDELIDVMKCCLARDPKKRWSIPELLQHPFLQIQPIPV 637 (677)
T ss_pred cCC----------C-ccccccCC-----------CCchHHHHHHHHHHhcCcccCCCcHHHhcCcccccccccc
Confidence 111 1 11222221 0122399999999999999999999999999998754443
|
|
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=315.23 Aligned_cols=251 Identities=25% Similarity=0.407 Sum_probs=205.6
Q ss_pred eEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccch-----hhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEEEE
Q 016184 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL 157 (394)
Q Consensus 83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 157 (394)
+|++.+.||.|++|.||+|++..+++.||+|.+.... ..+.+|+++++.++|+||+++.+++. +..+.++
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~~ 76 (274)
T cd06609 2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFL-----KGSKLWI 76 (274)
T ss_pred hhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEE-----ECCeEEE
Confidence 5889999999999999999999999999999875432 23467999999999999999999874 3355889
Q ss_pred EEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCccccc
Q 016184 158 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV 236 (394)
Q Consensus 158 v~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~ 236 (394)
++||+++ ++.+.+.. ..+++..++.++.|++.||.|||+ .+++|+||+|+||+++.++ .++|+|||++....
T Consensus 77 v~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lh~-~~i~h~dl~p~ni~i~~~~-~~~l~d~g~~~~~~ 149 (274)
T cd06609 77 IMEYCGGGSCLDLLKP-----GKLDETYIAFILREVLLGLEYLHE-EGKIHRDIKAANILLSEEG-DVKLADFGVSGQLT 149 (274)
T ss_pred EEEeeCCCcHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHHEEECCCC-CEEEcccccceeec
Confidence 9999986 66665553 378999999999999999999999 8999999999999999887 69999999997765
Q ss_pred cC-CCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCC
Q 016184 237 KG-EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 315 (394)
Q Consensus 237 ~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 315 (394)
.. .......+++.|+|||.+.+.. ++.++||||||+++|+|++|..||...+.......+.....
T Consensus 150 ~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~------------- 215 (274)
T cd06609 150 STMSKRNTFVGTPFWMAPEVIKQSG-YDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNP------------- 215 (274)
T ss_pred ccccccccccCCccccChhhhccCC-CCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcCC-------------
Confidence 43 2233456788899999996554 89999999999999999999999977654443333222100
Q ss_pred CcccCCCCCCCCCcchhcccc-CChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCC
Q 016184 316 YTEFKFPQIKPHPWHKVFQKR-LPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP 374 (394)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~ 374 (394)
..+... ++.++.++|.+||..||++|||++++++||||++....
T Consensus 216 ---------------~~~~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~~~~~~~~~~ 260 (274)
T cd06609 216 ---------------PSLEGNKFSKPFKDFVSLCLNKDPKERPSAKELLKHKFIKKAKKT 260 (274)
T ss_pred ---------------CCCcccccCHHHHHHHHHHhhCChhhCcCHHHHhhChhhcCCCcc
Confidence 001122 68899999999999999999999999999999987655
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-43 Score=339.37 Aligned_cols=256 Identities=25% Similarity=0.411 Sum_probs=203.3
Q ss_pred eeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccc----hhhhHHHHHHHHHcC-CCCeeeece-EEEecCCCc-eeE
Q 016184 82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD----KRYKNRELQIMQMLD-HPNIVALKH-CFFSTTDKE-ELY 154 (394)
Q Consensus 82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~E~~~l~~l~-h~~iv~~~~-~~~~~~~~~-~~~ 154 (394)
.+++|.++|.+|||+.||+|++...|..||+|++... .+...+|+++|++|. |+|||.+++ ......... ..-
T Consensus 37 ~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~E 116 (738)
T KOG1989|consen 37 HRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWE 116 (738)
T ss_pred EEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeE
Confidence 3599999999999999999999988899999987533 244568999999995 999999999 444333333 455
Q ss_pred EEEEEeccc-ccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCC--ceeccCCCCceEEeCCCCcEEEEeecC
Q 016184 155 LNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG--ICHRDIKPQNLLVNPHTHQLKLCDFGS 231 (394)
Q Consensus 155 ~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~g--ivH~Dlkp~Nil~~~~~~~vkl~Dfg~ 231 (394)
+.|+||||. ++|.+++..+.. .+|.+.++++|+.++++|+.+||. .. |||||||-|||||..++ .+||||||.
T Consensus 117 vllLmEyC~gg~Lvd~mn~Rlq--~~lte~eVLkIf~dv~~AVa~mH~-~~pPiIHRDLKiENvLls~~g-~~KLCDFGS 192 (738)
T KOG1989|consen 117 VLLLMEYCKGGSLVDFMNTRLQ--TRLTEDEVLKIFYDVCEAVAAMHY-LKPPIIHRDLKIENVLLSADG-NYKLCDFGS 192 (738)
T ss_pred EEeehhhccCCcHHHHHHHHHh--ccCChHHHHHHHHHHHHHHHHHhc-CCCccchhhhhhhheEEcCCC-CEEeCcccc
Confidence 778999999 689888886554 569999999999999999999998 66 99999999999999988 699999999
Q ss_pred ccccccCCC----------ccccccccccccccccc--CCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHH
Q 016184 232 AKVLVKGEP----------NVSYICSRYYRAPELIF--GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIK 299 (394)
Q Consensus 232 a~~~~~~~~----------~~~~~~t~~y~aPE~~~--~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~ 299 (394)
|+....... ......|+.|+|||++. .....++|+|||+|||+||.|+....||....... |+.
T Consensus 193 att~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~la----Iln 268 (738)
T KOG1989|consen 193 ATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLA----ILN 268 (738)
T ss_pred cccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCccee----EEe
Confidence 865432221 12235699999999972 34458999999999999999999999997653211 111
Q ss_pred HhCCCChhhhhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhc--------CCCCCCC
Q 016184 300 VLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV--------HPFFDEL 371 (394)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~--------hp~f~~~ 371 (394)
..|.+|.. +.++..+.+||+.||+.||.+||++-+++. ++|+.++
T Consensus 269 -----------------g~Y~~P~~----------p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~~~~~~~ 321 (738)
T KOG1989|consen 269 -----------------GNYSFPPF----------PNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKPCPIPDI 321 (738)
T ss_pred -----------------ccccCCCC----------ccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCCCCcccc
Confidence 12333321 457899999999999999999999988873 5666665
Q ss_pred C
Q 016184 372 R 372 (394)
Q Consensus 372 ~ 372 (394)
.
T Consensus 322 ~ 322 (738)
T KOG1989|consen 322 Y 322 (738)
T ss_pred c
Confidence 5
|
|
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-42 Score=307.93 Aligned_cols=249 Identities=27% Similarity=0.450 Sum_probs=204.6
Q ss_pred eEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccc------hhhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEEE
Q 016184 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN 156 (394)
Q Consensus 83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 156 (394)
+|++.+.||+|+||.||+|.+..+++.+|+|.+... ...+.+|+++++.++|+|++++++.+. .....+
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-----~~~~~~ 75 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFL-----EDKALM 75 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEe-----cCCEEE
Confidence 489999999999999999999999999999987543 234557999999999999999998773 334578
Q ss_pred EEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCcccc
Q 016184 157 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL 235 (394)
Q Consensus 157 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~ 235 (394)
+||||+++ +|.+++.... ...+++..+..++.|++.||+|||+ +|++|+||||+||+++.++..++|+|||.+...
T Consensus 76 lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lh~-~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~ 152 (256)
T cd08220 76 IVMEYAPGGTLAEYIQKRC--NSLLDEDTILHFFVQILLALHHVHT-KLILHRDLKTQNILLDKHKMVVKIGDFGISKIL 152 (256)
T ss_pred EEEecCCCCCHHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEcCCCCEEEEccCCCceec
Confidence 99999975 7777665422 3458999999999999999999999 899999999999999876657899999999876
Q ss_pred ccCCCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCC
Q 016184 236 VKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 315 (394)
Q Consensus 236 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 315 (394)
..........++..|+|||.+.+. .++.++|+||||+++|+|++|..||...+.......+......
T Consensus 153 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~------------ 219 (256)
T cd08220 153 SSKSKAYTVVGTPCYISPELCEGK-PYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFA------------ 219 (256)
T ss_pred CCCccccccccCCcccCchhccCC-CCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCCC------------
Confidence 555444456678899999998654 4789999999999999999999999876655444443321100
Q ss_pred CcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 016184 316 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368 (394)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f 368 (394)
.++..++.++.+++.+||+.||++|||+.++++||||
T Consensus 220 ----------------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~p~~ 256 (256)
T cd08220 220 ----------------PISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQPIC 256 (256)
T ss_pred ----------------CCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhCCCC
Confidence 0123578899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-42 Score=314.36 Aligned_cols=256 Identities=26% Similarity=0.396 Sum_probs=201.8
Q ss_pred eeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccch---hhhHHHHHHHHHc-CCCCeeeeceEEEecCC-CceeEEE
Q 016184 82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---RYKNRELQIMQML-DHPNIVALKHCFFSTTD-KEELYLN 156 (394)
Q Consensus 82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~-~~~~~~~ 156 (394)
+.|++.+.||.|+||.||+|.+..+++.+|+|++.... .....|+.+++++ +|+||+++++++..... ....+.+
T Consensus 16 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~ 95 (282)
T cd06636 16 GIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLW 95 (282)
T ss_pred hhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCEEE
Confidence 35999999999999999999999999999999875432 3445688888888 79999999998854322 2345688
Q ss_pred EEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCcccc
Q 016184 157 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL 235 (394)
Q Consensus 157 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~ 235 (394)
++|||+++ ++.+++.... ...+++..++.++.|++.||.|||+ .||+|+||||+||+++.++ .++|+|||++...
T Consensus 96 iv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~-~~ivH~dl~~~nili~~~~-~~~l~dfg~~~~~ 171 (282)
T cd06636 96 LVMEFCGAGSVTDLVKNTK--GNALKEDWIAYICREILRGLAHLHA-HKVIHRDIKGQNVLLTENA-EVKLVDFGVSAQL 171 (282)
T ss_pred EEEEeCCCCcHHHHHHHcc--CCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEECCCC-CEEEeeCcchhhh
Confidence 99999986 7777665432 3568888899999999999999999 8999999999999999887 6999999998754
Q ss_pred ccC-CCcccccccccccccccccC----CCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhh
Q 016184 236 VKG-EPNVSYICSRYYRAPELIFG----ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 310 (394)
Q Consensus 236 ~~~-~~~~~~~~t~~y~aPE~~~~----~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 310 (394)
... .......+++.|+|||.+.. ...++.++|+|||||++|+|++|..||........+..+... ..
T Consensus 172 ~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~---~~----- 243 (282)
T cd06636 172 DRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRN---PP----- 243 (282)
T ss_pred hccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhC---CC-----
Confidence 322 22234567889999998752 234788999999999999999999999765543333222110 00
Q ss_pred ccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 016184 311 CMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368 (394)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f 368 (394)
.......++.++.+||.+||+.||.+|||+.+||+||||
T Consensus 244 -------------------~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~ 282 (282)
T cd06636 244 -------------------PKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI 282 (282)
T ss_pred -------------------CCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence 000113578899999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-43 Score=293.84 Aligned_cols=257 Identities=25% Similarity=0.341 Sum_probs=203.8
Q ss_pred eeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccch----hhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEEEE
Q 016184 82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL 157 (394)
Q Consensus 82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 157 (394)
.+|+|.+.||+|||+.||+++...++..||+|++.-.. ....+|++..++++|||+++++++.+....+.....|+
T Consensus 21 ~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~yl 100 (302)
T KOG2345|consen 21 KRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAYL 100 (302)
T ss_pred ceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEEE
Confidence 36999999999999999999999999999999885433 34457999999999999999988876555445566789
Q ss_pred EEeccc-ccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCC--ceeccCCCCceEEeCCCCcEEEEeecCccc
Q 016184 158 VLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG--ICHRDIKPQNLLVNPHTHQLKLCDFGSAKV 234 (394)
Q Consensus 158 v~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~g--ivH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~ 234 (394)
+++|.. |++.+.+......+..+++..+..|+.+|+.||++||+ .. ++||||||.|||+...+ .++|.|||+++.
T Consensus 101 l~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~-~~~~yAH~DiKP~NILls~~~-~~vl~D~GS~~~ 178 (302)
T KOG2345|consen 101 LLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHE-KEPPYAHRDIKPANILLSDSG-LPVLMDLGSATQ 178 (302)
T ss_pred EeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhc-cCCcccccCCCcceeEecCCC-ceEEEeccCccc
Confidence 999877 67988888888777899999999999999999999999 78 99999999999999877 799999999876
Q ss_pred cccCC----------CcccccccccccccccccC--CCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhC
Q 016184 235 LVKGE----------PNVSYICSRYYRAPELIFG--ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLG 302 (394)
Q Consensus 235 ~~~~~----------~~~~~~~t~~y~aPE~~~~--~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~ 302 (394)
..-.- ......+|..|+|||.+.- ....++++|||||||++|+|+.|..||.... +..|
T Consensus 179 a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~---------~~Gg 249 (302)
T KOG2345|consen 179 APIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIY---------QQGG 249 (302)
T ss_pred cceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHh---------hcCC
Confidence 53221 1233457999999999832 2236889999999999999999999995321 1111
Q ss_pred CCChhhhhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 016184 303 TPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH 365 (394)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 365 (394)
..... -.+ ..+.+|+ ...+|+.+.+||+.||+.||.+||++.+++.+
T Consensus 250 SlaLA---v~n---~q~s~P~----------~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~ 296 (302)
T KOG2345|consen 250 SLALA---VQN---AQISIPN----------SSRYSEALHQLIKSMLQVDPNQRPTIPELLSK 296 (302)
T ss_pred eEEEe---eec---cccccCC----------CCCccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence 00000 000 1222222 13489999999999999999999999999864
|
|
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=317.70 Aligned_cols=265 Identities=22% Similarity=0.363 Sum_probs=204.4
Q ss_pred eEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccc-----hhhhHHHHHHHHHcC-CCCeeeeceEEEecCCCceeEEE
Q 016184 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-----KRYKNRELQIMQMLD-HPNIVALKHCFFSTTDKEELYLN 156 (394)
Q Consensus 83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~~ 156 (394)
.|...+.||+|+||.||++.+..+++.||+|.+... .....+|+.++.++. |+||+++++++... ...+
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~-----~~~~ 79 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFRE-----GDCW 79 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecC-----CcEE
Confidence 366778899999999999999999999999988643 223456888888885 99999999987432 2367
Q ss_pred EEEecccccHHHHHHHh-hhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCcccc
Q 016184 157 LVLEYVPETVNRIARNY-SRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL 235 (394)
Q Consensus 157 lv~e~~~~~l~~~~~~~-~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~ 235 (394)
++|||+..++..+.... ......+++..+..++.|++.||+|||+..+++||||||+||+++.++ .++|+|||++...
T Consensus 80 ~~~e~~~~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~-~~kl~dfg~~~~~ 158 (288)
T cd06616 80 ICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNG-NIKLCDFGISGQL 158 (288)
T ss_pred EEEecccCCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCC-cEEEeecchhHHh
Confidence 89999987766554332 222367999999999999999999999735999999999999999887 6999999999766
Q ss_pred ccCCCcccccccccccccccccCC--CCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccC
Q 016184 236 VKGEPNVSYICSRYYRAPELIFGA--TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 313 (394)
Q Consensus 236 ~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 313 (394)
..........++..|+|||++.+. ..++.++|||||||++|+|++|+.||.... .....+.+.....+.
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~--~~~~~~~~~~~~~~~------- 229 (288)
T cd06616 159 VDSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN--SVFDQLTQVVKGDPP------- 229 (288)
T ss_pred ccCCccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc--hHHHHHhhhcCCCCC-------
Confidence 544444445678899999998655 358899999999999999999999997654 222222221111000
Q ss_pred CCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCC
Q 016184 314 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNT 376 (394)
Q Consensus 314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~ 376 (394)
... ......++.++.+||.+||+.||++|||++++++||||++....+.
T Consensus 230 ---------~~~-----~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~~~~~~~ 278 (288)
T cd06616 230 ---------ILS-----NSEEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKDYEERNV 278 (288)
T ss_pred ---------cCC-----CcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhchhhcch
Confidence 000 0011347889999999999999999999999999999998765443
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=311.09 Aligned_cols=278 Identities=35% Similarity=0.608 Sum_probs=215.0
Q ss_pred EEEeeEEeecCceEEEEEEECCCCcEEEEEEeccch------hhhHHHHHHHHHc---CCCCeeeeceEEEecCCCceeE
Q 016184 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQML---DHPNIVALKHCFFSTTDKEELY 154 (394)
Q Consensus 84 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l---~h~~iv~~~~~~~~~~~~~~~~ 154 (394)
|++.+.||.|+||.||+|++..+++.||+|++.... ....+|+.+++++ .|+|++++++++..........
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 678899999999999999998889999999886321 2234577777666 6999999999986655444556
Q ss_pred EEEEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCccc
Q 016184 155 LNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV 234 (394)
Q Consensus 155 ~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~ 234 (394)
.+++|||+.+++.+++.... ...+++..++.++.|++.||.|||+ .|++|+||+|+||+++.++ .++|+|||++..
T Consensus 81 ~~l~~e~~~~~l~~~l~~~~--~~~l~~~~~~~~~~~i~~al~~LH~-~~i~h~~l~~~nili~~~~-~~~l~dfg~~~~ 156 (287)
T cd07838 81 LTLVFEHVDQDLATYLSKCP--KPGLPPETIKDLMRQLLRGVDFLHS-HRIVHRDLKPQNILVTSDG-QVKIADFGLARI 156 (287)
T ss_pred eEEEehhcccCHHHHHHHcc--CCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeccCChhhEEEccCC-CEEEeccCccee
Confidence 88999999988777665422 2368999999999999999999999 8999999999999999987 799999999977
Q ss_pred cccCCCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCC
Q 016184 235 LVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 314 (394)
Q Consensus 235 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 314 (394)
...........++..|+|||.+.+.. ++.++|+|||||++|+|++|.+||.+....+.+..+.+..+.+....+....
T Consensus 157 ~~~~~~~~~~~~~~~~~~PE~~~~~~-~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 234 (287)
T cd07838 157 YSFEMALTSVVVTLWYRAPEVLLQSS-YATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNV- 234 (287)
T ss_pred ccCCcccccccccccccChHHhccCC-CCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCc-
Confidence 65444444455788899999986544 8999999999999999999999999888888888887766554433221110
Q ss_pred CCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 016184 315 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368 (394)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f 368 (394)
......++....... ......+++.+.+||++||+.||.+||++.++++||||
T Consensus 235 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~ 287 (287)
T cd07838 235 SLPRSSFPSYTPRSF-KSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287 (287)
T ss_pred ccchhhcccccccch-hhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence 000011111111111 11223567889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-42 Score=316.01 Aligned_cols=260 Identities=27% Similarity=0.442 Sum_probs=204.3
Q ss_pred eEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccc-----hhhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEEEE
Q 016184 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL 157 (394)
Q Consensus 83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 157 (394)
+|++.+.||+|+||.||+|.+..+|+.||+|.+... .....+|+.+++.++|+||+++++++.. ..+.++
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-----~~~~~l 76 (286)
T cd06622 2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFI-----EGAVYM 76 (286)
T ss_pred hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheec-----CCeEEE
Confidence 489999999999999999999989999999987542 1234579999999999999999998733 345889
Q ss_pred EEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCccccc
Q 016184 158 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV 236 (394)
Q Consensus 158 v~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~ 236 (394)
+|||+++ ++..++... .....+++..+..++.|++.||.|||+..||+|+||||+||+++.++ .++|+|||++....
T Consensus 77 v~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~-~~~l~dfg~~~~~~ 154 (286)
T cd06622 77 CMEYMDAGSLDKLYAGG-VATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNG-QVKLCDFGVSGNLV 154 (286)
T ss_pred EEeecCCCCHHHHHHhc-cccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCC-CEEEeecCCccccc
Confidence 9999986 565555431 11347899999999999999999999635999999999999999877 79999999987553
Q ss_pred cCCCcccccccccccccccccCCC-----CCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhc
Q 016184 237 KGEPNVSYICSRYYRAPELIFGAT-----EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 311 (394)
Q Consensus 237 ~~~~~~~~~~t~~y~aPE~~~~~~-----~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 311 (394)
.. ......+++.|+|||.+.+.. .++.++|+|||||++|+|++|+.||...........+.......+.
T Consensus 155 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~----- 228 (286)
T cd06622 155 AS-LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPP----- 228 (286)
T ss_pred CC-ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCCC-----
Confidence 22 222345678899999985432 2578999999999999999999999765544333332222111100
Q ss_pred cCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCC
Q 016184 312 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 375 (394)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~ 375 (394)
.++..++.++.+||.+||+.||.+||++.++++||||.......
T Consensus 229 --------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~~~~~ 272 (286)
T cd06622 229 --------------------TLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYKNAD 272 (286)
T ss_pred --------------------CCCcccCHHHHHHHHHHcccCcccCCCHHHHhcChhhhhccCCc
Confidence 01234789999999999999999999999999999999887664
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=312.51 Aligned_cols=253 Identities=28% Similarity=0.442 Sum_probs=204.6
Q ss_pred eeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccc----hhhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEEEE
Q 016184 82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL 157 (394)
Q Consensus 82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 157 (394)
.+|++.+.||.|++|.||+|.+..+++.||+|.+... .....+|+.+++.++|+|++++++.+. .....++
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~~~~~l 93 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFL-----VGDELFV 93 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEe-----cCceEEE
Confidence 4599999999999999999999999999999987543 233457899999999999999999883 3345789
Q ss_pred EEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCccccc
Q 016184 158 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV 236 (394)
Q Consensus 158 v~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~ 236 (394)
|+||+.+ ++..++.. ..+++..+..++.|++.||+|||+ .|++|+||||+||+++.++ .++|+|||++....
T Consensus 94 v~e~~~~~~L~~~~~~-----~~l~~~~~~~i~~~l~~al~~LH~-~~i~H~dL~p~Nili~~~~-~~kl~dfg~~~~~~ 166 (296)
T cd06655 94 VMEYLAGGSLTDVVTE-----TCMDEAQIAAVCRECLQALEFLHA-NQVIHRDIKSDNVLLGMDG-SVKLTDFGFCAQIT 166 (296)
T ss_pred EEEecCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEECCCC-CEEEccCccchhcc
Confidence 9999985 66555542 568999999999999999999999 8999999999999999887 79999999987553
Q ss_pred cCCC-cccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCC
Q 016184 237 KGEP-NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 315 (394)
Q Consensus 237 ~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 315 (394)
.... .....++..|+|||.+.+. .++.++|+|||||++|+|++|+.||...+.......+... ..+..
T Consensus 167 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~-~~~~~--------- 235 (296)
T cd06655 167 PEQSKRSTMVGTPYWMAPEVVTRK-AYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATN-GTPEL--------- 235 (296)
T ss_pred cccccCCCcCCCccccCcchhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc-CCccc---------
Confidence 3322 2234678899999998644 4889999999999999999999999887655444333221 11000
Q ss_pred CcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q 016184 316 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD 373 (394)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~ 373 (394)
..+..+++.+.+||++||..||.+|||+.+++.||||+..+.
T Consensus 236 ----------------~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~~~~~~~~~ 277 (296)
T cd06655 236 ----------------QNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQHPFLKLAKP 277 (296)
T ss_pred ----------------CCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhChHhhhccc
Confidence 011357889999999999999999999999999999987764
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-42 Score=314.85 Aligned_cols=253 Identities=25% Similarity=0.397 Sum_probs=203.5
Q ss_pred eeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccch----hhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEEEE
Q 016184 82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL 157 (394)
Q Consensus 82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 157 (394)
.+|++.+.||+|+||.||+|.+..+++.||+|.+.... ....+|+.+++.+.|+||+++++.+.. ....++
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~-----~~~~~l 94 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLV-----GDELWV 94 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEe-----CCEEEE
Confidence 46999999999999999999999999999999875432 345578999999999999999998843 335789
Q ss_pred EEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCccccc
Q 016184 158 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV 236 (394)
Q Consensus 158 v~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~ 236 (394)
||||+++ ++.+++.. ..+++..+..++.|++.||.|||+ .||+|+||||+||+++.++ .++|+|||++....
T Consensus 95 v~e~~~~~~L~~~~~~-----~~~~~~~~~~i~~ql~~aL~~LH~-~gi~H~dLkp~Nill~~~~-~~kl~dfg~~~~~~ 167 (296)
T cd06654 95 VMEYLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHS-NQVIHRDIKSDNILLGMDG-SVKLTDFGFCAQIT 167 (296)
T ss_pred eecccCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEEcCCC-CEEECccccchhcc
Confidence 9999985 67666543 467889999999999999999999 8999999999999999887 79999999987543
Q ss_pred cCCC-cccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCC
Q 016184 237 KGEP-NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 315 (394)
Q Consensus 237 ~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 315 (394)
.... .....+++.|+|||.+.+. .++.++|+|||||++|+|++|+.||........+..+.. .+.+..
T Consensus 168 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~-~~~~~~--------- 236 (296)
T cd06654 168 PEQSKRSTMVGTPYWMAPEVVTRK-AYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIAT-NGTPEL--------- 236 (296)
T ss_pred ccccccCcccCCccccCHHHHcCC-CCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhc-CCCCCC---------
Confidence 3221 2234678899999998654 478999999999999999999999987665433322211 000000
Q ss_pred CcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q 016184 316 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD 373 (394)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~ 373 (394)
..+..++..+.+||.+||..||++|||+.++++||||+..+.
T Consensus 237 ----------------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~~ 278 (296)
T cd06654 237 ----------------QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIAKP 278 (296)
T ss_pred ----------------CCccccCHHHHHHHHHHCcCCcccCcCHHHHhhChhhhccCC
Confidence 011357888999999999999999999999999999987644
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=314.24 Aligned_cols=282 Identities=31% Similarity=0.505 Sum_probs=217.0
Q ss_pred ceeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccch------hhhHHHHHHHHHcCCCCeeeeceEEEecCC-----
Q 016184 81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTD----- 149 (394)
Q Consensus 81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~----- 149 (394)
..+|++.+.||+|+||.||+|.++.+|+.||+|++.... ....+|+++++.++||||+++++++....+
T Consensus 6 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~ 85 (302)
T cd07864 6 VDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFK 85 (302)
T ss_pred hhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhcc
Confidence 346999999999999999999999999999999885432 234579999999999999999988744331
Q ss_pred CceeEEEEEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEee
Q 016184 150 KEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDF 229 (394)
Q Consensus 150 ~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Df 229 (394)
....++++++||+++++...+... ...+++..++.++.|++.||.|||+ .||+|+||||+||+++.++ .+||+||
T Consensus 86 ~~~~~~~lv~e~~~~~l~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~-~~i~H~dl~p~nili~~~~-~~kl~df 160 (302)
T cd07864 86 KDKGAFYLVFEYMDHDLMGLLESG---LVHFSEDHIKSFMKQLLEGLNYCHK-KNFLHRDIKCSNILLNNKG-QIKLADF 160 (302)
T ss_pred ccCCcEEEEEcccCccHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEECCCC-cEEeCcc
Confidence 112368899999998776655432 3578999999999999999999999 8999999999999999887 6999999
Q ss_pred cCccccccCCC--cccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChh
Q 016184 230 GSAKVLVKGEP--NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 307 (394)
Q Consensus 230 g~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~ 307 (394)
|++........ .....++..|+|||.+.+...++.++|||||||++|+|++|++||...+..+.+..+.+..+.+...
T Consensus 161 g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (302)
T cd07864 161 GLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPA 240 (302)
T ss_pred cccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChh
Confidence 99876543321 1223457789999988655557899999999999999999999999888888888888777766655
Q ss_pred hhhccCCC--CcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 016184 308 EIKCMNPN--YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368 (394)
Q Consensus 308 ~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f 368 (394)
.+...... +............+.. ....++..+.+||.+||+.||.+|||+.+++.||||
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 302 (302)
T cd07864 241 VWPDVIKLPYFNTMKPKKQYRRRLRE-EFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL 302 (302)
T ss_pred hcccccccccccccccccccccchhh-hcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence 44322110 0000000000011111 123468999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-42 Score=311.26 Aligned_cols=260 Identities=26% Similarity=0.397 Sum_probs=207.4
Q ss_pred ceeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccch---hhhHHHHHHHHHc-CCCCeeeeceEEEecCC-CceeEE
Q 016184 81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---RYKNRELQIMQML-DHPNIVALKHCFFSTTD-KEELYL 155 (394)
Q Consensus 81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~-~~~~~~ 155 (394)
.++|++.+.||.|++|.||+|.+..+++.+++|++.... ..+.+|+.+++.+ .|+||+++++++..... ....+.
T Consensus 5 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~ 84 (275)
T cd06608 5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQL 84 (275)
T ss_pred hhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCchhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceEE
Confidence 457999999999999999999999889999999876432 3456799999998 79999999999865543 345667
Q ss_pred EEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCccc
Q 016184 156 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV 234 (394)
Q Consensus 156 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~ 234 (394)
+++|||+++ ++.+++.........+++..++.++.|++.||.|||+ .|++|+||+|+||+++.++ .++|+|||++..
T Consensus 85 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~-~~i~H~~l~p~ni~~~~~~-~~~l~d~~~~~~ 162 (275)
T cd06608 85 WLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHE-NKVIHRDIKGQNILLTKNA-EVKLVDFGVSAQ 162 (275)
T ss_pred EEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhc-CCcccCCCCHHHEEEccCC-eEEECCCcccee
Confidence 899999996 7777766544445789999999999999999999999 8999999999999999887 699999999875
Q ss_pred cccCC-CcccccccccccccccccC----CCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhh
Q 016184 235 LVKGE-PNVSYICSRYYRAPELIFG----ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI 309 (394)
Q Consensus 235 ~~~~~-~~~~~~~t~~y~aPE~~~~----~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 309 (394)
..... ......++..|+|||.+.. ...++.++||||||+++|+|++|..||........+..+.... ..
T Consensus 163 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~---~~--- 236 (275)
T cd06608 163 LDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNP---PP--- 236 (275)
T ss_pred cccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhccC---CC---
Confidence 43322 2234567889999998743 2346789999999999999999999997665544444332210 00
Q ss_pred hccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 016184 310 KCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368 (394)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f 368 (394)
. + ......+.++.+||.+||..||++|||+.++++|||+
T Consensus 237 -------------~-----~--~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~ 275 (275)
T cd06608 237 -------------T-----L--KSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI 275 (275)
T ss_pred -------------C-----C--CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence 0 0 0012367899999999999999999999999999996
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-42 Score=315.91 Aligned_cols=257 Identities=27% Similarity=0.411 Sum_probs=204.8
Q ss_pred ceeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccc----hhhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEEE
Q 016184 81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN 156 (394)
Q Consensus 81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 156 (394)
..+|++.+.||.|+||.||+|.+..+++.||+|.+... .....+|+.+++.++|+||+++++++. ...+.+
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~-----~~~~~~ 92 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL-----VGDELW 92 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEe-----cCCEEE
Confidence 34699999999999999999999999999999988542 233457899999999999999999883 334578
Q ss_pred EEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCcccc
Q 016184 157 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL 235 (394)
Q Consensus 157 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~ 235 (394)
+||||+++ ++.+++.. ..+++..+..++.|++.||.|||+ .|++|+||||+|||++.++ .++|+|||++...
T Consensus 93 lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~l~~~L~~LH~-~~i~H~dL~p~Nili~~~~-~~~l~Dfg~~~~~ 165 (297)
T cd06656 93 VVMEYLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALDFLHS-NQVIHRDIKSDNILLGMDG-SVKLTDFGFCAQI 165 (297)
T ss_pred EeecccCCCCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEECCCC-CEEECcCccceEc
Confidence 99999985 66665543 568889999999999999999999 8999999999999999887 7999999998765
Q ss_pred ccCCC-cccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCC
Q 016184 236 VKGEP-NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 314 (394)
Q Consensus 236 ~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 314 (394)
..... .....+++.|+|||.+.+ ..++.++|+|||||++|+|++|..||.+.+....+..+.. .+.+.
T Consensus 166 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~-~~~~~--------- 234 (297)
T cd06656 166 TPEQSKRSTMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT-NGTPE--------- 234 (297)
T ss_pred cCCccCcCcccCCccccCHHHHcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeecc-CCCCC---------
Confidence 33322 223467889999999865 4488999999999999999999999976554322211111 00000
Q ss_pred CCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCC
Q 016184 315 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNT 376 (394)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~ 376 (394)
...+..++..+.+||.+||..||++||++.++++||||+..+....
T Consensus 235 ----------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~~~ 280 (297)
T cd06656 235 ----------------LQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPFLKLAKPLSS 280 (297)
T ss_pred ----------------CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhcccccccc
Confidence 0012356888999999999999999999999999999998766544
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-42 Score=313.94 Aligned_cols=258 Identities=28% Similarity=0.423 Sum_probs=202.6
Q ss_pred eeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccch----hhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEEEE
Q 016184 82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL 157 (394)
Q Consensus 82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 157 (394)
..|++.+.||.|+||.||+|++..+++.||+|.+.... ....+|+.+++.++|+||+++++++.. ....++
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~l 86 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYW-----DGKLWI 86 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEe-----CCeEEE
Confidence 35999999999999999999999999999999986432 234568999999999999999998843 335789
Q ss_pred EEeccccc-HHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCccccc
Q 016184 158 VLEYVPET-VNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV 236 (394)
Q Consensus 158 v~e~~~~~-l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~ 236 (394)
||||++++ +..++.. ....+++..++.++.|++.||.|||+ .|++||||||+||+++.++ .++|+|||++....
T Consensus 87 v~e~~~~~~l~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lH~-~~i~H~dlkp~Nili~~~~-~~kl~dfg~~~~~~ 161 (292)
T cd06644 87 MIEFCPGGAVDAIMLE---LDRGLTEPQIQVICRQMLEALQYLHS-MKIIHRDLKAGNVLLTLDG-DIKLADFGVSAKNV 161 (292)
T ss_pred EEecCCCCcHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHhc-CCeeecCCCcceEEEcCCC-CEEEccCccceecc
Confidence 99999874 4333322 23568999999999999999999999 8999999999999999877 79999999886543
Q ss_pred cCC-CcccccccccccccccccC----CCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhc
Q 016184 237 KGE-PNVSYICSRYYRAPELIFG----ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 311 (394)
Q Consensus 237 ~~~-~~~~~~~t~~y~aPE~~~~----~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 311 (394)
... ......+++.|+|||.+.+ ...++.++|+|||||++|+|++|..||...+.......+.... .+
T Consensus 162 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~--~~------ 233 (292)
T cd06644 162 KTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSE--PP------ 233 (292)
T ss_pred ccccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCC--Cc------
Confidence 221 1234467889999999842 2346889999999999999999999997765444333332210 00
Q ss_pred cCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCC
Q 016184 312 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 375 (394)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~ 375 (394)
....+..++.++.++|++||..||++||+++++++||||+.+....
T Consensus 234 ------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~~ 279 (292)
T cd06644 234 ------------------TLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEHPFVSSVTSNR 279 (292)
T ss_pred ------------------cCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccccch
Confidence 0001235678999999999999999999999999999998775544
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=305.73 Aligned_cols=247 Identities=24% Similarity=0.376 Sum_probs=201.5
Q ss_pred EEEeeEEeecCceEEEEEEECCCCcEEEEEEeccc------hhhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEEEE
Q 016184 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL 157 (394)
Q Consensus 84 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 157 (394)
|.+.+.||+|++|.||+|.+..+++.|++|.+... .....+|+++++.++|+||+++++++. .....++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~l 76 (256)
T cd08529 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFL-----DKGKLNI 76 (256)
T ss_pred ceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeec-----cCCEEEE
Confidence 88999999999999999999999999999987532 233456899999999999999999873 3345789
Q ss_pred EEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCccccc
Q 016184 158 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV 236 (394)
Q Consensus 158 v~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~ 236 (394)
+|||+++ +|.+++... ....+++..++.++.|++.||.|||+ .|++|+||||+||+++.++ .++|+|||++....
T Consensus 77 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~~l~~al~~lH~-~~i~h~dl~~~nili~~~~-~~~l~df~~~~~~~ 152 (256)
T cd08529 77 VMEYAENGDLHKLLKMQ--RGRPLPEDQVWRFFIQILLGLAHLHS-KKILHRDIKSLNLFLDAYD-NVKIGDLGVAKLLS 152 (256)
T ss_pred EEEeCCCCcHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCcceEEEeCCC-CEEEcccccceecc
Confidence 9999975 777766643 23678999999999999999999999 8999999999999999887 69999999987654
Q ss_pred cCCC-cccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCC
Q 016184 237 KGEP-NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 315 (394)
Q Consensus 237 ~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 315 (394)
.... .....+++.|+|||++.+. .++.++|+||||+++|+|++|+.||...+.......+.....
T Consensus 153 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~------------- 218 (256)
T cd08529 153 DNTNFANTIVGTPYYLSPELCEDK-PYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVF------------- 218 (256)
T ss_pred CccchhhccccCccccCHHHhcCC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC-------------
Confidence 3322 2234578889999998654 488999999999999999999999987765444443322100
Q ss_pred CcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 016184 316 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368 (394)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f 368 (394)
..+...++..+.++|++||+.+|++||++.++++|||+
T Consensus 219 ---------------~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 256 (256)
T cd08529 219 ---------------PPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRNPSL 256 (256)
T ss_pred ---------------CCCccccCHHHHHHHHHHccCCcccCcCHHHHhhCCCC
Confidence 00123578899999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-42 Score=315.79 Aligned_cols=278 Identities=26% Similarity=0.406 Sum_probs=202.5
Q ss_pred eEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccc-----hhhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEEEE
Q 016184 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL 157 (394)
Q Consensus 83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 157 (394)
+|++.+.||+|+||.||+|.+..++..+|+|.+... .....+|+++++.++||||+++++++.. ..+.++
T Consensus 2 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~~l 76 (308)
T cd06615 2 DFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYS-----DGEISI 76 (308)
T ss_pred CceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEee-----CCEEEE
Confidence 499999999999999999999999999999987543 1234579999999999999999998843 345889
Q ss_pred EEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCccccc
Q 016184 158 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV 236 (394)
Q Consensus 158 v~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~ 236 (394)
+|||+++ +|.+++.. ...+++..+..++.|++.||.|||+..+++|+||||+|||++.++ .++|+|||++....
T Consensus 77 v~ey~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~-~~~l~dfg~~~~~~ 151 (308)
T cd06615 77 CMEHMDGGSLDQVLKK----AGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRG-EIKLCDFGVSGQLI 151 (308)
T ss_pred EeeccCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCC-cEEEccCCCccccc
Confidence 9999985 67666553 367899999999999999999999734899999999999999887 69999999987553
Q ss_pred cCCCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCCC
Q 016184 237 KGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 316 (394)
Q Consensus 237 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 316 (394)
.. ......+++.|+|||.+.+. .++.++|+||||+++|+|++|+.||...+... ...+...................
T Consensus 152 ~~-~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 228 (308)
T cd06615 152 DS-MANSFVGTRSYMSPERLQGT-HYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKE-LEAMFGRPVSEGEAKESHRPVSG 228 (308)
T ss_pred cc-ccccCCCCcCccChhHhcCC-CCCccchHHHHHHHHHHHHhCCCCCCCcchhh-HHHhhcCccccccccCCcccccC
Confidence 32 22345678899999998654 48899999999999999999999997655322 22222111000000000000000
Q ss_pred cccCCCC----------CCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q 016184 317 TEFKFPQ----------IKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD 373 (394)
Q Consensus 317 ~~~~~~~----------~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~ 373 (394)
.....+. .........-...++.++.+||.+||..||++|||+.++++||||++...
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~ 295 (308)
T cd06615 229 HPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRAEL 295 (308)
T ss_pred CCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhccc
Confidence 0000000 00000000001236788999999999999999999999999999987533
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=311.31 Aligned_cols=274 Identities=41% Similarity=0.711 Sum_probs=220.7
Q ss_pred EEEeeEEeecCceEEEEEEECCCCcEEEEEEeccch------hhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEEEE
Q 016184 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL 157 (394)
Q Consensus 84 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 157 (394)
|++.+.||+|++|.||+|++..+++.||+|++.... ....+|+.+++.++|+|++++++++.. ..+.++
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-----~~~~~~ 75 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHT-----ERKLYL 75 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhc-----CCceEE
Confidence 567889999999999999999999999999886532 233468999999999999999998833 345889
Q ss_pred EEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCcccccc
Q 016184 158 VLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK 237 (394)
Q Consensus 158 v~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~ 237 (394)
|+||+++++.+++.... ..+++..++.++.|++.||++||+ .||+|+||+|+||+++.++ .++|+|||++.....
T Consensus 76 v~e~~~~~l~~~i~~~~---~~~~~~~~~~~~~~i~~~l~~LH~-~~i~H~~l~~~ni~~~~~~-~~~l~d~g~~~~~~~ 150 (282)
T cd07829 76 VFEYCDMDLKKYLDKRP---GPLSPNLIKSIMYQLLRGLAYCHS-HRILHRDLKPQNILINRDG-VLKLADFGLARAFGI 150 (282)
T ss_pred EecCcCcCHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCChheEEEcCCC-CEEEecCCcccccCC
Confidence 99999988877766522 478999999999999999999999 8999999999999999887 799999999876543
Q ss_pred CC-CcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCC-
Q 016184 238 GE-PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN- 315 (394)
Q Consensus 238 ~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~- 315 (394)
.. .......+..|+|||.+.+...++.++|+||||+++|+|++|+.||...+..+.+..+.+..+.+....+..+...
T Consensus 151 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (282)
T cd07829 151 PLRTYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLP 230 (282)
T ss_pred CccccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccc
Confidence 32 2223445778999999866646899999999999999999999999998888888888888888877666433221
Q ss_pred CcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 016184 316 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368 (394)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f 368 (394)
.....++..........+ ..++..+.++|++||+.||++||++.++++||||
T Consensus 231 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~ 282 (282)
T cd07829 231 DYKPTFPKFPPKDLEKVL-PRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282 (282)
T ss_pred cccccccccCccchHHhc-ccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence 112223333223332222 3458899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=307.21 Aligned_cols=252 Identities=26% Similarity=0.435 Sum_probs=205.3
Q ss_pred eEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccc------hhhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEEE
Q 016184 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN 156 (394)
Q Consensus 83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 156 (394)
+|++.+.||.|+||.||+|.+..+++.||+|++... .....+|+.+++.++|+||+++++++... .....+
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~---~~~~~~ 77 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDR---SNQTLY 77 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecC---CCCEEE
Confidence 389999999999999999999999999999987532 22344689999999999999998877432 234578
Q ss_pred EEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHH-----hCCCceeccCCCCceEEeCCCCcEEEEeec
Q 016184 157 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH-----NCIGICHRDIKPQNLLVNPHTHQLKLCDFG 230 (394)
Q Consensus 157 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH-----~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg 230 (394)
++|||+++ +|.+++.........+++..++.++.|++.||.||| + .+++|+||||+||+++.++ .+||+|||
T Consensus 78 ~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~-~~i~h~dl~p~nili~~~~-~~kl~d~g 155 (265)
T cd08217 78 IVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPG-NTVLHRDLKPANIFLDANN-NVKLGDFG 155 (265)
T ss_pred EEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCcccc-CcceecCCCHHHEEEecCC-CEEEeccc
Confidence 99999975 788877765555678999999999999999999999 8 7999999999999999887 79999999
Q ss_pred CccccccCCC-cccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhh
Q 016184 231 SAKVLVKGEP-NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI 309 (394)
Q Consensus 231 ~a~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 309 (394)
++........ .....+++.|+|||.+.+. .++.++|+||||+++|+|++|..||...+.......+....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~pE~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-------- 226 (265)
T cd08217 156 LAKILGHDSSFAKTYVGTPYYMSPEQLNHM-SYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGK-------- 226 (265)
T ss_pred ccccccCCcccccccccCCCccChhhhcCC-CCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcCC--------
Confidence 9987654433 3345678999999998654 48899999999999999999999998766433333222100
Q ss_pred hccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 016184 310 KCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368 (394)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f 368 (394)
. ..++...+..+.+++.+||+.||++|||+.++++|||+
T Consensus 227 -----------~---------~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~~~~ 265 (265)
T cd08217 227 -----------F---------RRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQLPLI 265 (265)
T ss_pred -----------C---------CCCccccCHHHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence 0 01224578899999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=308.65 Aligned_cols=255 Identities=26% Similarity=0.388 Sum_probs=203.1
Q ss_pred eEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccc-----hhhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEEEE
Q 016184 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL 157 (394)
Q Consensus 83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 157 (394)
+|++.+.||.|+||.||+|....++..+|+|++... .....+|+++++.++|+|++++++.+. .....++
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~i 76 (267)
T cd06610 2 DYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFV-----VGDELWL 76 (267)
T ss_pred cceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEe-----eCCEEEE
Confidence 599999999999999999999889999999987543 234567999999999999999988773 3345789
Q ss_pred EEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCccccc
Q 016184 158 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV 236 (394)
Q Consensus 158 v~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~ 236 (394)
+||++++ ++.+++..... ...+++..++.++.|++.||.|||+ .|++|+||||+||+++.++ .++|+|||++....
T Consensus 77 v~e~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~ql~~al~~lh~-~~i~h~~l~p~ni~~~~~~-~~~l~df~~~~~~~ 153 (267)
T cd06610 77 VMPYLSGGSLLDIMKSSYP-RGGLDEAIIATVLKEVLKGLEYLHS-NGQIHRDIKAGNILLGEDG-SVKIADFGVSASLA 153 (267)
T ss_pred EEeccCCCcHHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHhEEEcCCC-CEEEcccchHHHhc
Confidence 9999985 66666554221 2568999999999999999999999 8999999999999999887 69999999987664
Q ss_pred cCCCc-----ccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhc
Q 016184 237 KGEPN-----VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 311 (394)
Q Consensus 237 ~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 311 (394)
..... ....++..|+|||++.....++.++|+||||+++|+|++|+.||...+....+...... .+..
T Consensus 154 ~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~---~~~~---- 226 (267)
T cd06610 154 DGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQN---DPPS---- 226 (267)
T ss_pred cCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcC---CCCC----
Confidence 43222 23457889999999866545899999999999999999999999876655444443331 0000
Q ss_pred cCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 016184 312 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368 (394)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f 368 (394)
++. ......+++.+.+|+.+||..||++|||+.++++||||
T Consensus 227 ---------~~~-------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~~ 267 (267)
T cd06610 227 ---------LET-------GADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKHKFF 267 (267)
T ss_pred ---------cCC-------ccccccccHHHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence 000 00013578899999999999999999999999999998
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-42 Score=309.49 Aligned_cols=246 Identities=33% Similarity=0.539 Sum_probs=198.1
Q ss_pred eEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccch-------------hhhHHHHHHHHHcCCCCeeeeceEEEecCC
Q 016184 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------------RYKNRELQIMQMLDHPNIVALKHCFFSTTD 149 (394)
Q Consensus 83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 149 (394)
+|.+...||.|++|.||+|.+..+++.||+|.+.... ....+|+.+++.++|+||+++++++..
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--- 77 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLD--- 77 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEe---
Confidence 3888899999999999999998889999999875321 234578999999999999999998733
Q ss_pred CceeEEEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEe
Q 016184 150 KEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCD 228 (394)
Q Consensus 150 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~D 228 (394)
..+.+++|||+++ +|..++.. ...+++..+..++.|++.||+|||+ .|++|+||+|+||+++.++ .++|+|
T Consensus 78 --~~~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~~l~~~l~~lH~-~~ivH~di~p~nil~~~~~-~~~l~d 149 (267)
T cd06628 78 --ADHLNIFLEYVPGGSVAALLNN----YGAFEETLVRNFVRQILKGLNYLHN-RGIIHRDIKGANILVDNKG-GIKISD 149 (267)
T ss_pred --CCccEEEEEecCCCCHHHHHHh----ccCccHHHHHHHHHHHHHHHHHHHh-cCcccccCCHHHEEEcCCC-CEEecc
Confidence 3457799999976 66666543 3568899999999999999999999 8999999999999999887 799999
Q ss_pred ecCccccccCCC-------cccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHh
Q 016184 229 FGSAKVLVKGEP-------NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVL 301 (394)
Q Consensus 229 fg~a~~~~~~~~-------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~ 301 (394)
||.+........ .....++..|+|||.+.+. .++.++|+||||+++|+|++|+.||...+....+..+....
T Consensus 150 fg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~ 228 (267)
T cd06628 150 FGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQT-SYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENA 228 (267)
T ss_pred cCCCcccccccccCCccccccccCCCcCccChhHhccC-CCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhccC
Confidence 999876642111 1123467889999998654 47899999999999999999999998765544333322210
Q ss_pred CCCChhhhhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 016184 302 GTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368 (394)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f 368 (394)
...++..++..+.++|++||+.||.+||++.++++||||
T Consensus 229 ----------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 267 (267)
T cd06628 229 ----------------------------SPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL 267 (267)
T ss_pred ----------------------------CCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence 001124578899999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-43 Score=325.20 Aligned_cols=244 Identities=19% Similarity=0.275 Sum_probs=195.5
Q ss_pred eEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccc------hhhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEEE
Q 016184 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN 156 (394)
Q Consensus 83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 156 (394)
...+...||+|+||+||+|++.. .||||++... ...+++|+.++++-+|.||+-+.+++ .+..+ .
T Consensus 393 ev~l~~rIGsGsFGtV~Rg~whG---dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~-----~~p~~-A 463 (678)
T KOG0193|consen 393 EVLLGERIGSGSFGTVYRGRWHG---DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGAC-----MNPPL-A 463 (678)
T ss_pred Hhhccceeccccccceeeccccc---ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhh-----cCCce-e
Confidence 45678899999999999999964 4999988543 35667899999999999999999998 44444 7
Q ss_pred EEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCcccc
Q 016184 157 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL 235 (394)
Q Consensus 157 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~ 235 (394)
||+.+|+| +|+.+++... ..|.....+.|+.||++|+.|||. ++|||||||..||++.+++ +|||+|||++..-
T Consensus 464 IiTqwCeGsSLY~hlHv~e---tkfdm~~~idIAqQiaqGM~YLHA-K~IIHrDLKSnNIFl~~~~-kVkIgDFGLatvk 538 (678)
T KOG0193|consen 464 IITQWCEGSSLYTHLHVQE---TKFDMNTTIDIAQQIAQGMDYLHA-KNIIHRDLKSNNIFLHEDL-KVKIGDFGLATVK 538 (678)
T ss_pred eeehhccCchhhhhccchh---hhhhHHHHHHHHHHHHHhhhhhhh-hhhhhhhccccceEEccCC-cEEEecccceeee
Confidence 99999998 7888777644 678999999999999999999999 9999999999999999887 8999999998542
Q ss_pred c---cCCCcccccccccccccccccC--CCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhh
Q 016184 236 V---KGEPNVSYICSRYYRAPELIFG--ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 310 (394)
Q Consensus 236 ~---~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 310 (394)
. .........+...|||||+++. ..+|+..+||||||+++|||+||..||........+..+-+....+....
T Consensus 539 ~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~pd~s~-- 616 (678)
T KOG0193|consen 539 TRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMPDLSK-- 616 (678)
T ss_pred eeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCccchh--
Confidence 1 1222233456788999999853 34589999999999999999999999985554444433333222222211
Q ss_pred ccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 016184 311 CMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV 364 (394)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 364 (394)
....++.++++|+..||.+++++||+..+||.
T Consensus 617 ----------------------~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~ 648 (678)
T KOG0193|consen 617 ----------------------IRSNCPKAMKRLLSDCWKFDREERPLFPQLLS 648 (678)
T ss_pred ----------------------hhccCHHHHHHHHHHHHhcCcccCccHHHHHH
Confidence 12457889999999999999999999998876
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-43 Score=324.39 Aligned_cols=236 Identities=24% Similarity=0.404 Sum_probs=198.3
Q ss_pred eeEEeecCceEEEEEEECCCCcEEEEEEeccchhhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEEEEEEeccc-cc
Q 016184 87 EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVP-ET 165 (394)
Q Consensus 87 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~ 165 (394)
++.||.|+.|.||+|+.. ++.||||+++.- .+.+++-|++|+|+||+.+.++| ....++|||||||. |-
T Consensus 129 LeWlGSGaQGAVF~Grl~--netVAVKKV~el---kETdIKHLRkLkH~NII~FkGVC-----tqsPcyCIiMEfCa~Gq 198 (904)
T KOG4721|consen 129 LEWLGSGAQGAVFLGRLH--NETVAVKKVREL---KETDIKHLRKLKHPNIITFKGVC-----TQSPCYCIIMEFCAQGQ 198 (904)
T ss_pred hhhhccCcccceeeeecc--CceehhHHHhhh---hhhhHHHHHhccCcceeeEeeee-----cCCceeEEeeecccccc
Confidence 356999999999999986 789999987532 34578889999999999999999 66677999999999 56
Q ss_pred HHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCccccccCCCccccc
Q 016184 166 VNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYI 245 (394)
Q Consensus 166 l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~ 245 (394)
|...++. ...+....+..|..+|+.|+.|||. +.|||||||.-||||..+. .|||+|||-++.........++.
T Consensus 199 L~~VLka----~~~itp~llv~Wsk~IA~GM~YLH~-hKIIHRDLKSPNiLIs~~d-~VKIsDFGTS~e~~~~STkMSFa 272 (904)
T KOG4721|consen 199 LYEVLKA----GRPITPSLLVDWSKGIAGGMNYLHL-HKIIHRDLKSPNILISYDD-VVKISDFGTSKELSDKSTKMSFA 272 (904)
T ss_pred HHHHHhc----cCccCHHHHHHHHHHhhhhhHHHHH-hhHhhhccCCCceEeeccc-eEEeccccchHhhhhhhhhhhhh
Confidence 7676665 4678888999999999999999999 8999999999999999887 79999999998887777778899
Q ss_pred ccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCCCcccCCCCCC
Q 016184 246 CSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIK 325 (394)
Q Consensus 246 ~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (394)
||..|||||++.+.+ .+.|+|||||||+||||+||..||.+.+....+.-+ |
T Consensus 273 GTVaWMAPEvIrneP-csEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGV----G----------------------- 324 (904)
T KOG4721|consen 273 GTVAWMAPEVIRNEP-CSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGV----G----------------------- 324 (904)
T ss_pred hhHhhhCHHHhhcCC-cccccceehhHHHHHHHHhcCCCccccchheeEEec----c-----------------------
Confidence 999999999997654 899999999999999999999999766543222211 1
Q ss_pred CCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCC
Q 016184 326 PHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHP 366 (394)
Q Consensus 326 ~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp 366 (394)
...+.-..+..+++-++-||+.||.-.|..||+..++|.|=
T Consensus 325 sNsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~Hl 365 (904)
T KOG4721|consen 325 SNSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHL 365 (904)
T ss_pred CCcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHH
Confidence 01111223467899999999999999999999999999983
|
|
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-42 Score=313.50 Aligned_cols=256 Identities=26% Similarity=0.398 Sum_probs=204.2
Q ss_pred eeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccch----hhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEEEE
Q 016184 82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL 157 (394)
Q Consensus 82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 157 (394)
++|++.+.||.|+||.||+|.+..+++.||+|++.... ....+|+++++.++|+||+++++.+. .....++
T Consensus 5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~l 79 (280)
T cd06611 5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF-----YENKLWI 79 (280)
T ss_pred hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEe-----cCCeEEE
Confidence 45999999999999999999998899999999875432 23457999999999999999999884 3345789
Q ss_pred EEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCccccc
Q 016184 158 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV 236 (394)
Q Consensus 158 v~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~ 236 (394)
||||+++ ++.+++... ...+++..++.++.|++.||.|||+ .||+|+||||+||+++.++ .++|+|||++....
T Consensus 80 v~e~~~~~~L~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lh~-~~i~h~dl~p~nili~~~~-~~~l~d~g~~~~~~ 154 (280)
T cd06611 80 LIEFCDGGALDSIMLEL---ERGLTEPQIRYVCRQMLEALNFLHS-HKVIHRDLKAGNILLTLDG-DVKLADFGVSAKNK 154 (280)
T ss_pred EeeccCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCChhhEEECCCC-CEEEccCccchhhc
Confidence 9999986 665555432 3568999999999999999999999 8999999999999999887 79999999876543
Q ss_pred cCC-CcccccccccccccccccC----CCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhc
Q 016184 237 KGE-PNVSYICSRYYRAPELIFG----ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 311 (394)
Q Consensus 237 ~~~-~~~~~~~t~~y~aPE~~~~----~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 311 (394)
... ......+++.|+|||.+.. ...++.++|+||||+++|+|++|+.||...+....+..+.... ++
T Consensus 155 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--~~------ 226 (280)
T cd06611 155 STLQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSE--PP------ 226 (280)
T ss_pred ccccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCC--CC------
Confidence 222 2233467889999998742 2346889999999999999999999998766554443332210 00
Q ss_pred cCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q 016184 312 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD 373 (394)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~ 373 (394)
.. ..+..++.++.+||.+||+.||.+||++.++++||||.+..+
T Consensus 227 ------~~------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~ 270 (280)
T cd06611 227 ------TL------------DQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFVSDQSD 270 (280)
T ss_pred ------Cc------------CCcccCCHHHHHHHHHHhccChhhCcCHHHHhcChhhcccch
Confidence 00 012356889999999999999999999999999999988743
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=308.67 Aligned_cols=249 Identities=29% Similarity=0.457 Sum_probs=196.9
Q ss_pred eEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccc---------hhhhHHHHHHHHHcCCCCeeeeceEEEecCCCcee
Q 016184 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD---------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL 153 (394)
Q Consensus 83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 153 (394)
+|++.+.||+|+||.||+|.+..++..||+|++... .....+|+.+++.++|+||+++++++.. ....
T Consensus 3 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~~~~ 79 (266)
T cd06651 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRD---RAEK 79 (266)
T ss_pred CccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEc---CCCC
Confidence 589999999999999999999999999999987532 1235579999999999999999987743 2234
Q ss_pred EEEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCc
Q 016184 154 YLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA 232 (394)
Q Consensus 154 ~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a 232 (394)
..++++||+++ +|.+.+.. ...+++..++.++.|++.||+|||+ .+|+|+||||+||+++.++ .++|+|||++
T Consensus 80 ~~~l~~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~LH~-~~i~H~~l~p~nil~~~~~-~~~l~dfg~~ 153 (266)
T cd06651 80 TLTIFMEYMPGGSVKDQLKA----YGALTESVTRKYTRQILEGMSYLHS-NMIVHRDIKGANILRDSAG-NVKLGDFGAS 153 (266)
T ss_pred EEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeeeCCCCHHHEEECCCC-CEEEccCCCc
Confidence 57799999985 67665543 3568899999999999999999999 8999999999999999887 6999999998
Q ss_pred cccccC----CCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhh
Q 016184 233 KVLVKG----EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 308 (394)
Q Consensus 233 ~~~~~~----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~ 308 (394)
...... .......++..|+|||.+.+. .++.++|+|||||++|+|++|+.||........+..+... ..
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~---~~--- 226 (266)
T cd06651 154 KRLQTICMSGTGIRSVTGTPYWMSPEVISGE-GYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQ---PT--- 226 (266)
T ss_pred cccccccccCCccccCCccccccCHHHhCCC-CCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcC---CC---
Confidence 754321 111234578889999998654 4899999999999999999999999876544433322211 00
Q ss_pred hhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCC
Q 016184 309 IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFD 369 (394)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~ 369 (394)
...++..+++.+++|| +||..||++||+++++++||||+
T Consensus 227 ---------------------~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~hp~~~ 265 (266)
T cd06651 227 ---------------------NPQLPSHISEHARDFL-GCIFVEARHRPSAEELLRHPFAQ 265 (266)
T ss_pred ---------------------CCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcCcccc
Confidence 0012235678899999 67778999999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=306.98 Aligned_cols=247 Identities=28% Similarity=0.461 Sum_probs=197.2
Q ss_pred eEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccch----------hhhHHHHHHHHHcCCCCeeeeceEEEecCCCce
Q 016184 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK----------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE 152 (394)
Q Consensus 83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 152 (394)
+|++.+.||.|+||.||+|.. .+|+.+|+|.+.... ....+|+++++.++|+||+++++++ ...
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~ 74 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTC-----LDD 74 (265)
T ss_pred CccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEe-----ecC
Confidence 388999999999999999987 578899999875321 2345799999999999999999988 333
Q ss_pred eEEEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecC
Q 016184 153 LYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS 231 (394)
Q Consensus 153 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~ 231 (394)
.+.++++||+++ +|.+++.. ...+++..+..++.|++.||+|||+ .||+|+||+|+||+++.++ .++|+|||+
T Consensus 75 ~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~p~nil~~~~~-~~~l~dfg~ 148 (265)
T cd06631 75 NTISIFMEFVPGGSISSILNR----FGPLPEPVFCKYTKQILDGVAYLHN-NCVVHRDIKGNNVMLMPNG-IIKLIDFGC 148 (265)
T ss_pred CeEEEEEecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCcCHHhEEECCCC-eEEeccchh
Confidence 568899999986 66665543 3568899999999999999999999 8999999999999999887 799999999
Q ss_pred ccccccC-------CCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCC
Q 016184 232 AKVLVKG-------EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTP 304 (394)
Q Consensus 232 a~~~~~~-------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~ 304 (394)
+...... .......++..|+|||.+.+. .++.++|+||||+++|+|++|..||...+.......+....+..
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 227 (265)
T cd06631 149 ARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINES-GYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLM 227 (265)
T ss_pred hHhhhhccccccccccccccCCCccccChhhhcCC-CCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCC
Confidence 8754211 111234578899999998654 48899999999999999999999998765444333322211000
Q ss_pred ChhhhhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 016184 305 TREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368 (394)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f 368 (394)
..++..++.++.++|++||+.||.+||++.++++||||
T Consensus 228 --------------------------~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~ 265 (265)
T cd06631 228 --------------------------PRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLRHDFL 265 (265)
T ss_pred --------------------------CCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 01224578899999999999999999999999999997
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=309.11 Aligned_cols=252 Identities=28% Similarity=0.500 Sum_probs=200.5
Q ss_pred eEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccch----------hhhHHHHHHHHHcCCCCeeeeceEEEecCCCce
Q 016184 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK----------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE 152 (394)
Q Consensus 83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 152 (394)
+|+..+.||+|++|.||+|.+..+++.||+|++.... ....+|+.+++.++|+||+++++++ ...
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-----~~~ 75 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGAT-----CED 75 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhcee-----ccC
Confidence 3888899999999999999999999999999885422 3445799999999999999999988 334
Q ss_pred eEEEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecC
Q 016184 153 LYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS 231 (394)
Q Consensus 153 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~ 231 (394)
...++|+||+.+ +|.+++.. ...+++..++.++.|++.||.|||+ +|++|+||||+||+++.++..++|+|||.
T Consensus 76 ~~~~~v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~ql~~al~~LH~-~~i~H~~i~~~nil~~~~~~~~~l~dfg~ 150 (268)
T cd06630 76 SHFNLFVEWMAGGSVSHLLSK----YGAFKEAVIINYTEQLLRGLSYLHE-NQIIHRDVKGANLLIDSTGQRLRIADFGA 150 (268)
T ss_pred CeEEEEEeccCCCcHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEcCCCCEEEEccccc
Confidence 457899999985 67666543 3578899999999999999999999 89999999999999987765799999999
Q ss_pred ccccccCCC-----cccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCh
Q 016184 232 AKVLVKGEP-----NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTR 306 (394)
Q Consensus 232 a~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~ 306 (394)
+........ .....++..|+|||.+.+. .++.++|+||||+++|+|++|..||...........+.+.....
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-- 227 (268)
T cd06630 151 AARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGE-QYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASAT-- 227 (268)
T ss_pred ccccccccccCCccccccccccceeCHhHhccC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccC--
Confidence 876543211 1234568899999998654 48899999999999999999999997554333332222211000
Q ss_pred hhhhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCC
Q 016184 307 EEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFD 369 (394)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~ 369 (394)
....++..+++++.+++.+||..||.+|||+.++++||||+
T Consensus 228 ----------------------~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~~~~~ 268 (268)
T cd06630 228 ----------------------TAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKHPVFR 268 (268)
T ss_pred ----------------------CCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence 00012245788999999999999999999999999999995
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=323.55 Aligned_cols=251 Identities=31% Similarity=0.549 Sum_probs=210.6
Q ss_pred EEE--eeEEeecCceEEEEEEECCCCcEEEEEEecc------chhhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEE
Q 016184 84 YIA--EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQ------DKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL 155 (394)
Q Consensus 84 y~~--~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~------~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 155 (394)
|+| .++||+|.||+||-|.++.+|+.||||++.+ .....++|+.||+.+.||.||.+...|.+ ...+
T Consensus 564 YQif~devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET-----~erv 638 (888)
T KOG4236|consen 564 YQIFADEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFET-----PERV 638 (888)
T ss_pred HHhhhHhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecC-----CceE
Confidence 554 4789999999999999999999999999854 34556789999999999999998776622 2237
Q ss_pred EEEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCC--CCcEEEEeecCcc
Q 016184 156 NLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPH--THQLKLCDFGSAK 233 (394)
Q Consensus 156 ~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~--~~~vkl~Dfg~a~ 233 (394)
++|||-+.|+..+++-...+ +++++...+.++.||+.||.|||- ++|+|+||||+|||+... ...+||||||+|+
T Consensus 639 FVVMEKl~GDMLEMILSsEk--gRL~er~TkFlvtQIL~ALr~LH~-knIvHCDLKPENVLLas~~~FPQvKlCDFGfAR 715 (888)
T KOG4236|consen 639 FVVMEKLHGDMLEMILSSEK--GRLPERITKFLVTQILVALRYLHF-KNIVHCDLKPENVLLASASPFPQVKLCDFGFAR 715 (888)
T ss_pred EEEehhhcchHHHHHHHhhc--ccchHHHHHHHHHHHHHHHHHhhh-cceeeccCCchheeeccCCCCCceeecccccee
Confidence 79999999987777665444 889999999999999999999999 899999999999999753 3479999999999
Q ss_pred ccccCCCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcH-HHHHHHHHHhCCCChhhhhcc
Q 016184 234 VLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGV-DQLVEIIKVLGTPTREEIKCM 312 (394)
Q Consensus 234 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~ 312 (394)
.+.+..-..+.+|||.|.|||+++.. .|++.-|+||+|||+|--+.|..||....+. +++++.
T Consensus 716 iIgEksFRrsVVGTPAYLaPEVLrnk-GyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQIQNA--------------- 779 (888)
T KOG4236|consen 716 IIGEKSFRRSVVGTPAYLAPEVLRNK-GYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQIQNA--------------- 779 (888)
T ss_pred ecchhhhhhhhcCCccccCHHHHhhc-cccccccceeeeEEEEEEecccccCCCccchhHHhhcc---------------
Confidence 99887777788999999999999755 4999999999999999999999999754432 222211
Q ss_pred CCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 016184 313 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL 371 (394)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 371 (394)
.+.+ .+.+| ..+++++.+||..+|++.-++|.|.+..|.|||+|+.
T Consensus 780 -----aFMy---Pp~PW-----~eis~~AidlIn~LLqVkm~kRysvdk~lsh~Wlq~y 825 (888)
T KOG4236|consen 780 -----AFMY---PPNPW-----SEISPEAIDLINNLLQVKMRKRYSVDKSLSHPWLQDY 825 (888)
T ss_pred -----cccc---CCCch-----hhcCHHHHHHHHHHHHHHHHHhcchHhhccchhhhcc
Confidence 1111 23455 5689999999999999999999999999999999984
|
|
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-41 Score=307.90 Aligned_cols=267 Identities=25% Similarity=0.423 Sum_probs=204.1
Q ss_pred eEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccch-----hhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEEEE
Q 016184 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL 157 (394)
Q Consensus 83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 157 (394)
+|...+.||.|++|.||+|.+..+++.+|+|.+.... ....+|+++++.++|+||+++++++... ....+++
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~---~~~~~~l 78 (287)
T cd06621 2 KIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDE---SSSSIGI 78 (287)
T ss_pred ceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcc---CCCeEEE
Confidence 5899999999999999999999999999999886432 3356799999999999999999987432 2334779
Q ss_pred EEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCccccc
Q 016184 158 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV 236 (394)
Q Consensus 158 v~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~ 236 (394)
+|||+++ +|.+++.........+++..+..++.|++.||.|||+ .|++|+||+|+||+++.++ .++|+|||++....
T Consensus 79 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~-~~i~H~dl~~~nil~~~~~-~~~l~dfg~~~~~~ 156 (287)
T cd06621 79 AMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHS-RKIIHRDIKPSNILLTRKG-QVKLCDFGVSGELV 156 (287)
T ss_pred EEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEEecCC-eEEEeecccccccc
Confidence 9999975 7777665544445678999999999999999999999 8999999999999999887 69999999987553
Q ss_pred cCCCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCc--HHHHHHHHHHhCCCChhhhhccCC
Q 016184 237 KGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESG--VDQLVEIIKVLGTPTREEIKCMNP 314 (394)
Q Consensus 237 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~--~~~~~~i~~~~~~~~~~~~~~~~~ 314 (394)
... .....++..|+|||.+.+. .++.++|+||||+++|+|++|..||..... ..... .............
T Consensus 157 ~~~-~~~~~~~~~y~~pE~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~----- 228 (287)
T cd06621 157 NSL-AGTFTGTSFYMAPERIQGK-PYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIE-LLSYIVNMPNPEL----- 228 (287)
T ss_pred ccc-cccccCCccccCHHHhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHH-HHHHHhcCCchhh-----
Confidence 322 1234567889999998544 489999999999999999999999976522 11111 1111111000000
Q ss_pred CCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCC
Q 016184 315 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 375 (394)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~ 375 (394)
+. .. ......++.+.+||.+||..||++|||+.|+++||||++.....
T Consensus 229 -------~~---~~---~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~~~~ 276 (287)
T cd06621 229 -------KD---EP---GNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQMKKK 276 (287)
T ss_pred -------cc---CC---CCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCccccccccch
Confidence 00 00 00012467899999999999999999999999999997765543
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=310.30 Aligned_cols=253 Identities=26% Similarity=0.404 Sum_probs=201.3
Q ss_pred EEEeeEEeecCceEEEEEEECCCCcEEEEEEeccch----hhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEEEEEE
Q 016184 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVL 159 (394)
Q Consensus 84 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~ 159 (394)
|++.+.||.|+||.||+|.+..++..+++|.+.... ....+|+++++.+.|+|++++++++.. ....++++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~-----~~~~~~v~ 81 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYY-----ENNLWILI 81 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEee-----CCEEEEEE
Confidence 788999999999999999999999999999875432 234568999999999999999998843 33578999
Q ss_pred ecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCccccccC
Q 016184 160 EYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG 238 (394)
Q Consensus 160 e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~~ 238 (394)
||+++ ++..++.. ....+++..+..++.|++.||.|||+ .|++||||||+||+++.++ .++|+|||++......
T Consensus 82 e~~~~~~l~~~~~~---~~~~l~~~~~~~~~~qi~~~L~~LH~-~~i~H~dlkp~nili~~~~-~~kl~dfg~~~~~~~~ 156 (282)
T cd06643 82 EFCAGGAVDAVMLE---LERPLTEPQIRVVCKQTLEALNYLHE-NKIIHRDLKAGNILFTLDG-DIKLADFGVSAKNTRT 156 (282)
T ss_pred EecCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCCcccEEEccCC-CEEEcccccccccccc
Confidence 99986 44443332 23578999999999999999999999 8999999999999999887 7999999998654322
Q ss_pred C-Cccccccccccccccccc----CCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccC
Q 016184 239 E-PNVSYICSRYYRAPELIF----GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 313 (394)
Q Consensus 239 ~-~~~~~~~t~~y~aPE~~~----~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 313 (394)
. ......+++.|+|||++. ....++.++|+|||||++|+|++|..||...+.......+.......
T Consensus 157 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~--------- 227 (282)
T cd06643 157 IQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPT--------- 227 (282)
T ss_pred ccccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCC---------
Confidence 1 223346788999999874 23347789999999999999999999998776555544443311000
Q ss_pred CCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 016184 314 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR 372 (394)
Q Consensus 314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 372 (394)
...+..++.++.+||.+||+.||.+|||+.++++||||+...
T Consensus 228 -----------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 269 (282)
T cd06643 228 -----------------LAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPFVTVNS 269 (282)
T ss_pred -----------------CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCCCEeccC
Confidence 001234688999999999999999999999999999998753
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=309.26 Aligned_cols=263 Identities=26% Similarity=0.391 Sum_probs=202.4
Q ss_pred EeecCceEEEEEEECCCCcEEEEEEeccch-------hhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEEEEEEecc
Q 016184 90 VGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYV 162 (394)
Q Consensus 90 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~ 162 (394)
||+|+||+||+|.+..+|+.||+|.+.... ....+|+++++.++||||+++++++ ......|+||||+
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~lv~e~~ 75 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAF-----ETKDDLCLVMTLM 75 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEE-----ecCCeEEEEEecC
Confidence 689999999999999999999999875421 2234689999999999999998887 3334578999999
Q ss_pred cc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCccccccCCCc
Q 016184 163 PE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN 241 (394)
Q Consensus 163 ~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~~~~~ 241 (394)
++ +|.+.+.... ...+++..+..++.|++.||.|||+ .|++|+||+|+||+++.++ .++|+|||.+.........
T Consensus 76 ~~~~L~~~l~~~~--~~~~~~~~~~~~~~ql~~~l~~lH~-~~i~H~di~p~Nil~~~~~-~~~l~dfg~~~~~~~~~~~ 151 (277)
T cd05577 76 NGGDLKYHIYNVG--EPGFPEARAIFYAAQIICGLEHLHQ-RRIVYRDLKPENVLLDDHG-NVRISDLGLAVELKGGKKI 151 (277)
T ss_pred CCCcHHHHHHHcC--cCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHHEEECCCC-CEEEccCcchhhhccCCcc
Confidence 85 6666555422 2468999999999999999999999 8999999999999999887 6999999998765443333
Q ss_pred ccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCCCcccCC
Q 016184 242 VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF 321 (394)
Q Consensus 242 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 321 (394)
....++..|+|||.+.+.. ++.++|+||||+++|+|++|+.||...........+......
T Consensus 152 ~~~~~~~~y~~PE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~------------------ 212 (277)
T cd05577 152 KGRAGTPGYMAPEVLQGEV-YDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLE------------------ 212 (277)
T ss_pred ccccCCCCcCCHHHhcCCC-CCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhcccc------------------
Confidence 4456788899999986554 899999999999999999999999775542222222111000
Q ss_pred CCCCCCCcchhccccCChHHHHHHHHhcccCCCCCC-----CHHHHhcCCCCCCCCCCCCCCCCCCCCCCCCCC
Q 016184 322 PQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-----TALEACVHPFFDELRDPNTRLPNGRPLPPLFNF 390 (394)
Q Consensus 322 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----t~~ell~hp~f~~~~~~~~~~~~~~~~~~~~~~ 390 (394)
....++..+++.+.++|++||+.||.+|| ++.++++||||+++..... .....+|+|-.
T Consensus 213 -------~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h~~~~~~~~~~~---~~~~~~~~~~~ 276 (277)
T cd05577 213 -------MAVEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFKDLNWRRL---EAGMLEPPFIP 276 (277)
T ss_pred -------ccccCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHhChhhhcCChhhh---hcCCCCCCCCC
Confidence 00012245689999999999999999999 9999999999988754333 23333355543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=323.21 Aligned_cols=259 Identities=28% Similarity=0.414 Sum_probs=218.1
Q ss_pred CCccceeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccch------hhhHHHHHHHHHcCCCCeeeeceEEEecCCC
Q 016184 77 NSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDK 150 (394)
Q Consensus 77 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 150 (394)
.......|.+.+.||+|.|+.|.+|++..++..||||.+.+.. ....+|+++|+.++|||||+++.+......
T Consensus 51 ~~~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~- 129 (596)
T KOG0586|consen 51 DSNSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEAT- 129 (596)
T ss_pred ccccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecce-
Confidence 3344556999999999999999999999999999999986542 234579999999999999999998844443
Q ss_pred ceeEEEEEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeec
Q 016184 151 EELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFG 230 (394)
Q Consensus 151 ~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg 230 (394)
+|+||||+.++- +..+...+.++.+..++.++.|++.|++|||+ ++|||||||++|||++.+. ++||+|||
T Consensus 130 ----lylV~eya~~ge---~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~-k~ivHrdLk~eNilL~~~m-nikIaDfg 200 (596)
T KOG0586|consen 130 ----LYLVMEYASGGE---LFDYLVKHGRMKEKEARAKFRQIVSAVEYCHS-KNIVHRDLKAENILLDENM-NIKIADFG 200 (596)
T ss_pred ----eEEEEEeccCch---hHHHHHhcccchhhhhhhhhHHHHHHHHHHhh-cceeccccchhhccccccc-ceeeeccc
Confidence 889999998632 33344446788889999999999999999999 8999999999999999988 59999999
Q ss_pred CccccccCCCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhh
Q 016184 231 SAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 310 (394)
Q Consensus 231 ~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 310 (394)
++..+..+....+.+|++.|.|||++.+..+.+..+|+||+|+++|.|+.|..||.+.+-.+.-...+.
T Consensus 201 fS~~~~~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~----------- 269 (596)
T KOG0586|consen 201 FSTFFDYGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLR----------- 269 (596)
T ss_pred cceeecccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchhee-----------
Confidence 999998888888999999999999999888889999999999999999999999988764332222211
Q ss_pred ccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCC
Q 016184 311 CMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP 374 (394)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~ 374 (394)
..+. ++--++.++.+||+++|..+|.+|++.+++..|.|.-.....
T Consensus 270 ------gk~r------------Ip~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~W~n~~~~~ 315 (596)
T KOG0586|consen 270 ------GKYR------------IPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDRWRNDLLEA 315 (596)
T ss_pred ------eeec------------ccceeechhHHHHHHhhccCccccCCHHHhhhhcccchhhhh
Confidence 1111 123478999999999999999999999999999999877665
|
|
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=308.97 Aligned_cols=251 Identities=27% Similarity=0.374 Sum_probs=196.9
Q ss_pred eeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccc----hhhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEEEE
Q 016184 82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL 157 (394)
Q Consensus 82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 157 (394)
.+|++.+.||+|+||.||+|++..+++.||+|++... .....+|+.+++.++|+||+++++++.. ....++
T Consensus 9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~-----~~~~~i 83 (267)
T cd06646 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLS-----REKLWI 83 (267)
T ss_pred hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEe-----CCEEEE
Confidence 3599999999999999999999999999999988532 2335679999999999999999998843 234789
Q ss_pred EEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCccccc
Q 016184 158 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV 236 (394)
Q Consensus 158 v~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~ 236 (394)
||||+++ +|.+++.. ...+++..+..++.|++.||.|||+ .||+||||||+||+++.++ .++|+|||++....
T Consensus 84 v~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~p~nill~~~~-~~~l~dfg~~~~~~ 157 (267)
T cd06646 84 CMEYCGGGSLQDIYHV----TGPLSELQIAYVCRETLQGLAYLHS-KGKMHRDIKGANILLTDNG-DVKLADFGVAAKIT 157 (267)
T ss_pred EEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCHHHEEECCCC-CEEECcCccceeec
Confidence 9999985 66665542 3578999999999999999999999 8999999999999999887 69999999987653
Q ss_pred cCC-CcccccccccccccccccC--CCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccC
Q 016184 237 KGE-PNVSYICSRYYRAPELIFG--ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 313 (394)
Q Consensus 237 ~~~-~~~~~~~t~~y~aPE~~~~--~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 313 (394)
... ......+++.|+|||.+.. ...++.++|+||+||++|+|++|+.||...........+...
T Consensus 158 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~------------- 224 (267)
T cd06646 158 ATIAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKS------------- 224 (267)
T ss_pred ccccccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecC-------------
Confidence 322 2234567889999998742 233678999999999999999999999655433222111110
Q ss_pred CCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCC
Q 016184 314 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 367 (394)
Q Consensus 314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~ 367 (394)
.+..+. +. ....++..+.+||++||+.||++|||++++|+|+|
T Consensus 225 ----~~~~~~-----~~--~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l~ 267 (267)
T cd06646 225 ----NFQPPK-----LK--DKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHLF 267 (267)
T ss_pred ----CCCCCC-----Cc--cccccCHHHHHHHHHHhhCChhhCcCHHHHhcCCC
Confidence 000000 00 01346889999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=308.23 Aligned_cols=248 Identities=24% Similarity=0.379 Sum_probs=190.7
Q ss_pred EEeecCceEEEEEEECCCCcEEEEEEeccch-------hhhHHHHHHHHH---cCCCCeeeeceEEEecCCCceeEEEEE
Q 016184 89 VVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQM---LDHPNIVALKHCFFSTTDKEELYLNLV 158 (394)
Q Consensus 89 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~---l~h~~iv~~~~~~~~~~~~~~~~~~lv 158 (394)
+||+|+||.||++.+..+++.+|+|.+.+.. ....+|..+++. ..|+||+.+++++.. ....++|
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~-----~~~~~lv 75 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHT-----PDKLCFI 75 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEec-----CCeEEEE
Confidence 4899999999999999999999999875432 112234433333 479999999888732 3347899
Q ss_pred Eecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCcccccc
Q 016184 159 LEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK 237 (394)
Q Consensus 159 ~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~ 237 (394)
|||+++ +|...+. ....+++..+..++.|++.||+|||+ .||+|+||||+|||++.++ .++|+|||++.....
T Consensus 76 ~e~~~~~~L~~~i~----~~~~l~~~~~~~i~~qi~~al~~lH~-~~ivH~dikp~Nil~~~~~-~~~l~dfg~~~~~~~ 149 (279)
T cd05633 76 LDLMNGGDLHYHLS----QHGVFSEKEMRFYATEIILGLEHMHN-RFVVYRDLKPANILLDEHG-HVRISDLGLACDFSK 149 (279)
T ss_pred EecCCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHH-CCcCCCCCCHHHEEECCCC-CEEEccCCcceeccc
Confidence 999985 5554443 24679999999999999999999999 8999999999999999887 799999999865433
Q ss_pred CCCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHH--HHHHHHHHhCCCChhhhhccCCC
Q 016184 238 GEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVD--QLVEIIKVLGTPTREEIKCMNPN 315 (394)
Q Consensus 238 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~--~~~~i~~~~~~~~~~~~~~~~~~ 315 (394)
.. .....+++.|+|||.+.+...++.++|+||+||++|+|++|..||....... .+......
T Consensus 150 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~--------------- 213 (279)
T cd05633 150 KK-PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT--------------- 213 (279)
T ss_pred cC-ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhhc---------------
Confidence 22 2334678999999998644558899999999999999999999997643321 11111100
Q ss_pred CcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCC-----CHHHHhcCCCCCCCCCCCC
Q 016184 316 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-----TALEACVHPFFDELRDPNT 376 (394)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----t~~ell~hp~f~~~~~~~~ 376 (394)
....++..++.++.++|++||..||.+|+ |+.++++||||+++.....
T Consensus 214 -------------~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~~~~~~~~~~~ 266 (279)
T cd05633 214 -------------VNVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFFKGIDWQQV 266 (279)
T ss_pred -------------CCcCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCccccCCCHhHH
Confidence 00012245789999999999999999999 6999999999999765544
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-41 Score=303.86 Aligned_cols=248 Identities=34% Similarity=0.539 Sum_probs=200.7
Q ss_pred eEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccch---------hhhHHHHHHHHHcCCCCeeeeceEEEecCCCcee
Q 016184 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL 153 (394)
Q Consensus 83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 153 (394)
+|+..+.||+|++|.||+|....+++.|++|.+.... ..+.+|+.+++.++|+||+++++++ ....
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-----~~~~ 75 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTE-----REED 75 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeE-----ecCC
Confidence 3788899999999999999998899999999875422 3355799999999999999999877 3334
Q ss_pred EEEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCc
Q 016184 154 YLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA 232 (394)
Q Consensus 154 ~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a 232 (394)
..++++||+++ ++.+++.. ...+++..++.++.|++.||.|||+ .|++|+||+|+||+++.++ .+||+|||.+
T Consensus 76 ~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dl~~~ni~~~~~~-~~kl~d~~~~ 149 (258)
T cd06632 76 NLYIFLELVPGGSLAKLLKK----YGSFPEPVIRLYTRQILLGLEYLHD-RNTVHRDIKGANILVDTNG-VVKLADFGMA 149 (258)
T ss_pred eEEEEEEecCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEECCCC-CEEEccCccc
Confidence 57899999985 66665543 3568899999999999999999999 8999999999999999887 7999999998
Q ss_pred cccccCCCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhcc
Q 016184 233 KVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 312 (394)
Q Consensus 233 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 312 (394)
.............++..|+|||.+.....++.++|+||||+++|+|++|+.||...........+......
T Consensus 150 ~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~--------- 220 (258)
T cd06632 150 KQVVEFSFAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKEL--------- 220 (258)
T ss_pred eeccccccccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcccC---------
Confidence 76544443345667889999999854333789999999999999999999999776544333332221100
Q ss_pred CCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 016184 313 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368 (394)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f 368 (394)
..++..+++++.+|+++||+.||.+||++.++++|||+
T Consensus 221 ------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~ 258 (258)
T cd06632 221 ------------------PPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEHPFV 258 (258)
T ss_pred ------------------CCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcCCCC
Confidence 01224578999999999999999999999999999997
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-44 Score=299.70 Aligned_cols=283 Identities=31% Similarity=0.520 Sum_probs=226.7
Q ss_pred eEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccc--hh----hhHHHHHHHHHcCCCCeeeeceEEEe---cCCCcee
Q 016184 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD--KR----YKNRELQIMQMLDHPNIVALKHCFFS---TTDKEEL 153 (394)
Q Consensus 83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~----~~~~E~~~l~~l~h~~iv~~~~~~~~---~~~~~~~ 153 (394)
.|.-..+||+|.||.||+|+.+.+|+.||+|++.-+ +. ..-+|+.+|..|+|+|++.+++.|-. +......
T Consensus 18 ~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~ 97 (376)
T KOG0669|consen 18 KYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRA 97 (376)
T ss_pred HHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccc
Confidence 377788999999999999999999999999976431 11 22479999999999999999888733 2233445
Q ss_pred EEEEEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCcc
Q 016184 154 YLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK 233 (394)
Q Consensus 154 ~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~ 233 (394)
.+|+||.+|+.+|..++.+. ..+++..+++.++.++..||.|+|+ ..|+|||+|++|+||+.++ .+||+|||+++
T Consensus 98 t~ylVf~~cehDLaGlLsn~---~vr~sls~Ikk~Mk~Lm~GL~~iHr-~kilHRDmKaaNvLIt~dg-ilklADFGlar 172 (376)
T KOG0669|consen 98 TFYLVFDFCEHDLAGLLSNR---KVRFSLSEIKKVMKGLMNGLYYIHR-NKILHRDMKAANVLITKDG-ILKLADFGLAR 172 (376)
T ss_pred eeeeeHHHhhhhHHHHhcCc---cccccHHHHHHHHHHHHHHHHHHHH-hhHHhhcccHhhEEEcCCc-eEEeecccccc
Confidence 68899999999988888763 3689999999999999999999999 8999999999999999998 79999999997
Q ss_pred ccccCCC-----cccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhh
Q 016184 234 VLVKGEP-----NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 308 (394)
Q Consensus 234 ~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~ 308 (394)
.+..... ....+.|..|.+||.+.+...|+.+.|||..|||+.+|+|+.+.+.+.+...++..|....|....+.
T Consensus 173 ~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkev 252 (376)
T KOG0669|consen 173 AFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEV 252 (376)
T ss_pred ceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCccc
Confidence 6543322 12345599999999999999999999999999999999999999999999999999999999988888
Q ss_pred hhccCCC--CcccCCCCCCCCCcc---hhc-cccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 016184 309 IKCMNPN--YTEFKFPQIKPHPWH---KVF-QKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE 370 (394)
Q Consensus 309 ~~~~~~~--~~~~~~~~~~~~~~~---~~~-~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~ 370 (394)
|..++.- +..++.+-+.....+ ... +-.-.+++.+|+..+|..||.+|++++++|+|.||..
T Consensus 253 WP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~k 320 (376)
T KOG0669|consen 253 WPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWK 320 (376)
T ss_pred CCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhc
Confidence 8755421 111111111111111 111 0112568999999999999999999999999999965
|
|
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=304.50 Aligned_cols=250 Identities=29% Similarity=0.455 Sum_probs=201.3
Q ss_pred eeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccc--hhhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEEEEEE
Q 016184 82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD--KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVL 159 (394)
Q Consensus 82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~ 159 (394)
++|++.+.||.|+||.||+|.+..+++.+|+|.+... ...+.+|+++++.++|+||+++++++.. ..+.++++
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~-----~~~~~l~~ 77 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIKEISILKQCDSPYIVKYYGSYFK-----NTDLWIVM 77 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHHHHHHHHHHHHHHhCCCCcEeeeeeeeec-----CCcEEEEE
Confidence 3599999999999999999999988999999988654 3456689999999999999999998843 34588999
Q ss_pred ecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCccccccC
Q 016184 160 EYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG 238 (394)
Q Consensus 160 e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~~ 238 (394)
||+++ +|.+++.. ....+++..++.++.|++.||.|||+ .|++|+||+|+||+++.++ .++|+|||++......
T Consensus 78 e~~~~~~L~~~l~~---~~~~l~~~~~~~~~~~l~~~l~~lh~-~~i~H~dl~~~ni~~~~~~-~~~l~dfg~~~~~~~~ 152 (256)
T cd06612 78 EYCGAGSVSDIMKI---TNKTLTEEEIAAILYQTLKGLEYLHS-NKKIHRDIKAGNILLNEEG-QAKLADFGVSGQLTDT 152 (256)
T ss_pred ecCCCCcHHHHHHh---CccCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCcceEEECCCC-cEEEcccccchhcccC
Confidence 99986 66666543 23578999999999999999999999 8999999999999999887 6999999998765443
Q ss_pred C-CcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCCCc
Q 016184 239 E-PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 317 (394)
Q Consensus 239 ~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 317 (394)
. ......++..|+|||++.+. .++.++||||||+++|+|++|+.||...........+... .. .
T Consensus 153 ~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~---~~-----------~ 217 (256)
T cd06612 153 MAKRNTVIGTPFWMAPEVIQEI-GYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNK---PP-----------P 217 (256)
T ss_pred ccccccccCCccccCHHHHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccC---CC-----------C
Confidence 3 22234568889999998654 4899999999999999999999999765543322211110 00 0
Q ss_pred ccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 016184 318 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368 (394)
Q Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f 368 (394)
.. ..+..++.++.++|.+||+.||.+|||+.++|.||||
T Consensus 218 ~~------------~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~~~~ 256 (256)
T cd06612 218 TL------------SDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQHPFI 256 (256)
T ss_pred CC------------CchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcCCCC
Confidence 00 0123467899999999999999999999999999997
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-41 Score=303.67 Aligned_cols=249 Identities=29% Similarity=0.457 Sum_probs=196.9
Q ss_pred eEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccc---------hhhhHHHHHHHHHcCCCCeeeeceEEEecCCCcee
Q 016184 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD---------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL 153 (394)
Q Consensus 83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 153 (394)
+|++.+.||+|+||.||+|.+..+|+.||||.+... .....+|+.+++.+.|+||+++++++.. ....
T Consensus 3 ~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~~~ 79 (265)
T cd06652 3 NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRD---PMER 79 (265)
T ss_pred cceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEecc---CCCc
Confidence 499999999999999999999999999999987421 1234569999999999999999987732 2234
Q ss_pred EEEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCc
Q 016184 154 YLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA 232 (394)
Q Consensus 154 ~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a 232 (394)
.++++|||+++ +|.+.+.. ...+++..+..++.|++.||+|||+ .|++|+||||+||+++.++ .++|+|||.+
T Consensus 80 ~~~~v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~l~~~l~~lH~-~~i~H~dl~p~nil~~~~~-~~~l~Dfg~~ 153 (265)
T cd06652 80 TLSIFMEHMPGGSIKDQLKS----YGALTENVTRKYTRQILEGVSYLHS-NMIVHRDIKGANILRDSVG-NVKLGDFGAS 153 (265)
T ss_pred eEEEEEEecCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHh-CCEecCCCCHHHEEecCCC-CEEECcCccc
Confidence 57789999985 66665543 3567889999999999999999999 8999999999999999887 7999999998
Q ss_pred cccccC----CCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhh
Q 016184 233 KVLVKG----EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 308 (394)
Q Consensus 233 ~~~~~~----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~ 308 (394)
...... .......++..|+|||.+.+. .++.++|+|||||++|+|++|+.||........+..+.. .+.
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~---~~~--- 226 (265)
T cd06652 154 KRLQTICLSGTGMKSVTGTPYWMSPEVISGE-GYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIAT---QPT--- 226 (265)
T ss_pred cccccccccccccccCCCCccccChhhhcCC-CCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhc---CCC---
Confidence 754321 112234578899999998654 489999999999999999999999976644433332211 110
Q ss_pred hhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCC
Q 016184 309 IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFD 369 (394)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~ 369 (394)
...++..++..+.++|++||. +|.+||+++++++|||+.
T Consensus 227 ---------------------~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~~~~~ 265 (265)
T cd06652 227 ---------------------NPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRHTFVH 265 (265)
T ss_pred ---------------------CCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcCcccC
Confidence 011224567889999999995 999999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-41 Score=302.45 Aligned_cols=248 Identities=27% Similarity=0.433 Sum_probs=201.2
Q ss_pred eEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccc------hhhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEEE
Q 016184 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN 156 (394)
Q Consensus 83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 156 (394)
+|++.+.||+|+||.||++.+..+|+.||+|.+... .....+|+.+++.++|+||+++.+++ ....+.+
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~ 75 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESF-----EENGNLY 75 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeee-----cCCCeEE
Confidence 489999999999999999999999999999987532 22456799999999999999999987 3344688
Q ss_pred EEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCcccc
Q 016184 157 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL 235 (394)
Q Consensus 157 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~ 235 (394)
+|+||+.+ ++.+.+... ....+++..+..++.|++.||.|||+ .|++|+||+|+||+++.++ .++|+|||.+...
T Consensus 76 lv~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lh~-~~i~h~~l~~~nil~~~~~-~~~l~d~~~~~~~ 151 (256)
T cd08218 76 IVMDYCEGGDLYKKINAQ--RGVLFPEDQILDWFVQICLALKHVHD-RKILHRDIKSQNIFLTKDG-TIKLGDFGIARVL 151 (256)
T ss_pred EEEecCCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHh-CCEecCCCCHHHEEEcCCC-CEEEeeccceeec
Confidence 99999975 666655431 22467899999999999999999999 8999999999999999887 7999999998765
Q ss_pred ccCCCc-ccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCC
Q 016184 236 VKGEPN-VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 314 (394)
Q Consensus 236 ~~~~~~-~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 314 (394)
...... ....+++.|+|||++.+. .++.++|+|||||++|+|++|..||...+..+....+.... .+
T Consensus 152 ~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~--~~--------- 219 (256)
T cd08218 152 NSTVELARTCIGTPYYLSPEICENR-PYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGS--YP--------- 219 (256)
T ss_pred CcchhhhhhccCCccccCHHHhCCC-CCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCC--CC---------
Confidence 432221 234578889999998654 48899999999999999999999998766555544443211 00
Q ss_pred CCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 016184 315 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368 (394)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f 368 (394)
..+..++.++.++|.+||+.||.+||++.++++||||
T Consensus 220 -----------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~~~~ 256 (256)
T cd08218 220 -----------------PVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEKNFI 256 (256)
T ss_pred -----------------CCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhCcCC
Confidence 0124578899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=312.30 Aligned_cols=255 Identities=29% Similarity=0.437 Sum_probs=204.1
Q ss_pred eEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccch----hhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEEEEE
Q 016184 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLV 158 (394)
Q Consensus 83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv 158 (394)
.|.....||.|+||.||++.+..+++.||||.+.... ....+|+.+++.++|+||+++++.+. ...+.+++
T Consensus 23 ~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~-----~~~~~~lv 97 (292)
T cd06658 23 YLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYL-----VGDELWVV 97 (292)
T ss_pred HHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHhee-----cCCeEEEE
Confidence 3666678999999999999999899999999875422 33457999999999999999999873 33457899
Q ss_pred Eecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCcccccc
Q 016184 159 LEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK 237 (394)
Q Consensus 159 ~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~ 237 (394)
|||+++ ++..++.. ..+++..++.++.||+.||.|||+ +||+||||||+||+++.++ .++|+|||++.....
T Consensus 98 ~e~~~~~~L~~~~~~-----~~l~~~~~~~~~~qi~~~l~~LH~-~~ivH~dlkp~Nill~~~~-~~kL~dfg~~~~~~~ 170 (292)
T cd06658 98 MEFLEGGALTDIVTH-----TRMNEEQIATVCLSVLRALSYLHN-QGVIHRDIKSDSILLTSDG-RIKLSDFGFCAQVSK 170 (292)
T ss_pred EeCCCCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH-CCEeecCCCHHHEEEcCCC-CEEEccCcchhhccc
Confidence 999986 55554432 568899999999999999999999 8999999999999999887 799999999865432
Q ss_pred CCC-cccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCCC
Q 016184 238 GEP-NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 316 (394)
Q Consensus 238 ~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 316 (394)
... .....++..|+|||.+.+. .++.++|+||||+++|+|++|+.||...+....+..+.........
T Consensus 171 ~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~---------- 239 (292)
T cd06658 171 EVPKRKSLVGTPYWMAPEVISRL-PYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVK---------- 239 (292)
T ss_pred ccccCceeecCccccCHHHHccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCccc----------
Confidence 221 2335678899999998544 4899999999999999999999999877655544433321110000
Q ss_pred cccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCC
Q 016184 317 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNT 376 (394)
Q Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~ 376 (394)
....++..+.++|.+||..||.+|||++++++||||+....+..
T Consensus 240 ----------------~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~~~~~~~~~ 283 (292)
T cd06658 240 ----------------DSHKVSSVLRGFLDLMLVREPSQRATAQELLQHPFLKLAGPPSC 283 (292)
T ss_pred ----------------cccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhhccCCccc
Confidence 01246888999999999999999999999999999998877764
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=308.10 Aligned_cols=251 Identities=25% Similarity=0.356 Sum_probs=198.2
Q ss_pred eeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccch----hhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEEEE
Q 016184 82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL 157 (394)
Q Consensus 82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 157 (394)
.+|.+.+.||+|+||.||+|++..+++.||+|++.... ....+|+.+++.++||||+++++.+. .....++
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~-----~~~~~~l 83 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYL-----RRDKLWI 83 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEE-----eCCEEEE
Confidence 46999999999999999999999999999999875432 23457899999999999999999873 3345789
Q ss_pred EEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCccccc
Q 016184 158 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV 236 (394)
Q Consensus 158 v~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~ 236 (394)
+|||+++ +|.+++.. ...+++..++.++.|++.||.|||+ .|++|+||||+||+++.++ .++|+|||++....
T Consensus 84 v~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dlkp~nili~~~~-~~~l~dfg~~~~~~ 157 (267)
T cd06645 84 CMEFCGGGSLQDIYHV----TGPLSESQIAYVSRETLQGLYYLHS-KGKMHRDIKGANILLTDNG-HVKLADFGVSAQIT 157 (267)
T ss_pred EEeccCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEECCCC-CEEECcceeeeEcc
Confidence 9999985 67665543 3678999999999999999999999 8999999999999999887 69999999986553
Q ss_pred cCC-Cccccccccccccccccc--CCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccC
Q 016184 237 KGE-PNVSYICSRYYRAPELIF--GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 313 (394)
Q Consensus 237 ~~~-~~~~~~~t~~y~aPE~~~--~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 313 (394)
... ......+++.|+|||.+. ....++.++|+|||||++|+|++|..||........+..+....-.++
T Consensus 158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~-------- 229 (267)
T cd06645 158 ATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPP-------- 229 (267)
T ss_pred CcccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCC--------
Confidence 221 223456789999999874 123478899999999999999999999976554433322221100000
Q ss_pred CCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCC
Q 016184 314 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 367 (394)
Q Consensus 314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~ 367 (394)
.+. ....++..+.+||.+||+.||++|||++++++|||
T Consensus 230 --------------~~~--~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~~~ 267 (267)
T cd06645 230 --------------KLK--DKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQHPF 267 (267)
T ss_pred --------------ccc--ccCCCCHHHHHHHHHHccCCchhCcCHHHHhcCCC
Confidence 000 00246788999999999999999999999999999
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-42 Score=321.92 Aligned_cols=244 Identities=30% Similarity=0.461 Sum_probs=199.4
Q ss_pred ceeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccchhhhHHHHHHHHHc-CCCCeeeeceEEEecCCCceeEEEEEE
Q 016184 81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQML-DHPNIVALKHCFFSTTDKEELYLNLVL 159 (394)
Q Consensus 81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~lv~ 159 (394)
..+|.+...+|.|+|+.|-.+.+..+++..++|++.+......+|+.++... +|+||+++.+.+ .+....++||
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~~~~~e~~~~~~~~~h~niv~~~~v~-----~~~~~~~~v~ 395 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRADDNQDEIPISLLVRDHPNIVKSHDVY-----EDGKEIYLVM 395 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheeccccccccccccchhhhhcCCCcceeeccee-----cCCceeeeee
Confidence 4468999999999999999999999999999999988877777888766655 899999999988 6666789999
Q ss_pred ecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEE-eCCCCcEEEEeecCccccccC
Q 016184 160 EYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLV-NPHTHQLKLCDFGSAKVLVKG 238 (394)
Q Consensus 160 e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~-~~~~~~vkl~Dfg~a~~~~~~ 238 (394)
|.+.|.. ++.. ... .+.....+..|+.+|+.|+.|||+ +|+|||||||+|||+ +..+ .++|+|||.++.....
T Consensus 396 e~l~g~e--ll~r-i~~-~~~~~~e~~~w~~~lv~Av~~LH~-~gvvhRDLkp~NIL~~~~~g-~lrltyFG~a~~~~~~ 469 (612)
T KOG0603|consen 396 ELLDGGE--LLRR-IRS-KPEFCSEASQWAAELVSAVDYLHE-QGVVHRDLKPGNILLDGSAG-HLRLTYFGFWSELERS 469 (612)
T ss_pred hhccccH--HHHH-HHh-cchhHHHHHHHHHHHHHHHHHHHh-cCeeecCCChhheeecCCCC-cEEEEEechhhhCchh
Confidence 9999732 1221 111 333337788899999999999999 899999999999999 4666 6999999999865443
Q ss_pred CCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCCCcc
Q 016184 239 EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 318 (394)
Q Consensus 239 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 318 (394)
....+-|..|.|||++. ...|+.++||||||++||+|++|+.||...... .++...++.+.
T Consensus 470 --~~tp~~t~~y~APEvl~-~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~---~ei~~~i~~~~------------- 530 (612)
T KOG0603|consen 470 --CDTPALTLQYVAPEVLA-IQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG---IEIHTRIQMPK------------- 530 (612)
T ss_pred --hcccchhhcccChhhhc-cCCCCcchhhHHHHHHHHHHHhCCCccccCCch---HHHHHhhcCCc-------------
Confidence 22334578899999996 455999999999999999999999999877655 23333333222
Q ss_pred cCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 016184 319 FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368 (394)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f 368 (394)
+...+|.++++||++||++||.+|+++.+++.||||
T Consensus 531 --------------~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 531 --------------FSECVSDEAKDLLQQLLQVDPALRLGADEIGAHPWF 566 (612)
T ss_pred --------------cccccCHHHHHHHHHhccCChhhCcChhhhccCcch
Confidence 124689999999999999999999999999999999
|
|
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-41 Score=302.96 Aligned_cols=252 Identities=28% Similarity=0.409 Sum_probs=200.9
Q ss_pred eeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccc----hhhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEEEE
Q 016184 82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL 157 (394)
Q Consensus 82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 157 (394)
.+|++.+.||.|+||.||+|.+..+++.+|+|++... .....+|+++++.++|+||+++++++.. ....++
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-----~~~~~l 77 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLR-----RDKLWI 77 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEe-----CCEEEE
Confidence 4699999999999999999999989999999987643 2345679999999999999999988733 335789
Q ss_pred EEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCccccc
Q 016184 158 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV 236 (394)
Q Consensus 158 v~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~ 236 (394)
+|||+++ ++..++... ...+++..++.++.|++.||.|||+ .|++|+||||+||+++.++ .++|+|||.+....
T Consensus 78 ~~e~~~~~~l~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lh~-~~i~h~dl~p~ni~i~~~~-~~~l~d~g~~~~~~ 152 (262)
T cd06613 78 VMEYCGGGSLQDIYQVT---RGPLSELQIAYVCRETLKGLAYLHE-TGKIHRDIKGANILLTEDG-DVKLADFGVSAQLT 152 (262)
T ss_pred EEeCCCCCcHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCChhhEEECCCC-CEEECccccchhhh
Confidence 9999986 665554431 2578999999999999999999999 8999999999999999887 69999999987654
Q ss_pred cCC-CcccccccccccccccccCC--CCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccC
Q 016184 237 KGE-PNVSYICSRYYRAPELIFGA--TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 313 (394)
Q Consensus 237 ~~~-~~~~~~~t~~y~aPE~~~~~--~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 313 (394)
... ......++..|+|||.+.+. ..++.++|+||||+++|+|++|..||...........+....-.+..
T Consensus 153 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~------- 225 (262)
T cd06613 153 ATIAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPK------- 225 (262)
T ss_pred hhhhccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCcc-------
Confidence 322 22334678889999998543 14788999999999999999999999877655544433221000000
Q ss_pred CCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCC
Q 016184 314 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 367 (394)
Q Consensus 314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~ 367 (394)
.......+.++.+||++||..||.+|||+.+++.|||
T Consensus 226 -----------------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~ 262 (262)
T cd06613 226 -----------------LKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQHPF 262 (262)
T ss_pred -----------------ccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcCCC
Confidence 0011345788999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=304.68 Aligned_cols=246 Identities=28% Similarity=0.454 Sum_probs=201.6
Q ss_pred eEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccc-------hhhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEE
Q 016184 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL 155 (394)
Q Consensus 83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 155 (394)
+|++.+.||.|+||.||+|.+..+++.||+|++.+. .....+|++++++++||||+++++++ .+....
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~ 75 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSF-----QDEENM 75 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhh-----cCCCeE
Confidence 489999999999999999999999999999988643 23445789999999999999999887 444568
Q ss_pred EEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCccc
Q 016184 156 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV 234 (394)
Q Consensus 156 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~ 234 (394)
++++||+.+ +|...+.. ...+++..+..++.|++.||.|||+ +|++|+||+|+||+++.++ .++|+|||.+..
T Consensus 76 ~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~~i~~~l~~lh~-~~i~h~dl~~~nil~~~~~-~~~l~d~~~~~~ 149 (258)
T cd05578 76 YLVVDLLLGGDLRYHLSQ----KVKFSEEQVKFWICEIVLALEYLHS-KGIIHRDIKPDNILLDEQG-HVHITDFNIATK 149 (258)
T ss_pred EEEEeCCCCCCHHHHHHh----cCCcCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCHHHeEEcCCC-CEEEeecccccc
Confidence 899999986 66555543 2578999999999999999999999 8999999999999999888 699999999876
Q ss_pred cccCCCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcH--HHHHHHHHHhCCCChhhhhcc
Q 016184 235 LVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGV--DQLVEIIKVLGTPTREEIKCM 312 (394)
Q Consensus 235 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~--~~~~~i~~~~~~~~~~~~~~~ 312 (394)
...........++..|+|||.+.... ++.++|+||||+++|+|++|..||...+.. ..+..... .
T Consensus 150 ~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~---~--------- 216 (258)
T cd05578 150 VTPDTLTTSTSGTPGYMAPEVLCRQG-YSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQE---T--------- 216 (258)
T ss_pred cCCCccccccCCChhhcCHHHHcccC-CCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhc---c---------
Confidence 65443444566788899999986544 899999999999999999999999876642 22221111 0
Q ss_pred CCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCH--HHHhcCCCC
Q 016184 313 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTA--LEACVHPFF 368 (394)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~--~ell~hp~f 368 (394)
....++..++..+.++|.+||+.||.+||++ .|+++||||
T Consensus 217 ----------------~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~~~~~ 258 (258)
T cd05578 217 ----------------ADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKNHPYF 258 (258)
T ss_pred ----------------ccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHhcCCCC
Confidence 0011224568999999999999999999999 999999998
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=299.79 Aligned_cols=248 Identities=32% Similarity=0.469 Sum_probs=203.5
Q ss_pred eEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccc------hhhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEEE
Q 016184 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN 156 (394)
Q Consensus 83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 156 (394)
+|++.++||.|+||.||.++...+++.+++|.+... .....+|+++++.++|+||+++++++.. ....+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-----~~~~~ 75 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMD-----DNTLL 75 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEec-----CCeEE
Confidence 499999999999999999999999999999987532 1234579999999999999999999843 34588
Q ss_pred EEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCcccc
Q 016184 157 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL 235 (394)
Q Consensus 157 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~ 235 (394)
++|||+++ +|.+.+.... ...+++..+..++.|++.||.|||+ .|++|+||+|+||+++.++ .+||+|||++...
T Consensus 76 ~~~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~-~~i~h~dl~p~ni~~~~~~-~~kl~d~~~~~~~ 151 (256)
T cd08221 76 IEMEYANGGTLYDKIVRQK--GQLFEEEMVLWYLFQIVSAVSYIHK-AGILHRDIKTLNIFLTKAG-LIKLGDFGISKIL 151 (256)
T ss_pred EEEEecCCCcHHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCChHhEEEeCCC-CEEECcCcceEEc
Confidence 99999985 7777665432 3568999999999999999999999 8999999999999999887 6999999998765
Q ss_pred ccCC-CcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCC
Q 016184 236 VKGE-PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 314 (394)
Q Consensus 236 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 314 (394)
.... ......+++.|+|||.+.+.. ++.++|+||||+++|+|++|..||......+....+.... ..
T Consensus 152 ~~~~~~~~~~~~~~~y~ape~~~~~~-~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~--~~--------- 219 (256)
T cd08221 152 GSEYSMAETVVGTPYYMSPELCQGVK-YNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGN--YT--------- 219 (256)
T ss_pred ccccccccccCCCccccCHhhcCCCC-CCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCC--CC---------
Confidence 4333 223456789999999986544 7899999999999999999999998766655555443210 00
Q ss_pred CCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 016184 315 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368 (394)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f 368 (394)
.....++.++.++|.+||..||.+||++.++++|||+
T Consensus 220 -----------------~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~~l 256 (256)
T cd08221 220 -----------------PVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQPLL 256 (256)
T ss_pred -----------------CCccccCHHHHHHHHHHcccCcccCCCHHHHhhCcCC
Confidence 0113568899999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-41 Score=304.17 Aligned_cols=245 Identities=29% Similarity=0.476 Sum_probs=197.7
Q ss_pred EeecCceEEEEEEECCCCcEEEEEEeccch-------hhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEEEEEEecc
Q 016184 90 VGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYV 162 (394)
Q Consensus 90 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~ 162 (394)
||.|++|.||+|++..+++.||+|++.+.. ..+.+|+.+++.++|+||+++++.+. .....++++||+
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~lv~e~~ 75 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFK-----DKKYIYMLMEYC 75 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEE-----cCCccEEEEecC
Confidence 689999999999999999999999885432 33557999999999999999999873 334478999998
Q ss_pred cc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCccccccCCCc
Q 016184 163 PE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN 241 (394)
Q Consensus 163 ~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~~~~~ 241 (394)
++ +|.+.+.. ...+++..+..++.|++.||+|||+ .|++|+||+|+||+++.++ .++|+|||++.........
T Consensus 76 ~~~~L~~~l~~----~~~l~~~~~~~~~~~i~~~l~~lH~-~~~~h~dl~~~nilv~~~~-~~~l~df~~~~~~~~~~~~ 149 (262)
T cd05572 76 LGGELWTILRD----RGLFDEYTARFYIACVVLAFEYLHN-RGIIYRDLKPENLLLDSNG-YVKLVDFGFAKKLKSGQKT 149 (262)
T ss_pred CCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHhh-CCcccCCCCHHHEEEcCCC-CEEEeeCCcccccCccccc
Confidence 74 77666654 2458999999999999999999999 8999999999999999888 7999999999876544333
Q ss_pred ccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCC--cHHHHHHHHHHhCCCChhhhhccCCCCccc
Q 016184 242 VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGES--GVDQLVEIIKVLGTPTREEIKCMNPNYTEF 319 (394)
Q Consensus 242 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~--~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 319 (394)
....+++.|+|||.+.+. .++.++|+||||+++|+|++|..||.... .......+.... ...
T Consensus 150 ~~~~~~~~~~~PE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~---------------~~~ 213 (262)
T cd05572 150 WTFCGTPEYVAPEIILNK-GYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGN---------------GKL 213 (262)
T ss_pred ccccCCcCccChhHhcCC-CCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccC---------------CCC
Confidence 445678899999998544 48999999999999999999999998765 333333322100 000
Q ss_pred CCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCC-----HHHHhcCCCCCCCCC
Q 016184 320 KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCT-----ALEACVHPFFDELRD 373 (394)
Q Consensus 320 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt-----~~ell~hp~f~~~~~ 373 (394)
.++...++++.++|.+||+.||++||+ ++|+++||||++...
T Consensus 214 ------------~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~ 260 (262)
T cd05572 214 ------------EFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKWFNGFDW 260 (262)
T ss_pred ------------CCCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhcChhhhCCCC
Confidence 112345889999999999999999999 999999999998743
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-41 Score=301.39 Aligned_cols=249 Identities=27% Similarity=0.407 Sum_probs=200.7
Q ss_pred eEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccc------hhhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEEE
Q 016184 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN 156 (394)
Q Consensus 83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 156 (394)
+|++.+.||.|+||.||+|.++.+|..||+|.+... .....+|+.+++.++|+||+++++.+ ......+
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~-----~~~~~~~ 75 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASF-----QENGRLF 75 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhhee-----ccCCeEE
Confidence 489999999999999999999999999999987542 23456799999999999999999987 3344588
Q ss_pred EEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCcccc
Q 016184 157 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL 235 (394)
Q Consensus 157 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~ 235 (394)
+++||+++ ++.+.+... ....+++..+..++.|++.||.|||+ .+++|+||||+||+++.++..++|+|||.+...
T Consensus 76 lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lh~-~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~ 152 (257)
T cd08225 76 IVMEYCDGGDLMKRINRQ--RGVLFSEDQILSWFVQISLGLKHIHD-RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQL 152 (257)
T ss_pred EEEecCCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccccCCHHHEEEcCCCCeEEecccccchhc
Confidence 99999975 666655432 22457899999999999999999999 899999999999999988656899999998765
Q ss_pred ccCCCc-ccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCC
Q 016184 236 VKGEPN-VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 314 (394)
Q Consensus 236 ~~~~~~-~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 314 (394)
...... ....+++.|+|||.+... .++.++|+||||+++|+|++|..||...+.......+.... .
T Consensus 153 ~~~~~~~~~~~~~~~~~ape~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--~---------- 219 (257)
T cd08225 153 NDSMELAYTCVGTPYYLSPEICQNR-PYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGY--F---------- 219 (257)
T ss_pred cCCcccccccCCCccccCHHHHcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccc--C----------
Confidence 433222 234578889999988544 48899999999999999999999997765444443322210 0
Q ss_pred CCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 016184 315 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368 (394)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f 368 (394)
..+...++.++.++|.+||..+|++|||+.++++||||
T Consensus 220 ----------------~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~~~~ 257 (257)
T cd08225 220 ----------------APISPNFSRDLRSLISQLFKVSPRDRPSITSILKRPFL 257 (257)
T ss_pred ----------------CCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhCCCC
Confidence 00123568899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=306.65 Aligned_cols=253 Identities=28% Similarity=0.489 Sum_probs=201.1
Q ss_pred eEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccch-------hhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEE
Q 016184 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL 155 (394)
Q Consensus 83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 155 (394)
.|++.+.||+|+||.||++.+..+++.||+|.+.... ....+|+++++.++|+||+++++.+ ....+.
T Consensus 2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~~ 76 (305)
T cd05609 2 DFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSF-----ETKRHL 76 (305)
T ss_pred CceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEE-----ecCCEE
Confidence 4999999999999999999999999999999876432 2334788999999999999999887 334468
Q ss_pred EEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCccc
Q 016184 156 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV 234 (394)
Q Consensus 156 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~ 234 (394)
+++|||+++ +|.+++.. ...+++..+..++.|++.||+|||+ .|++||||||+||+++.++ .++|+|||+++.
T Consensus 77 ~lv~e~~~g~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dl~p~NIll~~~~-~~~l~dfg~~~~ 150 (305)
T cd05609 77 CMVMEYVEGGDCATLLKN----IGALPVDMARMYFAETVLALEYLHN-YGIVHRDLKPDNLLITSMG-HIKLTDFGLSKI 150 (305)
T ss_pred EEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCchHHEEECCCC-CEEEeeCCCccc
Confidence 899999986 66666643 3568999999999999999999999 8999999999999999887 799999998863
Q ss_pred cccCC----------------CcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHH
Q 016184 235 LVKGE----------------PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEII 298 (394)
Q Consensus 235 ~~~~~----------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~ 298 (394)
..... ......++..|+|||.+.+. .++.++|+||||+++|+|++|..||.+....+....+.
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~ 229 (305)
T cd05609 151 GLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQ-GYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVI 229 (305)
T ss_pred cCcCccccccccccccchhhccccCCccCccccCchhccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 21000 00123467889999998654 48999999999999999999999998766555444433
Q ss_pred HHhCCCChhhhhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCC---HHHHhcCCCCCCCCC
Q 016184 299 KVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCT---ALEACVHPFFDELRD 373 (394)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt---~~ell~hp~f~~~~~ 373 (394)
..... .+. ....++.++.++|.+||+.||++||+ +.++|+||||+....
T Consensus 230 ~~~~~-----------------~~~---------~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~~~~ 281 (305)
T cd05609 230 SDDIE-----------------WPE---------GDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGLDW 281 (305)
T ss_pred hcccC-----------------CCC---------ccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccCCCH
Confidence 31100 000 01247889999999999999999997 799999999977543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-41 Score=309.75 Aligned_cols=250 Identities=28% Similarity=0.421 Sum_probs=201.6
Q ss_pred eEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccch-------hhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEE
Q 016184 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL 155 (394)
Q Consensus 83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 155 (394)
.|.+.+.||+|+||.||+|.+..+++.||+|++.... ....+|+++++.++||||+++.+++... ...
T Consensus 16 ~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~-----~~~ 90 (307)
T cd06607 16 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLRE-----HTA 90 (307)
T ss_pred hhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeC-----CeE
Confidence 4999999999999999999999899999999875321 2345799999999999999999988432 337
Q ss_pred EEEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCcccc
Q 016184 156 NLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL 235 (394)
Q Consensus 156 ~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~ 235 (394)
++||||+.+++.+++... ...+++..+..++.|++.||.|||+ .|++|+||+|+||+++.++ .++|+|||++...
T Consensus 91 ~lv~e~~~g~l~~~~~~~---~~~l~~~~~~~~~~ql~~~L~~LH~-~~i~H~dl~p~nIl~~~~~-~~kL~dfg~~~~~ 165 (307)
T cd06607 91 WLVMEYCLGSASDILEVH---KKPLQEVEIAAICHGALQGLAYLHS-HERIHRDIKAGNILLTEPG-TVKLADFGSASLV 165 (307)
T ss_pred EEEHHhhCCCHHHHHHHc---ccCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCcccEEECCCC-CEEEeecCcceec
Confidence 799999998876665432 2568999999999999999999999 8999999999999999887 7999999998654
Q ss_pred ccCCCcccccccccccccccccC--CCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccC
Q 016184 236 VKGEPNVSYICSRYYRAPELIFG--ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 313 (394)
Q Consensus 236 ~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 313 (394)
... ....+++.|+|||++.+ ...++.++||||||+++|+|++|..||...+.......+... .+
T Consensus 166 ~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~--~~--------- 231 (307)
T cd06607 166 SPA---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN--DS--------- 231 (307)
T ss_pred CCC---CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcC--CC---------
Confidence 322 23467888999998742 344788999999999999999999999876654443332210 00
Q ss_pred CCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 016184 314 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR 372 (394)
Q Consensus 314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 372 (394)
+. ......+..+.++|.+||+.||++||++.+++.||||....
T Consensus 232 --------~~--------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 274 (307)
T cd06607 232 --------PT--------LSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFVLRER 274 (307)
T ss_pred --------CC--------CCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcChhhcccC
Confidence 00 00123578899999999999999999999999999998754
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=306.25 Aligned_cols=255 Identities=29% Similarity=0.519 Sum_probs=201.1
Q ss_pred eEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccch-----hhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEEEE
Q 016184 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL 157 (394)
Q Consensus 83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 157 (394)
+|++.+.||.|++|.||+|.++.+++.||+|.+.... ....+|+++++.+.|+||+++++.+.. ....++
T Consensus 2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-----~~~~~l 76 (265)
T cd06605 2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYN-----NGDISI 76 (265)
T ss_pred cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeec-----CCEEEE
Confidence 4888899999999999999999999999999876442 234578999999999999999998833 345889
Q ss_pred EEeccc-ccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCccccc
Q 016184 158 VLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV 236 (394)
Q Consensus 158 v~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~ 236 (394)
++||++ ++|.+++.... ..+++..+..++.|++.||+|||+..|++|+||||+||+++.++ .++|+|||.+....
T Consensus 77 v~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~-~~~l~d~g~~~~~~ 152 (265)
T cd06605 77 CMEYMDGGSLDKILKEVQ---GRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRG-QIKLCDFGVSGQLV 152 (265)
T ss_pred EEEecCCCcHHHHHHHcc---CCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCC-CEEEeecccchhhH
Confidence 999999 57777665432 67899999999999999999999735999999999999999887 69999999987653
Q ss_pred cCCCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCc-HHHHHHHHH-HhCCCChhhhhccCC
Q 016184 237 KGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESG-VDQLVEIIK-VLGTPTREEIKCMNP 314 (394)
Q Consensus 237 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~-~~~~~~i~~-~~~~~~~~~~~~~~~ 314 (394)
..... ...++..|+|||.+.+. .++.++|+||||+++|+|++|..||..... ........+ ........
T Consensus 153 ~~~~~-~~~~~~~y~~PE~~~~~-~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~------- 223 (265)
T cd06605 153 NSLAK-TFVGTSSYMAPERIQGN-DYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPR------- 223 (265)
T ss_pred HHHhh-cccCChhccCHHHHcCC-CCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCCCC-------
Confidence 32222 26678889999998655 589999999999999999999999976521 111111111 11110000
Q ss_pred CCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 016184 315 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR 372 (394)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 372 (394)
. ....++..+.++|.+||..||.+|||+.+++.||||++..
T Consensus 224 ------~-----------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~~~~~ 264 (265)
T cd06605 224 ------L-----------PSGKFSPDFQDFVNLCLIKDPRERPSYKELLEHPFIKKYE 264 (265)
T ss_pred ------C-----------ChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhCchhhccc
Confidence 0 0012688999999999999999999999999999998763
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=302.49 Aligned_cols=252 Identities=33% Similarity=0.524 Sum_probs=197.4
Q ss_pred eEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccc--------------hhhhHHHHHHHHHcCCCCeeeeceEEEecC
Q 016184 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD--------------KRYKNRELQIMQMLDHPNIVALKHCFFSTT 148 (394)
Q Consensus 83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--------------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 148 (394)
+|.+.+.||.|+||.||+|.+..+|+.||+|.+... ...+.+|+.+++.++|+|++++++++.
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--- 78 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFET--- 78 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEec---
Confidence 599999999999999999999889999999987421 113456899999999999999998873
Q ss_pred CCceeEEEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEE
Q 016184 149 DKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLC 227 (394)
Q Consensus 149 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~ 227 (394)
.....++||||+++ +|.+.+.. ...+++..++.++.|++.||.|||+ .|++|+||+|+||+++.++ .++|+
T Consensus 79 --~~~~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~~~nil~~~~~-~~~l~ 150 (272)
T cd06629 79 --TEEYLSIFLEYVPGGSIGSCLRT----YGRFEEQLVRFFTEQVLEGLAYLHS-KGILHRDLKADNLLVDADG-ICKIS 150 (272)
T ss_pred --cCCceEEEEecCCCCcHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHhh-CCeeecCCChhhEEEcCCC-eEEEe
Confidence 33447899999975 66665544 2578899999999999999999999 8999999999999999887 79999
Q ss_pred eecCccccccCC---CcccccccccccccccccCCC-CCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCC
Q 016184 228 DFGSAKVLVKGE---PNVSYICSRYYRAPELIFGAT-EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGT 303 (394)
Q Consensus 228 Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~-~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~ 303 (394)
|||++....... ......++..|+|||.+.... .++.++|+||||+++|++++|..||........+.++......
T Consensus 151 d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 230 (272)
T cd06629 151 DFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSA 230 (272)
T ss_pred eccccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccC
Confidence 999987543221 122345688899999986443 3789999999999999999999999755443333222110000
Q ss_pred CChhhhhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 016184 304 PTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368 (394)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f 368 (394)
. .........++.++.+||.+||..||.+|||++++|+||||
T Consensus 231 ---------------~--------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~ 272 (272)
T cd06629 231 ---------------P--------PIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQHPFI 272 (272)
T ss_pred ---------------C--------cCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence 0 00011123578999999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-41 Score=305.61 Aligned_cols=253 Identities=27% Similarity=0.480 Sum_probs=201.3
Q ss_pred eEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccc-----hhhhHHHHHHHHHcC---CCCeeeeceEEEecCCCceeE
Q 016184 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-----KRYKNRELQIMQMLD---HPNIVALKHCFFSTTDKEELY 154 (394)
Q Consensus 83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~---h~~iv~~~~~~~~~~~~~~~~ 154 (394)
.|++.+.||.|+||.||+|.+..+++.||+|.+... .....+|+++++.+. |+|++++++++. ....
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~-----~~~~ 76 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYL-----KGPR 76 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeee-----eCCE
Confidence 388889999999999999999999999999987542 234557888999986 999999999873 2345
Q ss_pred EEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCcc
Q 016184 155 LNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK 233 (394)
Q Consensus 155 ~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~ 233 (394)
.+++|||+.+ +|.+++.. ..+++..++.++.|++.||.|||+ .||+|+||+|+||+++.++ .++|+|||++.
T Consensus 77 ~~lv~e~~~~~~L~~~~~~-----~~l~~~~~~~i~~~i~~~l~~lh~-~~i~H~dl~p~ni~i~~~~-~~~l~dfg~~~ 149 (277)
T cd06917 77 LWIIMEYAEGGSVRTLMKA-----GPIAEKYISVIIREVLVALKYIHK-VGVIHRDIKAANILVTNTG-NVKLCDFGVAA 149 (277)
T ss_pred EEEEEecCCCCcHHHHHHc-----cCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCcCHHHEEEcCCC-CEEEccCCcee
Confidence 7899999976 66655443 478899999999999999999999 8999999999999999877 79999999987
Q ss_pred ccccCCC-cccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhcc
Q 016184 234 VLVKGEP-NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 312 (394)
Q Consensus 234 ~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 312 (394)
....... .....++..|+|||.+.+...++.++|+||||+++|+|++|..||.+.........+...
T Consensus 150 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~------------ 217 (277)
T cd06917 150 LLNQNSSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKS------------ 217 (277)
T ss_pred ecCCCccccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccC------------
Confidence 6644332 233467889999999866555789999999999999999999999765433222111000
Q ss_pred CCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCC
Q 016184 313 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP 374 (394)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~ 374 (394)
..+. ......+.++.+++.+||+.||++||++.++++||||++....
T Consensus 218 -------~~~~--------~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~~~~~~~~~~ 264 (277)
T cd06917 218 -------KPPR--------LEDNGYSKLLREFVAACLDEEPKERLSAEELLKSKWIKAHSKT 264 (277)
T ss_pred -------CCCC--------CCcccCCHHHHHHHHHHcCCCcccCcCHHHHhhChHhhccccC
Confidence 0000 0012367899999999999999999999999999999887544
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=316.53 Aligned_cols=280 Identities=20% Similarity=0.303 Sum_probs=199.4
Q ss_pred eEEeec--CceEEEEEEECCCCcEEEEEEeccch------hhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEEEEEE
Q 016184 88 HVVGTG--SFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVL 159 (394)
Q Consensus 88 ~~lg~G--~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~ 159 (394)
..||.| +||+||+|.+..+|+.||+|++.... ..+.+|+.+++.++||||+++++++. ...+.+++|
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~-----~~~~~~~v~ 78 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFT-----TGSWLWVIS 78 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEe-----cCCceEEEE
Confidence 345666 99999999999999999999875422 33457888999999999999999883 334578999
Q ss_pred ecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCccccccC
Q 016184 160 EYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG 238 (394)
Q Consensus 160 e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~~ 238 (394)
||+.+ ++..++.... ...+++..+..++.|++.||+|||+ .||+||||||+|||++.++ .++++||+.+......
T Consensus 79 e~~~~~~l~~~l~~~~--~~~~~~~~~~~~~~qi~~aL~~lH~-~~ivHrDlkp~Nill~~~~-~~~~~~~~~~~~~~~~ 154 (328)
T cd08226 79 PFMAYGSANSLLKTYF--PEGMSEALIGNILFGALRGLNYLHQ-NGYIHRNIKASHILISGDG-LVSLSGLSHLYSLVRN 154 (328)
T ss_pred ecccCCCHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEeCCC-cEEEechHHHhhhhcc
Confidence 99985 7766666532 2468999999999999999999999 8999999999999999887 7999999865433221
Q ss_pred CCc--------ccccccccccccccccCC-CCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhh
Q 016184 239 EPN--------VSYICSRYYRAPELIFGA-TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI 309 (394)
Q Consensus 239 ~~~--------~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 309 (394)
... ....++..|+|||++.+. ..++.++|||||||++|+|++|..||........+..........+....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (328)
T cd08226 155 GQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDIT 234 (328)
T ss_pred CccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCcccc
Confidence 111 012235669999998653 34789999999999999999999999877655444433331111110000
Q ss_pred ---------hccCCCC----cccCCC-----CCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 016184 310 ---------KCMNPNY----TEFKFP-----QIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL 371 (394)
Q Consensus 310 ---------~~~~~~~----~~~~~~-----~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 371 (394)
....... ...... ......+.......++..+.+||++||+.||++|||+.++|+||||+.+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~ 314 (328)
T cd08226 235 TFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQV 314 (328)
T ss_pred ccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHH
Confidence 0000000 000000 0000111111223467889999999999999999999999999999998
Q ss_pred CCCCC
Q 016184 372 RDPNT 376 (394)
Q Consensus 372 ~~~~~ 376 (394)
.+.+.
T Consensus 315 ~~~~~ 319 (328)
T cd08226 315 KEQTQ 319 (328)
T ss_pred HHhcc
Confidence 87654
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=300.06 Aligned_cols=247 Identities=29% Similarity=0.474 Sum_probs=191.8
Q ss_pred eeEEeecCceEEEEEEECCCCcEEEEEEeccc----hhhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEEEEEEecc
Q 016184 87 EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYV 162 (394)
Q Consensus 87 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~ 162 (394)
...||+|+||.||+|++..++..||+|.+... .....+|+.+++.++|+||+++++++. ...+.++++||+
T Consensus 13 ~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~~~~~lv~e~~ 87 (268)
T cd06624 13 RVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDS-----ENGFFKIFMEQV 87 (268)
T ss_pred eEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeec-----cCCEEEEEEecC
Confidence 35799999999999999989999999987543 234567999999999999999999873 334578999999
Q ss_pred cc-cHHHHHHHhhhhcCCC--CHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCccccccCC
Q 016184 163 PE-TVNRIARNYSRIHQRM--PLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE 239 (394)
Q Consensus 163 ~~-~l~~~~~~~~~~~~~l--~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~~~ 239 (394)
++ +|...+.... ..+ ++..+..++.|++.||+|||+ .||+||||||+||+++.+...++|+|||.+.......
T Consensus 88 ~~~~L~~~l~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~-~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~ 163 (268)
T cd06624 88 PGGSLSALLRSKW---GPLKDNEQTIIFYTKQILEGLKYLHD-NQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGIN 163 (268)
T ss_pred CCCCHHHHHHHhc---ccCCCcHHHHHHHHHHHHHHHHHHHH-CCEeecCCCHHHEEEcCCCCeEEEecchhheecccCC
Confidence 85 7776665421 334 778888899999999999999 8999999999999998744479999999987553322
Q ss_pred C-cccccccccccccccccCC-CCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCCCc
Q 016184 240 P-NVSYICSRYYRAPELIFGA-TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 317 (394)
Q Consensus 240 ~-~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 317 (394)
. .....+++.|+|||.+.+. ..++.++|+||||+++|+|++|+.||.................
T Consensus 164 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~--------------- 228 (268)
T cd06624 164 PCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFK--------------- 228 (268)
T ss_pred CccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhc---------------
Confidence 2 2234578899999998543 2378899999999999999999999975432211111100000
Q ss_pred ccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 016184 318 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368 (394)
Q Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f 368 (394)
....++..+++++.+|+++||+.+|.+|||+.+++.||||
T Consensus 229 -----------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~ 268 (268)
T cd06624 229 -----------IHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQDPFL 268 (268)
T ss_pred -----------cCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhCCCC
Confidence 0001234578899999999999999999999999999997
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=307.80 Aligned_cols=255 Identities=20% Similarity=0.286 Sum_probs=192.1
Q ss_pred ceeEEEeeEEeecCceEEEEEEECC----------------CCcEEEEEEeccch-----hhhHHHHHHHHHcCCCCeee
Q 016184 81 KVSYIAEHVVGTGSFGVVFQAKCRE----------------TGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVA 139 (394)
Q Consensus 81 ~~~y~~~~~lg~G~~g~V~~~~~~~----------------~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~ 139 (394)
..+|++.+.||+|+||.||+|.+.. ++..||+|++.... ..+.+|+++++.++||||++
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 83 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR 83 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence 3469999999999999999998632 34579999876432 23557999999999999999
Q ss_pred eceEEEecCCCceeEEEEEEecccc-cHHHHHHHhhh---------------hcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 016184 140 LKHCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSR---------------IHQRMPLIYVKLYTYQICRALAYIHNCI 203 (394)
Q Consensus 140 ~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~---------------~~~~l~~~~~~~~~~qi~~al~~LH~~~ 203 (394)
+++++... ...+++|||+.+ +|.+++..... ....+++..++.++.||+.||.|||+ .
T Consensus 84 ~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~-~ 157 (304)
T cd05096 84 LLGVCVDE-----DPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSS-L 157 (304)
T ss_pred EEEEEecC-----CceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHH-C
Confidence 99988432 337899999975 77777654321 11346778899999999999999999 8
Q ss_pred CceeccCCCCceEEeCCCCcEEEEeecCccccccCCC---cccccccccccccccccCCCCCCChhhHHHHHHHHHHHHh
Q 016184 204 GICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP---NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL 280 (394)
Q Consensus 204 givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt 280 (394)
||+||||||+|||++.++ .+||+|||+++....... .....++..|+|||++... .++.++||||||+++|+|++
T Consensus 158 ~ivH~dlkp~Nill~~~~-~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~~ 235 (304)
T cd05096 158 NFVHRDLATRNCLVGENL-TIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMG-KFTTASDVWAFGVTLWEILM 235 (304)
T ss_pred CccccCcchhheEEcCCc-cEEECCCccceecccCceeEecCcCCCCccccCHHHHhcC-CCCchhhhHHHHHHHHHHHH
Confidence 999999999999999887 699999999976533321 1123346789999998654 48999999999999999986
Q ss_pred --CCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCC
Q 016184 281 --GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCT 358 (394)
Q Consensus 281 --g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt 358 (394)
+..||......+.+..+.......... . ....+..++..+.+|+.+||+.||.+|||
T Consensus 236 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~-----------~----------~~~~~~~~~~~~~~li~~cl~~~p~~RPs 294 (304)
T cd05096 236 LCKEQPYGELTDEQVIENAGEFFRDQGRQ-----------V----------YLFRPPPCPQGLYELMLQCWSRDCRERPS 294 (304)
T ss_pred ccCCCCCCcCCHHHHHHHHHHHhhhcccc-----------c----------cccCCCCCCHHHHHHHHHHccCCchhCcC
Confidence 567887766555544443321100000 0 00012356889999999999999999999
Q ss_pred HHHHhc
Q 016184 359 ALEACV 364 (394)
Q Consensus 359 ~~ell~ 364 (394)
+.++.+
T Consensus 295 ~~~i~~ 300 (304)
T cd05096 295 FSDIHA 300 (304)
T ss_pred HHHHHH
Confidence 999943
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=304.01 Aligned_cols=255 Identities=29% Similarity=0.463 Sum_probs=203.6
Q ss_pred eEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccc----hhhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEEEEE
Q 016184 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLV 158 (394)
Q Consensus 83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv 158 (394)
.|...+.||+|++|.||++.+..+++.+|+|++... .....+|+.+++.++|+||+++++++.. ..+.+++
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~-----~~~~~~v 94 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLV-----GDELWVV 94 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEc-----CCeEEEE
Confidence 366668999999999999999889999999987532 2234578999999999999999998743 3347899
Q ss_pred Eecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCcccccc
Q 016184 159 LEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK 237 (394)
Q Consensus 159 ~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~ 237 (394)
+||+.+ +|.+.+.. ..+++..+..++.|++.||+|||+ +|++||||+|+||+++.++ .++|+|||.+.....
T Consensus 95 ~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH~-~~i~H~dl~p~Nil~~~~~-~~~l~d~g~~~~~~~ 167 (285)
T cd06648 95 MEFLEGGALTDIVTH-----TRMNEEQIATVCLAVLKALSFLHA-QGVIHRDIKSDSILLTSDG-RVKLSDFGFCAQVSK 167 (285)
T ss_pred EeccCCCCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCChhhEEEcCCC-cEEEcccccchhhcc
Confidence 999975 66665543 568999999999999999999999 8999999999999999887 799999998765433
Q ss_pred CCC-cccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCCC
Q 016184 238 GEP-NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 316 (394)
Q Consensus 238 ~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 316 (394)
... .....+++.|+|||.+.+.. ++.++|+||||+++|+|++|+.||...+.......+.... .+..
T Consensus 168 ~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~-~~~~---------- 235 (285)
T cd06648 168 EVPRRKSLVGTPYWMAPEVISRLP-YGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNL-PPKL---------- 235 (285)
T ss_pred CCcccccccCCccccCHHHhcCCC-CCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcC-CCCC----------
Confidence 221 22345788999999986544 8999999999999999999999998766544444333210 0000
Q ss_pred cccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCC
Q 016184 317 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNT 376 (394)
Q Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~ 376 (394)
.....++..+.+||++||+.||++|||+.++++||||++.+++..
T Consensus 236 ---------------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~~~~ 280 (285)
T cd06648 236 ---------------KNLHKVSPRLRSFLDRMLVRDPAQRATAAELLNHPFLAKAGPPSS 280 (285)
T ss_pred ---------------cccccCCHHHHHHHHHHcccChhhCcCHHHHccCcccccCCCcch
Confidence 001236789999999999999999999999999999999887653
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=303.20 Aligned_cols=250 Identities=25% Similarity=0.370 Sum_probs=191.3
Q ss_pred EEeecCceEEEEEEECCCCcEEEEEEeccchh-------hhHHHH---HHHHHcCCCCeeeeceEEEecCCCceeEEEEE
Q 016184 89 VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-------YKNREL---QIMQMLDHPNIVALKHCFFSTTDKEELYLNLV 158 (394)
Q Consensus 89 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-------~~~~E~---~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv 158 (394)
+||+|+||.||+|++..+++.||+|.+.+... ....|. ..++...|++|+.+.+++ ......++|
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~-----~~~~~~~~v 75 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAF-----HTPDKLSFI 75 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeee-----ecCCEEEEE
Confidence 48999999999999999999999998754321 112233 334445899999998887 333457899
Q ss_pred Eecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCcccccc
Q 016184 159 LEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK 237 (394)
Q Consensus 159 ~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~ 237 (394)
|||+.+ +|...+. ....+++..++.++.|++.||+|||+ .+|+||||||+||+++.++ .++|+|||++.....
T Consensus 76 ~e~~~g~~L~~~l~----~~~~l~~~~~~~~~~ql~~~l~~lH~-~~i~H~di~p~nili~~~~-~~kl~dfg~~~~~~~ 149 (278)
T cd05606 76 LDLMNGGDLHYHLS----QHGVFSEAEMRFYAAEIILGLEHMHN-RFVVYRDLKPANILLDEHG-HVRISDLGLACDFSK 149 (278)
T ss_pred EecCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHH-CCEEcCCCCHHHEEECCCC-CEEEccCcCccccCc
Confidence 999986 5544443 24679999999999999999999999 8999999999999999887 799999999875533
Q ss_pred CCCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCCCc
Q 016184 238 GEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 317 (394)
Q Consensus 238 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 317 (394)
. ......++..|+|||.+.+...++.++||||+|+++|+|++|+.||..................
T Consensus 150 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~-------------- 214 (278)
T cd05606 150 K-KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTM-------------- 214 (278)
T ss_pred c-CCcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhcc--------------
Confidence 2 2234568899999999865545889999999999999999999999765322111111000000
Q ss_pred ccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCC-----CHHHHhcCCCCCCCCCCCC
Q 016184 318 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-----TALEACVHPFFDELRDPNT 376 (394)
Q Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----t~~ell~hp~f~~~~~~~~ 376 (394)
.. .++..++.++.++|.+||..||.+|| ++.++++||||++....-.
T Consensus 215 ~~------------~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~~~~~~~~~~~~ 266 (278)
T cd05606 215 AV------------ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRSLDWQMV 266 (278)
T ss_pred CC------------CCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhCccccCCCchHh
Confidence 00 11234689999999999999999999 9999999999999764433
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-41 Score=305.27 Aligned_cols=251 Identities=25% Similarity=0.391 Sum_probs=202.3
Q ss_pred eEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccch-----hhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEEEE
Q 016184 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL 157 (394)
Q Consensus 83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 157 (394)
.|+..+.||.|+||.||+|.+..++..||||++.... ....+|+.+++.+.|+||+++++++. ...+.++
T Consensus 5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~l 79 (277)
T cd06640 5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYL-----KGTKLWI 79 (277)
T ss_pred hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE-----ECCEEEE
Confidence 3888899999999999999999899999999876432 23457999999999999999999883 3345889
Q ss_pred EEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCccccc
Q 016184 158 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV 236 (394)
Q Consensus 158 v~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~ 236 (394)
||||+++ +|.+++.. ..+++..+..++.|++.||+|||+ .+++|+||+|+||+++.++ .++|+|||++....
T Consensus 80 v~e~~~~~~L~~~i~~-----~~l~~~~~~~~~~~l~~~l~~lh~-~~ivH~dl~p~Nil~~~~~-~~~l~dfg~~~~~~ 152 (277)
T cd06640 80 IMEYLGGGSALDLLRA-----GPFDEFQIATMLKEILKGLDYLHS-EKKIHRDIKAANVLLSEQG-DVKLADFGVAGQLT 152 (277)
T ss_pred EEecCCCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHh-CCccCcCCChhhEEEcCCC-CEEEcccccceecc
Confidence 9999986 66665543 568899999999999999999999 8999999999999999887 69999999987654
Q ss_pred cCCC-cccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCC
Q 016184 237 KGEP-NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 315 (394)
Q Consensus 237 ~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 315 (394)
.... .....++..|+|||.+.+. .++.++|+|||||++|+|++|..||...........+... . +
T Consensus 153 ~~~~~~~~~~~~~~y~apE~~~~~-~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~-~-~----------- 218 (277)
T cd06640 153 DTQIKRNTFVGTPFWMAPEVIQQS-AYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKN-N-P----------- 218 (277)
T ss_pred CCccccccccCcccccCHhHhccC-CCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhcC-C-C-----------
Confidence 3322 2234567889999998654 4899999999999999999999999876544333222110 0 0
Q ss_pred CcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCC
Q 016184 316 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP 374 (394)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~ 374 (394)
..+...++..+.++|.+||+.||.+||++.++++||||.+....
T Consensus 219 ---------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~ 262 (277)
T cd06640 219 ---------------PTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHKFIVKNAKK 262 (277)
T ss_pred ---------------CCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhChHhhhcchh
Confidence 01123467889999999999999999999999999999876544
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-41 Score=317.27 Aligned_cols=249 Identities=23% Similarity=0.314 Sum_probs=191.7
Q ss_pred ceeEEEeeEEeecCceEEEEEEECCCC-----cEEEEEEeccch-----hhhHHHHHHHHHc-CCCCeeeeceEEEecCC
Q 016184 81 KVSYIAEHVVGTGSFGVVFQAKCRETG-----EIVAIKKVLQDK-----RYKNRELQIMQML-DHPNIVALKHCFFSTTD 149 (394)
Q Consensus 81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~vaiK~~~~~~-----~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~ 149 (394)
..+|++.+.||+|+||.||+|++..+| ..||+|++.... ....+|+++++.+ +|+||+++++++.
T Consensus 37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~---- 112 (374)
T cd05106 37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACT---- 112 (374)
T ss_pred HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEec----
Confidence 446999999999999999999865443 579999886432 2345799999999 8999999999883
Q ss_pred CceeEEEEEEecccc-cHHHHHHHhhh-----------------------------------------------------
Q 016184 150 KEELYLNLVLEYVPE-TVNRIARNYSR----------------------------------------------------- 175 (394)
Q Consensus 150 ~~~~~~~lv~e~~~~-~l~~~~~~~~~----------------------------------------------------- 175 (394)
.....++||||+.+ +|.+++.....
T Consensus 113 -~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (374)
T cd05106 113 -HGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSS 191 (374)
T ss_pred -CCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccc
Confidence 33447899999984 77666643211
Q ss_pred -------------hcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCccccccCCCc-
Q 016184 176 -------------IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN- 241 (394)
Q Consensus 176 -------------~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~~~~~- 241 (394)
....+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||+++........
T Consensus 192 ~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~-~giiHrDLkp~Nil~~~~~-~~kL~DfGla~~~~~~~~~~ 269 (374)
T cd05106 192 SQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLAS-KNCIHRDVAARNVLLTDGR-VAKICDFGLARDIMNDSNYV 269 (374)
T ss_pred cccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHH-CCEEeccCchheEEEeCCC-eEEEeeceeeeeccCCccee
Confidence 11357888999999999999999999 8999999999999999877 7999999998765433211
Q ss_pred --ccccccccccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCCCcc
Q 016184 242 --VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 318 (394)
Q Consensus 242 --~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 318 (394)
....+++.|+|||++.+. .++.++|||||||++|+|++ |+.||........+..+......+
T Consensus 270 ~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~-------------- 334 (374)
T cd05106 270 VKGNARLPVKWMAPESIFDC-VYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQM-------------- 334 (374)
T ss_pred eccCCCCccceeCHHHhcCC-CCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCc--------------
Confidence 112235679999998654 48999999999999999997 999998765444333333211000
Q ss_pred cCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 016184 319 FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV 364 (394)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 364 (394)
..+..+++++.++|.+||+.||.+|||+.++++
T Consensus 335 -------------~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~ 367 (374)
T cd05106 335 -------------SRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQ 367 (374)
T ss_pred -------------cCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 011346889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=285.71 Aligned_cols=286 Identities=31% Similarity=0.584 Sum_probs=231.5
Q ss_pred ceeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccc-hhhhHHHHHHHHHcC-CCCeeeeceEEEecCCCceeEEEEE
Q 016184 81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-KRYKNRELQIMQMLD-HPNIVALKHCFFSTTDKEELYLNLV 158 (394)
Q Consensus 81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~~lv 158 (394)
+.+|++.+++|+|-++.||.|....+++.++||+++.- ...+.+|+.+|+.|. ||||+++++++ .+.......++
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVkkkKIkREikIL~nL~gg~NIi~L~DiV---~Dp~SktpaLi 113 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVKKKKIKREIKILQNLRGGPNIIKLLDIV---KDPESKTPSLI 113 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHHHHHHHHHHHHHHhccCCCCeeehhhhh---cCccccCchhH
Confidence 34699999999999999999999999999999988653 456789999999995 99999999988 33444556789
Q ss_pred EecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCccccccC
Q 016184 159 LEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG 238 (394)
Q Consensus 159 ~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~~ 238 (394)
+||+...-. ...-..++...++.++.+++.||.|+|+ .||+|||+||.|++||.....++|+|+|+|.+...+
T Consensus 114 FE~v~n~Df------k~ly~tl~d~dIryY~~elLkALdyCHS-~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~ 186 (338)
T KOG0668|consen 114 FEYVNNTDF------KQLYPTLTDYDIRYYIYELLKALDYCHS-MGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 186 (338)
T ss_pred hhhhccccH------HHHhhhhchhhHHHHHHHHHHHHhHHHh-cCcccccCCcceeeechhhceeeeeecchHhhcCCC
Confidence 999986321 1222567888999999999999999999 899999999999999988778999999999988777
Q ss_pred CCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCC-CCCCCcHHHHHHHHHHhCCCChhhhh-----cc
Q 016184 239 EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPL-FPGESGVDQLVEIIKVLGTPTREEIK-----CM 312 (394)
Q Consensus 239 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~p-f~~~~~~~~~~~i~~~~~~~~~~~~~-----~~ 312 (394)
..-.....+..|-.||.+..-..|+..-|+|||||++..|+..+.| |.|.++.+++..|.+.+|........ .+
T Consensus 187 ~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~L 266 (338)
T KOG0668|consen 187 KEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQIDL 266 (338)
T ss_pred ceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccCC
Confidence 6666777889999999998888899999999999999999998766 56788999999999999875443221 12
Q ss_pred CCCCcccCCCCCCCCCcchhcccc----CChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCCC
Q 016184 313 NPNYTEFKFPQIKPHPWHKVFQKR----LPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTR 377 (394)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~~ 377 (394)
++.+... +..-...+|..++... +++++.|||.++|..|-.+|+||.|++.||||.-++....+
T Consensus 267 dp~~~~i-~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~~~~~~~~ 334 (338)
T KOG0668|consen 267 DPQFEDI-LGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAPVREAESS 334 (338)
T ss_pred ChhHhhH-hhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHHHHHHhhc
Confidence 2332221 1122344566555432 57999999999999999999999999999999877655443
|
|
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-41 Score=309.14 Aligned_cols=254 Identities=27% Similarity=0.436 Sum_probs=202.4
Q ss_pred EEEeeEEeecCceEEEEEEECCCCcEEEEEEeccc----hhhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEEEEEE
Q 016184 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVL 159 (394)
Q Consensus 84 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~ 159 (394)
|.....||+|+||.||+|.+..+++.||+|.+... .....+|+.+++.+.||||+++++++.. ....++++
T Consensus 23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~-----~~~~~iv~ 97 (297)
T cd06659 23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLV-----GEELWVLM 97 (297)
T ss_pred HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheee-----CCeEEEEE
Confidence 55556799999999999999989999999987532 2334578999999999999999998743 34478999
Q ss_pred ecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCccccccC
Q 016184 160 EYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG 238 (394)
Q Consensus 160 e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~~ 238 (394)
||+++ ++..++.. ..+++..++.++.|++.||.|||+ .|++|+||||+||+++.++ .++|+|||++......
T Consensus 98 e~~~~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~-~~ivH~dl~p~Nill~~~~-~~kL~dfg~~~~~~~~ 170 (297)
T cd06659 98 EFLQGGALTDIVSQ-----TRLNEEQIATVCESVLQALCYLHS-QGVIHRDIKSDSILLTLDG-RVKLSDFGFCAQISKD 170 (297)
T ss_pred ecCCCCCHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHeEEccCC-cEEEeechhHhhcccc
Confidence 99986 55554432 568999999999999999999999 8999999999999999888 7999999998654332
Q ss_pred C-CcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCCCc
Q 016184 239 E-PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 317 (394)
Q Consensus 239 ~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 317 (394)
. ......++..|+|||.+.+. .++.++|+|||||++|+|++|+.||......+.+..+... +..
T Consensus 171 ~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~---~~~----------- 235 (297)
T cd06659 171 VPKRKSLVGTPYWMAPEVISRT-PYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDS---PPP----------- 235 (297)
T ss_pred cccccceecCccccCHHHHccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcc---CCC-----------
Confidence 2 22345678999999998654 4899999999999999999999999876655444333210 000
Q ss_pred ccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCC
Q 016184 318 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNT 376 (394)
Q Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~ 376 (394)
.+ .....++..+.++|.+||+.||.+||++.++++||||.+...+..
T Consensus 236 ----------~~--~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~~~~~~~~~~~~ 282 (297)
T cd06659 236 ----------KL--KNAHKISPVLRDFLERMLTREPQERATAQELLDHPFLLQTGLPEC 282 (297)
T ss_pred ----------Cc--cccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhChhhccCCCccc
Confidence 00 011346888999999999999999999999999999998766555
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=297.90 Aligned_cols=250 Identities=30% Similarity=0.487 Sum_probs=204.3
Q ss_pred eEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccc------hhhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEEE
Q 016184 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN 156 (394)
Q Consensus 83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 156 (394)
+|.+.+.||.|+||.||++.+..+++.||+|++... .....+|+++++.++|+|++++.+.+.. ....+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~-----~~~~~ 75 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEE-----KGKLC 75 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEec-----CCEEE
Confidence 489999999999999999999989999999988643 2335579999999999999999988743 24578
Q ss_pred EEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCcccc
Q 016184 157 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL 235 (394)
Q Consensus 157 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~ 235 (394)
+++|++++ ++...+.........+++..+..++.+++.||.+||+ .|++|+||+|+||+++.++ .++|+|||.+...
T Consensus 76 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~-~~~~H~dl~~~nil~~~~~-~~~l~d~~~~~~~ 153 (258)
T cd08215 76 IVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHS-RKILHRDIKPQNIFLTSNG-LVKLGDFGISKVL 153 (258)
T ss_pred EEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHh-CCEecccCChHHeEEcCCC-cEEECCccceeec
Confidence 99999985 7777776654345789999999999999999999999 8999999999999999877 7999999998765
Q ss_pred ccCC-CcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCC
Q 016184 236 VKGE-PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 314 (394)
Q Consensus 236 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 314 (394)
.... ......+++.|+|||.+.+.. ++.++|+||+|+++|+|++|..||...+.............
T Consensus 154 ~~~~~~~~~~~~~~~y~~pe~~~~~~-~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~------------ 220 (258)
T cd08215 154 SSTVDLAKTVVGTPYYLSPELCQNKP-YNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQY------------ 220 (258)
T ss_pred ccCcceecceeeeecccChhHhccCC-CCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCCC------------
Confidence 4432 222346788899999986544 88999999999999999999999977664443333322100
Q ss_pred CCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 016184 315 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368 (394)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f 368 (394)
+ .++..++..+.+++.+||..||++|||+.++|+||||
T Consensus 221 -------~---------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 258 (258)
T cd08215 221 -------P---------PIPSQYSSELRNLVSSLLQKDPEERPSIAQILQSPFI 258 (258)
T ss_pred -------C---------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCCCC
Confidence 0 0123578899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=303.24 Aligned_cols=240 Identities=17% Similarity=0.209 Sum_probs=191.6
Q ss_pred eEEeecCceEEEEEEECCCCcEEEEEEeccch-------hhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEEEEEEe
Q 016184 88 HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLE 160 (394)
Q Consensus 88 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e 160 (394)
..||+|+++.||+|.+ +|+.||||++.... ..+.+|+.++++++||||+++++++.... ....+++++||
T Consensus 26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~-~~~~~~~lv~E 102 (283)
T PHA02988 26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIV-DDLPRLSLILE 102 (283)
T ss_pred eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecc-cCCCceEEEEE
Confidence 4689999999999998 58999999886432 33458999999999999999999885421 22345789999
Q ss_pred cccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCccccccCC
Q 016184 161 YVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE 239 (394)
Q Consensus 161 ~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~~~ 239 (394)
|+.+ +|.+++.. ...+++.....++.|++.||.|||+..+++||||||+|||++.++ .+||+|||+++....
T Consensus 103 y~~~g~L~~~l~~----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~-~~kl~dfg~~~~~~~-- 175 (283)
T PHA02988 103 YCTRGYLREVLDK----EKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENY-KLKIICHGLEKILSS-- 175 (283)
T ss_pred eCCCCcHHHHHhh----CCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCC-cEEEcccchHhhhcc--
Confidence 9996 67666653 357888999999999999999999734899999999999999887 799999999875532
Q ss_pred CcccccccccccccccccCC-CCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCCCcc
Q 016184 240 PNVSYICSRYYRAPELIFGA-TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 318 (394)
Q Consensus 240 ~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 318 (394)
......++..|+|||.+.+. ..++.++|||||||++|+|++|+.||.+.+..+....+......+.
T Consensus 176 ~~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~------------- 242 (283)
T PHA02988 176 PPFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLK------------- 242 (283)
T ss_pred ccccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCC-------------
Confidence 22345678899999998542 4589999999999999999999999987765555544433111100
Q ss_pred cCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 016184 319 FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV 364 (394)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 364 (394)
++..+++.+.+||.+||+.||++|||+.++++
T Consensus 243 --------------~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~ 274 (283)
T PHA02988 243 --------------LPLDCPLEIKCIVEACTSHDSIKRPNIKEILY 274 (283)
T ss_pred --------------CCCcCcHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence 11346889999999999999999999999985
|
|
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=305.73 Aligned_cols=260 Identities=23% Similarity=0.393 Sum_probs=200.1
Q ss_pred ceeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccch-----hhhHHHHHHHHHc-CCCCeeeeceEEEecCCCceeE
Q 016184 81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQML-DHPNIVALKHCFFSTTDKEELY 154 (394)
Q Consensus 81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~ 154 (394)
.++|++.+.||+|+||.||+|.+..+++.||||.+.... ....+|+.++... .|+||+++++++. ....
T Consensus 14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~-----~~~~ 88 (296)
T cd06618 14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFI-----TDSD 88 (296)
T ss_pred cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeee-----cCCe
Confidence 346999999999999999999999889999999986432 1223456555555 5999999999883 3345
Q ss_pred EEEEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCccc
Q 016184 155 LNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV 234 (394)
Q Consensus 155 ~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~ 234 (394)
.+++|||+++.+..+.... ...+++..+..++.|++.||.|||+..||+||||+|+||+++.++ .++|+|||++..
T Consensus 89 ~~~v~e~~~~~l~~l~~~~---~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~-~~kL~dfg~~~~ 164 (296)
T cd06618 89 VFICMELMSTCLDKLLKRI---QGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASG-NVKLCDFGISGR 164 (296)
T ss_pred EEEEeeccCcCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCC-CEEECccccchh
Confidence 8899999988776665442 357899999999999999999999625999999999999999887 799999999876
Q ss_pred cccCCCcccccccccccccccccCC---CCCCChhhHHHHHHHHHHHHhCCCCCCCCCcH-HHHHHHHHHhCCCChhhhh
Q 016184 235 LVKGEPNVSYICSRYYRAPELIFGA---TEYTTAIDIWSTGCVMAELLLGQPLFPGESGV-DQLVEIIKVLGTPTREEIK 310 (394)
Q Consensus 235 ~~~~~~~~~~~~t~~y~aPE~~~~~---~~~~~~~DiwslG~il~~lltg~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~ 310 (394)
...........++..|+|||.+.+. ..++.++|+||||+++|+|++|+.||...... +.+..+... ...
T Consensus 165 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~---~~~---- 237 (296)
T cd06618 165 LVDSKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQE---EPP---- 237 (296)
T ss_pred ccCCCcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcC---CCC----
Confidence 6444333344567889999998543 23788999999999999999999999754322 222222211 000
Q ss_pred ccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCC
Q 016184 311 CMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 375 (394)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~ 375 (394)
..+ ....++.++.+||.+||..||.+||+++++++||||+..+...
T Consensus 238 ---------~~~----------~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~~ 283 (296)
T cd06618 238 ---------SLP----------PNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRYETAE 283 (296)
T ss_pred ---------CCC----------CCCCCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhccchhH
Confidence 000 0024678999999999999999999999999999998765443
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=309.43 Aligned_cols=251 Identities=25% Similarity=0.396 Sum_probs=200.7
Q ss_pred EEEeeEEeecCceEEEEEEECCCCcEEEEEEeccch-----hhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEEEEE
Q 016184 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLV 158 (394)
Q Consensus 84 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv 158 (394)
|++.+.||.|+||.||+|.+..+++.||+|.+.... ..+.+|+++++.++|+||+++++++. .....++|
T Consensus 6 y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~lv 80 (277)
T cd06642 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYL-----KGTKLWII 80 (277)
T ss_pred HHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccc-----cCCceEEE
Confidence 778889999999999999999899999999876332 24567999999999999999999883 33457899
Q ss_pred Eecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCcccccc
Q 016184 159 LEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK 237 (394)
Q Consensus 159 ~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~ 237 (394)
|||+++ ++.+++.. ..+++..++.++.|++.||.|||+ .|++|+||+|+||+++.++ .++|+|||++.....
T Consensus 81 ~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~-~~ivH~dl~p~ni~i~~~~-~~~l~dfg~~~~~~~ 153 (277)
T cd06642 81 MEYLGGGSALDLLKP-----GPLEETYIATILREILKGLDYLHS-ERKIHRDIKAANVLLSEQG-DVKLADFGVAGQLTD 153 (277)
T ss_pred EEccCCCcHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHhc-CCeeccCCChheEEEeCCC-CEEEccccccccccC
Confidence 999986 56555432 568999999999999999999999 8999999999999999887 799999999876543
Q ss_pred CCC-cccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCCC
Q 016184 238 GEP-NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 316 (394)
Q Consensus 238 ~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 316 (394)
... .....++..|+|||.+.+. .++.++|+||||+++|+|++|+.||...........+... .
T Consensus 154 ~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~--~------------- 217 (277)
T cd06642 154 TQIKRNTFVGTPFWMAPEVIKQS-AYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKN--S------------- 217 (277)
T ss_pred cchhhhcccCcccccCHHHhCcC-CCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcC--C-------------
Confidence 321 1234568889999998654 4899999999999999999999999765443332221110 0
Q ss_pred cccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCC
Q 016184 317 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 375 (394)
Q Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~ 375 (394)
...+...++.++.++|.+||+.+|++|||+.++++||||+.....+
T Consensus 218 -------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~~ 263 (277)
T cd06642 218 -------------PPTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKHKFITRYTKKT 263 (277)
T ss_pred -------------CCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHhHHHHHHhhhH
Confidence 0011234678899999999999999999999999999998765443
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=305.65 Aligned_cols=254 Identities=27% Similarity=0.420 Sum_probs=201.8
Q ss_pred ceeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccc----hhhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEEE
Q 016184 81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN 156 (394)
Q Consensus 81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 156 (394)
..+|.+.+.||+|+||.||++.+..+++.||+|.+... .....+|+.+++.++||||+++++.+.. ....+
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~-----~~~~~ 92 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLV-----GDELW 92 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeee-----CCcEE
Confidence 35699999999999999999999888999999987532 2334568899999999999999998843 33478
Q ss_pred EEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCcccc
Q 016184 157 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL 235 (394)
Q Consensus 157 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~ 235 (394)
+|+||+++ ++.+++.. ..+++..+..++.|++.||.|||+ +|++|+||||+||+++.++ .++|+|||++...
T Consensus 93 lv~e~~~~~~L~~~~~~-----~~l~~~~~~~i~~~l~~al~~LH~-~gi~H~dL~p~Nili~~~~-~~kL~dfg~~~~~ 165 (293)
T cd06647 93 VVMEYLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHS-NQVIHRDIKSDNILLGMDG-SVKLTDFGFCAQI 165 (293)
T ss_pred EEEecCCCCcHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHh-CCEeeccCCHHHEEEcCCC-CEEEccCcceecc
Confidence 99999985 66665543 467888999999999999999999 8999999999999999887 7999999987654
Q ss_pred ccCCC-cccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCC
Q 016184 236 VKGEP-NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 314 (394)
Q Consensus 236 ~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 314 (394)
..... .....+++.|+|||.+... .++.++|+||||+++|++++|+.||...+....+..+.. .+.+.
T Consensus 166 ~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~-~~~~~--------- 234 (293)
T cd06647 166 TPEQSKRSTMVGTPYWMAPEVVTRK-AYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT-NGTPE--------- 234 (293)
T ss_pred cccccccccccCChhhcCchhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhc-CCCCC---------
Confidence 33222 2234578889999998654 488999999999999999999999987654332222111 00000
Q ss_pred CCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q 016184 315 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD 373 (394)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~ 373 (394)
+ .....++..+.++|++||+.||++||++.+++.||||+..+.
T Consensus 235 --------------~--~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h~~~~~~~~ 277 (293)
T cd06647 235 --------------L--QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHPFLKIAKP 277 (293)
T ss_pred --------------C--CCccccCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcCcc
Confidence 0 011346788999999999999999999999999999988764
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=299.68 Aligned_cols=247 Identities=26% Similarity=0.374 Sum_probs=191.5
Q ss_pred eEEEeeEE--eecCceEEEEEEECCCCcEEEEEEeccchhhhHHHHHHHHHc-CCCCeeeeceEEEecCCCceeEEEEEE
Q 016184 83 SYIAEHVV--GTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQML-DHPNIVALKHCFFSTTDKEELYLNLVL 159 (394)
Q Consensus 83 ~y~~~~~l--g~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~lv~ 159 (394)
.|.+.+.+ |+|+||.||+++++.++..+|+|.+...... ..|+.....+ +|+||+++++++.. ....++||
T Consensus 15 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~-~~e~~~~~~~~~h~~iv~~~~~~~~-----~~~~~iv~ 88 (267)
T PHA03390 15 NCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFN-AIEPMVHQLMKDNPNFIKLYYSVTT-----LKGHVLIM 88 (267)
T ss_pred hhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcc-hhhHHHHHHhhcCCCEEEEEEEEec-----CCeeEEEE
Confidence 46666665 9999999999999999999999987653221 2234333333 79999999998843 33588999
Q ss_pred ecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCccccccC
Q 016184 160 EYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG 238 (394)
Q Consensus 160 e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~~ 238 (394)
||+++ +|.+++.. ...+++..++.++.|++.||.|||+ .|++||||||+||+++.++..++|+|||++......
T Consensus 89 e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~ 163 (267)
T PHA03390 89 DYIKDGDLFDLLKK----EGKLSEAEVKKIIRQLVEALNDLHK-HNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP 163 (267)
T ss_pred EcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeeeCCCCHHHEEEeCCCCeEEEecCccceecCCC
Confidence 99974 77766654 2478999999999999999999999 899999999999999988746999999998765322
Q ss_pred CCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHH-HHHHHHHhCCCChhhhhccCCCCc
Q 016184 239 EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQ-LVEIIKVLGTPTREEIKCMNPNYT 317 (394)
Q Consensus 239 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~~~~~~ 317 (394)
....++..|+|||++.+. .++.++|+||+|+++|+|++|..||........ ...+......+.
T Consensus 164 ---~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~------------ 227 (267)
T PHA03390 164 ---SCYDGTLDYFSPEKIKGH-NYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKL------------ 227 (267)
T ss_pred ---ccCCCCCcccChhhhcCC-CCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhcccC------------
Confidence 234678899999999654 489999999999999999999999985543321 122222110000
Q ss_pred ccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCC-HHHHhcCCCCCC
Q 016184 318 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCT-ALEACVHPFFDE 370 (394)
Q Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt-~~ell~hp~f~~ 370 (394)
...+.+++.+.+||.+||+.||.+|++ .+++|+||||+.
T Consensus 228 --------------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h~~~~~ 267 (267)
T PHA03390 228 --------------PFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKHPFLKI 267 (267)
T ss_pred --------------CcccccCHHHHHHHHHHhccChhhCCchHHHHhcCCcccC
Confidence 011357899999999999999999996 599999999974
|
|
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-40 Score=297.90 Aligned_cols=250 Identities=30% Similarity=0.519 Sum_probs=196.9
Q ss_pred eEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccch------hhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEEE
Q 016184 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN 156 (394)
Q Consensus 83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 156 (394)
+|.+.+.||+|+||.||+|.+..+++.||+|.+.... ....+|+.+++.++|+||+++++.+ ......+
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~-----~~~~~~~ 75 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVE-----VHREKVY 75 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeE-----ecCCEEE
Confidence 4899999999999999999998899999999876432 3445799999999999999999876 2334478
Q ss_pred EEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCcccc
Q 016184 157 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL 235 (394)
Q Consensus 157 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~ 235 (394)
+++||+++ ++.+++.. ...+++..++.++.|++.||+|||+ .|++|+||+|+||+++.++ .+||+|||++...
T Consensus 76 lv~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lh~-~~i~H~dl~~~nil~~~~~-~~kl~d~g~~~~~ 149 (264)
T cd06626 76 IFMEYCSGGTLEELLEH----GRILDEHVIRVYTLQLLEGLAYLHS-HGIVHRDIKPANIFLDHNG-VIKLGDFGCAVKL 149 (264)
T ss_pred EEEecCCCCcHHHHHhh----cCCCChHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEECCCC-CEEEccccccccc
Confidence 99999985 66665543 3458899999999999999999999 8999999999999999877 7999999998766
Q ss_pred ccCCCcc-----cccccccccccccccCCC--CCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhh
Q 016184 236 VKGEPNV-----SYICSRYYRAPELIFGAT--EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 308 (394)
Q Consensus 236 ~~~~~~~-----~~~~t~~y~aPE~~~~~~--~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~ 308 (394)
....... ...+++.|+|||++.+.. ..+.++||||||+++|+|++|+.||...+........... +..+
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~-~~~~--- 225 (264)
T cd06626 150 KNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGA-GHKP--- 225 (264)
T ss_pred CCCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhc-CCCC---
Confidence 4332221 245678899999985432 2788999999999999999999999765433222211111 1000
Q ss_pred hhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 016184 309 IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368 (394)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f 368 (394)
.++. ...++..+.+||++||+.||.+|||+.++++|||+
T Consensus 226 -----------~~~~----------~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~~~~ 264 (264)
T cd06626 226 -----------PIPD----------SLQLSPEGKDFLDRCLESDPKKRPTASELLQHPFV 264 (264)
T ss_pred -----------CCCc----------ccccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 0000 02358889999999999999999999999999997
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-40 Score=297.62 Aligned_cols=251 Identities=31% Similarity=0.514 Sum_probs=203.9
Q ss_pred eEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccc-----hhhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEEEE
Q 016184 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL 157 (394)
Q Consensus 83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 157 (394)
+|++.+.||.|++|.||+|++..+++.||+|++... .....+|+..+..++|+|++++++++. .....++
T Consensus 2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~l 76 (264)
T cd06623 2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFY-----KEGEISI 76 (264)
T ss_pred cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-----cCCeEEE
Confidence 489999999999999999999999999999988654 234567899999999999999999883 3355889
Q ss_pred EEeccc-ccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCccccc
Q 016184 158 VLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV 236 (394)
Q Consensus 158 v~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~ 236 (394)
+|||++ ++|.+++.. ...+++..++.++.|++.||.|||+..|++|+||+|+||+++.++ .++|+|||.+....
T Consensus 77 v~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~-~~~l~df~~~~~~~ 151 (264)
T cd06623 77 VLEYMDGGSLADLLKK----VGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKG-EVKIADFGISKVLE 151 (264)
T ss_pred EEEecCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCC-CEEEccCccceecc
Confidence 999999 577666654 267899999999999999999999735999999999999999887 79999999987664
Q ss_pred cCCCcc-cccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCc--H-HHHHHHHHHhCCCChhhhhcc
Q 016184 237 KGEPNV-SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESG--V-DQLVEIIKVLGTPTREEIKCM 312 (394)
Q Consensus 237 ~~~~~~-~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~--~-~~~~~i~~~~~~~~~~~~~~~ 312 (394)
...... ...++..|+|||.+.+. .++.++|+||||+++|+|++|..||..... . +....+.. ....
T Consensus 152 ~~~~~~~~~~~~~~y~~pE~~~~~-~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~---~~~~------ 221 (264)
T cd06623 152 NTLDQCNTFVGTVTYMSPERIQGE-SYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICD---GPPP------ 221 (264)
T ss_pred cCCCcccceeecccccCHhhhCCC-CCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhc---CCCC------
Confidence 433332 45678889999998654 589999999999999999999999987642 2 22222211 0000
Q ss_pred CCCCcccCCCCCCCCCcchhcccc-CChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 016184 313 NPNYTEFKFPQIKPHPWHKVFQKR-LPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR 372 (394)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 372 (394)
.+... ++..+.++|.+||..+|++|||+.++++||||+.+.
T Consensus 222 -------------------~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~~~~~~~~ 263 (264)
T cd06623 222 -------------------SLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQHPFIKKAD 263 (264)
T ss_pred -------------------CCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhCHHHHhcc
Confidence 01123 788999999999999999999999999999998764
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=301.85 Aligned_cols=250 Identities=25% Similarity=0.399 Sum_probs=201.2
Q ss_pred EEEeeEEeecCceEEEEEEECCCCcEEEEEEeccch-----hhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEEEEE
Q 016184 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLV 158 (394)
Q Consensus 84 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv 158 (394)
|++.+.||.|+||.||+|.+..+++.||||.+.... ..+.+|+.+++.++|+||+++++++. ...+.++|
T Consensus 6 ~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~~~~~lv 80 (277)
T cd06641 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYL-----KDTKLWII 80 (277)
T ss_pred hhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEE-----eCCeEEEE
Confidence 788899999999999999998899999999875322 33457899999999999999999883 33457899
Q ss_pred Eecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCcccccc
Q 016184 159 LEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK 237 (394)
Q Consensus 159 ~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~ 237 (394)
|||+++ ++..++.. ..+++..+..++.|++.||.+||+ .|++|+||||+||+++.++ .++|+|||++.....
T Consensus 81 ~e~~~~~~l~~~i~~-----~~~~~~~~~~~~~~l~~~l~~lh~-~~i~h~dl~p~Ni~i~~~~-~~~l~dfg~~~~~~~ 153 (277)
T cd06641 81 MEYLGGGSALDLLEP-----GPLDETQIATILREILKGLDYLHS-EKKIHRDIKAANVLLSEHG-EVKLADFGVAGQLTD 153 (277)
T ss_pred EEeCCCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHcc-CCeecCCCCHHhEEECCCC-CEEEeecccceeccc
Confidence 999986 56555542 568899999999999999999999 8999999999999999887 699999999875533
Q ss_pred CCC-cccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCCC
Q 016184 238 GEP-NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 316 (394)
Q Consensus 238 ~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 316 (394)
... .....++..|+|||.+.+. .++.++|+|||||++|+|++|..||...........+... ..
T Consensus 154 ~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~-~~------------- 218 (277)
T cd06641 154 TQIKRNTFVGTPFWMAPEVIKQS-AYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKN-NP------------- 218 (277)
T ss_pred chhhhccccCCccccChhhhccC-CCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcC-CC-------------
Confidence 221 1234568889999998544 4789999999999999999999999765543333332110 00
Q ss_pred cccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCC
Q 016184 317 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP 374 (394)
Q Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~ 374 (394)
..+...++.++.++|.+||+.||.+||++.++++||||.+....
T Consensus 219 --------------~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~~~~~~~ 262 (277)
T cd06641 219 --------------PTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFIVRFAKK 262 (277)
T ss_pred --------------CCCCcccCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhhhhhc
Confidence 00124578899999999999999999999999999999987554
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-40 Score=304.74 Aligned_cols=249 Identities=29% Similarity=0.449 Sum_probs=201.4
Q ss_pred EEEeeEEeecCceEEEEEEECCCCcEEEEEEeccch-------hhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEEE
Q 016184 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN 156 (394)
Q Consensus 84 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 156 (394)
|...+.||+|+||.||+|++..+++.||+|++.... ....+|+++++.++|+|++++++++.. ....+
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~~ 97 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLK-----EHTAW 97 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEe-----CCEEE
Confidence 777888999999999999999999999999875321 234578999999999999999998843 34478
Q ss_pred EEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCccccc
Q 016184 157 LVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV 236 (394)
Q Consensus 157 lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~ 236 (394)
++|||+.+++...+.. ....+++..+..++.|++.||.|||+ .|++|+||+|+||+++.++ .++|+|||++....
T Consensus 98 lv~e~~~~~l~~~l~~---~~~~l~~~~~~~~~~qi~~al~~LH~-~gi~H~dl~p~nili~~~~-~~kL~dfg~~~~~~ 172 (313)
T cd06633 98 LVMEYCLGSASDLLEV---HKKPLQEVEIAAITHGALQGLAYLHS-HNMIHRDIKAGNILLTEPG-QVKLADFGSASKSS 172 (313)
T ss_pred EEEecCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCChhhEEECCCC-CEEEeecCCCcccC
Confidence 9999999887666543 23568999999999999999999999 8999999999999999887 69999999986432
Q ss_pred cCCCcccccccccccccccccC--CCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCC
Q 016184 237 KGEPNVSYICSRYYRAPELIFG--ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 314 (394)
Q Consensus 237 ~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 314 (394)
......++..|+|||.+.. ...++.++|+|||||++|+|++|..||...+.......+.... .+
T Consensus 173 ---~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~--~~--------- 238 (313)
T cd06633 173 ---PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQND--SP--------- 238 (313)
T ss_pred ---CCCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcC--CC---------
Confidence 2234567889999999742 2447889999999999999999999998776555554443210 00
Q ss_pred CCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 016184 315 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR 372 (394)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 372 (394)
. .....++..+++|+.+||+.+|.+||++.++++||||+...
T Consensus 239 --------~--------~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~~~~~~~~ 280 (313)
T cd06633 239 --------T--------LQSNEWTDSFRGFVDYCLQKIPQERPASAELLRHDFVRRDR 280 (313)
T ss_pred --------C--------CCccccCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCCc
Confidence 0 01134577899999999999999999999999999998753
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=304.52 Aligned_cols=257 Identities=28% Similarity=0.438 Sum_probs=199.7
Q ss_pred eeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccc-----hhhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEEE
Q 016184 82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN 156 (394)
Q Consensus 82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 156 (394)
.+|++.+.||+|+||+||+|.+..+|+.||+|++... ...+.+|+++++.++|+||+++++++.. ....+
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----~~~~~ 79 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLN-----ENNIC 79 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEec-----CCEEE
Confidence 4599999999999999999999999999999987543 2344579999999999999999998833 34578
Q ss_pred EEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCcccc
Q 016184 157 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL 235 (394)
Q Consensus 157 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~ 235 (394)
+||||+++ ++..++.. .+.+++..+..++.+++.||.|||+..+++|+||||+||+++.++ .++|+|||++...
T Consensus 80 lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~-~~~l~d~gl~~~~ 154 (284)
T cd06620 80 MCMEFMDCGSLDRIYKK----GGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRG-QIKLCDFGVSGEL 154 (284)
T ss_pred EEEecCCCCCHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCC-cEEEccCCcccch
Confidence 99999986 55554432 357899999999999999999999635899999999999999887 7999999998654
Q ss_pred ccCCCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHH-------HHHHHHHhCCCChhh
Q 016184 236 VKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQ-------LVEIIKVLGTPTREE 308 (394)
Q Consensus 236 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~-------~~~i~~~~~~~~~~~ 308 (394)
... ......++..|+|||++.+. .++.++|+|||||++|+|++|+.||........ +...........
T Consensus 155 ~~~-~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~--- 229 (284)
T cd06620 155 INS-IADTFVGTSTYMSPERIQGG-KYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEP--- 229 (284)
T ss_pred hhh-ccCccccCcccCCHHHHccC-CCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhcc---
Confidence 322 22245678999999998654 589999999999999999999999986543210 111111100000
Q ss_pred hhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q 016184 309 IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD 373 (394)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~ 373 (394)
...+ ....++.++.+||.+||+.||.+|||+.++++||||.+...
T Consensus 230 ---------~~~~-----------~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~~~ 274 (284)
T cd06620 230 ---------PPRL-----------PSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQALR 274 (284)
T ss_pred ---------CCCC-----------CchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccccc
Confidence 0000 00236788999999999999999999999999999977543
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=318.29 Aligned_cols=250 Identities=28% Similarity=0.435 Sum_probs=204.0
Q ss_pred EEeeEEeecCceEEEEEEECCCCcEEEEEEec-----c-c--hhhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEEE
Q 016184 85 IAEHVVGTGSFGVVFQAKCRETGEIVAIKKVL-----Q-D--KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN 156 (394)
Q Consensus 85 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~-----~-~--~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 156 (394)
+...+||+|+|-+||+|.+..+|..||--.++ + . ...+..|+.+|+.|+|+||++++..+..... ..+.
T Consensus 43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n---~~in 119 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDN---KTIN 119 (632)
T ss_pred ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCC---ceee
Confidence 34567999999999999999999888765332 1 2 2455679999999999999999998865443 5677
Q ss_pred EEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhC-CCceeccCCCCceEEeCCCCcEEEEeecCccc
Q 016184 157 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC-IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV 234 (394)
Q Consensus 157 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~-~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~ 234 (394)
+|+|++.. +| +.|.+.++.++.+.++.|++||+.||.|||++ -.|+|||||.+||+|+.+.+.|||+|+|+|+.
T Consensus 120 ~iTEL~TSGtL----r~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl 195 (632)
T KOG0584|consen 120 FITELFTSGTL----REYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATL 195 (632)
T ss_pred eeeecccCCcH----HHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHH
Confidence 89999984 54 44555578899999999999999999999983 35999999999999998877999999999987
Q ss_pred cccCCCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCC
Q 016184 235 LVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 314 (394)
Q Consensus 235 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 314 (394)
..... .....|||.|||||.+. ..|+...||||||+.++||+|+.+||.......++++.+.- |..|..
T Consensus 196 ~r~s~-aksvIGTPEFMAPEmYE--E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~S-GiKP~s------- 264 (632)
T KOG0584|consen 196 LRKSH-AKSVIGTPEFMAPEMYE--ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTS-GIKPAA------- 264 (632)
T ss_pred hhccc-cceeccCccccChHHHh--hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHc-CCCHHH-------
Confidence 64433 34589999999999994 45999999999999999999999999988777666554432 222222
Q ss_pred CCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 016184 315 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL 371 (394)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 371 (394)
+.+--.+++++||.+||.. .++|+|+.|||.||||+.-
T Consensus 265 ------------------l~kV~dPevr~fIekCl~~-~~~R~sa~eLL~d~Ff~~d 302 (632)
T KOG0584|consen 265 ------------------LSKVKDPEVREFIEKCLAT-KSERLSAKELLKDPFFDED 302 (632)
T ss_pred ------------------hhccCCHHHHHHHHHHhcC-chhccCHHHHhhChhhccc
Confidence 1123478999999999999 9999999999999999984
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=314.68 Aligned_cols=250 Identities=22% Similarity=0.314 Sum_probs=191.9
Q ss_pred ceeEEEeeEEeecCceEEEEEEE-----CCCCcEEEEEEeccch-----hhhHHHHHHHHHc-CCCCeeeeceEEEecCC
Q 016184 81 KVSYIAEHVVGTGSFGVVFQAKC-----RETGEIVAIKKVLQDK-----RYKNRELQIMQML-DHPNIVALKHCFFSTTD 149 (394)
Q Consensus 81 ~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~ 149 (394)
..+|++.+.||+|+||.||+|++ ..++..||||++.... ....+|+.+++.+ +||||+++++++.
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~---- 109 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACT---- 109 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeec----
Confidence 34699999999999999999974 3456789999885432 2345799999999 8999999999883
Q ss_pred CceeEEEEEEecccc-cHHHHHHHhhh-----------------------------------------------------
Q 016184 150 KEELYLNLVLEYVPE-TVNRIARNYSR----------------------------------------------------- 175 (394)
Q Consensus 150 ~~~~~~~lv~e~~~~-~l~~~~~~~~~----------------------------------------------------- 175 (394)
.....++||||+++ +|.+++.....
T Consensus 110 -~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 188 (375)
T cd05104 110 -VGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRS 188 (375)
T ss_pred -cCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccc
Confidence 33347899999984 67666653210
Q ss_pred ------------------hcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCcccccc
Q 016184 176 ------------------IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK 237 (394)
Q Consensus 176 ------------------~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~ 237 (394)
....+++..+..++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||+++....
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~-~~ivH~Dlkp~Nill~~~~-~~kl~DfG~a~~~~~ 266 (375)
T cd05104 189 VRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLAS-KNCIHRDLAARNILLTHGR-ITKICDFGLARDIRN 266 (375)
T ss_pred cccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCchhhEEEECCC-cEEEecCccceeccC
Confidence 11257888899999999999999999 8999999999999999876 799999999976543
Q ss_pred CCCc---ccccccccccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCChhhhhccC
Q 016184 238 GEPN---VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 313 (394)
Q Consensus 238 ~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 313 (394)
.... ....++..|+|||++.+. .++.++|||||||++|+|++ |..||........+.........
T Consensus 267 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~---------- 335 (375)
T cd05104 267 DSNYVVKGNARLPVKWMAPESIFNC-VYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYR---------- 335 (375)
T ss_pred cccccccCCCCCCcceeChhHhcCC-CCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCcc----------
Confidence 3211 122335679999999654 48999999999999999998 88999876554444433331100
Q ss_pred CCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 016184 314 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH 365 (394)
Q Consensus 314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 365 (394)
...+...+.++.+||.+||+.||++|||+.++++.
T Consensus 336 -----------------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 370 (375)
T cd05104 336 -----------------MLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQL 370 (375)
T ss_pred -----------------CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence 00113457899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=297.90 Aligned_cols=245 Identities=33% Similarity=0.525 Sum_probs=192.2
Q ss_pred eEEeecCceEEEEEEECCCCcEEEEEEeccchh-------hhHHHHHH-HHHcCCCCeeeeceEEEecCCCceeEEEEEE
Q 016184 88 HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-------YKNRELQI-MQMLDHPNIVALKHCFFSTTDKEELYLNLVL 159 (394)
Q Consensus 88 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-------~~~~E~~~-l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~ 159 (394)
+.||.|+||.||+|.+..+|+.||+|++.+... ....|..+ .....|+|++++++++. .....++++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~-----~~~~~~lv~ 76 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQ-----SKDYLYLVM 76 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEE-----cCCeEEEEE
Confidence 568999999999999999999999998864321 11234333 34458999999999883 334588999
Q ss_pred ecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCccccccC
Q 016184 160 EYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG 238 (394)
Q Consensus 160 e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~~ 238 (394)
||+++ +|..++.. ...+++..+..++.|++.||.|||+ .|++|+||+|+||+++.++ .++|+|||++.....
T Consensus 77 e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~lH~-~~i~H~dl~p~nil~~~~~-~~~l~dfg~~~~~~~- 149 (260)
T cd05611 77 EYLNGGDCASLIKT----LGGLPEDWAKQYIAEVVLGVEDLHQ-RGIIHRDIKPENLLIDQTG-HLKLTDFGLSRNGLE- 149 (260)
T ss_pred eccCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHeEECCCC-cEEEeecccceeccc-
Confidence 99975 67666543 3568999999999999999999999 8999999999999999887 799999999875432
Q ss_pred CCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCCCcc
Q 016184 239 EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 318 (394)
Q Consensus 239 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 318 (394)
.....++..|+|||.+.+.. ++.++|+||||+++|+|++|..||...+.......+......
T Consensus 150 --~~~~~~~~~y~~pe~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~--------------- 211 (260)
T cd05611 150 --NKKFVGTPDYLAPETILGVG-DDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRIN--------------- 211 (260)
T ss_pred --cccCCCCcCccChhhhcCCC-CcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccC---------------
Confidence 22345788899999986654 899999999999999999999999877655444433221100
Q ss_pred cCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCC---HHHHhcCCCCCCCC
Q 016184 319 FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCT---ALEACVHPFFDELR 372 (394)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt---~~ell~hp~f~~~~ 372 (394)
+.......++.++.++|.+||+.||++||+ ++|++.||||++++
T Consensus 212 ----------~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~~~~~~~~ 258 (260)
T cd05611 212 ----------WPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHPFFKSIN 258 (260)
T ss_pred ----------CCCcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcChHhhcCC
Confidence 001112357899999999999999999995 47999999998865
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=299.28 Aligned_cols=244 Identities=21% Similarity=0.245 Sum_probs=191.4
Q ss_pred eeEEEeeEEeecCceEEEEEEEC---CCCcEEEEEEeccch-----hhhHHHHHHHHHcCCCCeeeeceEEEecCCCcee
Q 016184 82 VSYIAEHVVGTGSFGVVFQAKCR---ETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL 153 (394)
Q Consensus 82 ~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 153 (394)
.+|++.+.||+|+||.||+|.++ ..+..||+|.+.... ..+.+|+.+++.++||||+++++++. ...
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~~ 79 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVIT-----RGN 79 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEe-----cCC
Confidence 35999999999999999999875 346789999876432 23457999999999999999999873 233
Q ss_pred EEEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCc
Q 016184 154 YLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA 232 (394)
Q Consensus 154 ~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a 232 (394)
..++||||+++ +|.+++... ...+++..++.++.|++.||+|||+ .|++||||||+|||++.++ .++++|||.+
T Consensus 80 ~~~lv~e~~~~~~L~~~l~~~---~~~l~~~~~~~~~~~i~~al~~lH~-~~iiH~dikp~nili~~~~-~~~l~dfg~~ 154 (266)
T cd05064 80 TMMIVTEYMSNGALDSFLRKH---EGQLVAGQLMGMLPGLASGMKYLSE-MGYVHKGLAAHKVLVNSDL-VCKISGFRRL 154 (266)
T ss_pred CcEEEEEeCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHH-CCEeeccccHhhEEEcCCC-cEEECCCccc
Confidence 47899999986 565555432 2578999999999999999999999 8999999999999999887 7999999987
Q ss_pred cccccCCCcc--cccccccccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCChhhh
Q 016184 233 KVLVKGEPNV--SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEI 309 (394)
Q Consensus 233 ~~~~~~~~~~--~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 309 (394)
.......... ...++..|+|||.+.+. .++.++|||||||++|++++ |..||......+.+..+.+....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~------ 227 (266)
T cd05064 155 QEDKSEAIYTTMSGKSPVLWAAPEAIQYH-HFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRL------ 227 (266)
T ss_pred ccccccchhcccCCCCceeecCHHHHhhC-CccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCC------
Confidence 5432221111 22345789999998654 48999999999999999875 99999877665554444321100
Q ss_pred hccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 016184 310 KCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV 364 (394)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 364 (394)
..+..++..+.+++.+||+.||.+|||++++++
T Consensus 228 ----------------------~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~ 260 (266)
T cd05064 228 ----------------------PAPRNCPNLLHQLMLDCWQKERGERPRFSQIHS 260 (266)
T ss_pred ----------------------CCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHH
Confidence 012457889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=304.92 Aligned_cols=258 Identities=28% Similarity=0.438 Sum_probs=204.5
Q ss_pred EEEeeEEeecCceEEEEEEECCCCcEEEEEEeccc----hhhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEEEEEE
Q 016184 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVL 159 (394)
Q Consensus 84 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~ 159 (394)
|....+||+|+||.||++....+++.||||++... .....+|+.+++.++|+|++++++++.. ..+.+++|
T Consensus 22 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~~~~~lv~ 96 (292)
T cd06657 22 LDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLV-----GDELWVVM 96 (292)
T ss_pred hhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEe-----CCEEEEEE
Confidence 44457899999999999999999999999987432 2234578999999999999999998843 34578999
Q ss_pred ecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCccccccC
Q 016184 160 EYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG 238 (394)
Q Consensus 160 e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~~ 238 (394)
||+++ ++.+++. ...+++..++.++.|++.||+|||+ .|++|+||+|+||+++.++ .++|+|||++......
T Consensus 97 e~~~~~~L~~~~~-----~~~~~~~~~~~~~~ql~~~l~~lH~-~givH~dl~p~Nilv~~~~-~~~l~dfg~~~~~~~~ 169 (292)
T cd06657 97 EFLEGGALTDIVT-----HTRMNEEQIAAVCLAVLKALSVLHA-QGVIHRDIKSDSILLTHDG-RVKLSDFGFCAQVSKE 169 (292)
T ss_pred ecCCCCcHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEECCCC-CEEEcccccceecccc
Confidence 99986 5555443 2568999999999999999999999 8999999999999999887 6999999988655332
Q ss_pred C-CcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCCCc
Q 016184 239 E-PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 317 (394)
Q Consensus 239 ~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 317 (394)
. ......+++.|+|||.+.+ ..++.++|+||+|+++|+|++|..||.+.........+.......
T Consensus 170 ~~~~~~~~~~~~y~~pE~~~~-~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~------------- 235 (292)
T cd06657 170 VPRRKSLVGTPYWMAPELISR-LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPK------------- 235 (292)
T ss_pred cccccccccCccccCHHHhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCcc-------------
Confidence 2 1233467889999998854 447899999999999999999999998766554444333211000
Q ss_pred ccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCCCCCC
Q 016184 318 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPN 380 (394)
Q Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~~~~~ 380 (394)
+. ....++..+.+++.+||+.||.+||++.++++||||.+...++...+.
T Consensus 236 ---~~----------~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~~~~~~~~~~~~~~~~ 285 (292)
T cd06657 236 ---LK----------NLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGPPSCIVPL 285 (292)
T ss_pred ---cC----------CcccCCHHHHHHHHHHHhCCcccCcCHHHHhcChHHhccCCCcccccH
Confidence 00 013468899999999999999999999999999999999877654443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-40 Score=296.59 Aligned_cols=245 Identities=26% Similarity=0.421 Sum_probs=196.8
Q ss_pred eEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccc-----hhhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEEEE
Q 016184 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL 157 (394)
Q Consensus 83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 157 (394)
+|++.+.||.|+||.||++.+..+++.+|+|.+... .....+|+.+++.++|+||+++.+.+ ....+.++
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~l 75 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESF-----EADGHLYI 75 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEE-----EECCEEEE
Confidence 489999999999999999999999999999987532 23345688999999999999999987 33345889
Q ss_pred EEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCccccc
Q 016184 158 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV 236 (394)
Q Consensus 158 v~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~ 236 (394)
+|||+++ ++.+.+... ....+++..++.++.|++.||.|||+ +||+|+||||+||+++.++ .++|+|||.+....
T Consensus 76 v~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~~~i~~al~~lH~-~~i~H~dl~p~nili~~~~-~~~l~dfg~~~~~~ 151 (255)
T cd08219 76 VMEYCDGGDLMQKIKLQ--RGKLFPEDTILQWFVQMCLGVQHIHE-KRVLHRDIKSKNIFLTQNG-KVKLGDFGSARLLT 151 (255)
T ss_pred EEeeCCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHhh-CCcccCCCCcceEEECCCC-cEEEcccCcceeec
Confidence 9999985 666655432 23568899999999999999999999 8999999999999999887 79999999987654
Q ss_pred cCCC-cccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCC
Q 016184 237 KGEP-NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 315 (394)
Q Consensus 237 ~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 315 (394)
.... .....+++.|+|||++.+. .++.++|+||||+++|+|++|..||...+.......+..... .
T Consensus 152 ~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~-~----------- 218 (255)
T cd08219 152 SPGAYACTYVGTPYYVPPEIWENM-PYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSY-K----------- 218 (255)
T ss_pred ccccccccccCCccccCHHHHccC-CcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCC-C-----------
Confidence 3222 2345678889999998554 489999999999999999999999987655444443322100 0
Q ss_pred CcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 016184 316 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH 365 (394)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 365 (394)
.++..++..+.+||.+||+.||++|||+.++++-
T Consensus 219 ----------------~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 219 ----------------PLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred ----------------CCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 0123467889999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=302.82 Aligned_cols=265 Identities=28% Similarity=0.436 Sum_probs=214.9
Q ss_pred eeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccchhhh-------HHHHHHHHHcC-CCCeeeeceEEEecCCCcee
Q 016184 82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------NRELQIMQMLD-HPNIVALKHCFFSTTDKEEL 153 (394)
Q Consensus 82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-------~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~ 153 (394)
.+|..+.+||+|+||+|.+|..+.+.+.+|||+++++.-.. ..|-++|.... -|.+++++.|| +.-.
T Consensus 349 tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScF-----QTmD 423 (683)
T KOG0696|consen 349 TDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCF-----QTMD 423 (683)
T ss_pred cccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHh-----hhhh
Confidence 46889999999999999999999999999999887653222 24667777664 46778888877 3233
Q ss_pred EEEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCc
Q 016184 154 YLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA 232 (394)
Q Consensus 154 ~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a 232 (394)
.+|+||||+.| +|--. ....+++.+..+..++..|+.||-+||+ +||++||||.+|||++.+|+ +||+|||++
T Consensus 424 RLyFVMEyvnGGDLMyh----iQQ~GkFKEp~AvFYAaEiaigLFFLh~-kgIiYRDLKLDNvmLd~eGH-iKi~DFGmc 497 (683)
T KOG0696|consen 424 RLYFVMEYVNGGDLMYH----IQQVGKFKEPVAVFYAAEIAIGLFFLHS-KGIIYRDLKLDNVMLDSEGH-IKIADFGMC 497 (683)
T ss_pred heeeEEEEecCchhhhH----HHHhcccCCchhhhhhHHHHHHhhhhhc-CCeeeeeccccceEeccCCc-eEeeecccc
Confidence 38899999986 33222 2224778899999999999999999999 89999999999999999995 999999999
Q ss_pred cccccC-CCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhc
Q 016184 233 KVLVKG-EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 311 (394)
Q Consensus 233 ~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 311 (394)
+.-..+ ....+.+|||.|+|||++.- .+|+..+|+||+||+||||+.|++||.+.+..+.++.|.+.-
T Consensus 498 KEni~~~~TTkTFCGTPdYiAPEIi~Y-qPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehn---------- 566 (683)
T KOG0696|consen 498 KENIFDGVTTKTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHN---------- 566 (683)
T ss_pred cccccCCcceeeecCCCcccccceEEe-cccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcc----------
Confidence 865443 34456789999999999954 459999999999999999999999999999999999988721
Q ss_pred cCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCH-----HHHhcCCCCCCCCCCCCCCCCCCCCCC
Q 016184 312 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTA-----LEACVHPFFDELRDPNTRLPNGRPLPP 386 (394)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~-----~ell~hp~f~~~~~~~~~~~~~~~~~~ 386 (394)
. .+++.+|.++.++++.+|.+.|.+|... .++-.||||+.+-.... ..+-++|
T Consensus 567 -------v------------syPKslSkEAv~ickg~ltK~P~kRLGcg~~ge~di~~H~FFR~iDWek~---E~~eiqP 624 (683)
T KOG0696|consen 567 -------V------------SYPKSLSKEAVAICKGLLTKHPGKRLGCGPEGERDIREHPFFRRIDWEKL---ERREIQP 624 (683)
T ss_pred -------C------------cCcccccHHHHHHHHHHhhcCCccccCCCCccccchhhCcchhhccHHHH---hhccCCC
Confidence 1 2346799999999999999999999854 58999999999865554 2344555
Q ss_pred CCCC
Q 016184 387 LFNF 390 (394)
Q Consensus 387 ~~~~ 390 (394)
+|-+
T Consensus 625 PfkP 628 (683)
T KOG0696|consen 625 PFKP 628 (683)
T ss_pred CCCC
Confidence 5554
|
|
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=307.81 Aligned_cols=274 Identities=20% Similarity=0.306 Sum_probs=193.6
Q ss_pred CceEEEEEEECCCCcEEEEEEeccc------hhhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEEEEEEecccc-cH
Q 016184 94 SFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPE-TV 166 (394)
Q Consensus 94 ~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~~-~l 166 (394)
+++.||.++...+++.||||++... .....+|+++++.++|+||+++++++.. ....+++|||+++ ++
T Consensus 12 ~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~-----~~~~~~~~e~~~~~~l 86 (314)
T cd08216 12 DLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIV-----DSELYVVSPLMAYGSC 86 (314)
T ss_pred CCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeec-----CCeEEEEEeccCCCCH
Confidence 4456666667678999999987543 1345679999999999999999998843 3347899999984 67
Q ss_pred HHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCccccccCCC------
Q 016184 167 NRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP------ 240 (394)
Q Consensus 167 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~~~~------ 240 (394)
.+++.... ...+++..+..++.|++.||+|||+ +||+||||||+||+++.++ .++|+|||.+........
T Consensus 87 ~~~l~~~~--~~~~~~~~~~~~~~~l~~~L~~LH~-~~ivH~dlk~~Nili~~~~-~~kl~d~~~~~~~~~~~~~~~~~~ 162 (314)
T cd08216 87 EDLLKTHF--PEGLPELAIAFILKDVLNALDYIHS-KGFIHRSVKASHILLSGDG-KVVLSGLRYSVSMIKHGKRQRVVH 162 (314)
T ss_pred HHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCcceEEEecCC-ceEEecCccceeeccccccccccc
Confidence 66666432 2568899999999999999999999 8999999999999999887 799999998865532211
Q ss_pred --cccccccccccccccccCC-CCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhh--hhccCCC
Q 016184 241 --NVSYICSRYYRAPELIFGA-TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE--IKCMNPN 315 (394)
Q Consensus 241 --~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~--~~~~~~~ 315 (394)
.....++..|+|||++... ..++.++|+|||||++|+|++|..||........+.+............ .......
T Consensus 163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (314)
T cd08216 163 DFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDS 242 (314)
T ss_pred cccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcCC
Confidence 1223457789999998543 3478899999999999999999999987654443332222110000000 0000000
Q ss_pred Ccc----cCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCCC
Q 016184 316 YTE----FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTR 377 (394)
Q Consensus 316 ~~~----~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~~ 377 (394)
... ...+. ............++.++.+|+.+||+.||++|||++++|+||||+.++.....
T Consensus 243 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~~~~~~~ 307 (314)
T cd08216 243 MSQSRSSNEHPN-NRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQCKRRNTS 307 (314)
T ss_pred cCcccccccccc-hhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhhcccchh
Confidence 000 00000 00111111223456789999999999999999999999999999998855553
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-40 Score=297.12 Aligned_cols=248 Identities=26% Similarity=0.426 Sum_probs=196.6
Q ss_pred eEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccc-------hhhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEE
Q 016184 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL 155 (394)
Q Consensus 83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 155 (394)
+|++.+.||+|+||.||+|++..+++.||||.+... .....+|+++++.++||||+++++++... ...
T Consensus 3 ~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~ 77 (267)
T cd08228 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIED-----NEL 77 (267)
T ss_pred ceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEEC-----CeE
Confidence 599999999999999999999999999999976431 12345799999999999999999987432 347
Q ss_pred EEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCccc
Q 016184 156 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV 234 (394)
Q Consensus 156 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~ 234 (394)
++++||+++ ++..++.........+++..+..++.|++.||.|||+ +|++|+||||+||+++.++ .++|+|||++..
T Consensus 78 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~-~~i~H~dl~~~nil~~~~~-~~~l~d~g~~~~ 155 (267)
T cd08228 78 NIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHS-RRVMHRDIKPANVFITATG-VVKLGDLGLGRF 155 (267)
T ss_pred EEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhh-CCeeCCCCCHHHEEEcCCC-CEEECcccccee
Confidence 799999985 7777776555445668999999999999999999999 8999999999999999887 699999999876
Q ss_pred cccCCC-cccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCc-HHHHHHHHHHhCCCChhhhhcc
Q 016184 235 LVKGEP-NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESG-VDQLVEIIKVLGTPTREEIKCM 312 (394)
Q Consensus 235 ~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~ 312 (394)
...... .....+++.|+|||.+.+. .++.++|+||||+++|+|++|+.||..... ...+.......+.++.
T Consensus 156 ~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~------ 228 (267)
T cd08228 156 FSSKTTAAHSLVGTPYYMSPERIHEN-GYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPL------ 228 (267)
T ss_pred ccchhHHHhcCCCCccccChhhhccC-CCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCCC------
Confidence 543221 1234578889999998654 488999999999999999999999965432 1222222221111110
Q ss_pred CCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 016184 313 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV 364 (394)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 364 (394)
.....+..+.++|.+||+.||++||++.++++
T Consensus 229 --------------------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~ 260 (267)
T cd08228 229 --------------------PTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQ 260 (267)
T ss_pred --------------------ChhhcCHHHHHHHHHHCCCCcccCcCHHHHHH
Confidence 11346788999999999999999999999987
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-40 Score=301.50 Aligned_cols=248 Identities=22% Similarity=0.315 Sum_probs=195.8
Q ss_pred eeEEEeeEEeecCceEEEEEEECCCC-----cEEEEEEeccch-----hhhHHHHHHHHHcCCCCeeeeceEEEecCCCc
Q 016184 82 VSYIAEHVVGTGSFGVVFQAKCRETG-----EIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKE 151 (394)
Q Consensus 82 ~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 151 (394)
.+|++.+.||+|+||.||+|.+...+ ..||+|.+.... ..+.+|+.+++.++||||+++++++. .
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~-----~ 79 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCT-----K 79 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEc-----C
Confidence 35899999999999999999986554 679999885432 23467999999999999999999873 2
Q ss_pred eeEEEEEEecccc-cHHHHHHHhhh------------hcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEe
Q 016184 152 ELYLNLVLEYVPE-TVNRIARNYSR------------IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVN 218 (394)
Q Consensus 152 ~~~~~lv~e~~~~-~l~~~~~~~~~------------~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~ 218 (394)
....+++|||+++ +|.+++..... ....+++..+..++.|++.||.|||+ .|++|+||||+||+++
T Consensus 80 ~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~-~~i~H~dlkp~Nil~~ 158 (283)
T cd05048 80 EQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSS-HHFVHRDLAARNCLVG 158 (283)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccccccceEEEc
Confidence 3347799999984 77776654321 11468889999999999999999999 8999999999999999
Q ss_pred CCCCcEEEEeecCccccccCC---CcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHH
Q 016184 219 PHTHQLKLCDFGSAKVLVKGE---PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQL 294 (394)
Q Consensus 219 ~~~~~vkl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~ 294 (394)
.++ .++|+|||++....... ......+++.|+|||.+.+. .++.++|||||||++|+|++ |..||.+....+..
T Consensus 159 ~~~-~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~ 236 (283)
T cd05048 159 EGL-TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYG-KFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVI 236 (283)
T ss_pred CCC-cEEECCCcceeeccccccccccCCCcccccccCHHHhccC-cCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Confidence 887 69999999987553322 12233457889999998654 48999999999999999998 99999887665544
Q ss_pred HHHHHHhCCCChhhhhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 016184 295 VEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH 365 (394)
Q Consensus 295 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 365 (394)
..+...... ..+..++.++.+|+.+||+.||.+||++.+++++
T Consensus 237 ~~i~~~~~~----------------------------~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~ 279 (283)
T cd05048 237 EMIRSRQLL----------------------------PCPEDCPARVYALMIECWNEIPARRPRFKDIHTR 279 (283)
T ss_pred HHHHcCCcC----------------------------CCcccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 433321000 0124678999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=294.92 Aligned_cols=248 Identities=28% Similarity=0.456 Sum_probs=197.3
Q ss_pred eEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccc---------hhhhHHHHHHHHHcCCCCeeeeceEEEecCCCcee
Q 016184 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD---------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL 153 (394)
Q Consensus 83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 153 (394)
+|++.+.||+|+||.||+|.+..+++.||+|.+... ...+.+|+++++.++|+||+++++++.. ....
T Consensus 3 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~---~~~~ 79 (264)
T cd06653 3 NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRD---PEEK 79 (264)
T ss_pred ceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEc---CCCC
Confidence 599999999999999999999999999999986421 1234579999999999999999998733 2233
Q ss_pred EEEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCc
Q 016184 154 YLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA 232 (394)
Q Consensus 154 ~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a 232 (394)
.+++++||+++ +|.+.+.. ...+++..++.++.|++.||.|||+ .|++|+||||+||+++.++ .++|+|||++
T Consensus 80 ~~~~v~e~~~~~~L~~~~~~----~~~l~~~~~~~~~~~i~~al~~LH~-~~i~H~dl~p~ni~i~~~~-~~~l~dfg~~ 153 (264)
T cd06653 80 KLSIFVEYMPGGSIKDQLKA----YGALTENVTRRYTRQILQGVSYLHS-NMIVHRDIKGANILRDSAG-NVKLGDFGAS 153 (264)
T ss_pred EEEEEEEeCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHh-CCEecCCCCHHHEEEcCCC-CEEECccccc
Confidence 46789999975 66555543 3568899999999999999999999 8999999999999999887 6999999998
Q ss_pred cccccC----CCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhh
Q 016184 233 KVLVKG----EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 308 (394)
Q Consensus 233 ~~~~~~----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~ 308 (394)
+..... .......++..|+|||.+.+. .++.++|+|||||++|+|++|+.||........+.++. ..+.
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~---~~~~--- 226 (264)
T cd06653 154 KRIQTICMSGTGIKSVTGTPYWMSPEVISGE-GYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIA---TQPT--- 226 (264)
T ss_pred cccccccccCccccccCCcccccCHhhhcCC-CCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHH---cCCC---
Confidence 755321 111234578899999998654 47899999999999999999999998765444333322 1111
Q ss_pred hhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 016184 309 IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368 (394)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f 368 (394)
...++..+++.+.++|.+||+ +|.+|||+.++++|||.
T Consensus 227 ---------------------~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~~~~ 264 (264)
T cd06653 227 ---------------------KPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRHPFV 264 (264)
T ss_pred ---------------------CCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcCCCC
Confidence 111335688999999999999 57999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=293.73 Aligned_cols=249 Identities=26% Similarity=0.420 Sum_probs=202.4
Q ss_pred eEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccc------hhhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEEE
Q 016184 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN 156 (394)
Q Consensus 83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 156 (394)
+|++.+.||+|+||.||++.+..+++.+|+|.+... .....+|+++++.++|+||+++.+++.. ....+
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~~ 75 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLD-----GNKLC 75 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhcc-----CCEEE
Confidence 489999999999999999999999999999987542 2233468899999999999999988843 24578
Q ss_pred EEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCcccc
Q 016184 157 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL 235 (394)
Q Consensus 157 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~ 235 (394)
+++||+++ ++...+.........+++..++.++.|++.||.|||+ .|++|+||+|+||+++.++ .+||+|||++...
T Consensus 76 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~-~~i~h~~l~~~ni~~~~~~-~~kl~d~g~~~~~ 153 (256)
T cd08530 76 IVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHE-QKILHRDLKSANILLVAND-LVKIGDLGISKVL 153 (256)
T ss_pred EEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh-CCcccCCCCcceEEEecCC-cEEEeeccchhhh
Confidence 99999975 7777766544445678999999999999999999999 8999999999999999877 7999999999766
Q ss_pred ccCCCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCC
Q 016184 236 VKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 315 (394)
Q Consensus 236 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 315 (394)
... ......+++.|+|||.+.+. .++.++|+||||+++|+|++|+.||...+.......+....
T Consensus 154 ~~~-~~~~~~~~~~~~~Pe~~~~~-~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~-------------- 217 (256)
T cd08530 154 KKN-MAKTQIGTPHYMAPEVWKGR-PYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGK-------------- 217 (256)
T ss_pred ccC-CcccccCCccccCHHHHCCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC--------------
Confidence 444 33345678899999998654 48889999999999999999999998766543333222100
Q ss_pred CcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 016184 316 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368 (394)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f 368 (394)
++ .+...++.+++++|.+||+.+|++|||+.++++||++
T Consensus 218 -----~~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~p~~ 256 (256)
T cd08530 218 -----YP---------PIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILASPAV 256 (256)
T ss_pred -----CC---------CCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcCCCC
Confidence 00 0113468889999999999999999999999999985
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-40 Score=296.31 Aligned_cols=244 Identities=21% Similarity=0.346 Sum_probs=194.5
Q ss_pred eEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccchh---hhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEEEEEE
Q 016184 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR---YKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVL 159 (394)
Q Consensus 83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~ 159 (394)
.|++.+.||+|+||.||+|.+..+++.||+|.+..+.. ...+|+++++.++|+||+++++++. ....++++|
T Consensus 7 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~lv~ 81 (263)
T cd05052 7 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT-----REPPFYIIT 81 (263)
T ss_pred HeEEeeecCCcccceEEEEEEecCCceEEEEEecCCchHHHHHHHHHHHHHhCCCCChhheEEEEc-----CCCCcEEEE
Confidence 49999999999999999999999999999998865432 3457999999999999999999873 233478999
Q ss_pred ecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCccccccC
Q 016184 160 EYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG 238 (394)
Q Consensus 160 e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~~ 238 (394)
||+++ +|.+.+.... ...+++..++.++.|++.||+|||+ .|++||||||+||+++.++ .+||+|||++......
T Consensus 82 e~~~~~~L~~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lH~-~~i~H~dlkp~nil~~~~~-~~kl~df~~~~~~~~~ 157 (263)
T cd05052 82 EFMTYGNLLDYLRECN--RQEVNAVVLLYMATQISSAMEYLEK-KNFIHRDLAARNCLVGENH-LVKVADFGLSRLMTGD 157 (263)
T ss_pred EeCCCCcHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHh-CCEeecccCcceEEEcCCC-cEEeCCCccccccccc
Confidence 99974 6766664322 3568899999999999999999999 8999999999999999887 7999999998765432
Q ss_pred CCc--ccccccccccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCC
Q 016184 239 EPN--VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 315 (394)
Q Consensus 239 ~~~--~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 315 (394)
... .....+..|+|||.+.+. .++.++|||||||++|+|++ |..||.+.+..+....+.....
T Consensus 158 ~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~------------- 223 (263)
T cd05052 158 TYTAHAGAKFPIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYR------------- 223 (263)
T ss_pred eeeccCCCCCccccCCHHHhccC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCC-------------
Confidence 211 112235679999988654 48999999999999999998 9999987665444333322100
Q ss_pred CcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 016184 316 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV 364 (394)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 364 (394)
...+..++.++.++|.+||+.||++|||+.++++
T Consensus 224 ---------------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 257 (263)
T cd05052 224 ---------------MERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQ 257 (263)
T ss_pred ---------------CCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 0112457899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-40 Score=300.71 Aligned_cols=257 Identities=27% Similarity=0.463 Sum_probs=199.9
Q ss_pred eEEEeeEEeecCceEEEEEEEC---CCCcEEEEEEeccch--------hhhHHHHHHHHHc-CCCCeeeeceEEEecCCC
Q 016184 83 SYIAEHVVGTGSFGVVFQAKCR---ETGEIVAIKKVLQDK--------RYKNRELQIMQML-DHPNIVALKHCFFSTTDK 150 (394)
Q Consensus 83 ~y~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~--------~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~ 150 (394)
.|++.+.||.|+||.||+|.+. .+|+.||+|++.... ....+|+.+++.+ +|+||+.+++++ .
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~-----~ 75 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAF-----Q 75 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEe-----e
Confidence 3889999999999999999875 478999999886421 3345689999999 589999998887 3
Q ss_pred ceeEEEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEee
Q 016184 151 EELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDF 229 (394)
Q Consensus 151 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Df 229 (394)
.....++||||+++ ++.+.+.. ...+++..+..++.|++.||.|||+ .|++||||||+|||++.++ .++|+||
T Consensus 76 ~~~~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~al~~lH~-~~i~H~dl~p~nil~~~~~-~~kl~df 149 (290)
T cd05613 76 TDTKLHLILDYINGGELFTHLSQ----RERFKEQEVQIYSGEIVLALEHLHK-LGIIYRDIKLENILLDSNG-HVVLTDF 149 (290)
T ss_pred cCCeEEEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCHHHeEECCCC-CEEEeeC
Confidence 34457899999985 56555443 3568899999999999999999999 8999999999999999887 7999999
Q ss_pred cCccccccCC--CcccccccccccccccccCC-CCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCh
Q 016184 230 GSAKVLVKGE--PNVSYICSRYYRAPELIFGA-TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTR 306 (394)
Q Consensus 230 g~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~ 306 (394)
|++....... ......++..|+|||.+... ..++.++||||||+++|+|++|..||...........+........
T Consensus 150 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~- 228 (290)
T cd05613 150 GLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSE- 228 (290)
T ss_pred ccceecccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccC-
Confidence 9987653322 12234578899999998542 2367899999999999999999999975433222222222110000
Q ss_pred hhhhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCC-----CHHHHhcCCCCCCCCCCC
Q 016184 307 EEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-----TALEACVHPFFDELRDPN 375 (394)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----t~~ell~hp~f~~~~~~~ 375 (394)
..++..+++.+.+|+++||+.||.+|| ++++++.||||++.+...
T Consensus 229 ------------------------~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~~~ 278 (290)
T cd05613 229 ------------------------PPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKINWDD 278 (290)
T ss_pred ------------------------CCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccCCHHH
Confidence 001245788999999999999999997 899999999999987533
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-40 Score=303.79 Aligned_cols=253 Identities=28% Similarity=0.415 Sum_probs=203.5
Q ss_pred eEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccch-------hhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEE
Q 016184 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL 155 (394)
Q Consensus 83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 155 (394)
.|...+.||+|+||.||+|++..++..||+|.+.... ..+.+|+++++.++|+|++++++++.. ....
T Consensus 26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~~~~ 100 (317)
T cd06635 26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLR-----EHTA 100 (317)
T ss_pred hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-----CCeE
Confidence 3888999999999999999999999999999875321 234568999999999999999998843 3347
Q ss_pred EEEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCcccc
Q 016184 156 NLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL 235 (394)
Q Consensus 156 ~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~ 235 (394)
++||||+.+++.+++... ...+++..+..++.|++.||.|||+ .||+|+||+|+||+++.++ .++|+|||++...
T Consensus 101 ~lv~e~~~g~l~~~~~~~---~~~l~~~~~~~i~~~i~~~l~~lH~-~~i~H~dL~p~Nil~~~~~-~~kl~dfg~~~~~ 175 (317)
T cd06635 101 WLVMEYCLGSASDLLEVH---KKPLQEVEIAAITHGALQGLAYLHS-HNMIHRDIKAGNILLTEPG-QVKLADFGSASIA 175 (317)
T ss_pred EEEEeCCCCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCcccEEECCCC-CEEEecCCCcccc
Confidence 799999999877665432 3568999999999999999999999 8999999999999999887 6999999998654
Q ss_pred ccCCCcccccccccccccccccC--CCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccC
Q 016184 236 VKGEPNVSYICSRYYRAPELIFG--ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 313 (394)
Q Consensus 236 ~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 313 (394)
.. .....+++.|+|||.+.. ...++.++|+|||||++|+|++|..||........+..+.......
T Consensus 176 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~--------- 243 (317)
T cd06635 176 SP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPT--------- 243 (317)
T ss_pred CC---cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCC---------
Confidence 32 234467888999999742 2347889999999999999999999998766555554444321100
Q ss_pred CCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCC
Q 016184 314 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 375 (394)
Q Consensus 314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~ 375 (394)
......+..+++||.+||+.||.+||++.++++|||+.......
T Consensus 244 ------------------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~~~ 287 (317)
T cd06635 244 ------------------LQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRERPET 287 (317)
T ss_pred ------------------CCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhccCccc
Confidence 00134678899999999999999999999999999997654433
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=292.25 Aligned_cols=250 Identities=35% Similarity=0.538 Sum_probs=201.2
Q ss_pred eEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccch------hhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEEE
Q 016184 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN 156 (394)
Q Consensus 83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 156 (394)
+|.+.+.||+|++|.||+|.+..+++.|++|++.... ....+|+.++++++|+||+++++.+.... ....+
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~---~~~~~ 77 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEE---KNTLN 77 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCC---CCeEE
Confidence 3888999999999999999999899999999876543 34567999999999999999998874321 24578
Q ss_pred EEEeccc-ccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCcccc
Q 016184 157 LVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL 235 (394)
Q Consensus 157 lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~ 235 (394)
+++||++ +++.+++... ..+++..++.++.|++.||.|||+ .|++|+||+|+||+++.++ .++|+|||.+...
T Consensus 78 lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lh~-~~~~h~dl~p~ni~i~~~~-~~~l~d~~~~~~~ 151 (260)
T cd06606 78 IFLEYVSGGSLSSLLKKF----GKLPEPVIRKYTRQILEGLAYLHS-NGIVHRDIKGANILVDSDG-VVKLADFGCAKRL 151 (260)
T ss_pred EEEEecCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCHHHEEEcCCC-CEEEcccccEEec
Confidence 9999995 5776666542 388999999999999999999999 8999999999999999877 7999999998876
Q ss_pred ccCCC---cccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhcc
Q 016184 236 VKGEP---NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 312 (394)
Q Consensus 236 ~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 312 (394)
..... .....++..|+|||.+.+.. .+.++|+||||+++|+|++|..||....... ..+.....
T Consensus 152 ~~~~~~~~~~~~~~~~~y~~pE~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~--~~~~~~~~---------- 218 (260)
T cd06606 152 GDIETGEGTGSVRGTPYWMAPEVIRGEE-YGRAADIWSLGCTVIEMATGKPPWSELGNPM--AALYKIGS---------- 218 (260)
T ss_pred ccccccccccCCCCCccccCHhhhcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCchH--HHHHhccc----------
Confidence 55443 34456788999999985544 8999999999999999999999998765221 11111100
Q ss_pred CCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 016184 313 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368 (394)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f 368 (394)
......++..++..+.+||.+||+.||++||++.++++||||
T Consensus 219 --------------~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 260 (260)
T cd06606 219 --------------SGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQHPFL 260 (260)
T ss_pred --------------cCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhCCCC
Confidence 000001224568899999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=290.61 Aligned_cols=247 Identities=29% Similarity=0.489 Sum_probs=200.9
Q ss_pred EEEeeEEeecCceEEEEEEECCCCcEEEEEEeccch----hhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEEEEEE
Q 016184 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVL 159 (394)
Q Consensus 84 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~ 159 (394)
|++.+.||+|++|.||++.+..+++.+++|++.... ....+|+++++.++|+|++++++++... ...++++
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~l~~ 76 (253)
T cd05122 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKK-----DELWIVM 76 (253)
T ss_pred ceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecC-----CeEEEEE
Confidence 888999999999999999999899999999886543 4556799999999999999999988433 3477999
Q ss_pred eccc-ccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCccccccC
Q 016184 160 EYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG 238 (394)
Q Consensus 160 e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~~ 238 (394)
||++ ++|.+++.... ..+++..+..++.|++.||.+||+ .|++|+||+|+||+++.++ .++|+|||.+......
T Consensus 77 e~~~~~~L~~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lh~-~~i~h~dl~p~ni~i~~~~-~~~l~d~~~~~~~~~~ 151 (253)
T cd05122 77 EFCSGGSLKDLLKSTN---QTLTESQIAYVCKELLKGLEYLHS-NGIIHRDIKAANILLTSDG-EVKLIDFGLSAQLSDT 151 (253)
T ss_pred ecCCCCcHHHHHhhcC---CCCCHHHHHHHHHHHHHHHHHhhc-CCEecCCCCHHHEEEccCC-eEEEeecccccccccc
Confidence 9999 57766655421 578999999999999999999999 8999999999999999877 7999999998776544
Q ss_pred CCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCCCcc
Q 016184 239 EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 318 (394)
Q Consensus 239 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 318 (394)
.......++..|+|||.+.+.. ++.++|+||||+++|+|++|+.||...+.......+... ..+.
T Consensus 152 ~~~~~~~~~~~~~~PE~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~------------- 216 (253)
T cd05122 152 KARNTMVGTPYWMAPEVINGKP-YDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATN-GPPG------------- 216 (253)
T ss_pred ccccceecCCcccCHHHHcCCC-CCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhc-CCCC-------------
Confidence 3334556788999999986544 889999999999999999999999876544444333221 0000
Q ss_pred cCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCC
Q 016184 319 FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 367 (394)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~ 367 (394)
.+ ....++..+.++|++||+.||++|||+.++++|||
T Consensus 217 --~~----------~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~~~ 253 (253)
T cd05122 217 --LR----------NPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKHPF 253 (253)
T ss_pred --cC----------cccccCHHHHHHHHHHccCChhhCCCHHHHhcCCC
Confidence 00 00124788999999999999999999999999999
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=298.47 Aligned_cols=254 Identities=23% Similarity=0.321 Sum_probs=195.6
Q ss_pred eeEEEeeEEeecCceEEEEEEECC-----CCcEEEEEEeccch-----hhhHHHHHHHHHcCCCCeeeeceEEEecCCCc
Q 016184 82 VSYIAEHVVGTGSFGVVFQAKCRE-----TGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKE 151 (394)
Q Consensus 82 ~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 151 (394)
.+|++.+.||+|+||.||+|.++. .+..||+|.+.... ....+|+.+++.++|+||+++++++. .
T Consensus 6 ~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~ 80 (288)
T cd05061 6 EKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVS-----K 80 (288)
T ss_pred HHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEc-----C
Confidence 469999999999999999997652 34589999875332 22346889999999999999999873 2
Q ss_pred eeEEEEEEeccc-ccHHHHHHHhhhh------cCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcE
Q 016184 152 ELYLNLVLEYVP-ETVNRIARNYSRI------HQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQL 224 (394)
Q Consensus 152 ~~~~~lv~e~~~-~~l~~~~~~~~~~------~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~v 224 (394)
....+++|||++ ++|.+++...... ........+..++.|++.||.|||+ +||+||||||+|||++.++ .+
T Consensus 81 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~-~~i~H~dikp~nili~~~~-~~ 158 (288)
T cd05061 81 GQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNA-KKFVHRDLAARNCMVAHDF-TV 158 (288)
T ss_pred CCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCcCCCCChheEEEcCCC-cE
Confidence 234789999997 5887777653221 1334667888999999999999999 8999999999999999887 79
Q ss_pred EEEeecCccccccCCC---cccccccccccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHH
Q 016184 225 KLCDFGSAKVLVKGEP---NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKV 300 (394)
Q Consensus 225 kl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~ 300 (394)
+|+|||+++....... .....++..|+|||.+.+. .++.++|+|||||++|+|++ |..||.+....+....+...
T Consensus 159 ~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~-~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~ 237 (288)
T cd05061 159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDG-VFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDG 237 (288)
T ss_pred EECcCCccccccccccccccCCCcccccccCHHHhccC-CCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC
Confidence 9999999875433221 1122346679999998654 48999999999999999998 78899876654433332210
Q ss_pred hCCCChhhhhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhc------CCCCCCC
Q 016184 301 LGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV------HPFFDEL 371 (394)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~------hp~f~~~ 371 (394)
+.+ .++..+++.+.+++.+||+.||++|||+.++++ ||||+++
T Consensus 238 -~~~---------------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~~ 286 (288)
T cd05061 238 -GYL---------------------------DQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPEV 286 (288)
T ss_pred -CCC---------------------------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCCC
Confidence 000 011346789999999999999999999999986 9999876
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=308.84 Aligned_cols=250 Identities=24% Similarity=0.351 Sum_probs=192.5
Q ss_pred eeEEEeeEEeecCceEEEEEEECC-----CCcEEEEEEeccch-----hhhHHHHHHHHHc-CCCCeeeeceEEEecCCC
Q 016184 82 VSYIAEHVVGTGSFGVVFQAKCRE-----TGEIVAIKKVLQDK-----RYKNRELQIMQML-DHPNIVALKHCFFSTTDK 150 (394)
Q Consensus 82 ~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~-----~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~ 150 (394)
.+|++.++||.|+||.||+|.+.. +++.||+|++.... ....+|+.+++++ .|+||+++++++...
T Consensus 7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~--- 83 (337)
T cd05054 7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKP--- 83 (337)
T ss_pred HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecC---
Confidence 369999999999999999997543 45789999875422 2334689999999 899999999977432
Q ss_pred ceeEEEEEEecccc-cHHHHHHHhhh------------------------------------------------------
Q 016184 151 EELYLNLVLEYVPE-TVNRIARNYSR------------------------------------------------------ 175 (394)
Q Consensus 151 ~~~~~~lv~e~~~~-~l~~~~~~~~~------------------------------------------------------ 175 (394)
...++++|||+++ +|.+++.....
T Consensus 84 -~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (337)
T cd05054 84 -GGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEG 162 (337)
T ss_pred -CCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhh
Confidence 2347789999985 67666643211
Q ss_pred ---hcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCccccccCCC---ccccccccc
Q 016184 176 ---IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP---NVSYICSRY 249 (394)
Q Consensus 176 ---~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~~t~~ 249 (394)
....+++..+..++.||+.||+|||+ .||+||||||+|||++.++ .++|+|||++..+..... .....++..
T Consensus 163 ~~~~~~~l~~~~~~~~~~qi~~aL~~lH~-~~ivHrDikp~Nill~~~~-~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~ 240 (337)
T cd05054 163 DELYKEPLTLEDLISYSFQVARGMEFLAS-RKCIHRDLAARNILLSENN-VVKICDFGLARDIYKDPDYVRKGDARLPLK 240 (337)
T ss_pred hHHhhcCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCcceEEEeCCC-cEEEeccccchhcccCcchhhccCCCCCcc
Confidence 12368899999999999999999999 8999999999999999887 799999999986533221 122344677
Q ss_pred ccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCCCcccCCCCCCCCC
Q 016184 250 YRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHP 328 (394)
Q Consensus 250 y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 328 (394)
|+|||++.+. .++.++|||||||++|+|++ |..||.+....+.+.........+
T Consensus 241 y~aPE~~~~~-~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~------------------------ 295 (337)
T cd05054 241 WMAPESIFDK-VYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRM------------------------ 295 (337)
T ss_pred ccCcHHhcCC-CCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCC------------------------
Confidence 9999998655 48999999999999999998 999998755444333332211000
Q ss_pred cchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 016184 329 WHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH 365 (394)
Q Consensus 329 ~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 365 (394)
..+...++++.+++.+||+.+|++||++.++++|
T Consensus 296 ---~~~~~~~~~~~~l~~~cl~~~p~~RPs~~ell~~ 329 (337)
T cd05054 296 ---RAPEYATPEIYSIMLDCWHNNPEDRPTFSELVEI 329 (337)
T ss_pred ---CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 0123467899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-41 Score=308.10 Aligned_cols=280 Identities=33% Similarity=0.548 Sum_probs=226.5
Q ss_pred eeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccchhh---hHHHHHHHHHcCC------CCeeeeceEEEecCCCce
Q 016184 82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRY---KNRELQIMQMLDH------PNIVALKHCFFSTTDKEE 152 (394)
Q Consensus 82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~E~~~l~~l~h------~~iv~~~~~~~~~~~~~~ 152 (394)
.+|.+....|+|-|++|..|.+..-|..||||+|...... -.+|+++|++|+. -|++.++..| ...
T Consensus 432 ~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F-----~hk 506 (752)
T KOG0670|consen 432 SRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHF-----KHK 506 (752)
T ss_pred ceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHh-----hhc
Confidence 3699999999999999999999999999999999876543 3479999999953 4778887777 556
Q ss_pred eEEEEEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCc
Q 016184 153 LYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA 232 (394)
Q Consensus 153 ~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a 232 (394)
.++|||+|.+.-+|.++++.+.. ...+....++.|+.|+..||..|-. .||+|.||||+||||++..+.+||||||.|
T Consensus 507 nHLClVFE~LslNLRevLKKyG~-nvGL~ikaVRsYaqQLflALklLK~-c~vlHaDIKPDNiLVNE~k~iLKLCDfGSA 584 (752)
T KOG0670|consen 507 NHLCLVFEPLSLNLREVLKKYGR-NVGLHIKAVRSYAQQLFLALKLLKK-CGVLHADIKPDNILVNESKNILKLCDFGSA 584 (752)
T ss_pred ceeEEEehhhhchHHHHHHHhCc-ccceeehHHHHHHHHHHHHHHHHHh-cCeeecccCccceEeccCcceeeeccCccc
Confidence 67999999999999999988765 5678999999999999999999999 799999999999999988889999999999
Q ss_pred cccccCCCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhcc
Q 016184 233 KVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 312 (394)
Q Consensus 233 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 312 (394)
......+ ...+..+..|.|||++.|-+ |+...|+||+||+||||.||+..|+|.+...++...+.+-|..+...+...
T Consensus 585 ~~~~ene-itPYLVSRFYRaPEIiLG~~-yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlRKg 662 (752)
T KOG0670|consen 585 SFASENE-ITPYLVSRFYRAPEIILGLP-YDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLRKG 662 (752)
T ss_pred ccccccc-ccHHHHHHhccCcceeecCc-ccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhhhc
Confidence 8665443 44667788999999998765 999999999999999999999999999999999999999888887666422
Q ss_pred C-------C--CCccc------------CCCCCCCC-Ccchhc--cccCC-------hHHHHHHHHhcccCCCCCCCHHH
Q 016184 313 N-------P--NYTEF------------KFPQIKPH-PWHKVF--QKRLP-------PEAVDLVCRFFQYSPNLRCTALE 361 (394)
Q Consensus 313 ~-------~--~~~~~------------~~~~~~~~-~~~~~~--~~~~~-------~~~~~li~~~L~~dP~~Rpt~~e 361 (394)
. . ++-.. .+...++. .+...+ ...++ ..+++||.+||..||++|.|..+
T Consensus 663 qF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~nq 742 (752)
T KOG0670|consen 663 QFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITVNQ 742 (752)
T ss_pred chhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCHHH
Confidence 1 0 10000 01111110 011111 01122 35899999999999999999999
Q ss_pred HhcCCCCCC
Q 016184 362 ACVHPFFDE 370 (394)
Q Consensus 362 ll~hp~f~~ 370 (394)
+|.||||++
T Consensus 743 AL~HpFi~~ 751 (752)
T KOG0670|consen 743 ALKHPFITE 751 (752)
T ss_pred HhcCCcccC
Confidence 999999975
|
|
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-40 Score=296.62 Aligned_cols=244 Identities=33% Similarity=0.578 Sum_probs=196.5
Q ss_pred EeecCceEEEEEEECCCCcEEEEEEeccch-------hhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEEEEEEecc
Q 016184 90 VGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYV 162 (394)
Q Consensus 90 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~ 162 (394)
||.|+||.||+|++..+|+.+|+|++.... ....+|+++++.++|+||+++++.+ ......++++||+
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-----~~~~~~~lv~e~~ 75 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSF-----QGKKNLYLVMEYL 75 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHhe-----ecCcEEEEEEecC
Confidence 689999999999999899999999886432 2345688999999999999998877 3345578999999
Q ss_pred cc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCccccccCC--
Q 016184 163 PE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE-- 239 (394)
Q Consensus 163 ~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~~~-- 239 (394)
.+ +|.+++.. ...+++..++.++.||+.||.|||+ .|++|+||+|+||+++.++ .++|+|||++.......
T Consensus 76 ~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~L~~lH~-~~i~H~di~~~nil~~~~~-~~~l~dfg~~~~~~~~~~~ 149 (265)
T cd05579 76 PGGDLASLLEN----VGSLDEDVARIYIAEIVLALEYLHS-NGIIHRDLKPDNILIDSNG-HLKLTDFGLSKVGLVRRQI 149 (265)
T ss_pred CCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-cCeecCCCCHHHeEEcCCC-CEEEEecccchhcccCccc
Confidence 75 77666654 2478999999999999999999999 8999999999999999888 79999999987553332
Q ss_pred -------CcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhcc
Q 016184 240 -------PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 312 (394)
Q Consensus 240 -------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 312 (394)
......++..|+|||.+.... .+.++|+||||+++|+|++|..||...........+... .
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~Pe~~~~~~-~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~--~--------- 217 (265)
T cd05579 150 NLNDDEKEDKRIVGTPDYIAPEVILGQG-HSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNG--K--------- 217 (265)
T ss_pred ccccccccccCcccCccccCHHHhcCCC-CCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC--C---------
Confidence 122345678899999986544 889999999999999999999999877655544443321 0
Q ss_pred CCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCH---HHHhcCCCCCCCC
Q 016184 313 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTA---LEACVHPFFDELR 372 (394)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~---~ell~hp~f~~~~ 372 (394)
...+. ...++..+.+||++||+.||.+|||+ .++|+||||+++.
T Consensus 218 ------~~~~~----------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~~~~~~~~ 264 (265)
T cd05579 218 ------IEWPE----------DVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFKGID 264 (265)
T ss_pred ------cCCCc----------cccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcCccccCCC
Confidence 00000 01248899999999999999999999 9999999998763
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-40 Score=304.81 Aligned_cols=244 Identities=23% Similarity=0.359 Sum_probs=189.6
Q ss_pred eeEEEeeEEeecCceEEEEEEECCCCcE----EEEEEeccc-----hhhhHHHHHHHHHcCCCCeeeeceEEEecCCCce
Q 016184 82 VSYIAEHVVGTGSFGVVFQAKCRETGEI----VAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE 152 (394)
Q Consensus 82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~----vaiK~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 152 (394)
.+|++.+.||+|+||.||+|++..+++. ||+|++... ...+.+|+.+++.++|+||+++++++...
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~----- 81 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS----- 81 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-----
Confidence 3599999999999999999998766654 899987532 23345689999999999999999987432
Q ss_pred eEEEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecC
Q 016184 153 LYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS 231 (394)
Q Consensus 153 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~ 231 (394)
..+++++|+.+ ++.+.+... ...++...+..++.||+.||+|||+ .||+||||||+|||++.++ .+||+|||+
T Consensus 82 -~~~~v~e~~~~g~l~~~l~~~---~~~~~~~~~~~~~~qi~~~L~~LH~-~~iiH~dlkp~Nill~~~~-~~kl~DfG~ 155 (316)
T cd05108 82 -TVQLITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLEE-RRLVHRDLAARNVLVKTPQ-HVKITDFGL 155 (316)
T ss_pred -CceeeeecCCCCCHHHHHHhc---cccCCHHHHHHHHHHHHHHHHHHHh-cCeeccccchhheEecCCC-cEEEccccc
Confidence 14578898874 666655532 2468888999999999999999999 8999999999999999887 699999999
Q ss_pred ccccccCCCcc---cccccccccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCChh
Q 016184 232 AKVLVKGEPNV---SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTRE 307 (394)
Q Consensus 232 a~~~~~~~~~~---~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~ 307 (394)
++......... ...++..|+|||.+.+. .++.++||||||+++|+|++ |..||.+....+ +..+.......
T Consensus 156 a~~~~~~~~~~~~~~~~~~~~y~apE~~~~~-~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~-~~~~~~~~~~~--- 230 (316)
T cd05108 156 AKLLGADEKEYHAEGGKVPIKWMALESILHR-IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-ISSILEKGERL--- 230 (316)
T ss_pred cccccCCCcceeccCCccceeecChHHhccC-CCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH-HHHHHhCCCCC---
Confidence 98664333221 12235679999998654 48999999999999999997 999997655433 23332211000
Q ss_pred hhhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 016184 308 EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH 365 (394)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 365 (394)
+ .+..++.++.+++.+||..||.+|||+.+++.+
T Consensus 231 --------------~----------~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~ 264 (316)
T cd05108 231 --------------P----------QPPICTIDVYMIMVKCWMIDADSRPKFRELIIE 264 (316)
T ss_pred --------------C----------CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 0 013467889999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=292.05 Aligned_cols=265 Identities=24% Similarity=0.345 Sum_probs=208.2
Q ss_pred EEEeeEEeecCceEEEEEEECCCCcEEEEEEeccchh-----hhHHHHHH-HHHcCCCCeeeeceEEEecCCCceeEEEE
Q 016184 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-----YKNRELQI-MQMLDHPNIVALKHCFFSTTDKEELYLNL 157 (394)
Q Consensus 84 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-----~~~~E~~~-l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 157 (394)
.+-+..||.|+||+|++..++.+|+..|||.++.... .+..|.+. ++.-+.||||++++..+...+ .+|
T Consensus 66 Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGd-----cWi 140 (361)
T KOG1006|consen 66 LQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGD-----CWI 140 (361)
T ss_pred HHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCc-----eee
Confidence 4445679999999999999999999999999865332 23345544 334478999999999876665 788
Q ss_pred EEecccccHHHHHH-HhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCccccc
Q 016184 158 VLEYVPETVNRIAR-NYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV 236 (394)
Q Consensus 158 v~e~~~~~l~~~~~-~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~ 236 (394)
-||+|.-++..+-+ .+.-....+++..+-.+....+.||.||-+...|+|||+||+|||++..| .|||||||.+..+.
T Consensus 141 CMELMd~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G-~vKLCDFGIcGqLv 219 (361)
T KOG1006|consen 141 CMELMDISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHG-DVKLCDFGICGQLV 219 (361)
T ss_pred eHHHHhhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCC-CEeeecccchHhHH
Confidence 99999977765533 23344578999999999999999999998878999999999999999998 69999999997776
Q ss_pred cCCCcccccccccccccccccCCCC-CCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHh-CCCChhhhhccCC
Q 016184 237 KGEPNVSYICSRYYRAPELIFGATE-YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVL-GTPTREEIKCMNP 314 (394)
Q Consensus 237 ~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~ 314 (394)
..-......|...|||||.+..... |+.++|+||||++|||+.||..||.+.+. .+.++.+.. |.|+.-....
T Consensus 220 ~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s--vfeql~~Vv~gdpp~l~~~~--- 294 (361)
T KOG1006|consen 220 DSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS--VFEQLCQVVIGDPPILLFDK--- 294 (361)
T ss_pred HHHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH--HHHHHHHHHcCCCCeecCcc---
Confidence 6555566778899999999965444 89999999999999999999999977543 333333332 3333211110
Q ss_pred CCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCCC
Q 016184 315 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTR 377 (394)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~~ 377 (394)
-.-+++..+..+|..||.+|-+.||...+|++|||++........
T Consensus 295 ------------------~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~y~~~~~~ 339 (361)
T KOG1006|consen 295 ------------------ECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKFPFYRMYAVEGPD 339 (361)
T ss_pred ------------------cccccCHHHHHHHHHHhhcccccCcchhhhhcCchhhhhhhcCCc
Confidence 012478899999999999999999999999999999987655544
|
|
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-40 Score=298.53 Aligned_cols=245 Identities=33% Similarity=0.587 Sum_probs=200.8
Q ss_pred eEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccc-------hhhhHHHHHHHHHcC-CCCeeeeceEEEecCCCceeE
Q 016184 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLD-HPNIVALKHCFFSTTDKEELY 154 (394)
Q Consensus 83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~ 154 (394)
+|.+.+.||.|+||.||+|.+..+|+.||+|++... .....+|.++++.+. |+||+++++++ .....
T Consensus 2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~-----~~~~~ 76 (280)
T cd05581 2 DFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTF-----QDEEN 76 (280)
T ss_pred CceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHh-----cCCce
Confidence 599999999999999999999999999999988642 233456889999998 99999999887 33345
Q ss_pred EEEEEeccc-ccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCcc
Q 016184 155 LNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK 233 (394)
Q Consensus 155 ~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~ 233 (394)
.+++||++. ++|.+++.. ...+++..++.++.|++.||.+||+ .|++|+||+|+||+++.++ .++|+|||++.
T Consensus 77 ~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~ql~~~l~~Lh~-~~~~H~dl~~~ni~i~~~~-~~~l~df~~~~ 150 (280)
T cd05581 77 LYFVLEYAPNGELLQYIRK----YGSLDEKCTRFYAAEILLALEYLHS-KGIIHRDLKPENILLDKDM-HIKITDFGTAK 150 (280)
T ss_pred EEEEEcCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCCHHHeEECCCC-CEEecCCcccc
Confidence 789999995 577766654 3479999999999999999999999 8999999999999999888 69999999987
Q ss_pred ccccCCC---------------------cccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHH
Q 016184 234 VLVKGEP---------------------NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVD 292 (394)
Q Consensus 234 ~~~~~~~---------------------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~ 292 (394)
....... .....++..|+|||.+... .++.++|+||||+++|++++|+.||.......
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~ 229 (280)
T cd05581 151 VLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEK-PAGKSSDLWALGCIIYQMLTGKPPFRGSNEYL 229 (280)
T ss_pred ccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCC-CCChhhhHHHHHHHHHHHHhCCCCCCCccHHH
Confidence 5533221 1223467889999998654 48899999999999999999999998777555
Q ss_pred HHHHHHHHhCCCChhhhhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCH----HHHhcCCCC
Q 016184 293 QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTA----LEACVHPFF 368 (394)
Q Consensus 293 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~----~ell~hp~f 368 (394)
.+..+.... . .++..+++.+.+||.+||+.||.+|||+ +++++||||
T Consensus 230 ~~~~~~~~~-----------------~------------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~ 280 (280)
T cd05581 230 TFQKILKLE-----------------Y------------SFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280 (280)
T ss_pred HHHHHHhcC-----------------C------------CCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence 444443210 0 1124568899999999999999999999 999999998
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-40 Score=303.33 Aligned_cols=254 Identities=27% Similarity=0.416 Sum_probs=203.2
Q ss_pred eEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccc-------hhhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEE
Q 016184 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL 155 (394)
Q Consensus 83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 155 (394)
.|...+.||+|+||.||+|++..+++.+|+|.+... .....+|+++++.++|+|++++.+++.. ....
T Consensus 16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~ 90 (308)
T cd06634 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR-----EHTA 90 (308)
T ss_pred HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEc-----CCee
Confidence 488889999999999999999999999999987532 1123468999999999999999998843 2347
Q ss_pred EEEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCcccc
Q 016184 156 NLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL 235 (394)
Q Consensus 156 ~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~ 235 (394)
++||||+.+++..++... ...+++..+..++.|++.||.|||+ .|++|+||||+||+++.++ .++|+|||++...
T Consensus 91 ~lv~e~~~~~l~~~~~~~---~~~l~~~~~~~~~~~l~~~l~~LH~-~~i~H~dl~p~nil~~~~~-~~kl~dfg~~~~~ 165 (308)
T cd06634 91 WLVMEYCLGSASDLLEVH---KKPLQEVEIAAVTHGALQGLAYLHS-HNMIHRDVKAGNILLSEPG-LVKLGDFGSASIM 165 (308)
T ss_pred EEEEEccCCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHhEEECCCC-cEEECCcccceee
Confidence 799999998876665432 3568899999999999999999999 8999999999999999887 7999999998754
Q ss_pred ccCCCcccccccccccccccccC--CCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccC
Q 016184 236 VKGEPNVSYICSRYYRAPELIFG--ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 313 (394)
Q Consensus 236 ~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 313 (394)
... ....+++.|+|||.+.+ ...++.++|||||||++|+|++|..||...+..+....+..... +
T Consensus 166 ~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~-~--------- 232 (308)
T cd06634 166 APA---NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNES-P--------- 232 (308)
T ss_pred cCc---ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCC-C---------
Confidence 322 23467888999999742 23478899999999999999999999977655444443332100 0
Q ss_pred CCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCC
Q 016184 314 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNT 376 (394)
Q Consensus 314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~ 376 (394)
......++..+.+||++||+.+|.+||+++++++|||+.....++.
T Consensus 233 -----------------~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~~~~~~~ 278 (308)
T cd06634 233 -----------------ALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPTV 278 (308)
T ss_pred -----------------CcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCccccccCChhH
Confidence 0011356888999999999999999999999999999998765544
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-40 Score=299.85 Aligned_cols=247 Identities=23% Similarity=0.348 Sum_probs=195.2
Q ss_pred eeEEEeeEEeecCceEEEEEEECC-----CCcEEEEEEeccc-----hhhhHHHHHHHHHcCCCCeeeeceEEEecCCCc
Q 016184 82 VSYIAEHVVGTGSFGVVFQAKCRE-----TGEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKE 151 (394)
Q Consensus 82 ~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 151 (394)
.+|.+.+.||+|+||.||+|.+.. +++.||+|.+... ...+.+|+++++.+.|+||+++++++...
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~---- 80 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEG---- 80 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecC----
Confidence 459999999999999999998743 3578999988643 23456799999999999999999988433
Q ss_pred eeEEEEEEecccc-cHHHHHHHhh----------hhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCC
Q 016184 152 ELYLNLVLEYVPE-TVNRIARNYS----------RIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPH 220 (394)
Q Consensus 152 ~~~~~lv~e~~~~-~l~~~~~~~~----------~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~ 220 (394)
...+++|||+++ +|.+++.... .....+++..+..++.|++.||.|||+ +|++||||||+||+++.+
T Consensus 81 -~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~-~~i~h~dlkp~nili~~~ 158 (280)
T cd05049 81 -DPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLAS-QHFVHRDLATRNCLVGYD 158 (280)
T ss_pred -CCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhh-CCeeccccccceEEEcCC
Confidence 447899999985 7777665431 123457888999999999999999999 899999999999999988
Q ss_pred CCcEEEEeecCccccccCCC---cccccccccccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHH
Q 016184 221 THQLKLCDFGSAKVLVKGEP---NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVE 296 (394)
Q Consensus 221 ~~~vkl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~ 296 (394)
+ .++|+|||++........ .....+++.|+|||++.+. .++.++|||||||++|+|++ |..||...+..+....
T Consensus 159 ~-~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~ 236 (280)
T cd05049 159 L-VVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYR-KFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIEC 236 (280)
T ss_pred C-eEEECCcccceecccCcceecCCCCcccceecChhhhccC-CcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Confidence 7 799999999875432221 1233456789999998654 48999999999999999998 9999987766554444
Q ss_pred HHHHhCCCChhhhhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 016184 297 IIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV 364 (394)
Q Consensus 297 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 364 (394)
+.... .. ..+..++..+.+|+++||+.||++|||+.|+++
T Consensus 237 ~~~~~--~~--------------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 276 (280)
T cd05049 237 ITQGR--LL--------------------------QRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHE 276 (280)
T ss_pred HHcCC--cC--------------------------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 33210 00 011357889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=296.67 Aligned_cols=249 Identities=20% Similarity=0.280 Sum_probs=191.8
Q ss_pred ceeEEEeeEEeecCceEEEEEEECC-----CCcEEEEEEeccch-----hhhHHHHHHHHHcCCCCeeeeceEEEecCCC
Q 016184 81 KVSYIAEHVVGTGSFGVVFQAKCRE-----TGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDK 150 (394)
Q Consensus 81 ~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 150 (394)
.++|++.+.||+|+||.||+|.+.. ++..||+|++.... ..+.+|+.+++.++|+||+++++++ .
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~-----~ 79 (277)
T cd05062 5 REKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVV-----S 79 (277)
T ss_pred HHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEE-----c
Confidence 4569999999999999999998752 35679999875422 2345789999999999999999887 3
Q ss_pred ceeEEEEEEecccc-cHHHHHHHhhhh------cCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCc
Q 016184 151 EELYLNLVLEYVPE-TVNRIARNYSRI------HQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQ 223 (394)
Q Consensus 151 ~~~~~~lv~e~~~~-~l~~~~~~~~~~------~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~ 223 (394)
.....++||||+++ +|.+++...... ...+++..+..++.|++.||.|||+ .|++|+||||+||+++.++ .
T Consensus 80 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~-~~~vH~dlkp~Nil~~~~~-~ 157 (277)
T cd05062 80 QGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNA-NKFVHRDLAARNCMVAEDF-T 157 (277)
T ss_pred CCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCcchheEEEcCCC-C
Confidence 33347899999985 777766543211 1345778888999999999999999 8999999999999999887 6
Q ss_pred EEEEeecCccccccCCC---cccccccccccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHH
Q 016184 224 LKLCDFGSAKVLVKGEP---NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIK 299 (394)
Q Consensus 224 vkl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~ 299 (394)
++|+|||++........ .....+++.|+|||++.+. .++.++|||||||++|+|++ |..||.+.........+..
T Consensus 158 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~ 236 (277)
T cd05062 158 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDG-VFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVME 236 (277)
T ss_pred EEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcC-CcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc
Confidence 99999999875433221 1122346789999998654 48999999999999999999 7899987665444433322
Q ss_pred HhCCCChhhhhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 016184 300 VLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH 365 (394)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 365 (394)
.. .+ .++..++..+.+++.+||+.||++|||+.+++++
T Consensus 237 ~~-~~---------------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 274 (277)
T cd05062 237 GG-LL---------------------------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 274 (277)
T ss_pred CC-cC---------------------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 10 00 0123568899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=327.12 Aligned_cols=248 Identities=23% Similarity=0.366 Sum_probs=191.4
Q ss_pred eeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccc-------hhhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeE
Q 016184 82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY 154 (394)
Q Consensus 82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 154 (394)
++|++.++||+|+||.||+|++..+|+.||||++... .....+|+++++.++||||+++++++. ....
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~-----d~~~ 76 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICS-----DGDP 76 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEe-----eCCE
Confidence 3599999999999999999999999999999988643 123457999999999999999999873 3345
Q ss_pred EEEEEecccc-cHHHHHHHhhh-------hcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEE
Q 016184 155 LNLVLEYVPE-TVNRIARNYSR-------IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKL 226 (394)
Q Consensus 155 ~~lv~e~~~~-~l~~~~~~~~~-------~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl 226 (394)
.+++|||+++ +|.+++..... ....++...+..++.||+.||+|||+ .||+||||||+|||++.++ .++|
T Consensus 77 lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs-~GIIHRDLKPeNILLd~dg-~vKL 154 (932)
T PRK13184 77 VYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHS-KGVLHRDLKPDNILLGLFG-EVVI 154 (932)
T ss_pred EEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHH-CCccccCCchheEEEcCCC-CEEE
Confidence 7899999985 77777664321 12345667788999999999999999 8999999999999999888 6999
Q ss_pred EeecCccccccCC-------------------CcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCC
Q 016184 227 CDFGSAKVLVKGE-------------------PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPG 287 (394)
Q Consensus 227 ~Dfg~a~~~~~~~-------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~ 287 (394)
+|||++....... ......||+.|+|||++.+. .++.++|||||||++|+|+||+.||..
T Consensus 155 iDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~-~~S~kSDIWSLGVILyELLTG~~PF~~ 233 (932)
T PRK13184 155 LDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGV-PASESTDIYALGVILYQMLTLSFPYRR 233 (932)
T ss_pred EecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCC-CCCcHhHHHHHHHHHHHHHHCCCCCCC
Confidence 9999997652110 01124689999999998655 489999999999999999999999977
Q ss_pred CCcHHHHHHHHHHhCCCChhhhhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHh
Q 016184 288 ESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEAC 363 (394)
Q Consensus 288 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell 363 (394)
......... .....+. . . .+ ...+++.+.+++.+||+.||++|++..+.+
T Consensus 234 ~~~~ki~~~--~~i~~P~-~-------------~-----~p-----~~~iP~~L~~LI~rcL~~DP~kR~ss~eeL 283 (932)
T PRK13184 234 KKGRKISYR--DVILSPI-E-------------V-----AP-----YREIPPFLSQIAMKALAVDPAERYSSVQEL 283 (932)
T ss_pred cchhhhhhh--hhccChh-h-------------c-----cc-----cccCCHHHHHHHHHHccCChhhCcCHHHHH
Confidence 543322111 1000000 0 0 00 135788999999999999999998765544
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-40 Score=295.10 Aligned_cols=249 Identities=24% Similarity=0.429 Sum_probs=197.1
Q ss_pred eEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccc---------hhhhHHHHHHHHHcCCCCeeeeceEEEecCCCcee
Q 016184 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD---------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL 153 (394)
Q Consensus 83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 153 (394)
+|.+.+.||+|+||.||++++...+..+++|++... .....+|+.+++.++||||+++++++.. ..
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~ 75 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLE-----RD 75 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhc-----CC
Confidence 489999999999999999999877777777765421 1223468889999999999999988732 23
Q ss_pred EEEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCc
Q 016184 154 YLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA 232 (394)
Q Consensus 154 ~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a 232 (394)
..++++||+++ ++..++.........+++..++.++.|++.||.|||+ .|++|+||||+||+++. + .++|+|||.+
T Consensus 76 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~-~~i~h~~l~~~nili~~-~-~~~l~d~g~~ 152 (260)
T cd08222 76 AFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQ-RRILHRDLKAKNIFLKN-N-LLKIGDFGVS 152 (260)
T ss_pred ceEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHH-cCccccCCChhheEeec-C-CEeecccCce
Confidence 47799999985 7777776655556789999999999999999999999 89999999999999985 4 5999999998
Q ss_pred cccccCCC-cccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhc
Q 016184 233 KVLVKGEP-NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 311 (394)
Q Consensus 233 ~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 311 (394)
........ .....+++.|+|||.+.+. .++.++|+||||+++|+|++|..||...........+... ..+
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~--~~~------ 223 (260)
T cd08222 153 RLLMGSCDLATTFTGTPYYMSPEALKHQ-GYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEG--PTP------ 223 (260)
T ss_pred eecCCCcccccCCCCCcCccCHHHHccC-CCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHcC--CCC------
Confidence 76543322 2234578889999998544 4788999999999999999999999765544333332210 000
Q ss_pred cCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 016184 312 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368 (394)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f 368 (394)
.++..++.++.++|.+||..||++||++.++++||||
T Consensus 224 --------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 260 (260)
T cd08222 224 --------------------SLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRNPFI 260 (260)
T ss_pred --------------------CCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhCCCC
Confidence 0124578899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-40 Score=302.36 Aligned_cols=248 Identities=23% Similarity=0.326 Sum_probs=190.5
Q ss_pred eeEEEeeEEeecCceEEEEEEECCCCcE--EEEEEeccc-----hhhhHHHHHHHHHc-CCCCeeeeceEEEecCCCcee
Q 016184 82 VSYIAEHVVGTGSFGVVFQAKCRETGEI--VAIKKVLQD-----KRYKNRELQIMQML-DHPNIVALKHCFFSTTDKEEL 153 (394)
Q Consensus 82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~--vaiK~~~~~-----~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~ 153 (394)
++|++.+.||+|+||.||+|.+..++.. +|+|.+... ...+.+|++++.++ +|+||+++++++ ....
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~-----~~~~ 81 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGAC-----EHRG 81 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEE-----CCCC
Confidence 4699999999999999999999877754 577765432 22345799999999 899999999987 3334
Q ss_pred EEEEEEeccc-ccHHHHHHHhhh------------hcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCC
Q 016184 154 YLNLVLEYVP-ETVNRIARNYSR------------IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPH 220 (394)
Q Consensus 154 ~~~lv~e~~~-~~l~~~~~~~~~------------~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~ 220 (394)
+.+++|||++ ++|.+++..... ....+++..++.++.|++.||+|||+ +|++||||||+|||++.+
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~-~gi~H~dlkp~Nili~~~ 160 (303)
T cd05088 82 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ-KQFIHRDLAARNILVGEN 160 (303)
T ss_pred CceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHh-CCccccccchheEEecCC
Confidence 5789999997 477777654321 12358899999999999999999999 899999999999999988
Q ss_pred CCcEEEEeecCccccccCCCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHH
Q 016184 221 THQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIK 299 (394)
Q Consensus 221 ~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~ 299 (394)
+ .+||+|||++..............+..|+|||.+.+. .++.++|||||||++|+|+| |..||.+.+..+....+..
T Consensus 161 ~-~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~ 238 (303)
T cd05088 161 Y-VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYS-VYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ 238 (303)
T ss_pred C-cEEeCccccCcccchhhhcccCCCcccccCHHHHhcc-CCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHhc
Confidence 7 7999999998643211111122335679999988544 48899999999999999998 9999977655443332211
Q ss_pred HhCCCChhhhhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 016184 300 VLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH 365 (394)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 365 (394)
.. .. ..+..+++++.+||.+||+.||++||++++++.+
T Consensus 239 ~~------------------~~----------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 276 (303)
T cd05088 239 GY------------------RL----------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 276 (303)
T ss_pred CC------------------cC----------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 00 00 0113467899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=297.65 Aligned_cols=248 Identities=24% Similarity=0.351 Sum_probs=194.0
Q ss_pred ceeEEEeeEEeecCceEEEEEEEC-----CCCcEEEEEEeccch----hhhHHHHHHHHHcCCCCeeeeceEEEecCCCc
Q 016184 81 KVSYIAEHVVGTGSFGVVFQAKCR-----ETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKE 151 (394)
Q Consensus 81 ~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 151 (394)
+.+|.+.+.||+|+||.||++.+. .++..+|+|.+.... ....+|+++++.++|+||+++++++. .
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~ 78 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCV-----E 78 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEe-----c
Confidence 346999999999999999999852 345679999876432 23567999999999999999999873 3
Q ss_pred eeEEEEEEeccc-ccHHHHHHHhhh---------hcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCC
Q 016184 152 ELYLNLVLEYVP-ETVNRIARNYSR---------IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHT 221 (394)
Q Consensus 152 ~~~~~lv~e~~~-~~l~~~~~~~~~---------~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~ 221 (394)
..+.+++|||++ ++|.+++..... ....+++..++.++.|++.||+|||+ +|++||||||+|||++.++
T Consensus 79 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~-~~i~H~dlkp~Nili~~~~ 157 (288)
T cd05093 79 GDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLAS-QHFVHRDLATRNCLVGENL 157 (288)
T ss_pred CCccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeecccCcceEEEccCC
Confidence 345789999998 477776654321 12358999999999999999999999 8999999999999999887
Q ss_pred CcEEEEeecCccccccCCC---cccccccccccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHH
Q 016184 222 HQLKLCDFGSAKVLVKGEP---NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEI 297 (394)
Q Consensus 222 ~~vkl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i 297 (394)
.++|+|||++........ .....++..|+|||.+.+. .++.++|+|||||++|+|++ |..||......+.+..+
T Consensus 158 -~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i 235 (288)
T cd05093 158 -LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYR-KFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECI 235 (288)
T ss_pred -cEEeccCCccccccCCceeecCCCCCccccccCHHHhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 699999999875533221 1123346789999998654 48999999999999999998 89999877655544444
Q ss_pred HHHhCCCChhhhhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 016184 298 IKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV 364 (394)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 364 (394)
.... .. .....++.++.+|+.+||+.||.+|||+.+++.
T Consensus 236 ~~~~--~~--------------------------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~ 274 (288)
T cd05093 236 TQGR--VL--------------------------QRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHS 274 (288)
T ss_pred HcCC--cC--------------------------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 3210 00 011346889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=292.56 Aligned_cols=245 Identities=24% Similarity=0.330 Sum_probs=193.3
Q ss_pred ceeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccch---hhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEEEE
Q 016184 81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL 157 (394)
Q Consensus 81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 157 (394)
..+|++.++||+|+||.||+|.+. ++..||+|.+.... ....+|+.+++.++|+||+++++++ ......++
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~l 78 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVV-----TKEEPIYI 78 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCCchhHHHHHHHHHHHHhCCCCCeeeEEEEE-----cCCCCcEE
Confidence 346999999999999999999974 56779999876432 3455799999999999999998887 23344789
Q ss_pred EEeccc-ccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCccccc
Q 016184 158 VLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV 236 (394)
Q Consensus 158 v~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~ 236 (394)
+|||++ +++.+++... ....+++..+..++.|++.||+|||+ .|++|+||||+||+++.++ .++|+|||++....
T Consensus 79 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~~l~~~l~~LH~-~~i~H~dl~p~nili~~~~-~~~l~dfg~~~~~~ 154 (261)
T cd05072 79 ITEYMAKGSLLDFLKSD--EGGKVLLPKLIDFSAQIAEGMAYIER-KNYIHRDLRAANVLVSESL-MCKIADFGLARVIE 154 (261)
T ss_pred EEecCCCCcHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccccchhhEEecCCC-cEEECCCccceecC
Confidence 999997 4777766542 23568888999999999999999999 8999999999999999887 79999999997654
Q ss_pred cCCCc--ccccccccccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCChhhhhccC
Q 016184 237 KGEPN--VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 313 (394)
Q Consensus 237 ~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 313 (394)
..... ....++..|+|||.+.+. .++.++|||||||++|+|++ |..||...........+.....
T Consensus 155 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~----------- 222 (261)
T cd05072 155 DNEYTAREGAKFPIKWTAPEAINFG-SFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYR----------- 222 (261)
T ss_pred CCceeccCCCccceecCCHHHhccC-CCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCC-----------
Confidence 32211 122346679999998554 48899999999999999998 9999987665554444332110
Q ss_pred CCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 016184 314 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV 364 (394)
Q Consensus 314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 364 (394)
.+ ....++.++.+++.+||..||++|||++++++
T Consensus 223 -------~~----------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 256 (261)
T cd05072 223 -------MP----------RMENCPDELYDIMKTCWKEKAEERPTFDYLQS 256 (261)
T ss_pred -------CC----------CCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 00 11347889999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=289.45 Aligned_cols=246 Identities=35% Similarity=0.586 Sum_probs=201.5
Q ss_pred eEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccch------hhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEEE
Q 016184 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN 156 (394)
Q Consensus 83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 156 (394)
+|++.+.||+|++|.||+|++..+++.||+|.+.... ....+|++++++++|+|++++++++. .....+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~ 75 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIE-----TSDSLY 75 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEE-----eCCEEE
Confidence 3889999999999999999999899999999886543 23457999999999999999998873 234578
Q ss_pred EEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCcccc
Q 016184 157 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL 235 (394)
Q Consensus 157 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~ 235 (394)
++|||+++ +|.+++.. ...+++..++.++.|++.||.+||+ .|++|+||||+||+++.++ .++|+|||.+...
T Consensus 76 ~v~e~~~~~~L~~~~~~----~~~l~~~~~~~~~~~i~~~l~~lH~-~~i~H~dl~p~ni~i~~~~-~~~l~d~~~~~~~ 149 (254)
T cd06627 76 IILEYAENGSLRQIIKK----FGPFPESLVAVYVYQVLQGLAYLHE-QGVIHRDIKAANILTTKDG-VVKLADFGVATKL 149 (254)
T ss_pred EEEecCCCCcHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHhh-CCcccCCCCHHHEEECCCC-CEEEeccccceec
Confidence 99999986 66665543 2678999999999999999999999 8999999999999999877 7999999999766
Q ss_pred ccCCC-cccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCC
Q 016184 236 VKGEP-NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 314 (394)
Q Consensus 236 ~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 314 (394)
..... .....++..|+|||.+.+.. ++.++|+||||+++|+|++|..||...........+....
T Consensus 150 ~~~~~~~~~~~~~~~y~~pe~~~~~~-~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~------------- 215 (254)
T cd06627 150 NDVSKDDASVVGTPYWMAPEVIEMSG-ASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDD------------- 215 (254)
T ss_pred CCCcccccccccchhhcCHhhhcCCC-CCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccC-------------
Confidence 44332 23346788899999986554 8899999999999999999999998766443333322100
Q ss_pred CCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 016184 315 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368 (394)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f 368 (394)
...++..++..+.++|.+||..+|++|||+.++++||||
T Consensus 216 ---------------~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~~ 254 (254)
T cd06627 216 ---------------HPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLKHPWI 254 (254)
T ss_pred ---------------CCCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhcCCCC
Confidence 001224578899999999999999999999999999998
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=291.44 Aligned_cols=242 Identities=22% Similarity=0.321 Sum_probs=191.8
Q ss_pred eEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccc---hhhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEEEEEE
Q 016184 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD---KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVL 159 (394)
Q Consensus 83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~ 159 (394)
.|++.+.||+|+||.||+|..+ ++..+|+|.+... .....+|+.+++.++||||+++++++. .....+++|
T Consensus 5 ~~~~~~~lg~G~~~~vy~~~~~-~~~~~a~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~iv~ 78 (256)
T cd05114 5 ELTFMKELGSGQFGVVHLGKWR-AQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCT-----QQKPLYIVT 78 (256)
T ss_pred HcEEeeEecCCcCceEEEEEec-cCceEEEEecccCCccHHHHHHHHHHHHHCCCCCceeEEEEEc-----cCCCEEEEE
Confidence 4899999999999999999885 4567999987643 234567999999999999999999873 333478999
Q ss_pred ecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCccccccC
Q 016184 160 EYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG 238 (394)
Q Consensus 160 e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~~ 238 (394)
||+++ +|.+.+... ...+++..++.++.|++.||+|||+ +||+|+||||+||+++.++ .+||+|||.++.....
T Consensus 79 e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dl~p~ni~i~~~~-~~kl~d~g~~~~~~~~ 153 (256)
T cd05114 79 EFMENGCLLNYLRQR---QGKLSKDMLLSMCQDVCEGMEYLER-NSFIHRDLAARNCLVSSTG-VVKVSDFGMTRYVLDD 153 (256)
T ss_pred EcCCCCcHHHHHHhC---ccCCCHHHHHHHHHHHHHHHHHHHH-CCccccccCcceEEEcCCC-eEEECCCCCccccCCC
Confidence 99974 676655431 2458899999999999999999999 8999999999999999887 7999999998765332
Q ss_pred CCcc--cccccccccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCC
Q 016184 239 EPNV--SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 315 (394)
Q Consensus 239 ~~~~--~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 315 (394)
.... ...++..|+|||.+.+. .++.++|+||||+++|+|++ |+.||...+..+.+..+.+....
T Consensus 154 ~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~------------ 220 (256)
T cd05114 154 EYTSSSGAKFPVKWSPPEVFNFS-KYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRL------------ 220 (256)
T ss_pred ceeccCCCCCchhhCChhhcccC-ccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCC------------
Confidence 2211 22345679999998644 48999999999999999999 89999877766555554331100
Q ss_pred CcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 016184 316 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV 364 (394)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 364 (394)
..+...+..+.+|+.+||+.||.+|||++++++
T Consensus 221 ----------------~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~ 253 (256)
T cd05114 221 ----------------YRPKLASMTVYEVMYSCWHEKPEGRPTFAELLR 253 (256)
T ss_pred ----------------CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 011235778999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=299.51 Aligned_cols=247 Identities=22% Similarity=0.298 Sum_probs=190.5
Q ss_pred eEEEeeEEeecCceEEEEEEECCCCc--EEEEEEeccc-----hhhhHHHHHHHHHc-CCCCeeeeceEEEecCCCceeE
Q 016184 83 SYIAEHVVGTGSFGVVFQAKCRETGE--IVAIKKVLQD-----KRYKNRELQIMQML-DHPNIVALKHCFFSTTDKEELY 154 (394)
Q Consensus 83 ~y~~~~~lg~G~~g~V~~~~~~~~~~--~vaiK~~~~~-----~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~ 154 (394)
+|++.++||+|+||.||+|....++. .+++|.+... ...+.+|+++++++ .||||+++++++. ....
T Consensus 3 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~-----~~~~ 77 (297)
T cd05089 3 DIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACE-----NRGY 77 (297)
T ss_pred cceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEc-----cCCc
Confidence 59999999999999999999877765 4688877532 12355799999999 7999999999873 3334
Q ss_pred EEEEEeccc-ccHHHHHHHhhh------------hcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCC
Q 016184 155 LNLVLEYVP-ETVNRIARNYSR------------IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHT 221 (394)
Q Consensus 155 ~~lv~e~~~-~~l~~~~~~~~~------------~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~ 221 (394)
.+++|||++ ++|.+++..... ....+++..++.++.|++.||+|||+ +||+||||||+|||++.++
T Consensus 78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~-~~ivH~dlkp~Nill~~~~ 156 (297)
T cd05089 78 LYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSE-KQFIHRDLAARNVLVGENL 156 (297)
T ss_pred ceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCcCCcceEEECCCC
Confidence 789999997 477777654221 12358899999999999999999999 8999999999999999887
Q ss_pred CcEEEEeecCccccccCCCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHH
Q 016184 222 HQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKV 300 (394)
Q Consensus 222 ~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~ 300 (394)
.+||+|||++..............+..|+|||.+.+. .++.++|||||||++|+|++ |..||.+....+....+...
T Consensus 157 -~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~~ 234 (297)
T cd05089 157 -ASKIADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYS-VYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQG 234 (297)
T ss_pred -eEEECCcCCCccccceeccCCCCcCccccCchhhccC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcC
Confidence 6999999998643221111112234569999998544 48999999999999999997 99999877655544433221
Q ss_pred hCCCChhhhhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 016184 301 LGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH 365 (394)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 365 (394)
.. ...+..++..+.+||.+||+.||.+|||++++++.
T Consensus 235 ~~----------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~ 271 (297)
T cd05089 235 YR----------------------------MEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQ 271 (297)
T ss_pred CC----------------------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 00 00123578899999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=309.59 Aligned_cols=256 Identities=27% Similarity=0.415 Sum_probs=222.7
Q ss_pred eEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccch-------hhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEE
Q 016184 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL 155 (394)
Q Consensus 83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 155 (394)
+..++..||-|+||.|-++..+.....+|+|++++.. ...-.|..+|.....|.||+++..| .+..|+
T Consensus 421 dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTf-----rd~kyv 495 (732)
T KOG0614|consen 421 DLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTF-----RDSKYV 495 (732)
T ss_pred hhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHh-----ccchhh
Confidence 4667788999999999999987666668999876532 2233588999999999999999988 778889
Q ss_pred EEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCccc
Q 016184 156 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV 234 (394)
Q Consensus 156 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~ 234 (394)
||+||-|-| .+..+++. .+.+....++.++..++.|++|||+ +|||+|||||+|.+++.+| -+||.|||+|+.
T Consensus 496 YmLmEaClGGElWTiLrd----Rg~Fdd~tarF~~acv~EAfeYLH~-k~iIYRDLKPENllLd~~G-y~KLVDFGFAKk 569 (732)
T KOG0614|consen 496 YMLMEACLGGELWTILRD----RGSFDDYTARFYVACVLEAFEYLHR-KGIIYRDLKPENLLLDNRG-YLKLVDFGFAKK 569 (732)
T ss_pred hhhHHhhcCchhhhhhhh----cCCcccchhhhhHHHHHHHHHHHHh-cCceeccCChhheeeccCC-ceEEeehhhHHH
Confidence 999998765 66666654 4779999999999999999999999 9999999999999999998 699999999999
Q ss_pred cccCCCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCC
Q 016184 235 LVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 314 (394)
Q Consensus 235 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 314 (394)
+..+..+-+++|||.|.|||++.+.. .+.++|.||||+++|||++|.+||.+.+++..+..|.+.+
T Consensus 570 i~~g~KTwTFcGTpEYVAPEIILnKG-HD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGi------------- 635 (732)
T KOG0614|consen 570 IGSGRKTWTFCGTPEYVAPEIILNKG-HDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGI------------- 635 (732)
T ss_pred hccCCceeeecCCcccccchhhhccC-cchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhh-------------
Confidence 99999999999999999999997655 8999999999999999999999999999999998888754
Q ss_pred CCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCC-----HHHHhcCCCCCCCCCCCCC
Q 016184 315 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCT-----ALEACVHPFFDELRDPNTR 377 (394)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt-----~~ell~hp~f~~~~~~~~~ 377 (394)
..+. +++.++..+.+||+++-..+|.+|.. +.++.+|-||........+
T Consensus 636 --d~i~------------~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gfdweglr 689 (732)
T KOG0614|consen 636 --DKIE------------FPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFEGFDWEGLR 689 (732)
T ss_pred --hhhh------------cccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhhcCChhhhh
Confidence 2222 33678999999999999999999996 8899999999998666554
|
|
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=294.41 Aligned_cols=249 Identities=21% Similarity=0.291 Sum_probs=193.3
Q ss_pred eeEEEeeEEeecCceEEEEEEECC-----CCcEEEEEEeccch-----hhhHHHHHHHHHcCCCCeeeeceEEEecCCCc
Q 016184 82 VSYIAEHVVGTGSFGVVFQAKCRE-----TGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKE 151 (394)
Q Consensus 82 ~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 151 (394)
++|.+.+.||+|++|.||+|.+.. ++..||+|.+.... ..+.+|+.+++.++|+||+++++++...
T Consensus 6 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~---- 81 (277)
T cd05036 6 DSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFER---- 81 (277)
T ss_pred HHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccC----
Confidence 469999999999999999999976 67889999875322 2345689999999999999999987432
Q ss_pred eeEEEEEEeccc-ccHHHHHHHhhhh---cCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCC--CcEE
Q 016184 152 ELYLNLVLEYVP-ETVNRIARNYSRI---HQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHT--HQLK 225 (394)
Q Consensus 152 ~~~~~lv~e~~~-~~l~~~~~~~~~~---~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~--~~vk 225 (394)
...+++|||+. ++|.+++...... ...+++..+..++.||+.||+|||+ ++++|+||||+||+++.++ ..+|
T Consensus 82 -~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~-~~ivH~dlkp~nil~~~~~~~~~~k 159 (277)
T cd05036 82 -LPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEE-NHFIHRDIAARNCLLTCKGPGRVAK 159 (277)
T ss_pred -CCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCEeecccchheEEEeccCCCcceE
Confidence 23679999996 4777776653211 1358899999999999999999999 8999999999999998654 2599
Q ss_pred EEeecCccccccCCC---cccccccccccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHh
Q 016184 226 LCDFGSAKVLVKGEP---NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVL 301 (394)
Q Consensus 226 l~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~ 301 (394)
|+|||+++....... ......+..|+|||++.+.. ++.++|||||||++|+|++ |..||.+.+.......+...
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~- 237 (277)
T cd05036 160 IADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGI-FTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGG- 237 (277)
T ss_pred eccCccccccCCccceecCCCCCccHhhCCHHHHhcCC-cCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC-
Confidence 999999976532211 11222356799999986544 8999999999999999997 99999876655433322211
Q ss_pred CCCChhhhhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 016184 302 GTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH 365 (394)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 365 (394)
..+ ..+..++..+.+++.+||+.||++|||+.++++|
T Consensus 238 ~~~---------------------------~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~ 274 (277)
T cd05036 238 GRL---------------------------DPPKGCPGPVYRIMTDCWQHTPEDRPNFATILER 274 (277)
T ss_pred CcC---------------------------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 000 0124578899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=319.07 Aligned_cols=290 Identities=21% Similarity=0.258 Sum_probs=186.8
Q ss_pred ccceeEEEeeEEeecCceEEEEEEECCC----CcEEEEEEeccchhhhHHHHHHH---HHcCCCCeeeeceEEEecC-CC
Q 016184 79 KQKVSYIAEHVVGTGSFGVVFQAKCRET----GEIVAIKKVLQDKRYKNRELQIM---QMLDHPNIVALKHCFFSTT-DK 150 (394)
Q Consensus 79 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~----~~~vaiK~~~~~~~~~~~E~~~l---~~l~h~~iv~~~~~~~~~~-~~ 150 (394)
...++|.+.+.||+|+||.||+|++..+ +..||||++..... .|..+. +...+.++..+...+.... ..
T Consensus 129 ~~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~---~e~~~~e~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 129 FKKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA---VEIWMNERVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred CccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch---hHHHHHHHHHhhchhhHHHHHHhhhcccccc
Confidence 3556899999999999999999999988 89999998754321 222222 2222333333333222111 13
Q ss_pred ceeEEEEEEecccc-cHHHHHHHhhh----------------hcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCC
Q 016184 151 EELYLNLVLEYVPE-TVNRIARNYSR----------------IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQ 213 (394)
Q Consensus 151 ~~~~~~lv~e~~~~-~l~~~~~~~~~----------------~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~ 213 (394)
.....++|+||+++ +|.+++..... .........+..++.||+.||+|||+ .||+||||||+
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~-~gIiHRDLKP~ 284 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHS-TGIVHRDVKPQ 284 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHH-CCEEeCcCCHH
Confidence 34457799999985 67666653210 00112234567899999999999999 89999999999
Q ss_pred ceEEeCCCCcEEEEeecCccccccCC--CcccccccccccccccccCCC---------------------CCCChhhHHH
Q 016184 214 NLLVNPHTHQLKLCDFGSAKVLVKGE--PNVSYICSRYYRAPELIFGAT---------------------EYTTAIDIWS 270 (394)
Q Consensus 214 Nil~~~~~~~vkl~Dfg~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~---------------------~~~~~~Diws 270 (394)
|||++.+...+||+|||+|+...... ......+++.|+|||.+.... .++.++||||
T Consensus 285 NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwS 364 (566)
T PLN03225 285 NIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYS 364 (566)
T ss_pred HEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHH
Confidence 99999654479999999997553322 223467799999999763211 2345679999
Q ss_pred HHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcc
Q 016184 271 TGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQ 350 (394)
Q Consensus 271 lG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~ 350 (394)
|||++|+|+++..++ ......+..+....+...........+... +... .... +.........+||++||+
T Consensus 365 lGviL~el~~~~~~~--~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~----~~~~--~~~~-~~d~~~~~~~dLi~~mL~ 435 (566)
T PLN03225 365 AGLIFLQMAFPNLRS--DSNLIQFNRQLKRNDYDLVAWRKLVEPRAS----PDLR--RGFE-VLDLDGGAGWELLKSMMR 435 (566)
T ss_pred HHHHHHHHHhCcCCC--chHHHHHHHHHHhcCCcHHHHHHhhccccc----hhhh--hhhh-hccccchHHHHHHHHHcc
Confidence 999999999976554 333334444444333322221111111000 0000 0000 012234567799999999
Q ss_pred cCCCCCCCHHHHhcCCCCCCCCCCCCCCCCC
Q 016184 351 YSPNLRCTALEACVHPFFDELRDPNTRLPNG 381 (394)
Q Consensus 351 ~dP~~Rpt~~ell~hp~f~~~~~~~~~~~~~ 381 (394)
.||++|||+.++|+||||++......+..+.
T Consensus 436 ~dP~kR~ta~e~L~Hpff~~~~~~~~~~~~~ 466 (566)
T PLN03225 436 FKGRQRISAKAALAHPYFDREGLLGLSVMQN 466 (566)
T ss_pred CCcccCCCHHHHhCCcCcCCCCccccccccc
Confidence 9999999999999999999876654444443
|
|
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=294.61 Aligned_cols=250 Identities=20% Similarity=0.262 Sum_probs=190.5
Q ss_pred EEeeEEeecCceEEEEEEECCCCc--EEEEEEeccc------hhhhHHHHHHHHHcCCCCeeeeceEEEecCC-CceeEE
Q 016184 85 IAEHVVGTGSFGVVFQAKCRETGE--IVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTD-KEELYL 155 (394)
Q Consensus 85 ~~~~~lg~G~~g~V~~~~~~~~~~--~vaiK~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~~~~~~ 155 (394)
.+.+.||+|+||.||+|.+..++. .||+|.+... .....+|+++++.++|+||+++++.++.... ......
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 81 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP 81 (272)
T ss_pred ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence 467889999999999999877765 5899987532 2334568999999999999999987754332 222346
Q ss_pred EEEEecccc-cHHHHHHHhh--hhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCc
Q 016184 156 NLVLEYVPE-TVNRIARNYS--RIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA 232 (394)
Q Consensus 156 ~lv~e~~~~-~l~~~~~~~~--~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a 232 (394)
+++|||+.+ ++.+.+.... .....+++..+..++.|++.||+|||+ +||+||||||+|||++.++ .++|+|||++
T Consensus 82 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dlkp~Nil~~~~~-~~kl~Dfg~~ 159 (272)
T cd05075 82 VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSS-KSFIHRDLAARNCMLNENM-NVCVADFGLS 159 (272)
T ss_pred EEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHH-CCeeccccchhheEEcCCC-CEEECCCCcc
Confidence 789999984 6666553322 122458899999999999999999999 8999999999999999887 6999999999
Q ss_pred cccccCCC---cccccccccccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCChhh
Q 016184 233 KVLVKGEP---NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREE 308 (394)
Q Consensus 233 ~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 308 (394)
+....... .....+++.|+|||.+.+. .++.++||||||+++|+|++ |+.||.+.........+.... .+
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~-~~---- 233 (272)
T cd05075 160 KKIYNGDYYRQGRIAKMPVKWIAIESLADR-VYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGN-RL---- 233 (272)
T ss_pred cccCcccceecCCcccCCcccCCHHHccCC-CcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC-CC----
Confidence 86543321 1122346789999998654 48999999999999999999 889998765544333332210 00
Q ss_pred hhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 016184 309 IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH 365 (394)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 365 (394)
.....++..+.++|.+||+.||++|||+.+++++
T Consensus 234 -----------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 267 (272)
T cd05075 234 -----------------------KQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCE 267 (272)
T ss_pred -----------------------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 0113567889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=307.96 Aligned_cols=249 Identities=24% Similarity=0.349 Sum_probs=191.4
Q ss_pred ceeEEEeeEEeecCceEEEEEEECCC-----CcEEEEEEeccch-----hhhHHHHHHHHHcC-CCCeeeeceEEEecCC
Q 016184 81 KVSYIAEHVVGTGSFGVVFQAKCRET-----GEIVAIKKVLQDK-----RYKNRELQIMQMLD-HPNIVALKHCFFSTTD 149 (394)
Q Consensus 81 ~~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~vaiK~~~~~~-----~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~ 149 (394)
..+|++.++||+|+||.||+|++... +..||||++.... ..+.+|+++++.+. ||||+++++++
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~----- 110 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGAC----- 110 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEE-----
Confidence 44699999999999999999987433 3469999886432 23457999999996 99999999988
Q ss_pred CceeEEEEEEecccc-cHHHHHHHhhh-----------------------------------------------------
Q 016184 150 KEELYLNLVLEYVPE-TVNRIARNYSR----------------------------------------------------- 175 (394)
Q Consensus 150 ~~~~~~~lv~e~~~~-~l~~~~~~~~~----------------------------------------------------- 175 (394)
......++||||+++ +|.+++.....
T Consensus 111 ~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (400)
T cd05105 111 TKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVP 190 (400)
T ss_pred ccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccch
Confidence 333457899999984 77666543211
Q ss_pred ---------------------------------------hcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceE
Q 016184 176 ---------------------------------------IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLL 216 (394)
Q Consensus 176 ---------------------------------------~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil 216 (394)
....+++..+..++.|++.||.|||+ .+|+||||||+|||
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~-~~ivH~dikp~Nil 269 (400)
T cd05105 191 MLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLAS-KNCVHRDLAARNVL 269 (400)
T ss_pred hhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHh-CCeeCCCCChHhEE
Confidence 11347888889999999999999999 89999999999999
Q ss_pred EeCCCCcEEEEeecCccccccCCC---cccccccccccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHH
Q 016184 217 VNPHTHQLKLCDFGSAKVLVKGEP---NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVD 292 (394)
Q Consensus 217 ~~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~ 292 (394)
++.++ .+||+|||+++....... .....+++.|+|||.+.+. .++.++|||||||++|+|++ |..||.......
T Consensus 270 l~~~~-~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~ 347 (400)
T cd05105 270 LAQGK-IVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDN-LYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDS 347 (400)
T ss_pred EeCCC-EEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCC-CCCchhhHHHHHHHHHHHHHCCCCCCcccchhH
Confidence 99887 799999999876533221 1233456789999998654 48999999999999999997 999998754443
Q ss_pred HHHHHHHHhCCCChhhhhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 016184 293 QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV 364 (394)
Q Consensus 293 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 364 (394)
.+.........+ ..+..++.++.+++.+||+.||++|||+.++.+
T Consensus 348 ~~~~~~~~~~~~---------------------------~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~ 392 (400)
T cd05105 348 TFYNKIKSGYRM---------------------------AKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSD 392 (400)
T ss_pred HHHHHHhcCCCC---------------------------CCCccCCHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence 333322211000 012357889999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=291.08 Aligned_cols=244 Identities=22% Similarity=0.304 Sum_probs=193.1
Q ss_pred eeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccch---hhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEEEEE
Q 016184 82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLV 158 (394)
Q Consensus 82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv 158 (394)
.+|++.+.||+|++|.||+|.+. +++.||+|.+.... ....+|+.+++.++|+||+++++++. .....+++
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~lv 79 (261)
T cd05068 6 TSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCT-----LEEPIYIV 79 (261)
T ss_pred hheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCcccHHHHHHHHHHHHHCCCCCccceeEEEe-----cCCCeeee
Confidence 45999999999999999999975 45789999886532 34567999999999999999998773 23347899
Q ss_pred Eeccc-ccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCcccccc
Q 016184 159 LEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK 237 (394)
Q Consensus 159 ~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~ 237 (394)
|||++ ++|.+++.... ...+++..+..++.|++.||.+||+ .|++|+||||+||+++.++ .++|+|||++.....
T Consensus 80 ~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dl~p~Nil~~~~~-~~~l~dfg~~~~~~~ 155 (261)
T cd05068 80 TELMKYGSLLEYLQGGA--GRALKLPQLIDMAAQVASGMAYLEA-QNYIHRDLAARNVLVGENN-ICKVADFGLARVIKE 155 (261)
T ss_pred eecccCCcHHHHHhccC--CCCCCHHHHHHHHHHHHHHHHHHHh-CCeeeccCCcceEEEcCCC-CEEECCcceEEEccC
Confidence 99995 67777665422 3568999999999999999999999 8999999999999999888 699999999976643
Q ss_pred CCCc--ccccccccccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCC
Q 016184 238 GEPN--VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 314 (394)
Q Consensus 238 ~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 314 (394)
.... .....+..|+|||.+.+. .++.++|+||||+++|+|++ |+.||.+......+..+......
T Consensus 156 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~----------- 223 (261)
T cd05068 156 DIYEAREGAKFPIKWTAPEAALYN-RFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRM----------- 223 (261)
T ss_pred CcccccCCCcCceeccCccccccC-CCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC-----------
Confidence 2211 111223579999988654 48999999999999999999 99999877655555444321100
Q ss_pred CCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 016184 315 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV 364 (394)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 364 (394)
..+..++..+.+++.+||+.||.+||++.++++
T Consensus 224 -----------------~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~ 256 (261)
T cd05068 224 -----------------PCPPGCPKELYDIMLDCWKEDPDDRPTFETLQW 256 (261)
T ss_pred -----------------CCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence 011346889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=294.80 Aligned_cols=248 Identities=28% Similarity=0.444 Sum_probs=195.2
Q ss_pred eEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccc-------hhhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEE
Q 016184 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL 155 (394)
Q Consensus 83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 155 (394)
+|++.+.||.|+||.||+|++..+++.+|||.+... .....+|+.+++.++|+||+++++++.. ....
T Consensus 3 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-----~~~~ 77 (267)
T cd08229 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIE-----DNEL 77 (267)
T ss_pred hhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEe-----CCeE
Confidence 588999999999999999999999999999977532 1234568999999999999999998843 3347
Q ss_pred EEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCccc
Q 016184 156 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV 234 (394)
Q Consensus 156 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~ 234 (394)
+++|||+++ ++.+++.........+++..++.++.|++.||.|||+ .|++|+||||+||+++.++ .++|+|||++..
T Consensus 78 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~-~~i~H~dl~p~nili~~~~-~~~l~dfg~~~~ 155 (267)
T cd08229 78 NIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHS-RRVMHRDIKPANVFITATG-VVKLGDLGLGRF 155 (267)
T ss_pred EEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEEcCCC-CEEECcchhhhc
Confidence 799999985 7877776544445678999999999999999999999 8999999999999999887 799999999876
Q ss_pred cccCCC-cccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcH-HHHHHHHHHhCCCChhhhhcc
Q 016184 235 LVKGEP-NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGV-DQLVEIIKVLGTPTREEIKCM 312 (394)
Q Consensus 235 ~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~ 312 (394)
...... .....++..|+|||.+.+. .++.++|+||||+++|+|++|..||.+.... ............+
T Consensus 156 ~~~~~~~~~~~~~~~~~~ape~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-------- 226 (267)
T cd08229 156 FSSKTTAAHSLVGTPYYMSPERIHEN-GYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYP-------- 226 (267)
T ss_pred cccCCcccccccCCcCccCHHHhcCC-CccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCCCC--------
Confidence 543322 2234678899999998654 4889999999999999999999999754321 1111111100000
Q ss_pred CCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 016184 313 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV 364 (394)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 364 (394)
......+++.+.+||.+||+.||.+|||+.++++
T Consensus 227 ------------------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~ 260 (267)
T cd08229 227 ------------------PLPSDHYSEELRQLVNMCINPDPEKRPDITYVYD 260 (267)
T ss_pred ------------------CCCcccccHHHHHHHHHhcCCCcccCCCHHHHHH
Confidence 0011346889999999999999999999997764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=296.02 Aligned_cols=255 Identities=31% Similarity=0.458 Sum_probs=205.5
Q ss_pred ceeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccch---hhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEEEE
Q 016184 81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL 157 (394)
Q Consensus 81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 157 (394)
...|++...||+|++|.||+|.+..+++.||+|++.... ....+|+++++.++|+|++++++++... ...++
T Consensus 18 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~l 92 (286)
T cd06614 18 RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYDSYLVG-----DELWV 92 (286)
T ss_pred cccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCchhHHHHHHHHHHHHHCCCCCeeEEEEEEEEC-----CEEEE
Confidence 345999999999999999999999889999999886543 3456799999999999999999988443 45789
Q ss_pred EEeccc-ccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCccccc
Q 016184 158 VLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV 236 (394)
Q Consensus 158 v~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~ 236 (394)
++||++ ++|.+++.... ..+++..+..++.|++.||.|||+ .|++|+||+|+||+++.++ .++|+|||++....
T Consensus 93 v~e~~~~~~L~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~lH~-~gi~H~dl~p~ni~i~~~~-~~~l~d~~~~~~~~ 167 (286)
T cd06614 93 VMEYMDGGSLTDIITQNF---VRMNEPQIAYVCREVLQGLEYLHS-QNVIHRDIKSDNILLSKDG-SVKLADFGFAAQLT 167 (286)
T ss_pred EEeccCCCcHHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHh-CCeeeCCCChhhEEEcCCC-CEEECccchhhhhc
Confidence 999999 58877776522 378999999999999999999999 8999999999999999887 69999999876543
Q ss_pred cCCC-cccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCC
Q 016184 237 KGEP-NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 315 (394)
Q Consensus 237 ~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 315 (394)
.... .....++..|+|||.+.+. .++.++|+||||+++|+|++|..||...........+... +.+..
T Consensus 168 ~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~--------- 236 (286)
T cd06614 168 KEKSKRNSVVGTPYWMAPEVIKRK-DYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTK-GIPPL--------- 236 (286)
T ss_pred cchhhhccccCCcccCCHhHhcCC-CCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc-CCCCC---------
Confidence 3221 1234567889999998654 4899999999999999999999999876655444333221 00000
Q ss_pred CcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 016184 316 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR 372 (394)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 372 (394)
.....++..+.+||++||+.||.+|||+.++++||||++..
T Consensus 237 ----------------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~ 277 (286)
T cd06614 237 ----------------KNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFLKKAC 277 (286)
T ss_pred ----------------cchhhCCHHHHHHHHHHhccChhhCcCHHHHhhChHhhccC
Confidence 00123688999999999999999999999999999999843
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=293.81 Aligned_cols=251 Identities=21% Similarity=0.294 Sum_probs=193.8
Q ss_pred EEEeeEEeecCceEEEEEEECCC---CcEEEEEEeccch------hhhHHHHHHHHHcCCCCeeeeceEEEecCC-Ccee
Q 016184 84 YIAEHVVGTGSFGVVFQAKCRET---GEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTD-KEEL 153 (394)
Q Consensus 84 y~~~~~lg~G~~g~V~~~~~~~~---~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~~~~ 153 (394)
|.+.+.||+|+||.||+|....+ +..||+|.+.... ....+|+++++.++|+||+++++++..... ....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 56788999999999999987643 4789999886432 234578999999999999999988754433 2334
Q ss_pred EEEEEEecccc-cHHHHHHHhhh--hcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeec
Q 016184 154 YLNLVLEYVPE-TVNRIARNYSR--IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFG 230 (394)
Q Consensus 154 ~~~lv~e~~~~-~l~~~~~~~~~--~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg 230 (394)
+.+++|||+++ ++..++..... ....+++..+..++.|++.||.|||+ .|++||||||+||+++.++ .+||+|||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~-~~i~H~dlkp~Nil~~~~~-~~kl~dfg 158 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSN-RNFIHRDLAARNCMLREDM-TVCVADFG 158 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHh-CCeeccccchheEEECCCC-eEEECCcc
Confidence 57899999984 77666654322 22468999999999999999999999 8999999999999999887 79999999
Q ss_pred CccccccCCCc---ccccccccccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCh
Q 016184 231 SAKVLVKGEPN---VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTR 306 (394)
Q Consensus 231 ~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~ 306 (394)
+++........ .....+..|+|||.+.+ ..++.++|||||||++|+|++ |..||.+....+.+..+....
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~~----- 232 (273)
T cd05035 159 LSKKIYSGDYYRQGRIAKMPVKWIAIESLAD-RVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGN----- 232 (273)
T ss_pred ceeeccccccccccccccCCccccCHhhccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-----
Confidence 99765433211 11234567999999854 448999999999999999999 889998766554443332210
Q ss_pred hhhhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 016184 307 EEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH 365 (394)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 365 (394)
... .+..++..+.+++.+||+.||.+|||+.+++++
T Consensus 233 -----------~~~------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~ 268 (273)
T cd05035 233 -----------RLK------------QPEDCLDELYDLMYSCWRADPKDRPTFTKLREV 268 (273)
T ss_pred -----------CCC------------CCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 000 123578899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=290.40 Aligned_cols=244 Identities=20% Similarity=0.290 Sum_probs=191.6
Q ss_pred eeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccch---hhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEEEEE
Q 016184 82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLV 158 (394)
Q Consensus 82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv 158 (394)
..|++.+.||+|+||.||+|.+.. +..+|+|.+.... ..+.+|+.+++.++||||+++++++. .....+++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~lv 77 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCT-----KQRPIYIV 77 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCcccHHHHHHHHHHHhcCCCCCeeeEEEEEc-----cCCCcEEE
Confidence 359999999999999999998754 4569999876432 34567999999999999999999873 22346899
Q ss_pred Eecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCcccccc
Q 016184 159 LEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK 237 (394)
Q Consensus 159 ~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~ 237 (394)
|||+.+ ++.+++... ...+++..++.++.|++.||+|||+ .|++|+||||+||+++.++ .+||+|||.++....
T Consensus 78 ~e~~~~~~l~~~i~~~---~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dl~p~nili~~~~-~~kl~d~g~~~~~~~ 152 (256)
T cd05113 78 TEYMSNGCLLNYLREH---GKRFQPSQLLEMCKDVCEGMAYLES-KQFIHRDLAARNCLVDDQG-CVKVSDFGLSRYVLD 152 (256)
T ss_pred EEcCCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccccCcceEEEcCCC-CEEECCCccceecCC
Confidence 999975 666655432 2368999999999999999999999 8999999999999999887 799999999876543
Q ss_pred CCCc--ccccccccccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCC
Q 016184 238 GEPN--VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 314 (394)
Q Consensus 238 ~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 314 (394)
.... ....++..|+|||.+.+. .++.++||||||+++|+|++ |..||......+....+.+.....
T Consensus 153 ~~~~~~~~~~~~~~y~~pe~~~~~-~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~---------- 221 (256)
T cd05113 153 DEYTSSVGSKFPVRWSPPEVLLYS-KFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLY---------- 221 (256)
T ss_pred CceeecCCCccChhhCCHHHHhcC-cccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCCC----------
Confidence 3211 122345679999998654 48999999999999999998 999997766544444443311000
Q ss_pred CCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 016184 315 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH 365 (394)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 365 (394)
.....+..+.+++.+||..||.+|||+.+++.+
T Consensus 222 ------------------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~ 254 (256)
T cd05113 222 ------------------RPHLASEKVYAIMYSCWHEKAEERPTFQQLLSS 254 (256)
T ss_pred ------------------CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHh
Confidence 112357899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=325.57 Aligned_cols=141 Identities=26% Similarity=0.440 Sum_probs=122.1
Q ss_pred eeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccch-------hhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeE
Q 016184 82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY 154 (394)
Q Consensus 82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 154 (394)
.+|++.+.||+|+||.||+|.+..+++.||||++.... ..+.+|+.+++.++|+||++++.++ ....+
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~-----~~~~~ 78 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSL-----QSANN 78 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEE-----EECCE
Confidence 45999999999999999999999999999999986532 4456789999999999999998877 33345
Q ss_pred EEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCcc
Q 016184 155 LNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK 233 (394)
Q Consensus 155 ~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~ 233 (394)
+|+||||+.+ +|..++.. ...+++..++.++.||+.||+|||. +||+||||||+|||++.++ .+||+|||+++
T Consensus 79 ~~lVmEy~~g~~L~~li~~----~~~l~~~~~~~i~~qil~aL~yLH~-~gIiHrDLKP~NILl~~~g-~vkL~DFGls~ 152 (669)
T cd05610 79 VYLVMEYLIGGDVKSLLHI----YGYFDEEMAVKYISEVALALDYLHR-HGIIHRDLKPDNMLISNEG-HIKLTDFGLSK 152 (669)
T ss_pred EEEEEeCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCEEeCCccHHHEEEcCCC-CEEEEeCCCCc
Confidence 8899999964 77666653 3568899999999999999999999 8999999999999999887 69999999875
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=295.45 Aligned_cols=248 Identities=20% Similarity=0.312 Sum_probs=192.2
Q ss_pred eeEEEeeEEeecCceEEEEEEEC----CCCcEEEEEEeccch-----hhhHHHHHHHHHcCCCCeeeeceEEEecCCCce
Q 016184 82 VSYIAEHVVGTGSFGVVFQAKCR----ETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE 152 (394)
Q Consensus 82 ~~y~~~~~lg~G~~g~V~~~~~~----~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 152 (394)
..|++.+.||+|+||.||+|... .++..||+|.+.... ..+.+|+++++.++|+||+++++++.. .
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-----~ 79 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQ-----E 79 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEec-----C
Confidence 35899999999999999999853 456789999886321 345679999999999999999998733 2
Q ss_pred eEEEEEEecccc-cHHHHHHHhhh-------------hcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEe
Q 016184 153 LYLNLVLEYVPE-TVNRIARNYSR-------------IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVN 218 (394)
Q Consensus 153 ~~~~lv~e~~~~-~l~~~~~~~~~-------------~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~ 218 (394)
...+++|||+++ +|.+++..... ....+++..+..++.|++.||+|||+ +|++|+||||+|||++
T Consensus 80 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~-~~i~H~dlkp~nili~ 158 (283)
T cd05090 80 QPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSS-HFFVHKDLAARNILIG 158 (283)
T ss_pred CceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHh-cCeehhccccceEEEc
Confidence 347899999985 77766642211 12357888899999999999999999 8999999999999999
Q ss_pred CCCCcEEEEeecCccccccCCC---cccccccccccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHH
Q 016184 219 PHTHQLKLCDFGSAKVLVKGEP---NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQL 294 (394)
Q Consensus 219 ~~~~~vkl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~ 294 (394)
.++ .+||+|||+++....... .....++..|+|||.+.+. .++.++|+||||+++|+|++ |..||.+.......
T Consensus 159 ~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~ 236 (283)
T cd05090 159 EQL-HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYG-KFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVI 236 (283)
T ss_pred CCC-cEEeccccccccccCCcceecccCCCccceecChHHhccC-CCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHH
Confidence 887 699999999976533221 2233446679999998654 48999999999999999998 99999876544333
Q ss_pred HHHHHHhCCCChhhhhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 016184 295 VEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH 365 (394)
Q Consensus 295 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 365 (394)
..+... ..+ ..+..+++.+.+++.+||+.||.+||++.+++++
T Consensus 237 ~~~~~~-~~~---------------------------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 279 (283)
T cd05090 237 EMVRKR-QLL---------------------------PCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR 279 (283)
T ss_pred HHHHcC-CcC---------------------------CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 333221 000 0124578899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=297.78 Aligned_cols=246 Identities=20% Similarity=0.265 Sum_probs=191.8
Q ss_pred eEEEeeEEeecCceEEEEEEECCC-----CcEEEEEEeccch-----hhhHHHHHHHHHcCCCCeeeeceEEEecCCCce
Q 016184 83 SYIAEHVVGTGSFGVVFQAKCRET-----GEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE 152 (394)
Q Consensus 83 ~y~~~~~lg~G~~g~V~~~~~~~~-----~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 152 (394)
.|.+.+.||.|+||.||+|.+..+ ++.||+|++.... ..+.+|+.++..++||||+++++++. ..
T Consensus 6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~-----~~ 80 (283)
T cd05091 6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVT-----KE 80 (283)
T ss_pred HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-----CC
Confidence 488899999999999999987543 5789999986432 23457889999999999999999873 22
Q ss_pred eEEEEEEecccc-cHHHHHHHhh------------hhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeC
Q 016184 153 LYLNLVLEYVPE-TVNRIARNYS------------RIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNP 219 (394)
Q Consensus 153 ~~~~lv~e~~~~-~l~~~~~~~~------------~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~ 219 (394)
...++++||+.+ ++..++.... .....+++..+..++.|++.||.|||+ +||+||||||+|||++.
T Consensus 81 ~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~-~gi~H~dlkp~Nil~~~ 159 (283)
T cd05091 81 QPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSS-HHVVHKDLATRNVLVFD 159 (283)
T ss_pred CceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH-cCccccccchhheEecC
Confidence 337789999874 6666654211 112458888999999999999999999 89999999999999998
Q ss_pred CCCcEEEEeecCccccccCCC---cccccccccccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHH
Q 016184 220 HTHQLKLCDFGSAKVLVKGEP---NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLV 295 (394)
Q Consensus 220 ~~~~vkl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~ 295 (394)
++ .+||+|||+++....... .....+++.|+|||.+.+.. ++.++|||||||++|+|++ |..||.+....+.+.
T Consensus 160 ~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~ 237 (283)
T cd05091 160 KL-NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGK-FSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIE 237 (283)
T ss_pred CC-ceEecccccccccccchheeeccCccCCccccCHHHHhcCC-CCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence 77 699999999876533221 12234467899999986544 8999999999999999998 888998776655544
Q ss_pred HHHHHhCCCChhhhhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 016184 296 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV 364 (394)
Q Consensus 296 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 364 (394)
.+.+.... ..+..++.++.+|+.+||+.||.+||++.+++.
T Consensus 238 ~i~~~~~~----------------------------~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~ 278 (283)
T cd05091 238 MIRNRQVL----------------------------PCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHS 278 (283)
T ss_pred HHHcCCcC----------------------------CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence 44331100 012457899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=289.35 Aligned_cols=238 Identities=23% Similarity=0.313 Sum_probs=184.7
Q ss_pred eEEeecCceEEEEEEECCCCcEEEEEEeccc-----hhhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEEEEEEecc
Q 016184 88 HVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYV 162 (394)
Q Consensus 88 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~ 162 (394)
+.||+|+||.||+|++..+++.||+|.+... .....+|+++++.++|+||+++++++.. ....++||||+
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~lv~e~~ 75 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQ-----KQPIYIVMELV 75 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-----CCCeEEEEeec
Confidence 3589999999999999999999999987532 2345679999999999999999998732 33478999999
Q ss_pred cc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCccccccCCCc
Q 016184 163 PE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN 241 (394)
Q Consensus 163 ~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~~~~~ 241 (394)
++ ++.+++.. ....+++..++.++.|++.||.|||+ .|++|+||||+||+++.++ .+||+|||.+.........
T Consensus 76 ~~~~L~~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~-~~i~H~dl~p~nil~~~~~-~~kl~dfg~~~~~~~~~~~ 150 (252)
T cd05084 76 QGGDFLTFLRT---EGPRLKVKELIQMVENAAAGMEYLES-KHCIHRDLAARNCLVTEKN-VLKISDFGMSREEEDGVYA 150 (252)
T ss_pred cCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccccchheEEEcCCC-cEEECccccCccccccccc
Confidence 75 66655543 23468899999999999999999999 8999999999999999887 6999999998754322111
Q ss_pred c---cccccccccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCCCc
Q 016184 242 V---SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 317 (394)
Q Consensus 242 ~---~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 317 (394)
. ....+..|+|||.+.+.. ++.++|+||||+++|+|++ |..||...........+.... ..
T Consensus 151 ~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~-~~------------- 215 (252)
T cd05084 151 STGGMKQIPVKWTAPEALNYGR-YSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGV-RL------------- 215 (252)
T ss_pred ccCCCCCCceeecCchhhcCCC-CChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCC-CC-------------
Confidence 1 111245699999986544 8999999999999999997 889997655433322222110 00
Q ss_pred ccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 016184 318 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV 364 (394)
Q Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 364 (394)
..+..++..+.+|+.+||+.||++|||+.++++
T Consensus 216 --------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 248 (252)
T cd05084 216 --------------PCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQ 248 (252)
T ss_pred --------------CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 012356889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=288.75 Aligned_cols=248 Identities=29% Similarity=0.482 Sum_probs=196.1
Q ss_pred eeEEEeeEEeecCceEEEEEEECCCCcEEEEEEecc-------chhhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeE
Q 016184 82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQ-------DKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY 154 (394)
Q Consensus 82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-------~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 154 (394)
++|++.+.||+|+||.||+|.+..+|+.||+|.+.. ......+|+++++.++|+|++++++++.. ...
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~-----~~~ 76 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIE-----NNE 76 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeec-----CCe
Confidence 359999999999999999999998999999998742 12345679999999999999999998843 334
Q ss_pred EEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCcc
Q 016184 155 LNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK 233 (394)
Q Consensus 155 ~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~ 233 (394)
.+++|||+++ +|..++.........+++..++.++.|++.||.|||+ .|++|+||+|+||+++.++ .++|+|||++.
T Consensus 77 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~-~~i~h~dl~p~nil~~~~~-~~~l~d~~~~~ 154 (267)
T cd08224 77 LNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHS-KRIMHRDIKPANVFITATG-VVKLGDLGLGR 154 (267)
T ss_pred EEEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHh-CCEecCCcChhhEEECCCC-cEEEeccceee
Confidence 7899999985 7877776554445668999999999999999999999 8999999999999999887 69999999987
Q ss_pred ccccCC-CcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcH--HHHHHHHHHhCCCChhhhh
Q 016184 234 VLVKGE-PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGV--DQLVEIIKVLGTPTREEIK 310 (394)
Q Consensus 234 ~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~--~~~~~i~~~~~~~~~~~~~ 310 (394)
...... ......+++.|+|||.+.+. .++.++|+||||+++|+|++|+.||...... +....+....
T Consensus 155 ~~~~~~~~~~~~~~~~~y~apE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~--------- 224 (267)
T cd08224 155 FFSSKTTAAHSLVGTPYYMSPERIHEN-GYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCD--------- 224 (267)
T ss_pred eccCCCcccceecCCccccCHHHhccC-CCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCC---------
Confidence 653322 12234678889999998654 4899999999999999999999999654311 1111111100
Q ss_pred ccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 016184 311 CMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV 364 (394)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 364 (394)
.+ ......++..+.++|.+||..+|++|||+.++++
T Consensus 225 ----------~~--------~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~ 260 (267)
T cd08224 225 ----------YP--------PLPADHYSEELRDLVSRCINPDPEKRPDISYVLQ 260 (267)
T ss_pred ----------CC--------CCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 00 0001256789999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-39 Score=292.62 Aligned_cols=248 Identities=23% Similarity=0.315 Sum_probs=194.4
Q ss_pred ceeEEEeeEEeecCceEEEEEEECCC-----CcEEEEEEeccch-----hhhHHHHHHHHHcCCCCeeeeceEEEecCCC
Q 016184 81 KVSYIAEHVVGTGSFGVVFQAKCRET-----GEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDK 150 (394)
Q Consensus 81 ~~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 150 (394)
.++|++.+.||+|+||.||+|.+... +..||+|.+.... ....+|+.+++.++|+||+++++++.
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~----- 79 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVS----- 79 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEc-----
Confidence 34699999999999999999998643 3789999875432 23457899999999999999999883
Q ss_pred ceeEEEEEEeccc-ccHHHHHHHhhhh------cCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCc
Q 016184 151 EELYLNLVLEYVP-ETVNRIARNYSRI------HQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQ 223 (394)
Q Consensus 151 ~~~~~~lv~e~~~-~~l~~~~~~~~~~------~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~ 223 (394)
.....+++|||++ ++|.+++...... ...+++..+..++.|++.||.|||+ .|++||||||+|||++.++ .
T Consensus 80 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~di~p~nill~~~~-~ 157 (277)
T cd05032 80 TGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAA-KKFVHRDLAARNCMVAEDL-T 157 (277)
T ss_pred CCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccccChheEEEcCCC-C
Confidence 3345789999997 5887777643321 2347888899999999999999999 8999999999999999988 7
Q ss_pred EEEEeecCccccccCCC---cccccccccccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHH
Q 016184 224 LKLCDFGSAKVLVKGEP---NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIK 299 (394)
Q Consensus 224 vkl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~ 299 (394)
+||+|||+++....... .....++..|+|||.+.+. .++.++|||||||++|+|++ |..||.+.+..+....+..
T Consensus 158 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~ 236 (277)
T cd05032 158 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDG-VFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVID 236 (277)
T ss_pred EEECCcccchhhccCcccccCCCCCccccccCHHHHhcC-CCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHhc
Confidence 99999999876543321 1233457789999998654 48999999999999999998 9999987665544433321
Q ss_pred HhCCCChhhhhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 016184 300 VLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV 364 (394)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 364 (394)
... .. ++..++..+.+||.+||+.+|++|||+.++++
T Consensus 237 -~~~---------------~~------------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 273 (277)
T cd05032 237 -GGH---------------LD------------LPENCPDKLLELMRMCWQYNPKMRPTFLEIVS 273 (277)
T ss_pred -CCC---------------CC------------CCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 100 00 12346889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=292.82 Aligned_cols=246 Identities=21% Similarity=0.322 Sum_probs=197.0
Q ss_pred cceeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccch----hhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEE
Q 016184 80 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL 155 (394)
Q Consensus 80 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 155 (394)
.+.+|++.++||.|+||.||+|.+.. ++.+|+|++.... ....+|+.+++.++|+||+++++++. .....
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~ 77 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCS-----VGEPV 77 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEe-----cCCCe
Confidence 34569999999999999999999977 8899999886443 34567999999999999999998873 23347
Q ss_pred EEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCccc
Q 016184 156 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV 234 (394)
Q Consensus 156 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~ 234 (394)
+++|||+++ +|.+++.... ...+++..+..++.|++.||.|||+ .|++|+||||+||+++.++ .+||+|||.+..
T Consensus 78 ~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~al~~lH~-~~i~h~dl~~~nilv~~~~-~~kl~d~g~~~~ 153 (261)
T cd05148 78 YIITELMEKGSLLAFLRSPE--GQVLPVASLIDMACQVAEGMAYLEE-QNSIHRDLAARNILVGEDL-VCKVADFGLARL 153 (261)
T ss_pred EEEEeecccCCHHHHHhcCC--CCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccccCcceEEEcCCc-eEEEccccchhh
Confidence 899999985 7777766432 3568999999999999999999999 8999999999999999887 799999999876
Q ss_pred cccCCC-cccccccccccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCChhhhhcc
Q 016184 235 LVKGEP-NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 312 (394)
Q Consensus 235 ~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 312 (394)
...... .....++..|+|||.+... .++.++|+||||+++|+|++ |+.||......+.+..+......
T Consensus 154 ~~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~--------- 223 (261)
T cd05148 154 IKEDVYLSSDKKIPYKWTAPEAASHG-TFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRM--------- 223 (261)
T ss_pred cCCccccccCCCCceEecCHHHHccC-CCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCCcC---------
Confidence 533211 1122346679999998554 48999999999999999998 89999877655555544321110
Q ss_pred CCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 016184 313 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV 364 (394)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 364 (394)
..+..+++.+.+++.+||+.||.+|||+.++++
T Consensus 224 -------------------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~ 256 (261)
T cd05148 224 -------------------PCPAKCPQEIYKIMLECWAAEPEDRPSFKALRE 256 (261)
T ss_pred -------------------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 012457889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=303.43 Aligned_cols=262 Identities=26% Similarity=0.366 Sum_probs=193.4
Q ss_pred ceeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccc----hhhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEEE
Q 016184 81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN 156 (394)
Q Consensus 81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 156 (394)
.++|.-...||+|+||.||+|... +|..||||++... ...+.+|++++.+++|||+|++++||..... ..+
T Consensus 74 T~~Fs~~~~ig~Ggfg~VYkG~l~-~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~----~~~ 148 (361)
T KOG1187|consen 74 TNNFSESNLIGEGGFGTVYKGVLS-DGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYCLEGGE----HRL 148 (361)
T ss_pred HhCCchhcceecCCCeEEEEEEEC-CCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEEecCCc----eEE
Confidence 456888889999999999999985 4589999987543 3457899999999999999999999954332 477
Q ss_pred EEEeccc-ccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC--CceeccCCCCceEEeCCCCcEEEEeecCcc
Q 016184 157 LVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI--GICHRDIKPQNLLVNPHTHQLKLCDFGSAK 233 (394)
Q Consensus 157 lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~--givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~ 233 (394)
+|+||++ |+|.+.+...... .++|....+|+.+++.||+|||... .|+|||||+.|||+|.+. ..||+|||+|+
T Consensus 149 LVYEym~nGsL~d~L~~~~~~--~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~-~aKlsDFGLa~ 225 (361)
T KOG1187|consen 149 LVYEYMPNGSLEDHLHGKKGE--PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDF-NAKLSDFGLAK 225 (361)
T ss_pred EEEEccCCCCHHHHhCCCCCC--CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCC-CEEccCccCcc
Confidence 9999999 5887777653322 8899999999999999999999843 499999999999999988 69999999997
Q ss_pred cccc-CCCcccc-cccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCC--cHHHHHHHH-HHhCCCChhh
Q 016184 234 VLVK-GEPNVSY-ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGES--GVDQLVEII-KVLGTPTREE 308 (394)
Q Consensus 234 ~~~~-~~~~~~~-~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~--~~~~~~~i~-~~~~~~~~~~ 308 (394)
.... ....... .||.+|+|||++.. ...+.++|||||||+|.||+||+.+..... ....+..+. ..+... .
T Consensus 226 ~~~~~~~~~~~~~~gt~gY~~PEy~~~-g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~--~- 301 (361)
T KOG1187|consen 226 LGPEGDTSVSTTVMGTFGYLAPEYAST-GKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEG--K- 301 (361)
T ss_pred cCCccccceeeecCCCCccCChhhhcc-CCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCc--c-
Confidence 6554 3333333 78999999999854 458999999999999999999998776432 222233322 111111 1
Q ss_pred hhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 016184 309 IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV 364 (394)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 364 (394)
..++--+.+....... ...-..+..+..+|++.+|.+||+..++++
T Consensus 302 -------~~eiiD~~l~~~~~~~---~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~ 347 (361)
T KOG1187|consen 302 -------LREIVDPRLKEGEYPD---EKEVKKLAELALRCLRPDPKERPTMSQVVK 347 (361)
T ss_pred -------hhheeCCCccCCCCCh---HHHHHHHHHHHHHHcCcCCCcCcCHHHHHH
Confidence 1111111111000000 001123678899999999999999998754
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=319.37 Aligned_cols=245 Identities=25% Similarity=0.368 Sum_probs=202.5
Q ss_pred eEEEeeEEeecCceEEEEEEEC-----CCCcEEEEEEeccc-----hhhhHHHHHHHHHcCCCCeeeeceEEEecCCCce
Q 016184 83 SYIAEHVVGTGSFGVVFQAKCR-----ETGEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE 152 (394)
Q Consensus 83 ~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 152 (394)
+-...+.||+|+||+||+|+.. .+...||||.++.. ...+++|++++..|+|||||+++|+| .++
T Consensus 487 ~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC-----~~~ 561 (774)
T KOG1026|consen 487 DIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVC-----REG 561 (774)
T ss_pred heeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEE-----ccC
Confidence 3556788999999999999864 23467999988653 34578999999999999999999999 444
Q ss_pred eEEEEEEeccc-ccHHHHHHHhhhh------cC----CCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCC
Q 016184 153 LYLNLVLEYVP-ETVNRIARNYSRI------HQ----RMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHT 221 (394)
Q Consensus 153 ~~~~lv~e~~~-~~l~~~~~~~~~~------~~----~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~ 221 (394)
.-+|||+|||. |+|.+++...... +. +++..+...|+.||+.|++||-+ +.+|||||-..|.||+++.
T Consensus 562 ~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~-~~FVHRDLATRNCLVge~l 640 (774)
T KOG1026|consen 562 DPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSS-HHFVHRDLATRNCLVGENL 640 (774)
T ss_pred CeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-Ccccccchhhhhceeccce
Confidence 44889999998 6899888764432 12 27888999999999999999999 8999999999999999887
Q ss_pred CcEEEEeecCccccccCCCcc---cccccccccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHH
Q 016184 222 HQLKLCDFGSAKVLVKGEPNV---SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEI 297 (394)
Q Consensus 222 ~~vkl~Dfg~a~~~~~~~~~~---~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i 297 (394)
.|||+|||+++.....+-.. ...-..+|||||.+.-.. |+++|||||+||+|||+++ |+.||.+..+.+.++.+
T Consensus 641 -~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~k-FTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i 718 (774)
T KOG1026|consen 641 -VVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGK-FTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECI 718 (774)
T ss_pred -EEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCc-ccchhhhhhhhhhhhhhhccccCcccccchHHHHHHH
Confidence 79999999998775543221 223367799999997554 9999999999999999997 99999999999988887
Q ss_pred HHHhCCCChhhhhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHh
Q 016184 298 IKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEAC 363 (394)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell 363 (394)
.+..- .. -++.+|.++.+|+..||+.+|.+||++.||-
T Consensus 719 ~~g~l----------------L~------------~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~ 756 (774)
T KOG1026|consen 719 RAGQL----------------LS------------CPENCPTEVYSLMLECWNENPKRRPSFKEIH 756 (774)
T ss_pred HcCCc----------------cc------------CCCCCCHHHHHHHHHHhhcCcccCCCHHHHH
Confidence 66311 11 1367999999999999999999999999884
|
|
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-39 Score=289.21 Aligned_cols=243 Identities=25% Similarity=0.355 Sum_probs=190.6
Q ss_pred eeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccch---hhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEEEEE
Q 016184 82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLV 158 (394)
Q Consensus 82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv 158 (394)
.+|++.++||+|+||.||+|++..+ ..||+|.+.... ....+|+++++.++|+||+++++.+. . .+.+++
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-----~-~~~~lv 78 (262)
T cd05071 6 ESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-----E-EPIYIV 78 (262)
T ss_pred HHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCccCHHHHHHHHHHHHhCCCCCcceEEEEEC-----C-CCcEEE
Confidence 3599999999999999999998655 459999886532 34567999999999999999987651 1 125799
Q ss_pred Eecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCcccccc
Q 016184 159 LEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK 237 (394)
Q Consensus 159 ~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~ 237 (394)
|||+++ ++.+++... ....+++..+..++.|++.||+|||+ .|++|+||||+||+++.++ .++|+|||.+.....
T Consensus 79 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~aL~~lH~-~~i~H~dl~p~Nill~~~~-~~~L~dfg~~~~~~~ 154 (262)
T cd05071 79 TEYMSKGSLLDFLKGE--MGKYLRLPQLVDMAAQIASGMAYVER-MNYVHRDLRAANILVGENL-VCKVADFGLARLIED 154 (262)
T ss_pred EEcCCCCcHHHHHhhc--cccCCCHHHHHHHHHHHHHHHHHHHH-CCccccccCcccEEEcCCC-cEEeccCCceeeccc
Confidence 999985 776666542 23467899999999999999999999 8999999999999999887 699999999976543
Q ss_pred CCCc--ccccccccccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCC
Q 016184 238 GEPN--VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 314 (394)
Q Consensus 238 ~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 314 (394)
.... ....++..|+|||...+. .++.++|+||||+++|+|++ |..||.+.........+......
T Consensus 155 ~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~----------- 222 (262)
T cd05071 155 NEYTARQGAKFPIKWTAPEAALYG-RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM----------- 222 (262)
T ss_pred cccccccCCcccceecCHhHhccC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCCCC-----------
Confidence 3221 123346679999988544 48999999999999999999 88899876655444333221000
Q ss_pred CCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 016184 315 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV 364 (394)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 364 (394)
.....++..+.+|+.+||+.||++||++.+++.
T Consensus 223 -----------------~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~ 255 (262)
T cd05071 223 -----------------PCPPECPESLHDLMCQCWRKEPEERPTFEYLQA 255 (262)
T ss_pred -----------------CCccccCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 011356889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-39 Score=288.92 Aligned_cols=242 Identities=26% Similarity=0.387 Sum_probs=195.6
Q ss_pred eEEeecCceEEEEEEECCC---CcEEEEEEeccch-----hhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEEEEEE
Q 016184 88 HVVGTGSFGVVFQAKCRET---GEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVL 159 (394)
Q Consensus 88 ~~lg~G~~g~V~~~~~~~~---~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~ 159 (394)
+.||+|+||.||+|.+... +..||+|.+.... ....+|+++++.++|+|++++++++.. ....+++|
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-----~~~~~lv~ 75 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTE-----EEPLYLVL 75 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecC-----CCceEEEE
Confidence 4689999999999999866 8899999886532 345579999999999999999998833 44578999
Q ss_pred eccc-ccHHHHHHHhhhh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCcc
Q 016184 160 EYVP-ETVNRIARNYSRI-----HQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK 233 (394)
Q Consensus 160 e~~~-~~l~~~~~~~~~~-----~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~ 233 (394)
||++ ++|.+.+...... ...+++..++.++.|++.||+|||+ +|++|+||||+||+++.++ .++|+|||.+.
T Consensus 76 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~-~~i~H~di~p~nili~~~~-~~~l~dfg~~~ 153 (262)
T cd00192 76 EYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLAS-KKFVHRDLAARNCLVGEDL-VVKISDFGLSR 153 (262)
T ss_pred EeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHc-CCcccCccCcceEEECCCC-cEEEccccccc
Confidence 9995 6887777654222 3779999999999999999999999 8999999999999999887 69999999998
Q ss_pred ccccCC---CcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCChhhh
Q 016184 234 VLVKGE---PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEI 309 (394)
Q Consensus 234 ~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 309 (394)
...... ......++..|+|||.+... .++.++||||||+++|+|++ |..||......+....+....
T Consensus 154 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~-------- 224 (262)
T cd00192 154 DVYDDDYYRKKTGGKLPIRWMAPESLKDG-IFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGY-------- 224 (262)
T ss_pred ccccccccccccCCCcCccccCHHHhccC-CcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC--------
Confidence 765432 22344568889999998654 58999999999999999999 699998876554444433210
Q ss_pred hccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 016184 310 KCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH 365 (394)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 365 (394)
....+..++.++.+++.+||..||.+|||+.+++++
T Consensus 225 --------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 260 (262)
T cd00192 225 --------------------RLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVER 260 (262)
T ss_pred --------------------CCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 001124568999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-39 Score=287.12 Aligned_cols=238 Identities=35% Similarity=0.598 Sum_probs=194.4
Q ss_pred EeecCceEEEEEEECCCCcEEEEEEeccch-------hhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEEEEEEecc
Q 016184 90 VGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYV 162 (394)
Q Consensus 90 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~ 162 (394)
||.|+||.||++.+..+++.+|+|++.... ....+|+.+++.++|+||+++++.+ ....+.+++|||+
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~~v~e~~ 75 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAF-----QTEEKLYLVLEYA 75 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHe-----ecCCeeEEEEecC
Confidence 689999999999998889999999876532 2456789999999999999999887 4445688999999
Q ss_pred c-ccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCccccccC-CC
Q 016184 163 P-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-EP 240 (394)
Q Consensus 163 ~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~~-~~ 240 (394)
+ ++|.+.+.. ...+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++ .++|+|||++...... ..
T Consensus 76 ~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lh~-~~~~H~~l~p~ni~~~~~~-~~~l~d~~~~~~~~~~~~~ 149 (250)
T cd05123 76 PGGELFSHLSK----EGRFSEERARFYAAEIVLALEYLHS-LGIIYRDLKPENILLDADG-HIKLTDFGLAKELSSEGSR 149 (250)
T ss_pred CCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCcceEEEcCCC-cEEEeecCcceecccCCCc
Confidence 5 577666554 2468999999999999999999999 8999999999999999887 7999999998765443 22
Q ss_pred cccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCCCcccC
Q 016184 241 NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 320 (394)
Q Consensus 241 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 320 (394)
.....++..|+|||...+.. .+.++|+||||+++|+|++|..||...+.......+.. . ...
T Consensus 150 ~~~~~~~~~~~~Pe~~~~~~-~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~--~---------------~~~ 211 (250)
T cd05123 150 TNTFCGTPEYLAPEVLLGKG-YGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILK--D---------------PLR 211 (250)
T ss_pred ccCCcCCccccChHHhCCCC-CCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhc--C---------------CCC
Confidence 33456788899999986544 78899999999999999999999977665333333322 0 001
Q ss_pred CCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCH---HHHhcCCCC
Q 016184 321 FPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTA---LEACVHPFF 368 (394)
Q Consensus 321 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~---~ell~hp~f 368 (394)
++..++..+.++|++||..||++||++ +++++||||
T Consensus 212 ------------~~~~~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~~~~f 250 (250)
T cd05123 212 ------------FPEFLSPEARDLISGLLQKDPTKRLGSGGAEEIKAHPFF 250 (250)
T ss_pred ------------CCCCCCHHHHHHHHHHhcCCHhhCCCcccHHHHHhCCCC
Confidence 123468899999999999999999999 999999998
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-39 Score=293.81 Aligned_cols=247 Identities=23% Similarity=0.336 Sum_probs=193.6
Q ss_pred eeEEEeeEEeecCceEEEEEEEC-----CCCcEEEEEEeccch----hhhHHHHHHHHHcCCCCeeeeceEEEecCCCce
Q 016184 82 VSYIAEHVVGTGSFGVVFQAKCR-----ETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE 152 (394)
Q Consensus 82 ~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 152 (394)
.+|.+.+.||+|+||.||+|.+. .++..+++|.+.... ....+|+++++.++|+||+++++++. ..
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~ 79 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCG-----DG 79 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEc-----cC
Confidence 35999999999999999999864 345679999875432 34567999999999999999999873 33
Q ss_pred eEEEEEEeccc-ccHHHHHHHhhh------------hcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeC
Q 016184 153 LYLNLVLEYVP-ETVNRIARNYSR------------IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNP 219 (394)
Q Consensus 153 ~~~~lv~e~~~-~~l~~~~~~~~~------------~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~ 219 (394)
...++||||++ ++|.+++..... ....+++..++.++.||+.||+|||+ +||+||||||+|||++.
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~-~~i~H~dlkp~Nil~~~ 158 (291)
T cd05094 80 DPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLAS-QHFVHRDLATRNCLVGA 158 (291)
T ss_pred CceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHh-CCeeecccCcceEEEcc
Confidence 34789999997 477777654321 12458899999999999999999999 89999999999999998
Q ss_pred CCCcEEEEeecCccccccCCC---cccccccccccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHH
Q 016184 220 HTHQLKLCDFGSAKVLVKGEP---NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLV 295 (394)
Q Consensus 220 ~~~~vkl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~ 295 (394)
++ .++|+|||++........ .....++..|+|||.+.+. .++.++||||||+++|+|++ |..||......+...
T Consensus 159 ~~-~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~ 236 (291)
T cd05094 159 NL-LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYR-KFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIE 236 (291)
T ss_pred CC-cEEECCCCcccccCCCceeecCCCCCcceeecChHHhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 87 799999999875533221 2234457789999998654 48999999999999999998 999998766555443
Q ss_pred HHHHHhCCCChhhhhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 016184 296 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV 364 (394)
Q Consensus 296 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 364 (394)
.+.... . + ......+..+.+|+.+||+.||++|||+.++++
T Consensus 237 ~~~~~~--~-----------------~---------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~ 277 (291)
T cd05094 237 CITQGR--V-----------------L---------ERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYK 277 (291)
T ss_pred HHhCCC--C-----------------C---------CCCccCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence 322210 0 0 011346889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-39 Score=289.29 Aligned_cols=243 Identities=22% Similarity=0.326 Sum_probs=191.0
Q ss_pred eEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccc---hhhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEEEEEE
Q 016184 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD---KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVL 159 (394)
Q Consensus 83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~ 159 (394)
.|++.+.||+|+||.||+|.++ ++..+|+|.+... .....+|+++++.++|+||+++++++ ....+.+++|
T Consensus 5 ~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~lv~ 78 (256)
T cd05059 5 ELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVC-----TKQRPIFIVT 78 (256)
T ss_pred HcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEEEEEEEE-----cCCCceEEEE
Confidence 4889999999999999999985 4678999987643 23455799999999999999998887 3334578999
Q ss_pred ecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCccccccC
Q 016184 160 EYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG 238 (394)
Q Consensus 160 e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~~ 238 (394)
||+++ +|.+++... ...+++..++.++.|++.||.|||+ .|++||||||+||+++.++ .+||+|||+++.....
T Consensus 79 e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dl~p~ni~i~~~~-~~kl~dfg~~~~~~~~ 153 (256)
T cd05059 79 EYMANGCLLNYLRER---KGKLGTEWLLDMCSDVCEAMEYLES-NGFIHRDLAARNCLVGEDN-VVKVSDFGLARYVLDD 153 (256)
T ss_pred ecCCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHH-CCcccccccHhhEEECCCC-cEEECCcccceecccc
Confidence 99975 676655432 2468999999999999999999999 8999999999999999887 6999999998765432
Q ss_pred CCcc--cccccccccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCC
Q 016184 239 EPNV--SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 315 (394)
Q Consensus 239 ~~~~--~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 315 (394)
.... ...++..|+|||.+.+. .++.++|+||||+++|+|++ |..||...+..+....+......
T Consensus 154 ~~~~~~~~~~~~~y~~Pe~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~------------ 220 (256)
T cd05059 154 QYTSSQGTKFPVKWAPPEVFDYS-RFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRL------------ 220 (256)
T ss_pred cccccCCCCCCccccCHHHhccC-CCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCCcC------------
Confidence 2111 11234579999998654 48999999999999999999 89999876655444433221000
Q ss_pred CcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 016184 316 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH 365 (394)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 365 (394)
..+..++.++.+++.+||..+|++|||+.++++.
T Consensus 221 ----------------~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~ 254 (256)
T cd05059 221 ----------------YRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQ 254 (256)
T ss_pred ----------------CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 0113468899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-39 Score=289.46 Aligned_cols=245 Identities=25% Similarity=0.331 Sum_probs=191.8
Q ss_pred eeEEEeeEEeecCceEEEEEEECCC---CcEEEEEEeccch-----hhhHHHHHHHHHcCCCCeeeeceEEEecCCCcee
Q 016184 82 VSYIAEHVVGTGSFGVVFQAKCRET---GEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL 153 (394)
Q Consensus 82 ~~y~~~~~lg~G~~g~V~~~~~~~~---~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 153 (394)
.+|++.+.||+|+||.||+|.+..+ ...||+|.+.... ..+.+|+.+++.++|+||+++++.+. ...
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~ 78 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVT-----KSR 78 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEe-----cCC
Confidence 3599999999999999999998644 4579999875432 23456899999999999999999873 233
Q ss_pred EEEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCc
Q 016184 154 YLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA 232 (394)
Q Consensus 154 ~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a 232 (394)
..+++|||+++ +|.+++... ...+++..+..++.|++.||+|||+ .||+|+||||+|||++.++ .++|+|||++
T Consensus 79 ~~~iv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~Lh~-~~i~H~di~p~nili~~~~-~~~l~dfg~~ 153 (266)
T cd05033 79 PVMIITEYMENGSLDKFLREN---DGKFTVGQLVGMLRGIASGMKYLSE-MNYVHRDLAARNILVNSNL-VCKVSDFGLS 153 (266)
T ss_pred ceEEEEEcCCCCCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCcceEEEcCCC-CEEECccchh
Confidence 47899999985 676665432 2478999999999999999999999 8999999999999999887 6999999999
Q ss_pred cccccCCCc-c--cccccccccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCChhh
Q 016184 233 KVLVKGEPN-V--SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREE 308 (394)
Q Consensus 233 ~~~~~~~~~-~--~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 308 (394)
......... . ...++..|+|||.+.+. .++.++||||||+++|+|++ |..||...........+......+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~-~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~---- 228 (266)
T cd05033 154 RRLEDSEATYTTKGGKIPIRWTAPEAIAYR-KFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRLP---- 228 (266)
T ss_pred hcccccccceeccCCCCCccccChhhhccC-CCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCC----
Confidence 876422111 1 12335679999998654 48999999999999999998 999997765544443332210000
Q ss_pred hhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 016184 309 IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH 365 (394)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 365 (394)
.+..++..+.+|+.+||+.||++||++.+++++
T Consensus 229 ------------------------~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~ 261 (266)
T cd05033 229 ------------------------PPMDCPSALYQLMLDCWQKDRNERPTFSQIVST 261 (266)
T ss_pred ------------------------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 113568899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-40 Score=284.97 Aligned_cols=279 Identities=33% Similarity=0.569 Sum_probs=225.5
Q ss_pred eeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccc------hhhhHHHHHHHHHcCCCCeeeeceEEEecCC-CceeE
Q 016184 82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTD-KEELY 154 (394)
Q Consensus 82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~~~~~ 154 (394)
.+|.-++.+|.|.- .|-.|.+.-+++.||+|.+... .+...+|..++..++|+||++++.+|.-... .+..-
T Consensus 17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e 95 (369)
T KOG0665|consen 17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE 95 (369)
T ss_pred eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence 35999999999999 7888888889999999987543 2333579999999999999999998843322 12234
Q ss_pred EEEEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCccc
Q 016184 155 LNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV 234 (394)
Q Consensus 155 ~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~ 234 (394)
+|+|||+|..++..... ..++-..+..++.|++.|+++||+ .||+||||||+||++..+. .+||.|||+|+.
T Consensus 96 ~y~v~e~m~~nl~~vi~------~elDH~tis~i~yq~~~~ik~lhs-~~IihRdLkPsnivv~~~~-~lKi~dfg~ar~ 167 (369)
T KOG0665|consen 96 VYLVMELMDANLCQVIL------MELDHETISYILYQMLCGIKHLHS-AGIIHRDLKPSNIVVNSDC-TLKILDFGLART 167 (369)
T ss_pred HHHHHHhhhhHHHHHHH------HhcchHHHHHHHHHHHHHHHHHHh-cceeecccCcccceecchh-heeeccchhhcc
Confidence 67999999988876655 456677889999999999999999 8999999999999999887 799999999987
Q ss_pred cccCCCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCC
Q 016184 235 LVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 314 (394)
Q Consensus 235 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 314 (394)
....-....++.|..|.|||++.+.. +...+||||+||++.||++|...|++.+..++..++.+.+|.|.+.....+.+
T Consensus 168 e~~~~~mtpyVvtRyyrapevil~~~-~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~ 246 (369)
T KOG0665|consen 168 EDTDFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQP 246 (369)
T ss_pred cCcccccCchhheeeccCchheeccC-CcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhH
Confidence 65554566788899999999998877 99999999999999999999999999999999999999999999988765542
Q ss_pred ----------CCcccCCCCCCCC-Ccchhcc--ccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 016184 315 ----------NYTEFKFPQIKPH-PWHKVFQ--KRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE 370 (394)
Q Consensus 315 ----------~~~~~~~~~~~~~-~~~~~~~--~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~ 370 (394)
.+..+.+...-++ .|..... +.-...+++|+.+||..||++|.+++++|+||+|+-
T Consensus 247 ~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~v 315 (369)
T KOG0665|consen 247 TVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIKV 315 (369)
T ss_pred HHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeeee
Confidence 2222222222221 1221111 122345899999999999999999999999999993
|
|
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-39 Score=294.64 Aligned_cols=249 Identities=22% Similarity=0.339 Sum_probs=193.4
Q ss_pred ceeEEEeeEEeecCceEEEEEEECCCC-----cEEEEEEeccch-----hhhHHHHHHHHHc-CCCCeeeeceEEEecCC
Q 016184 81 KVSYIAEHVVGTGSFGVVFQAKCRETG-----EIVAIKKVLQDK-----RYKNRELQIMQML-DHPNIVALKHCFFSTTD 149 (394)
Q Consensus 81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~vaiK~~~~~~-----~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~ 149 (394)
..+|++.+.||+|+||.||++.+...+ ..+|+|.+.... ....+|+++++.+ +|+||+++++++.
T Consensus 11 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~---- 86 (293)
T cd05053 11 RDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCT---- 86 (293)
T ss_pred HhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEc----
Confidence 346999999999999999999986433 789999876432 2345789999999 8999999999873
Q ss_pred CceeEEEEEEecccc-cHHHHHHHhh------------hhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceE
Q 016184 150 KEELYLNLVLEYVPE-TVNRIARNYS------------RIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLL 216 (394)
Q Consensus 150 ~~~~~~~lv~e~~~~-~l~~~~~~~~------------~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil 216 (394)
.....+++|||+++ ++..++.... .....+++..+..++.|++.||.|||+ .||+||||||+|||
T Consensus 87 -~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~-~~ivH~dlkp~Nil 164 (293)
T cd05053 87 -QEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLAS-KKCIHRDLAARNVL 164 (293)
T ss_pred -CCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH-CCccccccceeeEE
Confidence 23347899999874 7777665421 234578899999999999999999999 89999999999999
Q ss_pred EeCCCCcEEEEeecCccccccCCC---cccccccccccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHH
Q 016184 217 VNPHTHQLKLCDFGSAKVLVKGEP---NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVD 292 (394)
Q Consensus 217 ~~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~ 292 (394)
++.++ .+||+|||+++....... .....++..|+|||++.+. .++.++|||||||++|+|++ |..||.+....+
T Consensus 165 ~~~~~-~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~ 242 (293)
T cd05053 165 VTEDH-VMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDR-VYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE 242 (293)
T ss_pred EcCCC-eEEeCccccccccccccceeccCCCCCCccccCHHHhccC-CcCcccceeehhhHHHHHhcCCCCCCCCCCHHH
Confidence 99887 799999999976543221 1122335679999988544 48999999999999999997 999998766544
Q ss_pred HHHHHHHHhCCCChhhhhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 016184 293 QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH 365 (394)
Q Consensus 293 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 365 (394)
....+..... . ..+...+..+.+|+.+||..||.+|||+.+++++
T Consensus 243 ~~~~~~~~~~----------------~------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~ 287 (293)
T cd05053 243 LFKLLKEGYR----------------M------------EKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED 287 (293)
T ss_pred HHHHHHcCCc----------------C------------CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 4433322100 0 0113467899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=290.70 Aligned_cols=243 Identities=21% Similarity=0.311 Sum_probs=188.6
Q ss_pred eeEEEeeEEeecCceEEEEEEECCCCc----EEEEEEeccc-----hhhhHHHHHHHHHcCCCCeeeeceEEEecCCCce
Q 016184 82 VSYIAEHVVGTGSFGVVFQAKCRETGE----IVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE 152 (394)
Q Consensus 82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~----~vaiK~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 152 (394)
.+|++.++||+|+||+||+|++..+|. .||+|++... .....+|+.+++.+.|+||+++++++...
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~----- 81 (279)
T cd05109 7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS----- 81 (279)
T ss_pred hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-----
Confidence 459999999999999999999877776 4899987532 22345688899999999999999887321
Q ss_pred eEEEEEEeccc-ccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecC
Q 016184 153 LYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS 231 (394)
Q Consensus 153 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~ 231 (394)
..+++++|++ +++.+.+... ...+++..+..++.|++.||+|||+ .||+||||||+|||++.++ .+||+|||+
T Consensus 82 -~~~l~~~~~~~g~l~~~l~~~---~~~~~~~~~~~~~~qi~~~L~~lH~-~~iiH~dlkp~Nil~~~~~-~~kL~dfG~ 155 (279)
T cd05109 82 -TVQLVTQLMPYGCLLDYVREN---KDRIGSQDLLNWCVQIAKGMSYLEE-VRLVHRDLAARNVLVKSPN-HVKITDFGL 155 (279)
T ss_pred -CcEEEEEcCCCCCHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccccccceEEEcCCC-cEEECCCCc
Confidence 2557899988 4666655431 3568999999999999999999999 8999999999999999877 699999999
Q ss_pred ccccccCCCcc---cccccccccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCChh
Q 016184 232 AKVLVKGEPNV---SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTRE 307 (394)
Q Consensus 232 a~~~~~~~~~~---~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~ 307 (394)
++......... ...+++.|+|||.+.+. .++.++|||||||++|||++ |..||.......... .......++
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~-~~~~~~~~~-- 231 (279)
T cd05109 156 ARLLDIDETEYHADGGKVPIKWMALESILHR-RFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPD-LLEKGERLP-- 231 (279)
T ss_pred eeecccccceeecCCCccchhhCCHHHhccC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH-HHHCCCcCC--
Confidence 97664332211 12335679999998654 48999999999999999998 899997665443332 222111100
Q ss_pred hhhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 016184 308 EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV 364 (394)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 364 (394)
.+..++.++.+++.+||..||++||++.+++.
T Consensus 232 -------------------------~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~ 263 (279)
T cd05109 232 -------------------------QPPICTIDVYMIMVKCWMIDSECRPRFRELVD 263 (279)
T ss_pred -------------------------CCccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 11346889999999999999999999999984
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=291.02 Aligned_cols=251 Identities=19% Similarity=0.198 Sum_probs=184.6
Q ss_pred eEEEeeEEeecCceEEEEEEECCC---CcEEEEEEeccchhhhH---------------HHHHHHHHcCCCCeeeeceEE
Q 016184 83 SYIAEHVVGTGSFGVVFQAKCRET---GEIVAIKKVLQDKRYKN---------------RELQIMQMLDHPNIVALKHCF 144 (394)
Q Consensus 83 ~y~~~~~lg~G~~g~V~~~~~~~~---~~~vaiK~~~~~~~~~~---------------~E~~~l~~l~h~~iv~~~~~~ 144 (394)
+|.+.+.||+|+||.||+|.+..+ +..+|+|+......... .+...+..+.|++++.++++.
T Consensus 13 ~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~ 92 (294)
T PHA02882 13 EWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGCG 92 (294)
T ss_pred ceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEee
Confidence 599999999999999999999877 67788886432221111 122334556899999998876
Q ss_pred EecCCCceeEEEEEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcE
Q 016184 145 FSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQL 224 (394)
Q Consensus 145 ~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~v 224 (394)
.... ....+.+++++++..++..++.. ....++..++.++.|++.||+|||+ .+|+||||||+|||++.++ .+
T Consensus 93 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~-~~iiHrDiKp~Nill~~~~-~~ 165 (294)
T PHA02882 93 SFKR-CRMYYRFILLEKLVENTKEIFKR----IKCKNKKLIKNIMKDMLTTLEYIHE-HGISHGDIKPENIMVDGNN-RG 165 (294)
T ss_pred eEec-CCceEEEEEEehhccCHHHHHHh----hccCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEcCCC-cE
Confidence 4333 22345678899887776655543 2346788899999999999999999 8999999999999999887 69
Q ss_pred EEEeecCccccccCC--------CcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHH
Q 016184 225 KLCDFGSAKVLVKGE--------PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVE 296 (394)
Q Consensus 225 kl~Dfg~a~~~~~~~--------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~ 296 (394)
+|+|||+|+...... ......||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.........
T Consensus 166 ~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~-~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~ 244 (294)
T PHA02882 166 YIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGA-CVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIH 244 (294)
T ss_pred EEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCC-CCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHH
Confidence 999999997653221 11234689999999998654 489999999999999999999999987643222221
Q ss_pred HHH--HhCCCChhhhhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 016184 297 IIK--VLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV 364 (394)
Q Consensus 297 i~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 364 (394)
... ........ .. .....+..+.+++..|+..+|++||+..++++
T Consensus 245 ~~~~~~~~~~~~~----------~~-------------~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~ 291 (294)
T PHA02882 245 AAKCDFIKRLHEG----------KI-------------KIKNANKFIYDFIECVTKLSYEEKPDYDALIK 291 (294)
T ss_pred HhHHHHHHHhhhh----------hh-------------ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 111 11000000 00 01346789999999999999999999999875
|
|
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-39 Score=293.40 Aligned_cols=246 Identities=21% Similarity=0.360 Sum_probs=189.0
Q ss_pred eEEEeeEEeecCceEEEEEEECC-----CCcEEEEEEeccch-----hhhHHHHHHHHHcCCCCeeeeceEEEecCCCce
Q 016184 83 SYIAEHVVGTGSFGVVFQAKCRE-----TGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE 152 (394)
Q Consensus 83 ~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 152 (394)
+|++.+.||+|+||.||+|++.. ....+|+|.+.... ....+|+.+++.++||||+++++.+. ..
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~ 75 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACS-----QD 75 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEe-----cC
Confidence 37889999999999999998753 23568999875432 23457999999999999999999873 23
Q ss_pred eEEEEEEeccc-ccHHHHHHHhhh--------------------hcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCC
Q 016184 153 LYLNLVLEYVP-ETVNRIARNYSR--------------------IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIK 211 (394)
Q Consensus 153 ~~~~lv~e~~~-~~l~~~~~~~~~--------------------~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlk 211 (394)
...++++||+. ++|.+++..... ....+++..++.++.|++.||+|||+ .|++|||||
T Consensus 76 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~ivH~dik 154 (290)
T cd05045 76 GPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAE-MKLVHRDLA 154 (290)
T ss_pred CCcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHH-CCeehhhhh
Confidence 33678999998 477776654221 12457889999999999999999999 899999999
Q ss_pred CCceEEeCCCCcEEEEeecCccccccCCC---cccccccccccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCC
Q 016184 212 PQNLLVNPHTHQLKLCDFGSAKVLVKGEP---NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPG 287 (394)
Q Consensus 212 p~Nil~~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~ 287 (394)
|+|||++.++ .+||+|||+++....... .....++..|+|||.+.+. .++.++||||||+++|+|++ |..||.+
T Consensus 155 p~nill~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~-~~~~~~Di~slG~~l~el~t~g~~p~~~ 232 (290)
T cd05045 155 ARNVLVAEGR-KMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDH-IYTTQSDVWSFGVLLWEIVTLGGNPYPG 232 (290)
T ss_pred hheEEEcCCC-cEEeccccccccccCccchhcccCCCCCccccCHHHHccC-CcchHhHHHHHHHHHHHHHhcCCCCCCC
Confidence 9999999877 799999999875533221 1122346679999988554 48999999999999999998 9999977
Q ss_pred CCcHHHHHHHHHHhCCCChhhhhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 016184 288 ESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV 364 (394)
Q Consensus 288 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 364 (394)
.........+.... . ...+..++.++.+|+.+||+.||++||++.++++
T Consensus 233 ~~~~~~~~~~~~~~------------------~----------~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~ 281 (290)
T cd05045 233 IAPERLFNLLKTGY------------------R----------MERPENCSEEMYNLMLTCWKQEPDKRPTFADISK 281 (290)
T ss_pred CCHHHHHHHHhCCC------------------C----------CCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 65443332221100 0 0012457889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=292.50 Aligned_cols=255 Identities=29% Similarity=0.457 Sum_probs=195.7
Q ss_pred EEEeeEEeecCceEEEEEEEC---CCCcEEEEEEeccch--------hhhHHHHHHHHHc-CCCCeeeeceEEEecCCCc
Q 016184 84 YIAEHVVGTGSFGVVFQAKCR---ETGEIVAIKKVLQDK--------RYKNRELQIMQML-DHPNIVALKHCFFSTTDKE 151 (394)
Q Consensus 84 y~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~--------~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~ 151 (394)
|++.+.||+|++|.||+|++. .+++.||||++.+.. ....+|+.++..+ +|+||+++.+++ ..
T Consensus 2 ~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~-----~~ 76 (288)
T cd05583 2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAF-----QT 76 (288)
T ss_pred ceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheee-----ec
Confidence 889999999999999999864 467889999886421 2345689999999 599999998887 33
Q ss_pred eeEEEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeec
Q 016184 152 ELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFG 230 (394)
Q Consensus 152 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg 230 (394)
....++||||+.+ ++...+.. ...+++..++.++.|++.||.|||+ .|++|+||||+||+++.++ .++|+|||
T Consensus 77 ~~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~ql~~~l~~lH~-~~~~H~dl~p~nil~~~~~-~~~l~dfg 150 (288)
T cd05583 77 DTKLHLILDYVNGGELFTHLYQ----REHFTESEVRVYIAEIVLALDHLHQ-LGIIYRDIKLENILLDSEG-HVVLTDFG 150 (288)
T ss_pred CCEEEEEEecCCCCcHHHHHhh----cCCcCHHHHHHHHHHHHHHHHHHHH-CCeeccCCCHHHeEECCCC-CEEEEECc
Confidence 3457899999985 55554432 3568899999999999999999999 8999999999999999887 69999999
Q ss_pred CccccccCCC--cccccccccccccccccCCC-CCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChh
Q 016184 231 SAKVLVKGEP--NVSYICSRYYRAPELIFGAT-EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 307 (394)
Q Consensus 231 ~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~-~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~ 307 (394)
++........ .....++..|+|||.+.+.. ..+.++|+||||+++|+|++|..||...........+.+.....
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~--- 227 (288)
T cd05583 151 LSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKS--- 227 (288)
T ss_pred cccccccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHcc---
Confidence 9876533322 12345788999999985432 26789999999999999999999996543222222221110000
Q ss_pred hhhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCC---HHHHhcCCCCCCCCCC
Q 016184 308 EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCT---ALEACVHPFFDELRDP 374 (394)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt---~~ell~hp~f~~~~~~ 374 (394)
. ...+..++..+.++|.+||+.||++||| +.++|+||||+.+...
T Consensus 228 ----------~------------~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~~~~ 275 (288)
T cd05583 228 ----------K------------PPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGIDWD 275 (288)
T ss_pred ----------C------------CCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCcccccCCHH
Confidence 0 0012346889999999999999999998 5688999999998654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=285.78 Aligned_cols=243 Identities=24% Similarity=0.319 Sum_probs=191.1
Q ss_pred eeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccch---hhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEEEEE
Q 016184 82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLV 158 (394)
Q Consensus 82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv 158 (394)
.+|.+.+.||+|++|.||+|.+..+ ..+|+|.+.... ....+|+.+++.++|+|++++++++. . ...+++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~-~~~~~v 78 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVS-----E-EPIYIV 78 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCCccHHHHHHHHHHHHhCCCCCeeeEEEEEc-----C-CCcEEE
Confidence 3599999999999999999998654 459999876432 34457999999999999999988762 1 125799
Q ss_pred Eecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCcccccc
Q 016184 159 LEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK 237 (394)
Q Consensus 159 ~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~ 237 (394)
|||+.+ +|.+++... ....+++..+..++.|++.||.|||+ .|++|+||||+||+++.++ .++|+|||.+.....
T Consensus 79 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~al~~lH~-~~i~H~dl~~~Nill~~~~-~~~l~dfg~~~~~~~ 154 (260)
T cd05069 79 TEFMGKGSLLDFLKEG--DGKYLKLPQLVDMAAQIADGMAYIER-MNYIHRDLRAANILVGDNL-VCKIADFGLARLIED 154 (260)
T ss_pred EEcCCCCCHHHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHHh-CCEeecccCcceEEEcCCC-eEEECCCccceEccC
Confidence 999985 777766542 23457899999999999999999999 8999999999999999887 799999999976533
Q ss_pred CCCc--ccccccccccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCC
Q 016184 238 GEPN--VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 314 (394)
Q Consensus 238 ~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 314 (394)
.... ....++..|+|||...+. .++.++|+||||+++|+|++ |..||.+....+....+..... +
T Consensus 155 ~~~~~~~~~~~~~~y~~Pe~~~~~-~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~-~---------- 222 (260)
T cd05069 155 NEYTARQGAKFPIKWTAPEAALYG-RFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYR-M---------- 222 (260)
T ss_pred CcccccCCCccchhhCCHHHhccC-CcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC-C----------
Confidence 2211 123346779999988544 48999999999999999999 8999988765554444322100 0
Q ss_pred CCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 016184 315 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV 364 (394)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 364 (394)
..+...+..+.+++++||..||++||+++++++
T Consensus 223 -----------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 255 (260)
T cd05069 223 -----------------PCPQGCPESLHELMKLCWKKDPDERPTFEYIQS 255 (260)
T ss_pred -----------------CCCcccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 012356889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=285.50 Aligned_cols=241 Identities=23% Similarity=0.335 Sum_probs=190.4
Q ss_pred eEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccch--hhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEEEEEEe
Q 016184 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK--RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLE 160 (394)
Q Consensus 83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e 160 (394)
+|++.+.||+|+||.||++... |..||+|.+.... ....+|+.+++.++|+|++++++++... ....+++||
T Consensus 7 ~~~~~~~lg~g~~~~v~~~~~~--~~~~~~k~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~----~~~~~lv~e 80 (256)
T cd05082 7 ELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEE----KGGLYIVTE 80 (256)
T ss_pred hCeeeeeecccCCCeEEEEEEc--CCcEEEEEeCCCchHHHHHHHHHHHHhCCCCCeeeEEEEEEcC----CCceEEEEE
Confidence 5999999999999999999875 7889999886543 2356799999999999999999876432 223679999
Q ss_pred cccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCccccccCC
Q 016184 161 YVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE 239 (394)
Q Consensus 161 ~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~~~ 239 (394)
|+++ ++.+++.... ...+++..+..++.|++.||+|||+ +|++||||||+||+++.++ .+||+|||++.......
T Consensus 81 ~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dlkp~nil~~~~~-~~kl~dfg~~~~~~~~~ 156 (256)
T cd05082 81 YMAKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEA-NNFVHRDLAARNVLVSEDN-VAKVSDFGLTKEASSTQ 156 (256)
T ss_pred CCCCCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHh-CCEeccccchheEEEcCCC-cEEecCCccceeccccC
Confidence 9985 7776665422 2458889999999999999999999 8999999999999999887 79999999987543322
Q ss_pred CcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCCCcc
Q 016184 240 PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 318 (394)
Q Consensus 240 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 318 (394)
.....+..|+|||++.+. .++.++|||||||++|+|++ |+.||......+....+....
T Consensus 157 --~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~----------------- 216 (256)
T cd05082 157 --DTGKLPVKWTAPEALREK-KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGY----------------- 216 (256)
T ss_pred --CCCccceeecCHHHHccC-CCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCC-----------------
Confidence 223345679999998554 48999999999999999997 999997665444333332210
Q ss_pred cCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 016184 319 FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV 364 (394)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 364 (394)
.......+++.+.+++.+||+.||++|||+.++++
T Consensus 217 -----------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 251 (256)
T cd05082 217 -----------KMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLRE 251 (256)
T ss_pred -----------CCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 00012457899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-39 Score=289.52 Aligned_cols=242 Identities=26% Similarity=0.391 Sum_probs=187.4
Q ss_pred EEeeEEeecCceEEEEEEEC----CCCcEEEEEEeccc-----hhhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEE
Q 016184 85 IAEHVVGTGSFGVVFQAKCR----ETGEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL 155 (394)
Q Consensus 85 ~~~~~lg~G~~g~V~~~~~~----~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 155 (394)
.+.+.||.|.||.||+|.+. ..+..|+||.+... ...+.+|++.++.++||||+++++++..... .
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~-----~ 76 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEP-----L 76 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSS-----E
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccc-----c
Confidence 46788999999999999997 44678999998532 2445679999999999999999999863222 7
Q ss_pred EEEEeccc-ccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCccc
Q 016184 156 NLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV 234 (394)
Q Consensus 156 ~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~ 234 (394)
++|+||++ ++|.+.+... ....+++..+..++.|++.||.|||+ .+++|++|+++|||++.++ .+||+|||++..
T Consensus 77 ~lv~e~~~~g~L~~~L~~~--~~~~~~~~~~~~i~~~i~~~l~~Lh~-~~iiH~~l~~~nill~~~~-~~Kl~~f~~~~~ 152 (259)
T PF07714_consen 77 FLVMEYCPGGSLDDYLKSK--NKEPLSEQQRLSIAIQIAEALSYLHS-NNIIHGNLSPSNILLDSNG-QVKLSDFGLSRP 152 (259)
T ss_dssp EEEEE--TTEBHHHHHHHT--CTTTSBHHHHHHHHHHHHHHHHHHHH-TTEEEST-SGGGEEEETTT-EEEEESTTTGEE
T ss_pred ccccccccccccccccccc--cccccccccccccccccccccccccc-ccccccccccccccccccc-cccccccccccc
Confidence 79999998 5788777764 13678999999999999999999999 8999999999999999888 899999999876
Q ss_pred cccCCC---cccccccccccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCChhhhh
Q 016184 235 LVKGEP---NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIK 310 (394)
Q Consensus 235 ~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 310 (394)
...... .........|+|||.+.... ++.++||||||+++|||++ |+.||...+..+....+.+...
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~-~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~-------- 223 (259)
T PF07714_consen 153 ISEKSKYKNDSSQQLPLRYLAPEVLKDGE-YTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQR-------- 223 (259)
T ss_dssp TTTSSSEEESTTSESGGGGS-HHHHHHSE-ESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEE--------
T ss_pred ccccccccccccccccccccccccccccc-cccccccccccccccccccccccccccccccccccccccccc--------
Confidence 522211 12334577899999986544 8999999999999999999 7899988866665555533110
Q ss_pred ccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 016184 311 CMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV 364 (394)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 364 (394)
..++..++..+.++|..||..||.+|||+.++++
T Consensus 224 --------------------~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~ 257 (259)
T PF07714_consen 224 --------------------LPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQ 257 (259)
T ss_dssp --------------------TTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHH
T ss_pred --------------------ceeccchhHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 0122467899999999999999999999999874
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=292.53 Aligned_cols=247 Identities=24% Similarity=0.355 Sum_probs=192.5
Q ss_pred ceeEEEeeEEeecCceEEEEEEE-----CCCCcEEEEEEeccch-----hhhHHHHHHHHHc-CCCCeeeeceEEEecCC
Q 016184 81 KVSYIAEHVVGTGSFGVVFQAKC-----RETGEIVAIKKVLQDK-----RYKNRELQIMQML-DHPNIVALKHCFFSTTD 149 (394)
Q Consensus 81 ~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~ 149 (394)
.++|.+.+.||+|+||.||+|.+ ..++..||+|.+.... ....+|+++++++ +|+||+++++++..
T Consensus 34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~--- 110 (302)
T cd05055 34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTI--- 110 (302)
T ss_pred HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEec---
Confidence 44699999999999999999985 3345689999876432 2355799999999 79999999998733
Q ss_pred CceeEEEEEEeccc-ccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEe
Q 016184 150 KEELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCD 228 (394)
Q Consensus 150 ~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~D 228 (394)
....+++|||+. ++|.+++.... ...+++..+..++.|++.||.|||+ .+|+|+||||+|||++.++ .++|+|
T Consensus 111 --~~~~~lv~e~~~~~~L~~~i~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~-~~ivH~dlkp~Nil~~~~~-~~~l~d 184 (302)
T cd05055 111 --GGPILVITEYCCYGDLLNFLRRKR--ESFLTLEDLLSFSYQVAKGMAFLAS-KNCIHRDLAARNVLLTHGK-IVKICD 184 (302)
T ss_pred --CCceEEEEEcCCCCcHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHH-CCeehhhhccceEEEcCCC-eEEECC
Confidence 234789999998 47766665321 2348999999999999999999999 8999999999999999777 799999
Q ss_pred ecCccccccCCC---cccccccccccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCC
Q 016184 229 FGSAKVLVKGEP---NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTP 304 (394)
Q Consensus 229 fg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~ 304 (394)
||++........ .....++..|+|||.+.+.. ++.++|||||||++|+|++ |..||.+......+.........
T Consensus 185 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~~- 262 (302)
T cd05055 185 FGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCV-YTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYR- 262 (302)
T ss_pred CcccccccCCCceeecCCCCcccccCCHhhhccCC-CCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCCc-
Confidence 999876533221 11233467899999986554 8999999999999999998 99999877655544443321100
Q ss_pred ChhhhhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 016184 305 TREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV 364 (394)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 364 (394)
...+...++.+.+|+.+||..||++|||+.++++
T Consensus 263 --------------------------~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~ 296 (302)
T cd05055 263 --------------------------MAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQ 296 (302)
T ss_pred --------------------------CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 0011346789999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=288.20 Aligned_cols=248 Identities=22% Similarity=0.386 Sum_probs=195.7
Q ss_pred EEEeeEEeecCceEEEEEEECC-CCcEEEEEEeccch--------------hhhHHHHHHHHH-cCCCCeeeeceEEEec
Q 016184 84 YIAEHVVGTGSFGVVFQAKCRE-TGEIVAIKKVLQDK--------------RYKNRELQIMQM-LDHPNIVALKHCFFST 147 (394)
Q Consensus 84 y~~~~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~~~--------------~~~~~E~~~l~~-l~h~~iv~~~~~~~~~ 147 (394)
|++.+.||+|+||.||+|.+.. +++.+|+|.+.... ....+|+.++.. ++|+||+++++++.
T Consensus 2 y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~-- 79 (269)
T cd08528 2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFL-- 79 (269)
T ss_pred chhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEc--
Confidence 8889999999999999999987 67899999874221 112346666654 79999999999883
Q ss_pred CCCceeEEEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEE
Q 016184 148 TDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKL 226 (394)
Q Consensus 148 ~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl 226 (394)
...+.+++|||+++ ++.+++.........+++..++.++.|++.||.|||...|++|+||+|+||+++.++ .++|
T Consensus 80 ---~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~-~~~l 155 (269)
T cd08528 80 ---ENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDD-KVTI 155 (269)
T ss_pred ---cCCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCC-cEEE
Confidence 34458899999985 777777655555567999999999999999999999536899999999999999888 7999
Q ss_pred EeecCccccccCCCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCh
Q 016184 227 CDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTR 306 (394)
Q Consensus 227 ~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~ 306 (394)
+|||.+.............++..|+|||.+.+. .++.++|+||||+++|+|++|+.||...........+......+.
T Consensus 156 ~dfg~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~-~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~- 233 (269)
T cd08528 156 TDFGLAKQKQPESKLTSVVGTILYSCPEIVKNE-PYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPL- 233 (269)
T ss_pred ecccceeecccccccccccCcccCcChhhhcCC-CCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCcC-
Confidence 999999766544433455678899999999654 489999999999999999999999976655444443332111100
Q ss_pred hhhhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 016184 307 EEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH 365 (394)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 365 (394)
....+++.+.++|++||+.||++||++.|+..+
T Consensus 234 --------------------------~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~ 266 (269)
T cd08528 234 --------------------------PEGMYSEDVTDVITSCLTPDAEARPDIIQVSAM 266 (269)
T ss_pred --------------------------CcccCCHHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence 012467899999999999999999999998653
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=291.49 Aligned_cols=256 Identities=26% Similarity=0.362 Sum_probs=188.2
Q ss_pred EEEeeEEeecCceEEEEEEE----CCCCcEEEEEEeccc-----hhhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeE
Q 016184 84 YIAEHVVGTGSFGVVFQAKC----RETGEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY 154 (394)
Q Consensus 84 y~~~~~lg~G~~g~V~~~~~----~~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 154 (394)
|.+.+.||+|+||+||++.. ..++..||+|.+... .....+|+++++.++||||+++++++.. ....+
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~~~~ 82 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSE---QGGKG 82 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEec---CCCce
Confidence 48999999999999988653 356789999988643 2334579999999999999999987743 22345
Q ss_pred EEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCcc
Q 016184 155 LNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK 233 (394)
Q Consensus 155 ~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~ 233 (394)
.+++|||+.+ ++.+++.. ..+++..++.++.|++.||+|||+ +||+|+||||+|||++.++ .++|+|||++.
T Consensus 83 ~~lv~e~~~~~~l~~~~~~-----~~l~~~~~~~i~~~l~~~l~~lH~-~~i~H~dlkp~Nili~~~~-~~~l~dfg~~~ 155 (283)
T cd05080 83 LQLIMEYVPLGSLRDYLPK-----HKLNLAQLLLFAQQICEGMAYLHS-QHYIHRDLAARNVLLDNDR-LVKIGDFGLAK 155 (283)
T ss_pred EEEEecCCCCCCHHHHHHH-----cCCCHHHHHHHHHHHHHHHHHHHH-CCeeccccChheEEEcCCC-cEEEeeccccc
Confidence 7899999985 66665543 469999999999999999999999 8999999999999999887 69999999987
Q ss_pred ccccCCCc----ccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHh-CCCChhh
Q 016184 234 VLVKGEPN----VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVL-GTPTREE 308 (394)
Q Consensus 234 ~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~-~~~~~~~ 308 (394)
........ ....++..|+|||.+.+. .++.++||||||+++|+|++|..||...... +..+.... +......
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~Di~slG~~l~el~tg~~p~~~~~~~--~~~~~~~~~~~~~~~~ 232 (283)
T cd05080 156 AVPEGHEYYRVREDGDSPVFWYAVECLKEN-KFSYASDVWSFGVTLYELLTHCDSKQSPPKK--FEEMIGPKQGQMTVVR 232 (283)
T ss_pred ccCCcchhhccCCCCCCCceeeCHhHhccc-CCCcccccHHHHHHHHHHHhCCCCCCCCcch--hhhhhcccccccchhh
Confidence 65433221 122345679999998654 4899999999999999999999998654321 11111100 0000000
Q ss_pred hhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 016184 309 IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV 364 (394)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 364 (394)
.... .........+..++..+.+++.+||+.||++|||++++++
T Consensus 233 ~~~~------------~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~ 276 (283)
T cd05080 233 LIEL------------LERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP 276 (283)
T ss_pred hhhh------------hhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 0000 0000000123457889999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=292.27 Aligned_cols=254 Identities=19% Similarity=0.268 Sum_probs=193.2
Q ss_pred eeEEEeeEEeecCceEEEEEEECCCC----------------cEEEEEEeccch-----hhhHHHHHHHHHcCCCCeeee
Q 016184 82 VSYIAEHVVGTGSFGVVFQAKCRETG----------------EIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVAL 140 (394)
Q Consensus 82 ~~y~~~~~lg~G~~g~V~~~~~~~~~----------------~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~ 140 (394)
.+|++.+.||+|+||.||+|.+...+ ..||+|.+.... ....+|+++++.++|+||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~ 84 (296)
T cd05051 5 QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARL 84 (296)
T ss_pred hhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeEE
Confidence 45999999999999999999876543 568999876432 334579999999999999999
Q ss_pred ceEEEecCCCceeEEEEEEecccc-cHHHHHHHhhh-------hcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCC
Q 016184 141 KHCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSR-------IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKP 212 (394)
Q Consensus 141 ~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~-------~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp 212 (394)
++++.. ..+.+++||++.+ +|..++..... ....+++..++.++.|++.||+|||+ .||+|+||||
T Consensus 85 ~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~-~~i~H~dlkp 158 (296)
T cd05051 85 LGVCTV-----DPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLES-LNFVHRDLAT 158 (296)
T ss_pred EEEEec-----CCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHH-cCccccccch
Confidence 998732 2457899999974 77776654321 11368999999999999999999999 8999999999
Q ss_pred CceEEeCCCCcEEEEeecCccccccCCC---cccccccccccccccccCCCCCCChhhHHHHHHHHHHHHh--CCCCCCC
Q 016184 213 QNLLVNPHTHQLKLCDFGSAKVLVKGEP---NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL--GQPLFPG 287 (394)
Q Consensus 213 ~Nil~~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt--g~~pf~~ 287 (394)
+||+++.++ .++|+|||++........ .....+++.|+|||.+.+. .++.++|||||||++|+|++ |..||..
T Consensus 159 ~Nili~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~~~~~~~p~~~ 236 (296)
T cd05051 159 RNCLVGKNY-TIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLG-KFTTKSDVWAFGVTLWEILTLCREQPYEH 236 (296)
T ss_pred hceeecCCC-ceEEccccceeecccCcceeecCcCCCCceecCHHHhhcC-CCCccchhhhhHHHHHHHHhcCCCCCCCC
Confidence 999999887 799999999876533321 1233456789999998654 48999999999999999998 6788876
Q ss_pred CCcHHHHHHHHHHhCCCChhhhhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 016184 288 ESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV 364 (394)
Q Consensus 288 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 364 (394)
......+........... ... ....+..++.++.+|+.+||+.||.+|||+.++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~-----------~~~----------~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~ 292 (296)
T cd05051 237 LTDQQVIENAGHFFRDDG-----------RQI----------YLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHL 292 (296)
T ss_pred cChHHHHHHHHhcccccc-----------ccc----------cCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence 665554444432110000 000 00012346789999999999999999999999964
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-41 Score=286.11 Aligned_cols=287 Identities=33% Similarity=0.539 Sum_probs=225.4
Q ss_pred EEEeeEEeecCceEEEEEEECCCCcEEEEEEecc------chhhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEEEE
Q 016184 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQ------DKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL 157 (394)
Q Consensus 84 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~------~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 157 (394)
.+-.+.||.|+||.||.+++..+|+.||+|++.. ......+|.++|..++|.|++..+++.-...-....-+|+
T Consensus 55 i~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV 134 (449)
T KOG0664|consen 55 IQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYV 134 (449)
T ss_pred CCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHH
Confidence 4455789999999999999999999999998743 2334457999999999999999888763222222222567
Q ss_pred EEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCcccccc
Q 016184 158 VLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK 237 (394)
Q Consensus 158 v~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~ 237 (394)
++|++..+|..++-. .+.++...++.+++||++||+|||+ .||.||||||.|.|++.+- .+||||||+++....
T Consensus 135 ~TELmQSDLHKIIVS----PQ~Ls~DHvKVFlYQILRGLKYLHs-A~ILHRDIKPGNLLVNSNC-vLKICDFGLARvee~ 208 (449)
T KOG0664|consen 135 LTELMQSDLHKIIVS----PQALTPDHVKVFVYQILRGLKYLHT-ANILHRDIKPGNLLVNSNC-ILKICDFGLARTWDQ 208 (449)
T ss_pred HHHHHHhhhhheecc----CCCCCcchhhhhHHHHHhhhHHHhh-cchhhccCCCccEEeccCc-eEEecccccccccch
Confidence 888888766555443 4778889999999999999999999 9999999999999999886 799999999987644
Q ss_pred CCCc--ccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCC
Q 016184 238 GEPN--VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 315 (394)
Q Consensus 238 ~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 315 (394)
++.. .....|.+|.|||++.+...|+.+.||||+|||+.||+..+..|....+.+++..|.+.+|.|..+.+....++
T Consensus 209 d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEG 288 (449)
T KOG0664|consen 209 RDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEG 288 (449)
T ss_pred hhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhh
Confidence 3322 23456899999999999999999999999999999999999999999999999999999999999988755443
Q ss_pred CcccCCCCCCCCC----cchh-ccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCC
Q 016184 316 YTEFKFPQIKPHP----WHKV-FQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNT 376 (394)
Q Consensus 316 ~~~~~~~~~~~~~----~~~~-~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~ 376 (394)
-..-.+......+ +..+ -+..-..+..+++..+|.+||++|.+.++.+.|+++.+.+-...
T Consensus 289 Ak~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e~R~r~~ 354 (449)
T KOG0664|consen 289 AKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEEGRLRFH 354 (449)
T ss_pred hHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccccccccceeee
Confidence 2211111000000 1110 11233457889999999999999999999999999999876544
|
|
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=285.94 Aligned_cols=243 Identities=22% Similarity=0.310 Sum_probs=192.0
Q ss_pred eeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccch---hhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEEEEE
Q 016184 82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLV 158 (394)
Q Consensus 82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv 158 (394)
.+|++.++||+|+||.||+|... +++.||+|.+.... ....+|+.+++.++|+||+++++++. . ...+++
T Consensus 6 ~~~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~----~--~~~~~v 78 (260)
T cd05067 6 ETLKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVT----Q--EPIYII 78 (260)
T ss_pred HHceeeeeeccCccceEEeeecC-CCceEEEEEecCCCCcHHHHHHHHHHHHhcCCcCeeeEEEEEc----c--CCcEEE
Confidence 46999999999999999999874 57889999886533 34567999999999999999987651 1 136799
Q ss_pred Eecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCcccccc
Q 016184 159 LEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK 237 (394)
Q Consensus 159 ~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~ 237 (394)
|||+.+ ++.+.+... ....+++..+..++.|++.||+|||+ .|++|+||||+||+++.++ .++|+|||++.....
T Consensus 79 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~i~~~i~~al~~LH~-~~i~H~dl~p~ni~i~~~~-~~~l~dfg~~~~~~~ 154 (260)
T cd05067 79 TEYMENGSLVDFLKTP--EGIKLTINKLIDMAAQIAEGMAFIER-KNYIHRDLRAANILVSETL-CCKIADFGLARLIED 154 (260)
T ss_pred EEcCCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHhc-CCeecccccHHhEEEcCCC-CEEEccCcceeecCC
Confidence 999974 676665432 23568899999999999999999999 8999999999999999887 799999999876542
Q ss_pred CCC--cccccccccccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCC
Q 016184 238 GEP--NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 314 (394)
Q Consensus 238 ~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 314 (394)
... .....++..|+|||.+... .++.++||||||+++|+|++ |+.||.+.+..+....+......
T Consensus 155 ~~~~~~~~~~~~~~y~~pe~~~~~-~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~----------- 222 (260)
T cd05067 155 NEYTAREGAKFPIKWTAPEAINYG-TFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRM----------- 222 (260)
T ss_pred CCcccccCCcccccccCHHHhccC-CcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCC-----------
Confidence 221 1123346779999998544 48899999999999999999 99999877655544443221100
Q ss_pred CCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 016184 315 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV 364 (394)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 364 (394)
......+.++.++|.+||..||++|||++++++
T Consensus 223 -----------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05067 223 -----------------PRPDNCPEELYELMRLCWKEKPEERPTFEYLRS 255 (260)
T ss_pred -----------------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 011346789999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-41 Score=333.46 Aligned_cols=257 Identities=28% Similarity=0.462 Sum_probs=206.1
Q ss_pred ceeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccc------hhhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeE
Q 016184 81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY 154 (394)
Q Consensus 81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 154 (394)
..+|.-..+||.|.||.||.|.+..+|+..|+|-+.-. .....+|..++..++|||+|+.+++-.....
T Consensus 1234 ~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRek----- 1308 (1509)
T KOG4645|consen 1234 TFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREK----- 1308 (1509)
T ss_pred eeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHH-----
Confidence 34688888999999999999999999999999976432 2334589999999999999999987643332
Q ss_pred EEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCcc
Q 016184 155 LNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK 233 (394)
Q Consensus 155 ~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~ 233 (394)
++|.||||.+ +|.+++.. +...++...+.+..|++.|+.|||+ +|||||||||+||+++.+| .+|++|||.|.
T Consensus 1309 v~IFMEyC~~GsLa~ll~~----gri~dE~vt~vyt~qll~gla~LH~-~gIVHRDIK~aNI~Ld~~g-~iK~~DFGsa~ 1382 (1509)
T KOG4645|consen 1309 VYIFMEYCEGGSLASLLEH----GRIEDEMVTRVYTKQLLEGLAYLHE-HGIVHRDIKPANILLDFNG-LIKYGDFGSAV 1382 (1509)
T ss_pred HHHHHHHhccCcHHHHHHh----cchhhhhHHHHHHHHHHHHHHHHHh-cCceecCCCccceeeecCC-cEEeeccccee
Confidence 6789999995 66666553 3557777888889999999999999 8999999999999999888 79999999998
Q ss_pred ccccCC-----CcccccccccccccccccCCC--CCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCh
Q 016184 234 VLVKGE-----PNVSYICSRYYRAPELIFGAT--EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTR 306 (394)
Q Consensus 234 ~~~~~~-----~~~~~~~t~~y~aPE~~~~~~--~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~ 306 (394)
.+...- ......||+.|||||++.+.. ....++|||||||++.||+||+.||...+..=++.-.+.....|.
T Consensus 1383 ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~Pq- 1461 (1509)
T KOG4645|consen 1383 KIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKPQ- 1461 (1509)
T ss_pred EecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCCC-
Confidence 765442 223578999999999997654 256789999999999999999999987554322222222211111
Q ss_pred hhhhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCC
Q 016184 307 EEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 375 (394)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~ 375 (394)
++.+++.+.++||.+||..||.+|.++.|||.|-|=+.-.+.-
T Consensus 1462 --------------------------~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~f~~~~~d~~ 1504 (1509)
T KOG4645|consen 1462 --------------------------IPERLSSEGRDFLEHCLEQDPKMRWTASQLLEHAFGKSCTDED 1504 (1509)
T ss_pred --------------------------CchhhhHhHHHHHHHHHhcCchhhhHHHHHHHhhccccccccc
Confidence 3456899999999999999999999999999999987765543
|
|
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=286.18 Aligned_cols=243 Identities=23% Similarity=0.318 Sum_probs=190.8
Q ss_pred eeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccc---hhhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEEEEE
Q 016184 82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD---KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLV 158 (394)
Q Consensus 82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv 158 (394)
.+|++.+.||+|+||.||+|.+. ++..||+|.+... .....+|+.+++.++|+|++++++++. . ...+++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~----~--~~~~lv 78 (260)
T cd05070 6 ESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVS----E--EPIYIV 78 (260)
T ss_pred HHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCCCHHHHHHHHHHHHhcCCCceEEEEeEEC----C--CCcEEE
Confidence 35999999999999999999875 5677999988643 234568999999999999999988662 1 125699
Q ss_pred Eecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCcccccc
Q 016184 159 LEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK 237 (394)
Q Consensus 159 ~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~ 237 (394)
|||+++ +|.+++... ....+++..++.++.|++.||+|||+ .|++|+||||+||+++.++ .++|+|||++.....
T Consensus 79 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~al~~lH~-~~i~H~di~p~Nili~~~~-~~~l~dfg~~~~~~~ 154 (260)
T cd05070 79 TEYMSKGSLLDFLKDG--EGRALKLPNLVDMAAQVAAGMAYIER-MNYIHRDLRSANILVGDGL-VCKIADFGLARLIED 154 (260)
T ss_pred EEecCCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCccceEEEeCCc-eEEeCCceeeeeccC
Confidence 999975 777766542 23468999999999999999999999 8999999999999999887 799999999976543
Q ss_pred CCCc--ccccccccccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCC
Q 016184 238 GEPN--VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 314 (394)
Q Consensus 238 ~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 314 (394)
.... ....++..|+|||.+.+. .++.++|+||||+++|+|++ |..||.+.+..+....+..... +
T Consensus 155 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~-~---------- 222 (260)
T cd05070 155 NEYTARQGAKFPIKWTAPEAALYG-RFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYR-M---------- 222 (260)
T ss_pred cccccccCCCCCccccChHHHhcC-CCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC-C----------
Confidence 2211 122345679999988544 48899999999999999999 8999987665554444332100 0
Q ss_pred CCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 016184 315 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV 364 (394)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 364 (394)
..+...+..+.+|+.+||..||++|||+.++++
T Consensus 223 -----------------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 255 (260)
T cd05070 223 -----------------PCPQDCPISLHELMLQCWKKDPEERPTFEYLQS 255 (260)
T ss_pred -----------------CCCCcCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence 012356889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=298.53 Aligned_cols=251 Identities=24% Similarity=0.359 Sum_probs=190.0
Q ss_pred ceeEEEeeEEeecCceEEEEEEE-----CCCCcEEEEEEeccch-----hhhHHHHHHHHHc-CCCCeeeeceEEEecCC
Q 016184 81 KVSYIAEHVVGTGSFGVVFQAKC-----RETGEIVAIKKVLQDK-----RYKNRELQIMQML-DHPNIVALKHCFFSTTD 149 (394)
Q Consensus 81 ~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~ 149 (394)
.++|++.+.||.|+||.||+|.+ ..+++.||||++.... ....+|+.++..+ +|+||+++++++...
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~-- 83 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP-- 83 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecC--
Confidence 34699999999999999999985 3467899999886422 2345799999999 689999999877432
Q ss_pred CceeEEEEEEecccc-cHHHHHHHhhh-----------------------------------------------------
Q 016184 150 KEELYLNLVLEYVPE-TVNRIARNYSR----------------------------------------------------- 175 (394)
Q Consensus 150 ~~~~~~~lv~e~~~~-~l~~~~~~~~~----------------------------------------------------- 175 (394)
....+++|||+++ +|.+++.....
T Consensus 84 --~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (343)
T cd05103 84 --GGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDV 161 (343)
T ss_pred --CCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccc
Confidence 2346799999985 77666643210
Q ss_pred ----------hcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCccccccCCC---cc
Q 016184 176 ----------IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP---NV 242 (394)
Q Consensus 176 ----------~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~~~~---~~ 242 (394)
....+++..+..++.|++.||+|||+ +||+||||||+|||++.++ .+||+|||++........ ..
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~-~~i~H~dikp~Nil~~~~~-~~kl~dfg~~~~~~~~~~~~~~~ 239 (343)
T cd05103 162 EEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLAS-RKCIHRDLAARNILLSENN-VVKICDFGLARDIYKDPDYVRKG 239 (343)
T ss_pred hhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCccCeEEEcCCC-cEEEEecccccccccCcchhhcC
Confidence 01346788889999999999999999 8999999999999999887 799999999876532211 11
Q ss_pred cccccccccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCCCcccCC
Q 016184 243 SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF 321 (394)
Q Consensus 243 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 321 (394)
...++..|+|||.+.+. .++.++||||||+++|+|++ |..||........+.........+ .
T Consensus 240 ~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~---------------~- 302 (343)
T cd05103 240 DARLPLKWMAPETIFDR-VYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM---------------R- 302 (343)
T ss_pred CCCCCcceECcHHhcCC-CCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCC---------------C-
Confidence 22345679999998654 48999999999999999997 999997754433332222211000 0
Q ss_pred CCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 016184 322 PQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH 365 (394)
Q Consensus 322 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 365 (394)
.+...++++.+++.+||+.||.+|||+.++++|
T Consensus 303 -----------~~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~ 335 (343)
T cd05103 303 -----------APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 335 (343)
T ss_pred -----------CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 112357789999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=283.75 Aligned_cols=240 Identities=25% Similarity=0.374 Sum_probs=191.6
Q ss_pred eEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccchh---hhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEEEEEE
Q 016184 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR---YKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVL 159 (394)
Q Consensus 83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~ 159 (394)
.|++.+.||.|+||.||+|... |+.||+|.+..... ...+|+.+++.++|+||+++++++.. ....++||
T Consensus 7 ~~~~~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~~~v~ 79 (256)
T cd05039 7 ELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQ-----GNPLYIVT 79 (256)
T ss_pred hccceeeeecCCCceEEEEEec--CcEEEEEEeccchhHHHHHHHHHHHHHhcCCcceeeeEEEEcC-----CCCeEEEE
Confidence 5899999999999999999875 78999999876543 45579999999999999999998743 33478999
Q ss_pred ecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCccccccC
Q 016184 160 EYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG 238 (394)
Q Consensus 160 e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~~ 238 (394)
||+++ ++.+++.... ...+++..++.++.|++.||.|||+ .|++|+||||+||+++.++ .++|+|||.+......
T Consensus 80 e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lh~-~~i~H~di~p~Nili~~~~-~~~l~d~g~~~~~~~~ 155 (256)
T cd05039 80 EYMAKGSLVDYLRSRG--RAVITLAQQLGFALDVCEGMEYLEE-KNFVHRDLAARNVLVSEDL-VAKVSDFGLAKEASQG 155 (256)
T ss_pred EecCCCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHh-CCccchhcccceEEEeCCC-CEEEcccccccccccc
Confidence 99984 7777665422 1368999999999999999999999 8999999999999999887 7999999999766322
Q ss_pred CCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCCCc
Q 016184 239 EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 317 (394)
Q Consensus 239 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 317 (394)
.. ....+..|+|||.+... .++.++|+||||+++|+|++ |..||......+....+....
T Consensus 156 ~~--~~~~~~~~~ape~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~---------------- 216 (256)
T cd05039 156 QD--SGKLPVKWTAPEALREK-KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGY---------------- 216 (256)
T ss_pred cc--cCCCcccccCchhhcCC-cCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCC----------------
Confidence 21 23345679999998644 48899999999999999997 999997665443333222100
Q ss_pred ccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 016184 318 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV 364 (394)
Q Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 364 (394)
....+..+++.+.++|.+||..+|++|||+.++++
T Consensus 217 ------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 251 (256)
T cd05039 217 ------------RMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLRE 251 (256)
T ss_pred ------------CCCCccCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 00012346889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=291.90 Aligned_cols=255 Identities=21% Similarity=0.303 Sum_probs=191.7
Q ss_pred ceeEEEeeEEeecCceEEEEEEECCCC--------------cEEEEEEeccch-----hhhHHHHHHHHHcCCCCeeeec
Q 016184 81 KVSYIAEHVVGTGSFGVVFQAKCRETG--------------EIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALK 141 (394)
Q Consensus 81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~--------------~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~ 141 (394)
+.+|++.+.||+|+||.||+|++..++ ..||+|.+.... ..+.+|+++++.++|+|+++++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~ 83 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL 83 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence 346999999999999999999875432 358999886431 2345799999999999999999
Q ss_pred eEEEecCCCceeEEEEEEecccc-cHHHHHHHhhh--------hcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCC
Q 016184 142 HCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSR--------IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKP 212 (394)
Q Consensus 142 ~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~--------~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp 212 (394)
+++. .....++||||+.+ ++.+++..... ....+++..+..++.|++.||.|||+ .|++|+||||
T Consensus 84 ~~~~-----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~-~~i~H~dlkp 157 (295)
T cd05097 84 GVCV-----SDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLAS-LNFVHRDLAT 157 (295)
T ss_pred EEEc-----CCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHh-cCeeccccCh
Confidence 9883 23347899999985 77776654211 01246788899999999999999999 8999999999
Q ss_pred CceEEeCCCCcEEEEeecCccccccCCC---cccccccccccccccccCCCCCCChhhHHHHHHHHHHHHh--CCCCCCC
Q 016184 213 QNLLVNPHTHQLKLCDFGSAKVLVKGEP---NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL--GQPLFPG 287 (394)
Q Consensus 213 ~Nil~~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt--g~~pf~~ 287 (394)
+||+++.++ .+||+|||++........ .....++..|+|||++.+.. ++.++|+|||||++|+|++ |..||..
T Consensus 158 ~Nill~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwSlG~~l~el~~~~~~~p~~~ 235 (295)
T cd05097 158 RNCLVGNHY-TIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGK-FTTASDVWAFGVTLWEMFTLCKEQPYSL 235 (295)
T ss_pred hhEEEcCCC-cEEecccccccccccCcceeccCcCcCceeecChhhhccCC-cCchhhHHHHHHHHHHHHHcCCCCCCcc
Confidence 999999887 699999999876533221 11223467899999986544 8999999999999999998 6678887
Q ss_pred CCcHHHHHHHHHHhCCCChhhhhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 016184 288 ESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV 364 (394)
Q Consensus 288 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 364 (394)
....+.+..+......... .. . .......++.+.+|+.+||+.||++|||++++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~-----------~~-~---------~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 291 (295)
T cd05097 236 LSDEQVIENTGEFFRNQGR-----------QI-Y---------LSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH 291 (295)
T ss_pred cChHHHHHHHHHhhhhccc-----------cc-c---------CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 6665555444331100000 00 0 0011346889999999999999999999999965
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=284.76 Aligned_cols=245 Identities=25% Similarity=0.344 Sum_probs=194.0
Q ss_pred ceeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccc---hhhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEEEE
Q 016184 81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD---KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL 157 (394)
Q Consensus 81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 157 (394)
.++|++.+.||+|+||.||+|.+. +++.||||.+... .....+|+.+++.++|+||+++++++. .....++
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~~ 78 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCS-----EEEPIYI 78 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCccCHHHHHHHHHHHhhCCCCCEeeeeeeee-----cCCceEE
Confidence 346999999999999999999985 4578999988643 234567999999999999999998873 2234789
Q ss_pred EEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCccccc
Q 016184 158 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV 236 (394)
Q Consensus 158 v~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~ 236 (394)
+|||+++ +|.+++... ....+++..+..++.|++.||.|||+ +|++|+||||+||+++.++ .++|+|||++....
T Consensus 79 v~e~~~~~~L~~~i~~~--~~~~~~~~~~~~~~~~i~~al~~lh~-~~i~h~di~p~nili~~~~-~~~l~d~g~~~~~~ 154 (261)
T cd05034 79 VTEYMSKGSLLDFLKSG--EGKKLRLPQLVDMAAQIAEGMAYLES-RNYIHRDLAARNILVGENL-VCKIADFGLARLIE 154 (261)
T ss_pred EEeccCCCCHHHHHhcc--ccCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCcchheEEEcCCC-CEEECccccceecc
Confidence 9999975 676666542 23568999999999999999999999 8999999999999999887 79999999987654
Q ss_pred cCCCc--ccccccccccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCChhhhhccC
Q 016184 237 KGEPN--VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 313 (394)
Q Consensus 237 ~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 313 (394)
..... .....+..|+|||.+.+. .++.++|+||||+++|+|++ |+.||.+......+..+......+
T Consensus 155 ~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~--------- 224 (261)
T cd05034 155 DDEYTAREGAKFPIKWTAPEAANYG-RFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRMP--------- 224 (261)
T ss_pred chhhhhhhccCCCccccCHHHhccC-CcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC---------
Confidence 32111 122235679999998654 48999999999999999998 999998776655555543311000
Q ss_pred CCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 016184 314 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV 364 (394)
Q Consensus 314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 364 (394)
.+...+.++.+++.+||+.||.+||+++++++
T Consensus 225 -------------------~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~ 256 (261)
T cd05034 225 -------------------RPPNCPEELYDLMLQCWDKDPEERPTFEYLQS 256 (261)
T ss_pred -------------------CCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 11345789999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=291.50 Aligned_cols=250 Identities=23% Similarity=0.326 Sum_probs=193.0
Q ss_pred cceeEEEeeEEeecCceEEEEEEEC-------CCCcEEEEEEeccc-----hhhhHHHHHHHHHc-CCCCeeeeceEEEe
Q 016184 80 QKVSYIAEHVVGTGSFGVVFQAKCR-------ETGEIVAIKKVLQD-----KRYKNRELQIMQML-DHPNIVALKHCFFS 146 (394)
Q Consensus 80 ~~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l-~h~~iv~~~~~~~~ 146 (394)
...+|++.+.||+|+||.||+|++. .++..||+|.+... .....+|+.+++.+ +|+||+++++++.
T Consensus 13 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~- 91 (304)
T cd05101 13 SRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT- 91 (304)
T ss_pred cHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEe-
Confidence 3456999999999999999999753 23457999987542 23355799999999 8999999999873
Q ss_pred cCCCceeEEEEEEecccc-cHHHHHHHhhh------------hcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCC
Q 016184 147 TTDKEELYLNLVLEYVPE-TVNRIARNYSR------------IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQ 213 (394)
Q Consensus 147 ~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~------------~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~ 213 (394)
.....+++|||+++ +|.+++..... ....+++..+..++.||+.||.|||+ +|++||||||+
T Consensus 92 ----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~-~givH~dlkp~ 166 (304)
T cd05101 92 ----QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLAS-QKCIHRDLAAR 166 (304)
T ss_pred ----cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHH-CCeeecccccc
Confidence 33457899999985 77777765321 12457888899999999999999999 89999999999
Q ss_pred ceEEeCCCCcEEEEeecCccccccCCC---cccccccccccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCC
Q 016184 214 NLLVNPHTHQLKLCDFGSAKVLVKGEP---NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGES 289 (394)
Q Consensus 214 Nil~~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~ 289 (394)
|||++.++ .+||+|||+++....... .....+++.|+|||++.+. .++.++||||||+++|+|++ |..||.+..
T Consensus 167 Nili~~~~-~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~g~~p~~~~~ 244 (304)
T cd05101 167 NVLVTENN-VMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDR-VYTHQSDVWSFGVLMWEIFTLGGSPYPGIP 244 (304)
T ss_pred eEEEcCCC-cEEECCCccceecccccccccccCCCCCceeeCchhhccC-CCCchhhHHHHHHHHHHHHcCCCCCcccCC
Confidence 99999877 799999999976643221 1122346779999998654 48999999999999999998 788887765
Q ss_pred cHHHHHHHHHHhCCCChhhhhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 016184 290 GVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH 365 (394)
Q Consensus 290 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 365 (394)
..+....+.... . ...+..++.++.+||.+||..+|.+|||+.++++.
T Consensus 245 ~~~~~~~~~~~~-~---------------------------~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~ 292 (304)
T cd05101 245 VEELFKLLKEGH-R---------------------------MDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVED 292 (304)
T ss_pred HHHHHHHHHcCC-c---------------------------CCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence 444433332110 0 00113578899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=293.16 Aligned_cols=248 Identities=22% Similarity=0.315 Sum_probs=190.1
Q ss_pred eeEEEeeEEeecCceEEEEEEECC-------CCcEEEEEEeccch-----hhhHHHHHHHHHc-CCCCeeeeceEEEecC
Q 016184 82 VSYIAEHVVGTGSFGVVFQAKCRE-------TGEIVAIKKVLQDK-----RYKNRELQIMQML-DHPNIVALKHCFFSTT 148 (394)
Q Consensus 82 ~~y~~~~~lg~G~~g~V~~~~~~~-------~~~~vaiK~~~~~~-----~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~ 148 (394)
.+|.+.+.||+|+||.||+|++.. ++..+|+|.+.... ....+|+++++.+ +|+||+++++++.
T Consensus 18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~--- 94 (307)
T cd05098 18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT--- 94 (307)
T ss_pred HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEe---
Confidence 469999999999999999998743 23569999886432 2344688999999 7999999999883
Q ss_pred CCceeEEEEEEecccc-cHHHHHHHhhh------------hcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCce
Q 016184 149 DKEELYLNLVLEYVPE-TVNRIARNYSR------------IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNL 215 (394)
Q Consensus 149 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~------------~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Ni 215 (394)
.....++||||+++ +|.+++..... ....+++..+..++.|++.||+|||+ .|++||||||+||
T Consensus 95 --~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~-~gi~H~dlkp~Ni 171 (307)
T cd05098 95 --QDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLAS-KKCIHRDLAARNV 171 (307)
T ss_pred --cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH-CCcccccccHHhe
Confidence 23347899999985 77777765321 12358889999999999999999999 8999999999999
Q ss_pred EEeCCCCcEEEEeecCccccccCCCc---ccccccccccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcH
Q 016184 216 LVNPHTHQLKLCDFGSAKVLVKGEPN---VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGV 291 (394)
Q Consensus 216 l~~~~~~~vkl~Dfg~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~ 291 (394)
+++.++ .++|+|||.+......... ....+++.|+|||.+.+. .++.++|+|||||++|+|++ |..||.+....
T Consensus 172 ll~~~~-~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~ 249 (307)
T cd05098 172 LVTEDN-VMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDR-IYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE 249 (307)
T ss_pred EEcCCC-cEEECCCcccccccccchhhccccCCCccceeChHHhccC-CCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHH
Confidence 999887 7999999998765332211 112234679999998654 48999999999999999998 88899765543
Q ss_pred HHHHHHHHHhCCCChhhhhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 016184 292 DQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH 365 (394)
Q Consensus 292 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 365 (394)
+....+.. ... ...+..++.++.+||.+||..+|.+|||+.+++++
T Consensus 250 ~~~~~~~~-~~~---------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~ 295 (307)
T cd05098 250 ELFKLLKE-GHR---------------------------MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 295 (307)
T ss_pred HHHHHHHc-CCC---------------------------CCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 33322221 000 00123568899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=285.23 Aligned_cols=235 Identities=25% Similarity=0.343 Sum_probs=183.1
Q ss_pred EEeecCceEEEEEEE--CCCCcEEEEEEeccch------hhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEEEEEEe
Q 016184 89 VVGTGSFGVVFQAKC--RETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLE 160 (394)
Q Consensus 89 ~lg~G~~g~V~~~~~--~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e 160 (394)
.||+|+||.||+|.+ ..++..+|+|++.... ....+|+.+++.+.|+||+++++++. .. ..+++||
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~-~~~lv~e 75 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-----AE-SWMLVME 75 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-----CC-CcEEEEe
Confidence 589999999999965 4567899999875432 23457899999999999999988761 11 2578999
Q ss_pred cccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCccccccCC
Q 016184 161 YVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE 239 (394)
Q Consensus 161 ~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~~~ 239 (394)
|+++ +|.+++.. ...+++..+..++.|++.||+|||+ +||+||||||.||+++.++ .+||+|||++.......
T Consensus 76 ~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~-~~i~H~dlkp~nill~~~~-~~kl~Dfg~~~~~~~~~ 149 (257)
T cd05116 76 LAELGPLNKFLQK----NKHVTEKNITELVHQVSMGMKYLEE-TNFVHRDLAARNVLLVTQH-YAKISDFGLSKALGADE 149 (257)
T ss_pred cCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCEeecccchhhEEEcCCC-eEEECCCccccccCCCC
Confidence 9985 56665543 3568999999999999999999999 8999999999999999887 69999999987654332
Q ss_pred Cc----ccccccccccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCC
Q 016184 240 PN----VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 314 (394)
Q Consensus 240 ~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 314 (394)
.. ....++..|+|||.+.. ..++.++|+|||||++|+|++ |..||......+....+.... .+
T Consensus 150 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~-~~---------- 217 (257)
T cd05116 150 NYYKAKTHGKWPVKWYAPECMNY-YKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGE-RM---------- 217 (257)
T ss_pred CeeeecCCCCCCccccCHhHhcc-CCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCC-CC----------
Confidence 21 11223578999998854 348899999999999999998 999998766544433332210 00
Q ss_pred CCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 016184 315 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV 364 (394)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 364 (394)
..+..+++++.+||.+||+.||++||++.+|..
T Consensus 218 -----------------~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~ 250 (257)
T cd05116 218 -----------------ECPQRCPPEMYDLMKLCWTYGVDERPGFAVVEL 250 (257)
T ss_pred -----------------CCCCCCCHHHHHHHHHHhccCchhCcCHHHHHH
Confidence 012457899999999999999999999998854
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=321.01 Aligned_cols=260 Identities=28% Similarity=0.410 Sum_probs=193.1
Q ss_pred CccceeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccc-----hhhhHHHHHHHHHcCCCCeeeeceEEEe------
Q 016184 78 SKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFS------ 146 (394)
Q Consensus 78 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~------ 146 (394)
++....|+.+.+||+||||.||+++++-+|+.||||++... ...+.+|+.+|.+|+|||||+++..+.+
T Consensus 475 SRY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~ 554 (1351)
T KOG1035|consen 475 SRYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELT 554 (1351)
T ss_pred hhHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccc
Confidence 44556688899999999999999999999999999998644 2334579999999999999998665210
Q ss_pred ----------------------------------------------------c---------------------------
Q 016184 147 ----------------------------------------------------T--------------------------- 147 (394)
Q Consensus 147 ----------------------------------------------------~--------------------------- 147 (394)
.
T Consensus 555 ~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS 634 (1351)
T KOG1035|consen 555 VLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTS 634 (1351)
T ss_pred cccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccc
Confidence 0
Q ss_pred ----------------------CCCc-------eeEEEEEEecccccHHHHHHHhhhhcCCC-CHHHHHHHHHHHHHHHH
Q 016184 148 ----------------------TDKE-------ELYLNLVLEYVPETVNRIARNYSRIHQRM-PLIYVKLYTYQICRALA 197 (394)
Q Consensus 148 ----------------------~~~~-------~~~~~lv~e~~~~~l~~~~~~~~~~~~~l-~~~~~~~~~~qi~~al~ 197 (394)
...+ ..++||-||||+.++.+.+-... ... ....+|+++++|+.||.
T Consensus 635 ~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N---~~~~~~d~~wrLFreIlEGLa 711 (1351)
T KOG1035|consen 635 DSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRN---HFNSQRDEAWRLFREILEGLA 711 (1351)
T ss_pred ccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhc---ccchhhHHHHHHHHHHHHHHH
Confidence 0000 15789999999976544433322 222 46788999999999999
Q ss_pred HHHhCCCceeccCCCCceEEeCCCCcEEEEeecCccccc-------------------cCCCcccccccccccccccccC
Q 016184 198 YIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV-------------------KGEPNVSYICSRYYRAPELIFG 258 (394)
Q Consensus 198 ~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~-------------------~~~~~~~~~~t~~y~aPE~~~~ 258 (394)
|+|+ .|||||||||.||+++++. .|||+|||+|+... ......+.+||.-|+|||++.+
T Consensus 712 YIH~-~giIHRDLKP~NIFLd~~~-~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~ 789 (1351)
T KOG1035|consen 712 YIHD-QGIIHRDLKPRNIFLDSRN-SVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSD 789 (1351)
T ss_pred HHHh-CceeeccCCcceeEEcCCC-CeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcc
Confidence 9999 8999999999999999887 69999999998621 1113345788999999999976
Q ss_pred CC--CCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCCCcccCCCCCCCCCcchhcccc
Q 016184 259 AT--EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKR 336 (394)
Q Consensus 259 ~~--~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 336 (394)
.. .|+.|.|+||||+|++||+. ||.. .++... ++..+..+ .+|.. ..|...
T Consensus 790 ~~~~~Yn~KiDmYSLGIVlFEM~y---PF~T--sMERa~-iL~~LR~g---------------~iP~~------~~f~~~ 842 (1351)
T KOG1035|consen 790 TSSNKYNSKIDMYSLGIVLFEMLY---PFGT--SMERAS-ILTNLRKG---------------SIPEP------ADFFDP 842 (1351)
T ss_pred cccccccchhhhHHHHHHHHHHhc---cCCc--hHHHHH-HHHhcccC---------------CCCCC------cccccc
Confidence 66 69999999999999999984 4543 222222 22222111 11110 001122
Q ss_pred CChHHHHHHHHhcccCCCCCCCHHHHhcCCCCC
Q 016184 337 LPPEAVDLVCRFFQYSPNLRCTALEACVHPFFD 369 (394)
Q Consensus 337 ~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~ 369 (394)
--+.-..+|++||++||++||||.|||++.||-
T Consensus 843 ~~~~e~slI~~Ll~hdP~kRPtA~eLL~s~llp 875 (1351)
T KOG1035|consen 843 EHPEEASLIRWLLSHDPSKRPTATELLNSELLP 875 (1351)
T ss_pred cchHHHHHHHHHhcCCCccCCCHHHHhhccCCC
Confidence 234567899999999999999999999999996
|
|
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=289.27 Aligned_cols=247 Identities=24% Similarity=0.374 Sum_probs=191.7
Q ss_pred eeEEEeeEEeecCceEEEEEEEC-----CCCcEEEEEEeccc----hhhhHHHHHHHHHcCCCCeeeeceEEEecCCCce
Q 016184 82 VSYIAEHVVGTGSFGVVFQAKCR-----ETGEIVAIKKVLQD----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE 152 (394)
Q Consensus 82 ~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 152 (394)
.+|.+.++||+|+||.||+|... .++..+|+|.+... ...+.+|+++++.++|+||+++++++.. .
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~ 79 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTE-----G 79 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEec-----C
Confidence 35888999999999999999743 35678999987543 2345679999999999999999887732 2
Q ss_pred eEEEEEEecccc-cHHHHHHHhhh-----------hcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCC
Q 016184 153 LYLNLVLEYVPE-TVNRIARNYSR-----------IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPH 220 (394)
Q Consensus 153 ~~~~lv~e~~~~-~l~~~~~~~~~-----------~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~ 220 (394)
...+++|||+++ +|.+++..... ....+++..+..++.|++.||+|||+ .|++|+||||+|||++.+
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~-~~i~H~dlkp~nil~~~~ 158 (280)
T cd05092 80 RPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLAS-LHFVHRDLATRNCLVGQG 158 (280)
T ss_pred CceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHH-CCeecccccHhhEEEcCC
Confidence 347899999984 77776654321 11357889999999999999999999 899999999999999987
Q ss_pred CCcEEEEeecCccccccCCC---cccccccccccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHH
Q 016184 221 THQLKLCDFGSAKVLVKGEP---NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVE 296 (394)
Q Consensus 221 ~~~vkl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~ 296 (394)
+ .+||+|||++........ .....+++.|+|||.+.+. .++.++|||||||++|+|++ |..||......+.+..
T Consensus 159 ~-~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~ 236 (280)
T cd05092 159 L-VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYR-KFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIEC 236 (280)
T ss_pred C-CEEECCCCceeEcCCCceeecCCCccccccccCHHHhccC-CcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHH
Confidence 7 799999999875532221 1223346789999998654 48999999999999999998 9999977665554444
Q ss_pred HHHHhCCCChhhhhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 016184 297 IIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV 364 (394)
Q Consensus 297 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 364 (394)
+..... . ..+..+++.+.+||.+||+.||.+||++.++++
T Consensus 237 ~~~~~~----------------~------------~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~ 276 (280)
T cd05092 237 ITQGRE----------------L------------ERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS 276 (280)
T ss_pred HHcCcc----------------C------------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 332100 0 011357889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=289.91 Aligned_cols=247 Identities=24% Similarity=0.316 Sum_probs=192.0
Q ss_pred eeEEEeeEEeecCceEEEEEEECC-----CCcEEEEEEeccc-----hhhhHHHHHHHHHcCCCCeeeeceEEEecCCCc
Q 016184 82 VSYIAEHVVGTGSFGVVFQAKCRE-----TGEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKE 151 (394)
Q Consensus 82 ~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 151 (394)
++|++.+.||+|+||.||+|.+.. ++..||+|++... ...+.+|+.+++.+.|+||+++++++. .
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~-----~ 79 (288)
T cd05050 5 NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCA-----V 79 (288)
T ss_pred HhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEc-----C
Confidence 469999999999999999998743 6788999987643 234557999999999999999998773 2
Q ss_pred eeEEEEEEecccc-cHHHHHHHhhh------------------hcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCC
Q 016184 152 ELYLNLVLEYVPE-TVNRIARNYSR------------------IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKP 212 (394)
Q Consensus 152 ~~~~~lv~e~~~~-~l~~~~~~~~~------------------~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp 212 (394)
....+++|||+++ +|.+++..... ....+++..++.++.|++.||.|||+ .|++||||||
T Consensus 80 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~-~~i~H~dl~p 158 (288)
T cd05050 80 GKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSE-RKFVHRDLAT 158 (288)
T ss_pred CCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh-CCeecccccH
Confidence 3347899999985 77777654221 11347888899999999999999999 8999999999
Q ss_pred CceEEeCCCCcEEEEeecCccccccCCC---cccccccccccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCC
Q 016184 213 QNLLVNPHTHQLKLCDFGSAKVLVKGEP---NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGE 288 (394)
Q Consensus 213 ~Nil~~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~ 288 (394)
+||+++.++ .++|+|||++........ ......+..|+|||.+.+. .++.++|||||||++|+|++ |..||.+.
T Consensus 159 ~nil~~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~~~~~~p~~~~ 236 (288)
T cd05050 159 RNCLVGENM-VVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYN-RYTTESDVWAYGVVLWEIFSYGMQPYYGM 236 (288)
T ss_pred hheEecCCC-ceEECccccceecccCccccccCCCccChhhcCHHHHhcC-CCCchhHHHHHHHHHHHHHhCCCCCCCCC
Confidence 999999888 799999999875432211 1122345679999998554 48999999999999999997 88899776
Q ss_pred CcHHHHHHHHHHhCCCChhhhhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 016184 289 SGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV 364 (394)
Q Consensus 289 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 364 (394)
...+....+.... .. ..+..++.++.+||.+||+.||.+|||+.|+++
T Consensus 237 ~~~~~~~~~~~~~----------------~~------------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~ 284 (288)
T cd05050 237 AHEEVIYYVRDGN----------------VL------------SCPDNCPLELYNLMRLCWSKLPSDRPSFASINR 284 (288)
T ss_pred CHHHHHHHHhcCC----------------CC------------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 6554443332210 00 011346889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=287.34 Aligned_cols=249 Identities=18% Similarity=0.249 Sum_probs=193.0
Q ss_pred ceeEEEeeEEeecCceEEEEEEECC----CCcEEEEEEeccc-----hhhhHHHHHHHHHcCCCCeeeeceEEEecCCCc
Q 016184 81 KVSYIAEHVVGTGSFGVVFQAKCRE----TGEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKE 151 (394)
Q Consensus 81 ~~~y~~~~~lg~G~~g~V~~~~~~~----~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 151 (394)
..+|++.++||+|+||.||+|.+.. ++..|++|.+... .....+|+.+++.++|+||+++++++...
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~---- 80 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIED---- 80 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC----
Confidence 3469999999999999999999875 3578999987643 23345789999999999999999977432
Q ss_pred eeEEEEEEeccc-ccHHHHHHHhhhh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEE
Q 016184 152 ELYLNLVLEYVP-ETVNRIARNYSRI----HQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKL 226 (394)
Q Consensus 152 ~~~~~lv~e~~~-~~l~~~~~~~~~~----~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl 226 (394)
....+++++|++ +++..++...... ...+++..++.++.|++.||+|||+ .+++|+||||+||+++.++ .+||
T Consensus 81 ~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~i~H~di~p~nil~~~~~-~~kl 158 (280)
T cd05043 81 GEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHK-RGVIHKDIAARNCVIDEEL-QVKI 158 (280)
T ss_pred CCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHH-CCEeecccCHhhEEEcCCC-cEEE
Confidence 223568999987 5777766553322 1568999999999999999999999 8999999999999999887 7999
Q ss_pred EeecCccccccCCCc---ccccccccccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhC
Q 016184 227 CDFGSAKVLVKGEPN---VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLG 302 (394)
Q Consensus 227 ~Dfg~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~ 302 (394)
+|||+++.+...... ....++..|+|||++.+. .++.++||||||+++|++++ |+.||...+..+....+....
T Consensus 159 ~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~-~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~- 236 (280)
T cd05043 159 TDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNK-EYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDGY- 236 (280)
T ss_pred CCCCCcccccCCceEEeCCCCCcchhccCHHHHhcC-CCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcCC-
Confidence 999999765332211 123346679999998654 48999999999999999998 999998765544333222110
Q ss_pred CCChhhhhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 016184 303 TPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV 364 (394)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 364 (394)
..+ ....+++++.+++.+||..||++|||+.++++
T Consensus 237 -----------------~~~----------~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 271 (280)
T cd05043 237 -----------------RLA----------QPINCPDELFAVMACCWALDPEERPSFSQLVQ 271 (280)
T ss_pred -----------------CCC----------CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 000 01346889999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=285.93 Aligned_cols=244 Identities=27% Similarity=0.376 Sum_probs=190.8
Q ss_pred eeEEEeeEEeecCceEEEEEEECCCC---cEEEEEEeccc-----hhhhHHHHHHHHHcCCCCeeeeceEEEecCCCcee
Q 016184 82 VSYIAEHVVGTGSFGVVFQAKCRETG---EIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL 153 (394)
Q Consensus 82 ~~y~~~~~lg~G~~g~V~~~~~~~~~---~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 153 (394)
.+|++.+.||+|+||.||+|.+..++ ..+|+|.+... .....+|+.+++.++||||+++++++. ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~ 78 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVT-----KSK 78 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEe-----cCC
Confidence 35999999999999999999986544 37999987542 234467899999999999999999873 333
Q ss_pred EEEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCc
Q 016184 154 YLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA 232 (394)
Q Consensus 154 ~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a 232 (394)
+.+++|||+++ +|.+++... ...+++..+..++.|++.||.|||+ .|++|+||||+|||++.++ .++|+|||++
T Consensus 79 ~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~-~~i~h~dlkp~nili~~~~-~~~l~dfg~~ 153 (267)
T cd05066 79 PVMIVTEYMENGSLDAFLRKH---DGQFTVIQLVGMLRGIASGMKYLSD-MGYVHRDLAARNILVNSNL-VCKVSDFGLS 153 (267)
T ss_pred ccEEEEEcCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHH-CCEeehhhchhcEEECCCC-eEEeCCCCcc
Confidence 57899999985 676665432 2468999999999999999999999 8999999999999999887 7999999998
Q ss_pred cccccCCCcc----cccccccccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCChh
Q 016184 233 KVLVKGEPNV----SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTRE 307 (394)
Q Consensus 233 ~~~~~~~~~~----~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~ 307 (394)
.......... ...++..|+|||.+.+. .++.++|+||||+++|++++ |..||......+....+.+...
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~-~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~----- 227 (267)
T cd05066 154 RVLEDDPEAAYTTRGGKIPIRWTAPEAIAYR-KFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYR----- 227 (267)
T ss_pred cccccccceeeecCCCccceeecCHhHhccC-ccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCCc-----
Confidence 7654332211 11224679999998654 48999999999999999886 9999987665544443332110
Q ss_pred hhhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 016184 308 EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV 364 (394)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 364 (394)
.+ ....+++.+.+++.+||+.+|.+||++.++++
T Consensus 228 -------------~~----------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 261 (267)
T cd05066 228 -------------LP----------APMDCPAALHQLMLDCWQKDRNERPKFEQIVS 261 (267)
T ss_pred -------------CC----------CCCCCCHHHHHHHHHHcccCchhCCCHHHHHH
Confidence 00 11346889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=299.63 Aligned_cols=251 Identities=22% Similarity=0.325 Sum_probs=193.6
Q ss_pred cceeEEEeeEEeecCceEEEEEEEC-----CCCcEEEEEEeccch-----hhhHHHHHHHHHcC-CCCeeeeceEEEecC
Q 016184 80 QKVSYIAEHVVGTGSFGVVFQAKCR-----ETGEIVAIKKVLQDK-----RYKNRELQIMQMLD-HPNIVALKHCFFSTT 148 (394)
Q Consensus 80 ~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~ 148 (394)
...+|.+.+.||+|+||.||+|++. .+++.||+|++.... ..+.+|++++.++. ||||+++++++..
T Consensus 35 ~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~-- 112 (401)
T cd05107 35 PRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTK-- 112 (401)
T ss_pred cHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEcc--
Confidence 3456899999999999999999964 345689999986432 23457999999997 9999999998833
Q ss_pred CCceeEEEEEEecccc-cHHHHHHHhhh----------------------------------------------------
Q 016184 149 DKEELYLNLVLEYVPE-TVNRIARNYSR---------------------------------------------------- 175 (394)
Q Consensus 149 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~---------------------------------------------------- 175 (394)
....++||||+.+ +|.+++.....
T Consensus 113 ---~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 189 (401)
T cd05107 113 ---GGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADY 189 (401)
T ss_pred ---CCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCc
Confidence 2347899999984 77777653211
Q ss_pred ------------------------------------------hcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCC
Q 016184 176 ------------------------------------------IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQ 213 (394)
Q Consensus 176 ------------------------------------------~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~ 213 (394)
....+++..++.++.|++.||.|||+ .|++||||||+
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~-~~ivHrdlkp~ 268 (401)
T cd05107 190 VPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLAS-KNCVHRDLAAR 268 (401)
T ss_pred cchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhc-CCcCcccCCcc
Confidence 11236677788999999999999999 89999999999
Q ss_pred ceEEeCCCCcEEEEeecCccccccCCC---cccccccccccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCC
Q 016184 214 NLLVNPHTHQLKLCDFGSAKVLVKGEP---NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGES 289 (394)
Q Consensus 214 Nil~~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~ 289 (394)
|||++.++ .+||+|||+++....... .....+++.|+|||.+.+. .++.++||||||+++|+|++ |..||....
T Consensus 269 NiLl~~~~-~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslGvil~e~l~~g~~P~~~~~ 346 (401)
T cd05107 269 NVLICEGK-LVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNN-LYTTLSDVWSFGILLWEIFTLGGTPYPELP 346 (401)
T ss_pred eEEEeCCC-EEEEEecCcceecccccccccCCCcCCCCceeChHHhcCC-CCCcHhHHHHHHHHHHHHHHcCCCCCCCCC
Confidence 99999877 799999999976432221 1234567889999998654 48999999999999999998 889998765
Q ss_pred cHHHHHHHHHHhCCCChhhhhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 016184 290 GVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH 365 (394)
Q Consensus 290 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 365 (394)
..+.+.......-.+ ..+..++.++.+|+.+||..||.+||++.+|++.
T Consensus 347 ~~~~~~~~~~~~~~~---------------------------~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 395 (401)
T cd05107 347 MNEQFYNAIKRGYRM---------------------------AKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHL 395 (401)
T ss_pred chHHHHHHHHcCCCC---------------------------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 555444333211000 0123568899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-38 Score=291.67 Aligned_cols=248 Identities=22% Similarity=0.331 Sum_probs=191.0
Q ss_pred ceeEEEeeEEeecCceEEEEEEECC-------CCcEEEEEEeccch-----hhhHHHHHHHHHc-CCCCeeeeceEEEec
Q 016184 81 KVSYIAEHVVGTGSFGVVFQAKCRE-------TGEIVAIKKVLQDK-----RYKNRELQIMQML-DHPNIVALKHCFFST 147 (394)
Q Consensus 81 ~~~y~~~~~lg~G~~g~V~~~~~~~-------~~~~vaiK~~~~~~-----~~~~~E~~~l~~l-~h~~iv~~~~~~~~~ 147 (394)
..+|.+.+.||+|+||.||+|++.. ....+|+|.+.... ....+|+++++.+ +|+||+++++++.
T Consensus 11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~-- 88 (314)
T cd05099 11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCT-- 88 (314)
T ss_pred HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEc--
Confidence 3469999999999999999998632 34579999876432 2345789999999 6999999999873
Q ss_pred CCCceeEEEEEEecccc-cHHHHHHHhhh------------hcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCc
Q 016184 148 TDKEELYLNLVLEYVPE-TVNRIARNYSR------------IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQN 214 (394)
Q Consensus 148 ~~~~~~~~~lv~e~~~~-~l~~~~~~~~~------------~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~N 214 (394)
...+.+++|||+++ +|.+++..... ....+++..+..++.|++.||.|||+ +|++||||||+|
T Consensus 89 ---~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~-~gi~H~dlkp~N 164 (314)
T cd05099 89 ---QEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLES-RRCIHRDLAARN 164 (314)
T ss_pred ---cCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHH-CCeeecccccee
Confidence 23347899999984 77777765321 12458889999999999999999999 899999999999
Q ss_pred eEEeCCCCcEEEEeecCccccccCCC---cccccccccccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCc
Q 016184 215 LLVNPHTHQLKLCDFGSAKVLVKGEP---NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESG 290 (394)
Q Consensus 215 il~~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~ 290 (394)
||++.++ .+||+|||+++....... .....++..|+|||.+.+. .++.++||||||+++|+|++ |..||.+...
T Consensus 165 ill~~~~-~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~~g~~p~~~~~~ 242 (314)
T cd05099 165 VLVTEDN-VMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDR-VYTHQSDVWSFGILMWEIFTLGGSPYPGIPV 242 (314)
T ss_pred EEEcCCC-cEEEccccccccccccccccccccCCCCccccCHHHHccC-CcCccchhhHHHHHHHHHHhCCCCCCCCCCH
Confidence 9999887 699999999976533211 1112234679999998654 48999999999999999999 8899977655
Q ss_pred HHHHHHHHHHhCCCChhhhhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 016184 291 VDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV 364 (394)
Q Consensus 291 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 364 (394)
.+.+..+.... .. .++..++.++.+|+.+||..||++|||+.++++
T Consensus 243 ~~~~~~~~~~~----------------~~------------~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 288 (314)
T cd05099 243 EELFKLLREGH----------------RM------------DKPSNCTHELYMLMRECWHAVPTQRPTFKQLVE 288 (314)
T ss_pred HHHHHHHHcCC----------------CC------------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 44443332210 00 012356889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-38 Score=284.57 Aligned_cols=243 Identities=24% Similarity=0.348 Sum_probs=190.3
Q ss_pred eEEEeeEEeecCceEEEEEEECCCCc---EEEEEEeccc-----hhhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeE
Q 016184 83 SYIAEHVVGTGSFGVVFQAKCRETGE---IVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY 154 (394)
Q Consensus 83 ~y~~~~~lg~G~~g~V~~~~~~~~~~---~vaiK~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 154 (394)
.|+..+.||+|+||.||+|++..+++ .+|+|.+... .....+|+++++.++|+|++++.+++. ....
T Consensus 6 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~ 80 (268)
T cd05063 6 HITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVT-----KFKP 80 (268)
T ss_pred HceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEc-----cCCC
Confidence 58899999999999999999876654 7999987543 223457899999999999999998873 2334
Q ss_pred EEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCcc
Q 016184 155 LNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK 233 (394)
Q Consensus 155 ~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~ 233 (394)
.+++|||+++ +|..++.. ....+++..+..++.|++.||+|||+ .|++|+||||+||+++.++ .+||+|||++.
T Consensus 81 ~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~l~~al~~lH~-~~i~H~dlkp~Nili~~~~-~~kl~dfg~~~ 155 (268)
T cd05063 81 AMIITEYMENGALDKYLRD---HDGEFSSYQLVGMLRGIAAGMKYLSD-MNYVHRDLAARNILVNSNL-ECKVSDFGLSR 155 (268)
T ss_pred cEEEEEcCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccccchhhEEEcCCC-cEEECCCccce
Confidence 7799999986 66555543 23568999999999999999999999 8999999999999999887 69999999987
Q ss_pred ccccCCCcc----cccccccccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCChhh
Q 016184 234 VLVKGEPNV----SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREE 308 (394)
Q Consensus 234 ~~~~~~~~~----~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 308 (394)
......... ....+..|+|||.+... .++.++|||||||++|+|++ |+.||...+..+....+......+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~~~~---- 230 (268)
T cd05063 156 VLEDDPEGTYTTSGGKIPIRWTAPEAIAYR-KFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRLP---- 230 (268)
T ss_pred ecccccccceeccCCCcCceecCHHHhhcC-CcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCCCCC----
Confidence 654322111 11224569999998654 48999999999999999997 999998766555444443211000
Q ss_pred hhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 016184 309 IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV 364 (394)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 364 (394)
....++.++.+++.+||+.||++||++.++++
T Consensus 231 ------------------------~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~ 262 (268)
T cd05063 231 ------------------------APMDCPSAVYQLMLQCWQQDRARRPRFVDIVN 262 (268)
T ss_pred ------------------------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 01346789999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=294.39 Aligned_cols=248 Identities=22% Similarity=0.311 Sum_probs=191.1
Q ss_pred eeEEEeeEEeecCceEEEEEEECCC-------CcEEEEEEeccc-----hhhhHHHHHHHHHc-CCCCeeeeceEEEecC
Q 016184 82 VSYIAEHVVGTGSFGVVFQAKCRET-------GEIVAIKKVLQD-----KRYKNRELQIMQML-DHPNIVALKHCFFSTT 148 (394)
Q Consensus 82 ~~y~~~~~lg~G~~g~V~~~~~~~~-------~~~vaiK~~~~~-----~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~ 148 (394)
.+|++.+.||+|+||.||+|++... +..||+|.+... .....+|+++++++ +|+||+++++++.
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~--- 88 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACT--- 88 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEc---
Confidence 4699999999999999999986432 236899987642 23445799999999 8999999999883
Q ss_pred CCceeEEEEEEecccc-cHHHHHHHhhh------------hcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCce
Q 016184 149 DKEELYLNLVLEYVPE-TVNRIARNYSR------------IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNL 215 (394)
Q Consensus 149 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~------------~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Ni 215 (394)
.....+++|||+++ +|.+++..... ....++...+..++.|++.||.|||+ +|++||||||+||
T Consensus 89 --~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~-~givH~dlkp~Ni 165 (334)
T cd05100 89 --QDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLAS-QKCIHRDLAARNV 165 (334)
T ss_pred --cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH-CCeeccccccceE
Confidence 33347899999985 77777664321 12357888899999999999999999 8999999999999
Q ss_pred EEeCCCCcEEEEeecCccccccCCCc---ccccccccccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcH
Q 016184 216 LVNPHTHQLKLCDFGSAKVLVKGEPN---VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGV 291 (394)
Q Consensus 216 l~~~~~~~vkl~Dfg~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~ 291 (394)
|++.++ .+||+|||+++........ ....++..|+|||++.+. .++.++||||||+++|+|++ |..||.+.+..
T Consensus 166 ll~~~~-~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~g~~p~~~~~~~ 243 (334)
T cd05100 166 LVTEDN-VMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDR-VYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE 243 (334)
T ss_pred EEcCCC-cEEECCcccceecccccccccccCCCcCceEcCHHHhccC-CcCchhhhHHHHHHHHHHHhcCCCCCCCCCHH
Confidence 999887 7999999998765432211 112234679999998654 48999999999999999998 88999876644
Q ss_pred HHHHHHHHHhCCCChhhhhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 016184 292 DQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH 365 (394)
Q Consensus 292 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 365 (394)
+....+..... ...+..++.++.+|+.+||+.+|.+|||+.+++++
T Consensus 244 ~~~~~~~~~~~----------------------------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~ 289 (334)
T cd05100 244 ELFKLLKEGHR----------------------------MDKPANCTHELYMIMRECWHAVPSQRPTFKQLVED 289 (334)
T ss_pred HHHHHHHcCCC----------------------------CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 44333322100 00123567899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-38 Score=284.60 Aligned_cols=243 Identities=26% Similarity=0.400 Sum_probs=190.2
Q ss_pred eEEEeeEEeecCceEEEEEEECCCCc---EEEEEEeccc-----hhhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeE
Q 016184 83 SYIAEHVVGTGSFGVVFQAKCRETGE---IVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY 154 (394)
Q Consensus 83 ~y~~~~~lg~G~~g~V~~~~~~~~~~---~vaiK~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 154 (394)
.|.+.+.||+|+||.||+|.+..+++ .||||.+... ...+.+|+.+++.+.||||+++++++ .....
T Consensus 5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~-----~~~~~ 79 (269)
T cd05065 5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVV-----TKSRP 79 (269)
T ss_pred HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEE-----CCCCc
Confidence 48999999999999999999987665 5999987643 23455799999999999999999887 33334
Q ss_pred EEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCcc
Q 016184 155 LNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK 233 (394)
Q Consensus 155 ~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~ 233 (394)
.+++|||+++ +|.+++... ...+++..++.++.|++.||+|||+ +|++|+||||+||+++.++ .++|+|||++.
T Consensus 80 ~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~~l~~al~~lH~-~g~~H~dl~p~nili~~~~-~~kl~dfg~~~ 154 (269)
T cd05065 80 VMIITEFMENGALDSFLRQN---DGQFTVIQLVGMLRGIAAGMKYLSE-MNYVHRDLAARNILVNSNL-VCKVSDFGLSR 154 (269)
T ss_pred eEEEEecCCCCcHHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHHH-CCEeecccChheEEEcCCC-cEEECCCcccc
Confidence 7799999986 666655432 3568999999999999999999999 8999999999999999877 79999999987
Q ss_pred ccccCCCcccc---c---ccccccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCh
Q 016184 234 VLVKGEPNVSY---I---CSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTR 306 (394)
Q Consensus 234 ~~~~~~~~~~~---~---~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~ 306 (394)
........... . .+..|+|||.+.+. .++.++|||||||++|||++ |..||...+..+....+.....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~~~---- 229 (269)
T cd05065 155 FLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYR-KFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYR---- 229 (269)
T ss_pred ccccCccccccccccCCCcceeecCHhHhccC-cccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCc----
Confidence 55432221111 1 13469999998644 48999999999999999886 9999987665544443322100
Q ss_pred hhhhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 016184 307 EEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV 364 (394)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 364 (394)
.+ .+..++..+.+++.+||..+|++||++.+++.
T Consensus 230 --------------~~----------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 263 (269)
T cd05065 230 --------------LP----------PPMDCPTALHQLMLDCWQKDRNARPKFGQIVS 263 (269)
T ss_pred --------------CC----------CcccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 00 11346888999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-38 Score=282.80 Aligned_cols=236 Identities=24% Similarity=0.298 Sum_probs=183.0
Q ss_pred EEeecCceEEEEEEEC--CCCcEEEEEEeccch-----hhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEEEEEEec
Q 016184 89 VVGTGSFGVVFQAKCR--ETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEY 161 (394)
Q Consensus 89 ~lg~G~~g~V~~~~~~--~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~ 161 (394)
.||+|+||.||+|.+. ..+..||+|++.... ....+|+.+++.++|+||+++++++. . ...++||||
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-----~-~~~~lv~e~ 75 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-----A-EALMLVMEM 75 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-----C-CCeEEEEEe
Confidence 3899999999999875 445679999875432 23457999999999999999998762 1 236799999
Q ss_pred ccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCccccccCCC
Q 016184 162 VPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP 240 (394)
Q Consensus 162 ~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~~~~ 240 (394)
+++ +|.+++.. ....+++..++.++.|++.||.|||+ +|++|+||||+|||++.++ .+||+|||++........
T Consensus 76 ~~~~~L~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dlkp~nil~~~~~-~~kl~dfg~~~~~~~~~~ 150 (257)
T cd05115 76 ASGGPLNKFLSG---KKDEITVSNVVELMHQVSMGMKYLEG-KNFVHRDLAARNVLLVNQH-YAKISDFGLSKALGADDS 150 (257)
T ss_pred CCCCCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHh-cCeeecccchheEEEcCCC-cEEeccCCccccccCCcc
Confidence 985 66655542 23578999999999999999999999 8999999999999999877 799999999875533322
Q ss_pred c----ccccccccccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCC
Q 016184 241 N----VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 315 (394)
Q Consensus 241 ~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 315 (394)
. ....++..|+|||.+... .++.++||||||+++|+|++ |..||......+....+.... .
T Consensus 151 ~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~-~------------ 216 (257)
T cd05115 151 YYKARSAGKWPLKWYAPECINFR-KFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGK-R------------ 216 (257)
T ss_pred ceeccCCCCCCcccCCHHHHccC-CCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCC-C------------
Confidence 1 111225679999998544 48999999999999999996 999998776555443332210 0
Q ss_pred CcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 016184 316 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV 364 (394)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 364 (394)
..++...++++.++|.+||..||++||++.++++
T Consensus 217 ---------------~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~ 250 (257)
T cd05115 217 ---------------LDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEE 250 (257)
T ss_pred ---------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 0012456899999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-38 Score=286.79 Aligned_cols=259 Identities=26% Similarity=0.387 Sum_probs=188.2
Q ss_pred eEEEeeEEeecCceEEEEEEE----CCCCcEEEEEEeccch----hhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeE
Q 016184 83 SYIAEHVVGTGSFGVVFQAKC----RETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY 154 (394)
Q Consensus 83 ~y~~~~~lg~G~~g~V~~~~~----~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 154 (394)
+|++.+.||+|+||.||+|.. ..++..||+|.+.... ..+.+|+++++.++|+||+++++++... +...
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~---~~~~ 81 (284)
T cd05081 5 HLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSA---GRRN 81 (284)
T ss_pred cceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccC---CCCc
Confidence 599999999999999999984 4578899999875432 2456799999999999999999877432 2234
Q ss_pred EEEEEeccc-ccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCcc
Q 016184 155 LNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK 233 (394)
Q Consensus 155 ~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~ 233 (394)
.++||||++ ++|.+++... ...+++..++.++.|++.||+|||+ .||+||||||+||+++.++ .++|+|||++.
T Consensus 82 ~~lv~e~~~~~~L~~~l~~~---~~~l~~~~~~~~~~~l~~aL~~LH~-~~i~H~dlkp~nili~~~~-~~~l~dfg~~~ 156 (284)
T cd05081 82 LRLVMEYLPYGSLRDYLQKH---RERLDHRKLLLYASQICKGMEYLGS-KRYVHRDLATRNILVESEN-RVKIGDFGLTK 156 (284)
T ss_pred eEEEEEecCCCCHHHHHHhc---CcCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCHhhEEECCCC-eEEECCCcccc
Confidence 789999997 4777766432 2458899999999999999999999 8999999999999999887 69999999998
Q ss_pred ccccCCCc----ccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhC-CCChh-
Q 016184 234 VLVKGEPN----VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLG-TPTRE- 307 (394)
Q Consensus 234 ~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~-~~~~~- 307 (394)
........ ....++..|+|||.+.+. .++.++|+||||+++|+|++|..++...... ....+..... .....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~ 234 (284)
T cd05081 157 VLPQDKEYYKVREPGESPIFWYAPESLTES-KFSVASDVWSFGVVLYELFTYSDKSCSPPAE-FMRMMGNDKQGQMIVYH 234 (284)
T ss_pred cccCCCcceeecCCCCCceEeeCHHHhccC-CcChHHHHHHHHHHHHHHhhcCCcCCCcchh-hhhhcccccccccchHH
Confidence 65433221 111234569999998654 4899999999999999999988776433211 1100000000 00000
Q ss_pred hhhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 016184 308 EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV 364 (394)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 364 (394)
........ ... .....++.++.+||.+||..||++|||+.++++
T Consensus 235 ~~~~~~~~---~~~----------~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05081 235 LIELLKNN---GRL----------PAPPGCPAEIYAIMKECWNNDPSQRPSFSELAL 278 (284)
T ss_pred HHHHHhcC---CcC----------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 00000000 000 012457889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=286.37 Aligned_cols=240 Identities=24% Similarity=0.335 Sum_probs=183.3
Q ss_pred EEeecCceEEEEEEECCCCc--EEEEEEeccc-----hhhhHHHHHHHHHc-CCCCeeeeceEEEecCCCceeEEEEEEe
Q 016184 89 VVGTGSFGVVFQAKCRETGE--IVAIKKVLQD-----KRYKNRELQIMQML-DHPNIVALKHCFFSTTDKEELYLNLVLE 160 (394)
Q Consensus 89 ~lg~G~~g~V~~~~~~~~~~--~vaiK~~~~~-----~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~lv~e 160 (394)
.||+|+||.||+|++..++. .+|+|.+... .....+|++++.++ .||||+++++++. ...+.+++||
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~-----~~~~~~lv~e 76 (270)
T cd05047 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACE-----HRGYLYLAIE 76 (270)
T ss_pred cCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEe-----cCCCceEEEE
Confidence 58999999999999987775 4688877532 12345799999999 8999999999883 2334789999
Q ss_pred ccc-ccHHHHHHHhhh------------hcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEE
Q 016184 161 YVP-ETVNRIARNYSR------------IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLC 227 (394)
Q Consensus 161 ~~~-~~l~~~~~~~~~------------~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~ 227 (394)
|++ ++|.+++..... ....+++..++.++.|++.||+|||+ .|++|+||||+|||++.++ .+||+
T Consensus 77 ~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~-~~i~H~dikp~nili~~~~-~~kl~ 154 (270)
T cd05047 77 YAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ-KQFIHRDLAARNILVGENY-VAKIA 154 (270)
T ss_pred eCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHH-CCEeecccccceEEEcCCC-eEEEC
Confidence 997 477777654321 12357899999999999999999999 8999999999999999887 79999
Q ss_pred eecCccccccCCCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCh
Q 016184 228 DFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTR 306 (394)
Q Consensus 228 Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~ 306 (394)
|||++..............+..|+|||++.. ..++.++|+||||+++|+|++ |..||.+.+..+....+....
T Consensus 155 dfgl~~~~~~~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~----- 228 (270)
T cd05047 155 DFGLSRGQEVYVKKTMGRLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY----- 228 (270)
T ss_pred CCCCccccchhhhccCCCCccccCChHHHcc-CCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCCC-----
Confidence 9999853321111112223567999999854 448999999999999999997 999997765444333322100
Q ss_pred hhhhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 016184 307 EEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV 364 (394)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 364 (394)
.. .....++.++.+|+.+||..||.+|||+.+++.
T Consensus 229 -------------~~----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (270)
T cd05047 229 -------------RL----------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILV 263 (270)
T ss_pred -------------CC----------CCCCcCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence 00 011346788999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-38 Score=281.09 Aligned_cols=243 Identities=21% Similarity=0.328 Sum_probs=190.8
Q ss_pred eEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccc---hhhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEEEEEE
Q 016184 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD---KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVL 159 (394)
Q Consensus 83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~ 159 (394)
.|++.+.||.|+||.||+|.+. .+..+|+|.+... ...+.+|+++++.++|+|++++++++ ......+++|
T Consensus 5 ~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~~v~ 78 (256)
T cd05112 5 ELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVC-----TERSPICLVF 78 (256)
T ss_pred HeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCCCHHHHHHHHHHHHhCCCCCeeeEEEEE-----ccCCceEEEE
Confidence 5899999999999999999885 4678999987643 23456799999999999999999887 3333578999
Q ss_pred ecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCccccccC
Q 016184 160 EYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG 238 (394)
Q Consensus 160 e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~~ 238 (394)
||+.+ +|.+++.. ....+++..++.++.|++.||++||+ .|++|+||||+||+++.++ .++|+|||.+......
T Consensus 79 e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~l~~~l~~lH~-~~i~h~dl~p~ni~i~~~~-~~~l~d~g~~~~~~~~ 153 (256)
T cd05112 79 EFMEHGCLSDYLRA---QRGKFSQETLLGMCLDVCEGMAYLES-SNVIHRDLAARNCLVGENQ-VVKVSDFGMTRFVLDD 153 (256)
T ss_pred EcCCCCcHHHHHHh---CccCCCHHHHHHHHHHHHHHHHHHHH-CCccccccccceEEEcCCC-eEEECCCcceeecccC
Confidence 99985 56555443 12457899999999999999999999 8999999999999999877 7999999998755332
Q ss_pred CCc--ccccccccccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCC
Q 016184 239 EPN--VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 315 (394)
Q Consensus 239 ~~~--~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 315 (394)
... ....++..|+|||.+.+. .++.++|+||||+++|+|++ |+.||........+..+.....
T Consensus 154 ~~~~~~~~~~~~~~~aPe~~~~~-~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~------------- 219 (256)
T cd05112 154 QYTSSTGTKFPVKWSSPEVFSFS-KYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFR------------- 219 (256)
T ss_pred cccccCCCccchhhcCHhHhccC-CcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCCC-------------
Confidence 211 122345679999998654 48899999999999999998 9999987665544444322100
Q ss_pred CcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 016184 316 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH 365 (394)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 365 (394)
...+...+..+.+|+++||+.+|++|||+.+++++
T Consensus 220 ---------------~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~ 254 (256)
T cd05112 220 ---------------LYKPRLASQSVYELMQHCWKERPEDRPSFSLLLHQ 254 (256)
T ss_pred ---------------CCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHh
Confidence 00113357899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=283.35 Aligned_cols=228 Identities=25% Similarity=0.325 Sum_probs=180.2
Q ss_pred cCceEEEEEEECCCCcEEEEEEeccchhhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEEEEEEecccc-cHHHHHH
Q 016184 93 GSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPE-TVNRIAR 171 (394)
Q Consensus 93 G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~ 171 (394)
|.+|.||++++..+++.||+|.+..... ..+|...+....||||+++++++. .....+++|||+++ +|.+.+.
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~~-~~~~~~~~~~~~~~~i~~~~~~~~-----~~~~~~lv~e~~~~~~L~~~l~ 77 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSSE-YSRERLTIIPHCVPNMVCLHKYIV-----SEDSVFLVLQHAEGGKLWSHIS 77 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchhh-hhhHHHHHHhcCCCceeehhhhee-----cCCeEEEEEecCCCCCHHHHHH
Confidence 8999999999999999999999876543 344555666678999999999873 33457899999985 6766654
Q ss_pred HhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCccccccCCCccccccccccc
Q 016184 172 NYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR 251 (394)
Q Consensus 172 ~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~ 251 (394)
. ...+++..+..++.|++.||+|||+ .||+||||||+||+++.++ .++|+|||.+...... .....++..|+
T Consensus 78 ~----~~~l~~~~~~~~~~ql~~~l~~lH~-~~i~H~dlkp~Nil~~~~~-~~~l~df~~~~~~~~~--~~~~~~~~~y~ 149 (237)
T cd05576 78 K----FLNIPEECVKRWAAEMVVALDALHR-EGIVCRDLNPNNILLDDRG-HIQLTYFSRWSEVEDS--CDGEAVENMYC 149 (237)
T ss_pred H----hcCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCHHHEEEcCCC-CEEEecccchhccccc--cccCCcCcccc
Confidence 3 2468999999999999999999999 8999999999999999888 6999999987654322 22344567799
Q ss_pred ccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCCCcccCCCCCCCCCcch
Q 016184 252 APELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHK 331 (394)
Q Consensus 252 aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 331 (394)
|||.+.+. .++.++|+||+|+++|+|++|+.||...... + . .....
T Consensus 150 aPE~~~~~-~~~~~~DvwslG~il~el~~g~~~~~~~~~~-----~-~---------------~~~~~------------ 195 (237)
T cd05576 150 APEVGGIS-EETEACDWWSLGAILFELLTGKTLVECHPSG-----I-N---------------THTTL------------ 195 (237)
T ss_pred CCcccCCC-CCCchhhHHHHHHHHHHHHHCcchhhcCchh-----c-c---------------ccccc------------
Confidence 99988543 4789999999999999999999887432110 0 0 00000
Q ss_pred hccccCChHHHHHHHHhcccCCCCCCCH-----HHHhcCCCC
Q 016184 332 VFQKRLPPEAVDLVCRFFQYSPNLRCTA-----LEACVHPFF 368 (394)
Q Consensus 332 ~~~~~~~~~~~~li~~~L~~dP~~Rpt~-----~ell~hp~f 368 (394)
.++..+++.+++||.+||+.||++|+|+ +++++||||
T Consensus 196 ~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h~~~ 237 (237)
T cd05576 196 NIPEWVSEEARSLLQQLLQFNPTERLGAGVAGVEDIKSHPFF 237 (237)
T ss_pred CCcccCCHHHHHHHHHHccCCHHHhcCCCccchHHHHcCCCC
Confidence 1224578899999999999999999986 999999998
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-38 Score=288.42 Aligned_cols=254 Identities=20% Similarity=0.300 Sum_probs=189.6
Q ss_pred eeEEEeeEEeecCceEEEEEEECC----------------CCcEEEEEEeccch-----hhhHHHHHHHHHcCCCCeeee
Q 016184 82 VSYIAEHVVGTGSFGVVFQAKCRE----------------TGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVAL 140 (394)
Q Consensus 82 ~~y~~~~~lg~G~~g~V~~~~~~~----------------~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~ 140 (394)
++|++.+.||+|+||.||++.+.. ++..||+|++.... ..+.+|+++++.++|+||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~ 84 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL 84 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence 459999999999999999986532 34579999886432 345679999999999999999
Q ss_pred ceEEEecCCCceeEEEEEEecccc-cHHHHHHHhhhh-------cCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCC
Q 016184 141 KHCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRI-------HQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKP 212 (394)
Q Consensus 141 ~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~-------~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp 212 (394)
++++.. ....+++|||+.+ +|.+++...... ...+++..+..++.|++.||+|||+ .|++|+||||
T Consensus 85 ~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~-~~i~H~dlkp 158 (296)
T cd05095 85 LAVCIT-----SDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSS-LNFVHRDLAT 158 (296)
T ss_pred EEEEec-----CCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHH-CCeecccCCh
Confidence 998733 2337899999974 777776653211 1347788899999999999999999 8999999999
Q ss_pred CceEEeCCCCcEEEEeecCccccccCCC---cccccccccccccccccCCCCCCChhhHHHHHHHHHHHHh--CCCCCCC
Q 016184 213 QNLLVNPHTHQLKLCDFGSAKVLVKGEP---NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL--GQPLFPG 287 (394)
Q Consensus 213 ~Nil~~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt--g~~pf~~ 287 (394)
+|||++.++ .++|+|||++........ ......+..|++||...+. .++.++|+|||||++|+|++ |..||..
T Consensus 159 ~Nili~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~DiwSlG~~l~el~~~~~~~p~~~ 236 (296)
T cd05095 159 RNCLVGKNY-TIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLG-KFTTASDVWAFGVTLWEILTLCKEQPYSQ 236 (296)
T ss_pred heEEEcCCC-CEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcC-CccchhhhhHHHHHHHHHHHhCCCCCccc
Confidence 999999877 699999999876533221 1122335679999987654 48999999999999999998 7788876
Q ss_pred CCcHHHHHHHHHHhCCCChhhhhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 016184 288 ESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV 364 (394)
Q Consensus 288 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 364 (394)
....+.+........ ........+ .+..+++.+.+|+.+||+.||.+|||+.++++
T Consensus 237 ~~~~~~~~~~~~~~~-----------~~~~~~~~~----------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~ 292 (296)
T cd05095 237 LSDEQVIENTGEFFR-----------DQGRQVYLP----------KPALCPDSLYKLMLSCWRRNAKERPSFQEIHA 292 (296)
T ss_pred cChHHHHHHHHHHHh-----------hccccccCC----------CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 655444433221100 000000000 11346789999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-38 Score=281.31 Aligned_cols=242 Identities=27% Similarity=0.387 Sum_probs=192.6
Q ss_pred EEeeEEeecCceEEEEEEECCCC----cEEEEEEeccch-----hhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEE
Q 016184 85 IAEHVVGTGSFGVVFQAKCRETG----EIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL 155 (394)
Q Consensus 85 ~~~~~lg~G~~g~V~~~~~~~~~----~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 155 (394)
++.+.||.|+||.||+|++...+ ..||+|++.... ....+|+.+++.++|+||+++++++... ...
T Consensus 2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~ 76 (258)
T smart00219 2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEE-----EPL 76 (258)
T ss_pred cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCC-----Cee
Confidence 56788999999999999998766 899999986443 2455799999999999999999988332 457
Q ss_pred EEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCccc
Q 016184 156 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV 234 (394)
Q Consensus 156 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~ 234 (394)
+++|||+++ ++.+++..... ..+++..+..++.|++.||++||+ .|++|+||||+||+++.++ .++|+|||++..
T Consensus 77 ~~i~e~~~~~~l~~~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lh~-~~~~h~dl~~~nil~~~~~-~~~l~dfg~~~~ 152 (258)
T smart00219 77 MIVMEYMEGGDLLDYLRKNRP--KELSLSDLLSFALQIARGMEYLES-KNFIHRDLAARNCLVGENL-VVKISDFGLSRD 152 (258)
T ss_pred EEEEeccCCCCHHHHHHhhhh--ccCCHHHHHHHHHHHHHHHHHHhc-CCeeecccccceEEEccCC-eEEEcccCCcee
Confidence 899999975 77666654221 228999999999999999999999 8999999999999999887 799999999976
Q ss_pred cccCCCcc--cccccccccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCChhhhhc
Q 016184 235 LVKGEPNV--SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKC 311 (394)
Q Consensus 235 ~~~~~~~~--~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 311 (394)
........ ...+++.|+|||.+.+ ..++.++|+||||+++|+|++ |..||...+.......+.....
T Consensus 153 ~~~~~~~~~~~~~~~~~y~~Pe~~~~-~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~--------- 222 (258)
T smart00219 153 LYDDDYYKKKGGKLPIRWMAPESLKD-GKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYR--------- 222 (258)
T ss_pred cccccccccccCCCcccccChHHhcc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCC---------
Confidence 65432221 1235688999999844 458999999999999999998 8899987665555444432110
Q ss_pred cCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 016184 312 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV 364 (394)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 364 (394)
......++.++.+++.+||..||++|||+.++++
T Consensus 223 -------------------~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 256 (258)
T smart00219 223 -------------------LPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVE 256 (258)
T ss_pred -------------------CCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHh
Confidence 0011347889999999999999999999999986
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-38 Score=281.82 Aligned_cols=239 Identities=25% Similarity=0.346 Sum_probs=188.5
Q ss_pred eEEeecCceEEEEEEECC-CC--cEEEEEEeccchh-----hhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEEEEEE
Q 016184 88 HVVGTGSFGVVFQAKCRE-TG--EIVAIKKVLQDKR-----YKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVL 159 (394)
Q Consensus 88 ~~lg~G~~g~V~~~~~~~-~~--~~vaiK~~~~~~~-----~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~ 159 (394)
++||+|++|.||+|.+.. .+ ..||||.+..... .+.+|+.+++.++|+||+++++.+.. ...+++|
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~------~~~~~v~ 74 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT------HPLMMVT 74 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC------CeEEEEE
Confidence 368999999999999865 33 3699998865433 45579999999999999999988733 4578999
Q ss_pred eccc-ccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCccccccC
Q 016184 160 EYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG 238 (394)
Q Consensus 160 e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~~ 238 (394)
||++ ++|.+.+..... ..+++..++.++.|++.||+|||+ +|++|+||||+||+++.++ .+||+|||++......
T Consensus 75 e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~-~~i~H~di~p~nil~~~~~-~~kl~dfg~~~~~~~~ 150 (257)
T cd05040 75 ELAPLGSLLDRLRKDAL--GHFLISTLCDYAVQIANGMRYLES-KRFIHRDLAARNILLASDD-KVKIGDFGLMRALPQN 150 (257)
T ss_pred EecCCCcHHHHHHhccc--ccCcHHHHHHHHHHHHHHHHHHHh-CCccccccCcccEEEecCC-EEEecccccccccccc
Confidence 9997 577776665322 568999999999999999999999 8999999999999999887 7999999998766442
Q ss_pred CCc----ccccccccccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCChhhhhccC
Q 016184 239 EPN----VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 313 (394)
Q Consensus 239 ~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 313 (394)
... ....++..|+|||.+.+. .++.++|||||||++|+|++ |..||...+..+....+.....
T Consensus 151 ~~~~~~~~~~~~~~~y~~pE~~~~~-~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~----------- 218 (257)
T cd05040 151 EDHYVMEEHLKVPFAWCAPESLRTR-TFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGE----------- 218 (257)
T ss_pred ccceecccCCCCCceecCHHHhccc-CcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCC-----------
Confidence 211 123456789999998544 48999999999999999998 9999987766555444432100
Q ss_pred CCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 016184 314 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV 364 (394)
Q Consensus 314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 364 (394)
.. ..+..++..+.+++.+||+.+|++|||+.++++
T Consensus 219 ----~~------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 253 (257)
T cd05040 219 ----RL------------ERPEACPQDIYNVMLQCWAHNPADRPTFAALRE 253 (257)
T ss_pred ----cC------------CCCccCCHHHHHHHHHHCCCCcccCCCHHHHHH
Confidence 00 011346889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=306.14 Aligned_cols=259 Identities=26% Similarity=0.402 Sum_probs=215.8
Q ss_pred EEEeeEEeecCceEEEEEEECCCCcEEEEEEeccc---hhhhHHHHHHHHHc-CCCCeeeeceEEEecCCCceeEEEEEE
Q 016184 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD---KRYKNRELQIMQML-DHPNIVALKHCFFSTTDKEELYLNLVL 159 (394)
Q Consensus 84 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~lv~ 159 (394)
|+|..+||.|.+|.||+++++.+|+.+|+|+.... ...++.|.++|+.+ .|||++.++++|.......+..+++||
T Consensus 21 ~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLWLVM 100 (953)
T KOG0587|consen 21 FEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLWLVM 100 (953)
T ss_pred cEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEEEEe
Confidence 99999999999999999999999999999987543 34555678888887 699999999999877766777799999
Q ss_pred ecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCccccccC
Q 016184 160 EYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG 238 (394)
Q Consensus 160 e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~~ 238 (394)
|||++ +..++++... +.++.+..+..|++.++.||.+||. ..++|||||-.|||++.++ .|||+|||.+......
T Consensus 101 EfC~gGSVTDLVKn~~--g~rl~E~~IaYI~re~lrgl~HLH~-nkviHRDikG~NiLLT~e~-~VKLvDFGvSaQldsT 176 (953)
T KOG0587|consen 101 EFCGGGSVTDLVKNTK--GNRLKEEWIAYILREILRGLAHLHN-NKVIHRDIKGQNVLLTENA-EVKLVDFGVSAQLDST 176 (953)
T ss_pred eccCCccHHHHHhhhc--ccchhhHHHHHHHHHHHHHHHHHhh-cceeeecccCceEEEeccC-cEEEeeeeeeeeeecc
Confidence 99994 8889888876 7899999999999999999999999 8999999999999999998 6999999998655332
Q ss_pred -CCcccccccccccccccccCC----CCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccC
Q 016184 239 -EPNVSYICSRYYRAPELIFGA----TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 313 (394)
Q Consensus 239 -~~~~~~~~t~~y~aPE~~~~~----~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 313 (394)
....+..|||+|||||++... ..|+..+|+||||++..||.-|.+|+.+.-+...+..| ..-|++.+.
T Consensus 177 ~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~I---pRNPPPkLk---- 249 (953)
T KOG0587|consen 177 VGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLI---PRNPPPKLK---- 249 (953)
T ss_pred cccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccC---CCCCCcccc----
Confidence 344567899999999999543 23778999999999999999999999876655443332 222332211
Q ss_pred CCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 016184 314 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR 372 (394)
Q Consensus 314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 372 (394)
-++.-+..+.+||..||.+|..+||+..++|+|||+++..
T Consensus 250 -------------------rp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~e~~ 289 (953)
T KOG0587|consen 250 -------------------RPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFITEQP 289 (953)
T ss_pred -------------------chhhHHHHHHHHHHHHHhhccccCcchhhhccCCcccccc
Confidence 1134578899999999999999999999999999998543
|
|
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-38 Score=284.65 Aligned_cols=249 Identities=23% Similarity=0.312 Sum_probs=193.1
Q ss_pred eeEEEeeEEeecCceEEEEEEECC-----CCcEEEEEEeccch-----hhhHHHHHHHHHcCCCCeeeeceEEEecCCCc
Q 016184 82 VSYIAEHVVGTGSFGVVFQAKCRE-----TGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKE 151 (394)
Q Consensus 82 ~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 151 (394)
.+|++.+.||.|+||.||+|+.+. +.+.||+|.+.... ....+|+++++.++|+||+++++++ ..
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~ 79 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLC-----RE 79 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEE-----CC
Confidence 459999999999999999999754 34679999875432 2356799999999999999999877 33
Q ss_pred eeEEEEEEeccc-ccHHHHHHHhhhhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEE
Q 016184 152 ELYLNLVLEYVP-ETVNRIARNYSRIH-----QRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLK 225 (394)
Q Consensus 152 ~~~~~lv~e~~~-~~l~~~~~~~~~~~-----~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vk 225 (394)
..+.++||||++ ++|.+++....... ..+++..+..++.|++.||+|||+ .||+||||||+||+++.++ .++
T Consensus 80 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~-~~i~H~dlkp~Nili~~~~-~~~ 157 (275)
T cd05046 80 AEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSN-ARFVHRDLAARNCLVSSQR-EVK 157 (275)
T ss_pred CCcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhh-cCcccCcCccceEEEeCCC-cEE
Confidence 345789999998 57777766433111 268999999999999999999999 8999999999999999888 699
Q ss_pred EEeecCccccccCC--CcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhC
Q 016184 226 LCDFGSAKVLVKGE--PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLG 302 (394)
Q Consensus 226 l~Dfg~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~ 302 (394)
|+|||++....... ......++..|+|||.+.+. .++.++||||||+++|+|++ |..||...........+....
T Consensus 158 l~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~- 235 (275)
T cd05046 158 VSLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQED-DFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGK- 235 (275)
T ss_pred EcccccccccCcccccccCCceeEEeecChhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcCC-
Confidence 99999986443221 11233457779999988654 47899999999999999998 888997655444333322100
Q ss_pred CCChhhhhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 016184 303 TPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH 365 (394)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 365 (394)
.. | .....++..+.+++.+||+.||.+|||+.+++.+
T Consensus 236 ----------------~~--------~--~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~ 272 (275)
T cd05046 236 ----------------LE--------L--PVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSA 272 (275)
T ss_pred ----------------cC--------C--CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence 00 0 0123578899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=284.53 Aligned_cols=243 Identities=21% Similarity=0.295 Sum_probs=186.1
Q ss_pred eeEEEeeEEeecCceEEEEEEECCCCc----EEEEEEeccch-----hhhHHHHHHHHHcCCCCeeeeceEEEecCCCce
Q 016184 82 VSYIAEHVVGTGSFGVVFQAKCRETGE----IVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE 152 (394)
Q Consensus 82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~----~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 152 (394)
..|++.+.||+|+||.||+|.+..+++ .+++|.+.... .....|+.+++.+.||||+++++++. ..
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-----~~ 81 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-----GA 81 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-----CC
Confidence 358999999999999999999977776 47777764321 22345667788999999999998762 11
Q ss_pred eEEEEEEeccc-ccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecC
Q 016184 153 LYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS 231 (394)
Q Consensus 153 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~ 231 (394)
..++++||++ ++|.+++... ...+++..+..++.|++.||+|||+ +|++||||||+|||++.++ .+||+|||+
T Consensus 82 -~~~~i~e~~~~gsL~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~-~~iiH~dlkp~nili~~~~-~~kl~Dfg~ 155 (279)
T cd05111 82 -SLQLVTQLSPLGSLLDHVRQH---RDSLDPQRLLNWCVQIAKGMYYLEE-HRMVHRNLAARNILLKSDS-IVQIADFGV 155 (279)
T ss_pred -ccEEEEEeCCCCcHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHH-CCEeccccCcceEEEcCCC-cEEEcCCcc
Confidence 2457889987 5776666532 3568999999999999999999999 8999999999999999887 799999999
Q ss_pred ccccccCCCc---ccccccccccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCChh
Q 016184 232 AKVLVKGEPN---VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTRE 307 (394)
Q Consensus 232 a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~ 307 (394)
++........ ....++..|+|||.+.+. .++.++||||||+++|+|++ |..||.+...... .++......+.
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~-~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~-~~~~~~~~~~~-- 231 (279)
T cd05111 156 ADLLYPDDKKYFYSEHKTPIKWMALESILFG-RYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEV-PDLLEKGERLA-- 231 (279)
T ss_pred ceeccCCCcccccCCCCCcccccCHHHhccC-CcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHH-HHHHHCCCcCC--
Confidence 9765433221 123456789999998654 48999999999999999998 9999987654332 22222110000
Q ss_pred hhhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 016184 308 EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV 364 (394)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 364 (394)
.+..++.++.+++.+||..||++|||+.++++
T Consensus 232 -------------------------~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~ 263 (279)
T cd05111 232 -------------------------QPQICTIDVYMVMVKCWMIDENVRPTFKELAN 263 (279)
T ss_pred -------------------------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 01235778999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=280.81 Aligned_cols=236 Identities=25% Similarity=0.342 Sum_probs=184.3
Q ss_pred eEEeecCceEEEEEEECCCC---cEEEEEEeccchh-----hhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEEEEEE
Q 016184 88 HVVGTGSFGVVFQAKCRETG---EIVAIKKVLQDKR-----YKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVL 159 (394)
Q Consensus 88 ~~lg~G~~g~V~~~~~~~~~---~~vaiK~~~~~~~-----~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~ 159 (394)
++||+|+||.||+|.+...+ ..+|+|.+..... ...+|+.+++.+.|+||+++++++. . ...+++|
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~-~~~~~v~ 74 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-----G-EPLMLVM 74 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-----C-CceEEEE
Confidence 46999999999999876554 7899998864432 3457899999999999999988762 1 1257999
Q ss_pred ecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCccccccC
Q 016184 160 EYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG 238 (394)
Q Consensus 160 e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~~ 238 (394)
||+.+ +|.+++.. ...+++..+..++.|++.||+|||. .|++|+||||+|||++.++ .+||+|||+++.....
T Consensus 75 e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lh~-~~i~H~di~p~nili~~~~-~~kl~df~~~~~~~~~ 148 (257)
T cd05060 75 ELAPLGPLLKYLKK----RREIPVSDLKELAHQVAMGMAYLES-KHFVHRDLAARNVLLVNRH-QAKISDFGMSRALGAG 148 (257)
T ss_pred EeCCCCcHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHhh-cCeeccCcccceEEEcCCC-cEEeccccccceeecC
Confidence 99874 67666653 2468999999999999999999999 8999999999999999887 6999999998766433
Q ss_pred CCcc----cccccccccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCChhhhhccC
Q 016184 239 EPNV----SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 313 (394)
Q Consensus 239 ~~~~----~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 313 (394)
.... ...++..|+|||.+.+. .++.++||||||+++|+|++ |..||...+..+....+... ..
T Consensus 149 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~-~~---------- 216 (257)
T cd05060 149 SDYYRATTAGRWPLKWYAPECINYG-KFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESG-ER---------- 216 (257)
T ss_pred CcccccccCccccccccCHHHhcCC-CCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcC-Cc----------
Confidence 3211 11224579999998554 48999999999999999998 99999776654433332221 00
Q ss_pred CCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 016184 314 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV 364 (394)
Q Consensus 314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 364 (394)
...+..++..+.++|.+||..||.+||++.++++
T Consensus 217 -----------------~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~ 250 (257)
T cd05060 217 -----------------LPRPEECPQEIYSIMLSCWKYRPEDRPTFSELES 250 (257)
T ss_pred -----------------CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 0012356889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=282.50 Aligned_cols=246 Identities=21% Similarity=0.291 Sum_probs=183.1
Q ss_pred eEEeecCceEEEEEEECC--CCcEEEEEEeccch-----hhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEEEEEEe
Q 016184 88 HVVGTGSFGVVFQAKCRE--TGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLE 160 (394)
Q Consensus 88 ~~lg~G~~g~V~~~~~~~--~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e 160 (394)
+.||+|+||.||+|.... ....+|+|.+.... ..+.+|+++++.++|+||+++++.+. .....++|||
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~-----~~~~~~lv~e 75 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCI-----ESIPYLLVLE 75 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEEC-----CCCceEEEEE
Confidence 358999999999997532 34578889765332 23457899999999999999999873 3344789999
Q ss_pred cccc-cHHHHHHHhhhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCccccccC
Q 016184 161 YVPE-TVNRIARNYSRI-HQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG 238 (394)
Q Consensus 161 ~~~~-~l~~~~~~~~~~-~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~~ 238 (394)
|+++ +|.+++...... ....++..+..++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||++......
T Consensus 76 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~dlkp~Nill~~~~-~~kl~dfg~~~~~~~~ 153 (269)
T cd05042 76 FCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQ-ADFIHSDLALRNCQLTADL-SVKIGDYGLALEQYPE 153 (269)
T ss_pred eCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHh-cCEecccccHhheEecCCC-cEEEeccccccccccc
Confidence 9985 787776654321 2345677888999999999999999 8999999999999999887 7999999998654322
Q ss_pred CC---cccccccccccccccccC------CCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCChhh
Q 016184 239 EP---NVSYICSRYYRAPELIFG------ATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREE 308 (394)
Q Consensus 239 ~~---~~~~~~t~~y~aPE~~~~------~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 308 (394)
.. .....+++.|+|||++.. ...++.++|||||||++|+|++ |..||......+.+...........
T Consensus 154 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~--- 230 (269)
T cd05042 154 DYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKL--- 230 (269)
T ss_pred hheeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccC---
Confidence 11 122334677999998742 2346889999999999999999 7889987766555554433211100
Q ss_pred hhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 016184 309 IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV 364 (394)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 364 (394)
+ ...+...++..+.+++..|+ .||++|||++++++
T Consensus 231 -------------~-------~~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~ 265 (269)
T cd05042 231 -------------P-------KPQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHE 265 (269)
T ss_pred -------------C-------CCcccccCCHHHHHHHHHHh-cCcccccCHHHHHH
Confidence 0 01122457888999999998 59999999999875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-38 Score=286.31 Aligned_cols=259 Identities=23% Similarity=0.354 Sum_probs=187.7
Q ss_pred eEEEeeEEeecCceEEEEEEE----CCCCcEEEEEEeccc-----hhhhHHHHHHHHHcCCCCeeeeceEEEecCCCcee
Q 016184 83 SYIAEHVVGTGSFGVVFQAKC----RETGEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL 153 (394)
Q Consensus 83 ~y~~~~~lg~G~~g~V~~~~~----~~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 153 (394)
-|++.+.||+|+||.||+|+. ..++..||+|.+... .....+|+++++.+.|+|++++.+++... ...
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~~~ 81 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTED---GGN 81 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecC---CCC
Confidence 389999999999999999984 456889999987533 23456799999999999999998877332 234
Q ss_pred EEEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCc
Q 016184 154 YLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA 232 (394)
Q Consensus 154 ~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a 232 (394)
..+++|||+++ +|.+++... ...+++..+..++.|++.||+|||+ +|++||||||+||+++.++ .++|+|||++
T Consensus 82 ~~~lv~e~~~g~~L~~~l~~~---~~~~~~~~~~~i~~~i~~aL~~lH~-~gi~H~dlkp~Nil~~~~~-~~~l~dfg~~ 156 (284)
T cd05079 82 GIKLIMEFLPSGSLKEYLPRN---KNKINLKQQLKYAVQICKGMDYLGS-RQYVHRDLAARNVLVESEH-QVKIGDFGLT 156 (284)
T ss_pred ceEEEEEccCCCCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecccchheEEEcCCC-CEEECCCccc
Confidence 47799999974 676665431 2468999999999999999999999 8999999999999999887 6999999998
Q ss_pred cccccCCCc----ccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHH-HhCCCChh
Q 016184 233 KVLVKGEPN----VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIK-VLGTPTRE 307 (394)
Q Consensus 233 ~~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~-~~~~~~~~ 307 (394)
......... ....++..|+|||.+.+. .++.++||||||+++|+|++++.|+..... ....... ..+.....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~-~~~~~~Di~slG~il~ellt~~~~~~~~~~--~~~~~~~~~~~~~~~~ 233 (284)
T cd05079 157 KAIETDKEYYTVKDDLDSPVFWYAPECLIQS-KFYIASDVWSFGVTLYELLTYCDSESSPMT--LFLKMIGPTHGQMTVT 233 (284)
T ss_pred cccccCccceeecCCCCCCccccCHHHhccC-CCCccccchhhhhhhhhhhcCCCCCccccc--hhhhhcccccccccHH
Confidence 765433221 123456679999998654 488999999999999999998766533211 0100000 00000000
Q ss_pred -hhhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 016184 308 -EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH 365 (394)
Q Consensus 308 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 365 (394)
........ . .......++..+.+|+.+||+.||.+|||+.+++++
T Consensus 234 ~~~~~~~~~---~----------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 279 (284)
T cd05079 234 RLVRVLEEG---K----------RLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEG 279 (284)
T ss_pred HHHHHHHcC---c----------cCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 00000000 0 000124578999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=279.82 Aligned_cols=243 Identities=24% Similarity=0.362 Sum_probs=190.2
Q ss_pred eeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccch---hhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEEEEE
Q 016184 82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLV 158 (394)
Q Consensus 82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv 158 (394)
.+|.+.+.||+|+||.||+|.+. .+..+|+|.+.... ....+|+++++.++|+||+++++.+.. ...+++
T Consensus 6 ~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~------~~~~~v 78 (260)
T cd05073 6 ESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK------EPIYII 78 (260)
T ss_pred cceeEEeEecCccceEEEEEEec-CCccEEEEecCCChhHHHHHHHHHHHHHhcCCCCcceEEEEEcC------CCeEEE
Confidence 46999999999999999999865 45679999876533 345579999999999999999887732 236789
Q ss_pred Eecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCcccccc
Q 016184 159 LEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK 237 (394)
Q Consensus 159 ~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~ 237 (394)
|||+++ ++.+++... ....+++..+..++.|++.||.|||+ .|++|+||||+||+++.++ .++|+|||.+.....
T Consensus 79 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~aL~~lH~-~~i~H~dl~p~ni~i~~~~-~~~l~d~~~~~~~~~ 154 (260)
T cd05073 79 TEFMAKGSLLDFLKSD--EGSKQPLPKLIDFSAQIAEGMAFIEQ-RNYIHRDLRAANILVSASL-VCKIADFGLARVIED 154 (260)
T ss_pred EEeCCCCcHHHHHHhC--CccccCHHHHHHHHHHHHHHHHHHHh-CCccccccCcceEEEcCCC-cEEECCCcceeeccC
Confidence 999974 777766542 23567888899999999999999999 8999999999999999887 799999999876533
Q ss_pred CCCc--ccccccccccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCC
Q 016184 238 GEPN--VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 314 (394)
Q Consensus 238 ~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 314 (394)
.... ....++..|+|||++... .++.++|+|||||++|++++ |..||.+.+.......+....
T Consensus 155 ~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~------------- 220 (260)
T cd05073 155 NEYTAREGAKFPIKWTAPEAINFG-SFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGY------------- 220 (260)
T ss_pred CCcccccCCcccccccCHhHhccC-CcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCC-------------
Confidence 2211 122345679999998544 48899999999999999998 999998766544443332210
Q ss_pred CCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 016184 315 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV 364 (394)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 364 (394)
..+ .....+.++.+++.+||+.||++||++.++++
T Consensus 221 -----~~~----------~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05073 221 -----RMP----------RPENCPEELYNIMMRCWKNRPEERPTFEYIQS 255 (260)
T ss_pred -----CCC----------CcccCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence 000 11356889999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=283.04 Aligned_cols=243 Identities=25% Similarity=0.329 Sum_probs=190.3
Q ss_pred eeEEEeeEEeecCceEEEEEEECCCCc----EEEEEEeccch-----hhhHHHHHHHHHcCCCCeeeeceEEEecCCCce
Q 016184 82 VSYIAEHVVGTGSFGVVFQAKCRETGE----IVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE 152 (394)
Q Consensus 82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~----~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 152 (394)
.+|++.+.||+|+||.||+|.++.+|. .+|+|.+.... ....+|+.+++.++|+||+++++++..
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------ 80 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS------ 80 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec------
Confidence 359999999999999999999876665 58999875442 234579999999999999999998743
Q ss_pred eEEEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecC
Q 016184 153 LYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS 231 (394)
Q Consensus 153 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~ 231 (394)
...+++|||+++ ++.+.+... ...+++..+..++.|++.||+|||+ .|++|+||||+|||++.++ .+||+|||.
T Consensus 81 ~~~~~v~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~LH~-~~i~H~di~p~nil~~~~~-~~kL~dfg~ 155 (279)
T cd05057 81 SQVQLITQLMPLGCLLDYVRNH---KDNIGSQYLLNWCVQIAKGMSYLEE-KRLVHRDLAARNVLVKTPQ-HVKITDFGL 155 (279)
T ss_pred CceEEEEecCCCCcHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHh-CCEEecccCcceEEEcCCC-eEEECCCcc
Confidence 236789999974 676655432 2458999999999999999999999 8999999999999999887 799999999
Q ss_pred ccccccCCCccc---ccccccccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCChh
Q 016184 232 AKVLVKGEPNVS---YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTRE 307 (394)
Q Consensus 232 a~~~~~~~~~~~---~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~ 307 (394)
++.......... ..++..|+|||.+... .++.++|+||||+++|++++ |+.||.+....+....+.... ..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~-~~--- 230 (279)
T cd05057 156 AKLLDVDEKEYHAEGGKVPIKWMALESILHR-IYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGE-RL--- 230 (279)
T ss_pred cccccCcccceecCCCcccccccCHHHhhcC-CcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCC-CC---
Confidence 976543322111 1225679999988543 48999999999999999998 999998766544333332210 00
Q ss_pred hhhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 016184 308 EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV 364 (394)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 364 (394)
..+...+..+.+++.+||..||.+|||+.++++
T Consensus 231 ------------------------~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~ 263 (279)
T cd05057 231 ------------------------PQPPICTIDVYMVLVKCWMIDAESRPTFKELIN 263 (279)
T ss_pred ------------------------CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 011346788999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=281.47 Aligned_cols=246 Identities=20% Similarity=0.244 Sum_probs=181.9
Q ss_pred eEEeecCceEEEEEEEC--CCCcEEEEEEeccch-----hhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEEEEEEe
Q 016184 88 HVVGTGSFGVVFQAKCR--ETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLE 160 (394)
Q Consensus 88 ~~lg~G~~g~V~~~~~~--~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e 160 (394)
+.||+|+||.||+|... .++..+|+|.+.... ....+|+.+++.++||||+++++++. .....++|||
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~~lv~e 75 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCT-----EVTPYLLVME 75 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEc-----CCCCcEEEEE
Confidence 35899999999999864 345679999875432 24456999999999999999999873 2334779999
Q ss_pred ccc-ccHHHHHHHhhhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCccccccC
Q 016184 161 YVP-ETVNRIARNYSRI-HQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG 238 (394)
Q Consensus 161 ~~~-~~l~~~~~~~~~~-~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~~ 238 (394)
|++ ++|.+++...... ....++..+..++.|++.||+|||+ .|++|+||||+||+++.++ .++|+|||++......
T Consensus 76 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~-~~i~H~dlkp~nil~~~~~-~~kL~dfg~~~~~~~~ 153 (269)
T cd05087 76 FCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHK-NNFIHSDLALRNCLLTADL-TVKIGDYGLSHNKYKE 153 (269)
T ss_pred CCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHH-CCEeccccCcceEEEcCCC-cEEECCccccccccCc
Confidence 998 5777776543321 2345677888899999999999999 8999999999999999887 7999999998654322
Q ss_pred CC---cccccccccccccccccCC------CCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCChhh
Q 016184 239 EP---NVSYICSRYYRAPELIFGA------TEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREE 308 (394)
Q Consensus 239 ~~---~~~~~~t~~y~aPE~~~~~------~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 308 (394)
.. .....++..|+|||++.+. ..++.++|+||||+++|+|++ |+.||......+...........
T Consensus 154 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~----- 228 (269)
T cd05087 154 DYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQL----- 228 (269)
T ss_pred ceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccC-----
Confidence 21 1123457789999998432 125789999999999999996 99999876655443322211000
Q ss_pred hhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 016184 309 IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV 364 (394)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 364 (394)
.++ ...+....+..+.+++..|+ .||++|||+++|+.
T Consensus 229 -----------~~~-------~~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~ 265 (269)
T cd05087 229 -----------KLP-------KPRLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHL 265 (269)
T ss_pred -----------CCC-------CCccCCCCChHHHHHHHHHh-cCcccCCCHHHHHH
Confidence 000 00011346788999999999 68999999999974
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=281.74 Aligned_cols=236 Identities=17% Similarity=0.200 Sum_probs=176.7
Q ss_pred eEEeecCceEEEEEEECCC------------CcEEEEEEeccchh----hhHHHHHHHHHcCCCCeeeeceEEEecCCCc
Q 016184 88 HVVGTGSFGVVFQAKCRET------------GEIVAIKKVLQDKR----YKNRELQIMQMLDHPNIVALKHCFFSTTDKE 151 (394)
Q Consensus 88 ~~lg~G~~g~V~~~~~~~~------------~~~vaiK~~~~~~~----~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 151 (394)
+.||+|+||.||+|..... ...||+|++..... .+.+|+.+++.++||||+++++++...
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~---- 76 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRD---- 76 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecC----
Confidence 3589999999999985322 23588898754322 345678899999999999999987432
Q ss_pred eeEEEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCC------cE
Q 016184 152 ELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTH------QL 224 (394)
Q Consensus 152 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~------~v 224 (394)
...+++|||+++ ++..++.. ....+++..++.++.||+.||+|||+ .||+||||||+|||++.++. .+
T Consensus 77 -~~~~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~-~~ivH~dlkp~Nill~~~~~~~~~~~~~ 151 (262)
T cd05077 77 -VENIMVEEFVEFGPLDLFMHR---KSDVLTTPWKFKVAKQLASALSYLED-KDLVHGNVCTKNILLAREGIDGECGPFI 151 (262)
T ss_pred -CCCEEEEecccCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHhhh-CCeECCCCCcccEEEecCCccCCCCcee
Confidence 235799999986 44443322 23568999999999999999999999 89999999999999986552 28
Q ss_pred EEEeecCccccccCCCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHH-hCCCCCCCCCcHHHHHHHHHHhCC
Q 016184 225 KLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQLVEIIKVLGT 303 (394)
Q Consensus 225 kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll-tg~~pf~~~~~~~~~~~i~~~~~~ 303 (394)
+++|||++...... ....++..|+|||.+.....++.++|||||||++|+|+ +|..||......+.. .....
T Consensus 152 ~l~d~g~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~-~~~~~--- 224 (262)
T cd05077 152 KLSDPGIPITVLSR---QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKE-RFYEG--- 224 (262)
T ss_pred EeCCCCCCccccCc---ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHH-HHHhc---
Confidence 99999998654322 23456788999998864556899999999999999998 588888765432221 11110
Q ss_pred CChhhhhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 016184 304 PTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH 365 (394)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 365 (394)
... .....+.++.+||.+||+.||.+||++.+|+++
T Consensus 225 --------------~~~------------~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~ 260 (262)
T cd05077 225 --------------QCM------------LVTPSCKELADLMTHCMNYDPNQRPFFRAIMRD 260 (262)
T ss_pred --------------Ccc------------CCCCChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence 000 012245789999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=279.59 Aligned_cols=240 Identities=23% Similarity=0.358 Sum_probs=189.3
Q ss_pred eeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccc--hhhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEEEEEE
Q 016184 82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD--KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVL 159 (394)
Q Consensus 82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~ 159 (394)
.+|++.+.||+|+||.||++.. +++.||+|.+... .....+|+.+++.++|+|++++++++.. +. .+++|
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~--~~~~~~iK~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~----~~--~~~v~ 77 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY--TGQKVAVKNIKCDVTAQAFLEETAVMTKLHHKNLVRLLGVILH----NG--LYIVM 77 (254)
T ss_pred HHceeeeeeccCCCCceEeccc--CCCceEEEeecCcchHHHHHHHHHHHHhCCCCCcCeEEEEEcC----CC--cEEEE
Confidence 3599999999999999999874 5788999987643 2345679999999999999999988732 11 57899
Q ss_pred ecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCccccccC
Q 016184 160 EYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG 238 (394)
Q Consensus 160 e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~~ 238 (394)
||+.+ +|.+++.... ...+++..+..++.|++.||.|||+ .|++||||||+||+++.++ .++|+|||++......
T Consensus 78 e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~qi~~al~~lH~-~~~~H~dl~p~nili~~~~-~~kl~Dfg~~~~~~~~ 153 (254)
T cd05083 78 ELMSKGNLVNFLRTRG--RALVSVIQLLQFSLDVAEGMEYLES-KKLVHRDLAARNILVSEDG-VAKVSDFGLARVGSMG 153 (254)
T ss_pred ECCCCCCHHHHHHhcC--cCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccccCcceEEEcCCC-cEEECCCccceecccc
Confidence 99984 7777765422 2468899999999999999999999 8999999999999999887 7999999998754322
Q ss_pred CCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCCCc
Q 016184 239 EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 317 (394)
Q Consensus 239 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 317 (394)
......+..|+|||.+.+. .++.++|+||||+++|+|++ |+.||......+....+.+...
T Consensus 154 --~~~~~~~~~y~~pe~~~~~-~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~--------------- 215 (254)
T cd05083 154 --VDNSKLPVKWTAPEALKHK-KFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYR--------------- 215 (254)
T ss_pred --CCCCCCCceecCHHHhccC-CcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCCC---------------
Confidence 1223345679999988544 48999999999999999997 9999987665443333221100
Q ss_pred ccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 016184 318 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV 364 (394)
Q Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 364 (394)
. .....++..+.+++++||+.+|.+||++++++.
T Consensus 216 ---~----------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 249 (254)
T cd05083 216 ---M----------EPPEGCPADVYVLMTSCWETEPKKRPSFHKLRE 249 (254)
T ss_pred ---C----------CCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 0 011357889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=283.25 Aligned_cols=235 Identities=17% Similarity=0.230 Sum_probs=177.9
Q ss_pred EEeecCceEEEEEEECCC------------------------CcEEEEEEeccch----hhhHHHHHHHHHcCCCCeeee
Q 016184 89 VVGTGSFGVVFQAKCRET------------------------GEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVAL 140 (394)
Q Consensus 89 ~lg~G~~g~V~~~~~~~~------------------------~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~~iv~~ 140 (394)
.||+|+||.||+|....+ ...||+|++.... ..+.+|+.+++.++|+||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 589999999999985322 2458899875432 234467889999999999999
Q ss_pred ceEEEecCCCceeEEEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeC
Q 016184 141 KHCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNP 219 (394)
Q Consensus 141 ~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~ 219 (394)
++++... .+.++||||+++ +|..++.. ....+++..+..++.|++.||+|||+ +||+||||||+|||++.
T Consensus 82 ~~~~~~~-----~~~~lv~ey~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~-~~iiH~dlkp~Nill~~ 152 (274)
T cd05076 82 HGVCVRG-----SENIMVEEFVEHGPLDVCLRK---EKGRVPVAWKITVAQQLASALSYLED-KNLVHGNVCAKNILLAR 152 (274)
T ss_pred EEEEEeC-----CceEEEEecCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHc-CCccCCCCCcccEEEec
Confidence 9988432 347799999996 45444432 23578999999999999999999999 89999999999999975
Q ss_pred CCC------cEEEEeecCccccccCCCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHH-hCCCCCCCCCcHH
Q 016184 220 HTH------QLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVD 292 (394)
Q Consensus 220 ~~~------~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll-tg~~pf~~~~~~~ 292 (394)
.+. .+|++|||.+...... ....++..|+|||.+.+...++.++||||||+++|+|+ +|..||......+
T Consensus 153 ~~~~~~~~~~~kl~d~g~~~~~~~~---~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~ 229 (274)
T cd05076 153 LGLAEGTSPFIKLSDPGVSFTALSR---EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSE 229 (274)
T ss_pred cCcccCccceeeecCCccccccccc---cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHH
Confidence 431 3899999987543222 22356788999999866556899999999999999995 6999997765433
Q ss_pred HHHHHHHHhCCCChhhhhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 016184 293 QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH 365 (394)
Q Consensus 293 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 365 (394)
... ..... .. ++...++.+.++|.+||+.||++|||+.++|++
T Consensus 230 ~~~-~~~~~-----------------~~------------~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~ 272 (274)
T cd05076 230 KER-FYEKK-----------------HR------------LPEPSCKELATLISQCLTYEPTQRPSFRTILRD 272 (274)
T ss_pred HHH-HHHhc-----------------cC------------CCCCCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence 222 11100 00 112345689999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-39 Score=304.66 Aligned_cols=204 Identities=28% Similarity=0.429 Sum_probs=170.7
Q ss_pred EEEeeEEeecCceEEEEEEECCCCcEEEEEEeccc-----hhhhHHHHHHHHHcCCCCeeeeceEEEecC-CCceeEEEE
Q 016184 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTT-DKEELYLNL 157 (394)
Q Consensus 84 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~~~~~~l 157 (394)
|...+.||+|+||.||+++++.+|+.||||.+... ....-+|+++|++++|+|||+++++-.... ..-...-.+
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl 94 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL 94 (732)
T ss_pred eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence 78889999999999999999999999999988653 233347999999999999999977541111 000233568
Q ss_pred EEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeC--CC-CcEEEEeecCcc
Q 016184 158 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNP--HT-HQLKLCDFGSAK 233 (394)
Q Consensus 158 v~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~--~~-~~vkl~Dfg~a~ 233 (394)
+||||.| +|...+.. .....++++.++..++..++.||.|||+ +|||||||||.||++-. +| ...||+|||.|+
T Consensus 95 vmEyC~gGsL~~~L~~-PEN~~GLpE~e~l~lL~d~~~al~~LrE-n~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Ar 172 (732)
T KOG4250|consen 95 VMEYCSGGSLRKVLNS-PENAYGLPESEFLDLLSDLVSALRHLRE-NGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAAR 172 (732)
T ss_pred EEeecCCCcHHHHhcC-cccccCCCHHHHHHHHHHHHHHHHHHHH-cCceeccCCCCcEEEeecCCCceEEeeecccccc
Confidence 9999996 66655554 4557889999999999999999999999 89999999999999743 22 258999999999
Q ss_pred ccccCCCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCC
Q 016184 234 VLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGES 289 (394)
Q Consensus 234 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~ 289 (394)
...++....+.+||+.|.+||.+.....|+..+|.|||||++|+.+||..||-...
T Consensus 173 el~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~ 228 (732)
T KOG4250|consen 173 ELDDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFG 228 (732)
T ss_pred cCCCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCC
Confidence 99988888899999999999999655679999999999999999999999996543
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=275.86 Aligned_cols=256 Identities=26% Similarity=0.457 Sum_probs=204.2
Q ss_pred CccceeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccch-------hhhHHHHHHHHHc-CCCCeeeeceEEEecCC
Q 016184 78 SKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQML-DHPNIVALKHCFFSTTD 149 (394)
Q Consensus 78 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~ 149 (394)
......|.++++||+|+|++|.+++++.|.+.+|+|+++++- ...+.|-.+.... +||.+|-++.||
T Consensus 246 ~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscf----- 320 (593)
T KOG0695|consen 246 GLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCF----- 320 (593)
T ss_pred ccccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhh-----
Confidence 334457999999999999999999999999999999986542 2334566666665 799999999998
Q ss_pred CceeEEEEEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEee
Q 016184 150 KEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDF 229 (394)
Q Consensus 150 ~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Df 229 (394)
+....+++|.||++|+- +..+......+|++.++.+...|+.||.|||+ .||++||||.+|||+|.+|+ +||+|+
T Consensus 321 qtesrlffvieyv~ggd---lmfhmqrqrklpeeharfys~ei~lal~flh~-rgiiyrdlkldnvlldaegh-ikltdy 395 (593)
T KOG0695|consen 321 QTESRLFFVIEYVNGGD---LMFHMQRQRKLPEEHARFYSAEICLALNFLHE-RGIIYRDLKLDNVLLDAEGH-IKLTDY 395 (593)
T ss_pred cccceEEEEEEEecCcc---eeeehhhhhcCcHHHhhhhhHHHHHHHHHHhh-cCeeeeeccccceEEccCCc-eeeccc
Confidence 44445788999999732 12223345789999999999999999999999 89999999999999999995 999999
Q ss_pred cCcccc-ccCCCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCC-------CcHHHHHH-HHHH
Q 016184 230 GSAKVL-VKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGE-------SGVDQLVE-IIKV 300 (394)
Q Consensus 230 g~a~~~-~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~-------~~~~~~~~-i~~~ 300 (394)
|+++.- ..+....+.+|||.|.|||++++.. |+...|+|+|||+++||+.|+.||.-. +..+.+.+ |...
T Consensus 396 gmcke~l~~gd~tstfcgtpnyiapeilrgee-ygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilek 474 (593)
T KOG0695|consen 396 GMCKEGLGPGDTTSTFCGTPNYIAPEILRGEE-YGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEK 474 (593)
T ss_pred chhhcCCCCCcccccccCCCcccchhhhcccc-cCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhh
Confidence 999765 3455567789999999999998765 999999999999999999999999621 11222222 2221
Q ss_pred hCCCChhhhhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCC------CHHHHhcCCCCCCCCC
Q 016184 301 LGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC------TALEACVHPFFDELRD 373 (394)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp------t~~ell~hp~f~~~~~ 373 (394)
.+ .+++.+|..+..+++..|.+||.+|. ...++..||||+.+-.
T Consensus 475 -----------------qi------------riprslsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~idw 524 (593)
T KOG0695|consen 475 -----------------QI------------RIPRSLSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSIDW 524 (593)
T ss_pred -----------------cc------------cccceeehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhhCCH
Confidence 01 13356788889999999999999998 4679999999996643
|
|
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=280.52 Aligned_cols=243 Identities=28% Similarity=0.367 Sum_probs=189.7
Q ss_pred eeEEEeeEEeecCceEEEEEEECCC---CcEEEEEEeccch-----hhhHHHHHHHHHcCCCCeeeeceEEEecCCCcee
Q 016184 82 VSYIAEHVVGTGSFGVVFQAKCRET---GEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL 153 (394)
Q Consensus 82 ~~y~~~~~lg~G~~g~V~~~~~~~~---~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 153 (394)
.+|++.+.||+|+||.||+|.+... ...||||...... ..+.+|+.+++.+.|+||+++++++.. .
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-----~- 79 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-----N- 79 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-----C-
Confidence 4599999999999999999987543 3568999875432 245579999999999999999987631 1
Q ss_pred EEEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCc
Q 016184 154 YLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA 232 (394)
Q Consensus 154 ~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a 232 (394)
..+++|||+++ +|.+++... ...+++..++.++.|++.||+|||+ .|++|+||||+||+++.++ .++|+|||++
T Consensus 80 ~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~l~~~l~~lH~-~~~~H~dl~p~nili~~~~-~~~l~d~g~~ 154 (270)
T cd05056 80 PVWIVMELAPLGELRSYLQVN---KYSLDLASLILYSYQLSTALAYLES-KRFVHRDIAARNVLVSSPD-CVKLGDFGLS 154 (270)
T ss_pred CcEEEEEcCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccccChheEEEecCC-CeEEccCcee
Confidence 25689999974 676666542 2458999999999999999999999 8999999999999999887 7999999998
Q ss_pred cccccCCCc--ccccccccccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCChhhh
Q 016184 233 KVLVKGEPN--VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEI 309 (394)
Q Consensus 233 ~~~~~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 309 (394)
......... ....++..|+|||.+... .++.++||||||+++|+|++ |..||.+.+..+....+......
T Consensus 155 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~------ 227 (270)
T cd05056 155 RYLEDESYYKASKGKLPIKWMAPESINFR-RFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERL------ 227 (270)
T ss_pred eecccccceecCCCCccccccChhhhccC-CCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCcC------
Confidence 765433211 112234679999988544 48999999999999999986 99999877765554443221000
Q ss_pred hccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 016184 310 KCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV 364 (394)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 364 (394)
..+..++..+.++|.+||..+|++|||+.+++.
T Consensus 228 ----------------------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~ 260 (270)
T cd05056 228 ----------------------PMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKA 260 (270)
T ss_pred ----------------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 012457889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=283.68 Aligned_cols=235 Identities=19% Similarity=0.269 Sum_probs=180.0
Q ss_pred EEeecCceEEEEEEECCCCc-------EEEEEEeccch----hhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEEEE
Q 016184 89 VVGTGSFGVVFQAKCRETGE-------IVAIKKVLQDK----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL 157 (394)
Q Consensus 89 ~lg~G~~g~V~~~~~~~~~~-------~vaiK~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 157 (394)
.||.|+||.||+|.+...+. .||+|.+.... ....+|+.+++.+.||||+++++++... ...++
T Consensus 2 ~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~-----~~~~l 76 (258)
T cd05078 2 SLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCG-----DESIM 76 (258)
T ss_pred CCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeC-----CCcEE
Confidence 58999999999999865544 38888775432 2345688999999999999999988443 23679
Q ss_pred EEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCc-------EEEEee
Q 016184 158 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQ-------LKLCDF 229 (394)
Q Consensus 158 v~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~-------vkl~Df 229 (394)
||||+++ +|..++... ...+++..+..++.||+.||+|||+ +||+||||||+||+++.++.. ++++||
T Consensus 77 v~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~-~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~ 152 (258)
T cd05078 77 VQEYVKFGSLDTYLKKN---KNLINISWKLEVAKQLAWALHFLED-KGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDP 152 (258)
T ss_pred EEecCCCCcHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCccceEEEecccccccCCCceEEeccc
Confidence 9999985 666655432 2468899999999999999999999 899999999999999876632 799999
Q ss_pred cCccccccCCCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCC-CCCCCCCcHHHHHHHHHHhCCCChhh
Q 016184 230 GSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQ-PLFPGESGVDQLVEIIKVLGTPTREE 308 (394)
Q Consensus 230 g~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~-~pf~~~~~~~~~~~i~~~~~~~~~~~ 308 (394)
|.+..... .....++..|+|||.+.+...++.++||||||+++|+|++|. .||...+...... ....
T Consensus 153 g~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~-~~~~-------- 220 (258)
T cd05078 153 GISITVLP---KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQ-FYED-------- 220 (258)
T ss_pred ccccccCC---chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHH-HHHc--------
Confidence 99865432 223456788999999976555799999999999999999985 6665544333222 1110
Q ss_pred hhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 016184 309 IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH 365 (394)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 365 (394)
... ++...+.++.+||.+||+.||++|||++++++.
T Consensus 221 ---------~~~------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 256 (258)
T cd05078 221 ---------RHQ------------LPAPKWTELANLINQCMDYEPDFRPSFRAIIRD 256 (258)
T ss_pred ---------ccc------------CCCCCcHHHHHHHHHHhccChhhCCCHHHHHHh
Confidence 000 113356789999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=295.95 Aligned_cols=256 Identities=27% Similarity=0.458 Sum_probs=200.1
Q ss_pred eeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccchhh-------hHHHHHHHHHcCCCCeeeeceEEEecCCCceeE
Q 016184 82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRY-------KNRELQIMQMLDHPNIVALKHCFFSTTDKEELY 154 (394)
Q Consensus 82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-------~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 154 (394)
.-|..++.||-|+||.|.+++...|...||.|.+++.... .+.|..||.....+-||+++-.| .+...
T Consensus 629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySF-----QDkdn 703 (1034)
T KOG0608|consen 629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSF-----QDKDN 703 (1034)
T ss_pred cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEe-----ccCCc
Confidence 3589999999999999999999999999999988664332 34688999999999999998877 44444
Q ss_pred EEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCcc
Q 016184 155 LNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK 233 (394)
Q Consensus 155 ~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~ 233 (394)
+|+||+|++| ++-.++-. .+-|++..++.++..+..|+++.|. .|+|||||||+|||||.+|+ +||+|||+|+
T Consensus 704 LYFVMdYIPGGDmMSLLIr----mgIFeE~LARFYIAEltcAiesVHk-mGFIHRDiKPDNILIDrdGH-IKLTDFGLCT 777 (1034)
T KOG0608|consen 704 LYFVMDYIPGGDMMSLLIR----MGIFEEDLARFYIAELTCAIESVHK-MGFIHRDIKPDNILIDRDGH-IKLTDFGLCT 777 (1034)
T ss_pred eEEEEeccCCccHHHHHHH----hccCHHHHHHHHHHHHHHHHHHHHh-ccceecccCccceEEccCCc-eeeeeccccc
Confidence 8899999996 44444433 2678999999999999999999999 89999999999999999995 9999999985
Q ss_pred ccc---------cCC----------------------------------CcccccccccccccccccCCCCCCChhhHHH
Q 016184 234 VLV---------KGE----------------------------------PNVSYICSRYYRAPELIFGATEYTTAIDIWS 270 (394)
Q Consensus 234 ~~~---------~~~----------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~Diws 270 (394)
-+. ++. ..-..+||+.|+|||++.... ++.-+|+||
T Consensus 778 GfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g-~~q~cdwws 856 (1034)
T KOG0608|consen 778 GFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTG-YTQLCDWWS 856 (1034)
T ss_pred cceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccC-ccccchhhH
Confidence 431 000 001346899999999996554 899999999
Q ss_pred HHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcc
Q 016184 271 TGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQ 350 (394)
Q Consensus 271 lG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~ 350 (394)
.|||||||+.|++||......+.-.+++.... ...+ .....++.++.+||.++.
T Consensus 857 ~gvil~em~~g~~pf~~~tp~~tq~kv~nw~~---------------~l~~----------~~~~~ls~e~~~li~kLc- 910 (1034)
T KOG0608|consen 857 VGVILYEMLVGQPPFLADTPGETQYKVINWRN---------------FLHI----------PYQGNLSKEALDLIQKLC- 910 (1034)
T ss_pred hhHHHHHHhhCCCCccCCCCCcceeeeeehhh---------------cccc----------ccccccCHHHHHHHHHHh-
Confidence 99999999999999988765544333332100 0001 122568999999998765
Q ss_pred cCCCCCC---CHHHHhcCCCCCCCCCCC
Q 016184 351 YSPNLRC---TALEACVHPFFDELRDPN 375 (394)
Q Consensus 351 ~dP~~Rp---t~~ell~hp~f~~~~~~~ 375 (394)
.+++.|. .++++..||||+.+--..
T Consensus 911 ~sad~RLGkng~d~vKaHpfFkgIDfss 938 (1034)
T KOG0608|consen 911 CSADSRLGKNGADQVKAHPFFKGIDFSS 938 (1034)
T ss_pred cChhhhhcccchhhhhcCccccccchHh
Confidence 4577777 477899999999875443
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-38 Score=314.31 Aligned_cols=247 Identities=20% Similarity=0.337 Sum_probs=200.6
Q ss_pred eeEEEeeEEeecCceEEEEEEECCCCc-----EEEEEEeccc-----hhhhHHHHHHHHHcCCCCeeeeceEEEecCCCc
Q 016184 82 VSYIAEHVVGTGSFGVVFQAKCRETGE-----IVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKE 151 (394)
Q Consensus 82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~-----~vaiK~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 151 (394)
.+-+..+.||+|.||.||.|+...-.. .||||.+.+. ...+-+|..+|+.++|||||+++++++....
T Consensus 692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~-- 769 (1025)
T KOG1095|consen 692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGP-- 769 (1025)
T ss_pred hheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCC--
Confidence 347788999999999999999864433 4999988653 3445579999999999999999999976333
Q ss_pred eeEEEEEEecccc-cHHHHHHHhhhh---cCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEE
Q 016184 152 ELYLNLVLEYVPE-TVNRIARNYSRI---HQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLC 227 (394)
Q Consensus 152 ~~~~~lv~e~~~~-~l~~~~~~~~~~---~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~ 227 (394)
.+|++|||.+ +|..+++.-+.. ...++......++.+|++|++||++ +++|||||...|+|++... .|||+
T Consensus 770 ---~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~-~~fvHRDLAaRNCLL~~~r-~VKIa 844 (1025)
T KOG1095|consen 770 ---PLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLES-KHFVHRDLAARNCLLDERR-VVKIA 844 (1025)
T ss_pred ---cEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHh-CCCcCcchhhhheeecccC-cEEEc
Confidence 6689999985 777777664221 3568899999999999999999999 8999999999999999886 89999
Q ss_pred eecCccccccCCCcc---cccccccccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCC
Q 016184 228 DFGSAKVLVKGEPNV---SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGT 303 (394)
Q Consensus 228 Dfg~a~~~~~~~~~~---~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~ 303 (394)
|||+|+.+...+... ...-...|||||.+.. ..++.|+|||||||++||++| |..||++.++.+.+....... +
T Consensus 845 DFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d-~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~gg-R 922 (1025)
T KOG1095|consen 845 DFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKD-GIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGG-R 922 (1025)
T ss_pred ccchhHhhhhchheeccCccccceecCCHHHHhh-cccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCC-c
Confidence 999998553332211 1222467999999965 559999999999999999998 899999999888877666532 1
Q ss_pred CChhhhhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 016184 304 PTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV 364 (394)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 364 (394)
.+ .+..++..+.+++..||+.+|++||+...|++
T Consensus 923 L~---------------------------~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~ 956 (1025)
T KOG1095|consen 923 LD---------------------------PPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVE 956 (1025)
T ss_pred cC---------------------------CCCCCChHHHHHHHHHccCChhhCccHHHHHh
Confidence 11 12578999999999999999999999998886
|
|
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=286.12 Aligned_cols=245 Identities=22% Similarity=0.320 Sum_probs=188.3
Q ss_pred ceeEEEeeEEeecCceEEEEEEECCCCc----EEEEEEeccch-----hhhHHHHHHHHHcCCCCeeeeceEEEecCCCc
Q 016184 81 KVSYIAEHVVGTGSFGVVFQAKCRETGE----IVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKE 151 (394)
Q Consensus 81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~----~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 151 (394)
...|++.+.||+|+||.||+|.+..+|. .||+|.+.... ....+|+.+++.+.|+||+++++++...
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~---- 81 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP---- 81 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC----
Confidence 3458999999999999999999877776 46888775432 1345789999999999999999987321
Q ss_pred eeEEEEEEeccc-ccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeec
Q 016184 152 ELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFG 230 (394)
Q Consensus 152 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg 230 (394)
..++++||++ +++.+.+.. ....+++..+..++.|++.||.|||+ .||+|+||||+||+++.++ .+||+|||
T Consensus 82 --~~~~v~e~~~~g~l~~~~~~---~~~~~~~~~~~~~~~qi~~~L~~LH~-~~ivH~dikp~Nill~~~~-~~kL~Dfg 154 (303)
T cd05110 82 --TIQLVTQLMPHGCLLDYVHE---HKDNIGSQLLLNWCVQIAKGMMYLEE-RRLVHRDLAARNVLVKSPN-HVKITDFG 154 (303)
T ss_pred --CceeeehhcCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHhh-cCeeccccccceeeecCCC-ceEEcccc
Confidence 1457899998 466665543 22468899999999999999999999 8999999999999999877 69999999
Q ss_pred CccccccCCCc---ccccccccccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCh
Q 016184 231 SAKVLVKGEPN---VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTR 306 (394)
Q Consensus 231 ~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~ 306 (394)
+++........ ....++..|+|||.+.+. .++.++||||||+++|+|++ |..||.+..... ...+......++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~-~~~~~~~~~~~~- 231 (303)
T cd05110 155 LARLLEGDEKEYNADGGKMPIKWMALECIHYR-KFTHQSDVWSYGVTIWELMTFGGKPYDGIPTRE-IPDLLEKGERLP- 231 (303)
T ss_pred ccccccCcccccccCCCccccccCCHHHhccC-CCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH-HHHHHHCCCCCC-
Confidence 99765432221 123346789999998544 48999999999999999997 899997654332 333322111000
Q ss_pred hhhhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 016184 307 EEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH 365 (394)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 365 (394)
.+...+..+.+++.+||..||++||++.++++.
T Consensus 232 --------------------------~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~ 264 (303)
T cd05110 232 --------------------------QPPICTIDVYMVMVKCWMIDADSRPKFKELAAE 264 (303)
T ss_pred --------------------------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 013357789999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=276.81 Aligned_cols=237 Identities=24% Similarity=0.357 Sum_probs=183.8
Q ss_pred eEEeecCceEEEEEEECCCCcEEEEEEeccch-----hhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEEEEEEecc
Q 016184 88 HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYV 162 (394)
Q Consensus 88 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~ 162 (394)
++||+|+||.||+|... ++..+|+|.+.... ..+.+|+++++.+.|+||+++++++.. ....+++|||+
T Consensus 1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~lv~e~~ 74 (250)
T cd05085 1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQ-----RQPIYIVMELV 74 (250)
T ss_pred CccCCCCCceEEEEEec-CCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEec-----CCccEEEEECC
Confidence 36899999999999864 68899999875432 234579999999999999999998732 23478999999
Q ss_pred cc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCccccccCCCc
Q 016184 163 PE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN 241 (394)
Q Consensus 163 ~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~~~~~ 241 (394)
++ ++.+.+.. ....+++..+..++.|++.||.|||+ .|++|+||||+||+++.++ .++|+|||++.........
T Consensus 75 ~~~~L~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~-~~~~H~dl~p~nili~~~~-~~~l~d~g~~~~~~~~~~~ 149 (250)
T cd05085 75 PGGDFLSFLRK---KKDELKTKQLVKFALDAAAGMAYLES-KNCIHRDLAARNCLVGENN-VLKISDFGMSRQEDDGIYS 149 (250)
T ss_pred CCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeecccChheEEEcCCC-eEEECCCccceeccccccc
Confidence 75 66555432 22457899999999999999999999 8999999999999999887 7999999998654322111
Q ss_pred --ccccccccccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCCCcc
Q 016184 242 --VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 318 (394)
Q Consensus 242 --~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 318 (394)
....++..|+|||++.. ..++.++||||||+++|++++ |..||.+.........+....
T Consensus 150 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~----------------- 211 (250)
T cd05085 150 SSGLKQIPIKWTAPEALNY-GRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGY----------------- 211 (250)
T ss_pred cCCCCCCcccccCHHHhcc-CCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCC-----------------
Confidence 11233567999999854 448999999999999999998 999998765544433332210
Q ss_pred cCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 016184 319 FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV 364 (394)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 364 (394)
...++..++..+.+++.+||+.||++||++.++++
T Consensus 212 -----------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 246 (250)
T cd05085 212 -----------RMSCPQKCPDDVYKVMQRCWDYKPENRPKFSELQK 246 (250)
T ss_pred -----------CCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 00012356889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=277.18 Aligned_cols=237 Identities=25% Similarity=0.365 Sum_probs=184.4
Q ss_pred eEEeecCceEEEEEEECCCCcEEEEEEeccc-----hhhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEEEEEEecc
Q 016184 88 HVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYV 162 (394)
Q Consensus 88 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~ 162 (394)
++||.|+||.||+|.+.. ++.||+|.+... ...+.+|+++++.+.|+||+++++++.. ....+++|||+
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~~~v~e~~ 74 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQ-----KQPIYIVMELV 74 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEec-----CCCeEEEEEcC
Confidence 368999999999999977 999999987643 2345679999999999999999988733 33478999999
Q ss_pred cc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCccccccCCCc
Q 016184 163 PE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN 241 (394)
Q Consensus 163 ~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~~~~~ 241 (394)
++ ++.+.+.. ....+++..+..++.+++.||.|||+ +|++||||||+||+++.++ .++|+|||.+.........
T Consensus 75 ~~~~l~~~l~~---~~~~~~~~~~~~~~~~~~~~l~~lH~-~~i~h~di~p~nili~~~~-~~~l~d~g~~~~~~~~~~~ 149 (251)
T cd05041 75 PGGSLLTFLRK---KKNRLTVKKLLQMSLDAAAGMEYLES-KNCIHRDLAARNCLVGENN-VLKISDFGMSREEEGGIYT 149 (251)
T ss_pred CCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHh-CCEehhhcCcceEEEcCCC-cEEEeeccccccccCCcce
Confidence 75 56555543 23467889999999999999999999 8999999999999999887 7999999998754322111
Q ss_pred ---ccccccccccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCCCc
Q 016184 242 ---VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 317 (394)
Q Consensus 242 ---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 317 (394)
.....+..|+|||.+.+. .++.++|+||||+++|+|++ |..||...........+.....
T Consensus 150 ~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~~--------------- 213 (251)
T cd05041 150 VSDGLKQIPIKWTAPEALNYG-RYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYR--------------- 213 (251)
T ss_pred eccccCcceeccCChHhhccC-CCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCCC---------------
Confidence 111225569999998654 48999999999999999999 8899977664433333221000
Q ss_pred ccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 016184 318 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV 364 (394)
Q Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 364 (394)
...+..++.++.+++.+||..+|.+|||+.++++
T Consensus 214 -------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~ 247 (251)
T cd05041 214 -------------MPAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYN 247 (251)
T ss_pred -------------CCCCccCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 0012356889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=280.44 Aligned_cols=242 Identities=23% Similarity=0.345 Sum_probs=185.7
Q ss_pred eEEeecCceEEEEEEECCCC------cEEEEEEeccc-----hhhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEEE
Q 016184 88 HVVGTGSFGVVFQAKCRETG------EIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN 156 (394)
Q Consensus 88 ~~lg~G~~g~V~~~~~~~~~------~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 156 (394)
+.||+|+||.||+|++.... +.+|||.+... .....+|+.+++.++||||+++++++.. ....+
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~ 75 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLL-----NEPQY 75 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecC-----CCCeE
Confidence 36899999999999986443 68999987543 2344579999999999999999998732 23478
Q ss_pred EEEecccc-cHHHHHHHhhh---hcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCC----CcEEEEe
Q 016184 157 LVLEYVPE-TVNRIARNYSR---IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHT----HQLKLCD 228 (394)
Q Consensus 157 lv~e~~~~-~l~~~~~~~~~---~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~----~~vkl~D 228 (394)
++|||+++ +|.+.+..... ....+++..+..++.|++.||+|||+ .+++|+||||+||+++.++ ..++|+|
T Consensus 76 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~-~~i~H~dl~p~nil~~~~~~~~~~~~~l~d 154 (269)
T cd05044 76 IIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQ-MHFIHRDLAARNCLVSEKGYDADRVVKIGD 154 (269)
T ss_pred EEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHh-CCcccCCCChheEEEecCCCCCCcceEECC
Confidence 99999984 77776654322 12447889999999999999999999 8999999999999998754 2599999
Q ss_pred ecCccccccCCC---cccccccccccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCC
Q 016184 229 FGSAKVLVKGEP---NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTP 304 (394)
Q Consensus 229 fg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~ 304 (394)
||++........ .....++..|+|||.+.+. .++.++|||||||++|+|++ |..||...+..+....+... ..
T Consensus 155 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~-~~- 231 (269)
T cd05044 155 FGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDG-KFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAG-GR- 231 (269)
T ss_pred cccccccccccccccCcccCCCccccCHHHHccC-CcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcC-Cc-
Confidence 999875533221 1123446789999998654 48999999999999999998 99999876655443333210 00
Q ss_pred ChhhhhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 016184 305 TREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV 364 (394)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 364 (394)
. .....++..+.+||.+||..+|.+||+++++++
T Consensus 232 --------------~------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 265 (269)
T cd05044 232 --------------L------------QKPENCPDKIYQLMTNCWAQDPSERPTFDRIQE 265 (269)
T ss_pred --------------c------------CCcccchHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 0 012356889999999999999999999999875
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-37 Score=277.10 Aligned_cols=239 Identities=21% Similarity=0.327 Sum_probs=179.0
Q ss_pred eEEeecCceEEEEEEECC---CCcEEEEEEeccc-----hhhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEEEEEE
Q 016184 88 HVVGTGSFGVVFQAKCRE---TGEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVL 159 (394)
Q Consensus 88 ~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~ 159 (394)
+.||+|+||.||+|.+.. .+..||+|.+... .....+|+.+++.++||||+++++++... ....+++|
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~----~~~~~lv~ 76 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPS----EGSPLVVL 76 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecC----CCCcEEEE
Confidence 368999999999998643 3457999987432 12345688999999999999999866432 22356899
Q ss_pred ecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCccccccC
Q 016184 160 EYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG 238 (394)
Q Consensus 160 e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~~ 238 (394)
||+.+ ++.+++... .....+..+..++.|++.||.|||+ .+++||||||+|||++.++ .+||+|||+++.....
T Consensus 77 e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dlk~~nili~~~~-~~kl~dfg~~~~~~~~ 151 (262)
T cd05058 77 PYMKHGDLRNFIRSE---THNPTVKDLIGFGLQVAKGMEYLAS-KKFVHRDLAARNCMLDESF-TVKVADFGLARDIYDK 151 (262)
T ss_pred ecCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHh-CCccccccCcceEEEcCCC-cEEECCccccccccCC
Confidence 99884 776665432 2346777788899999999999999 8999999999999999887 6999999998754322
Q ss_pred CC-----cccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhC-CCCCCCCCcHHHHHHHHHHhCCCChhhhhcc
Q 016184 239 EP-----NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLG-QPLFPGESGVDQLVEIIKVLGTPTREEIKCM 312 (394)
Q Consensus 239 ~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg-~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 312 (394)
.. .....++..|+|||.+.+. .++.++||||||+++|+|++| .+||...+..+....+... ..+
T Consensus 152 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~--~~~------- 221 (262)
T cd05058 152 EYYSVHNHTGAKLPVKWMALESLQTQ-KFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQG--RRL------- 221 (262)
T ss_pred cceeecccccCcCCccccChhHhccC-ccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcC--CCC-------
Confidence 11 1123346789999998654 489999999999999999995 5677665544433322210 000
Q ss_pred CCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 016184 313 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV 364 (394)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 364 (394)
..+..++..+.+++.+||..||++||++.++++
T Consensus 222 -------------------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~ 254 (262)
T cd05058 222 -------------------LQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVS 254 (262)
T ss_pred -------------------CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 011346788999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-37 Score=276.82 Aligned_cols=245 Identities=19% Similarity=0.252 Sum_probs=181.1
Q ss_pred EEeecCceEEEEEEECCC--CcEEEEEEeccc-----hhhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEEEEEEec
Q 016184 89 VVGTGSFGVVFQAKCRET--GEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEY 161 (394)
Q Consensus 89 ~lg~G~~g~V~~~~~~~~--~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~ 161 (394)
.||+|+||.||+|..... ...+++|.+... .....+|+.+++.++||||+++++.+. .....+++|||
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~-----~~~~~~lv~e~ 76 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCV-----EAIPYLLVFEY 76 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEec-----CCCccEEEEec
Confidence 589999999999976433 235667765432 234557888999999999999999883 33447899999
Q ss_pred ccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCccccccCC-
Q 016184 162 VPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE- 239 (394)
Q Consensus 162 ~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~~~- 239 (394)
+++ +|.+++..........++..++.++.||+.||+|||+ .+++||||||+|||++.++ .++|+|||++.......
T Consensus 77 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~-~~i~H~dikp~nil~~~~~-~~~l~Dfg~~~~~~~~~~ 154 (268)
T cd05086 77 CELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHK-HNFLHSDLALRNCFLTSDL-TVKVGDYGIGPSRYKEDY 154 (268)
T ss_pred CCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHH-CCeeccCCccceEEEcCCc-cEEecccccccccCcchh
Confidence 984 7777776543334557778888999999999999999 8999999999999999888 69999999985432211
Q ss_pred --CcccccccccccccccccCC------CCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCChhhhh
Q 016184 240 --PNVSYICSRYYRAPELIFGA------TEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIK 310 (394)
Q Consensus 240 --~~~~~~~t~~y~aPE~~~~~------~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 310 (394)
......++..|+|||++... ..++.++||||||+++|+|++ |..||...+..+.+..+.......
T Consensus 155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~------ 228 (268)
T cd05086 155 IETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVK------ 228 (268)
T ss_pred hhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccc------
Confidence 12234567889999987421 235789999999999999997 567887766655555443311100
Q ss_pred ccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 016184 311 CMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV 364 (394)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 364 (394)
.+...+...+++.+.+++..|| .+|.+||+++++++
T Consensus 229 -----------------~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~ 264 (268)
T cd05086 229 -----------------LFKPQLELPYSERWYEVLQFCW-LSPEKRATAEEVHR 264 (268)
T ss_pred -----------------cCCCccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHH
Confidence 0011112346788999999999 68999999999975
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-37 Score=278.82 Aligned_cols=250 Identities=22% Similarity=0.327 Sum_probs=188.3
Q ss_pred EEEeeEEeecCceEEEEEEEC---CCCcEEEEEEeccch------hhhHHHHHHHHHcCCCCeeeeceEEEecCCCc-ee
Q 016184 84 YIAEHVVGTGSFGVVFQAKCR---ETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKE-EL 153 (394)
Q Consensus 84 y~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~-~~ 153 (394)
|.+.+.||+|+||.||+|.+. .+++.||||++.... ....+|+++++.++||||+++++++....... ..
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 567889999999999999864 357889999876432 23457899999999999999999775443222 23
Q ss_pred EEEEEEeccc-ccHHHHHHHhh--hhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeec
Q 016184 154 YLNLVLEYVP-ETVNRIARNYS--RIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFG 230 (394)
Q Consensus 154 ~~~lv~e~~~-~~l~~~~~~~~--~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg 230 (394)
..+++++|+. +++..++.... .....+++..++.++.|++.||+|||+ .||+||||||+||+++.++ .+||+|||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~-~~i~H~dikp~nili~~~~-~~kl~dfg 158 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSS-KNFIHRDLAARNCMLNENM-TVCVADFG 158 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCEeecccchhhEEEcCCC-CEEECccc
Confidence 3567889887 46655543221 112357889999999999999999999 8999999999999999877 69999999
Q ss_pred CccccccCCC---cccccccccccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCh
Q 016184 231 SAKVLVKGEP---NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTR 306 (394)
Q Consensus 231 ~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~ 306 (394)
+++....... .....+++.|++||.+... .++.++||||||+++|+|++ |+.||.+.+..+....+... ..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~-~~--- 233 (273)
T cd05074 159 LSKKIYSGDYYRQGCASKLPVKWLALESLADN-VYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKG-NR--- 233 (273)
T ss_pred ccccccCCcceecCCCccCchhhcCHhHHhcC-ccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcC-Cc---
Confidence 9876543221 1222345779999998544 47899999999999999999 88999776554433332221 00
Q ss_pred hhhhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 016184 307 EEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV 364 (394)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 364 (394)
.. .....+..+.+++.+||+.+|++|||+.+++.
T Consensus 234 ------------~~------------~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~ 267 (273)
T cd05074 234 ------------LK------------QPPDCLEDVYELMCQCWSPEPKCRPSFQHLRD 267 (273)
T ss_pred ------------CC------------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 00 11346789999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-38 Score=292.90 Aligned_cols=244 Identities=23% Similarity=0.350 Sum_probs=192.5
Q ss_pred eEEEeeEEeecCceEEEEEEECCCCc---E-EEEEEeccc-------hhhhHHHHHHHHHcCCCCeeeeceEEEecCCCc
Q 016184 83 SYIAEHVVGTGSFGVVFQAKCRETGE---I-VAIKKVLQD-------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKE 151 (394)
Q Consensus 83 ~y~~~~~lg~G~~g~V~~~~~~~~~~---~-vaiK~~~~~-------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 151 (394)
+-.+.++||+|+||.||+|+.+..+. . ||+|....+ ...+-+|+++++.++|||||+++|+.....
T Consensus 158 ~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~--- 234 (474)
T KOG0194|consen 158 DIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEE--- 234 (474)
T ss_pred CccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCC---
Confidence 34456799999999999999875432 3 899987642 233447999999999999999999883322
Q ss_pred eeEEEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeec
Q 016184 152 ELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFG 230 (394)
Q Consensus 152 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg 230 (394)
-+++|||+|.| +|.+.+.... ..++..+...++.+.+.||+|||+ ++++||||-.+|+|++.++ .+||+|||
T Consensus 235 --Pl~ivmEl~~gGsL~~~L~k~~---~~v~~~ek~~~~~~AA~Gl~YLh~-k~~IHRDIAARNcL~~~~~-~vKISDFG 307 (474)
T KOG0194|consen 235 --PLMLVMELCNGGSLDDYLKKNK---KSLPTLEKLRFCYDAARGLEYLHS-KNCIHRDIAARNCLYSKKG-VVKISDFG 307 (474)
T ss_pred --ccEEEEEecCCCcHHHHHHhCC---CCCCHHHHHHHHHHHHhHHHHHHH-CCCcchhHhHHHheecCCC-eEEeCccc
Confidence 27799999996 7766666522 369999999999999999999999 8999999999999999876 68999999
Q ss_pred CccccccCCCcc-cccccccccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCChhh
Q 016184 231 SAKVLVKGEPNV-SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREE 308 (394)
Q Consensus 231 ~a~~~~~~~~~~-~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 308 (394)
+++......... ..--...|+|||.+... .|+.++|||||||++||+++ |..||.+....+....+....
T Consensus 308 Ls~~~~~~~~~~~~~klPirWLAPEtl~~~-~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~------- 379 (474)
T KOG0194|consen 308 LSRAGSQYVMKKFLKKLPIRWLAPETLNTG-IFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNG------- 379 (474)
T ss_pred cccCCcceeeccccccCcceecChhhhccC-ccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcC-------
Confidence 987543111111 11235679999999655 69999999999999999998 889999998887777774421
Q ss_pred hhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 016184 309 IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV 364 (394)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 364 (394)
++..++...+.++..++.+|+..||+.|||+.++.+
T Consensus 380 --------------------~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~ 415 (474)
T KOG0194|consen 380 --------------------YRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKK 415 (474)
T ss_pred --------------------ccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHH
Confidence 111123467889999999999999999999988764
|
|
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-37 Score=275.51 Aligned_cols=234 Identities=20% Similarity=0.220 Sum_probs=179.5
Q ss_pred eEEeecCceEEEEEEECCCC----------cEEEEEEeccch---hhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeE
Q 016184 88 HVVGTGSFGVVFQAKCRETG----------EIVAIKKVLQDK---RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY 154 (394)
Q Consensus 88 ~~lg~G~~g~V~~~~~~~~~----------~~vaiK~~~~~~---~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 154 (394)
+.||+|+||.||+|.+..++ ..+++|.+.... ..+.+|+.+++.++|+||+++++++.. ..
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------~~ 74 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKHLVKLYGVCVR------DE 74 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhhHHHHHHHHHHHHcCCCcchhheeeEEec------CC
Confidence 36899999999999998766 358888765433 345678999999999999999998744 22
Q ss_pred EEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCC------cEEEE
Q 016184 155 LNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTH------QLKLC 227 (394)
Q Consensus 155 ~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~------~vkl~ 227 (394)
.++||||+++ +|..++... ...+++..+..++.||+.||.|||+ +||+||||||+|||++.++. .+||+
T Consensus 75 ~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~LH~-~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~ 150 (259)
T cd05037 75 NIMVEEYVKFGPLDVFLHRE---KNNVSLHWKLDVAKQLASALHYLED-KKLVHGNVCGKNILVARYGLNEGYVPFIKLS 150 (259)
T ss_pred cEEEEEcCCCCcHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHhh-CCeecccCccceEEEecCccccCCceeEEeC
Confidence 5789999985 665555432 1268999999999999999999999 89999999999999997652 49999
Q ss_pred eecCccccccCCCcccccccccccccccccCC-CCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCC
Q 016184 228 DFGSAKVLVKGEPNVSYICSRYYRAPELIFGA-TEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPT 305 (394)
Q Consensus 228 Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~ 305 (394)
|||++..... .....++..|+|||++.+. ..++.++||||||+++|+|++ |..||...+.......... .
T Consensus 151 Dfg~a~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~~-~---- 222 (259)
T cd05037 151 DPGIPITVLS---REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQD-Q---- 222 (259)
T ss_pred CCCccccccc---ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHhc-C----
Confidence 9999876543 2234456779999998655 358999999999999999999 5788866543222111110 0
Q ss_pred hhhhhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 016184 306 REEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV 364 (394)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 364 (394)
.. .+......+.++|.+||..||.+|||+.++++
T Consensus 223 -----------~~--------------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 256 (259)
T cd05037 223 -----------HR--------------LPMPDCAELANLINQCWTYDPTKRPSFRAILR 256 (259)
T ss_pred -----------CC--------------CCCCCchHHHHHHHHHhccChhhCCCHHHHHH
Confidence 00 00112378999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=283.92 Aligned_cols=261 Identities=27% Similarity=0.418 Sum_probs=202.9
Q ss_pred ceeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccchhhh-----------HHHHHHHHHcCCCCeeeeceEEEecCC
Q 016184 81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-----------NRELQIMQMLDHPNIVALKHCFFSTTD 149 (394)
Q Consensus 81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-----------~~E~~~l~~l~h~~iv~~~~~~~~~~~ 149 (394)
..+|.++++||+|||+.||+|.+....+.||+|+-...+... -+|..|-+.|.||.||+++++|....+
T Consensus 462 n~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtd 541 (775)
T KOG1151|consen 462 NDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTD 541 (775)
T ss_pred HHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccc
Confidence 346999999999999999999999999999999764322211 158899999999999999999854433
Q ss_pred CceeEEEEEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhC-CCceeccCCCCceEEeCC--CCcEEE
Q 016184 150 KEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC-IGICHRDIKPQNLLVNPH--THQLKL 226 (394)
Q Consensus 150 ~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~-~givH~Dlkp~Nil~~~~--~~~vkl 226 (394)
.+|-|+|||+|+- +..+.+.++.+++++++.|+.||+.||.||..- -.|||-||||.|||+-.. .+.+||
T Consensus 542 ----sFCTVLEYceGND---LDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKI 614 (775)
T KOG1151|consen 542 ----SFCTVLEYCEGND---LDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKI 614 (775)
T ss_pred ----cceeeeeecCCCc---hhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEe
Confidence 2789999999854 333444568899999999999999999999862 369999999999998532 126999
Q ss_pred EeecCccccccCCCc--------ccccccccccccccccC---CCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHH
Q 016184 227 CDFGSAKVLVKGEPN--------VSYICSRYYRAPELIFG---ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLV 295 (394)
Q Consensus 227 ~Dfg~a~~~~~~~~~--------~~~~~t~~y~aPE~~~~---~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~ 295 (394)
+|||+++.+...... ....||..|.+||.+.- .+..+.++||||+|||+|..+.|+.||........+.
T Consensus 615 TDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdIL 694 (775)
T KOG1151|consen 615 TDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDIL 694 (775)
T ss_pred eecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHH
Confidence 999999988654322 34568999999999842 3457899999999999999999999997553332222
Q ss_pred HHHHHhCCCChhhhhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 016184 296 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL 371 (394)
Q Consensus 296 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 371 (394)
..-.++ +-.+..||. .+.++.++++||++||++.-+.|....+|..||+|.-.
T Consensus 695 qeNTIl-------------kAtEVqFP~----------KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyllPh 747 (775)
T KOG1151|consen 695 QENTIL-------------KATEVQFPP----------KPVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLLPH 747 (775)
T ss_pred hhhchh-------------cceeccCCC----------CCccCHHHHHHHHHHHHhhhhhhhhHHHHccCccccch
Confidence 211111 012222322 14689999999999999999999999999999999763
|
|
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=276.47 Aligned_cols=249 Identities=25% Similarity=0.390 Sum_probs=188.9
Q ss_pred eEEEeeEEeecCceEEEEEEEC----CCCcEEEEEEeccchh-----hhHHHHHHHHHcCCCCeeeeceEEEecCCCcee
Q 016184 83 SYIAEHVVGTGSFGVVFQAKCR----ETGEIVAIKKVLQDKR-----YKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL 153 (394)
Q Consensus 83 ~y~~~~~lg~G~~g~V~~~~~~----~~~~~vaiK~~~~~~~-----~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 153 (394)
.|++.+.||+|+||.||+|+.. .+++.||||++..... .+.+|+++++.+.|+||+++++++.. ....
T Consensus 5 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~---~~~~ 81 (284)
T cd05038 5 HLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEK---PGGR 81 (284)
T ss_pred hchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeec---CCCC
Confidence 4888899999999999999864 3478999998865433 45679999999999999999887732 2244
Q ss_pred EEEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCc
Q 016184 154 YLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA 232 (394)
Q Consensus 154 ~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a 232 (394)
+.+++|||+++ ++.+++... ...+++..+..++.|++.||+|||+ +|++|+||||+||+++.++ .++|+|||.+
T Consensus 82 ~~~lv~e~~~~~~l~~~l~~~---~~~~~~~~~~~~~~~l~~aL~~lH~-~~i~H~dl~p~nil~~~~~-~~~l~dfg~~ 156 (284)
T cd05038 82 SLRLIMEYLPSGSLRDYLQRH---RDQINLKRLLLFSSQICKGMDYLGS-QRYIHRDLAARNILVESED-LVKISDFGLA 156 (284)
T ss_pred ceEEEEecCCCCCHHHHHHhC---ccccCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHhEEEcCCC-CEEEcccccc
Confidence 57899999974 777666542 2358999999999999999999999 8999999999999999887 7999999999
Q ss_pred cccccCCCc----ccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHH-----------HHHH
Q 016184 233 KVLVKGEPN----VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQ-----------LVEI 297 (394)
Q Consensus 233 ~~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~-----------~~~i 297 (394)
......... ....++..|+|||.+.+. .++.++|+||||+++|+|++|..||........ ...+
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~-~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd05038 157 KVLPEDKDYYYVKEPGESPIFWYAPECLRTS-KFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRL 235 (284)
T ss_pred cccccCCcceeccCCCCCcccccCcHHHccC-CCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHH
Confidence 766432211 112335569999998654 489999999999999999999998865322110 1111
Q ss_pred HHHhCCCChhhhhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 016184 298 IKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV 364 (394)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 364 (394)
...+.. . ... ..+..++.++.+|+.+||..||.+|||+.++++
T Consensus 236 ~~~~~~-----------~---~~~----------~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05038 236 LELLKE-----------G---ERL----------PRPPSCPDEVYDLMKLCWEAEPQDRPSFADLIL 278 (284)
T ss_pred HHHHHc-----------C---CcC----------CCCccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 111000 0 000 011346788999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=286.70 Aligned_cols=243 Identities=22% Similarity=0.361 Sum_probs=198.4
Q ss_pred eEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccc---hhhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEEEEEE
Q 016184 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD---KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVL 159 (394)
Q Consensus 83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~ 159 (394)
..++.++||.|.||.||.|.++...-.||||.++.+ ...+.+|+.+|+.+.|||+|+++++| ....-+|||+
T Consensus 268 dItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMeveEFLkEAAvMKeikHpNLVqLLGVC-----T~EpPFYIiT 342 (1157)
T KOG4278|consen 268 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC-----THEPPFYIIT 342 (1157)
T ss_pred heeeeeccCCCcccceeeeeeeccceeeehhhhhhcchhHHHHHHHHHHHHhhcCccHHHHhhhh-----ccCCCeEEEE
Confidence 456678999999999999999998999999998765 35566899999999999999999999 3334478999
Q ss_pred eccc-ccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCccccccC
Q 016184 160 EYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG 238 (394)
Q Consensus 160 e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~~ 238 (394)
|||. |+|.++++...+ ..++...+..++.||..|++||.. +++|||||...|.||.++. .||++|||+++.+..+
T Consensus 343 EfM~yGNLLdYLRecnr--~ev~avvLlyMAtQIsSaMeYLEk-knFIHRDLAARNCLVgEnh-iVKvADFGLsRlMtgD 418 (1157)
T KOG4278|consen 343 EFMCYGNLLDYLRECNR--SEVPAVVLLYMATQISSAMEYLEK-KNFIHRDLAARNCLVGENH-IVKVADFGLSRLMTGD 418 (1157)
T ss_pred ecccCccHHHHHHHhch--hhcchhHHHHHHHHHHHHHHHHHH-hhhhhhhhhhhhccccccc-eEEeeccchhhhhcCC
Confidence 9998 788888887665 567778888999999999999999 8999999999999999875 8999999999977433
Q ss_pred CCc--ccccccccccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCC
Q 016184 239 EPN--VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 315 (394)
Q Consensus 239 ~~~--~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 315 (394)
... ...--...|.|||.+. ...++.++|||+|||+|||+.| |..||++.+..+.+..+.+..
T Consensus 419 TYTAHAGAKFPIKWTAPEsLA-yNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkgy-------------- 483 (1157)
T KOG4278|consen 419 TYTAHAGAKFPIKWTAPESLA-YNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKGY-------------- 483 (1157)
T ss_pred ceecccCccCcccccCccccc-ccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhccc--------------
Confidence 221 1112256699999984 4458999999999999999997 889999887554444333211
Q ss_pred CcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHh
Q 016184 316 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEAC 363 (394)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell 363 (394)
+..-++.+++.+.+|++.||++.|..||+..|+-
T Consensus 484 --------------RM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiH 517 (1157)
T KOG4278|consen 484 --------------RMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIH 517 (1157)
T ss_pred --------------cccCCCCCCHHHHHHHHHHhcCCcccCccHHHHH
Confidence 1112368999999999999999999999998773
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=285.80 Aligned_cols=240 Identities=30% Similarity=0.459 Sum_probs=190.9
Q ss_pred EEEeeEEeecCceEEEEEEECCC----CcEEEEEEeccc-----hhhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeE
Q 016184 84 YIAEHVVGTGSFGVVFQAKCRET----GEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY 154 (394)
Q Consensus 84 y~~~~~lg~G~~g~V~~~~~~~~----~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 154 (394)
.++.++||.|-||.||+|....- .-.||||..+.+ ...+..|+-+++.+.||||+++++++....
T Consensus 391 Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~P------ 464 (974)
T KOG4257|consen 391 ITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQP------ 464 (974)
T ss_pred ccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeeccc------
Confidence 34556899999999999987432 235899987653 334457999999999999999999983322
Q ss_pred EEEEEeccc-ccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCcc
Q 016184 155 LNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK 233 (394)
Q Consensus 155 ~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~ 233 (394)
.+||||+++ |.|..++.. ....++......++.||+.||.|||+ +.+|||||...||||.... .|||+|||+++
T Consensus 465 ~WivmEL~~~GELr~yLq~---nk~sL~l~tL~ly~~Qi~talaYLeS-krfVHRDIAaRNiLVsSp~-CVKLaDFGLSR 539 (974)
T KOG4257|consen 465 MWIVMELAPLGELREYLQQ---NKDSLPLRTLTLYCYQICTALAYLES-KRFVHRDIAARNILVSSPQ-CVKLADFGLSR 539 (974)
T ss_pred eeEEEecccchhHHHHHHh---ccccchHHHHHHHHHHHHHHHHHHHh-hchhhhhhhhhheeecCcc-eeeecccchhh
Confidence 679999998 556555554 34679999999999999999999999 8999999999999999887 79999999999
Q ss_pred ccccCCCcccccc--cccccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCChhhhh
Q 016184 234 VLVKGEPNVSYIC--SRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIK 310 (394)
Q Consensus 234 ~~~~~~~~~~~~~--t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 310 (394)
.+..........+ ...|||||.+ +...++.++|||.|||.+||++. |..||.+..+.+.+..+.+.-..|
T Consensus 540 ~~ed~~yYkaS~~kLPIKWmaPESI-NfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGeRlP------ 612 (974)
T KOG4257|consen 540 YLEDDAYYKASRGKLPIKWMAPESI-NFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGERLP------ 612 (974)
T ss_pred hccccchhhccccccceeecCcccc-chhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecCCCCCC------
Confidence 8765543322233 4569999998 45569999999999999999985 999999987766555444321111
Q ss_pred ccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHh
Q 016184 311 CMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEAC 363 (394)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell 363 (394)
.++.+|+.+..|+.+||++||.+||...++.
T Consensus 613 ----------------------~P~nCPp~LYslmskcWayeP~kRPrftei~ 643 (974)
T KOG4257|consen 613 ----------------------CPPNCPPALYSLMSKCWAYEPSKRPRFTEIK 643 (974)
T ss_pred ----------------------CCCCCChHHHHHHHHHhccCcccCCcHHHHH
Confidence 2367999999999999999999999876554
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=286.13 Aligned_cols=274 Identities=21% Similarity=0.284 Sum_probs=182.3
Q ss_pred ccceeEEEeeEEeecCceEEEEEEEC----------------CCCcEEEEEEeccchh------------------hhHH
Q 016184 79 KQKVSYIAEHVVGTGSFGVVFQAKCR----------------ETGEIVAIKKVLQDKR------------------YKNR 124 (394)
Q Consensus 79 ~~~~~y~~~~~lg~G~~g~V~~~~~~----------------~~~~~vaiK~~~~~~~------------------~~~~ 124 (394)
...++|.+.++||+|+||.||+|... ..++.||||.+..... ....
T Consensus 142 ~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~v 221 (507)
T PLN03224 142 WSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMV 221 (507)
T ss_pred ccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHH
Confidence 34568999999999999999999752 2356799998754321 1123
Q ss_pred HHHHHHHcCCCCe-----eeeceEEEecCC---CceeEEEEEEecccc-cHHHHHHHhhh--------------------
Q 016184 125 ELQIMQMLDHPNI-----VALKHCFFSTTD---KEELYLNLVLEYVPE-TVNRIARNYSR-------------------- 175 (394)
Q Consensus 125 E~~~l~~l~h~~i-----v~~~~~~~~~~~---~~~~~~~lv~e~~~~-~l~~~~~~~~~-------------------- 175 (394)
|+.++.+++|.++ +.++++|..... ......++||||+++ +|.+++.....
T Consensus 222 E~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~ 301 (507)
T PLN03224 222 EAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNM 301 (507)
T ss_pred HHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhc
Confidence 6666777776654 566666543211 112346799999985 77776653110
Q ss_pred hcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCccccccCCCccc--cccccccccc
Q 016184 176 IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVS--YICSRYYRAP 253 (394)
Q Consensus 176 ~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~~~~~~~--~~~t~~y~aP 253 (394)
....+++..++.++.|++.||.|||+ .+|+||||||+|||++.++ .+||+|||++........... ..+++.|+||
T Consensus 302 ~~~~~~~~~~~~i~~ql~~aL~~lH~-~~ivHrDLKp~NILl~~~~-~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aP 379 (507)
T PLN03224 302 PQDKRDINVIKGVMRQVLTGLRKLHR-IGIVHRDIKPENLLVTVDG-QVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPP 379 (507)
T ss_pred ccccCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCchHhEEECCCC-cEEEEeCcCccccccCCccCccccCCCcceeCh
Confidence 11234667889999999999999999 8999999999999999887 799999999975533322222 2347899999
Q ss_pred ccccCCCC-------------------C--CChhhHHHHHHHHHHHHhCCC-CCCCCCcHHHHHHHHHHhCCCChhhhhc
Q 016184 254 ELIFGATE-------------------Y--TTAIDIWSTGCVMAELLLGQP-LFPGESGVDQLVEIIKVLGTPTREEIKC 311 (394)
Q Consensus 254 E~~~~~~~-------------------~--~~~~DiwslG~il~~lltg~~-pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 311 (394)
|.+..... + ..+.|+||+||++|+|++|.. ||.+........ .... .....|..
T Consensus 380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~---~~~~-~~~~~~r~ 455 (507)
T PLN03224 380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTEL---RQYD-NDLNRWRM 455 (507)
T ss_pred hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHH---hhcc-chHHHHHh
Confidence 99743210 1 124799999999999999875 775432111100 0000 00000100
Q ss_pred cCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCC---CCCCCHHHHhcCCCCCC
Q 016184 312 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSP---NLRCTALEACVHPFFDE 370 (394)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP---~~Rpt~~ell~hp~f~~ 370 (394)
... ..+.++ .....++..++|+++||..+| .+|+|++|+|+||||..
T Consensus 456 ~~~--~~~~~~----------~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~ 505 (507)
T PLN03224 456 YKG--QKYDFS----------LLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFLP 505 (507)
T ss_pred hcc--cCCCcc----------cccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcCC
Confidence 000 000111 124578999999999999876 68999999999999953
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=292.88 Aligned_cols=243 Identities=26% Similarity=0.391 Sum_probs=206.5
Q ss_pred eEEEeeEEeecCceEEEEEEECCCC---cEEEEEEecc-----chhhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeE
Q 016184 83 SYIAEHVVGTGSFGVVFQAKCRETG---EIVAIKKVLQ-----DKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY 154 (394)
Q Consensus 83 ~y~~~~~lg~G~~g~V~~~~~~~~~---~~vaiK~~~~-----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 154 (394)
.-.|.++||.|.||.|++|+.+..| ..||||.++. .+..+..|+.||-++.||||+.+.+++ ....-
T Consensus 630 ~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVV-----Tks~P 704 (996)
T KOG0196|consen 630 CVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVV-----TKSKP 704 (996)
T ss_pred heEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEE-----ecCce
Confidence 3578999999999999999998766 4699999864 345556799999999999999999998 34444
Q ss_pred EEEEEeccc-ccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCcc
Q 016184 155 LNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK 233 (394)
Q Consensus 155 ~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~ 233 (394)
+.||+|||+ |+|..+++... +.+...++..+++.|+.|++||-+ .|+|||||...||||+.+- .+|++|||+++
T Consensus 705 vMIiTEyMENGsLDsFLR~~D---GqftviQLVgMLrGIAsGMkYLsd-m~YVHRDLAARNILVNsnL-vCKVsDFGLSR 779 (996)
T KOG0196|consen 705 VMIITEYMENGSLDSFLRQND---GQFTVIQLVGMLRGIASGMKYLSD-MNYVHRDLAARNILVNSNL-VCKVSDFGLSR 779 (996)
T ss_pred eEEEhhhhhCCcHHHHHhhcC---CceEeehHHHHHHHHHHHhHHHhh-cCchhhhhhhhheeeccce-EEEecccccee
Confidence 789999999 57888777644 668999999999999999999999 8999999999999999988 79999999999
Q ss_pred ccccCCCc-ccccc---cccccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCChhh
Q 016184 234 VLVKGEPN-VSYIC---SRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREE 308 (394)
Q Consensus 234 ~~~~~~~~-~~~~~---t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 308 (394)
.+.++... .+..| ..+|.|||.+. ...++.++||||+|++|||.++ |..||-+..+.+.+..|.+..+-|++
T Consensus 780 vledd~~~~ytt~GGKIPiRWTAPEAIa-~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gyRLPpP-- 856 (996)
T KOG0196|consen 780 VLEDDPEAAYTTLGGKIPIRWTAPEAIA-YRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGYRLPPP-- 856 (996)
T ss_pred ecccCCCccccccCCccceeecChhHhh-hcccCchhhccccceEEEEecccCCCcccccchHHHHHHHHhccCCCCC--
Confidence 77554422 22222 46799999995 4559999999999999999885 99999999999999999886665554
Q ss_pred hhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 016184 309 IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV 364 (394)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 364 (394)
.++|..+-+|+..||++|-.+||...+|+.
T Consensus 857 --------------------------mDCP~aL~qLMldCWqkdR~~RP~F~qiV~ 886 (996)
T KOG0196|consen 857 --------------------------MDCPAALYQLMLDCWQKDRNRRPKFAQIVS 886 (996)
T ss_pred --------------------------CCCcHHHHHHHHHHHHHHhhcCCCHHHHHH
Confidence 468999999999999999999999998875
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=276.18 Aligned_cols=281 Identities=30% Similarity=0.482 Sum_probs=212.5
Q ss_pred eEEEeeEEeecCceEEEEEEECC---CCcEEEEEEecc--chhhhHHHHHHHHHc-CCCCeeeeceEEEecCCCceeEEE
Q 016184 83 SYIAEHVVGTGSFGVVFQAKCRE---TGEIVAIKKVLQ--DKRYKNRELQIMQML-DHPNIVALKHCFFSTTDKEELYLN 156 (394)
Q Consensus 83 ~y~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~--~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~ 156 (394)
.|.++++||+|.|++||+|.+.. ..+.||+|.+.. ......+|+++|..+ .+.||+++.+++ ......+
T Consensus 37 ~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p~ri~~El~~L~~~gG~~ni~~~~~~~-----rnnd~v~ 111 (418)
T KOG1167|consen 37 AYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSPSRILNELEMLYRLGGSDNIIKLNGCF-----RNNDQVA 111 (418)
T ss_pred hhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCchHHHHHHHHHHHhccchhhhcchhhh-----ccCCeeE
Confidence 49999999999999999999877 678999998753 345567899999988 688999999988 4455588
Q ss_pred EEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCcccc
Q 016184 157 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL 235 (394)
Q Consensus 157 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~ 235 (394)
+|+||++. ...++. ..++...++.+++.++.||.++|. +|||||||||.|+|.+.....-.|+|||+|...
T Consensus 112 ivlp~~~H~~f~~l~-------~~l~~~~i~~Yl~~ll~Al~~~h~-~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~ 183 (418)
T KOG1167|consen 112 IVLPYFEHDRFRDLY-------RSLSLAEIRWYLRNLLKALAHLHK-NGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRY 183 (418)
T ss_pred EEecccCccCHHHHH-------hcCCHHHHHHHHHHHHHHhhhhhc-cCccccCCCccccccccccCCceEEechhHHHH
Confidence 99999996 333322 457789999999999999999999 899999999999999988778999999998621
Q ss_pred c-----------------c--C--------------------------CCcccccccccccccccccCCCCCCChhhHHH
Q 016184 236 V-----------------K--G--------------------------EPNVSYICSRYYRAPELIFGATEYTTAIDIWS 270 (394)
Q Consensus 236 ~-----------------~--~--------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diws 270 (394)
. . + .......||++|.|||++...+..+.+.||||
T Consensus 184 d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws 263 (418)
T KOG1167|consen 184 DGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWS 263 (418)
T ss_pred HhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceee
Confidence 0 0 0 00123457999999999998888899999999
Q ss_pred HHHHHHHHHhCCCCCCC-CCcHHHHHHHHHHhCCCChhhhhccCCC------------------CcccCCCCCCC-C---
Q 016184 271 TGCVMAELLLGQPLFPG-ESGVDQLVEIIKVLGTPTREEIKCMNPN------------------YTEFKFPQIKP-H--- 327 (394)
Q Consensus 271 lG~il~~lltg~~pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~~~~------------------~~~~~~~~~~~-~--- 327 (394)
.|||+..+++++.||.. .++.+.+.++....|.........+... +.......... .
T Consensus 264 ~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n 343 (418)
T KOG1167|consen 264 AGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPN 343 (418)
T ss_pred ccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccc
Confidence 99999999999999764 4556777777666665333322211111 10000000000 0
Q ss_pred CcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCC
Q 016184 328 PWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNT 376 (394)
Q Consensus 328 ~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~ 376 (394)
.+.....+..+..+.+|+.+||..||.+|.||+++|+||||.+......
T Consensus 344 ~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~~~~~~~ 392 (418)
T KOG1167|consen 344 TEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDEADRTER 392 (418)
T ss_pred eeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcchhhhhh
Confidence 1222233445678999999999999999999999999999997654433
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-37 Score=293.27 Aligned_cols=249 Identities=29% Similarity=0.445 Sum_probs=190.2
Q ss_pred EEEeeEEeecCce-EEEEEEECCCCcEEEEEEeccchh-hhHHHHHHHHHc-CCCCeeeeceEEEecCCCceeEEEEEEe
Q 016184 84 YIAEHVVGTGSFG-VVFQAKCRETGEIVAIKKVLQDKR-YKNRELQIMQML-DHPNIVALKHCFFSTTDKEELYLNLVLE 160 (394)
Q Consensus 84 y~~~~~lg~G~~g-~V~~~~~~~~~~~vaiK~~~~~~~-~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~lv~e 160 (394)
|.-.+++|.|+.| .||+|... |+.||||.+..+.. ..++|+..|+.- .||||+++++.- .+..+.||..|
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~ye--~R~VAVKrll~e~~~~A~rEi~lL~eSD~H~NviRyyc~E-----~d~qF~YIalE 583 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVYE--GREVAVKRLLEEFFDFAQREIQLLQESDEHPNVIRYYCSE-----QDRQFLYIALE 583 (903)
T ss_pred eccHHHcccCCCCcEEEEEeeC--CceehHHHHhhHhHHHHHHHHHHHHhccCCCceEEEEeec-----cCCceEEEEeh
Confidence 4555678999987 68999985 88999999876654 567899999987 799999976533 66778889999
Q ss_pred cccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeC---CC-CcEEEEeecCccccc
Q 016184 161 YVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNP---HT-HQLKLCDFGSAKVLV 236 (394)
Q Consensus 161 ~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~---~~-~~vkl~Dfg~a~~~~ 236 (394)
.|..+|.++++..............+.+..|++.||++||+ .+||||||||.||||+. ++ -.++|+|||+++.+.
T Consensus 584 LC~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHs-l~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~ 662 (903)
T KOG1027|consen 584 LCACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHS-LKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA 662 (903)
T ss_pred HhhhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHh-cccccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence 99999999988741111111114556778899999999999 89999999999999986 33 369999999999886
Q ss_pred cCCC----cccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhC-CCCCCCCCcHHHHHHHHHHhCCCChhhhhc
Q 016184 237 KGEP----NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLG-QPLFPGESGVDQLVEIIKVLGTPTREEIKC 311 (394)
Q Consensus 237 ~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg-~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 311 (394)
.+.. .....||-+|+|||++.... .+.++|||||||++|+.++| ..||.... +.-.+|..
T Consensus 663 ~~~sS~~r~s~~sGt~GW~APE~L~~~~-~~~avDiFslGCvfyYvltgG~HpFGd~~--~R~~NIl~------------ 727 (903)
T KOG1027|consen 663 GGKSSFSRLSGGSGTSGWQAPEQLREDR-KTQAVDIFSLGCVFYYVLTGGSHPFGDSL--ERQANILT------------ 727 (903)
T ss_pred CCcchhhcccCCCCcccccCHHHHhccc-cCcccchhhcCceEEEEecCCccCCCchH--Hhhhhhhc------------
Confidence 5543 34457899999999997655 57799999999999999986 89996542 22222222
Q ss_pred cCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCC
Q 016184 312 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFD 369 (394)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~ 369 (394)
..+....+. .....++.+||.+||.+||..||+|.++|.||||=
T Consensus 728 -----~~~~L~~L~---------~~~d~eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW 771 (903)
T KOG1027|consen 728 -----GNYTLVHLE---------PLPDCEAKDLISRMLNPDPQLRPSATDVLNHPLFW 771 (903)
T ss_pred -----Cccceeeec---------cCchHHHHHHHHHhcCCCcccCCCHHHHhCCCccC
Confidence 111111111 11112899999999999999999999999999993
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=261.78 Aligned_cols=238 Identities=38% Similarity=0.628 Sum_probs=191.6
Q ss_pred CceEEEEEEECCCCcEEEEEEeccc-----hhhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEEEEEEecccc-cHH
Q 016184 94 SFGVVFQAKCRETGEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPE-TVN 167 (394)
Q Consensus 94 ~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~ 167 (394)
+||.||+|.+..+|+.+|+|++... .....+|++.++.++|+|++++++++.. ....++++|++++ ++.
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~-----~~~~~l~~e~~~~~~L~ 75 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFED-----EDKLYLVMEYCDGGDLF 75 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheee-----CCEEEEEEeCCCCCCHH
Confidence 5899999999988999999998643 3456689999999999999999998843 2457899999997 777
Q ss_pred HHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCccccccCCCccccccc
Q 016184 168 RIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICS 247 (394)
Q Consensus 168 ~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~t 247 (394)
..+... ..++...++.++.+++.+|.+||+ .+++|+||+|.||+++.++ .++|+|||.+.............++
T Consensus 76 ~~~~~~----~~~~~~~~~~~~~~l~~~l~~lh~-~~i~h~~i~~~ni~~~~~~-~~~l~d~~~~~~~~~~~~~~~~~~~ 149 (244)
T smart00220 76 DLLKKR----GRLSEDEARFYARQILSALEYLHS-NGIIHRDLKPENILLDEDG-HVKLADFGLARQLDPGGLLTTFVGT 149 (244)
T ss_pred HHHHhc----cCCCHHHHHHHHHHHHHHHHHHHH-cCeecCCcCHHHeEECCCC-cEEEccccceeeeccccccccccCC
Confidence 666542 238899999999999999999999 8999999999999999887 7999999999876554444556678
Q ss_pred ccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCCCcccCCCCCCCC
Q 016184 248 RYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPH 327 (394)
Q Consensus 248 ~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (394)
..|++||.+.+. .++.++|+||||+++|+|++|..||........+.+..........
T Consensus 150 ~~~~~pE~~~~~-~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~--------------------- 207 (244)
T smart00220 150 PEYMAPEVLLGK-GYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFP--------------------- 207 (244)
T ss_pred cCCCCHHHHccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCc---------------------
Confidence 889999998644 4788999999999999999999999774444333333221100000
Q ss_pred CcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 016184 328 PWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368 (394)
Q Consensus 328 ~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f 368 (394)
.....++.++.+++.+||..||++||++.++++||||
T Consensus 208 ----~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~~~~~ 244 (244)
T smart00220 208 ----PPEWKISPEAKDLIRKLLVKDPEKRLTAEEALQHPFF 244 (244)
T ss_pred ----cccccCCHHHHHHHHHHccCCchhccCHHHHhhCCCC
Confidence 0001167899999999999999999999999999997
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=245.74 Aligned_cols=214 Identities=24% Similarity=0.425 Sum_probs=176.4
Q ss_pred cceeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccchh-----hhHHHHHHHH-HcCCCCeeeeceEEEecCCCcee
Q 016184 80 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-----YKNRELQIMQ-MLDHPNIVALKHCFFSTTDKEEL 153 (394)
Q Consensus 80 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-----~~~~E~~~l~-~l~h~~iv~~~~~~~~~~~~~~~ 153 (394)
..+....+..||+|++|.|-+.++..+|+..|+|.+..... ...+|+.+.. ...+|.+|.+++.++...+
T Consensus 44 ~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regd---- 119 (282)
T KOG0984|consen 44 PADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGD---- 119 (282)
T ss_pred chhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhcccc----
Confidence 34445666789999999999999999999999998854322 2224555433 3478999999998865554
Q ss_pred EEEEEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCcc
Q 016184 154 YLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK 233 (394)
Q Consensus 154 ~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~ 233 (394)
+++.||.|..++..+.+.....++.+++..+-+++..++.||.|||++..++|||+||.||||+.+| .||+||||.+.
T Consensus 120 -vwIcME~M~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~G-qVKiCDFGIsG 197 (282)
T KOG0984|consen 120 -VWICMELMDTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDG-QVKICDFGISG 197 (282)
T ss_pred -EEEeHHHhhhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCC-cEEEcccccce
Confidence 7899999999998888888888899999999999999999999999988999999999999999999 79999999998
Q ss_pred ccccCCCcccccccccccccccccC---CCCCCChhhHHHHHHHHHHHHhCCCCCCCC-CcHHHHHHHHH
Q 016184 234 VLVKGEPNVSYICSRYYRAPELIFG---ATEYTTAIDIWSTGCVMAELLLGQPLFPGE-SGVDQLVEIIK 299 (394)
Q Consensus 234 ~~~~~~~~~~~~~t~~y~aPE~~~~---~~~~~~~~DiwslG~il~~lltg~~pf~~~-~~~~~~~~i~~ 299 (394)
.+.+.-......|...|||||.+.. ...|+.++||||||+++.||.+++.||... ++.+++.+++.
T Consensus 198 ~L~dSiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVe 267 (282)
T KOG0984|consen 198 YLVDSIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVE 267 (282)
T ss_pred eehhhhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhc
Confidence 7766555555678889999999843 235899999999999999999999999764 44455555544
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=275.44 Aligned_cols=250 Identities=21% Similarity=0.282 Sum_probs=197.4
Q ss_pred eEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccc-----hhhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEEEE
Q 016184 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL 157 (394)
Q Consensus 83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 157 (394)
...+.++||+|-||.|.+|... .+..||+|.++.. ...+.+|+++|.+|+||||+.++++|...+- +|+
T Consensus 539 ~L~~~ekiGeGqFGEVhLCeve-g~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DeP-----icm 612 (807)
T KOG1094|consen 539 RLRFKEKIGEGQFGEVHLCEVE-GPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDP-----LCM 612 (807)
T ss_pred heehhhhhcCcccceeEEEEec-CceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCc-----hHH
Confidence 4788999999999999999874 3689999998653 3556789999999999999999999954433 889
Q ss_pred EEeccc-ccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCccccc
Q 016184 158 VLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV 236 (394)
Q Consensus 158 v~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~ 236 (394)
|+||++ |.|.+++....... +.-.....++.||+.|++||.+ .++|||||.+.|+|++.++ ++||+|||+++.+.
T Consensus 613 I~EYmEnGDLnqFl~aheapt--~~t~~~vsi~tqiasgmaYLes-~nfVHrd~a~rNcLv~~e~-~iKiadfgmsR~ly 688 (807)
T KOG1094|consen 613 ITEYMENGDLNQFLSAHELPT--AETAPGVSICTQIASGMAYLES-LNFVHRDLATRNCLVDGEF-TIKIADFGMSRNLY 688 (807)
T ss_pred HHHHHhcCcHHHHHHhccCcc--cccchhHHHHHHHHHHHHHHHh-hchhhccccccceeecCcc-cEEecCcccccccc
Confidence 999998 57877777643211 3444556699999999999999 8999999999999999998 69999999998776
Q ss_pred cCCCc---ccccccccccccccccCCCCCCChhhHHHHHHHHHHHH--hCCCCCCCCCcHHHHHHHHHHhCCCChhhhhc
Q 016184 237 KGEPN---VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELL--LGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 311 (394)
Q Consensus 237 ~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll--tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 311 (394)
.++.. ...+-...|||+|.+...+ +++++|+|+||+++||++ +...||....+.+...+.-..+.......
T Consensus 689 sg~yy~vqgr~vlpiRwmawEsillgk-FttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~--- 764 (807)
T KOG1094|consen 689 SGDYYRVQGRAVLPIRWMAWESILLGK-FTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQV--- 764 (807)
T ss_pred cCCceeeecceeeeeeehhHHHHHhcc-ccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcce---
Confidence 55432 2233467899999997554 999999999999999987 57799988777766665544332222111
Q ss_pred cCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 016184 312 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV 364 (394)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 364 (394)
....+.-++..+.+|+.+||.+|-.+|||.+++-.
T Consensus 765 ------------------~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~ 799 (807)
T KOG1094|consen 765 ------------------VLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHL 799 (807)
T ss_pred ------------------eccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHH
Confidence 01122457889999999999999999999999843
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-36 Score=282.18 Aligned_cols=248 Identities=24% Similarity=0.326 Sum_probs=199.9
Q ss_pred EEEeeEEeecCceEEEEEEECCC-C--cEEEEEEeccch-----hhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEE
Q 016184 84 YIAEHVVGTGSFGVVFQAKCRET-G--EIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL 155 (394)
Q Consensus 84 y~~~~~lg~G~~g~V~~~~~~~~-~--~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 155 (394)
..+.++||+|+||.|++|.+... | ..||||.+..+. ..+.+|+.+|.+|+|+|++++++++... -+
T Consensus 112 i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~q------p~ 185 (1039)
T KOG0199|consen 112 IKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLDQ------PA 185 (1039)
T ss_pred HHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeeccc------hh
Confidence 55678899999999999998643 3 458999886543 4567899999999999999999998542 25
Q ss_pred EEEEeccc-ccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCccc
Q 016184 156 NLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV 234 (394)
Q Consensus 156 ~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~ 234 (394)
.||||+++ |+|.+.++. .....|....+..|+.||+.||.||.. +++|||||-..|+|+-... .|||+|||+.+.
T Consensus 186 mMV~ELaplGSLldrLrk--a~~~~llv~~Lcdya~QiA~aM~YLes-krlvHRDLAARNlllaspr-tVKI~DFGLmRa 261 (1039)
T KOG0199|consen 186 MMVFELAPLGSLLDRLRK--AKKAILLVSRLCDYAMQIAKAMQYLES-KRLVHRDLAARNLLLASPR-TVKICDFGLMRA 261 (1039)
T ss_pred hHHhhhcccchHHHHHhh--ccccceeHHHHHHHHHHHHHHHHHHhh-hhhhhhhhhhhhheecccc-eeeeecccceec
Confidence 68999998 577666665 234778899999999999999999999 8999999999999998765 799999999988
Q ss_pred cccCCCcccccc----cccccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCChhhh
Q 016184 235 LVKGEPNVSYIC----SRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEI 309 (394)
Q Consensus 235 ~~~~~~~~~~~~----t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 309 (394)
+...+....... ...|+|||.+. ...++.++|+|++||+||||+| |..||.+....+.+..+-+.- ..+
T Consensus 262 Lg~ned~Yvm~p~rkvPfAWCaPEsLr-h~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~e-rLp---- 335 (1039)
T KOG0199|consen 262 LGENEDMYVMAPQRKVPFAWCAPESLR-HRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAGE-RLP---- 335 (1039)
T ss_pred cCCCCcceEecCCCcCcccccCHhHhc-cccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhccccc-cCC----
Confidence 766655432221 45599999995 4559999999999999999997 789999999887777664211 000
Q ss_pred hccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 016184 310 KCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE 370 (394)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~ 370 (394)
-++.+++++.+++..||+++|++|||...|...-++++
T Consensus 336 -----------------------RPk~csedIY~imk~cWah~paDRptFsair~~~~l~e 373 (1039)
T KOG0199|consen 336 -----------------------RPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLVLAE 373 (1039)
T ss_pred -----------------------CCCCChHHHHHHHHHhccCCccccccHHHHHHhHHHHh
Confidence 12568999999999999999999999998865444444
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=305.48 Aligned_cols=258 Identities=21% Similarity=0.291 Sum_probs=185.8
Q ss_pred eEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccchhhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEEEEEEecc
Q 016184 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYV 162 (394)
Q Consensus 83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~ 162 (394)
.|...++||+|+||.||+|++..++..||||.+........+|++++++++||||+++++++... ...++||||+
T Consensus 691 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~l~~l~HpnIv~~~~~~~~~-----~~~~lv~Ey~ 765 (968)
T PLN00113 691 SLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSEIADMGKLQHPNIVKLIGLCRSE-----KGAYLIHEYI 765 (968)
T ss_pred hCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccccHHHHHHHhhCCCCCcceEEEEEEcC-----CCCEEEEeCC
Confidence 36667889999999999999998999999999876555556789999999999999999998433 2367999999
Q ss_pred cc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHH---hCCCceeccCCCCceEEeCCCCcEEEEeecCccccccC
Q 016184 163 PE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH---NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG 238 (394)
Q Consensus 163 ~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~~ 238 (394)
++ +|.++++ .+++..+..++.|++.||+||| + .+|+||||||+||+++.++ ..++. ||.......
T Consensus 766 ~~g~L~~~l~-------~l~~~~~~~i~~~ia~~L~yLH~~~~-~~iiH~dlkp~Nil~~~~~-~~~~~-~~~~~~~~~- 834 (968)
T PLN00113 766 EGKNLSEVLR-------NLSWERRRKIAIGIAKALRFLHCRCS-PAVVVGNLSPEKIIIDGKD-EPHLR-LSLPGLLCT- 834 (968)
T ss_pred CCCcHHHHHh-------cCCHHHHHHHHHHHHHHHHHhccCCC-CCeecCCCCHHhEEECCCC-ceEEE-ecccccccc-
Confidence 84 6766653 3788899999999999999999 5 6999999999999999776 56664 665543221
Q ss_pred CCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcH-HHHHHHHHHhCCCChhhhhccCCCCc
Q 016184 239 EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGV-DQLVEIIKVLGTPTREEIKCMNPNYT 317 (394)
Q Consensus 239 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~~~~~~ 317 (394)
.....+++.|+|||++.+. .++.++|||||||++|||+||+.||...... ..+..+.+..-.... ..
T Consensus 835 --~~~~~~t~~y~aPE~~~~~-~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~---------~~ 902 (968)
T PLN00113 835 --DTKCFISSAYVAPETRETK-DITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCH---------LD 902 (968)
T ss_pred --CCCccccccccCcccccCC-CCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccc---------hh
Confidence 1233678999999998654 5899999999999999999999998543211 112222111100000 00
Q ss_pred ccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q 016184 318 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD 373 (394)
Q Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~ 373 (394)
.+..+...... ........++.+++.+||+.||++|||+.++++. ++++..
T Consensus 903 ~~~~~~~~~~~---~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~--L~~~~~ 953 (968)
T PLN00113 903 MWIDPSIRGDV---SVNQNEIVEVMNLALHCTATDPTARPCANDVLKT--LESASR 953 (968)
T ss_pred heeCccccCCC---CccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHH--HHHhhc
Confidence 00000000000 0011123467899999999999999999999874 554433
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=257.72 Aligned_cols=255 Identities=24% Similarity=0.285 Sum_probs=188.5
Q ss_pred eEEEeeEEeecCceEEEEEEECCCCcEEEEEEecc-chhhhHHHHHHHHH--cCCCCeeeeceEEEecCCCceeEEEEEE
Q 016184 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQ-DKRYKNRELQIMQM--LDHPNIVALKHCFFSTTDKEELYLNLVL 159 (394)
Q Consensus 83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-~~~~~~~E~~~l~~--l~h~~iv~~~~~~~~~~~~~~~~~~lv~ 159 (394)
+-++.+.||+|.||.||+|+++ |+.||||++.. +.....+|.++++. |+|+||+.+++.=.... ..-..+++|+
T Consensus 212 qI~L~e~IGkGRyGEVwrG~wr--Ge~VAVKiF~srdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~-gs~TQLwLvT 288 (513)
T KOG2052|consen 212 QIVLQEIIGKGRFGEVWRGRWR--GEDVAVKIFSSRDERSWFRETEIYQTVMLRHENILGFIAADNKDN-GSWTQLWLVT 288 (513)
T ss_pred eeEEEEEecCccccceeecccc--CCceEEEEecccchhhhhhHHHHHHHHHhccchhhhhhhccccCC-CceEEEEEee
Confidence 4889999999999999999997 89999999864 45566788888876 59999999877532222 3345689999
Q ss_pred eccc-ccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhC-------CCceeccCCCCceEEeCCCCcEEEEeecC
Q 016184 160 EYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC-------IGICHRDIKPQNLLVNPHTHQLKLCDFGS 231 (394)
Q Consensus 160 e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~-------~givH~Dlkp~Nil~~~~~~~vkl~Dfg~ 231 (394)
+|.+ |+|.+++.. ..++.....+++..++.||++||.. -.|.|||||..||||..++ .+.|+|+|+
T Consensus 289 dYHe~GSL~DyL~r-----~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~-~C~IADLGL 362 (513)
T KOG2052|consen 289 DYHEHGSLYDYLNR-----NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG-TCCIADLGL 362 (513)
T ss_pred ecccCCcHHHHHhh-----ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCC-cEEEeecee
Confidence 9998 689888876 7788999999999999999999952 3599999999999999998 799999999
Q ss_pred ccccccC-----CCcccccccccccccccccCCCCC-----CChhhHHHHHHHHHHHHh-----C-----CCCCCCCCcH
Q 016184 232 AKVLVKG-----EPNVSYICSRYYRAPELIFGATEY-----TTAIDIWSTGCVMAELLL-----G-----QPLFPGESGV 291 (394)
Q Consensus 232 a~~~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~-----~~~~DiwslG~il~~llt-----g-----~~pf~~~~~~ 291 (394)
|-..... ......+||.+|||||++....+. -..+||||||.++||++. | ++||.+..+.
T Consensus 363 Av~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~ 442 (513)
T KOG2052|consen 363 AVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPS 442 (513)
T ss_pred eEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCC
Confidence 9655433 233467899999999999554321 236899999999999984 2 3677654322
Q ss_pred -HHHHHHHHHhCCCChhhhhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 016184 292 -DQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV 364 (394)
Q Consensus 292 -~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 364 (394)
..+++|.+.+ ....+++..-..+.....-..+.+|++.||..+|.-|.||--+.+
T Consensus 443 DPs~eeMrkVV------------------Cv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKK 498 (513)
T KOG2052|consen 443 DPSFEEMRKVV------------------CVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKK 498 (513)
T ss_pred CCCHHHHhcce------------------eecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHH
Confidence 2233332211 111111111111111223345788999999999999999876643
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=267.14 Aligned_cols=199 Identities=29% Similarity=0.441 Sum_probs=171.5
Q ss_pred ccceeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccchhhh------------HHHHHHHHHcC---CCCeeeeceE
Q 016184 79 KQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK------------NRELQIMQMLD---HPNIVALKHC 143 (394)
Q Consensus 79 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~------------~~E~~~l~~l~---h~~iv~~~~~ 143 (394)
++...|+.++.||.|+||.|++|.++.....|+||.+.+++-.. --|+.||..++ |+||++++++
T Consensus 558 ~k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdf 637 (772)
T KOG1152|consen 558 KKFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDF 637 (772)
T ss_pred cccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhhe
Confidence 34456999999999999999999999999999999887654222 25999999997 9999999999
Q ss_pred EEecCCCceeEEEEEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCc
Q 016184 144 FFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQ 223 (394)
Q Consensus 144 ~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~ 223 (394)
| .+..|+|++||-.+.++ + +..+......+++.+++.|+.|++.|+++||+ .||||||||-+||.++.+| -
T Consensus 638 F-----Eddd~yyl~te~hg~gI-D-LFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~-~~ivhrdikdenvivd~~g-~ 708 (772)
T KOG1152|consen 638 F-----EDDDYYYLETEVHGEGI-D-LFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHD-QGIVHRDIKDENVIVDSNG-F 708 (772)
T ss_pred e-----ecCCeeEEEecCCCCCc-c-hhhhhhccCccchHHHHHHHHHHHhccccccc-cCceecccccccEEEecCC-e
Confidence 9 56667889999887542 2 22344556889999999999999999999999 8999999999999999999 6
Q ss_pred EEEEeecCccccccCCCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCC
Q 016184 224 LKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPG 287 (394)
Q Consensus 224 vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~ 287 (394)
+||+|||.|... ..++...+.||..|.|||++.+.++.+...|||+||++||.++....||..
T Consensus 709 ~klidfgsaa~~-ksgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 709 VKLIDFGSAAYT-KSGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred EEEeeccchhhh-cCCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 999999998754 445666789999999999998888889999999999999999999999863
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-34 Score=258.85 Aligned_cols=269 Identities=25% Similarity=0.322 Sum_probs=188.9
Q ss_pred EEEeeEEeecCceEEEEEEECCCCcEEEEEEecc-chhhhHHHHHHHHH--cCCCCeeeeceEEEecCCCceeEEEEEEe
Q 016184 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQ-DKRYKNRELQIMQM--LDHPNIVALKHCFFSTTDKEELYLNLVLE 160 (394)
Q Consensus 84 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-~~~~~~~E~~~l~~--l~h~~iv~~~~~~~~~~~~~~~~~~lv~e 160 (394)
.++..+||+|.||.||+|... ++.||||++.. ++.....|.+|++. ++|+||+++++.--.... ...-+++|++
T Consensus 212 l~l~eli~~Grfg~V~KaqL~--~~~VAVKifp~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~-~~~eywLVt~ 288 (534)
T KOG3653|consen 212 LQLLELIGRGRFGCVWKAQLD--NRLVAVKIFPEQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTA-DRMEYWLVTE 288 (534)
T ss_pred hhhHHHhhcCccceeehhhcc--CceeEEEecCHHHHHHHHhHHHHHhccCccchhHHHhhchhccCCc-cccceeEEee
Confidence 667788999999999999975 69999999864 45666778888776 489999999875422221 2344679999
Q ss_pred ccc-ccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhC--------CCceeccCCCCceEEeCCCCcEEEEeecC
Q 016184 161 YVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC--------IGICHRDIKPQNLLVNPHTHQLKLCDFGS 231 (394)
Q Consensus 161 ~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~--------~givH~Dlkp~Nil~~~~~~~vkl~Dfg~ 231 (394)
|.+ |+|.++++. ..+++....+++..+++||+|||+. ..|+|||||..||||..|. +..|+|||+
T Consensus 289 fh~kGsL~dyL~~-----ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~Dl-TccIaDFGL 362 (534)
T KOG3653|consen 289 FHPKGSLCDYLKA-----NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDL-TCCIADFGL 362 (534)
T ss_pred eccCCcHHHHHHh-----ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCC-cEEeeccce
Confidence 998 689888887 7799999999999999999999962 3599999999999999998 799999999
Q ss_pred ccccccCCC---cccccccccccccccccCCCCCC-----ChhhHHHHHHHHHHHHhCCCCCC-CCCcHHHHHHHHHHhC
Q 016184 232 AKVLVKGEP---NVSYICSRYYRAPELIFGATEYT-----TAIDIWSTGCVMAELLLGQPLFP-GESGVDQLVEIIKVLG 302 (394)
Q Consensus 232 a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~-----~~~DiwslG~il~~lltg~~pf~-~~~~~~~~~~i~~~~~ 302 (394)
|.++..+.. ....+||.+|||||++.+..++. .+.||||+|.+||||++...-+. +..+.-++.--.....
T Consensus 363 Al~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~ 442 (534)
T KOG3653|consen 363 ALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGN 442 (534)
T ss_pred eEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcC
Confidence 988764433 33578899999999997765555 36899999999999998643332 1111100000001111
Q ss_pred CCChhhhhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHH------HHhcCCC
Q 016184 303 TPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTAL------EACVHPF 367 (394)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~------ell~hp~ 367 (394)
.|..+.+...-- .....|. .++.|.. -.--..+++.+..||+.||+-|.||. ..+.|.|
T Consensus 443 hPt~e~mq~~VV--~kK~RP~-~p~~W~~---h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~ 507 (534)
T KOG3653|consen 443 HPTLEEMQELVV--RKKQRPK-IPDAWRK---HAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLW 507 (534)
T ss_pred CCCHHHHHHHHH--hhccCCC-Chhhhhc---CccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccC
Confidence 222222211000 0000000 0111221 12345689999999999999999985 3445665
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-32 Score=268.54 Aligned_cols=246 Identities=25% Similarity=0.378 Sum_probs=189.6
Q ss_pred EEEeeEEeecCceEEEEEEEC---C----CCcEEEEEEeccc-----hhhhHHHHHHHHHc-CCCCeeeeceEEEecCCC
Q 016184 84 YIAEHVVGTGSFGVVFQAKCR---E----TGEIVAIKKVLQD-----KRYKNRELQIMQML-DHPNIVALKHCFFSTTDK 150 (394)
Q Consensus 84 y~~~~~lg~G~~g~V~~~~~~---~----~~~~vaiK~~~~~-----~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~ 150 (394)
..+.+.||+|.||.|++|... . ....||||..... ...+..|+++|+.+ .|+||+.+++++..
T Consensus 298 l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~---- 373 (609)
T KOG0200|consen 298 LKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQ---- 373 (609)
T ss_pred ccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeecc----
Confidence 456679999999999999753 1 1457999987543 34455799999988 59999999999843
Q ss_pred ceeEEEEEEeccc-ccHHHHHHHhh---hh-------c--CCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEE
Q 016184 151 EELYLNLVLEYVP-ETVNRIARNYS---RI-------H--QRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLV 217 (394)
Q Consensus 151 ~~~~~~lv~e~~~-~~l~~~~~~~~---~~-------~--~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~ 217 (394)
....++|+||+. |+|..+++..+ .. . ..++......++.||+.|++||++ .++|||||-..|||+
T Consensus 374 -~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~-~~~vHRDLAaRNVLi 451 (609)
T KOG0200|consen 374 -DGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLAS-VPCVHRDLAARNVLI 451 (609)
T ss_pred -CCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhh-CCccchhhhhhhEEe
Confidence 445789999998 57877777644 11 1 138899999999999999999999 899999999999999
Q ss_pred eCCCCcEEEEeecCccccccCCCccc--cc--ccccccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHH
Q 016184 218 NPHTHQLKLCDFGSAKVLVKGEPNVS--YI--CSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVD 292 (394)
Q Consensus 218 ~~~~~~vkl~Dfg~a~~~~~~~~~~~--~~--~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~ 292 (394)
+.+. .+||+|||+|+.......... .. -...|||||.+.. ..|+.++||||+|++||||++ |..||++.....
T Consensus 452 ~~~~-~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~-~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~ 529 (609)
T KOG0200|consen 452 TKNK-VIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFD-RVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTE 529 (609)
T ss_pred cCCC-EEEEccccceeccCCCCceEecCCCCccceeecCHHHhcc-CcccccchhhHHHHHHHHHhhCCCCCCCCCCcHH
Confidence 9876 899999999986544332221 11 1344999999976 559999999999999999998 889998855333
Q ss_pred HHHHHHHHhCCCChhhhhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 016184 293 QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV 364 (394)
Q Consensus 293 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 364 (394)
.+.+..+...+. ..+..++.++.++++.||..+|++||+..++..
T Consensus 530 ~l~~~l~~G~r~---------------------------~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~ 574 (609)
T KOG0200|consen 530 ELLEFLKEGNRM---------------------------EQPEHCSDEIYDLMKSCWNADPEDRPTFSECVE 574 (609)
T ss_pred HHHHHHhcCCCC---------------------------CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence 333333321111 123568999999999999999999999988764
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=263.35 Aligned_cols=240 Identities=25% Similarity=0.362 Sum_probs=190.9
Q ss_pred EEEeeEEeecCceEEEEEEECCCCc----EEEEEEeccc-----hhhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeE
Q 016184 84 YIAEHVVGTGSFGVVFQAKCRETGE----IVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY 154 (394)
Q Consensus 84 y~~~~~lg~G~~g~V~~~~~~~~~~----~vaiK~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 154 (394)
....++||.|+||+||+|.+...|+ +||||++... ...+.+|+-+|..+.|||++++++++....
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~------ 771 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST------ 771 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch------
Confidence 3445789999999999999876664 5788877532 344567899999999999999999884433
Q ss_pred EEEEEeccc-ccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCcc
Q 016184 155 LNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK 233 (394)
Q Consensus 155 ~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~ 233 (394)
+.||++|++ |.|.++++..+ ..+-......|..||++||.|||. +++|||||-..||||..-. .+||.|||+++
T Consensus 772 ~qlvtq~mP~G~LlDyvr~hr---~~igsq~lLnw~~QIAkgM~YLe~-qrlVHrdLaaRNVLVksP~-hvkitdfgla~ 846 (1177)
T KOG1025|consen 772 LQLVTQLMPLGCLLDYVREHR---DNIGSQDLLNWCYQIAKGMKYLEE-QRLVHRDLAARNVLVKSPN-HVKITDFGLAK 846 (1177)
T ss_pred HHHHHHhcccchHHHHHHHhh---ccccHHHHHHHHHHHHHHHHHHHh-cchhhhhhhhhheeecCCC-eEEEEecchhh
Confidence 558999999 57777777643 678889999999999999999999 8999999999999999877 69999999999
Q ss_pred ccccCCCcccccc---cccccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCChhhh
Q 016184 234 VLVKGEPNVSYIC---SRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEI 309 (394)
Q Consensus 234 ~~~~~~~~~~~~~---t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 309 (394)
.....+......+ .+.|||-|.+... .|+.++||||+||++||++| |..|+.+....+ +.+.++...+
T Consensus 847 ll~~d~~ey~~~~gK~pikwmale~i~~~-~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~e-I~dlle~geR------ 918 (1177)
T KOG1025|consen 847 LLAPDEKEYSAPGGKVPIKWMALESIRIR-KYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEE-IPDLLEKGER------ 918 (1177)
T ss_pred ccCcccccccccccccCcHHHHHHHhhcc-CCCchhhhhhhhhhHHHHHhcCCCccCCCCHHH-hhHHHhcccc------
Confidence 8766554443332 5669999998654 49999999999999999998 999998765433 2222221100
Q ss_pred hccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHh
Q 016184 310 KCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEAC 363 (394)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell 363 (394)
+ ..++.++.++..++.+||..|+..||+++++.
T Consensus 919 -----------L----------sqPpiCtiDVy~~mvkCwmid~~~rp~fkel~ 951 (1177)
T KOG1025|consen 919 -----------L----------SQPPICTIDVYMVMVKCWMIDADSRPTFKELA 951 (1177)
T ss_pred -----------C----------CCCCCccHHHHHHHHHHhccCcccCccHHHHH
Confidence 1 12356889999999999999999999998775
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.9e-33 Score=264.13 Aligned_cols=256 Identities=25% Similarity=0.371 Sum_probs=205.3
Q ss_pred ceeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccc----hhhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEEE
Q 016184 81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN 156 (394)
Q Consensus 81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 156 (394)
+.+|..+..+|.|.||.||+|+++.+++..|+|+++.. ....++|+-+++..+|+||+.+++.|..... .+
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dk-----lw 88 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDK-----LW 88 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcC-----cE
Confidence 45699999999999999999999999999999998643 3455789999999999999999998854433 78
Q ss_pred EEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCcccc
Q 016184 157 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL 235 (394)
Q Consensus 157 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~ 235 (394)
+.||||++ ++.++- ...+.+++.++..+++..+.+|+|||+ .|-+|||||-.|||++..+ .+|++|||.+..+
T Consensus 89 icMEycgggslQdiy----~~TgplselqiayvcRetl~gl~ylhs-~gk~hRdiKGanilltd~g-DvklaDfgvsaqi 162 (829)
T KOG0576|consen 89 ICMEYCGGGSLQDIY----HVTGPLSELQIAYVCRETLQGLKYLHS-QGKIHRDIKGANILLTDEG-DVKLADFGVSAQI 162 (829)
T ss_pred EEEEecCCCccccee----eecccchhHHHHHHHhhhhccchhhhc-CCcccccccccceeecccC-ceeecccCchhhh
Confidence 99999996 554432 234788999999999999999999999 8999999999999999888 6999999987544
Q ss_pred cc-CCCccccccccccccccccc--CCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhcc
Q 016184 236 VK-GEPNVSYICSRYYRAPELIF--GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 312 (394)
Q Consensus 236 ~~-~~~~~~~~~t~~y~aPE~~~--~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 312 (394)
.. -....+..||++|||||+.. ....|...+|||++|+...|+---++|....-++..+..+.+-.-+|+..
T Consensus 163 tati~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~l----- 237 (829)
T KOG0576|consen 163 TATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTL----- 237 (829)
T ss_pred hhhhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcc-----
Confidence 22 12335688999999999862 22348999999999999999988888876666666555554422222210
Q ss_pred CCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 016184 313 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL 371 (394)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 371 (394)
. .. ..-++.+-+|++.+|..+|.+|||++.+|.|||....
T Consensus 238 ---------k--Dk--------~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~ 277 (829)
T KOG0576|consen 238 ---------K--DK--------TKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT 277 (829)
T ss_pred ---------c--CC--------ccchHHHHHHHHHHhcCCCccCCChhhheeceeeccc
Confidence 0 01 2346778899999999999999999999999998764
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.8e-33 Score=235.97 Aligned_cols=257 Identities=23% Similarity=0.303 Sum_probs=188.8
Q ss_pred eeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccch---hhhHHHHHHHHHc-CCCCeeeeceEEEecCCCceeEEEE
Q 016184 82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---RYKNRELQIMQML-DHPNIVALKHCFFSTTDKEELYLNL 157 (394)
Q Consensus 82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~l 157 (394)
+.|.|.+.||+|.||.+.+|+++.++..+++|.+.+.. ..+.+|...--.| .|.||+..+++-+...+ ++++
T Consensus 24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d----~YvF 99 (378)
T KOG1345|consen 24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSD----AYVF 99 (378)
T ss_pred hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhhHHHHHHHhccceeeccchhhhHHHHHHhhcCc----eEEE
Confidence 35999999999999999999999999999999886543 3444565544444 58999988877654443 5678
Q ss_pred EEeccc-ccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEE-eCCCCcEEEEeecCcccc
Q 016184 158 VLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLV-NPHTHQLKLCDFGSAKVL 235 (394)
Q Consensus 158 v~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~-~~~~~~vkl~Dfg~a~~~ 235 (394)
++||++ |+|..-+.. .++.+...+.++.|++.||.|||+ +++||||||.+|||| +.|...|||||||+.+..
T Consensus 100 ~qE~aP~gdL~snv~~-----~GigE~~~K~v~~ql~SAi~fMHs-knlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~ 173 (378)
T KOG1345|consen 100 VQEFAPRGDLRSNVEA-----AGIGEANTKKVFAQLLSAIEFMHS-KNLVHRDLKAENILIFDADFYRVKLCDFGLTRKV 173 (378)
T ss_pred eeccCccchhhhhcCc-----ccccHHHHHHHHHHHHHHHHHhhc-cchhhcccccceEEEecCCccEEEeeeccccccc
Confidence 999999 566444433 678899999999999999999999 899999999999998 445558999999998654
Q ss_pred ccCCCcccccccccccccccccCC----CCCCChhhHHHHHHHHHHHHhCCCCCCCCCcH-HHHHHHHHHhCCCChhhhh
Q 016184 236 VKGEPNVSYICSRYYRAPELIFGA----TEYTTAIDIWSTGCVMAELLLGQPLFPGESGV-DQLVEIIKVLGTPTREEIK 310 (394)
Q Consensus 236 ~~~~~~~~~~~t~~y~aPE~~~~~----~~~~~~~DiwslG~il~~lltg~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~ 310 (394)
... ....--+..|.+||....- ...+..+|+|.||+++|.++||.+||+..... ..+.+..+.++......
T Consensus 174 g~t--V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~~-- 249 (378)
T KOG1345|consen 174 GTT--VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPAL-- 249 (378)
T ss_pred Cce--ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCccC--
Confidence 221 1112225568999987432 22466799999999999999999999854322 33445554443322111
Q ss_pred ccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCC---CCHHHHhcCCCCCCCC
Q 016184 311 CMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLR---CTALEACVHPFFDELR 372 (394)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R---pt~~ell~hp~f~~~~ 372 (394)
| ..| ..+++.+..+.++-|+++|++| -++......-|.....
T Consensus 250 -----------P--------~~F-~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~E~~i 294 (378)
T KOG1345|consen 250 -----------P--------KKF-NPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWKEKLI 294 (378)
T ss_pred -----------c--------hhh-cccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHHHhhh
Confidence 0 001 4578999999999999999999 5666666666665543
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-29 Score=219.73 Aligned_cols=207 Identities=35% Similarity=0.584 Sum_probs=174.2
Q ss_pred EeecCceEEEEEEECCCCcEEEEEEeccch-----hhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEEEEEEeccc-
Q 016184 90 VGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVP- 163 (394)
Q Consensus 90 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~- 163 (394)
||+|++|.||++....+++.+++|++.... ....+|++.++.+.|++++++++++.. ....++++|+++
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~-----~~~~~~~~e~~~~ 75 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFED-----ENHLYLVMEYCEG 75 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeec-----CCeEEEEEecCCC
Confidence 689999999999998889999999987654 357789999999999999999988833 245789999999
Q ss_pred ccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeC-CCCcEEEEeecCccccccCC-Cc
Q 016184 164 ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNP-HTHQLKLCDFGSAKVLVKGE-PN 241 (394)
Q Consensus 164 ~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~-~~~~vkl~Dfg~a~~~~~~~-~~ 241 (394)
+++.+++.... ..++...++.++.+++.+|.+||+ .|++|+||+|.||+++. ++ .++|+|||.+....... ..
T Consensus 76 ~~l~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~-~~~~H~dl~~~ni~~~~~~~-~~~l~d~~~~~~~~~~~~~~ 150 (215)
T cd00180 76 GSLKDLLKENE---GKLSEDEILRILLQILEGLEYLHS-NGIIHRDLKPENILLDSDNG-KVKLADFGLSKLLTSDKSLL 150 (215)
T ss_pred CcHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCHhhEEEeCCCC-cEEEecCCceEEccCCcchh
Confidence 57777665421 468899999999999999999999 89999999999999998 56 79999999987654332 12
Q ss_pred ccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCCCcccCC
Q 016184 242 VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF 321 (394)
Q Consensus 242 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 321 (394)
....+...|++||.+......+.+.|+|++|+++++|
T Consensus 151 ~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l------------------------------------------- 187 (215)
T cd00180 151 KTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL------------------------------------------- 187 (215)
T ss_pred hcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH-------------------------------------------
Confidence 3355678899999985542578999999999999999
Q ss_pred CCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCC
Q 016184 322 PQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHP 366 (394)
Q Consensus 322 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp 366 (394)
..+.+++.+||+.||++||++.++++|+
T Consensus 188 -----------------~~~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 188 -----------------PELKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred -----------------HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 1467899999999999999999999885
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=269.83 Aligned_cols=207 Identities=16% Similarity=0.172 Sum_probs=144.4
Q ss_pred HcCC-CCeeeeceEEEecC--CCceeEEEEEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcee
Q 016184 131 MLDH-PNIVALKHCFFSTT--DKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICH 207 (394)
Q Consensus 131 ~l~h-~~iv~~~~~~~~~~--~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH 207 (394)
.+.| .||+.+++.|-... ......+++++|+++++|..++... ...+++..++.++.||+.||+|||+ +||+|
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~-~gIvH 103 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECEDVSLRQWLDNP---DRSVDAFECFHVFRQIVEIVNAAHS-QGIVV 103 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccCCccHHHHHhcc---cccccHHHHHHHHHHHHHHHHHHHh-CCeee
Confidence 3455 47777777651111 1122346678999999988887632 3569999999999999999999999 89999
Q ss_pred ccCCCCceEEeCCC------------------CcEEEEeecCccccccCC-----------------Ccccccccccccc
Q 016184 208 RDIKPQNLLVNPHT------------------HQLKLCDFGSAKVLVKGE-----------------PNVSYICSRYYRA 252 (394)
Q Consensus 208 ~Dlkp~Nil~~~~~------------------~~vkl~Dfg~a~~~~~~~-----------------~~~~~~~t~~y~a 252 (394)
|||||+||||+..+ ..+|++|||+++...... ......+|+.|||
T Consensus 104 rDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~A 183 (793)
T PLN00181 104 HNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTS 183 (793)
T ss_pred ccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEC
Confidence 99999999996433 146666666665321100 0011357888999
Q ss_pred cccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCCCcccCCCCCCCCCcchh
Q 016184 253 PELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKV 332 (394)
Q Consensus 253 PE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 332 (394)
||++.+.. ++.++|||||||+||||++|.+|+.... ..+..+.... .++ ..
T Consensus 184 PE~~~~~~-~~~~sDVwSlGviL~ELl~~~~~~~~~~--~~~~~~~~~~-~~~-~~------------------------ 234 (793)
T PLN00181 184 PEEDNGSS-SNCASDVYRLGVLLFELFCPVSSREEKS--RTMSSLRHRV-LPP-QI------------------------ 234 (793)
T ss_pred hhhhccCC-CCchhhhhhHHHHHHHHhhCCCchhhHH--HHHHHHHHhh-cCh-hh------------------------
Confidence 99986654 8999999999999999999988875321 1122221110 000 00
Q ss_pred ccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 016184 333 FQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR 372 (394)
Q Consensus 333 ~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 372 (394)
....+...+++.+||+.||.+|||+.|+|+||||++..
T Consensus 235 --~~~~~~~~~~~~~~L~~~P~~Rps~~eil~h~~~~~~~ 272 (793)
T PLN00181 235 --LLNWPKEASFCLWLLHPEPSCRPSMSELLQSEFINEPR 272 (793)
T ss_pred --hhcCHHHHHHHHHhCCCChhhCcChHHHhhchhhhhhh
Confidence 01134567899999999999999999999999998753
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-28 Score=217.16 Aligned_cols=202 Identities=35% Similarity=0.578 Sum_probs=165.7
Q ss_pred EEEeeEEeecCceEEEEEEECCCCcEEEEEEeccc-----hhhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEEEEE
Q 016184 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLV 158 (394)
Q Consensus 84 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv 158 (394)
|.+.+.||.|++|.||+|.+..+++.+|+|.+... .....+|++.++.++|+|++++++.+.. ....+++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~-----~~~~~~v 75 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFED-----PEPLYLV 75 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeec-----CCceEEE
Confidence 56788999999999999999888999999998653 3455679999999999999999988732 2347789
Q ss_pred Eecccc-cHHHHHHHhhhhcCC-CCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCccccc
Q 016184 159 LEYVPE-TVNRIARNYSRIHQR-MPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV 236 (394)
Q Consensus 159 ~e~~~~-~l~~~~~~~~~~~~~-l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~ 236 (394)
+|++++ +|.+++... .. +++..++.++.+++.+|.+||+ .+++|+||+|.||+++.++ .++|+|||.+....
T Consensus 76 ~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lh~-~~i~h~di~~~ni~v~~~~-~~~l~d~g~~~~~~ 149 (225)
T smart00221 76 MEYCEGGDLFDYLRKK----GGKLSEEEARFYLRQILEALEYLHS-LGIVHRDLKPENILLGMDG-LVKLADFGLARFIH 149 (225)
T ss_pred EeccCCCCHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEcCCC-CEEEeeCceeeEec
Confidence 999997 777766542 23 8899999999999999999999 8999999999999999886 79999999987765
Q ss_pred cCC--CcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCC-CCcHHHHHH
Q 016184 237 KGE--PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPG-ESGVDQLVE 296 (394)
Q Consensus 237 ~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~-~~~~~~~~~ 296 (394)
... ......++..|++||.+.+...++.++|+|+||+++++|++|+.||.. .+....+.+
T Consensus 150 ~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~ 212 (225)
T smart00221 150 RDLAALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSD 212 (225)
T ss_pred CcccccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHH
Confidence 443 334456778899999874334477899999999999999999999977 444433333
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-29 Score=225.49 Aligned_cols=250 Identities=18% Similarity=0.261 Sum_probs=190.5
Q ss_pred cceeEEEeeEEeecCceEEEEEEECCCC-----cEEEEEEeccchhhh-----HHHHHHHHHcCCCCeeeeceEEEecCC
Q 016184 80 QKVSYIAEHVVGTGSFGVVFQAKCRETG-----EIVAIKKVLQDKRYK-----NRELQIMQMLDHPNIVALKHCFFSTTD 149 (394)
Q Consensus 80 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~vaiK~~~~~~~~~-----~~E~~~l~~l~h~~iv~~~~~~~~~~~ 149 (394)
.+.+++...++-+|.||.||.|.++... +.|.+|.++.....+ ..|...+.-+.|||+..+.++..+..+
T Consensus 282 ~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~ 361 (563)
T KOG1024|consen 282 QRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYA 361 (563)
T ss_pred hhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccC
Confidence 3456888889999999999999776443 345666665443332 357777888899999999998755322
Q ss_pred CceeEEEEEEeccc-ccHHHHHHHhhh----hcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcE
Q 016184 150 KEELYLNLVLEYVP-ETVNRIARNYSR----IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQL 224 (394)
Q Consensus 150 ~~~~~~~lv~e~~~-~~l~~~~~~~~~----~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~v 224 (394)
..++++.+++ ++|..++...+. ..+.+.-.++..++.|++.|++|||+ .|+||.||...|.+|++.- .|
T Consensus 362 ----~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~-~~ViHkDiAaRNCvIdd~L-qV 435 (563)
T KOG1024|consen 362 ----TPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHN-HGVIHKDIAARNCVIDDQL-QV 435 (563)
T ss_pred ----cceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHh-cCcccchhhhhcceehhhe-eE
Confidence 2445677776 577666663221 12345666788899999999999999 9999999999999999776 79
Q ss_pred EEEeecCccccccCCCcc---cccccccccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHH
Q 016184 225 KLCDFGSAKVLVKGEPNV---SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKV 300 (394)
Q Consensus 225 kl~Dfg~a~~~~~~~~~~---~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~ 300 (394)
||+|=.+++.....+-.. .......||+||.+.. ..|+.++|+|||||+||||+| |+.||...++.+....+.+.
T Consensus 436 kltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n-~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkdG 514 (563)
T KOG1024|consen 436 KLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQN-SHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKDG 514 (563)
T ss_pred EeccchhccccCcccccccCCCCCCcccccCHHHHhh-hhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhcc
Confidence 999999998765443321 1223567999999965 459999999999999999998 99999988887776665542
Q ss_pred hCCCChhhhhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 016184 301 LGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV 364 (394)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 364 (394)
. .+ ..+-++|+++..++..||+.+|++||+.+++..
T Consensus 515 y------------------Rl----------aQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~ 550 (563)
T KOG1024|consen 515 Y------------------RL----------AQPFNCPDELFTVMACCWALLPEERPSFSQLVI 550 (563)
T ss_pred c------------------ee----------cCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence 1 11 123579999999999999999999999999864
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.8e-28 Score=201.94 Aligned_cols=205 Identities=24% Similarity=0.325 Sum_probs=167.4
Q ss_pred eEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccc--hhhhHHHHHHHHHcCC-CCeeeeceEEEecCCCceeEEEEEE
Q 016184 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD--KRYKNRELQIMQMLDH-PNIVALKHCFFSTTDKEELYLNLVL 159 (394)
Q Consensus 83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~~~~~~~~lv~ 159 (394)
+|.++++||.|+||.+|+|....+|+.||||+-... ......|..+.+.|++ ..|..+..+. .+..|-.+||
T Consensus 16 ky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~hpqL~yEskvY~iL~~g~GiP~i~~y~-----~e~~ynvlVM 90 (341)
T KOG1163|consen 16 KYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKHPQLLYESKVYRILQGGVGIPHIRHYG-----TEKDYNVLVM 90 (341)
T ss_pred ceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCCcchhHHHHHHHHhccCCCCchhhhhc-----cccccceeee
Confidence 599999999999999999999999999999976543 3345679999999965 5666665554 5556678999
Q ss_pred ecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeC--CCCcEEEEeecCcccccc
Q 016184 160 EYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNP--HTHQLKLCDFGSAKVLVK 237 (394)
Q Consensus 160 e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~--~~~~vkl~Dfg~a~~~~~ 237 (394)
++++.+|.+++... ...++.+++..++-|++.-++|+|. ++++||||||+|+|..- ..+.+.|+|||+|+...+
T Consensus 91 dLLGPsLEdLfnfC---~R~ftmkTvLMLaDQml~RiEyvH~-r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d 166 (341)
T KOG1163|consen 91 DLLGPSLEDLFNFC---SRRFTMKTVLMLADQMLSRIEYVHL-RNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRD 166 (341)
T ss_pred eccCccHHHHHHHH---hhhhhHHhHHHHHHHHHHHHHHHHh-hccccccCCccceeeccccccceEEEEeccchhhhcc
Confidence 99999998876543 3789999999999999999999999 89999999999999754 445799999999987744
Q ss_pred CC--------CcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHH
Q 016184 238 GE--------PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEI 297 (394)
Q Consensus 238 ~~--------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i 297 (394)
.. ......||..|.+-....+. ..+.+.|+-|+|.+|.++.-|..||++.......++.
T Consensus 167 ~~t~~HIpyre~r~ltGTaRYASinAh~g~-eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKy 233 (341)
T KOG1163|consen 167 IRTRQHIPYREDRNLTGTARYASINAHLGI-EQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKY 233 (341)
T ss_pred ccccccCccccCCccceeeeehhhhhhhhh-hhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHH
Confidence 32 23456789999998776544 3789999999999999999999999997665444433
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.7e-28 Score=206.02 Aligned_cols=167 Identities=21% Similarity=0.159 Sum_probs=124.4
Q ss_pred ccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCccccccCCCccc
Q 016184 164 ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVS 243 (394)
Q Consensus 164 ~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~~~~~~~ 243 (394)
|+|.+++... ...+++..++.++.|++.||.|||+ .+ ||+|||++.++ .+|+ ||++...... .
T Consensus 1 GsL~~~l~~~---~~~l~~~~~~~i~~qi~~~L~~lH~-~~------kp~Nil~~~~~-~~~~--fG~~~~~~~~----~ 63 (176)
T smart00750 1 VSLADILEVR---GRPLNEEEIWAVCLQCLRALRELHR-QA------KSGNILLTWDG-LLKL--DGSVAFKTPE----Q 63 (176)
T ss_pred CcHHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHh-cC------CcccEeEcCcc-ceee--ccceEeeccc----c
Confidence 4566666532 3569999999999999999999999 67 99999999887 6888 9998765332 2
Q ss_pred ccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcH-HHHHHHHHHhCCCChhhhhccCCCCcccCCC
Q 016184 244 YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGV-DQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 322 (394)
Q Consensus 244 ~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (394)
..+|+.|+|||++.+. .++.++|||||||++|+|++|+.||...... ..+..+..........
T Consensus 64 ~~g~~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~--------------- 127 (176)
T smart00750 64 SRVDPYFMAPEVIQGQ-SYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPR--------------- 127 (176)
T ss_pred CCCcccccChHHhcCC-CCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCcc---------------
Confidence 3678999999999655 4899999999999999999999999765433 2233322211100000
Q ss_pred CCCCCCcchhccccCCh--HHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 016184 323 QIKPHPWHKVFQKRLPP--EAVDLVCRFFQYSPNLRCTALEACVHPFFDE 370 (394)
Q Consensus 323 ~~~~~~~~~~~~~~~~~--~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~ 370 (394)
.......++. ++.++|.+||..||.+|||+.++++|+|+..
T Consensus 128 -------~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~ 170 (176)
T smart00750 128 -------DRSNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALF 170 (176)
T ss_pred -------ccccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHH
Confidence 0000012333 6999999999999999999999999999753
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.7e-26 Score=214.43 Aligned_cols=251 Identities=20% Similarity=0.211 Sum_probs=190.2
Q ss_pred eEEEeeEEeecCceEEEEEEECCCC-cEEEEEEeccch----hhhHHHHHHHHHcCC----CCeeeeceEEEecCCCcee
Q 016184 83 SYIAEHVVGTGSFGVVFQAKCRETG-EIVAIKKVLQDK----RYKNRELQIMQMLDH----PNIVALKHCFFSTTDKEEL 153 (394)
Q Consensus 83 ~y~~~~~lg~G~~g~V~~~~~~~~~-~~vaiK~~~~~~----~~~~~E~~~l~~l~h----~~iv~~~~~~~~~~~~~~~ 153 (394)
+|.+.+.||+|+||.||+|.+..++ ..+|+|...... .....|..++..+.. +++..+++... ....
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~----~~~~ 94 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGR----STED 94 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEecc----CCCc
Confidence 5999999999999999999997764 678999765431 156789999999873 57777766541 3455
Q ss_pred EEEEEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCC----CcEEEEee
Q 016184 154 YLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHT----HQLKLCDF 229 (394)
Q Consensus 154 ~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~----~~vkl~Df 229 (394)
+-++||+.++.+|.++..... .+.++..++..++.|++.+|++||+ .|++||||||.|++++... ..+.|.||
T Consensus 95 ~~~iVM~l~G~sL~dl~~~~~--~~~fs~~T~l~ia~q~l~~l~~lH~-~G~iHRDiKp~N~~~g~~~~~~~~~~~llDf 171 (322)
T KOG1164|consen 95 FNFIVMSLLGPSLEDLRKRNP--PGRFSRKTVLRIAIQNLNALEDLHS-KGFIHRDIKPENFVVGQSSRSEVRTLYLLDF 171 (322)
T ss_pred eeEEEEeccCccHHHHHHhCC--CCCcCHhHHHHHHHHHHHHHHHHHh-cCcccCCcCHHHeeecCCCCcccceEEEEec
Confidence 678999999999998776654 5889999999999999999999999 8999999999999998653 46999999
Q ss_pred cCcc--ccccCC--------C-cccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHH
Q 016184 230 GSAK--VLVKGE--------P-NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEII 298 (394)
Q Consensus 230 g~a~--~~~~~~--------~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~ 298 (394)
|+++ ...... . .....||..|+++....+. ..+.+.|+||+++++.+++.|..||.............
T Consensus 172 Glar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~-e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~ 250 (322)
T KOG1164|consen 172 GLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGI-EQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFE 250 (322)
T ss_pred CCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCC-ccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHH
Confidence 9998 321111 1 2235589999999988654 48999999999999999999999998766544433333
Q ss_pred HHhCCCChhhhhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 016184 299 KVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH 365 (394)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 365 (394)
+......... .....+.++.++...+-..+...+|....+...
T Consensus 251 ~~~~~~~~~~------------------------~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~ 293 (322)
T KOG1164|consen 251 KDPRKLLTDR------------------------FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAEL 293 (322)
T ss_pred HHhhhhcccc------------------------ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHH
Confidence 3211000000 112345677778777777888899987766543
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.3e-27 Score=203.18 Aligned_cols=200 Identities=24% Similarity=0.308 Sum_probs=168.8
Q ss_pred eEEEeeEEeecCceEEEEEEECCCCcEEEEEEe--ccchhhhHHHHHHHHHcC-CCCeeeeceEEEecCCCceeEEEEEE
Q 016184 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV--LQDKRYKNRELQIMQMLD-HPNIVALKHCFFSTTDKEELYLNLVL 159 (394)
Q Consensus 83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~--~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~~lv~ 159 (394)
.|.++++||+|+||.++.|++.-+++.||||.- +.+...+..|.+.++.|. .++|..++-+. .++.|-.||+
T Consensus 29 hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~APQLrdEYr~YKlL~g~~GIP~vYYFG-----qeG~~NiLVi 103 (449)
T KOG1165|consen 29 HYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSEAPQLRDEYRTYKLLGGTEGIPQVYYFG-----QEGKYNILVI 103 (449)
T ss_pred cceeccccccCcceeeecccccccCceEEEEeccccCCcchHHHHHHHHHHHcCCCCCCceeeec-----cccchhhhhh
Confidence 399999999999999999999999999999964 334456678999999884 57888765433 6667777999
Q ss_pred ecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCC----CCcEEEEeecCcccc
Q 016184 160 EYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPH----THQLKLCDFGSAKVL 235 (394)
Q Consensus 160 e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~----~~~vkl~Dfg~a~~~ 235 (394)
|+++.+|.+++.- .+..++.+.+..++.|++.-++++|+ +.+|.|||||+|+||... .+.+.|+|||+|+..
T Consensus 104 dLLGPSLEDLFD~---CgR~FSvKTV~miA~Qmi~rie~vH~-k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Y 179 (449)
T KOG1165|consen 104 DLLGPSLEDLFDL---CGRRFSVKTVAMIAKQMITRIEYVHE-KDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEY 179 (449)
T ss_pred hhhCcCHHHHHHH---hcCcccHHhHHHHHHHHHHHHHHHHh-cceeecccCccceeecCCCCCCCceEEEEeccchhhh
Confidence 9999999887664 45789999999999999999999999 899999999999999753 346999999999877
Q ss_pred ccCCC--------cccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHH
Q 016184 236 VKGEP--------NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVD 292 (394)
Q Consensus 236 ~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~ 292 (394)
.+... ..+..||..||+-....+.. .+++.|+-|||-++++.+-|..||.+.....
T Consensus 180 rDp~TkqHIPYrE~KSLsGTARYMSINTHlGrE-QSRRDDLEaLGHvFmYFLRGsLPWQGLKA~t 243 (449)
T KOG1165|consen 180 RDPKTKQHIPYREHKSLSGTARYMSINTHLGRE-QSRRDDLEALGHVFMYFLRGSLPWQGLKADT 243 (449)
T ss_pred cCccccccCccccccccccceeeeEeeccccch-hhhhhhHHHhhhhhhhhccCCCccccccCcc
Confidence 54432 34567899999998887655 7999999999999999999999999875543
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.3e-28 Score=238.33 Aligned_cols=260 Identities=23% Similarity=0.331 Sum_probs=190.9
Q ss_pred EEeeEEeecCceEEEEEEECCCCcEEEEEEecc----chhh------hHHHHHHHHHcCCCCeeeeceEEEecCCCceeE
Q 016184 85 IAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQ----DKRY------KNRELQIMQMLDHPNIVALKHCFFSTTDKEELY 154 (394)
Q Consensus 85 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~----~~~~------~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 154 (394)
....++|.|++|.|+.+......+.++.|.+.. .... ...|+.+-..+.|+|++..+..+.....
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~----- 395 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDG----- 395 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhccc-----
Confidence 356789999999999998877777777775431 1111 2246666677899999877665533222
Q ss_pred EEEEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCccc
Q 016184 155 LNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV 234 (394)
Q Consensus 155 ~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~ 234 (394)
..-.||||+.+|..++.. ...+....+..++.|++.|++|||. .||.|||+|++|++++.++ .+||+|||.+..
T Consensus 396 ~~~~mE~~~~Dlf~~~~~----~~~~~~~e~~c~fKqL~~Gv~y~h~-~GiahrdlK~enll~~~~g-~lki~Dfg~~~v 469 (601)
T KOG0590|consen 396 ILQSMEYCPYDLFSLVMS----NGKLTPLEADCFFKQLLRGVKYLHS-MGLAHRDLKLENLLVTENG-ILKIIDFGAASV 469 (601)
T ss_pred chhhhhcccHHHHHHHhc----ccccchhhhhHHHHHHHHHHHHHHh-cCceeccCccccEEEecCC-ceEEeecCccee
Confidence 222399999866555543 2478888999999999999999999 8999999999999999988 799999999876
Q ss_pred cccCCC-----cccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHH-HHHHHhCCCChhh
Q 016184 235 LVKGEP-----NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLV-EIIKVLGTPTREE 308 (394)
Q Consensus 235 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~-~i~~~~~~~~~~~ 308 (394)
...... .....|+..|+|||++.+........||||.|++++.|++|+.||.-....+... ....
T Consensus 470 f~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~--------- 540 (601)
T KOG0590|consen 470 FRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNY--------- 540 (601)
T ss_pred eccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhcc---------
Confidence 543322 3456789999999999776656678999999999999999999997654332211 0000
Q ss_pred hhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCC
Q 016184 309 IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNT 376 (394)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~ 376 (394)
..+..... . ...+...++...+.+|.+||++||.+|.|+++|++.+||+.+..=.+
T Consensus 541 -------~~~~~~~~---~--~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i~~c~v 596 (601)
T KOG0590|consen 541 -------SDQRNIFE---G--PNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSIECCHV 596 (601)
T ss_pred -------cccccccc---C--hHHHHHhchhhHHHHHHHHccCChhheecHHHHhhChHhhhcceEEe
Confidence 00111110 0 11123567889999999999999999999999999999999865443
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.7e-25 Score=197.57 Aligned_cols=237 Identities=22% Similarity=0.290 Sum_probs=146.4
Q ss_pred eEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccchhhh-------HHHHHHHHHcC----------CCCeeeeceEEE
Q 016184 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------NRELQIMQMLD----------HPNIVALKHCFF 145 (394)
Q Consensus 83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-------~~E~~~l~~l~----------h~~iv~~~~~~~ 145 (394)
.+...+.||.|+++.||.+++..||+.+|+|++....... ++|.-....+. |-.++.-++...
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 4778899999999999999999999999999875332221 22222222211 112222222221
Q ss_pred --------ecC-CCcee---EEEEEEecccccHHHHHHHhhhhcCC---CCHHHHHHHHHHHHHHHHHHHhCCCceeccC
Q 016184 146 --------STT-DKEEL---YLNLVLEYVPETVNRIARNYSRIHQR---MPLIYVKLYTYQICRALAYIHNCIGICHRDI 210 (394)
Q Consensus 146 --------~~~-~~~~~---~~~lv~e~~~~~l~~~~~~~~~~~~~---l~~~~~~~~~~qi~~al~~LH~~~givH~Dl 210 (394)
... +.... ..+++|+-+.++|..++......... +.......+..|++..+++||. .|+||+||
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~-~GlVHgdi 171 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRAQGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHS-YGLVHGDI 171 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE--SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHH-TTEEEST-
T ss_pred EcCCCcceecCCCCccceeehhhhccchhhhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhh-cceEeccc
Confidence 111 11112 14678888888888876654443332 2233334455799999999999 89999999
Q ss_pred CCCceEEeCCCCcEEEEeecCccccccCCCcccccccccccccccccCC-------CCCCChhhHHHHHHHHHHHHhCCC
Q 016184 211 KPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGA-------TEYTTAIDIWSTGCVMAELLLGQP 283 (394)
Q Consensus 211 kp~Nil~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~-------~~~~~~~DiwslG~il~~lltg~~ 283 (394)
+|+|++++.+| .++|+||+........... ...+..|.+||..... ..++.+.|.|+||+++|.|+||+.
T Consensus 172 ~~~nfll~~~G-~v~Lg~F~~~~r~g~~~~~--~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~l 248 (288)
T PF14531_consen 172 KPENFLLDQDG-GVFLGDFSSLVRAGTRYRC--SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRL 248 (288)
T ss_dssp SGGGEEE-TTS--EEE--GGGEEETTEEEEG--GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-
T ss_pred ceeeEEEcCCC-CEEEcChHHHeecCceeec--cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccC
Confidence 99999999998 6999999987654322111 3345779999976321 237889999999999999999999
Q ss_pred CCCCCCcHHHHHHHHHHhCCCChhhhhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCC
Q 016184 284 LFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLR 356 (394)
Q Consensus 284 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 356 (394)
||.......... . .+..+ .++|+.+++||+.+|++||.+|
T Consensus 249 Pf~~~~~~~~~~-----------------------~--------~f~~C--~~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 249 PFGLSSPEADPE-----------------------W--------DFSRC--RDMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp STCCCGGGSTSG-----------------------G--------GGTTS--S---HHHHHHHHHHT-SSGGGS
T ss_pred CCCCCCcccccc-----------------------c--------cchhc--CCcCHHHHHHHHHHccCCcccC
Confidence 997543210000 0 11111 3689999999999999999988
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.5e-23 Score=191.47 Aligned_cols=263 Identities=33% Similarity=0.496 Sum_probs=196.0
Q ss_pred EEEeeEEeecCceEEEEEEECCCCcEEEEEEeccc-------hhhhHHHHHHHHHcCCC-CeeeeceEEEecCCCceeEE
Q 016184 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHP-NIVALKHCFFSTTDKEELYL 155 (394)
Q Consensus 84 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~-~iv~~~~~~~~~~~~~~~~~ 155 (394)
|.+...||.|+||.||++.+. ..+++|.+... ...+.+|+.+++.+.|+ +++.+.+.+. .....
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~-----~~~~~ 73 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQ-----DEGSL 73 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEe-----cCCEE
Confidence 788899999999999999997 77899987543 23455788899999988 7999988882 22226
Q ss_pred EEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCccc
Q 016184 156 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV 234 (394)
Q Consensus 156 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~ 234 (394)
+++++++.+ .+..++...... ..+.......++.|++.++.|+|+ .+++|||+||+||+++..+..++++|||.+..
T Consensus 74 ~~~~~~~~~~~l~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~~H~-~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~ 151 (384)
T COG0515 74 YLVMEYVDGGSLEDLLKKIGRK-GPLSESEALFILAQILSALEYLHS-KGIIHRDIKPENILLDRDGRVVKLIDFGLAKL 151 (384)
T ss_pred EEEEecCCCCcHHHHHHhcccc-cCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCHHHeeecCCCCeEEEeccCccee
Confidence 789999986 444333321110 278999999999999999999999 89999999999999998764599999999875
Q ss_pred cccCC-------CcccccccccccccccccCC--CCCCChhhHHHHHHHHHHHHhCCCCCCCCCc---HHHHHHHHHHhC
Q 016184 235 LVKGE-------PNVSYICSRYYRAPELIFGA--TEYTTAIDIWSTGCVMAELLLGQPLFPGESG---VDQLVEIIKVLG 302 (394)
Q Consensus 235 ~~~~~-------~~~~~~~t~~y~aPE~~~~~--~~~~~~~DiwslG~il~~lltg~~pf~~~~~---~~~~~~i~~~~~ 302 (394)
..... ......++..|++||.+.+. ..+....|+||+|++++++++|..||..... ............
T Consensus 152 ~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~ 231 (384)
T COG0515 152 LPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELP 231 (384)
T ss_pred cCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcC
Confidence 54332 23566789999999999663 4689999999999999999999999877664 333443333222
Q ss_pred CC-ChhhhhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCC
Q 016184 303 TP-TREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNT 376 (394)
Q Consensus 303 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~ 376 (394)
.+ ..... .. . ........+.+++..++..+|..|.+..+...++|.........
T Consensus 232 ~~~~~~~~------------~~----~----~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~~~~~~~ 286 (384)
T COG0515 232 TPSLASPL------------SP----S----NPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKLKES 286 (384)
T ss_pred Cccccccc------------Cc----c----ccchhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhhCcccccc
Confidence 21 00000 00 0 00112367899999999999999999999998877766544444
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.8e-24 Score=200.64 Aligned_cols=156 Identities=20% Similarity=0.280 Sum_probs=117.8
Q ss_pred eeEEEeeEEeecCceEEEEEEECC-CCcEEEEEEeccc---------hhhhHHHHHHHHHcCCCCeeeeceEEEecCCCc
Q 016184 82 VSYIAEHVVGTGSFGVVFQAKCRE-TGEIVAIKKVLQD---------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKE 151 (394)
Q Consensus 82 ~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~~---------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 151 (394)
.+|.+.+.||+|+||+||+|++.. +++.||||++... ...+.+|+++|+.++|+|++..+..+ .
T Consensus 18 ~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~---~--- 91 (365)
T PRK09188 18 ARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT---G--- 91 (365)
T ss_pred CCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc---C---
Confidence 359999999999999999999876 6788899986422 23457899999999999998532211 1
Q ss_pred eeEEEEEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccC-CCCceEEeCCCCcEEEEeec
Q 016184 152 ELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDI-KPQNLLVNPHTHQLKLCDFG 230 (394)
Q Consensus 152 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dl-kp~Nil~~~~~~~vkl~Dfg 230 (394)
..++||||++|...... .... ...++.|++.||.|||+ .||+|||| ||+|||++.++ .+||+|||
T Consensus 92 --~~~LVmE~~~G~~L~~~-------~~~~---~~~~~~~i~~aL~~lH~-~gIiHrDL~KP~NILv~~~~-~ikLiDFG 157 (365)
T PRK09188 92 --KDGLVRGWTEGVPLHLA-------RPHG---DPAWFRSAHRALRDLHR-AGITHNDLAKPQNWLMGPDG-EAAVIDFQ 157 (365)
T ss_pred --CcEEEEEccCCCCHHHh-------Cccc---hHHHHHHHHHHHHHHHH-CCCeeCCCCCcceEEEcCCC-CEEEEECc
Confidence 25799999987432211 1111 14567899999999999 89999999 99999998777 69999999
Q ss_pred CccccccCCCc---------cccccccccccccccc
Q 016184 231 SAKVLVKGEPN---------VSYICSRYYRAPELIF 257 (394)
Q Consensus 231 ~a~~~~~~~~~---------~~~~~t~~y~aPE~~~ 257 (394)
+|+........ ....+++.|+|||.+.
T Consensus 158 lA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~ 193 (365)
T PRK09188 158 LASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALT 193 (365)
T ss_pred cceecccCcchhhhhhhhhhhhhhccCccCCcccCC
Confidence 99866443221 2345677899999873
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.91 E-value=6e-25 Score=217.24 Aligned_cols=223 Identities=28% Similarity=0.481 Sum_probs=169.1
Q ss_pred eeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccchhhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEEEEEEec
Q 016184 82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEY 161 (394)
Q Consensus 82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~ 161 (394)
..|..++.|-.|+||.||.++|+.+.+.+|+| +.++.-..++ ++.....|.+|
T Consensus 83 ~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~lilRn---ilt~a~npfvv----------------------- 135 (1205)
T KOG0606|consen 83 SDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQNLILRN---ILTFAGNPFVV----------------------- 135 (1205)
T ss_pred cccceeEeeccCCCCceeeeeccccccchhhc-ccccchhhhc---cccccCCccee-----------------------
Confidence 46999999999999999999999999999995 4444333222 22222222222
Q ss_pred ccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCccccccCC--
Q 016184 162 VPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE-- 239 (394)
Q Consensus 162 ~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~~~-- 239 (394)
|+...+++. -+.++. +++.|++|||+ .||+|||+||+|.+|+.-| .+|+.|||+.+......
T Consensus 136 --gDc~tllk~----~g~lPv--------dmvla~Eylh~-ygivhrdlkpdnllIT~mG-hiKlTDfgLsk~GLms~at 199 (1205)
T KOG0606|consen 136 --GDCATLLKN----IGPLPV--------DMVLAVEYLHS-YGIVHRDLKPDNLLITSMG-HIKLTDFGLSKKGLMSLAT 199 (1205)
T ss_pred --chhhhhccc----CCCCcc--------hhhHHhHhhcc-CCeecCCCCCCcceeeecc-cccccchhhhhhhhhhccc
Confidence 222233332 134443 34789999999 9999999999999999988 59999999986432110
Q ss_pred --------------CcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCC
Q 016184 240 --------------PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPT 305 (394)
Q Consensus 240 --------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~ 305 (394)
.....+|||.|+|||++.... |+..+|+|++|+|+|+.+.|..||.+.+..+.+...+......+
T Consensus 200 nl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqg-ygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~wp 278 (1205)
T KOG0606|consen 200 NLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQG-YGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWP 278 (1205)
T ss_pred hhhhcchHHHHHHhhhccccCCccccChhhhhhhc-cCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhcccc
Confidence 112357899999999996554 99999999999999999999999999999998888777443322
Q ss_pred hhhhhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCC---CHHHHhcCCCCCCCCCC
Q 016184 306 REEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC---TALEACVHPFFDELRDP 374 (394)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp---t~~ell~hp~f~~~~~~ 374 (394)
+. ...++++++++|.++|+.+|..|. .+-++.+|+||+.+-..
T Consensus 279 E~--------------------------dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~LDw~ 324 (1205)
T KOG0606|consen 279 EE--------------------------DEALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLLDWK 324 (1205)
T ss_pred cc--------------------------CcCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceeecccc
Confidence 22 145789999999999999999997 56688999999998554
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.5e-24 Score=192.23 Aligned_cols=195 Identities=24% Similarity=0.352 Sum_probs=141.5
Q ss_pred CCCCeeeeceEEEec----------------------CCCceeEEEEEEecccccHHHHHHHhhhhcCCCCHHHHHHHHH
Q 016184 133 DHPNIVALKHCFFST----------------------TDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTY 190 (394)
Q Consensus 133 ~h~~iv~~~~~~~~~----------------------~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~ 190 (394)
+|||||.+...|... .-.+...+|+||.....+|.+++.. ...+......++.
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~tLr~yl~~-----~~~s~r~~~~~la 348 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQTLREYLWT-----RHRSYRTGRVILA 348 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchhhHHHHHhc-----CCCchHHHHHHHH
Confidence 699999998877321 1234456889999999888888775 5667777788889
Q ss_pred HHHHHHHHHHhCCCceeccCCCCceEEeCC--C-CcEEEEeecCccccccC-------CCcccccccccccccccccCCC
Q 016184 191 QICRALAYIHNCIGICHRDIKPQNLLVNPH--T-HQLKLCDFGSAKVLVKG-------EPNVSYICSRYYRAPELIFGAT 260 (394)
Q Consensus 191 qi~~al~~LH~~~givH~Dlkp~Nil~~~~--~-~~vkl~Dfg~a~~~~~~-------~~~~~~~~t~~y~aPE~~~~~~ 260 (394)
|+++|+.|||+ +||.|||+|.+|||+.-+ + ..+.|+|||++--.... ......-|.-.-||||+....+
T Consensus 349 QlLEav~hL~~-hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~P 427 (598)
T KOG4158|consen 349 QLLEAVTHLHK-HGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVP 427 (598)
T ss_pred HHHHHHHHHHH-ccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCC
Confidence 99999999999 899999999999998432 2 25889999997432211 1222344677789999984332
Q ss_pred C-----CCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCCCcccCCCCCCCCCcchhccc
Q 016184 261 E-----YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQK 335 (394)
Q Consensus 261 ~-----~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 335 (394)
. .-.++|.|+.|.+.||+++...||.+......-.. +|.+-.+| .+++
T Consensus 428 Gp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r------------------~Yqe~qLP---------alp~ 480 (598)
T KOG4158|consen 428 GPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTR------------------TYQESQLP---------ALPS 480 (598)
T ss_pred CCceeeccchhhhhhhhhhHHHHhccCCcccccchheechh------------------hhhhhhCC---------CCcc
Confidence 1 13489999999999999999999987322110000 01111122 2346
Q ss_pred cCChHHHHHHHHhcccCCCCCCCHH
Q 016184 336 RLPPEAVDLVCRFFQYSPNLRCTAL 360 (394)
Q Consensus 336 ~~~~~~~~li~~~L~~dP~~Rpt~~ 360 (394)
.+++.+++|+..+|+.||++|+++.
T Consensus 481 ~vpp~~rqlV~~lL~r~pskRvsp~ 505 (598)
T KOG4158|consen 481 RVPPVARQLVFDLLKRDPSKRVSPN 505 (598)
T ss_pred cCChHHHHHHHHHhcCCccccCCcc
Confidence 7899999999999999999999864
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.4e-25 Score=218.49 Aligned_cols=241 Identities=29% Similarity=0.414 Sum_probs=173.4
Q ss_pred eEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccch-----hhhH---HHHHHHHHcCCCCeeeeceEEEecCCCceeE
Q 016184 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKN---RELQIMQMLDHPNIVALKHCFFSTTDKEELY 154 (394)
Q Consensus 83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~---~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 154 (394)
.|...+.||.+.|=+|.+|++.+ |. |+||++.+.. +.+. +|++ ...+++||++.+..+. .....
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~e-G~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~-----~t~kA 95 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDRE-GL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVL-----VTDKA 95 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCC-ce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHH-----HhhHH
Confidence 47888999999999999999853 44 8999986543 1122 2444 6667999999876654 22333
Q ss_pred EEEEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCccc
Q 016184 155 LNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV 234 (394)
Q Consensus 155 ~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~ 234 (394)
.|||-+|+..+|++.+... .-+.+.+.+.|+.|++.||..+|+ .||+|||||.+||||+.= +.+.|+||..-+.
T Consensus 96 AylvRqyvkhnLyDRlSTR----PFL~~iEKkWiaFQLL~al~qcH~-~gVcHGDIKsENILiTSW-NW~~LtDFAsFKP 169 (1431)
T KOG1240|consen 96 AYLVRQYVKHNLYDRLSTR----PFLVLIEKKWIAFQLLKALSQCHK-LGVCHGDIKSENILITSW-NWLYLTDFASFKP 169 (1431)
T ss_pred HHHHHHHHhhhhhhhhccc----hHHHHHHHHHHHHHHHHHHHHHHH-cCccccccccceEEEeee-chhhhhcccccCC
Confidence 5678888888887776652 446777888999999999999999 999999999999999964 4799999998765
Q ss_pred cccCCCccc----cc----ccccccccccccCCC----------CCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHH
Q 016184 235 LVKGEPNVS----YI----CSRYYRAPELIFGAT----------EYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLV 295 (394)
Q Consensus 235 ~~~~~~~~~----~~----~t~~y~aPE~~~~~~----------~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~ 295 (394)
..-.+.+.. ++ .-.+|.|||.+.... ..+.+.||||+||++.||++ |++||. ..++-
T Consensus 170 tYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~----LSQL~ 245 (1431)
T KOG1240|consen 170 TYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFT----LSQLL 245 (1431)
T ss_pred ccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCccc----HHHHH
Confidence 543333221 11 235699999985421 14678999999999999987 788884 22222
Q ss_pred HHHHHhCCCChhhhhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 016184 296 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH 365 (394)
Q Consensus 296 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 365 (394)
.........+...+. .--+..++.||..|++.||++|.+|++.|+-
T Consensus 246 aYr~~~~~~~e~~Le------------------------~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 246 AYRSGNADDPEQLLE------------------------KIEDVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred hHhccCccCHHHHHH------------------------hCcCccHHHHHHHHHccCchhccCHHHHHHh
Confidence 222211111111111 1124579999999999999999999999975
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.3e-25 Score=208.39 Aligned_cols=239 Identities=30% Similarity=0.423 Sum_probs=185.4
Q ss_pred EEeecCceEEEEEEE---CCCCcEEEEEEeccc------hhhhHHHHHHHHHcC-CCCeeeeceEEEecCCCceeEEEEE
Q 016184 89 VVGTGSFGVVFQAKC---RETGEIVAIKKVLQD------KRYKNRELQIMQMLD-HPNIVALKHCFFSTTDKEELYLNLV 158 (394)
Q Consensus 89 ~lg~G~~g~V~~~~~---~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~~lv 158 (394)
++|.|+||.|++++- ...|..+|+|+..+. ......|..++...+ ||.++++..++... ...+++
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~-----~kl~l~ 75 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTD-----GKLYLI 75 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccc-----cchhHh
Confidence 379999999998754 244677888876432 123345888888886 99999998877333 336788
Q ss_pred EecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCccccccC
Q 016184 159 LEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG 238 (394)
Q Consensus 159 ~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~~ 238 (394)
+++..++. +.........+.+...+.+...++.|++++|+ .||+|||+|++||+++.+| .+++.|||+++.....
T Consensus 76 ld~~rgg~---lft~l~~~~~f~~~~~~~~~aelaLald~lh~-l~iiyrd~k~enilld~~G-hi~~tdfglske~v~~ 150 (612)
T KOG0603|consen 76 LDFLRGGD---LFTRLSKEVMFDELDVAFYLAELALALDHLHK-LGIAYRDYKLENVLLLLEG-HIKLTDFGLSKEAVKE 150 (612)
T ss_pred hhhcccch---hhhccccCCchHHHHHHHHHHHHHHHHhhcch-hHHHHhcccccceeecccC-ccccCCchhhhHhHhh
Confidence 88887632 12222234567778888889999999999999 9999999999999999999 4999999999876555
Q ss_pred CCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCCCcc
Q 016184 239 EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 318 (394)
Q Consensus 239 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 318 (394)
+.. +||..|||||++. ....++|.||+|+++++|+||..||.+ +....|...-
T Consensus 151 ~~~---cgt~eymApEI~~---gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~~----------------- 203 (612)
T KOG0603|consen 151 KIA---CGTYEYRAPEIIN---GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRILKAE----------------- 203 (612)
T ss_pred hhc---ccchhhhhhHhhh---ccCCcccchhhhhhHHHHhhCCCCCch----HHHHHHhhhc-----------------
Confidence 443 8899999999985 367889999999999999999999987 3333333310
Q ss_pred cCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCH-----HHHhcCCCCCCCCCCCC
Q 016184 319 FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTA-----LEACVHPFFDELRDPNT 376 (394)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~-----~ell~hp~f~~~~~~~~ 376 (394)
. .++..++..+++++..++..+|.+|..+ .++++|+||+.+.....
T Consensus 204 ~------------~~p~~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik~h~f~~~i~~~~l 254 (612)
T KOG0603|consen 204 L------------EMPRELSAEARSLFRQLFKRNPENRLGAGPDGVDEIKQHEFFQSIDWNEL 254 (612)
T ss_pred c------------CCchhhhHHHHHHHHHHHhhCHHHHhccCcchhHHHhccchheeeeHhhH
Confidence 0 0224578899999999999999999965 69999999999876643
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.89 E-value=6.2e-23 Score=175.23 Aligned_cols=135 Identities=18% Similarity=0.218 Sum_probs=102.2
Q ss_pred eeEEeecCceEEEEEEECCCCcEEEEEEeccchh------------------------------hhHHHHHHHHHcCCCC
Q 016184 87 EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR------------------------------YKNRELQIMQMLDHPN 136 (394)
Q Consensus 87 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~------------------------------~~~~E~~~l~~l~h~~ 136 (394)
...||+|+||.||+|.+. +|+.||||++..... ...+|++++..+.+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG 80 (190)
T ss_pred CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence 467999999999999996 899999999864311 1124889999998877
Q ss_pred eeeeceEEEecCCCceeEEEEEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHH-HhCCCceeccCCCCce
Q 016184 137 IVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI-HNCIGICHRDIKPQNL 215 (394)
Q Consensus 137 iv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~L-H~~~givH~Dlkp~Ni 215 (394)
+....... ... .++||||++++...... .....+++..+..++.|++.+|.+| |+ .||+||||||+||
T Consensus 81 v~~p~~~~--~~~-----~~iVmE~i~g~~l~~~~---~~~~~~~~~~~~~i~~qi~~~L~~l~H~-~giiHrDlkP~NI 149 (190)
T cd05147 81 IPCPEPIL--LKS-----HVLVMEFIGDDGWAAPR---LKDAPLSESKARELYLQVIQIMRILYQD-CRLVHADLSEYNL 149 (190)
T ss_pred CCCCcEEE--ecC-----CEEEEEEeCCCCCcchh---hhcCCCCHHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHHE
Confidence 64322211 111 25999999974321111 1135788999999999999999999 68 8999999999999
Q ss_pred EEeCCCCcEEEEeecCcccc
Q 016184 216 LVNPHTHQLKLCDFGSAKVL 235 (394)
Q Consensus 216 l~~~~~~~vkl~Dfg~a~~~ 235 (394)
|++. + .++|+|||+|...
T Consensus 150 li~~-~-~v~LiDFG~a~~~ 167 (190)
T cd05147 150 LYHD-G-KLYIIDVSQSVEH 167 (190)
T ss_pred EEEC-C-cEEEEEccccccC
Confidence 9994 4 6999999999654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.8e-22 Score=174.33 Aligned_cols=169 Identities=12% Similarity=0.148 Sum_probs=123.6
Q ss_pred eeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccch----hh---------hHHHHHHHHHcCCCCeeeeceEEEecC
Q 016184 82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK----RY---------KNRELQIMQMLDHPNIVALKHCFFSTT 148 (394)
Q Consensus 82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~---------~~~E~~~l~~l~h~~iv~~~~~~~~~~ 148 (394)
++|.+.++||.|+||.||++.. ++..+|||++.... .. .++|+..+.++.|++|..+.+++....
T Consensus 31 ~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~ 108 (232)
T PRK10359 31 YNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAE 108 (232)
T ss_pred CceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeecc
Confidence 4699999999999999999765 46689999985321 11 457888999999999999988765432
Q ss_pred CC---ceeEEEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcE
Q 016184 149 DK---EELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQL 224 (394)
Q Consensus 149 ~~---~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~v 224 (394)
.. .....+++|||++| ++.++. .+++. ...+++.+|..||+ .|++|||+||.||+++.++ +
T Consensus 109 ~~~~~~~~~~~lvmEyi~G~tL~~~~--------~~~~~----~~~~i~~~l~~lH~-~gi~H~Dikp~Nili~~~g--i 173 (232)
T PRK10359 109 RKTLRYAHTYIMLIEYIEGVELNDMP--------EISED----VKAKIKASIESLHQ-HGMVSGDPHKGNFIVSKNG--L 173 (232)
T ss_pred cccccccCCeEEEEEEECCccHHHhh--------hccHH----HHHHHHHHHHHHHH-cCCccCCCChHHEEEeCCC--E
Confidence 11 12246789999997 554431 12222 35599999999999 8999999999999999776 9
Q ss_pred EEEeecCccccccCCCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHH
Q 016184 225 KLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELL 279 (394)
Q Consensus 225 kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll 279 (394)
+|+|||........... . ..+... .++.++|+|+||+++..+.
T Consensus 174 ~liDfg~~~~~~e~~a~-d----------~~vler-~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 174 RIIDLSGKRCTAQRKAK-D----------RIDLER-HYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred EEEECCCcccccchhhH-H----------HHHHHh-HhcccccccceeEeehHHH
Confidence 99999988654222111 0 022223 3668999999999987654
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.6e-21 Score=167.19 Aligned_cols=134 Identities=16% Similarity=0.230 Sum_probs=104.2
Q ss_pred eeEEeecCceEEEEEEECCCCcEEEEEEeccchh------------------------------hhHHHHHHHHHcCCCC
Q 016184 87 EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR------------------------------YKNRELQIMQMLDHPN 136 (394)
Q Consensus 87 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~------------------------------~~~~E~~~l~~l~h~~ 136 (394)
.+.||+|++|.||+|.+. +|+.||||++..... ...+|.+.+.++.|++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05145 2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG 80 (190)
T ss_pred CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence 568999999999999987 899999998764311 1246888899999988
Q ss_pred eeeeceEEEecCCCceeEEEEEEeccccc-HH-HHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCc
Q 016184 137 IVALKHCFFSTTDKEELYLNLVLEYVPET-VN-RIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQN 214 (394)
Q Consensus 137 iv~~~~~~~~~~~~~~~~~~lv~e~~~~~-l~-~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~N 214 (394)
+.....+... . .++||||+++. +. ..+. ...++...+..++.|++.+|.+||...||+||||||+|
T Consensus 81 i~~p~~~~~~-----~--~~lVmE~~~g~~~~~~~l~-----~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~N 148 (190)
T cd05145 81 VPVPEPILLK-----K--NVLVMEFIGDDGSPAPRLK-----DVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYN 148 (190)
T ss_pred CCCceEEEec-----C--CEEEEEEecCCCchhhhhh-----hccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhh
Confidence 7543332211 1 36899999974 22 1122 25678889999999999999999974599999999999
Q ss_pred eEEeCCCCcEEEEeecCcccc
Q 016184 215 LLVNPHTHQLKLCDFGSAKVL 235 (394)
Q Consensus 215 il~~~~~~~vkl~Dfg~a~~~ 235 (394)
||++ ++ .++|+|||++...
T Consensus 149 Ill~-~~-~~~liDFG~a~~~ 167 (190)
T cd05145 149 ILYH-DG-KPYIIDVSQAVEL 167 (190)
T ss_pred EEEE-CC-CEEEEEcccceec
Confidence 9999 55 6999999999765
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.1e-21 Score=164.22 Aligned_cols=181 Identities=17% Similarity=0.123 Sum_probs=130.6
Q ss_pred EEEeeEEeecCceEEEEEEECCCCcEEEEEEeccchh--------hhHHHHHHHHHcC-CCCeeeeceEEEecCCCceeE
Q 016184 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR--------YKNRELQIMQMLD-HPNIVALKHCFFSTTDKEELY 154 (394)
Q Consensus 84 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--------~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~ 154 (394)
..+...|++|+||+||++.. .+..++.+.+..... ...+|+++|++|. |+++++++++. .
T Consensus 4 ~~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~~-----~---- 72 (218)
T PRK12274 4 PAVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHWD-----G---- 72 (218)
T ss_pred cccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEEc-----C----
Confidence 34567899999999998775 467788776644322 3568999999995 47788887642 1
Q ss_pred EEEEEeccccc-HHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccC-CCCceEEeCCCCcEEEEeecCc
Q 016184 155 LNLVLEYVPET-VNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDI-KPQNLLVNPHTHQLKLCDFGSA 232 (394)
Q Consensus 155 ~~lv~e~~~~~-l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dl-kp~Nil~~~~~~~vkl~Dfg~a 232 (394)
.+++|+|+.|. |.... +.. ...++.|++.+|+++|+ .||+|||| ||+|||++.++ .++|+|||+|
T Consensus 73 ~~lvmeyI~G~~L~~~~----------~~~-~~~~~~qi~~~L~~lH~-~GIvHrDL~kp~NILv~~~g-~i~LIDFG~A 139 (218)
T PRK12274 73 RHLDRSYLAGAAMYQRP----------PRG-DLAYFRAARRLLQQLHR-CGVAHNDLAKEANWLVQEDG-SPAVIDFQLA 139 (218)
T ss_pred EEEEEeeecCccHHhhh----------hhh-hHHHHHHHHHHHHHHHH-CcCccCCCCCcceEEEcCCC-CEEEEECCCc
Confidence 57899999874 32211 111 13467899999999999 89999999 79999999887 6999999999
Q ss_pred cccccCCCcc--------------cccccccccccccccCCCCCC-ChhhHHHHHHHHHHHHhCCCCCCCC
Q 016184 233 KVLVKGEPNV--------------SYICSRYYRAPELIFGATEYT-TAIDIWSTGCVMAELLLGQPLFPGE 288 (394)
Q Consensus 233 ~~~~~~~~~~--------------~~~~t~~y~aPE~~~~~~~~~-~~~DiwslG~il~~lltg~~pf~~~ 288 (394)
.......... -...++.|+.|+.-.--...+ ...+.++.|+-+|.++|++.++.+.
T Consensus 140 ~~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~ 210 (218)
T PRK12274 140 VRGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWED 210 (218)
T ss_pred eecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcccc
Confidence 8554333210 012377788887653222234 4678889999999999999887554
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=4.5e-22 Score=169.58 Aligned_cols=237 Identities=15% Similarity=0.206 Sum_probs=177.9
Q ss_pred EEEeeEEeecCceEEEEEEECCCCcEEEEEEecc------chhhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEEEE
Q 016184 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQ------DKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL 157 (394)
Q Consensus 84 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~------~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 157 (394)
..+..+|.+...|..|+|++. |..+++|++.- -.+.++.|.-.|+.+.||||+.+++.+ .......+
T Consensus 192 lnl~tkl~e~hsgelwrgrwq--gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgac-----nsppnlv~ 264 (448)
T KOG0195|consen 192 LNLITKLAESHSGELWRGRWQ--GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGAC-----NSPPNLVI 264 (448)
T ss_pred hhhhhhhccCCCccccccccc--CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhc-----cCCCCceE
Confidence 455677899999999999996 45566776532 235566788889999999999999998 44455789
Q ss_pred EEeccc-ccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceec-cCCCCceEEeCCCCcEEEE--eecCcc
Q 016184 158 VLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHR-DIKPQNLLVNPHTHQLKLC--DFGSAK 233 (394)
Q Consensus 158 v~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~-Dlkp~Nil~~~~~~~vkl~--Dfg~a~ 233 (394)
+..||+ ++|+..+.... ..-.+-.++.+++.++++|++|||+-..++-| -|+...++||++- +.+|+ |--++.
T Consensus 265 isq~mp~gslynvlhe~t--~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedl-tarismad~kfsf 341 (448)
T KOG0195|consen 265 ISQYMPFGSLYNVLHEQT--SVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDL-TARISMADTKFSF 341 (448)
T ss_pred eeeeccchHHHHHHhcCc--cEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchh-hhheecccceeee
Confidence 999999 68888777533 24466678889999999999999984355555 6888999999876 45543 322221
Q ss_pred ccccCCCcccccccccccccccccCCCC--CCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhc
Q 016184 234 VLVKGEPNVSYICSRYYRAPELIFGATE--YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 311 (394)
Q Consensus 234 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~--~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 311 (394)
........|.||+||.+...+. .-+++|+|||++++|||.|...||....+++.-.++.-
T Consensus 342 ------qe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkial------------ 403 (448)
T KOG0195|consen 342 ------QEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIAL------------ 403 (448)
T ss_pred ------eccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhh------------
Confidence 1123344788999999965433 24579999999999999999999998887765544422
Q ss_pred cCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHh
Q 016184 312 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEAC 363 (394)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell 363 (394)
+.++..+++.++..+..|+.-|+..||.+||..+.++
T Consensus 404 ---------------eglrv~ippgis~hm~klm~icmnedpgkrpkfdmiv 440 (448)
T KOG0195|consen 404 ---------------EGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIV 440 (448)
T ss_pred ---------------ccccccCCCCccHHHHHHHHHHhcCCCCcCCCcceeh
Confidence 1123335678899999999999999999999887653
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.1e-19 Score=156.54 Aligned_cols=134 Identities=20% Similarity=0.237 Sum_probs=101.0
Q ss_pred eeEEeecCceEEEEEEECCCCcEEEEEEeccc----hhhhHHHHHHHHHc-----CCCCeeeeceEEEecCCCceeEEEE
Q 016184 87 EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD----KRYKNRELQIMQML-----DHPNIVALKHCFFSTTDKEELYLNL 157 (394)
Q Consensus 87 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~E~~~l~~l-----~h~~iv~~~~~~~~~~~~~~~~~~l 157 (394)
.+.||+|+||.||. +..++.. +||++... .....+|+.+++.+ .||||+++++++.+.. ..+..+.+
T Consensus 7 ~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~-g~g~v~~~ 82 (210)
T PRK10345 7 QSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDC-GTGYVYDV 82 (210)
T ss_pred cceecCCCceEEEE--CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCC-CCeEEEEE
Confidence 46799999999995 7666665 69987643 34567899999999 6799999999885432 22333457
Q ss_pred EEeccc---ccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHH-HHHHhCCCceeccCCCCceEEeCCC---CcEEEEeec
Q 016184 158 VLEYVP---ETVNRIARNYSRIHQRMPLIYVKLYTYQICRAL-AYIHNCIGICHRDIKPQNLLVNPHT---HQLKLCDFG 230 (394)
Q Consensus 158 v~e~~~---~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al-~~LH~~~givH~Dlkp~Nil~~~~~---~~vkl~Dfg 230 (394)
|+||.+ ++|.+++.. ..+++. ..++.|++.++ +|||+ ++|+||||||+|||++..+ ..++|+||+
T Consensus 83 I~e~~G~~~~tL~~~l~~-----~~~~e~--~~~~~~~L~~l~~yLh~-~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~ 154 (210)
T PRK10345 83 IADFDGKPSITLTEFAEQ-----CRYEED--VAQLRQLLKKLKRYLLD-NRIVTMELKPQNILCQRISESEVIPVVCDNI 154 (210)
T ss_pred EecCCCCcchhHHHHHHc-----ccccHh--HHHHHHHHHHHHHHHHH-CCEeecCCCHHHEEEeccCCCCCcEEEEECC
Confidence 899955 588887754 335555 35577888777 99999 8999999999999997432 269999955
Q ss_pred Cc
Q 016184 231 SA 232 (394)
Q Consensus 231 ~a 232 (394)
.+
T Consensus 155 G~ 156 (210)
T PRK10345 155 GE 156 (210)
T ss_pred CC
Confidence 44
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.2e-19 Score=182.97 Aligned_cols=191 Identities=26% Similarity=0.411 Sum_probs=144.4
Q ss_pred cceeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccchhh-hHHHHHHHHHcC---CCCeeeeceEEEecCCCceeEE
Q 016184 80 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRY-KNRELQIMQMLD---HPNIVALKHCFFSTTDKEELYL 155 (394)
Q Consensus 80 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~E~~~l~~l~---h~~iv~~~~~~~~~~~~~~~~~ 155 (394)
....|.|.+.||+|+||+||+|.+.. |+.||||+-+..... +---.+++.+|+ -+.|+.+..++...+. .
T Consensus 696 ~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WEfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~-----S 769 (974)
T KOG1166|consen 696 GGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWEFYICLQVMERLKPQMLPSIMHISSAHVFQNA-----S 769 (974)
T ss_pred cceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCceeeeehHHHHHhhchhhhcchHHHHHHHccCCc-----c
Confidence 34579999999999999999999976 999999975433211 101123344444 2334444444432222 5
Q ss_pred EEEEeccc-ccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeC------CCCcEEEEe
Q 016184 156 NLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNP------HTHQLKLCD 228 (394)
Q Consensus 156 ~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~------~~~~vkl~D 228 (394)
++|+||.+ |+|.+++. ..+.+++..+..+..|++..++.||. .+|||+||||+|+||.. +...++|+|
T Consensus 770 ~lv~ey~~~Gtlld~~N----~~~~m~e~lv~~~~~qml~ive~lH~-~~IIHgDiKPDNfll~~~~~~~~~~~~l~lID 844 (974)
T KOG1166|consen 770 VLVSEYSPYGTLLDLIN----TNKVMDEYLVMFFSCQMLRIVEHLHA-MGIIHGDIKPDNFLLRREICADSDSKGLYLID 844 (974)
T ss_pred eeeeeccccccHHHhhc----cCCCCCchhhhHHHHHHHHHHHHHHh-cceecccCCcceeEeecccCCCCcccceEEEe
Confidence 68999998 67877665 46889999999999999999999999 89999999999999842 222599999
Q ss_pred ecCccccc---cCCCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCC
Q 016184 229 FGSAKVLV---KGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQ 282 (394)
Q Consensus 229 fg~a~~~~---~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~ 282 (394)
||.+.-+. ++........|-.+-.+|...|.. ++...|.|.|+.+++-||.|+
T Consensus 845 fG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grp-WtYq~DyfGlAa~~h~mLFG~ 900 (974)
T KOG1166|consen 845 FGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRP-WTYQIDYFGLAATVHVMLFGK 900 (974)
T ss_pred cccceeeeEcCCCcEEeeeeccccchhHHHhcCCC-CchhhhhHHHHHHHHHHHHHH
Confidence 99985542 333344566788899999986655 999999999999999999997
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.2e-19 Score=160.28 Aligned_cols=138 Identities=16% Similarity=0.140 Sum_probs=103.5
Q ss_pred eEEEeeEEeecCceEEEEEE-ECCCCcEEEEEEeccch----------------------------hhhHHHHHHHHHcC
Q 016184 83 SYIAEHVVGTGSFGVVFQAK-CRETGEIVAIKKVLQDK----------------------------RYKNRELQIMQMLD 133 (394)
Q Consensus 83 ~y~~~~~lg~G~~g~V~~~~-~~~~~~~vaiK~~~~~~----------------------------~~~~~E~~~l~~l~ 133 (394)
-|.+.+.||+|++|.||+|. +..+|+.||||++.... ....+|+.++.++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 38899999999999999999 66789999999876321 11346899999997
Q ss_pred CCCeeeeceEEEecCCCceeEEEEEEeccccc-HHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCC-ceeccCC
Q 016184 134 HPNIVALKHCFFSTTDKEELYLNLVLEYVPET-VNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG-ICHRDIK 211 (394)
Q Consensus 134 h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~g-ivH~Dlk 211 (394)
+.. +.+...+.. . . .++||||+++. +.... .....+....+..++.|++.+|.+||. .| |+|||||
T Consensus 109 ~~~-i~~p~~~~~-~-~----~~lV~E~~~g~~L~~~~----~~~~~~~~~~~~~i~~qi~~~l~~LH~-~g~iiH~Dik 176 (237)
T smart00090 109 EAG-VPVPKPIAW-R-R----NVLVMEFIGGDGLPAPR----LKDVEPEEEEEFELYDDILEEMRKLYK-EGELVHGDLS 176 (237)
T ss_pred hcC-CCCCeeeEe-c-C----ceEEEEEecCCcccccc----cccCCcchHHHHHHHHHHHHHHHHHHh-cCCEEeCCCC
Confidence 533 222222211 1 1 36999999983 32211 112345566678899999999999999 89 9999999
Q ss_pred CCceEEeCCCCcEEEEeecCccc
Q 016184 212 PQNLLVNPHTHQLKLCDFGSAKV 234 (394)
Q Consensus 212 p~Nil~~~~~~~vkl~Dfg~a~~ 234 (394)
|+||+++ ++ .++|+|||.+..
T Consensus 177 p~NIli~-~~-~i~LiDFg~a~~ 197 (237)
T smart00090 177 EYNILVH-DG-KVVIIDVSQSVE 197 (237)
T ss_pred hhhEEEE-CC-CEEEEEChhhhc
Confidence 9999999 55 799999999864
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.81 E-value=4.4e-20 Score=171.47 Aligned_cols=180 Identities=29% Similarity=0.450 Sum_probs=133.6
Q ss_pred eeEEEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeec
Q 016184 152 ELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFG 230 (394)
Q Consensus 152 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg 230 (394)
..|++|.|++|.. +|.+++.. .+.....+....+.++.|++.|++| +|.+|+|+||.||++..+. .+||.|||
T Consensus 328 ~~~lyI~Mn~c~~~tledWl~r-r~~~e~~s~s~~~~~~~q~~~~~~y----k~~ihrdlkp~nif~~~d~-q~kIgDFg 401 (516)
T KOG1033|consen 328 KVYLYIQMNLCEKETLEDWLRR-RRTGEERSLSLMLDIFKQIAPAVEY----KGLIHRDLKPSNIFFSDDD-QLKIGDFG 401 (516)
T ss_pred ccchhhhhhhhhhhhHHHHhhC-CCcccccchhHHHHHHHhhccchhh----ccchhhhccccccccccch-hhhhhhhh
Confidence 4468899999985 55555543 4445677888899999999999999 4999999999999998777 79999999
Q ss_pred CccccccCC-------CcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhC-CCCCCCCCcHHHHHHHHHHhC
Q 016184 231 SAKVLVKGE-------PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLG-QPLFPGESGVDQLVEIIKVLG 302 (394)
Q Consensus 231 ~a~~~~~~~-------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg-~~pf~~~~~~~~~~~i~~~~~ 302 (394)
+........ ......||..||+||++.+.. |+.++||||||++++|+++- ...|.. ......++..
T Consensus 402 l~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~-y~~kvdIyaLGlil~EL~~~f~T~~er----~~t~~d~r~g- 475 (516)
T KOG1033|consen 402 LVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQ-YSEKVDIYALGLILAELLIQFSTQFER----IATLTDIRDG- 475 (516)
T ss_pred heeecccCCcccchhhhhhhcccccccCCHHHHhhhh-hhhhcchhhHHHHHHHHHHHhccHHHH----HHhhhhhhcC-
Confidence 998776555 345678899999999997665 99999999999999999972 222211 1111111111
Q ss_pred CCChhhhhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCC
Q 016184 303 TPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFD 369 (394)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~ 369 (394)
..++. +..+ .+.-..|+.+||...|.+||++.+.-.|+|.+
T Consensus 476 ~ip~~-------------------------~~~d-~p~e~~ll~~lls~~p~~RP~~~~~~~~~~~~ 516 (516)
T KOG1033|consen 476 IIPPE-------------------------FLQD-YPEEYTLLQQLLSPSPEERPSAIEVALHEFLQ 516 (516)
T ss_pred CCChH-------------------------Hhhc-CcHHHHHHHHhcCCCcccCchHHHHhhhhhcC
Confidence 11111 1111 23456899999999999999988888888864
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.74 E-value=2.6e-17 Score=143.62 Aligned_cols=129 Identities=19% Similarity=0.332 Sum_probs=99.9
Q ss_pred eEEeecCceEEEEEEECCCCcEEEEEEeccch------------hhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEE
Q 016184 88 HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL 155 (394)
Q Consensus 88 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 155 (394)
+.||+|++|.||+|++ .|..|++|+..... ....+|++++..+.|+++.....++.... ..
T Consensus 2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~-----~~ 74 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPE-----NF 74 (211)
T ss_pred cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCC-----CC
Confidence 5799999999999987 57789999754211 22446889999999988776555543222 25
Q ss_pred EEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCccc
Q 016184 156 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV 234 (394)
Q Consensus 156 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~ 234 (394)
+++|||++| ++.+++... .. ....++.+++.+|.+||+ .|++|+|++|.|||++ ++ .++|+|||.+..
T Consensus 75 ~lv~e~~~G~~L~~~~~~~-------~~-~~~~i~~~i~~~l~~lH~-~~i~H~Dl~p~Nil~~-~~-~~~liDf~~a~~ 143 (211)
T PRK14879 75 IIVMEYIEGEPLKDLINSN-------GM-EELELSREIGRLVGKLHS-AGIIHGDLTTSNMILS-GG-KIYLIDFGLAEF 143 (211)
T ss_pred EEEEEEeCCcCHHHHHHhc-------cH-HHHHHHHHHHHHHHHHHh-CCcccCCCCcccEEEE-CC-CEEEEECCcccC
Confidence 689999986 666555421 11 677889999999999999 8999999999999999 55 699999999865
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.4e-17 Score=143.76 Aligned_cols=130 Identities=18% Similarity=0.182 Sum_probs=98.2
Q ss_pred EEEeeEEeecCceEEEEEEECCCCcEEEEEEeccch--------------------------hhhHHHHHHHHHcCCCCe
Q 016184 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK--------------------------RYKNRELQIMQMLDHPNI 137 (394)
Q Consensus 84 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--------------------------~~~~~E~~~l~~l~h~~i 137 (394)
|.+.+.||.|+||.||+|... +|+.||||++.... ....+|..++..+.|.++
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 95 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF 95 (198)
T ss_pred hhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence 888899999999999999874 79999999864321 113467888888877743
Q ss_pred --eeeceEEEecCCCceeEEEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCc
Q 016184 138 --VALKHCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQN 214 (394)
Q Consensus 138 --v~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~N 214 (394)
+..++. ...+++|||+++ ++..+.. ......++.+++.++.++|. .||+|+||||+|
T Consensus 96 ~v~~~~~~---------~~~~lv~e~~~g~~L~~~~~----------~~~~~~~~~~i~~~l~~lh~-~gi~H~Dl~p~N 155 (198)
T cd05144 96 PVPKPIDW---------NRHAVVMEYIDGVELYRVRV----------LEDPEEVLDEILEEIVKAYK-HGIIHGDLSEFN 155 (198)
T ss_pred CCCceeec---------CCceEEEEEeCCcchhhccc----------cccHHHHHHHHHHHHHHHHH-CCCCcCCCCccc
Confidence 333221 114689999997 3322211 13355678899999999999 899999999999
Q ss_pred eEEeCCCCcEEEEeecCcccc
Q 016184 215 LLVNPHTHQLKLCDFGSAKVL 235 (394)
Q Consensus 215 il~~~~~~~vkl~Dfg~a~~~ 235 (394)
|+++.++ .++|+|||.+...
T Consensus 156 ill~~~~-~~~liDfg~~~~~ 175 (198)
T cd05144 156 ILVDDDE-KIYIIDWPQMVST 175 (198)
T ss_pred EEEcCCC-cEEEEECCccccC
Confidence 9999877 7999999998654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.73 E-value=1.4e-17 Score=157.57 Aligned_cols=205 Identities=27% Similarity=0.349 Sum_probs=148.1
Q ss_pred HHHcCCCCeeeeceEEEecCCCceeEEEEEEeccc-ccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcee
Q 016184 129 MQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICH 207 (394)
Q Consensus 129 l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH 207 (394)
|+.+.|.|+.++++.++.. ...++|.+||. |++.+.+.. ....++......++++++.||.|||......|
T Consensus 1 l~~l~h~n~~~f~g~~~~~-----~~~~~i~~~c~rGsl~D~i~~---~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~h 72 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDG-----PEMIVIWEYCSRGSLLDILSN---EDIKLDYFFILSFIRDISKGLAYLHNSPIGYH 72 (484)
T ss_pred CcccchhhhhhheeeEecC-----CceEEEEeeecCccHHhHHhc---cccCccHHHHHHHHHHHHHHHHHHhcCcceee
Confidence 3568999999999998655 33778999998 688887776 34678888888899999999999998433399
Q ss_pred ccCCCCceEEeCCCCcEEEEeecCccccccC---CCcccccccccccccccccCCCC------CCChhhHHHHHHHHHHH
Q 016184 208 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG---EPNVSYICSRYYRAPELIFGATE------YTTAIDIWSTGCVMAEL 278 (394)
Q Consensus 208 ~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~------~~~~~DiwslG~il~~l 278 (394)
+.++..|.+++... .+||+|||+....... .......-..-|.|||.+.+... .+.+.|+||+|++++|+
T Consensus 73 g~l~s~nClvd~~w-~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei 151 (484)
T KOG1023|consen 73 GALKSSNCLVDSRW-VLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEI 151 (484)
T ss_pred eeeccccceeeeeE-EEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHH
Confidence 99999999999988 7999999998765321 11112223455999999965321 36679999999999999
Q ss_pred HhCCCCCCCCCcH----HHHHHHHHHhCCCChhhhhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCC
Q 016184 279 LLGQPLFPGESGV----DQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPN 354 (394)
Q Consensus 279 ltg~~pf~~~~~~----~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~ 354 (394)
++...||...... +.+..+......+... ..+. . ....+++..++++||..+|.
T Consensus 152 ~~r~~~~~~~~~~~~~~eii~~~~~~~~~~~rP-------------------~i~~--~-~e~~~~l~~l~~~cw~e~P~ 209 (484)
T KOG1023|consen 152 LFRSGPFDLRNLVEDPDEIILRVKKGGSNPFRP-------------------SIEL--L-NELPPELLLLVARCWEEIPE 209 (484)
T ss_pred HhccCccccccccCChHHHHHHHHhcCCCCcCc-------------------chhh--h-hhcchHHHHHHHHhcccChh
Confidence 9999999864322 2222222201111110 0010 0 13556899999999999999
Q ss_pred CCCCHHHHhc
Q 016184 355 LRCTALEACV 364 (394)
Q Consensus 355 ~Rpt~~ell~ 364 (394)
+||+++++-.
T Consensus 210 ~rPs~~~i~~ 219 (484)
T KOG1023|consen 210 KRPSIEQIRS 219 (484)
T ss_pred hCccHHHHHh
Confidence 9999998753
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.72 E-value=8e-17 Score=139.25 Aligned_cols=125 Identities=18% Similarity=0.324 Sum_probs=92.7
Q ss_pred EEeecCceEEEEEEECCCCcEEEEEEeccc------------hhhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEEE
Q 016184 89 VVGTGSFGVVFQAKCRETGEIVAIKKVLQD------------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN 156 (394)
Q Consensus 89 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 156 (394)
.||+|+||.||+|.. +|..|++|+.... .....+|+++++.+.|+++.....++.... ..+
T Consensus 1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~-----~~~ 73 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPD-----NKT 73 (199)
T ss_pred CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECC-----CCE
Confidence 379999999999985 4778999975421 122346999999998877544333332211 146
Q ss_pred EEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCccc
Q 016184 157 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV 234 (394)
Q Consensus 157 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~ 234 (394)
++|||++| ++.+.+... . . .++.+++.+|.+||+ .|++|+|++|.||+++ ++ .++++|||++..
T Consensus 74 lv~e~~~g~~l~~~~~~~----~-~------~~~~~i~~~l~~lH~-~gi~H~Dl~~~Nil~~-~~-~~~liDfg~a~~ 138 (199)
T TIGR03724 74 IVMEYIEGKPLKDVIEEG----N-D------ELLREIGRLVGKLHK-AGIVHGDLTTSNIIVR-DD-KLYLIDFGLGKY 138 (199)
T ss_pred EEEEEECCccHHHHHhhc----H-H------HHHHHHHHHHHHHHH-CCeecCCCCcceEEEE-CC-cEEEEECCCCcC
Confidence 89999986 554443321 0 0 678899999999999 8999999999999999 55 799999999865
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.71 E-value=1.7e-18 Score=171.24 Aligned_cols=256 Identities=23% Similarity=0.275 Sum_probs=187.0
Q ss_pred eeEEEeeEEeecCceEEEEEEECCC-CcEEEEEEeccch---h---hhHHHHHHHHHcC-CCCeeeeceEEEecCCCcee
Q 016184 82 VSYIAEHVVGTGSFGVVFQAKCRET-GEIVAIKKVLQDK---R---YKNRELQIMQMLD-HPNIVALKHCFFSTTDKEEL 153 (394)
Q Consensus 82 ~~y~~~~~lg~G~~g~V~~~~~~~~-~~~vaiK~~~~~~---~---~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~ 153 (394)
..|.+.+.||+|+|+.|-.+....+ ...+|.|.+.... . ....|..+-..+. |.|++.+++.. ....
T Consensus 20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~-----~~~~ 94 (601)
T KOG0590|consen 20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPS-----SSPR 94 (601)
T ss_pred ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCcc-----CCCc
Confidence 3588899999999999998877433 3446666553321 1 1223666666666 99999998876 5555
Q ss_pred EEEEEEecccc-cHHHHHHHhhhhcC-CCCHHHHHHHHHHHHHHHHHHH-hCCCceeccCCCCceEEeCCCCcEEEEeec
Q 016184 154 YLNLVLEYVPE-TVNRIARNYSRIHQ-RMPLIYVKLYTYQICRALAYIH-NCIGICHRDIKPQNLLVNPHTHQLKLCDFG 230 (394)
Q Consensus 154 ~~~lv~e~~~~-~l~~~~~~~~~~~~-~l~~~~~~~~~~qi~~al~~LH-~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg 230 (394)
+.++++++..+ .+..... .... ..+...+..++.|+..++.|+| . .++.|+|+||+|.+++..+..++++|||
T Consensus 95 ~~~~~~~~s~g~~~f~~i~---~~~~~~~~~~~~~~~~~ql~s~l~~~H~~-~~~~h~~ikP~n~~l~~s~~~l~~~df~ 170 (601)
T KOG0590|consen 95 SYLLSLSYSDGGSLFSKIS---HPDSTGTSSSSASRYLPQLNSGLSYLHPE-NGVTHRDIKPSNSLLDESGSALKIADFG 170 (601)
T ss_pred ccccccCcccccccccccc---cCCccCCCCcchhhhhhhhccCccccCcc-cccccCCCCCccchhccCCCcccCCCch
Confidence 57789999765 2222111 2222 6677788889999999999999 7 8999999999999999776359999999
Q ss_pred Ccccccc-CCC---cccccc-cccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCC
Q 016184 231 SAKVLVK-GEP---NVSYIC-SRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPT 305 (394)
Q Consensus 231 ~a~~~~~-~~~---~~~~~~-t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~ 305 (394)
+|..... .+. ....+| ++.|+|||...+........|+||.|+++..+++|..||......+....
T Consensus 171 ~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~--------- 241 (601)
T KOG0590|consen 171 LATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYS--------- 241 (601)
T ss_pred hhccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccce---------
Confidence 9987755 222 234567 99999999997655678889999999999999999999976543221100
Q ss_pred hhhhhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 016184 306 REEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE 370 (394)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~ 370 (394)
...... ..........++....+++.++|..+|+.|.+.+++..+||+..
T Consensus 242 -----------~~~~~~----~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~ 291 (601)
T KOG0590|consen 242 -----------SWKSNK----GRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS 291 (601)
T ss_pred -----------eecccc----cccccCccccCChhhhhcccccccCCchhccccccccccccccc
Confidence 000000 00011122567888999999999999999999999999999998
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.69 E-value=2.1e-16 Score=156.67 Aligned_cols=130 Identities=18% Similarity=0.286 Sum_probs=97.4
Q ss_pred eEEEeeEEeecCceEEEEEEECCCCcEEEEEEec-cc-----------hhhhHHHHHHHHHcCCCCeeeeceEEEecCCC
Q 016184 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVL-QD-----------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDK 150 (394)
Q Consensus 83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~-~~-----------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 150 (394)
.|...+.||+|+||.||+|.+... .+++|+.. +. .....+|+++++.++|++++....+.....
T Consensus 334 ~~~~~~~iG~G~~g~Vy~~~~~~~--~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~-- 409 (535)
T PRK09605 334 RKIPDHLIGKGAEADIKKGEYLGR--DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPE-- 409 (535)
T ss_pred ccCccceeccCCcEEEEEEeecCc--cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCC--
Confidence 356788999999999999987533 34444321 10 123457999999999999887655443221
Q ss_pred ceeEEEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEee
Q 016184 151 EELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDF 229 (394)
Q Consensus 151 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Df 229 (394)
..++||||+++ +|.+.+. ....++.+++.+|.+||+ .|++||||||+|||++ ++ .++|+||
T Consensus 410 ---~~~lv~E~~~g~~L~~~l~------------~~~~~~~~i~~~L~~lH~-~giiHrDlkp~NILl~-~~-~~~liDF 471 (535)
T PRK09605 410 ---EKTIVMEYIGGKDLKDVLE------------GNPELVRKVGEIVAKLHK-AGIVHGDLTTSNFIVR-DD-RLYLIDF 471 (535)
T ss_pred ---CCEEEEEecCCCcHHHHHH------------HHHHHHHHHHHHHHHHHh-CCCccCCCChHHEEEE-CC-cEEEEeC
Confidence 24689999986 5555443 245678899999999999 8999999999999995 44 6999999
Q ss_pred cCccc
Q 016184 230 GSAKV 234 (394)
Q Consensus 230 g~a~~ 234 (394)
|+++.
T Consensus 472 Gla~~ 476 (535)
T PRK09605 472 GLGKY 476 (535)
T ss_pred ccccc
Confidence 99865
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.67 E-value=3.2e-16 Score=134.04 Aligned_cols=131 Identities=19% Similarity=0.178 Sum_probs=90.8
Q ss_pred eeEEeecCceEEEEEEECCCCcEEEEEEeccchhhh----------------------------HHHHHHHHHcCCCC--
Q 016184 87 EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK----------------------------NRELQIMQMLDHPN-- 136 (394)
Q Consensus 87 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~----------------------------~~E~~~l~~l~h~~-- 136 (394)
.+.||+|+||+||+|.+. +|+.||||++....... ..|...+..+.+..
T Consensus 2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~ 80 (187)
T cd05119 2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP 80 (187)
T ss_pred CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence 467999999999999986 79999999876432111 23444455544332
Q ss_pred eeeeceEEEecCCCceeEEEEEEecccccH--HHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCc
Q 016184 137 IVALKHCFFSTTDKEELYLNLVLEYVPETV--NRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQN 214 (394)
Q Consensus 137 iv~~~~~~~~~~~~~~~~~~lv~e~~~~~l--~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~N 214 (394)
+.+.+.+. ..+++|||+++.. ...+.... .. ..++.++.+++.++.++|...||+|+||||+|
T Consensus 81 ~~~~~~~~---------~~~lv~e~~~g~~~~~~~l~~~~-----~~-~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~N 145 (187)
T cd05119 81 VPKPIDLN---------RHVLVMEFIGGDGIPAPRLKDVR-----LL-EDPEELYDQILELMRKLYREAGLVHGDLSEYN 145 (187)
T ss_pred CCceEecC---------CCEEEEEEeCCCCccChhhhhhh-----hc-ccHHHHHHHHHHHHHHHhhccCcCcCCCChhh
Confidence 22222211 1479999999721 01122111 11 56778899999999999974699999999999
Q ss_pred eEEeCCCCcEEEEeecCcccc
Q 016184 215 LLVNPHTHQLKLCDFGSAKVL 235 (394)
Q Consensus 215 il~~~~~~~vkl~Dfg~a~~~ 235 (394)
|+++ ++ .++|+|||.+...
T Consensus 146 ili~-~~-~~~liDfg~a~~~ 164 (187)
T cd05119 146 ILVD-DG-KVYIIDVPQAVEI 164 (187)
T ss_pred EEEE-CC-cEEEEECcccccc
Confidence 9999 65 6999999999654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.66 E-value=2e-15 Score=133.64 Aligned_cols=133 Identities=15% Similarity=0.244 Sum_probs=96.7
Q ss_pred eEEe-ecCceEEEEEEECCCCcEEEEEEeccc-----------------hhhhHHHHHHHHHcCCCCe--eeeceEEEec
Q 016184 88 HVVG-TGSFGVVFQAKCRETGEIVAIKKVLQD-----------------KRYKNRELQIMQMLDHPNI--VALKHCFFST 147 (394)
Q Consensus 88 ~~lg-~G~~g~V~~~~~~~~~~~vaiK~~~~~-----------------~~~~~~E~~~l~~l~h~~i--v~~~~~~~~~ 147 (394)
..|| .|+.|+||.+... +..++||.+... .....+|++++..|.|+++ +..+++....
T Consensus 37 ~~lg~~~g~gtv~~v~~~--~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTP--GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred ceeecCCCCccEEEEEeC--CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 4577 8888999988774 678999977421 1223569999999998875 4555543222
Q ss_pred CCCceeEEEEEEecccc--cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEE
Q 016184 148 TDKEELYLNLVLEYVPE--TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLK 225 (394)
Q Consensus 148 ~~~~~~~~~lv~e~~~~--~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vk 225 (394)
. ......++|||++++ ++.+++.. ..+++.. +.+++.+|.+||+ .||+|+||||+|||++.++ .++
T Consensus 115 ~-~~~~~~~lV~e~l~G~~~L~~~l~~-----~~l~~~~----~~~i~~~l~~lH~-~GI~HrDlkp~NILv~~~~-~v~ 182 (239)
T PRK01723 115 H-GLFYRADILIERIEGARDLVALLQE-----APLSEEQ----WQAIGQLIARFHD-AGVYHADLNAHNILLDPDG-KFW 182 (239)
T ss_pred c-CcceeeeEEEEecCCCCCHHHHHhc-----CCCCHHH----HHHHHHHHHHHHH-CCCCCCCCCchhEEEcCCC-CEE
Confidence 1 112224589999986 66655442 3455543 4689999999999 8999999999999999877 799
Q ss_pred EEeecCccc
Q 016184 226 LCDFGSAKV 234 (394)
Q Consensus 226 l~Dfg~a~~ 234 (394)
|+|||.+..
T Consensus 183 LIDfg~~~~ 191 (239)
T PRK01723 183 LIDFDRGEL 191 (239)
T ss_pred EEECCCccc
Confidence 999998864
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.66 E-value=2.8e-16 Score=148.91 Aligned_cols=259 Identities=25% Similarity=0.250 Sum_probs=192.9
Q ss_pred cCCCCCCCccceeEEEeeEEee--cCceEEEEEEE--CCCCcEEEEEEecc------chhhhHHHHHHHHHc-CCCCeee
Q 016184 71 IGGRNGNSKQKVSYIAEHVVGT--GSFGVVFQAKC--RETGEIVAIKKVLQ------DKRYKNRELQIMQML-DHPNIVA 139 (394)
Q Consensus 71 ~~~~~~~~~~~~~y~~~~~lg~--G~~g~V~~~~~--~~~~~~vaiK~~~~------~~~~~~~E~~~l~~l-~h~~iv~ 139 (394)
++.....+.....+.+.+.+|. |.+|.||.+.. ..++..+|+|.-.. ......+|+...+.+ .|++.++
T Consensus 103 ~~~S~~~s~~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~ 182 (524)
T KOG0601|consen 103 YGASPFDSFFDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVR 182 (524)
T ss_pred cCCCCccchhhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccc
Confidence 3344444445556788899999 99999999999 88999999997321 122233566655555 5888888
Q ss_pred eceEEEecCCCceeEEEEEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHH----HHHHHHhCCCceeccCCCCce
Q 016184 140 LKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICR----ALAYIHNCIGICHRDIKPQNL 215 (394)
Q Consensus 140 ~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~----al~~LH~~~givH~Dlkp~Ni 215 (394)
.+..+ .+....++-+|+++.++...... ....++...++..+.+... ||..+|. .+++|-|+||.||
T Consensus 183 ~~~~~-----e~~~~lfiqtE~~~~sl~~~~~~---~~~~~p~~~l~~~~~~~~~~~~~al~~~hs-~~~~~~~~kp~~i 253 (524)
T KOG0601|consen 183 DSPAW-----EGSGILFIQTELCGESLQSYCHT---PCNFLPDNLLWNSLRDWLSRDVTALSHLHS-NNIVHDDLKPANI 253 (524)
T ss_pred cCccc-----ccCCcceeeeccccchhHHhhhc---ccccCCchhhhhHHhhhhhcccccccccCC-Ccccccccchhhe
Confidence 66655 44555778999999776554443 3355888999999999999 9999999 8999999999999
Q ss_pred EEeCCCCcEEEEeecCccccccCCCcc------cccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCC-
Q 016184 216 LVNPHTHQLKLCDFGSAKVLVKGEPNV------SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGE- 288 (394)
Q Consensus 216 l~~~~~~~vkl~Dfg~a~~~~~~~~~~------~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~- 288 (394)
+...+....+++|||+...+....... ...+...|++||...+ -++..+|+|++|.++.+..++..+....
T Consensus 254 ~~~~~~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~--l~~~~~di~sl~ev~l~~~l~~~~~~~g~ 331 (524)
T KOG0601|consen 254 FTTSDWTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG--LATFASDIFSLGEVILEAILGSHLPSVGK 331 (524)
T ss_pred ecccccceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhcc--ccchHhhhcchhhhhHhhHhhcccccCCC
Confidence 999884479999999988775554221 1256777999999843 4799999999999999999987666544
Q ss_pred -CcHHHHHHHHHHhCCCChhhhhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCC
Q 016184 289 -SGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 367 (394)
Q Consensus 289 -~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~ 367 (394)
..|..+..+. ....+....+.++...+..+++.||..|+++..+++|++
T Consensus 332 ~~~W~~~r~~~------------------------------ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~ 381 (524)
T KOG0601|consen 332 NSSWSQLRQGY------------------------------IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNV 381 (524)
T ss_pred CCCcccccccc------------------------------CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhcccc
Confidence 3332222111 111233456777888999999999999999999999999
Q ss_pred CCC
Q 016184 368 FDE 370 (394)
Q Consensus 368 f~~ 370 (394)
+..
T Consensus 382 i~s 384 (524)
T KOG0601|consen 382 IHS 384 (524)
T ss_pred ccc
Confidence 874
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.65 E-value=1.7e-16 Score=139.34 Aligned_cols=243 Identities=19% Similarity=0.225 Sum_probs=164.2
Q ss_pred eEEEEEEECCCCcEEEEEEecc----c----hhhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEEEEEEeccc-ccH
Q 016184 96 GVVFQAKCRETGEIVAIKKVLQ----D----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVP-ETV 166 (394)
Q Consensus 96 g~V~~~~~~~~~~~vaiK~~~~----~----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l 166 (394)
-.||++.+...|..|.--.+.- + ....+.-+..|-.+-|.||++++.++-.....+.....++.||+. +++
T Consensus 80 d~v~lamd~e~g~evvwneVq~~~rK~~~~qeek~~~vFdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~ 159 (458)
T KOG1266|consen 80 DDVYLAMDTEEGVEVVWNEVQFSERKNPKEQEEKRRAVFDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSL 159 (458)
T ss_pred HHHHHHhhhccCchhhHHHHHHHHhcChhhCHHHHHHHHHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhH
Confidence 4577888877776654332211 1 111112234466678999999999885555445555778999998 688
Q ss_pred HHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhC-CCceeccCCCCceEEeCCCCcEEEEeecCccccc-----cCCC
Q 016184 167 NRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC-IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV-----KGEP 240 (394)
Q Consensus 167 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~-~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~-----~~~~ 240 (394)
...++...+.+..+.....++|+.||+.||.|||++ --|+|+++..+.|++..++ -+|+.--.-..... ....
T Consensus 160 ~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~PpiihgnlTc~tifiq~ng-LIkig~~ap~s~h~s~~~~~~~E 238 (458)
T KOG1266|consen 160 KQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPIIHGNLTCDTIFIQHNG-LIKIGSVAPDSTHPSVNSTREAE 238 (458)
T ss_pred HHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccccCCcchhheeecCCc-eEEecccCccccchhhhhhhHhh
Confidence 899999999999999999999999999999999985 4599999999999999776 56653211111000 0011
Q ss_pred cccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCC-CCCCCcHHHHHHHHHHhCCCChhhhhccCCCCccc
Q 016184 241 NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPL-FPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 319 (394)
Q Consensus 241 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~p-f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 319 (394)
.....+-++|.+||.=. ....+.++|||++|....+|..+..- -.+......-..+.+.+
T Consensus 239 k~~~~~~~g~~a~~sg~-~tn~~~a~dIy~fgmcAlemailEiq~tnseS~~~~ee~ia~~i------------------ 299 (458)
T KOG1266|consen 239 KSVNTSLPGFSAPESGT-TTNTTGASDIYKFGMCALEMAILEIQSTNSESKVEVEENIANVI------------------ 299 (458)
T ss_pred hhccccCCccccCCcCc-ccccccchhhhhhhHHHHHHHHheeccCCCcceeehhhhhhhhe------------------
Confidence 12234567899999642 23467799999999999999987632 22222111111111110
Q ss_pred CCCCCCCCCcchhccccC-ChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q 016184 320 KFPQIKPHPWHKVFQKRL-PPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD 373 (394)
Q Consensus 320 ~~~~~~~~~~~~~~~~~~-~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~ 373 (394)
-.+ ...-++++..||+-.|..||++.++|.||.+-++..
T Consensus 300 ---------------~~len~lqr~~i~kcl~~eP~~rp~ar~llfHpllfeVhs 339 (458)
T KOG1266|consen 300 ---------------IGLENGLQRGSITKCLEGEPNGRPDARLLLFHPLLFEVHS 339 (458)
T ss_pred ---------------eeccCccccCcCcccccCCCCCCcchhhhhcCceeeecch
Confidence 011 122356899999999999999999999999877643
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.60 E-value=7.2e-15 Score=120.72 Aligned_cols=131 Identities=19% Similarity=0.253 Sum_probs=100.8
Q ss_pred EeeEEeecCceEEEEEEECCCCcEEEEEEeccch--hhhHHHHHHHHHcCC--CCeeeeceEEEecCCCceeEEEEEEec
Q 016184 86 AEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK--RYKNRELQIMQMLDH--PNIVALKHCFFSTTDKEELYLNLVLEY 161 (394)
Q Consensus 86 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~E~~~l~~l~h--~~iv~~~~~~~~~~~~~~~~~~lv~e~ 161 (394)
+.+.||.|.++.||++.... ..+++|.+.... ....+|..+++.+.+ .++++++..+. .....+++|||
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~--~~~~iK~~~~~~~~~~~~~e~~~~~~l~~~~~~~p~~~~~~~-----~~~~~~~v~e~ 74 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD--EDYVLKINPSREKGADREREVAILQLLARKGLPVPKVLASGE-----SDGWSYLLMEW 74 (155)
T ss_pred cceecccccccceEEEEecC--CeEEEEecCCCCchhHHHHHHHHHHHHHHcCCCCCeEEEEcC-----CCCccEEEEEe
Confidence 45779999999999999853 789999886654 356789999999976 47777766552 22346789999
Q ss_pred ccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhC--CCceeccCCCCceEEeCCCCcEEEEeecCccc
Q 016184 162 VPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC--IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV 234 (394)
Q Consensus 162 ~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~--~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~ 234 (394)
+.+.... .++......++.+++.+|++||.. .+++|+|++|+||+++..+ .++++|||.+..
T Consensus 75 ~~g~~~~----------~~~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~-~~~l~Df~~~~~ 138 (155)
T cd05120 75 IEGETLD----------EVSEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGK-ILGIIDWEYAGY 138 (155)
T ss_pred cCCeecc----------cCCHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCc-EEEEEecccccC
Confidence 9863211 114456667788999999999972 2699999999999999765 799999998853
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.48 E-value=1.7e-14 Score=143.96 Aligned_cols=271 Identities=23% Similarity=0.257 Sum_probs=192.2
Q ss_pred cceeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccch-------hhhHHHHHHHHHcCCCCeeeeceEEEecCCCce
Q 016184 80 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE 152 (394)
Q Consensus 80 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 152 (394)
..+.+.+.+-+-+|+++.++.+.-..+|...++|+..... .....+-.++-...+|.++.....+ ...
T Consensus 802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~-----~~r 876 (1205)
T KOG0606|consen 802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSF-----PCR 876 (1205)
T ss_pred CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCC-----CCC
Confidence 3445788889999999999999988888777777543322 1222233333333445555433222 122
Q ss_pred eEEEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecC
Q 016184 153 LYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS 231 (394)
Q Consensus 153 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~ 231 (394)
.-.+++++|+++ ++...++. ....+...++.+...+..++++||. ..+.|+|++|.|+|+..++ ..++.|||.
T Consensus 877 sP~~L~~~~~~~~~~~Skl~~----~~~~saepaRs~i~~~vqs~e~L~s-~~r~h~~~~p~~~l~~~~g-h~~l~~~~t 950 (1205)
T KOG0606|consen 877 SPLPLVGHYLNGGDLPSKLHN----SGCLSAEPARSPILERVQSLESLHS-SLRKHRDLKPDSLLIAYDG-HRPLTDFGT 950 (1205)
T ss_pred CCcchhhHHhccCCchhhhhc----CCCcccccccchhHHHHhhhhcccc-chhhcccccccchhhcccC-CcccCcccc
Confidence 226689999864 55444443 2346666777778889999999998 6799999999999999888 499999984
Q ss_pred ccccccC--------------------------------CCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHH
Q 016184 232 AKVLVKG--------------------------------EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELL 279 (394)
Q Consensus 232 a~~~~~~--------------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll 279 (394)
....... .......+|+.|.+||...+.. ....+|+|++|+++++.+
T Consensus 951 ~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~-hgs~ad~~~~g~~l~e~l 1029 (1205)
T KOG0606|consen 951 LSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRR-HGSAADWWSSGVCLFEVL 1029 (1205)
T ss_pred ccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCccccccc-CCCcchhhhhhhhhhhhh
Confidence 3222100 0112345789999999997655 788899999999999999
Q ss_pred hCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCH
Q 016184 280 LGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTA 359 (394)
Q Consensus 280 tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~ 359 (394)
+|.+||........+..+....-. |.. -+...+.++++++..+|..+|.+|..+
T Consensus 1030 ~g~pp~na~tpq~~f~ni~~~~~~-------------------------~p~-g~~~~s~~aq~~~~~ll~~~~~qr~~a 1083 (1205)
T KOG0606|consen 1030 TGIPPFNAETPQQIFENILNRDIP-------------------------WPE-GPEEGSYEAQDLINRLLTEEPTQRLGA 1083 (1205)
T ss_pred cCCCCCCCcchhhhhhccccCCCC-------------------------CCC-CccccChhhhhhhhhhhccCchhccCc
Confidence 999999988877666555442111 110 123468899999999999999999988
Q ss_pred H---HHhcCCCCCCCCCCCCCCCCCCCCCCCC
Q 016184 360 L---EACVHPFFDELRDPNTRLPNGRPLPPLF 388 (394)
Q Consensus 360 ~---ell~hp~f~~~~~~~~~~~~~~~~~~~~ 388 (394)
. ++-.||||+.....+..+-+..++|.+-
T Consensus 1084 ~~~~e~k~~~~~~~~~~~~l~~q~~~~~p~~~ 1115 (1205)
T KOG0606|consen 1084 KGAAEVKGHPFFQDVDWENLALQKAEFVPQPE 1115 (1205)
T ss_pred ccccccccCCccCCCCccccccccCccCCCCC
Confidence 8 9999999999988888766666665443
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.43 E-value=1.1e-12 Score=126.02 Aligned_cols=136 Identities=21% Similarity=0.253 Sum_probs=88.5
Q ss_pred eEEeecCceEEEEEEECCCCcEEEEEEeccchh--------------------------------------------hhH
Q 016184 88 HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR--------------------------------------------YKN 123 (394)
Q Consensus 88 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--------------------------------------------~~~ 123 (394)
+.||.|++|.||+|+.+ +|+.||||+...... .+.
T Consensus 123 ~plasaSigQVh~A~l~-~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 123 KPLAAASIAQVHRARLV-DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred cceeeeehhheEEEEec-CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 56999999999999974 789999998743210 011
Q ss_pred HHHHHHHHc----CCCCeeeeceEEEecCCCceeEEEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHH-HHH
Q 016184 124 RELQIMQML----DHPNIVALKHCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICR-ALA 197 (394)
Q Consensus 124 ~E~~~l~~l----~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~-al~ 197 (394)
+|+..+.++ .+.+-+.+..++....+ ..+++|||++| .+.++..... .... ...++.+++. .+.
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~----~~vLvmE~i~G~~L~~~~~~~~---~~~~---~~~ia~~~~~~~l~ 271 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRTS----ERVLTMEWIDGIPLSDIAALDE---AGLD---RKALAENLARSFLN 271 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhcC----CceEEEEeECCcccccHHHHHh---cCCC---HHHHHHHHHHHHHH
Confidence 244444444 23333444444422111 14699999987 4444333211 1122 2334555555 467
Q ss_pred HHHhCCCceeccCCCCceEEeCCCCcEEEEeecCccccc
Q 016184 198 YIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV 236 (394)
Q Consensus 198 ~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~ 236 (394)
.+|. .|++|+|+||.||+++.++ .++|+|||++..+.
T Consensus 272 ql~~-~g~~H~D~hPgNilv~~~g-~i~liDfG~~~~l~ 308 (437)
T TIGR01982 272 QVLR-DGFFHADLHPGNIFVLKDG-KIIALDFGIVGRLS 308 (437)
T ss_pred HHHh-CCceeCCCCcccEEECCCC-cEEEEeCCCeeECC
Confidence 8898 8999999999999999887 79999999987653
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.41 E-value=4.7e-12 Score=121.71 Aligned_cols=181 Identities=22% Similarity=0.270 Sum_probs=126.4
Q ss_pred eEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccchh----hhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEEEEE
Q 016184 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR----YKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLV 158 (394)
Q Consensus 83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv 158 (394)
-|.+ ...+-++.+..-.|..+.++.+|.|........ ..++-++.|+.++||||+++++.+ .....+|+|
T Consensus 14 pY~l-e~~~~~~~a~~~~~t~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~-----e~~~~~ylv 87 (690)
T KOG1243|consen 14 PYDL-EETAFSSEALWPDGTRKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTT-----EEEGTLYLV 87 (690)
T ss_pred Cccc-ccccCCCcccccccceeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhh-----cccCceEEE
Confidence 3666 334444444322567778899999987754433 245677889999999999999987 334458899
Q ss_pred EecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCccccccC
Q 016184 159 LEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG 238 (394)
Q Consensus 159 ~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~~ 238 (394)
+|.+... ...++. +....+..-++||+.||.|||...+++|++|.-.-|+|+..| ..||++|..+......
T Consensus 88 TErV~Pl-~~~lk~-------l~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~G-eWkLggle~v~~~~~~ 158 (690)
T KOG1243|consen 88 TERVRPL-ETVLKE-------LGKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESG-EWKLGGLELVSKASGF 158 (690)
T ss_pred eeccccH-HHHHHH-------hHHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCC-cEEEeeeEEEeccccC
Confidence 9998752 222222 225666777889999999998547999999999999999998 6999999987544222
Q ss_pred CC-cccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhC
Q 016184 239 EP-NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLG 281 (394)
Q Consensus 239 ~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg 281 (394)
.. ......--.|..|+.+.. -.-..|.|-|||++++++.|
T Consensus 159 ~~~~~~~~~~~s~~~P~~~~~---s~~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 159 NAPAKSLYLIESFDDPEEIDP---SEWSIDSWGLGCLIEELFNG 199 (690)
T ss_pred CcccccchhhhcccChhhcCc---cccchhhhhHHHHHHHHhCc
Confidence 21 111111223666665421 22457999999999999999
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.40 E-value=1.6e-11 Score=114.60 Aligned_cols=216 Identities=18% Similarity=0.227 Sum_probs=154.5
Q ss_pred CceEEEEEEECCCCcEEEEEEeccchh----hhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEEEEEEecccc--cHH
Q 016184 94 SFGVVFQAKCRETGEIVAIKKVLQDKR----YKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPE--TVN 167 (394)
Q Consensus 94 ~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~~--~l~ 167 (394)
--.+.|++....+|..|++|++...+. ....-+++++++.|.|+|++.++|.+.. -.+..+++|++|.++ +|.
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~t-F~D~SlvlvYDYyP~s~TL~ 366 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYT-FGDLSLVLVYDYYPSSPTLY 366 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhc-cCcceEEEEEecCCCCchHH
Confidence 346889999999999999999832221 2235689999999999999999886433 344558899999985 555
Q ss_pred HHHHHh-----------hhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCccccc
Q 016184 168 RIARNY-----------SRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV 236 (394)
Q Consensus 168 ~~~~~~-----------~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~ 236 (394)
++...- ...+...++..+|.++.|+..||.++|+ .|+.-+-|.|.+||++.+. +++|+..|......
T Consensus 367 d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHs-sGLAck~L~~~kIlv~G~~-RIriS~C~i~Dvl~ 444 (655)
T KOG3741|consen 367 DLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHS-SGLACKTLDLKKILVTGKM-RIRISGCGIMDVLQ 444 (655)
T ss_pred HHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHh-cCceeecccHhHeEeeCcc-eEEEecccceeeec
Confidence 443221 1123457889999999999999999999 8999999999999999776 68888777665443
Q ss_pred cCCCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCC-CCCCCcHHHHHHHHHHhCCCChhhhhccCCC
Q 016184 237 KGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPL-FPGESGVDQLVEIIKVLGTPTREEIKCMNPN 315 (394)
Q Consensus 237 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~p-f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 315 (394)
.+. . |-+ .--.+-|.-.||.++..|.||..- +............+
T Consensus 445 ~d~-----------~--~~l----e~~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~~~~I----------------- 490 (655)
T KOG3741|consen 445 EDP-----------T--EPL----ESQQQNDLRDLGLLLLALATGTENSNRTDSTQSSHLTRI----------------- 490 (655)
T ss_pred CCC-----------C--cch----hHHhhhhHHHHHHHHHHHhhcccccccccchHHHHHHHh-----------------
Confidence 322 0 111 123456999999999999999632 22222222211111
Q ss_pred CcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 016184 316 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH 365 (394)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 365 (394)
...++.+++++|..+...++++ -++.+++.|
T Consensus 491 ------------------~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~ 521 (655)
T KOG3741|consen 491 ------------------TTTYSTDLRNVVEYLESLNFRE-KSIQDLLPM 521 (655)
T ss_pred ------------------hhhhhHHHHHHHHHHHhcCccc-ccHHHHHHH
Confidence 1457888999999998888887 677777754
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.40 E-value=1.1e-13 Score=131.39 Aligned_cols=253 Identities=22% Similarity=0.185 Sum_probs=174.1
Q ss_pred ccceeEEEeeEEeecCceEEEEEEEC-CCCcEEEEEEeccchhhhH------HHHHHHHHc-CCCCeeeeceEEEecCCC
Q 016184 79 KQKVSYIAEHVVGTGSFGVVFQAKCR-ETGEIVAIKKVLQDKRYKN------RELQIMQML-DHPNIVALKHCFFSTTDK 150 (394)
Q Consensus 79 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~~~------~E~~~l~~l-~h~~iv~~~~~~~~~~~~ 150 (394)
....+|..+..||.|.|+.|+.+..+ .++..|++|...+...... .|+-+...+ .|.+++.....+..
T Consensus 262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~---- 337 (524)
T KOG0601|consen 262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQ---- 337 (524)
T ss_pred eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccc----
Confidence 34456888999999999999998766 6788899997765433322 355444444 57777776555522
Q ss_pred ceeEEEEEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeec
Q 016184 151 EELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFG 230 (394)
Q Consensus 151 ~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg 230 (394)
....++-.|||.+....+-. .....+.+...+.+..|++.++.++|+ ..++|+|+||+||++..++...++.|||
T Consensus 338 -~r~~~ip~e~~~~~s~~l~~---~~~~~~d~~~~~~~~~q~~~~l~~i~s-~~~~~~d~~psni~i~~~~~~~~~~~~~ 412 (524)
T KOG0601|consen 338 -LRQGYIPLEFCEGGSSSLRS---VTSQMLDEDPRLRLTAQILTALNVIHS-KLFVHLDVKPSNILISNDGFFSKLGDFG 412 (524)
T ss_pred -cccccCchhhhcCcchhhhh---HHHHhcCcchhhhhHHHHHhccccccc-hhhhcccccccceeeccchhhhhccccc
Confidence 22245788999764333322 233567778888899999999999999 9999999999999999864479999999
Q ss_pred CccccccCCCccccccccccc-ccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhh
Q 016184 231 SAKVLVKGEPNVSYICSRYYR-APELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI 309 (394)
Q Consensus 231 ~a~~~~~~~~~~~~~~t~~y~-aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 309 (394)
+++.+.-. .......-.+. ..|++.....+..+.|++|||..+.+.++|...-.....+. .+.+.
T Consensus 413 ~~t~~~~~--~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~~~---~i~~~--------- 478 (524)
T KOG0601|consen 413 CWTRLAFS--SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQSL---TIRSG--------- 478 (524)
T ss_pred ccccccee--cccccccccccccchhhccccccccccccccccccccccccCcccCcccccce---eeecc---------
Confidence 98653211 11222233344 35666566668999999999999999999974332222111 11110
Q ss_pred hccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCC
Q 016184 310 KCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP 374 (394)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~ 374 (394)
..+ ........+..+.+.++..|+..|+.+.++..|.-|....++
T Consensus 479 ----------~~p----------~~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~~~~~~ 523 (524)
T KOG0601|consen 479 ----------DTP----------NLPGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFYRDSRP 523 (524)
T ss_pred ----------ccc----------CCCchHHhhhhhhhhhcCCccccchhhhhhcccchhhhhccC
Confidence 000 012334678889999999999999999999999887665443
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.40 E-value=3.6e-12 Score=108.00 Aligned_cols=132 Identities=15% Similarity=0.187 Sum_probs=92.1
Q ss_pred eeEEeecCceEEEEEEECC------CCcEEEEEEeccc--------------h------------hhh----HHHHHHHH
Q 016184 87 EHVVGTGSFGVVFQAKCRE------TGEIVAIKKVLQD--------------K------------RYK----NRELQIMQ 130 (394)
Q Consensus 87 ~~~lg~G~~g~V~~~~~~~------~~~~vaiK~~~~~--------------~------------~~~----~~E~~~l~ 130 (394)
...||.|--+.||.|.... .+..+|||+.+.. . ... ++|+..|+
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 3568999999999998643 3578999976210 0 011 26888888
Q ss_pred HcCCC--CeeeeceEEEecCCCceeEEEEEEeccccc-H-HHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHH-HhCCCc
Q 016184 131 MLDHP--NIVALKHCFFSTTDKEELYLNLVLEYVPET-V-NRIARNYSRIHQRMPLIYVKLYTYQICRALAYI-HNCIGI 205 (394)
Q Consensus 131 ~l~h~--~iv~~~~~~~~~~~~~~~~~~lv~e~~~~~-l-~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~L-H~~~gi 205 (394)
++..- ++.+.+.+. . -++||||+++. + ...++. ..++......+..+++.+|..| |+ .|+
T Consensus 82 rl~~~Gv~vP~pi~~~----~-----~~lvME~Ig~~~~~~~~Lkd-----~~~~~~~~~~i~~~i~~~l~~l~H~-~gl 146 (197)
T cd05146 82 RMQKAGIPCPEVVVLK----K-----HVLVMSFIGDDQVPAPKLKD-----AKLNDEEMKNAYYQVLSMMKQLYKE-CNL 146 (197)
T ss_pred HHHHcCCCCCeEEEec----C-----CEEEEEEcCCCCccchhhhc-----cccCHHHHHHHHHHHHHHHHHHHHh-CCe
Confidence 88543 344444321 1 35899999863 1 111221 2345556677788999999998 88 899
Q ss_pred eeccCCCCceEEeCCCCcEEEEeecCcccc
Q 016184 206 CHRDIKPQNLLVNPHTHQLKLCDFGSAKVL 235 (394)
Q Consensus 206 vH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~ 235 (394)
||+||++.|||++. + .+.|+|||.+-..
T Consensus 147 VHGDLs~~NIL~~~-~-~v~iIDF~qav~~ 174 (197)
T cd05146 147 VHADLSEYNMLWHD-G-KVWFIDVSQSVEP 174 (197)
T ss_pred ecCCCCHHHEEEEC-C-cEEEEECCCceeC
Confidence 99999999999984 4 6999999988543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.39 E-value=2.9e-12 Score=107.68 Aligned_cols=124 Identities=16% Similarity=0.168 Sum_probs=88.9
Q ss_pred eeEEeecCceEEEEEEECCCCcEEEEEEeccch---hhhHHHHHHHHHcCCCCee-eeceEEEecCCCceeEEEEEEecc
Q 016184 87 EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---RYKNRELQIMQMLDHPNIV-ALKHCFFSTTDKEELYLNLVLEYV 162 (394)
Q Consensus 87 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~h~~iv-~~~~~~~~~~~~~~~~~~lv~e~~ 162 (394)
.+.|+.|.++.||+++.. ++.|++|+..... ....+|+.+++.+.+.+++ +++... ... .++||||+
T Consensus 3 ~~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~~~~~~P~~~~~~-----~~~--~~lv~e~i 73 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTELLINRENEAENSKLAAEAGIGPKLYYFD-----PET--GVLITEFI 73 (170)
T ss_pred eeecCCcccCceEEEEEC--CeEEEEEeCCCCcccccCHHHHHHHHHHHHHhCCCCceEEEe-----CCC--CeEEEEec
Confidence 356899999999999874 7789999875443 3457899999998665544 333322 111 25899999
Q ss_pred cccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCc-----eeccCCCCceEEeCCCCcEEEEeecCcc
Q 016184 163 PETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGI-----CHRDIKPQNLLVNPHTHQLKLCDFGSAK 233 (394)
Q Consensus 163 ~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~gi-----vH~Dlkp~Nil~~~~~~~vkl~Dfg~a~ 233 (394)
+|.... .. . .....++.+++.+|..||. .++ +|+|++|.||+++ ++ .++++||+.+.
T Consensus 74 ~G~~l~---~~-----~---~~~~~~~~~l~~~l~~LH~-~~~~~~~~~HgD~~~~Nil~~-~~-~~~liDf~~a~ 135 (170)
T cd05151 74 EGSELL---TE-----D---FSDPENLEKIAKLLKKLHS-SPLPDLVPCHNDLLPGNFLLD-DG-RLWLIDWEYAG 135 (170)
T ss_pred CCCccc---cc-----c---ccCHHHHHHHHHHHHHHhC-CCCCCceeecCCCCcCcEEEE-CC-eEEEEeccccc
Confidence 973211 00 0 1112346789999999998 775 9999999999999 44 69999999875
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.38 E-value=2.3e-12 Score=125.42 Aligned_cols=139 Identities=19% Similarity=0.245 Sum_probs=86.9
Q ss_pred EEEeeEEeecCceEEEEEEECCCCcEEEEEEeccchhh------------------------------------------
Q 016184 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRY------------------------------------------ 121 (394)
Q Consensus 84 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~------------------------------------------ 121 (394)
|.. +.||+|++|+||+|+.+.+|+.||||+.......
T Consensus 122 fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~E 200 (537)
T PRK04750 122 FDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHDE 200 (537)
T ss_pred cCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHHh
Confidence 555 6899999999999999888999999988543100
Q ss_pred --hHHHHHHHHHc----CCCCeeeeceEEEecCCCceeEEEEEEecccc-cHHHHHHHhhhhc---CCCCHHHHHHHHHH
Q 016184 122 --KNRELQIMQML----DHPNIVALKHCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIH---QRMPLIYVKLYTYQ 191 (394)
Q Consensus 122 --~~~E~~~l~~l----~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~---~~l~~~~~~~~~~q 191 (394)
+.+|+..+.++ .+.+.+.+..++.... ...++||||+.| .+.++.. ....+ ..+.+..+..++.|
T Consensus 201 lD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~s----t~~VLvmE~i~G~~l~d~~~-l~~~g~d~~~la~~~v~~~~~Q 275 (537)
T PRK04750 201 LDLMREAANASQLRRNFEDSDMLYVPEVYWDYC----SETVMVMERMYGIPVSDVAA-LRAAGTDMKLLAERGVEVFFTQ 275 (537)
T ss_pred hCHHHHHHHHHHHHHHccCCCCeecceeecccC----CCceEEEeeecCccHHhHHH-HHhcCCCHHHHHHHHHHHHHHH
Confidence 11233333333 2334444444442211 125699999997 4433211 11101 12333334444444
Q ss_pred HHHHHHHHHhCCCceeccCCCCceEEeCCC---CcEEEEeecCccccc
Q 016184 192 ICRALAYIHNCIGICHRDIKPQNLLVNPHT---HQLKLCDFGSAKVLV 236 (394)
Q Consensus 192 i~~al~~LH~~~givH~Dlkp~Nil~~~~~---~~vkl~Dfg~a~~~~ 236 (394)
+ .. .|++|+|+||.||+++.++ ..++++|||++....
T Consensus 276 i-------f~-~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~ 315 (537)
T PRK04750 276 V-------FR-DGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN 315 (537)
T ss_pred H-------Hh-CCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence 4 45 7999999999999999775 269999999987664
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.28 E-value=9.4e-11 Score=95.70 Aligned_cols=140 Identities=19% Similarity=0.254 Sum_probs=96.8
Q ss_pred EeeEEeecCceEEEEEEECCCCcEEEEEEe-cc-----------chhhhHHHHHHHHHcCCCCeeeeceEEEecCCCcee
Q 016184 86 AEHVVGTGSFGVVFQAKCRETGEIVAIKKV-LQ-----------DKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL 153 (394)
Q Consensus 86 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~-~~-----------~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 153 (394)
...+|-+|+-+.|+++.+. |+.+.||.= .+ ......+|++.|.++.--.|..-.-++.+.. .
T Consensus 11 ~l~likQGAEArv~~~~~~--Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~---~- 84 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS--GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTY---G- 84 (229)
T ss_pred cceeeeccceeeEeeeccC--CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecC---C-
Confidence 4577889999999999875 888888842 11 1233456888888875444432222222222 1
Q ss_pred EEEEEEecccc--cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcE--EEEee
Q 016184 154 YLNLVLEYVPE--TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQL--KLCDF 229 (394)
Q Consensus 154 ~~~lv~e~~~~--~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~v--kl~Df 229 (394)
-+++|||++| ++.+.+..... ..........++.+|-..+.-||. .+|+|+||..+||++.++++.+ .++||
T Consensus 85 -~~i~ME~~~g~~~vk~~i~~~~~--~~~~d~~~~~~~~~iG~~igklH~-ndiiHGDLTTSNill~~~~~~~~~~lIdf 160 (229)
T KOG3087|consen 85 -GQIYMEFIDGASTVKDFILSTME--DESEDEGLAELARRIGELIGKLHD-NDIIHGDLTTSNILLRSDGNQITPILIDF 160 (229)
T ss_pred -CeEEEEeccchhHHHHHHHHHcc--CcccchhHHHHHHHHHHHHHHhhh-CCeecccccccceEEecCCCcCceEEEee
Confidence 3479999998 55555444332 233333336788899999999999 8999999999999998887655 89999
Q ss_pred cCcccc
Q 016184 230 GSAKVL 235 (394)
Q Consensus 230 g~a~~~ 235 (394)
|++...
T Consensus 161 gls~~s 166 (229)
T KOG3087|consen 161 GLSSVS 166 (229)
T ss_pred cchhcc
Confidence 998643
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.17 E-value=3.9e-10 Score=92.57 Aligned_cols=126 Identities=15% Similarity=0.282 Sum_probs=84.1
Q ss_pred eEEeecCceEEEEEEECCCCcEEEEEEe-ccc-----------hhhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEE
Q 016184 88 HVVGTGSFGVVFQAKCRETGEIVAIKKV-LQD-----------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL 155 (394)
Q Consensus 88 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~-~~~-----------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 155 (394)
..+++|+-+.+|.+.+. |..+++|.= .+. .....+|+.++.++..-.|..-.-+.+.+.. .
T Consensus 2 ~~i~~GAEa~i~~~~~~--g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~-----~ 74 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL--GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDN-----G 74 (204)
T ss_pred chhhCCcceeEEeeecc--CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCC-----C
Confidence 35788999999999764 555677742 211 1223468999888855443322222222222 3
Q ss_pred EEEEecccccH-HHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCccc
Q 016184 156 NLVLEYVPETV-NRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV 234 (394)
Q Consensus 156 ~lv~e~~~~~l-~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~ 234 (394)
.|+|||++|.+ .+.+.. . . ..++..+-.-+.-||. .||||+||.++||++..+ .+.++|||++..
T Consensus 75 ~I~me~I~G~~lkd~l~~----~---~----~~~~r~vG~~vg~lH~-~givHGDLTtsNiIl~~~--~i~~IDfGLg~~ 140 (204)
T COG3642 75 LIVMEYIEGELLKDALEE----A---R----PDLLREVGRLVGKLHK-AGIVHGDLTTSNIILSGG--RIYFIDFGLGEF 140 (204)
T ss_pred EEEEEEeCChhHHHHHHh----c---c----hHHHHHHHHHHHHHHh-cCeecCCCccceEEEeCC--cEEEEECCcccc
Confidence 48999999854 223332 1 1 3345667777888999 899999999999999965 499999999964
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.16 E-value=1e-11 Score=119.91 Aligned_cols=164 Identities=20% Similarity=0.299 Sum_probs=119.1
Q ss_pred HHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCccccccCCC--------c--ccccccccccccccccCCC
Q 016184 191 QICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP--------N--VSYICSRYYRAPELIFGAT 260 (394)
Q Consensus 191 qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~~~~--------~--~~~~~t~~y~aPE~~~~~~ 260 (394)
+++.||.|+|+..++||++|.|++|.++..+ .+||+.|+++-....... . ....-...|.|||.+.. .
T Consensus 107 ~v~dgl~flh~sAk~VH~ni~p~~i~~na~~-~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~-~ 184 (700)
T KOG2137|consen 107 NVADGLAFLHRSAKVVHGNIQPEAIVVNANG-DWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG-T 184 (700)
T ss_pred cccchhhhhccCcceeecccchhheeeccCc-ceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc-c
Confidence 4448999999878999999999999999888 799999998754322110 0 01122566999999965 4
Q ss_pred CCCChhhHHHHHHHHHHHH-hCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCCCcccCCCCCCCCCcchhccccCCh
Q 016184 261 EYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPP 339 (394)
Q Consensus 261 ~~~~~~DiwslG~il~~ll-tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 339 (394)
..+.++|+||+|+++|.+. .|+..+...........-.... . .-.......++.
T Consensus 185 ~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~-~------------------------~~~~~~s~~~p~ 239 (700)
T KOG2137|consen 185 TNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLL-N------------------------AGAFGYSNNLPS 239 (700)
T ss_pred cccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhccc-c------------------------cccccccccCcH
Confidence 4788999999999999998 5666665443222211111100 0 000112256899
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCCCCCCC
Q 016184 340 EAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPNG 381 (394)
Q Consensus 340 ~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~~~~~~ 381 (394)
++++=|.++|..|+..||++..++.-|||.+..-.+.+....
T Consensus 240 el~~~l~k~l~~~~~~rp~~~~l~~~~ff~D~~~~aLrfLD~ 281 (700)
T KOG2137|consen 240 ELRESLKKLLNGDSAVRPTLDLLLSIPFFSDPGLKALRFLDD 281 (700)
T ss_pred HHHHHHHHHhcCCcccCcchhhhhcccccCCchhhhhhhccc
Confidence 999999999999999999999999999999998887765543
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.15 E-value=2.1e-09 Score=98.44 Aligned_cols=259 Identities=15% Similarity=0.152 Sum_probs=153.4
Q ss_pred EeeEEeecCceEEEEEEECCCCcEEEEEEeccchh-hhHHHHHHHHHc-CCCCeeeeceEE--EecCCCceeEEEEEEec
Q 016184 86 AEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-YKNRELQIMQML-DHPNIVALKHCF--FSTTDKEELYLNLVLEY 161 (394)
Q Consensus 86 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~E~~~l~~l-~h~~iv~~~~~~--~~~~~~~~~~~~lv~e~ 161 (394)
..+.||+|+.+.+|-.-.. + ..+.|+...... ...+-++.|... .||-+..-+.+- ..........+.++|+.
T Consensus 15 ~gr~LgqGgea~ly~l~e~--~-d~VAKIYh~Pppa~~aqk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflmP~ 91 (637)
T COG4248 15 PGRPLGQGGEADLYTLGEV--R-DQVAKIYHAPPPAAQAQKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLMPK 91 (637)
T ss_pred CCccccCCccceeeecchh--h-chhheeecCCCchHHHHHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEeccc
Confidence 3467999999999965432 2 234566544322 222233333333 455332211110 00112233336778888
Q ss_pred cccc--HHHHHH--HhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCcccccc
Q 016184 162 VPET--VNRIAR--NYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK 237 (394)
Q Consensus 162 ~~~~--l~~~~~--~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~ 237 (394)
+.+. ...+.. ..+.......+..+.+.++.++.|.+.||. .|.+-+|++++|+|+++++ .|.|.|=..-....+
T Consensus 92 v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~-~Gh~vGDVn~~~~lVsd~~-~V~LVdsDsfqi~~n 169 (637)
T COG4248 92 VSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHE-HGHVVGDVNQNSFLVSDDS-KVVLVDSDSFQINAN 169 (637)
T ss_pred CCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHh-cCCcccccCccceeeecCc-eEEEEcccceeeccC
Confidence 8752 222211 111222346777889999999999999999 8999999999999999887 799998655433334
Q ss_pred CCCccccccccccccccccc----CCCCCCChhhHHHHHHHHHHHHhC-CCCCCCCCcH----HHHH-HHHHHhCCCChh
Q 016184 238 GEPNVSYICSRYYRAPELIF----GATEYTTAIDIWSTGCVMAELLLG-QPLFPGESGV----DQLV-EIIKVLGTPTRE 307 (394)
Q Consensus 238 ~~~~~~~~~t~~y~aPE~~~----~~~~~~~~~DiwslG~il~~lltg-~~pf~~~~~~----~~~~-~i~~~~~~~~~~ 307 (394)
+......+|...|.+||.-. ....-+...|.|.||+++++++.| +.||.+.... ..++ .|.... ..
T Consensus 170 g~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~-f~--- 245 (637)
T COG4248 170 GTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGR-FA--- 245 (637)
T ss_pred CceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcce-ee---
Confidence 44444557788999999752 112246679999999999999986 8999874211 1111 111000 00
Q ss_pred hhhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhccc--CCCCCCCHHHH
Q 016184 308 EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQY--SPNLRCTALEA 362 (394)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~--dP~~Rpt~~el 362 (394)
+ .++-..-..+.....+| .-+++++.-|..+|+.. ++.-|||++..
T Consensus 246 ---y-a~~~~~g~~p~P~~~P~-----~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW 293 (637)
T COG4248 246 ---Y-ASDQRRGLKPPPRSIPL-----SMLPPDVQALFQQAFTESGVATPRPTAKAW 293 (637)
T ss_pred ---e-chhccCCCCCCCCCCCh-----hhcCHHHHHHHHHHhcccCCCCCCCCHHHH
Confidence 0 00001111122222233 34788999999999974 57789998643
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.13 E-value=4.4e-10 Score=94.96 Aligned_cols=121 Identities=21% Similarity=0.273 Sum_probs=75.3
Q ss_pred EEEEEEECCCCcEEEEEEeccch------------------------------hhhHHHHHHHHHcCCCC--eeeeceEE
Q 016184 97 VVFQAKCRETGEIVAIKKVLQDK------------------------------RYKNRELQIMQMLDHPN--IVALKHCF 144 (394)
Q Consensus 97 ~V~~~~~~~~~~~vaiK~~~~~~------------------------------~~~~~E~~~l~~l~h~~--iv~~~~~~ 144 (394)
.||.|.. .+|..+|||+.+... ...++|.+.|.++..-+ +.+.+.+.
T Consensus 1 ~Vy~~~~-~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~ 79 (188)
T PF01163_consen 1 DVYHAID-PDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN 79 (188)
T ss_dssp EEEEEEE-CTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred CEEEEEC-CCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence 3899988 467899999763210 11236999999997664 45554322
Q ss_pred EecCCCceeEEEEEEeccc--ccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHH-HHhCCCceeccCCCCceEEeCCC
Q 016184 145 FSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY-IHNCIGICHRDIKPQNLLVNPHT 221 (394)
Q Consensus 145 ~~~~~~~~~~~~lv~e~~~--~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~-LH~~~givH~Dlkp~Nil~~~~~ 221 (394)
. -++||||++ |.....+.. ..+.......++.+++..+.. +|. .||+|+||.+.|||++.+
T Consensus 80 -----~----~~ivME~I~~~G~~~~~l~~-----~~~~~~~~~~~~~~il~~~~~~~~~-~givHGDLs~~NIlv~~~- 143 (188)
T PF01163_consen 80 -----R----NVIVMEYIGEDGVPLPRLKD-----VDLSPEEPKELLEEILEEIIKMLHK-AGIVHGDLSEYNILVDDG- 143 (188)
T ss_dssp -----T----TEEEEE--EETTEEGGCHHH-----CGGGGSTHHHHHHHHHHHHHHHHHC-TTEEESS-STTSEEEETT-
T ss_pred -----C----CEEEEEecCCCccchhhHHh-----ccccchhHHHHHHHHHHHHHHHHHh-cCceecCCChhhEEeecc-
Confidence 1 248999999 632222222 111133455667788885555 578 899999999999999965
Q ss_pred CcEEEEeecCcccc
Q 016184 222 HQLKLCDFGSAKVL 235 (394)
Q Consensus 222 ~~vkl~Dfg~a~~~ 235 (394)
.+.|+|||.+...
T Consensus 144 -~~~iIDf~qav~~ 156 (188)
T PF01163_consen 144 -KVYIIDFGQAVDS 156 (188)
T ss_dssp -CEEE--GTTEEET
T ss_pred -eEEEEecCcceec
Confidence 5999999988543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.08 E-value=4.8e-09 Score=94.01 Aligned_cols=109 Identities=13% Similarity=0.172 Sum_probs=77.3
Q ss_pred hHHHHHHHHHcCCCCeeee--ceEEEecCCCceeEEEEEEecccc--cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHH
Q 016184 122 KNRELQIMQMLDHPNIVAL--KHCFFSTTDKEELYLNLVLEYVPE--TVNRIARNYSRIHQRMPLIYVKLYTYQICRALA 197 (394)
Q Consensus 122 ~~~E~~~l~~l~h~~iv~~--~~~~~~~~~~~~~~~~lv~e~~~~--~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ 197 (394)
..+|...+.++...+|... +.+.....+......++|||++++ ++.+++.... ....+......++.+++..+.
T Consensus 75 a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte~l~~~~sL~~~~~~~~--~~~~~~~~~~~ll~~la~~i~ 152 (268)
T PRK15123 75 ADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITEDLAPTISLEDYCADWA--TNPPDPRLKRMLIKRVATMVR 152 (268)
T ss_pred HHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEeeCCCCccHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHH
Confidence 4578888888855444333 333322222223345689999997 5666654322 244566777889999999999
Q ss_pred HHHhCCCceeccCCCCceEEeCC------CCcEEEEeecCcc
Q 016184 198 YIHNCIGICHRDIKPQNLLVNPH------THQLKLCDFGSAK 233 (394)
Q Consensus 198 ~LH~~~givH~Dlkp~Nil~~~~------~~~vkl~Dfg~a~ 233 (394)
-||. .||+|+|+++.|||++.+ ...+.|+||+.+.
T Consensus 153 ~LH~-~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~ 193 (268)
T PRK15123 153 DMHA-AGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQ 193 (268)
T ss_pred HHHH-CcCccCCCChhhEEEeccccCCCCCceEEEEECCccc
Confidence 9999 899999999999999852 2379999999875
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.03 E-value=2.4e-09 Score=93.87 Aligned_cols=138 Identities=14% Similarity=0.165 Sum_probs=88.6
Q ss_pred eEEeecCceEEEEEEECCCCcEEEEEEeccc-----hhhhHHHHHHHHHcCCCC--eeeeceEEEecCCCceeEEEEEEe
Q 016184 88 HVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-----KRYKNRELQIMQMLDHPN--IVALKHCFFSTTDKEELYLNLVLE 160 (394)
Q Consensus 88 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~~--iv~~~~~~~~~~~~~~~~~~lv~e 160 (394)
+.|+.|..+.||+++.. +|+.+++|..... .....+|+++++.+.+.+ +.+++.+.. ........++|||
T Consensus 4 ~~l~~G~~n~~~~v~~~-~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~--~~~~~~~~~~v~e 80 (223)
T cd05154 4 RQLSGGQSNLTYLLTAG-GGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCE--DPSVLGTPFYVME 80 (223)
T ss_pred eecCCCccceEEEEEec-CCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECC--CCCccCCceEEEE
Confidence 56899999999999874 3678999987543 345678999999997644 445544331 1111123468999
Q ss_pred ccccc-HHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHh--------------------------------------
Q 016184 161 YVPET-VNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN-------------------------------------- 201 (394)
Q Consensus 161 ~~~~~-l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~-------------------------------------- 201 (394)
|++|. +..... ...+++.....++.+++.+|..||+
T Consensus 81 ~i~G~~l~~~~~-----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (223)
T cd05154 81 RVDGRVLRDRLL-----RPELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPP 155 (223)
T ss_pred EeCCEecCCCCC-----CCCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccH
Confidence 99863 211110 0123444444444455555555542
Q ss_pred -----------------CCCceeccCCCCceEEeCC-CCcEEEEeecCcc
Q 016184 202 -----------------CIGICHRDIKPQNLLVNPH-THQLKLCDFGSAK 233 (394)
Q Consensus 202 -----------------~~givH~Dlkp~Nil~~~~-~~~vkl~Dfg~a~ 233 (394)
...++|+|++|.||+++.+ ...+.|+||+.+.
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~ 205 (223)
T cd05154 156 AMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELAT 205 (223)
T ss_pred HHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccc
Confidence 1357999999999999973 2258999999875
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.89 E-value=1.2e-08 Score=88.83 Aligned_cols=131 Identities=20% Similarity=0.182 Sum_probs=91.4
Q ss_pred EEEeeEEeecCceEEEEEEECCCCcEEEEEEeccc--------------------------hhhhHHHHHHHHHcCCC--
Q 016184 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD--------------------------KRYKNRELQIMQMLDHP-- 135 (394)
Q Consensus 84 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--------------------------~~~~~~E~~~l~~l~h~-- 135 (394)
+.+...||-|--+.||.|.+. .|..+|||.-+.. ....++|.++|.+|...
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~ 171 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV 171 (304)
T ss_pred HhhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence 557788999999999999985 6889999953211 11124689999998655
Q ss_pred CeeeeceEEEecCCCceeEEEEEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCce
Q 016184 136 NIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNL 215 (394)
Q Consensus 136 ~iv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Ni 215 (394)
.+.+.+++ + .-++|||++.|.. +.. -++.......++..|+.-+..+-. .||||+|+++-||
T Consensus 172 ~VP~P~~~-------n--RHaVvMe~ieG~e---L~~-----~r~~~en~~~il~~il~~~~~~~~-~GiVHGDlSefNI 233 (304)
T COG0478 172 KVPKPIAW-------N--RHAVVMEYIEGVE---LYR-----LRLDVENPDEILDKILEEVRKAYR-RGIVHGDLSEFNI 233 (304)
T ss_pred CCCCcccc-------c--cceeeeehcccce---eec-----ccCcccCHHHHHHHHHHHHHHHHH-cCccccCCchheE
Confidence 55554331 1 1458999999832 111 112344444555566666665556 7999999999999
Q ss_pred EEeCCCCcEEEEeecCccc
Q 016184 216 LVNPHTHQLKLCDFGSAKV 234 (394)
Q Consensus 216 l~~~~~~~vkl~Dfg~a~~ 234 (394)
++++|| .+.++||--+..
T Consensus 234 lV~~dg-~~~vIDwPQ~v~ 251 (304)
T COG0478 234 LVTEDG-DIVVIDWPQAVP 251 (304)
T ss_pred EEecCC-CEEEEeCccccc
Confidence 999998 699999987643
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.85 E-value=1.3e-07 Score=80.60 Aligned_cols=138 Identities=11% Similarity=0.088 Sum_probs=97.1
Q ss_pred eecCceEEEEEEECCCCcEEEEEEec----------cchhhhHHHHHHHHHcCCCCee--eeceEEEecCCCceeEEEEE
Q 016184 91 GTGSFGVVFQAKCRETGEIVAIKKVL----------QDKRYKNRELQIMQMLDHPNIV--ALKHCFFSTTDKEELYLNLV 158 (394)
Q Consensus 91 g~G~~g~V~~~~~~~~~~~vaiK~~~----------~~~~~~~~E~~~l~~l~h~~iv--~~~~~~~~~~~~~~~~~~lv 158 (394)
|.||-+.|+..... |+.+-+|.-. .....+.+|+..+..|...+|. +.. ++...........+||
T Consensus 27 ~rgG~SgV~r~~~~--g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV 103 (216)
T PRK09902 27 RRNGMSGVQCVERN--GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV 103 (216)
T ss_pred CCCCcceEEEEEeC--CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence 56788888887653 4467788643 1234567899999988654443 333 2222233334556789
Q ss_pred Eecccc--cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCC-cEEEEeecCccc
Q 016184 159 LEYVPE--TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTH-QLKLCDFGSAKV 234 (394)
Q Consensus 159 ~e~~~~--~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~-~vkl~Dfg~a~~ 234 (394)
+|-+++ +|.+++.... ..+.+......++.+++.++.-||+ .|+.|+|+.+.|||++.++. .++++||.-++.
T Consensus 104 Te~L~g~~~L~~~l~~~~--~~~~~~~~k~~il~~va~~ia~LH~-~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 104 TEDMAGFISIADWYAQHA--VSPYSDEVRQAMLKAVALAFKKMHS-VNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EEeCCCCccHHHHHhcCC--cCCcchHHHHHHHHHHHHHHHHHHH-CCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 998884 6766654421 1345677777889999999999999 89999999999999986552 499999997754
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.79 E-value=1.4e-07 Score=81.69 Aligned_cols=108 Identities=20% Similarity=0.305 Sum_probs=77.1
Q ss_pred hhHHHHHHHHHcCCCCee--eeceEEEecCCCceeEEEEEEecccc--cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHH
Q 016184 121 YKNRELQIMQMLDHPNIV--ALKHCFFSTTDKEELYLNLVLEYVPE--TVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196 (394)
Q Consensus 121 ~~~~E~~~l~~l~h~~iv--~~~~~~~~~~~~~~~~~~lv~e~~~~--~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al 196 (394)
...+|...+..|....|. +.+.+........ ...++|+|++++ +|.+++.... ..+......++.+++..+
T Consensus 57 ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~-~~s~lite~l~~~~~L~~~~~~~~----~~~~~~~~~ll~~l~~~i 131 (206)
T PF06293_consen 57 RAKREWRNLQRLREAGIPTPEPVAYGERRKGGG-YRSYLITEALPGAQDLRDLLQQWE----QLDPSQRRELLRALARLI 131 (206)
T ss_pred HHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCc-eeEEEEEEeCCCcccHHHHHHhhc----ccchhhHHHHHHHHHHHH
Confidence 345788887777544433 3333333322222 456789999987 4655555422 256667788899999999
Q ss_pred HHHHhCCCceeccCCCCceEEeCCC--CcEEEEeecCccc
Q 016184 197 AYIHNCIGICHRDIKPQNLLVNPHT--HQLKLCDFGSAKV 234 (394)
Q Consensus 197 ~~LH~~~givH~Dlkp~Nil~~~~~--~~vkl~Dfg~a~~ 234 (394)
.-||. .||+|+|+++.|||++.++ ..+.|+||+.++.
T Consensus 132 ~~lH~-~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 132 AKLHD-AGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHHHH-CcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 99999 8999999999999999764 2599999998764
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.75 E-value=3.5e-07 Score=78.23 Aligned_cols=135 Identities=17% Similarity=0.197 Sum_probs=84.8
Q ss_pred eeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccchhhhH-------------HHHHHHHHcCCCC---eeeeceEEE
Q 016184 82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-------------RELQIMQMLDHPN---IVALKHCFF 145 (394)
Q Consensus 82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~-------------~E~~~l~~l~h~~---iv~~~~~~~ 145 (394)
.+|.+.+++-......|.+... +|+.+++|..+......+ +++..+..+.... ...++-+..
T Consensus 31 ~~~~~~kv~k~~~r~~ValIei--~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~e 108 (229)
T PF06176_consen 31 NNYKIIKVFKNTKRNYVALIEI--DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAE 108 (229)
T ss_pred CCceEEEeecCCCccEEEEEEE--CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeee
Confidence 3588889998888887877765 478899997754332221 2333333332222 222222221
Q ss_pred ecCCCceeEEEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcE
Q 016184 146 STTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQL 224 (394)
Q Consensus 146 ~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~v 224 (394)
..........+++|||++| .+.++. .+++ .+...+..++.-||+ .|++|+|.+|.|++++.+ .+
T Consensus 109 kk~~~~~~~~~ll~EYIeG~~l~d~~--------~i~e----~~~~ki~~~ikqlH~-~G~~HGD~hpgNFlv~~~--~i 173 (229)
T PF06176_consen 109 KKIFRYTSSYVLLMEYIEGVELNDIE--------DIDE----DLAEKIVEAIKQLHK-HGFYHGDPHPGNFLVSNN--GI 173 (229)
T ss_pred eeeccceeEEEEEEEEecCeecccch--------hcCH----HHHHHHHHHHHHHHH-cCCccCCCCcCcEEEECC--cE
Confidence 1111223345689999998 232221 1222 233467788999999 999999999999999955 49
Q ss_pred EEEeecCcc
Q 016184 225 KLCDFGSAK 233 (394)
Q Consensus 225 kl~Dfg~a~ 233 (394)
+++||+..+
T Consensus 174 ~iID~~~k~ 182 (229)
T PF06176_consen 174 RIIDTQGKR 182 (229)
T ss_pred EEEECcccc
Confidence 999998764
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.71 E-value=4e-08 Score=95.36 Aligned_cols=137 Identities=22% Similarity=0.257 Sum_probs=83.9
Q ss_pred eEEeecCceEEEEEEECCCCcEEEEEEeccchhh--------------------------------------------hH
Q 016184 88 HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRY--------------------------------------------KN 123 (394)
Q Consensus 88 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--------------------------------------------~~ 123 (394)
.-|+.++-|.||+|+.+ +|+.||||+....-.. ..
T Consensus 131 ~PiAsASIaQVH~A~L~-sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~ 209 (517)
T COG0661 131 EPIASASIAQVHRAVLK-SGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR 209 (517)
T ss_pred CchhhhhHhhheeEEec-CCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence 56899999999999995 4999999986432100 01
Q ss_pred HHHHHHHHc----CCCCeeeeceEEEecCCCceeEEEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHH
Q 016184 124 RELQIMQML----DHPNIVALKHCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198 (394)
Q Consensus 124 ~E~~~l~~l----~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~ 198 (394)
+|+..+.++ ....-+.+-.+|.+.... -.++|||+.| .+.+.... .. ..++.+.+.....++. +..
T Consensus 210 ~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~----~VLtmE~i~Gi~i~d~~~l-~~--~g~d~k~ia~~~~~~f--~~q 280 (517)
T COG0661 210 REAANAERFRENFKDDPDVYVPKVYWEYTTR----RVLTMEWIDGIKISDIAAL-KS--AGIDRKELAELLVRAF--LRQ 280 (517)
T ss_pred HHHHHHHHHHHHcCCCCCeEeceeehhccCC----cEEEEEeeCCEecccHHHH-Hh--cCCCHHHHHHHHHHHH--HHH
Confidence 355444444 222233444444322211 4589999998 33333211 11 3444333332222221 222
Q ss_pred HHhCCCceeccCCCCceEEeCCCCcEEEEeecCccccc
Q 016184 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV 236 (394)
Q Consensus 199 LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~ 236 (394)
+-. .|++|.|.+|.||+++.++ .+.+.|||+.....
T Consensus 281 ~~~-dgffHaDpHpGNi~v~~~g-~i~~lDfGi~g~l~ 316 (517)
T COG0661 281 LLR-DGFFHADPHPGNILVRSDG-RIVLLDFGIVGRLD 316 (517)
T ss_pred HHh-cCccccCCCccceEEecCC-cEEEEcCcceecCC
Confidence 323 6999999999999999998 79999999987654
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.66 E-value=3.8e-07 Score=78.83 Aligned_cols=134 Identities=16% Similarity=0.155 Sum_probs=89.0
Q ss_pred eeEEeecCceEEEEEEECCCCcEEEEEEeccchhh----------------------------hHHHHHHHHHcCCCC--
Q 016184 87 EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRY----------------------------KNRELQIMQMLDHPN-- 136 (394)
Q Consensus 87 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~----------------------------~~~E~~~l~~l~h~~-- 136 (394)
...|..|--+.||+|.. .++..+|+|++...... ..+|+.-|+++..-+
T Consensus 53 ~g~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVr 131 (268)
T COG1718 53 VGCISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVR 131 (268)
T ss_pred EeeecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCC
Confidence 34678888899999987 56889999987432111 125777777774333
Q ss_pred eeeeceEEEecCCCceeEEEEEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceE
Q 016184 137 IVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLL 216 (394)
Q Consensus 137 iv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil 216 (394)
+.+-+.+. . -.+||||++... ...-......+....+..+..+++..+.-|-...|+||+||+.-|||
T Consensus 132 vP~Pi~~~-----~----nVLvMEfIg~~g---~pAP~LkDv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL 199 (268)
T COG1718 132 VPEPIAFR-----N----NVLVMEFIGDDG---LPAPRLKDVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNIL 199 (268)
T ss_pred CCCceeec-----C----CeEEEEeccCCC---CCCCCcccCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheE
Confidence 33333322 1 348999998531 11101111233333677778888888888765479999999999999
Q ss_pred EeCCCCcEEEEeecCcccc
Q 016184 217 VNPHTHQLKLCDFGSAKVL 235 (394)
Q Consensus 217 ~~~~~~~vkl~Dfg~a~~~ 235 (394)
+. ++ .+.|+|||-|...
T Consensus 200 ~~-~~-~p~iID~~QaV~~ 216 (268)
T COG1718 200 VH-DG-EPYIIDVSQAVTI 216 (268)
T ss_pred EE-CC-eEEEEECcccccc
Confidence 99 55 6999999988543
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.55 E-value=7.8e-09 Score=99.35 Aligned_cols=246 Identities=18% Similarity=0.149 Sum_probs=161.6
Q ss_pred eEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccchhhhHHHHHHHHHcCCCC-eeeeceEEEecCCCceeEEEEEEec
Q 016184 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPN-IVALKHCFFSTTDKEELYLNLVLEY 161 (394)
Q Consensus 83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~E~~~l~~l~h~~-iv~~~~~~~~~~~~~~~~~~lv~e~ 161 (394)
.|...+.+++|+++++++.+...+...+ .+.+... ....-++++|.+++||| .+..++ +...+.+..+.+++
T Consensus 243 ws~~fh~fvK~altknpKkRptaeklL~-h~fvs~~-l~~rl~~eLLdK~n~P~~~v~~~~-----d~~~E~~~~i~~~i 315 (829)
T KOG0576|consen 243 WSEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT-LSRRLAIELLDKVNNPNPVVRYLE-----DYDGEDYLWIPMRI 315 (829)
T ss_pred chHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc-hhhHHHHHHHHHccCCCCcccccc-----cCCcccccchhhhh
Confidence 4667788999999999999988776665 7766554 44456899999999999 333222 33556678899999
Q ss_pred ccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCccccccCCCc
Q 016184 162 VPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN 241 (394)
Q Consensus 162 ~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~~~~~ 241 (394)
+.+.-.. ..........+..-....+.+.-+.++++||+ .-=+|+| ||+..+. ..+..||+....+......
T Consensus 316 ~s~~rs~-~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~-~~~~~~d----~~l~s~~--~~~~~~~~v~~~L~~~~~~ 387 (829)
T KOG0576|consen 316 CSTGRSS-ALEMTVSEIALEQYQFAYPLRKETRPLAELHS-SYKVHRD----NILGSEE--EVKLLDFAVPPQLTRTMKP 387 (829)
T ss_pred hcCCccc-cccCChhhHhhhhhhhhhhhhhhccccccccc-ccccCcc----ccccccc--ccccccccCCcccCccccc
Confidence 8753000 00000111222233344455566778999998 5568888 8888753 5999999998766555455
Q ss_pred ccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCCCcccCC
Q 016184 242 VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF 321 (394)
Q Consensus 242 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 321 (394)
....+++.++|||+..... +....|+|++++--.++.-|-+|-... +.......+ ....
T Consensus 388 ~t~~~~~~~~~pev~~~~~-~~~~p~~~~~~~~~~~~ap~~pPr~~P----------------~~~~~~~g~----~p~s 446 (829)
T KOG0576|consen 388 RTAIGTPEPLAPEVIQENT-IDGCPDSGSLAVSAIQMAPGLPPRSSP----------------PAVLPMIGN----GPNS 446 (829)
T ss_pred ccCCCCCCCCCchhhcccc-cccCCCccCCCcchhhcCCCCCCCCCC----------------ccccCCCCC----CCCc
Confidence 6778899999999885544 899999999998777777776665431 110000000 0001
Q ss_pred CCCCC-CCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 016184 322 PQIKP-HPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL 371 (394)
Q Consensus 322 ~~~~~-~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 371 (394)
+.+.. ..|...+. .++...|+...|..|+.+..++.|.+|...
T Consensus 447 ~~L~~~~aw~~~~~-------~~~~~~~~~g~P~~pkv~mgacfsKvfngC 490 (829)
T KOG0576|consen 447 PMLTDKSAWSPVFH-------RDFPAPCLNGLPPTPKVHMGACFSKVFNGC 490 (829)
T ss_pred cccchhhhcCcccc-------cCCcccccCCCCCCCcchhhHHHHHHhccC
Confidence 11111 22222221 157788999999999999999999999875
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.55 E-value=4.7e-07 Score=92.94 Aligned_cols=209 Identities=19% Similarity=0.287 Sum_probs=138.1
Q ss_pred HHHHHHHHHcCCCCeeeeceEEEecCCCceeEEEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHh
Q 016184 123 NRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201 (394)
Q Consensus 123 ~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~ 201 (394)
+-|.+.+..+.|+|++.++.+-+...+.. ....+..+++.. .+..++.. ....+...++.+..+++.||.++|+
T Consensus 230 E~e~~~l~k~~~~n~~~~~~~~le~~~~g-~~~~v~~~~~s~~~~~~~~q~----v~~i~~~~~r~~~~~~~~GL~~~h~ 304 (1351)
T KOG1035|consen 230 EIELESLSKIAHDNLGGYFVYGLERLFRG-IVLDVLQEICSKVELRSLLQS----VGSIPLETLRILHQKLLEGLAYLHS 304 (1351)
T ss_pred HHHHHHHHhhccccccceeEEeehhhcch-HHHHHHHhhcCccchHHHHhh----ccccCHHHHHHHHHHHhhhHHHHHH
Confidence 34677788889999999877765444332 122234455553 33333332 3678899999999999999999999
Q ss_pred CCCceeccCCCC---ceEEeCCCCcEEEE--eecCccccccCCCcccccccccccccccccCCC-CCCChhhHHHHHHHH
Q 016184 202 CIGICHRDIKPQ---NLLVNPHTHQLKLC--DFGSAKVLVKGEPNVSYICSRYYRAPELIFGAT-EYTTAIDIWSTGCVM 275 (394)
Q Consensus 202 ~~givH~Dlkp~---Nil~~~~~~~vkl~--Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~~DiwslG~il 275 (394)
....|.-|... +..++.++ .+.++ ||+...................+.++|...... ......|+|.+|...
T Consensus 305 -~~l~~v~L~~s~~~~~~~~~e~-~~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~ 382 (1351)
T KOG1035|consen 305 -LSLEHVVLSASSSKESTVDGEG-VVAISLSDFDSSKPLPDNEKSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLL 382 (1351)
T ss_pred -hccceeEEecccccccccCccc-eeecchhhhcccccCCCcccchhhcCccccccccccccccchhhhhhHHHHHHHHH
Confidence 66555555444 33344444 46666 888887776665555566677788888774322 123347999999999
Q ss_pred HHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCC
Q 016184 276 AELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNL 355 (394)
Q Consensus 276 ~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 355 (394)
..+..|..+-.-.. .+... .+........+++.+|+..|+++
T Consensus 383 ~~~~~~~~i~~~~~------~~~~~--------------------------------l~~~~~~~~~d~~~~~~~~~~~~ 424 (1351)
T KOG1035|consen 383 LQLSQGEDISEKSA------VPVSL--------------------------------LDVLSTSELLDALPKCLDEDSEE 424 (1351)
T ss_pred hhhhhcCccccccc------chhhh--------------------------------hccccchhhhhhhhhhcchhhhh
Confidence 99988764321110 00000 00111226889999999999999
Q ss_pred CCCHHHHhcCCCCCCCCCCCC
Q 016184 356 RCTALEACVHPFFDELRDPNT 376 (394)
Q Consensus 356 Rpt~~ell~hp~f~~~~~~~~ 376 (394)
|+++.+++.|||.+-..+...
T Consensus 425 Rl~~~~ll~~~f~~~~~~~~~ 445 (1351)
T KOG1035|consen 425 RLSALELLTHPFLRFPTDNES 445 (1351)
T ss_pred ccchhhhhhchhccccccccc
Confidence 999999999999976544433
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.45 E-value=3.2e-06 Score=74.56 Aligned_cols=74 Identities=16% Similarity=0.201 Sum_probs=50.1
Q ss_pred eeEEeecCceEEEEEEECCCCcEEEEEEeccc--hhhhHHHHHHHHHcCCCC--eeeeceEEEecCCCceeEEEEEEecc
Q 016184 87 EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD--KRYKNRELQIMQMLDHPN--IVALKHCFFSTTDKEELYLNLVLEYV 162 (394)
Q Consensus 87 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~E~~~l~~l~h~~--iv~~~~~~~~~~~~~~~~~~lv~e~~ 162 (394)
++.|+.|..+.||++.... ..+++|..... .....+|..+++.+.... +.+++... .........+++|+++
T Consensus 2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~--~~~~~~~~~~~~~~~i 77 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPPDAAERLRREAAVLRQLAEHGIPVPRVLAFD--TSDEFNGFPYLLMEYI 77 (239)
T ss_dssp EEEEEESSSSEEEEEEETT--SEEEEEEESSHHHHHHHHHHHHHHHHHHHTTSBS--EEEEE--EETEETSEEEEEEEEE
T ss_pred CccCCCCCeeeEEEEEECC--cEEEEEEeCCCCCHHHHHHHHHHHHHHHhcCCCCceEEeec--ccccccccceEEEEEe
Confidence 4679999999999999864 48999987654 345567888888885443 34444322 1222333467899999
Q ss_pred cc
Q 016184 163 PE 164 (394)
Q Consensus 163 ~~ 164 (394)
+|
T Consensus 78 ~g 79 (239)
T PF01636_consen 78 PG 79 (239)
T ss_dssp SS
T ss_pred cc
Confidence 86
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.29 E-value=1.2e-05 Score=70.62 Aligned_cols=135 Identities=18% Similarity=0.156 Sum_probs=74.7
Q ss_pred eEEeecCceEEEEEEECCCCcEEEEEEeccc--hhhhHHHHHHHHHcCCCCe--eeeceEEEecCCCceeEEEEEEeccc
Q 016184 88 HVVGTGSFGVVFQAKCRETGEIVAIKKVLQD--KRYKNRELQIMQMLDHPNI--VALKHCFFSTTDKEELYLNLVLEYVP 163 (394)
Q Consensus 88 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~E~~~l~~l~h~~i--v~~~~~~~~~~~~~~~~~~lv~e~~~ 163 (394)
..||.|..+.||+. .|..+++|..... .....+|.++++.+..-.+ .+.+.+. .......++||++.
T Consensus 7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~~~~~~i~~E~~~l~~l~~~glpvP~~~~~~-----~~~~~~glv~e~i~ 77 (226)
T TIGR02172 7 TQTGEGGNGESYTH----KTGKWMLKLYNPGFDKETIKREFDASRKVFSLGIPTPHPFDLV-----EDGGRLGLIYELIV 77 (226)
T ss_pred eeecCCCCcceeEe----cCCCEEEEeCCCCCCHHHHHHHHHHHHHHHHcCCCCCceEEEE-----ecCCeeeeeeeecC
Confidence 46899999999983 2456788976542 3446789999988864433 3443333 11112457999998
Q ss_pred cc--HHH-----------HHH---H-hhhhcC----CCCHHH-HHHHHHH----------HHH-HHHHHHh---CCCcee
Q 016184 164 ET--VNR-----------IAR---N-YSRIHQ----RMPLIY-VKLYTYQ----------ICR-ALAYIHN---CIGICH 207 (394)
Q Consensus 164 ~~--l~~-----------~~~---~-~~~~~~----~l~~~~-~~~~~~q----------i~~-al~~LH~---~~givH 207 (394)
|. +.. +.. . ..+.+. ..+... ...+..+ +.. ..++|.. ...++|
T Consensus 78 G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~H 157 (226)
T TIGR02172 78 GKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLH 157 (226)
T ss_pred CccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEe
Confidence 73 110 111 0 111111 111111 0011000 111 1222221 135799
Q ss_pred ccCCCCceEEeCCCCcEEEEeecCcc
Q 016184 208 RDIKPQNLLVNPHTHQLKLCDFGSAK 233 (394)
Q Consensus 208 ~Dlkp~Nil~~~~~~~vkl~Dfg~a~ 233 (394)
+|+.|.||+++.++ +.|+||+.+.
T Consensus 158 gD~~~~Nii~~~~~--~~iIDwe~a~ 181 (226)
T TIGR02172 158 GDFQIGNLITSGKG--TYWIDLGDFG 181 (226)
T ss_pred cCCCCCcEEEcCCC--cEEEechhcC
Confidence 99999999999754 8999999875
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.28 E-value=1.2e-05 Score=78.08 Aligned_cols=137 Identities=20% Similarity=0.284 Sum_probs=81.6
Q ss_pred eEEeecCceEEEEEEECCCCcEEEEEEeccchhh-----------------------------------------hHHHH
Q 016184 88 HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRY-----------------------------------------KNREL 126 (394)
Q Consensus 88 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-----------------------------------------~~~E~ 126 (394)
+.||.-+.|.||+|+.+. |+.||||+-...-.. +.+|+
T Consensus 167 ~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA 245 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKN-GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA 245 (538)
T ss_pred chhhhcchhheEEEEecC-CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence 569999999999999965 999999975321100 01243
Q ss_pred HHHH----HcCCCC---eeeeceEEEecCCCceeEEEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHH
Q 016184 127 QIMQ----MLDHPN---IVALKHCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198 (394)
Q Consensus 127 ~~l~----~l~h~~---iv~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~ 198 (394)
+... .+.|-+ -|.+-.++..-.. ...++||||+| .+.++ ..... ..++...+...+.+... +-
T Consensus 246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~~st----~RVLtME~~~G~~i~Dl-~~i~~--~gi~~~~i~~~l~~~~~--~q 316 (538)
T KOG1235|consen 246 KNAERFRENFKDFSLLTYVLVPKVYWDLST----KRVLTMEYVDGIKINDL-DAIDK--RGISPHDILNKLVEAYL--EQ 316 (538)
T ss_pred HhHHHHHHHHHhcccccceeCCeehhhcCc----ceEEEEEecCCccCCCH-HHHHH--cCCCHHHHHHHHHHHHH--HH
Confidence 3322 234444 2233333322111 25689999997 22222 11111 45555554433333222 11
Q ss_pred HHhCCCceeccCCCCceEEeC---CCCcEEEEeecCcccc
Q 016184 199 IHNCIGICHRDIKPQNLLVNP---HTHQLKLCDFGSAKVL 235 (394)
Q Consensus 199 LH~~~givH~Dlkp~Nil~~~---~~~~vkl~Dfg~a~~~ 235 (394)
|-. .|++|+|=+|.||+++. .+..+.+.|||+....
T Consensus 317 If~-~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~i 355 (538)
T KOG1235|consen 317 IFK-TGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVI 355 (538)
T ss_pred HHh-cCCccCCCCCCcEEEecCCCCCccEEEEcccccccc
Confidence 223 59999999999999994 2447999999998655
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.27 E-value=6.1e-06 Score=67.64 Aligned_cols=126 Identities=19% Similarity=0.294 Sum_probs=83.8
Q ss_pred EEeeEEeecCceEEEEEEECCCCcEEEEEEeccc--hhhhHHHHHHHHHcCCCCeee-eceEEEecCCCceeEEEEEEec
Q 016184 85 IAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD--KRYKNRELQIMQMLDHPNIVA-LKHCFFSTTDKEELYLNLVLEY 161 (394)
Q Consensus 85 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~E~~~l~~l~h~~iv~-~~~~~~~~~~~~~~~~~lv~e~ 161 (394)
.+.+.||+|.+|.||++.+. |..+|+|+-+.+ ...+..|+++|..+.--++.. ++.+- . .++.|||
T Consensus 25 ~v~~~L~KG~~s~Vyl~~~~--~~~~a~Kvrr~ds~r~~l~kEakiLeil~g~~~~p~vy~yg-----~----~~i~me~ 93 (201)
T COG2112 25 RVEKELAKGTTSVVYLGEWR--GGEVALKVRRRDSPRRNLEKEAKILEILAGEGVTPEVYFYG-----E----DFIRMEY 93 (201)
T ss_pred hhhhhhhcccccEEEEeecc--CceEEEEEecCCcchhhHHHHHHHHHHhhhcCCCceEEEec-----h----hhhhhhh
Confidence 45678999999999999986 668999976543 456678999999998766653 32211 1 2356999
Q ss_pred ccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCC-CCceEEeCCCCcEEEEeecCccc
Q 016184 162 VPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIK-PQNLLVNPHTHQLKLCDFGSAKV 234 (394)
Q Consensus 162 ~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlk-p~Nil~~~~~~~vkl~Dfg~a~~ 234 (394)
+.| .|...... ..... ...++.+---|-. .||-|+.|. |..+++..++ .+.|+||..|+.
T Consensus 94 i~G~~L~~~~~~-------~~rk~----l~~vlE~a~~LD~-~GI~H~El~~~~k~vlv~~~-~~~iIDFd~At~ 155 (201)
T COG2112 94 IDGRPLGKLEIG-------GDRKH----LLRVLEKAYKLDR-LGIEHGELSRPWKNVLVNDR-DVYIIDFDSATF 155 (201)
T ss_pred hcCcchhhhhhc-------ccHHH----HHHHHHHHHHHHH-hccchhhhcCCceeEEecCC-cEEEEEccchhh
Confidence 998 44332221 01122 2345555444555 899999886 4444454455 699999999973
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=98.19 E-value=1.5e-05 Score=67.51 Aligned_cols=126 Identities=28% Similarity=0.370 Sum_probs=87.7
Q ss_pred eeEEEeeEEeecCc-eEEEEEEECCCCcEEEEEEecc--------------c-h----------hhhHHHHHHHHHc---
Q 016184 82 VSYIAEHVVGTGSF-GVVFQAKCRETGEIVAIKKVLQ--------------D-K----------RYKNRELQIMQML--- 132 (394)
Q Consensus 82 ~~y~~~~~lg~G~~-g~V~~~~~~~~~~~vaiK~~~~--------------~-~----------~~~~~E~~~l~~l--- 132 (394)
..++.++.||.|.. |.||+++.. |+.+|||++.. . . ..+..|-+...+|
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I~--g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~ 114 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEID--GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA 114 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEEC--CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence 45899999999999 999999985 78999998321 0 0 1122455554444
Q ss_pred CCCCe--eeeceEEEecCC-------------CceeEEEEEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHH
Q 016184 133 DHPNI--VALKHCFFSTTD-------------KEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALA 197 (394)
Q Consensus 133 ~h~~i--v~~~~~~~~~~~-------------~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ 197 (394)
.+.++ +++++++....+ .......||.||++... .+.... +.+|.+-|.
T Consensus 115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~------------~~~~~~----~~~~~~dl~ 178 (207)
T PF13095_consen 115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP------------PLQIRD----IPQMLRDLK 178 (207)
T ss_pred cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc------------ccchhH----HHHHHHHHH
Confidence 45566 888888754421 22234568888887532 122222 457888899
Q ss_pred HHHhCCCceeccCCCCceEEeCCCCcEEEEeecCc
Q 016184 198 YIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA 232 (394)
Q Consensus 198 ~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a 232 (394)
.+|. .||+-+|+++.|.. .-+|+|||.+
T Consensus 179 ~~~k-~gI~~~Dv~~~ny~------~G~lvDfs~~ 206 (207)
T PF13095_consen 179 ILHK-LGIVPRDVKPRNYR------GGKLVDFSSS 206 (207)
T ss_pred HHHH-CCeeeccCcccccc------CCEEEecccC
Confidence 9999 89999999999986 2589999965
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.05 E-value=8e-05 Score=78.03 Aligned_cols=77 Identities=16% Similarity=0.189 Sum_probs=49.4
Q ss_pred eeEEeecCceEEEEEEECCCC--cEEEEEEecc-----chhhhHHHHHHHHHcC-CCCe--eeeceEEEecCCCceeEEE
Q 016184 87 EHVVGTGSFGVVFQAKCRETG--EIVAIKKVLQ-----DKRYKNRELQIMQMLD-HPNI--VALKHCFFSTTDKEELYLN 156 (394)
Q Consensus 87 ~~~lg~G~~g~V~~~~~~~~~--~~vaiK~~~~-----~~~~~~~E~~~l~~l~-h~~i--v~~~~~~~~~~~~~~~~~~ 156 (394)
.+.|+.|.++.+|+......+ ..+++|+... ......+|+++++.+. |.++ .+++.++. +.......+
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~--d~~v~G~~f 120 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCT--DASVIGTAF 120 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEec--CCCcCCCce
Confidence 466799999999998765332 3577776532 2245678999999995 6664 45444431 111112356
Q ss_pred EEEeccccc
Q 016184 157 LVLEYVPET 165 (394)
Q Consensus 157 lv~e~~~~~ 165 (394)
+||||++|.
T Consensus 121 lVME~v~G~ 129 (822)
T PLN02876 121 YIMEYLEGR 129 (822)
T ss_pred EEEEecCCc
Confidence 899999863
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.00 E-value=0.00022 Score=60.94 Aligned_cols=123 Identities=21% Similarity=0.311 Sum_probs=81.0
Q ss_pred eEEeecCceEEEEEEECCCCcEEEEEEeccch--------------------hhhHHHHHHHHHcC------CCCeeeec
Q 016184 88 HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK--------------------RYKNRELQIMQMLD------HPNIVALK 141 (394)
Q Consensus 88 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--------------------~~~~~E~~~l~~l~------h~~iv~~~ 141 (394)
..||+|+.=.||. | ......+||+..... ....+|+.....+. +.+|.+++
T Consensus 7 ~~i~~G~~R~cy~--H-P~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~ 83 (199)
T PF10707_consen 7 DLIAQGGERDCYQ--H-PDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY 83 (199)
T ss_pred cccccCCCceEEE--C-CCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence 5689999999985 3 334557899886554 44456777766665 77888998
Q ss_pred eEEEecCCCceeEEEEEEeccc---c----cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCc
Q 016184 142 HCFFSTTDKEELYLNLVLEYVP---E----TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQN 214 (394)
Q Consensus 142 ~~~~~~~~~~~~~~~lv~e~~~---~----~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~N 214 (394)
|...+..+ ..+|+|.+. | +|.+++.. ..++. .+. ..+-.-.++|-+ .+|+.+||+|.|
T Consensus 84 G~veT~~G-----~Glv~e~I~d~dG~~s~TL~~~l~~-----~~~~~-~~~---~~L~~f~~~l~~-~~Iv~~dl~~~N 148 (199)
T PF10707_consen 84 GFVETNLG-----LGLVVELIRDADGNISPTLEDYLKE-----GGLTE-ELR---QALDEFKRYLLD-HHIVIRDLNPHN 148 (199)
T ss_pred EEEecCCc-----eEEEEEEEECCCCCcCccHHHHHHc-----CCccH-HHH---HHHHHHHHHHHH-cCCeecCCCccc
Confidence 87744333 445666553 2 45555532 45555 332 233444567777 899999999999
Q ss_pred eEEeCCC--C-cEEEEe
Q 016184 215 LLVNPHT--H-QLKLCD 228 (394)
Q Consensus 215 il~~~~~--~-~vkl~D 228 (394)
|++.... . .+.|+|
T Consensus 149 Iv~~~~~~~~~~lvlID 165 (199)
T PF10707_consen 149 IVVQRRDSGEFRLVLID 165 (199)
T ss_pred EEEEecCCCceEEEEEe
Confidence 9997543 2 466776
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.97 E-value=8e-05 Score=65.94 Aligned_cols=30 Identities=33% Similarity=0.407 Sum_probs=24.9
Q ss_pred CCceeccCCCCceEEeCCCCcEEEEeecCcc
Q 016184 203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAK 233 (394)
Q Consensus 203 ~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~ 233 (394)
.+++|+|+.+.|||++.+. ..-|+||+.+.
T Consensus 164 ~~l~HGD~~~~Nvlv~~~~-i~giIDw~~a~ 193 (235)
T cd05155 164 PVWFHGDLAPGNLLVQDGR-LSAVIDFGCLG 193 (235)
T ss_pred ceEEeCCCCCCcEEEECCC-EEEEEeCcccC
Confidence 4589999999999998553 45799999874
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=97.93 E-value=0.00011 Score=65.38 Aligned_cols=67 Identities=13% Similarity=0.048 Sum_probs=40.7
Q ss_pred eecCc-eEEEEEEECCCCcEEEEEEeccc-hhhhHHHHHHHHHcCC-CCeeeeceEEEecCCCceeEEEEEEecccc
Q 016184 91 GTGSF-GVVFQAKCRETGEIVAIKKVLQD-KRYKNRELQIMQMLDH-PNIVALKHCFFSTTDKEELYLNLVLEYVPE 164 (394)
Q Consensus 91 g~G~~-g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~~~~~~~~lv~e~~~~ 164 (394)
-.|.. ..||++... +..+.+|+.... .....+|+++++.+.. --+.+++.+... . ...++||++++|
T Consensus 7 ~~g~~~~~v~~~~~~--~~~~~vk~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~---~--~~~~lv~e~i~G 76 (244)
T cd05150 7 TEGQSGATVYRLDGK--NPGLYLKIAPSGPTYELEREAERLRWLAGKLPVPEVIDYGSD---D--GRAWLLTSAVPG 76 (244)
T ss_pred CCCCCcCeEEEEcCC--CCcEEEEecCCCcccchHHHHHHHHHHHhcCCCCeEEEEEec---C--CccEEEEEeeCC
Confidence 33444 789998753 467888876432 2345679999888843 233344443311 1 224579999987
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.80 E-value=0.00014 Score=65.33 Aligned_cols=132 Identities=22% Similarity=0.251 Sum_probs=72.7
Q ss_pred EeecCceEEEEEEECCCCcEEEEEEeccchh----hhHHHHHHHHHcCCCCee-eeceEEEecCCCceeEEEEEEecccc
Q 016184 90 VGTGSFGVVFQAKCRETGEIVAIKKVLQDKR----YKNRELQIMQMLDHPNIV-ALKHCFFSTTDKEELYLNLVLEYVPE 164 (394)
Q Consensus 90 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~E~~~l~~l~h~~iv-~~~~~~~~~~~~~~~~~~lv~e~~~~ 164 (394)
+..|-.+.+|+... +++.+++|....... ...+|.++++.+....++ +++... . -++||||++|
T Consensus 4 ~~~G~tn~~y~~~~--~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~-----~----~~~v~e~i~G 72 (256)
T TIGR02721 4 LSGGLTNRSWRIEH--PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVN-----E----HWLLVEWLEG 72 (256)
T ss_pred CCCcCcCCeEEEEe--CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEe-----C----CEEEEEeccC
Confidence 45677778888863 466788887543322 346799999998654443 222211 1 1478999886
Q ss_pred cH------------HHHHHHhhhhc------CCCCHH-HHHHHHHHH---------HHHHHHHHh-------CCCceecc
Q 016184 165 TV------------NRIARNYSRIH------QRMPLI-YVKLYTYQI---------CRALAYIHN-------CIGICHRD 209 (394)
Q Consensus 165 ~l------------~~~~~~~~~~~------~~l~~~-~~~~~~~qi---------~~al~~LH~-------~~givH~D 209 (394)
.. ..+.....+.+ ..++.. .+..+..++ ...++.+-. ...++|+|
T Consensus 73 ~~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~D 152 (256)
T TIGR02721 73 EVITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMD 152 (256)
T ss_pred cccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCC
Confidence 21 11111111111 111111 111221111 111222211 02589999
Q ss_pred CCCCceEEeCCCCcEEEEeecCccc
Q 016184 210 IKPQNLLVNPHTHQLKLCDFGSAKV 234 (394)
Q Consensus 210 lkp~Nil~~~~~~~vkl~Dfg~a~~ 234 (394)
+.|.||+++.++ +.|+||..|..
T Consensus 153 l~~~Nil~~~~~--~~lIDwE~a~~ 175 (256)
T TIGR02721 153 VHAYNLVVTPQG--LKLIDWEYASD 175 (256)
T ss_pred CCcCcEEEeCCC--CEEEeccccCc
Confidence 999999999765 78999998853
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.72 E-value=0.00019 Score=65.76 Aligned_cols=136 Identities=18% Similarity=0.206 Sum_probs=92.8
Q ss_pred EEeeEEeecCceEEEEEEECCCCcEEEEEEeccc-------h-----------------------hhhHHHHHHHHHcCC
Q 016184 85 IAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------K-----------------------RYKNRELQIMQMLDH 134 (394)
Q Consensus 85 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~-----------------------~~~~~E~~~l~~l~h 134 (394)
.|...|..|--+.||.|.. .+|..+|||+++.+ . ...++|++-|+++..
T Consensus 147 ~inGCiSTGKEANVYHat~-~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~ 225 (520)
T KOG2270|consen 147 EINGCISTGKEANVYHATE-EDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNN 225 (520)
T ss_pred ecccccccCccceeEeeec-CCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHh
Confidence 4556788999999999987 57888999976321 0 111358888888866
Q ss_pred CCeeeeceEEEecCCCceeEEEEEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCc
Q 016184 135 PNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQN 214 (394)
Q Consensus 135 ~~iv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~N 214 (394)
..|..---+.+.. -.|||++++..- ..........++...+..+-.|++.-+.-|-...++||.||.=-|
T Consensus 226 aGIP~PePIlLk~-------hVLVM~FlGrdg---w~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN 295 (520)
T KOG2270|consen 226 AGIPCPEPILLKN-------HVLVMEFLGRDG---WAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFN 295 (520)
T ss_pred cCCCCCCceeeec-------ceEeeeeccCCC---CcCcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhh
Confidence 5544322222111 348999998421 111111124566677888888888888887554799999999999
Q ss_pred eEEeCCCCcEEEEeecCcc
Q 016184 215 LLVNPHTHQLKLCDFGSAK 233 (394)
Q Consensus 215 il~~~~~~~vkl~Dfg~a~ 233 (394)
+|+. +| .+.|+|-+-+-
T Consensus 296 ~Lyh-dG-~lyiIDVSQSV 312 (520)
T KOG2270|consen 296 LLYH-DG-KLYIIDVSQSV 312 (520)
T ss_pred heEE-CC-EEEEEEccccc
Confidence 9998 45 69999988763
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.69 E-value=0.00067 Score=59.97 Aligned_cols=69 Identities=19% Similarity=0.327 Sum_probs=43.7
Q ss_pred eeEEeecCceEEEEEEECC-CCcEEEEEEeccch---hhhHHHHHHHHHcCCCCee-eeceEEEecCCCceeEEEEEEec
Q 016184 87 EHVVGTGSFGVVFQAKCRE-TGEIVAIKKVLQDK---RYKNRELQIMQMLDHPNIV-ALKHCFFSTTDKEELYLNLVLEY 161 (394)
Q Consensus 87 ~~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~~~---~~~~~E~~~l~~l~h~~iv-~~~~~~~~~~~~~~~~~~lv~e~ 161 (394)
++.|..|-...+|++.... .++.|++|+..... ....+|+.+++.+...+++ +++... .+ .++|||
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~~~d~~~E~~~~~~l~~~gl~P~v~~~~---~~------~~l~e~ 73 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTELIIDRERELRIHKLLSKHGLAPKLYATF---QN------GLIYEF 73 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCccceecHHHHHHHHHHHHhCCCCCeEEEEe---CC------cEEEEe
Confidence 3567788888999987643 35678899764322 2234788899988554443 332221 11 269999
Q ss_pred ccc
Q 016184 162 VPE 164 (394)
Q Consensus 162 ~~~ 164 (394)
++|
T Consensus 74 i~G 76 (235)
T cd05157 74 IPG 76 (235)
T ss_pred eCC
Confidence 875
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.60 E-value=8.3e-05 Score=66.95 Aligned_cols=128 Identities=16% Similarity=0.176 Sum_probs=83.9
Q ss_pred EEEeeEEeecCceEEEEEEECCCCcEEEEEEeccc----------h----------------hhhHHHHHHHHHcCCCC-
Q 016184 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD----------K----------------RYKNRELQIMQMLDHPN- 136 (394)
Q Consensus 84 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----------~----------------~~~~~E~~~l~~l~h~~- 136 (394)
|.++..||-|--+-||.+-+ ..|++.++|.-+.. . -...+|+..|+.|....
T Consensus 94 ~svGnqIGVGKESDIY~v~d-~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf 172 (465)
T KOG2268|consen 94 ESVGNQIGVGKESDIYVVAD-EEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF 172 (465)
T ss_pred hhhccccccccccceEEEec-CCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence 67888999999999999988 46888999953211 1 11135888888874322
Q ss_pred -eeeeceEEEecCCCceeEEEEEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCce
Q 016184 137 -IVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNL 215 (394)
Q Consensus 137 -iv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Ni 215 (394)
+.+.+++. .-|+|||++.+-....++ .-.. ...+...+..-+--|.. +|+||+|.+-=||
T Consensus 173 pVPkpiD~~---------RH~Vvmelv~g~Pl~~v~------~v~d---~~~ly~~lm~~Iv~la~-~GlIHgDFNEFNi 233 (465)
T KOG2268|consen 173 PVPKPIDHN---------RHCVVMELVDGYPLRQVR------HVED---PPTLYDDLMGLIVRLAN-HGLIHGDFNEFNI 233 (465)
T ss_pred CCCCccccc---------ceeeHHHhhcccceeeee------ecCC---hHHHHHHHHHHHHHHHH-cCceecccchhee
Confidence 23333222 146899998862211111 1111 22233445555566777 8999999999999
Q ss_pred EEeCCCCcEEEEeecCc
Q 016184 216 LVNPHTHQLKLCDFGSA 232 (394)
Q Consensus 216 l~~~~~~~vkl~Dfg~a 232 (394)
+++.++ .++++||--.
T Consensus 234 mv~dd~-~i~vIDFPQm 249 (465)
T KOG2268|consen 234 MVKDDD-KIVVIDFPQM 249 (465)
T ss_pred EEecCC-CEEEeechHh
Confidence 999877 6999999855
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.58 E-value=0.0018 Score=59.36 Aligned_cols=74 Identities=9% Similarity=0.018 Sum_probs=49.3
Q ss_pred eeEEeecCceEEEEEEECCCCcEEEEEEecc--chhhhHHHHHHHHHcCC---CCeeeeceEEEecCCCceeEEEEEEec
Q 016184 87 EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQ--DKRYKNRELQIMQMLDH---PNIVALKHCFFSTTDKEELYLNLVLEY 161 (394)
Q Consensus 87 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~--~~~~~~~E~~~l~~l~h---~~iv~~~~~~~~~~~~~~~~~~lv~e~ 161 (394)
.+.||.|..+.||..... ++ .+.+|.... ....+..|.+.|+.|.. -.+.++++++... ......++|||+
T Consensus 19 ~~~i~~G~~~~vy~~~~~-~~-~~~~k~~~~~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~--~~~g~~~LVmE~ 94 (297)
T PRK10593 19 VECISEQPYAALWALYDS-QG-NPMPLMARSFSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHE--QSPGPDVLLLER 94 (297)
T ss_pred eeecCCccceeEEEEEcC-CC-CEEEEEecccccchHHHHHHHHHHHHccCCCCCcCcEEEEeccC--CcCCCeEEEEec
Confidence 467999999999998653 23 467787543 23577889999998854 2456666554221 112225689999
Q ss_pred ccc
Q 016184 162 VPE 164 (394)
Q Consensus 162 ~~~ 164 (394)
+++
T Consensus 95 i~G 97 (297)
T PRK10593 95 LRG 97 (297)
T ss_pred cCC
Confidence 886
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.57 E-value=0.0018 Score=61.51 Aligned_cols=70 Identities=20% Similarity=0.283 Sum_probs=45.8
Q ss_pred eEEeecCceEEEEEEECCCCcEEEEEEecc-----------chhhhHHHHHHHHHcC---CCCeeeeceEEEecCCCcee
Q 016184 88 HVVGTGSFGVVFQAKCRETGEIVAIKKVLQ-----------DKRYKNRELQIMQMLD---HPNIVALKHCFFSTTDKEEL 153 (394)
Q Consensus 88 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-----------~~~~~~~E~~~l~~l~---h~~iv~~~~~~~~~~~~~~~ 153 (394)
+.||.|.+..||++.....++.|+||.-.. .......|.+.|+.+. -.++++++.+- .+.
T Consensus 32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D-----~~~- 105 (401)
T PRK09550 32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYD-----EEL- 105 (401)
T ss_pred eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEEC-----CCC-
Confidence 579999999999999864335899997421 1223356788887763 23455665532 211
Q ss_pred EEEEEEecccc
Q 016184 154 YLNLVLEYVPE 164 (394)
Q Consensus 154 ~~~lv~e~~~~ 164 (394)
.++|||++++
T Consensus 106 -~~lVME~L~~ 115 (401)
T PRK09550 106 -AVTVMEDLSD 115 (401)
T ss_pred -CEEEEecCCC
Confidence 4589999874
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.55 E-value=0.00047 Score=63.27 Aligned_cols=141 Identities=13% Similarity=0.103 Sum_probs=76.5
Q ss_pred eeEEeecCceEEEEEEECCCCcEEEEEEecc-chhhhHHHHHHHHHcCCCC--eeeeceEEEecCC----CceeEEEEEE
Q 016184 87 EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQ-DKRYKNRELQIMQMLDHPN--IVALKHCFFSTTD----KEELYLNLVL 159 (394)
Q Consensus 87 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-~~~~~~~E~~~l~~l~h~~--iv~~~~~~~~~~~----~~~~~~~lv~ 159 (394)
.+.|..|....+|+.... +..+++|+... .......|++++..+.+.+ +.+++.. ..+ ......++++
T Consensus 19 i~~i~~G~~n~~y~v~~~--~~~~vLr~~~~~~~~~~~~e~~~l~~L~~~g~~vp~~i~~---~~g~~~~~~~~~~~~l~ 93 (296)
T cd05153 19 FEGISAGIENTNYFVTTD--SGRYVLTLFEKVSAEELPFFLALLDHLAERGLPVPRPIAD---RDGEYLSELAGKPAALV 93 (296)
T ss_pred eecccCccccceEEEEeC--CCcEEEEEcCCCChHhccHHHHHHHHHHHCCCCCCccccC---CCCcEeeeeCCceEEEE
Confidence 456777888899988653 44688998763 3344567888888885433 3333221 010 0012346899
Q ss_pred ecccccH---------HHHHHHhhhhc---CCC--------CHHHHHH------------HHHHHHHHHHHHHh------
Q 016184 160 EYVPETV---------NRIARNYSRIH---QRM--------PLIYVKL------------YTYQICRALAYIHN------ 201 (394)
Q Consensus 160 e~~~~~l---------~~~~~~~~~~~---~~l--------~~~~~~~------------~~~qi~~al~~LH~------ 201 (394)
++++|.. ..+.+...+.+ ..+ ....... ....+..++.++.+
T Consensus 94 ~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~ 173 (296)
T cd05153 94 EFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDL 173 (296)
T ss_pred EeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcC
Confidence 9987521 11111111100 000 0000000 01112233444432
Q ss_pred CCCceeccCCCCceEEeCCCCcEEEEeecCcc
Q 016184 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK 233 (394)
Q Consensus 202 ~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~ 233 (394)
..+++|+|+.|.|||++.++ .+.|+||+.+.
T Consensus 174 ~~~l~HgD~~~~Nil~~~~~-~~~iIDfe~a~ 204 (296)
T cd05153 174 PRGVIHADLFRDNVLFDGDE-LSGVIDFYFAC 204 (296)
T ss_pred CCcCCccCcCcccEEEeCCc-eEEEeehhhhc
Confidence 14799999999999999764 46899999874
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.51 E-value=0.0021 Score=59.75 Aligned_cols=30 Identities=27% Similarity=0.286 Sum_probs=25.5
Q ss_pred CCceeccCCCCceEEeCCCCcEEEEeecCcc
Q 016184 203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAK 233 (394)
Q Consensus 203 ~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~ 233 (394)
.++||+|++|.|||++.+. ..-|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~~~-~~~iIDf~~~~ 216 (319)
T PRK05231 187 RGVIHADLFRDNVLFEGDR-LSGFIDFYFAC 216 (319)
T ss_pred cccCCCCCCCCcEEEECCc-eEEEEeccccc
Confidence 4899999999999999553 45899999875
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.47 E-value=0.00043 Score=58.80 Aligned_cols=102 Identities=24% Similarity=0.190 Sum_probs=74.7
Q ss_pred HHHHHHHHHcCC-CCeeeeceEEEecCCCceeEEEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHH
Q 016184 123 NRELQIMQMLDH-PNIVALKHCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 200 (394)
Q Consensus 123 ~~E~~~l~~l~h-~~iv~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH 200 (394)
+.|.-+++.+++ +++++++|.| . -.++.||.+. .+..... ........++.....++.+++..+++|+
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~C-----G----~~~v~E~~~~~~~~~~~~-~l~~~~~~~w~~R~~iA~~lL~~l~~l~ 76 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSC-----G----RFYVVEYVGAGSLYGIYR-PLSQFLQSPWEQRAKIALQLLELLEELD 76 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeEC-----C----CEEEEEeecCcccccccc-ccccccccCHHHHHHHHHHHHHHHHHHh
Confidence 358888999976 5899999988 2 2468899884 3321100 0001134688899999999999999998
Q ss_pred hC--CCceeccCCCCceEEeCCCCcEEEEeecCcccc
Q 016184 201 NC--IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL 235 (394)
Q Consensus 201 ~~--~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~ 235 (394)
.. ..+.-.|++++|+-++.++ .+|++|...+...
T Consensus 77 ~~~~~~~~lcDv~~~nfgv~~~~-~lk~iDld~v~~~ 112 (188)
T PF12260_consen 77 HGPLGFFYLCDVSPDNFGVNDDG-RLKLIDLDDVFVE 112 (188)
T ss_pred cCCCCcEEEeecchHHeEEeCCC-cEEEEechhcchh
Confidence 62 2366689999999999887 6999999987543
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.37 E-value=0.0023 Score=59.09 Aligned_cols=145 Identities=13% Similarity=0.100 Sum_probs=76.8
Q ss_pred EeeEEeecCceEEEEEEECCCCcEEEEEEeccc--hhhhHHHHHHHHHcCCCCe--eeeceEEEec-CCCceeEEEEEEe
Q 016184 86 AEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD--KRYKNRELQIMQMLDHPNI--VALKHCFFST-TDKEELYLNLVLE 160 (394)
Q Consensus 86 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~E~~~l~~l~h~~i--v~~~~~~~~~-~~~~~~~~~lv~e 160 (394)
..+.++.|....+|++.. .+| .+++|+.... ......|.+++..|....+ ++++...-.. ........+++++
T Consensus 26 ~i~~~~~G~~n~~y~v~t-~~~-~~vLK~~~~~~~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e 103 (307)
T TIGR00938 26 SLKGIAEGVENSNYLLTT-DVG-RYILTLYEKRVKAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVE 103 (307)
T ss_pred eccccCCccccceEEEEe-CCC-cEEEEEecCCCCHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEE
Confidence 356677887789998865 334 5778976542 3445567888887743332 3332211000 0001223568999
Q ss_pred cccccH---------HHHHHHhhhhc---CCC--------CHHH-----HH----------HHHHHHHHHHHHHHh----
Q 016184 161 YVPETV---------NRIARNYSRIH---QRM--------PLIY-----VK----------LYTYQICRALAYIHN---- 201 (394)
Q Consensus 161 ~~~~~l---------~~~~~~~~~~~---~~l--------~~~~-----~~----------~~~~qi~~al~~LH~---- 201 (394)
|++|.. ..+-+.....+ ..+ .... .. .....+...++++..
T Consensus 104 ~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~ 183 (307)
T TIGR00938 104 FLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPR 183 (307)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhh
Confidence 987621 01111100000 000 0000 00 001112334444432
Q ss_pred --CCCceeccCCCCceEEeCCCCcEEEEeecCcc
Q 016184 202 --CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK 233 (394)
Q Consensus 202 --~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~ 233 (394)
..+++|+|+++.||+++.++ .+.|+||+.+.
T Consensus 184 ~~~~~l~HgD~~~~Nvl~~~~~-~~~vIDfd~~~ 216 (307)
T TIGR00938 184 DLPRGVIHADLFPDNVLFDGDS-VKGVIDFYFAC 216 (307)
T ss_pred cCCCccCCCCCCcCcEEEECCc-eEEEeeccccc
Confidence 26899999999999999775 56899999874
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.31 E-value=0.00045 Score=65.94 Aligned_cols=172 Identities=20% Similarity=0.245 Sum_probs=106.5
Q ss_pred hHHHHHHHHHcCCCCeeeeceEEEecCCCceeEEEEEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHh
Q 016184 122 KNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201 (394)
Q Consensus 122 ~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~ 201 (394)
..-.+.+++.+.|+|....+++- ...... ..+|||+++.++.+.+.... +.. .++. .
T Consensus 29 ilgr~~~lktl~~~~l~~yl~~~---r~~~~r-~IVV~e~~~~Sled~~~~~~-----l~~-------~s~~-------~ 85 (725)
T KOG1093|consen 29 ILGRFQYLKSLQHDNLCQYLDFS---RGKHER-VIVVMEHYTMSLEDILKTGN-----LKD-------ESLL-------A 85 (725)
T ss_pred HhhhhHHHHhhcCccceeeEeee---cCccce-EEEEehhhccchHHHHHhcc-----cch-------hhhc-------c
Confidence 34567889999999999887654 111222 66899999999888776522 100 0111 1
Q ss_pred CCCceeccCCCCceEEeCCCCcEEEEeecCccccccCCCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhC
Q 016184 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLG 281 (394)
Q Consensus 202 ~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg 281 (394)
+|+.|- | .++.+| .++. . | |- ....|+|||++|.++.++.-|
T Consensus 86 -~~~~~~-----~--------~~~~td-~~~t----~-----------~--~~------~~~pKsdVwsl~~i~~el~L~ 127 (725)
T KOG1093|consen 86 -HGVLHL-----N--------IIYITD-HFLT----K-----------Y--PS------PIGPKSDVWSLGFIILELYLG 127 (725)
T ss_pred -ccccee-----h--------hhhccc-cccc----c-----------C--CC------CCCcchhhhhHHHHHHHHHHh
Confidence 233322 1 233334 1110 0 0 10 112499999999999999999
Q ss_pred CCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHH
Q 016184 282 QPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALE 361 (394)
Q Consensus 282 ~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e 361 (394)
...+......+.+..+....-.+.......+ ...+.-.++....+++..|+...|..||...+
T Consensus 128 ~~l~~~~~~s~~l~~i~k~~~~d~~~~~~a~-----------------e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~ 190 (725)
T KOG1093|consen 128 ISLEAELTESEYLEILLKYYTDDQELLSTAM-----------------EHLIQLLADKKRLPLLKKCLWLEPIIRPLPME 190 (725)
T ss_pred hHHHHHHHHHHHHHHHHHhccCchhHHHHHH-----------------HHHHHHhhhHhHHHHhccCCccccccccchhH
Confidence 9888766655555555443222222111110 01122346778899999999999999999999
Q ss_pred HhcCCCCCCC
Q 016184 362 ACVHPFFDEL 371 (394)
Q Consensus 362 ll~hp~f~~~ 371 (394)
+.+|+-|.++
T Consensus 191 ~~k~~i~~ev 200 (725)
T KOG1093|consen 191 LSKRCSFTEV 200 (725)
T ss_pred HhcCccHHHH
Confidence 9999999876
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.18 E-value=0.0078 Score=55.39 Aligned_cols=30 Identities=33% Similarity=0.576 Sum_probs=26.2
Q ss_pred CCceeccCCCCceEEeCC----CCcEEEEeecCcc
Q 016184 203 IGICHRDIKPQNLLVNPH----THQLKLCDFGSAK 233 (394)
Q Consensus 203 ~givH~Dlkp~Nil~~~~----~~~vkl~Dfg~a~ 233 (394)
..++|+|+.+.|||++.+ + .+.|+||..|.
T Consensus 179 ~~lcH~Dl~~~Nil~~~~~~~~~-~i~lIDwEya~ 212 (302)
T cd05156 179 VVFCHNDLQEGNILLLNPSSETK-KLVLIDFEYAS 212 (302)
T ss_pred ceEEecCCCcCeEEecCCCCCCC-cEEEEeeCCCC
Confidence 468999999999999974 5 69999999874
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=97.17 E-value=0.0061 Score=57.16 Aligned_cols=32 Identities=28% Similarity=0.676 Sum_probs=26.8
Q ss_pred CCceeccCCCCceEEeCCCCcEEEEeecCccc
Q 016184 203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV 234 (394)
Q Consensus 203 ~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~ 234 (394)
..++|+|+++.|||++.+...+.|+||..+..
T Consensus 200 ~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 200 IGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred ceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 36899999999999986434699999998853
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=97.15 E-value=0.0064 Score=55.10 Aligned_cols=31 Identities=29% Similarity=0.528 Sum_probs=25.6
Q ss_pred CceeccCCCCceEEeCCCCcEEEEeecCccc
Q 016184 204 GICHRDIKPQNLLVNPHTHQLKLCDFGSAKV 234 (394)
Q Consensus 204 givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~ 234 (394)
.++|+|++|.|||++.++...-|+||+.+..
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 4899999999999996553457999998853
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=97.03 E-value=0.0078 Score=56.16 Aligned_cols=30 Identities=27% Similarity=0.445 Sum_probs=25.8
Q ss_pred ceeccCCCCceEEeCCCCcEEEEeecCccc
Q 016184 205 ICHRDIKPQNLLVNPHTHQLKLCDFGSAKV 234 (394)
Q Consensus 205 ivH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~ 234 (394)
++|+|+.+.|||+++++..++++||..|..
T Consensus 184 ~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 184 FAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred EEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 799999999999986544799999998854
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=96.99 E-value=0.016 Score=53.51 Aligned_cols=29 Identities=28% Similarity=0.592 Sum_probs=25.3
Q ss_pred CCceeccCCCCceEEeCCCCcEEEEeecCcc
Q 016184 203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAK 233 (394)
Q Consensus 203 ~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~ 233 (394)
.+++|+|+++.||+++. + .+.|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~-~-~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-N-EVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeC-C-cEEEEECcccc
Confidence 57999999999999996 4 58999999764
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=96.97 E-value=0.013 Score=54.16 Aligned_cols=30 Identities=13% Similarity=0.190 Sum_probs=26.8
Q ss_pred CCceeccCCCCceEEeCCCCcEEEEeecCcc
Q 016184 203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAK 233 (394)
Q Consensus 203 ~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~ 233 (394)
.++||+|+.+.|||++.++ .+.++||..+.
T Consensus 196 ~~lcHgD~~~~Nvl~~~~~-~~~iIDfd~~~ 225 (309)
T TIGR02904 196 TVLVHGKLSLSHFLYDETR-GGYFINFEKAS 225 (309)
T ss_pred eeeeCCCCcHHhEEEcCCC-CEEEEEhhhcc
Confidence 4799999999999999776 69999999875
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.90 E-value=0.0044 Score=57.02 Aligned_cols=76 Identities=18% Similarity=0.260 Sum_probs=60.7
Q ss_pred CceeEEEEEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEee
Q 016184 150 KEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDF 229 (394)
Q Consensus 150 ~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Df 229 (394)
.+..|.|++|++.++.+..+ +....+++..++++.+..+.-+...-.+-|||+...||||+ +| .|.|+||
T Consensus 296 de~~y~yl~~kdhgt~is~i--------k~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~G-nvtLIDf 365 (488)
T COG5072 296 DETLYLYLHFKDHGTPISII--------KADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EG-NVTLIDF 365 (488)
T ss_pred CCceEEEEEEecCCceeeee--------ecccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cC-ceEEEEe
Confidence 56678899999988765321 33456778888888888888887656799999999999999 77 6999999
Q ss_pred cCcccc
Q 016184 230 GSAKVL 235 (394)
Q Consensus 230 g~a~~~ 235 (394)
-+++..
T Consensus 366 klsRl~ 371 (488)
T COG5072 366 KLSRLS 371 (488)
T ss_pred eeeecc
Confidence 999843
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=96.84 E-value=0.018 Score=53.63 Aligned_cols=30 Identities=23% Similarity=0.261 Sum_probs=25.4
Q ss_pred CCceeccCCCCceEEeCCCCcEEEEeecCccc
Q 016184 203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV 234 (394)
Q Consensus 203 ~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~ 234 (394)
..++|||+.+.||+++.++ ++++||..+..
T Consensus 192 ~~llHGDl~~gNi~~~~~~--~~~iD~e~~~~ 221 (370)
T TIGR01767 192 ETLLHGDLHSGSIFVSEHE--TKVIDPEFAFY 221 (370)
T ss_pred ceeeeccCCcccEEEcCCC--CEEEcCccccc
Confidence 4689999999999998653 88999997753
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.80 E-value=0.015 Score=53.44 Aligned_cols=30 Identities=27% Similarity=0.524 Sum_probs=26.8
Q ss_pred CceeccCCCCceEEeCCCCcEEEEeecCccc
Q 016184 204 GICHRDIKPQNLLVNPHTHQLKLCDFGSAKV 234 (394)
Q Consensus 204 givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~ 234 (394)
.++|+|+.+.|++++.++ .+-|.||+++..
T Consensus 199 ~lvHGD~~~gNlii~~~~-~~gVlDwe~~~l 228 (321)
T COG3173 199 VLVHGDYRPGNLIIDPGR-PTGVLDWELATL 228 (321)
T ss_pred eeeeCCcccCCEEEeCCC-eeEEEecccccc
Confidence 389999999999999887 499999999864
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.68 E-value=0.016 Score=54.67 Aligned_cols=71 Identities=15% Similarity=0.200 Sum_probs=44.0
Q ss_pred eeEEeecCceEEEEEEECCCCcEEEEEEecc----------chhhhHHHHHHHHHcC--CC-CeeeeceEEEecCCCcee
Q 016184 87 EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQ----------DKRYKNRELQIMQMLD--HP-NIVALKHCFFSTTDKEEL 153 (394)
Q Consensus 87 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~----------~~~~~~~E~~~l~~l~--h~-~iv~~~~~~~~~~~~~~~ 153 (394)
.+.||.|.-..||++.+...++.|+||.-.. ......-|.+.|+.+. .| .+++++.+ ....
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~------D~e~ 107 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF------DSVM 107 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE------CcHH
Confidence 5678999999999999844356799996421 1122245778887763 23 34455432 1111
Q ss_pred EEEEEEecccc
Q 016184 154 YLNLVLEYVPE 164 (394)
Q Consensus 154 ~~~lv~e~~~~ 164 (394)
..+|||+++.
T Consensus 108 -~~~vMEdL~~ 117 (409)
T PRK12396 108 -NCCVMEDLSD 117 (409)
T ss_pred -hhHHHHhCcc
Confidence 3478998863
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=96.59 E-value=0.00095 Score=71.37 Aligned_cols=156 Identities=14% Similarity=-0.013 Sum_probs=102.0
Q ss_pred HHHHHHHcCCCCeeeeceEEEecCCCceeEEEEEEeccc-ccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 016184 125 ELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203 (394)
Q Consensus 125 E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~ 203 (394)
|+..++...|+++.....-... .+..-.+..++|+. |.+...+-........+....+.....+.+.+..-+|+..
T Consensus 1279 e~de~~~~~h~~~~~~p~rI~p---s~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~t 1355 (2724)
T KOG1826|consen 1279 ERDELREAKHYLTEVDPLRIPP---SESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLT 1355 (2724)
T ss_pred hhhhhhhhhceeeecccccCCC---CCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcc
Confidence 4445666788887765433311 12222345677776 3555555443333344444444444444466666666522
Q ss_pred C----ceeccCCCCceEEeCCCCcEEEEeecCcccc-ccCCCcccccccccccccccccCCCCCCChhhHHHHHHHHHHH
Q 016184 204 G----ICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL-VKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAEL 278 (394)
Q Consensus 204 g----ivH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~-~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l 278 (394)
+ .+|++||+-|.+|..+- .+++.++|+.+.. ..........+++.|++|++. +...++.++|+|..|+.+|..
T Consensus 1356 nlg~T~v~~~Lkf~lpmIVtny-~v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~-N~ik~t~rsdilr~s~~ly~r 1433 (2724)
T KOG1826|consen 1356 NLGNTNVSKSLKFTLPMIVTNY-NVKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIK-NEIKFTKRSDILRRSLSLYLR 1433 (2724)
T ss_pred cCCccchhhhhhhhccceecCC-cccccccccccccCchHhhhhhhhCCHHHHHHHHH-HHHhhhhHHHHHHHHHHHHHH
Confidence 2 68999999999998876 6999999999832 222223445678889999987 444578889999999999999
Q ss_pred HhCCCCC
Q 016184 279 LLGQPLF 285 (394)
Q Consensus 279 ltg~~pf 285 (394)
-.|..+|
T Consensus 1434 s~~n~~f 1440 (2724)
T KOG1826|consen 1434 SDGNAYF 1440 (2724)
T ss_pred hcccHHH
Confidence 8887766
|
|
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.46 E-value=0.033 Score=51.62 Aligned_cols=29 Identities=34% Similarity=0.562 Sum_probs=25.3
Q ss_pred ceeccCCCCceEEeCCCCcEEEEeecCcc
Q 016184 205 ICHRDIKPQNLLVNPHTHQLKLCDFGSAK 233 (394)
Q Consensus 205 ivH~Dlkp~Nil~~~~~~~vkl~Dfg~a~ 233 (394)
+||+|+.|.||+++.+...+.++||+-+.
T Consensus 199 iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 199 IIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred eeecCCCccceeEcCCCCeeeEEEccccc
Confidence 99999999999999775338899999874
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=96.34 E-value=0.065 Score=50.94 Aligned_cols=69 Identities=16% Similarity=0.191 Sum_probs=43.8
Q ss_pred eeEEeecCceEEEEEEECCCCcEEEEEEecc-----------chhhhHHHHHHHHHcC---CCCeeeeceEEEecCCCce
Q 016184 87 EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQ-----------DKRYKNRELQIMQMLD---HPNIVALKHCFFSTTDKEE 152 (394)
Q Consensus 87 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-----------~~~~~~~E~~~l~~l~---h~~iv~~~~~~~~~~~~~~ 152 (394)
.+.||.|....||+..+. +..++||.-.. .......|.+.|+.+. -.++++++.+. .+.
T Consensus 37 ~~eiggGn~N~VyrV~~~--~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~d-----ed~ 109 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVSS--SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFD-----RTM 109 (418)
T ss_pred EEEcCCCceeeEEEEEcC--CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEEC-----CCC
Confidence 567899999999998873 45688996431 1122234666666653 23566666654 211
Q ss_pred eEEEEEEecccc
Q 016184 153 LYLNLVLEYVPE 164 (394)
Q Consensus 153 ~~~~lv~e~~~~ 164 (394)
.+++||++++
T Consensus 110 --~vlvME~L~~ 119 (418)
T PLN02756 110 --ALIGMRYLEP 119 (418)
T ss_pred --CEEEEeecCC
Confidence 3478999864
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.97 E-value=0.15 Score=47.51 Aligned_cols=28 Identities=25% Similarity=0.367 Sum_probs=24.0
Q ss_pred CCceeccCCCCceEEeCCCCcEEEEeecCcc
Q 016184 203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAK 233 (394)
Q Consensus 203 ~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~ 233 (394)
.++||+|+.+.|||++ + .+.|+||+.+.
T Consensus 196 ~~liHgD~h~~NvL~~-d--~~~iIDFDd~~ 223 (325)
T PRK11768 196 LLRLHGDCHPGNILWR-D--GPHFVDLDDAR 223 (325)
T ss_pred ccceecCCCchhcccc-C--CcEEEeCCCCC
Confidence 5799999999999995 4 37899999874
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=95.97 E-value=0.088 Score=47.92 Aligned_cols=71 Identities=14% Similarity=0.122 Sum_probs=42.5
Q ss_pred EeeEEeecCceEEEEEEECCCCcEEEEEEeccc-hhhhHHHHHHHHHcC---CCCeeeeceEEEecCCCceeEEEEEEec
Q 016184 86 AEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-KRYKNRELQIMQMLD---HPNIVALKHCFFSTTDKEELYLNLVLEY 161 (394)
Q Consensus 86 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~E~~~l~~l~---h~~iv~~~~~~~~~~~~~~~~~~lv~e~ 161 (394)
-.+.++.|....+|+.. .+++.+.||+-... ...+..|.+-|+.|. --.+++++.+...... .+++|||
T Consensus 21 ~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~-----~fLlle~ 93 (288)
T PF03881_consen 21 SIEPVSGGDINEAYRLD--TDGGSYFVKVNSESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDD-----AFLLLEF 93 (288)
T ss_dssp EEEEE--SSSSEEEEEE--TTS-EEEEEEEEGGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSC-----CEEEEE-
T ss_pred eeEecCCCChhheEEEE--CCCccEEEEecChhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCC-----ceEEEEe
Confidence 34668899999999987 56788999976633 345678998888883 2345565554422221 2689999
Q ss_pred cc
Q 016184 162 VP 163 (394)
Q Consensus 162 ~~ 163 (394)
++
T Consensus 94 l~ 95 (288)
T PF03881_consen 94 LE 95 (288)
T ss_dssp --
T ss_pred ec
Confidence 86
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.79 E-value=0.16 Score=48.25 Aligned_cols=29 Identities=28% Similarity=0.389 Sum_probs=24.6
Q ss_pred CCceeccCCCCceEEeCCCCcEEEEeecCcc
Q 016184 203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAK 233 (394)
Q Consensus 203 ~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~ 233 (394)
..++|.|+-+.||+.+.+ .+.++||..|.
T Consensus 227 ~VfCHNDL~~gNIL~~~~--~l~lID~EYA~ 255 (383)
T PTZ00384 227 VLFCHNDLFFTNILDFNQ--GIYFIDFDFAG 255 (383)
T ss_pred eeeeeccCCcccEEecCC--CEEEEEecccc
Confidence 468999999999998754 49999999875
|
|
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.41 E-value=0.037 Score=51.94 Aligned_cols=60 Identities=25% Similarity=0.239 Sum_probs=39.8
Q ss_pred EEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCC
Q 016184 156 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPH 220 (394)
Q Consensus 156 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~ 220 (394)
.++-+|..| ++..+++. ...+++..+.++.-.+.||-.+---.+++|.|++|.||++..+
T Consensus 321 vl~E~~~~Gl~v~~~v~~-----~~~pe~l~kkva~lg~~AllkMl~vDNFvHaDlHPGNVlirf~ 381 (565)
T KOG1236|consen 321 VLVETYERGLSVLRFVKW-----KSQPEALVKKVAKLGVNALLKMLIVDNFVHADLHPGNVLIRFN 381 (565)
T ss_pred eeeeeccccccHHhhhhc-----ccChHHHHHHHHHHHHHHHHHHHHhhcceecccCCCcEEEEec
Confidence 355566665 45444443 5566667777776666666554322589999999999998543
|
|
| >PF07914 DUF1679: Protein of unknown function (DUF1679); InterPro: IPR012877 This region is found in a number of Caenorhabditis elegans and Caenorhabditis briggsae proteins, in one case (Q19034 from SWISSPROT) as a repeat | Back alignment and domain information |
|---|
Probab=95.36 E-value=0.038 Score=53.02 Aligned_cols=31 Identities=16% Similarity=0.256 Sum_probs=25.2
Q ss_pred ceeccCCCCceEEeCCCC----cEEEEeecCcccc
Q 016184 205 ICHRDIKPQNLLVNPHTH----QLKLCDFGSAKVL 235 (394)
Q Consensus 205 ivH~Dlkp~Nil~~~~~~----~vkl~Dfg~a~~~ 235 (394)
++|+||...|||++.++. ...|+||-++..-
T Consensus 270 L~HGDLw~~NiLw~k~~~g~~~l~AIIDwQ~vh~G 304 (414)
T PF07914_consen 270 LVHGDLWSSNILWDKDSDGKLKLKAIIDWQCVHRG 304 (414)
T ss_pred eecCCccHHheeeecCCchhHHHHHHHHHHHhhcC
Confidence 799999999999998654 4668899887543
|
In many of the family members, this region is associated with the CHK region described by SMART as being found in zinc finger-C4 and HLH domain-containing kinases. In fact, one member of this family (Q9GUC1 from SWISSPROT) is annotated as being a member of the nuclear hormone receptor family, and contains regions typical of such proteins (IPR000536 from INTERPRO, IPR008946 from INTERPRO, and IPR001628 from INTERPRO). |
| >PF05445 Pox_ser-thr_kin: Poxvirus serine/threonine protein kinase; InterPro: IPR008790 This family of proteins contain poxvirus serine/threonine protein kinases, which are essential for phosphorylation of virion proteins during virion assembly | Back alignment and domain information |
|---|
Probab=95.03 E-value=0.039 Score=50.52 Aligned_cols=79 Identities=20% Similarity=0.348 Sum_probs=46.8
Q ss_pred EEEEecccccHHHHHHH-hhhhcCCCCHHHHHHHHHHHHHHHH---HHHhCCCceeccCCCCceEEeCCCC---------
Q 016184 156 NLVLEYVPETVNRIARN-YSRIHQRMPLIYVKLYTYQICRALA---YIHNCIGICHRDIKPQNLLVNPHTH--------- 222 (394)
Q Consensus 156 ~lv~e~~~~~l~~~~~~-~~~~~~~l~~~~~~~~~~qi~~al~---~LH~~~givH~Dlkp~Nil~~~~~~--------- 222 (394)
.+|++++-++...+... ....+-..-...++.++.||+.-.- .|-.+..++|-||||+|||+-+...
T Consensus 247 IIIfPLA~~Sadkv~~~~~~e~GF~s~~~YvkfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds~~~i~I~~~~~ 326 (434)
T PF05445_consen 247 IIIFPLARCSADKVTESNAAELGFKSNVEYVKFIFLQIALLYIKIYELPCCTNFLHVDLKPDNILIFDSKEPIRIKFGNR 326 (434)
T ss_pred EEEEehhhcchhhcCHHHHHhcCchhHHHHHHHHHHHHHHHHeeeecCCCcceeeecccCcCcEEEecCCCceEEEECCe
Confidence 37888876554433222 1222222334566777778766431 2323467999999999999853221
Q ss_pred --------cEEEEeecCccc
Q 016184 223 --------QLKLCDFGSAKV 234 (394)
Q Consensus 223 --------~vkl~Dfg~a~~ 234 (394)
.++|.||.++..
T Consensus 327 ~~vF~Epi~~~LnDFDfSqv 346 (434)
T PF05445_consen 327 NYVFKEPIRCCLNDFDFSQV 346 (434)
T ss_pred EEEecccceeeecccCHHHh
Confidence 356777777754
|
; GO: 0004672 protein kinase activity, 0005524 ATP binding |
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=94.64 E-value=0.53 Score=50.79 Aligned_cols=32 Identities=31% Similarity=0.434 Sum_probs=26.1
Q ss_pred CCceeccCCCCceEEeCCC--CcEEEEeecCccc
Q 016184 203 IGICHRDIKPQNLLVNPHT--HQLKLCDFGSAKV 234 (394)
Q Consensus 203 ~givH~Dlkp~Nil~~~~~--~~vkl~Dfg~a~~ 234 (394)
.++||+|+++.|||++.++ ...-|+|||-+..
T Consensus 203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 203 AQVIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred cceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 5799999999999999764 3345999998753
|
|
| >KOG2269 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=94.62 E-value=0.049 Score=49.59 Aligned_cols=130 Identities=18% Similarity=0.187 Sum_probs=84.3
Q ss_pred EeeEEeecCceEEEEEEEC------C----CCcEEEEEEeccchhhh------------------------------HHH
Q 016184 86 AEHVVGTGSFGVVFQAKCR------E----TGEIVAIKKVLQDKRYK------------------------------NRE 125 (394)
Q Consensus 86 ~~~~lg~G~~g~V~~~~~~------~----~~~~vaiK~~~~~~~~~------------------------------~~E 125 (394)
|...|..|--+.|+.|.-. . .-..+|||+++.....+ ++|
T Consensus 256 i~GiIsTGKEsvvlHAY~GS~E~~~qd~ql~ptecAIKvfKTTLnEFKnRd~YiKDDfRFKDRFSK~NpR~i~~mWAEkE 335 (531)
T KOG2269|consen 256 IDGIISTGKESVVLHAYAGSNEHGHQDPQLSPTECAIKVFKTTLNEFKNRDEYIKDDFRFKDRFSKQNPRGILKMWAEKE 335 (531)
T ss_pred hhhhhhcCcceEEEEeccCcccccccCcccCchHHHHHHHHHHHHHHhhhhhhhccchhhhhhhcccCcHHHHHHHHHHH
Confidence 4566888888888887320 0 12458999763211100 134
Q ss_pred HHHHHHc-----CCCCeeeeceEEEecCCCceeEEEEEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHH
Q 016184 126 LQIMQML-----DHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 200 (394)
Q Consensus 126 ~~~l~~l-----~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH 200 (394)
..-|.++ ..|-+|.+... .+||-|++..- +..-......++..+.+..-.|+..++.-|-
T Consensus 336 mhNL~RMq~~GlpcP~vV~lkkh------------vLVMsFiGd~~---~aAPkLK~v~l~d~E~~~aY~q~~~~M~~lY 400 (531)
T KOG2269|consen 336 MHNLSRMQKHGLPCPQVVKLKKH------------VLVMSFIGDQG---LAAPKLKNVELTDDERRNAYDQVQSIMCRLY 400 (531)
T ss_pred HHHHHHHHhcCCCCCceeeeecc------------eEEEEeecCCC---CCCccccccccChHHHHHHHHHHHHHHHHHH
Confidence 4445554 45677766443 37999987421 1111222356788888888889998888774
Q ss_pred hCCCceeccCCCCceEEeCCCCcEEEEeecCc
Q 016184 201 NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA 232 (394)
Q Consensus 201 ~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a 232 (394)
...-+||-|+.--|+|+... .|.++|-.-+
T Consensus 401 ~Ec~LVHADlSEyN~Lw~~g--Kvw~IDVsQs 430 (531)
T KOG2269|consen 401 KECLLVHADLSEYNLLWTPG--KVWVIDVSQS 430 (531)
T ss_pred HhhheeecchhhhhheecCC--ceEEEechhc
Confidence 33789999999999999964 6999998765
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 394 | ||||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 1e-127 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 1e-127 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 1e-127 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 1e-127 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 1e-127 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 1e-127 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 1e-127 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 1e-126 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 1e-126 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 1e-126 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 1e-126 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 1e-126 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 1e-126 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 1e-125 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 1e-125 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 1e-125 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 1e-125 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-125 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 1e-124 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 1e-124 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-123 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 1e-119 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 5e-82 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 3e-78 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 2e-42 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-42 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-42 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 3e-42 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 3e-42 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 3e-42 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 4e-42 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 4e-42 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 4e-42 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 5e-42 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 5e-42 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 5e-42 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 5e-42 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 5e-42 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 5e-42 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 5e-42 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 5e-42 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 5e-42 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 5e-42 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 5e-42 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 5e-42 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 5e-42 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 5e-42 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 6e-42 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 6e-42 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 7e-42 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 8e-42 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 8e-42 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 9e-42 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 1e-41 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-41 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-41 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 1e-41 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 1e-41 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-41 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-41 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-41 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 2e-41 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-41 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 2e-41 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 3e-41 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 4e-41 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 9e-41 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 1e-40 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 1e-40 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 4e-40 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 5e-40 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-39 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-39 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 1e-39 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 1e-39 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 1e-39 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 2e-39 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 2e-39 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 3e-39 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 3e-39 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 3e-39 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-39 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-39 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 3e-39 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 3e-39 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 3e-39 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 3e-39 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 3e-39 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 4e-39 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 6e-39 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 6e-39 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 8e-39 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 1e-38 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 1e-38 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 1e-38 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 1e-38 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-38 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 1e-38 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 2e-38 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 2e-38 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 1e-37 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 1e-37 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-37 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 1e-37 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 1e-37 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 1e-37 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 2e-37 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 2e-37 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-37 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-37 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 2e-37 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 3e-37 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 3e-37 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 3e-37 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 3e-37 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 3e-37 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 3e-37 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 3e-37 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 4e-37 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 4e-37 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 4e-37 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 4e-37 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 5e-37 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 5e-37 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 5e-37 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 5e-37 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 5e-37 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 5e-37 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 5e-37 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 5e-37 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 5e-37 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 5e-37 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 5e-37 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 5e-37 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 5e-37 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 6e-37 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 6e-37 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 6e-37 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 6e-37 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 6e-37 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 6e-37 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 6e-37 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 6e-37 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 6e-37 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 6e-37 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 6e-37 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 6e-37 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 6e-37 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 6e-37 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 6e-37 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 6e-37 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 6e-37 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 6e-37 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 7e-37 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 7e-37 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 8e-37 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 1e-36 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-36 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 3e-36 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 4e-36 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 4e-36 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 5e-36 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 5e-36 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 7e-36 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 8e-36 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 4e-35 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 5e-34 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 8e-32 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 9e-32 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 4e-31 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 1e-30 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-30 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 1e-30 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 2e-30 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 3e-30 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 3e-30 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 3e-30 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 4e-30 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 6e-30 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 7e-30 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 8e-30 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 2e-29 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 2e-29 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 2e-29 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 2e-29 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 2e-29 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 2e-29 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 2e-29 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 2e-29 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 2e-29 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 2e-29 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 2e-29 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 2e-29 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 2e-29 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 3e-29 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 3e-29 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 3e-29 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 3e-29 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 4e-29 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 4e-29 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 4e-29 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 4e-29 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 5e-29 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 5e-29 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 5e-29 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 6e-29 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 6e-29 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 7e-29 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 7e-29 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 8e-29 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 1e-28 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 2e-28 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 2e-28 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 3e-28 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 4e-28 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 4e-28 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 4e-28 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 4e-28 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 4e-28 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 5e-28 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 5e-28 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 5e-28 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 5e-28 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 5e-28 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 5e-28 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 7e-28 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 7e-28 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 8e-28 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 9e-28 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 1e-27 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 2e-27 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 2e-27 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 1e-26 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 1e-26 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-26 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 2e-26 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-26 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 2e-26 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 2e-26 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 3e-26 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-26 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 5e-26 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 5e-26 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 3e-24 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 4e-24 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 5e-24 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 4e-23 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 6e-23 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 6e-23 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 3e-22 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 3e-22 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 4e-22 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 6e-22 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 1e-21 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 3e-21 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 7e-20 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 7e-20 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-19 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 5e-19 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 5e-19 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 5e-19 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 9e-19 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 1e-18 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 1e-18 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-18 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-18 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 1e-18 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 2e-18 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 3e-18 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 3e-18 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-18 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-18 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 4e-18 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 4e-18 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 4e-18 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-18 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 5e-18 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 8e-18 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 9e-18 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 9e-18 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 9e-18 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 9e-18 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 9e-18 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 9e-18 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 1e-17 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 1e-17 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 1e-17 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 1e-17 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 1e-17 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 1e-17 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 1e-17 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-17 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 1e-17 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 2e-17 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-17 | ||
| 2vag_A | 339 | Crystal Structure Of Di-Phosphorylated Human Clk1 I | 3e-17 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 4e-17 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 4e-17 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 4e-17 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 6e-17 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 6e-17 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-17 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 8e-17 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 8e-17 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 8e-17 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 9e-17 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 9e-17 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 9e-17 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 9e-17 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 9e-17 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 1e-16 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 2e-16 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 2e-16 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 2e-16 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 2e-16 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 2e-16 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 3e-16 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 3e-16 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 3e-16 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 3e-16 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 3e-16 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 4e-16 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 4e-16 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 4e-16 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 4e-16 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 4e-16 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 4e-16 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 4e-16 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 5e-16 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 5e-16 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 5e-16 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 5e-16 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 5e-16 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 5e-16 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 6e-16 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 6e-16 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 6e-16 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 6e-16 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 6e-16 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 6e-16 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 6e-16 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 6e-16 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 6e-16 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 7e-16 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 7e-16 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 7e-16 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 7e-16 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 7e-16 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 7e-16 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 7e-16 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 8e-16 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 8e-16 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 8e-16 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 8e-16 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 8e-16 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 8e-16 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 9e-16 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 9e-16 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 9e-16 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 9e-16 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 9e-16 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 9e-16 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 1e-15 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 1e-15 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 1e-15 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 1e-15 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 1e-15 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 1e-15 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 1e-15 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 1e-15 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 1e-15 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 1e-15 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-15 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-15 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-15 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 2e-15 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-15 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 2e-15 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 2e-15 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 2e-15 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 2e-15 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 2e-15 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 2e-15 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 2e-15 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 2e-15 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 2e-15 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 2e-15 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 2e-15 | ||
| 3nr9_A | 368 | Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length | 2e-15 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-15 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 3e-15 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-15 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 3e-15 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 3e-15 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 3e-15 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 3e-15 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 3e-15 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 3e-15 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 3e-15 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 4e-15 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 4e-15 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 4e-15 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 5e-15 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 5e-15 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 5e-15 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 5e-15 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 5e-15 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 5e-15 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 5e-15 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 5e-15 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 5e-15 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 6e-15 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 6e-15 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 6e-15 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 7e-15 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 7e-15 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 7e-15 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 7e-15 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 8e-15 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 8e-15 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 8e-15 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 8e-15 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 9e-15 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-14 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 1e-14 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-14 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 1e-14 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 1e-14 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-14 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 1e-14 | ||
| 2wu6_A | 381 | Crystal Structure Of The Human Clk3 In Complex With | 1e-14 | ||
| 2exe_A | 357 | Crystal Structure Of The Phosphorylated Clk3 Length | 1e-14 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 1e-14 | ||
| 2eu9_A | 355 | Crystal Structure Of Clk3 Length = 355 | 2e-14 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 2e-14 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 2e-14 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 2e-14 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 2e-14 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 2e-14 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 2e-14 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 2e-14 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 3e-14 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-14 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 3e-14 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 5e-14 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 5e-14 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 5e-14 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 5e-14 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 5e-14 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-14 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-14 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 6e-14 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 7e-14 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 7e-14 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 7e-14 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 8e-14 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 8e-14 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 9e-14 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 9e-14 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 9e-14 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 1e-13 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 1e-13 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 1e-13 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 1e-13 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 2e-13 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 2e-13 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 2e-13 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 2e-13 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 2e-13 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 2e-13 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 2e-13 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-13 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 2e-13 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 2e-13 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 2e-13 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 2e-13 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 2e-13 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 2e-13 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 2e-13 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 2e-13 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 2e-13 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 3e-13 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 3e-13 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 3e-13 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 3e-13 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 3e-13 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 3e-13 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 4e-13 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 4e-13 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 4e-13 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 5e-13 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 5e-13 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 5e-13 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 5e-13 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 6e-13 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 6e-13 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 6e-13 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 8e-13 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-13 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 8e-13 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 8e-13 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 8e-13 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 8e-13 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 8e-13 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 8e-13 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 8e-13 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 9e-13 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 9e-13 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 9e-13 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 1e-12 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 1e-12 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 1e-12 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 1e-12 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 1e-12 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 1e-12 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 1e-12 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 1e-12 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 1e-12 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 1e-12 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 1e-12 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 1e-12 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 1e-12 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 1e-12 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 1e-12 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 2e-12 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 2e-12 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-12 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 2e-12 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 2e-12 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 2e-12 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 2e-12 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-12 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 2e-12 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-12 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 2e-12 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 2e-12 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 2e-12 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 2e-12 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 2e-12 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 2e-12 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-12 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 2e-12 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 2e-12 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 2e-12 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 2e-12 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 2e-12 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 2e-12 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 2e-12 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 2e-12 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-12 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-12 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 3e-12 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 3e-12 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 3e-12 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 3e-12 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 3e-12 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 3e-12 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 4e-12 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 4e-12 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 4e-12 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 4e-12 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 4e-12 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 4e-12 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 4e-12 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-12 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 4e-12 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 4e-12 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 5e-12 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 5e-12 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 5e-12 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 5e-12 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-12 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 6e-12 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 6e-12 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 6e-12 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 7e-12 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 7e-12 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-12 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 8e-12 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 8e-12 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 9e-12 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 1e-11 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 1e-11 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 1e-11 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 1e-11 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 1e-11 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 2e-11 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 2e-11 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 2e-11 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 2e-11 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 3e-11 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 3e-11 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 3e-11 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 3e-11 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 4e-11 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 5e-11 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 5e-11 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 6e-11 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 7e-11 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 7e-11 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 8e-11 | ||
| 3llt_A | 360 | Crystal Structure Of Pf14_0431, Kinase Domain Lengt | 9e-11 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 9e-11 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-10 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 1e-10 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 1e-10 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 1e-10 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 2e-10 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 2e-10 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-10 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 2e-10 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 2e-10 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 3e-10 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 3e-10 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-10 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 3e-10 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 3e-10 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 4e-10 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 4e-10 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 4e-10 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 4e-10 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 4e-10 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 4e-10 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 4e-10 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 5e-10 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 5e-10 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 5e-10 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 5e-10 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 5e-10 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 5e-10 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 5e-10 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 5e-10 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 5e-10 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 5e-10 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 6e-10 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 6e-10 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 6e-10 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 6e-10 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 6e-10 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 6e-10 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 6e-10 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 6e-10 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 7e-10 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 7e-10 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 7e-10 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 7e-10 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 8e-10 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 8e-10 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 8e-10 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 8e-10 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 8e-10 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 8e-10 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 8e-10 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 9e-10 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 9e-10 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 1e-09 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 1e-09 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 1e-09 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 1e-09 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-09 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 1e-09 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 1e-09 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 2e-09 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 2e-09 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 2e-09 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 2e-09 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 2e-09 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 2e-09 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 2e-09 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-09 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 2e-09 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 3e-09 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 3e-09 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 3e-09 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 3e-09 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 4e-09 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-09 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 4e-09 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 4e-09 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 4e-09 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-09 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 5e-09 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-09 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 5e-09 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 5e-09 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 6e-09 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 6e-09 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 7e-09 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 7e-09 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 7e-09 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 7e-09 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 7e-09 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 7e-09 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 7e-09 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 7e-09 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 7e-09 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 7e-09 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 7e-09 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 7e-09 | ||
| 2x7g_A | 389 | Structure Of Human Serine-Arginine-Rich Protein-Spe | 8e-09 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 8e-09 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 8e-09 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 8e-09 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 8e-09 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 8e-09 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 9e-09 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 9e-09 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 9e-09 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 9e-09 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 9e-09 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 1e-08 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-08 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 1e-08 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 1e-08 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 1e-08 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 1e-08 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 1e-08 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 1e-08 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 1e-08 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 1e-08 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 1e-08 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 1e-08 | ||
| 1wbp_A | 397 | Srpk1 Bound To 9mer Docking Motif Peptide Length = | 1e-08 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 1e-08 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 2e-08 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-08 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 2e-08 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-08 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-08 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-08 | ||
| 3beg_A | 381 | Crystal Structure Of Sr Protein Kinase 1 Complexed | 2e-08 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 2e-08 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 2e-08 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-08 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-08 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 2e-08 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 2e-08 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-08 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 2e-08 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 3e-08 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 3e-08 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 3e-08 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-08 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-08 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-08 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 3e-08 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 3e-08 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 4e-08 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-08 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-08 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 4e-08 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 4e-08 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 4e-08 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 5e-08 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 5e-08 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 6e-08 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 7e-08 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 7e-08 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 7e-08 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 8e-08 | ||
| 2pzi_A | 681 | Crystal Structure Of Protein Kinase Pkng From Mycob | 9e-08 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 1e-07 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 2e-07 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 2e-07 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-07 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-07 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-07 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 2e-07 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 2e-07 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 2e-07 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 2e-07 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 3e-07 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 3e-07 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-07 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 3e-07 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 3e-07 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 3e-07 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 3e-07 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 3e-07 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 3e-07 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 4e-07 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 4e-07 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 4e-07 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 4e-07 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 4e-07 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 4e-07 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 4e-07 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 4e-07 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 4e-07 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 5e-07 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 5e-07 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 6e-07 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 6e-07 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 7e-07 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 7e-07 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 8e-07 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 8e-07 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 8e-07 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 8e-07 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 9e-07 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 9e-07 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 9e-07 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 1e-06 | ||
| 2wtk_B | 373 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 1e-06 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-06 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-06 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 1e-06 | ||
| 3gni_B | 389 | Structure Of Strad And Mo25 Length = 389 | 1e-06 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-06 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-06 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 1e-06 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-06 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-06 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 2e-06 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 2e-06 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 2e-06 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 2e-06 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 2e-06 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 2e-06 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 3e-06 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 3e-06 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 3e-06 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 3e-06 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 4e-06 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 4e-06 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 4e-06 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 4e-06 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 5e-06 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 5e-06 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 5e-06 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 5e-06 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 6e-06 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 6e-06 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 6e-06 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 6e-06 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 6e-06 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 6e-06 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 6e-06 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 7e-06 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 8e-06 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 8e-06 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 8e-06 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 8e-06 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 8e-06 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 8e-06 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 8e-06 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 8e-06 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 8e-06 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 9e-06 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 9e-06 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 9e-06 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 9e-06 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 9e-06 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-05 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 1e-05 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 1e-05 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 1e-05 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 1e-05 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-05 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 1e-05 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 1e-05 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 1e-05 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 1e-05 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-05 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 2e-05 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 2e-05 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 2e-05 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 2e-05 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 3e-05 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 4e-05 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 4e-05 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 4e-05 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 4e-05 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 4e-05 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 4e-05 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 5e-05 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 5e-05 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 5e-05 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 5e-05 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 5e-05 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 5e-05 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 5e-05 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 5e-05 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 5e-05 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 5e-05 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 7e-05 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 9e-05 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 1e-04 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-04 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-04 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 1e-04 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 1e-04 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 1e-04 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 1e-04 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 1e-04 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 2e-04 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 2e-04 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-04 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 2e-04 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 2e-04 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 2e-04 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 2e-04 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 2e-04 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 2e-04 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 2e-04 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 2e-04 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 2e-04 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 2e-04 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 2e-04 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 2e-04 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 3e-04 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 3e-04 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 3e-04 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 3e-04 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 3e-04 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 3e-04 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 4e-04 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 6e-04 |
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381 | Back alignment and structure |
|
| >pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2X7G|A Chain A, Structure Of Human Serine-Arginine-Rich Protein-Specific Kinase 2 (Srpk2) Bound To Purvalanol B Length = 389 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|1WBP|A Chain A, Srpk1 Bound To 9mer Docking Motif Peptide Length = 397 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3BEG|A Chain A, Crystal Structure Of Sr Protein Kinase 1 Complexed To Its Substrate AsfSF2 Length = 381 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 604 bits (1558), Expect = 0.0
Identities = 231/337 (68%), Positives = 276/337 (81%), Gaps = 4/337 (1%)
Query: 57 DGVGAETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVL 116
D G++ V+ T G+ + Q+VSY V+G GSFGVV+QAK ++GE+VAIKKVL
Sbjct: 31 DKDGSKVTTVVATP--GQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL 88
Query: 117 QDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDK-EELYLNLVLEYVPETVNRIARNYSR 175
QDKR+KNRELQIM+ LDH NIV L++ F+S+ +K +E+YLNLVL+YVPETV R+AR+YSR
Sbjct: 89 QDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSR 148
Query: 176 IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL 235
Q +P+IYVKLY YQ+ R+LAYIH+ GICHRDIKPQNLL++P T LKLCDFGSAK L
Sbjct: 149 AKQTLPVIYVKLYMYQLFRSLAYIHS-FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 207
Query: 236 VKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLV 295
V+GEPNVSYICSRYYRAPELIFGAT+YT++ID+WS GCV+AELLLGQP+FPG+SGVDQLV
Sbjct: 208 VRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 267
Query: 296 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNL 355
EIIKVLGTPTRE+I+ MNPNYTEFKFPQIK HPW KVF+ R PPEA+ L R +Y+P
Sbjct: 268 EIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTA 327
Query: 356 RCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKP 392
R T LEAC H FFDELRDPN +LPNGR P LFNF
Sbjct: 328 RLTPLEACAHSFFDELRDPNVKLPNGRDTPALFNFTT 364
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 600 bits (1550), Expect = 0.0
Identities = 217/342 (63%), Positives = 269/342 (78%), Gaps = 4/342 (1%)
Query: 52 EPDIIDGVGAETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVA 111
++ + + G+ G ++ ++Y V+G GSFGVVFQAK E+ E VA
Sbjct: 11 NGVKLNPLDDPNKVIKVLASDGKTGEQRE-IAYTNCKVIGNGSFGVVFQAKLVESDE-VA 68
Query: 112 IKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKE-ELYLNLVLEYVPETVNRIA 170
IKKVLQDKR+KNRELQIM+++ HPN+V LK F+S DK+ E++LNLVLEYVPETV R +
Sbjct: 69 IKKVLQDKRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRAS 128
Query: 171 RNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFG 230
R+Y+++ Q MP++ +KLY YQ+ R+LAYIH+ IGICHRDIKPQNLL++P + LKL DFG
Sbjct: 129 RHYAKLKQTMPMLLIKLYMYQLLRSLAYIHS-IGICHRDIKPQNLLLDPPSGVLKLIDFG 187
Query: 231 SAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESG 290
SAK+L+ GEPNVSYICSRYYRAPELIFGAT YTT IDIWSTGCVMAEL+ GQPLFPGESG
Sbjct: 188 SAKILIAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESG 247
Query: 291 VDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQ 350
+DQLVEIIKVLGTP+RE+IK MNPNY E KFPQI+PHP+ KVF+ R PP+A+DL+ R +
Sbjct: 248 IDQLVEIIKVLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLE 307
Query: 351 YSPNLRCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKP 392
Y+P+ R TA+EA HPFFDELR R+PNGR LPPLFN+
Sbjct: 308 YTPSARLTAIEALCHPFFDELRTGEARMPNGRELPPLFNWTK 349
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 579 bits (1495), Expect = 0.0
Identities = 161/341 (47%), Positives = 217/341 (63%), Gaps = 12/341 (3%)
Query: 64 GHVIRTTIGGRNG--NSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRY 121
G ++ + K+ + E + G G+FG V K + TG VAIKKV+QD R+
Sbjct: 3 GSMMSLNAAAAADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRF 62
Query: 122 KNRELQIMQML---DHPNIVALKHCFFSTT--DKEELYLNLVLEYVPETVNRIARNYSRI 176
+NRELQIMQ L HPNIV L+ F++ D+ ++YLN+V+EYVP+T++R RNY R
Sbjct: 63 RNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRR 122
Query: 177 HQRMPLIYVKLYTYQICRALAYIH-NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL 235
P I +K++ +Q+ R++ +H + +CHRDIKP N+LVN LKLCDFGSAK L
Sbjct: 123 QVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKL 182
Query: 236 VKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLV 295
EPNV+YICSRYYRAPELIFG YTTA+DIWS GC+ AE++LG+P+F G++ QL
Sbjct: 183 SPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLH 242
Query: 296 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQK---RLPPEAVDLVCRFFQYS 352
EI++VLG P+RE ++ +NP++T+ K PW VF + EA DL+ QY
Sbjct: 243 EIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYL 302
Query: 353 PNLRCTALEACVHPFFDELRDPNTRLPNGRPLPP-LFNFKP 392
P R EA HP+FDEL DP T+LPN + LP LF F P
Sbjct: 303 PEERMKPYEALCHPYFDELHDPATKLPNNKDLPEDLFRFLP 343
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 547 bits (1412), Expect = 0.0
Identities = 163/359 (45%), Positives = 230/359 (64%), Gaps = 43/359 (11%)
Query: 76 GNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHP 135
G Y +GTGSFG+V + E+G+ A+KKVLQD RYKNREL IM++LDH
Sbjct: 1 GLETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRELDIMKVLDHV 60
Query: 136 NIVALKHCFFSTTDK---------------------------------EELYLNLVLEYV 162
NI+ L F++T D+ + YLN+++EYV
Sbjct: 61 NIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYV 120
Query: 163 PETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTH 222
P+T++++ +++ R + +P+ + +Y YQ+ RA+ +IH+ +GICHRDIKPQNLLVN +
Sbjct: 121 PDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHS-LGICHRDIKPQNLLVNSKDN 179
Query: 223 QLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQ 282
LKLCDFGSAK L+ EP+V+YICSR+YRAPEL+ GATEYT +ID+WS GCV EL+LG+
Sbjct: 180 TLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGK 239
Query: 283 PLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAV 342
PLF GE+ +DQLV II+++GTPT+E++ MNP+YTE +FP +K W K+ + P A+
Sbjct: 240 PLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAI 299
Query: 343 DLVCRFFQYSPNLRCTALEACVHPFFDELRDP-------NTRLPNG--RPLPPLFNFKP 392
DL+ + +Y P+LR EA HPFFD LR+ N+ P+G + +P LFNF P
Sbjct: 300 DLLEQILRYEPDLRINPYEAMAHPFFDHLRNSYESEVKNNSNFPHGVNQNIPQLFNFSP 358
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 304 bits (782), Expect = e-102
Identities = 106/312 (33%), Positives = 160/312 (51%), Gaps = 22/312 (7%)
Query: 90 VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 143
+G GS+GVVF+ + R+TG+IVAIKK L+ + RE+++++ L HPN+V L
Sbjct: 11 IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEV 70
Query: 144 FFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203
F K L+L V EY TV Y + +P VK T+Q +A+ + H
Sbjct: 71 F---RRKRRLHL--VFEYCDHTVLHELDRYQ---RGVPEHLVKSITWQTLQAVNFCHKH- 121
Query: 204 GICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL-VKGEPNVSYICSRYYRAPELIFGATEY 262
HRD+KP+N+L+ H+ +KLCDFG A++L + + +R+YR+PEL+ G T+Y
Sbjct: 122 NCIHRDVKPENILITKHS-VIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVGDTQY 180
Query: 263 TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM--NPNYTEFK 320
+D+W+ GCV AELL G PL+PG+S VDQL I K LG + N ++ K
Sbjct: 181 GPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVK 240
Query: 321 FPQIKP-HPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLP 379
P + P F + A+ L+ P R T + HP+F+ +R+ L
Sbjct: 241 IPDPEDMEPLELKF-PNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIREI-EDLA 298
Query: 380 NGRPLPPLFNFK 391
P +
Sbjct: 299 KEHDKPAENLYF 310
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 299 bits (767), Expect = e-100
Identities = 99/295 (33%), Positives = 154/295 (52%), Gaps = 21/295 (7%)
Query: 90 VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 143
VG GS+G+V + + ++TG IVAIKK L+ K RE+++++ L H N+V L
Sbjct: 33 VGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEV 92
Query: 144 FFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203
K+ YL V E+V T+ + + V+ Y +QI + + H+
Sbjct: 93 C---KKKKRWYL--VFEFVDHTILDDLELFP---NGLDYQVVQKYLFQIINGIGFCHSH- 143
Query: 204 GICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL-VKGEPNVSYICSRYYRAPELIFGATEY 262
I HRDIKP+N+LV+ + +KLCDFG A+ L GE + +R+YRAPEL+ G +Y
Sbjct: 144 NIIHRDIKPENILVS-QSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGDVKY 202
Query: 263 TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE--EIKCMNPNYTEFK 320
A+D+W+ GC++ E+ +G+PLFPG+S +DQL I+ LG E+ NP + +
Sbjct: 203 GKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVR 262
Query: 321 FPQIKPH-PWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP 374
P+IK P + + +L +DL + P+ R E H FF
Sbjct: 263 LPEIKEREPLERRY-PKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMDGFA 316
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 296 bits (760), Expect = 6e-99
Identities = 99/324 (30%), Positives = 167/324 (51%), Gaps = 33/324 (10%)
Query: 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---------RELQIMQMLD 133
+YI +G G++ V++ K + T +VA+K++ R ++ RE+ +++ L
Sbjct: 3 TYIKLDKLGEGTYATVYKGKSKLTDNLVALKEI----RLEHEEGAPCTAIREVSLLKDLK 58
Query: 134 HPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQIC 193
H NIV L ++ L L V EY+ + + + + + + VKL+ +Q+
Sbjct: 59 HANIVTLHDII---HTEKSLTL--VFEYLDKDLKQYLDDCG---NIINMHNVKLFLFQLL 110
Query: 194 RALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSRYY 250
R LAY H + HRD+KPQNLL+N +LKL DFG A+ K P +Y + + +Y
Sbjct: 111 RGLAYCHRQ-KVLHRDLKPQNLLIN-ERGELKLADFGLARA--KSIPTKTYDNEVVTLWY 166
Query: 251 RAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE--- 307
R P+++ G+T+Y+T ID+W GC+ E+ G+PLFPG + +QL I ++LGTPT E
Sbjct: 167 RPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWP 226
Query: 308 EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 367
I + + +P+ + RL + DL+ + Q+ R +A +A HPF
Sbjct: 227 GILSN-EEFKTYNYPKYRAEALLSHA-PRLDSDGADLLTKLLQFEGRNRISAEDAMKHPF 284
Query: 368 FDELRDPNTRLPNGRPLPPLFNFK 391
F L + +LP+ + L +
Sbjct: 285 FLSLGERIHKLPDTTSIFALKEIQ 308
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 294 bits (756), Expect = 5e-98
Identities = 107/312 (34%), Positives = 158/312 (50%), Gaps = 33/312 (10%)
Query: 90 VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---------RELQIMQMLDHPNIVAL 140
+G G F V++A+ + T +IVAIKK+ R + RE++++Q L HPNI+ L
Sbjct: 18 LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 77
Query: 141 KHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 200
F ++LV +++ + I ++ S + ++K Y + L Y+H
Sbjct: 78 -LDAFGHKSN----ISLVFDFMETDLEVIIKDNS---LVLTPSHIKAYMLMTLQGLEYLH 129
Query: 201 NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSRYYRAPELIF 257
I HRD+KP NLL++ LKL DFG AK G PN +Y + +R+YRAPEL+F
Sbjct: 130 QH-WILHRDLKPNNLLLD-ENGVLKLADFGLAKS--FGSPNRAYTHQVVTRWYRAPELLF 185
Query: 258 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI---KCMNP 314
GA Y +D+W+ GC++AELLL P PG+S +DQL I + LGTPT EE C P
Sbjct: 186 GARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPT-EEQWPDMCSLP 244
Query: 315 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP 374
+Y F P H +F + +DL+ F ++P R TA +A +F P
Sbjct: 245 DYVT--FKSFPGIPLHHIF-SAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNR--P 299
Query: 375 NTRLPNGRPLPP 386
P P
Sbjct: 300 GPTPGCQLPRPN 311
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 289 bits (742), Expect = 3e-96
Identities = 88/303 (29%), Positives = 146/303 (48%), Gaps = 23/303 (7%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV--LQDKRYKNRELQIMQML-DHPNIVAL 140
Y +G G + VF+A E V +K + ++ K+ K RE++I++ L PNI+ L
Sbjct: 38 YQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIK-REIKILENLRGGPNIITL 96
Query: 141 KHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 200
+ V E+V T ++ +++Q + ++ Y Y+I +AL Y H
Sbjct: 97 ADIVKDPVSRTPAL---VFEHVNNT------DFKQLYQTLTDYDIRFYMYEILKALDYCH 147
Query: 201 NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGAT 260
+ GI HRD+KP N++++ +L+L D+G A+ G+ + SRY++ PEL+
Sbjct: 148 SM-GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 206
Query: 261 EYTTAIDIWSTGCVMAELLLG-QPLFPGESGVDQLVEIIKVLGTPTREEI--KCMNPNYT 317
Y ++D+WS GC++A ++ +P F G DQLV I KVLGT + K
Sbjct: 207 MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDP 266
Query: 318 EFK--FPQIKPHPWHKVF----QKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL 371
F + W + Q + PEA+D + + +Y R TA EA HP+F +
Sbjct: 267 RFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTV 326
Query: 372 RDP 374
Sbjct: 327 VKD 329
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 287 bits (737), Expect = 1e-95
Identities = 101/294 (34%), Positives = 163/294 (55%), Gaps = 27/294 (9%)
Query: 90 VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 143
VG G++GVV++AK G IVA+K++ D + RE+ +++ L HPNIV+L
Sbjct: 29 VGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDV 87
Query: 144 FFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203
+ L L V E++ + + ++ + +K+Y YQ+ R +A+ H
Sbjct: 88 I---HSERCLTL--VFEFMEKDLKKVLDENK---TGLQDSQIKIYLYQLLRGVAHCHQH- 138
Query: 204 GICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSRYYRAPELIFGAT 260
I HRD+KPQNLL+N LKL DFG A+ G P SY + + +YRAP+++ G+
Sbjct: 139 RILHRDLKPQNLLIN-SDGALKLADFGLARA--FGIPVRSYTHEVVTLWYRAPDVLMGSK 195
Query: 261 EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE---EIKCMNPNYT 317
+Y+T++DIWS GC+ AE++ G+PLFPG + DQL +I +LGTP +++ + P +
Sbjct: 196 KYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQEL-PLWK 254
Query: 318 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL 371
+ F + PW + E +DL+ + PN R +A +A HP+F +L
Sbjct: 255 QRTFQVFEKKPWSSII-PGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDL 307
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 287 bits (737), Expect = 1e-95
Identities = 89/315 (28%), Positives = 148/315 (46%), Gaps = 34/315 (10%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV-LQD----KR-YKNRELQIMQMLDHPNI 137
Y+ +G G G+VF A + + VAIKK+ L D K RE++I++ LDH NI
Sbjct: 13 YMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHAL--REIKIIRRLDHDNI 70
Query: 138 VALKHCF-----------FSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVK 186
V + S T+ +Y+ V EY+ + + + + +
Sbjct: 71 VKVFEILGPSGSQLTDDVGSLTELNSVYI--VQEYMETDLANVLE-----QGPLLEEHAR 123
Query: 187 LYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVS--- 243
L+ YQ+ R L YIH+ + HRD+KP NL +N LK+ DFG A+++ +
Sbjct: 124 LFMYQLLRGLKYIHSA-NVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLS 182
Query: 244 -YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLG 302
+ +++YR+P L+ YT AID+W+ GC+ AE+L G+ LF G ++Q+ I++ +
Sbjct: 183 EGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIP 242
Query: 303 TPTREEIKCMNPNYTEF--KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTAL 360
E+ + + + P ++ + EAVD + + +SP R TA
Sbjct: 243 VVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPG-ISREAVDFLEQILTFSPMDRLTAE 301
Query: 361 EACVHPFFDELRDPN 375
EA HP+ P
Sbjct: 302 EALSHPYMSIYSFPM 316
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 286 bits (735), Expect = 3e-95
Identities = 90/313 (28%), Positives = 151/313 (48%), Gaps = 41/313 (13%)
Query: 90 VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 143
+G G++G V++A T E VAIK++ + + RE+ +++ L H NI+ LK
Sbjct: 42 LGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSV 101
Query: 144 FFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203
L+L + EY + + + + + +K + YQ+ + + H+
Sbjct: 102 I---HHNHRLHL--IFEYAENDLKKYMDK----NPDVSMRVIKSFLYQLINGVNFCHSR- 151
Query: 204 GICHRDIKPQNLLVNPHTH----QLKLCDFGSAKVLVKGEPNVSY---ICSRYYRAPELI 256
HRD+KPQNLL++ LK+ DFG A+ G P + I + +YR PE++
Sbjct: 152 RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARA--FGIPIRQFTHEIITLWYRPPEIL 209
Query: 257 FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE---EIKCMN 313
G+ Y+T++DIWS C+ AE+L+ PLFPG+S +DQL +I +VLG P + +
Sbjct: 210 LGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTAL- 268
Query: 314 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD 373
P++ + FP+ + +V L E +DL+ + P R +A A HP+F
Sbjct: 269 PDWKQS-FPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHN-- 325
Query: 374 PNTRLPNGRPLPP 386
P
Sbjct: 326 ---------DFDP 329
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 283 bits (726), Expect = 3e-94
Identities = 101/294 (34%), Positives = 158/294 (53%), Gaps = 28/294 (9%)
Query: 90 VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 143
+G G++GVV++A+ GE A+KK+ +K + RE+ I++ L H NIV L
Sbjct: 10 IGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68
Query: 144 FFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203
K+ L L V E++ + + ++ + + K + Q+ +AY H+
Sbjct: 69 I---HTKKRLVL--VFEHLDQDLKKLLDVCE---GGLESVTAKSFLLQLLNGIAYCHDR- 119
Query: 204 GICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSRYYRAPELIFGAT 260
+ HRD+KPQNLL+N +LK+ DFG A+ G P Y I + +YRAP+++ G+
Sbjct: 120 RVLHRDLKPQNLLIN-REGELKIADFGLARA--FGIPVRKYTHEIVTLWYRAPDVLMGSK 176
Query: 261 EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE---EIKCMNPNYT 317
+Y+T IDIWS GC+ AE++ G PLFPG S DQL+ I ++LGTP + + + P Y
Sbjct: 177 KYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTEL-PKY- 234
Query: 318 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL 371
+ F +P PW K L +DL+ + + PN R TA +A H +F E
Sbjct: 235 DPNFTVYEPLPWESFL-KGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKEN 287
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 281 bits (721), Expect = 3e-93
Identities = 97/318 (30%), Positives = 159/318 (50%), Gaps = 37/318 (11%)
Query: 90 VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---------RELQIMQMLDHPNIVAL 140
+G G++ V++ + TG VA+K+V + + RE+ +M+ L H NIV L
Sbjct: 13 LGNGTYATVYKGLNKTTGVYVALKEV----KLDSEEGTPSTAIREISLMKELKHENIVRL 68
Query: 141 KHCFFSTTDKEELYLNLVLEYVPETVNRI--ARNYSRIHQRMPLIYVKLYTYQICRALAY 198
+ +L L V E++ + + +R + + L VK + +Q+ + LA+
Sbjct: 69 YDVI---HTENKLTL--VFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAF 123
Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSRYYRAPEL 255
H I HRD+KPQNLL+N QLKL DFG A+ G P ++ + + +YRAP++
Sbjct: 124 CHEN-KILHRDLKPQNLLIN-KRGQLKLGDFGLARA--FGIPVNTFSSEVVTLWYRAPDV 179
Query: 256 IFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE---EIKCM 312
+ G+ Y+T+IDIWS GC++AE++ G+PLFPG + +QL I ++GTP + +
Sbjct: 180 LMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKL 239
Query: 313 NPNYTEFKFPQIKPHPWHKVFQK----RLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368
P Y Q P +V Q L +D + Q +P++R +A +A HP+F
Sbjct: 240 -PKY-NPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWF 297
Query: 369 DELRDPNTRLPNGRPLPP 386
E + R
Sbjct: 298 AEYYHH-ASMGGSRSHHH 314
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 279 bits (717), Expect = 6e-93
Identities = 101/298 (33%), Positives = 157/298 (52%), Gaps = 28/298 (9%)
Query: 90 VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 143
+G G++G VF+AK RET EIVA+K+V D + RE+ +++ L H NIV L
Sbjct: 10 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV 69
Query: 144 FFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203
++L L V E+ + + + + + + VK + +Q+ + L + H+
Sbjct: 70 L---HSDKKLTL--VFEFCDQDLKKYFDSCN---GDLDPEIVKSFLFQLLKGLGFCHSR- 120
Query: 204 GICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSRYYRAPELIFGAT 260
+ HRD+KPQNLL+N +LKL +FG A+ G P Y + + +YR P+++FGA
Sbjct: 121 NVLHRDLKPQNLLIN-RNGELKLANFGLARA--FGIPVRCYSAEVVTLWYRPPDVLFGAK 177
Query: 261 EYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQLVEIIKVLGTPTRE---EIKCMNPNY 316
Y+T+ID+WS GC+ AEL G+PLFPG DQL I ++LGTPT E + + P+Y
Sbjct: 178 LYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKL-PDY 236
Query: 317 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP 374
+ V +L DL+ + +P R +A EA HP+F + P
Sbjct: 237 KPYPMYP-ATTSLVNVV-PKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCPP 292
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 282 bits (723), Expect = 6e-93
Identities = 104/332 (31%), Positives = 174/332 (52%), Gaps = 38/332 (11%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV-----LQD-KR-YKNRELQIMQMLDHPN 136
+ + ++G G++GVV A + TGEIVAIKK+ R RE++I++ H N
Sbjct: 13 FQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTL--REIKILKHFKHEN 70
Query: 137 IVALKHCFFSTTDKE--ELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICR 194
I+ + + + + E+Y+ + E + ++R+ Q + +++ + YQ R
Sbjct: 71 IITIFNIQRPDSFENFNEVYI--IQELMQTDLHRVIST-----QMLSDDHIQYFIYQTLR 123
Query: 195 ALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVS----------- 243
A+ +H + HRD+KP NLL+N LK+CDFG A+++ + + S
Sbjct: 124 AVKVLHGS-NVIHRDLKPSNLLIN-SNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVE 181
Query: 244 YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGT 303
++ +R+YRAPE++ + +Y+ A+D+WS GC++AEL L +P+FPG QL+ I ++GT
Sbjct: 182 FVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGT 241
Query: 304 PTREEI--KCMNPNYTEF--KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTA 359
P + +P E+ P P K+F + + P+ +DL+ R + P R TA
Sbjct: 242 PHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPR-VNPKGIDLLQRMLVFDPAKRITA 300
Query: 360 LEACVHPFFDELRDPNTRLPNGRPLPPL-FNF 390
EA HP+ DPN P G P+PP F F
Sbjct: 301 KEALEHPYLQTYHDPN-DEPEGEPIPPSFFEF 331
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 280 bits (718), Expect = 3e-92
Identities = 92/330 (27%), Positives = 153/330 (46%), Gaps = 37/330 (11%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---------------RELQI 128
Y + + +GS+G V G VAIK+V RE+++
Sbjct: 24 YTVQRFISSGSYGAVCAGVDS-EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRL 82
Query: 129 MQMLDHPNIVALKHCF--FSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPL--IY 184
+ HPNI+ L+ F F +LYL V E + + ++ QR+ + +
Sbjct: 83 LNHFHHPNILGLRDIFVHFEEPAMHKLYL--VTELMRTDLAQVIH-----DQRIVISPQH 135
Query: 185 VKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY 244
++ + Y I L +H G+ HRD+ P N+L+ + + +CDF A+ Y
Sbjct: 136 IQYFMYHILLGLHVLHEA-GVVHRDLHPGNILLA-DNNDITICDFNLAREDTADANKTHY 193
Query: 245 ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTP 304
+ R+YRAPEL+ +T +D+WS GCVMAE+ + LF G + +QL +I++V+GTP
Sbjct: 194 VTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTP 253
Query: 305 TREEIKCM-NP---NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTAL 360
E++ +P +Y + W V P A+DL+ + +++P R +
Sbjct: 254 KIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPT-ADPVALDLIAKMLEFNPQRRISTE 312
Query: 361 EACVHPFFDELRDPNTRLPNGRPLPPLFNF 390
+A HP+F+ L DP L G F+F
Sbjct: 313 QALRHPYFESLFDPL-DLTEGLSER--FHF 339
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 277 bits (710), Expect = 5e-91
Identities = 102/307 (33%), Positives = 164/307 (53%), Gaps = 31/307 (10%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV---LQD----KR-YKNRELQIMQMLDHP 135
Y++ VG+G++G V A + +GE VAIKK+ Q KR Y REL +++ + H
Sbjct: 26 YVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAY--RELLLLKHMQHE 83
Query: 136 NIVALKHCFFSTTDKE---ELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQI 192
N++ L F + + YL V+ ++ + +I + + ++ YQ+
Sbjct: 84 NVIGLLDVFTPASSLRNFYDFYL--VMPFMQTDLQKI------MGLKFSEEKIQYLVYQM 135
Query: 193 CRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVS-YICSRYYR 251
+ L YIH+ G+ HRD+KP NL VN LK+ DFG A+ + ++ Y+ +R+YR
Sbjct: 136 LKGLKYIHSA-GVVHRDLKPGNLAVNEDCE-LKILDFGLARHA---DAEMTGYVVTRWYR 190
Query: 252 APELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 311
APE+I Y +DIWS GC+MAE+L G+ LF G+ +DQL +I+KV G P E ++
Sbjct: 191 APEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQK 250
Query: 312 M-NPNYTEF--KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368
+ + + PQ + ++F R P+A DL+ + + + R TA +A HPFF
Sbjct: 251 LNDKAAKSYIQSLPQTPRKDFTQLF-PRASPQAADLLEKMLELDVDKRLTAAQALTHPFF 309
Query: 369 DELRDPN 375
+ RDP
Sbjct: 310 EPFRDPE 316
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 277 bits (710), Expect = 6e-91
Identities = 94/308 (30%), Positives = 166/308 (53%), Gaps = 28/308 (9%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV--LQD----KR-YKNRELQIMQMLDHPN 136
Y +G G++G+V A VAIKK+ + +R RE++I+ H N
Sbjct: 29 YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTL--REIKILLRFRHEN 86
Query: 137 IVALKHCFF--STTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICR 194
I+ + + +++Y+ V + + + ++ + Q + ++ + YQI R
Sbjct: 87 IIGINDIIRAPTIEQMKDVYI--VQDLMETDLYKLLKT-----QHLSNDHICYFLYQILR 139
Query: 195 ALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVS----YICSRYY 250
L YIH+ + HRD+KP NLL+N T LK+CDFG A+V + Y+ +R+Y
Sbjct: 140 GLKYIHSA-NVLHRDLKPSNLLLN-TTCDLKICDFGLARVADPDHDHTGFLTEYVATRWY 197
Query: 251 RAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 310
RAPE++ + YT +IDIWS GC++AE+L +P+FPG+ +DQL I+ +LG+P++E++
Sbjct: 198 RAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLN 257
Query: 311 CM-NPNYTEF--KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 367
C+ N + P PW+++F +A+DL+ + ++P+ R +A HP+
Sbjct: 258 CIINLKARNYLLSLPHKNKVPWNRLF-PNADSKALDLLDKMLTFNPHKRIEVEQALAHPY 316
Query: 368 FDELRDPN 375
++ DP+
Sbjct: 317 LEQYYDPS 324
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 274 bits (704), Expect = 9e-91
Identities = 83/304 (27%), Positives = 141/304 (46%), Gaps = 32/304 (10%)
Query: 90 VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---------RELQIMQML---DHPNI 137
+G G++G V++A+ +G VA+K V RE+ +++ L +HPN+
Sbjct: 17 IGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNV 76
Query: 138 VALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALA 197
V L ++ E+ + LV E+V + + +P +K Q R L
Sbjct: 77 VRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPG--LPAETIKDLMRQFLRGLD 134
Query: 198 YIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSRYYRAPE 254
++H I HRD+KP+N+LV +KL DFG A++ ++ + + +YRAPE
Sbjct: 135 FLHAN-CIVHRDLKPENILVT-SGGTVKLADFGLARI--YSYQ-MALTPVVVTLWYRAPE 189
Query: 255 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 314
++ +T Y T +D+WS GC+ AE+ +PLF G S DQL +I ++G P ++ P
Sbjct: 190 VLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDW----P 244
Query: 315 NYTE---FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL 371
FP P P V + L+ ++P+ R +A A H + +
Sbjct: 245 RDVSLPRGAFPPRGPRPVQSVV-PEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKD 303
Query: 372 RDPN 375
+ N
Sbjct: 304 -EGN 306
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 275 bits (705), Expect = 1e-90
Identities = 95/330 (28%), Positives = 158/330 (47%), Gaps = 33/330 (10%)
Query: 74 RNGNSKQKVSYIAEHVVGTGSFGVVFQAK-CRETGEIVAIKKVLQDKRYKN-------RE 125
++G + Y +G G++G VF+A+ + G VA+K+V + RE
Sbjct: 3 KDGLCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTG-EEGMPLSTIRE 61
Query: 126 LQIMQML---DHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPL 182
+ +++ L +HPN+V L + E L LV E+V + + +P
Sbjct: 62 VAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPG--VPT 119
Query: 183 IYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNV 242
+K +Q+ R L ++H+ + HRD+KPQN+LV + Q+KL DFG A++ +
Sbjct: 120 ETIKDMMFQLLRGLDFLHSH-RVVHRDLKPQNILVT-SSGQIKLADFGLARI--YSFQ-M 174
Query: 243 SY---ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIK 299
+ + + +YRAPE++ ++ Y T +D+WS GC+ AE+ +PLF G S VDQL +I+
Sbjct: 175 ALTSVVVTLWYRAPEVLLQSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILD 233
Query: 300 VLGTPTREEIKCMNPNYTE---FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLR 356
V+G P E+ P F P K + DL+ + ++P R
Sbjct: 234 VIGLPGEEDW----PRDVALPRQAFHSKSAQPIEKFV-TDIDELGKDLLLKCLTFNPAKR 288
Query: 357 CTALEACVHPFFDELRDPNTRLPNGRPLPP 386
+A A HP+F +L L + LPP
Sbjct: 289 ISAYSALSHPYFQDLERCKENLDS--HLPP 316
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 274 bits (703), Expect = 7e-90
Identities = 97/305 (31%), Positives = 158/305 (51%), Gaps = 26/305 (8%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV------LQDKRYKNRELQIMQMLDHPNI 137
Y VG+G++G V A TG VAIKK+ + REL++++ + H N+
Sbjct: 27 YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENV 86
Query: 138 VALKHCFF---STTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICR 194
+ L F + D + YL V+ ++ + ++ ++ +++ ++ YQ+ +
Sbjct: 87 IGLLDVFTPDETLDDFTDFYL--VMPFMGTDLGKLMKH-----EKLGEDRIQFLVYQMLK 139
Query: 195 ALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVS-YICSRYYRAP 253
L YIH GI HRD+KP NL VN LK+ DFG A+ + ++ Y+ +R+YRAP
Sbjct: 140 GLRYIHAA-GIIHRDLKPGNLAVNEDCE-LKILDFGLARQA---DSEMTGYVVTRWYRAP 194
Query: 254 ELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM- 312
E+I YT +DIWS GC+MAE++ G+ LF G +DQL EI+KV GTP E ++ +
Sbjct: 195 EVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQ 254
Query: 313 NPNYTEF--KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE 370
+ + P+++ + + P AV+L+ + R TA EA HP+F+
Sbjct: 255 SDEAKNYMKGLPELEKKDFASIL-TNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFES 313
Query: 371 LRDPN 375
L D
Sbjct: 314 LHDTE 318
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 273 bits (701), Expect = 2e-89
Identities = 97/331 (29%), Positives = 155/331 (46%), Gaps = 38/331 (11%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV---LQD----KR-YKNRELQIMQMLDHP 135
Y +G+G+ G+V A VAIKK+ Q+ KR Y REL +M+ ++H
Sbjct: 27 YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAY--RELVLMKCVNHK 84
Query: 136 NIVALKHCFFSTTDKE---ELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQI 192
NI+ L + F E ++Y+ V+E + + ++ I + + YQ+
Sbjct: 85 NIIGLLNVFTPQKSLEEFQDVYI--VMELMDANLCQV------IQMELDHERMSYLLYQM 136
Query: 193 CRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRA 252
+ ++H+ GI HRD+KP N++V LK+ DFG A+ Y+ +RYYRA
Sbjct: 137 LCGIKHLHSA-GIIHRDLKPSNIVVK-SDCTLKILDFGLARTAGTSFMMTPYVVTRYYRA 194
Query: 253 PELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 312
PE+I G Y +DIWS GC+M E++ G LFPG +DQ ++I+ LGTP E +K +
Sbjct: 195 PEVILG-MGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKL 253
Query: 313 NPNYTEF--KFPQIKPHPWHKVFQ-----------KRLPPEAVDLVCRFFQYSPNLRCTA 359
P + P+ + + K+F K +A DL+ + + R +
Sbjct: 254 QPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISV 313
Query: 360 LEACVHPFFDELRDPNTRLPNGRPLPPLFNF 390
EA HP+ + DP+ P P
Sbjct: 314 DEALQHPYINVWYDPS-EAEAPPPKIPDKQL 343
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 270 bits (692), Expect = 3e-88
Identities = 88/315 (27%), Positives = 139/315 (44%), Gaps = 26/315 (8%)
Query: 90 VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 143
+G G+FG VF+A+ R+TG+ VA+KKVL + + RE++I+Q+L H N+V L
Sbjct: 25 IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 84
Query: 144 FFSTTDKEELYLN---LVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 200
+ LV ++ + + N + + L +K + L YIH
Sbjct: 85 CRTKASPYNRCKGSIYLVFDFCEHDLAGLLSN---VLVKFTLSEIKRVMQMLLNGLYYIH 141
Query: 201 NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV--LVKGEPNVSY---ICSRYYRAPEL 255
I HRD+K N+L+ LKL DFG A+ L K Y + + +YR PEL
Sbjct: 142 RN-KILHRDMKAANVLIT-RDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPEL 199
Query: 256 IFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE---EIKCM 312
+ G +Y ID+W GC+MAE+ P+ G + QL I ++ G+ T E +
Sbjct: 200 LLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNY 259
Query: 313 NPNYTEFKFPQIKPHPWHKVFQK-RLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL 371
Y + + + + + P A+DL+ + P R + +A H FF
Sbjct: 260 -ELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWS- 317
Query: 372 RDPNTRLPNGRPLPP 386
DP G
Sbjct: 318 -DPMPSDLKGMLSTH 331
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 269 bits (690), Expect = 7e-88
Identities = 104/307 (33%), Positives = 161/307 (52%), Gaps = 30/307 (9%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KR-YKNRELQIMQMLDHP 135
Y VG+G++G V A +TG VA+KK+ + KR Y REL++++ + H
Sbjct: 31 YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY--RELRLLKHMKHE 88
Query: 136 NIVALKHCFFSTTDKE---ELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQI 192
N++ L F E ++YL V + +N I + Q++ +V+ YQI
Sbjct: 89 NVIGLLDVFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHVQFLIYQI 141
Query: 193 CRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVS-YICSRYYR 251
R L YIH+ I HRD+KP NL VN +LK+ DFG A+ ++ Y+ +R+YR
Sbjct: 142 LRGLKYIHSA-DIIHRDLKPSNLAVN-EDCELKILDFGLARHT---ADEMTGYVATRWYR 196
Query: 252 APELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 311
APE++ Y +DIWS GC+MAELL G+ LFPG +DQL I++++GTP E +K
Sbjct: 197 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKK 256
Query: 312 M-NPNYTEF--KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368
+ + + + Q+ + VF P AVDL+ + + R TA +A H +F
Sbjct: 257 ISSESARNYIQSLTQMPKMNFANVF-IGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 315
Query: 369 DELRDPN 375
+ DP+
Sbjct: 316 AQYHDPD 322
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 272 bits (697), Expect = 1e-87
Identities = 96/331 (29%), Positives = 156/331 (47%), Gaps = 40/331 (12%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KR-YKNRELQIMQMLDHP 135
Y +G+G+ G+V A VAIKK+ + KR Y REL +M+ ++H
Sbjct: 64 YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAY--RELVLMKCVNHK 121
Query: 136 NIVALKHCFFSTTDKE---ELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQI 192
NI++L + F E ++YL V+E + + ++ I + + YQ+
Sbjct: 122 NIISLLNVFTPQKTLEEFQDVYL--VMELMDANLCQV------IQMELDHERMSYLLYQM 173
Query: 193 CRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRA 252
+ ++H+ GI HRD+KP N++V LK+ DFG A+ Y+ +RYYRA
Sbjct: 174 LCGIKHLHSA-GIIHRDLKPSNIVVK-SDCTLKILDFGLARTAGTSFMMTPYVVTRYYRA 231
Query: 253 PELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 312
PE+I G Y +DIWS GC+M E++ + LFPG +DQ ++I+ LGTP E +K +
Sbjct: 232 PEVILG-MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 290
Query: 313 NPNYTEF--KFPQIKPHPWHKVF-----------QKRLPPEAVDLVCRFFQYSPNLRCTA 359
P + P+ + K+F K +A DL+ + P R +
Sbjct: 291 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISV 350
Query: 360 LEACVHPFFDELRDPNTRLPNGRPLPPLFNF 390
+A HP+ + DP P P +++
Sbjct: 351 DDALQHPYINVWYDPAEVEA---PPPQIYDK 378
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 266 bits (682), Expect = 2e-85
Identities = 107/366 (29%), Positives = 160/366 (43%), Gaps = 87/366 (23%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KR-YKNRELQIMQMLDHP 135
Y H++GTGS+G V +A + +VAIKK+L+ KR RE+ I+ L+H
Sbjct: 55 YEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRIL--REIAILNRLNHD 112
Query: 136 NIVALKHCFF--STTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPL--IYVKLYTYQ 191
++V + +ELY+ VLE ++ + L +++K Y
Sbjct: 113 HVVKVLDIVIPKDVEKFDELYV--VLEIADSDFKKL------FRTPVYLTELHIKTLLYN 164
Query: 192 ICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVS-------- 243
+ + Y+H+ GI HRD+KP N LVN +K+CDFG A+ + E S
Sbjct: 165 LLVGVKYVHSA-GILHRDLKPANCLVNQDCS-VKVCDFGLARTVDYPENGNSQLPISPRE 222
Query: 244 --------------------YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL--- 280
++ +R+YRAPELI YT AID+WS GC+ AELL
Sbjct: 223 DDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIK 282
Query: 281 --------GQPLFPGES--------------------GVDQLVEIIKVLGTPTREEIKCM 312
PLFPG S DQL I +LGTP+ E+I+ +
Sbjct: 283 ENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEAL 342
Query: 313 -NPNYTEF--KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFD 369
+ + FP+ + + F +A+ L+ R ++PN R T E HPFF
Sbjct: 343 EKEDAKRYIRIFPKREGTDLAERF-PASSADAIHLLKRMLVFNPNKRITINECLAHPFFK 401
Query: 370 ELRDPN 375
E+R
Sbjct: 402 EVRIAE 407
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 265 bits (680), Expect = 2e-85
Identities = 104/358 (29%), Positives = 159/358 (44%), Gaps = 79/358 (22%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV------LQD-KR-YKNRELQIMQMLDHP 135
YI +H++G GS+G V+ A + T + VAIKKV L D KR RE+ I+ L
Sbjct: 28 YIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRIL--REITILNRLKSD 85
Query: 136 NIVALKHCFF--STTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPL--IYVKLYTYQ 191
I+ L +ELY+ VLE + ++ + L ++K Y
Sbjct: 86 YIIRLYDLIIPDDLLKFDELYI--VLEIADSDLKKL------FKTPIFLTEEHIKTILYN 137
Query: 192 ICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVS-------- 243
+ +IH GI HRD+KP N L+N +K+CDFG A+ + +
Sbjct: 138 LLLGENFIHES-GIIHRDLKPANCLLNQDCS-VKVCDFGLARTINSEKDTNIVNDLEENE 195
Query: 244 ---------------YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQ------ 282
++ +R+YRAPELI YT +IDIWSTGC+ AELL
Sbjct: 196 EPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHIND 255
Query: 283 -----PLFPGESG-----------------VDQLVEIIKVLGTPTREEIKCM-NPNYTEF 319
PLFPG S DQL I ++GTPT +++K + P ++
Sbjct: 256 PTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKY 315
Query: 320 --KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 375
FP KP + + + + ++L+ +++PN R T +A HP+ ++R
Sbjct: 316 IKLFPHRKPINLKQKY-PSISDDGINLLESMLKFNPNKRITIDQALDHPYLKDVRKKK 372
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 263 bits (674), Expect = 3e-85
Identities = 96/341 (28%), Positives = 171/341 (50%), Gaps = 61/341 (17%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVL---QD----KR-YKNRELQIMQ-MLDH 134
Y +G G++G+V+++ R TGE+VA+KK+ Q+ +R + RE+ I+ + H
Sbjct: 11 YELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTF--REIMILTELSGH 68
Query: 135 PNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICR 194
NIV L + + D++ +YL V +Y+ ++ + R + ++ + YQ+ +
Sbjct: 69 ENIVNLLNVLRADNDRD-VYL--VFDYMETDLHAVIRA-----NILEPVHKQYVVYQLIK 120
Query: 195 ALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVS----------- 243
+ Y+H+ G+ HRD+KP N+L+N H +K+ DFG ++ V +
Sbjct: 121 VIKYLHSG-GLLHRDMKPSNILLNAECH-VKVADFGLSRSFVNIRRVTNNIPLSINENTE 178
Query: 244 -----------YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVD 292
Y+ +R+YRAPE++ G+T+YT ID+WS GC++ E+L G+P+FPG S ++
Sbjct: 179 NFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMN 238
Query: 293 QLVEIIKVLGTPTREEIKCM-NPNYTEF--KFPQIKPHPWHKVFQKRLP----------- 338
QL II V+ P+ E+++ + +P +
Sbjct: 239 QLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPK 298
Query: 339 ----PEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 375
EA+DL+ + Q++PN R +A +A HPF +PN
Sbjct: 299 ADCNEEALDLLDKLLQFNPNKRISANDALKHPFVSIFHNPN 339
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 255 bits (652), Expect = 9e-82
Identities = 87/335 (25%), Positives = 151/335 (45%), Gaps = 44/335 (13%)
Query: 90 VGTGSFGVVFQAKCRE--TGEIVAIKKVLQDKRYKN--RELQIMQMLDHPNIVALKHCFF 145
VG G++G V++AK ++ + A+K++ + RE+ +++ L HPN+++L+ F
Sbjct: 29 VGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFL 88
Query: 146 STTDKEELYLNLVLEYVPETVNRI-----ARNYSRIHQRMPLIYVKLYTYQICRALAYIH 200
S D++ + L+ +Y + I A ++ ++P VK YQI + Y+H
Sbjct: 89 SHADRK---VWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH 145
Query: 201 NCIGICHRDIKPQNLLVN---PHTHQLKLCDFGSAKVLVKGEPNVSY------ICSRYYR 251
+ HRD+KP N+LV P ++K+ D G A++ P + + +YR
Sbjct: 146 AN-WVLHRDLKPANILVMGEGPERGRVKIADMGFARLF--NSPLKPLADLDPVVVTFWYR 202
Query: 252 APELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGES---------GVDQLVEIIKVLG 302
APEL+ GA YT AIDIW+ GC+ AELL +P+F DQL I V+G
Sbjct: 203 APELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMG 262
Query: 303 TPTRE---------EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSP 353
P + E + ++ + + + + + +A L+ + P
Sbjct: 263 FPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDP 322
Query: 354 NLRCTALEACVHPFFDELRDPNTRLPNGRPLPPLF 388
R T+ +A P+F E DP +
Sbjct: 323 IKRITSEQAMQDPYFLE--DPLPTSDVFAGCQIPY 355
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 208 bits (531), Expect = 2e-63
Identities = 92/338 (27%), Positives = 149/338 (44%), Gaps = 73/338 (21%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQML------DH 134
Y V+G GSFG V +A + + VA+K V +KR+ E++I++ L +
Sbjct: 99 YEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNT 158
Query: 135 PNIVALKHCF---------FSTTDKEELYLNL--VLEYVPETVNRIARNYSRIHQRMPLI 183
N++ + F F E L +NL +++ N+ Q L
Sbjct: 159 MNVIHMLENFTFRNHICMTF-----ELLSMNLYELIKK-----NK--------FQGFSLP 200
Query: 184 YVKLYTYQICRALAYIHNCIGICHRDIKPQN-LLVNPHTHQLKLCDFGSAKVLVKGEPNV 242
V+ + + I + L +H I H D+KP+N LL +K+ DFGS+ +
Sbjct: 201 LVRKFAHSILQCLDALHKN-RIIHCDLKPENILLKQQGRSGIKVIDFGSSCYE--HQRVY 257
Query: 243 SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLG 302
+YI SR+YRAPE+I GA Y ID+WS GC++AELL G PL PGE DQL +I++LG
Sbjct: 258 TYIQSRFYRAPEVILGA-RYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLG 316
Query: 303 TPTREEIK-----------CMNPNYTEFKF---------------PQIKPHPWHKVFQKR 336
P+++ + P Y +++ P + +
Sbjct: 317 MPSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNA 376
Query: 337 LPPEA----VDLVCRFFQYSPNLRCTALEACVHPFFDE 370
L +D + + ++ P +R T +A HP+
Sbjct: 377 LKGCDDPLFLDFLKQCLEWDPAVRMTPGQALRHPWLRR 414
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 199 bits (507), Expect = 2e-60
Identities = 86/340 (25%), Positives = 137/340 (40%), Gaps = 44/340 (12%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQML-----DHP 135
YI +G G F V+ AK VA+K V DK Y E++++Q +
Sbjct: 21 YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKE 80
Query: 136 NIVALKHC-----FFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTY 190
+ + H F+ +++ +V E + E + + + Y H+ +PLIYVK +
Sbjct: 81 DSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYE--HRGIPLIYVKQISK 138
Query: 191 QICRALAYIHNCIGICHRDIKPQNLLVNPHTHQ-----LKLCDFGSAKVLVKGEPNVSYI 245
Q+ L Y+H GI H DIKP+N+L+ +K+ D G+A E + I
Sbjct: 139 QLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA--CWYDEHYTNSI 196
Query: 246 CSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESG------VDQLVEIIK 299
+R YR+PE++ GA + DIWST C++ EL+ G LF + G D + +II+
Sbjct: 197 QTREYRSPEVLLGA-PWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIE 255
Query: 300 VLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPP--------------EAVDLV 345
+LG ++ F + K+ L E D +
Sbjct: 256 LLGELPSYLLR-NGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFL 314
Query: 346 CRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPNGRPLP 385
Q P R A HP+ + R L
Sbjct: 315 SPMLQLDPRKRADAGGLVNHPWLKDTLGMEEIRVPDRELY 354
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 199 bits (507), Expect = 2e-60
Identities = 96/347 (27%), Positives = 143/347 (41%), Gaps = 78/347 (22%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQML------DH 134
Y + ++G GSFG V +A R E VAIK + K + N E+++++++
Sbjct: 56 YEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMK 115
Query: 135 PNIVALKHCF---------FSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQR--MPLI 183
IV LK F F E L NL + R + L
Sbjct: 116 YYIVHLKRHFMFRNHLCLVF-----EMLSYNL-------------YDLLRNTNFRGVSLN 157
Query: 184 YVKLYTYQICRALAYIHNC-IGICHRDIKPQN-LLVNPHTHQLKLCDFGSAKVLVKGEPN 241
+ + Q+C AL ++ + I H D+KP+N LL NP +K+ DFGS+ G+
Sbjct: 158 LTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSS--CQLGQRI 215
Query: 242 VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVL 301
YI SR+YR+PE++ G Y AID+WS GC++ E+ G+PLF G + VDQ+ +I++VL
Sbjct: 216 YQYIQSRFYRSPEVLLGM-PYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVL 274
Query: 302 GTPTRE--------------------EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEA 341
G P +K E+K P + + P
Sbjct: 275 GIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGR 334
Query: 342 ---------------VDLVCRFFQYSPNLRCTALEACVHPFFDELRD 373
DL+ R Y P R A H FF + D
Sbjct: 335 RAGESGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQHSFFKKTAD 381
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 195 bits (499), Expect = 6e-60
Identities = 72/344 (20%), Positives = 123/344 (35%), Gaps = 68/344 (19%)
Query: 59 VGAETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV--- 115
+G E + ++ GR Y +G+G VFQ E +I AIK V
Sbjct: 13 LGTENLYFQSMSVKGRI--------YSILKQIGSGGSSKVFQVL-NEKKQIYAIKYVNLE 63
Query: 116 -LQDKRYKN--RELQIMQMLDHPN--IVALKHCFFSTTDKEELYLNLVLEYVPETVNRIA 170
++ + E+ + L + I+ L + +Y+ V+E +N
Sbjct: 64 EADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE---ITDQYIYM--VMECGNIDLNSWL 118
Query: 171 RNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFG 230
+ + + K Y + A+ IH GI H D+KP N L+ LKL DFG
Sbjct: 119 KK----KKSIDPWERKSYWKNMLEAVHTIHQH-GIVHSDLKPANFLI--VDGMLKLIDFG 171
Query: 231 SAKVLVKGEPNV---SYICSRYYRAPELIFGA----------TEYTTAIDIWSTGCVMAE 277
A + +V S + + Y PE I ++ + D+WS GC++
Sbjct: 172 IANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYY 231
Query: 278 LLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRL 337
+ G+ F + I ++PN+ E +FP I
Sbjct: 232 MTYGKTPFQQIINQISKLHAI-------------IDPNH-EIEFPDI------------P 265
Query: 338 PPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPNG 381
+ D++ + P R + E HP+ P ++ G
Sbjct: 266 EKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKG 309
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 195 bits (497), Expect = 4e-59
Identities = 79/346 (22%), Positives = 131/346 (37%), Gaps = 82/346 (23%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQML-----DHP 135
++ +G G+FG V + + + A+K V K+Y E I++ + ++
Sbjct: 37 FLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNN 96
Query: 136 NIVALKHCF---------FSTTDKEELYLNL--VLEYVPETVNRIARNYSRIHQRMPLIY 184
NIV F F E L +L ++ NY +
Sbjct: 97 NIVKYHGKFMYYDHMCLIF-----EPLGPSLYEIIT---------RNNY----NGFHIED 138
Query: 185 VKLYTYQICRALAYIHNCIGICHRDIKPQN-LLVNPHTH--------------------- 222
+KLY +I +AL Y+ + H D+KP+N LL +P+
Sbjct: 139 IKLYCIEILKALNYLRKM-SLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTK 197
Query: 223 --QLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL 280
+KL DFG A K + + S I +R YRAPE+I + + D+WS GCV+AEL
Sbjct: 198 STGIKLIDFGCA--TFKSDYHGSIINTRQYRAPEVILNL-GWDVSSDMWSFGCVLAELYT 254
Query: 281 GQPLFPGESGVDQLVEIIKVLGTPTREEI---------KCMNPNYTEFKFPQIKPHPWHK 331
G LF ++ L + ++ + + K +N + + +P+
Sbjct: 255 GSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSI 314
Query: 332 VFQKRLPPEA--------VDLVCRFFQYSPNLRCTALEACVHPFFD 369
K+ P D + Q P LR + E H F +
Sbjct: 315 KHVKKCLPLYKIIKHELFCDFLYSILQIDPTLRPSPAELLKHKFLE 360
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 194 bits (495), Expect = 6e-59
Identities = 79/354 (22%), Positives = 129/354 (36%), Gaps = 76/354 (21%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETG-EIVAIKKVLQDKRYKN---RELQIMQML------D 133
Y +G G+FG V + G VA+K + +Y+ E+ +++ + +
Sbjct: 21 YEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKEN 80
Query: 134 HPNIVALKHCF---------FSTTDKEELYLNL--VLEYVPETVNRIARNYSRIHQRMPL 182
V + F F E L N L+ N+ Q PL
Sbjct: 81 KFLCVLMSDWFNFHGHMCIAF-----ELLGKNTFEFLK---------ENNF----QPYPL 122
Query: 183 IYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVN------------------PHTHQL 224
+V+ YQ+C AL ++H + H D+KP+N+L +
Sbjct: 123 PHVRHMAYQLCHALRFLHEN-QLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSI 181
Query: 225 KLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPL 284
++ DFGSA E + + + +R+YR PE+I + D+WS GC++ E G L
Sbjct: 182 RVADFGSA--TFDHEHHTTIVATRHYRPPEVILE-LGWAQPCDVWSIGCILFEYYRGFTL 238
Query: 285 FPGESGVDQLVEIIKVLGTPTREEIKCM---------NPNYTEFKFPQIKPHPWHKVFQK 335
F + LV + K+LG I + E K +
Sbjct: 239 FQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKS 298
Query: 336 RLPPEA------VDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPNGRP 383
+ ++ DL+ R ++ P R T EA +HPFF L R
Sbjct: 299 YMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALLHPFFAGLTPEERSFHTSRN 352
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 193 bits (493), Expect = 8e-59
Identities = 68/319 (21%), Positives = 114/319 (35%), Gaps = 60/319 (18%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPN- 136
Y +G+G VFQ E +I AIK V ++ E+ + L +
Sbjct: 11 YSILKQIGSGGSSKVFQVL-NEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 69
Query: 137 -IVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRA 195
I+ L + +Y+ V+E +N + + + K Y + A
Sbjct: 70 KIIRLYDYE---ITDQYIYM--VMECGNIDLNSWLKK----KKSIDPWERKSYWKNMLEA 120
Query: 196 LAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNV---SYICSRYYRA 252
+ IH GI H D+KP N L+ LKL DFG A + +V S + + Y
Sbjct: 121 VHTIHQH-GIVHSDLKPANFLI--VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMP 177
Query: 253 PELIFG----------ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLG 302
PE I ++ + D+WS GC++ + G+ F + I
Sbjct: 178 PEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAI---- 233
Query: 303 TPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEA 362
++PN+ E +FP I + D++ + P R + E
Sbjct: 234 ---------IDPNH-EIEFPDI------------PEKDLQDVLKCCLKRDPKQRISIPEL 271
Query: 363 CVHPFFDELRDPNTRLPNG 381
HP+ P ++ G
Sbjct: 272 LAHPYVQIQTHPVNQMAKG 290
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 195 bits (496), Expect = 1e-58
Identities = 69/325 (21%), Positives = 116/325 (35%), Gaps = 60/325 (18%)
Query: 78 SKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQM 131
S + Y +G+G VFQ E +I AIK V ++ E+ +
Sbjct: 52 SVKGRIYSILKQIGSGGSSKVFQVL-NEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNK 110
Query: 132 LDHPN--IVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYT 189
L + I+ L + +Y+ V+E +N + + + K Y
Sbjct: 111 LQQHSDKIIRLYDYE---ITDQYIYM--VMECGNIDLNSWLKK----KKSIDPWERKSYW 161
Query: 190 YQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNV---SYIC 246
+ A+ IH GI H D+KP N L+ LKL DFG A + +V S +
Sbjct: 162 KNMLEAVHTIHQH-GIVHSDLKPANFLI--VDGMLKLIDFGIANQMQPDTTSVVKDSQVG 218
Query: 247 SRYYRAPELIFGA----------TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVE 296
+ Y PE I ++ + D+WS GC++ + G+ F +
Sbjct: 219 AVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLH 278
Query: 297 IIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLR 356
I ++PN+ E +FP I + D++ + P R
Sbjct: 279 AI-------------IDPNH-EIEFPDI------------PEKDLQDVLKCCLKRDPKQR 312
Query: 357 CTALEACVHPFFDELRDPNTRLPNG 381
+ E HP+ P ++ G
Sbjct: 313 ISIPELLAHPYVQIQTHPVNQMAKG 337
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 192 bits (490), Expect = 1e-58
Identities = 58/304 (19%), Positives = 110/304 (36%), Gaps = 27/304 (8%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKRYKNRELQIMQMLDHPNIV 138
++ ++G G+ VF+ + ++TG++ AIK L+ + RE ++++ L+H NIV
Sbjct: 11 WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIV 70
Query: 139 ALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
L TT + L ++E+ P + + +P + + +
Sbjct: 71 KLFAIEEETTTRH-KVL--IMEFCPCGSLYTVLEEPSNA--YGLPESEFLIVLRDVVGGM 125
Query: 197 AYIHNCIGICHRDIKPQNLLVNP---HTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAP 253
++ GI HR+IKP N++ KL DFG+A+ L E VS + Y P
Sbjct: 126 NHLREN-GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHP 184
Query: 254 ELIFGAT-------EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIK--VLGTP 304
++ A +Y +D+WS G G F G + E++ + G P
Sbjct: 185 DMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKP 244
Query: 305 TREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV 364
+ + P + L ++ + +
Sbjct: 245 SGAISGVQKAENGPIDWSGDMPVSCS--LSRGLQVLLTPVLANILEADQEKCWGFDQFFA 302
Query: 365 HPFF 368
Sbjct: 303 ETSD 306
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 191 bits (487), Expect = 6e-58
Identities = 79/345 (22%), Positives = 135/345 (39%), Gaps = 76/345 (22%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETG-EIVAIKKVLQDKRYKN---RELQIMQML------D 133
Y +G G+FG V + + G VA+K V RY E+Q+++ L
Sbjct: 16 YEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNS 75
Query: 134 HPNIVALKHCF---------FSTTDKEELYLNL--VLEYVPETVNRIARNYSRIHQRMPL 182
V + F F E L L+ ++ + L
Sbjct: 76 TFRCVQMLEWFEHHGHICIVF-----ELLGLSTYDFIK---------ENGF----LPFRL 117
Query: 183 IYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVN------------------PHTHQL 224
+++ YQIC+++ ++H+ + H D+KP+N+L +
Sbjct: 118 DHIRKMAYQICKSVNFLHSN-KLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDI 176
Query: 225 KLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPL 284
K+ DFGSA E + + + +R+YRAPE+I ++ D+WS GC++ E LG +
Sbjct: 177 KVVDFGSA--TYDDEHHSTLVSTRHYRAPEVILA-LGWSQPCDVWSIGCILIEYYLGFTV 233
Query: 285 FPGESGVDQLVEIIKVLGTPTREEI-KCMNPNY---TEFKFPQIKP-----HPWHKVFQK 335
FP + L + ++LG + I K Y + + K ++
Sbjct: 234 FPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKE 293
Query: 336 RLPPE------AVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP 374
+ + DL+ + +Y P R T EA HPFFD L+
Sbjct: 294 FMLSQDVEHERLFDLIQKMLEYDPAKRITLREALKHPFFDLLKKS 338
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 187 bits (477), Expect = 1e-56
Identities = 67/287 (23%), Positives = 106/287 (36%), Gaps = 49/287 (17%)
Query: 89 VVGTGSFGVVFQAKCRETGEIVAIKKVL------QDKRYKNRELQIM-QMLDHPNIVALK 141
+G GS+G VF+ + +E G + A+K+ + +D+ K E+ ++ HP V L+
Sbjct: 64 RLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLE 123
Query: 142 HCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
+ + LY L E + + ++ +P V Y ALA++H+
Sbjct: 124 QAWE---EGGILY--LQTELCGPS---LQQHCEAWGASLPEAQVWGYLRDTLLALAHLHS 175
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 261
G+ H D+KP N+ + P KL DFG L Y APEL+
Sbjct: 176 Q-GLVHLDVKPANIFLGPRGR-CKLGDFGLLVELGTAGAGEVQEGDPRYMAPELL--QGS 231
Query: 262 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF 321
Y TA D++S G + E+ L G G QL +
Sbjct: 232 YGTAADVFSLGLTILEVACNMELPHGGEGWQQLRQGYLP--------------------- 270
Query: 322 PQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368
P+ L E ++ + P LR TA P
Sbjct: 271 PEFTAG---------LSSELRSVLVMMLEPDPKLRATAEALLALPVL 308
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 185 bits (473), Expect = 2e-56
Identities = 80/299 (26%), Positives = 131/299 (43%), Gaps = 42/299 (14%)
Query: 89 VVGTGSFGVVFQAKCRETGEIVAIKKV-LQDKRYKN---RELQIMQMLDHPNIVALKHCF 144
V+G G++G+V+ + +AIK++ +D RY E+ + + L H NIV
Sbjct: 29 VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQ----- 83
Query: 145 FSTTDKEELYLNLVLEYVPE-TVNRIARN-YSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
+ + E ++ + +E VP +++ + R+ + + I YT QI L Y+H+
Sbjct: 84 YLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTI--GFYTKQILEGLKYLHDN 141
Query: 203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNV-SYICSRYYRAPELIFGATE 261
I HRDIK N+L+N ++ LK+ DFG++K L P ++ + Y APE+I
Sbjct: 142 -QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPR 200
Query: 262 -YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 320
Y A DIWS GC + E+ G+P F +L E + FK
Sbjct: 201 GYGKAADIWSLGCTIIEMATGKPPFY------ELGEPQAAM-----------------FK 237
Query: 321 FPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLP 379
K HP + + EA + + F+ P+ R A + V F P
Sbjct: 238 VGMFKVHP---EIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKVSSKKKKTQP 293
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 189 bits (482), Expect = 4e-56
Identities = 62/302 (20%), Positives = 118/302 (39%), Gaps = 51/302 (16%)
Query: 81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-RYKNRELQIMQMLD-HPNIV 138
K+S+ + V+G G+ G + + VA+K++L + + +RE+Q+++ D HPN++
Sbjct: 23 KISFCPKDVLGHGAEGTIV-YRGMFDNRDVAVKRILPECFSFADREVQLLRESDEHPNVI 81
Query: 139 ALKHCFFSTTDKEELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALA 197
K+ + + +E + + P+ ++ Q LA
Sbjct: 82 RYFCTE-----KDRQFQYIAIELCAATLQEYVEQKDFAHLGLEPITLLQ----QTTSGLA 132
Query: 198 YIHNCIGICHRDIKPQNLLVNPH----THQLKLCDFGSAKVLVKGEPNVSY---IC-SRY 249
++H+ I HRD+KP N+L++ + + DFG K L G + S + +
Sbjct: 133 HLHSL-NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEG 191
Query: 250 YRAPELIFGATE--YTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTR 306
+ APE++ + T +DI+S GCV ++ G F G +
Sbjct: 192 WIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPF----------------GKSLQ 235
Query: 307 EEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHP 366
+ + + H A +L+ + P R +A HP
Sbjct: 236 RQANILLGAC-SLDCLHPEKH---------EDVIARELIEKMIAMDPQKRPSAKHVLKHP 285
Query: 367 FF 368
FF
Sbjct: 286 FF 287
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 186 bits (474), Expect = 1e-55
Identities = 58/394 (14%), Positives = 105/394 (26%), Gaps = 57/394 (14%)
Query: 22 SSSSSVDWLGREMLEMRLRDQVDNDEDRDSEPDIIDGVGAETGHVIRTTIGGRNGNSKQK 81
S + D R++L+ E+ EP + T + S+ +
Sbjct: 2 SHMEAGDSFMRDLLKREEELIGYCREEALKEPAAMVEAVTATVWPQNAETTVDSLLSQGE 61
Query: 82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------NRELQIMQMLDH 134
+ G VVF + E E A+K + L
Sbjct: 62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLG 121
Query: 135 PNIVALKHCF---------------------FSTTDKEELYLNLVLEYVP---ETVNRIA 170
+ + D L++ E +
Sbjct: 122 ESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTL 181
Query: 171 RNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFG 230
++ + + T Q+ R A + + G+ H P NL + P L L D
Sbjct: 182 DFVYVFRGDEGILALHILTAQLIRLAANLQSK-GLVHGHFTPDNLFIMPDGR-LMLGDVS 239
Query: 231 SAKVLVKGEPNVSYICSRYYRAPELIFG-ATEYTTAIDIWSTGCVMAELLLGQPLFPGES 289
+ + G + Y E + +T A++ W G + + F +
Sbjct: 240 ALWKV--GTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVT 297
Query: 290 GVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFF 349
+ L P + LP L+ RF
Sbjct: 298 PGIKGSWKRPSLRVPGTD--------------------SLAFGSCTPLPDFVKTLIGRFL 337
Query: 350 QYSPNLRCTALEACVHPFFDELRD-PNTRLPNGR 382
+ R LEA P F +L++ ++ L G+
Sbjct: 338 NFDRRRRLLPLEAMETPEFLQLQNEISSSLSTGQ 371
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 186 bits (475), Expect = 1e-55
Identities = 63/313 (20%), Positives = 115/313 (36%), Gaps = 32/313 (10%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKRYKNRELQIMQMLDHPNIV 138
++ ++G G+ VF+ + ++TG++ AIK L+ + RE ++++ L+H NIV
Sbjct: 11 WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIV 70
Query: 139 ALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
L TT + L++E+ P + + +P + + +
Sbjct: 71 KLFAIEEETTTR-HKV--LIMEFCPCGSLYTVLEEPSN--AYGLPESEFLIVLRDVVGGM 125
Query: 197 AYIHNCIGICHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAP 253
++ GI HR+IKP N++ KL DFG+A+ L E VS + Y P
Sbjct: 126 NHLREN-GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHP 184
Query: 254 ELIFGAT-------EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIK--VLGTP 304
++ A +Y +D+WS G G F G + E++ + G P
Sbjct: 185 DMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKP 244
Query: 305 TREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV 364
+ + P + L ++ + +
Sbjct: 245 SGAISGVQKAENGPIDWSGDMPVSCS--LSRGLQVLLTPVLANILEADQEKCWGFDQ--- 299
Query: 365 HPFFDELRDPNTR 377
FF E D R
Sbjct: 300 --FFAETSDILHR 310
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 181 bits (461), Expect = 2e-54
Identities = 66/320 (20%), Positives = 115/320 (35%), Gaps = 61/320 (19%)
Query: 77 NSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLD 133
+ + + V+G G+FG V +A+ AIKK+ + + E+ ++ L+
Sbjct: 1 SLRYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLN 60
Query: 134 HPNIVALKHCF--------FSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLI 183
H +V + T K++ L + +EY + I +
Sbjct: 61 HQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWR 120
Query: 184 YVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVS 243
+ QI AL+YIH+ GI HRD+KP N+ ++ + +K+ DFG AK + + +
Sbjct: 121 LFR----QILEALSYIHSQ-GIIHRDLKPMNIFID-ESRNVKIGDFGLAKNVHRSLDILK 174
Query: 244 YICSR---------------YYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGE 288
Y A E++ G Y ID++S G + E++ P G
Sbjct: 175 LDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI--YPFSTGM 232
Query: 289 SGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRF 348
V I+K L + +FP P F ++
Sbjct: 233 E----RVNILKKLRSV-------------SIEFP-----PD---FDDNKMKVEKKIIRLL 267
Query: 349 FQYSPNLRCTALEACVHPFF 368
+ PN R A +
Sbjct: 268 IDHDPNKRPGARTLLNSGWL 287
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 184 bits (469), Expect = 3e-54
Identities = 75/323 (23%), Positives = 127/323 (39%), Gaps = 60/323 (18%)
Query: 75 NGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-RYKNRELQIMQMLD 133
N K ++E ++G GS G V + G VA+K++L D E++++ D
Sbjct: 8 NFEQSLKNLVVSEKILGYGSSGTVV-FQGSFQGRPVAVKRMLIDFCDIALMEIKLLTESD 66
Query: 134 -HPNIVALKHCFFSTTDKEELYLNLVLEYVP-ETVNRIARN--YSRIHQRMPLIYVKLYT 189
HPN++ +C + LY+ LE + + +
Sbjct: 67 DHPNVIRY-YCSET--TDRFLYI--ALELCNLNLQDLVESKNVSDENLKLQKEYNPISLL 121
Query: 190 YQICRALAYIHNCIGICHRDIKPQNLLVNPHTH------------QLKLCDFGSAKVLVK 237
QI +A++H+ I HRD+KPQN+LV+ + ++ + DFG K L
Sbjct: 122 RQIASGVAHLHSL-KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDS 180
Query: 238 GEPNVSY----IC-SRYYRAPELIFGATE------YTTAIDIWSTGCVMAELL-LGQPLF 285
G+ + + +RAPEL+ + T +IDI+S GCV +L G+ F
Sbjct: 181 GQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPF 240
Query: 286 PGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLV 345
+ + II+ F ++K + EA DL+
Sbjct: 241 GDKY--SRESNIIR-----------------GIFSLDEMKCLHDRSL-----IAEATDLI 276
Query: 346 CRFFQYSPNLRCTALEACVHPFF 368
+ + P R TA++ HP F
Sbjct: 277 SQMIDHDPLKRPTAMKVLRHPLF 299
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 179 bits (457), Expect = 4e-54
Identities = 69/299 (23%), Positives = 116/299 (38%), Gaps = 45/299 (15%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV------LQDKRYKNRELQIMQMLDHPNI 137
Y + +GTGS+G + + + G+I+ K++ +K+ E+ +++ L HPNI
Sbjct: 8 YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNI 67
Query: 138 VALKHCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
V D+ L +V+EY + + ++ Q + +V Q+ AL
Sbjct: 68 VRYYDRII---DRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 124
Query: 197 AYIH----NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYIC-SRYYR 251
H + HRD+KP N+ ++ +KL DFG A++L + YY
Sbjct: 125 KECHRRSDGGHTVLHRDLKPANVFLD-GKQNVKLGDFGLARILNHDTSFAKTFVGTPYYM 183
Query: 252 APELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 311
+PE + Y DIWS GC++ EL P F S +L I+
Sbjct: 184 SPEQMNRM-SYNEKSDIWSLGCLLYELCALMPPFTAFS-QKELAGKIR------------ 229
Query: 312 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE 370
E KF +I E +++ R R + E +P E
Sbjct: 230 ------EGKFRRIPYR---------YSDELNEIITRMLNLKDYHRPSVEEILENPLILE 273
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 188 bits (478), Expect = 7e-54
Identities = 81/322 (25%), Positives = 132/322 (40%), Gaps = 29/322 (9%)
Query: 72 GGRNGNSKQKV--SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-----R 124
GGR+ + + + + +GTG FG V + ++TGE VAIK+ Q+ KN
Sbjct: 2 GGRSPSLPTQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCL 61
Query: 125 ELQIMQMLDHPNIVALKHCFFSTTDKEELYLN-LVLEYVP--ETVNRIARNYSRIHQRMP 181
E+QIM+ L+HPN+V+ + L L +EY + + + +
Sbjct: 62 EIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQF--ENCCGLK 119
Query: 182 LIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGE 239
++ I AL Y+H I HRD+KP+N+++ P + K+ D G AK L +GE
Sbjct: 120 EGPIRTLLSDISSALRYLHEN-RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGE 178
Query: 240 PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIK 299
++ + Y APEL+ +YT +D WS G + E + G F Q ++
Sbjct: 179 LCTEFVGTLQYLAPELLEQ-KKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVR 237
Query: 300 VLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQ----YSPNL 355
+ E I + KF + P P L + R+ Q +
Sbjct: 238 ---EKSNEHIVVYDDLTGAVKFSSVLPTP------NHLSGILAGKLERWLQCMLMWHQRQ 288
Query: 356 RCTALEACVHPFFDELRDPNTR 377
R T + F L +
Sbjct: 289 RGTDPQNPNVGCFQALDSILSL 310
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 184 bits (468), Expect = 2e-53
Identities = 73/318 (22%), Positives = 127/318 (39%), Gaps = 52/318 (16%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVL------QDKRYKNRELQIMQMLDHPNI 137
Y +G+G++G V + + T AIK + E+ ++++LDHPNI
Sbjct: 39 YQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNI 98
Query: 138 VALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIAR--NYSRIHQRMPLIYVKLYTYQIC 193
+ L F +++ LV+E E + I ++ + + Q+
Sbjct: 99 MKLYDFF-----EDKRNYYLVMECYKGGELFDEIIHRMKFNE-------VDAAVIIKQVL 146
Query: 194 RALAYIHNCIGICHRDIKPQN-LLVNPHTH-QLKLCDFGSAKVLVKGEPNVSYICSRYYR 251
+ Y+H I HRD+KP+N LL + +K+ DFG + V + + + YY
Sbjct: 147 SGVTYLHKH-NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYI 205
Query: 252 APELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 311
APE++ +Y D+WS G ++ LL G P F G++ DQ EI+ +++
Sbjct: 206 APEVLRK--KYDEKCDVWSIGVILFILLAGYPPFGGQT--DQ--EIL--------RKVEK 251
Query: 312 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL 371
+ W V A DL+ + Q+ R +A +A HP+ E+
Sbjct: 252 GKYTFDS--------PEWKNV-----SEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEM 298
Query: 372 RDPNTRLPNGRPLPPLFN 389
L
Sbjct: 299 CSKKESGIELPSLANAIE 316
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 182 bits (465), Expect = 3e-53
Identities = 80/296 (27%), Positives = 132/296 (44%), Gaps = 49/296 (16%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV----LQDKRYKN---RELQIMQMLDHPN 136
Y + V+G GSFG V K + TG+ A+K + ++ K K RE+Q+++ LDHPN
Sbjct: 28 YKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPN 87
Query: 137 IVALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICR 194
I+ L F +++ Y LV E E + I +R + Q+
Sbjct: 88 IMKLYEFF-----EDKGYFYLVGEVYTGGELFDEIIS-----RKRFSEVDAARIIRQVLS 137
Query: 195 ALAYIHNCIGICHRDIKPQN-LLVNPHTH-QLKLCDFGSAKVLVKGEPNVSYICSRYYRA 252
+ Y+H I HRD+KP+N LL + +++ DFG + + I + YY A
Sbjct: 138 GITYMHKN-KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIA 196
Query: 253 PELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 312
PE++ G Y D+WSTG ++ LL G P F G + + +I+ ++++
Sbjct: 197 PEVLHG--TYDEKCDVWSTGVILYILLSGCPPFNGAN--EY--DIL--------KKVEKG 242
Query: 313 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368
+ W KV A DL+ + Y P++R +A +A H +
Sbjct: 243 KYTFEL--------PQWKKV-----SESAKDLIRKMLTYVPSMRISARDALDHEWI 285
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 182 bits (464), Expect = 4e-53
Identities = 76/318 (23%), Positives = 129/318 (40%), Gaps = 52/318 (16%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVL------QDKRYKNRELQIMQMLDHPNI 137
Y ++G GSFG V + K R T + A+K + +D RE+++++ LDHPNI
Sbjct: 24 YNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNI 83
Query: 138 VALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIAR--NYSRIHQRMPLIYVKLYTYQIC 193
+ L D Y +V E E + I + +S Q+
Sbjct: 84 MKLFEIL---EDSSSFY--IVGELYTGGELFDEIIKRKRFSE-------HDAARIIKQVF 131
Query: 194 RALAYIHNCIGICHRDIKPQN-LLVNPHTH-QLKLCDFGSAKVLVKGEPNVSYICSRYYR 251
+ Y+H I HRD+KP+N LL + +K+ DFG + + I + YY
Sbjct: 132 SGITYMHKH-NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYI 190
Query: 252 APELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 311
APE++ G Y D+WS G ++ LL G P F G++ + +I+ + ++
Sbjct: 191 APEVLRG--TYDEKCDVWSAGVILYILLSGTPPFYGKN--EY--DIL--------KRVET 236
Query: 312 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL 371
+ W + +A DL+ + + P+LR TA + HP+ +
Sbjct: 237 GKYAFDL--------PQWRTI-----SDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKY 283
Query: 372 RDPNTRLPNGRPLPPLFN 389
+ + L
Sbjct: 284 SSETPTISDLPSLESAMT 301
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 177 bits (450), Expect = 9e-53
Identities = 66/328 (20%), Positives = 103/328 (31%), Gaps = 56/328 (17%)
Query: 70 TIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVL----QDKRYKNRE 125
I ++ Y+ +G G F V + G A+K++L QD+ RE
Sbjct: 25 IIDNKH--------YLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQRE 76
Query: 126 LQIMQMLDHPNIVALKHCFF-STTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLI 183
+ ++ +HPNI+ L K E + L+L + T+ +
Sbjct: 77 ADMHRLFNHPNILRLVAYCLRERGAKHEAW--LLLPFFKRGTLWNEIERLKDKGNFLTED 134
Query: 184 YVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG----- 238
+ ICR L IH G HRD+KP N+L+ Q L D GS
Sbjct: 135 QILWLLLGICRGLEAIHAK-GYAHRDLKPTNILLG-DEGQPVLMDLGSMNQACIHVEGSR 192
Query: 239 -----EPNVSYICSRYYRAPELIFGA--TEYTTAIDIWSTGCVMAELLLGQPLFPGESGV 291
+ + C+ YRAPEL D+WS GCV+ ++ G+ +
Sbjct: 193 QALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQK 252
Query: 292 DQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQY 351
V + V + PQ R L+
Sbjct: 253 GDSVALA-VQN---------------QLSIPQ----------SPRHSSALWQLLNSMMTV 286
Query: 352 SPNLRCTALEACVHPFFDELRDPNTRLP 379
P+ R + P
Sbjct: 287 DPHQRPHIPLLLSQLEALQPPAPGQHTT 314
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 175 bits (447), Expect = 1e-52
Identities = 77/327 (23%), Positives = 121/327 (37%), Gaps = 68/327 (20%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIK----KVLQDKRYKN---RELQIMQMLDHPN 136
Y+ +G G F F+ +T E+ A K +L + E+ I + L H +
Sbjct: 17 YVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQH 76
Query: 137 IVALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICR 194
+V F D + ++ +VLE + R + + + Y QI
Sbjct: 77 VVGFHGFF---EDNDFVF--VVLELCRRRSLLELHKR-----RKALTEPEARYYLRQIVL 126
Query: 195 ALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGE--------PNVSYI 245
Y+H + HRD+K NL +N ++K+ DFG + KV GE PN
Sbjct: 127 GCQYLHR-NRVIHRDLKLGNLFLNED-LEVKIGDFGLATKVEYDGERKKVLCGTPN---- 180
Query: 246 CSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPT 305
Y APE++ ++ +D+WS GC+M LL+G+P F + + I K
Sbjct: 181 ----YIAPEVLSK-KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKN----- 230
Query: 306 REEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH 365
E+ P + P A L+ + Q P R T E
Sbjct: 231 ------------EYSIP-----KH-------INPVAASLIQKMLQTDPTARPTINELLND 266
Query: 366 PFFDELRDPNTRLPNGRPLPPLFNFKP 392
FF P +PP F+ P
Sbjct: 267 EFFTSGYIPARLPITCLTIPPRFSIAP 293
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 181 bits (460), Expect = 2e-52
Identities = 81/306 (26%), Positives = 127/306 (41%), Gaps = 59/306 (19%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-----------------REL 126
Y +G+G++G V K + AIK + + + K E+
Sbjct: 38 YFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEI 97
Query: 127 QIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIY 184
+++ LDHPNI+ L F DK+ Y LV E+ E +I N + +
Sbjct: 98 SLLKSLDHPNIIKLFDVF---EDKKYFY--LVTEFYEGGELFEQII-NRHKFDEC----D 147
Query: 185 VKLYTYQICRALAYIHNCIGICHRDIKPQN-LLVNPHTH-QLKLCDFGSAKVLVKGEPNV 242
QI + Y+H I HRDIKP+N LL N ++ +K+ DFG + K
Sbjct: 148 AANIMKQILSGICYLHKH-NIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLR 206
Query: 243 SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLG 302
+ + YY APE++ +Y D+WS G +M LL G P F G++ DQ +II
Sbjct: 207 DRLGTAYYIAPEVLKK--KYNEKCDVWSCGVIMYILLCGYPPFGGQN--DQ--DII---- 256
Query: 303 TPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEA 362
++++ + + W + EA +L+ Y N RCTA EA
Sbjct: 257 ----KKVEKGKYYFDF--------NDWKNI-----SDEAKELIKLMLTYDYNKRCTAEEA 299
Query: 363 CVHPFF 368
+
Sbjct: 300 LNSRWI 305
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 178 bits (454), Expect = 3e-52
Identities = 84/305 (27%), Positives = 138/305 (45%), Gaps = 54/305 (17%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------------RELQIMQM 131
YI +G+G+ G V A R+T + VAI+ + + K E++I++
Sbjct: 137 YIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKK 196
Query: 132 LDHPNIVALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYT 189
L+HP I+ +K+ F D E+ Y +VLE + E +++ ++R+ KLY
Sbjct: 197 LNHPCIIKIKNFF----DAEDYY--IVLELMEGGELFDKVVG-----NKRLKEATCKLYF 245
Query: 190 YQICRALAYIHNCIGICHRDIKPQNLLVNPHTH--QLKLCDFGSAKVLVKGEPNVSYICS 247
YQ+ A+ Y+H GI HRD+KP+N+L++ +K+ DFG +K+L + + +
Sbjct: 246 YQMLLAVQYLHEN-GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGT 304
Query: 248 RYYRAPELIFGATE--YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPT 305
Y APE++ Y A+D WS G ++ L G P F L + I G
Sbjct: 305 PTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQIT-SG--- 360
Query: 306 REEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH 365
++ F P W +V +A+DLV + P R T EA H
Sbjct: 361 ------------KYNFI---PEVWAEV-----SEKALDLVKKLLVVDPKARFTTEEALRH 400
Query: 366 PFFDE 370
P+ +
Sbjct: 401 PWLQD 405
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 174 bits (444), Expect = 3e-52
Identities = 64/297 (21%), Positives = 118/297 (39%), Gaps = 56/297 (18%)
Query: 89 VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKH 142
+G GSF V++ ET VA ++ K K+ E ++++ L HPNIV
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92
Query: 143 CFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
+ ST ++ + LV E + T+ + Y + + M + ++ + QI + L ++H
Sbjct: 93 SWESTVKGKK-CIVLVTELMTSGTL----KTYLKRFKVMKIKVLRSWCRQILKGLQFLHT 147
Query: 202 C-IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL-------VKGEPNVSYICSRYYRAP 253
I HRD+K N+ + T +K+ D G A + V G P + AP
Sbjct: 148 RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVIGTP--------EFMAP 199
Query: 254 ELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 313
E+ +Y ++D+++ G M E+ + + Q+ +
Sbjct: 200 EMY--EEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVT-------------- 243
Query: 314 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE 370
+KP F K PE +++ + + + R + + H FF E
Sbjct: 244 --------SGVKP----ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 175 bits (446), Expect = 6e-52
Identities = 66/292 (22%), Positives = 108/292 (36%), Gaps = 47/292 (16%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV-LQDKRYKNRELQIMQMLDHPNIVALKH 142
+ VG GSFG V + K ++TG A+KKV L+ ++ EL L P IV L
Sbjct: 60 MTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEV--FRVEELVACAGLSSPRIVPLYG 117
Query: 143 CFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
+E ++N+ +E + ++ ++ + +P Y Q L Y+H
Sbjct: 118 AV-----REGPWVNIFMELLEGGSLGQLIKQMGC----LPEDRALYYLGQALEGLEYLHT 168
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR------YYRAPEL 255
I H D+K N+L++ + LCDFG A L S + + APE+
Sbjct: 169 R-RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEV 227
Query: 256 IFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 315
+ G +DIWS+ C+M +L G + ++I P
Sbjct: 228 VMG-KPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIAS-EPPPI---------- 275
Query: 316 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 367
+I P P + + P R +A+E
Sbjct: 276 ------REIPPS---------CAPLTAQAIQEGLRKEPVHRASAMELRRKVG 312
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 174 bits (444), Expect = 1e-51
Identities = 80/327 (24%), Positives = 122/327 (37%), Gaps = 68/327 (20%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIK----KVLQDKRYKN---RELQIMQMLDHPN 136
Y+ +G G F F+ +T E+ A K +L + E+ I + L H +
Sbjct: 43 YVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQH 102
Query: 137 IVALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICR 194
+V F D + ++ +VLE + R + + + Y QI
Sbjct: 103 VVGFHGFF---EDNDFVF--VVLELCRRRSLLELHKR-----RKALTEPEARYYLRQIVL 152
Query: 195 ALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGE--------PNVSYI 245
Y+H + HRD+K NL +N ++K+ DFG + KV GE PN
Sbjct: 153 GCQYLHR-NRVIHRDLKLGNLFLNED-LEVKIGDFGLATKVEYDGERKKVLCGTPN---- 206
Query: 246 CSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPT 305
Y APE++ ++ +D+WS GC+M LL+G+P F L E T
Sbjct: 207 ----YIAPEVLSK-KGHSFEVDVWSIGCIMYTLLVGKPPFETSC----LKE--------T 249
Query: 306 REEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH 365
IK E+ P + P A L+ + Q P R T E
Sbjct: 250 YLRIKK-----NEYSIP-----KH-------INPVAASLIQKMLQTDPTARPTINELLND 292
Query: 366 PFFDELRDPNTRLPNGRPLPPLFNFKP 392
FF P +PP F+ P
Sbjct: 293 EFFTSGYIPARLPITCLTIPPRFSIAP 319
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 172 bits (439), Expect = 2e-51
Identities = 79/317 (24%), Positives = 131/317 (41%), Gaps = 46/317 (14%)
Query: 65 HVIRTTIGGRNGNSKQKVS--YIAEHVVGTGSFGVVFQAKCRETGEIVAIK-----KVLQ 117
H + G N + + +I + +G+G+FG V + R +G IK +
Sbjct: 3 HHHHHSSGRENLYFQGTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQV 62
Query: 118 DKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSR 175
E+++++ LDHPNI+ + F D +Y +V+E E + RI +R
Sbjct: 63 PMEQIEAEIEVLKSLDHPNIIKIFEVF---EDYHNMY--IVMETCEGGELLERIVSAQAR 117
Query: 176 IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTH--QLKLCDFGSAK 233
+ + YV Q+ ALAY H+ + H+D+KP+N+L + +K+ DFG A+
Sbjct: 118 -GKALSEGYVAELMKQMMNALAYFHSQ-HVVHKDLKPENILFQDTSPHSPIKIIDFGLAE 175
Query: 234 VLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQ 293
+ E + + + Y APE+ + T DIWS G VM LL G F G S +
Sbjct: 176 LFKSDEHSTNAAGTALYMAPEVFKR--DVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEV 233
Query: 294 LVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSP 353
+ E + L P+AVDL+ + P
Sbjct: 234 QQKATYK-----------------EPNYA---VECRP------LTPQAVDLLKQMLTKDP 267
Query: 354 NLRCTALEACVHPFFDE 370
R +A + H +F +
Sbjct: 268 ERRPSAAQVLHHEWFKQ 284
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 176 bits (447), Expect = 2e-51
Identities = 87/360 (24%), Positives = 135/360 (37%), Gaps = 48/360 (13%)
Query: 41 DQVDNDEDRDSEPDIIDGVGAETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQ 100
+V D D + + + G+ Y +G+G+FGVV +
Sbjct: 12 SKVRGKYDGPKINDYDKFYEDIWKKYVPQPVEVKQGSVYDY--YDILEELGSGAFGVVHR 69
Query: 101 AKCRETGEIVAIK----KVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN 156
+ TG + K DK E+ IM L HP ++ L F DK E+
Sbjct: 70 CVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF---EDKYEMV-- 124
Query: 157 LVLEYVP--ETVNRI-ARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQ 213
L+LE++ E +RI A +Y M V Y Q C L ++H I H DIKP+
Sbjct: 125 LILEFLSGGELFDRIAAEDYK-----MSEAEVINYMRQACEGLKHMHEH-SIVHLDIKPE 178
Query: 214 NLL-VNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTG 272
N++ +K+ DFG A L E + + APE I D+W+ G
Sbjct: 179 NIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPE-IVDREPVGFYTDMWAIG 237
Query: 273 CVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKV 332
+ LL G F GE ++ L + + +++F + V
Sbjct: 238 VLGYVLLSGLSPFAGEDDLETLQNVKRC-----------------DWEFD---EDAFSSV 277
Query: 333 FQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF-DELRDPNTRLPNGRPLPPLFNFK 391
PEA D + Q P R T +A HP+ + + +R+P+ R K
Sbjct: 278 -----SPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNLTSRIPSSRYNKIRQKIK 332
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 172 bits (438), Expect = 3e-51
Identities = 58/305 (19%), Positives = 110/305 (36%), Gaps = 52/305 (17%)
Query: 77 NSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPN 136
+ + + + ++G+G FG VF+AK R G+ IK+V + RE++ + LDH N
Sbjct: 6 DKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVN 65
Query: 137 IVALKHCF-----------FSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLI 183
IV C+ +++ + L + +E+ I + R +++ +
Sbjct: 66 IVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEK---RRGEKLDKV 122
Query: 184 YVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVS 243
QI + + YIH+ + +RD+KP N+ + T Q+K+ DFG L
Sbjct: 123 LALELFEQITKGVDYIHSK-KLINRDLKPSNIFLV-DTKQVKIGDFGLVTSLKNDGKRTR 180
Query: 244 YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGT 303
+ Y +PE I +Y +D+++ G ++AELL ++
Sbjct: 181 SKGTLRYMSPEQISS-QDYGKEVDLYALGLILAELL--HVCDTAFETSKFFTDLRD---- 233
Query: 304 PTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEAC 363
+ + L+ + P R E
Sbjct: 234 ---------------------------GIISDIFDKKEKTLLQKLLSKKPEDRPNTSEIL 266
Query: 364 VHPFF 368
Sbjct: 267 RTLTV 271
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 172 bits (439), Expect = 3e-51
Identities = 72/302 (23%), Positives = 119/302 (39%), Gaps = 60/302 (19%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV-------LQDKRYKNRELQIMQMLDHPN 136
+ E +G G F V++A C G VA+KKV + + +E+ +++ L+HPN
Sbjct: 34 FRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPN 93
Query: 137 IVALKHCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRA 195
++ F E+ LN+VLE ++R+ +++ + + +P V Y Q+C A
Sbjct: 94 VIKYYASF-----IEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSA 148
Query: 196 LAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL---------VKGEPNVSYIC 246
L ++H+ + HRDIKP N+ + T +KL D G + + G P
Sbjct: 149 LEHMHSR-RVMHRDIKPANVFITA-TGVVKLGDLGLGRFFSSKTTAAHSLVGTP------ 200
Query: 247 SRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESG-VDQLVEIIKVLGTPT 305
YY +PE I Y DIWS GC++ E+ Q F G+ + L + I+
Sbjct: 201 --YYMSPERIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIE------ 251
Query: 306 REEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH 365
+ +P + E LV P R
Sbjct: 252 ------------QCDYPPLPS--------DHYSEELRQLVNMCINPDPEKRPDVTYVYDV 291
Query: 366 PF 367
Sbjct: 292 AK 293
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 172 bits (437), Expect = 4e-51
Identities = 76/306 (24%), Positives = 123/306 (40%), Gaps = 66/306 (21%)
Query: 91 GTGSFGVVFQAKCRETGEIVAIK-----KVLQDKRYK--NRELQIMQMLDHPNIVALKHC 143
G G FG V+ A+ +++ I+A+K ++ + RE++I L HPNI+ L
Sbjct: 18 GKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGY 77
Query: 144 FFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
F D +Y L+LEY P + + + Y ++ AL+Y H+
Sbjct: 78 FH---DATRVY--LILEYAPLGTVYRELQK-----LSKFDEQRTATYITELANALSYCHS 127
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK-------GEPNVSYICSRYYRAPE 254
+ HRDIKP+NLL+ LK+ DFG + G + Y PE
Sbjct: 128 K-RVIHRDIKPENLLLGSAGE-LKIADFGWSVHAPSSRRTDLCGTLD--------YLPPE 177
Query: 255 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 314
+I G + +D+WS G + E L+G+P F + + I +V
Sbjct: 178 MIEG-RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-------------- 222
Query: 315 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP 374
EF FP + + A DL+ R +++P+ R E HP+
Sbjct: 223 ---EFTFP-----DF-------VTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSK 267
Query: 375 NTRLPN 380
+ N
Sbjct: 268 PSNCQN 273
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 172 bits (438), Expect = 6e-51
Identities = 84/303 (27%), Positives = 136/303 (44%), Gaps = 54/303 (17%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIK----KVLQDKRYKN--------RELQIMQM 131
YI +G+G+ G V A R+T + VAIK + + E++I++
Sbjct: 12 YIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKK 71
Query: 132 LDHPNIVALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYT 189
L+HP I+ +K+ F D E+ Y +VLE + E +++ ++R+ KLY
Sbjct: 72 LNHPCIIKIKNFF----DAEDYY--IVLELMEGGELFDKVVG-----NKRLKEATCKLYF 120
Query: 190 YQICRALAYIHNCIGICHRDIKPQNLLVNPHTH--QLKLCDFGSAKVLVKGEPNVSYICS 247
YQ+ A+ Y+H GI HRD+KP+N+L++ +K+ DFG +K+L + + +
Sbjct: 121 YQMLLAVQYLHEN-GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGT 179
Query: 248 RYYRAPELIFGATE--YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPT 305
Y APE++ Y A+D WS G ++ L G P F L + I G
Sbjct: 180 PTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQIT-SG--- 235
Query: 306 REEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH 365
++ F P W +V +A+DLV + P R T EA H
Sbjct: 236 ------------KYNFI---PEVWAEV-----SEKALDLVKKLLVVDPKARFTTEEALRH 275
Query: 366 PFF 368
P+
Sbjct: 276 PWL 278
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 171 bits (437), Expect = 7e-51
Identities = 79/306 (25%), Positives = 136/306 (44%), Gaps = 52/306 (16%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN----RELQIMQMLDHPNIVA 139
+I V+G+G+F VF K R TG++ A+K + + +++ E+ +++ + H NIV
Sbjct: 11 FIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVT 70
Query: 140 LKHCFFSTTDKEELYLNLVLEYVP--ETVNRIAR--NYSRIHQRMPLIYVKLYTYQICRA 195
L+ + Y LV++ V E +RI Y+ ++ + ++ Q+ A
Sbjct: 71 LEDIY---ESTTHYY--LVMQLVSGGELFDRILERGVYT---EKDASLVIQ----QVLSA 118
Query: 196 LAYIHNCIGICHRDIKPQNLLV-NPHTH-QLKLCDFGSAKVLVKGEPNVSYIC-SRYYRA 252
+ Y+H GI HRD+KP+NLL P + ++ + DFG +K+ G +S C + Y A
Sbjct: 119 VKYLHEN-GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGI--MSTACGTPGYVA 175
Query: 253 PELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 312
PE + Y+ A+D WS G + LL G P F E+ +I +
Sbjct: 176 PE-VLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEG------------ 222
Query: 313 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR 372
++F W + A D +C + PN R T +A HP+ D
Sbjct: 223 -----YYEFE---SPFWDDI-----SESAKDFICHLLEKDPNERYTCEKALSHPWIDGNT 269
Query: 373 DPNTRL 378
+ +
Sbjct: 270 ALHRDI 275
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 170 bits (433), Expect = 1e-50
Identities = 84/307 (27%), Positives = 132/307 (42%), Gaps = 52/307 (16%)
Query: 76 GNSKQKVS--YIAEHVVGTGSFGVVFQAKCRETGEIVAIK----KVLQDKRYKNRELQIM 129
G++K ++ Y E+ +G GS+G V A + T A K ++D +E++IM
Sbjct: 1 GSTKGDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIM 60
Query: 130 QMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIAR--NYSRIHQRMPLIYV 185
+ LDHPNI+ L F D ++Y LV+E E R+ +
Sbjct: 61 KSLDHPNIIRLYETF---EDNTDIY--LVMELCTGGELFERVVHKRVFRE-------SDA 108
Query: 186 KLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTH--QLKLCDFGSAKVLVKGEPNVS 243
+ A+AY H + HRD+KP+N L + LKL DFG A G+ +
Sbjct: 109 ARIMKDVLSAVAYCHKL-NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRT 167
Query: 244 YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGT 303
+ + YY +P+++ G Y D WS G +M LL G P F + + +++I +
Sbjct: 168 KVGTPYYVSPQVLEG--LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREG--- 222
Query: 304 PTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEAC 363
F FP W V P+A L+ R SP R T+L+A
Sbjct: 223 --------------TFTFP---EKDWLNV-----SPQAESLIRRLLTKSPKQRITSLQAL 260
Query: 364 VHPFFDE 370
H +F++
Sbjct: 261 EHEWFEK 267
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 172 bits (438), Expect = 1e-50
Identities = 82/348 (23%), Positives = 133/348 (38%), Gaps = 84/348 (24%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVL---------QDKRYKNRELQIMQMLDH 134
Y + +G GS+GVV A +T I AIK + +D E+++M+ L H
Sbjct: 28 YHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHH 87
Query: 135 PNIVALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKL----- 187
PNI L + D++ + L V+E ++++ + + VK
Sbjct: 88 PNIARLYEVY---EDEQYICL--VMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPC 142
Query: 188 ------------------------------YTYQICRALAYIHNCIGICHRDIKPQN-LL 216
QI AL Y+HN GICHRDIKP+N L
Sbjct: 143 PECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ-GICHRDIKPENFLF 201
Query: 217 VNPHTHQLKLCDFGSAKVLVKGEPNVSYIC-----SRYYRAPELIFGATE-YTTAIDIWS 270
+ ++KL DFG +K K Y + Y+ APE++ E Y D WS
Sbjct: 202 STNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWS 261
Query: 271 TGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWH 330
G ++ LL+G FPG + D + +++ + F ++
Sbjct: 262 AGVLLHLLLMGAVPFPGVNDADTISQVLN-----------------KKLCFE---NPNYN 301
Query: 331 KVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRL 378
+ P A DL+ + + R A+ A HP+ + D ++
Sbjct: 302 VL-----SPLARDLLSNLLNRNVDERFDAMRALQHPWISQFSDKIYKM 344
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 172 bits (438), Expect = 1e-50
Identities = 71/294 (24%), Positives = 114/294 (38%), Gaps = 48/294 (16%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV------LQDKRYKNRELQIMQMLDHPNI 137
Y+ +G GSFG K E G IK++ +++ RE+ ++ + HPNI
Sbjct: 26 YVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNI 85
Query: 138 VALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRA 195
V + F +E L +V++Y + RI + + + QIC A
Sbjct: 86 VQYRESF-----EENGSLYIVMDYCEGGDLFKRINA---QKGVLFQEDQILDWFVQICLA 137
Query: 196 LAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYIC-SRYYRAPE 254
L ++H+ I HRDIK QN+ + ++L DFG A+VL + YY +PE
Sbjct: 138 LKHVHDR-KILHRDIKSQNIFLTKD-GTVQLGDFGIARVLNSTVELARACIGTPYYLSPE 195
Query: 255 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 314
+ Y DIW+ GCV+ EL + F S + LV I ++
Sbjct: 196 ICEN-KPYNNKSDIWALGCVLYELCTLKHAFEAGS-MKNLVLKII------SGSFPPVSL 247
Query: 315 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368
+Y + LV + F+ +P R + F
Sbjct: 248 HY---------------------SYDLRSLVSQLFKRNPRDRPSVNSILEKGFI 280
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 169 bits (431), Expect = 8e-50
Identities = 74/295 (25%), Positives = 122/295 (41%), Gaps = 54/295 (18%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGEIVA---IKKVLQDKRYKNRELQIMQMLDHPNIVAL 140
Y+ +G G FG+V + + + +K D+ +E+ I+ + H NI+ L
Sbjct: 7 YMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHL 66
Query: 141 KHCFFSTTDKEELYLNLVLEYVP--ETVNRI-ARNYSRIHQRMPLIY----VKLYTYQIC 193
F EEL ++ E++ + RI + + Y +Q+C
Sbjct: 67 HESF---ESMEELV--MIFEFISGLDIFERINTSAFE---------LNEREIVSYVHQVC 112
Query: 194 RALAYIHNCIGICHRDIKPQNLL-VNPHTHQLKLCDFGSAKVLVKGEPNVSYIC-SRYYR 251
AL ++H+ I H DI+P+N++ + +K+ +FG A+ L G+ + + Y
Sbjct: 113 EALQFLHSH-NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN-FRLLFTAPEYY 170
Query: 252 APELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 311
APE + +TA D+WS G ++ LL G F E+ +Q +II E I
Sbjct: 171 APE-VHQHDVVSTATDMWSLGTLVYVLLSGINPFLAET--NQ--QII--------ENIMN 217
Query: 312 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHP 366
+ E F +I EA+D V R R TA EA HP
Sbjct: 218 AEYTFDEEAFKEIS-------------IEAMDFVDRLLVKERKSRMTASEALQHP 259
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 169 bits (431), Expect = 1e-49
Identities = 62/325 (19%), Positives = 122/325 (37%), Gaps = 52/325 (16%)
Query: 91 GTGSFGVVFQAKCRETGEIVAIK-----KVLQDKRYKN----------------RELQIM 129
G F + + + A+K + + + + ELQI+
Sbjct: 40 NQGKFNKIILC--EKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQII 97
Query: 130 QMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVP-----ETVNRIARNYSRIHQRMPLIY 184
+ + + + T+ +E+Y+ + EY+ + +P+
Sbjct: 98 TDIKNEYCLTCEGII---TNYDEVYI--IYEYMENDSILKFDEYFFVLDKNYTCFIPIQV 152
Query: 185 VKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY 244
+K + + +YIHN ICHRD+KP N+L++ + +KL DFG ++ +V + S
Sbjct: 153 IKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGR-VKLSDFGESEYMVDKKIKGS- 210
Query: 245 IC-SRYYRAPELIFGATEY-TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLG 302
+ + PE + Y +DIWS G + + F + + +L I+
Sbjct: 211 -RGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIR--- 266
Query: 303 TPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEA 362
+ I+ P F + L E +D + F + +P R T+ +A
Sbjct: 267 ---TKNIEY--PLDRN-HFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDA 320
Query: 363 CVHPFF-----DELRDPNTRLPNGR 382
H + ++LR+ + L R
Sbjct: 321 LKHEWLADTNIEDLREFSKELYKKR 345
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 167 bits (426), Expect = 1e-49
Identities = 73/305 (23%), Positives = 126/305 (41%), Gaps = 67/305 (21%)
Query: 91 GTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-------RELQIMQMLDHPNIVALKHC 143
G GSF V++A+ TG VAIK + + YK E++I L HP+I+ L +
Sbjct: 20 GKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNY 79
Query: 144 FFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
F D +Y LVLE E + + + + +QI + Y+H+
Sbjct: 80 F---EDSNYVY--LVLEMCHNGEMNRYLKNR----VKPFSENEARHFMHQIITGMLYLHS 130
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGE--------PNVSYICSRYYRA 252
GI HRD+ NLL+ + +K+ DFG + ++ + E PN Y +
Sbjct: 131 H-GILHRDLTLSNLLLTRN-MNIKIADFGLATQLKMPHEKHYTLCGTPN--------YIS 180
Query: 253 PELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 312
PE+ + + D+WS GC+ LL+G+P F ++ + L +++
Sbjct: 181 PEIATR-SAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLA------------ 227
Query: 313 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR 372
+++ P + L EA DL+ + + +P R + HPF
Sbjct: 228 -----DYEMP-----SF-------LSIEAKDLIHQLLRRNPADRLSLSSVLDHPFMSRNS 270
Query: 373 DPNTR 377
++
Sbjct: 271 STKSK 275
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 167 bits (426), Expect = 2e-49
Identities = 75/299 (25%), Positives = 123/299 (41%), Gaps = 52/299 (17%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNI 137
Y ++G GSFG V + K R T + A+K + + RE+++++ LDHPNI
Sbjct: 24 YNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNI 83
Query: 138 VALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIAR--NYSRIHQRMPLIYVKLYTYQIC 193
+ L D Y +V E E + I + +S Q+
Sbjct: 84 MKLFEIL---EDSSSFY--IVGELYTGGELFDEIIKRKRFSE-------HDAARIIKQVF 131
Query: 194 RALAYIHNCIGICHRDIKPQNLLV--NPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR 251
+ Y+H I HRD+KP+N+L+ +K+ DFG + + I + YY
Sbjct: 132 SGITYMHKH-NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYI 190
Query: 252 APELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 311
APE++ G Y D+WS G ++ LL G P F G++ D L +
Sbjct: 191 APEVLRG--TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVET------------ 236
Query: 312 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE 370
++ F W + +A DL+ + + P+LR TA + HP+ +
Sbjct: 237 -----GKYAFD---LPQWRTI-----SDDAKDLIRKMLTFHPSLRITATQCLEHPWIQK 282
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 169 bits (431), Expect = 2e-49
Identities = 85/325 (26%), Positives = 122/325 (37%), Gaps = 56/325 (17%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---------RELQIMQMLDH 134
Y V+G G F VV + RETG+ A+K V K + RE I ML H
Sbjct: 26 YELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKH 85
Query: 135 PNIVALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIY----VKLY 188
P+IV L + + LY +V E++ + I + +Y Y
Sbjct: 86 PHIVELLETY---SSDGMLY--MVFEFMDGADLCFEIVK-----RADAGFVYSEAVASHY 135
Query: 189 TYQICRALAYIHNCIGICHRDIKPQN-LLVNPH-THQLKLCDFGSAKVLVKGEPNVSYIC 246
QI AL Y H+ I HRD+KP LL + + +KL FG A L +
Sbjct: 136 MRQILEALRYCHDN-NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRV 194
Query: 247 -SRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPT 305
+ ++ APE + Y +D+W G ++ LL G F G ++L E I
Sbjct: 195 GTPHFMAPE-VVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK--ERLFEGII------ 245
Query: 306 REEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH 365
++K P W + A DLV R P R T EA H
Sbjct: 246 ----------KGKYKMN---PRQWSHI-----SESAKDLVRRMLMLDPAERITVYEALNH 287
Query: 366 PFFDELRDPNTRLPNGRPLPPLFNF 390
P+ E ++ + L F
Sbjct: 288 PWLKERDRYAYKIHLPETVEQLRKF 312
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 167 bits (424), Expect = 3e-49
Identities = 74/296 (25%), Positives = 121/296 (40%), Gaps = 66/296 (22%)
Query: 89 VVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKRYK--NRELQIMQMLDHPNIVALK 141
+G G FG V+ A+ ++ I+A+K ++ ++ RE++I L HPNI+ +
Sbjct: 21 PLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMY 80
Query: 142 HCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 199
+ F D++ +Y L+LE+ P E + + H R + ++ AL Y
Sbjct: 81 NYFH---DRKRIY--LMLEFAPRGELYKELQK-----HGRFDEQRSATFMEELADALHYC 130
Query: 200 HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK-------GEPNVSYICSRYYRA 252
H + HRDIKP+NLL+ LK+ DFG + G + Y
Sbjct: 131 HER-KVIHRDIKPENLLMGYKGE-LKIADFGWSVHAPSLRRRTMCGTLD--------YLP 180
Query: 253 PELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 312
PE+I G + +D+W G + E L+G P F S + I+ V
Sbjct: 181 PEMIEG-KTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNV------------ 227
Query: 313 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368
+ KFP P+ L + DL+ + +Y P R HP+
Sbjct: 228 -----DLKFP-----PF-------LSDGSKDLISKLLRYHPPQRLPLKGVMEHPWV 266
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 173 bits (441), Expect = 4e-49
Identities = 76/308 (24%), Positives = 130/308 (42%), Gaps = 45/308 (14%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV----LQDKRYKNRELQIMQMLDHPNIVA 139
Y +GTG+FGVV + R TG A K V DK +E+Q M +L HP +V
Sbjct: 159 YDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVN 218
Query: 140 LKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALA 197
L F D E+ ++ E++ E ++A ++++ + + Y++ Q+C+ L
Sbjct: 219 LHDAF---EDDNEMV--MIYEFMSGGELFEKVADEHNKMSEDEAVEYMR----QVCKGLC 269
Query: 198 YIHNCIGICHRDIKPQNLL-VNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELI 256
++H H D+KP+N++ +++LKL DFG L + + + APE+
Sbjct: 270 HMHEN-NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVA 328
Query: 257 FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 316
G D+WS G + LL G F GE+ + T +K + N
Sbjct: 329 EG-KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDE------------TLRNVKSCDWNM 375
Query: 317 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF--DELRDP 374
+ F I + D + + PN R T +A HP+
Sbjct: 376 DDSAFSGIS-------------EDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGR 422
Query: 375 NTRLPNGR 382
++++P+ R
Sbjct: 423 DSQIPSSR 430
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 167 bits (424), Expect = 4e-49
Identities = 58/339 (17%), Positives = 101/339 (29%), Gaps = 90/339 (26%)
Query: 72 GGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKNRELQ- 127
G S+ + +G+G FG VF+ R G I AIK+ L + L+
Sbjct: 1 GAMGMKSRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALRE 60
Query: 128 ---IMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLI 183
+ H ++V + E+ ++ + EY ++ RI
Sbjct: 61 VYAHAVLGQHSHVVRYFSAWA-----EDDHMLIQNEYCNGGSLADAISENYRIMSYFKEA 115
Query: 184 YVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPH------------------THQLK 225
+K Q+ R L YIH+ + H DIKP N+ ++ K
Sbjct: 116 ELKDLLLQVGRGLRYIHSM-SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFK 174
Query: 226 LCDFGSAKVL-----VKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL 280
+ D G + +G+ + A E++ + DI++ +
Sbjct: 175 IGDLGHVTRISSPQVEEGDS--------RFLANEVLQENYTHLPKADIFALALTVVCAAG 226
Query: 281 GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPP- 339
+PL WH++ Q RLP
Sbjct: 227 AEPLPRNG--------------------------------------DQWHEIRQGRLPRI 248
Query: 340 ------EAVDLVCRFFQYSPNLRCTALEACVHPFFDELR 372
E +L+ P R +A+ H
Sbjct: 249 PQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSAS 287
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 167 bits (424), Expect = 4e-49
Identities = 67/318 (21%), Positives = 117/318 (36%), Gaps = 60/318 (18%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVL-----QDKRYKNRELQIMQMLDHPNIV 138
+ +G G FGVVF+AK + AIK++ + RE++ + L+HP IV
Sbjct: 7 FEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIV 66
Query: 139 ALKHCFF-------STTDKEELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTY 190
+ + ++YL + ++ E + I +R
Sbjct: 67 RYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEER-ERSVCLHIFL 125
Query: 191 QICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-- 248
QI A+ ++H+ G+ HRD+KP N+ +K+ DFG + + E + +
Sbjct: 126 QIAEAVEFLHSK-GLMHRDLKPSNIFFT-MDDVVKVGDFGLVTAMDQDEEEQTVLTPMPA 183
Query: 249 -----------YYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEI 297
Y +PE I G Y+ +DI+S G ++ ELL P F + + +
Sbjct: 184 YARHTGQVGTKLYMSPEQIHG-NSYSHKVDIFSLGLILFELL--YP-FSTQMERVRTLTD 239
Query: 298 IKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC 357
++ KFP + P +V SP R
Sbjct: 240 VR------------------NLKFPPLFTQ---------KYPCEYVMVQDMLSPSPMERP 272
Query: 358 TALEACVHPFFDELRDPN 375
A+ + F++L P
Sbjct: 273 EAINIIENAVFEDLDFPG 290
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 168 bits (427), Expect = 4e-49
Identities = 79/319 (24%), Positives = 129/319 (40%), Gaps = 45/319 (14%)
Query: 85 IAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQML-DHPNIVALKHC 143
+++ V+G G G V + R TG+ A+K +L D +E+ P+IV +
Sbjct: 32 LSKQVLGLGVNGKVLECFHRRTGQKCALK-LLYDSPKARQEVDHHWQASGGPHIVCILD- 89
Query: 144 FFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIY----VKLYTYQICRALA 197
+ + L +++E + E +SRI +R + I A+
Sbjct: 90 VYENMHHGKRCLLIIMECMEGGEL-------FSRIQERGDQAFTEREAAEIMRDIGTAIQ 142
Query: 198 YIHNCIGICHRDIKPQNLL-VNPHTH-QLKLCDFGSAKVLVKGEPNVSYIC-SRYYRAPE 254
++H+ I HRD+KP+NLL + LKL DFG AK + + C + YY APE
Sbjct: 143 FLHSH-NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA--LQTPCYTPYYVAPE 199
Query: 255 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 314
+ G +Y + D+WS G +M LL G P F +G + + I+
Sbjct: 200 -VLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKR--------RIRLG-- 248
Query: 315 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF-DELRD 373
++ FP W +V +A L+ + P R T + HP+ +
Sbjct: 249 ---QYGFP---NPEWSEV-----SEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSMVV 297
Query: 374 PNTRLPNGRPLPPLFNFKP 392
P T L R L +
Sbjct: 298 PQTPLHTARVLQEDKDHWD 316
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 169 bits (429), Expect = 5e-49
Identities = 73/304 (24%), Positives = 124/304 (40%), Gaps = 45/304 (14%)
Query: 71 IGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIK----KVLQDKRYKNREL 126
+ + G + ++G G FG V + + TG +A K + ++DK E+
Sbjct: 78 VTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEI 137
Query: 127 QIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVP--ETVNRI-ARNYSRIHQRMPLI 183
+M LDH N++ L F K ++ LV+EYV E +RI +Y+ + +
Sbjct: 138 SVMNQLDHANLIQLYDAF---ESKNDIV--LVMEYVDGGELFDRIIDESYN-----LTEL 187
Query: 184 YVKLYTYQICRALAYIHNCIGICHRDIKPQNLL-VNPHTHQLKLCDFGSAKVLVKGEPNV 242
L+ QIC + ++H I H D+KP+N+L VN Q+K+ DFG A+ E
Sbjct: 188 DTILFMKQICEGIRHMHQM-YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLK 246
Query: 243 SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLG 302
+ + APE + + D+WS G + LL G F G++ + L I+
Sbjct: 247 VNFGTPEFLAPE-VVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILAC-- 303
Query: 303 TPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEA 362
+ + + EA + + + + R +A EA
Sbjct: 304 ---------------RWDLE---DEEFQDI-----SEEAKEFISKLLIKEKSWRISASEA 340
Query: 363 CVHP 366
HP
Sbjct: 341 LKHP 344
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 167 bits (425), Expect = 5e-49
Identities = 70/326 (21%), Positives = 119/326 (36%), Gaps = 59/326 (18%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIK----------KVLQDKRYKNRELQIMQMLD 133
Y +G+G F +V + + + TG A K + + RE+ I++ +
Sbjct: 14 YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL 73
Query: 134 HPNIVALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIAR--NYSRIHQRMPLIYVKLYT 189
H N++ L + ++ ++ L+LE V E + +A+ + S +
Sbjct: 74 HHNVITLHDVY---ENRTDVV--LILELVSGGELFDFLAQKESLSE-------EEATSFI 121
Query: 190 YQICRALAYIHNCIGICHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNVSYIC 246
QI + Y+H I H D+KP+N+++ N +KL DFG A + G I
Sbjct: 122 KQILDGVNYLHTK-KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE-FKNIF 179
Query: 247 -SRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPT 305
+ + APE I D+WS G + LL G F G++ + L I V
Sbjct: 180 GTPEFVAPE-IVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSV----- 233
Query: 306 REEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH 365
+ F + A D + + R T EA H
Sbjct: 234 ------------SYDFD---EEFFSHT-----SELAKDFIRKLLVKETRKRLTIQEALRH 273
Query: 366 PFFDELRDPNTRLPNGRPLPPLFNFK 391
P+ D + + L NF+
Sbjct: 274 PWITP-VDNQQAMVRRESVVNLENFR 298
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 167 bits (425), Expect = 1e-48
Identities = 87/291 (29%), Positives = 123/291 (42%), Gaps = 46/291 (15%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN--RELQIMQMLDHPNIVALK 141
+ E +G G+ +V++ K + T + A+K + + K E+ ++ L HPNI+ LK
Sbjct: 55 FEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLLRLSHPNIIKLK 114
Query: 142 HCFFSTTDKEELYLNLVLEYVP--ETVNRIAR--NYSRIHQRMPLIYVKLYTYQICRALA 197
F E+ LVLE V E +RI YS +R VK QI A+A
Sbjct: 115 EIF---ETPTEIS--LVLELVTGGELFDRIVEKGYYS---ERDAADAVK----QILEAVA 162
Query: 198 YIHNCIGICHRDIKPQNLL-VNPHTH-QLKLCDFGSAKVLVKGEPNVSYICSRYYRAPEL 255
Y+H GI HRD+KP+NLL P LK+ DFG +K++ + + Y APE
Sbjct: 163 YLHEN-GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPE- 220
Query: 256 IFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 315
I Y +D+WS G + LL G F E G + I C
Sbjct: 221 ILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRIL----------NC---- 266
Query: 316 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHP 366
E+ F W +V A DLV + P R T +A HP
Sbjct: 267 --EYYFI---SPWWDEV-----SLNAKDLVRKLIVLDPKKRLTTFQALQHP 307
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 165 bits (420), Expect = 1e-48
Identities = 73/314 (23%), Positives = 118/314 (37%), Gaps = 62/314 (19%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIK----------KVLQDKRYKNRELQIMQMLD 133
Y +G+G F +V + + + TG+ A K + + RE+ I++ +
Sbjct: 7 YEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIR 66
Query: 134 HPNIVALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIY----VKL 187
HPNI+ L F +K ++ L+LE V E + +A S
Sbjct: 67 HPNIITLHDIF---ENKTDVV--LILELVSGGELFDFLAEKES---------LTEDEATQ 112
Query: 188 YTYQICRALAYIHNCIGICHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNVSY 244
+ QI + Y+H+ I H D+KP+N+++ N ++KL DFG A + G
Sbjct: 113 FLKQILDGVHYLHSK-RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNE-FKN 170
Query: 245 IC-SRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGT 303
I + + APE I D+WS G + LL G F GE+ + L I V
Sbjct: 171 IFGTPEFVAPE-IVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAV--- 226
Query: 304 PTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEAC 363
+ F + A D + R P R T ++
Sbjct: 227 --------------NYDFD---EEYFSNT-----SELAKDFIRRLLVKDPKRRMTIAQSL 264
Query: 364 VHPFFDELRDPNTR 377
H + +R N R
Sbjct: 265 EHSWIKAIRRRNVR 278
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 167 bits (424), Expect = 2e-48
Identities = 80/319 (25%), Positives = 120/319 (37%), Gaps = 51/319 (15%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNI 137
Y + +G G+F VV + + TG A K + K RE +I + L HPNI
Sbjct: 31 YDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNI 90
Query: 138 VALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIAR--NYSRIHQRMPLIYVKLYTYQIC 193
V L ++ Y LV + V E I YS QI
Sbjct: 91 VRLHDSI---QEESFHY--LVFDLVTGGELFEDIVAREFYSEADAS-------HCIQQIL 138
Query: 194 RALAYIHNCIGICHRDIKPQNLLV--NPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR 251
++AY H+ GI HR++KP+NLL+ +KL DFG A + E + + Y
Sbjct: 139 ESIAYCHSN-GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYL 197
Query: 252 APELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 311
+PE + Y+ +DIW+ G ++ LL+G P F E +I
Sbjct: 198 SPE-VLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAG----------- 245
Query: 312 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL 371
+ +P W V PEA L+ +P R TA +A P+
Sbjct: 246 ------AYDYP---SPEWDTV-----TPEAKSLIDSMLTVNPKKRITADQALKVPWICNR 291
Query: 372 RDPNTRLPNGRPLPPLFNF 390
+ + + L F
Sbjct: 292 ERVASAIHRQDTVDCLKKF 310
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 165 bits (421), Expect = 3e-48
Identities = 71/328 (21%), Positives = 121/328 (36%), Gaps = 63/328 (19%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIK----------KVLQDKRYKNRELQIMQMLD 133
Y +G+G F VV + + + TG A K + + RE+ I++ +
Sbjct: 13 YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 134 HPNIVALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIY----VKL 187
HPN++ L + +K ++ L+LE V E + +A S
Sbjct: 73 HPNVITLHEVY---ENKTDVI--LILELVAGGELFDFLAEKES---------LTEEEATE 118
Query: 188 YTYQICRALAYIHNCIGICHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNVSY 244
+ QI + Y+H+ I H D+KP+N+++ N ++K+ DFG A + G
Sbjct: 119 FLKQILNGVYYLHSL-QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE-FKN 176
Query: 245 IC-SRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGT 303
I + + APE I D+WS G + LL G F G++ + L + V
Sbjct: 177 IFGTPEFVAPE-IVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAV--- 232
Query: 304 PTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEAC 363
++F + A D + R P R T ++
Sbjct: 233 --------------NYEFE---DEYFSNT-----SALAKDFIRRLLVKDPKKRMTIQDSL 270
Query: 364 VHPFFDELRDPNTRLPNGRPLPPLFNFK 391
HP+ +D L + FK
Sbjct: 271 QHPWIKP-KDTQQALSRKASAVNMEKFK 297
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 167 bits (424), Expect = 4e-48
Identities = 83/311 (26%), Positives = 124/311 (39%), Gaps = 42/311 (13%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQML-DHPNIVALKH 142
+ V+G G G V Q + T E A+ K+LQD RE+++ P+IV +
Sbjct: 64 KVTSQVLGLGINGKVLQIFNKRTQEKFAL-KMLQDCPKARREVELHWRASQCPHIVRI-V 121
Query: 143 CFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIY----VKLYTYQICRAL 196
+ L +V+E + E +SRI R + I A+
Sbjct: 122 DVYENLYAGRKCLLIVMECLDGGEL-------FSRIQDRGDQAFTEREASEIMKSIGEAI 174
Query: 197 AYIHNCIGICHRDIKPQNLL-VNPHTH-QLKLCDFGSAKVLVKGEPNVSYICSRYYRAPE 254
Y+H+ I HRD+KP+NLL + + LKL DFG AK + + YY APE
Sbjct: 175 QYLHSI-NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPE 233
Query: 255 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 314
+ G +Y + D+WS G +M LL G P F G+ + I+
Sbjct: 234 -VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMK--------TRIR---- 280
Query: 315 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD- 373
+++FP W +V E L+ + P R T E HP+ +
Sbjct: 281 -MGQYEFPN---PEWSEV-----SEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKV 331
Query: 374 PNTRLPNGRPL 384
P T L R L
Sbjct: 332 PQTPLHTSRVL 342
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 165 bits (421), Expect = 5e-48
Identities = 71/329 (21%), Positives = 118/329 (35%), Gaps = 65/329 (19%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIK----------KVLQDKRYKNRELQIMQMLD 133
Y +G+G F +V + + + TG A K + + RE+ I++ +
Sbjct: 14 YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVL 73
Query: 134 HPNIVALKHCFFSTTDKEELYLNLVLEYVP--ETVNRI-ARNYSRIHQRMPLIY----VK 186
HPNI+ L + ++ ++ L+LE V E + + +
Sbjct: 74 HPNIITLHDVY---ENRTDVV--LILELVSGGELFDFLAQKES----------LSEEEAT 118
Query: 187 LYTYQICRALAYIHNCIGICHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNVS 243
+ QI + Y+H I H D+KP+N+++ N +KL DFG A + G
Sbjct: 119 SFIKQILDGVNYLHTK-KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE-FK 176
Query: 244 YIC-SRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLG 302
I + + APE I D+WS G + LL G F G++ + L I V
Sbjct: 177 NIFGTPEFVAPE-IVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAV-- 233
Query: 303 TPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEA 362
+ F + + A D + + R T EA
Sbjct: 234 ---------------SYDFD---EEFFSQT-----SELAKDFIRKLLVKETRKRLTIQEA 270
Query: 363 CVHPFFDELRDPNTRLPNGRPLPPLFNFK 391
HP+ D + + L NFK
Sbjct: 271 LRHPWITP-VDTQQAMVRRESVVNLENFK 298
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 167 bits (426), Expect = 6e-48
Identities = 77/320 (24%), Positives = 122/320 (38%), Gaps = 52/320 (16%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNI 137
Y +G G+F VV + G+ A + K RE +I ++L HPNI
Sbjct: 13 YQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNI 72
Query: 138 VALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIAR--NYSRIHQRMPLIYVKLYTYQIC 193
V L +++ Y L+ + V E I YS + ++ QI
Sbjct: 73 VRLHDSI---SEEGHHY--LIFDLVTGGELFEDIVAREYYS---EADASHCIQ----QIL 120
Query: 194 RALAYIHNCIGICHRDIKPQNLL-VNPHTH-QLKLCDFGSAKVLVKGEPNVSYIC-SRYY 250
A+ + H G+ HR++KP+NLL + +KL DFG A + + + Y
Sbjct: 121 EAVLHCHQM-GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGY 179
Query: 251 RAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 310
+PE + Y +D+W+ G ++ LL+G P F E +I
Sbjct: 180 LSPE-VLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKA----------- 227
Query: 311 CMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE 370
+ FP W V PEA DL+ + +P+ R TA EA HP+
Sbjct: 228 ------GAYDFP---SPEWDTV-----TPEAKDLINKMLTINPSKRITAAEALKHPWISH 273
Query: 371 LRDPNTRLPNGRPLPPLFNF 390
+ + + L F
Sbjct: 274 RSTVASCMHRQETVDCLKKF 293
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 165 bits (419), Expect = 6e-48
Identities = 74/319 (23%), Positives = 125/319 (39%), Gaps = 59/319 (18%)
Query: 65 HVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR 124
H I + + Y + +G GS+ V + + T A+K + + KR
Sbjct: 7 HSIVQQLHRNSIQFTDG--YEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTE 64
Query: 125 ELQIMQML-DHPNIVALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIAR--NYS----- 174
E++I+ HPNI+ LK + D + +Y +V E + E +++I R +S
Sbjct: 65 EIEILLRYGQHPNIITLKDVY---DDGKYVY--VVTELMKGGELLDKILRQKFFSEREAS 119
Query: 175 RIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLV---NPHTHQLKLCDFGS 231
+ + I + + Y+H G+ HRD+KP N+L + + +++CDFG
Sbjct: 120 AV------------LFTITKTVEYLHAQ-GVVHRDLKPSNILYVDESGNPESIRICDFGF 166
Query: 232 AKVLVKGEPNVSYIC-SRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESG 290
AK L + C + + APE + Y A DIWS G ++ +L G F
Sbjct: 167 AKQLRAENGLLMTPCYTANFVAPE-VLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPD 225
Query: 291 VDQLVEIIKVL-GTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFF 349
+ ++ G +F W+ V A DLV +
Sbjct: 226 DTPEEILARIGSG---------------KFSLS---GGYWNSV-----SDTAKDLVSKML 262
Query: 350 QYSPNLRCTALEACVHPFF 368
P+ R TA HP+
Sbjct: 263 HVDPHQRLTAALVLRHPWI 281
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 161 bits (411), Expect = 2e-47
Identities = 78/297 (26%), Positives = 115/297 (38%), Gaps = 51/297 (17%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNI 137
Y + +G G+F VV + + TG A K + K RE +I + L HPNI
Sbjct: 8 YDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNI 67
Query: 138 VALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIAR--NYSRIHQRMPLIYVKLYTYQIC 193
V L ++ Y LV + V E I YS QI
Sbjct: 68 VRLHDSI---QEESFHY--LVFDLVTGGELFEDIVAREFYSEADAS-------HCIQQIL 115
Query: 194 RALAYIHNCIGICHRDIKPQNLLV--NPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR 251
++AY H+ GI HR++KP+NLL+ +KL DFG A + E + + Y
Sbjct: 116 ESIAYCHSN-GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYL 174
Query: 252 APELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 311
+PE + Y+ +DIW+ G ++ LL+G P F E +I
Sbjct: 175 SPE-VLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAG----------- 222
Query: 312 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368
+ +P W V PEA L+ +P R TA +A P+
Sbjct: 223 ------AYDYP---SPEWDTV-----TPEAKSLIDSMLTVNPKKRITADQALKVPWI 265
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 1e-46
Identities = 68/309 (22%), Positives = 113/309 (36%), Gaps = 52/309 (16%)
Query: 85 IAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN--------RELQIMQMLDH-P 135
+ +G G F VV Q + TG+ A K + KR + E+ ++++ P
Sbjct: 32 LTSKELGRGKFAVVRQCISKSTGQEYAAKFL--KKRRRGQDCRAEILHEIAVLELAKSCP 89
Query: 136 NIVALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQIC 193
++ L + + E+ L+LEY E + + + + V QI
Sbjct: 90 RVINLHEVY---ENTSEII--LILEYAAGGEIFSLCL---PELAEMVSENDVIRLIKQIL 141
Query: 194 RALAYIHNCIGICHRDIKPQN-LLVNPH-THQLKLCDFGSAKVLVKGEPNVSYIC-SRYY 250
+ Y+H I H D+KPQN LL + + +K+ DFG ++ + + I + Y
Sbjct: 142 EGVYYLHQN-NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACE-LREIMGTPEY 199
Query: 251 RAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 310
APE I TTA D+W+ G + LL F GE + + I +V
Sbjct: 200 LAPE-ILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQV---------- 248
Query: 311 CMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE 370
+ + V A D + +P R TA H + +
Sbjct: 249 -------NVDYS---EETFSSV-----SQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQ 293
Query: 371 LRDPNTRLP 379
N P
Sbjct: 294 WDFENLFHP 302
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 161 bits (409), Expect = 1e-46
Identities = 67/311 (21%), Positives = 132/311 (42%), Gaps = 42/311 (13%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-NRELQIMQMLD-HPNIVALK 141
+ + +G GSF + + +++ + A+K + + +E+ +++ + HPNIV L
Sbjct: 13 DLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEITALKLCEGHPNIVKLH 72
Query: 142 HCFFSTTDKEELYLNLVLEYVP--ETVNRIAR--NYSRIHQRMPLIYVKLYTYQICRALA 197
F D+ + LV+E + E RI + ++S + ++ A++
Sbjct: 73 EVF---HDQLHTF--LVMELLNGGELFERIKKKKHFS---ETE----ASYIMRKLVSAVS 120
Query: 198 YIHNCIGICHRDIKPQNLL-VNPHTH-QLKLCDFGSAKVLVKGEPNVSYIC-SRYYRAPE 254
++H+ G+ HRD+KP+NLL + + + ++K+ DFG A++ + C + +Y APE
Sbjct: 121 HMHDV-GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPE 179
Query: 255 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 314
+ Y + D+WS G ++ +L GQ F ++++ ++IK
Sbjct: 180 -LLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIM-----KKIKKG-- 231
Query: 315 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD- 373
+F F W V EA DL+ PN R + + +
Sbjct: 232 ---DFSFE---GEAWKNV-----SQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQL 280
Query: 374 PNTRLPNGRPL 384
+ L L
Sbjct: 281 SSNPLMTPDIL 291
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 160 bits (407), Expect = 2e-46
Identities = 77/317 (24%), Positives = 121/317 (38%), Gaps = 62/317 (19%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIK------------KVLQDKRYK-NRELQIMQ 130
Y + ++G G VV + + T + A+K + +Q+ R +E+ I++
Sbjct: 19 YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILR 78
Query: 131 MLD-HPNIVALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIAR--NYSRIHQRMPLIYV 185
+ HPNI+ LK + + LV + + E + + S R
Sbjct: 79 KVSGHPNIIQLKDTY---ETNTFFF--LVFDLMKKGELFDYLTEKVTLSEKETR------ 127
Query: 186 KLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYI 245
+ + +H I HRD+KP+N+L++ + +KL DFG + L GE
Sbjct: 128 -KIMRALLEVICALHKL-NIVHRDLKPENILLDDDMN-IKLTDFGFSCQLDPGEKLREVC 184
Query: 246 CSRYYRAPELIFGATE-----YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV 300
+ Y APE+I + Y +D+WSTG +M LL G P F + L I+
Sbjct: 185 GTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSG 244
Query: 301 LGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTAL 360
++F W DLV RF P R TA
Sbjct: 245 -----------------NYQFG---SPEWDDY-----SDTVKDLVSRFLVVQPQKRYTAE 279
Query: 361 EACVHPFFDELRDPNTR 377
EA HPFF + R
Sbjct: 280 EALAHPFFQQYVVEEVR 296
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 159 bits (403), Expect = 1e-45
Identities = 70/327 (21%), Positives = 114/327 (34%), Gaps = 58/327 (17%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVL----QDKRYKNRELQIMQML-DHPNIV 138
V+ G F V++A+ +G A+K++L + R +E+ M+ L HPNIV
Sbjct: 30 LRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIV 89
Query: 139 ALKHCFFSTTD--KEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
+ L+L + + + V YQ CRA+
Sbjct: 90 QFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAV 149
Query: 197 AYIHNC-IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-------------EPNV 242
++H I HRD+K +NLL++ +KLCDFGSA + E +
Sbjct: 150 QHMHRQKPPIIHRDLKVENLLLSNQ-GTIKLCDFGSATTISHYPDYSWSAQRRALVEEEI 208
Query: 243 SYICSRYYRAPELI--FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV 300
+ + YR PE+I + DIW+ GC++ L Q F + + I+
Sbjct: 209 TRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGA----KLRIVNG 264
Query: 301 LGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTAL 360
++ P PH L+ Q +P R +
Sbjct: 265 -----------------KYSIP---PHD-------TQYTVFHSLIRAMLQVNPEERLSIA 297
Query: 361 EACVHPFFDELRDPNTRLPNGRPLPPL 387
E E+ P P+ L
Sbjct: 298 EVVHQLQ--EIAAARNVNPK-SPITEL 321
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 4e-45
Identities = 79/307 (25%), Positives = 121/307 (39%), Gaps = 72/307 (23%)
Query: 89 VVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDK--RYKNRELQIMQMLDHPNIVALK 141
++G GSF V A+ T AIK ++++ Y RE +M LDHP V L
Sbjct: 37 ILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY 96
Query: 142 HCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 199
F D E+LY L Y E + I + + YT +I AL Y+
Sbjct: 97 FTF---QDDEKLY--FGLSYAKNGELLKYIRKI-----GSFDETCTRFYTAEIVSALEYL 146
Query: 200 HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVS---------YICSRYY 250
H GI HRD+KP+N+L+N H +++ DFG+AKVL Y+
Sbjct: 147 HGK-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANSFVGTAQYV----- 199
Query: 251 RAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 310
+PEL+ + D+W+ GC++ +L+ G P F + + + I
Sbjct: 200 -SPELLTE-KSACKSSDLWALGCIIYQLVAGLPPFRAGN-EYLIFQKII----------- 245
Query: 311 CMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSP------NLRCTALEACV 364
E+ FP ++ P+A DLV +
Sbjct: 246 -----KLEYDFP------------EKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKA 288
Query: 365 HPFFDEL 371
HPFF+ +
Sbjct: 289 HPFFESV 295
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 5e-45
Identities = 52/338 (15%), Positives = 108/338 (31%), Gaps = 80/338 (23%)
Query: 78 SKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-------RELQIMQ 130
++ + + V+G +A +ETGE + +R + E+ ++
Sbjct: 69 GERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLR 128
Query: 131 ML-------------------------DHPNIVALKHCFFSTTDKEELYLNLVLEYVPET 165
+L ++ ++ +L ++ +T
Sbjct: 129 LLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQT 188
Query: 166 VNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLK 225
+ ++S H+ + T Q+ R LA +H+ G+ H ++P +++++ +
Sbjct: 189 FGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY-GLVHTYLRPVDIVLDQRGG-VF 246
Query: 226 LCDFGSAKVLVKGEPNVSYICSRYYRAPELI----------FGATEYTTAIDIWSTGCVM 275
L F V+ V SR + PEL T T + D W+ G V+
Sbjct: 247 LTGFEHL---VRDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVI 303
Query: 276 AELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQK 335
+ ++ + E I F+ K
Sbjct: 304 YWIWCADLPITKDAALG------------GSEWI---------FRSC------------K 330
Query: 336 RLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD 373
+P L+ F +Y R L+A P +++LR
Sbjct: 331 NIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLRT 368
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 156 bits (395), Expect = 3e-44
Identities = 73/309 (23%), Positives = 128/309 (41%), Gaps = 65/309 (21%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIK-----------KVLQDKRYK-NRELQIMQM 131
Y + V+G G VV + R TG A+K + L++ R RE I++
Sbjct: 96 YDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQ 155
Query: 132 L-DHPNIVALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIAR--NYS-RIHQRMPLIYV 185
+ HP+I+ L + ++ LV + + E + + S +
Sbjct: 156 VAGHPHIITLIDSY---ESSSFMF--LVFDLMRKGELFDYLTEKVALSEK--------ET 202
Query: 186 KLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYI 245
+ + A++++H I HRD+KP+N+L++ + Q++L DFG + L GE + +
Sbjct: 203 RSIMRSLLEAVSFLHAN-NIVHRDLKPENILLDDNM-QIRLSDFGFSCHLEPGEK-LREL 259
Query: 246 C-SRYYRAPELIFGATE-----YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIK 299
C + Y APE++ + + Y +D+W+ G ++ LL G P F + L I++
Sbjct: 260 CGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIME 319
Query: 300 VLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTA 359
+++F W DL+ R Q P R TA
Sbjct: 320 G-----------------QYQFS---SPEWDDR-----SSTVKDLISRLLQVDPEARLTA 354
Query: 360 LEACVHPFF 368
+A HPFF
Sbjct: 355 EQALQHPFF 363
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 9e-44
Identities = 79/320 (24%), Positives = 135/320 (42%), Gaps = 61/320 (19%)
Query: 89 VVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDK--RYKNRELQIMQMLDHPNIVALK 141
+G GSFG V + +T ++ A+K K ++ R +ELQIMQ L+HP +V L
Sbjct: 22 AIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLW 81
Query: 142 HCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 199
+ F D+E+++ +V++ + + + +N VKL+ ++ AL Y+
Sbjct: 82 YSF---QDEEDMF--MVVDLLLGGDLRYHLQQN-----VHFKEETVKLFICELVMALDYL 131
Query: 200 HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIF-- 257
N I HRD+KP N+L++ H H + + DF A +L + + ++ Y APE+
Sbjct: 132 QNQ-RIIHRDMKPDNILLDEHGH-VHITDFNIAAMLPRETQITTMAGTKPYMAPEMFSSR 189
Query: 258 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESG--VDQLVEIIKVLGTPTREEIKCMNPN 315
Y+ A+D WS G ELL G+ + S ++V +
Sbjct: 190 KGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFE---------------- 233
Query: 316 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEA-CVHPFFDELRDP 374
T +P E V L+ + + +P+ R + L P+ D
Sbjct: 234 TTVVTYPS------------AWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYM---NDI 278
Query: 375 N-TRLPNGRPLPPLFNFKPP 393
N + R +P F P
Sbjct: 279 NWDAVFQKRLIPG---FIPN 295
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 2e-43
Identities = 70/316 (22%), Positives = 129/316 (40%), Gaps = 33/316 (10%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKN--RELQIMQMLDHPNIV 138
+ +G G+ GVVF+ + +G ++A K + ++ RELQ++ + P IV
Sbjct: 35 FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 94
Query: 139 ALKHCFFSTTDKEELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALA 197
F+S + +++ +E++ +++++ + RI P + + + + L
Sbjct: 95 GFYGAFYSDGE-----ISICMEHMDGGSLDQVLKKAGRI----PEQILGKVSIAVIKGLT 145
Query: 198 YIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIF 257
Y+ I HRD+KP N+LVN ++KLCDFG + L+ N S++ +R Y +PE +
Sbjct: 146 YLREKHKIMHRDVKPSNILVN-SRGEIKLCDFGVSGQLIDSMAN-SFVGTRSYMSPERLQ 203
Query: 258 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 317
G Y+ DIWS G + E+ +G+ P + + + E
Sbjct: 204 GTH-YSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGR 262
Query: 318 EFKFPQIKPHPWHKVFQ----------KRLP-----PEAVDLVCRFFQYSPNLRCTALEA 362
+ P +F+ +LP E D V + +P R +
Sbjct: 263 PLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQL 322
Query: 363 CVHPFFDELRDPNTRL 378
VH F
Sbjct: 323 MVHAFIKRSDAEEVDF 338
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 3e-43
Identities = 77/332 (23%), Positives = 126/332 (37%), Gaps = 65/332 (19%)
Query: 85 IAEHVVGTGSFGVVFQAKCRETGEIVAIK----KVLQDKRYKNRELQIMQML-DHPNIVA 139
+ E V+G G+ V T + A+K + + RE++++ H N++
Sbjct: 16 LQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLE 75
Query: 140 LKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYT-------- 189
L F +++ Y LV E + S IH+R + +
Sbjct: 76 LIEFF---EEEDRFY--LVFEKMRGGSI-------LSHIHKR------RHFNELEASVVV 117
Query: 190 YQICRALAYIHNCIGICHRDIKPQNLL-VNP-HTHQLKLCDFGSAKVLVKGE-------P 240
+ AL ++HN GI HRD+KP+N+L +P +K+CDF + P
Sbjct: 118 QDVASALDFLHNK-GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTP 176
Query: 241 NVSYIC-SRYYRAPELI----FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLV 295
+ C S Y APE++ A+ Y D+WS G ++ LL G P F G G D
Sbjct: 177 ELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGW 236
Query: 296 EIIKVLGTPTR---EEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYS 352
+ + E I+ +++FP W + A DL+ +
Sbjct: 237 DRGEACPACQNMLFESIQEG-----KYEFP---DKDWAHI-----SCAAKDLISKLLVRD 283
Query: 353 PNLRCTALEACVHPFFDELRDPNTRLPNGRPL 384
R +A + HP+ P LP L
Sbjct: 284 AKQRLSAAQVLQHPWVQG-CAPENTLPTPMVL 314
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 3e-43
Identities = 72/288 (25%), Positives = 107/288 (37%), Gaps = 54/288 (18%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQ-MLDHPNIVALKH 142
+ V+G G G V Q + T E A+ K+LQD RE+++ P+IV +
Sbjct: 20 KVTSQVLGLGINGKVLQIFNKRTQEKFAL-KMLQDCPKARREVELHWRASQCPHIVRIVD 78
Query: 143 CFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 200
+ L +V+E + E +RI R Q I A+ Y+H
Sbjct: 79 -VYENLYAGRKCLLIVMECLDGGELFSRIQ---DRGDQAFTEREASEIMKSIGEAIQYLH 134
Query: 201 NCIGICHRDIKPQNLL-VNPHTH-QLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFG 258
+ I HRD+KP+NLL + + LKL DFG A E
Sbjct: 135 SI-NIAHRDVKPENLLYTSKRPNAILKLTDFG--------------------FAKETT-- 171
Query: 259 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 318
+Y + D+WS G +M LL G P F G+ + I+ +
Sbjct: 172 GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMK--------TRIR-----MGQ 218
Query: 319 FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHP 366
++FP W +V E L+ + P R T E HP
Sbjct: 219 YEFP---NPEWSEV-----SEEVKMLIRNLLKTEPTQRMTITEFMNHP 258
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 154 bits (389), Expect = 6e-43
Identities = 59/430 (13%), Positives = 125/430 (29%), Gaps = 93/430 (21%)
Query: 13 SSRSVNGFKSSSSSVDWLGREMLEMRLRDQVDNDEDRDSEPD--IIDGVGAETGHV-IRT 69
+ GF+ + + + + E S D + + + +
Sbjct: 12 ENLYFQGFRGTDPGDVVIEELFNRIPQANVRTTSEYMQSAADSLVSTSLWNTGQPFRVES 71
Query: 70 TIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------ 123
+G R + + V+G +A +ETGE + +R +
Sbjct: 72 ELGER------PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQM 125
Query: 124 -RELQIMQML-------------------------DHPNIVALKHCFFSTTDKEELYLNL 157
E+ +++L ++ ++ +L
Sbjct: 126 KEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYP 185
Query: 158 VLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLV 217
++ +T + ++S H+ + T Q+ R LA +H+ G+ H ++P ++++
Sbjct: 186 RMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY-GLVHTYLRPVDIVL 244
Query: 218 NPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY----YRAPELIFGA----TEYTTAIDIW 269
+ + L F G VS I + A ++ T T A D W
Sbjct: 245 DQRGG-VFLTGFEHLVRD--GASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTW 301
Query: 270 STGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPW 329
+ G + + ++ +
Sbjct: 302 TLGLAIYWIWCADLPNTDDAALGGS----------------------------------- 326
Query: 330 HKVFQ--KRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD---PNTRLPNGRPL 384
+F+ K +P L+ F +Y R L+A P +++LR L
Sbjct: 327 EWIFRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLRTELSAALPLYQTDGE 386
Query: 385 PPLFNFKPPG 394
P PP
Sbjct: 387 PTREGGAPPS 396
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 9e-43
Identities = 78/316 (24%), Positives = 121/316 (38%), Gaps = 73/316 (23%)
Query: 89 VVGTGSFGVVFQAKCRETGEIVAIKK-----VLQDKR--YKNRELQIMQMLDHPNIVALK 141
V+G G+F V K ++TG++ A+K +L+ E ++ D I L
Sbjct: 68 VIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLH 127
Query: 142 HCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 199
F D+ LY LV+EY + + + S+ +R+P + Y +I A+ +
Sbjct: 128 FAF---QDENYLY--LVMEYYVGGDLLTLL----SKFGERIPAEMARFYLAEIVMAIDSV 178
Query: 200 HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVS--------YICSRYYR 251
H +G HRDIKP N+L++ H ++L DFGS L S Y+
Sbjct: 179 HR-LGYVHRDIKPDNILLDRCGH-IRLADFGSCLKLRADGTVRSLVAVGTPDYL------ 230
Query: 252 APELI------FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPT 305
+PE++ G Y D W+ G E+ GQ F +S + I
Sbjct: 231 SPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADS-TAETYGKI------- 282
Query: 306 REEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLR---CTALEA 362
++ P + +P EA D + R P R A +
Sbjct: 283 ------VHYK-EHLSLPLVDEG---------VPEEARDFIQRLLC-PPETRLGRGGAGDF 325
Query: 363 CVHPFF-----DELRD 373
HPFF D LRD
Sbjct: 326 RTHPFFFGLDWDGLRD 341
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 1e-42
Identities = 76/307 (24%), Positives = 123/307 (40%), Gaps = 57/307 (18%)
Query: 89 VVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDK--RYKNRELQIMQMLDHPNIVALK 141
V+G G+FG V K + ++ A+K ++L+ E ++ D I L
Sbjct: 81 VIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLH 140
Query: 142 HCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 199
+ F D LY LV++Y + + + S+ R+P + Y ++ A+ +
Sbjct: 141 YAF---QDDNNLY--LVMDYYVGGDLLTLL----SKFEDRLPEEMARFYLAEMVIAIDSV 191
Query: 200 HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY-ICSRY-YRAPELI- 256
H + HRDIKP N+L++ + H ++L DFGS L++ S Y +PE++
Sbjct: 192 HQ-LHYVHRDIKPDNILMDMNGH-IRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQ 249
Query: 257 ---FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 313
G Y D WS G M E+L G+ F ES + + I MN
Sbjct: 250 AMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAES-LVETYGKI-------------MN 295
Query: 314 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPN-LRCT-ALEACVHPFF--- 368
F+FP + A DL+ R + L + HPFF
Sbjct: 296 HK-ERFQFPTQVTD---------VSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGI 345
Query: 369 --DELRD 373
D +R+
Sbjct: 346 DWDNIRN 352
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 151 bits (382), Expect = 2e-42
Identities = 44/297 (14%), Positives = 92/297 (30%), Gaps = 36/297 (12%)
Query: 83 SYIAEHVVGTGSFGVVFQAKCR-----ETGEIVAIK----KVLQDKRYKNRELQIMQMLD 133
H++G G+F V++A + + +K + + ++ ++
Sbjct: 66 LVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSM 125
Query: 134 HPNIVALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQ 191
+ + L V E +N I + + MP V + +
Sbjct: 126 QHMFMKFYSAHL---FQNGSVL--VGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMR 180
Query: 192 ICRALAYIHNCIGICHRDIKPQNLLVNPHTHQ----------LKLCDFGSAKVLVKGEPN 241
+ + +H+C I H DIKP N ++ + L L D G + +
Sbjct: 181 MLYMIEQVHDC-EIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKG 239
Query: 242 V---SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLF-PGESGVDQLVEI 297
+ + ++ E++ + ID + + +L G + E G + +
Sbjct: 240 TIFTAKCETSGFQCVEMLSN-KPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGL 298
Query: 298 IKVL-GTPTREEIKCMNPNYTEFKFPQIKP---HPWHKVFQKRLPPEAVDLVCRFFQ 350
+ L E + N + KVFQ+ + L R
Sbjct: 299 FRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIV 355
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 150 bits (382), Expect = 3e-42
Identities = 74/294 (25%), Positives = 119/294 (40%), Gaps = 46/294 (15%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKRYKNRELQIMQMLDHPNIV 138
Y +G+G+FGV + + T E+VA+K + + RE+ + L HPNIV
Sbjct: 22 YDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQ--REIINHRSLRHPNIV 79
Query: 139 ALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
K + T L +++EY E RI R + + Q+ +
Sbjct: 80 RFKEVILTPTH---LA--IIMEYASGGELYERICN-----AGRFSEDEARFFFQQLLSGV 129
Query: 197 AYIHNCIGICHRDIKPQNLLVNPHTH-QLKLCDFGSAKVLVKGEPNVSYICSRYYRAPEL 255
+Y H+ + ICHRD+K +N L++ +LK+CDFG +K V S + + Y APE+
Sbjct: 130 SYCHS-MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEV 188
Query: 256 IFGATEYT-TAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 314
+ EY D+WS G + +L+G F T + I +
Sbjct: 189 LLR-QEYDGKIADVWSCGVTLYVMLVGAYPFEDPE--------EPRDYRKTIQRILSV-- 237
Query: 315 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368
++ P + PE L+ R F P R + E H +F
Sbjct: 238 ---KYSIP---DDIR-------ISPECCHLISRIFVADPATRISIPEIKTHSWF 278
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 148 bits (377), Expect = 3e-42
Identities = 75/326 (23%), Positives = 130/326 (39%), Gaps = 59/326 (18%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKRYKN---RELQIMQMLDHP 135
Y+ ++G GS+G V + ET A+K K+ + + +E+Q+++ L H
Sbjct: 7 YLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHK 66
Query: 136 NIVALKHCFFSTTDKEELYLNLVLEYVP----ETVNRIARNYSRIHQRMPLIYVKLYTYQ 191
N++ L ++ K+++Y +V+EY E ++ + +R P+ Y Q
Sbjct: 67 NVIQLVDVLYNEE-KQKMY--MVMEYCVCGMQEMLDSVP------EKRFPVCQAHGYFCQ 117
Query: 192 ICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN--VSYIC-SR 248
+ L Y+H+ GI H+DIKP NLL+ LK+ G A+ L + S
Sbjct: 118 LIDGLEYLHSQ-GIVHKDIKPGNLLLTTG-GTLKISALGVAEALHPFAADDTCRTSQGSP 175
Query: 249 YYRAPELIFGATEYT-TAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 307
++ PE+ G ++ +DIWS G + + G F G++ I L E
Sbjct: 176 AFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDN--------IYKL----FE 223
Query: 308 EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 367
I + P P DL+ +Y P R + + H +
Sbjct: 224 NIG-----KGSYAIP-----GD-------CGPPLSDLLKGMLEYEPAKRFSIRQIRQHSW 266
Query: 368 FDELRDPNTRLPNGRPLPPLFNFKPP 393
F + P P+PP + K
Sbjct: 267 FRKKHPPAEAPV---PIPPSPDTKDR 289
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 151 bits (382), Expect = 1e-41
Identities = 87/374 (23%), Positives = 150/374 (40%), Gaps = 70/374 (18%)
Query: 41 DQVDNDEDRDSEPDIIDGVGAETGHVIRTTIGGRNGNSKQKVS-----YIAEHVVGTGSF 95
V + + + ++ G+ + + + K +V+ Y+ ++G G+F
Sbjct: 104 QTVADGLKKQAAAEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLK--LLGKGTF 161
Query: 96 GVVFQAKCRETGEIVAIK-----KVLQDKRYKN--RELQIMQMLDHPNIVALKHCFFSTT 148
G V K + TG A+K ++ + E +++Q HP + ALK+ F T
Sbjct: 162 GKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSF-QTH 220
Query: 149 DKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGIC 206
D+ L V+EY E ++R + + Y +I AL Y+H+ +
Sbjct: 221 DR--LCF--VMEYANGGELFFHLSR-----ERVFSEDRARFYGAEIVSALDYLHSEKNVV 271
Query: 207 HRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYIC-SRYYRAPELIFGATEYTTA 265
+RD+K +NL+++ H +K+ DFG K +K + C + Y APE++ +Y A
Sbjct: 272 YRDLKLENLMLDKDGH-IKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLED-NDYGRA 329
Query: 266 IDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIK 325
+D W G VM E++ G+ F + ++L E+I E +FP
Sbjct: 330 VDWWGLGVVMYEMMCGRLPFYNQD-HEKLFELIL----------------MEEIRFP--- 369
Query: 326 PHPWHKVFQKRLPPEAVDLVCRFFQYSPNLR-----CTALEACVHPFFDELRDPN-TRLP 379
+ L PEA L+ + P R A E H FF +
Sbjct: 370 ---------RTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFF---AGIVWQHVY 417
Query: 380 NGRPLPPLFNFKPP 393
+ PP FKP
Sbjct: 418 EKKLSPP---FKPQ 428
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 6e-41
Identities = 73/296 (24%), Positives = 121/296 (40%), Gaps = 50/296 (16%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKRYKNRELQIMQMLDHPNIV 138
+ +G G++G V A R T E VA+K + + +E+ I +ML+H N+V
Sbjct: 9 WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 68
Query: 139 ALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
Y L LEY E +RI MP + + +Q+ +
Sbjct: 69 KFYGHRREGNI---QY--LFLEYCSGGELFDRIEP-----DIGMPEPDAQRFFHQLMAGV 118
Query: 197 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN--VSYIC-SRYYRAP 253
Y+H IGI HRDIKP+NLL++ LK+ DFG A V ++ +C + Y AP
Sbjct: 119 VYLHG-IGITHRDIKPENLLLDER-DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176
Query: 254 ELIFGATEYT-TAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 312
EL+ E+ +D+WS G V+ +L G+ + DQ + + ++
Sbjct: 177 ELLKR-REFHAEPVDVWSCGIVLTAMLAGELPW------DQPSDSCQEYSDWKEKKTYLN 229
Query: 313 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368
PW K + + L+ + +P+ R T + ++
Sbjct: 230 ---------------PWKK-----IDSAPLALLHKILVENPSARITIPDIKKDRWY 265
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 1e-40
Identities = 83/320 (25%), Positives = 133/320 (41%), Gaps = 64/320 (20%)
Query: 89 VVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKRYKN--RELQIMQMLDHPNIVALK 141
++G G+FG V + + TG A+K ++ + E +++Q HP + ALK
Sbjct: 12 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 71
Query: 142 HCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 199
+ F T D+ L V+EY E ++R + + Y +I AL Y+
Sbjct: 72 YA-FQTHDR--LC--FVMEYANGGELFFHLSR-----ERVFTEERARFYGAEIVSALEYL 121
Query: 200 HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY-YRAPELIFG 258
H+ + +RDIK +NL+++ H +K+ DFG K + + C Y APE++
Sbjct: 122 HS-RDVVYRDIKLENLMLDKDGH-IKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLED 179
Query: 259 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 318
+Y A+D W G VM E++ G+ F + ++L E+I E
Sbjct: 180 -NDYGRAVDWWGLGVVMYEMMCGRLPFYNQD-HERLFELIL----------------MEE 221
Query: 319 FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLR-----CTALEACVHPFFDELRD 373
+FP + L PEA L+ + P R A E H FF
Sbjct: 222 IRFP------------RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFF---LS 266
Query: 374 PN-TRLPNGRPLPPLFNFKP 392
N + + LPP FKP
Sbjct: 267 INWQDVVQKKLLPP---FKP 283
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 1e-40
Identities = 75/313 (23%), Positives = 124/313 (39%), Gaps = 50/313 (15%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-----RELQIMQMLDHPNIV 138
+ +G G++G V A R T E VA+K V + +E+ I +ML+H N+V
Sbjct: 9 WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 68
Query: 139 ALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
Y L LEY E +RI MP + + +Q+ +
Sbjct: 69 KFYGHRREGNI---QY--LFLEYCSGGELFDRIEP-----DIGMPEPDAQRFFHQLMAGV 118
Query: 197 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNV--SYIC-SRYYRAP 253
Y+H IGI HRDIKP+NLL++ LK+ DFG A V + +C + Y AP
Sbjct: 119 VYLHG-IGITHRDIKPENLLLDER-DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176
Query: 254 ELIFGATEYT-TAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 312
EL+ E+ +D+WS G V+ +L G+ + DQ + + ++
Sbjct: 177 ELLKR-REFHAEPVDVWSCGIVLTAMLAGELPW------DQPSDSCQEYSDWKEKKTYLN 229
Query: 313 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR 372
PW K + + L+ + +P+ R T + ++++
Sbjct: 230 ---------------PWKK-----IDSAPLALLHKILVENPSARITIPDIKKDRWYNKPL 269
Query: 373 DPNTRLPNGRPLP 385
+ P
Sbjct: 270 KKGAKRPRVTSGG 282
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 1e-40
Identities = 78/317 (24%), Positives = 131/317 (41%), Gaps = 55/317 (17%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN--------RELQIMQMLDHP 135
Y +G G+F V A+ TG VAIK + DK N RE++IM++L+HP
Sbjct: 17 YRLLKTIGKGNFAKVKLARHILTGREVAIKII--DKTQLNPTSLQKLFREVRIMKILNHP 74
Query: 136 NIVALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQIC 193
NIV L + L L++EY E + + H RM + QI
Sbjct: 75 NIVKLFEVIETEKT-----LYLIMEYASGGEVFDYLVA-----HGRMKEKEARSKFRQIV 124
Query: 194 RALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAP 253
A+ Y H I HRD+K +NLL++ +K+ DFG + G ++ + Y AP
Sbjct: 125 SAVQYCHQ-KRIVHRDLKAENLLLD-ADMNIKIADFGFSNEFTVGGKLDAFCGAPPYAAP 182
Query: 254 ELIFGATEYT-TAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 312
EL G +Y +D+WS G ++ L+ G F G++ + +L E +
Sbjct: 183 ELFQG-KKYDGPEVDVWSLGVILYTLVSGSLPFDGQN-LKELRERVL------------- 227
Query: 313 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR 372
+++ P + + + +L+ RF +P R T + + +
Sbjct: 228 ---RGKYRIP-----FY-------MSTDCENLLKRFLVLNPIKRGTLEQIMKDRWINAGH 272
Query: 373 DPNTRLPNGRPLPPLFN 389
+ + P P + +
Sbjct: 273 EEDELKPFVEPELDISD 289
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 2e-40
Identities = 74/322 (22%), Positives = 121/322 (37%), Gaps = 58/322 (18%)
Query: 89 VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR--------ELQIMQMLDHPNIVAL 140
V+G G FG VF + + TG++ A K L KR K R E +I+ + IV+L
Sbjct: 192 VLGRGGFGEVFACQMKATGKLYAC-KKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSL 250
Query: 141 KHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
+ F T L LV+ + + I + YT QI L +
Sbjct: 251 AYA-FETKTD----LCLVMTIMNGGDIRYHIYNVDED-NPGFQEPRAIFYTAQIVSGLEH 304
Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYIC-SRYYRAPELIF 257
+H I +RD+KP+N+L++ + +++ D G A L G+ + + APEL+
Sbjct: 305 LHQR-NIIYRDLKPENVLLDDDGN-VRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLL 362
Query: 258 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 317
G EY ++D ++ G + E++ + F + E+ + + Y
Sbjct: 363 G-EEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELK--------QRVLEQAVTYP 413
Query: 318 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLR-----CTALEACVHPFFDELR 372
+ P + D Q P R + HP F R
Sbjct: 414 DK-----------------FSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLF---R 453
Query: 373 DPN-TRLPNGRPLPPLFNFKPP 393
D + +L G PP F P
Sbjct: 454 DISWRQLEAGMLTPP---FVPD 472
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 151 bits (382), Expect = 2e-40
Identities = 73/324 (22%), Positives = 128/324 (39%), Gaps = 65/324 (20%)
Query: 89 VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRE-----------LQIMQMLDHPNI 137
++G G FG V+ + +TG++ A+K L KR K ++ L ++ D P I
Sbjct: 196 IIGRGGFGEVYGCRKADTGKMYAMK-CLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI 254
Query: 138 VALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRA 195
V + + F ++L +L+ + + +++ H ++ Y +I
Sbjct: 255 VCMSYAF---HTPDKLSF--ILDLMNGGDLHYHLSQ-----HGVFSEADMRFYAAEIILG 304
Query: 196 LAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPEL 255
L ++HN + +RD+KP N+L++ H H +++ D G A K +P+ + + + Y APE+
Sbjct: 305 LEHMHN-RFVVYRDLKPANILLDEHGH-VRISDLGLACDFSKKKPH-ASVGTHGYMAPEV 361
Query: 256 IFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 315
+ Y ++ D +S GC++ +LL G F D + EI
Sbjct: 362 LQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD-------------KHEI------ 402
Query: 316 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLR--CT---ALEACVHPFFDE 370
PE L+ Q N R C A E PFF
Sbjct: 403 -----DRMTLTMA--VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRS 455
Query: 371 LRDPN-TRLPNGRPLPPLFNFKPP 393
L + + + PP PP
Sbjct: 456 L---DWQMVFLQKYPPP---LIPP 473
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 3e-40
Identities = 70/299 (23%), Positives = 123/299 (41%), Gaps = 41/299 (13%)
Query: 89 VVGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKN--RELQI-MQMLDHPNIVALKH 142
+G G++GVV + + +G+I+A+K++ + + K +L I M+ +D P V
Sbjct: 14 ELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYG 73
Query: 143 CFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
F D + + +E + ++++ + Q +P + I +AL ++H+
Sbjct: 74 ALFREGD-----VWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSK 128
Query: 203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFG---A 259
+ + HRD+KP N+L+N Q+K+CDFG + LV + Y APE I
Sbjct: 129 LSVIHRDVKPSNVLIN-ALGQVKMCDFGISGYLVDDVAKDIDAGCKPYMAPERINPELNQ 187
Query: 260 TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 319
Y+ DIWS G M EL + + + Q ++ + V
Sbjct: 188 KGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQV-VEEPS--------------- 231
Query: 320 KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRL 378
PQ+ + E VD + + + R T E HPFF T +
Sbjct: 232 --PQLPADKF--------SAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLHESKGTDV 280
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 5e-40
Identities = 67/321 (20%), Positives = 118/321 (36%), Gaps = 67/321 (20%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKRYKN-----RELQIMQMLD 133
Y ++G+G FG V+ VAIK ++ N E+ +++ +
Sbjct: 45 YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 104
Query: 134 H--PNIVALKHCFFSTTDKEELYLNLVLEYVP---ETVNRIARNYSRIHQRMPLIYVKLY 188
++ L +F D L +LE + + I + + +
Sbjct: 105 SGFSGVIRLLD-WFERPDS--FVL--ILERPEPVQDLFDFITE-----RGALQEELARSF 154
Query: 189 TYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYIC-S 247
+Q+ A+ + HNC G+ HRDIK +N+L++ + +LKL DFGS +L +
Sbjct: 155 FWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDF--DGT 211
Query: 248 RYYRAPELIFGATEYT-TAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTR 306
R Y PE I Y + +WS G ++ +++ G F + EII+
Sbjct: 212 RVYSPPEWIRY-HRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIR------- 257
Query: 307 EEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHP 366
+ F +R+ E L+ P+ R T E HP
Sbjct: 258 ----------GQVFFR------------QRVSSECQHLIRWCLALRPSDRPTFEEIQNHP 295
Query: 367 FFDELRDPNTRLP-NGRPLPP 386
+ ++ P + L P
Sbjct: 296 WMQDVLLPQETAEIHLHSLSP 316
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 148 bits (374), Expect = 1e-39
Identities = 85/321 (26%), Positives = 135/321 (42%), Gaps = 59/321 (18%)
Query: 89 VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR--------ELQIMQMLDHPNIVAL 140
V+G G FG V + R TG++ A K L+ KR K R E QI++ ++ +V+L
Sbjct: 191 VLGKGGFGEVCACQVRATGKMYAC-KKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSL 249
Query: 141 KHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
+ + T D L LVL + + I Y P Y +IC L
Sbjct: 250 AYA-YETKDA----LCLVLTLMNGGDLKFHI---YHMGQAGFPEARAVFYAAEICCGLED 301
Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFG 258
+H I +RD+KP+N+L++ H H +++ D G A + +G+ + + Y APE++
Sbjct: 302 LHRE-RIVYRDLKPENILLDDHGH-IRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKN 359
Query: 259 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 318
YT + D W+ GC++ E++ GQ F + E+ ++ +K + Y+E
Sbjct: 360 -ERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERL--------VKEVPEEYSE 410
Query: 319 FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLR-----CTALEACVHPFFDELRD 373
P+A L + P R +A E HP F +
Sbjct: 411 R-----------------FSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLF---KK 450
Query: 374 PN-TRLPNGRPLPPLFNFKPP 393
N RL G PP FKP
Sbjct: 451 LNFKRLGAGMLEPP---FKPD 468
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 1e-39
Identities = 80/289 (27%), Positives = 129/289 (44%), Gaps = 40/289 (13%)
Query: 73 GRNGNSKQKV-SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-------R 124
G + + K+ Y+ +G G+FG V + + TG VA+K + + K R
Sbjct: 1 GSKHDGRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKR 60
Query: 125 ELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPL 182
E+Q +++ HP+I+ L + TD + +V+EYV E + I + H R+
Sbjct: 61 EIQNLKLFRHPHIIKLYQVISTPTD---FF--MVMEYVSGGELFDYICK-----HGRVEE 110
Query: 183 IYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNV 242
+ + QI A+ Y H + HRD+KP+N+L++ H K+ DFG + ++ GE +
Sbjct: 111 MEARRLFQQILSAVDYCHR-HMVVHRDLKPENVLLDAH-MNAKIADFGLSNMMSDGEF-L 167
Query: 243 SYIC-SRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV- 300
C S Y APE+I G +DIWS G ++ LL G F E V L + I+
Sbjct: 168 RTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEH-VPTLFKKIRGG 226
Query: 301 -------LGTPTREEIKCM---NPNYTEFKFPQIKPHPWHKVFQKRLPP 339
L + M +P I+ H W F++ LP
Sbjct: 227 VFYIPEYLNRSVATLLMHMLQVDPL-KRATIKDIREHEW---FKQDLPS 271
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 1e-39
Identities = 80/306 (26%), Positives = 125/306 (40%), Gaps = 68/306 (22%)
Query: 89 VVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDK--RYKNRELQIMQMLDHPNIVALK 141
V+G G+FG V + + T ++ A+K ++++ + E IM + P +V L
Sbjct: 76 VIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF 135
Query: 142 HCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 199
+ F D LY +V+EY+P + VN ++ +P + + YT ++ AL I
Sbjct: 136 YAF---QDDRYLY--MVMEYMPGGDLVNLMSN------YDVPEKWARFYTAEVVLALDAI 184
Query: 200 HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVS--------YICSRYYR 251
H+ +G HRD+KP N+L++ H LKL DFG+ + K YI
Sbjct: 185 HS-MGFIHRDVKPDNMLLDKSGH-LKLADFGTCMKMNKEGMVRCDTAVGTPDYI------ 236
Query: 252 APELIF---GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 308
+PE++ G Y D WS G + E+L+G F +S LV
Sbjct: 237 SPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS----LVGTYS--------- 283
Query: 309 IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCT---ALEACVH 365
K MN FP + EA +L+C F +R E H
Sbjct: 284 -KIMNHK-NSLTFP---DDND-------ISKEAKNLICAFLT-DREVRLGRNGVEEIKRH 330
Query: 366 PFFDEL 371
FF
Sbjct: 331 LFFKND 336
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 141 bits (359), Expect = 2e-39
Identities = 80/326 (24%), Positives = 139/326 (42%), Gaps = 77/326 (23%)
Query: 89 VVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDK--RYKNRELQIMQMLDHPNIVALK 141
+GTGSFG V + R G A+K V++ K + N E ++ ++ HP I+ +
Sbjct: 13 TLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMW 72
Query: 142 HCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 199
F D ++++ ++++Y+ E + + ++ QR P K Y ++C AL Y+
Sbjct: 73 GTF---QDAQQIF--MIMDYIEGGELFSLLRKS-----QRFPNPVAKFYAAEVCLALEYL 122
Query: 200 HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK------GEPNVSYICSRYYRAP 253
H+ I +RD+KP+N+L++ + H +K+ DFG AK + G P+ Y AP
Sbjct: 123 HSK-DIIYRDLKPENILLDKNGH-IKITDFGFAKYVPDVTYTLCGTPD--------YIAP 172
Query: 254 ELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 313
E++ Y +ID WS G ++ E+L G F + + E I
Sbjct: 173 EVVST-KPYNKSIDWWSFGILIYEMLAGYTPFYDSN-TMKTYEKIL-------------- 216
Query: 314 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSP-----NLRCTALEACVHPFF 368
E +FP + DL+ R NL+ + HP+F
Sbjct: 217 --NAELRFP------------PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWF 262
Query: 369 DELRDPN-TRLPNGRPLPPLFNFKPP 393
E+ +L + P ++PP
Sbjct: 263 KEV---VWEKLLSRNIETP---YEPP 282
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 8e-39
Identities = 89/324 (27%), Positives = 136/324 (41%), Gaps = 68/324 (20%)
Query: 89 VVGTGSFGVVFQAK---CRETGEIVAIK-----KVLQDKRYKNR---ELQIMQMLDHPNI 137
V+G G +G VFQ + TG+I A+K ++++ + E I++ + HP I
Sbjct: 24 VLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFI 83
Query: 138 VALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRA 195
V L + F T K LYL +LEY+ E ++ R Y +I A
Sbjct: 84 VDLIYAF-QTGGK--LYL--ILEYLSGGELFMQLER-----EGIFMEDTACFYLAEISMA 133
Query: 196 LAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY-YRAPE 254
L ++H GI +RD+KP+N+++N H +KL DFG K + C Y APE
Sbjct: 134 LGHLHQK-GIIYRDLKPENIMLNHQGH-VKLTDFGLCKESIHDGTVTHTFCGTIEYMAPE 191
Query: 255 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 314
++ + + A+D WS G +M ++L G P F GE+ + ++ I
Sbjct: 192 ILMR-SGHNRAVDWWSLGALMYDMLTGAPPFTGEN-RKKTIDKIL--------------- 234
Query: 315 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLR-----CTALEACVHPFFD 369
+ P L EA DL+ + + + R A E HPFF
Sbjct: 235 -KCKLNLP------------PYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFF- 280
Query: 370 ELRDPN-TRLPNGRPLPPLFNFKP 392
R N L + PP FKP
Sbjct: 281 --RHINWEELLARKVEPP---FKP 299
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 8e-39
Identities = 86/322 (26%), Positives = 137/322 (42%), Gaps = 66/322 (20%)
Query: 89 VVGTGSFGVVFQAK---CRETGEIVAIK-----KVLQDKRYKNR-ELQIMQMLDHPNIVA 139
V+G GSFG VF K + ++ A+K + R + + E I+ ++HP IV
Sbjct: 31 VLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVK 90
Query: 140 LKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALA 197
L + F T K LYL +L+++ + R+++ VK Y ++ AL
Sbjct: 91 LHYAF-QTEGK--LYL--ILDFLRGGDLFTRLSK-----EVMFTEEDVKFYLAELALALD 140
Query: 198 YIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYIC-SRYYRAPELI 256
++H+ GI +RD+KP+N+L++ H +KL DFG +K + E C + Y APE++
Sbjct: 141 HLHSL-GIIYRDLKPENILLDEEGH-IKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVV 198
Query: 257 FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 316
+T + D WS G +M E+L G F G+ + + +I
Sbjct: 199 NR-RGHTQSADWWSFGVLMFEMLTGTLPFQGKD-RKETMTMIL----------------K 240
Query: 317 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLR-----CTALEACVHPFFDEL 371
+ PQ L PEA L+ F+ +P R E H FF
Sbjct: 241 AKLGMPQ------------FLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFF--- 285
Query: 372 RDPN-TRLPNGRPLPPLFNFKP 392
+ +L PP FKP
Sbjct: 286 STIDWNKLYRREIHPP---FKP 304
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 2e-38
Identities = 68/313 (21%), Positives = 114/313 (36%), Gaps = 73/313 (23%)
Query: 91 GTGSFGVVFQAKCRETGEIVAIK-----KVLQDKRYKN---------------------- 123
G GS+GVV A A+K K+++ +
Sbjct: 22 GKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIE 81
Query: 124 ---RELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQ 178
+E+ I++ LDHPN+V L +++ LY+ V E V + +
Sbjct: 82 QVYQEIAILKKLDHPNVVKL-VEVLDDPNEDHLYM--VFELVNQGPVMEVPT------LK 132
Query: 179 RMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG 238
+ + Y + + + Y+H I HRDIKP NLLV +K+ DFG +
Sbjct: 133 PLSEDQARFYFQDLIKGIEYLHY-QKIIHRDIKPSNLLVG-EDGHIKIADFGVSNEFKGS 190
Query: 239 EPNVSYIC-SRYYRAPELIFGAT-EYT-TAIDIWSTGCVMAELLLGQPLFPGESGVDQLV 295
+ +S + + APE + ++ A+D+W+ G + + GQ F E + L
Sbjct: 191 DALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDER-IMCLH 249
Query: 296 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNL 355
IK +FP P + + DL+ R +P
Sbjct: 250 SKIK----------------SQALEFPD---QPD-------IAEDLKDLITRMLDKNPES 283
Query: 356 RCTALEACVHPFF 368
R E +HP+
Sbjct: 284 RIVVPEIKLHPWV 296
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 5e-38
Identities = 68/323 (21%), Positives = 115/323 (35%), Gaps = 68/323 (21%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKRYKN-----RELQIMQMLD 133
Y ++G G FG VF VAIK +VL + E+ ++ +
Sbjct: 33 YRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVG 92
Query: 134 ----HPNIVALKHCFFSTTDKEELYLNLVLEYVP---ETVNRIARNYSRIHQRMPLIYVK 186
HP ++ L +F T + L VLE + + I + +
Sbjct: 93 AGGGHPGVIRL-LDWFETQEG--FML--VLERPLPAQDLFDYITE-----KGPLGEGPSR 142
Query: 187 LYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYIC 246
+ Q+ A+ + H+ G+ HRDIK +N+L++ KL DFGS +L
Sbjct: 143 CFFGQVVAAIQHCHSR-GVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDF--D 199
Query: 247 -SRYYRAPELIFGATEYT-TAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTP 304
+R Y PE I +Y +WS G ++ +++ G F + EI++
Sbjct: 200 GTRVYSPPEWISR-HQYHALPATVWSLGILLYDMVCGDIPFERDQ------EILEA---- 248
Query: 305 TREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV 364
E FP + P+ L+ R P+ R + E +
Sbjct: 249 -------------ELHFP------------AHVSPDCCALIRRCLAPKPSSRPSLEEILL 283
Query: 365 HPFFDELRDPNTRLPNGRPLPPL 387
P+ + P+ PL
Sbjct: 284 DPWMQTPAEDVPLNPSKGGPAPL 306
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 6e-38
Identities = 79/326 (24%), Positives = 130/326 (39%), Gaps = 77/326 (23%)
Query: 89 VVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDK--RYKNRELQIMQMLDHPNIVALK 141
+GTGSFG V K +E+G A+K KV++ K + E +I+Q ++ P +V L+
Sbjct: 48 TLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 142 HCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 199
F D LY +V+EYV E + + R R + + Y QI Y+
Sbjct: 108 FSF---KDNSNLY--MVMEYVAGGEMFSHL-----RRIGRFSEPHARFYAAQIVLTFEYL 157
Query: 200 HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK------GEPNVSYICSRYYRAP 253
H+ + +RD+KP+NLL++ + +++ DFG AK + G P AP
Sbjct: 158 HSL-DLIYRDLKPENLLIDQQGY-IQVTDFGFAKRVKGRTWTLCGTPE--------ALAP 207
Query: 254 ELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 313
E+I Y A+D W+ G ++ E+ G P F + Q+ E I +
Sbjct: 208 EIILS-KGYNKAVDWWALGVLIYEMAAGYPPFFADQ-PIQIYEKI----------VSG-- 253
Query: 314 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSP-----NLRCTALEACVHPFF 368
+ +FP + DL+ Q NL+ + H +F
Sbjct: 254 ----KVRFP------------SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWF 297
Query: 369 DELRDPN-TRLPNGRPLPPLFNFKPP 393
+ + + P F P
Sbjct: 298 ATT---DWIAIYQRKVEAP---FIPK 317
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 1e-37
Identities = 80/301 (26%), Positives = 129/301 (42%), Gaps = 52/301 (17%)
Query: 78 SKQKV-SYIAEHVVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKRYKN--RELQIM 129
SK+ + YI +G GSFG V A +T + VA+K + + + RE+ +
Sbjct: 4 SKRHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYL 63
Query: 130 QMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLY 188
++L HP+I+ L + TD + +V+EY E + I +RM + +
Sbjct: 64 KLLRHPHIIKLYDVITTPTD---IV--MVIEYAGGELFDYIVE-----KKRMTEDEGRRF 113
Query: 189 TYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYIC-S 247
QI A+ Y H I HRD+KP+NLL++ + +K+ DFG + ++ G + C S
Sbjct: 114 FQQIICAIEYCH-RHKIVHRDLKPENLLLDDN-LNVKIADFGLSNIMTDGNF-LKTSCGS 170
Query: 248 RYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 307
Y APE+I G +D+WS G V+ +L+G+ F E + L + +
Sbjct: 171 PNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEF-IPNLFKKVN-------- 221
Query: 308 EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 367
+ P + L P A L+ R P R T E P+
Sbjct: 222 --------SCVYVMP-----DF-------LSPGAQSLIRRMIVADPMQRITIQEIRRDPW 261
Query: 368 F 368
F
Sbjct: 262 F 262
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 1e-37
Identities = 65/220 (29%), Positives = 104/220 (47%), Gaps = 28/220 (12%)
Query: 87 EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN--RELQIMQMLDHPNIVALKHCF 144
E VVG G+FGVV +AK R + VAIK++ + K EL+ + ++HPNIV L
Sbjct: 13 EEVVGRGAFGVVCKAKWR--AKDVAIKQIESESERKAFIVELRQLSRVNHPNIVKLYGA- 69
Query: 145 FSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYT-----YQICRALAY 198
+ + LV+EY ++ Y+ +H PL Y Q + +AY
Sbjct: 70 --CLNP----VCLVMEYAEGGSL------YNVLHGAEPLPYYTAAHAMSWCLQCSQGVAY 117
Query: 199 IHNC--IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELI 256
+H+ + HRD+KP NLL+ LK+CDFG+A + S + APE+
Sbjct: 118 LHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTAC--DIQTHMTNNKGSAAWMAPEVF 175
Query: 257 FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVE 296
G + Y+ D++S G ++ E++ + F G +
Sbjct: 176 EG-SNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIM 214
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 1e-37
Identities = 64/358 (17%), Positives = 115/358 (32%), Gaps = 103/358 (28%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-----RELQIMQMLDHPNIV 138
+ +G G FGVVF+AK + AIK++ R RE++ + L+HP IV
Sbjct: 8 FEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIV 67
Query: 139 ALKHCF----------------------------------------------------FS 146
+ +
Sbjct: 68 RYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQL 127
Query: 147 TTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGIC 206
++YL + ++ + + N + QI A+ ++H+ G+
Sbjct: 128 QPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSK-GLM 186
Query: 207 HRDIKPQNLLVNPHTHQLKLCDFGSAKVL-------------VKGEPNVSYICSRYYRAP 253
HRD+KP N+ +K+ DFG + + + ++ Y +P
Sbjct: 187 HRDLKPSNIFFTMD-DVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSP 245
Query: 254 ELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 313
E I G Y+ +DI+S G ++ ELL F + +++ ++
Sbjct: 246 EQIHG-NNYSHKVDIFSLGLILFELLYS---FSTQMERVRIITDVR-------------- 287
Query: 314 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL 371
KFP K P+ +V SP R A + + F+ L
Sbjct: 288 ----NLKFP---LLFTQK------YPQEHMMVQDMLSPSPTERPEATDIIENAIFENL 332
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 2e-37
Identities = 80/321 (24%), Positives = 128/321 (39%), Gaps = 65/321 (20%)
Query: 89 VVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKRYKN--RELQIMQMLD-HPNIVAL 140
V+G GSFG V ++ + T E+ A+K V+QD + E +++ + P + L
Sbjct: 27 VLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQL 86
Query: 141 KHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
C F T D+ LY V+EYV + + I + R + Y +I L +
Sbjct: 87 HSC-FQTMDR--LY--FVMEYVNGGDLMYHIQQ-----VGRFKEPHAVFYAAEIAIGLFF 136
Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY-YRAPELIF 257
+ + GI +RD+K N++++ H +K+ DFG K + C Y APE+I
Sbjct: 137 LQS-KGIIYRDLKLDNVMLDSEGH-IKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIA 194
Query: 258 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 317
Y ++D W+ G ++ E+L GQ F GE D+L + I
Sbjct: 195 Y-QPYGKSVDWWAFGVLLYEMLAGQAPFEGED-EDELFQSIM----------------EH 236
Query: 318 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLR-----CTALEACVHPFFDELR 372
+P K + EAV + P R + H FF R
Sbjct: 237 NVAYP------------KSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFF---R 281
Query: 373 DPN-TRLPNGRPLPPLFNFKP 392
+ +L PP +KP
Sbjct: 282 YIDWEKLERKEIQPP---YKP 299
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 2e-37
Identities = 65/301 (21%), Positives = 115/301 (38%), Gaps = 46/301 (15%)
Query: 89 VVGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKN--RELQI-MQMLDHPNIVALKH 142
+G+G+ G V++ + R+TG ++A+K++ + K +L + ++ D P IV
Sbjct: 32 EMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFG 91
Query: 143 CFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
F + TD + + +E + ++ R+ +P + T I +AL Y+
Sbjct: 92 TFITNTD-----VFIAMELMGTCAEKL---KKRMQGPIPERILGKMTVAIVKALYYLKEK 143
Query: 203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELI----FG 258
G+ HRD+KP N+L++ Q+KLCDFG + LV + Y APE I
Sbjct: 144 HGVIHRDVKPSNILLD-ERGQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPERIDPPDPT 202
Query: 259 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGV-DQLVEIIKVLGTPTREEIKCMNPNYT 317
+Y D+WS G + EL GQ + + L ++++ P
Sbjct: 203 KPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQ--EEP------------- 247
Query: 318 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTR 377
P + H + V R + H F
Sbjct: 248 ----PLLPGH-------MGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRYETLEVD 296
Query: 378 L 378
+
Sbjct: 297 V 297
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 4e-37
Identities = 82/318 (25%), Positives = 136/318 (42%), Gaps = 61/318 (19%)
Query: 89 VVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKRYKN--RELQIMQM-LDHPNIVAL 140
++G GSFG VF A+ ++T + AIK VL D + E +++ + +HP + +
Sbjct: 24 MLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHM 83
Query: 141 KHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
F T + L+ V+EY+ + + I + L Y +I L +
Sbjct: 84 FCT-FQTKEN--LF--FVMEYLNGGDLMYHIQS-----CHKFDLSRATFYAAEIILGLQF 133
Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY-YRAPELIF 257
+H+ GI +RD+K N+L++ H +K+ DFG K + G+ + C Y APE++
Sbjct: 134 LHS-KGIVYRDLKLDNILLDKDGH-IKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILL 191
Query: 258 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 317
G +Y ++D WS G ++ E+L+GQ F G+ ++L I+
Sbjct: 192 G-QKYNHSVDWWSFGVLLYEMLIGQSPFHGQD-EEELFHSIR----------------MD 233
Query: 318 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEA-CVHPFFDELRDPN- 375
+P + L EA DL+ + F P R HP F R+ N
Sbjct: 234 NPFYP------------RWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLF---REINW 278
Query: 376 TRLPNGRPLPPLFNFKPP 393
L PP F+P
Sbjct: 279 EELERKEIDPP---FRPK 293
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 4e-37
Identities = 69/300 (23%), Positives = 121/300 (40%), Gaps = 39/300 (13%)
Query: 89 VVGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKN--RELQI-MQMLDHPNIVALKH 142
+G G++G V + + +G+I+A+K++ + +K K +L + M+ D P IV
Sbjct: 29 EIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYG 88
Query: 143 CFFSTTDKEELYLNLVLEYVPETVNRIARN-YSRIHQRMPLIYVKLYTYQICRALAYIHN 201
F D + +E + + ++ + YS + +P + T +AL ++
Sbjct: 89 ALFREGD-----CWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKE 143
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 261
+ I HRDIKP N+L++ + +KLCDFG + LV R Y APE I +
Sbjct: 144 NLKIIHRDIKPSNILLD-RSGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSAS 202
Query: 262 ---YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 318
Y D+WS G + EL G+ +P + V + + V G P P
Sbjct: 203 RQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQV-VKGDP---------P---- 248
Query: 319 FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRL 378
+ + + P ++ V + R E HPF + +
Sbjct: 249 -QLSNSEEREF--------SPSFINFVNLCLTKDESKRPKYKELLKHPFILMYEERAVEV 299
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 6e-37
Identities = 79/320 (24%), Positives = 124/320 (38%), Gaps = 64/320 (20%)
Query: 89 VVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDK--RYKNRELQIM-QMLDHPNIVAL 140
V+G GSFG V A+ + A+K +L+ K ++ E ++ + + HP +V L
Sbjct: 45 VIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 104
Query: 141 KHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
F T DK LY VL+Y+ E + R + + Y +I AL Y
Sbjct: 105 HFS-FQTADK--LY--FVLDYINGGELFYHLQR-----ERCFLEPRARFYAAEIASALGY 154
Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY-YRAPELIF 257
+H+ + I +RD+KP+N+L++ H + L DFG K ++ S C Y APE++
Sbjct: 155 LHS-LNIVYRDLKPENILLDSQGH-IVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEVLH 212
Query: 258 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 317
Y +D W G V+ E+L G P F + ++ + I
Sbjct: 213 K-QPYDRTVDWWCLGAVLYEMLYGLPPFYSRN-TAEMYDNIL----------------NK 254
Query: 318 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLR----CTALEACVHPFFDELRD 373
+ + A L+ Q R +E H FF
Sbjct: 255 PLQLK------------PNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFF---SL 299
Query: 374 PN-TRLPNGRPLPPLFNFKP 392
N L N + PP F P
Sbjct: 300 INWDDLINKKITPP---FNP 316
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 7e-37
Identities = 85/322 (26%), Positives = 139/322 (43%), Gaps = 66/322 (20%)
Query: 89 VVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKRYKN--RELQIMQM-LDHPNIVAL 140
V+G GSFG V A+ +ETG++ A+K +LQD + E +I+ + +HP + L
Sbjct: 30 VLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQL 89
Query: 141 KHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
C F T D+ L+ V+E+V + + I + +R + Y +I AL +
Sbjct: 90 FCC-FQTPDR--LF--FVMEFVNGGDLMFHIQK-----SRRFDEARARFYAAEIISALMF 139
Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY-YRAPELIF 257
+H+ GI +RD+K N+L++ H KL DFG K + + C Y APE++
Sbjct: 140 LHD-KGIIYRDLKLDNVLLDHEGH-CKLADFGMCKEGICNGVTTATFCGTPDYIAPEILQ 197
Query: 258 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 317
Y A+D W+ G ++ E+L G F E+ D L E I
Sbjct: 198 E-MLYGPAVDWWAMGVLLYEMLCGHAPFEAEN-EDDLFEAIL----------------ND 239
Query: 318 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLR------CTALEACVHPFFDEL 371
E +P L +A ++ F +P +R HPFF
Sbjct: 240 EVVYP------------TWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFF--- 284
Query: 372 RDPN-TRLPNGRPLPPLFNFKP 392
++ + +L + + PP F+P
Sbjct: 285 KEIDWAQLNHRQIEPP---FRP 303
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 1e-36
Identities = 88/328 (26%), Positives = 143/328 (43%), Gaps = 66/328 (20%)
Query: 89 VVGTGSFGVVFQAK---CRETGEIVAIK-----KVLQDKRYKNR---ELQIMQMLDH-PN 136
V+GTG++G VF + +TG++ A+K ++Q + E Q+++ + P
Sbjct: 61 VLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPF 120
Query: 137 IVALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICR 194
+V L + F T K L+L +L+Y+ E +++ +R V++Y +I
Sbjct: 121 LVTLHYAF-QTETK--LHL--ILDYINGGELFTHLSQ-----RERFTEHEVQIYVGEIVL 170
Query: 195 ALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY-IC-SRYYRA 252
AL ++H +GI +RDIK +N+L++ + H + L DFG +K V E +Y C + Y A
Sbjct: 171 ALEHLHK-LGIIYRDIKLENILLDSNGH-VVLTDFGLSKEFVADETERAYDFCGTIEYMA 228
Query: 253 PELIFGATE-YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 311
P+++ G + A+D WS G +M ELL G F + + EI I
Sbjct: 229 PDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEIS--------RRIL- 279
Query: 312 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLR-----CTALEACVHP 366
+E +PQ + A DL+ R P R A E H
Sbjct: 280 ----KSEPPYPQ------------EMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL 323
Query: 367 FFDELRDPN-TRLPNGRPLPPLFNFKPP 393
FF + N L + P FKP
Sbjct: 324 FF---QKINWDDLAAKKVPAP---FKPV 345
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 2e-36
Identities = 79/290 (27%), Positives = 128/290 (44%), Gaps = 42/290 (14%)
Query: 73 GRNGNSKQKV-SYIAEHVVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKRYKN--R 124
+ + + K+ YI +G G+FG V K TG VA+K K+ R
Sbjct: 6 KQKHDGRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRR 65
Query: 125 ELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPL 182
E+Q +++ HP+I+ L + +D ++ +V+EYV E + I + + R+
Sbjct: 66 EIQNLKLFRHPHIIKLYQVISTPSD---IF--MVMEYVSGGELFDYICK-----NGRLDE 115
Query: 183 IYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNV 242
+ QI + Y H + HRD+KP+N+L++ H K+ DFG + ++ GE +
Sbjct: 116 KESRRLFQQILSGVDYCH-RHMVVHRDLKPENVLLDAH-MNAKIADFGLSNMMSDGEF-L 172
Query: 243 SYIC-SRYYRAPELIFGATEYT-TAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV 300
C S Y APE+I G Y +DIWS+G ++ LL G F + V L + I
Sbjct: 173 RTSCGSPNYAAPEVISG-RLYAGPEVDIWSSGVILYALLCGTLPFDDDH-VPTLFKKICD 230
Query: 301 --------LGTPTREEIKCM---NPNYTEFKFPQIKPHPWHKVFQKRLPP 339
L +K M +P I+ H W F++ LP
Sbjct: 231 GIFYTPQYLNPSVISLLKHMLQVDPM-KRATIKDIREHEW---FKQDLPK 276
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 2e-36
Identities = 79/364 (21%), Positives = 136/364 (37%), Gaps = 84/364 (23%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK---NRELQIMQML-----DHP 135
Y +G G F V+ + + + VA+K V + Y E+++++ + + P
Sbjct: 39 YHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDP 98
Query: 136 N---IVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQI 192
N +V L F + ++ +V E + + + + +Q +PL VK Q+
Sbjct: 99 NREMVVQLLDDF-KISGVNGTHICMVFEVLGHHLLKWIIKSN--YQGLPLPCVKKIIQQV 155
Query: 193 CRALAYIHNCIGICHRDIKPQNLLV----------------------------------- 217
+ L Y+H I H DIKP+N+L+
Sbjct: 156 LQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPA 215
Query: 218 -------------NPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTT 264
N ++K+ D G+A + + I +R YR+ E++ G+ Y T
Sbjct: 216 TAGNFLVNPLEPKNAEKLKVKIADLGNACWV--HKHFTEDIQTRQYRSLEVLIGS-GYNT 272
Query: 265 AIDIWSTGCVMAELLLGQPLFPGESG------VDQLVEIIKVLGTPTREEI-------KC 311
DIWST C+ EL G LF SG D + II++LG R+ I +
Sbjct: 273 PADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEF 332
Query: 312 MNPNYTEFKFPQIKPHPWHKVFQKRLP------PEAVDLVCRFFQYSPNLRCTALEACVH 365
++KP +V ++ D + + P R TA E H
Sbjct: 333 FTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRH 392
Query: 366 PFFD 369
P+ +
Sbjct: 393 PWLN 396
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 6e-36
Identities = 79/322 (24%), Positives = 138/322 (42%), Gaps = 57/322 (17%)
Query: 89 VVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKR--YKNRELQIMQM-LDHPNIVAL 140
V+G GS+ V + ++T I A+K V D+ + E + + +HP +V L
Sbjct: 16 VIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 75
Query: 141 KHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
C F T + L+ V+EYV + + + R +++P + + Y+ +I AL Y
Sbjct: 76 HSC-FQTESR--LF--FVIEYVNGGDLMFHMQR-----QRKLPEEHARFYSAEISLALNY 125
Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYIC-SRYYRAPELIF 257
+H GI +RD+K N+L++ H +KL D+G K ++ S C + Y APE++
Sbjct: 126 LHE-RGIIYRDLKLDNVLLDSEGH-IKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILR 183
Query: 258 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 317
G +Y ++D W+ G +M E++ G+ F D + T + +
Sbjct: 184 G-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQ-------NTEDYL-------- 227
Query: 318 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLR------CTALEACVHPFFDEL 371
F I + L +A ++ F P R + HPFF
Sbjct: 228 ---FQVILEKQIR--IPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFF--- 279
Query: 372 RDPN-TRLPNGRPLPPLFNFKP 392
R+ + + + +PP FKP
Sbjct: 280 RNVDWDMMEQKQVVPP---FKP 298
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 6e-36
Identities = 69/308 (22%), Positives = 118/308 (38%), Gaps = 66/308 (21%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKRYKN-------RELQIMQM 131
Y +G+G+FG V+ A +E + V +K KVL+D ++ E+ I+
Sbjct: 26 YSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSR 85
Query: 132 LDHPNIVALKHCFFSTTDKEELYLNLVLEYVP---ETVNRIARNYSRIHQRMPLIYVKLY 188
++H NI+ + F ++ LV+E + I R H R+
Sbjct: 86 VEHANIIKVLDIF---ENQGFFQ--LVMEKHGSGLDLFAFIDR-----HPRLDEPLASYI 135
Query: 189 TYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYIC-S 247
Q+ A+ Y+ I HRDIK +N+++ +KL DFGSA L +G+ C +
Sbjct: 136 FRQLVSAVGYLRL-KDIIHRDIKDENIVIAED-FTIKLIDFGSAAYLERGKL-FYTFCGT 192
Query: 248 RYYRAPELIFGATEYT-TAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTR 306
Y APE++ G Y +++WS G + L+ + F +L E ++
Sbjct: 193 IEYCAPEVLMG-NPYRGPELEMWSLGVTLYTLVFEENPF------CELEETVE------- 238
Query: 307 EEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHP 366
P + E + LV Q P R T + P
Sbjct: 239 ----------AAIHPP-----YL-------VSKELMSLVSGLLQPVPERRTTLEKLVTDP 276
Query: 367 FFDELRDP 374
+ + +
Sbjct: 277 WVTQPVNL 284
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 1e-35
Identities = 83/372 (22%), Positives = 148/372 (39%), Gaps = 64/372 (17%)
Query: 44 DNDEDRDSEPDIIDGVGAETGHVIRTTIGGRNGNSKQKVSYIAEH-----VVGTGSFGVV 98
D D +G+ +G + + + V+G GS+ V
Sbjct: 11 DYDIPTTENLYFQGAMGSGIEEEKEAMNTRESGKASSSLG--LQDFDLLRVIGRGSYAKV 68
Query: 99 FQAKCRETGEIVAIK-----KVLQDKR--YKNRELQIMQM-LDHPNIVALKHCFFSTTDK 150
+ ++T I A++ V D+ + E + + +HP +V L C F T +
Sbjct: 69 LLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSC-FQTESR 127
Query: 151 EELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHR 208
L+ V+EYV + + + R +++P + + Y+ +I AL Y+H GI +R
Sbjct: 128 --LF--FVIEYVNGGDLMFHMQR-----QRKLPEEHARFYSAEISLALNYLHE-RGIIYR 177
Query: 209 DIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYIC-SRYYRAPELIFGATEYTTAID 267
D+K N+L++ H +KL D+G K ++ S C + Y APE++ G +Y ++D
Sbjct: 178 DLKLDNVLLDSEGH-IKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRG-EDYGFSVD 235
Query: 268 IWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPH 327
W+ G +M E++ G+ F D + T + + F I
Sbjct: 236 WWALGVLMFEMMAGRSPFDIVGSSDNPDQ-------NTEDYL-----------FQVILEK 277
Query: 328 PWHKVFQKRLPPEAVDLVCRFFQYSPNLR--CTALEAC----VHPFFDELRDPN-TRLPN 380
+ L +A ++ F P R C HPFF R+ + +
Sbjct: 278 QIR--IPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFF---RNVDWDMMEQ 332
Query: 381 GRPLPPLFNFKP 392
+ +PP FKP
Sbjct: 333 KQVVPP---FKP 341
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 2e-34
Identities = 50/224 (22%), Positives = 85/224 (37%), Gaps = 30/224 (13%)
Query: 87 EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-----------RELQIMQMLDHP 135
E +G G FG+V + + + +VAIK ++ RE+ IM L+HP
Sbjct: 24 EKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHP 83
Query: 136 NIVALKHCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICR 194
NIV L + +V+E+VP + + + + I
Sbjct: 84 NIVKLYGL---MHNP----PRMVMEFVPCGDLYHRLLDKAH---PIKWSVKLRLMLDIAL 133
Query: 195 ALAYIHNC-IGICHRDIKPQNLLVNPHTHQ----LKLCDFGSAKVLVKGEPNVSYICSRY 249
+ Y+ N I HRD++ N+ + K+ DFG ++ + +
Sbjct: 134 GIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ--QSVHSVSGLLGNFQ 191
Query: 250 YRAPELIFGATE-YTTAIDIWSTGCVMAELLLGQPLFPGESGVD 292
+ APE I E YT D +S ++ +L G+ F S
Sbjct: 192 WMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGK 235
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 2e-34
Identities = 63/220 (28%), Positives = 104/220 (47%), Gaps = 34/220 (15%)
Query: 87 EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN--------RELQIMQMLDHPNIV 138
E ++G G FG V++A G+ VA+K D +E ++ ML HPNI+
Sbjct: 12 EEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNII 69
Query: 139 ALK-HCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
AL+ C + L LV+E+ +NR+ +R+P + + QI R +
Sbjct: 70 ALRGVC----LKEPNLC--LVMEFARGGPLNRVLSG-----KRIPPDILVNWAVQIARGM 118
Query: 197 AYIHNC--IGICHRDIKPQNLLVN-------PHTHQLKLCDFGSAKVLVKGEPNVSYICS 247
Y+H+ + I HRD+K N+L+ LK+ DFG A+ + +S +
Sbjct: 119 NYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTT-KMSAAGA 177
Query: 248 RYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPG 287
+ APE+I + ++ D+WS G ++ ELL G+ F G
Sbjct: 178 YAWMAPEVIRASM-FSKGSDVWSYGVLLWELLTGEVPFRG 216
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 132 bits (332), Expect = 9e-34
Identities = 80/321 (24%), Positives = 128/321 (39%), Gaps = 65/321 (20%)
Query: 89 VVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDK--RYKNRELQIMQM-LDHPNIVAL 140
V+G GSFG V ++ + T E+ A+K V+QD E +++ + P + L
Sbjct: 348 VLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQL 407
Query: 141 KHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
C F T D+ LY V+EYV + + I + R + Y +I L +
Sbjct: 408 HSC-FQTMDR--LY--FVMEYVNGGDLMYHIQQ-----VGRFKEPHAVFYAAEIAIGLFF 457
Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYIC-SRYYRAPELIF 257
+ + GI +RD+K N++++ H +K+ DFG K + C + Y APE+I
Sbjct: 458 LQS-KGIIYRDLKLDNVMLDSEGH-IKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIA 515
Query: 258 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 317
Y ++D W+ G ++ E+L GQ F GE D+L + I
Sbjct: 516 Y-QPYGKSVDWWAFGVLLYEMLAGQAPFEGED-EDELFQSIM----------------EH 557
Query: 318 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLR-----CTALEACVHPFFDELR 372
+P K + EAV + P R + H FF R
Sbjct: 558 NVAYP------------KSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFF---R 602
Query: 373 DPN-TRLPNGRPLPPLFNFKP 392
+ +L PP +KP
Sbjct: 603 YIDWEKLERKEIQPP---YKP 620
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 3e-33
Identities = 73/311 (23%), Positives = 120/311 (38%), Gaps = 46/311 (14%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-----RELQIMQMLDHPNIV 138
Y + V+G+G+ VV A C E VAIK++ +K + +E+Q M HPNIV
Sbjct: 17 YELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIV 76
Query: 139 ALKHCFFSTTDKEELYLNLVLEY-----VPETVNRIARNYSRIHQRMPLIYVKLYTYQIC 193
+ F K+EL+ LV++ V + + I + + ++
Sbjct: 77 SYYTSFV---VKDELW--LVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVL 131
Query: 194 RALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPNVSYICSR---- 248
L Y+H G HRD+K N+L+ +++ DFG SA + G+ + R
Sbjct: 132 EGLEYLHK-NGQIHRDVKAGNILLG-EDGSVQIADFGVSAFLATGGDITRNK--VRKTFV 187
Query: 249 ---YYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPT 305
+ APE++ Y DIWS G EL G + + L+ ++
Sbjct: 188 GTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQ------ 241
Query: 306 REEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH 365
N P ++ K K+ ++ Q P R TA E H
Sbjct: 242 -------ND------PPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRH 288
Query: 366 PFFDELRDPNT 376
FF + ++
Sbjct: 289 KFFQKAKNKEF 299
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 126 bits (317), Expect = 7e-33
Identities = 57/336 (16%), Positives = 114/336 (33%), Gaps = 47/336 (13%)
Query: 91 GTGSFGVVFQAKCRETGEIVAIKKV----LQDKRYKN--RELQIMQMLDHPNIVALKHCF 144
G V A+ + TGE V ++++ ++ EL + ++ +HPNIV + F
Sbjct: 36 GFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATF 95
Query: 145 FSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203
+ + L +V ++ + + + M + + + +AL YIH+ +
Sbjct: 96 IADNE-----LWVVTSFMAYGSAKDLICTH--FMDGMNELAIAYILQGVLKALDYIHH-M 147
Query: 204 GICHRDIKPQNLLVNPHTHQLKLCDFGSA--------KVLVKGEPNVSYICSRYYRAPEL 255
G HR +K ++L++ ++ L S + V + + + +PE+
Sbjct: 148 GYVHRSVKASHILIS-VDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEV 206
Query: 256 IF-GATEYTTAIDIWSTGCVMAELLLGQP----------LF-------PGESGVDQLVEI 297
+ Y DI+S G EL G L P +
Sbjct: 207 LQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIPAE 266
Query: 298 IKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC 357
+ ++ + T + + P V + Q +P+ R
Sbjct: 267 ELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARP 326
Query: 358 TALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKPP 393
+A H FF +++ + LP L P
Sbjct: 327 SASTLLNHSFFKQIKRRASEA-----LPELLRPVTP 357
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 7e-33
Identities = 55/211 (26%), Positives = 97/211 (45%), Gaps = 21/211 (9%)
Query: 87 EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVAL 140
+ +G GSFG V +A+ G VA+K +++ + RE+ IM+ L HPNIV
Sbjct: 42 KEKIGAGSFGTVHRAEWH--GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLF 99
Query: 141 K-HCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
T L +V EY+ ++ R+ S +++ Y + + + Y
Sbjct: 100 MGAV----TQPPNLS--IVTEYLSRGSLYRLLHK-SGAREQLDERRRLSMAYDVAKGMNY 152
Query: 199 IHNC-IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNV-SYICSRYYRAPELI 256
+HN I HR++K NLLV+ + +K+CDFG +++ + S + + APE++
Sbjct: 153 LHNRNPPIVHRNLKSPNLLVDKK-YTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVL 211
Query: 257 FGATEYTTAIDIWSTGCVMAELLLGQPLFPG 287
D++S G ++ EL Q +
Sbjct: 212 RD-EPSNEKSDVYSFGVILWELATLQQPWGN 241
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 9e-33
Identities = 60/259 (23%), Positives = 103/259 (39%), Gaps = 44/259 (16%)
Query: 49 RDSEPDIIDGVGAETGH--------VIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQ 100
+G G + G+ Y + + G G ++
Sbjct: 48 DSETKGASEGWCPYCGSPYSFLPQLNPGDIVAGQ---------YEVKGCIAHGGLGWIYL 98
Query: 101 AKCRE-TGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE 152
A R G V +K L E Q + + HP+IV + F TD+
Sbjct: 99 ALDRNVNGRPVVLK-GLVHSGDAEAQAMAM-AERQFLAEVVHPSIVQI-FNFVEHTDRHG 155
Query: 153 LYLN-LVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDI 210
+ +V+EYV +++ R Q++P+ Y +I AL+Y+H+ IG+ + D+
Sbjct: 156 DPVGYIVMEYVGGQSLKRS------KGQKLPVAEAIAYLLEILPALSYLHS-IGLVYNDL 208
Query: 211 KPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWS 270
KP+N+++ QLKL D G+ + Y + ++APE++ T A DI++
Sbjct: 209 KPENIMLTEE--QLKLIDLGAVSRI--NSFGYLYG-TPGFQAPEIVRTGP--TVATDIYT 261
Query: 271 TGCVMAELLLGQPLFPGES 289
G +A L L P G
Sbjct: 262 VGRTLAALTLDLPTRNGRY 280
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 4e-32
Identities = 72/303 (23%), Positives = 125/303 (41%), Gaps = 51/303 (16%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-------RELQIMQMLDHPN 136
+ +G GSFG V+ A+ E+VAIKK+ + N +E++ +Q L HPN
Sbjct: 56 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115
Query: 137 IVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
+ + C+ LV+EY + + + + + + + + T+ + L
Sbjct: 116 TIQYRGCYLREHT-----AWLVMEYCLGSASDLLEVHKK---PLQEVEIAAVTHGALQGL 167
Query: 197 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELI 256
AY+H+ + HRD+K N+L++ +KL DFGSA ++ S++ + Y+ APE+I
Sbjct: 168 AYLHS-HNMIHRDVKAGNILLS-EPGLVKLGDFGSASIMAPAN---SFVGTPYWMAPEVI 222
Query: 257 FGATE--YTTAIDIWSTGCVMA-ELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 313
E Y +D+WS G + EL +P + + L I +
Sbjct: 223 LAMDEGQYDGKVDVWSLG-ITCIELAERKPPLFNMNAMSALYHIAQ------------NE 269
Query: 314 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD 373
P ++ W + F+ + V Q P R T+ H F R
Sbjct: 270 S-------PALQSGHWSEYFR--------NFVDSCLQKIPQDRPTSEVLLKHRFVLRERP 314
Query: 374 PNT 376
P
Sbjct: 315 PTV 317
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 1e-31
Identities = 53/221 (23%), Positives = 100/221 (45%), Gaps = 31/221 (14%)
Query: 87 EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQ--DKRYKN--RELQIMQMLDHPNIVALKH 142
V+G G FG + RETGE++ +K++++ ++ + +E+++M+ L+HPN++
Sbjct: 15 GEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKF-- 72
Query: 143 CFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
+ L + EY+ T+ I ++ + P + I +AY+H+
Sbjct: 73 -IGVLYKDKRLN--FITEYIKGGTLRGIIKSMDS---QYPWSQRVSFAKDIASGMAYLHS 126
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR------------- 248
I HRD+ N LV + + DFG A+++V + + S
Sbjct: 127 M-NIIHRDLNSHNCLVR-ENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVG 184
Query: 249 --YYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPG 287
Y+ APE+I G Y +D++S G V+ E++ P
Sbjct: 185 NPYWMAPEMING-RSYDEKVDVFSFGIVLCEIIGRVNADPD 224
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 4e-31
Identities = 70/241 (29%), Positives = 108/241 (44%), Gaps = 39/241 (16%)
Query: 65 HVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------ 118
H+I I R Y +G G V+ A+ VAIK +
Sbjct: 3 HMIGKIINER---------YKIVDKLGGGGMSTVYLAEDTILNIKVAIK-AIFIPPREKE 52
Query: 119 ---KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVP-ETVNRIARNYS 174
KR++ RE+ L H NIV++ + + YL V+EY+ T+ Y
Sbjct: 53 ETLKRFE-REVHNSSQLSHQNIVSM---IDVDEEDDCYYL--VMEYIEGPTL----SEYI 102
Query: 175 RIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV 234
H + + +T QI + + H+ + I HRDIKPQN+L++ LK+ DFG AK
Sbjct: 103 ESHGPLSVDTAINFTNQILDGIKHAHD-MRIVHRDIKPQNILIDS-NKTLKIFDFGIAKA 160
Query: 235 LVKGEPNVSY----ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESG 290
L E +++ + + Y +PE G DI+S G V+ E+L+G+P F GE+
Sbjct: 161 L--SETSLTQTNHVLGTVQYFSPEQAKGEAT-DECTDIYSIGIVLYEMLVGEPPFNGETA 217
Query: 291 V 291
V
Sbjct: 218 V 218
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 4e-31
Identities = 65/241 (26%), Positives = 103/241 (42%), Gaps = 37/241 (15%)
Query: 67 IRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVL-----QDKRY 121
+ + R Y ++G G V A+ VA+K VL +D +
Sbjct: 6 TPSHLSDR---------YELGEILGFGGMSEVHLARDLRDHRDVAVK-VLRADLARDPSF 55
Query: 122 KNR---ELQIMQMLDHPNIVALKHCFF---STTDKEELYLNLVLEYVP-ETVNRIARNYS 174
R E Q L+HP IVA+ + +V+EYV T+ R+
Sbjct: 56 YLRFRREAQNAAALNHPAIVAV----YDTGEAETPAGPLPYIVMEYVDGVTL----RDIV 107
Query: 175 RIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV 234
M C+AL + H GI HRD+KP N++++ T+ +K+ DFG A+
Sbjct: 108 HTEGPMTPKRAIEVIADACQALNFSHQ-NGIIHRDVKPANIMISA-TNAVKVMDFGIARA 165
Query: 235 LVKGEPNVSY----ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESG 290
+ +V+ I + Y +PE G + D++S GCV+ E+L G+P F G+S
Sbjct: 166 IADSGNSVTQTAAVIGTAQYLSPEQARGDSV-DARSDVYSLGCVLYEVLTGEPPFTGDSP 224
Query: 291 V 291
V
Sbjct: 225 V 225
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 5e-31
Identities = 65/302 (21%), Positives = 116/302 (38%), Gaps = 48/302 (15%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-----RELQIMQMLDHPNIV 138
+ +G GSFG VF+ T ++VAIK + ++ +E+ ++ D P +
Sbjct: 24 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83
Query: 139 ALKHCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALA 197
+ T L +++EY+ + + + + +I + L
Sbjct: 84 KYYGSYLKDTK-----LWIIMEYLGGGSALDLLEP-----GPLDETQIATILREILKGLD 133
Query: 198 YIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPNVSYICSRYYRAPELI 256
Y+H+ HRDIK N+L++ ++KL DFG + ++ +++ + ++ APE+I
Sbjct: 134 YLHS-EKKIHRDIKAANVLLS-EHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVI 191
Query: 257 FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 316
+ Y + DIWS G EL G+P P E ++P
Sbjct: 192 KQS-AYDSKADIWSLGITAIELARGEP--------------------PHSE----LHPMK 226
Query: 317 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNT 376
F P+ P P + + V P+ R TA E H F +
Sbjct: 227 VLFLIPKNNP-P---TLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILRNAKKTS 282
Query: 377 RL 378
L
Sbjct: 283 YL 284
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 6e-31
Identities = 68/292 (23%), Positives = 119/292 (40%), Gaps = 47/292 (16%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVL----QDKRYKNRELQIMQMLDHPNIVA 139
Y +G G+ G V+ A TG+ VAI+++ K E+ +M+ +PNIV
Sbjct: 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81
Query: 140 LKHCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
+ + L +V+EY+ ++ + M + + +AL +
Sbjct: 82 YLDSYLVGDE-----LWVVMEYLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEF 131
Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-VSYICSRYYRAPELIF 257
+H+ + HRDIK N+L+ +KL DFG + + + + + Y+ APE++
Sbjct: 132 LHS-NQVIHRDIKSDNILLG-MDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVT 189
Query: 258 GATEYTTAIDIWSTGCVMA-ELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 316
Y +DIWS G +MA E++ G+P + E+ + L I GTP +
Sbjct: 190 R-KAYGPKVDIWSLG-IMAIEMIEGEPPYLNENPLRALYLIATN-GTPELQN-------- 238
Query: 317 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368
P +F+ D + R + R +A E H F
Sbjct: 239 ---------PEKLSAIFR--------DFLNRCLEMDVEKRGSAKELLQHQFL 273
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 6e-31
Identities = 47/216 (21%), Positives = 85/216 (39%), Gaps = 34/216 (15%)
Query: 87 EHVVGTGSFGVVFQAKCRETGEIVAIKKVL-QDKRYKNRELQIMQM--LDHPNIVA-LKH 142
+G G +G V+ K R GE VA+K ++ RE +I Q + H NI+ +
Sbjct: 42 VKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTEEASWFRETEIYQTVLMRHENILGFIAA 99
Query: 143 CFFSTTDKEELYLNLVLEYVPE-TVNRIARNYS-RIHQRMPLIYVKLYTYQICRALAYIH 200
T +LYL + +Y ++ ++ + + L Y L ++H
Sbjct: 100 DIKGTGSWTQLYL--ITDYHENGSLYDYLKSTTLDAKSMLKLAY------SSVSGLCHLH 151
Query: 201 NCI-------GICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICS-----R 248
I I HRD+K +N+LV + + D G A + V + +
Sbjct: 152 TEIFSTQGKPAIAHRDLKSKNILVKKN-GTCCIADLGLAVKFISDTNEVDIPPNTRVGTK 210
Query: 249 YYRAPELIFGAT-----EYTTAIDIWSTGCVMAELL 279
Y PE++ + + D++S G ++ E+
Sbjct: 211 RYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVA 246
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 1e-30
Identities = 47/216 (21%), Positives = 88/216 (40%), Gaps = 34/216 (15%)
Query: 87 EHVVGTGSFGVVFQAKCRETGEIVAIKKVL-QDKRYKNRELQIMQM--LDHPNIVA-LKH 142
VG G +G V++ + GE VA+K +D++ RE ++ L H NI+ +
Sbjct: 13 LECVGKGRYGEVWRGSWQ--GENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIAS 70
Query: 143 CFFSTTDKEELYLNLVLEYVPE-TVNRIARNYS-RIHQRMPLIYVKLYTYQICRALAYIH 200
S +L+L + Y ++ + + + ++ I LA++H
Sbjct: 71 DMTSRHSSTQLWL--ITHYHEMGSLYDYLQLTTLDTVSCLRIVL------SIASGLAHLH 122
Query: 201 NCI-------GICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICS-----R 248
I I HRD+K +N+LV + + D G A + + + + +
Sbjct: 123 IEIFGTQGKPAIAHRDLKSKNILVKKNGQ-CCIADLGLAVMHSQSTNQLDVGNNPRVGTK 181
Query: 249 YYRAPELI-----FGATEYTTAIDIWSTGCVMAELL 279
Y APE++ + +DIW+ G V+ E+
Sbjct: 182 RYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVA 217
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 1e-30
Identities = 48/224 (21%), Positives = 95/224 (42%), Gaps = 26/224 (11%)
Query: 87 EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVAL 140
+G+GSFG V++ K VA+K + E+ +++ H NI+
Sbjct: 29 GQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILL- 84
Query: 141 KHCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 199
F + +L + V ++ ++ + + + Q R + Y+
Sbjct: 85 ---FMGYSTAPQLAI--VTQWCEGSSLYHHLHASET---KFEMKKLIDIARQTARGMDYL 136
Query: 200 HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSRYYRAPELI 256
H I HRD+K N+ ++ + +K+ DFG A + + + S + APE+I
Sbjct: 137 HAK-SIIHRDLKSNNIFLHED-NTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVI 194
Query: 257 FGATE--YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEII 298
Y+ D+++ G V+ EL+ GQ + + DQ++E++
Sbjct: 195 RMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMV 238
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 1e-30
Identities = 24/211 (11%), Positives = 71/211 (33%), Gaps = 22/211 (10%)
Query: 87 EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVAL 140
+ G +++ + + G + +K + R N E +++ HPN++ +
Sbjct: 15 LTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPV 72
Query: 141 KHCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 199
+ L+ ++P ++ + + + + + R +A++
Sbjct: 73 LGA---CQSPPAPHPTLITHWMPYGSLYNVLHEGTNF--VVDQSQAVKFALDMARGMAFL 127
Query: 200 HNC-IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFG 258
H I + ++++++ ++ + + APE +
Sbjct: 128 HTLEPLIPRHALNSRSVMIDED-MTARISMADVKFSFQSPGRMYAPA----WVAPEALQK 182
Query: 259 --ATEYTTAIDIWSTGCVMAELLLGQPLFPG 287
+ D+WS ++ EL+ + F
Sbjct: 183 KPEDTNRRSADMWSFAVLLWELVTREVPFAD 213
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 2e-30
Identities = 78/298 (26%), Positives = 125/298 (41%), Gaps = 43/298 (14%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN--RELQIMQMLDHPNIVALK 141
+ +G GS+G V++A +ETG+IVAIK+V + + +E+ IMQ D P++V
Sbjct: 31 FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIMQQCDSPHVVKYY 90
Query: 142 HCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 200
+F TD L +V+EY +V+ I ++ + + + L Y+H
Sbjct: 91 GSYFKNTD-----LWIVMEYCGAGSVSDI---IRLRNKTLTEDEIATILQSTLKGLEYLH 142
Query: 201 NCIGICHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPNVSYICSRYYRAPELIFGA 259
+ HRDIK N+L+N KL DFG + ++ + I + ++ APE+I
Sbjct: 143 F-MRKIHRDIKAGNILLN-TEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEI 200
Query: 260 TEYTTAIDIWSTGCVMA-ELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 318
Y DIWS G + A E+ G+P + + + I PT +
Sbjct: 201 -GYNCVADIWSLG-ITAIEMAEGKPPYADIHPMRAIFMIPTN-PPPTFRK---------- 247
Query: 319 FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNT 376
P W F D V + SP R TA + HPF + +
Sbjct: 248 -------PELWSDNFT--------DFVKQCLVKSPEQRATATQLLQHPFVRSAKGVSI 290
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 3e-30
Identities = 73/286 (25%), Positives = 123/286 (43%), Gaps = 47/286 (16%)
Query: 90 VGTGSFGVVFQAKCRETGEIVAIKKVL----QDKRYKNRELQIMQMLDHPNIVALKHCFF 145
+G GS G+V A+ + +G VA+K + Q + E+ IM+ H N+V + +
Sbjct: 53 IGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYL 112
Query: 146 STTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG 204
EEL++ ++E++ + I R+ + + +ALAY+H G
Sbjct: 113 V---GEELWV--LMEFLQGGALTDIVS-----QVRLNEEQIATVCEAVLQALAYLHA-QG 161
Query: 205 ICHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPNVSYICSRYYRAPELIFGATEYT 263
+ HRDIK ++L+ ++KL DFG A++ S + + Y+ APE+I + Y
Sbjct: 162 VIHRDIKSDSILLT-LDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISR-SLYA 219
Query: 264 TAIDIWSTGCVMA-ELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 322
T +DIWS G +M E++ G+P + +S V + + P +
Sbjct: 220 TEVDIWSLG-IMVIEMVDGEPPYFSDSPVQAMKRLRDS-PPPKLKN-------------- 263
Query: 323 QIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368
H V + D + R P R TA E HPF
Sbjct: 264 ---SHKVSPVLR--------DFLERMLVRDPQERATAQELLDHPFL 298
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 4e-30
Identities = 73/307 (23%), Positives = 126/307 (41%), Gaps = 54/307 (17%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVL----QDKRYKNRELQIMQMLDHPNIVA 139
+ +G G+FG V++AK +ETG + A K + ++ E++I+ DHP IV
Sbjct: 21 WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVK 80
Query: 140 LKHCFFSTTDKEELYLNLVLEY-----VPETVNRIARNYSRIHQRMPLIYVKLYTYQICR 194
L ++ L +++E+ V + + R + +++ Q+
Sbjct: 81 LLGAYYHDGK-----LWIMIEFCPGGAVDAIMLELDR-------GLTEPQIQVVCRQMLE 128
Query: 195 ALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPNVSYICSRYYRAP 253
AL ++H+ I HRD+K N+L+ ++L DFG SAK L + S+I + Y+ AP
Sbjct: 129 ALNFLHSK-RIIHRDLKAGNVLMT-LEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAP 186
Query: 254 ELIFGAT----EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI 309
E++ T Y DIWS G + E+ +P + + L++I K PT
Sbjct: 187 EVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKS-DPPTLLT- 244
Query: 310 KCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFD 369
P W F+ D + +P R +A + HPF
Sbjct: 245 ----------------PSKWSVEFR--------DFLKIALDKNPETRPSAAQLLEHPFVS 280
Query: 370 ELRDPNT 376
+
Sbjct: 281 SITSNKA 287
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 1e-29
Identities = 68/307 (22%), Positives = 123/307 (40%), Gaps = 42/307 (13%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKNRELQIMQML-DHPNIVA 139
+ +VG G++G V++ + +TG++ AIK + ++ +E+ +++ H NI
Sbjct: 26 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIAT 85
Query: 140 LKHCFF-STTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALA 197
F + L LV+E+ +V + +N + ++ +I R L+
Sbjct: 86 YYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKG--NTLKEEWIAYICREILRGLS 143
Query: 198 YIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPNVSYICSRYYRAPELI 256
++H + HRDIK QN+L+ ++KL DFG SA++ ++I + Y+ APE+I
Sbjct: 144 HLHQ-HKVIHRDIKGQNVLLT-ENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVI 201
Query: 257 ----FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 312
Y D+WS G E+ G P + L I +
Sbjct: 202 ACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPR------------- 248
Query: 313 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR 372
NP P++K W K FQ + + + R + HPF +
Sbjct: 249 NP------APRLKSKKWSKKFQ--------SFIESCLVKNHSQRPATEQLMKHPFIRDQP 294
Query: 373 DPNTRLP 379
+
Sbjct: 295 NERQVRI 301
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 1e-29
Identities = 56/259 (21%), Positives = 91/259 (35%), Gaps = 38/259 (14%)
Query: 44 DNDEDRDSEPDIIDGVGAETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKC 103
+ + T G Y +VG G G V++A+
Sbjct: 6 HHHHHSSGLVPRGSHMDGTAESREGTQFGP----------YRLRRLVGRGGMGDVYEAED 55
Query: 104 RETGEIVAIKKVL-----QDKRYK---NRELQIMQMLDHPNIVALKHCFFSTTDKEELYL 155
IVA+K ++ D ++ RE + L P++V + +LY+
Sbjct: 56 TVRERIVALK-LMSETLSSDPVFRTRMQREARTAGRLQEPHVVPI---HDFGEIDGQLYV 111
Query: 156 NLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQN 214
+ + R + QI AL H G HRD+KP+N
Sbjct: 112 --DMRLINGVD----LAAMLRRQGPLAPPRAVAIVRQIGSALDAAHA-AGATHRDVKPEN 164
Query: 215 LLVNPHTHQLKLCDFGSAKVLVKGEPNV----SYICSRYYRAPELIFGATEYTTAIDIWS 270
+LV+ L DFG A + + + + + YY APE + T DI++
Sbjct: 165 ILVSA-DDFAYLVDFGIASAT--TDEKLTQLGNTVGTLYYMAPERFSES-HATYRADIYA 220
Query: 271 TGCVMAELLLGQPLFPGES 289
CV+ E L G P + G+
Sbjct: 221 LTCVLYECLTGSPPYQGDQ 239
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 7e-29
Identities = 39/223 (17%), Positives = 83/223 (37%), Gaps = 37/223 (16%)
Query: 87 EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVAL 140
++G G FG V+ + VAI+ + ++ ++ RE+ + H N+V
Sbjct: 38 GELIGKGRFGQVYHGRWHGE---VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLF 94
Query: 141 K-HCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
C L ++ T+ + R+ + + + +I + + Y
Sbjct: 95 MGAC----MSPPHLA--IITSLCKGRTLYSVVRD---AKIVLDVNKTRQIAQEIVKGMGY 145
Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR------YYRA 252
+H GI H+D+K +N+ + + + DFG + + R + A
Sbjct: 146 LHAK-GILHKDLKSKNVFYDNGK--VVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLA 202
Query: 253 PELIFGATE--------YTTAIDIWSTGCVMAELLLGQPLFPG 287
PE+I + ++ D+++ G + EL + F
Sbjct: 203 PEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKT 245
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 9e-29
Identities = 54/215 (25%), Positives = 89/215 (41%), Gaps = 32/215 (14%)
Query: 87 EHVVGTGSFGVVFQAKCRETGEIVAIKKVL-QDKRYKNRELQIMQM--LDHPNIVA-LKH 142
+ +G G FG V++ K R GE VA+K +++R RE +I Q L H NI+ +
Sbjct: 47 QESIGKGRFGEVWRGKWR--GEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAA 104
Query: 143 CFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
+L+L V +Y ++ Y+ + M +KL LA++H
Sbjct: 105 DNKDNGTWTQLWL--VSDYHEHGSLFDYLNRYTVTVEGM----IKL-ALSTASGLAHLHM 157
Query: 202 CI-------GICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICS-----RY 249
I I HRD+K +N+LV + + D G A + + +
Sbjct: 158 EIVGTQGKPAIAHRDLKSKNILVKKNGT-CCIADLGLAVRHDSATDTIDIAPNHRVGTKR 216
Query: 250 YRAPELIFGAT-----EYTTAIDIWSTGCVMAELL 279
Y APE++ + E DI++ G V E+
Sbjct: 217 YMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA 251
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 1e-28
Identities = 56/247 (22%), Positives = 98/247 (39%), Gaps = 35/247 (14%)
Query: 87 EHVVGTGSFGVVFQAKCRETGEIVAIKKVL-QDKRYKNRELQIMQM--LDHPNIVA-LKH 142
V G FG V++A+ E VA+K QDK+ E ++ + + H NI+ +
Sbjct: 29 LEVKARGRFGCVWKAQLL--NEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIGA 86
Query: 143 CFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
T+ +L+L + + ++ + + + + R LAY+H
Sbjct: 87 EKRGTSVDVDLWL--ITAFHE---KGSLSDFLKANVVSWNELCHIA-ETMARGLAYLHED 140
Query: 203 I---------GICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---- 249
I I HRDIK +N+L+ + + DFG A E S +
Sbjct: 141 IPGLKDGHKPAISHRDIKSKNVLLKNN-LTACIADFGLALKF---EAGKSAGDTHGQVGT 196
Query: 250 --YRAPELIFGA----TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGT 303
Y APE++ GA + ID+++ G V+ EL G L ++
Sbjct: 197 RRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQH 256
Query: 304 PTREEIK 310
P+ E+++
Sbjct: 257 PSLEDMQ 263
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 113 bits (283), Expect = 2e-28
Identities = 56/254 (22%), Positives = 98/254 (38%), Gaps = 39/254 (15%)
Query: 87 EHVVGTGSFGVVFQAKCRETGEIVAIKKV-LQDKRYKNRELQIMQM--LDHPNIVALKHC 143
++G G +G V++ VA+K +++ E I ++ ++H NI
Sbjct: 18 LELIGRGRYGAVYKGSLD--ERPVAVKVFSFANRQNFINEKNIYRVPLMEHDNIARFIVG 75
Query: 144 FFSTTDKEELYLNLVLEYVPET--VNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
T + LV+EY P ++ + S L + + R LAY+H
Sbjct: 76 DERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSDWVSSCRLAH------SVTRGLAYLHT 129
Query: 202 CI--------GICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---- 249
+ I HRD+ +N+LV + DFG + L
Sbjct: 130 ELPRGDHYKPAISHRDLNSRNVLVKNDGT-CVISDFGLSMRLTGNRLVRPGEEDNAAISE 188
Query: 250 -----YRAPELIFGA------TEYTTAIDIWSTGCVMAELLLG-QPLFPGESGVD-QLVE 296
Y APE++ GA +D+++ G + E+ + LFPGES + Q+
Sbjct: 189 VGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAF 248
Query: 297 IIKVLGTPTREEIK 310
+V PT E+++
Sbjct: 249 QTEVGNHPTFEDMQ 262
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 6e-26
Identities = 56/238 (23%), Positives = 97/238 (40%), Gaps = 52/238 (21%)
Query: 87 EHVVGTGSFGVVFQAKCRETGE----IVAIKKVLQDKRYKN-----RELQIMQMLDHPNI 137
V+G+G+FG V++ GE VAIK++ + K E +M +D+P++
Sbjct: 20 IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 79
Query: 138 VALKH-CFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQ-RMPLIYVKLYTYQICRA 195
L C + L+ + +P +Y R H+ + Y+ + QI +
Sbjct: 80 CRLLGICL-----TSTVQ--LITQLMP---FGCLLDYVREHKDNIGSQYLLNWCVQIAKG 129
Query: 196 LAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR-- 251
+ Y+ + HRD+ +N+LV +K+ DFG AK+L E Y
Sbjct: 130 MNYLEDRRLV---HRDLAARNVLVK-TPQHVKITDFGLAKLLGAEEK--------EYHAE 177
Query: 252 ---------APE-LIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVD--QLVE 296
A E ++ YT D+WS G + EL+ G + G + ++E
Sbjct: 178 GGKVPIKWMALESILHR--IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE 233
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 9e-26
Identities = 64/218 (29%), Positives = 106/218 (48%), Gaps = 46/218 (21%)
Query: 87 EHVVGTGSFGVVFQAKCR----ETGEIVAIKKVLQDKRYKN-----RELQIMQMLDHPNI 137
+G G+FG V + TGE+VA+KK LQ ++ RE++I++ L H NI
Sbjct: 15 LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKK-LQHSTEEHLRDFEREIEILKSLQHDNI 73
Query: 138 VALKHCFFSTTDKEE-LYLNLVLEYVPETVNRIARNYSRIHQ-RMPLIYVKLYTYQICRA 195
V K + L L++EY+P R+Y + H+ R+ I + YT QIC+
Sbjct: 74 VKYKGV--CYSAGRRNLK--LIMEYLP---YGSLRDYLQKHKERIDHIKLLQYTSQICKG 126
Query: 196 LAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR-- 251
+ Y+ I HRD+ +N+LV +++K+ DFG KVL + + +++
Sbjct: 127 MEYLGTKRYI---HRDLATRNILVENE-NRVKIGDFGLTKVLPQDKE--------FFKVK 174
Query: 252 ----------APELIFGATEYTTAIDIWSTGCVMAELL 279
APE + ++++ A D+WS G V+ EL
Sbjct: 175 EPGESPIFWYAPESLT-ESKFSVASDVWSFGVVLYELF 211
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 2e-25
Identities = 63/217 (29%), Positives = 106/217 (48%), Gaps = 44/217 (20%)
Query: 87 EHVVGTGSFGVVFQAKCR----ETGEIVAIK--KVLQDKRYKN--RELQIMQMLDHPNIV 138
+G G+FG V + TGE+VA+K + ++ ++ RE++I++ L H NIV
Sbjct: 46 LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIV 105
Query: 139 ALKHCFFSTTDKEE-LYLNLVLEYVPETVNRIARNYSRIHQ-RMPLIYVKLYTYQICRAL 196
K + L L++EY+P R+Y + H+ R+ I + YT QIC+ +
Sbjct: 106 KYKGV--CYSAGRRNLK--LIMEYLP---YGSLRDYLQKHKERIDHIKLLQYTSQICKGM 158
Query: 197 AYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR--- 251
Y+ I HRD+ +N+LV +++K+ DFG KVL + + YY+
Sbjct: 159 EYLGTKRYI---HRDLATRNILVENE-NRVKIGDFGLTKVLPQDK--------EYYKVKE 206
Query: 252 ---------APELIFGATEYTTAIDIWSTGCVMAELL 279
APE + ++++ A D+WS G V+ EL
Sbjct: 207 PGESPIFWYAPESLT-ESKFSVASDVWSFGVVLYELF 242
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 1e-24
Identities = 67/235 (28%), Positives = 104/235 (44%), Gaps = 44/235 (18%)
Query: 87 EHVVGTGSFGVVFQAKCR----ETGEIVAIKKVLQDKRYKN-----RELQIMQMLDHPNI 137
+G G FG V TGE+VA+K + D ++ +E+ I++ L H +I
Sbjct: 36 IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHI 95
Query: 138 VALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALA 197
+ K C D L LV+EYVP R+Y H + L + L+ QIC +A
Sbjct: 96 IKYKGC---CEDAGAASLQLVMEYVP---LGSLRDYLPRH-SIGLAQLLLFAQQICEGMA 148
Query: 198 YIH--NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR---- 251
Y+H + I HRD+ +N+L++ + +K+ DFG AK + +G YYR
Sbjct: 149 YLHAQHYI---HRDLAARNVLLD-NDRLVKIGDFGLAKAVPEGH--------EYYRVRED 196
Query: 252 --------APELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQLVEI 297
APE + + A D+WS G + ELL + +L+ I
Sbjct: 197 GDSPVFWYAPECLKEYK-FYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGI 250
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 1e-24
Identities = 61/218 (27%), Positives = 97/218 (44%), Gaps = 46/218 (21%)
Query: 87 EHVVGTGSFGVVFQAKCR----ETGEIVAIKKVLQDKRYKN-----RELQIMQMLDHPNI 137
+G G+FG V + TG +VA+K LQ RE+QI++ L I
Sbjct: 28 ISQLGKGNFGSVELCRYDPLGDNTGALVAVK-QLQHSGPDQQRDFQREIQILKALHSDFI 86
Query: 138 VALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQ-RMPLIYVKLYTYQICRAL 196
V + ++ L LV+EY+P + R++ + H+ R+ + LY+ QIC+ +
Sbjct: 87 VKYRGV-SYGPGRQSLR--LVMEYLP---SGCLRDFLQRHRARLDASRLLLYSSQICKGM 140
Query: 197 AYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR--- 251
Y+ C+ HRD+ +N+LV +K+ DFG AK+L + YY
Sbjct: 141 EYLGSRRCV---HRDLAARNILVE-SEAHVKIADFGLAKLLPLDK--------DYYVVRE 188
Query: 252 ---------APE-LIFGATEYTTAIDIWSTGCVMAELL 279
APE L ++ D+WS G V+ EL
Sbjct: 189 PGQSPIFWYAPESLSDN--IFSRQSDVWSFGVVLYELF 224
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 3e-24
Identities = 56/217 (25%), Positives = 94/217 (43%), Gaps = 43/217 (19%)
Query: 87 EHVVGTGSFGVVFQAKCR----ETGEIVAIKKVLQDKRYKN-----RELQIMQMLDHPNI 137
+G G FG V + TGE VA+K + + + +E++I++ L H NI
Sbjct: 26 IRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENI 85
Query: 138 VALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIH-QRMPLIYVKLYTYQICRAL 196
V K T+ + L++E++P + + Y + ++ L Y QIC+ +
Sbjct: 86 VKYKGI---CTEDGGNGIKLIMEFLP---SGSLKEYLPKNKNKINLKQQLKYAVQICKGM 139
Query: 197 AYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR--- 251
Y+ + HRD+ +N+LV HQ+K+ DFG K + + YY
Sbjct: 140 DYLGSRQYV---HRDLAARNVLVE-SEHQVKIGDFGLTKAIETDK--------EYYTVKD 187
Query: 252 ---------APELIFGATEYTTAIDIWSTGCVMAELL 279
APE + + + A D+WS G + ELL
Sbjct: 188 DRDSPVFWYAPECLMQSK-FYIASDVWSFGVTLHELL 223
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 3e-24
Identities = 55/238 (23%), Positives = 100/238 (42%), Gaps = 49/238 (20%)
Query: 85 IAEHVVGTGSFGVVFQAKCRETGEI--VAIKKV---LQDKRYKN---RELQIMQMLDHPN 136
+ + +G+G+FG V + + + VA+K + D K+ E +MQ LD+P
Sbjct: 20 LEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPY 79
Query: 137 IVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
IV + + E LV+E Y + ++ + + +Q+ +
Sbjct: 80 IVRM----IGICEAESWM--LVMEMAE---LGPLNKYLQQNRHVKDKNIIELVHQVSMGM 130
Query: 197 AYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR--- 251
Y+ N + HRD+ +N+L+ H K+ DFG +K L E YY+
Sbjct: 131 KYLEESNFV---HRDLAARNVLLVTQ-HYAKISDFGLSKALRADEN--------YYKAQT 178
Query: 252 ---------APE-LIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVD--QLVE 296
APE + + ++++ D+WS G +M E GQ + G G + ++E
Sbjct: 179 HGKWPVKWYAPECINYY--KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE 234
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 9e-24
Identities = 53/216 (24%), Positives = 97/216 (44%), Gaps = 33/216 (15%)
Query: 87 EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPNIVALKHC 143
+H +G G +G V++ ++ VA+K + +D +E +M+ + HPN+V L
Sbjct: 18 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 77
Query: 144 FFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKL--YTYQICRALAYI-- 199
T + Y ++ E++ +Y R R + V L QI A+ Y+
Sbjct: 78 ---CTREPPFY--IITEFMT---YGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK 129
Query: 200 HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR------AP 253
N I HRD+ +N LV + H +K+ DFG ++++ Y + AP
Sbjct: 130 KNFI---HRDLAARNCLVGEN-HLVKVADFGLSRLMTGDT----YTAHAGAKFPIKWTAP 181
Query: 254 E-LIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPG 287
E L + +++ D+W+ G ++ E+ G +PG
Sbjct: 182 ESLAYN--KFSIKSDVWAFGVLLWEIATYGMSPYPG 215
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 98.0 bits (245), Expect = 2e-23
Identities = 57/220 (25%), Positives = 90/220 (40%), Gaps = 37/220 (16%)
Query: 87 EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN--RELQIMQMLDHPNIVALKHCF 144
+G G FG V R G VA+K + D + E +M L H N+V L
Sbjct: 26 LQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGV- 82
Query: 145 FSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKL--YTYQICRALAYI--H 200
+K LY +V EY+ +Y R R L L ++ +C A+ Y+ +
Sbjct: 83 -IVEEKGGLY--IVTEYMA---KGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN 136
Query: 201 NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR------APE 254
N + HRD+ +N+LV+ + K+ DFG K + APE
Sbjct: 137 NFV---HRDLAARNVLVSED-NVAKVSDFGLTKEA--------SSTQDTGKLPVKWTAPE 184
Query: 255 -LIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVD 292
L +++T D+WS G ++ E+ G+ +P D
Sbjct: 185 ALREK--KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD 222
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 2e-23
Identities = 63/238 (26%), Positives = 97/238 (40%), Gaps = 49/238 (20%)
Query: 85 IAEHVVGTGSFGVVFQAKCRETGEI--VAIKKVLQDKRYKNR-----ELQIMQMLDHPNI 137
IA+ +G G+FG V Q R + VAIK + Q + E QIM LD+P I
Sbjct: 13 IADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYI 72
Query: 138 VALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQ-RMPLIYVKLYTYQICRAL 196
V L E L LV+E + + +P+ V +Q+ +
Sbjct: 73 VRL----IGVCQAEALM--LVMEMAG---GGPLHKFLVGKREEIPVSNVAELLHQVSMGM 123
Query: 197 AYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR--- 251
Y+ N + HRD+ +N+L+ + H K+ DFG +K L + YY
Sbjct: 124 KYLEEKNFV---HRDLAARNVLLV-NRHYAKISDFGLSKALGADDS--------YYTARS 171
Query: 252 ---------APE-LIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVD--QLVE 296
APE + F ++++ D+WS G M E L GQ + G + +E
Sbjct: 172 AGKWPLKWYAPECINFR--KFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE 227
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 3e-23
Identities = 56/215 (26%), Positives = 89/215 (41%), Gaps = 37/215 (17%)
Query: 87 EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN--RELQIMQMLDHPNIVALKHCF 144
+G G FG V R G VA+K + D + E +M L H N+V L
Sbjct: 198 LQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGV- 254
Query: 145 FSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKL--YTYQICRALAYI--H 200
+K LY +V EY+ +Y R R L L ++ +C A+ Y+ +
Sbjct: 255 -IVEEKGGLY--IVTEYMA---KGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN 308
Query: 201 NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR------APE 254
N + HRD+ +N+LV+ + K+ DFG K + APE
Sbjct: 309 NFV---HRDLAARNVLVSED-NVAKVSDFGLTKEA--------SSTQDTGKLPVKWTAPE 356
Query: 255 -LIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPG 287
L +++T D+WS G ++ E+ G+ +P
Sbjct: 357 ALREK--KFSTKSDVWSFGILLWEIYSFGRVPYPR 389
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 3e-23
Identities = 53/226 (23%), Positives = 98/226 (43%), Gaps = 33/226 (14%)
Query: 87 EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPNIVALKHC 143
+H +G G +G V++ ++ VA+K + +D +E +M+ + HPN+V L
Sbjct: 225 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 284
Query: 144 FFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKL--YTYQICRALAYI-- 199
T + Y ++ E++ +Y R R + V L QI A+ Y+
Sbjct: 285 ---CTREPPFY--IITEFMT---YGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK 336
Query: 200 HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR------AP 253
N I HR++ +N LV H +K+ DFG ++++ Y + AP
Sbjct: 337 KNFI---HRNLAARNCLVG-ENHLVKVADFGLSRLMTGDT----YTAHAGAKFPIKWTAP 388
Query: 254 ELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVD--QLVE 296
E + ++ D+W+ G ++ E+ G +PG +L+E
Sbjct: 389 ESLAYNK-FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE 433
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 3e-23
Identities = 57/237 (24%), Positives = 96/237 (40%), Gaps = 50/237 (21%)
Query: 87 EHVVGTGSFGVVFQAKCRETGE----IVAIKKVLQDKRYKN-----RELQIMQMLDHPNI 137
V+G+G+FG V++ GE VAIK++ + K E +M +D+P++
Sbjct: 20 IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 79
Query: 138 VALKH-CFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQ-RMPLIYVKLYTYQICRA 195
L C + L+ + +P +Y R H+ + Y+ + QI +
Sbjct: 80 CRLLGICL-----TSTVQ--LITQLMP---FGCLLDYVREHKDNIGSQYLLNWCVQIAKG 129
Query: 196 LAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR-- 251
+ Y+ + HRD+ +N+LV +K+ DFG AK+L E Y
Sbjct: 130 MNYLEDRRLV---HRDLAARNVLVK-TPQHVKITDFGLAKLLGAEEK--------EYHAE 177
Query: 252 ---------APELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVD--QLVE 296
A E I YT D+WS G + EL+ G + G + ++E
Sbjct: 178 GGKVPIKWMALESILHRI-YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE 233
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 99.4 bits (248), Expect = 4e-23
Identities = 58/226 (25%), Positives = 95/226 (42%), Gaps = 35/226 (15%)
Query: 87 EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPNIVALKHC 143
E +G G FG V+ T VAIK + +E Q+M+ L H +V L
Sbjct: 189 EVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQL--- 244
Query: 144 FFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKL--YTYQICRALAYI-- 199
++ +E +Y +V EY+ ++ + L +L QI +AY+
Sbjct: 245 -YAVVSEEPIY--IVTEYMS---KGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER 298
Query: 200 HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR------AP 253
N + HRD++ N+LV + K+ DFG A+++ E Y + + AP
Sbjct: 299 MNYV---HRDLRAANILVGEN-LVCKVADFGLARLIEDNE----YTARQGAKFPIKWTAP 350
Query: 254 ELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVD--QLVE 296
E +T D+WS G ++ EL G+ +PG + VE
Sbjct: 351 EAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE 395
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 7e-23
Identities = 53/231 (22%), Positives = 92/231 (39%), Gaps = 38/231 (16%)
Query: 87 EHVVGTGSFGVVFQAKCRETGE----IVAIKKVLQDKRYKN-----RELQIMQMLDHPNI 137
V+G+G FG V + GE V IK + ++ + + LDH +I
Sbjct: 18 LKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHI 77
Query: 138 VALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQ-RMPLIYVKLYTYQICRAL 196
V L L LV +Y+P ++ R H+ + + + QI + +
Sbjct: 78 VRL----LGLCPGSSLQ--LVTQYLP---LGSLLDHVRQHRGALGPQLLLNWGVQIAKGM 128
Query: 197 AYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR--- 251
Y+ H + HR++ +N+L+ Q+++ DFG A +L + + +
Sbjct: 129 YYLEEHGMV---HRNLAARNVLLKSP-SQVQVADFGVADLLPPDD---KQLLYSEAKTPI 181
Query: 252 ---APELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVD--QLVE 296
A E I YT D+WS G + EL+ G + G + L+E
Sbjct: 182 KWMALESIHFGK-YTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLE 231
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 8e-23
Identities = 44/235 (18%), Positives = 79/235 (33%), Gaps = 50/235 (21%)
Query: 87 EHVVGTGSFGVVFQAKCRETGEI-------VAIKKVLQDKRYKN----RELQIMQMLDHP 135
+G G+F +F+ RE G+ V +K + + R + +M L H
Sbjct: 13 NESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHK 72
Query: 136 NIVALKH-CFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKL-YTYQIC 193
++V C +E LV E+V Y + ++ I KL Q+
Sbjct: 73 HLVLNYGVC----VCGDENI--LVQEFVK---FGSLDTYLKKNKNCINILWKLEVAKQLA 123
Query: 194 RALAYI--HNCIGICHRDIKPQNLLVNPHTHQL-------KLCDFGSAKVLVKGEPNVSY 244
A+ ++ + I H ++ +N+L+ + KL D G + ++ +
Sbjct: 124 AAMHFLEENTLI---HGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD----- 175
Query: 245 ICSRYYR------APELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVD 292
+ PE I A D WS G + E+ G
Sbjct: 176 ----ILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQR 226
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 98.8 bits (246), Expect = 1e-22
Identities = 58/226 (25%), Positives = 95/226 (42%), Gaps = 35/226 (15%)
Query: 87 EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPNIVALKHC 143
E +G G FG V+ T VAIK + +E Q+M+ L H +V L
Sbjct: 272 EVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQL--- 327
Query: 144 FFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKL--YTYQICRALAYI-- 199
++ +E +Y +V EY+ ++ + L +L QI +AY+
Sbjct: 328 -YAVVSEEPIY--IVTEYMS---KGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER 381
Query: 200 HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR------AP 253
N + HRD++ N+LV + K+ DFG A+++ E Y + + AP
Sbjct: 382 MNYV---HRDLRAANILVGEN-LVCKVADFGLARLIEDNE----YTARQGAKFPIKWTAP 433
Query: 254 ELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVD--QLVE 296
E +T D+WS G ++ EL G+ +PG + VE
Sbjct: 434 EAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE 478
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 1e-22
Identities = 58/232 (25%), Positives = 100/232 (43%), Gaps = 47/232 (20%)
Query: 87 EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPNIVALKHC 143
+G G FG V+ + VA+K + Q + E +M+ L H +V L
Sbjct: 18 VERLGAGQFGEVWMGYYNGHTK-VAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRL--- 73
Query: 144 FFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKL--YTYQICRALAYI-- 199
++ +E +Y ++ EY+ N ++ + + L KL QI +A+I
Sbjct: 74 -YAVVTQEPIY--IITEYME---NGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE 127
Query: 200 HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR-------- 251
N I HRD++ N+LV+ K+ DFG A+++ E Y
Sbjct: 128 RNYI---HRDLRAANILVSDT-LSCKIADFGLARLIEDNE---------YTAREGAKFPI 174
Query: 252 ---APE-LIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESG--VDQLVE 296
APE + +G +T D+WS G ++ E++ G+ +PG + V Q +E
Sbjct: 175 KWTAPEAINYG--TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLE 224
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 98.1 bits (244), Expect = 2e-22
Identities = 62/232 (26%), Positives = 96/232 (41%), Gaps = 47/232 (20%)
Query: 85 IAEHVVGTGSFGVVFQAKCR-ETGEI-VAIKKVLQDKRYKNR-----ELQIMQMLDHPNI 137
IA+ +G G+FG V Q R +I VAIK + Q + E QIM LD+P I
Sbjct: 339 IADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYI 398
Query: 138 VALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQ-RMPLIYVKLYTYQICRAL 196
V L E L LV+E + + +P+ V +Q+ +
Sbjct: 399 VRL----IGVCQAEALM--LVMEMAG---GGPLHKFLVGKREEIPVSNVAELLHQVSMGM 449
Query: 197 AYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR--- 251
Y+ N + HR++ +N+L+ + H K+ DFG +K L + YY
Sbjct: 450 KYLEEKNFV---HRNLAARNVLLV-NRHYAKISDFGLSKALGADDS--------YYTARS 497
Query: 252 ---------APE-LIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVD 292
APE + F ++++ D+WS G M E L GQ + G +
Sbjct: 498 AGKWPLKWYAPECINFR--KFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE 547
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 3e-22
Identities = 57/232 (24%), Positives = 98/232 (42%), Gaps = 47/232 (20%)
Query: 87 EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPNIVALKH- 142
+G+G FGVV K + + VA+K + + ++ +E Q M L HP +V
Sbjct: 13 LKELGSGQFGVVKLGKWKGQYD-VAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGV 71
Query: 143 CFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLY-TYQICRALAYI-- 199
C + + +Y +V EY+ N NY R H + L Y +C +A++
Sbjct: 72 C----SKEYPIY--IVTEYIS---NGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLES 122
Query: 200 HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR-------- 251
H I HRD+ +N LV+ +K+ DFG + ++ + Y
Sbjct: 123 HQFI---HRDLAARNCLVDRD-LCVKVSDFGMTRYVLDDQ---------YVSSVGTKFPV 169
Query: 252 ---APE-LIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESG--VDQLVE 296
APE + +Y++ D+W+ G +M E+ LG+ + + V V
Sbjct: 170 KWSAPEVFHYF--KYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVS 219
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 93.4 bits (233), Expect = 5e-22
Identities = 50/226 (22%), Positives = 90/226 (39%), Gaps = 45/226 (19%)
Query: 87 EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPNIVALKH- 142
+G+G FG+V + VAIK + + + E ++M L HP +V L
Sbjct: 13 VQEIGSGQFGLVHLGYWLNKDK-VAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGV 71
Query: 143 CFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLY-TYQICRALAYI-- 199
C ++ + LV E++ + +Y R + + L +C +AY+
Sbjct: 72 C----LEQAPIC--LVTEFME---HGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEE 122
Query: 200 HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR-------- 251
I HRD+ +N LV + +K+ DFG + ++ + Y
Sbjct: 123 ACVI---HRDLAARNCLVGEN-QVIKVSDFGMTRFVLDDQ---------YTSSTGTKFPV 169
Query: 252 ---APE-LIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVD 292
+PE F Y++ D+WS G +M E+ G+ + S +
Sbjct: 170 KWASPEVFSFS--RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE 213
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 96.3 bits (240), Expect = 5e-22
Identities = 58/232 (25%), Positives = 99/232 (42%), Gaps = 47/232 (20%)
Query: 87 EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPNIVALKHC 143
E +G G FG V+ A + + VA+K + E +M+ L H +V L
Sbjct: 193 EKKLGAGQFGEVWMATYNKHTK-VAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAV 251
Query: 144 FFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKL--YTYQICRALAYI-- 199
KE +Y ++ E++ ++ + + KL ++ QI +A+I
Sbjct: 252 VT----KEPIY--IITEFMA---KGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ 302
Query: 200 HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR-------- 251
N I HRD++ N+LV+ K+ DFG A+V+ E Y
Sbjct: 303 RNYI---HRDLRAANILVSAS-LVCKIADFGLARVIEDNE---------YTAREGAKFPI 349
Query: 252 ---APE-LIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVD--QLVE 296
APE + FG +T D+WS G ++ E++ G+ +PG S + + +E
Sbjct: 350 KWTAPEAINFG--SFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALE 399
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 93.4 bits (233), Expect = 8e-22
Identities = 62/230 (26%), Positives = 103/230 (44%), Gaps = 48/230 (20%)
Query: 87 EHVVGTGSFGVVFQAKCRETGEI---VAIKKVLQDKRYKNR-----ELQIMQMLDHPNIV 138
++G G FG V++ VA+K +D N+ E IM+ LDHP+IV
Sbjct: 17 NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIV 76
Query: 139 ALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQ-RMPLIYVKLYTYQICRALA 197
L ++E + +++E P +Y ++ + ++ + LY+ QIC+A+A
Sbjct: 77 KL----IGIIEEEPTW--IIMELYP---YGELGHYLERNKNSLKVLTLVLYSLQICKAMA 127
Query: 198 YI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR---- 251
Y+ NC+ HRDI +N+LV +KL DFG ++ + + YY+
Sbjct: 128 YLESINCV---HRDIAVRNILVASP-ECVKLGDFGLSRYIEDED---------YYKASVT 174
Query: 252 -------APE-LIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVD 292
+PE + F +TTA D+W M E+L G+ F D
Sbjct: 175 RLPIKWMSPESINFRR--FTTASDVWMFAVCMWEILSFGKQPFFWLENKD 222
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 8e-22
Identities = 58/230 (25%), Positives = 89/230 (38%), Gaps = 49/230 (21%)
Query: 87 EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR-----ELQIMQMLDHPNIVALK 141
+G G+FG VF + R +VA+K + + E +I++ HPNIV L
Sbjct: 119 GEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRL- 177
Query: 142 H--CFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKL-YTYQICRALAY 198
C T K+ +Y +V+E V + R + L + Y
Sbjct: 178 IGVC----TQKQPIY--IVMELVQ---GGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEY 228
Query: 199 IH--NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR----- 251
+ CI HRD+ +N LV + LK+ DFG ++ G Y
Sbjct: 229 LESKCCI---HRDLAARNCLVTEK-NVLKISDFGMSREEADGV---------YAASGGLR 275
Query: 252 -------APE-LIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVD 292
APE L +G Y++ D+WS G ++ E LG +P S
Sbjct: 276 QVPVKWTAPEALNYG--RYSSESDVWSFGILLWETFSLGASPYPNLSNQQ 323
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 9e-22
Identities = 51/239 (21%), Positives = 90/239 (37%), Gaps = 52/239 (21%)
Query: 87 EHVVGTGSFGVVFQAKCRETGE---IVAIKKVLQDKRYKN------RELQIMQMLDHPNI 137
++G G FG V +A+ ++ VA+K + D + RE M+ DHP++
Sbjct: 28 GRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHV 87
Query: 138 VALKH-CFFSTTDKEELYLNLVLEYVPE-------TVNRIARNYSRIHQRMPLIYVKLYT 189
L S ++L ++ +RI N + + L+ +
Sbjct: 88 AKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQT-LVR---FM 143
Query: 190 YQICRALAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICS 247
I + Y+ N I HRD+ +N ++ + + DFG ++ + G+
Sbjct: 144 VDIACGMEYLSSRNFI---HRDLAARNCMLAED-MTVCVADFGLSRKIYSGD-------- 191
Query: 248 RYYR------------APE-LIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVD 292
YYR A E L YT D+W+ G M E++ GQ + G +
Sbjct: 192 -YYRQGCASKLPVKWLALESLADN--LYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAE 247
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 2e-21
Identities = 55/239 (23%), Positives = 89/239 (37%), Gaps = 52/239 (21%)
Query: 87 EHVVGTGSFGVVFQAKCRETGEI---VAIKKVLQDKRYKN-------RELQIMQMLDHPN 136
+G GSFGVV + + VA+K + D + RE+ M LDH N
Sbjct: 23 LEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRN 82
Query: 137 IVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQ-RMPLIYVKLYTYQICRA 195
++ L + + +V E P + R HQ L + Y Q+
Sbjct: 83 LIRL----YGVVLTPPMK--MVTELAP---LGSLLDRLRKHQGHFLLGTLSRYAVQVAEG 133
Query: 196 LAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR-- 251
+ Y+ I HRD+ +NLL+ +K+ DFG + L + + +Y
Sbjct: 134 MGYLESKRFI---HRDLAARNLLLATR-DLVKIGDFGLMRALPQNDD--------HYVMQ 181
Query: 252 ----------APE-LIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVD--QLVE 296
APE L ++ A D W G + E+ GQ + G +G ++
Sbjct: 182 EHRKVPFAWCAPESLKTRT--FSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKID 238
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 4e-21
Identities = 47/238 (19%), Positives = 87/238 (36%), Gaps = 51/238 (21%)
Query: 87 EHVVGTGSFGVVFQAKCRETGEI---VAIKKVLQDKRYKN------RELQIMQMLDHPNI 137
++G G FG V + ++ VA+K + D + E M+ HPN+
Sbjct: 39 GKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNV 98
Query: 138 VALKHCFFSTTDKEELYLNLVLEYVPE-------TVNRIARNYSRIHQRMPLIYVKLYTY 190
+ L + + ++L ++ +R+ I + L+ +
Sbjct: 99 IRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQT-LLK---FMV 154
Query: 191 QICRALAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR 248
I + Y+ N + HRD+ +N ++ + + DFG +K + G+
Sbjct: 155 DIALGMEYLSNRNFL---HRDLAARNCMLRDD-MTVCVADFGLSKKIYSGD--------- 201
Query: 249 YYR------------APE-LIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVD 292
YYR A E L YT+ D+W+ G M E+ G +PG +
Sbjct: 202 YYRQGRIAKMPVKWIAIESLADRV--YTSKSDVWAFGVTMWEIATRGMTPYPGVQNHE 257
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 91.1 bits (227), Expect = 5e-21
Identities = 55/226 (24%), Positives = 96/226 (42%), Gaps = 45/226 (19%)
Query: 87 EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPNIVALKH- 142
+GTG FGVV K R + VAIK + + ++ E ++M L H +V L
Sbjct: 29 LKELGTGQFGVVKYGKWRGQYD-VAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGV 87
Query: 143 CFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLY-TYQICRALAYI-- 199
C T + ++ ++ EY+ N NY R + L +C A+ Y+
Sbjct: 88 C----TKQRPIF--IITEYMA---NGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLES 138
Query: 200 HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR-------- 251
+ HRD+ +N LVN +K+ DFG ++ ++ E Y
Sbjct: 139 KQFL---HRDLAARNCLVNDQ-GVVKVSDFGLSRYVLDDE---------YTSSVGSKFPV 185
Query: 252 ---APE-LIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVD 292
PE L++ ++++ DIW+ G +M E+ LG+ + + +
Sbjct: 186 RWSPPEVLMYS--KFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE 229
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 7e-21
Identities = 61/236 (25%), Positives = 95/236 (40%), Gaps = 50/236 (21%)
Query: 87 EHVVGTGSFGVVFQAKCRETGEI---VAIKKVLQDKRYKNR-----ELQIMQMLDHPNIV 138
+G G FG V Q VAIK R E M+ DHP+IV
Sbjct: 20 GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 79
Query: 139 ALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQ-RMPLIYVKLYTYQICRALA 197
L + ++ +++E R++ ++ + + L + LY YQ+ ALA
Sbjct: 80 KL----IGVITENPVW--IIMELCT---LGELRSFLQVRKYSLDLASLILYAYQLSTALA 130
Query: 198 YI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR---- 251
Y+ + HRDI +N+LV+ + +KL DFG ++ + YY+
Sbjct: 131 YLESKRFV---HRDIAARNVLVSSN-DCVKLGDFGLSRYMEDST---------YYKASKG 177
Query: 252 -------APE-LIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVD--QLVE 296
APE + F +T+A D+W G M E+L G F G D +E
Sbjct: 178 KLPIKWMAPESINFRR--FTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE 231
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 1e-20
Identities = 60/250 (24%), Positives = 94/250 (37%), Gaps = 60/250 (24%)
Query: 91 GTGSFGVVFQAKCR-----ETGEIVAIKKV-----LQDKRYKNRELQIMQML-DHPNIVA 139
G G+FG V +A + VA+K + L ++ EL+++ L +H NIV
Sbjct: 32 GAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVN 91
Query: 140 LKHCFFSTTDKEELYLNLVLEYV-------------PETVNRIARNYSRIHQRMPLIYVK 186
L T ++ EY + + L
Sbjct: 92 LLGA---CTIGGPTL--VITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLED 146
Query: 187 LYT--YQICRALAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNV 242
L + YQ+ + +A++ NCI HRD+ +N+L+ K+CDFG A+ +
Sbjct: 147 LLSFSYQVAKGMAFLASKNCI---HRDLAARNILLTHG-RITKICDFGLARDIKNDS--- 199
Query: 243 SYICSRYYR------------APELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGES 289
Y APE IF YT D+WS G + EL LG +PG
Sbjct: 200 ------NYVVKGNARLPVKWMAPESIFNCV-YTFESDVWSYGIFLWELFSLGSSPYPGMP 252
Query: 290 GVDQLVEIIK 299
+ ++IK
Sbjct: 253 VDSKFYKMIK 262
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 1e-20
Identities = 59/238 (24%), Positives = 93/238 (39%), Gaps = 51/238 (21%)
Query: 87 EHVVGTGSFGVVFQAKCRETGE---IVAIKKVLQDKRYKNR-----ELQIMQMLDHPNIV 138
E ++G+G G V + R G+ VAIK + + R E IM DHPNI+
Sbjct: 54 EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNII 113
Query: 139 ALKH-CFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKL-YTYQICRAL 196
L+ T +V EY+ N + R H I + + +
Sbjct: 114 RLEGVV----TRGRLAM--IVTEYME---NGSLDTFLRTHDGQFTIMQLVGMLRGVGAGM 164
Query: 197 AYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR--- 251
Y+ + HRD+ +N+LV+ + K+ DFG ++VL
Sbjct: 165 RYLSDLGYV---HRDLAARNVLVDSN-LVCKVSDFGLSRVLEDDP--------DAAYTTT 212
Query: 252 ---------APE-LIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVD--QLVE 296
APE + F +++A D+WS G VM E+L G+ + + D VE
Sbjct: 213 GGKIPIRWTAPEAIAFR--TFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVE 268
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 92.6 bits (230), Expect = 1e-20
Identities = 61/236 (25%), Positives = 95/236 (40%), Gaps = 50/236 (21%)
Query: 87 EHVVGTGSFGVVFQAKCRETGEI---VAIKKVLQDKRYKNR-----ELQIMQMLDHPNIV 138
+G G FG V Q VAIK R E M+ DHP+IV
Sbjct: 395 GRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 454
Query: 139 ALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQ-RMPLIYVKLYTYQICRALA 197
L + ++ +++E R++ ++ + + L + LY YQ+ ALA
Sbjct: 455 KL----IGVITENPVW--IIMELCT---LGELRSFLQVRKFSLDLASLILYAYQLSTALA 505
Query: 198 YI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR---- 251
Y+ + HRDI +N+LV+ + +KL DFG ++ + YY+
Sbjct: 506 YLESKRFV---HRDIAARNVLVSSN-DCVKLGDFGLSRYMEDST---------YYKASKG 552
Query: 252 -------APE-LIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESG--VDQLVE 296
APE + F +T+A D+W G M E+L G F G V +E
Sbjct: 553 KLPIKWMAPESINFR--RFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE 606
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 89.4 bits (222), Expect = 2e-20
Identities = 31/263 (11%), Positives = 54/263 (20%), Gaps = 60/263 (22%)
Query: 50 DSEPDIIDGVGAETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEI 109
D V G I GR Y G +QA
Sbjct: 11 RESSAPPDDVQLVPGARI---ANGR---------YRLLIFHGGVPPLQFWQALDTALDRQ 58
Query: 110 VAIKKVL----QDKRYKNR---ELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYV 162
VA+ V + +D P + + + + V E++
Sbjct: 59 VALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARV---LDVVHTRAGGLV--VAEWI 113
Query: 163 P-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHT 221
++ +A + + A H G+ P + V+
Sbjct: 114 RGGSLQEVAD------TSPSPVGAIRAMQSLAAAADAAHR-AGVALSIDHPSRVRVSI-D 165
Query: 222 HQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLG 281
+ L DI G + LL+
Sbjct: 166 GDVVLAYPA-------------------TMPDA--------NPQDDIRGIGASLYALLVN 198
Query: 282 QPLFPGESGVDQLVEIIKVLGTP 304
+ P L +
Sbjct: 199 RWPLPEAGVRSGLAPAERDTAGQ 221
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 3e-20
Identities = 58/231 (25%), Positives = 96/231 (41%), Gaps = 47/231 (20%)
Query: 87 EHVVGTGSFGVVFQAKCRETGE---IVAIKKVLQDKRYKNR-----ELQIMQMLDHPNIV 138
+ VVG G FG V + + + VAIK + K R E IM DHPNI+
Sbjct: 50 DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 139 ALKH-CFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQ-RMPLIYVKLYTYQICRAL 196
L+ T + + +V EY+ N ++ R H + +I + I +
Sbjct: 110 RLEGVV----TKSKPVM--IVTEYME---NGSLDSFLRKHDAQFTVIQLVGMLRGIASGM 160
Query: 197 AYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR--- 251
Y+ + HRD+ +N+L+N + K+ DFG +VL Y
Sbjct: 161 KYLSDMGYV---HRDLAARNILINSN-LVCKVSDFGLGRVLEDDP-------EAAYTTRG 209
Query: 252 --------APE-LIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVD 292
+PE + + ++T+A D+WS G V+ E++ G+ + S D
Sbjct: 210 GKIPIRWTSPEAIAYR--KFTSASDVWSYGIVLWEVMSYGERPYWEMSNQD 258
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 6e-20
Identities = 59/236 (25%), Positives = 99/236 (41%), Gaps = 55/236 (23%)
Query: 87 EHVVGTGSFGVVFQAKCRETGE---IVAIK--KVLQDKRYKN---RELQIMQMLDHPNIV 138
+ V+G G FGVV+ + + + AIK + + + RE +M+ L+HPN++
Sbjct: 26 DRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVL 85
Query: 139 ALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMP----LIYVKLYTYQICR 194
AL E L ++L Y+ + + R QR P LI + Q+ R
Sbjct: 86 ALIGI---MLPPEGLPH-VLLPYMC---HGDLLQFIRSPQRNPTVKDLIS---FGLQVAR 135
Query: 195 ALAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR- 251
+ Y+ + HRD+ +N +++ + +K+ DFG A+ ++ E YY
Sbjct: 136 GMEYLAEQKFV---HRDLAARNCMLD-ESFTVKVADFGLARDILDRE---------YYSV 182
Query: 252 -------------APE-LIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVD 292
A E L +TT D+WS G ++ ELL G P + D
Sbjct: 183 QQHRHARLPVKWTALESLQTYR--FTTKSDVWSFGVLLWELLTRGAPPYRHIDPFD 236
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 6e-20
Identities = 54/231 (23%), Positives = 93/231 (40%), Gaps = 46/231 (19%)
Query: 87 EHVVGTGSFGVVFQAKCRETGEI----VAIKKVLQDKRYKNR-----ELQIMQMLDHPNI 137
+ V+G G FG V++ + + VAIK + K R E IM H NI
Sbjct: 49 QKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNI 108
Query: 138 VALKH-CFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQ-RMPLIYVKLYTYQICRA 195
+ L+ + + + ++ EY+ N + R ++ + I
Sbjct: 109 IRLEGVI----SKYKPMM--IITEYME---NGALDKFLREKDGEFSVLQLVGMLRGIAAG 159
Query: 196 LAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR-- 251
+ Y+ N + HRD+ +N+LVN + K+ DFG ++VL Y
Sbjct: 160 MKYLANMNYV---HRDLAARNILVNSN-LVCKVSDFGLSRVLEDDPEAT------YTTSG 209
Query: 252 --------APE-LIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVD 292
APE + + +T+A D+WS G VM E++ G+ + S +
Sbjct: 210 GKIPIRWTAPEAISYRK--FTSASDVWSFGIVMWEVMTYGERPYWELSNHE 258
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 7e-20
Identities = 56/248 (22%), Positives = 100/248 (40%), Gaps = 61/248 (24%)
Query: 91 GTGSFGVVFQAKCRETGE-----IVAIKKV----LQDKRYKNRELQIMQMLDHPNIVALK 141
G G+FG VF A+C +VA+K + L ++ RE +++ L H +IV
Sbjct: 24 GEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFY 83
Query: 142 HCFFSTTDKEELYLNLVLEYVP-----------ETVNRIARNYSRIHQRMPLIYVKLY-- 188
D + L +V EY+ I + + L ++
Sbjct: 84 GV---CGDGDPLI--MVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 138
Query: 189 TYQICRALAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYIC 246
QI + Y+ + + HRD+ +N LV + +K+ DFG ++ + +
Sbjct: 139 ASQIASGMVYLASQHFV---HRDLATRNCLVGAN-LLVKIGDFGMSRDVYSTD------- 187
Query: 247 SRYYR------------APE-LIFGATEYTTAIDIWSTGCVMAELL-LG-QPLFPGESGV 291
YYR PE +++ ++TT D+WS G ++ E+ G QP + S
Sbjct: 188 --YYRVGGHTMLPIRWMPPESIMYR--KFTTESDVWSFGVILWEIFTYGKQP-WFQLS-N 241
Query: 292 DQLVEIIK 299
+++E I
Sbjct: 242 TEVIECIT 249
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 1e-19
Identities = 58/251 (23%), Positives = 100/251 (39%), Gaps = 57/251 (22%)
Query: 88 HVVGTGSFGVVFQAKCR-----ETGEIVAIKKV-----LQDKRYKNRELQIMQMLD-HPN 136
+G G+FG V +A T VA+K + + R EL+I+ + H N
Sbjct: 33 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 92
Query: 137 IVALKHCFFSTTDKEELYLNLVLEYV-------------PETVNRIARNYSRIHQRMPLI 183
+V L T L +++E+ E V + L
Sbjct: 93 VVNLLGA--CTKPGGPLM--VIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLE 148
Query: 184 YVKLYTYQICRALAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN 241
++ Y++Q+ + + ++ CI HRD+ +N+L++ + +K+CDFG A+ + K
Sbjct: 149 HLICYSFQVAKGMEFLASRKCI---HRDLAARNILLSEK-NVVKICDFGLARDIYKDP-- 202
Query: 242 VSYICSRYYR------------APELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGE 288
Y APE IF YT D+WS G ++ E+ LG +PG
Sbjct: 203 -------DYVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPGV 254
Query: 289 SGVDQLVEIIK 299
++ +K
Sbjct: 255 KIDEEFCRRLK 265
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 1e-19
Identities = 54/236 (22%), Positives = 92/236 (38%), Gaps = 55/236 (23%)
Query: 87 EHVVGTGSFGVVFQAKCRETGEI---VAIK--KVLQDKRYKN---RELQIMQMLDHPNIV 138
V+G G FG V+ + A+K + D + E IM+ HPN++
Sbjct: 30 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 89
Query: 139 ALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMP----LIYVKLYTYQICR 194
+L + +VL Y+ + RN+ R P LI + Q+ +
Sbjct: 90 SLLGI--CLRSEGSPL--VVLPYMK---HGDLRNFIRNETHNPTVKDLIG---FGLQVAK 139
Query: 195 ALAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR- 251
+ Y+ + HRD+ +N +++ +K+ DFG A+ + E YY
Sbjct: 140 GMKYLASKKFV---HRDLAARNCMLDEK-FTVKVADFGLARDMYDKE---------YYSV 186
Query: 252 -------------APE-LIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVD 292
A E L ++TT D+WS G ++ EL+ G P +P + D
Sbjct: 187 HNKTGAKLPVKWMALESLQTQ--KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD 240
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 2e-19
Identities = 50/245 (20%), Positives = 99/245 (40%), Gaps = 54/245 (22%)
Query: 88 HVVGTGSFGVVFQAKCRETGE-----IVAIKKV-----LQDKRYKNRELQIMQMLDHPNI 137
+G GSFG+V++ + + VAIK V ++++ E +M+ + ++
Sbjct: 31 RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 90
Query: 138 VALKHCFFSTTDKEELYLNLVLEYVPE-------TVNRIARNYSRIHQRMPLIYVKLYTY 190
V L + + +++E + R A + + L +
Sbjct: 91 VRLLGV---VSQGQPTL--VIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAG 145
Query: 191 QICRALAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR 248
+I +AY+ + + HRD+ +N +V +K+ DFG + + + +
Sbjct: 146 EIADGMAYLNANKFV---HRDLAARNCMVAED-FTVKIGDFGMTRDIYETD--------- 192
Query: 249 YYR------------APE-LIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQL 294
YYR +PE L G +TT D+WS G V+ E+ L + + G S +Q+
Sbjct: 193 YYRKGGKGLLPVRWMSPESLKDG--VFTTYSDVWSFGVVLWEIATLAEQPYQGLS-NEQV 249
Query: 295 VEIIK 299
+ +
Sbjct: 250 LRFVM 254
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 86.7 bits (215), Expect = 5e-19
Identities = 51/233 (21%), Positives = 92/233 (39%), Gaps = 49/233 (21%)
Query: 87 EHVVGTGSFGVVFQAKCRETGEI---VAIK--KVLQDKRYKN---RELQIMQMLDHPNIV 138
V+G G FG V+ + A+K + D + E IM+ HPN++
Sbjct: 94 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 153
Query: 139 ALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMP----LIYVKLYTYQICR 194
+L + +VL Y+ + RN+ R P LI + Q+ +
Sbjct: 154 SLLGI--CLRSEGSPL--VVLPYMK---HGDLRNFIRNETHNPTVKDLIG---FGLQVAK 203
Query: 195 ALAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR- 251
+ ++ + HRD+ +N +++ +K+ DFG A+ + E + +
Sbjct: 204 GMKFLASKKFV---HRDLAARNCMLDEK-FTVKVADFGLARDMYDKEFD------SVHNK 253
Query: 252 ----------APE-LIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVD 292
A E L ++TT D+WS G ++ EL+ G P +P + D
Sbjct: 254 TGAKLPVKWMALESLQTQ--KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD 304
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 6e-19
Identities = 52/260 (20%), Positives = 98/260 (37%), Gaps = 68/260 (26%)
Query: 87 EHVVGTGSFGVVFQAKCR-----ETGEIVAIKKV-----LQDKRYKNRELQIMQMLDHPN 136
+G G FG V +A VA+K + + R E +++ ++HP+
Sbjct: 28 GKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPH 87
Query: 137 IVALKHCFFSTTDKEELYLNLVLEYVP-------------------ETVNRIARNYSRIH 177
++ L + L L++EY + +
Sbjct: 88 VIKLYGA---CSQDGPLL--LIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHP 142
Query: 178 QRMPLIYVKL--YTYQICRALAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK 233
L L + +QI + + Y+ + HRD+ +N+LV ++K+ DFG ++
Sbjct: 143 DERALTMGDLISFAWQISQGMQYLAEMKLV---HRDLAARNILVAEG-RKMKISDFGLSR 198
Query: 234 VLVKGEPNVSYICSRYYR------------APELIFGATEYTTAIDIWSTGCVMAELL-L 280
+ + + Y A E +F YTT D+WS G ++ E++ L
Sbjct: 199 DVYEED---------SYVKRSQGRIPVKWMAIESLFDHI-YTTQSDVWSFGVLLWEIVTL 248
Query: 281 G-QPLFPGESGVDQLVEIIK 299
G P +PG ++L ++K
Sbjct: 249 GGNP-YPGIP-PERLFNLLK 266
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 7e-19
Identities = 60/251 (23%), Positives = 98/251 (39%), Gaps = 58/251 (23%)
Query: 87 EHVVGTGSFGVVFQAKCRETGE-----IVAIKKV-----LQDKRYKNRELQIMQMLD-HP 135
+G G+FG V +A G+ VA+K + +K EL+IM L H
Sbjct: 51 GKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHE 110
Query: 136 NIVALKHCFFSTTDKEELYLNLVLEYVP---------ETVNRIARNYSRIHQRMPLIYVK 186
NIV L T + ++ EY + + +
Sbjct: 111 NIVNLLGA---CTHGGPVL--VITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRD 165
Query: 187 L--YTYQICRALAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNV 242
L ++ Q+ + +A++ NCI HRD+ +N+L+ H K+ DFG A+ ++
Sbjct: 166 LLHFSSQVAQGMAFLASKNCI---HRDVAARNVLLTNG-HVAKIGDFGLARDIMNDS--- 218
Query: 243 SYICSRYYR------------APELIFGATEYTTAIDIWSTGCVMAELL-LG-QPLFPGE 288
Y APE IF YT D+WS G ++ E+ LG P +PG
Sbjct: 219 ------NYIVKGNARLPVKWMAPESIFDCV-YTVQSDVWSYGILLWEIFSLGLNP-YPGI 270
Query: 289 SGVDQLVEIIK 299
+ +++K
Sbjct: 271 LVNSKFYKLVK 281
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 8e-19
Identities = 56/251 (22%), Positives = 99/251 (39%), Gaps = 60/251 (23%)
Query: 87 EHVVGTGSFGVVFQAKCRETGE-----IVAIKKV----LQDKRYKNRELQIMQMLDHPNI 137
+ +G G+FG VF A+C +VA+K + ++ RE +++ ML H +I
Sbjct: 46 KWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHI 105
Query: 138 VALKHCFFSTTDKEELYLNLVLEYVP----------ETVNRIARNYSRIHQRMPLIYVKL 187
V T+ L +V EY+ + PL +L
Sbjct: 106 VRFFGV---CTEGRPLL--MVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQL 160
Query: 188 --YTYQICRALAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVS 243
Q+ + Y+ + + HRD+ +N LV +K+ DFG ++ + +
Sbjct: 161 LAVASQVAAGMVYLAGLHFV---HRDLATRNCLVGQG-LVVKIGDFGMSRDIYSTD---- 212
Query: 244 YICSRYYR------------APE-LIFGATEYTTAIDIWSTGCVMAELL-LG-QPLFPGE 288
YYR PE +++ ++TT D+WS G V+ E+ G QP +
Sbjct: 213 -----YYRVGGRTMLPIRWMPPESILYR--KFTTESDVWSFGVVLWEIFTYGKQP-WYQL 264
Query: 289 SGVDQLVEIIK 299
S + ++ I
Sbjct: 265 S-NTEAIDCIT 274
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 9e-19
Identities = 50/245 (20%), Positives = 93/245 (37%), Gaps = 52/245 (21%)
Query: 87 EHVVGTGSFGVVFQAKCR-----ETGEIVAIKKV-----LQDKRYKNRELQIMQMLDHPN 136
+G G+FG V++ + + VA+K + QD+ E I+ +H N
Sbjct: 35 IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQN 94
Query: 137 IVALKHCFFSTTDKEELYLNLVLEYVPE----TVNRIARNYSRIHQRMPLIYVKLYTYQI 192
IV + + +++E + + R R + ++ + I
Sbjct: 95 IVRCIGV---SLQSLPRF--ILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 149
Query: 193 CRALAYI--HNCIGICHRDIKPQNLLVNPHTHQL--KLCDFGSAKVLVKGEPNVSYICSR 248
Y+ ++ I HRDI +N L+ K+ DFG A+ + +
Sbjct: 150 ACGCQYLEENHFI---HRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAS--------- 197
Query: 249 YYR------------APE-LIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQL 294
YYR PE + G +T+ D WS G ++ E+ LG +P +S ++
Sbjct: 198 YYRKGGCAMLPVKWMPPEAFMEG--IFTSKTDTWSFGVLLWEIFSLGYMPYPSKS-NQEV 254
Query: 295 VEIIK 299
+E +
Sbjct: 255 LEFVT 259
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 1e-18
Identities = 59/260 (22%), Positives = 97/260 (37%), Gaps = 67/260 (25%)
Query: 87 EHVVGTGSFGVVFQAKCR-----ETGEIVAIKKV-----LQDKRYKNRELQIMQML-DHP 135
V+G+G+FG V A VA+K + ++ EL++M L H
Sbjct: 50 GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHE 109
Query: 136 NIVALKHCFFSTTDKEELYLNLVLEYVP------------------ETVNRIARNYSRIH 177
NIV L T +Y L+ EY E +
Sbjct: 110 NIVNLLGA---CTLSGPIY--LIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 164
Query: 178 QRMPLIYVKL--YTYQICRALAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK 233
L + L + YQ+ + + ++ +C+ HRD+ +N+LV +K+CDFG A+
Sbjct: 165 DLNVLTFEDLLCFAYQVAKGMEFLEFKSCV---HRDLAARNVLVTHG-KVVKICDFGLAR 220
Query: 234 VLVKGEPNVSYICSRYYR------------APELIFGATEYTTAIDIWSTGCVMAEL--L 279
++ Y APE +F YT D+WS G ++ E+ L
Sbjct: 221 DIMSDS---------NYVVRGNARLPVKWMAPESLFEGI-YTIKSDVWSYGILLWEIFSL 270
Query: 280 LGQPLFPGESGVDQLVEIIK 299
P +PG ++I+
Sbjct: 271 GVNP-YPGIPVDANFYKLIQ 289
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 84.8 bits (210), Expect = 2e-18
Identities = 51/245 (20%), Positives = 93/245 (37%), Gaps = 52/245 (21%)
Query: 87 EHVVGTGSFGVVFQAKCR-----ETGEIVAIKKV-----LQDKRYKNRELQIMQMLDHPN 136
+G G+FG V++ + + VA+K + QD+ E I+ +H N
Sbjct: 76 IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQN 135
Query: 137 IVALKHCFFSTTDKEELYLNLVLEYVPE----TVNRIARNYSRIHQRMPLIYVKLYTYQI 192
IV + + ++LE + + R R + ++ + I
Sbjct: 136 IVRCIGV---SLQSLPRF--ILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 190
Query: 193 CRALAYI--HNCIGICHRDIKPQNLLVNPHTHQL--KLCDFGSAKVLVKGEPNVSYICSR 248
Y+ ++ I HRDI +N L+ K+ DFG A+ + +
Sbjct: 191 ACGCQYLEENHFI---HRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAG--------- 238
Query: 249 YYR------------APE-LIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQL 294
YYR PE + G +T+ D WS G ++ E+ LG +P +S ++
Sbjct: 239 YYRKGGCAMLPVKWMPPEAFMEG--IFTSKTDTWSFGVLLWEIFSLGYMPYPSKS-NQEV 295
Query: 295 VEIIK 299
+E +
Sbjct: 296 LEFVT 300
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 83.0 bits (206), Expect = 4e-18
Identities = 53/253 (20%), Positives = 93/253 (36%), Gaps = 62/253 (24%)
Query: 87 EHVVGTGSFGVVFQAKCR-----ETGEIVAIKKV-----LQDKRYKNRELQIMQMLDHPN 136
+G FG V++ E + VAIK + + E + L HPN
Sbjct: 14 MEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPN 73
Query: 137 IVALKHCFFSTTDKEELYLNLVLEYVP-----------ETVNRIARNYSRIHQRMPLIYV 185
+V L T + L ++ Y + + + L
Sbjct: 74 VVCLLGV---VTKDQPLS--MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPP 128
Query: 186 KL--YTYQICRALAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN 241
QI + Y+ H+ + H+D+ +N+LV +K+ D G + + +
Sbjct: 129 DFVHLVAQIAAGMEYLSSHHVV---HKDLATRNVLVYDK-LNVKISDLGLFREVYAAD-- 182
Query: 242 VSYICSRYYR------------APE-LIFGATEYTTAIDIWSTGCVMAELL-LG-QPLFP 286
YY+ APE +++G +++ DIWS G V+ E+ G QP +
Sbjct: 183 -------YYKLLGNSLLPIRWMAPEAIMYG--KFSIDSDIWSYGVVLWEVFSYGLQP-YC 232
Query: 287 GESGVDQLVEIIK 299
G S +VE+I+
Sbjct: 233 GYS-NQDVVEMIR 244
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 5e-18
Identities = 56/261 (21%), Positives = 99/261 (37%), Gaps = 70/261 (26%)
Query: 87 EHVVGTGSFGVVFQAKCR-----ETGEIVAIKKV-----LQDKRYKNRELQIMQMLDHPN 136
+G G+FG VFQA+ E +VA+K + + RE +M D+PN
Sbjct: 52 VRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPN 111
Query: 137 IVALKHCFFSTTDKEELYLNLVLEYVP-------------------ETVNRIARNYSRIH 177
IV L + + L+ EY+ + R
Sbjct: 112 IVKLLGV---CAVGKPMC--LLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 166
Query: 178 QRMPLIYVKL--YTYQICRALAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK 233
PL + Q+ +AY+ + HRD+ +N LV + +K+ DFG ++
Sbjct: 167 GPPPLSCAEQLCIARQVAAGMAYLSERKFV---HRDLATRNCLVGEN-MVVKIADFGLSR 222
Query: 234 VLVKGEPNVSYICSRYYR------------APE-LIFGATEYTTAIDIWSTGCVMAELL- 279
+ + YY+ PE + + YTT D+W+ G V+ E+
Sbjct: 223 NIYSAD---------YYKADGNDAIPIRWMPPESIFYN--RYTTESDVWAYGVVLWEIFS 271
Query: 280 LG-QPLFPGESGVDQLVEIIK 299
G QP + G + ++++ ++
Sbjct: 272 YGLQP-YYGMA-HEEVIYYVR 290
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 8e-18
Identities = 62/254 (24%), Positives = 104/254 (40%), Gaps = 61/254 (24%)
Query: 87 EHVVGTGSFGVVFQAKCR-------ETGEIVAIKKV-----LQDKRYKNRELQIMQML-D 133
+G G FG V A+ + VA+K + +D E+++M+M+
Sbjct: 86 GKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 145
Query: 134 HPNIVALKHCFFSTTDKEELYLNLVLEYVPE-----------TVNRIARNYSRIHQRMPL 182
H NI+ L T LY +++EY + +
Sbjct: 146 HKNIINLLGA---CTQDGPLY--VIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 200
Query: 183 IYVKL--YTYQICRALAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG 238
+ L TYQ+ R + Y+ CI HRD+ +N+LV + + +K+ DFG A+ +
Sbjct: 201 TFKDLVSCTYQLARGMEYLASQKCI---HRDLAARNVLVTEN-NVMKIADFGLARDINNI 256
Query: 239 EPNVSYICSRYYR------------APELIFGATEYTTAIDIWSTGCVMAELL-LGQPLF 285
+ YY+ APE +F YT D+WS G +M E+ LG +
Sbjct: 257 D---------YYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFTLGGSPY 306
Query: 286 PGESGVDQLVEIIK 299
PG V++L +++K
Sbjct: 307 PGIP-VEELFKLLK 319
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 1e-17
Identities = 61/254 (24%), Positives = 101/254 (39%), Gaps = 61/254 (24%)
Query: 87 EHVVGTGSFGVVFQAKCR-------ETGEIVAIKKV-----LQDKRYKNRELQIMQML-D 133
+G G+FG V A+ VA+K + +D E+++M+M+
Sbjct: 74 GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 133
Query: 134 HPNIVALKHCFFSTTDKEELYLNLVLEYVP-----------ETVNRIARNYSRIHQRMPL 182
H NI+ L T LY +++EY + L
Sbjct: 134 HKNIINLLGA---CTQDGPLY--VIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 188
Query: 183 IYVKL--YTYQICRALAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG 238
L YQ+ R + Y+ CI HRD+ +N+LV + +K+ DFG A+ +
Sbjct: 189 SSKDLVSCAYQVARGMEYLASKKCI---HRDLAARNVLVTED-NVMKIADFGLARDIHHI 244
Query: 239 EPNVSYICSRYYR------------APELIFGATEYTTAIDIWSTGCVMAELL-LGQPLF 285
+ YY+ APE +F YT D+WS G ++ E+ LG +
Sbjct: 245 D---------YYKKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEIFTLGGSPY 294
Query: 286 PGESGVDQLVEIIK 299
PG V++L +++K
Sbjct: 295 PGVP-VEELFKLLK 307
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 4e-17
Identities = 62/254 (24%), Positives = 105/254 (41%), Gaps = 61/254 (24%)
Query: 87 EHVVGTGSFGVVFQAKCR-------ETGEIVAIKKV-----LQDKRYKNRELQIMQML-D 133
+G G+FG V A+ + VA+K + +D E+++M+M+
Sbjct: 40 GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 99
Query: 134 HPNIVALKHCFFSTTDKEELYLNLVLEYVPE-----------TVNRIARNYSRIHQRMPL 182
H NI+ L T LY +++EY + +
Sbjct: 100 HKNIINLLGA---CTQDGPLY--VIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 183 IYVKL--YTYQICRALAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG 238
+ L TYQ+ R + Y+ CI HRD+ +N+LV + + +K+ DFG A+ +
Sbjct: 155 TFKDLVSCTYQLARGMEYLASQKCI---HRDLAARNVLVTEN-NVMKIADFGLARDINNI 210
Query: 239 EPNVSYICSRYYR------------APELIFGATEYTTAIDIWSTGCVMAELL-LGQPLF 285
+ YY+ APE +F YT D+WS G +M E+ LG +
Sbjct: 211 D---------YYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFTLGGSPY 260
Query: 286 PGESGVDQLVEIIK 299
PG V++L +++K
Sbjct: 261 PGIP-VEELFKLLK 273
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 80.7 bits (198), Expect = 4e-17
Identities = 46/330 (13%), Positives = 91/330 (27%), Gaps = 74/330 (22%)
Query: 90 VGTGSFGVVFQAKCRETGEIVAIKKV-LQDKRYKN-----------RELQIMQML----- 132
+G G FG VF + VAIK + ++ N E+ I + L
Sbjct: 28 IGEGVFGEVF--QTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSG 85
Query: 133 ----DHPNIVALKHCFFSTTDKEELYLNLVLEYVPE--TVNRIARNYSRIHQRMPLIY-- 184
+ L L L Y + N + + L +
Sbjct: 86 EVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEF 145
Query: 185 -----------------VKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLC 227
K +Q+ +LA + HRD+ N+L+ + + KL
Sbjct: 146 GGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLKKTSLK-KLH 204
Query: 228 DFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPG 287
+ K + +YT + V ++ + + LF G
Sbjct: 205 YTLNGKSSTIPSCGL-------------QVSIIDYTLSRLERDGIVVFCDVSMDEDLFTG 251
Query: 288 ESGVDQLVEIIKVLGTPTREEIKCMNP-------NYTEFKFPQIKPHPW--HKVFQKRLP 338
+ D +I +++ +P +Y K + + K++
Sbjct: 252 DG--DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIK 309
Query: 339 PEAVDLVCRFFQYSPNLRCTALEACVHPFF 368
+ + +S +A +
Sbjct: 310 RKIQEFHRTMLNFS-----SATDLLCQHSL 334
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 7e-17
Identities = 35/157 (22%), Positives = 66/157 (42%), Gaps = 16/157 (10%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN--RELQIMQMLDH-PNIVAL 140
Y +G GSFGV+F+ + VAIK + E + ++L I +
Sbjct: 12 YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNV 71
Query: 141 KHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 200
+ +E L+ LV++ + ++ + R + + V + Q+ + IH
Sbjct: 72 YYF-----GQEGLHNVLVIDLLGPSLEDLLDLCGR---KFSVKTVAMAAKQMLARVQSIH 123
Query: 201 NCIGICHRDIKPQNLLV----NPHTHQLKLCDFGSAK 233
+ +RDIKP N L+ + + + + + DFG K
Sbjct: 124 EK-SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 1e-16
Identities = 57/238 (23%), Positives = 93/238 (39%), Gaps = 60/238 (25%)
Query: 87 EHVVGTGSFGVVFQAKCRETGE--IVAIKKV-----LQDKRYKNRELQIMQML-DHPNIV 138
+ V+G G+FG V +A+ ++ G AIK++ D R EL+++ L HPNI+
Sbjct: 30 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 89
Query: 139 ALKHCFFSTTDKEELYLNLVLEYVP-----------ETVNRIARNYSRIHQRMPLIYVKL 187
L + LY L +EY P + L +L
Sbjct: 90 NLLGA---CEHRGYLY--LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 144
Query: 188 --YTYQICRALAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVS 243
+ + R + Y+ I HRD+ +N+LV + + K+ DFG ++
Sbjct: 145 LHFAADVARGMDYLSQKQFI---HRDLAARNILVGEN-YVAKIADFGLSRG--------- 191
Query: 244 YICSRYYR------------APE-LIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPG 287
Y A E L + YTT D+WS G ++ E++ LG + G
Sbjct: 192 ---QEVYVKKTMGRLPVRWMAIESLNYS--VYTTNSDVWSYGVLLWEIVSLGGTPYCG 244
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 78.2 bits (193), Expect = 3e-16
Identities = 35/157 (22%), Positives = 62/157 (39%), Gaps = 16/157 (10%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIK--KVLQDKRYKNRELQIMQMLDH-PNIVAL 140
+ +G G+FG + K T E VAIK + + E + + L I +
Sbjct: 11 FRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGDGIPQV 70
Query: 141 KHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 200
+ Y +VLE + ++ + R L V + Q+ + Y+H
Sbjct: 71 YYF-----GPCGKYNAMVLELLGPSLEDLFDLCDR---TFSLKTVLMIAIQLISRMEYVH 122
Query: 201 NCIGICHRDIKPQNLLV----NPHTHQLKLCDFGSAK 233
+ + +RD+KP+N L+ N + + DF AK
Sbjct: 123 SK-NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 75.9 bits (187), Expect = 1e-15
Identities = 42/155 (27%), Positives = 68/155 (43%), Gaps = 14/155 (9%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN--RELQIMQMLDH-PNIVAL 140
Y +G+GSFG ++ GE VAIK ++ E +I +M+ I +
Sbjct: 11 YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTI 70
Query: 141 KHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 200
+ C E Y +V+E + ++ + SR + L V L Q+ + YIH
Sbjct: 71 RWC-----GAEGDYNVMVMELLGPSLEDLFNFCSR---KFSLKTVLLLADQMISRIEYIH 122
Query: 201 NCIGICHRDIKPQNLLV--NPHTHQLKLCDFGSAK 233
+ HRD+KP N L+ + + + DFG AK
Sbjct: 123 SK-NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 75.4 bits (185), Expect = 5e-15
Identities = 37/155 (23%), Positives = 71/155 (45%), Gaps = 14/155 (9%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN--RELQIMQML-DHPNIVAL 140
+ +G+GSFG ++ +T E VAIK ++ E +I ++L I +
Sbjct: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQGGTGIPNV 68
Query: 141 KHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 200
+ E Y LV++ + ++ + ++ +++ L V + Q+ + ++H
Sbjct: 69 RWF-----GVEGDYNVLVMDLLGPSLEDL---FNFCSRKLSLKTVLMLADQMINRVEFVH 120
Query: 201 NCIGICHRDIKPQNLLV--NPHTHQLKLCDFGSAK 233
+ HRDIKP N L+ +Q+ + DFG AK
Sbjct: 121 SK-SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 73.6 bits (181), Expect = 1e-14
Identities = 45/250 (18%), Positives = 81/250 (32%), Gaps = 49/250 (19%)
Query: 63 TGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK 122
G V+ G + ++ +G+G FG+++ A E A V + +
Sbjct: 27 EGKVLDDMEGNQ---------WVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQEN 77
Query: 123 N---RELQIMQMLDHPNIVALK--------------HCFFSTTDKEELYLNLVLEYVPET 165
EL+ Q + + + + T K Y +V+E +
Sbjct: 78 GPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGID 137
Query: 166 VNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNP-HTHQL 224
+ +I + V ++ L YIH H DIK NLL+ + Q+
Sbjct: 138 LQKI-SGQNG---TFKKSTVLQLGIRMLDVLEYIHEN-EYVHGDIKAANLLLGYKNPDQV 192
Query: 225 KLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAI------------DIWSTG 272
L D+G + + Y + G E+ T++ D+ G
Sbjct: 193 YLADYGLSYRYCPNGNHKQYQ----ENPRKGHNGTIEF-TSLDAHKGVALSRRSDVEILG 247
Query: 273 CVMAELLLGQ 282
M L G+
Sbjct: 248 YCMLRWLCGK 257
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 70.3 bits (173), Expect = 8e-14
Identities = 61/236 (25%), Positives = 93/236 (39%), Gaps = 56/236 (23%)
Query: 76 GNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR--------ELQ 127
N ++ + + +G G FGVV+ K VA+KK+ E++
Sbjct: 25 NNFDERPISVGGNKMGEGGFGVVY--KGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIK 82
Query: 128 IMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYS------RIHQRMP 181
+M H N+V L S+ + LV Y+P N S + P
Sbjct: 83 VMAKCQHENLVELLGF--SSDGDDLC---LVYVYMP--------NGSLLDRLSCLDGTPP 129
Query: 182 LIYVKLYTYQIC----RALAYIH-NCIGICHRDIKPQNLLV----NPHTHQLKLCDFGSA 232
L + +I + ++H N I HRDIK N+L+ K+ DFG A
Sbjct: 130 LSWHM--RCKIAQGAANGINFLHENHH-I-HRDIKSANILLDEAFTA-----KISDFGLA 180
Query: 233 KVLVKGEPNVSYICSR----Y-YRAPELIFGATEYTTAIDIWSTGCVMAELLLGQP 283
+ K + + SR Y APE + G E T DI+S G V+ E++ G P
Sbjct: 181 RASEKFA--QTVMTSRIVGTTAYMAPEALRG--EITPKSDIYSFGVVLLEIITGLP 232
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 69.5 bits (171), Expect = 2e-13
Identities = 51/219 (23%), Positives = 94/219 (42%), Gaps = 45/219 (20%)
Query: 87 EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR----ELQIMQMLDHPNIVAL-K 141
+ ++G G FG V++ R+ G VA+K+ + E++ + HP++V+L
Sbjct: 44 KFLIGHGVFGKVYKGVLRD-GAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIG 102
Query: 142 HCFFSTTDKEELYLNLVLEYVPETVNRIARN--YSRIHQRMPLIYVKLYTYQIC----RA 195
C E + L+ +Y+ N + Y M + + + +IC R
Sbjct: 103 FC------DERNEMILIYKYME---NGNLKRHLYGSDLPTMSMSWEQ--RLEICIGAARG 151
Query: 196 LAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY-----Y 250
L Y+H I HRD+K N+L++ + K+ DFG +K + + +++ + Y
Sbjct: 152 LHYLHTR-AIIHRDVKSINILLDENFVP-KITDFGISKKGTELDQ--THLSTVVKGTLGY 207
Query: 251 RAPELIFGATEY------TTAIDIWSTGCVMAELLLGQP 283
P EY T D++S G V+ E+L +
Sbjct: 208 IDP-------EYFIKGRLTEKSDVYSFGVVLFEVLCARS 239
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 67.9 bits (166), Expect = 1e-12
Identities = 46/252 (18%), Positives = 76/252 (30%), Gaps = 52/252 (20%)
Query: 64 GHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN 123
G +I + +G G FG ++ A + E V K +
Sbjct: 26 GEIITDMAAAA---------WKVGLPIGQGGFGCIYLA-DMNSSESVGSDAPCVVKVEPS 75
Query: 124 R------ELQIMQMLDHPNIVALK--------------HCFFSTTDKEELYLNLVLEYVP 163
EL+ Q P + + Y ++++
Sbjct: 76 DNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFG 135
Query: 164 ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNP-HTH 222
+ +I ++ R V + +I L YIH H DIK NLL+N +
Sbjct: 136 SDLQKIYEANAK---RFSRKTVLQLSLRILDILEYIHEH-EYVHGDIKASNLLLNYKNPD 191
Query: 223 QLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAI------------DIWS 270
Q+ L D+G A + +Y G E+ T+I D+
Sbjct: 192 QVYLVDYGLAYRYCPEGVHKAYA----ADPKRCHDGTIEF-TSIDAHNGVAPSRRGDLEI 246
Query: 271 TGCVMAELLLGQ 282
G M + L G
Sbjct: 247 LGYCMIQWLTGH 258
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 67.1 bits (164), Expect = 2e-12
Identities = 37/255 (14%), Positives = 78/255 (30%), Gaps = 56/255 (21%)
Query: 63 TGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETG--------EIVAIK- 113
TG V+ G + + + + G++++A T + ++K
Sbjct: 32 TGTVLTDKSGRQ---------WKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKL 82
Query: 114 -----------KVLQD--KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLE 160
Q K + + + + I ++ Y LVL
Sbjct: 83 DAKDGRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAIPTCMGFGV----HQDKYRFLVLP 138
Query: 161 YVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNP- 219
+ ++ + + V ++ AL ++H H ++ +N+ V+P
Sbjct: 139 SLGRSLQSALDVSPK--HVLSERSVLQVACRLLDALEFLHEN-EYVHGNVTAENIFVDPE 195
Query: 220 HTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAI------------D 267
Q+ L +G A +V+Y G E+ ++ D
Sbjct: 196 DQSQVTLAGYGFAFRYCPSGKHVAY---VEGSRSPHE-GDLEF-ISMDLHKGCGPSRRSD 250
Query: 268 IWSTGCVMAELLLGQ 282
+ S G M + L G
Sbjct: 251 LQSLGYCMLKWLYGF 265
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 2e-12
Identities = 58/221 (26%), Positives = 106/221 (47%), Gaps = 48/221 (21%)
Query: 87 EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR-----ELQIMQMLDHPNIVALK 141
++++G G FG V++ + G +VA+K++ +++ E++++ M H N++ L+
Sbjct: 35 KNILGRGGFGKVYKGRL-ADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLR 93
Query: 142 HCFFSTTDKEELYLNLVLEYVPETVNRIARNYS-------RIHQRMPLIYVKLYTYQIC- 193
T E L LV Y+ N S R + PL + K +I
Sbjct: 94 GF--CMTPTERL---LVYPYMA--------NGSVASCLRERPESQPPLDWPK--RQRIAL 138
Query: 194 ---RALAYIHN-C-IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR 248
R LAY+H+ C I HRD+K N+L++ + + DFG AK++ + +++ +
Sbjct: 139 GSARGLAYLHDHCDPKIIHRDVKAANILLD-EEFEAVVGDFGLAKLM---DYKDTHVTTA 194
Query: 249 Y-----YRAPE-LIFG-ATEYTTAIDIWSTGCVMAELLLGQ 282
+ APE L G ++E T D++ G ++ EL+ GQ
Sbjct: 195 VRGTIGHIAPEYLSTGKSSEKT---DVFGYGVMLLELITGQ 232
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 56.5 bits (136), Expect = 4e-09
Identities = 34/127 (26%), Positives = 59/127 (46%), Gaps = 29/127 (22%)
Query: 188 YTYQICRALAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYI 245
Y++Q+ + + ++ CI HRD+ +N+L++ + +K+CDFG A+ + K
Sbjct: 198 YSFQVAKGMEFLASRKCI---HRDLAARNILLS-EKNVVKICDFGLARDIYKDP------ 247
Query: 246 CSRYYR------------APELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVD 292
Y APE IF YT D+WS G ++ E+ LG +PG +
Sbjct: 248 ---DYVRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE 303
Query: 293 QLVEIIK 299
+ +K
Sbjct: 304 EFCRRLK 310
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 394 | |||
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.97 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.93 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.9 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.85 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.73 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.3 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.16 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.04 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.01 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.69 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.61 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.43 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.35 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.21 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.21 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.12 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.03 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.78 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.77 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.68 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.53 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.51 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.47 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.35 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.34 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.26 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.23 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.15 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.12 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.79 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.53 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 95.28 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 94.22 |
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-63 Score=444.31 Aligned_cols=250 Identities=28% Similarity=0.415 Sum_probs=201.6
Q ss_pred ceeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccc-------hhhhHHHHHHHHHcCCCCeeeeceEEEecCCCcee
Q 016184 81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL 153 (394)
Q Consensus 81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 153 (394)
.++|++.+.||+|+||+||+|+++.+|+.||||++.+. ...+.+|+++++.++||||+++++++. ...
T Consensus 12 ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~-----~~~ 86 (275)
T 3hyh_A 12 IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIK-----SKD 86 (275)
T ss_dssp --CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEE-----CSS
T ss_pred eeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEE-----ECC
Confidence 35699999999999999999999999999999998543 234568999999999999999999983 334
Q ss_pred EEEEEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCcc
Q 016184 154 YLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK 233 (394)
Q Consensus 154 ~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~ 233 (394)
.+|+||||++|+|.+.+.. ...+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+|+
T Consensus 87 ~~~ivmEy~~g~L~~~l~~----~~~l~e~~~~~~~~qi~~al~ylH~-~~IiHRDiKP~NILl~~~~-~vkl~DFGla~ 160 (275)
T 3hyh_A 87 EIIMVIEYAGNELFDYIVQ----RDKMSEQEARRFFQQIISAVEYCHR-HKIVHRDLKPENLLLDEHL-NVKIADFGLSN 160 (275)
T ss_dssp EEEEEEECCCEEHHHHHHH----SCSCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCTTTEEECTTC-CEEECCSSCC-
T ss_pred EEEEEEeCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCcccccCChHHeEECCCC-CEEEeecCCCe
Confidence 5889999999988777654 4689999999999999999999999 8999999999999999888 69999999998
Q ss_pred ccccCCCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccC
Q 016184 234 VLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 313 (394)
Q Consensus 234 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 313 (394)
.........+.+||+.|||||++.+...++.++|||||||++|+|+||+.||.+.+....+..+....
T Consensus 161 ~~~~~~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~------------ 228 (275)
T 3hyh_A 161 IMTDGNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGV------------ 228 (275)
T ss_dssp --------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC------------
T ss_pred ecCCCCccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCC------------
Confidence 77665556678899999999999776656789999999999999999999998877666666655421
Q ss_pred CCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 016184 314 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE 370 (394)
Q Consensus 314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~ 370 (394)
.. ++..+|+++++||.+||+.||++|||++|+|+||||+.
T Consensus 229 -----~~------------~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hpw~k~ 268 (275)
T 3hyh_A 229 -----YT------------LPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQDDWFKV 268 (275)
T ss_dssp -----CC------------CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHCHHHHT
T ss_pred -----CC------------CCCCCCHHHHHHHHHHccCChhHCcCHHHHHcCccccc
Confidence 11 12457999999999999999999999999999999974
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-62 Score=451.11 Aligned_cols=255 Identities=27% Similarity=0.424 Sum_probs=217.4
Q ss_pred eeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccc----hhhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEEEE
Q 016184 82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL 157 (394)
Q Consensus 82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 157 (394)
..|++.+.||+|+||+||+|+++.+|+.||||++... ...+.+|+++|+.++|||||+++++|.. ...+||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~-----~~~~~i 148 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLV-----GDELWV 148 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEE-----TTEEEE
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEE-----CCEEEE
Confidence 3599999999999999999999999999999998532 3446789999999999999999999844 334889
Q ss_pred EEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCccccc
Q 016184 158 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV 236 (394)
Q Consensus 158 v~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~ 236 (394)
|||||++ +|.+++.. ..+++..++.++.||+.||+|||+ +|||||||||+||||+.++ .+||+|||+|+...
T Consensus 149 vmEy~~gg~L~~~l~~-----~~l~e~~~~~~~~qi~~aL~ylH~-~~IiHRDlKp~NILl~~~g-~vKl~DFGla~~~~ 221 (346)
T 4fih_A 149 VMEFLEGGALTDIVTH-----TRMNEEQIAAVCLAVLQALSVLHA-QGVIHRDIKSDSILLTHDG-RVKLSDFGFCAQVS 221 (346)
T ss_dssp EECCCTTEEHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECTTC-CEEECCCTTCEECC
T ss_pred EEeCCCCCcHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH-CCcccccCCHHHEEECCCC-CEEEecCcCceecC
Confidence 9999985 77776654 679999999999999999999999 8999999999999999988 69999999998765
Q ss_pred cC-CCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCC
Q 016184 237 KG-EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 315 (394)
Q Consensus 237 ~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 315 (394)
.. ......+||+.|||||++.+. .|+.++|||||||++|||++|+.||.+.+..+.+..+........
T Consensus 222 ~~~~~~~~~~GTp~YmAPEvl~~~-~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~---------- 290 (346)
T 4fih_A 222 KEVPRRKSLVGTPYWMAPELISRL-PYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRL---------- 290 (346)
T ss_dssp SSSCCBCCCCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCC----------
T ss_pred CCCCcccccccCcCcCCHHHHCCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCC----------
Confidence 43 334567899999999999654 489999999999999999999999998887777766654211000
Q ss_pred CcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCC
Q 016184 316 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 375 (394)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~ 375 (394)
.....+|+++++||.+||++||++|||++|+|+||||++...+.
T Consensus 291 ----------------~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~Hp~~~~~~~p~ 334 (346)
T 4fih_A 291 ----------------KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGPPA 334 (346)
T ss_dssp ----------------SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCCCGG
T ss_pred ----------------CccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhcCCCCCc
Confidence 01246899999999999999999999999999999999875443
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-62 Score=444.77 Aligned_cols=254 Identities=31% Similarity=0.523 Sum_probs=218.6
Q ss_pred eeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccc-------hhhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeE
Q 016184 82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY 154 (394)
Q Consensus 82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 154 (394)
.+|+++++||+|+||+||+|+++.+|+.||||++.+. .....+|+++|+.++|||||+++++| .+...
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~-----~~~~~ 106 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTF-----QDDEK 106 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEE-----ECSSE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE-----EeCCE
Confidence 3599999999999999999999999999999998643 23456899999999999999999998 33445
Q ss_pred EEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCcc
Q 016184 155 LNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK 233 (394)
Q Consensus 155 ~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~ 233 (394)
+|+|||||+| +|.+++.. .+.+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+|+
T Consensus 107 ~yivmEy~~gG~L~~~i~~----~~~l~e~~~~~~~~qi~~al~ylH~-~~IiHRDlKPeNILl~~~g-~vKl~DFGla~ 180 (311)
T 4aw0_A 107 LYFGLSYAKNGELLKYIRK----IGSFDETCTRFYTAEIVSALEYLHG-KGIIHRDLKPENILLNEDM-HIQITDFGTAK 180 (311)
T ss_dssp EEEEECCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECTTS-CEEECCCTTCE
T ss_pred EEEEEecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCCccCCCCHHHeEEcCCC-CEEEEEcCCce
Confidence 8899999985 88777754 3689999999999999999999999 8999999999999999988 69999999998
Q ss_pred ccccCC---CcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhh
Q 016184 234 VLVKGE---PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 310 (394)
Q Consensus 234 ~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 310 (394)
...... ...+.+||+.|||||++.+.. |+.++|||||||++|+|+||+.||.+.+..+.+..+.+.
T Consensus 181 ~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~-y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~---------- 249 (311)
T 4aw0_A 181 VLSPESKQARANSFVGTAQYVSPELLTEKS-ACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKL---------- 249 (311)
T ss_dssp ECCTTTTCCCBCCCCSCGGGCCHHHHHHSC-BCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT----------
T ss_pred ecCCCCCcccccCcccCcccCCHHHHcCCC-CCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcC----------
Confidence 764332 234568999999999997654 899999999999999999999999988877777777652
Q ss_pred ccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHH------HhcCCCCCCCCCCCC
Q 016184 311 CMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALE------ACVHPFFDELRDPNT 376 (394)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e------ll~hp~f~~~~~~~~ 376 (394)
.+. ++..+++++++||++||++||.+|||++| +++||||+++....+
T Consensus 250 -------~~~------------~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~idw~~l 302 (311)
T 4aw0_A 250 -------EYD------------FPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENL 302 (311)
T ss_dssp -------CCC------------CCTTCCHHHHHHHHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCTTG
T ss_pred -------CCC------------CCcccCHHHHHHHHHHccCCHhHCcChHHHcCCHHHHCCCCcCCCCHHHh
Confidence 111 22468999999999999999999999987 589999999976655
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-62 Score=452.05 Aligned_cols=255 Identities=26% Similarity=0.385 Sum_probs=210.4
Q ss_pred ccceeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccc------hhhhHHHHHHHHHcCCCCeeeeceEEEecCCCce
Q 016184 79 KQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE 152 (394)
Q Consensus 79 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 152 (394)
...++|++++.||+|+||+||+|+++.+|+.||||++... ...+.+|+++|+.++|||||++++++.. .
T Consensus 21 ~sme~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~-----~ 95 (350)
T 4b9d_A 21 QSMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEE-----N 95 (350)
T ss_dssp SCCCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE-----T
T ss_pred CcccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEE-----C
Confidence 3346799999999999999999999999999999998643 2345689999999999999999999843 3
Q ss_pred eEEEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecC
Q 016184 153 LYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS 231 (394)
Q Consensus 153 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~ 231 (394)
..+|||||||+| +|.+++.... ...+++..++.++.||+.||+|||+ +|||||||||+||||+.++ .+||+|||+
T Consensus 96 ~~~yiVmEy~~gg~L~~~i~~~~--~~~~~e~~~~~~~~qi~~aL~ylH~-~~IiHRDlKp~NILl~~~g-~vKl~DFGl 171 (350)
T 4b9d_A 96 GSLYIVMDYCEGGDLFKRINAQK--GVLFQEDQILDWFVQICLALKHVHD-RKILHRDIKSQNIFLTKDG-TVQLGDFGI 171 (350)
T ss_dssp TEEEEEEECCTTCBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHH-TTCEETTCCGGGEEECTTC-CEEECSTTE
T ss_pred CEEEEEEeCCCCCcHHHHHHHcC--CCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeccCCHHHEEECCCC-CEEEccccc
Confidence 458899999984 8888776432 3567999999999999999999999 8999999999999999988 699999999
Q ss_pred ccccccCCC-cccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhh
Q 016184 232 AKVLVKGEP-NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 310 (394)
Q Consensus 232 a~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 310 (394)
|+....... ....+||+.|||||++.+. .|+.++|||||||++|+|+||+.||.+.+..+.+..+....-.
T Consensus 172 a~~~~~~~~~~~~~~GT~~YmAPE~l~~~-~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~------- 243 (350)
T 4b9d_A 172 ARVLNSTVELARACIGTPYYLSPEICENK-PYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFP------- 243 (350)
T ss_dssp ESCCCHHHHHHHHHHSCCTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCC-------
T ss_pred ceeecCCcccccccCCCccccCHHHHCCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCC-------
Confidence 987643322 2346799999999999765 4899999999999999999999999998887777777652110
Q ss_pred ccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 016184 311 CMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL 371 (394)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 371 (394)
.++..+|+++++||.+||+.||++|||++|+|+||||++-
T Consensus 244 ---------------------~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~ 283 (350)
T 4b9d_A 244 ---------------------PVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFIAKR 283 (350)
T ss_dssp ---------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHTT
T ss_pred ---------------------CCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCHHhhcC
Confidence 0124579999999999999999999999999999999863
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-61 Score=454.37 Aligned_cols=287 Identities=37% Similarity=0.651 Sum_probs=237.4
Q ss_pred eEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccch------hhhHHHHHHHHHcCCCCeeeeceEEEecCC-CceeEE
Q 016184 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTD-KEELYL 155 (394)
Q Consensus 83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~~~~~~ 155 (394)
+|++++.||+|+||+||+|+++.+|+.||||++.+.. ....+|+++|+.++|||||++++++..... .+...+
T Consensus 55 ~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~~ 134 (398)
T 4b99_A 55 EYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKSV 134 (398)
T ss_dssp SEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCCE
T ss_pred CeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCEE
Confidence 5999999999999999999999999999999986432 234579999999999999999998744321 234558
Q ss_pred EEEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCcccc
Q 016184 156 NLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL 235 (394)
Q Consensus 156 ~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~ 235 (394)
|||||||+|+|.+++.. .+.+++..++.++.||+.||+|||+ +|||||||||+|||++.++ .+||+|||+|+..
T Consensus 135 ~ivmE~~~g~L~~~i~~----~~~l~~~~~~~~~~qil~al~ylH~-~~iiHRDlKP~NIl~~~~~-~~Ki~DFGla~~~ 208 (398)
T 4b99_A 135 YVVLDLMESDLHQIIHS----SQPLTLEHVRYFLYQLLRGLKYMHS-AQVIHRDLKPSNLLVNENC-ELKIGDFGMARGL 208 (398)
T ss_dssp EEEEECCSEEHHHHHTS----SSCCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCCGGGEEECTTC-CEEECCCTTCBCC
T ss_pred EEEEeCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CcCcCCCcCccccccCCCC-CEEEeecceeeec
Confidence 89999999988776643 4789999999999999999999999 8999999999999999988 6999999999865
Q ss_pred ccC-----CCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhh
Q 016184 236 VKG-----EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 310 (394)
Q Consensus 236 ~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 310 (394)
... ......+||+.|||||++.+...++.++||||+||++|+|++|++||.+.+..+.+..|....+.++...+.
T Consensus 209 ~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~ 288 (398)
T 4b99_A 209 CTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQ 288 (398)
T ss_dssp -------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC
T ss_pred ccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhh
Confidence 332 233467899999999999877778999999999999999999999999999999999999999998877654
Q ss_pred ccCCCCc---ccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCC
Q 016184 311 CMNPNYT---EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNT 376 (394)
Q Consensus 311 ~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~ 376 (394)
....... ...++.....+|...+ ..+++++.+||.+||++||.+|||++|+|+||||++..++..
T Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~p~~ 356 (398)
T 4b99_A 289 AVGAERVRAYIQSLPPRQPVPWETVY-PGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYHDPDD 356 (398)
T ss_dssp -----CHHHHHHSSCCCCCCCHHHHS-TTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTTCCGGG
T ss_pred hhhhhhhhhhhhcCCCcCCCCHHHhC-CCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcCCCCcc
Confidence 3321111 1123333444555544 468999999999999999999999999999999999887654
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-61 Score=453.38 Aligned_cols=255 Identities=27% Similarity=0.424 Sum_probs=217.5
Q ss_pred eeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccc----hhhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEEEE
Q 016184 82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL 157 (394)
Q Consensus 82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 157 (394)
..|++++.||+|+||.||+|+++.+|+.||||++... ...+.+|+.+|+.++|||||+++++|... ..+||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~-----~~~~i 225 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVG-----DELWV 225 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEET-----TEEEE
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEEC-----CEEEE
Confidence 4599999999999999999999999999999998532 34567899999999999999999998543 34889
Q ss_pred EEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCccccc
Q 016184 158 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV 236 (394)
Q Consensus 158 v~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~ 236 (394)
|||||+| +|.+++.. ..+++..++.++.||+.||+|||+ +|||||||||+||||+.++ .+||+|||+|+...
T Consensus 226 VmEy~~gG~L~~~i~~-----~~l~e~~~~~~~~qil~aL~ylH~-~~IiHRDiKp~NILl~~~g-~vKl~DFGla~~~~ 298 (423)
T 4fie_A 226 VMEFLEGGALTDIVTH-----TRMNEEQIAAVCLAVLQALSVLHA-QGVIHRDIKSDSILLTHDG-RVKLSDFGFCAQVS 298 (423)
T ss_dssp EEECCTTEEHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSTTTEEECTTC-CEEECCCTTCEECC
T ss_pred EEeCCCCCcHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHHH-CCeecccCCHHHEEEcCCC-CEEEecCccceECC
Confidence 9999985 77776653 679999999999999999999999 8999999999999999988 69999999998765
Q ss_pred cC-CCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCC
Q 016184 237 KG-EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 315 (394)
Q Consensus 237 ~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 315 (394)
.. ......+||+.|||||++.+. .|+.++|||||||++|||++|+.||.+.+..+.+..+........
T Consensus 299 ~~~~~~~~~~GTp~YmAPEvl~~~-~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~---------- 367 (423)
T 4fie_A 299 KEVPRRKSLVGTPYWMAPELISRL-PYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRL---------- 367 (423)
T ss_dssp SSCCCBCCCEECTTTCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCC----------
T ss_pred CCCccccccccCcCcCCHHHHCCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCC----------
Confidence 43 334567899999999999654 489999999999999999999999998887777766654211000
Q ss_pred CcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCC
Q 016184 316 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 375 (394)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~ 375 (394)
.....+|+++++||.+||+.||++|||++|+|+||||++...+.
T Consensus 368 ----------------~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~Hp~~~~~~~p~ 411 (423)
T 4fie_A 368 ----------------KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGPPA 411 (423)
T ss_dssp ----------------SCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCCCGG
T ss_pred ----------------cccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHHhcCCCCCc
Confidence 01146899999999999999999999999999999999865443
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-60 Score=429.15 Aligned_cols=251 Identities=23% Similarity=0.341 Sum_probs=207.6
Q ss_pred EEEeeEEeecCceEEEEEEECCCCcEEEEEEeccc------hhhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEEEE
Q 016184 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL 157 (394)
Q Consensus 84 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 157 (394)
|++.++||+|+||+||+|+++.+++.||+|++... ...+.+|+++++.++|||||+++++|.... ....+++|
T Consensus 28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~-~~~~~~~l 106 (290)
T 3fpq_A 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV-KGKKCIVL 106 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEE-TTEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeecc-CCCcEEEE
Confidence 47888999999999999999999999999998543 234568999999999999999999885433 23456789
Q ss_pred EEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCC--ceeccCCCCceEEeC-CCCcEEEEeecCcc
Q 016184 158 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG--ICHRDIKPQNLLVNP-HTHQLKLCDFGSAK 233 (394)
Q Consensus 158 v~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~g--ivH~Dlkp~Nil~~~-~~~~vkl~Dfg~a~ 233 (394)
|||||++ +|.+++.. ...+++..++.++.||+.||+|||+ +| |+||||||+|||++. ++ .+||+|||+|+
T Consensus 107 vmEy~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~ylH~-~~~~IiHRDlKp~NILl~~~~g-~vKl~DFGla~ 180 (290)
T 3fpq_A 107 VTELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLHT-RTPPIIHRDLKCDNIFITGPTG-SVKIGDLGLAT 180 (290)
T ss_dssp EEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHT-SSSCCCCCCCCGGGEEESSTTS-CEEECCTTGGG
T ss_pred EEeCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCCCEEecccChhheeEECCCC-CEEEEeCcCCE
Confidence 9999985 78777754 4689999999999999999999999 78 999999999999985 55 79999999997
Q ss_pred ccccCCCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccC
Q 016184 234 VLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 313 (394)
Q Consensus 234 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 313 (394)
.. ........+||+.|||||++.+ .|+.++|||||||++|+|+||+.||.+......+...+..... +
T Consensus 181 ~~-~~~~~~~~~GTp~YmAPE~~~~--~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~-~-------- 248 (290)
T 3fpq_A 181 LK-RASFAKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVK-P-------- 248 (290)
T ss_dssp GC-CTTSBEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCC-C--------
T ss_pred eC-CCCccCCcccCccccCHHHcCC--CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCC-C--------
Confidence 54 3334456789999999999854 4899999999999999999999999877665554443321111 1
Q ss_pred CCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 016184 314 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE 370 (394)
Q Consensus 314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~ 370 (394)
..++..+++++++||.+||+.||++|||++|+|+||||++
T Consensus 249 -----------------~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~Hp~~~~ 288 (290)
T 3fpq_A 249 -----------------ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288 (290)
T ss_dssp -----------------GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred -----------------CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccC
Confidence 1123457899999999999999999999999999999986
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-60 Score=438.40 Aligned_cols=258 Identities=25% Similarity=0.354 Sum_probs=215.2
Q ss_pred ceeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccchhhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEEEEEEe
Q 016184 81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLE 160 (394)
Q Consensus 81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e 160 (394)
...|++.++||+|+||+||+|+++.+|+.||||++..+.. ..+|+.+++.++|||||++++++. +..++|||||
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-~~~E~~il~~l~HpnIV~l~~~~~-----~~~~~~ivmE 130 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-RVEELVACAGLSSPRIVPLYGAVR-----EGPWVNIFME 130 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-CTHHHHTTTTCCCTTBCCEEEEEE-----ETTEEEEEEC
T ss_pred hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-HHHHHHHHHhCCCCCCCcEEEEEE-----ECCEEEEEEe
Confidence 3469999999999999999999999999999999876443 357999999999999999999984 3345889999
Q ss_pred cccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCccccccCC
Q 016184 161 YVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE 239 (394)
Q Consensus 161 ~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~~~ 239 (394)
||+| +|.+++.. ...+++..++.++.||+.||+|||+ +|||||||||+||||+.++..+||+|||+|+......
T Consensus 131 y~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~ylH~-~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~ 205 (336)
T 4g3f_A 131 LLEGGSLGQLIKQ----MGCLPEDRALYYLGQALEGLEYLHT-RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDG 205 (336)
T ss_dssp CCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHT-TTEECSCCCGGGEEECTTSCCEEECCCTTCEEC----
T ss_pred ccCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCC
Confidence 9985 88887764 3679999999999999999999999 8999999999999999887569999999998764432
Q ss_pred C------cccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccC
Q 016184 240 P------NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 313 (394)
Q Consensus 240 ~------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 313 (394)
. ....+||+.|||||++.+. .|+.++|||||||++|+|+||+.||.+.+....+..+... .++.
T Consensus 206 ~~~~~~~~~~~~GT~~YmAPE~~~~~-~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~--~~~~------- 275 (336)
T 4g3f_A 206 LGKSLLTGDYIPGTETHMAPEVVMGK-PCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASE--PPPI------- 275 (336)
T ss_dssp --------CCCCCCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHS--CCGG-------
T ss_pred cccceecCCccccCccccCHHHHCCC-CCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcC--CCCc-------
Confidence 1 1235799999999999765 4999999999999999999999999987766666665541 1100
Q ss_pred CCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHH-------------hcCCCCCCCCCCCC
Q 016184 314 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEA-------------CVHPFFDELRDPNT 376 (394)
Q Consensus 314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~el-------------l~hp~f~~~~~~~~ 376 (394)
..++..+++++.+||.+||++||.+|||+.|+ |+|||+++.++|.-
T Consensus 276 -----------------~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~~~~Pr~ 334 (336)
T 4g3f_A 276 -----------------REIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGEYKEPRG 334 (336)
T ss_dssp -----------------GGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSSCCCCCC
T ss_pred -----------------hhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCCCCCCCC
Confidence 11235689999999999999999999999997 68999999887653
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-61 Score=437.87 Aligned_cols=264 Identities=29% Similarity=0.434 Sum_probs=213.0
Q ss_pred eeEEEeeEEeecCceEEEEEEEC---CCCcEEEEEEeccc------hhhhHHHHHHHHHcCCCCeeeeceEEEecCCCce
Q 016184 82 VSYIAEHVVGTGSFGVVFQAKCR---ETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE 152 (394)
Q Consensus 82 ~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 152 (394)
.+|++++.||+|+||+||+|++. .+++.||||++.+. .....+|+++++.++|||||++++++.. .
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~-----~ 98 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQT-----E 98 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEE-----T
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE-----C
Confidence 46999999999999999999984 46789999998542 2345679999999999999999999843 3
Q ss_pred eEEEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecC
Q 016184 153 LYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS 231 (394)
Q Consensus 153 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~ 231 (394)
..+|+|||||+| +|.+++.. ...+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+
T Consensus 99 ~~~~ivmEy~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~ylH~-~~IiHRDlKp~NILl~~~g-~vKl~DFGl 172 (304)
T 3ubd_A 99 GKLYLILDFLRGGDLFTRLSK----EVMFTEEDVKFYLAELALALDHLHS-LGIIYRDLKPENILLDEEG-HIKLTDFGL 172 (304)
T ss_dssp TEEEEEECCCTTCEEHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSSCCGGGEEECTTS-CEEEESSEE
T ss_pred CEEEEEEEcCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCCcCCCCCHHHeEEcCCC-CEEeccccc
Confidence 458899999985 78777654 3679999999999999999999999 8999999999999999988 699999999
Q ss_pred ccccccC-CCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhh
Q 016184 232 AKVLVKG-EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 310 (394)
Q Consensus 232 a~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 310 (394)
|+..... ....+.+||+.|||||++.+. .|+.++|||||||++|+|+||+.||.+.+..+.+..+.+..
T Consensus 173 a~~~~~~~~~~~~~~GT~~YmAPE~~~~~-~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~--------- 242 (304)
T 3ubd_A 173 SKESIDHEKKAYSFCGTVEYMAPEVVNRR-GHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAK--------- 242 (304)
T ss_dssp EEC-----CCCCSCCCCGGGCCHHHHHTS-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC---------
T ss_pred ceeccCCCccccccccCcccCCHHHhccC-CCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCC---------
Confidence 9865433 334567899999999999765 48999999999999999999999999988877777776521
Q ss_pred ccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCC-----HHHHhcCCCCCCCCCCCCCCCCCCCCC
Q 016184 311 CMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCT-----ALEACVHPFFDELRDPNTRLPNGRPLP 385 (394)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt-----~~ell~hp~f~~~~~~~~~~~~~~~~~ 385 (394)
.. ++..+|+++++||++||++||++||| ++|+++||||+++..... ..+..+
T Consensus 243 --------~~------------~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~idw~~l---~~~~~~ 299 (304)
T 3ubd_A 243 --------LG------------MPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTIDWNKL---YRREIH 299 (304)
T ss_dssp --------CC------------CCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTSGGGTTCCHHHH---HTTCSC
T ss_pred --------CC------------CCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcCccccCCCHHHH---HhCCCC
Confidence 11 12468999999999999999999998 589999999998854332 123344
Q ss_pred CCCC
Q 016184 386 PLFN 389 (394)
Q Consensus 386 ~~~~ 389 (394)
|+|.
T Consensus 300 pP~~ 303 (304)
T 3ubd_A 300 PPFK 303 (304)
T ss_dssp CSSC
T ss_pred cCcC
Confidence 5553
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-58 Score=444.85 Aligned_cols=312 Identities=72% Similarity=1.242 Sum_probs=284.6
Q ss_pred ccceeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccchhhhHHHHHHHHHcCCCCeeeeceEEEecCC-CceeEEEE
Q 016184 79 KQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTD-KEELYLNL 157 (394)
Q Consensus 79 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~~~~~~~l 157 (394)
....+|++.++||+|+||.||+|++..+|+.||||++........+|+++++.++|+||+++++++..... ....++++
T Consensus 51 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~l 130 (420)
T 1j1b_A 51 PQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 130 (420)
T ss_dssp CEEEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTTSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEE
T ss_pred cccceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEe
Confidence 34557999999999999999999999999999999998777777789999999999999999998865433 45677889
Q ss_pred EEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCcccccc
Q 016184 158 VLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK 237 (394)
Q Consensus 158 v~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~ 237 (394)
||||+++++.+++..+......+++..++.++.||+.||+|||+ +||+||||||+|||++.++..+||+|||+++....
T Consensus 131 v~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~-~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~~ 209 (420)
T 1j1b_A 131 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS-FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR 209 (420)
T ss_dssp EEECCCEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT-TTEECSCCSGGGEEEETTTTEEEECCCTTCEECCT
T ss_pred ehhcccccHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCChhhEEEeCCCCeEEeccchhhhhccc
Confidence 99999999888888776767889999999999999999999999 89999999999999997765789999999987766
Q ss_pred CCCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCCCc
Q 016184 238 GEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 317 (394)
Q Consensus 238 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 317 (394)
........+|+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+.+..+++.++.+..+.+..+++++.
T Consensus 210 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~~~~~~ 289 (420)
T 1j1b_A 210 GEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYT 289 (420)
T ss_dssp TCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHHHCSCCC
T ss_pred CCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhhh
Confidence 66666778899999999997765699999999999999999999999999999999999999999999999999999999
Q ss_pred ccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCCCCCCCCCCCCCCCCC
Q 016184 318 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFK 391 (394)
Q Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~~~~~~~~~~~~~~~~ 391 (394)
.+.++.....+|...+...+++++.+||++||++||.+|||+.|+|+||||+++.++...++.....|++|+|+
T Consensus 290 ~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~~~~~~~~~~~~~~~ 363 (420)
T 1j1b_A 290 EFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVKLPNGRDTPALFNFT 363 (420)
T ss_dssp CCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGCTTCCCTTSCCCCCCCCCC
T ss_pred hhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhcccccccccCCCCCCCCccCCCC
Confidence 99999999999999998999999999999999999999999999999999999999998888888898988884
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-58 Score=436.39 Aligned_cols=309 Identities=70% Similarity=1.206 Sum_probs=282.2
Q ss_pred cceeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccchhhhHHHHHHHHHcCCCCeeeeceEEEecCC-CceeEEEEE
Q 016184 80 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTD-KEELYLNLV 158 (394)
Q Consensus 80 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~~~~~~~lv 158 (394)
...+|++.++||+|+||.||+|++..+++ ||+|++........+|+++++.++||||+++++++..... ....++++|
T Consensus 38 ~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~lv 116 (394)
T 4e7w_A 38 REIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLV 116 (394)
T ss_dssp EEEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTTSCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEEE
T ss_pred ccceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcchHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEEE
Confidence 34579999999999999999999977665 8999887777777789999999999999999999876654 556778899
Q ss_pred EecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEe-CCCCcEEEEeecCcccccc
Q 016184 159 LEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVN-PHTHQLKLCDFGSAKVLVK 237 (394)
Q Consensus 159 ~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~-~~~~~vkl~Dfg~a~~~~~ 237 (394)
|||+++++...+..+......+++..++.++.||+.||+|||+ +||+||||||+|||++ .++ .+||+|||+++....
T Consensus 117 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivHrDlkp~Nill~~~~~-~~kL~DFG~a~~~~~ 194 (394)
T 4e7w_A 117 LEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHS-IGICHRDIKPQNLLLDPPSG-VLKLIDFGSAKILIA 194 (394)
T ss_dssp EECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEETTTT-EEEECCCTTCEECCT
T ss_pred eeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHH-CCccCCCCCHHHEEEcCCCC-cEEEeeCCCcccccC
Confidence 9999998888777766667889999999999999999999999 8999999999999999 555 799999999988766
Q ss_pred CCCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCCCc
Q 016184 238 GEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 317 (394)
Q Consensus 238 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 317 (394)
........+|+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+.+..+.+.++.+..+.+..+++++.
T Consensus 195 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~ 274 (394)
T 4e7w_A 195 GEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNPNYM 274 (394)
T ss_dssp TCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCGGGS
T ss_pred CCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhhh
Confidence 66667788999999999997766799999999999999999999999999999999999999999999999999898888
Q ss_pred ccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCCCCCCCCCCCCCCCCC
Q 016184 318 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFK 391 (394)
Q Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~~~~~~~~~~~~~~~~ 391 (394)
...++.....++...+...+++++.+||.+||++||.+|||+.|+|+||||+++++.....+++...|++|+|+
T Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~~~~~~~~~~~~~~~ 348 (394)
T 4e7w_A 275 EHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELRTGEARMPNGRELPPLFNWT 348 (394)
T ss_dssp SSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTTSSCCCCTTSSCCCCSCCCC
T ss_pred hhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhccccccCCCCCCCCCcCCCC
Confidence 88999999999999998899999999999999999999999999999999999999999999999999999885
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-58 Score=439.62 Aligned_cols=310 Identities=52% Similarity=1.008 Sum_probs=270.4
Q ss_pred eeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccchhhhHHHHHHHHHcCCCCeeeeceEEEecCC------------
Q 016184 82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTD------------ 149 (394)
Q Consensus 82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~------------ 149 (394)
.+|++.+.||+|+||.||+|++..+|+.||||++..+.....+|+++++.++||||+++++++.....
T Consensus 7 ~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~ 86 (383)
T 3eb0_A 7 KKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDH 86 (383)
T ss_dssp TTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTSCCHHHHHHTTCCCTTBCCEEEEEEEC--------------
T ss_pred ceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcchHHHHHHHHHHcCCCCccchhheeeecCccccccccccccc
Confidence 45999999999999999999999999999999998877777899999999999999999999866443
Q ss_pred ---------------------CceeEEEEEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceec
Q 016184 150 ---------------------KEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHR 208 (394)
Q Consensus 150 ---------------------~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~ 208 (394)
....+.++||||++++|.+.+..+......+++..++.++.||+.||+|||+ .||+||
T Consensus 87 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~gi~H~ 165 (383)
T 3eb0_A 87 NKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHS-LGICHR 165 (383)
T ss_dssp -----------------------CCEEEEEECCCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT-TTEECS
T ss_pred ccccccccccccccccccccCCCceEEEEEEecCCccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CcCccC
Confidence 3455688999999999998888877777899999999999999999999999 899999
Q ss_pred cCCCCceEEeCCCCcEEEEeecCccccccCCCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 016184 209 DIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGE 288 (394)
Q Consensus 209 Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~ 288 (394)
||||+|||++.+...+||+|||+++............+|+.|+|||++.+...++.++|||||||++|+|++|+.||.+.
T Consensus 166 Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~ 245 (383)
T 3eb0_A 166 DIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLFSGE 245 (383)
T ss_dssp CCCGGGEEEETTTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ccCHHHEEEcCCCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHhCCCCCCCC
Confidence 99999999985434899999999987766666667788999999999877666899999999999999999999999999
Q ss_pred CcHHHHHHHHHHhCCCChhhhhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 016184 289 SGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368 (394)
Q Consensus 289 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f 368 (394)
+..+.+..+++.++.+..+.+..+++.+....++......|...++..+++++.+||.+||+.||.+|||+.|+|+||||
T Consensus 246 ~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f 325 (383)
T 3eb0_A 246 TSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEAMAHPFF 325 (383)
T ss_dssp SHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGG
T ss_pred ChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcCHHH
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCC-------CCCCCCCC--CCCCCCCCCCC
Q 016184 369 DELRD-------PNTRLPNG--RPLPPLFNFKP 392 (394)
Q Consensus 369 ~~~~~-------~~~~~~~~--~~~~~~~~~~~ 392 (394)
++++. ....++++ ...|++|+|++
T Consensus 326 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 358 (383)
T 3eb0_A 326 DHLRNSYESEVKNNSNFPHGVNQNIPQLFNFSP 358 (383)
T ss_dssp HHHHHC------------------CCCCSCCCH
T ss_pred HHHHhhccccccccccCCCcccCCCCCCCCCCH
Confidence 98765 45556666 67889999865
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-57 Score=427.88 Aligned_cols=278 Identities=27% Similarity=0.440 Sum_probs=212.5
Q ss_pred eeEEEeeEEeecCceEEEEEEEC---CCCcEEEEEEeccch--hhhHHHHHHHHHc-CCCCeeeeceEEEecCCCceeEE
Q 016184 82 VSYIAEHVVGTGSFGVVFQAKCR---ETGEIVAIKKVLQDK--RYKNRELQIMQML-DHPNIVALKHCFFSTTDKEELYL 155 (394)
Q Consensus 82 ~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~--~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~ 155 (394)
++|++.+.||+|+||+||+|+++ .+++.||||++.+.. ....+|+++|+.+ +||||++++++|. ...++
T Consensus 21 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~-----~~~~~ 95 (361)
T 4f9c_A 21 NVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSHPIRIAAELQCLTVAGGQDNVMGVKYCFR-----KNDHV 95 (361)
T ss_dssp GTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSCHHHHHHHHHHHHHTCSBTTBCCCSEEEE-----ETTEE
T ss_pred CcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccCHHHHHHHHHHHHHhcCCCCCceEEEEEE-----ECCEE
Confidence 45999999999999999999875 467899999886543 3456899999988 6999999999983 33458
Q ss_pred EEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCccc
Q 016184 156 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV 234 (394)
Q Consensus 156 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~ 234 (394)
|+||||+++ +|.+++ +.+++..++.++.||+.||+|||+ +||+||||||+|||++.+.+.+||+|||+|+.
T Consensus 96 ~lvmE~~~g~~L~~~~-------~~l~~~~~~~~~~qll~al~ylH~-~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~ 167 (361)
T 4f9c_A 96 VIAMPYLEHESFLDIL-------NSLSFQEVREYMLNLFKALKRIHQ-FGIVHRDVKPSNFLYNRRLKKYALVDFGLAQG 167 (361)
T ss_dssp EEEEECCCCCCHHHHH-------TTCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEEEeCCCcccHHHHH-------cCCCHHHHHHHHHHHHHHHHHHHH-CCeEeCcCCHHHeEEeCCCCeEEECcCCCCcc
Confidence 899999984 676554 358999999999999999999999 89999999999999998744899999999975
Q ss_pred cccCC-----------------------------CcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCC
Q 016184 235 LVKGE-----------------------------PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLF 285 (394)
Q Consensus 235 ~~~~~-----------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf 285 (394)
..... .....+||+.|+|||++.+...++.++||||+||++|+|++|+.||
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf 247 (361)
T 4f9c_A 168 THDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPF 247 (361)
T ss_dssp CTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSS
T ss_pred cCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCC
Confidence 43221 1223579999999999987777999999999999999999999998
Q ss_pred CC-CCcHHHHHHHHHHhCCCChhhhhccCCC-------C--------------cccCCCCCC----CCCcchhccccCCh
Q 016184 286 PG-ESGVDQLVEIIKVLGTPTREEIKCMNPN-------Y--------------TEFKFPQIK----PHPWHKVFQKRLPP 339 (394)
Q Consensus 286 ~~-~~~~~~~~~i~~~~~~~~~~~~~~~~~~-------~--------------~~~~~~~~~----~~~~~~~~~~~~~~ 339 (394)
.. .+..+++..+...+|.+........... . .....+... ...........+|+
T Consensus 248 ~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~ 327 (361)
T 4f9c_A 248 YKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPD 327 (361)
T ss_dssp SCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCH
T ss_pred CCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCH
Confidence 54 5666888888888775443222110000 0 000000000 00001112246899
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 016184 340 EAVDLVCRFFQYSPNLRCTALEACVHPFFDELR 372 (394)
Q Consensus 340 ~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 372 (394)
++++||++||++||++|+||+|+|+||||++++
T Consensus 328 ~a~DLl~~lL~~dP~~R~ta~eaL~Hp~f~~i~ 360 (361)
T 4f9c_A 328 EAYDLLDKLLDLNPASRITAEEALLHPFFKDMS 360 (361)
T ss_dssp HHHHHHHHHTCSCTTTSCCHHHHHTSGGGTTC-
T ss_pred HHHHHHHHHCcCChhHCcCHHHHhcCcccCCCC
Confidence 999999999999999999999999999999874
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-58 Score=417.30 Aligned_cols=261 Identities=23% Similarity=0.397 Sum_probs=194.0
Q ss_pred eeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccch-----hhhHHHHHHHHHcCCCCeeeeceEEEecCC-------
Q 016184 82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTD------- 149 (394)
Q Consensus 82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~------- 149 (394)
.+|++++.||+|+||+||+|+++.+|+.||||++.... ....+|+++|+.++|||||++++++.....
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 46999999999999999999999999999999985432 334579999999999999999999865443
Q ss_pred CceeEEEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEe
Q 016184 150 KEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCD 228 (394)
Q Consensus 150 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~D 228 (394)
....++|+|||||.+ +|.+++..... .....+..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~al~ylH~-~~IiHRDlKp~NILl~~~~-~vKl~D 161 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRCT-IEERERSVCLHIFLQIAEAVEFLHS-KGLMHRDLKPSNIFFTMDD-VVKVGD 161 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCCS-GGGSCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECTTC-CEEECC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcCC-CChhHHHHHHHHHHHHHHHHHHHHH-CcCccccCcHHHeEECCCC-cEEEcc
Confidence 234568999999985 78777764221 2335567788999999999999999 8999999999999999988 699999
Q ss_pred ecCccccccCCC-------------cccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHH
Q 016184 229 FGSAKVLVKGEP-------------NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLV 295 (394)
Q Consensus 229 fg~a~~~~~~~~-------------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~ 295 (394)
||+|+....... ....+||+.|||||++.+. .|+.++|||||||++|||++ ||.+. .+...
T Consensus 162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~-~y~~~~DiwSlGvilyell~---Pf~~~--~~~~~ 235 (299)
T 4g31_A 162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGN-SYSHKVDIFSLGLILFELLY---PFSTQ--MERVR 235 (299)
T ss_dssp CCCC--------------------------CCCTTSCHHHHTTC-CCCTHHHHHHHHHHHHHHHS---CCSSH--HHHHH
T ss_pred CccceecCCCccccccccccccccccCCcccCccccCHHHHcCC-CCCCHHHHHHHHHHHHHHcc---CCCCc--cHHHH
Confidence 999987643321 1235799999999999765 49999999999999999996 77543 22222
Q ss_pred HHHHHhCCCChhhhhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCC
Q 016184 296 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 375 (394)
Q Consensus 296 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~ 375 (394)
.+........+. .....++.+.+||++||+.||.+|||+.|+|+||||+++..+.
T Consensus 236 ~~~~~~~~~~p~-------------------------~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~~~~p~ 290 (299)
T 4g31_A 236 TLTDVRNLKFPP-------------------------LFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPG 290 (299)
T ss_dssp HHHHHHTTCCCH-------------------------HHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCCC----
T ss_pred HHHHHhcCCCCC-------------------------CCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCCCCCCC
Confidence 222221111100 0123467789999999999999999999999999999986554
Q ss_pred C
Q 016184 376 T 376 (394)
Q Consensus 376 ~ 376 (394)
.
T Consensus 291 ~ 291 (299)
T 4g31_A 291 K 291 (299)
T ss_dssp -
T ss_pred c
Confidence 3
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-56 Score=439.82 Aligned_cols=258 Identities=24% Similarity=0.370 Sum_probs=209.1
Q ss_pred ceeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccch-------hhhHHH---HHHHHHcCCCCeeeeceEEEecCCC
Q 016184 81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRE---LQIMQMLDHPNIVALKHCFFSTTDK 150 (394)
Q Consensus 81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E---~~~l~~l~h~~iv~~~~~~~~~~~~ 150 (394)
.++|+++++||+|+||+||+|+++.+|+.||||++.+.. ....+| +.+++.++|||||+++++| .
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f-----~ 262 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAF-----H 262 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEE-----E
T ss_pred hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEE-----E
Confidence 457999999999999999999999999999999986432 112233 4556667999999999998 3
Q ss_pred ceeEEEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEee
Q 016184 151 EELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDF 229 (394)
Q Consensus 151 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Df 229 (394)
....+|+|||||.| +|..++.. ...+++..++.++.||+.||+|||+ +|||||||||+||||+.+| .+||+||
T Consensus 263 ~~~~lylVmEy~~GGdL~~~l~~----~~~l~E~~a~~y~~qIl~aL~yLH~-~gIiHRDLKPeNILld~~G-~vKL~DF 336 (689)
T 3v5w_A 263 TPDKLSFILDLMNGGDLHYHLSQ----HGVFSEADMRFYAAEIILGLEHMHN-RFVVYRDLKPANILLDEHG-HVRISDL 336 (689)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHT-TTEECCCCSGGGEEECTTS-CEEECCC
T ss_pred ECCEEEEEEecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCchHHeEEeCCC-CEEeccc
Confidence 44458899999985 77777654 3679999999999999999999999 8999999999999999998 5999999
Q ss_pred cCccccccCCCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhh
Q 016184 230 GSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI 309 (394)
Q Consensus 230 g~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 309 (394)
|+|+..... ...+.+||+.|||||++.+...|+.++|||||||++|+|++|++||.+.+..+...........
T Consensus 337 GlA~~~~~~-~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~------ 409 (689)
T 3v5w_A 337 GLACDFSKK-KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTM------ 409 (689)
T ss_dssp TTCEECSSC-CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHC------
T ss_pred ceeeecCCC-CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCC------
Confidence 999876443 3456789999999999965556999999999999999999999999765332222111111100
Q ss_pred hccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCC-----HHHHhcCCCCCCCCCCCC
Q 016184 310 KCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCT-----ALEACVHPFFDELRDPNT 376 (394)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt-----~~ell~hp~f~~~~~~~~ 376 (394)
... ++..+|+++++||.+||++||.+|++ ++|+++||||+++.....
T Consensus 410 --------~~~------------~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~idW~~l 461 (689)
T 3v5w_A 410 --------AVE------------LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMV 461 (689)
T ss_dssp --------CCC------------CCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTTCCHHHH
T ss_pred --------CCC------------CCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccCCCHHHH
Confidence 011 23568999999999999999999998 799999999999865544
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-55 Score=435.32 Aligned_cols=261 Identities=26% Similarity=0.401 Sum_probs=221.0
Q ss_pred ceeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccc----hhhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEEE
Q 016184 81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN 156 (394)
Q Consensus 81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 156 (394)
.++|++++.||+|+||.||+|+++.+|+.||||++... .....+|+.+|+.++||||++++++| .....++
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~-----~~~~~~~ 230 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF-----EDDNEMV 230 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEE-----ECSSEEE
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEE-----EECCEEE
Confidence 35799999999999999999999999999999988643 23456799999999999999999998 3445588
Q ss_pred EEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCC-CCcEEEEeecCccc
Q 016184 157 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPH-THQLKLCDFGSAKV 234 (394)
Q Consensus 157 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~-~~~vkl~Dfg~a~~ 234 (394)
||||||.| +|.+.+.. ....+++..++.++.||+.||+|||+ +||+||||||+|||++.+ .+.+||+|||+|+.
T Consensus 231 iv~E~~~gg~L~~~i~~---~~~~l~e~~~~~~~~qi~~al~ylH~-~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~ 306 (573)
T 3uto_A 231 MIYEFMSGGELFEKVAD---EHNKMSEDEAVEYMRQVCKGLCHMHE-NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAH 306 (573)
T ss_dssp EEEECCCCCBHHHHHTC---TTSCEEHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEESSSSCCCEEECCCSSCEE
T ss_pred EEEeecCCCcHHHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeccCChhhccccCCCCCCEEEeeccceeE
Confidence 99999985 77655532 23679999999999999999999999 899999999999999864 23799999999998
Q ss_pred cccCCCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCC
Q 016184 235 LVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 314 (394)
Q Consensus 235 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 314 (394)
+.........+||+.|||||++.+. .|+.++|||||||++|+|++|+.||.+.+..+.+..+.......+.
T Consensus 307 ~~~~~~~~~~~GT~~y~APEv~~~~-~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~-------- 377 (573)
T 3uto_A 307 LDPKQSVKVTTGTAEFAAPEVAEGK-PVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDD-------- 377 (573)
T ss_dssp CCTTSEEEEECSSGGGCCHHHHTTC-CBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCS--------
T ss_pred ccCCCceeeeEECccccCHHHhCCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCc--------
Confidence 7666666677899999999999765 4899999999999999999999999998888777776653221111
Q ss_pred CCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCC
Q 016184 315 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNT 376 (394)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~ 376 (394)
.....+|+++++||++||++||.+|||+.|+|+||||+....+..
T Consensus 378 -----------------~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~Hpw~~~~~~~~~ 422 (573)
T 3uto_A 378 -----------------SAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGR 422 (573)
T ss_dssp -----------------GGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTSCCCCTTT
T ss_pred -----------------ccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcCcCCCCCCCc
Confidence 112468999999999999999999999999999999998776553
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-55 Score=399.41 Aligned_cols=254 Identities=23% Similarity=0.350 Sum_probs=206.2
Q ss_pred ceeEEEeeEEeecCceEEEEEEEC-----CCCcEEEEEEeccc----hhhhHHHHHHHHHcCCCCeeeeceEEEecCCCc
Q 016184 81 KVSYIAEHVVGTGSFGVVFQAKCR-----ETGEIVAIKKVLQD----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKE 151 (394)
Q Consensus 81 ~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 151 (394)
..+|.+.+.||+|+||+||+|++. .++..||||++... ...+.+|+++|++++|||||++++++...
T Consensus 12 r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~---- 87 (299)
T 4asz_A 12 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEG---- 87 (299)
T ss_dssp GGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS----
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeC----
Confidence 346999999999999999999875 35789999998643 23456899999999999999999998432
Q ss_pred eeEEEEEEeccc-ccHHHHHHHhh---------hhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCC
Q 016184 152 ELYLNLVLEYVP-ETVNRIARNYS---------RIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHT 221 (394)
Q Consensus 152 ~~~~~lv~e~~~-~~l~~~~~~~~---------~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~ 221 (394)
..+++|||||+ |+|.+++.... .....+++..+..++.||+.||+|||+ ++|+||||||+|||++.++
T Consensus 88 -~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~-~~iiHRDlKp~NILl~~~~ 165 (299)
T 4asz_A 88 -DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLAS-QHFVHRDLATRNCLVGENL 165 (299)
T ss_dssp -SSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECGGG
T ss_pred -CEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCccCHhhEEECCCC
Confidence 33789999998 58988887643 123579999999999999999999999 8999999999999999888
Q ss_pred CcEEEEeecCccccccCCCc---ccccccccccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHH
Q 016184 222 HQLKLCDFGSAKVLVKGEPN---VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEI 297 (394)
Q Consensus 222 ~~vkl~Dfg~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i 297 (394)
.+||+|||+|+........ ....||+.|||||++.+. .++.++|||||||++|||+| |+.||.+.+..+.+..+
T Consensus 166 -~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~-~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i 243 (299)
T 4asz_A 166 -LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYR-KFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECI 243 (299)
T ss_dssp -CEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHH
T ss_pred -cEEECCcccceecCCCCceeecCceecChhhcCHHHHcCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 6999999999865433221 234689999999999765 49999999999999999998 89999988877766666
Q ss_pred HHHhCCCChhhhhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 016184 298 IKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR 372 (394)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 372 (394)
.+... + ..+..+|+++.+||.+||+.||++|||+.++ |+|++++.
T Consensus 244 ~~~~~-~---------------------------~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i--~~~L~~~~ 288 (299)
T 4asz_A 244 TQGRV-L---------------------------QRPRTCPQEVYELMLGCWQREPHMRKNIKGI--HTLLQNLA 288 (299)
T ss_dssp HHTCC-C---------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH--HHHHHHHH
T ss_pred HcCCC-C---------------------------CCCccchHHHHHHHHHHcCCChhHCcCHHHH--HHHHHHHH
Confidence 54211 0 0124689999999999999999999999999 45777653
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-54 Score=400.39 Aligned_cols=248 Identities=23% Similarity=0.361 Sum_probs=197.8
Q ss_pred eeEEEeeEEeecCceEEEEEEEC-----CCCcEEEEEEeccc----hhhhHHHHHHHHHcCCCCeeeeceEEEecCCCce
Q 016184 82 VSYIAEHVVGTGSFGVVFQAKCR-----ETGEIVAIKKVLQD----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE 152 (394)
Q Consensus 82 ~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 152 (394)
.+|.+.++||+|+||+||+|+++ .+++.||||++... ...+.+|+++|++++|||||++++++.. .
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~-----~ 115 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTE-----G 115 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-----S
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE-----C
Confidence 35899999999999999999875 36889999998643 2345689999999999999999999843 3
Q ss_pred eEEEEEEeccc-ccHHHHHHHhhh-----------hcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCC
Q 016184 153 LYLNLVLEYVP-ETVNRIARNYSR-----------IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPH 220 (394)
Q Consensus 153 ~~~~lv~e~~~-~~l~~~~~~~~~-----------~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~ 220 (394)
..++||||||+ |+|.+++..... ....+++..+..++.||+.||+|||+ ++||||||||+||||+.+
T Consensus 116 ~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~-~~iiHRDLKp~NILl~~~ 194 (329)
T 4aoj_A 116 RPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAG-LHFVHRDLATRNCLVGQG 194 (329)
T ss_dssp SSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEEETT
T ss_pred CEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhc-CCeecccccHhhEEECCC
Confidence 33789999998 588888765322 23569999999999999999999999 899999999999999988
Q ss_pred CCcEEEEeecCccccccCCC---cccccccccccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHH
Q 016184 221 THQLKLCDFGSAKVLVKGEP---NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVE 296 (394)
Q Consensus 221 ~~~vkl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~ 296 (394)
+ .+||+|||+|+....... .....||+.|||||++.+. .++.++|||||||++|||+| |+.||.+.+..+.+..
T Consensus 195 ~-~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~-~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~ 272 (329)
T 4aoj_A 195 L-VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYR-KFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDC 272 (329)
T ss_dssp T-EEEECCCC----------------CCCCGGGCCHHHHTTC-CCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHH
T ss_pred C-cEEEcccccceeccCCCcceecCcccccccccChhhhcCC-CCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence 8 799999999986643322 2345789999999999655 49999999999999999999 8999998887776666
Q ss_pred HHHHhCCCChhhhhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 016184 297 IIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH 365 (394)
Q Consensus 297 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 365 (394)
+.+... + .++..+++++.+||.+||+.||++|||+.||+++
T Consensus 273 i~~g~~-~---------------------------~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~ 313 (329)
T 4aoj_A 273 ITQGRE-L---------------------------ERPRACPPEVYAIMRGCWQREPQQRHSIKDVHAR 313 (329)
T ss_dssp HHHTCC-C---------------------------CCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHH
T ss_pred HHcCCC-C---------------------------CCcccccHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 654211 0 0124689999999999999999999999999863
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-54 Score=394.83 Aligned_cols=245 Identities=20% Similarity=0.273 Sum_probs=194.3
Q ss_pred eeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccc------hhhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEE
Q 016184 82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL 155 (394)
Q Consensus 82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 155 (394)
.++++.+.||+|+||+||+|++. ..||||+++.. ...+.+|++++++++|||||++++++.. + .+
T Consensus 36 ~~l~l~~~iG~G~fG~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~----~--~~ 106 (307)
T 3omv_A 36 SEVMLSTRIGSGSFGTVYKGKWH---GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK----D--NL 106 (307)
T ss_dssp TSCCEEEECCCCSSSEEEEEESS---SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS----S--SC
T ss_pred HHeEEeeEEeeCCCcEEEEEEEC---CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC----C--eE
Confidence 35889999999999999999875 35999988532 2345689999999999999999997621 1 15
Q ss_pred EEEEeccc-ccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCccc
Q 016184 156 NLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV 234 (394)
Q Consensus 156 ~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~ 234 (394)
+||||||+ |+|.+++... ...+++..+..++.||+.||+|||+ ++||||||||+|||++.++ .+||+|||+|+.
T Consensus 107 ~iVmEy~~gGsL~~~l~~~---~~~l~~~~~~~i~~qia~gL~yLH~-~~IiHRDlKp~NILl~~~~-~~Ki~DFGla~~ 181 (307)
T 3omv_A 107 AIVTQWCEGSSLYKHLHVQ---ETKFQMFQLIDIARQTAQGMDYLHA-KNIIHRDMKSNNIFLHEGL-TVKIGDFGLATV 181 (307)
T ss_dssp EEEEECCSSCBHHHHHHTS---CCCCCHHHHHHHHHHHHHHHHHHHH-TTCBCSCCCSSSEEEETTE-EEEECCCSSCBC
T ss_pred EEEEEcCCCCCHHHHHhhc---CCCCCHHHHHHHHHHHHHHHHHHHH-CCccCCccCHHHEEECCCC-cEEEeeccCcee
Confidence 79999998 4887776542 3579999999999999999999999 8999999999999999888 799999999986
Q ss_pred cccCC---CcccccccccccccccccCC--CCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhh
Q 016184 235 LVKGE---PNVSYICSRYYRAPELIFGA--TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI 309 (394)
Q Consensus 235 ~~~~~---~~~~~~~t~~y~aPE~~~~~--~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 309 (394)
..... ......||+.|||||++.+. ..|+.++|||||||++|||+||+.||.+.+....+..+.......+.
T Consensus 182 ~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~--- 258 (307)
T 3omv_A 182 KSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPD--- 258 (307)
T ss_dssp ------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCC---
T ss_pred cccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCC---
Confidence 54322 23356799999999998643 34899999999999999999999999987777666655542211110
Q ss_pred hccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHh
Q 016184 310 KCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEAC 363 (394)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell 363 (394)
...++..+++++.+||.+||+.||++|||+.+++
T Consensus 259 --------------------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~ 292 (307)
T 3omv_A 259 --------------------LSKLYKNCPKAMKRLVADCVKKVKEERPLFPQIL 292 (307)
T ss_dssp --------------------STTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHH
T ss_pred --------------------cccccccchHHHHHHHHHHcCCCHhHCcCHHHHH
Confidence 0112356899999999999999999999998764
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-54 Score=395.82 Aligned_cols=247 Identities=20% Similarity=0.265 Sum_probs=202.4
Q ss_pred eEEEeeEEeecCceEEEEEEEC-----CCCcEEEEEEeccc-----hhhhHHHHHHHHHcCCCCeeeeceEEEecCCCce
Q 016184 83 SYIAEHVVGTGSFGVVFQAKCR-----ETGEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE 152 (394)
Q Consensus 83 ~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 152 (394)
.+++.++||+|+||+||+|++. .+++.||||++... ...+.+|+.++++++|||||++++++...
T Consensus 27 ~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~----- 101 (308)
T 4gt4_A 27 AVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKD----- 101 (308)
T ss_dssp GEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSS-----
T ss_pred HCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEEC-----
Confidence 4888999999999999999864 45789999998543 24567899999999999999999998432
Q ss_pred eEEEEEEeccc-ccHHHHHHHhh------------hhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeC
Q 016184 153 LYLNLVLEYVP-ETVNRIARNYS------------RIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNP 219 (394)
Q Consensus 153 ~~~~lv~e~~~-~~l~~~~~~~~------------~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~ 219 (394)
..+++|||||+ |+|.+++.... .....+++..+..++.||+.||+|||+ ++||||||||+||||+.
T Consensus 102 ~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~-~~iiHRDLK~~NILl~~ 180 (308)
T 4gt4_A 102 QPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSS-HHVVHKDLATRNVLVYD 180 (308)
T ss_dssp SSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECG
T ss_pred CEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh-CCCCCCCccccceEECC
Confidence 33779999998 58888886532 123568999999999999999999999 89999999999999998
Q ss_pred CCCcEEEEeecCccccccCC---CcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHH
Q 016184 220 HTHQLKLCDFGSAKVLVKGE---PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLV 295 (394)
Q Consensus 220 ~~~~vkl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~ 295 (394)
++ .+||+|||+|+...... ......||+.|||||++.+. .++.++|||||||++|||+| |..||.+.+..+.+.
T Consensus 181 ~~-~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~-~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~ 258 (308)
T 4gt4_A 181 KL-NVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYG-KFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVE 258 (308)
T ss_dssp GG-CEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHH
T ss_pred CC-CEEECCcccceeccCCCceeEecccccCCcccCHHHHhCC-CCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 88 69999999998664332 23346789999999999755 49999999999999999998 899999888766665
Q ss_pred HHHHHhCCCChhhhhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 016184 296 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH 365 (394)
Q Consensus 296 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 365 (394)
.+..... + ..+..+++++.+|+.+||+.||++|||+.||+++
T Consensus 259 ~i~~~~~-~---------------------------~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~ 300 (308)
T 4gt4_A 259 MIRNRQV-L---------------------------PCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSR 300 (308)
T ss_dssp HHHTTCC-C---------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHcCCC-C---------------------------CCcccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 5543111 0 0124689999999999999999999999999874
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-53 Score=399.67 Aligned_cols=303 Identities=49% Similarity=0.904 Sum_probs=251.4
Q ss_pred ceeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccchhh---hHHHHHHHHHcCCCCeeeeceEEEecCC--CceeEE
Q 016184 81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRY---KNRELQIMQMLDHPNIVALKHCFFSTTD--KEELYL 155 (394)
Q Consensus 81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~E~~~l~~l~h~~iv~~~~~~~~~~~--~~~~~~ 155 (394)
.++|++.+.||+|+||.||+|++..+|+.||||++...... ..+++..++.++||||+++++++..... ....+.
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~ 101 (360)
T 3e3p_A 22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYL 101 (360)
T ss_dssp HTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccccHHHHHHHHHHHhcCCCCcccHHHhhhccccccccceeE
Confidence 34699999999999999999999999999999988654433 3356667788899999999999866433 445678
Q ss_pred EEEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHH--hCCCceeccCCCCceEEeC-CCCcEEEEeecCc
Q 016184 156 NLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH--NCIGICHRDIKPQNLLVNP-HTHQLKLCDFGSA 232 (394)
Q Consensus 156 ~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH--~~~givH~Dlkp~Nil~~~-~~~~vkl~Dfg~a 232 (394)
++||||+++++...+.........+++..++.++.|++.||.||| + .||+||||||+|||++. ++ .+||+|||++
T Consensus 102 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~-~~ivH~Dlkp~NIll~~~~~-~~kl~Dfg~a 179 (360)
T 3e3p_A 102 NVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPS-VNVCHRDIKPHNVLVNEADG-TLKLCDFGSA 179 (360)
T ss_dssp EEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTT-TCCBCSCCCGGGEEEETTTT-EEEECCCTTC
T ss_pred EEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCC-CCeecCcCCHHHEEEeCCCC-cEEEeeCCCc
Confidence 899999999988877776667788999999999999999999999 8 89999999999999997 55 7999999999
Q ss_pred cccccCCCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhcc
Q 016184 233 KVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 312 (394)
Q Consensus 233 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 312 (394)
.............+|+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+....+..+.+..+.++.+.+..+
T Consensus 180 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (360)
T 3e3p_A 180 KKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRKL 259 (360)
T ss_dssp BCCCTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHH
T ss_pred eecCCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCHHHHHhc
Confidence 87766666667788999999999977666899999999999999999999999999999999999999999999988887
Q ss_pred CCCCcccCCCCCCCCCcchhccc---cCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCCCCCCCCCCC
Q 016184 313 NPNYTEFKFPQIKPHPWHKVFQK---RLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPNGRPLP 385 (394)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~~~~~~~~~~ 385 (394)
.+......+......+|...+.. ..++++.+||.+||+.||.+|||+.|+|+||||+++.++....+.....|
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~~~~~~~~~~~~ 335 (360)
T 3e3p_A 260 NPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELHDPATKLPNNKDLP 335 (360)
T ss_dssp CTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGGCTTCCCTTSCCCC
T ss_pred ccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccCCccccCCCCCCCC
Confidence 77766666666566666655543 25788999999999999999999999999999999999988877777766
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-52 Score=382.76 Aligned_cols=280 Identities=34% Similarity=0.562 Sum_probs=225.5
Q ss_pred eEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccch------hhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEEE
Q 016184 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN 156 (394)
Q Consensus 83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 156 (394)
+|++.+.||+|+||+||+|++..+|+.||||++.... ....+|+.+++.++||||+++++++.. ....+
T Consensus 3 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~~ 77 (292)
T 3o0g_A 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHS-----DKKLT 77 (292)
T ss_dssp SEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEE-----TTEEE
T ss_pred CceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEe-----CCEEE
Confidence 5999999999999999999999999999999986432 334579999999999999999999843 34578
Q ss_pred EEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCccccc
Q 016184 157 LVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV 236 (394)
Q Consensus 157 lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~ 236 (394)
+||||+++++...+.. ....+++..++.++.|++.||+|||+ +||+||||||+|||++.++ .+||+|||++....
T Consensus 78 lv~e~~~~~l~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lH~-~~ivH~dikp~Nil~~~~~-~~kl~Dfg~~~~~~ 152 (292)
T 3o0g_A 78 LVFEFCDQDLKKYFDS---CNGDLDPEIVKSFLFQLLKGLGFCHS-RNVLHRDLKPQNLLINRNG-ELKLANFGLARAFG 152 (292)
T ss_dssp EEEECCSEEHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECTTS-CEEECCCTTCEECC
T ss_pred EEEecCCCCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEcCCC-CEEEeecccceecC
Confidence 9999999987665543 34679999999999999999999999 8999999999999999888 69999999998664
Q ss_pred cC-CCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCC-CCCCCcHHHHHHHHHHhCCCChhhhhccCC
Q 016184 237 KG-EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPL-FPGESGVDQLVEIIKVLGTPTREEIKCMNP 314 (394)
Q Consensus 237 ~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~p-f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 314 (394)
.. .......+|+.|+|||++.+...++.++|||||||++|+|++|..| |.+.+..+.+..+.+..+.+....+.....
T Consensus 153 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 232 (292)
T 3o0g_A 153 IPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTK 232 (292)
T ss_dssp SCCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGG
T ss_pred CccccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcc
Confidence 33 2234457799999999997766689999999999999999988766 666677788888888888887766543322
Q ss_pred CCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 016184 315 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR 372 (394)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 372 (394)
.......+..............+++++++||++||+.||++|||++|+|+||||++..
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 290 (292)
T 3o0g_A 233 LPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFC 290 (292)
T ss_dssp STTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTC-
T ss_pred cccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcccccCC
Confidence 1111111111111122223356899999999999999999999999999999999864
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-53 Score=395.45 Aligned_cols=251 Identities=23% Similarity=0.344 Sum_probs=204.2
Q ss_pred ceeEEEeeEEeecCceEEEEEEECCC-----CcEEEEEEeccc-----hhhhHHHHHHHHHcCC-CCeeeeceEEEecCC
Q 016184 81 KVSYIAEHVVGTGSFGVVFQAKCRET-----GEIVAIKKVLQD-----KRYKNRELQIMQMLDH-PNIVALKHCFFSTTD 149 (394)
Q Consensus 81 ~~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~ 149 (394)
.++|++.+.||+|+||+||+|++..+ ++.||||++... ...+.+|+++|+.+.| ||||+++++|....
T Consensus 63 ~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~- 141 (353)
T 4ase_A 63 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG- 141 (353)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTT-
T ss_pred HHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecC-
Confidence 35699999999999999999998654 368999988643 2345679999999976 89999999884322
Q ss_pred CceeEEEEEEeccc-ccHHHHHHHhhhh------------cCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceE
Q 016184 150 KEELYLNLVLEYVP-ETVNRIARNYSRI------------HQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLL 216 (394)
Q Consensus 150 ~~~~~~~lv~e~~~-~~l~~~~~~~~~~------------~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil 216 (394)
..+++|||||+ |+|.++++..... ...+++..+..++.||+.||+|||+ ++||||||||+|||
T Consensus 142 ---~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~-~~iiHRDLK~~NIL 217 (353)
T 4ase_A 142 ---GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS-RKCIHRDLAARNIL 217 (353)
T ss_dssp ---SCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEE
T ss_pred ---CEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhh-CCeecCccCcccee
Confidence 23679999998 5888888764331 2458999999999999999999999 89999999999999
Q ss_pred EeCCCCcEEEEeecCccccccCCCc---ccccccccccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHH
Q 016184 217 VNPHTHQLKLCDFGSAKVLVKGEPN---VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVD 292 (394)
Q Consensus 217 ~~~~~~~vkl~Dfg~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~ 292 (394)
++.++ .+||+|||+|+........ ....||+.|||||++.+. .|+.++|||||||++|||+| |+.||.+....+
T Consensus 218 l~~~~-~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~-~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~ 295 (353)
T 4ase_A 218 LSEKN-VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDR-VYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE 295 (353)
T ss_dssp ECGGG-CEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH
T ss_pred eCCCC-CEEECcchhhhhcccCCCceeeccccccccccCHHHHhcC-CCCCcccEeehHHHHHHHHhCCCCCCCCCCHHH
Confidence 99888 7999999999876444322 245679999999999765 49999999999999999998 999999876555
Q ss_pred HHHHHHHHhCCCChhhhhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 016184 293 QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH 365 (394)
Q Consensus 293 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 365 (394)
.+..++.....++ ++..+++++.+||.+||+.||++|||+.+|++|
T Consensus 296 ~~~~~i~~g~~~~---------------------------~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~ 341 (353)
T 4ase_A 296 EFCRRLKEGTRMR---------------------------APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 341 (353)
T ss_dssp HHHHHHHHTCCCC---------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHcCCCCC---------------------------CCccCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 5554444221111 124578999999999999999999999999987
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-52 Score=399.27 Aligned_cols=297 Identities=31% Similarity=0.623 Sum_probs=227.5
Q ss_pred eeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccc------hhhhHHHHHHHHHcC-CCCeeeeceEEEecCCCceeE
Q 016184 82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLD-HPNIVALKHCFFSTTDKEELY 154 (394)
Q Consensus 82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~ 154 (394)
.+|++.+.||+|+||.||+|.+..+|+.||||++... .....+|+.+++.+. ||||+++++++... +...
T Consensus 9 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~---~~~~ 85 (388)
T 3oz6_A 9 RKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRAD---NDRD 85 (388)
T ss_dssp TTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECT---TSSC
T ss_pred CceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecC---CCCE
Confidence 4699999999999999999999999999999988532 233447999999997 99999999988532 2234
Q ss_pred EEEEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCccc
Q 016184 155 LNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV 234 (394)
Q Consensus 155 ~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~ 234 (394)
+|+||||++++|..++.. ..+++..++.++.||+.||+|||+ .||+||||||+|||++.++ .+||+|||+|+.
T Consensus 86 ~~lv~e~~~~~L~~~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~-~~ivHrDlkp~NIll~~~~-~~kl~DFG~a~~ 158 (388)
T 3oz6_A 86 VYLVFDYMETDLHAVIRA-----NILEPVHKQYVVYQLIKVIKYLHS-GGLLHRDMKPSNILLNAEC-HVKVADFGLSRS 158 (388)
T ss_dssp EEEEEECCSEEHHHHHHH-----TCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECTTC-CEEECCCTTCEE
T ss_pred EEEEecccCcCHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHh-CCEEeCCCCHHHeEEcCCC-CEEecCCccccc
Confidence 789999999998877764 579999999999999999999999 8999999999999999888 699999999976
Q ss_pred cccC----------------------CCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHH
Q 016184 235 LVKG----------------------EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVD 292 (394)
Q Consensus 235 ~~~~----------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~ 292 (394)
.... .......||+.|+|||++.+...++.++|||||||++|+|++|++||.+.+..+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~ 238 (388)
T 3oz6_A 159 FVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMN 238 (388)
T ss_dssp SSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred ccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 5321 112345789999999999776679999999999999999999999999999999
Q ss_pred HHHHHHHHhCCCChhhhhccCCCCcccCC------CCCCCCCcchhc------------cccCChHHHHHHHHhcccCCC
Q 016184 293 QLVEIIKVLGTPTREEIKCMNPNYTEFKF------PQIKPHPWHKVF------------QKRLPPEAVDLVCRFFQYSPN 354 (394)
Q Consensus 293 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~------------~~~~~~~~~~li~~~L~~dP~ 354 (394)
.+..+...++.|..+.+......+....+ .......+...+ ...+++++.+||++||++||.
T Consensus 239 ~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~ 318 (388)
T 3oz6_A 239 QLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPN 318 (388)
T ss_dssp HHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGG
T ss_pred HHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcc
Confidence 99999999999988776543322110000 000000111111 126789999999999999999
Q ss_pred CCCCHHHHhcCCCCCCCCCCCCCCCCCCCCCCCC
Q 016184 355 LRCTALEACVHPFFDELRDPNTRLPNGRPLPPLF 388 (394)
Q Consensus 355 ~Rpt~~ell~hp~f~~~~~~~~~~~~~~~~~~~~ 388 (394)
+|||++|+|+||||+.+..+...........++|
T Consensus 319 ~R~t~~e~l~Hp~~~~~~~~~~~~~~~~~~~~~~ 352 (388)
T 3oz6_A 319 KRISANDALKHPFVSIFHNPNEEPNCDHIITIPI 352 (388)
T ss_dssp GSCCHHHHTTSTTTTTTCCGGGCCCCSSCCCCC-
T ss_pred cCCCHHHHhCCHHHHHhcCCccCCCCCCCCCCCc
Confidence 9999999999999999887766544444444444
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-52 Score=407.43 Aligned_cols=285 Identities=31% Similarity=0.538 Sum_probs=226.5
Q ss_pred eeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccc------hhhhHHHHHHHHHcCCCCeeeeceEEEecCC-CceeE
Q 016184 82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTD-KEELY 154 (394)
Q Consensus 82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~~~~~ 154 (394)
.+|++.+.||+|+||.||+|++..+|+.||||++... .....+|+.+++.++||||+++++++..... .....
T Consensus 62 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~ 141 (464)
T 3ttj_A 62 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 141 (464)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCCe
Confidence 4699999999999999999999999999999998643 2334579999999999999999999854332 23356
Q ss_pred EEEEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCccc
Q 016184 155 LNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV 234 (394)
Q Consensus 155 ~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~ 234 (394)
+++||||+++++.+.+. ..+++..++.++.||+.||+|||+ .||+||||||+|||++.++ .+||+|||+++.
T Consensus 142 ~~lv~E~~~~~l~~~~~------~~l~~~~~~~~~~qil~aL~~lH~-~~iiHrDlkp~NIll~~~~-~~kl~DFG~a~~ 213 (464)
T 3ttj_A 142 VYLVMELMDANLCQVIQ------MELDHERMSYLLYQMLCGIKHLHS-AGIIHRDLKPSNIVVKSDC-TLKILDFGLART 213 (464)
T ss_dssp EEEEEECCSEEHHHHHT------SCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECTTS-CEEECCCCCC--
T ss_pred EEEEEeCCCCCHHHHHh------hcCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCChHhEEEeCCC-CEEEEEEEeeee
Confidence 78999999998765543 458999999999999999999999 8999999999999999988 699999999987
Q ss_pred cccCCCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCC
Q 016184 235 LVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 314 (394)
Q Consensus 235 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 314 (394)
...........||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+.+..+.+.+|.+..+.+.....
T Consensus 214 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~ 292 (464)
T 3ttj_A 214 AGTSFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP 292 (464)
T ss_dssp ---CCCC----CCCTTCCHHHHTTC-CCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCH
T ss_pred cCCCcccCCCcccccccCHHHHcCC-CCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcch
Confidence 7655555667899999999999765 589999999999999999999999999999999999999999998887754432
Q ss_pred CCccc--CCCCCCCCCcchhcccc-----------CChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCC
Q 016184 315 NYTEF--KFPQIKPHPWHKVFQKR-----------LPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 375 (394)
Q Consensus 315 ~~~~~--~~~~~~~~~~~~~~~~~-----------~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~ 375 (394)
....+ ..+......+...++.. .++++++||++||++||.+|||++|+|+||||+...++.
T Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~~~~~~ 366 (464)
T 3ttj_A 293 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDPA 366 (464)
T ss_dssp HHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGCCHH
T ss_pred hhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhhccCcc
Confidence 11111 11111112222222221 256799999999999999999999999999999776543
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-52 Score=405.38 Aligned_cols=294 Identities=35% Similarity=0.568 Sum_probs=222.4
Q ss_pred eeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccc------hhhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEE
Q 016184 82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL 155 (394)
Q Consensus 82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 155 (394)
.+|++.++||+|+||+||+|+++.+|+.||||++... .....+|+++|+.++||||+++++++..........+
T Consensus 53 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 132 (458)
T 3rp9_A 53 DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDEL 132 (458)
T ss_dssp TTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCE
T ss_pred CCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceE
Confidence 4599999999999999999999999999999988542 2344579999999999999999998865543444568
Q ss_pred EEEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCcccc
Q 016184 156 NLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL 235 (394)
Q Consensus 156 ~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~ 235 (394)
|+||||++++|..++.. ...+++..++.++.||+.||+|||+ .||+||||||+||||+.++ .+||+|||+++..
T Consensus 133 ~lv~e~~~~~L~~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~-~~iiHrDlKp~NILl~~~~-~~kl~DFGla~~~ 206 (458)
T 3rp9_A 133 YVVLEIADSDFKKLFRT----PVYLTELHIKTLLYNLLVGVKYVHS-AGILHRDLKPANCLVNQDC-SVKVCDFGLARTV 206 (458)
T ss_dssp EEEECCCSEEHHHHHHS----SCCCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCCGGGEEECTTC-CEEECCCTTCBCT
T ss_pred EEEEeccccchhhhccc----CCCCCHHHHHHHHHHHHHHHHHHHh-CCcCCCCCChhhEEECCCC-CEeecccccchhc
Confidence 89999999988777653 3679999999999999999999999 8999999999999999988 6999999999865
Q ss_pred ccCC----------------------------CcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHh-------
Q 016184 236 VKGE----------------------------PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL------- 280 (394)
Q Consensus 236 ~~~~----------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt------- 280 (394)
.... .....+||+.|+|||++.....++.++|||||||++|||++
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~ 286 (458)
T 3rp9_A 207 DYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVA 286 (458)
T ss_dssp TSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCS
T ss_pred cCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhcccccc
Confidence 4221 12345679999999987666669999999999999999999
Q ss_pred ----CCCCCCCCC--------------------cHHHHHHHHHHhCCCChhhhhccCCCCc---ccCCCCCCCCCcchhc
Q 016184 281 ----GQPLFPGES--------------------GVDQLVEIIKVLGTPTREEIKCMNPNYT---EFKFPQIKPHPWHKVF 333 (394)
Q Consensus 281 ----g~~pf~~~~--------------------~~~~~~~i~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~ 333 (394)
|+++|.+.. ..+.+..+...+|.+..+.+........ ...++......+...+
T Consensus 287 ~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 366 (458)
T 3rp9_A 287 YHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERF 366 (458)
T ss_dssp SGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGS
T ss_pred ccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHC
Confidence 777787654 2577888889999999887654432110 0112222222232222
Q ss_pred cccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCCCCCCCC
Q 016184 334 QKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPNGR 382 (394)
Q Consensus 334 ~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~~~~~~~ 382 (394)
..+++++.+||++||++||.+|||++|+|+||||+++..+........
T Consensus 367 -~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~~~~~~e~~~~~ 414 (458)
T 3rp9_A 367 -PASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEVRIAEVETNATE 414 (458)
T ss_dssp -TTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTCCGGGCCCCSS
T ss_pred -CCCCHHHHHHHHHHhccCccccCCHHHHhcCHhhhhcCCCccCCCCCC
Confidence 457999999999999999999999999999999999987776544333
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-52 Score=384.17 Aligned_cols=279 Identities=35% Similarity=0.665 Sum_probs=226.2
Q ss_pred eeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccch------hhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEE
Q 016184 82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL 155 (394)
Q Consensus 82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 155 (394)
++|++.+.||+|+||+||+|++. +|+.||+|++.... ....+|+++++.++||||+++++++. .....
T Consensus 21 ~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-----~~~~~ 94 (311)
T 3niz_A 21 EKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIH-----SERCL 94 (311)
T ss_dssp CEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEEC-----CSSCE
T ss_pred hhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEc-----cCCEE
Confidence 46999999999999999999995 58999999886432 33457999999999999999999883 33457
Q ss_pred EEEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCcccc
Q 016184 156 NLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL 235 (394)
Q Consensus 156 ~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~ 235 (394)
++||||+++++.+.+.. ....+++..++.++.|++.||+|||+ .||+||||||+|||++.++ .+||+|||++...
T Consensus 95 ~lv~e~~~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~LH~-~~ivH~Dikp~NIl~~~~~-~~kl~Dfg~a~~~ 169 (311)
T 3niz_A 95 TLVFEFMEKDLKKVLDE---NKTGLQDSQIKIYLYQLLRGVAHCHQ-HRILHRDLKPQNLLINSDG-ALKLADFGLARAF 169 (311)
T ss_dssp EEEEECCSEEHHHHHHT---CTTCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECTTC-CEEECCCTTCEET
T ss_pred EEEEcCCCCCHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCchHhEEECCCC-CEEEccCcCceec
Confidence 89999999988776654 23569999999999999999999999 8999999999999999888 6999999999866
Q ss_pred ccC-CCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCC
Q 016184 236 VKG-EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 314 (394)
Q Consensus 236 ~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 314 (394)
... .......+|+.|+|||++.+...++.++|||||||++|+|++|+.||.+....+.+..+...++.+....+.....
T Consensus 170 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 249 (311)
T 3niz_A 170 GIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQE 249 (311)
T ss_dssp TSCCC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTT
T ss_pred CCCcccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhc
Confidence 433 2233457799999999997766689999999999999999999999999998899999999888877665543221
Q ss_pred C--CcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 016184 315 N--YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR 372 (394)
Q Consensus 315 ~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 372 (394)
- +....+......++.. +...+++++.+||++||++||.+|||++|+|+||||+++.
T Consensus 250 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 308 (311)
T 3niz_A 250 LPLWKQRTFQVFEKKPWSS-IIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDLD 308 (311)
T ss_dssp SHHHHSCCCCCCCCCCHHH-HSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTSC
T ss_pred cchhhhcccccccCCcHHH-hCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccccCC
Confidence 1 1111122222223333 3356889999999999999999999999999999999875
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-52 Score=382.76 Aligned_cols=285 Identities=28% Similarity=0.522 Sum_probs=231.3
Q ss_pred ceeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccch---------hhhHHHHHHHHHc---CCCCeeeeceEEEecC
Q 016184 81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---------RYKNRELQIMQML---DHPNIVALKHCFFSTT 148 (394)
Q Consensus 81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---------~~~~~E~~~l~~l---~h~~iv~~~~~~~~~~ 148 (394)
..+|++.+.||+|+||+||+|++..+|+.||||++.... ....+|+++++.+ .||||+++++++....
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~ 87 (308)
T 3g33_A 8 TSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSR 87 (308)
T ss_dssp --CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccC
Confidence 346999999999999999999999999999999986322 2445788877776 4999999999997766
Q ss_pred CCceeEEEEEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEe
Q 016184 149 DKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCD 228 (394)
Q Consensus 149 ~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~D 228 (394)
.....+.+++|||++++|.+++.... ...+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|
T Consensus 88 ~~~~~~~~lv~e~~~~~L~~~~~~~~--~~~~~~~~~~~i~~qi~~al~~lH~-~~ivH~Dlkp~Nil~~~~~-~~kl~D 163 (308)
T 3g33_A 88 TDREIKVTLVFEHVDQDLRTYLDKAP--PPGLPAETIKDLMRQFLRGLDFLHA-NCIVHRDLKPENILVTSGG-TVKLAD 163 (308)
T ss_dssp SSSEEEEEEEEECCCCBHHHHHHTCC--TTCSCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCTTTEEECTTS-CEEECS
T ss_pred CCCceeEEEEehhhhcCHHHHHhhcc--CCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEEcCCC-CEEEee
Confidence 66667789999999999888776532 2449999999999999999999999 8999999999999999888 799999
Q ss_pred ecCccccccCCCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhh
Q 016184 229 FGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 308 (394)
Q Consensus 229 fg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~ 308 (394)
||++.............+|+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+..+.+..+....+.++...
T Consensus 164 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 242 (308)
T 3g33_A 164 FGLARIYSYQMALTPVVVTLWYRAPEVLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDD 242 (308)
T ss_dssp CSCTTTSTTCCCSGGGGCCCSSCCHHHHHTSC-CCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTTT
T ss_pred CccccccCCCcccCCccccccccCchHHcCCC-CCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhh
Confidence 99998776555566678899999999997654 89999999999999999999999999999999999999988887765
Q ss_pred hhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 016184 309 IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR 372 (394)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 372 (394)
+..... .....++.....+.. .....+++++.+||.+||+.||.+|||+.|+|+||||++..
T Consensus 243 ~~~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~~ 304 (308)
T 3g33_A 243 WPRDVS-LPRGAFPPRGPRPVQ-SVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKDE 304 (308)
T ss_dssp SCSSCS-SCGGGSCCCCCCCHH-HHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC----
T ss_pred ccchhh-ccccccCCCCCCcHH-HhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCCC
Confidence 532111 111112222222222 23356899999999999999999999999999999998754
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-51 Score=396.42 Aligned_cols=300 Identities=33% Similarity=0.535 Sum_probs=232.8
Q ss_pred eeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccc------hhhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEE
Q 016184 82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL 155 (394)
Q Consensus 82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 155 (394)
.+|++.+.||+|+||.||+|++..+|+.||||++... .....+|+.+++.++|+||+++++++..........+
T Consensus 26 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~ 105 (432)
T 3n9x_A 26 DNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDEL 105 (432)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCE
T ss_pred CCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCeE
Confidence 3599999999999999999999999999999998642 2344589999999999999999998855433333457
Q ss_pred EEEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCcccc
Q 016184 156 NLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL 235 (394)
Q Consensus 156 ~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~ 235 (394)
|+||||++++|.+++.. ...+++..++.++.||+.||+|||+ .||+||||||+|||++.++ .+||+|||+++..
T Consensus 106 ~lv~e~~~~~L~~~~~~----~~~l~~~~~~~i~~qil~aL~~LH~-~givHrDlkp~NILl~~~~-~~kL~DFGla~~~ 179 (432)
T 3n9x_A 106 YIVLEIADSDLKKLFKT----PIFLTEEHIKTILYNLLLGENFIHE-SGIIHRDLKPANCLLNQDC-SVKVCDFGLARTI 179 (432)
T ss_dssp EEEEECCSEEHHHHHHS----SCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECTTC-CEEECCCTTCEEC
T ss_pred EEEEecCCcCHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHH-CCCCCCCCCHHHeEECCCC-CEEEccCCCcccc
Confidence 89999999998777653 3569999999999999999999999 8999999999999999888 6999999999876
Q ss_pred ccCC-----------------------CcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHh-----------C
Q 016184 236 VKGE-----------------------PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-----------G 281 (394)
Q Consensus 236 ~~~~-----------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-----------g 281 (394)
.... ......||+.|+|||++.....++.++|||||||++|+|++ |
T Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~ 259 (432)
T 3n9x_A 180 NSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNR 259 (432)
T ss_dssp -------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGGC
T ss_pred cccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccccccccc
Confidence 4332 12456789999999997666679999999999999999998 4
Q ss_pred CCCCCCCC-----------------cHHHHHHHHHHhCCCChhhhhccCCCCcc---cCCCCCCCCCcchhccccCChHH
Q 016184 282 QPLFPGES-----------------GVDQLVEIIKVLGTPTREEIKCMNPNYTE---FKFPQIKPHPWHKVFQKRLPPEA 341 (394)
Q Consensus 282 ~~pf~~~~-----------------~~~~~~~i~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~ 341 (394)
.++|.+.+ ..+++..+.+.+|.++.+.+......... ..++......+...+ ..+++++
T Consensus 260 ~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~s~~~ 338 (432)
T 3n9x_A 260 FPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKY-PSISDDG 338 (432)
T ss_dssp CCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHS-TTSCHHH
T ss_pred cccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHC-CCCCHHH
Confidence 45555543 35778889999999998877654321100 011222222222222 4589999
Q ss_pred HHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCCCCCCCCCCCCCC
Q 016184 342 VDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPNGRPLPPLF 388 (394)
Q Consensus 342 ~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~~~~~~~~~~~~~ 388 (394)
.+||++||++||.+|||++|+|+||||+++.++........+..++|
T Consensus 339 ~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~~~e~~~~~~~~~~~ 385 (432)
T 3n9x_A 339 INLLESMLKFNPNKRITIDQALDHPYLKDVRKKKLENFSTKKIILPF 385 (432)
T ss_dssp HHHHHHHSCSSTTTSCCHHHHHTCGGGTTTCCTTTC---CCCCCCSS
T ss_pred HHHHHHHhcCCcccCCCHHHHhcChhhhhccCcccCcCCCCCCCCCh
Confidence 99999999999999999999999999999988776543333333333
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-51 Score=380.59 Aligned_cols=255 Identities=27% Similarity=0.398 Sum_probs=216.5
Q ss_pred ceeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccch------hhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeE
Q 016184 81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY 154 (394)
Q Consensus 81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 154 (394)
.++|++.+.||+|+||.||+|++..+|+.||||++.... ....+|+++++.++||||+++++++. ....
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~-----~~~~ 88 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIE-----TEKT 88 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----CSSE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE-----ECCE
Confidence 346999999999999999999999999999999986432 23457999999999999999999883 3345
Q ss_pred EEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCcc
Q 016184 155 LNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK 233 (394)
Q Consensus 155 ~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~ 233 (394)
.++||||+++ ++.+.+.. ...+++..++.++.|++.||+|||+ .||+||||||+|||++.++ .+||+|||++.
T Consensus 89 ~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~al~~lH~-~~ivHrDlkp~NIll~~~~-~~kl~DFG~a~ 162 (328)
T 3fe3_A 89 LYLIMEYASGGEVFDYLVA----HGRMKEKEARSKFRQIVSAVQYCHQ-KRIVHRDLKAENLLLDADM-NIKIADFGFSN 162 (328)
T ss_dssp EEEEECCCTTCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECTTS-CEEECSTTCCG
T ss_pred EEEEEECCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCEeccCCCHHHEEEcCCC-CEEEeeccCce
Confidence 7899999974 77766654 3679999999999999999999999 8999999999999999888 69999999998
Q ss_pred ccccCCCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccC
Q 016184 234 VLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 313 (394)
Q Consensus 234 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 313 (394)
............||+.|+|||++.+....+.++|||||||++|+|++|+.||.+.+..+....+....
T Consensus 163 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~------------ 230 (328)
T 3fe3_A 163 EFTVGGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGK------------ 230 (328)
T ss_dssp GGSSSCGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC------------
T ss_pred ecCCCCccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC------------
Confidence 77666666677899999999999876645689999999999999999999999887766666555421
Q ss_pred CCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCC
Q 016184 314 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 375 (394)
Q Consensus 314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~ 375 (394)
+. ++..+++++.+||++||+.||.+|||++|+++||||+...+..
T Consensus 231 -----~~------------~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~~~~ 275 (328)
T 3fe3_A 231 -----YR------------IPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKDRWINAGHEED 275 (328)
T ss_dssp -----CC------------CCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTCTTTTTTCTTC
T ss_pred -----CC------------CCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcCHhhcCCCccc
Confidence 11 1234789999999999999999999999999999999875543
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-51 Score=377.12 Aligned_cols=277 Identities=35% Similarity=0.634 Sum_probs=220.9
Q ss_pred eEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccch------hhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEEE
Q 016184 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN 156 (394)
Q Consensus 83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 156 (394)
+|++.+.||+|+||.||+|++ .+|+.||+|++.... ....+|+++++.++||||+++++++... ...+
T Consensus 3 ~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~~ 76 (288)
T 1ob3_A 3 KYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTK-----KRLV 76 (288)
T ss_dssp SEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECS-----SCEE
T ss_pred cchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccC-----CeEE
Confidence 599999999999999999999 678999999985432 3445899999999999999999988432 3478
Q ss_pred EEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCccccc
Q 016184 157 LVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV 236 (394)
Q Consensus 157 lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~ 236 (394)
+||||+++++.+++... ...+++..++.++.|++.||+|||+ +||+||||||+|||++.++ .+||+|||++....
T Consensus 77 lv~e~~~~~l~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~Nil~~~~~-~~kl~Dfg~~~~~~ 151 (288)
T 1ob3_A 77 LVFEHLDQDLKKLLDVC---EGGLESVTAKSFLLQLLNGIAYCHD-RRVLHRDLKPQNLLINREG-ELKIADFGLARAFG 151 (288)
T ss_dssp EEEECCSEEHHHHHHTS---TTCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECTTS-CEEECCTTHHHHHC
T ss_pred EEEEecCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEEcCCC-CEEEeECccccccC
Confidence 99999999887776542 3678999999999999999999999 8999999999999999888 69999999997654
Q ss_pred cC-CCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCC
Q 016184 237 KG-EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 315 (394)
Q Consensus 237 ~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 315 (394)
.. .......+|+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+.+..+.+..+.+....+......
T Consensus 152 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (288)
T 1ob3_A 152 IPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTEL 231 (288)
T ss_dssp C---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGS
T ss_pred ccccccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhcc
Confidence 32 22334577999999999976666899999999999999999999999999888888888888887765544321110
Q ss_pred C-cccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 016184 316 Y-TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL 371 (394)
Q Consensus 316 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 371 (394)
. ....+......+|.. +...+++++.+||++||+.||++|||+.|+|+||||++.
T Consensus 232 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 287 (288)
T 1ob3_A 232 PKYDPNFTVYEPLPWES-FLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKEN 287 (288)
T ss_dssp TTCCTTCCCCCCCCGGG-TCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC-
T ss_pred cccccccccccCccHHH-HhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhc
Confidence 0 000111222223332 335689999999999999999999999999999999875
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-51 Score=381.69 Aligned_cols=288 Identities=32% Similarity=0.565 Sum_probs=217.9
Q ss_pred eeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccch-----hhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEEE
Q 016184 82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN 156 (394)
Q Consensus 82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 156 (394)
.+|++.+.||+|+||.||+|++..+|+.||||++.... ....+|+++++.++||||+++++++ ......+
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~~~~~ 79 (317)
T 2pmi_A 5 SQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVI-----HTENKLT 79 (317)
T ss_dssp --------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEE-----CCTTEEE
T ss_pred cceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEE-----EECCeEE
Confidence 35999999999999999999999999999999886432 3456899999999999999999988 3334578
Q ss_pred EEEecccccHHHHHHHhhhh--cCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCccc
Q 016184 157 LVLEYVPETVNRIARNYSRI--HQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV 234 (394)
Q Consensus 157 lv~e~~~~~l~~~~~~~~~~--~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~ 234 (394)
+||||++++|.+++...... ...+++..++.++.||+.||.|||+ .||+||||||+|||++.++ .+||+|||++..
T Consensus 80 lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~-~~ivH~Dlkp~NIl~~~~~-~~kl~Dfg~~~~ 157 (317)
T 2pmi_A 80 LVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHE-NKILHRDLKPQNLLINKRG-QLKLGDFGLARA 157 (317)
T ss_dssp EEEECCCCBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECTTC-CEEECCCSSCEE
T ss_pred EEEEecCCCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHH-CCeeeCCCChHHeEEcCCC-CEEECcCcccee
Confidence 99999999988877654321 2458999999999999999999999 8999999999999999888 699999999986
Q ss_pred cccC-CCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccC
Q 016184 235 LVKG-EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 313 (394)
Q Consensus 235 ~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 313 (394)
.... .......+|+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+.+..+.+..+.+....+....
T Consensus 158 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 237 (317)
T 2pmi_A 158 FGIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVT 237 (317)
T ss_dssp TTSCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGG
T ss_pred cCCCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhh
Confidence 6433 223455789999999999765568999999999999999999999999999889999999988887765554321
Q ss_pred C--CCcccCCCCCCCCCcc----hhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCCC
Q 016184 314 P--NYTEFKFPQIKPHPWH----KVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTR 377 (394)
Q Consensus 314 ~--~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~~ 377 (394)
. .+. ..+.......+. ......++.++.+||.+||+.||++|||+.|+|+||||++...++..
T Consensus 238 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~~~~ 306 (317)
T 2pmi_A 238 KLPKYN-PNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYYHHASM 306 (317)
T ss_dssp GCTTCC-TTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCC----
T ss_pred hhhhcc-cccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhcccchhhc
Confidence 1 000 011111111111 12234678999999999999999999999999999999998777654
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-52 Score=384.79 Aligned_cols=292 Identities=33% Similarity=0.624 Sum_probs=231.2
Q ss_pred eeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccchh-----hhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEEE
Q 016184 82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-----YKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN 156 (394)
Q Consensus 82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-----~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 156 (394)
++|++.+.||+|+||.||+|++..+++.||||++..... ...+|+++++.++||||+++++++.. ....+
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~~ 76 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHT-----EKSLT 76 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEEC-----SSCEE
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEee-----CCEEE
Confidence 359999999999999999999999999999998864332 22369999999999999999998843 23378
Q ss_pred EEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCccccc
Q 016184 157 LVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV 236 (394)
Q Consensus 157 lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~ 236 (394)
+||||+++++.+.+... ...+++..++.++.||+.||.|||+ .||+||||||+|||++.++ .+||+|||++....
T Consensus 77 lv~e~~~~~l~~~~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivH~Dikp~NIl~~~~~-~~kl~Dfg~a~~~~ 151 (324)
T 3mtl_A 77 LVFEYLDKDLKQYLDDC---GNIINMHNVKLFLFQLLRGLAYCHR-QKVLHRDLKPQNLLINERG-ELKLADFGLARAKS 151 (324)
T ss_dssp EEEECCSEEHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHH-TTEEESSCCGGGEEECTTC-CEEECSSSEEECC-
T ss_pred EEecccccCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHH-CCccCCCcCHHHEEECCCC-CEEEccCccccccc
Confidence 99999999887776642 3569999999999999999999999 8999999999999999888 69999999997654
Q ss_pred cCC-CcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCC
Q 016184 237 KGE-PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 315 (394)
Q Consensus 237 ~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 315 (394)
... ......+|+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+.+..+.+.++.+....+......
T Consensus 152 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 231 (324)
T 3mtl_A 152 IPTKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSN 231 (324)
T ss_dssp -----------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGC
T ss_pred CCccccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcc
Confidence 322 2234567999999999977666899999999999999999999999999999999999999998887665432211
Q ss_pred --CcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCCCCCCCCCC
Q 016184 316 --YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPNGRPL 384 (394)
Q Consensus 316 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~~~~~~~~~ 384 (394)
+..+..+........ .....+++++.+||++||+.||.+|||++|+|+||||+++.+.....+.....
T Consensus 232 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~~~~~~~~ 301 (324)
T 3mtl_A 232 EEFKTYNYPKYRAEALL-SHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGERIHKLPDTTSI 301 (324)
T ss_dssp HHHHHTCCCCCCCCCHH-HHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCSTTSSSCTTSCG
T ss_pred hhhcccccccccchhhh-hhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhcccccccCCCCCcH
Confidence 111222222222221 12346899999999999999999999999999999999998776665555443
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-51 Score=384.32 Aligned_cols=287 Identities=32% Similarity=0.629 Sum_probs=237.6
Q ss_pred eEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccch-----hhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEEEE
Q 016184 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL 157 (394)
Q Consensus 83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 157 (394)
+|++.+.||+|+||.||+|++..+++.||||++.... ....+|+++++.++||||+++++++...........++
T Consensus 28 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~i 107 (364)
T 3qyz_A 28 RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYI 107 (364)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEE
T ss_pred cEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceEEE
Confidence 5999999999999999999999999999999986422 33457999999999999999999886544344455789
Q ss_pred EEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCcccccc
Q 016184 158 VLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK 237 (394)
Q Consensus 158 v~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~ 237 (394)
||||++++|.+++.. ..+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||++.....
T Consensus 108 v~e~~~~~L~~~l~~-----~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dikp~NIl~~~~~-~~kl~Dfg~a~~~~~ 180 (364)
T 3qyz_A 108 VQDLMETDLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHS-ANVLHRDLKPSNLLLNTTC-DLKICDFGLARVADP 180 (364)
T ss_dssp EEECCSEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECTTC-CEEECCCTTCEECCG
T ss_pred EEcccCcCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCChHhEEECCCC-CEEEEeCcceEecCC
Confidence 999999998887764 679999999999999999999999 8999999999999999888 699999999976543
Q ss_pred CCC----cccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccC
Q 016184 238 GEP----NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 313 (394)
Q Consensus 238 ~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 313 (394)
... .....||+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+.+..+...++.+..+.+....
T Consensus 181 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 260 (364)
T 3qyz_A 181 DHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCII 260 (364)
T ss_dssp GGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCC
T ss_pred CCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhh
Confidence 322 2345789999999998666668999999999999999999999999999999999999999999887765432
Q ss_pred CCC---cccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCCC
Q 016184 314 PNY---TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTR 377 (394)
Q Consensus 314 ~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~~ 377 (394)
... .....+.....+|...+ ..+++++.+||.+||++||.+|||+.|+|+||||++..++...
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~~~~~~ 326 (364)
T 3qyz_A 261 NLKARNYLLSLPHKNKVPWNRLF-PNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDE 326 (364)
T ss_dssp CHHHHHHHHTSCCCCCCCHHHHC-TTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTTCCGGGS
T ss_pred hhhHHHHHHhcCCccCCCHHHhC-CCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhccCcccc
Confidence 110 01122222333343333 5679999999999999999999999999999999998766543
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-51 Score=382.16 Aligned_cols=256 Identities=25% Similarity=0.361 Sum_probs=216.2
Q ss_pred ceeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccch----------hhhHHHHHHHHHcCCCCeeeeceEEEecCCC
Q 016184 81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK----------RYKNRELQIMQMLDHPNIVALKHCFFSTTDK 150 (394)
Q Consensus 81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 150 (394)
.+.|++.+.||+|+||.||+|+++.+|+.||+|++.... ..+.+|+.+++.++||||+++++++.
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~----- 85 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYE----- 85 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEE-----
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEE-----
Confidence 345999999999999999999999999999999986432 34568999999999999999999883
Q ss_pred ceeEEEEEEeccc-ccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCC---cEEE
Q 016184 151 EELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTH---QLKL 226 (394)
Q Consensus 151 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~---~vkl 226 (394)
....+++||||+. ++|.+++.. ...+++..++.++.||+.||.|||+ .||+||||||+|||++.++. .+||
T Consensus 86 ~~~~~~lv~e~~~gg~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~-~givHrDlkp~NIll~~~~~~~~~vkl 160 (361)
T 2yab_A 86 NRTDVVLILELVSGGELFDFLAQ----KESLSEEEATSFIKQILDGVNYLHT-KKIAHFDLKPENIMLLDKNIPIPHIKL 160 (361)
T ss_dssp CSSEEEEEEECCCSCBHHHHHTT----CSCCBHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEESCTTSSSCCEEE
T ss_pred eCCEEEEEEEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEEeCCCCCccCEEE
Confidence 3345889999996 577666543 4679999999999999999999999 89999999999999987653 5999
Q ss_pred EeecCccccccCCCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCh
Q 016184 227 CDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTR 306 (394)
Q Consensus 227 ~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~ 306 (394)
+|||++.............||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+.+..+.......+.
T Consensus 161 ~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~ 239 (361)
T 2yab_A 161 IDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYE-PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDE 239 (361)
T ss_dssp CCCSSCEECCTTCCCCCCCSCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCH
T ss_pred EecCCceEcCCCCccccCCCCccEECchHHcCC-CCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCc
Confidence 999999877665555667899999999999654 4899999999999999999999999988877777666543222111
Q ss_pred hhhhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 016184 307 EEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR 372 (394)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 372 (394)
. +...+++++++||++||..||.+|||+.|+|+||||+...
T Consensus 240 ~-------------------------~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~ 280 (361)
T 2yab_A 240 E-------------------------FFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVD 280 (361)
T ss_dssp H-------------------------HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTSCSS
T ss_pred h-------------------------hccCCCHHHHHHHHHHCCCChhHCcCHHHHhcCcCcCCCc
Confidence 1 2246799999999999999999999999999999998653
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-51 Score=384.26 Aligned_cols=286 Identities=33% Similarity=0.612 Sum_probs=227.6
Q ss_pred eeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccc------hhhhHHHHHHHHHcCCCCeeeeceEEEecCC-CceeE
Q 016184 82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTD-KEELY 154 (394)
Q Consensus 82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~~~~~ 154 (394)
.+|++.+.||+|+||.||+|++..+|+.||||++... .....+|+.+++.++||||+++++++..... .....
T Consensus 25 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~ 104 (367)
T 1cm8_A 25 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTD 104 (367)
T ss_dssp SSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCC
T ss_pred ceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCce
Confidence 3599999999999999999999999999999998542 2334579999999999999999998854322 12234
Q ss_pred EEEEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCccc
Q 016184 155 LNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV 234 (394)
Q Consensus 155 ~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~ 234 (394)
+++||||++++|.+++.. ..+++..++.++.||+.||+|||+ .||+||||||+|||++.++ .+||+|||+++.
T Consensus 105 ~~lv~e~~~~~L~~~~~~-----~~l~~~~~~~~~~qi~~~L~~LH~-~~ivH~Dlkp~NIll~~~~-~~kl~Dfg~a~~ 177 (367)
T 1cm8_A 105 FYLVMPFMGTDLGKLMKH-----EKLGEDRIQFLVYQMLKGLRYIHA-AGIIHRDLKPGNLAVNEDC-ELKILDFGLARQ 177 (367)
T ss_dssp CEEEEECCSEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECTTC-CEEECCCTTCEE
T ss_pred EEEEEecCCCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH-CCccccCcCHHHEEEcCCC-CEEEEeeecccc
Confidence 679999998888887764 679999999999999999999999 8999999999999999888 699999999986
Q ss_pred cccCCCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCC
Q 016184 235 LVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 314 (394)
Q Consensus 235 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 314 (394)
... ......+|+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+.+..+.+..+.++.+.+..+..
T Consensus 178 ~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~ 255 (367)
T 1cm8_A 178 ADS--EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQS 255 (367)
T ss_dssp CCS--SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSC
T ss_pred ccc--ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhh
Confidence 532 334567899999999997756699999999999999999999999999999999999999999999877654432
Q ss_pred CCcc---cCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCCC
Q 016184 315 NYTE---FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTR 377 (394)
Q Consensus 315 ~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~~ 377 (394)
.... ..++......+...+ ..+++++.+||.+||+.||.+|||++++|+||||+++.++...
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~~~~~~ 320 (367)
T 1cm8_A 256 DEAKNYMKGLPELEKKDFASIL-TNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTEDE 320 (367)
T ss_dssp HHHHHHHHHSCCCCCCCGGGTC-TTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC-----
T ss_pred HHHHHHHHhCCCCCCCCHHHHC-CCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhcCCccC
Confidence 1100 112222333333333 4679999999999999999999999999999999998877653
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-50 Score=372.77 Aligned_cols=285 Identities=35% Similarity=0.615 Sum_probs=220.8
Q ss_pred eeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccch------hhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEE
Q 016184 82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL 155 (394)
Q Consensus 82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 155 (394)
++|++.+.||+|+||.||+|++..+|+.||||++.... ....+|+++++.++||||+++++++.. ....
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----~~~~ 77 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRR-----KRRL 77 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE-----TTEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeec-----CCeE
Confidence 35999999999999999999999999999999885432 234579999999999999999999843 3347
Q ss_pred EEEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCcccc
Q 016184 156 NLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL 235 (394)
Q Consensus 156 ~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~ 235 (394)
++||||++++....+ ......+++..++.++.|++.||+|||+ .||+||||||+|||++.++ .+||+|||++...
T Consensus 78 ~lv~e~~~~~~l~~~---~~~~~~~~~~~~~~i~~~l~~~l~~lH~-~~ivH~dlkp~Nil~~~~~-~~kl~Dfg~~~~~ 152 (311)
T 4agu_A 78 HLVFEYCDHTVLHEL---DRYQRGVPEHLVKSITWQTLQAVNFCHK-HNCIHRDVKPENILITKHS-VIKLCDFGFARLL 152 (311)
T ss_dssp EEEEECCSEEHHHHH---HHTSSCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECTTS-CEEECCCTTCEEC
T ss_pred EEEEEeCCCchHHHH---HhhhcCCCHHHHHHHHHHHHHHHHHHHH-CCCcCCCCChhhEEEcCCC-CEEEeeCCCchhc
Confidence 899999997543322 2234679999999999999999999999 8999999999999999888 7999999999765
Q ss_pred ccCC-CcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccC-
Q 016184 236 VKGE-PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN- 313 (394)
Q Consensus 236 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~- 313 (394)
.... ......+|+.|+|||++.+...++.++||||||+++|+|++|..||.+....+.+..+....+...........
T Consensus 153 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (311)
T 4agu_A 153 TGPSDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFST 232 (311)
T ss_dssp C------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHT
T ss_pred cCcccccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccc
Confidence 4322 23455789999999999776668999999999999999999999999999888888888888776665433221
Q ss_pred -CCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCC
Q 016184 314 -PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNT 376 (394)
Q Consensus 314 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~ 376 (394)
..+.....+..............++.++.+||++||+.||.+|||++++|+||||+++++...
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~ 296 (311)
T 4agu_A 233 NQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIREIED 296 (311)
T ss_dssp CGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTCC----
T ss_pred ccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhccCHHH
Confidence 111222222222222222223568999999999999999999999999999999999876654
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-50 Score=380.36 Aligned_cols=286 Identities=34% Similarity=0.582 Sum_probs=228.4
Q ss_pred ceeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccch---------hhhHHHHHHHHHcCCCCeeeeceEEEecCCCc
Q 016184 81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKE 151 (394)
Q Consensus 81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 151 (394)
..+|++.+.||+|+||.||+|++..+|+.||||++.... ....+|+.+++.++||||+++++++..
T Consensus 9 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----- 83 (346)
T 1ua2_A 9 AKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGH----- 83 (346)
T ss_dssp ----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECC-----
T ss_pred hcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEee-----
Confidence 346999999999999999999999999999999986421 234579999999999999999998833
Q ss_pred eeEEEEEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecC
Q 016184 152 ELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS 231 (394)
Q Consensus 152 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~ 231 (394)
....++||||+++++...+.. ....+++..++.++.|++.||+|||+ .||+||||||+|||++.++ .+||+|||+
T Consensus 84 ~~~~~lv~e~~~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~Dlkp~Nil~~~~~-~~kl~Dfg~ 158 (346)
T 1ua2_A 84 KSNISLVFDFMETDLEVIIKD---NSLVLTPSHIKAYMLMTLQGLEYLHQ-HWILHRDLKPNNLLLDENG-VLKLADFGL 158 (346)
T ss_dssp TTCCEEEEECCSEEHHHHHTT---CCSSCCSSHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECTTC-CEEECCCGG
T ss_pred CCceEEEEEcCCCCHHHHHHh---cCcCCCHHHHHHHHHHHHHHHHHHHH-CCEECCCCCHHHEEEcCCC-CEEEEeccc
Confidence 233779999999987666543 23568999999999999999999999 8999999999999999888 699999999
Q ss_pred ccccccCC-CcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhh
Q 016184 232 AKVLVKGE-PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 310 (394)
Q Consensus 232 a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 310 (394)
++...... ......+|+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..+....+.+....+.
T Consensus 159 a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 238 (346)
T 1ua2_A 159 AKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWP 238 (346)
T ss_dssp GSTTTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSS
T ss_pred ceeccCCcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhh
Confidence 98664332 33456789999999999766668999999999999999999999999999999999999988888776655
Q ss_pred ccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCCC
Q 016184 311 CMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTR 377 (394)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~~ 377 (394)
..........+......++.. +...++.++.+||++||+.||.+|||+.|+|+||||++...+...
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~~~~~~~ 304 (346)
T 1ua2_A 239 DMCSLPDYVTFKSFPGIPLHH-IFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPTPG 304 (346)
T ss_dssp STTSSTTCCCCCCCCCCCHHH-HCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSCCCCS
T ss_pred hhccCcccccccccCCCChHH-hhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcCCCCCCc
Confidence 433221111222212222222 235678999999999999999999999999999999987666543
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-51 Score=379.90 Aligned_cols=282 Identities=31% Similarity=0.551 Sum_probs=226.3
Q ss_pred ceeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccch------hhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeE
Q 016184 81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY 154 (394)
Q Consensus 81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 154 (394)
.++|++.+.||+|+||+||+|++..+++.||||++.... ....+|+.+++.++||||+++++++.. ...
T Consensus 33 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~ 107 (329)
T 3gbz_A 33 IDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHH-----NHR 107 (329)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEE-----TTE
T ss_pred hhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEec-----CCE
Confidence 446999999999999999999999999999999986432 234579999999999999999998843 334
Q ss_pred EEEEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCC----CcEEEEeec
Q 016184 155 LNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHT----HQLKLCDFG 230 (394)
Q Consensus 155 ~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~----~~vkl~Dfg 230 (394)
.++||||++++|.+++.. ...+++..++.++.||+.||+|||+ +||+||||||+|||++.++ ..+||+|||
T Consensus 108 ~~lv~e~~~~~L~~~~~~----~~~~~~~~~~~i~~ql~~~l~~LH~-~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg 182 (329)
T 3gbz_A 108 LHLIFEYAENDLKKYMDK----NPDVSMRVIKSFLYQLINGVNFCHS-RRCLHRDLKPQNLLLSVSDASETPVLKIGDFG 182 (329)
T ss_dssp EEEEEECCSEEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEEEC-----CCEEEECCTT
T ss_pred EEEEEecCCCCHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCEECCCCCHHHEEEecCCCCccceEEECcCC
Confidence 789999999988777654 3569999999999999999999999 8999999999999995432 259999999
Q ss_pred CccccccC-CCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhh
Q 016184 231 SAKVLVKG-EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI 309 (394)
Q Consensus 231 ~a~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 309 (394)
++...... .......+|+.|+|||++.+...++.++|||||||++|+|++|+.||.+....+.+..+....+.+....+
T Consensus 183 ~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 262 (329)
T 3gbz_A 183 LARAFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTW 262 (329)
T ss_dssp HHHHHC-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTS
T ss_pred CccccCCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhh
Confidence 99765432 22334567999999999977666899999999999999999999999999999999999998888776654
Q ss_pred hccCCC-CcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 016184 310 KCMNPN-YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR 372 (394)
Q Consensus 310 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 372 (394)
...... .....++......+...+...+++++.+||.+||+.||.+|||++|+|+||||++..
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 326 (329)
T 3gbz_A 263 PGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHND 326 (329)
T ss_dssp TTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSSC
T ss_pred hhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCCC
Confidence 322110 011233444444555566667899999999999999999999999999999999863
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-50 Score=376.49 Aligned_cols=251 Identities=27% Similarity=0.421 Sum_probs=211.8
Q ss_pred eeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccc-------hhhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeE
Q 016184 82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY 154 (394)
Q Consensus 82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 154 (394)
++|++.+.||+|+||+||+|+++.+|+.||||++.+. .....+|+.+++.++||||+++++++. ....
T Consensus 5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~-----~~~~ 79 (337)
T 1o6l_A 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQ-----THDR 79 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEE-----CSSE
T ss_pred HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEE-----eCCE
Confidence 4699999999999999999999999999999998653 223457999999999999999999883 3345
Q ss_pred EEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCcc
Q 016184 155 LNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK 233 (394)
Q Consensus 155 ~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~ 233 (394)
+++||||+++ +|...+.. ...+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+++
T Consensus 80 ~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivHrDlkp~NIll~~~g-~vkL~DFG~a~ 153 (337)
T 1o6l_A 80 LCFVMEYANGGELFFHLSR----ERVFTEERARFYGAEIVSALEYLHS-RDVVYRDIKLENLMLDKDG-HIKITDFGLCK 153 (337)
T ss_dssp EEEEEECCTTCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCCGGGEEECTTS-CEEECCCTTCB
T ss_pred EEEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCcCCHHHEEECCCC-CEEEeeccchh
Confidence 8899999986 77665543 3679999999999999999999999 8999999999999999988 69999999997
Q ss_pred cccc-CCCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhcc
Q 016184 234 VLVK-GEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 312 (394)
Q Consensus 234 ~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 312 (394)
.... ........||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+.......+...
T Consensus 154 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~------------ 220 (337)
T 1o6l_A 154 EGISDGATMKTFCGTPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME------------ 220 (337)
T ss_dssp CSCCTTCCBCCCEECGGGCCGGGGSSS-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC------------
T ss_pred hcccCCCcccccccChhhCChhhhcCC-CCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcC------------
Confidence 6432 3334566889999999999654 4899999999999999999999999887766666555441
Q ss_pred CCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCC-----CHHHHhcCCCCCCCCC
Q 016184 313 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-----TALEACVHPFFDELRD 373 (394)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----t~~ell~hp~f~~~~~ 373 (394)
... ++..+++++.+||.+||+.||.+|| +++++++||||+.+..
T Consensus 221 -----~~~------------~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~~f~~~~~ 269 (337)
T 1o6l_A 221 -----EIR------------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINW 269 (337)
T ss_dssp -----CCC------------CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCH
T ss_pred -----CCC------------CCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCCCcCCCCH
Confidence 111 1245799999999999999999999 9999999999998753
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-51 Score=382.22 Aligned_cols=252 Identities=28% Similarity=0.473 Sum_probs=208.6
Q ss_pred ceeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccch-------hhhHHHHHHHHHc-CCCCeeeeceEEEecCCCce
Q 016184 81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQML-DHPNIVALKHCFFSTTDKEE 152 (394)
Q Consensus 81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~ 152 (394)
..+|++.++||+|+||.||+|+++.+|+.||||++.+.. ....+|..+++.+ +||||+++++++ ...
T Consensus 22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~-----~~~ 96 (353)
T 3txo_A 22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCF-----QTP 96 (353)
T ss_dssp -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEE-----ECS
T ss_pred hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEE-----EeC
Confidence 356999999999999999999999999999999986532 2345688899988 799999999988 333
Q ss_pred eEEEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecC
Q 016184 153 LYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS 231 (394)
Q Consensus 153 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~ 231 (394)
..+++||||+.+ +|..++.. ...+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+
T Consensus 97 ~~~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~-~givHrDlkp~NILl~~~g-~ikL~DFG~ 170 (353)
T 3txo_A 97 DRLFFVMEFVNGGDLMFHIQK----SRRFDEARARFYAAEIISALMFLHD-KGIIYRDLKLDNVLLDHEG-HCKLADFGM 170 (353)
T ss_dssp SEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCCGGGEEECTTS-CEEECCCTT
T ss_pred CEEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCCcccCCCHHHEEECCCC-CEEEccccc
Confidence 458899999985 77666554 3679999999999999999999999 8999999999999999988 699999999
Q ss_pred cccccc-CCCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhh
Q 016184 232 AKVLVK-GEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 310 (394)
Q Consensus 232 a~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 310 (394)
++.... .......+||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+.+..+....
T Consensus 171 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~--------- 240 (353)
T 3txo_A 171 CKEGICNGVTTATFCGTPDYIAPEILQEM-LYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDE--------- 240 (353)
T ss_dssp CBCSCC---------CCGGGCCHHHHHHH-HCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC---------
T ss_pred eeecccCCccccccCCCcCeEChhhcCCC-CcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCC---------
Confidence 975432 2334456789999999998654 48999999999999999999999999988877777776521
Q ss_pred ccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCH------HHHhcCCCCCCCCC
Q 016184 311 CMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTA------LEACVHPFFDELRD 373 (394)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~------~ell~hp~f~~~~~ 373 (394)
.. ++..+++++.+||++||+.||.+||++ +++++||||+++..
T Consensus 241 --------~~------------~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~~~w 289 (353)
T 3txo_A 241 --------VV------------YPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEIDW 289 (353)
T ss_dssp --------CC------------CCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTTCCH
T ss_pred --------CC------------CCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhCCcccCCCH
Confidence 11 124578999999999999999999999 89999999998753
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-50 Score=387.23 Aligned_cols=259 Identities=28% Similarity=0.471 Sum_probs=215.9
Q ss_pred ceeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccc-------hhhhHHHHHHHHHcCCCCeeeeceEEEecCCCcee
Q 016184 81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL 153 (394)
Q Consensus 81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 153 (394)
..+|++.++||+|+||+||+|+++.+++.||+|++.+. .....+|+.+++.++||||+++++++ ....
T Consensus 68 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~-----~~~~ 142 (410)
T 3v8s_A 68 AEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAF-----QDDR 142 (410)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEE-----ECSS
T ss_pred ccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEE-----EECC
Confidence 34699999999999999999999999999999998642 23356899999999999999999988 3445
Q ss_pred EEEEEEeccc-ccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCc
Q 016184 154 YLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA 232 (394)
Q Consensus 154 ~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a 232 (394)
++++||||++ ++|.+++.. ..+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||++
T Consensus 143 ~~~lV~E~~~gg~L~~~l~~-----~~~~e~~~~~~~~qi~~aL~~LH~-~givHrDLKp~NILl~~~g-~ikL~DFG~a 215 (410)
T 3v8s_A 143 YLYMVMEYMPGGDLVNLMSN-----YDVPEKWARFYTAEVVLALDAIHS-MGFIHRDVKPDNMLLDKSG-HLKLADFGTC 215 (410)
T ss_dssp EEEEEECCCTTEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECTTS-CEEECCCTTC
T ss_pred EEEEEEeCCCCCcHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH-CCeEeccCCHHHeeECCCC-CEEEecccee
Confidence 5889999996 478777654 579999999999999999999999 8999999999999999988 6999999999
Q ss_pred cccccCCC--cccccccccccccccccCCC---CCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChh
Q 016184 233 KVLVKGEP--NVSYICSRYYRAPELIFGAT---EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 307 (394)
Q Consensus 233 ~~~~~~~~--~~~~~~t~~y~aPE~~~~~~---~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~ 307 (394)
+....... .....||+.|+|||++.+.. .++.++|||||||++|+|++|+.||.+.+....+..+......
T Consensus 216 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~---- 291 (410)
T 3v8s_A 216 MKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNS---- 291 (410)
T ss_dssp EECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHH----
T ss_pred EeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhcccc----
Confidence 86644332 23567999999999996543 2788999999999999999999999988877777777642100
Q ss_pred hhhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCC--CCCHHHHhcCCCCCCCCCCCC
Q 016184 308 EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNL--RCTALEACVHPFFDELRDPNT 376 (394)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~--Rpt~~ell~hp~f~~~~~~~~ 376 (394)
..++. ...+++++++||++||+.+|.+ |++++|+++||||+++...+.
T Consensus 292 -----------~~~p~----------~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~~w~~~ 341 (410)
T 3v8s_A 292 -----------LTFPD----------DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQWAWE 341 (410)
T ss_dssp -----------CCCCT----------TCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCSSCCST
T ss_pred -----------ccCCC----------cccccHHHHHHHHHHccChhhhCCCCCHHHHhcCccccCCCHHHH
Confidence 01110 1357999999999999999988 999999999999999865444
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-50 Score=387.45 Aligned_cols=281 Identities=30% Similarity=0.530 Sum_probs=227.7
Q ss_pred ceeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccch---hhhHHHHHHHHHc------CCCCeeeeceEEEecCCCc
Q 016184 81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---RYKNRELQIMQML------DHPNIVALKHCFFSTTDKE 151 (394)
Q Consensus 81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l------~h~~iv~~~~~~~~~~~~~ 151 (394)
..+|++.++||+|+||.||+|++..+++.||||++.... ....+|+.+++.+ +|+||+.+++++..
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~----- 170 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTF----- 170 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEE-----
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeeccc-----
Confidence 346999999999999999999999999999999987653 3345688888887 57799999998843
Q ss_pred eeEEEEEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCC-cEEEEeec
Q 016184 152 ELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTH-QLKLCDFG 230 (394)
Q Consensus 152 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~-~vkl~Dfg 230 (394)
...+++||||+++++.+++.... ...+++..++.++.||+.||+|||+ .||+||||||+|||++.++. .+||+|||
T Consensus 171 ~~~~~lv~e~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlKp~NILl~~~~~~~vkL~DFG 247 (429)
T 3kvw_A 171 RNHICMTFELLSMNLYELIKKNK--FQGFSLPLVRKFAHSILQCLDALHK-NRIIHCDLKPENILLKQQGRSGIKVIDFG 247 (429)
T ss_dssp TTEEEEEECCCCCBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHH-HTEECSCCSGGGEEESSTTSCCEEECCCT
T ss_pred CCeEEEEEeccCCCHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHeEEccCCCcceEEeecc
Confidence 34588999999999888777533 2559999999999999999999999 89999999999999998762 29999999
Q ss_pred CccccccCCCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhh
Q 016184 231 SAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 310 (394)
Q Consensus 231 ~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 310 (394)
++.... .......+|+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+..+.+..+...++.++...+.
T Consensus 248 ~a~~~~--~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~~ 324 (429)
T 3kvw_A 248 SSCYEH--QRVYTYIQSRFYRAPEVILGAR-YGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLD 324 (429)
T ss_dssp TCEETT--CCCCSSCSCGGGCCHHHHHTBC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred cceecC--CcccccCCCCCccChHHHhCCC-CCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHH
Confidence 996543 3344567899999999997654 8999999999999999999999999999999999999999999887664
Q ss_pred ccCCC--------Cccc----------------------CCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHH
Q 016184 311 CMNPN--------YTEF----------------------KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTAL 360 (394)
Q Consensus 311 ~~~~~--------~~~~----------------------~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ 360 (394)
..... +..+ .........|...+....++++.+||++||++||++|||++
T Consensus 325 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta~ 404 (429)
T 3kvw_A 325 ASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPG 404 (429)
T ss_dssp TBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCHH
T ss_pred hhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCHH
Confidence 32211 0000 00011123344555566789999999999999999999999
Q ss_pred HHhcCCCCCCCC
Q 016184 361 EACVHPFFDELR 372 (394)
Q Consensus 361 ell~hp~f~~~~ 372 (394)
|+|+||||++..
T Consensus 405 e~L~Hpw~~~~~ 416 (429)
T 3kvw_A 405 QALRHPWLRRRL 416 (429)
T ss_dssp HHHTSTTTC---
T ss_pred HHhCChhhccCC
Confidence 999999998753
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-50 Score=367.56 Aligned_cols=253 Identities=25% Similarity=0.377 Sum_probs=212.4
Q ss_pred ceeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccc----hhhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEEE
Q 016184 81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN 156 (394)
Q Consensus 81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 156 (394)
..+|++.+.||+|+||+||+|++..+|+.||||++... .....+|+.+++.++||||+++++++... ...+
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-----~~~~ 93 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVG-----DELW 93 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEET-----TEEE
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEEC-----CEEE
Confidence 34699999999999999999999999999999988533 33456799999999999999999988443 3478
Q ss_pred EEEeccc-ccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCcccc
Q 016184 157 LVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL 235 (394)
Q Consensus 157 lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~ 235 (394)
+||||+. ++|.+++.. ..+++..++.++.|++.||+|||+ +||+||||||+|||++.++ .+||+|||++...
T Consensus 94 lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~Dlkp~Nil~~~~~-~~kl~Dfg~~~~~ 166 (297)
T 3fxz_A 94 VVMEYLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHS-NQVIHRDIKSDNILLGMDG-SVKLTDFGFCAQI 166 (297)
T ss_dssp EEEECCTTCBHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECTTC-CEEECCCTTCEEC
T ss_pred EEEECCCCCCHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHh-CCceeCCCCHHHEEECCCC-CEEEeeCCCceec
Confidence 9999996 578777654 579999999999999999999999 8999999999999999888 6999999998766
Q ss_pred ccCC-CcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCC
Q 016184 236 VKGE-PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 314 (394)
Q Consensus 236 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 314 (394)
.... ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+.......+........
T Consensus 167 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~--------- 236 (297)
T 3fxz_A 167 TPEQSKRSTMVGTPYWMAPEVVTRK-AYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPEL--------- 236 (297)
T ss_dssp CSTTCCBCCCCSCGGGCCHHHHHCS-CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCC---------
T ss_pred CCcccccCCccCCcCccChhhhcCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC---------
Confidence 4433 23456789999999999765 489999999999999999999999988877666655544221100
Q ss_pred CCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 016184 315 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR 372 (394)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 372 (394)
..+..+++.+.+||.+||+.||.+|||+.++|+||||+...
T Consensus 237 -----------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~ 277 (297)
T 3fxz_A 237 -----------------QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLKIAK 277 (297)
T ss_dssp -----------------SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred -----------------CCccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhcccC
Confidence 01246789999999999999999999999999999998764
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-51 Score=383.45 Aligned_cols=285 Identities=35% Similarity=0.594 Sum_probs=218.6
Q ss_pred eeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccc------hhhhHHHHHHHHHcCCCCeeeeceEEEecCC-CceeE
Q 016184 82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTD-KEELY 154 (394)
Q Consensus 82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~~~~~ 154 (394)
.+|++.+.||+|+||.||+|.+..+|+.||||++... .....+|+.+++.++||||+++++++..... .....
T Consensus 29 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~ 108 (367)
T 2fst_X 29 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND 108 (367)
T ss_dssp TTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred CceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCe
Confidence 3599999999999999999999999999999998542 2334579999999999999999998854321 12234
Q ss_pred EEEEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCccc
Q 016184 155 LNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV 234 (394)
Q Consensus 155 ~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~ 234 (394)
.++++|+++++|.+++.. ..+++..++.++.||+.||+|||+ .||+||||||+|||++.++ .+||+|||+++.
T Consensus 109 ~~lv~e~~~~~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~-~givH~Dlkp~NIll~~~~-~~kL~DFG~a~~ 181 (367)
T 2fst_X 109 VYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS-ADIIHRDLKPSNLAVNEDC-ELKILDFGLARH 181 (367)
T ss_dssp CEEEEECCCEECC----------CCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECTTC-CEEECC------
T ss_pred EEEEecccCCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH-CCeeeCCCCHhhEEECCCC-CEEEeecccccc
Confidence 679999999888777654 679999999999999999999999 8999999999999999888 699999999976
Q ss_pred cccCCCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCC
Q 016184 235 LVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 314 (394)
Q Consensus 235 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 314 (394)
... ......+|+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+.+..+.+.++.+..+.+.....
T Consensus 182 ~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~ 259 (367)
T 2fst_X 182 TAD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 259 (367)
T ss_dssp -----------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCCC
T ss_pred ccc--cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhh
Confidence 532 234567899999999997756689999999999999999999999999999999999999999998877654432
Q ss_pred CCcc---cCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCC
Q 016184 315 NYTE---FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNT 376 (394)
Q Consensus 315 ~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~ 376 (394)
.... ..++......+...+ ..+++++.+||.+||+.||.+|||+.++|+||||++..++..
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~~~~~~ 323 (367)
T 2fst_X 260 ESARNYIQSLTQMPKMNFANVF-IGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDD 323 (367)
T ss_dssp HHHHHHHHTSCCCCCCCHHHHT-TTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCGGG
T ss_pred HHHHHHHhccCCCCCCCHHHHC-CCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhccCCCC
Confidence 1100 112222233333333 467899999999999999999999999999999999877664
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-50 Score=371.29 Aligned_cols=256 Identities=23% Similarity=0.371 Sum_probs=215.1
Q ss_pred ceeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccc----------hhhhHHHHHHHHHcCCCCeeeeceEEEecCCC
Q 016184 81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD----------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDK 150 (394)
Q Consensus 81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 150 (394)
..+|.+.+.||+|+||.||+|++..+|+.||+|++... ...+.+|+.+++.++||||+++++++.
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~----- 84 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYE----- 84 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEE-----
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEE-----
Confidence 45699999999999999999999999999999988643 234668999999999999999999883
Q ss_pred ceeEEEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCC---cEEE
Q 016184 151 EELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTH---QLKL 226 (394)
Q Consensus 151 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~---~vkl 226 (394)
.....++||||+.+ +|.+++.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++.++. .+||
T Consensus 85 ~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~-~~ivH~Dlkp~NIll~~~~~~~~~~kl 159 (326)
T 2y0a_A 85 NKTDVILILELVAGGELFDFLAE----KESLTEEEATEFLKQILNGVYYLHS-LQIAHFDLKPENIMLLDRNVPKPRIKI 159 (326)
T ss_dssp CSSEEEEEEECCCSCBHHHHHTT----SSCCBHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEESCSSSSSCCEEE
T ss_pred eCCEEEEEEEcCCCCCHHHHHHh----cCCcCHHHHHHHHHHHHHHHHHHHH-CCeEcCCCCHHHEEEecCCCCCCCEEE
Confidence 33457899999974 77776643 4679999999999999999999999 89999999999999987652 5999
Q ss_pred EeecCccccccCCCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCh
Q 016184 227 CDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTR 306 (394)
Q Consensus 227 ~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~ 306 (394)
+|||++.............||+.|+|||++.+. .++.++|||||||++|+|++|..||.+....+.+..+.......+.
T Consensus 160 ~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~ 238 (326)
T 2y0a_A 160 IDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYE-PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFED 238 (326)
T ss_dssp CCCTTCEECCTTSCCCCCCSCTTTCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCCH
T ss_pred EECCCCeECCCCCccccccCCcCcCCceeecCC-CCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcCc
Confidence 999999877555555567899999999998544 4899999999999999999999999988777766666553222111
Q ss_pred hhhhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 016184 307 EEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR 372 (394)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 372 (394)
. ....++..+.+||++||+.||.+|||+.++|+||||+...
T Consensus 239 ~-------------------------~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~ 279 (326)
T 2y0a_A 239 E-------------------------YFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKD 279 (326)
T ss_dssp H-------------------------HHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTSCCS
T ss_pred c-------------------------ccccCCHHHHHHHHHHccCChhhCCCHHHHhcCCCccCCc
Confidence 1 2245789999999999999999999999999999998653
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-51 Score=381.65 Aligned_cols=251 Identities=29% Similarity=0.422 Sum_probs=209.4
Q ss_pred ceeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccc-------hhhhHHHHHHHHHcCCCCeeeeceEEEecCCCcee
Q 016184 81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL 153 (394)
Q Consensus 81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 153 (394)
.++|.+.+.||+|+||.||+|++..+|+.||||++... .....+|+.+++.++||||+++++++.. ..
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~-----~~ 82 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITT-----PT 82 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEEC-----SS
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEe-----CC
Confidence 45699999999999999999999999999999998643 2345689999999999999999998843 33
Q ss_pred EEEEEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCcc
Q 016184 154 YLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK 233 (394)
Q Consensus 154 ~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~ 233 (394)
..++||||+++++.+.+.. ...+++..++.++.|++.||.|||+ .||+||||||+|||++.++ .+||+|||++.
T Consensus 83 ~~~lv~E~~~g~l~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~-~givH~Dlkp~NIll~~~~-~~kl~DFG~s~ 156 (336)
T 3h4j_B 83 DIVMVIEYAGGELFDYIVE----KKRMTEDEGRRFFQQIICAIEYCHR-HKIVHRDLKPENLLLDDNL-NVKIADFGLSN 156 (336)
T ss_dssp EEEEEECCCCEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHH-HTCCCCCCSTTTEEECTTC-CEEECCSSCTB
T ss_pred EEEEEEECCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeEecCCchhhEEEcCCC-CEEEEEeccce
Confidence 4789999999888776654 3679999999999999999999999 8999999999999999888 69999999998
Q ss_pred ccccCCCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccC
Q 016184 234 VLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 313 (394)
Q Consensus 234 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 313 (394)
............||+.|+|||++.+....+.++|||||||++|+|++|+.||.+.........+ .
T Consensus 157 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i---------------~ 221 (336)
T 3h4j_B 157 IMTDGNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKV---------------N 221 (336)
T ss_dssp TTTTSBTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCC---------------C
T ss_pred eccCCcccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHH---------------H
Confidence 7766555566789999999999976654578999999999999999999999764321110000 0
Q ss_pred CCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 016184 314 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL 371 (394)
Q Consensus 314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 371 (394)
.....++..+++++.+||++||+.||.+|||++|+++||||+..
T Consensus 222 --------------~~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~ 265 (336)
T 3h4j_B 222 --------------SCVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDPWFNVN 265 (336)
T ss_dssp --------------SSCCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCHHHHTT
T ss_pred --------------cCCCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhChhhccC
Confidence 00011235679999999999999999999999999999999864
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-50 Score=382.68 Aligned_cols=286 Identities=31% Similarity=0.541 Sum_probs=217.4
Q ss_pred eeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccc------hhhhHHHHHHHHHcCCCCeeeeceEEEecCC-CceeE
Q 016184 82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTD-KEELY 154 (394)
Q Consensus 82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~~~~~ 154 (394)
.+|++.+.||+|+||.||+|++..+++.||||++... .....+|+.+++.++||||+++++++..... .....
T Consensus 25 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 104 (371)
T 2xrw_A 25 KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQD 104 (371)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCE
T ss_pred hheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccc
Confidence 3599999999999999999999999999999998642 1234579999999999999999998854321 22346
Q ss_pred EEEEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCccc
Q 016184 155 LNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV 234 (394)
Q Consensus 155 ~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~ 234 (394)
.++||||+++++.+.+. ..+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+++.
T Consensus 105 ~~lv~e~~~~~l~~~~~------~~~~~~~~~~i~~qi~~al~~lH~-~~ivH~Dlkp~NIl~~~~~-~~kl~Dfg~a~~ 176 (371)
T 2xrw_A 105 VYIVMELMDANLCQVIQ------MELDHERMSYLLYQMLCGIKHLHS-AGIIHRDLKPSNIVVKSDC-TLKILDFGLART 176 (371)
T ss_dssp EEEEEECCSEEHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECTTS-CEEECCCCC---
T ss_pred eEEEEEcCCCCHHHHHh------hccCHHHHHHHHHHHHHHHHHHHH-CCeecccCCHHHEEEcCCC-CEEEEEeecccc
Confidence 78999999998876654 468999999999999999999999 8999999999999999888 699999999987
Q ss_pred cccCCCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCC
Q 016184 235 LVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 314 (394)
Q Consensus 235 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 314 (394)
...........+|+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+.+..+.+.++.+..+.+..+.+
T Consensus 177 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 255 (371)
T 2xrw_A 177 AGTSFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQP 255 (371)
T ss_dssp -------------CTTCCHHHHTTC-CCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCH
T ss_pred cccccccCCceecCCccCHHHhcCC-CCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhh
Confidence 6554444566889999999999764 489999999999999999999999999998888999988888887766644322
Q ss_pred CCccc--CCCCCCCCCcchhcc-----------ccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCC
Q 016184 315 NYTEF--KFPQIKPHPWHKVFQ-----------KRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNT 376 (394)
Q Consensus 315 ~~~~~--~~~~~~~~~~~~~~~-----------~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~ 376 (394)
....+ ..+......+...++ ...+.++++||++||+.||.+|||++|+|+||||+...++..
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~~~~~ 330 (371)
T 2xrw_A 256 TVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDPSE 330 (371)
T ss_dssp HHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTTCCHHH
T ss_pred HHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhhhcCccc
Confidence 11000 001111111111111 123678999999999999999999999999999998766543
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-51 Score=373.36 Aligned_cols=255 Identities=21% Similarity=0.219 Sum_probs=186.8
Q ss_pred eEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccchh-hh--HHHHHHHHHcCCCCeeeeceEEEecCCCceeEEEEEE
Q 016184 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-YK--NRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVL 159 (394)
Q Consensus 83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~--~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~ 159 (394)
+|.+.++||+|+||+||+|++ +|+.||||++..... .. +.|+..+..++|||||++++++.... .....++|||
T Consensus 4 ~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~-~~~~~~~lV~ 80 (303)
T 3hmm_A 4 TIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDN-GTWTQLWLVS 80 (303)
T ss_dssp GEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEEC-SSSEEEEEEE
T ss_pred EEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccchhhHHHHHHHHHHhcCCCCCCCcEEEEEEecC-CCceEEEEEe
Confidence 599999999999999999998 489999999865432 22 23555566789999999999986543 2234578999
Q ss_pred eccc-ccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC--------CceeccCCCCceEEeCCCCcEEEEeec
Q 016184 160 EYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI--------GICHRDIKPQNLLVNPHTHQLKLCDFG 230 (394)
Q Consensus 160 e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~--------givH~Dlkp~Nil~~~~~~~vkl~Dfg 230 (394)
|||+ |+|.+++.. ..+++..+..++.|++.||+|||+ + +|+||||||+|||++.++ .+||+|||
T Consensus 81 Ey~~~gsL~~~l~~-----~~l~~~~~~~i~~~ia~gl~ylH~-~~~~~~~~~~IiHRDlKp~NILl~~~~-~~Ki~DFG 153 (303)
T 3hmm_A 81 DYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHM-EIVGTQGKPAIAHRDLKSKNILVKKNG-TCCIADLG 153 (303)
T ss_dssp ECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHC-CBCSTTCBCCEECSCCCGGGEEECTTS-CEEECCCT
T ss_pred cCCCCCcHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHH-hhhhccCCCCEeeccCCcccEEECCCC-CEEEEeCC
Confidence 9998 588888764 679999999999999999999997 5 899999999999999988 69999999
Q ss_pred CccccccCCCc-----ccccccccccccccccCCC-----CCCChhhHHHHHHHHHHHHhCCCCCCCCCcHH--------
Q 016184 231 SAKVLVKGEPN-----VSYICSRYYRAPELIFGAT-----EYTTAIDIWSTGCVMAELLLGQPLFPGESGVD-------- 292 (394)
Q Consensus 231 ~a~~~~~~~~~-----~~~~~t~~y~aPE~~~~~~-----~~~~~~DiwslG~il~~lltg~~pf~~~~~~~-------- 292 (394)
+|+........ ....||+.|||||++.+.. .++.++|||||||++|||+||..||.......
T Consensus 154 la~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~ 233 (303)
T 3hmm_A 154 LAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVP 233 (303)
T ss_dssp TCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSC
T ss_pred CCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhccc
Confidence 99876543322 2357899999999996532 25779999999999999999987764322110
Q ss_pred ---HHHHHHHHhCCCChhhhhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 016184 293 ---QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH 365 (394)
Q Consensus 293 ---~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 365 (394)
....+...... .. ..+...........+..+.+|+.+||+.||++|||+.|+++.
T Consensus 234 ~~~~~~~~~~~~~~----------~~--------~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 291 (303)
T 3hmm_A 234 SDPSVEEMRKVVCE----------QK--------LRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 291 (303)
T ss_dssp SSCCHHHHHHHHTT----------SC--------CCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred ccchHHHHHHHHhc----------cc--------CCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 01111111100 00 000000000011234578999999999999999999999863
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-50 Score=380.46 Aligned_cols=253 Identities=26% Similarity=0.479 Sum_probs=206.9
Q ss_pred ceeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccch-------hhhHHHHHHHHHc-CCCCeeeeceEEEecCCCce
Q 016184 81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQML-DHPNIVALKHCFFSTTDKEE 152 (394)
Q Consensus 81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~ 152 (394)
..+|+++++||+|+||+||+|+++.+++.||+|++.+.. ....+|..++..+ +||||+++++++. ..
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~-----~~ 125 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQ-----TE 125 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEE-----CS
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEE-----EC
Confidence 456999999999999999999999999999999986532 2345788888876 8999999999883 34
Q ss_pred eEEEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecC
Q 016184 153 LYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS 231 (394)
Q Consensus 153 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~ 231 (394)
..+++||||+++ +|...+.. ...+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+
T Consensus 126 ~~~~lV~E~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~-~givHrDLKp~NILl~~~g-~ikL~DFGl 199 (396)
T 4dc2_A 126 SRLFFVIEYVNGGDLMFHMQR----QRKLPEEHARFYSAEISLALNYLHE-RGIIYRDLKLDNVLLDSEG-HIKLTDYGM 199 (396)
T ss_dssp SEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCCGGGEEECTTS-CEEECCCTT
T ss_pred CEEEEEEEcCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCEEeccCCHHHEEECCCC-CEEEeecce
Confidence 458899999986 67665553 3679999999999999999999999 8999999999999999988 699999999
Q ss_pred cccc-ccCCCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCc--------HHHH-HHHHHHh
Q 016184 232 AKVL-VKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESG--------VDQL-VEIIKVL 301 (394)
Q Consensus 232 a~~~-~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~--------~~~~-~~i~~~~ 301 (394)
++.. .........+||+.|+|||++.+. .++.++|||||||++|+|++|+.||..... .+.+ ..+...
T Consensus 200 a~~~~~~~~~~~~~~gt~~Y~aPE~l~~~-~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~- 277 (396)
T 4dc2_A 200 CKEGLRPGDTTSTFCGTPNYIAPEILRGE-DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK- 277 (396)
T ss_dssp CBCCCCTTCCBCCCCBCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHC-
T ss_pred eeecccCCCccccccCCcccCCchhhcCC-CCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhcc-
Confidence 9863 333445567899999999999765 489999999999999999999999964321 1112 222210
Q ss_pred CCCChhhhhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCH------HHHhcCCCCCCCCCC
Q 016184 302 GTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTA------LEACVHPFFDELRDP 374 (394)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~------~ell~hp~f~~~~~~ 374 (394)
... ++..+++++++||++||+.||.+||++ +|+++||||+++...
T Consensus 278 ----------------~~~------------~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i~w~ 328 (396)
T 4dc2_A 278 ----------------QIR------------IPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWD 328 (396)
T ss_dssp ----------------CCC------------CCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTTCCHH
T ss_pred ----------------ccC------------CCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccCCCHH
Confidence 011 234689999999999999999999985 799999999987543
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-50 Score=376.50 Aligned_cols=288 Identities=29% Similarity=0.580 Sum_probs=227.6
Q ss_pred eeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccch---------------hhhHHHHHHHHHcCCCCeeeeceEEEe
Q 016184 82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---------------RYKNRELQIMQMLDHPNIVALKHCFFS 146 (394)
Q Consensus 82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---------------~~~~~E~~~l~~l~h~~iv~~~~~~~~ 146 (394)
.+|++.+.||+|+||.||+|.+.. |+.||||++.... ....+|+++++.++||||+++++++..
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 100 (362)
T 3pg1_A 22 SPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVH 100 (362)
T ss_dssp CSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEEE
T ss_pred cceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEEe
Confidence 459999999999999999999854 8999999885321 345689999999999999999999877
Q ss_pred cCCCceeEEEEEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEE
Q 016184 147 TTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKL 226 (394)
Q Consensus 147 ~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl 226 (394)
........+++||||+++++.+.+.. ....+++..++.++.||+.||.|||+ .||+||||||+|||++.++ .+||
T Consensus 101 ~~~~~~~~~~lv~e~~~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~Dlkp~NIl~~~~~-~~kl 175 (362)
T 3pg1_A 101 FEEPAMHKLYLVTELMRTDLAQVIHD---QRIVISPQHIQYFMYHILLGLHVLHE-AGVVHRDLHPGNILLADNN-DITI 175 (362)
T ss_dssp CCTTTCCEEEEEEECCSEEHHHHHHC---TTSCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECTTC-CEEE
T ss_pred ccCCCcceEEEEEccCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHH-CcCEecCCChHHEEEcCCC-CEEE
Confidence 66566677899999999988777663 23579999999999999999999999 8999999999999999887 6999
Q ss_pred EeecCccccccCCCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCh
Q 016184 227 CDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTR 306 (394)
Q Consensus 227 ~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~ 306 (394)
+|||++.............+|+.|+|||++.+...++.++|||||||++|+|++|+.||.+....+.+..+....+.+..
T Consensus 176 ~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~ 255 (362)
T 3pg1_A 176 CDFNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKI 255 (362)
T ss_dssp CCTTC---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCH
T ss_pred EecCcccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCh
Confidence 99999986655555556778999999999976566899999999999999999999999999999999999999998887
Q ss_pred hhhhccCCC----CcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCC
Q 016184 307 EEIKCMNPN----YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNT 376 (394)
Q Consensus 307 ~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~ 376 (394)
......... +............|. .....+++.+.+||.+||+.||.+|||+.++|+||||+.+.++..
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~ 328 (362)
T 3pg1_A 256 EDVVMFSSPSARDYLRNSLSNVPARAWT-AVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESLFDPLD 328 (362)
T ss_dssp HHHHHTSCHHHHHHTTTCCCCCCCCCHH-HHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTTCCGGG
T ss_pred HHhhhccchhhhHHHHhhcccCChhhHH-hhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhccCccc
Confidence 665432211 000111111222222 233567899999999999999999999999999999999866544
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-50 Score=375.08 Aligned_cols=255 Identities=26% Similarity=0.388 Sum_probs=215.4
Q ss_pred eeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccc---hhhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEEEEE
Q 016184 82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD---KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLV 158 (394)
Q Consensus 82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv 158 (394)
.+|++.+.||+|+||.||+|++..+++.||+|++... .....+|+.+++.++||||+++++++.. ....++|
T Consensus 5 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~-----~~~~~lv 79 (321)
T 1tki_A 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFES-----MEELVMI 79 (321)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEE-----TTEEEEE
T ss_pred hceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCcccHHHHHHHHHHHHhCCCCCCCeEeEEEec-----CCEEEEE
Confidence 3599999999999999999999999999999988643 2345689999999999999999998843 3348899
Q ss_pred Eecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeC--CCCcEEEEeecCcccc
Q 016184 159 LEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNP--HTHQLKLCDFGSAKVL 235 (394)
Q Consensus 159 ~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~--~~~~vkl~Dfg~a~~~ 235 (394)
|||+++ +|.+.+.. ....+++..++.++.|++.||.|||+ +||+||||||+|||++. ++ .+||+|||++...
T Consensus 80 ~e~~~g~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~-~givH~Dlkp~NIl~~~~~~~-~~kl~Dfg~a~~~ 154 (321)
T 1tki_A 80 FEFISGLDIFERINT---SAFELNEREIVSYVHQVCEALQFLHS-HNIGHFDIRPENIIYQTRRSS-TIKIIEFGQARQL 154 (321)
T ss_dssp ECCCCCCBHHHHHTS---SSCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEESSSSCC-CEEECCCTTCEEC
T ss_pred EEeCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCCCcCCCCHHHEEEccCCCC-CEEEEECCCCeEC
Confidence 999986 77665532 23469999999999999999999999 89999999999999987 45 7999999999877
Q ss_pred ccCCCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCC
Q 016184 236 VKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 315 (394)
Q Consensus 236 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 315 (394)
..........+|+.|+|||++.+. .++.++|||||||++|+|++|..||.+....+.+..+.......+...
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~------- 226 (321)
T 1tki_A 155 KPGDNFRLLFTAPEYYAPEVHQHD-VVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEA------- 226 (321)
T ss_dssp CTTCEEEEEESCGGGSCHHHHTTC-EECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHH-------
T ss_pred CCCCccccccCChhhcCcHHhcCC-CCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChhh-------
Confidence 665555567789999999999654 479999999999999999999999998887777777766432222221
Q ss_pred CcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 016184 316 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR 372 (394)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 372 (394)
...++.++.+||.+||+.||.+|||+.|+|+||||++..
T Consensus 227 ------------------~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~ 265 (321)
T 1tki_A 227 ------------------FKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQKI 265 (321)
T ss_dssp ------------------HTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSCG
T ss_pred ------------------hccCCHHHHHHHHHHcCCChhHCcCHHHHhcChhhccCc
Confidence 145799999999999999999999999999999998754
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-50 Score=375.29 Aligned_cols=258 Identities=29% Similarity=0.379 Sum_probs=210.8
Q ss_pred ceeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccc---------hhhhHHHHHHHHHcCCCCeeeeceEEEecCCCc
Q 016184 81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD---------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKE 151 (394)
Q Consensus 81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 151 (394)
..+|++.+.||+|+||.||+|+++.+|+.||||++... ...+.+|+.+++.++||||+++++++..
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~----- 97 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSS----- 97 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEE-----
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEe-----
Confidence 34699999999999999999999999999999998532 3445789999999999999999998843
Q ss_pred eeEEEEEEeccc-ccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCC--cEEEEe
Q 016184 152 ELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTH--QLKLCD 228 (394)
Q Consensus 152 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~--~vkl~D 228 (394)
...+++||||+. ++|...+.........+++..++.++.||+.||+|||+ +||+||||||+|||++.++. .+||+|
T Consensus 98 ~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~-~~ivHrDlkp~NIl~~~~~~~~~vkl~D 176 (351)
T 3c0i_A 98 DGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHD-NNIIHRDVKPHCVLLASKENSAPVKLGG 176 (351)
T ss_dssp TTEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECSSSTTCCEEECC
T ss_pred CCEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCChHHeEEecCCCCCcEEEec
Confidence 345889999998 47777666555545678999999999999999999999 89999999999999986542 499999
Q ss_pred ecCccccccCCC-cccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChh
Q 016184 229 FGSAKVLVKGEP-NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 307 (394)
Q Consensus 229 fg~a~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~ 307 (394)
||++........ .....||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.. ......+..........
T Consensus 177 fg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~i~~~~~~~~~~ 254 (351)
T 3c0i_A 177 FGVAIQLGESGLVAGGRVGTPHFMAPEVVKRE-PYGKPVDVWGCGVILFILLSGCLPFYGTK-ERLFEGIIKGKYKMNPR 254 (351)
T ss_dssp CTTCEECCTTSCBCCCCCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCSSH-HHHHHHHHHTCCCCCHH
T ss_pred CcceeEecCCCeeecCCcCCcCccCHHHHcCC-CCCchHhhHHHHHHHHHHHHCCCCCCCcH-HHHHHHHHcCCCCCCcc
Confidence 999987654332 3356789999999999654 48999999999999999999999998743 33344443321111111
Q ss_pred hhhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 016184 308 EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL 371 (394)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 371 (394)
....+++++.+||.+||+.||++|||+.++|+||||++.
T Consensus 255 -------------------------~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~ 293 (351)
T 3c0i_A 255 -------------------------QWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKER 293 (351)
T ss_dssp -------------------------HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTH
T ss_pred -------------------------ccccCCHHHHHHHHHHCCCChhHCcCHHHHhcChhhcCC
Confidence 114578999999999999999999999999999999874
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-49 Score=365.37 Aligned_cols=291 Identities=31% Similarity=0.531 Sum_probs=233.3
Q ss_pred ccceeEEEeeEEeecCceEEEEEEEC-CCCcEEEEEEeccch------hhhHHHHHHHHHc---CCCCeeeeceEEEecC
Q 016184 79 KQKVSYIAEHVVGTGSFGVVFQAKCR-ETGEIVAIKKVLQDK------RYKNRELQIMQML---DHPNIVALKHCFFSTT 148 (394)
Q Consensus 79 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~------~~~~~E~~~l~~l---~h~~iv~~~~~~~~~~ 148 (394)
....+|++.+.||+|+||.||+|++. .+|+.||+|++.... ....+|+.+++.+ .||||+++++++....
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~ 87 (326)
T 1blx_A 8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR 87 (326)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred CchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecc
Confidence 33456999999999999999999995 678999999885422 2445788877776 8999999999986544
Q ss_pred CCceeEEEEEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEe
Q 016184 149 DKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCD 228 (394)
Q Consensus 149 ~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~D 228 (394)
.......++||||+.++|.+++.... ...+++..++.++.|++.||.|||+ .||+||||||+|||++.++ .+||+|
T Consensus 88 ~~~~~~~~lv~e~~~~~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~-~gi~H~dlkp~Nili~~~~-~~kl~D 163 (326)
T 1blx_A 88 TDRETKLTLVFEHVDQDLTTYLDKVP--EPGVPTETIKDMMFQLLRGLDFLHS-HRVVHRDLKPQNILVTSSG-QIKLAD 163 (326)
T ss_dssp CSSEEEEEEEEECCSCBHHHHHHHSC--TTCSCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECTTC-CEEECS
T ss_pred cCCCceEEEEEecCCCCHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCHHHeEEcCCC-CEEEec
Confidence 45667788999999999888776533 2458999999999999999999999 8999999999999999888 799999
Q ss_pred ecCccccccCCCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhh
Q 016184 229 FGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 308 (394)
Q Consensus 229 fg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~ 308 (394)
||++.............+|+.|+|||++.+. .++.++||||||+++|+|++|+.||.+....+.+..+....+.+....
T Consensus 164 fg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 242 (326)
T 1blx_A 164 FGLARIYSFQMALTSVVVTLWYRAPEVLLQS-SYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED 242 (326)
T ss_dssp CCSCCCCCGGGGGCCCCCCCTTCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGG
T ss_pred CcccccccCCCCccccccccceeCHHHHhcC-CCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCccc
Confidence 9999766544444456789999999999654 489999999999999999999999999998888999998888877665
Q ss_pred hhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCC
Q 016184 309 IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNT 376 (394)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~ 376 (394)
+...... ....+...... ....+...++..+.+||.+||+.||.+|||+.++|+||||+++.....
T Consensus 243 ~~~~~~~-~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~~~~ 308 (326)
T 1blx_A 243 WPRDVAL-PRQAFHSKSAQ-PIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLERCKE 308 (326)
T ss_dssp SCTTCSS-CGGGSCCCCCC-CGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCCCCC
T ss_pred Ccccccc-chhhhcccCcc-hhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccccccchhhh
Confidence 4321110 00011111111 122234678999999999999999999999999999999999876554
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-49 Score=373.96 Aligned_cols=295 Identities=33% Similarity=0.620 Sum_probs=231.1
Q ss_pred eeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccch-----hhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEEE
Q 016184 82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN 156 (394)
Q Consensus 82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 156 (394)
.+|++.+.||+|+||.||+|++..+|+.||||++.... ....+|+.+++.++||||+++++++...........+
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 90 (353)
T 2b9h_A 11 SDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVY 90 (353)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCEE
T ss_pred cceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceEE
Confidence 35999999999999999999999999999999985422 2345799999999999999999987543333345578
Q ss_pred EEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCccccc
Q 016184 157 LVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV 236 (394)
Q Consensus 157 lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~ 236 (394)
+||||+.++|.+++.. ..+++..++.++.|++.||+|||+ +||+||||||+|||++.++ .+||+|||++....
T Consensus 91 lv~e~~~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~-~~ivH~Dlkp~Nil~~~~~-~~kl~Dfg~a~~~~ 163 (353)
T 2b9h_A 91 IIQELMQTDLHRVIST-----QMLSDDHIQYFIYQTLRAVKVLHG-SNVIHRDLKPSNLLINSNC-DLKVCDFGLARIID 163 (353)
T ss_dssp EEECCCSEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEECTTC-CEEECCCTTCEECC
T ss_pred EEEeccCccHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHeEEcCCC-cEEEEecccccccc
Confidence 9999999998877764 679999999999999999999999 8999999999999999888 69999999997654
Q ss_pred cCCC-----------cccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCC
Q 016184 237 KGEP-----------NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPT 305 (394)
Q Consensus 237 ~~~~-----------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~ 305 (394)
.... .....||+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+....+..+....+.+.
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 243 (353)
T 2b9h_A 164 ESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPH 243 (353)
T ss_dssp ----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred cccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCc
Confidence 3211 12346799999999986656689999999999999999999999999988888888888877765
Q ss_pred hhhhhccCCCCc--c--cCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCCCCCCC
Q 016184 306 REEIKCMNPNYT--E--FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPNG 381 (394)
Q Consensus 306 ~~~~~~~~~~~~--~--~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~~~~~~ 381 (394)
............ . ...+......+. .....+++++.+||.+||+.||++|||+.++|+||||+....+... +.+
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~~~-~~~ 321 (353)
T 2b9h_A 244 SDNDLRCIESPRAREYIKSLPMYPAAPLE-KMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYHDPNDE-PEG 321 (353)
T ss_dssp STTTTTTCCCHHHHHHHHTSCCCCCCCHH-HHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCTTSS-CCC
T ss_pred hhccccccccchhhHHhhcccCCCCcchh-hhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccCCcccc-ccc
Confidence 322111000000 0 011111111222 2234689999999999999999999999999999999999888765 344
Q ss_pred CCCC
Q 016184 382 RPLP 385 (394)
Q Consensus 382 ~~~~ 385 (394)
.+.|
T Consensus 322 ~~~~ 325 (353)
T 2b9h_A 322 EPIP 325 (353)
T ss_dssp CCCC
T ss_pred CCCC
Confidence 4444
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-49 Score=383.04 Aligned_cols=263 Identities=26% Similarity=0.422 Sum_probs=217.9
Q ss_pred ceeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccc-------hhhhHHHHHHHHHcCCCCeeeeceEEEecCCCcee
Q 016184 81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL 153 (394)
Q Consensus 81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 153 (394)
..+|++.++||+|+||+||+|+++.+++.||+|++.+. .....+|..++..++||||+++++++ ....
T Consensus 73 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~-----~~~~ 147 (437)
T 4aw2_A 73 REDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAF-----QDDN 147 (437)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEE-----ECSS
T ss_pred hhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-----eeCC
Confidence 34699999999999999999999999999999998642 22356899999999999999999988 3344
Q ss_pred EEEEEEeccc-ccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCc
Q 016184 154 YLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA 232 (394)
Q Consensus 154 ~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a 232 (394)
.+++||||++ ++|..++... ...+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||++
T Consensus 148 ~~~lV~Ey~~gg~L~~~l~~~---~~~l~e~~~~~~~~qi~~aL~~LH~-~giiHrDLKp~NILl~~~g-~vkL~DFGla 222 (437)
T 4aw2_A 148 NLYLVMDYYVGGDLLTLLSKF---EDRLPEEMARFYLAEMVIAIDSVHQ-LHYVHRDIKPDNILMDMNG-HIRLADFGSC 222 (437)
T ss_dssp EEEEEECCCTTCBHHHHHHTT---TTCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECTTS-CEEECCCTTC
T ss_pred EEEEEEecCCCCcHHHHHHHc---cCCCCHHHHHHHHHHHHHHHHHHHh-CCeEecccCHHHeeEcCCC-CEEEcchhhh
Confidence 5889999996 5787776542 3679999999999999999999999 8999999999999999988 6999999999
Q ss_pred cccccCCCc--cccccccccccccccc----CCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCh
Q 016184 233 KVLVKGEPN--VSYICSRYYRAPELIF----GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTR 306 (394)
Q Consensus 233 ~~~~~~~~~--~~~~~t~~y~aPE~~~----~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~ 306 (394)
+........ ....||+.|+|||++. +...++.++|||||||++|+|++|+.||.+.+..+.+..+......
T Consensus 223 ~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~--- 299 (437)
T 4aw2_A 223 LKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKER--- 299 (437)
T ss_dssp EECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHH---
T ss_pred hhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhcccc---
Confidence 766443332 2357899999999986 2345899999999999999999999999998887777777542110
Q ss_pred hhhhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCC--CCCHHHHhcCCCCCCCCCCCCC
Q 016184 307 EEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNL--RCTALEACVHPFFDELRDPNTR 377 (394)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~--Rpt~~ell~hp~f~~~~~~~~~ 377 (394)
..++. ....+++++++||++||+.+|++ |++++|+++||||+++.....+
T Consensus 300 ------------~~~p~---------~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~i~w~~l~ 351 (437)
T 4aw2_A 300 ------------FQFPT---------QVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGIDWDNIR 351 (437)
T ss_dssp ------------CCCCS---------SCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTTCCTTTGG
T ss_pred ------------ccCCc---------ccccCCHHHHHHHHHHhcccccccCCCCHHHHhCCCccCCCCHHHHh
Confidence 11111 01347999999999999999988 9999999999999998776664
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-49 Score=372.38 Aligned_cols=290 Identities=29% Similarity=0.476 Sum_probs=227.4
Q ss_pred ceeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccch------hhhHHHHHHHHHcCCCCeeeeceEEEecCC---Cc
Q 016184 81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTD---KE 151 (394)
Q Consensus 81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~---~~ 151 (394)
..+|++.+.||+|+||.||+|++..+|+.||||++.... ....+|+.+++.++||||+++++++..... ..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 95 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence 346999999999999999999999999999999885432 234579999999999999999998855332 12
Q ss_pred eeEEEEEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecC
Q 016184 152 ELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS 231 (394)
Q Consensus 152 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~ 231 (394)
...+++||||+++++...+... ...+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+
T Consensus 96 ~~~~~lv~e~~~~~l~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~LH~-~~ivH~Dlkp~NIl~~~~~-~~kl~Dfg~ 170 (351)
T 3mi9_A 96 KGSIYLVFDFCEHDLAGLLSNV---LVKFTLSEIKRVMQMLLNGLYYIHR-NKILHRDMKAANVLITRDG-VLKLADFGL 170 (351)
T ss_dssp -CEEEEEEECCSEEHHHHHHCT---TSCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECTTS-CEEECCCTT
T ss_pred CceEEEEEeccCCCHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHH-CCeeCCCCCHHHEEEcCCC-CEEEccchh
Confidence 4457899999999887666542 3579999999999999999999999 8999999999999999888 799999999
Q ss_pred ccccccC-----CCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCh
Q 016184 232 AKVLVKG-----EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTR 306 (394)
Q Consensus 232 a~~~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~ 306 (394)
+...... .......+|+.|+|||++.+...++.++|||||||++|+|++|..||.+......+..+....+.++.
T Consensus 171 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~ 250 (351)
T 3mi9_A 171 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITP 250 (351)
T ss_dssp CEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCT
T ss_pred cccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCh
Confidence 9765422 22234567999999999977666899999999999999999999999999988999999888888776
Q ss_pred hhhhccCCC--CcccCCCCCCCCCcc-hhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCC
Q 016184 307 EEIKCMNPN--YTEFKFPQIKPHPWH-KVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 375 (394)
Q Consensus 307 ~~~~~~~~~--~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~ 375 (394)
..+...... +.............. .......++.+.+||.+||+.||.+|||++|+|+||||+....+.
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~ 322 (351)
T 3mi9_A 251 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPMPS 322 (351)
T ss_dssp TTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSSSCCC
T ss_pred hhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCCCCcc
Confidence 655432211 011111111111111 111112478899999999999999999999999999998765443
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-50 Score=375.85 Aligned_cols=255 Identities=28% Similarity=0.380 Sum_probs=212.8
Q ss_pred ceeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccch------hhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeE
Q 016184 81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY 154 (394)
Q Consensus 81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 154 (394)
..+|++.+.||+|+||.||+|.++.+|+.||+|++.... ....+|+.+++.++||||+++++++. ....
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~-----~~~~ 102 (362)
T 2bdw_A 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQ-----EESF 102 (362)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----CSSE
T ss_pred ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEE-----eCCE
Confidence 346999999999999999999999999999999986432 34567999999999999999999883 3445
Q ss_pred EEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCC--CcEEEEeecC
Q 016184 155 LNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHT--HQLKLCDFGS 231 (394)
Q Consensus 155 ~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~--~~vkl~Dfg~ 231 (394)
.++||||+.+ +|.+.+.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++.++ ..+||+|||+
T Consensus 103 ~~lv~e~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~lH~-~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~ 177 (362)
T 2bdw_A 103 HYLVFDLVTGGELFEDIVA----REFYSEADASHCIQQILESIAYCHS-NGIVHRNLKPENLLLASKAKGAAVKLADFGL 177 (362)
T ss_dssp EEEEECCCCSCBHHHHHTT----CSCCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EEEEEecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeEeccCchHHEEEecCCCCCCEEEeecCc
Confidence 7899999986 66555442 3678999999999999999999999 8999999999999998653 2599999999
Q ss_pred ccccccCCCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhc
Q 016184 232 AKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 311 (394)
Q Consensus 232 a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 311 (394)
+.............||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+.......+.......+..
T Consensus 178 a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~---- 252 (362)
T 2bdw_A 178 AIEVNDSEAWHGFAGTPGYLSPEVLKKD-PYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSP---- 252 (362)
T ss_dssp CBCCTTCCSCCCSCSCTTTCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTT----
T ss_pred ceEecCCcccccCCCCccccCHHHHccC-CCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCcc----
Confidence 9877655555567899999999999654 48999999999999999999999999887766666665532111111
Q ss_pred cCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 016184 312 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL 371 (394)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 371 (394)
....+++++.+||.+||+.||.+|||+.++|+||||+..
T Consensus 253 ---------------------~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~ 291 (362)
T 2bdw_A 253 ---------------------EWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNR 291 (362)
T ss_dssp ---------------------GGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTSHHHHTH
T ss_pred ---------------------cccCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcccCCC
Confidence 114579999999999999999999999999999999753
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-49 Score=376.68 Aligned_cols=289 Identities=34% Similarity=0.613 Sum_probs=229.8
Q ss_pred eeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccc------hhhhHHHHHHHHHcCCCCeeeeceEEEecCCC-ceeE
Q 016184 82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDK-EELY 154 (394)
Q Consensus 82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~-~~~~ 154 (394)
.+|.+.+.||+|+||.||+|++..+|+.||||++... .....+|+.+++.++||||+++++++...... ....
T Consensus 42 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 121 (371)
T 4exu_A 42 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD 121 (371)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCC
T ss_pred ccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCccccee
Confidence 3699999999999999999999999999999998643 23345799999999999999999998543321 1223
Q ss_pred EEEEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCccc
Q 016184 155 LNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV 234 (394)
Q Consensus 155 ~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~ 234 (394)
.++||||+.+++...+ ...+++..++.++.||+.||+|||+ .||+||||||+|||++.++ .+||+|||+++.
T Consensus 122 ~~lv~e~~~~~l~~~~------~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dikp~NIll~~~~-~~kL~Dfg~a~~ 193 (371)
T 4exu_A 122 FYLVMPFMQTDLQKIM------GMEFSEEKIQYLVYQMLKGLKYIHS-AGVVHRDLKPGNLAVNEDC-ELKILDFGLARH 193 (371)
T ss_dssp CEEEEECCCEEHHHHT------TSCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECTTC-CEEECSTTCC--
T ss_pred EEEEEccccccHHHHh------hcCCCHHHHHHHHHHHHHHHHHHHH-CCCcCCCcCHHHeEECCCC-CEEEEecCcccc
Confidence 4799999998876554 2569999999999999999999999 8999999999999999888 699999999975
Q ss_pred cccCCCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCC
Q 016184 235 LVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 314 (394)
Q Consensus 235 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 314 (394)
... ......+|+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+.+..+....+.++.+....++.
T Consensus 194 ~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 271 (371)
T 4exu_A 194 ADA--EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLND 271 (371)
T ss_dssp --------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSC
T ss_pred ccc--CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhh
Confidence 532 334567899999999997756689999999999999999999999999999999999999999888876654432
Q ss_pred CCccc---CCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCCCCCCC
Q 016184 315 NYTEF---KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPNG 381 (394)
Q Consensus 315 ~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~~~~~~ 381 (394)
..... ..+......+.. ....+++++.+||++||+.||.+|||+.|+|+||||+.+..+.......
T Consensus 272 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~~~~~~ 340 (371)
T 4exu_A 272 KAAKSYIQSLPQTPRKDFTQ-LFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRDPEEETEAQ 340 (371)
T ss_dssp HHHHHHHHHSCCCCCCCHHH-HSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTCCGGGCCCCS
T ss_pred hhhhhhhhccCCCcchhHHH-hccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccCCCcccccccc
Confidence 11100 111111112222 2346799999999999999999999999999999999987776544333
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-49 Score=377.49 Aligned_cols=262 Identities=27% Similarity=0.452 Sum_probs=215.4
Q ss_pred ceeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccc-------hhhhHHHHHHHHHcCCCCeeeeceEEEecCCCcee
Q 016184 81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL 153 (394)
Q Consensus 81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 153 (394)
..+|++.++||+|+||.||+|+++.+|+.||||++.+. .....+|..++..++||||+++++++ ....
T Consensus 60 ~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~-----~~~~ 134 (412)
T 2vd5_A 60 RDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAF-----QDEN 134 (412)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEE-----ECSS
T ss_pred hhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEE-----eeCC
Confidence 35699999999999999999999999999999998642 23356799999999999999999988 3344
Q ss_pred EEEEEEeccc-ccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCc
Q 016184 154 YLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA 232 (394)
Q Consensus 154 ~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a 232 (394)
++|+||||++ ++|..++... ...+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||++
T Consensus 135 ~~~lVmE~~~gg~L~~~l~~~---~~~l~~~~~~~~~~qi~~aL~~LH~-~giiHrDLKp~NILld~~g-~vkL~DFGla 209 (412)
T 2vd5_A 135 YLYLVMEYYVGGDLLTLLSKF---GERIPAEMARFYLAEIVMAIDSVHR-LGYVHRDIKPDNILLDRCG-HIRLADFGSC 209 (412)
T ss_dssp EEEEEECCCCSCBHHHHHHHH---SSCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECTTS-CEEECCCTTC
T ss_pred EEEEEEcCCCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecccCHHHeeecCCC-CEEEeechhh
Confidence 5889999996 5887777542 3579999999999999999999999 8999999999999999988 6999999999
Q ss_pred cccccCCC--cccccccccccccccccC------CCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCC
Q 016184 233 KVLVKGEP--NVSYICSRYYRAPELIFG------ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTP 304 (394)
Q Consensus 233 ~~~~~~~~--~~~~~~t~~y~aPE~~~~------~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~ 304 (394)
+....... .....||+.|+|||++.. ...++.++|||||||++|+|++|+.||.+.+..+.+..+......
T Consensus 210 ~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~- 288 (412)
T 2vd5_A 210 LKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEH- 288 (412)
T ss_dssp EECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHH-
T ss_pred eeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccC-
Confidence 87644332 224578999999999862 345899999999999999999999999988877777666542100
Q ss_pred ChhhhhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCC---CCHHHHhcCCCCCCCCCCCCC
Q 016184 305 TREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLR---CTALEACVHPFFDELRDPNTR 377 (394)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R---pt~~ell~hp~f~~~~~~~~~ 377 (394)
..++. +...+++++++||++||+ ||.+| ++++|+++||||+++.....+
T Consensus 289 --------------~~~p~---------~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~i~w~~l~ 340 (412)
T 2vd5_A 289 --------------LSLPL---------VDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGLDWDGLR 340 (412)
T ss_dssp --------------CCCC-------------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTTCCSTTST
T ss_pred --------------cCCCc---------cccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCCCCHHHHh
Confidence 00110 124689999999999999 99998 599999999999998766654
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-49 Score=374.34 Aligned_cols=255 Identities=26% Similarity=0.419 Sum_probs=210.7
Q ss_pred ceeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccch-------hhhHHHHHHHHHcCCCCeeeeceEEEecCCCcee
Q 016184 81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL 153 (394)
Q Consensus 81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 153 (394)
.++|++.+.||+|+||.||+|++..+++.||+|++.+.. ....+|+.+++.++||||+++++++. ...
T Consensus 14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~-----~~~ 88 (384)
T 4fr4_A 14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQ-----DEE 88 (384)
T ss_dssp GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEE-----CSS
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE-----eCC
Confidence 346999999999999999999999999999999986432 34457999999999999999999883 334
Q ss_pred EEEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCc
Q 016184 154 YLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA 232 (394)
Q Consensus 154 ~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a 232 (394)
..++||||+.+ +|..++.. ...+++..++.++.||+.||.|||+ .||+||||||+|||++.++ .+||+|||++
T Consensus 89 ~~~lv~e~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~-~givHrDlkp~NIll~~~g-~vkL~DFG~a 162 (384)
T 4fr4_A 89 DMFMVVDLLLGGDLRYHLQQ----NVHFKEETVKLFICELVMALDYLQN-QRIIHRDMKPDNILLDEHG-HVHITDFNIA 162 (384)
T ss_dssp EEEEEECCCTTEEHHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECTTS-CEEECCCTTC
T ss_pred EEEEEEecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCcHHHeEECCCC-CEEEecccee
Confidence 57899999975 66665543 4679999999999999999999999 8999999999999999988 6999999999
Q ss_pred cccccCCCcccccccccccccccccCC--CCCCChhhHHHHHHHHHHHHhCCCCCCCCCcH--HHHHHHHHHhCCCChhh
Q 016184 233 KVLVKGEPNVSYICSRYYRAPELIFGA--TEYTTAIDIWSTGCVMAELLLGQPLFPGESGV--DQLVEIIKVLGTPTREE 308 (394)
Q Consensus 233 ~~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~~DiwslG~il~~lltg~~pf~~~~~~--~~~~~i~~~~~~~~~~~ 308 (394)
.............||+.|+|||++... ..++.++|||||||++|+|++|+.||...... ..+.......
T Consensus 163 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~------- 235 (384)
T 4fr4_A 163 AMLPRETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETT------- 235 (384)
T ss_dssp EECCTTCCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHC-------
T ss_pred eeccCCCceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhc-------
Confidence 877666666678899999999998542 34789999999999999999999999764332 2222221110
Q ss_pred hhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCC-HHHHhcCCCCCCCCCC
Q 016184 309 IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCT-ALEACVHPFFDELRDP 374 (394)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt-~~ell~hp~f~~~~~~ 374 (394)
.. .++..++.++.+||.+||+.||.+||+ ++++++||||+++...
T Consensus 236 ---------~~------------~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~hp~f~~~~w~ 281 (384)
T 4fr4_A 236 ---------VV------------TYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMNDINWD 281 (384)
T ss_dssp ---------CC------------CCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHTSGGGTTCCHH
T ss_pred ---------cc------------CCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHcChhhhcCCHH
Confidence 00 012457899999999999999999998 8999999999987543
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-49 Score=372.39 Aligned_cols=276 Identities=25% Similarity=0.420 Sum_probs=220.0
Q ss_pred eeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccch---hhhHHHHHHHHHcC-----CCCeeeeceEEEecCCCcee
Q 016184 82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---RYKNRELQIMQMLD-----HPNIVALKHCFFSTTDKEEL 153 (394)
Q Consensus 82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~-----h~~iv~~~~~~~~~~~~~~~ 153 (394)
++|++.++||+|+||.||+|++..+++.||||++.... .....|+.+++.+. ||||+++++++... .
T Consensus 35 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~-----~ 109 (360)
T 3llt_A 35 NAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYY-----D 109 (360)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEET-----T
T ss_pred CEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccchhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeEC-----C
Confidence 35999999999999999999999999999999986432 33456999999996 99999999988443 3
Q ss_pred EEEEEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeC--------------
Q 016184 154 YLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNP-------------- 219 (394)
Q Consensus 154 ~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~-------------- 219 (394)
..++||||++++|.+++.... ...+++..++.++.||+.||+|||+ +||+||||||+|||++.
T Consensus 110 ~~~lv~e~~~~~L~~~~~~~~--~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~ 186 (360)
T 3llt_A 110 HMCLIFEPLGPSLYEIITRNN--YNGFHIEDIKLYCIEILKALNYLRK-MSLTHTDLKPENILLDDPYFEKSLITVRRVT 186 (360)
T ss_dssp EEEEEECCCCCBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEESCTTCCEEEEEEECTT
T ss_pred eeEEEEcCCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeCCCCcccEEEccccccccccchhccc
Confidence 588999999889988877532 2469999999999999999999999 89999999999999974
Q ss_pred -----------CCCcEEEEeecCccccccCCCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 016184 220 -----------HTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGE 288 (394)
Q Consensus 220 -----------~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~ 288 (394)
++ .+||+|||++..... ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.
T Consensus 187 ~~~~~~~~~~~~~-~~kl~DFG~a~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~ 262 (360)
T 3llt_A 187 DGKKIQIYRTKST-GIKLIDFGCATFKSD--YHGSIINTRQYRAPEVILNL-GWDVSSDMWSFGCVLAELYTGSLLFRTH 262 (360)
T ss_dssp TCCEEEEEEESCC-CEEECCCTTCEETTS--CCCSCCSCGGGCCHHHHTTC-CCCTTHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred ccccccccccCCC-CEEEEeccCceecCC--CCcCccCcccccCcHHHcCC-CCCCccchHHHHHHHHHHHHCCCCCCCC
Confidence 44 799999999976432 33456789999999999765 4899999999999999999999999999
Q ss_pred CcHHHHHHHHHHhCCCChhhhhccCCCCcc---------cCCCCCCCCC--------cchhccccCChHHHHHHHHhccc
Q 016184 289 SGVDQLVEIIKVLGTPTREEIKCMNPNYTE---------FKFPQIKPHP--------WHKVFQKRLPPEAVDLVCRFFQY 351 (394)
Q Consensus 289 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~--------~~~~~~~~~~~~~~~li~~~L~~ 351 (394)
+..+.+..+....+..+............. ...+...... ....+....++.+.+||++||+.
T Consensus 263 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~ 342 (360)
T 3llt_A 263 EHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQI 342 (360)
T ss_dssp SHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCCS
T ss_pred cHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHhcC
Confidence 888888888888888776655332211000 0011000000 00111223457889999999999
Q ss_pred CCCCCCCHHHHhcCCCCC
Q 016184 352 SPNLRCTALEACVHPFFD 369 (394)
Q Consensus 352 dP~~Rpt~~ell~hp~f~ 369 (394)
||.+|||+.|+|+||||+
T Consensus 343 dP~~Rpta~elL~hp~f~ 360 (360)
T 3llt_A 343 DPTLRPSPAELLKHKFLE 360 (360)
T ss_dssp SGGGSCCHHHHTTSGGGC
T ss_pred ChhhCCCHHHHhcCcccC
Confidence 999999999999999996
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-50 Score=372.78 Aligned_cols=251 Identities=27% Similarity=0.476 Sum_probs=211.2
Q ss_pred eeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccch-------hhhHHHHHHHHHc-CCCCeeeeceEEEecCCCcee
Q 016184 82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQML-DHPNIVALKHCFFSTTDKEEL 153 (394)
Q Consensus 82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~ 153 (394)
.+|++.+.||+|+||.||+|+++.+|+.||||++.+.. .....|..++..+ +||||+++++++. ...
T Consensus 17 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~-----~~~ 91 (345)
T 1xjd_A 17 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQ-----TKE 91 (345)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEE-----CSS
T ss_pred HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEE-----eCC
Confidence 45999999999999999999999999999999986532 2345688888876 9999999999883 334
Q ss_pred EEEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCc
Q 016184 154 YLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA 232 (394)
Q Consensus 154 ~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a 232 (394)
.+++||||+++ +|..++.. ...+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||++
T Consensus 92 ~~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivHrDlkp~NIll~~~g-~vkL~DFG~a 165 (345)
T 1xjd_A 92 NLFFVMEYLNGGDLMYHIQS----CHKFDLSRATFYAAEIILGLQFLHS-KGIVYRDLKLDNILLDKDG-HIKIADFGMC 165 (345)
T ss_dssp EEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCCGGGEEECTTS-CEEECCCTTC
T ss_pred EEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeEeCCCChhhEEECCCC-CEEEeEChhh
Confidence 58899999975 77766654 3679999999999999999999999 8999999999999999988 6999999999
Q ss_pred ccccc-CCCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhc
Q 016184 233 KVLVK-GEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 311 (394)
Q Consensus 233 ~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 311 (394)
+.... ........||+.|+|||++.+. .++.++|+|||||++|+|++|+.||.+.+..+.+..+....
T Consensus 166 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~---------- 234 (345)
T 1xjd_A 166 KENMLGDAKTNTFCGTPDYIAPEILLGQ-KYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDN---------- 234 (345)
T ss_dssp BCCCCTTCCBCCCCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC----------
T ss_pred hhcccCCCcccCCCCCcccCChhhhcCC-CCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCC----------
Confidence 76433 2334566789999999999665 48999999999999999999999999887766666654411
Q ss_pred cCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHH-HHhcCCCCCCCCC
Q 016184 312 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTAL-EACVHPFFDELRD 373 (394)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~-ell~hp~f~~~~~ 373 (394)
.. ++..+++++.+||.+||+.||.+||++. ++++||||+++..
T Consensus 235 -------~~------------~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~hp~f~~~~w 278 (345)
T 1xjd_A 235 -------PF------------YPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREINW 278 (345)
T ss_dssp -------CC------------CCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTCCH
T ss_pred -------CC------------CCcccCHHHHHHHHHHhcCCHhHcCCChHHHHcCccccCCCH
Confidence 00 1245789999999999999999999998 9999999998753
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-49 Score=366.51 Aligned_cols=251 Identities=26% Similarity=0.467 Sum_probs=213.4
Q ss_pred ceeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccc-------hhhhHHHHHHHHHcCCCCeeeeceEEEecCCCcee
Q 016184 81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL 153 (394)
Q Consensus 81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 153 (394)
..+|++.+.||+|+||.||+|+++.+|+.||+|++.+. .....+|..+++.++||||+++++++. ...
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~-----~~~ 79 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQ-----DAQ 79 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEE-----CSS
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEE-----eCC
Confidence 34699999999999999999999999999999998643 233457999999999999999999883 334
Q ss_pred EEEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCc
Q 016184 154 YLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA 232 (394)
Q Consensus 154 ~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a 232 (394)
.+++||||+.+ +|.+++.. ...+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||++
T Consensus 80 ~~~lv~e~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivHrDlkp~NIll~~~g-~~kL~Dfg~a 153 (318)
T 1fot_A 80 QIFMIMDYIEGGELFSLLRK----SQRFPNPVAKFYAAEVCLALEYLHS-KDIIYRDLKPENILLDKNG-HIKITDFGFA 153 (318)
T ss_dssp EEEEEECCCCSCBHHHHHHH----TSSCCHHHHHHHHHHHHHHHHHHHT-TTEECCCCCGGGEEECTTS-CEEECCCSSC
T ss_pred EEEEEEeCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCChheEEEcCCC-CEEEeecCcc
Confidence 58899999985 77776654 3679999999999999999999999 8999999999999999888 6999999999
Q ss_pred cccccCCCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhcc
Q 016184 233 KVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 312 (394)
Q Consensus 233 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 312 (394)
+.... ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+....+..+....
T Consensus 154 ~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~----------- 219 (318)
T 1fot_A 154 KYVPD--VTYTLCGTPDYIAPEVVSTK-PYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAE----------- 219 (318)
T ss_dssp EECSS--CBCCCCSCTTTCCHHHHTTC-CBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCC-----------
T ss_pred eecCC--ccccccCCccccCHhHhcCC-CCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-----------
Confidence 76532 33456789999999999654 48999999999999999999999999887777776665521
Q ss_pred CCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCC-----CHHHHhcCCCCCCCCCC
Q 016184 313 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-----TALEACVHPFFDELRDP 374 (394)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----t~~ell~hp~f~~~~~~ 374 (394)
.. ++..+++++.+||++||+.||.+|| +++++++||||+++...
T Consensus 220 ------~~------------~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp~f~~~~~~ 268 (318)
T 1fot_A 220 ------LR------------FPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWE 268 (318)
T ss_dssp ------CC------------CCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCCHH
T ss_pred ------CC------------CCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcCccccCCCHH
Confidence 11 1245789999999999999999999 99999999999987543
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-49 Score=359.22 Aligned_cols=268 Identities=27% Similarity=0.370 Sum_probs=222.2
Q ss_pred ceeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccch------hhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeE
Q 016184 81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY 154 (394)
Q Consensus 81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 154 (394)
.++|++.+.||+|+||.||+|.+..+|+.||+|++.... ....+|+.+++.++||||+++++++ .....
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~ 79 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSI-----QEESF 79 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-----ECSSE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEE-----EcCCE
Confidence 346999999999999999999999999999999985432 3345799999999999999999988 33445
Q ss_pred EEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCC--cEEEEeecC
Q 016184 155 LNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTH--QLKLCDFGS 231 (394)
Q Consensus 155 ~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~--~vkl~Dfg~ 231 (394)
.++||||+.+ ++.+.+.. ...+++..++.++.|++.||.|||+ .||+||||||+||+++.++. .+||+|||+
T Consensus 80 ~~~v~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~ 154 (284)
T 3kk8_A 80 HYLVFDLVTGGELFEDIVA----REFYSEADASHCIQQILESIAYCHS-NGIVHRNLKPENLLLASKAKGAAVKLADFGL 154 (284)
T ss_dssp EEEEECCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEESSSSTTCCEEECCCTT
T ss_pred EEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCcCcCCCCHHHEEEecCCCCCcEEEeecee
Confidence 7899999986 66555543 3679999999999999999999999 89999999999999986542 499999999
Q ss_pred ccccccCCCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhc
Q 016184 232 AKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 311 (394)
Q Consensus 232 a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 311 (394)
+.............+|+.|+|||++.+. .++.++||||||+++|+|++|+.||.+.........+.......+..
T Consensus 155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~---- 229 (284)
T 3kk8_A 155 AIEVNDSEAWHGFAGTPGYLSPEVLKKD-PYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSP---- 229 (284)
T ss_dssp CEECCSSCBCCCSCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTT----
T ss_pred eEEcccCccccCCCCCcCCcCchhhcCC-CCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCch----
Confidence 9877665555567889999999999654 48999999999999999999999998887776666665532211111
Q ss_pred cCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCCCCCCCCCC
Q 016184 312 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPNGRPL 384 (394)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~~~~~~~~~ 384 (394)
....+++++.+||.+||+.||++|||+.++|+||||++............+.
T Consensus 230 ---------------------~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~~~~~~~~~~~ 281 (284)
T 3kk8_A 230 ---------------------EWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNRERVASAIHRQDTV 281 (284)
T ss_dssp ---------------------TTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTSHHHHSCCCGGGSCCCCCCC
T ss_pred ---------------------hhcccCHHHHHHHHHHcccChhhCCCHHHHhcCccccCChhHHhHhhcCCCc
Confidence 1135789999999999999999999999999999999988777776665554
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-50 Score=374.03 Aligned_cols=252 Identities=25% Similarity=0.408 Sum_probs=211.5
Q ss_pred eeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccch-------hhhHHHHHHHHHc-CCCCeeeeceEEEecCCCcee
Q 016184 82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQML-DHPNIVALKHCFFSTTDKEEL 153 (394)
Q Consensus 82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~ 153 (394)
.+|++.++||+|+||.||+|+++.+|+.||||++.+.. ....+|..++..+ .||+|+++++++ ....
T Consensus 20 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~-----~~~~ 94 (353)
T 2i0e_A 20 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCF-----QTMD 94 (353)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEE-----ECSS
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEE-----EcCC
Confidence 46999999999999999999999999999999986532 2345688888877 899999999988 3334
Q ss_pred EEEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCc
Q 016184 154 YLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA 232 (394)
Q Consensus 154 ~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a 232 (394)
.+|+||||+++ +|..++.. ...+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||++
T Consensus 95 ~~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~-~givHrDlkp~NIll~~~g-~vkL~DFG~a 168 (353)
T 2i0e_A 95 RLYFVMEYVNGGDLMYHIQQ----VGRFKEPHAVFYAAEIAIGLFFLQS-KGIIYRDLKLDNVMLDSEG-HIKIADFGMC 168 (353)
T ss_dssp EEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCCGGGEEECTTS-CEEECCCTTC
T ss_pred EEEEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCEEeccCCHHHEEEcCCC-cEEEEeCCcc
Confidence 58899999975 77766654 3679999999999999999999999 8999999999999999988 6999999999
Q ss_pred ccccc-CCCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhc
Q 016184 233 KVLVK-GEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 311 (394)
Q Consensus 233 ~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 311 (394)
+.... ........||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+.+..+....
T Consensus 169 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~---------- 237 (353)
T 2i0e_A 169 KENIWDGVTTKTFCGTPDYIAPEIIAYQ-PYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHN---------- 237 (353)
T ss_dssp BCCCCTTCCBCCCCSCGGGCCHHHHTTC-CBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC----------
T ss_pred cccccCCcccccccCCccccChhhhcCC-CcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCC----------
Confidence 76432 2334456789999999999654 48999999999999999999999999888777776665521
Q ss_pred cCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCC-----CHHHHhcCCCCCCCCCC
Q 016184 312 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-----TALEACVHPFFDELRDP 374 (394)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----t~~ell~hp~f~~~~~~ 374 (394)
.. ++..+++++.+||++||+.||.+|| +++++++||||+.+...
T Consensus 238 -------~~------------~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~~~w~ 286 (353)
T 2i0e_A 238 -------VA------------YPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWE 286 (353)
T ss_dssp -------CC------------CCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTSGGGTTCCHH
T ss_pred -------CC------------CCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCccccCCCHH
Confidence 11 1246799999999999999999999 47999999999987543
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-49 Score=370.99 Aligned_cols=289 Identities=33% Similarity=0.575 Sum_probs=226.3
Q ss_pred CCCCCCccceeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccch------hhhHHHHHHHHHcCCCCeeeeceEEEe
Q 016184 73 GRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFS 146 (394)
Q Consensus 73 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~ 146 (394)
..+.......+|++.+.||+|+||.||+|++..+|+.||||++.... ....+|+.+++.++||||+++++++.
T Consensus 16 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~- 94 (331)
T 4aaa_A 16 TENLYFQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCK- 94 (331)
T ss_dssp ---CCCBCGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-
T ss_pred cchhhhhhhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEee-
Confidence 33444455667999999999999999999999999999999875432 22457999999999999999999884
Q ss_pred cCCCceeEEEEEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEE
Q 016184 147 TTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKL 226 (394)
Q Consensus 147 ~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl 226 (394)
.....++||||+++++...+. .....+++..++.++.||+.||.|||+ .||+||||||+|||++.++ .+||
T Consensus 95 ----~~~~~~lv~e~~~~~~l~~~~---~~~~~~~~~~~~~~~~qi~~~l~~LH~-~~ivH~dlkp~Nil~~~~~-~~kl 165 (331)
T 4aaa_A 95 ----KKKRWYLVFEFVDHTILDDLE---LFPNGLDYQVVQKYLFQIINGIGFCHS-HNIIHRDIKPENILVSQSG-VVKL 165 (331)
T ss_dssp ----ETTEEEEEEECCSEEHHHHHH---HSTTCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECTTS-CEEE
T ss_pred ----cCCEEEEEEecCCcchHHHHH---hhccCCCHHHHHHHHHHHHHHHHHHHH-CCEEccCcChheEEEcCCC-cEEE
Confidence 334478999999986544332 234679999999999999999999999 8999999999999999888 7999
Q ss_pred EeecCccccccC-CCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCC
Q 016184 227 CDFGSAKVLVKG-EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPT 305 (394)
Q Consensus 227 ~Dfg~a~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~ 305 (394)
+|||++...... .......+|+.|+|||++.+...++.++|||||||++|+|++|+.||.+....+.+..+....+...
T Consensus 166 ~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 245 (331)
T 4aaa_A 166 CDFGFARTLAAPGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLI 245 (331)
T ss_dssp CCCTTC------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCC
T ss_pred EeCCCceeecCCccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCC
Confidence 999999765432 2233457899999999997765689999999999999999999999999998898988888888776
Q ss_pred hhhhhcc--CCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 016184 306 REEIKCM--NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL 371 (394)
Q Consensus 306 ~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 371 (394)
......+ .+.+.....+..............+++++.+||.+||+.||.+|||+.|+|+||||+..
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 313 (331)
T 4aaa_A 246 PRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMD 313 (331)
T ss_dssp HHHHHHHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHGG
T ss_pred hhhhhHhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhccC
Confidence 6544322 22223333333333333333345689999999999999999999999999999999864
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-49 Score=381.22 Aligned_cols=255 Identities=27% Similarity=0.363 Sum_probs=210.4
Q ss_pred ceeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccch------hhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeE
Q 016184 81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY 154 (394)
Q Consensus 81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 154 (394)
..+|++.+.||+|+||.||+|.+..+|+.||+|++.... ....+|+.+++.++||||+++++++ .....
T Consensus 10 ~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~-----~~~~~ 84 (444)
T 3soa_A 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSI-----SEEGH 84 (444)
T ss_dssp HHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEE-----ECSSE
T ss_pred cCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEE-----EECCE
Confidence 456999999999999999999999999999999986432 3456899999999999999999988 33445
Q ss_pred EEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCC--CCcEEEEeecC
Q 016184 155 LNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPH--THQLKLCDFGS 231 (394)
Q Consensus 155 ~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~--~~~vkl~Dfg~ 231 (394)
.++||||+.+ +|.+.+.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++.+ +..+||+|||+
T Consensus 85 ~~lv~E~~~gg~L~~~i~~----~~~~~e~~~~~i~~qil~aL~~lH~-~givHrDlKp~NIll~~~~~~~~vkL~DFG~ 159 (444)
T 3soa_A 85 HYLIFDLVTGGELFEDIVA----REYYSEADASHCIQQILEAVLHCHQ-MGVVHRNLKPENLLLASKLKGAAVKLADFGL 159 (444)
T ss_dssp EEEEECCCBCCBHHHHHHH----CSCCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCSSTTEEESBSSTTCCEEECCCSS
T ss_pred EEEEEEeCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCHHHEEEeccCCCCcEEEccCce
Confidence 7899999985 77665553 3679999999999999999999999 899999999999999842 23699999999
Q ss_pred ccccccCCC-cccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhh
Q 016184 232 AKVLVKGEP-NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 310 (394)
Q Consensus 232 a~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 310 (394)
+........ .....||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+....+..+.......+..
T Consensus 160 a~~~~~~~~~~~~~~gt~~Y~APE~l~~~-~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~--- 235 (444)
T 3soa_A 160 AIEVEGEQQAWFGFAGTPGYLSPEVLRKD-PYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSP--- 235 (444)
T ss_dssp CBCCCTTCCBCCCSCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTT---
T ss_pred eEEecCCCceeecccCCcccCCHHHhcCC-CCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCcc---
Confidence 976644332 3456789999999999654 48999999999999999999999999888777777666532111111
Q ss_pred ccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 016184 311 CMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL 371 (394)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 371 (394)
....+++++.+||.+||+.||.+|||+.|+|+||||++.
T Consensus 236 ----------------------~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~hp~~~~~ 274 (444)
T 3soa_A 236 ----------------------EWDTVTPEAKDLINKMLTINPSKRITAAEALKHPWISHR 274 (444)
T ss_dssp ----------------------TTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSCTTHHH
T ss_pred ----------------------ccccCCHHHHHHHHHHcCCChhHCCCHHHHhcCccccCC
Confidence 114579999999999999999999999999999999764
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-49 Score=380.35 Aligned_cols=291 Identities=28% Similarity=0.475 Sum_probs=212.7
Q ss_pred eeEEE-eeEEeecCceEEEEEEEC--CCCcEEEEEEeccc--hhhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEEE
Q 016184 82 VSYIA-EHVVGTGSFGVVFQAKCR--ETGEIVAIKKVLQD--KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN 156 (394)
Q Consensus 82 ~~y~~-~~~lg~G~~g~V~~~~~~--~~~~~vaiK~~~~~--~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 156 (394)
+.|.+ .++||+|+||.||+|+++ .+++.||||++... .....+|+.+++.++||||+++++++.... ...++
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~---~~~~~ 96 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFLSHA---DRKVW 96 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCCHHHHHHHHHHHHCCCTTBCCCCEEEEETT---TTEEE
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCCHHHHHHHHHHHhcCCCCeeeEeeEEecCC---CCeEE
Confidence 34877 458999999999999976 56889999998654 234568999999999999999999985433 33578
Q ss_pred EEEecccccHHHHHHHhhhh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEE----eCCCCcEEEE
Q 016184 157 LVLEYVPETVNRIARNYSRI-----HQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLV----NPHTHQLKLC 227 (394)
Q Consensus 157 lv~e~~~~~l~~~~~~~~~~-----~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~----~~~~~~vkl~ 227 (394)
+||||+++++.+++...... ...+++..++.++.||+.||+|||+ .||+||||||+|||+ +.++ .+||+
T Consensus 97 lv~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~-~~ivH~Dlkp~NIll~~~~~~~~-~~kl~ 174 (405)
T 3rgf_A 97 LLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA-NWVLHRDLKPANILVMGEGPERG-RVKIA 174 (405)
T ss_dssp EEEECCSEEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECCSSTTTT-CEEEC
T ss_pred EEEeCCCCCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHh-CCEeCCCcCHHHeEEecCCCCCC-cEEEE
Confidence 99999999988877654432 1249999999999999999999999 899999999999999 4455 79999
Q ss_pred eecCccccccC----CCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCc---------HHHH
Q 016184 228 DFGSAKVLVKG----EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESG---------VDQL 294 (394)
Q Consensus 228 Dfg~a~~~~~~----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~---------~~~~ 294 (394)
|||+++..... .......||+.|+|||++.+...++.++|||||||++|+|++|+.||.+... .+.+
T Consensus 175 Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l 254 (405)
T 3rgf_A 175 DMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQL 254 (405)
T ss_dssp CTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHH
T ss_pred ECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHH
Confidence 99999865432 2223467899999999997766689999999999999999999999976544 4788
Q ss_pred HHHHHHhCCCChhhhhccCCCCcc---------cCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 016184 295 VEIIKVLGTPTREEIKCMNPNYTE---------FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH 365 (394)
Q Consensus 295 ~~i~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 365 (394)
..+...++.+....+.....-... ..........+........++.+.+||++||++||.+|||++|+|+|
T Consensus 255 ~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~h 334 (405)
T 3rgf_A 255 DRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQD 334 (405)
T ss_dssp HHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 889999998887655432110000 00000000000011112347889999999999999999999999999
Q ss_pred CCCCCCCCCCCC
Q 016184 366 PFFDELRDPNTR 377 (394)
Q Consensus 366 p~f~~~~~~~~~ 377 (394)
|||++...+...
T Consensus 335 p~f~~~~~~~~~ 346 (405)
T 3rgf_A 335 PYFLEDPLPTSD 346 (405)
T ss_dssp GGGTSSSCCCSS
T ss_pred hhhccCCCCccc
Confidence 999987666553
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-49 Score=359.46 Aligned_cols=255 Identities=28% Similarity=0.414 Sum_probs=206.6
Q ss_pred ceeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccch-----hhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEE
Q 016184 81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL 155 (394)
Q Consensus 81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 155 (394)
.++|.+.+.||+|+||.||+|++..+++.||+|++.... ....+|+++++.++||||+++++++. .....
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-----~~~~~ 95 (285)
T 3is5_A 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFE-----DYHNM 95 (285)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEE-----CSSEE
T ss_pred hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHhee-----cCCeE
Confidence 356999999999999999999999999999999986543 44568999999999999999999883 33457
Q ss_pred EEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeC---CCCcEEEEeecC
Q 016184 156 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNP---HTHQLKLCDFGS 231 (394)
Q Consensus 156 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~---~~~~vkl~Dfg~ 231 (394)
++||||+++ +|.+.+.........+++..++.++.|++.||+|||+ .||+||||||+|||++. ++ .+||+|||+
T Consensus 96 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~-~~ivH~dikp~NIl~~~~~~~~-~~kl~Dfg~ 173 (285)
T 3is5_A 96 YIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHS-QHVVHKDLKPENILFQDTSPHS-PIKIIDFGL 173 (285)
T ss_dssp EEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCSGGGEEESSSSTTC-CEEECCCCC
T ss_pred EEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHh-CCEEECCCCHHHEEEecCCCCC-CEEEEeeec
Confidence 899999985 8888877766666889999999999999999999999 89999999999999953 34 699999999
Q ss_pred ccccccCCCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhc
Q 016184 232 AKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 311 (394)
Q Consensus 232 a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 311 (394)
+.............+|+.|+|||++.+ .++.++||||||+++|+|++|+.||.+....+....+........
T Consensus 174 a~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~------ 245 (285)
T 3is5_A 174 AELFKSDEHSTNAAGTALYMAPEVFKR--DVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYA------ 245 (285)
T ss_dssp CCC----------CTTGGGCCHHHHTT--CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC------
T ss_pred ceecCCcccCcCcccccCcCChHHhcc--CCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCcccc------
Confidence 987655555556778999999999843 489999999999999999999999988765554444332110000
Q ss_pred cCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 016184 312 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE 370 (394)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~ 370 (394)
.....+++++.+||.+||+.||++|||+.|+|+||||++
T Consensus 246 --------------------~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~f~~ 284 (285)
T 3is5_A 246 --------------------VECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQ 284 (285)
T ss_dssp --------------------C--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGGC
T ss_pred --------------------cccCcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHhhc
Confidence 011347899999999999999999999999999999986
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-49 Score=366.24 Aligned_cols=257 Identities=27% Similarity=0.344 Sum_probs=207.2
Q ss_pred eeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccc-----hhhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEEE
Q 016184 82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN 156 (394)
Q Consensus 82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 156 (394)
++|++.+.||+|+||.||+|++..+++.||||++... .....+|+.+++.++||||+++++++. .....+
T Consensus 7 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~-----~~~~~~ 81 (323)
T 3tki_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRR-----EGNIQY 81 (323)
T ss_dssp TCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEE-----CSSEEE
T ss_pred hhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEe-----cCCeEE
Confidence 4599999999999999999999999999999988533 244578999999999999999999883 344578
Q ss_pred EEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCcccc
Q 016184 157 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL 235 (394)
Q Consensus 157 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~ 235 (394)
+||||+++ +|.+.+ .....+++..++.++.||+.||+|||+ .||+||||||+|||++.++ .+||+|||++...
T Consensus 82 lv~e~~~~~~L~~~l----~~~~~~~~~~~~~i~~qi~~aL~~LH~-~givH~Dlkp~NIll~~~~-~~kl~Dfg~a~~~ 155 (323)
T 3tki_A 82 LFLEYCSGGELFDRI----EPDIGMPEPDAQRFFHQLMAGVVYLHG-IGITHRDIKPENLLLDERD-NLKISDFGLATVF 155 (323)
T ss_dssp EEEECCTTEEGGGGS----BTTTBCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECTTC-CEEECCCTTCEEC
T ss_pred EEEEcCCCCcHHHHH----hhcCCCCHHHHHHHHHHHHHHHHHHHH-CCccccccchHHEEEeCCC-CEEEEEeecccee
Confidence 99999975 654443 334579999999999999999999999 8999999999999999888 6999999999765
Q ss_pred ccCC---CcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhcc
Q 016184 236 VKGE---PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 312 (394)
Q Consensus 236 ~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 312 (394)
.... ......||+.|+|||++.+...++.++|||||||++|+|++|+.||...................
T Consensus 156 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~-------- 227 (323)
T 3tki_A 156 RYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTY-------- 227 (323)
T ss_dssp EETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTT--------
T ss_pred ccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhccccc--------
Confidence 3322 22356789999999999766655889999999999999999999998765443222221110000
Q ss_pred CCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCC
Q 016184 313 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 375 (394)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~ 375 (394)
..+ ...+++.+.+||++||+.||.+|||+.|+++||||++.....
T Consensus 228 -------------~~~-----~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~~~~ 272 (323)
T 3tki_A 228 -------------LNP-----WKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKKG 272 (323)
T ss_dssp -------------STT-----GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCCCCC
T ss_pred -------------CCc-----cccCCHHHHHHHHHHccCChhhCcCHHHHhhChhhccccccc
Confidence 000 145789999999999999999999999999999998765443
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-50 Score=367.29 Aligned_cols=253 Identities=26% Similarity=0.428 Sum_probs=203.2
Q ss_pred ceeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccch------------------------------hhhHHHHHHHH
Q 016184 81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------------------------------RYKNRELQIMQ 130 (394)
Q Consensus 81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------------------------------~~~~~E~~~l~ 130 (394)
.++|++.+.||+|+||.||+|++..+++.||||++.... ....+|+++++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 346999999999999999999999999999999985432 33567999999
Q ss_pred HcCCCCeeeeceEEEecCCCceeEEEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceecc
Q 016184 131 MLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRD 209 (394)
Q Consensus 131 ~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~D 209 (394)
.++||||+++++++... .....++||||+++ ++.++ .....+++..++.++.||+.||+|||+ +||+|||
T Consensus 92 ~l~h~~iv~~~~~~~~~---~~~~~~lv~e~~~~~~l~~~-----~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~D 162 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDP---NEDHLYMVFELVNQGPVMEV-----PTLKPLSEDQARFYFQDLIKGIEYLHY-QKIIHRD 162 (298)
T ss_dssp TCCCTTBCCEEEEEECS---SSSEEEEEEECCTTCBSCCS-----SCSSCCCHHHHHHHHHHHHHHHHHHHH-TTEECCC
T ss_pred hCCCCCCCeEEEEEEcC---CCCEEEEEEecCCCCcHHHH-----hhcCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccC
Confidence 99999999999988432 23457899999985 44332 123679999999999999999999999 8999999
Q ss_pred CCCCceEEeCCCCcEEEEeecCccccccCCC-cccccccccccccccccCCCC--CCChhhHHHHHHHHHHHHhCCCCCC
Q 016184 210 IKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP-NVSYICSRYYRAPELIFGATE--YTTAIDIWSTGCVMAELLLGQPLFP 286 (394)
Q Consensus 210 lkp~Nil~~~~~~~vkl~Dfg~a~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~--~~~~~DiwslG~il~~lltg~~pf~ 286 (394)
|||+|||++.++ .+||+|||++........ .....||+.|+|||++.+... ++.++|||||||++|+|++|+.||.
T Consensus 163 lkp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~ 241 (298)
T 2zv2_A 163 IKPSNLLVGEDG-HIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFM 241 (298)
T ss_dssp CCGGGEEECTTS-CEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred CCHHHEEECCCC-CEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCC
Confidence 999999999888 699999999986644322 234578999999999865432 4778999999999999999999998
Q ss_pred CCCcHHHHHHHHHHhCCCChhhhhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCC
Q 016184 287 GESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHP 366 (394)
Q Consensus 287 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp 366 (394)
+.........+.... ..++. ...+++++.+||.+||+.||++|||+.|+|+||
T Consensus 242 ~~~~~~~~~~~~~~~-----------------~~~~~----------~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp 294 (298)
T 2zv2_A 242 DERIMCLHSKIKSQA-----------------LEFPD----------QPDIAEDLKDLITRMLDKNPESRIVVPEIKLHP 294 (298)
T ss_dssp CSSHHHHHHHHHHCC-----------------CCCCS----------SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCH
T ss_pred CccHHHHHHHHhccc-----------------CCCCC----------ccccCHHHHHHHHHHhhcChhhCCCHHHHhcCc
Confidence 776555444443311 00110 135789999999999999999999999999999
Q ss_pred CCCC
Q 016184 367 FFDE 370 (394)
Q Consensus 367 ~f~~ 370 (394)
||++
T Consensus 295 ~~~~ 298 (298)
T 2zv2_A 295 WVTR 298 (298)
T ss_dssp HHHC
T ss_pred cccC
Confidence 9964
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-49 Score=375.18 Aligned_cols=287 Identities=20% Similarity=0.330 Sum_probs=208.7
Q ss_pred ceeEEEeeEEeec--CceEEEEEEECCCCcEEEEEEeccch------hhhHHHHHHHHHcCCCCeeeeceEEEecCCCce
Q 016184 81 KVSYIAEHVVGTG--SFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE 152 (394)
Q Consensus 81 ~~~y~~~~~lg~G--~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 152 (394)
.++|++.+.||+| +||.||+|++..+|+.||||++.... ....+|+.+++.++||||+++++++.. .
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-----~ 98 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIA-----D 98 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE-----T
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEE-----C
Confidence 4469999999999 99999999999999999999986432 344579999999999999999999843 3
Q ss_pred eEEEEEEeccc-ccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecC
Q 016184 153 LYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS 231 (394)
Q Consensus 153 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~ 231 (394)
...++||||+. ++|.+++.... ...+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||.
T Consensus 99 ~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~-~~ivHrDlkp~NIll~~~~-~~kl~dfg~ 174 (389)
T 3gni_B 99 NELWVVTSFMAYGSAKDLICTHF--MDGMNELAIAYILQGVLKALDYIHH-MGYVHRSVKASHILISVDG-KVYLSGLRS 174 (389)
T ss_dssp TEEEEEEECCTTCBHHHHHHHTC--TTCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECTTC-CEEECCGGG
T ss_pred CEEEEEEEccCCCCHHHHHhhhc--ccCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEcCCC-CEEEccccc
Confidence 34889999998 47877776532 2569999999999999999999999 8999999999999999888 799999998
Q ss_pred ccccccCC--------CcccccccccccccccccCC-CCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhC
Q 016184 232 AKVLVKGE--------PNVSYICSRYYRAPELIFGA-TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLG 302 (394)
Q Consensus 232 a~~~~~~~--------~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~ 302 (394)
+....... ......||+.|+|||++.+. ..++.++|||||||++|+|++|+.||.+.+....+..+....-
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~ 254 (389)
T 3gni_B 175 NLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTV 254 (389)
T ss_dssp CEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC-----
T ss_pred ceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCC
Confidence 86543221 12234678999999999763 4589999999999999999999999988766655544332110
Q ss_pred C--------CChhhhhccC-----CCCccc---CCC-CCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 016184 303 T--------PTREEIKCMN-----PNYTEF---KFP-QIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH 365 (394)
Q Consensus 303 ~--------~~~~~~~~~~-----~~~~~~---~~~-~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 365 (394)
. +......... ...... ..+ ..........+...+++++.+||++||+.||++|||+.|+|+|
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~h 334 (389)
T 3gni_B 255 PCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 334 (389)
T ss_dssp ---------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred CccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcC
Confidence 0 0000000000 000000 000 0000001112345689999999999999999999999999999
Q ss_pred CCCCCCCCCCC
Q 016184 366 PFFDELRDPNT 376 (394)
Q Consensus 366 p~f~~~~~~~~ 376 (394)
|||+++.....
T Consensus 335 p~f~~~~~~~~ 345 (389)
T 3gni_B 335 SFFKQIKRRAS 345 (389)
T ss_dssp GGGGGC---CC
T ss_pred HHHHHHhhcch
Confidence 99999876543
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-49 Score=366.69 Aligned_cols=252 Identities=27% Similarity=0.488 Sum_probs=205.6
Q ss_pred ceeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccch-------hhhHHHHHHHHHc-CCCCeeeeceEEEecCCCce
Q 016184 81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQML-DHPNIVALKHCFFSTTDKEE 152 (394)
Q Consensus 81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~ 152 (394)
..+|++.+.||+|+||.||+|+++.+++.||+|++.+.. ....+|..+++.+ +||||+++++++. ..
T Consensus 8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~-----~~ 82 (345)
T 3a8x_A 8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQ-----TE 82 (345)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEE-----CS
T ss_pred hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEE-----eC
Confidence 346999999999999999999999999999999986532 2345788999887 8999999999883 33
Q ss_pred eEEEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecC
Q 016184 153 LYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS 231 (394)
Q Consensus 153 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~ 231 (394)
..+++||||+.+ +|..++.. ...+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+
T Consensus 83 ~~~~lv~e~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~-~~ivHrDlkp~NIll~~~g-~~kL~DFG~ 156 (345)
T 3a8x_A 83 SRLFFVIEYVNGGDLMFHMQR----QRKLPEEHARFYSAEISLALNYLHE-RGIIYRDLKLDNVLLDSEG-HIKLTDYGM 156 (345)
T ss_dssp SEEEEEECCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCCGGGEEECTTS-CEEECCGGG
T ss_pred CEEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCHHHEEECCCC-CEEEEeccc
Confidence 458899999975 77666653 3679999999999999999999999 8999999999999999888 699999999
Q ss_pred ccccc-cCCCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCc--------HHHH-HHHHHHh
Q 016184 232 AKVLV-KGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESG--------VDQL-VEIIKVL 301 (394)
Q Consensus 232 a~~~~-~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~--------~~~~-~~i~~~~ 301 (394)
++... .........||+.|+|||++.+. .++.++|||||||++|+|++|+.||..... ...+ ..+...
T Consensus 157 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~- 234 (345)
T 3a8x_A 157 CKEGLRPGDTTSTFCGTPNYIAPEILRGE-DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK- 234 (345)
T ss_dssp CBCSCCTTCCBCCCCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHC-
T ss_pred cccccCCCCcccccCCCccccCccccCCC-CCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcC-
Confidence 97643 23334556889999999999654 489999999999999999999999975311 1111 222210
Q ss_pred CCCChhhhhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCH------HHHhcCCCCCCCCC
Q 016184 302 GTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTA------LEACVHPFFDELRD 373 (394)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~------~ell~hp~f~~~~~ 373 (394)
... ++..++.++++||.+||+.||.+||++ +++++||||+++..
T Consensus 235 ----------------~~~------------~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~~~w 284 (345)
T 3a8x_A 235 ----------------QIR------------IPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDW 284 (345)
T ss_dssp ----------------CCC------------CCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTTCCH
T ss_pred ----------------CCC------------CCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCCCCH
Confidence 001 224679999999999999999999995 89999999998753
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-49 Score=367.95 Aligned_cols=250 Identities=26% Similarity=0.411 Sum_probs=212.5
Q ss_pred ceeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccch-------hhhHHHHHHHHHcCCCCeeeeceEEEecCCCcee
Q 016184 81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL 153 (394)
Q Consensus 81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 153 (394)
..+|++.+.||+|+||.||+|+++.+|+.||||++.+.. ....+|+.+++.++||||+++++++. ...
T Consensus 40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-----~~~ 114 (350)
T 1rdq_E 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK-----DNS 114 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEE-----CSS
T ss_pred HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEE-----cCC
Confidence 346999999999999999999999999999999986432 23457999999999999999999883 334
Q ss_pred EEEEEEeccc-ccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCc
Q 016184 154 YLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA 232 (394)
Q Consensus 154 ~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a 232 (394)
.+++||||++ ++|.+++.. ...+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||++
T Consensus 115 ~~~lv~e~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivHrDlkp~NIll~~~g-~~kL~DFg~a 188 (350)
T 1rdq_E 115 NLYMVMEYVAGGEMFSHLRR----IGRFSEPHARFYAAQIVLTFEYLHS-LDLIYRDLKPENLLIDQQG-YIQVTDFGFA 188 (350)
T ss_dssp EEEEEEECCTTCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECTTS-CEEECCCTTC
T ss_pred EEEEEEcCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCcccccCccceEEECCCC-CEEEcccccc
Confidence 5889999997 577776654 3579999999999999999999999 8999999999999999888 6999999999
Q ss_pred cccccCCCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhcc
Q 016184 233 KVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 312 (394)
Q Consensus 233 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 312 (394)
+.... ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+.+..+....
T Consensus 189 ~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~----------- 254 (350)
T 1rdq_E 189 KRVKG--RTWTLCGTPEALAPEIILSK-GYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK----------- 254 (350)
T ss_dssp EECSS--CBCCCEECGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-----------
T ss_pred eeccC--CcccccCCccccCHHHhcCC-CCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCC-----------
Confidence 86533 23456789999999999654 48999999999999999999999999887777666665521
Q ss_pred CCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCC-----HHHHhcCCCCCCCCC
Q 016184 313 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCT-----ALEACVHPFFDELRD 373 (394)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt-----~~ell~hp~f~~~~~ 373 (394)
.. ++..+++++.+||++||+.||.+||+ ++++++||||+.+..
T Consensus 255 ------~~------------~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~~f~~~~w 302 (350)
T 1rdq_E 255 ------VR------------FPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDW 302 (350)
T ss_dssp ------CC------------CCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCCH
T ss_pred ------CC------------CCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhCcCcCCCCH
Confidence 11 12457999999999999999999998 999999999998643
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-48 Score=361.38 Aligned_cols=256 Identities=23% Similarity=0.343 Sum_probs=215.1
Q ss_pred ceeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccc----------hhhhHHHHHHHHHcCCCCeeeeceEEEecCCC
Q 016184 81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD----------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDK 150 (394)
Q Consensus 81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 150 (394)
.++|++.+.||+|+||.||+|++..+|+.||+|++... ...+.+|+.+++.++||||+++++++.
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~----- 85 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYE----- 85 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEE-----
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEe-----
Confidence 44699999999999999999999999999999988643 234668999999999999999999883
Q ss_pred ceeEEEEEEeccc-ccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCC---cEEE
Q 016184 151 EELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTH---QLKL 226 (394)
Q Consensus 151 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~---~vkl 226 (394)
.....++||||+. ++|.+++.. ...+++..++.++.|++.||+|||+ .||+||||||+|||++.++. .+||
T Consensus 86 ~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~lH~-~~ivH~dikp~NIl~~~~~~~~~~~kl 160 (321)
T 2a2a_A 86 NRTDVVLILELVSGGELFDFLAQ----KESLSEEEATSFIKQILDGVNYLHT-KKIAHFDLKPENIMLLDKNIPIPHIKL 160 (321)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHT----CSCEEHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEESCTTSSSCCEEE
T ss_pred cCCEEEEEEEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCChHHEEEecCCCCcCCEEE
Confidence 3345789999996 488777653 3678999999999999999999999 89999999999999997763 5999
Q ss_pred EeecCccccccCCCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCh
Q 016184 227 CDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTR 306 (394)
Q Consensus 227 ~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~ 306 (394)
+|||++.............+|+.|+|||++.+. .++.++||||||+++|+|++|..||.+....+.+..+.......+.
T Consensus 161 ~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~ 239 (321)
T 2a2a_A 161 IDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYE-PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDE 239 (321)
T ss_dssp CCCTTCEECCTTCCCCCCCSCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCH
T ss_pred ccCccceecCccccccccCCCCCccCcccccCC-CCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccCh
Confidence 999999877655555567789999999998654 4899999999999999999999999888776666665442211111
Q ss_pred hhhhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 016184 307 EEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR 372 (394)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 372 (394)
.+...+++.+.+||++||+.||.+|||+.++++||||+...
T Consensus 240 -------------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~~~~ 280 (321)
T 2a2a_A 240 -------------------------EFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVD 280 (321)
T ss_dssp -------------------------HHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTTTSCSS
T ss_pred -------------------------hhhcccCHHHHHHHHHHcCCChhhCcCHHHHhcCccccCCC
Confidence 12246789999999999999999999999999999998754
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-49 Score=374.93 Aligned_cols=260 Identities=27% Similarity=0.432 Sum_probs=197.2
Q ss_pred ceeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccch---hhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEEEE
Q 016184 81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL 157 (394)
Q Consensus 81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 157 (394)
.++|++.+.||+|+||.||+|++..+++.||||++.... ....+|+.+++.++||||+++++++.. ....++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-----~~~~~l 93 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRFKEVILT-----PTHLAI 93 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSCHHHHHHHHHHHHCCCTTBCCEEEEEEC-----SSEEEE
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccccHHHHHHHHHHHhCCCCCCCcEEEEEee-----CCEEEE
Confidence 346999999999999999999999999999999986532 445689999999999999999999843 344789
Q ss_pred EEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCC-cEEEEeecCcccc
Q 016184 158 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTH-QLKLCDFGSAKVL 235 (394)
Q Consensus 158 v~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~-~vkl~Dfg~a~~~ 235 (394)
||||+.+ +|.+.+.. ...+++..++.++.|++.||+|||+ +||+||||||+|||++.++. .+||+|||+++..
T Consensus 94 v~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~ql~~~L~~LH~-~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~ 168 (361)
T 3uc3_A 94 IMEYASGGELYERICN----AGRFSEDEARFFFQQLLSGVSYCHS-MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSS 168 (361)
T ss_dssp EEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTCCSCCCCGGGEEECSSSSCCEEECCCCCC---
T ss_pred EEEeCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEEcCCCCceEEEeecCccccc
Confidence 9999974 77666654 3679999999999999999999999 89999999999999986652 4999999999765
Q ss_pred ccCCCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCC
Q 016184 236 VKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 315 (394)
Q Consensus 236 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 315 (394)
..........||+.|+|||++.+....+.++|||||||++|+|++|+.||.+.........+.......
T Consensus 169 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~----------- 237 (361)
T 3uc3_A 169 VLHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSV----------- 237 (361)
T ss_dssp ------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTT-----------
T ss_pred cccCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcC-----------
Confidence 544455567899999999999766534455999999999999999999998765433333332211000
Q ss_pred CcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q 016184 316 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD 373 (394)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~ 373 (394)
...++. ...+++++.+||++||+.||.+|||+.++++||||++...
T Consensus 238 --~~~~~~----------~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~ 283 (361)
T 3uc3_A 238 --KYSIPD----------DIRISPECCHLISRIFVADPATRISIPEIKTHSWFLKNLP 283 (361)
T ss_dssp --CCCCCT----------TSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSHHHHTTCC
T ss_pred --CCCCCC----------cCCCCHHHHHHHHHHccCChhHCcCHHHHHhCcchhcCCc
Confidence 001110 1257899999999999999999999999999999976543
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-49 Score=371.28 Aligned_cols=255 Identities=25% Similarity=0.415 Sum_probs=207.3
Q ss_pred ceeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccchhhhHHHHHHHHHc-CCCCeeeeceEEEecCCCceeEEEEEE
Q 016184 81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQML-DHPNIVALKHCFFSTTDKEELYLNLVL 159 (394)
Q Consensus 81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~lv~ 159 (394)
.++|++.+.||+|+||.||+|+++.+|+.||||++.+......+|++++.++ +||||+++++++ ....+.++||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~-----~~~~~~~lv~ 95 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEIEILLRYGQHPNIITLKDVY-----DDGKYVYVVT 95 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCCCHHHHHHHHHHTTSTTBCCEEEEE-----ECSSEEEEEE
T ss_pred cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCChHHHHHHHHHhcCCCCcCeEEEEE-----EcCCEEEEEE
Confidence 3469999999999999999999999999999999988777778899999888 799999999988 3345688999
Q ss_pred ecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCC---cEEEEeecCcccc
Q 016184 160 EYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTH---QLKLCDFGSAKVL 235 (394)
Q Consensus 160 e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~---~vkl~Dfg~a~~~ 235 (394)
||+.+ +|.+.+.. ...+++..++.++.||+.||+|||+ +||+||||||+|||+..+.+ .+||+|||++...
T Consensus 96 E~~~gg~L~~~i~~----~~~~~~~~~~~~~~qi~~al~~lH~-~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~ 170 (342)
T 2qr7_A 96 ELMKGGELLDKILR----QKFFSEREASAVLFTITKTVEYLHA-QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQL 170 (342)
T ss_dssp CCCCSCBHHHHHHT----CTTCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEEC
T ss_pred eCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccC
Confidence 99975 77665543 3679999999999999999999999 89999999999999854321 4999999999866
Q ss_pred ccC-CCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCC---cHHHHHHHHHHhCCCChhhhhc
Q 016184 236 VKG-EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGES---GVDQLVEIIKVLGTPTREEIKC 311 (394)
Q Consensus 236 ~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~---~~~~~~~i~~~~~~~~~~~~~~ 311 (394)
... .......+|+.|+|||++.+. .++.++|||||||++|+|++|..||.+.. ..+.+..+....
T Consensus 171 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~---------- 239 (342)
T 2qr7_A 171 RAENGLLMTPCYTANFVAPEVLERQ-GYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGK---------- 239 (342)
T ss_dssp BCTTCCBCCSSCCSSCCCHHHHHHH-HHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCC----------
T ss_pred cCCCCceeccCCCccccCHHHhcCC-CCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCC----------
Confidence 443 233456789999999998654 38899999999999999999999998642 223333332210
Q ss_pred cCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 016184 312 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL 371 (394)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 371 (394)
+.++ ......+++++.+||++||+.||.+|||+.++++||||++.
T Consensus 240 -------~~~~--------~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~ 284 (342)
T 2qr7_A 240 -------FSLS--------GGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHW 284 (342)
T ss_dssp -------CCCC--------STTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHTG
T ss_pred -------cccC--------ccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCeecCc
Confidence 0000 00124589999999999999999999999999999999764
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-49 Score=372.21 Aligned_cols=257 Identities=26% Similarity=0.385 Sum_probs=213.0
Q ss_pred eeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccc----hhhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEEEE
Q 016184 82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL 157 (394)
Q Consensus 82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 157 (394)
++|++.+.||+|+||.||+|++..+|+.||+|++... .....+|+.+++.++||||+++++++. .....++
T Consensus 51 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~-----~~~~~~l 125 (387)
T 1kob_A 51 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFE-----DKYEMVL 125 (387)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEE-----CSSEEEE
T ss_pred cceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEE-----eCCEEEE
Confidence 4599999999999999999999999999999998643 334568999999999999999999883 3345789
Q ss_pred EEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCC-CCcEEEEeecCcccc
Q 016184 158 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPH-THQLKLCDFGSAKVL 235 (394)
Q Consensus 158 v~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~-~~~vkl~Dfg~a~~~ 235 (394)
||||+.+ +|.+.+.. ....+++..++.++.||+.||+|||+ +||+||||||+|||++.+ ...+||+|||++...
T Consensus 126 v~E~~~gg~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~-~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~ 201 (387)
T 1kob_A 126 ILEFLSGGELFDRIAA---EDYKMSEAEVINYMRQACEGLKHMHE-HSIVHLDIKPENIMCETKKASSVKIIDFGLATKL 201 (387)
T ss_dssp EEECCCCCBHHHHTTC---TTCCBCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEESSTTCCCEEECCCTTCEEC
T ss_pred EEEcCCCCcHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHh-CCeeecccchHHeEEecCCCCceEEEecccceec
Confidence 9999975 77555432 23579999999999999999999999 899999999999999753 236999999999877
Q ss_pred ccCCCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCC
Q 016184 236 VKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 315 (394)
Q Consensus 236 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 315 (394)
..........+|+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+.+..+.......+
T Consensus 202 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~---------- 270 (387)
T 1kob_A 202 NPDEIVKVTTATAEFAAPEIVDRE-PVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFD---------- 270 (387)
T ss_dssp CTTSCEEEECSSGGGCCHHHHTTC-CBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCC----------
T ss_pred CCCcceeeeccCCCccCchhccCC-CCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC----------
Confidence 655555566789999999999654 489999999999999999999999998877776666654211100
Q ss_pred CcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q 016184 316 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD 373 (394)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~ 373 (394)
......+++++.+||.+||+.||.+|||+.++|+||||+....
T Consensus 271 ---------------~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~ 313 (387)
T 1kob_A 271 ---------------EDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHS 313 (387)
T ss_dssp ---------------SSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCCT
T ss_pred ---------------ccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCccccCCcc
Confidence 0011457999999999999999999999999999999987543
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-49 Score=390.25 Aligned_cols=257 Identities=26% Similarity=0.438 Sum_probs=211.8
Q ss_pred cceeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccc-------hhhhHHHHHHHHHcCCCCeeeeceEEEecCCCce
Q 016184 80 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE 152 (394)
Q Consensus 80 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 152 (394)
...+|++.++||+|+||.||+|+++.+|+.||||++.+. .....+|+.+++.++||||+++++++. ..
T Consensus 182 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~-----~~ 256 (576)
T 2acx_A 182 TKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYE-----TK 256 (576)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEE-----CS
T ss_pred cccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEe-----eC
Confidence 345699999999999999999999999999999998543 223457999999999999999999883 33
Q ss_pred eEEEEEEeccc-ccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecC
Q 016184 153 LYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS 231 (394)
Q Consensus 153 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~ 231 (394)
..+++||||++ ++|..++.... ...+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+
T Consensus 257 ~~l~lVmEy~~gg~L~~~l~~~~--~~~l~e~~~~~i~~qIl~aL~yLH~-~gIvHrDLKPeNILld~~g-~vKL~DFGl 332 (576)
T 2acx_A 257 DALCLVLTLMNGGDLKFHIYHMG--QAGFPEARAVFYAAEICCGLEDLHR-ERIVYRDLKPENILLDDHG-HIRISDLGL 332 (576)
T ss_dssp SEEEEEECCCCSCBHHHHHHSSS--SCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECTTS-CEEECCCTT
T ss_pred CEEEEEEEcCCCCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHH-CCEeccCCchheEEEeCCC-CeEEEeccc
Confidence 45889999997 47776665422 2459999999999999999999999 8999999999999999888 699999999
Q ss_pred ccccccCCCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcH---HHHHHHHHHhCCCChhh
Q 016184 232 AKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGV---DQLVEIIKVLGTPTREE 308 (394)
Q Consensus 232 a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~---~~~~~i~~~~~~~~~~~ 308 (394)
+.............||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.... ..+...+....
T Consensus 333 a~~~~~~~~~~~~~GT~~Y~APEvl~~~-~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~------ 405 (576)
T 2acx_A 333 AVHVPEGQTIKGRVGTVGYMAPEVVKNE-RYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVP------ 405 (576)
T ss_dssp CEECCTTCCEECCCSCGGGCCHHHHTTC-EESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCC------
T ss_pred ceecccCccccccCCCccccCHHHHcCC-CCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhccc------
Confidence 9877655555567899999999999654 4899999999999999999999999876432 22222222110
Q ss_pred hhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCC-----CHHHHhcCCCCCCCCCC
Q 016184 309 IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-----TALEACVHPFFDELRDP 374 (394)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----t~~ell~hp~f~~~~~~ 374 (394)
. .++..+++++++||++||+.||.+|| +++|+++||||+++...
T Consensus 406 ----------~------------~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~i~w~ 454 (576)
T 2acx_A 406 ----------E------------EYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKLNFK 454 (576)
T ss_dssp ----------C------------CCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTTCCHH
T ss_pred ----------c------------cCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhccCCHH
Confidence 0 02246799999999999999999999 89999999999987543
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-49 Score=362.41 Aligned_cols=248 Identities=27% Similarity=0.380 Sum_probs=197.4
Q ss_pred ceeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccchh------hhHHHHHHHHH-cCCCCeeeeceEEEecCCCcee
Q 016184 81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR------YKNRELQIMQM-LDHPNIVALKHCFFSTTDKEEL 153 (394)
Q Consensus 81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~------~~~~E~~~l~~-l~h~~iv~~~~~~~~~~~~~~~ 153 (394)
.++|++.++||+|+||+||+|++..+|+.||||++..... ....|+..+.. ..|+||+++++++. ...
T Consensus 56 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~-----~~~ 130 (311)
T 3p1a_A 56 QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWE-----EGG 130 (311)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----ETT
T ss_pred hhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEE-----eCC
Confidence 3579999999999999999999999999999998754221 12234444444 49999999999883 344
Q ss_pred EEEEEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCcc
Q 016184 154 YLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK 233 (394)
Q Consensus 154 ~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~ 233 (394)
..++||||+++++.+.+... ...+++..++.++.||+.||+|||+ .||+||||||+|||++.++ .+||+|||++.
T Consensus 131 ~~~lv~e~~~~~L~~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dikp~NIll~~~~-~~kl~DFG~a~ 205 (311)
T 3p1a_A 131 ILYLQTELCGPSLQQHCEAW---GASLPEAQVWGYLRDTLLALAHLHS-QGLVHLDVKPANIFLGPRG-RCKLGDFGLLV 205 (311)
T ss_dssp EEEEEEECCCCBHHHHHHHH---CSCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECGGG-CEEECCCTTCE
T ss_pred EEEEEEeccCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHH-CCEecCCCCHHHEEECCCC-CEEEccceeee
Confidence 58899999999887776543 3679999999999999999999999 8999999999999999888 69999999998
Q ss_pred ccccCCCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccC
Q 016184 234 VLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 313 (394)
Q Consensus 234 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 313 (394)
............||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.... ..+.. +..
T Consensus 206 ~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~el~~g~~~~~~~~~~---~~~~~--~~~--------- 269 (311)
T 3p1a_A 206 ELGTAGAGEVQEGDPRYMAPELLQG--SYGTAADVFSLGLTILEVACNMELPHGGEGW---QQLRQ--GYL--------- 269 (311)
T ss_dssp ECC------CCCCCGGGCCGGGGGT--CCSTHHHHHHHHHHHHHHHHTCCCCSSHHHH---HHHTT--TCC---------
T ss_pred ecccCCCCcccCCCccccCHhHhcC--CCCchhhHHHHHHHHHHHHhCCCCCCCccHH---HHHhc--cCC---------
Confidence 7655555556678999999999865 4899999999999999999997766543222 11111 001
Q ss_pred CCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 016184 314 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE 370 (394)
Q Consensus 314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~ 370 (394)
...+...+++++.+||.+||+.||++|||++++|+||||++
T Consensus 270 ----------------~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 310 (311)
T 3p1a_A 270 ----------------PPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLALPVLRQ 310 (311)
T ss_dssp ----------------CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGSC
T ss_pred ----------------CcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHhCccccC
Confidence 11123568999999999999999999999999999999986
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-49 Score=372.16 Aligned_cols=254 Identities=24% Similarity=0.415 Sum_probs=207.4
Q ss_pred cceeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccchh-------hhHHHHHH-HHHcCCCCeeeeceEEEecCCCc
Q 016184 80 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-------YKNRELQI-MQMLDHPNIVALKHCFFSTTDKE 151 (394)
Q Consensus 80 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-------~~~~E~~~-l~~l~h~~iv~~~~~~~~~~~~~ 151 (394)
...+|++.++||+|+||.||+|+++.+++.||||++.+... ...+|..+ ++.++||||+++++++. .
T Consensus 36 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~-----~ 110 (373)
T 2r5t_A 36 KPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQ-----T 110 (373)
T ss_dssp CGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEE-----C
T ss_pred ChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEE-----e
Confidence 34569999999999999999999999999999999865432 12234444 46679999999999883 3
Q ss_pred eeEEEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeec
Q 016184 152 ELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFG 230 (394)
Q Consensus 152 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg 230 (394)
...+|+||||+.+ +|..++.. ...+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||
T Consensus 111 ~~~~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~-~givHrDlkp~NIll~~~g-~ikL~DFG 184 (373)
T 2r5t_A 111 ADKLYFVLDYINGGELFYHLQR----ERCFLEPRARFYAAEIASALGYLHS-LNIVYRDLKPENILLDSQG-HIVLTDFG 184 (373)
T ss_dssp SSEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECTTS-CEEECCCC
T ss_pred CCEEEEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCHHHEEECCCC-CEEEeeCc
Confidence 3458899999985 77666553 3678999999999999999999999 8999999999999999988 69999999
Q ss_pred Ccccccc-CCCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhh
Q 016184 231 SAKVLVK-GEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI 309 (394)
Q Consensus 231 ~a~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 309 (394)
+++.... ........||+.|+|||++.+. .++.++|+|||||++|+|++|..||.+.+..+....+....
T Consensus 185 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~-------- 255 (373)
T 2r5t_A 185 LCKENIEHNSTTSTFCGTPEYLAPEVLHKQ-PYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKP-------- 255 (373)
T ss_dssp BCGGGBCCCCCCCSBSCCCCCCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSC--------
T ss_pred cccccccCCCccccccCCccccCHHHhCCC-CCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcc--------
Confidence 9986433 3344567889999999999654 48999999999999999999999999887777776665520
Q ss_pred hccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCH----HHHhcCCCCCCCCCC
Q 016184 310 KCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTA----LEACVHPFFDELRDP 374 (394)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~----~ell~hp~f~~~~~~ 374 (394)
.. ++..++.++++||++||+.||.+||++ .++++||||+.+...
T Consensus 256 ---------~~------------~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h~~f~~~~w~ 303 (373)
T 2r5t_A 256 ---------LQ------------LKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSLINWD 303 (373)
T ss_dssp ---------CC------------CCSSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHTSGGGTTCCHH
T ss_pred ---------cC------------CCCCCCHHHHHHHHHHcccCHHhCCCCCCCHHHHhCCccccCCCHH
Confidence 11 124679999999999999999999986 699999999987543
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-49 Score=365.63 Aligned_cols=281 Identities=30% Similarity=0.512 Sum_probs=217.1
Q ss_pred eeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccc-hhhhHHHHHHHHHcC-CCCeeeeceEEEecCCCceeEEEEEE
Q 016184 82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-KRYKNRELQIMQMLD-HPNIVALKHCFFSTTDKEELYLNLVL 159 (394)
Q Consensus 82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~~lv~ 159 (394)
++|++.+.||+|+||.||+|++..+++.||||++... .....+|+.+++.+. ||||+++++++... .....++||
T Consensus 36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~---~~~~~~lv~ 112 (330)
T 3nsz_A 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDP---VSRTPALVF 112 (330)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCCHHHHHHHHHHHHHHTTSTTBCCEEEEEECT---TTCCEEEEE
T ss_pred CceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccchHHHHHHHHHHHHcCCCCCEEEeeeeeccC---CCCceEEEE
Confidence 4699999999999999999999999999999998643 455678999999997 99999999988432 234477999
Q ss_pred ecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCccccccC
Q 016184 160 EYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG 238 (394)
Q Consensus 160 e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~~ 238 (394)
||+.+ ++..++ ..+++..++.++.||+.||+|||+ +||+||||||+|||++.++..+||+|||++......
T Consensus 113 e~~~~~~l~~~~-------~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~ 184 (330)
T 3nsz_A 113 EHVNNTDFKQLY-------QTLTDYDIRFYMYEILKALDYCHS-MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG 184 (330)
T ss_dssp ECCCCCCHHHHG-------GGCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTT
T ss_pred eccCchhHHHHH-------HhCCHHHHHHHHHHHHHHHHHHHh-CCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCC
Confidence 99985 554433 348999999999999999999999 899999999999999977757999999999877666
Q ss_pred CCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCC-CCcHHHHHHHHHHhCCCChhhh-hccCCCC
Q 016184 239 EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPG-ESGVDQLVEIIKVLGTPTREEI-KCMNPNY 316 (394)
Q Consensus 239 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~-~~~~~~~~~i~~~~~~~~~~~~-~~~~~~~ 316 (394)
.......+++.|+|||++.+...++.++|||||||++|+|++|+.||.. ....+.+..+....+.+..... .......
T Consensus 185 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 264 (330)
T 3nsz_A 185 QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIEL 264 (330)
T ss_dssp CCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCC
T ss_pred CccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhcccc
Confidence 5556678899999999997656689999999999999999999999854 4555666666665553322111 0000000
Q ss_pred ccc---CCCCCCCCCcchh----ccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q 016184 317 TEF---KFPQIKPHPWHKV----FQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD 373 (394)
Q Consensus 317 ~~~---~~~~~~~~~~~~~----~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~ 373 (394)
... .........|... ....+++++.+||++||+.||.+|||++|+|+||||+++.+
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~~ 328 (330)
T 3nsz_A 265 DPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVK 328 (330)
T ss_dssp CTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTCC-
T ss_pred ccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhhhcc
Confidence 000 0000011112111 12347999999999999999999999999999999998764
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-49 Score=371.74 Aligned_cols=253 Identities=26% Similarity=0.380 Sum_probs=206.1
Q ss_pred EEEeeEEeecCceEEEEEEECCCCcEEEEEEeccc----hhhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEEEEEE
Q 016184 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVL 159 (394)
Q Consensus 84 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~ 159 (394)
|...+.||+|+||.||+|++..+|+.||+|++... ...+.+|+++++.++||||+++++++. .....++||
T Consensus 91 ~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~-----~~~~~~lv~ 165 (373)
T 2x4f_A 91 VSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFE-----SKNDIVLVM 165 (373)
T ss_dssp EEEEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEE-----CSSEEEEEE
T ss_pred eecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEE-----ECCEEEEEE
Confidence 44477899999999999999999999999998653 345568999999999999999999883 334478999
Q ss_pred ecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEe--CCCCcEEEEeecCccccc
Q 016184 160 EYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVN--PHTHQLKLCDFGSAKVLV 236 (394)
Q Consensus 160 e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~--~~~~~vkl~Dfg~a~~~~ 236 (394)
||+++ +|.+.+.. ....+++..++.++.||+.||+|||+ .||+||||||+|||++ .++ .+||+|||+++...
T Consensus 166 E~~~~~~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dlkp~NIll~~~~~~-~~kl~DFG~a~~~~ 240 (373)
T 2x4f_A 166 EYVDGGELFDRIID---ESYNLTELDTILFMKQICEGIRHMHQ-MYILHLDLKPENILCVNRDAK-QIKIIDFGLARRYK 240 (373)
T ss_dssp ECCTTCEEHHHHHH---TGGGCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEEEETTTT-EEEECCCSSCEECC
T ss_pred eCCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccccCCHHHEEEecCCCC-cEEEEeCCCceecC
Confidence 99975 77665543 23568999999999999999999999 8999999999999994 344 79999999998776
Q ss_pred cCCCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCCC
Q 016184 237 KGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 316 (394)
Q Consensus 237 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 316 (394)
.........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+.......+..
T Consensus 241 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~--------- 310 (373)
T 2x4f_A 241 PREKLKVNFGTPEFLAPEVVNY-DFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDE--------- 310 (373)
T ss_dssp TTCBCCCCCSSCTTCCHHHHTT-CBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCSG---------
T ss_pred CccccccccCCCcEeChhhccC-CCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCChh---------
Confidence 6555556679999999999854 458999999999999999999999999988877777776632111110
Q ss_pred cccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 016184 317 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR 372 (394)
Q Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 372 (394)
....+++++++||.+||+.||.+|||+.++|+||||++..
T Consensus 311 ----------------~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~hp~~~~~~ 350 (373)
T 2x4f_A 311 ----------------EFQDISEEAKEFISKLLIKEKSWRISASEALKHPWLSDHK 350 (373)
T ss_dssp ----------------GGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHCHH
T ss_pred ----------------hhccCCHHHHHHHHHHcCCChhhCCCHHHHhcCcCcCCCc
Confidence 1145799999999999999999999999999999998863
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-48 Score=379.50 Aligned_cols=251 Identities=28% Similarity=0.419 Sum_probs=213.6
Q ss_pred ceeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccch-------hhhHHHHHHHHHcCCCCeeeeceEEEecCCCcee
Q 016184 81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL 153 (394)
Q Consensus 81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 153 (394)
.++|.+.+.||+|+||.||+|++..+|+.||||++.... ....+|+.+++.++||||+++++++.. ..
T Consensus 15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~-----~~ 89 (476)
T 2y94_A 15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVIST-----PS 89 (476)
T ss_dssp ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEEC-----SS
T ss_pred ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE-----CC
Confidence 456999999999999999999999999999999986432 345689999999999999999998833 33
Q ss_pred EEEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCc
Q 016184 154 YLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA 232 (394)
Q Consensus 154 ~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a 232 (394)
..++||||+++ +|.+++. ....+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||++
T Consensus 90 ~~~lv~E~~~gg~L~~~l~----~~~~l~~~~~~~i~~qi~~aL~~LH~-~givHrDLkp~NIll~~~~-~vkL~DFG~a 163 (476)
T 2y94_A 90 DIFMVMEYVSGGELFDYIC----KNGRLDEKESRRLFQQILSGVDYCHR-HMVVHRDLKPENVLLDAHM-NAKIADFGLS 163 (476)
T ss_dssp EEEEEEECCSSEEHHHHTT----SSSSCCHHHHHHHHHHHHHHHHHHHT-TTEECSCCSGGGEEECTTC-CEEECCCSSC
T ss_pred EEEEEEeCCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHH-CCCCcccccHHHEEEecCC-CeEEEeccch
Confidence 47899999964 7766553 24679999999999999999999999 8999999999999999888 6999999999
Q ss_pred cccccCCCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhcc
Q 016184 233 KVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 312 (394)
Q Consensus 233 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 312 (394)
.............||+.|+|||++.+....+.++|||||||++|+|++|+.||.+.........+....
T Consensus 164 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~----------- 232 (476)
T 2y94_A 164 NMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGI----------- 232 (476)
T ss_dssp EECCTTCCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTC-----------
T ss_pred hhccccccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCC-----------
Confidence 877655555667899999999999776655789999999999999999999999877766666554321
Q ss_pred CCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 016184 313 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL 371 (394)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 371 (394)
+. .+..+++++.+||++||+.||.+|||+.++++||||++.
T Consensus 233 ------~~------------~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~~ 273 (476)
T 2y94_A 233 ------FY------------TPQYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQD 273 (476)
T ss_dssp ------CC------------CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHTT
T ss_pred ------cC------------CCccCCHHHHHHHHHHcCCCchhCcCHHHHHhCHHhhhc
Confidence 00 123578999999999999999999999999999999874
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-48 Score=356.25 Aligned_cols=271 Identities=26% Similarity=0.425 Sum_probs=224.6
Q ss_pred ceeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccc-------hhhhHHHHHHHHHcCCCCeeeeceEEEecCCCcee
Q 016184 81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL 153 (394)
Q Consensus 81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 153 (394)
..+|++.+.||+|+||.||+|++..+++.||+|++... .....+|+.+++.++|+||+++++++. ...
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~~ 88 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFE-----DND 88 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEE-----CSS
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeec-----cCC
Confidence 45699999999999999999999999999999988543 233457999999999999999999883 334
Q ss_pred EEEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCc
Q 016184 154 YLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA 232 (394)
Q Consensus 154 ~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a 232 (394)
..++||||+++ ++.+++.. ...+++..++.++.|++.||+|||+ +||+||||||+|||++.++ .+||+|||++
T Consensus 89 ~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dl~p~Nil~~~~~-~~kl~dfg~~ 162 (294)
T 2rku_A 89 FVFVVLELCRRRSLLELHKR----RKALTEPEARYYLRQIVLGCQYLHR-NRVIHRDLKLGNLFLNEDL-EVKIGDFGLA 162 (294)
T ss_dssp EEEEEEECCTTCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECTTC-CEEECCCTTC
T ss_pred EEEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCChHhEEEcCCC-CEEEEeccCc
Confidence 57899999984 77665543 3679999999999999999999999 8999999999999999888 6999999999
Q ss_pred cccccC-CCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhc
Q 016184 233 KVLVKG-EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 311 (394)
Q Consensus 233 ~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 311 (394)
...... .......+|+.|+|||.+.+. .++.++||||||+++|+|++|+.||......+....+...
T Consensus 163 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~----------- 230 (294)
T 2rku_A 163 TKVEYDGERKKVLCGTPNYIAPEVLSKK-GHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKN----------- 230 (294)
T ss_dssp EECCSTTCCBCCCCSCCSSCCHHHHTTS-CBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTT-----------
T ss_pred eecccCccccccccCCCCcCCcchhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhc-----------
Confidence 765432 223445689999999998654 4899999999999999999999999887765554444321
Q ss_pred cCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCCCCCCCCCCCCCCCCC
Q 016184 312 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFK 391 (394)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~~~~~~~~~~~~~~~~ 391 (394)
... ++..+++.+.+||.+||+.||++|||++++++||||++...+..........||.|.+.
T Consensus 231 ------~~~------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (294)
T 2rku_A 231 ------EYS------------IPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIPARLPITCLTIPPRFSIA 292 (294)
T ss_dssp ------CCC------------CCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSCCCSCCCGGGGTSCCCCCSS
T ss_pred ------cCC------------CccccCHHHHHHHHHHcccChhhCcCHHHHhhChheecCCcCCCCCccCCCCCCCcccC
Confidence 001 12457889999999999999999999999999999999888777666677788888874
Q ss_pred C
Q 016184 392 P 392 (394)
Q Consensus 392 ~ 392 (394)
|
T Consensus 293 ~ 293 (294)
T 2rku_A 293 P 293 (294)
T ss_dssp C
T ss_pred C
Confidence 3
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-48 Score=354.42 Aligned_cols=256 Identities=29% Similarity=0.441 Sum_probs=215.6
Q ss_pred ceeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccc----hhhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEEE
Q 016184 81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN 156 (394)
Q Consensus 81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 156 (394)
.++|++.+.||+|+||.||+|++..++..||+|++... .....+|+++++.++||||+++++++. .....+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~~~~~ 82 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFE-----DNTDIY 82 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEE-----CSSEEE
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEe-----cCCeEE
Confidence 34699999999999999999999999999999988543 345668999999999999999999883 334578
Q ss_pred EEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEE---eCCCCcEEEEeecCc
Q 016184 157 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLV---NPHTHQLKLCDFGSA 232 (394)
Q Consensus 157 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~---~~~~~~vkl~Dfg~a 232 (394)
+||||+++ +|.+.+.. ...+++..++.++.|++.||+|||+ +||+||||||+|||+ +.++ .+||+|||++
T Consensus 83 lv~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lH~-~~i~H~dlkp~Nil~~~~~~~~-~~~l~Dfg~~ 156 (277)
T 3f3z_A 83 LVMELCTGGELFERVVH----KRVFRESDAARIMKDVLSAVAYCHK-LNVAHRDLKPENFLFLTDSPDS-PLKLIDFGLA 156 (277)
T ss_dssp EEEECCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEESSSSTTC-CEEECCCTTC
T ss_pred EEEeccCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCccCCCCCHHHEEEecCCCCC-cEEEEecccc
Confidence 99999975 77665543 3679999999999999999999999 899999999999999 6555 7999999999
Q ss_pred cccccCCCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhcc
Q 016184 233 KVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 312 (394)
Q Consensus 233 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 312 (394)
.............+|+.|+|||++.+ .++.++||||||+++|+|++|+.||......+....+.......+...+
T Consensus 157 ~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~--- 231 (277)
T 3f3z_A 157 ARFKPGKMMRTKVGTPYYVSPQVLEG--LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDW--- 231 (277)
T ss_dssp EECCTTSCBCCCCSCTTTCCHHHHTT--CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHH---
T ss_pred eeccCccchhccCCCCCccChHHhcc--cCCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCchhh---
Confidence 87766655566788999999999854 3899999999999999999999999988877777666653322222211
Q ss_pred CCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCC
Q 016184 313 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP 374 (394)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~ 374 (394)
..+++.+.+||++||+.||.+|||+.++|+||||++....
T Consensus 232 ----------------------~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~~~ 271 (277)
T 3f3z_A 232 ----------------------LNVSPQAESLIRRLLTKSPKQRITSLQALEHEWFEKQLSS 271 (277)
T ss_dssp ----------------------TTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHHHHCC
T ss_pred ----------------------hcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhccccc
Confidence 3578999999999999999999999999999999875443
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-48 Score=365.64 Aligned_cols=256 Identities=28% Similarity=0.390 Sum_probs=195.0
Q ss_pred eeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccc--hhhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEEEEEE
Q 016184 82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD--KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVL 159 (394)
Q Consensus 82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~ 159 (394)
++|++.+.||+|+||.||+|++..+++.||||++... .....+|+++++.++||||+++++++. .....++||
T Consensus 53 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~-----~~~~~~lv~ 127 (349)
T 2w4o_A 53 DFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLLRLSHPNIIKLKEIFE-----TPTEISLVL 127 (349)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC----------CHHHHHCCCTTBCCEEEEEE-----CSSEEEEEE
T ss_pred CcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccchhHHHHHHHHHHHHhCCCCCCcceeeeEe-----cCCeEEEEE
Confidence 4599999999999999999999999999999998653 334567999999999999999999883 333478999
Q ss_pred ecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeC---CCCcEEEEeecCcccc
Q 016184 160 EYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNP---HTHQLKLCDFGSAKVL 235 (394)
Q Consensus 160 e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~---~~~~vkl~Dfg~a~~~ 235 (394)
||+.+ +|.+.+.. ...+++..++.++.||+.||.|||+ .||+||||||+|||++. ++ .+||+|||+++..
T Consensus 128 e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~L~~LH~-~~ivH~Dikp~NIll~~~~~~~-~~kl~Dfg~a~~~ 201 (349)
T 2w4o_A 128 ELVTGGELFDRIVE----KGYYSERDAADAVKQILEAVAYLHE-NGIVHRDLKPENLLYATPAPDA-PLKIADFGLSKIV 201 (349)
T ss_dssp CCCCSCBHHHHHTT----CSSCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEESSSSTTC-CEEECCCC-----
T ss_pred EeCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeEecCCCcccEEEecCCCCC-CEEEccCcccccc
Confidence 99975 77665543 4668999999999999999999999 89999999999999975 55 7999999999876
Q ss_pred ccCCCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHH-HHHHHHHhCCCChhhhhccCC
Q 016184 236 VKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQ-LVEIIKVLGTPTREEIKCMNP 314 (394)
Q Consensus 236 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~~~ 314 (394)
..........||+.|+|||++.+. .++.++|||||||++|+|++|..||.+...... +..+.......+
T Consensus 202 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~--------- 271 (349)
T 2w4o_A 202 EHQVLMKTVCGTPGYCAPEILRGC-AYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFI--------- 271 (349)
T ss_dssp -----------CGGGSCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCC---------
T ss_pred CcccccccccCCCCccCHHHhcCC-CCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccC---------
Confidence 554444566789999999999654 489999999999999999999999987766543 333322110000
Q ss_pred CCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCC
Q 016184 315 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP 374 (394)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~ 374 (394)
......++.++.+||++||+.||++|||+.++|+||||++....
T Consensus 272 ----------------~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~~ 315 (349)
T 2w4o_A 272 ----------------SPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWVTGKAAN 315 (349)
T ss_dssp ----------------TTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTTSTTCC
T ss_pred ----------------CchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCCccc
Confidence 00114578999999999999999999999999999999876543
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-49 Score=358.55 Aligned_cols=258 Identities=24% Similarity=0.361 Sum_probs=198.5
Q ss_pred ceeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccchh------hhHHHHHHHHHcCCCCeeeeceEEEecCCCceeE
Q 016184 81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR------YKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY 154 (394)
Q Consensus 81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 154 (394)
.++|++.+.||+|+||.||+|++..+|+.||||++..... ...++...++.++||||+++++++.... .
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~-----~ 80 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREG-----D 80 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSS-----S
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccC-----C
Confidence 4569999999999999999999999999999999864321 1223444577789999999999885332 3
Q ss_pred EEEEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC-CceeccCCCCceEEeCCCCcEEEEeecCcc
Q 016184 155 LNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI-GICHRDIKPQNLLVNPHTHQLKLCDFGSAK 233 (394)
Q Consensus 155 ~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~-givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~ 233 (394)
.++||||+++++.+++.........+++..++.++.|++.||+|||+ + ||+||||||+|||++.++ .+||+|||++.
T Consensus 81 ~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~~i~H~dlkp~Nil~~~~~-~~kl~Dfg~~~ 158 (290)
T 3fme_A 81 VWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHS-KLSVIHRDVKPSNVLINALG-QVKMCDFGISG 158 (290)
T ss_dssp EEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH-HSCCCCCCCSGGGCEECTTC-CEEBCCC----
T ss_pred EEEEEehhccchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhh-cCCeecCCCCHHHEEECCCC-CEEEeecCCcc
Confidence 78999999999988888766667889999999999999999999999 7 999999999999999887 79999999998
Q ss_pred ccccCCCcccccccccccccccc---cCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCC-cHHHHHHHHHHhCCCChhhh
Q 016184 234 VLVKGEPNVSYICSRYYRAPELI---FGATEYTTAIDIWSTGCVMAELLLGQPLFPGES-GVDQLVEIIKVLGTPTREEI 309 (394)
Q Consensus 234 ~~~~~~~~~~~~~t~~y~aPE~~---~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~-~~~~~~~i~~~~~~~~~~~~ 309 (394)
............+|+.|+|||++ .....++.++||||||+++|+|++|+.||.... ....+..........
T Consensus 159 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----- 233 (290)
T 3fme_A 159 YLVDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQ----- 233 (290)
T ss_dssp -----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCCC-----
T ss_pred cccccccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCCC-----
Confidence 76555555556789999999997 234458999999999999999999999998643 333343333311000
Q ss_pred hccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 016184 310 KCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR 372 (394)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 372 (394)
.....+++++.+||.+||+.||.+|||+.++++||||+...
T Consensus 234 ----------------------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~~~ 274 (290)
T 3fme_A 234 ----------------------LPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLHE 274 (290)
T ss_dssp ----------------------CCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHH
T ss_pred ----------------------cccccCCHHHHHHHHHHhhcChhhCcCHHHHHhCcccccCc
Confidence 01135789999999999999999999999999999998643
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-48 Score=371.23 Aligned_cols=282 Identities=27% Similarity=0.386 Sum_probs=220.3
Q ss_pred eeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccch---hhhHHHHHHHHHcC--------CCCeeeeceEEEecCCC
Q 016184 82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---RYKNRELQIMQMLD--------HPNIVALKHCFFSTTDK 150 (394)
Q Consensus 82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~--------h~~iv~~~~~~~~~~~~ 150 (394)
++|++.++||+|+||+||+|++..+++.||||++.... ....+|+.+++.+. |+||+++++++.... .
T Consensus 37 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~-~ 115 (397)
T 1wak_A 37 GRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG-V 115 (397)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE-T
T ss_pred CeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC-C
Confidence 46999999999999999999999999999999987543 34457999999885 788999999884332 2
Q ss_pred ceeEEEEEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC-CceeccCCCCceEEeCCC--------
Q 016184 151 EELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI-GICHRDIKPQNLLVNPHT-------- 221 (394)
Q Consensus 151 ~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~-givH~Dlkp~Nil~~~~~-------- 221 (394)
...+.++||||+++++.+.+.... ...+++..++.++.||+.||+|||+ + ||+||||||+|||++.++
T Consensus 116 ~~~~~~lv~e~~~~~l~~~~~~~~--~~~~~~~~~~~i~~qi~~aL~~lH~-~~givHrDikp~NIll~~~~~~~~~~~~ 192 (397)
T 1wak_A 116 NGTHICMVFEVLGHHLLKWIIKSN--YQGLPLPCVKKIIQQVLQGLDYLHT-KCRIIHTDIKPENILLSVNEQYIRRLAA 192 (397)
T ss_dssp TEEEEEEEECCCCCBHHHHHHHTT--TSCCCHHHHHHHHHHHHHHHHHHHH-TTCEECCCCSGGGEEECCCHHHHHHHHH
T ss_pred CCceEEEEEeccCccHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHH-hCCEecCCCCHHHeeEeccchhhhhhhh
Confidence 455788999999988877665422 2569999999999999999999999 8 999999999999998764
Q ss_pred ----------------------------------------CcEEEEeecCccccccCCCcccccccccccccccccCCCC
Q 016184 222 ----------------------------------------HQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 261 (394)
Q Consensus 222 ----------------------------------------~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~ 261 (394)
..+||+|||++..... ......+|+.|+|||++.+..
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~--~~~~~~gt~~y~aPE~~~~~~- 269 (397)
T 1wak_A 193 EATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHK--HFTEDIQTRQYRSLEVLIGSG- 269 (397)
T ss_dssp HHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTB--CSCSCCSCGGGCCHHHHHTSC-
T ss_pred hhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccc--cCccCCCCCcccCChhhcCCC-
Confidence 1699999999976543 234567899999999997654
Q ss_pred CCChhhHHHHHHHHHHHHhCCCCCCCCC------cHHHHHHHHHHhCCCChhhhhccCCCCcc-------cCCCCCCCCC
Q 016184 262 YTTAIDIWSTGCVMAELLLGQPLFPGES------GVDQLVEIIKVLGTPTREEIKCMNPNYTE-------FKFPQIKPHP 328 (394)
Q Consensus 262 ~~~~~DiwslG~il~~lltg~~pf~~~~------~~~~~~~i~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~ 328 (394)
++.++|||||||++|+|++|+.||.+.+ ....+..+.+..+.++...+......... ..+.......
T Consensus 270 ~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 349 (397)
T 1wak_A 270 YNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWG 349 (397)
T ss_dssp CCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCCCC
T ss_pred CCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCCcc
Confidence 8999999999999999999999998654 45667788888888887665332211110 1111111111
Q ss_pred cchh------ccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 016184 329 WHKV------FQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE 370 (394)
Q Consensus 329 ~~~~------~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~ 370 (394)
.... .....+..+.+||.+||+.||++|||+.|+|+||||+.
T Consensus 350 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~ 397 (397)
T 1wak_A 350 LFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLNS 397 (397)
T ss_dssp HHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGGC
T ss_pred hhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCccccC
Confidence 0000 12334567899999999999999999999999999973
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-48 Score=367.34 Aligned_cols=285 Identities=34% Similarity=0.624 Sum_probs=225.7
Q ss_pred eeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccch------hhhHHHHHHHHHcCCCCeeeeceEEEecCCC-ceeE
Q 016184 82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDK-EELY 154 (394)
Q Consensus 82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~-~~~~ 154 (394)
.+|.+.+.||+|+||.||+|++..+|+.||||++.... ....+|+.+++.++||||+++++++...... ....
T Consensus 24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 103 (353)
T 3coi_A 24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD 103 (353)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred ceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEeccccccccee
Confidence 35999999999999999999999999999999985431 2345799999999999999999988443221 1223
Q ss_pred EEEEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCccc
Q 016184 155 LNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV 234 (394)
Q Consensus 155 ~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~ 234 (394)
.++||||+.+++..++ ...+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||++..
T Consensus 104 ~~lv~e~~~~~l~~~~------~~~~~~~~~~~i~~qi~~al~~LH~-~~ivH~dlkp~NIl~~~~~-~~kl~Dfg~~~~ 175 (353)
T 3coi_A 104 FYLVMPFMQTDLQKIM------GLKFSEEKIQYLVYQMLKGLKYIHS-AGVVHRDLKPGNLAVNEDC-ELKILDFGLARH 175 (353)
T ss_dssp CEEEEECCSEEGGGTT------TSCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSSCCGGGEEECTTC-CEEECSTTCTTC
T ss_pred EEEEeccccCCHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEeECCCC-cEEEeecccccC
Confidence 5799999998775443 2469999999999999999999999 8999999999999999888 699999999976
Q ss_pred cccCCCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCC
Q 016184 235 LVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 314 (394)
Q Consensus 235 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 314 (394)
... ......+|+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+.+..+....+.++.+....+..
T Consensus 176 ~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 253 (353)
T 3coi_A 176 ADA--EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLND 253 (353)
T ss_dssp ----------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSC
T ss_pred CCC--CccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhh
Confidence 432 233457899999999997656689999999999999999999999999998899999999988888776654432
Q ss_pred CCcc---cCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCCC
Q 016184 315 NYTE---FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTR 377 (394)
Q Consensus 315 ~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~~ 377 (394)
.... ..++......+.. ....+++++.+||.+||+.||.+|||+.++|+||||+....+...
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~~~~~~ 318 (353)
T 3coi_A 254 KAAKSYIQSLPQTPRKDFTQ-LFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRDPEEE 318 (353)
T ss_dssp HHHHHHHHTSCBCSSCCTTT-TCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTCCGGGC
T ss_pred HHHHHHHHhCcCCCCccHHH-hcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhccCcccc
Confidence 1100 0111111111111 224679999999999999999999999999999999998776543
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-49 Score=381.98 Aligned_cols=254 Identities=26% Similarity=0.393 Sum_probs=205.8
Q ss_pred ceeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccch-------hhhHHHHHHHHHcCCCCeeeeceEEEecCCCcee
Q 016184 81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL 153 (394)
Q Consensus 81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 153 (394)
.++|++.++||+|+||.||+|++..+|+.||||++.... ....+|+.+++.++||||+++++++.. ..
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~-----~~ 221 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQT-----HD 221 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEE-----TT
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEee-----CC
Confidence 457999999999999999999999999999999986432 233468888999999999999998843 33
Q ss_pred EEEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCc
Q 016184 154 YLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA 232 (394)
Q Consensus 154 ~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a 232 (394)
.+++||||+++ +|...+.. ...+++..++.++.||+.||+|||+..||+||||||+|||++.++ .+||+|||++
T Consensus 222 ~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~-~~kl~DFG~a 296 (446)
T 4ejn_A 222 RLCFVMEYANGGELFFHLSR----ERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDG-HIKITDFGLC 296 (446)
T ss_dssp EEEEEECCCSSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSS-CEEECCCCCC
T ss_pred EEEEEEeeCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCC-CEEEccCCCc
Confidence 47899999986 66665543 367999999999999999999999536999999999999999888 6999999999
Q ss_pred cccccC-CCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhc
Q 016184 233 KVLVKG-EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 311 (394)
Q Consensus 233 ~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 311 (394)
+..... .......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+.......+....
T Consensus 297 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~---------- 365 (446)
T 4ejn_A 297 KEGIKDGATMKTFCGTPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEE---------- 365 (446)
T ss_dssp CTTCC-----CCSSSCGGGCCHHHHHTS-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC----------
T ss_pred eeccCCCcccccccCCccccCHhhcCCC-CCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCC----------
Confidence 764332 333456789999999999654 48999999999999999999999998887766666555411
Q ss_pred cCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCC-----CHHHHhcCCCCCCCCCC
Q 016184 312 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-----TALEACVHPFFDELRDP 374 (394)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----t~~ell~hp~f~~~~~~ 374 (394)
.. ++..+++++.+||.+||+.||.+|| |++|+++||||+++...
T Consensus 366 -------~~------------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~f~~~~~~ 414 (446)
T 4ejn_A 366 -------IR------------FPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQ 414 (446)
T ss_dssp -------CC------------CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHH
T ss_pred -------CC------------CCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCccccCCCHH
Confidence 11 1245789999999999999999999 99999999999987543
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-48 Score=382.70 Aligned_cols=257 Identities=23% Similarity=0.381 Sum_probs=211.6
Q ss_pred cceeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccch-------hhhHHHHHHHHHcCCCCeeeeceEEEecCCCce
Q 016184 80 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE 152 (394)
Q Consensus 80 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 152 (394)
...+|.+.++||+|+||.||+|+++.+|+.||||++.+.. ....+|+.+++.++||||+++++++. ..
T Consensus 183 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~-----~~ 257 (543)
T 3c4z_A 183 GEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFE-----TK 257 (543)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEE-----CS
T ss_pred ChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEe-----eC
Confidence 3457999999999999999999999999999999986432 23457999999999999999999883 33
Q ss_pred eEEEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecC
Q 016184 153 LYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS 231 (394)
Q Consensus 153 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~ 231 (394)
..+|+||||+.+ +|...+.........+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+
T Consensus 258 ~~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~-~gIvHrDLKP~NILl~~~g-~vkL~DFGl 335 (543)
T 3c4z_A 258 TDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQ-RNIIYRDLKPENVLLDDDG-NVRISDLGL 335 (543)
T ss_dssp SEEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECTTS-CEEECCCTT
T ss_pred CEEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHH-cCCcccCCChHHEEEeCCC-CEEEeecce
Confidence 458899999984 7877776544445679999999999999999999999 8999999999999999988 699999999
Q ss_pred ccccccCCCc-ccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCc----HHHHHHHHHHhCCCCh
Q 016184 232 AKVLVKGEPN-VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESG----VDQLVEIIKVLGTPTR 306 (394)
Q Consensus 232 a~~~~~~~~~-~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~----~~~~~~i~~~~~~~~~ 306 (394)
++........ ....||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+... ......+...
T Consensus 336 a~~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~------ 408 (543)
T 3c4z_A 336 AVELKAGQTKTKGYAGTPGFMAPELLLGE-EYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQ------ 408 (543)
T ss_dssp CEECCTTCCCBCCCCSCTTTSCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHC------
T ss_pred eeeccCCCcccccccCCccccChhhhcCC-CCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhc------
Confidence 9876544332 345899999999999764 489999999999999999999999987542 2222222221
Q ss_pred hhhhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCC-----HHHHhcCCCCCCCCC
Q 016184 307 EEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCT-----ALEACVHPFFDELRD 373 (394)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt-----~~ell~hp~f~~~~~ 373 (394)
... ++..+++++.+||++||+.||.+||+ ++++++||||+++..
T Consensus 409 -----------~~~------------~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~i~w 457 (543)
T 3c4z_A 409 -----------AVT------------YPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDISW 457 (543)
T ss_dssp -----------CCC------------CCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTTCCH
T ss_pred -----------ccC------------CCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccCCCH
Confidence 000 12467999999999999999999995 589999999998753
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-48 Score=382.04 Aligned_cols=258 Identities=27% Similarity=0.427 Sum_probs=213.5
Q ss_pred ceeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccc------hhhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeE
Q 016184 81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY 154 (394)
Q Consensus 81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 154 (394)
..+|++.++||+|+||+||+|++..+++.||||++... .....+|+++++.++||||+++++++. ....
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~-----~~~~ 95 (486)
T 3mwu_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILE-----DSSS 95 (486)
T ss_dssp HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEE-----CSSE
T ss_pred hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEE-----cCCE
Confidence 45799999999999999999999999999999998532 344568999999999999999999883 3445
Q ss_pred EEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCC--CcEEEEeecC
Q 016184 155 LNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHT--HQLKLCDFGS 231 (394)
Q Consensus 155 ~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~--~~vkl~Dfg~ 231 (394)
+++||||+.+ +|.+.+.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++..+ ..+||+|||+
T Consensus 96 ~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~qi~~al~~lH~-~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~ 170 (486)
T 3mwu_A 96 FYIVGELYTGGELFDEIIK----RKRFSEHDAARIIKQVFSGITYMHK-HNIVHRDLKPENILLESKEKDCDIKIIDFGL 170 (486)
T ss_dssp EEEEECCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEESSSSTTCCEEECSCSC
T ss_pred EEEEEEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeEeccCchHHEEEecCCCCCCEEEEECCc
Confidence 7899999985 66665543 3679999999999999999999999 8999999999999996432 2699999999
Q ss_pred ccccccCCCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhc
Q 016184 232 AKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 311 (394)
Q Consensus 232 a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 311 (394)
+.............||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+.+..+.+..+..........
T Consensus 171 a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~---- 244 (486)
T 3mwu_A 171 STCFQQNTKMKDRIGTAYYIAPEVLRG--TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLP---- 244 (486)
T ss_dssp TTTBCCC----CCTTGGGGCCGGGGGS--CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCSG----
T ss_pred CeECCCCCccCCCcCCCCCCCHHHhCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCc----
Confidence 987765555566789999999999964 48999999999999999999999999888777777665532111111
Q ss_pred cCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCC
Q 016184 312 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 375 (394)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~ 375 (394)
....+++++++||++||+.||.+|||+.++|+||||++.....
T Consensus 245 ---------------------~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~~~~~ 287 (486)
T 3mwu_A 245 ---------------------QWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSSET 287 (486)
T ss_dssp ---------------------GGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCHHHHHTCCCC
T ss_pred ---------------------ccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCHhhccCcccC
Confidence 1145799999999999999999999999999999999875543
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-48 Score=360.59 Aligned_cols=252 Identities=29% Similarity=0.440 Sum_probs=204.0
Q ss_pred ceeEEEeeEEeecCceEEEEEEEC---CCCcEEEEEEeccch--------hhhHHHHHHHHHcCCCCeeeeceEEEecCC
Q 016184 81 KVSYIAEHVVGTGSFGVVFQAKCR---ETGEIVAIKKVLQDK--------RYKNRELQIMQMLDHPNIVALKHCFFSTTD 149 (394)
Q Consensus 81 ~~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~--------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 149 (394)
..+|++.+.||+|+||.||+|++. .+|+.||+|++.+.. ....+|+.+++.++||||+++++++..
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--- 92 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQT--- 92 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEEC---
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEc---
Confidence 346999999999999999999985 689999999986432 234579999999999999999998843
Q ss_pred CceeEEEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEe
Q 016184 150 KEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCD 228 (394)
Q Consensus 150 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~D 228 (394)
....++||||+.+ +|.+.+.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+|
T Consensus 93 --~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~lH~-~~ivH~Dlkp~Nill~~~~-~~kl~D 164 (327)
T 3a62_A 93 --GGKLYLILEYLSGGELFMQLER----EGIFMEDTACFYLAEISMALGHLHQ-KGIIYRDLKPENIMLNHQG-HVKLTD 164 (327)
T ss_dssp --SSCEEEEEECCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCTTTEEECTTS-CEEECC
T ss_pred --CCEEEEEEeCCCCCcHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHh-CCEEcccCCHHHeEECCCC-cEEEEe
Confidence 3347899999974 77666653 3678999999999999999999999 8999999999999999888 699999
Q ss_pred ecCccccccC-CCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChh
Q 016184 229 FGSAKVLVKG-EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 307 (394)
Q Consensus 229 fg~a~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~ 307 (394)
||+++..... .......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+....+..+.....
T Consensus 165 fg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~----- 238 (327)
T 3a62_A 165 FGLCKESIHDGTVTHTFCGTIEYMAPEILMRS-GHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKL----- 238 (327)
T ss_dssp CSCC----------CTTSSCCTTSCHHHHTTS-CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCC-----
T ss_pred CCcccccccCCccccccCCCcCccCHhhCcCC-CCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCC-----
Confidence 9998754332 223456789999999999654 489999999999999999999999998877776666655210
Q ss_pred hhhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCC-----CHHHHhcCCCCCCCCC
Q 016184 308 EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-----TALEACVHPFFDELRD 373 (394)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----t~~ell~hp~f~~~~~ 373 (394)
. ++..++.++.+||.+||+.||.+|| ++.++++||||+++..
T Consensus 239 ------------~------------~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~~~~ 285 (327)
T 3a62_A 239 ------------N------------LPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHINW 285 (327)
T ss_dssp ------------C------------CCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSSCCH
T ss_pred ------------C------------CCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccCCCH
Confidence 1 1245789999999999999999999 8999999999998743
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-48 Score=363.52 Aligned_cols=253 Identities=26% Similarity=0.405 Sum_probs=211.3
Q ss_pred eeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccch-------hhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeE
Q 016184 82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY 154 (394)
Q Consensus 82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 154 (394)
..|.+.+.||+|+||.||+|++..+|+.||||++.... ..+.+|+++++.++||||+++++++... ..
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-----~~ 128 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLRE-----HT 128 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET-----TE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC-----Ce
Confidence 45999999999999999999999999999999985321 2345799999999999999999988443 34
Q ss_pred EEEEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCccc
Q 016184 155 LNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV 234 (394)
Q Consensus 155 ~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~ 234 (394)
.++||||+.+++.+++... ...+++..++.++.|++.||.|||+ .||+||||||+|||++.++ .+||+|||++..
T Consensus 129 ~~lv~e~~~g~l~~~l~~~---~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dlkp~NIll~~~~-~~kL~DfG~a~~ 203 (348)
T 1u5q_A 129 AWLVMEYCLGSASDLLEVH---KKPLQEVEIAAVTHGALQGLAYLHS-HNMIHRDVKAGNILLSEPG-LVKLGDFGSASI 203 (348)
T ss_dssp EEEEEECCSEEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCSGGGEEEETTT-EEEECCCTTCBS
T ss_pred EEEEEecCCCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHh-CCeeeCCCCHHHEEECCCC-CEEEeeccCcee
Confidence 7899999999887766542 3679999999999999999999999 8999999999999999887 799999999976
Q ss_pred cccCCCcccccccccccccccccC--CCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhcc
Q 016184 235 LVKGEPNVSYICSRYYRAPELIFG--ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 312 (394)
Q Consensus 235 ~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 312 (394)
... .....||+.|+|||++.+ ...++.++|||||||++|+|++|+.||.+.+....+..+.......
T Consensus 204 ~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~-------- 272 (348)
T 1u5q_A 204 MAP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPA-------- 272 (348)
T ss_dssp SSS---BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCC--------
T ss_pred cCC---CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC--------
Confidence 532 234678999999999853 3458999999999999999999999998887766666554421000
Q ss_pred CCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCC
Q 016184 313 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP 374 (394)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~ 374 (394)
.....+++.+.+||.+||+.||++|||++++++||||.....+
T Consensus 273 -------------------~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~~~~~~~~ 315 (348)
T 1u5q_A 273 -------------------LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPP 315 (348)
T ss_dssp -------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSCCCT
T ss_pred -------------------CCCCCCCHHHHHHHHHHcccChhhCcCHHHHhhChhhhccCCc
Confidence 0113578899999999999999999999999999999875443
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-48 Score=366.48 Aligned_cols=264 Identities=30% Similarity=0.455 Sum_probs=210.2
Q ss_pred ceeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccch---------hhhHHHHHHHHHcCCCCeeeeceEEEecCCCc
Q 016184 81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKE 151 (394)
Q Consensus 81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 151 (394)
..+|++.+.||+|+||.||+|++..+++.||+|++.... ....+|+.+++.++||||+++++++. .
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~-----~ 99 (345)
T 3hko_A 25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYE-----D 99 (345)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----C
T ss_pred hhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhc-----c
Confidence 346999999999999999999999999999999885432 34567999999999999999999983 3
Q ss_pred eeEEEEEEeccc-ccHHHHHHHhhhh------------------------------------cCCCCHHHHHHHHHHHHH
Q 016184 152 ELYLNLVLEYVP-ETVNRIARNYSRI------------------------------------HQRMPLIYVKLYTYQICR 194 (394)
Q Consensus 152 ~~~~~lv~e~~~-~~l~~~~~~~~~~------------------------------------~~~l~~~~~~~~~~qi~~ 194 (394)
....++||||++ ++|.+++..+... ...+++..++.++.||+.
T Consensus 100 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~ 179 (345)
T 3hko_A 100 EQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFS 179 (345)
T ss_dssp SSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHH
T ss_pred CCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHH
Confidence 445889999997 4776665321110 123467788999999999
Q ss_pred HHHHHHhCCCceeccCCCCceEEeCCCC-cEEEEeecCccccccCC-----CcccccccccccccccccCC-CCCCChhh
Q 016184 195 ALAYIHNCIGICHRDIKPQNLLVNPHTH-QLKLCDFGSAKVLVKGE-----PNVSYICSRYYRAPELIFGA-TEYTTAID 267 (394)
Q Consensus 195 al~~LH~~~givH~Dlkp~Nil~~~~~~-~vkl~Dfg~a~~~~~~~-----~~~~~~~t~~y~aPE~~~~~-~~~~~~~D 267 (394)
||+|||+ .||+||||||+|||++.++. .+||+|||++....... ......+|+.|+|||++.+. ..++.++|
T Consensus 180 ~l~~LH~-~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~D 258 (345)
T 3hko_A 180 ALHYLHN-QGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCD 258 (345)
T ss_dssp HHHHHHH-TTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHH
T ss_pred HHHHHHH-CCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHH
Confidence 9999999 89999999999999986542 69999999997653322 12355789999999998642 45899999
Q ss_pred HHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHH
Q 016184 268 IWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCR 347 (394)
Q Consensus 268 iwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 347 (394)
||||||++|+|++|+.||.+....+.+..+.......+.. ....+++++.+||.+
T Consensus 259 iwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~li~~ 313 (345)
T 3hko_A 259 AWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENP-------------------------NYNVLSPLARDLLSN 313 (345)
T ss_dssp HHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSG-------------------------GGGGSCHHHHHHHHH
T ss_pred HHHHHHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCCc-------------------------ccccCCHHHHHHHHH
Confidence 9999999999999999999888777777666532111110 113478999999999
Q ss_pred hcccCCCCCCCHHHHhcCCCCCCCCCCC
Q 016184 348 FFQYSPNLRCTALEACVHPFFDELRDPN 375 (394)
Q Consensus 348 ~L~~dP~~Rpt~~ell~hp~f~~~~~~~ 375 (394)
||+.||.+|||+.++|+||||+++.+.-
T Consensus 314 ~l~~~p~~Rps~~~~l~hp~~~~~~~~~ 341 (345)
T 3hko_A 314 LLNRNVDERFDAMRALQHPWISQFSDKI 341 (345)
T ss_dssp HSCSCTTTSCCHHHHHHSHHHHTTSSCS
T ss_pred HcCCChhHCCCHHHHhcChhhccChHhh
Confidence 9999999999999999999999986644
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-48 Score=363.86 Aligned_cols=253 Identities=26% Similarity=0.417 Sum_probs=211.9
Q ss_pred eeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccch------------hhhHHHHHHHHHc-CCCCeeeeceEEEecC
Q 016184 82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------------RYKNRELQIMQML-DHPNIVALKHCFFSTT 148 (394)
Q Consensus 82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------------~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~ 148 (394)
.+|.+.+.||+|+||.||+|++..+|+.||||++.... ....+|+.+++.+ +||||+++++++.
T Consensus 94 ~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~--- 170 (365)
T 2y7j_A 94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYE--- 170 (365)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE---
T ss_pred hhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEe---
Confidence 46999999999999999999999899999999885432 2345799999999 8999999999883
Q ss_pred CCceeEEEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEE
Q 016184 149 DKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLC 227 (394)
Q Consensus 149 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~ 227 (394)
.....++||||+.+ +|.+++.. ...+++..++.++.||+.||.|||+ .||+|+||||+|||++.++ .+||+
T Consensus 171 --~~~~~~lv~e~~~g~~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~~LH~-~gi~H~Dlkp~NIl~~~~~-~ikl~ 242 (365)
T 2y7j_A 171 --SSSFMFLVFDLMRKGELFDYLTE----KVALSEKETRSIMRSLLEAVSFLHA-NNIVHRDLKPENILLDDNM-QIRLS 242 (365)
T ss_dssp --BSSEEEEEECCCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECTTC-CEEEC
T ss_pred --eCCEEEEEEEeCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEECCCC-CEEEE
Confidence 34458899999986 77776653 3679999999999999999999999 8999999999999999888 79999
Q ss_pred eecCccccccCCCcccccccccccccccccC-----CCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhC
Q 016184 228 DFGSAKVLVKGEPNVSYICSRYYRAPELIFG-----ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLG 302 (394)
Q Consensus 228 Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~-----~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~ 302 (394)
|||++.............||+.|+|||++.+ ...++.++|||||||++|+|++|+.||.+......+..+.....
T Consensus 243 DfG~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~ 322 (365)
T 2y7j_A 243 DFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQY 322 (365)
T ss_dssp CCTTCEECCTTCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC
T ss_pred ecCcccccCCCcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCC
Confidence 9999987766555566788999999999853 23478899999999999999999999988776666665554322
Q ss_pred CCChhhhhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 016184 303 TPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE 370 (394)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~ 370 (394)
...... ...++..+.+||.+||+.||.+|||+.++|+||||++
T Consensus 323 ~~~~~~-------------------------~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~r 365 (365)
T 2y7j_A 323 QFSSPE-------------------------WDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFER 365 (365)
T ss_dssp CCCHHH-------------------------HSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred CCCCcc-------------------------cccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccCC
Confidence 211111 1357889999999999999999999999999999974
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-48 Score=361.25 Aligned_cols=288 Identities=30% Similarity=0.491 Sum_probs=217.3
Q ss_pred eeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccch----hhhHHHHHHHHHcCCCCeeeeceEEEecC---------
Q 016184 82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVALKHCFFSTT--------- 148 (394)
Q Consensus 82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--------- 148 (394)
.+|++.+.||+|+||.||+|++..+|+.||||++.... ....+|+++++.++||||+++++++....
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 90 (320)
T 2i6l_A 11 SRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGS 90 (320)
T ss_dssp TTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----
T ss_pred CceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccccccc
Confidence 35999999999999999999999999999999885432 34457999999999999999998873221
Q ss_pred CCceeEEEEEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEe
Q 016184 149 DKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCD 228 (394)
Q Consensus 149 ~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~D 228 (394)
.......++||||++++|.+++.. ..+++..++.++.|++.||+|||+ +||+||||||+|||++.++..+||+|
T Consensus 91 ~~~~~~~~lv~e~~~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~Nil~~~~~~~~kl~D 164 (320)
T 2i6l_A 91 LTELNSVYIVQEYMETDLANVLEQ-----GPLLEEHARLFMYQLLRGLKYIHS-ANVLHRDLKPANLFINTEDLVLKIGD 164 (320)
T ss_dssp CCSCSEEEEEEECCSEEHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCSGGGEEEETTTTEEEECC
T ss_pred ccccCceeEEeeccCCCHHHHhhc-----CCccHHHHHHHHHHHHHHHHHHHh-CCEecCCCCHHHEEEcCCCCeEEEcc
Confidence 123356789999999988777643 679999999999999999999999 89999999999999986554799999
Q ss_pred ecCccccccC----CCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCC
Q 016184 229 FGSAKVLVKG----EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTP 304 (394)
Q Consensus 229 fg~a~~~~~~----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~ 304 (394)
||++...... .......+|+.|+|||.+.+...++.++||||||+++|+|++|+.||.+....+.+..+.......
T Consensus 165 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 244 (320)
T 2i6l_A 165 FGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVV 244 (320)
T ss_dssp CTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCCC
T ss_pred CccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence 9999865322 122345668999999998765668999999999999999999999999988888888887776655
Q ss_pred ChhhhhccCCCCcccCCC-CCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCC
Q 016184 305 TREEIKCMNPNYTEFKFP-QIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 375 (394)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~ 375 (394)
..............+... ..........+...++.++.+||.+||+.||.+|||+.++|+||||+....+.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~p~ 316 (320)
T 2i6l_A 245 HEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIYSFPM 316 (320)
T ss_dssp CHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTTCC--
T ss_pred chhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcccccccCcc
Confidence 544332211110000000 00000111123356899999999999999999999999999999999875554
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-48 Score=368.06 Aligned_cols=281 Identities=32% Similarity=0.552 Sum_probs=216.7
Q ss_pred eeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccch---hhhHHHHHHHHHcC-CC-----CeeeeceEEEecCCCce
Q 016184 82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---RYKNRELQIMQMLD-HP-----NIVALKHCFFSTTDKEE 152 (394)
Q Consensus 82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~-h~-----~iv~~~~~~~~~~~~~~ 152 (394)
.+|++.+.||+|+||+||+|++..+++.||||++.... ....+|+.+++.+. |+ +|+.+++++.. .
T Consensus 54 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~-----~ 128 (382)
T 2vx3_A 54 DRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMF-----R 128 (382)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEE-----T
T ss_pred eeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeecc-----C
Confidence 46999999999999999999999999999999987543 23446888888885 44 48888888743 3
Q ss_pred eEEEEEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHh-CCCceeccCCCCceEEeC--CCCcEEEEee
Q 016184 153 LYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN-CIGICHRDIKPQNLLVNP--HTHQLKLCDF 229 (394)
Q Consensus 153 ~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~-~~givH~Dlkp~Nil~~~--~~~~vkl~Df 229 (394)
...++||||++++|.+++..... ..+++..++.++.|++.||.|||. ..||+||||||+|||++. ++ .+||+||
T Consensus 129 ~~~~lv~e~~~~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~-~~kL~DF 205 (382)
T 2vx3_A 129 NHLCLVFEMLSYNLYDLLRNTNF--RGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRS-AIKIVDF 205 (382)
T ss_dssp TEEEEEEECCCCBHHHHHHHTTT--SCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSC-CEEECCC
T ss_pred CceEEEEecCCCCHHHHHhhcCc--CCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCC-cEEEEec
Confidence 35889999999999888775332 568999999999999999999993 169999999999999964 44 6999999
Q ss_pred cCccccccCCCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhh
Q 016184 230 GSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI 309 (394)
Q Consensus 230 g~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 309 (394)
|+++.... ......+|+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+.+..+....+.++...+
T Consensus 206 G~a~~~~~--~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 282 (382)
T 2vx3_A 206 GSSCQLGQ--RIYQYIQSRFYRSPEVLLGM-PYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHIL 282 (382)
T ss_dssp TTCEETTC--CCCSSCSCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred cCceeccc--ccccccCCccccChHHHcCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 99976532 33456789999999999765 4899999999999999999999999999999999999999988887665
Q ss_pred hccCC-----------CCccc-------CCCCCCCCCcchhccc-----------------cCChHHHHHHHHhcccCCC
Q 016184 310 KCMNP-----------NYTEF-------KFPQIKPHPWHKVFQK-----------------RLPPEAVDLVCRFFQYSPN 354 (394)
Q Consensus 310 ~~~~~-----------~~~~~-------~~~~~~~~~~~~~~~~-----------------~~~~~~~~li~~~L~~dP~ 354 (394)
..... .+... .+.......+...+.. ..++++++||++||++||+
T Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~ 362 (382)
T 2vx3_A 283 DQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPK 362 (382)
T ss_dssp TTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSCTT
T ss_pred HhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCCChh
Confidence 42210 00000 0000000000000000 0114789999999999999
Q ss_pred CCCCHHHHhcCCCCCCCCC
Q 016184 355 LRCTALEACVHPFFDELRD 373 (394)
Q Consensus 355 ~Rpt~~ell~hp~f~~~~~ 373 (394)
+|||++|+|+||||++..+
T Consensus 363 ~Rpta~e~L~hp~f~~~~~ 381 (382)
T 2vx3_A 363 TRIQPYYALQHSFFKKTAD 381 (382)
T ss_dssp TSCCHHHHTTSGGGCC---
T ss_pred hCCCHHHHhcCcccccCCC
Confidence 9999999999999988653
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-48 Score=380.85 Aligned_cols=257 Identities=28% Similarity=0.448 Sum_probs=214.5
Q ss_pred ceeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccch-----------------hhhHHHHHHHHHcCCCCeeeeceE
Q 016184 81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----------------RYKNRELQIMQMLDHPNIVALKHC 143 (394)
Q Consensus 81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----------------~~~~~E~~~l~~l~h~~iv~~~~~ 143 (394)
..+|++.+.||+|+||+||+|+++.+++.||||++.... ....+|+.+++.++||||++++++
T Consensus 35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~ 114 (504)
T 3q5i_A 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV 114 (504)
T ss_dssp GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 346999999999999999999999999999999986432 334579999999999999999999
Q ss_pred EEecCCCceeEEEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCC
Q 016184 144 FFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTH 222 (394)
Q Consensus 144 ~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~ 222 (394)
+ ......++||||+++ +|.+.+.. ...+++..++.++.||+.||.|||+ .||+||||||+|||++.++.
T Consensus 115 ~-----~~~~~~~lv~e~~~gg~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~-~~ivH~Dlkp~Nil~~~~~~ 184 (504)
T 3q5i_A 115 F-----EDKKYFYLVTEFYEGGELFEQIIN----RHKFDECDAANIMKQILSGICYLHK-HNIVHRDIKPENILLENKNS 184 (504)
T ss_dssp E-----ECSSEEEEEEECCTTCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEESSTTC
T ss_pred E-----EcCCEEEEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeEeCCCcHHHEEEecCCC
Confidence 8 334458899999975 77665543 3679999999999999999999999 89999999999999987653
Q ss_pred --cEEEEeecCccccccCCCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHH
Q 016184 223 --QLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV 300 (394)
Q Consensus 223 --~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~ 300 (394)
.+||+|||++.............||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+.+..+...
T Consensus 185 ~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~ 262 (504)
T 3q5i_A 185 LLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLKK--KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKG 262 (504)
T ss_dssp CSSEEECCCTTCEECCTTSCBCCCCSCTTTCCHHHHTT--CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC
T ss_pred CccEEEEECCCCEEcCCCCccccccCCcCCCCHHHhcc--CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcC
Confidence 599999999987766555566789999999999853 4899999999999999999999999998877777776653
Q ss_pred hCCCChhhhhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCC
Q 016184 301 LGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP 374 (394)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~ 374 (394)
....+... ...+++++++||++||++||.+|||++++|+||||++....
T Consensus 263 ~~~~~~~~-------------------------~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~~ 311 (504)
T 3q5i_A 263 KYYFDFND-------------------------WKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYANN 311 (504)
T ss_dssp CCCCCHHH-------------------------HTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHTCCC
T ss_pred CCCCCccc-------------------------cCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhchhc
Confidence 22222111 14579999999999999999999999999999999986543
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-49 Score=384.04 Aligned_cols=257 Identities=30% Similarity=0.480 Sum_probs=215.2
Q ss_pred ceeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccc-------hhhhHHHHHHHHHcCCCCeeeeceEEEecCCCcee
Q 016184 81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL 153 (394)
Q Consensus 81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 153 (394)
..+|++.++||+|+||.||+|++..+|+.||||++... .....+|+.+++.++||||+++++++ ....
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~-----~~~~ 99 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFF-----EDKG 99 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEE-----ECSS
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEE-----EeCC
Confidence 34699999999999999999999999999999998532 34456899999999999999999988 3344
Q ss_pred EEEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEe---CCCCcEEEEee
Q 016184 154 YLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVN---PHTHQLKLCDF 229 (394)
Q Consensus 154 ~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~---~~~~~vkl~Df 229 (394)
+.++||||+.+ +|.+.+.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++ .++ .+||+||
T Consensus 100 ~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~-~~ivH~Dlkp~Nil~~~~~~~~-~~kl~Df 173 (484)
T 3nyv_A 100 YFYLVGEVYTGGELFDEIIS----RKRFSEVDAARIIRQVLSGITYMHK-NKIVHRDLKPENLLLESKSKDA-NIRIIDF 173 (484)
T ss_dssp EEEEEECCCCSCBHHHHHHT----CSCCBHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEESSSSTTC-CEEECCT
T ss_pred EEEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeCCCCHHHEEEecCCCCC-cEEEEee
Confidence 58899999975 66555543 4679999999999999999999999 8999999999999994 445 7999999
Q ss_pred cCccccccCCCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhh
Q 016184 230 GSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI 309 (394)
Q Consensus 230 g~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 309 (394)
|++.............||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+.+..+..........
T Consensus 174 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~-- 249 (484)
T 3nyv_A 174 GLSTHFEASKKMKDKIGTAYYIAPEVLHG--TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELP-- 249 (484)
T ss_dssp THHHHBCCCCSHHHHTTGGGTCCHHHHHT--CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSG--
T ss_pred eeeEEcccccccccCCCCccccCceeecC--CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCc--
Confidence 99987766655566789999999999965 48999999999999999999999999988777777665532111111
Q ss_pred hccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCC
Q 016184 310 KCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 375 (394)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~ 375 (394)
....+++++++||++||+.||.+|||+.++|+||||+......
T Consensus 250 -----------------------~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~~~~~~~~~ 292 (484)
T 3nyv_A 250 -----------------------QWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTYTKEQ 292 (484)
T ss_dssp -----------------------GGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHHHTC--
T ss_pred -----------------------ccccCCHHHHHHHHHHCCCChhHCcCHHHHhhChhhccccccc
Confidence 1145799999999999999999999999999999999876543
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-48 Score=359.98 Aligned_cols=271 Identities=26% Similarity=0.417 Sum_probs=222.9
Q ss_pred ceeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccc-------hhhhHHHHHHHHHcCCCCeeeeceEEEecCCCcee
Q 016184 81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL 153 (394)
Q Consensus 81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 153 (394)
..+|.+.+.||+|+||.||+|++..+++.||+|++... .....+|+.+++.++|+||+++++++. ...
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~ 114 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFE-----DND 114 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEE-----CSS
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-----cCC
Confidence 45699999999999999999999999999999998643 234567999999999999999999883 334
Q ss_pred EEEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCc
Q 016184 154 YLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA 232 (394)
Q Consensus 154 ~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a 232 (394)
..++||||+.+ +|.+++.. ...+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||++
T Consensus 115 ~~~lv~e~~~~~~L~~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivH~dlkp~NIl~~~~~-~~kl~Dfg~~ 188 (335)
T 2owb_A 115 FVFVVLELCRRRSLLELHKR----RKALTEPEARYYLRQIVLGCQYLHR-NRVIHRDLKLGNLFLNEDL-EVKIGDFGLA 188 (335)
T ss_dssp EEEEEECCCTTCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEECTTC-CEEECCCTTC
T ss_pred eEEEEEecCCCCCHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHH-CCCEecCCCchhEEEcCCC-CEEEeeccCc
Confidence 57899999984 77665543 3679999999999999999999999 8999999999999999887 6999999999
Q ss_pred cccccC-CCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhc
Q 016184 233 KVLVKG-EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 311 (394)
Q Consensus 233 ~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 311 (394)
...... .......+|+.|+|||++.+. .++.++||||||+++|+|++|+.||......+....+....
T Consensus 189 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~---------- 257 (335)
T 2owb_A 189 TKVEYDGERKKVLCGTPNYIAPEVLSKK-GHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNE---------- 257 (335)
T ss_dssp EECCSTTCCBCCCCSCCSSCCHHHHHTS-CBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTC----------
T ss_pred eecccCcccccccCCCccccCHHHhccC-CCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCC----------
Confidence 866433 233445789999999999654 48999999999999999999999998877665555444311
Q ss_pred cCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCCCCCCCCCCCCCCCCC
Q 016184 312 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFK 391 (394)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~~~~~~~~~~~~~~~~ 391 (394)
.. ++..+++.+.+||++||+.||++|||+.++|+||||+....+..........||.+...
T Consensus 258 -------~~------------~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (335)
T 2owb_A 258 -------YS------------IPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIPARLPITCLTIPPRFSIA 318 (335)
T ss_dssp -------CC------------CCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSCCCSCCCGGGGTSCCCCCSS
T ss_pred -------CC------------CCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccCCCccccCCcccccCCCccccC
Confidence 11 12457889999999999999999999999999999998877666555555566666554
Q ss_pred C
Q 016184 392 P 392 (394)
Q Consensus 392 ~ 392 (394)
|
T Consensus 319 ~ 319 (335)
T 2owb_A 319 P 319 (335)
T ss_dssp C
T ss_pred c
Confidence 4
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-48 Score=360.59 Aligned_cols=264 Identities=24% Similarity=0.340 Sum_probs=209.5
Q ss_pred eeEEEe-eEEeecCceEEEEEEECCCCcEEEEEEeccc------hhhhHHHHHHHHHc-CCCCeeeeceEEEecCCCcee
Q 016184 82 VSYIAE-HVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQML-DHPNIVALKHCFFSTTDKEEL 153 (394)
Q Consensus 82 ~~y~~~-~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~ 153 (394)
++|.+. +.||+|+||.||+|++..+|+.||||++... .....+|+.+++.+ .||||+++++++ ....
T Consensus 28 ~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~-----~~~~ 102 (327)
T 3lm5_A 28 NFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVY-----ENTS 102 (327)
T ss_dssp HHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEE-----ECSS
T ss_pred hEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEE-----EeCC
Confidence 458887 8999999999999999999999999988643 23456799999998 569999999988 3334
Q ss_pred EEEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeC---CCCcEEEEee
Q 016184 154 YLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNP---HTHQLKLCDF 229 (394)
Q Consensus 154 ~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~---~~~~vkl~Df 229 (394)
..++||||+.+ +|.+++.. .....+++..++.++.||+.||+|||+ .||+||||||+|||++. ++ .+||+||
T Consensus 103 ~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~i~~ql~~~L~~LH~-~givH~Dikp~NIl~~~~~~~~-~~kL~Df 178 (327)
T 3lm5_A 103 EIILILEYAAGGEIFSLCLP--ELAEMVSENDVIRLIKQILEGVYYLHQ-NNIVHLDLKPQNILLSSIYPLG-DIKIVDF 178 (327)
T ss_dssp EEEEEEECCTTEEGGGGGSS--CC-CCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEESCBTTBC-CEEECCG
T ss_pred eEEEEEEecCCCcHHHHHHH--hcccCCCHHHHHHHHHHHHHHHHHHHH-CCeecCcCChHHEEEecCCCCC-cEEEeeC
Confidence 47899999986 66544422 223679999999999999999999999 89999999999999987 45 7999999
Q ss_pred cCccccccCCCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhh
Q 016184 230 GSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI 309 (394)
Q Consensus 230 g~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 309 (394)
|++.............+|+.|+|||++.+. .++.++||||||+++|+|++|+.||.+.+..+....+.......+..
T Consensus 179 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~-- 255 (327)
T 3lm5_A 179 GMSRKIGHACELREIMGTPEYLAPEILNYD-PITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEE-- 255 (327)
T ss_dssp GGCEEC---------CCCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTT--
T ss_pred ccccccCCccccccccCCcCccCCeeecCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCch--
Confidence 999877655555567889999999999654 48999999999999999999999999888777776666533222111
Q ss_pred hccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCCCCCC
Q 016184 310 KCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPN 380 (394)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~~~~~ 380 (394)
....+++.+.+||.+||+.||.+|||++++|+||||++........+.
T Consensus 256 -----------------------~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~~~~~~~~~~ 303 (327)
T 3lm5_A 256 -----------------------TFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDFENLFHPE 303 (327)
T ss_dssp -----------------------TTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGGCCCCTTCC----
T ss_pred -----------------------hhcccCHHHHHHHHHHcCCChhhCcCHHHHhCCHhhcccccccccCcc
Confidence 114578999999999999999999999999999999998766554333
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-48 Score=352.30 Aligned_cols=259 Identities=25% Similarity=0.377 Sum_probs=211.2
Q ss_pred eeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccc----------hhhhHHHHHHHHHcCCCCeeeeceEEEecCCCc
Q 016184 82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD----------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKE 151 (394)
Q Consensus 82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 151 (394)
++|++.+.||+|+||.||+|++..+|+.||+|++... ...+.+|+.+++.++||||+++++++..
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~----- 79 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFEN----- 79 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC-----
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecC-----
Confidence 4699999999999999999999999999999988543 3446789999999999999999998833
Q ss_pred eeEEEEEEeccc-ccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCC---cEEEE
Q 016184 152 ELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTH---QLKLC 227 (394)
Q Consensus 152 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~---~vkl~ 227 (394)
....++||||++ ++|.+++.. ...+++..++.++.|++.||.|||+ .||+||||||+||+++.++. .+||+
T Consensus 80 ~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dl~p~Nil~~~~~~~~~~~kl~ 154 (283)
T 3bhy_A 80 KTDVVLILELVSGGELFDFLAE----KESLTEDEATQFLKQILDGVHYLHS-KRIAHFDLKPENIMLLDKNVPNPRIKLI 154 (283)
T ss_dssp SSEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEESCSSSSSCCEEEC
T ss_pred CCeEEEEEeecCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCccCCCCChHHEEEecCCCCCCceEEE
Confidence 344789999996 588777654 3679999999999999999999999 89999999999999987652 59999
Q ss_pred eecCccccccCCCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChh
Q 016184 228 DFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 307 (394)
Q Consensus 228 Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~ 307 (394)
|||++.............+++.|+|||++.+. .++.++||||||+++|+|++|..||.+....+.+..+.......+.
T Consensus 155 dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~- 232 (283)
T 3bhy_A 155 DFGIAHKIEAGNEFKNIFGTPEFVAPEIVNYE-PLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDE- 232 (283)
T ss_dssp CCTTCEECC--------CCCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCH-
T ss_pred ecccceeccCCCcccccCCCcCccCcceecCC-CCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCcc-
Confidence 99999876555555566789999999998654 4899999999999999999999999887766665555432111111
Q ss_pred hhhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCC
Q 016184 308 EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNT 376 (394)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~ 376 (394)
.....++..+.+||.+||+.||.+|||+.++++||||++++....
T Consensus 233 ------------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~~~ 277 (283)
T 3bhy_A 233 ------------------------EYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRRRNV 277 (283)
T ss_dssp ------------------------HHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHHHCCC
T ss_pred ------------------------hhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHHHHhh
Confidence 122457899999999999999999999999999999998765544
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=355.95 Aligned_cols=253 Identities=28% Similarity=0.422 Sum_probs=209.4
Q ss_pred eEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccch----hhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEEEEE
Q 016184 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLV 158 (394)
Q Consensus 83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv 158 (394)
.|...+.||+|+||.||+|++..+|+.||||++.... ....+|+.+++.++||||+++++++... ...++|
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~~~~lv 120 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVG-----EELWVL 120 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTTBCCEEEEEEET-----TEEEEE
T ss_pred hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEEC-----CEEEEE
Confidence 4888899999999999999999999999999986432 3456899999999999999999988543 347899
Q ss_pred Eecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCcccccc
Q 016184 159 LEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK 237 (394)
Q Consensus 159 ~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~ 237 (394)
|||+++ +|.+++.. ..+++..++.++.|++.||+|||+ .||+||||||+|||++.++ .+||+|||++.....
T Consensus 121 ~e~~~~~~L~~~l~~-----~~l~~~~~~~i~~qi~~~L~~LH~-~~ivH~Dlkp~NIll~~~~-~~kl~Dfg~~~~~~~ 193 (321)
T 2c30_A 121 MEFLQGGALTDIVSQ-----VRLNEEQIATVCEAVLQALAYLHA-QGVIHRDIKSDSILLTLDG-RVKLSDFGFCAQISK 193 (321)
T ss_dssp ECCCCSCBHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECTTC-CEEECCCTTCEECCS
T ss_pred EecCCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEECCCC-cEEEeeeeeeeeccc
Confidence 999975 67665542 579999999999999999999999 8999999999999999888 699999999876644
Q ss_pred CC-CcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCCC
Q 016184 238 GE-PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 316 (394)
Q Consensus 238 ~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 316 (394)
.. ......||+.|+|||++.+. .++.++||||||+++|+|++|+.||.+.........+..... +..
T Consensus 194 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~-~~~---------- 261 (321)
T 2c30_A 194 DVPKRKSLVGTPYWMAPEVISRS-LYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPP-PKL---------- 261 (321)
T ss_dssp SSCCBCCCCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSC-CCC----------
T ss_pred CccccccccCCccccCHhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCC-CCc----------
Confidence 32 23456789999999999654 489999999999999999999999988776665555443210 000
Q ss_pred cccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCC
Q 016184 317 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP 374 (394)
Q Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~ 374 (394)
.....+++.+.+||.+||+.||++|||+.++++||||++...+
T Consensus 262 ---------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~~~~ 304 (321)
T 2c30_A 262 ---------------KNSHKVSPVLRDFLERMLVRDPQERATAQELLDHPFLLQTGLP 304 (321)
T ss_dssp ---------------TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGGGCCCG
T ss_pred ---------------CccccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhccCCCc
Confidence 0113578999999999999999999999999999999876543
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-48 Score=367.97 Aligned_cols=260 Identities=27% Similarity=0.376 Sum_probs=199.1
Q ss_pred ceeEEEe-eEEeecCceEEEEEEECCCCcEEEEEEeccchhhhHHHHHHH-HHcCCCCeeeeceEEEecCCCceeEEEEE
Q 016184 81 KVSYIAE-HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIM-QMLDHPNIVALKHCFFSTTDKEELYLNLV 158 (394)
Q Consensus 81 ~~~y~~~-~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~E~~~l-~~l~h~~iv~~~~~~~~~~~~~~~~~~lv 158 (394)
..+|.+. ++||+|+||+||+|++..+|+.||||++... ....+|++++ +..+||||+++++++.... ....++++|
T Consensus 60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~-~~~~~~~lv 137 (400)
T 1nxk_A 60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-PKARREVELHWRASQCPHIVRIVDVYENLY-AGRKCLLIV 137 (400)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-HHHHHHHHHHHHHTTSTTBCCEEEEEEEEE-TTEEEEEEE
T ss_pred cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-hhHHHHHHHHHHhcCCCCcceEeEEEeecc-cCCcEEEEE
Confidence 3457776 7999999999999999999999999998643 4456788886 4558999999999874322 235568899
Q ss_pred Eecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeC---CCCcEEEEeecCccc
Q 016184 159 LEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNP---HTHQLKLCDFGSAKV 234 (394)
Q Consensus 159 ~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~---~~~~vkl~Dfg~a~~ 234 (394)
|||+.+ +|.+++.... ...+++..++.++.||+.||.|||+ +||+||||||+|||++. ++ .+||+|||+++.
T Consensus 138 ~E~~~gg~L~~~l~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlkp~Nill~~~~~~~-~~kl~DFG~a~~ 213 (400)
T 1nxk_A 138 MECLDGGELFSRIQDRG--DQAFTEREASEIMKSIGEAIQYLHS-INIAHRDVKPENLLYTSKRPNA-ILKLTDFGFAKE 213 (400)
T ss_dssp EECCCSEEHHHHHHCC-----CCBHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEESSSSTTC-CEEECCCTTCEE
T ss_pred EEeCCCCcHHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCcCcceEEEecCCCCc-cEEEEecccccc
Confidence 999975 8877776422 2469999999999999999999999 89999999999999997 45 799999999987
Q ss_pred cccCCCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHH----HHHHHHHHhCCCChhhhh
Q 016184 235 LVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVD----QLVEIIKVLGTPTREEIK 310 (394)
Q Consensus 235 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~----~~~~i~~~~~~~~~~~~~ 310 (394)
...........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+..... ....+...
T Consensus 214 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~---------- 282 (400)
T 1nxk_A 214 TTSHNSLTTPCYTPYYVAPEVLGP-EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMG---------- 282 (400)
T ss_dssp CC-----------CTTCCGGGSCC-CCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHT----------
T ss_pred cCCCCccccCCCCCCccCHhhcCC-CCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcC----------
Confidence 655555556778999999999854 458999999999999999999999998754322 22222211
Q ss_pred ccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 016184 311 CMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR 372 (394)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 372 (394)
.+.++. .....++.++.+||++||+.||.+|||+.++|+||||.+..
T Consensus 283 -------~~~~~~--------~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~ 329 (400)
T 1nxk_A 283 -------QYEFPN--------PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 329 (400)
T ss_dssp -------CCCCCT--------TTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTTT
T ss_pred -------cccCCC--------cccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccCCC
Confidence 011110 01145799999999999999999999999999999998643
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-48 Score=358.82 Aligned_cols=257 Identities=24% Similarity=0.377 Sum_probs=200.4
Q ss_pred ceeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccc-----hhhhHHHHHHHHHcCCCCeeeeceEEEecCC------
Q 016184 81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTD------ 149 (394)
Q Consensus 81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~------ 149 (394)
..+|++.+.||+|+||.||+|+++.+|+.||||++... .....+|+.+++.++||||+++++++.....
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 45799999999999999999999999999999998632 2345689999999999999999998865432
Q ss_pred ----------------------------------------------CceeEEEEEEecccc-cHHHHHHHhhhhcCCCCH
Q 016184 150 ----------------------------------------------KEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPL 182 (394)
Q Consensus 150 ----------------------------------------------~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~ 182 (394)
....+.++||||+.+ +|.+++..... .....+
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~-~~~~~~ 163 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCS-LEDREH 163 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCS-GGGSCH
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccC-ccchhh
Confidence 123357899999986 77777765322 344566
Q ss_pred HHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCccccccCC-------------Cccccccccc
Q 016184 183 IYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE-------------PNVSYICSRY 249 (394)
Q Consensus 183 ~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~~~-------------~~~~~~~t~~ 249 (394)
..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+++...... ......||+.
T Consensus 164 ~~~~~i~~qi~~aL~~LH~-~~ivH~Dlkp~NIll~~~~-~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 241 (332)
T 3qd2_B 164 GVCLHIFIQIAEAVEFLHS-KGLMHRDLKPSNIFFTMDD-VVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL 241 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECTTC-CEEECCCTTCEECSCC--------------CCCSCC-CGG
T ss_pred HHHHHHHHHHHHHHHHHHh-CCeeecCCCcccEEEeCCC-CEEEeecCcccccccchhhccccccccccccccccCCCcC
Confidence 7789999999999999999 8999999999999999888 79999999998765432 2234568999
Q ss_pred ccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCCCcccCCCCCCCCCc
Q 016184 250 YRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPW 329 (394)
Q Consensus 250 y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 329 (394)
|+|||++.+. .++.++|||||||++|+|++|..|+. +....+..........
T Consensus 242 y~aPE~~~~~-~~~~~~Di~slG~il~el~~~~~~~~-----~~~~~~~~~~~~~~~~---------------------- 293 (332)
T 3qd2_B 242 YMSPEQIHGN-NYSHKVDIFSLGLILFELLYSFSTQM-----ERVRIITDVRNLKFPL---------------------- 293 (332)
T ss_dssp GSCHHHHHCC-CCCTHHHHHHHHHHHHHHHSCCCCHH-----HHHHHHHHHHTTCCCH----------------------
T ss_pred ccChHHhcCC-CCcchhhHHHHHHHHHHHHHcCCChh-----HHHHHHHHhhccCCCc----------------------
Confidence 9999999765 48999999999999999999876542 1111111111110000
Q ss_pred chhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 016184 330 HKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL 371 (394)
Q Consensus 330 ~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 371 (394)
.....++++.+||.+||+.||.+|||+.++|+||||+++
T Consensus 294 ---~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~f~~~ 332 (332)
T 3qd2_B 294 ---LFTQKYPQEHMMVQDMLSPSPTERPEATDIIENAIFENL 332 (332)
T ss_dssp ---HHHHHCHHHHHHHHHHHCSSGGGSCCHHHHHHSTTCCCC
T ss_pred ---ccccCChhHHHHHHHHccCCCCcCCCHHHHhhchhhhcC
Confidence 113457788999999999999999999999999999874
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-47 Score=351.07 Aligned_cols=261 Identities=27% Similarity=0.387 Sum_probs=213.5
Q ss_pred ceeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccch-------------hhhHHHHHHHHHcC-CCCeeeeceEEEe
Q 016184 81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------------RYKNRELQIMQMLD-HPNIVALKHCFFS 146 (394)
Q Consensus 81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------------~~~~~E~~~l~~l~-h~~iv~~~~~~~~ 146 (394)
..+|++.+.||+|+||.||+|++..+|+.||||++.... ....+|+++++.+. ||||+++++++
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~-- 93 (298)
T 1phk_A 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY-- 93 (298)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE--
T ss_pred hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeee--
Confidence 346999999999999999999999999999999985331 23457999999995 99999999988
Q ss_pred cCCCceeEEEEEEeccc-ccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEE
Q 016184 147 TTDKEELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLK 225 (394)
Q Consensus 147 ~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vk 225 (394)
......++||||++ ++|.+++.. ...+++..++.++.||+.||.|||+ +||+|+||||+||+++.++ .+|
T Consensus 94 ---~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~p~Nil~~~~~-~~k 164 (298)
T 1phk_A 94 ---ETNTFFFLVFDLMKKGELFDYLTE----KVTLSEKETRKIMRALLEVICALHK-LNIVHRDLKPENILLDDDM-NIK 164 (298)
T ss_dssp ---ECSSEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECTTC-CEE
T ss_pred ---ccCCeEEEEEeccCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCcceEEEcCCC-cEE
Confidence 33445889999998 488777654 3679999999999999999999999 8999999999999999888 699
Q ss_pred EEeecCccccccCCCccccccccccccccccc-----CCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHH
Q 016184 226 LCDFGSAKVLVKGEPNVSYICSRYYRAPELIF-----GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV 300 (394)
Q Consensus 226 l~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~-----~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~ 300 (394)
|+|||++.............+++.|+|||++. ....++.++||||||+++|+|++|+.||...........+...
T Consensus 165 l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~ 244 (298)
T 1phk_A 165 LTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSG 244 (298)
T ss_dssp ECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT
T ss_pred EecccchhhcCCCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcC
Confidence 99999998776555555677899999999984 2345789999999999999999999999887766665555542
Q ss_pred hCCCChhhhhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCCC
Q 016184 301 LGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTR 377 (394)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~~ 377 (394)
....+. .....++..+.+||.+||+.||.+|||+.++|+||||++......+
T Consensus 245 ~~~~~~-------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~~~~ 296 (298)
T 1phk_A 245 NYQFGS-------------------------PEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYVVEEVR 296 (298)
T ss_dssp CCCCCT-------------------------TTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTTC-----
T ss_pred CcccCc-------------------------ccccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhccchhhc
Confidence 111110 0113578999999999999999999999999999999988766543
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-48 Score=358.91 Aligned_cols=256 Identities=23% Similarity=0.402 Sum_probs=187.1
Q ss_pred eeEEEe---eEEeecCceEEEEEEECCCCcEEEEEEeccc-hhhhHHHHHHHHHcC-CCCeeeeceEEEecCCCceeEEE
Q 016184 82 VSYIAE---HVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-KRYKNRELQIMQMLD-HPNIVALKHCFFSTTDKEELYLN 156 (394)
Q Consensus 82 ~~y~~~---~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~~ 156 (394)
.+|.+. +.||+|+||.||+|++..+|+.||||++... .....+|+.+++.+. ||||+++++++. .....+
T Consensus 8 ~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~e~~~l~~l~~h~niv~~~~~~~-----~~~~~~ 82 (325)
T 3kn6_A 8 QHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEITALKLCEGHPNIVKLHEVFH-----DQLHTF 82 (325)
T ss_dssp HHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGGGHHHHHHHHHHHHHTTTCTTBCCEEEEEE-----CSSEEE
T ss_pred hccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChhhhhhHHHHHHHHHHhcCCCCeeEEEEEEE-----cCCEEE
Confidence 357775 7899999999999999999999999998654 345568999999997 999999999983 344578
Q ss_pred EEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCC--cEEEEeecCcc
Q 016184 157 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTH--QLKLCDFGSAK 233 (394)
Q Consensus 157 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~--~vkl~Dfg~a~ 233 (394)
+||||+.+ +|.+.+.. ...+++..++.++.||+.||+|||+ +||+||||||+|||++.++. .+||+|||++.
T Consensus 83 lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~-~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~ 157 (325)
T 3kn6_A 83 LVMELLNGGELFERIKK----KKHFSETEASYIMRKLVSAVSHMHD-VGVVHRDLKPENLLFTDENDNLEIKIIDFGFAR 157 (325)
T ss_dssp EEECCCCSCBHHHHHHH----CSCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEEEC----CEEEECCCTTCE
T ss_pred EEEEccCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCCeecCCCHHHEEEecCCCcccEEEeccccce
Confidence 99999986 77776654 4679999999999999999999999 89999999999999986542 69999999997
Q ss_pred ccccCC-CcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcH-------HHHHHHHHHhCCCC
Q 016184 234 VLVKGE-PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGV-------DQLVEIIKVLGTPT 305 (394)
Q Consensus 234 ~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~-------~~~~~i~~~~~~~~ 305 (394)
...... ......+|+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+.. +.+..+.....
T Consensus 158 ~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~--- 233 (325)
T 3kn6_A 158 LKPPDNQPLKTPCFTLHYAAPELLNQN-GYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDF--- 233 (325)
T ss_dssp ECCC----------------------C-CCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCC---
T ss_pred ecCCCCCcccccCCCcCccCHHHhcCC-CCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCC---
Confidence 654332 23345679999999998654 4899999999999999999999999865432 12222211000
Q ss_pred hhhhhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q 016184 306 REEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD 373 (394)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~ 373 (394)
.+.......+++++++||++||+.||.+|||+.++++||||++...
T Consensus 234 ----------------------~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~~~ 279 (325)
T 3kn6_A 234 ----------------------SFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQ 279 (325)
T ss_dssp ----------------------CCCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTTCC
T ss_pred ----------------------CCCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhccCcc
Confidence 0011112458999999999999999999999999999999997643
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-48 Score=379.88 Aligned_cols=255 Identities=27% Similarity=0.420 Sum_probs=210.8
Q ss_pred ceeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccc------hhhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeE
Q 016184 81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY 154 (394)
Q Consensus 81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 154 (394)
..+|++.+.||+|+||+||+|+++.++..||||++... .....+|+.+++.++||||+++++++. ....
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~-----~~~~ 110 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFE-----DKRN 110 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEE-----CSSE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEE-----eCCE
Confidence 34699999999999999999999999999999998643 234568999999999999999999983 3345
Q ss_pred EEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCC--CcEEEEeecC
Q 016184 155 LNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHT--HQLKLCDFGS 231 (394)
Q Consensus 155 ~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~--~~vkl~Dfg~ 231 (394)
.++||||+.+ +|.+.+.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++..+ ..+||+|||+
T Consensus 111 ~~lv~e~~~~g~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~-~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~ 185 (494)
T 3lij_A 111 YYLVMECYKGGELFDEIIH----RMKFNEVDAAVIIKQVLSGVTYLHK-HNIVHRDLKPENLLLESKEKDALIKIVDFGL 185 (494)
T ss_dssp EEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EEEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCChhhEEEeCCCCCCcEEEEECCC
Confidence 7899999985 66555543 3679999999999999999999999 8999999999999997643 2599999999
Q ss_pred ccccccCCCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhc
Q 016184 232 AKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 311 (394)
Q Consensus 232 a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 311 (394)
+.............||+.|+|||++.+ .++.++|||||||++|+|++|..||.+....+.+..+.......+..
T Consensus 186 a~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~---- 259 (494)
T 3lij_A 186 SAVFENQKKMKERLGTAYYIAPEVLRK--KYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSP---- 259 (494)
T ss_dssp CEECBTTBCBCCCCSCTTTCCHHHHTT--CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSG----
T ss_pred CeECCCCccccccCCCcCeeCHHHHcc--cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCch----
Confidence 987766555566789999999999853 48999999999999999999999999888777777666532211111
Q ss_pred cCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 016184 312 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR 372 (394)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 372 (394)
....+++.+++||++||+.||.+|||+.++|+||||++..
T Consensus 260 ---------------------~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~ 299 (494)
T 3lij_A 260 ---------------------EWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEMC 299 (494)
T ss_dssp ---------------------GGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHHHH
T ss_pred ---------------------hcccCCHHHHHHHHHHCCCChhhCccHHHHhcCcccccCc
Confidence 1145799999999999999999999999999999998753
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-48 Score=371.70 Aligned_cols=256 Identities=30% Similarity=0.439 Sum_probs=197.9
Q ss_pred ceeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccch------------hhhHHHHHHHHHcCCCCeeeeceEEEecC
Q 016184 81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------------RYKNRELQIMQMLDHPNIVALKHCFFSTT 148 (394)
Q Consensus 81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 148 (394)
..+|.+.+.||+|+||.||+|.+..+++.||||++.... ....+|+.+++.++||||+++++++.
T Consensus 134 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~--- 210 (419)
T 3i6u_A 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD--- 210 (419)
T ss_dssp HTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE---
T ss_pred hccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe---
Confidence 457999999999999999999999999999999986432 13568999999999999999999872
Q ss_pred CCceeEEEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCC--CcEE
Q 016184 149 DKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHT--HQLK 225 (394)
Q Consensus 149 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~--~~vk 225 (394)
... .++||||+.+ +|.+.+ .....+++..++.++.|++.||+|||+ +||+||||||+|||++.++ ..+|
T Consensus 211 --~~~-~~lv~e~~~~g~L~~~l----~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~ivHrDlkp~NIll~~~~~~~~~k 282 (419)
T 3i6u_A 211 --AED-YYIVLELMEGGELFDKV----VGNKRLKEATCKLYFYQMLLAVQYLHE-NGIIHRDLKPENVLLSSQEEDCLIK 282 (419)
T ss_dssp --SSE-EEEEEECCTTCBGGGGT----SSSCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEESSSSSSCCEE
T ss_pred --cCc-eEEEEEcCCCCcHHHHH----hccCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCChHhEEEecCCCcceEE
Confidence 111 5799999975 554333 334679999999999999999999999 8999999999999997543 2599
Q ss_pred EEeecCccccccCCCcccccccccccccccccC--CCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCC
Q 016184 226 LCDFGSAKVLVKGEPNVSYICSRYYRAPELIFG--ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGT 303 (394)
Q Consensus 226 l~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~ 303 (394)
|+|||+++............||+.|+|||++.+ ...++.++|||||||++|+|++|+.||........+.........
T Consensus 283 l~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~ 362 (419)
T 3i6u_A 283 ITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKY 362 (419)
T ss_dssp ECCSSTTTSCC-----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCC
T ss_pred EeecccceecCCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCC
Confidence 999999987765555556788999999999853 345788999999999999999999999876544333333321111
Q ss_pred CChhhhhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 016184 304 PTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL 371 (394)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 371 (394)
.. .......+++.+.+||++||+.||.+|||++++|+||||++.
T Consensus 363 ~~------------------------~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~ 406 (419)
T 3i6u_A 363 NF------------------------IPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDE 406 (419)
T ss_dssp CC------------------------CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCCH
T ss_pred CC------------------------CchhhcccCHHHHHHHHHHccCChhHCcCHHHHhCCcccCCh
Confidence 00 011124579999999999999999999999999999999864
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-48 Score=350.57 Aligned_cols=254 Identities=28% Similarity=0.452 Sum_probs=208.8
Q ss_pred ceeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccc-------hhhhHHHHHHHHHcCCCCeeeeceEEEecCCCcee
Q 016184 81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL 153 (394)
Q Consensus 81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 153 (394)
..+|++.+.||+|+||.||+|++..+++.||+|++... .....+|+.+++.++||||+++++++. ...
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~ 82 (279)
T 3fdn_A 8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFH-----DAT 82 (279)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEE-----CSS
T ss_pred cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEe-----cCC
Confidence 45699999999999999999999999999999998543 234567999999999999999999883 334
Q ss_pred EEEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCc
Q 016184 154 YLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA 232 (394)
Q Consensus 154 ~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a 232 (394)
..++||||+++ ++.+.+.. ...+++..++.++.|++.||.|||+ .||+||||||+|||++.++ .++|+|||++
T Consensus 83 ~~~lv~e~~~~~~l~~~l~~----~~~~~~~~~~~~~~qi~~~l~~LH~-~~i~H~dlkp~Nili~~~~-~~~l~Dfg~~ 156 (279)
T 3fdn_A 83 RVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELANALSYCHS-KRVIHRDIKPENLLLGSAG-ELKIADFGWS 156 (279)
T ss_dssp EEEEEECCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHT-TTCEECCCCGGGEEECTTS-CEEECSCCEE
T ss_pred EEEEEEecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCEecccCChHhEEEcCCC-CEEEEecccc
Confidence 57899999985 77666654 3679999999999999999999999 8999999999999999888 6999999998
Q ss_pred cccccCCCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhcc
Q 016184 233 KVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 312 (394)
Q Consensus 233 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 312 (394)
...... ......+++.|+|||.+.+. .++.++||||||+++|+|++|..||......+....+.....
T Consensus 157 ~~~~~~-~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~---------- 224 (279)
T 3fdn_A 157 VHAPSS-RRTDLCGTLDYLPPEMIEGR-MHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF---------- 224 (279)
T ss_dssp SCC---------CCCCTTCCHHHHTTC-CCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCC----------
T ss_pred ccCCcc-cccccCCCCCccCHhHhccC-CCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCCC----------
Confidence 654332 23456789999999998654 489999999999999999999999988776666655544211
Q ss_pred CCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCC
Q 016184 313 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNT 376 (394)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~ 376 (394)
. ++..+++.+.+||.+||+.||.+|||+.++++||||+.......
T Consensus 225 -------~------------~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~~~~~~~~~~~ 269 (279)
T 3fdn_A 225 -------T------------FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKPS 269 (279)
T ss_dssp -------C------------CCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCHHHHHHCSSCC
T ss_pred -------C------------CCCcCCHHHHHHHHHHhccChhhCCCHHHHhhCccccCCccCcc
Confidence 0 12457899999999999999999999999999999998755443
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-48 Score=355.17 Aligned_cols=260 Identities=25% Similarity=0.401 Sum_probs=212.5
Q ss_pred eeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccc--------hhhhHHHHHHHHHcCCCCeeeeceEEEecCCCcee
Q 016184 82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD--------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL 153 (394)
Q Consensus 82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 153 (394)
++|++.+.||+|+||.||+|.+..+++.||+|++... .....+|+.+++.++|+||+++++++... ...
T Consensus 5 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~---~~~ 81 (305)
T 2wtk_C 5 GKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNE---EKQ 81 (305)
T ss_dssp CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC------
T ss_pred cceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcC---CCC
Confidence 4699999999999999999999999999999998643 23456899999999999999999987432 233
Q ss_pred EEEEEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCcc
Q 016184 154 YLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK 233 (394)
Q Consensus 154 ~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~ 233 (394)
..++||||+.+++.+++.... ...+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||++.
T Consensus 82 ~~~lv~e~~~~~l~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~-~~i~H~dlkp~NIl~~~~~-~~kl~dfg~~~ 157 (305)
T 2wtk_C 82 KMYMVMEYCVCGMQEMLDSVP--EKRFPVCQAHGYFCQLIDGLEYLHS-QGIVHKDIKPGNLLLTTGG-TLKISALGVAE 157 (305)
T ss_dssp CEEEEEECCSEEHHHHHHHST--TCSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECTTC-CEEECCCTTCE
T ss_pred eEEEEehhccCCHHHHHHhCc--ccccCHHHHHHHHHHHHHHHHHHHH-CCeeecCCCcccEEEcCCC-cEEeecccccc
Confidence 478999999988777766533 3679999999999999999999999 8999999999999999887 79999999997
Q ss_pred ccccC---CCcccccccccccccccccCCC-CCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhh
Q 016184 234 VLVKG---EPNVSYICSRYYRAPELIFGAT-EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI 309 (394)
Q Consensus 234 ~~~~~---~~~~~~~~t~~y~aPE~~~~~~-~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 309 (394)
..... .......+|+.|+|||++.+.. .++.++||||||+++|+|++|+.||.+.+.......+....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~-------- 229 (305)
T 2wtk_C 158 ALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGS-------- 229 (305)
T ss_dssp ECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCC--------
T ss_pred ccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCC--------
Confidence 65432 1223456899999999986532 24779999999999999999999998877655555544310
Q ss_pred hccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCCC
Q 016184 310 KCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTR 377 (394)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~~ 377 (394)
.. ++..+++.+.+||.+||+.||.+|||+.++++||||++...+...
T Consensus 230 ---------~~------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~~~~ 276 (305)
T 2wtk_C 230 ---------YA------------IPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHPPAEA 276 (305)
T ss_dssp ---------CC------------CCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSCCCC-CC
T ss_pred ---------CC------------CCCccCHHHHHHHHHHccCChhhCCCHHHHhcCcccccCCCCcCC
Confidence 00 124578999999999999999999999999999999987666543
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-48 Score=356.97 Aligned_cols=257 Identities=23% Similarity=0.336 Sum_probs=197.3
Q ss_pred ceeEEEe-eEEeecCceEEEEEEECCCCcEEEEEEeccc----hhhhHHHHHHHHHc-CCCCeeeeceEEEecCCCceeE
Q 016184 81 KVSYIAE-HVVGTGSFGVVFQAKCRETGEIVAIKKVLQD----KRYKNRELQIMQML-DHPNIVALKHCFFSTTDKEELY 154 (394)
Q Consensus 81 ~~~y~~~-~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~ 154 (394)
...|++. +.||+|+||.||+|++..+++.||||++... .....+|++++.++ +||||+++++++.. ...
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~-----~~~ 85 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEE-----EDR 85 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEE-----TTE
T ss_pred ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEee-----CCE
Confidence 3459985 7899999999999999999999999998643 23456799999885 79999999998843 335
Q ss_pred EEEEEeccc-ccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCC--cEEEEeecC
Q 016184 155 LNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTH--QLKLCDFGS 231 (394)
Q Consensus 155 ~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~--~vkl~Dfg~ 231 (394)
.++||||+. ++|.+++.. ...+++..++.++.||+.||+|||+ +||+||||||+|||++.++. .+||+|||+
T Consensus 86 ~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~-~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~ 160 (316)
T 2ac3_A 86 FYLVFEKMRGGSILSHIHK----RRHFNELEASVVVQDVASALDFLHN-KGIAHRDLKPENILCEHPNQVSPVKICDFDL 160 (316)
T ss_dssp EEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEESCSSSSCSEEECCTTC
T ss_pred EEEEEEcCCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHh-CCceeCCCCHHHEEEccCCCcCceEEEEccC
Confidence 789999997 577776654 3679999999999999999999999 89999999999999987652 399999999
Q ss_pred ccccccCC--------CcccccccccccccccccCC----CCCCChhhHHHHHHHHHHHHhCCCCCCCCCcH--------
Q 016184 232 AKVLVKGE--------PNVSYICSRYYRAPELIFGA----TEYTTAIDIWSTGCVMAELLLGQPLFPGESGV-------- 291 (394)
Q Consensus 232 a~~~~~~~--------~~~~~~~t~~y~aPE~~~~~----~~~~~~~DiwslG~il~~lltg~~pf~~~~~~-------- 291 (394)
+....... ......||+.|+|||++.+. ..++.++|||||||++|+|++|+.||.+....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~ 240 (316)
T 2ac3_A 161 GSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGE 240 (316)
T ss_dssp CC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----
T ss_pred ccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccc
Confidence 87553221 11234589999999998531 33788999999999999999999999875421
Q ss_pred -------HHHHHHHHHhCCCChhhhhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 016184 292 -------DQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV 364 (394)
Q Consensus 292 -------~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 364 (394)
.....+.......+. .....+++++++||++||+.||.+|||+.|+|+
T Consensus 241 ~~~~~~~~~~~~i~~~~~~~~~-------------------------~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 295 (316)
T 2ac3_A 241 ACPACQNMLFESIQEGKYEFPD-------------------------KDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQ 295 (316)
T ss_dssp CCHHHHHHHHHHHHHCCCCCCH-------------------------HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred cchhHHHHHHHHHhccCcccCc-------------------------hhcccCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence 112222221100110 011357899999999999999999999999999
Q ss_pred CCCCCCCC
Q 016184 365 HPFFDELR 372 (394)
Q Consensus 365 hp~f~~~~ 372 (394)
||||++..
T Consensus 296 hp~~~~~~ 303 (316)
T 2ac3_A 296 HPWVQGCA 303 (316)
T ss_dssp STTCC---
T ss_pred ChhhcCCC
Confidence 99999764
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-48 Score=361.69 Aligned_cols=245 Identities=24% Similarity=0.391 Sum_probs=205.8
Q ss_pred ceeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccch------------hhhHHHHHHHHHcCCCCeeeeceEEEecC
Q 016184 81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------------RYKNRELQIMQMLDHPNIVALKHCFFSTT 148 (394)
Q Consensus 81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 148 (394)
..+|++.+.||+|+||.||+|++..+++.||||++.... ....+|+.+++.++||||+++++++
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~---- 98 (335)
T 3dls_A 23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIF---- 98 (335)
T ss_dssp HHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEE----
T ss_pred ccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEE----
Confidence 456999999999999999999999999999999986532 2345799999999999999999988
Q ss_pred CCceeEEEEEEecccc--cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEE
Q 016184 149 DKEELYLNLVLEYVPE--TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKL 226 (394)
Q Consensus 149 ~~~~~~~~lv~e~~~~--~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl 226 (394)
......++||||+.+ ++..++.. ...+++..++.++.||+.||.|||+ .||+||||||+|||++.++ .+||
T Consensus 99 -~~~~~~~lv~e~~~~g~~l~~~~~~----~~~l~~~~~~~i~~qi~~~L~~LH~-~~ivH~Dlkp~NIll~~~~-~~kL 171 (335)
T 3dls_A 99 -ENQGFFQLVMEKHGSGLDLFAFIDR----HPRLDEPLASYIFRQLVSAVGYLRL-KDIIHRDIKDENIVIAEDF-TIKL 171 (335)
T ss_dssp -ECSSEEEEEEECCTTSCBHHHHHHT----CCCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECTTS-CEEE
T ss_pred -eeCCEEEEEEEeCCCCccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeEEeccCHHHEEEcCCC-cEEE
Confidence 334457899998864 66665543 4579999999999999999999999 8999999999999999887 6999
Q ss_pred EeecCccccccCCCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCh
Q 016184 227 CDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTR 306 (394)
Q Consensus 227 ~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~ 306 (394)
+|||++.............||+.|+|||++.+...++.++|||||||++|+|++|+.||...... ..
T Consensus 172 ~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~------~~------- 238 (335)
T 3dls_A 172 IDFGSAAYLERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET------VE------- 238 (335)
T ss_dssp CCCTTCEECCTTCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG------TT-------
T ss_pred eecccceECCCCCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH------Hh-------
Confidence 99999987766665666788999999999977664588999999999999999999999652210 00
Q ss_pred hhhhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 016184 307 EEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL 371 (394)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 371 (394)
... ..+..+++++.+||.+||+.||.+|||+.++++||||++.
T Consensus 239 ----------~~~------------~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~ 281 (335)
T 3dls_A 239 ----------AAI------------HPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQP 281 (335)
T ss_dssp ----------TCC------------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHCTTTTCC
T ss_pred ----------hcc------------CCCcccCHHHHHHHHHHccCChhhCcCHHHHhcCccccCC
Confidence 000 0123478999999999999999999999999999999874
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-48 Score=390.81 Aligned_cols=254 Identities=25% Similarity=0.409 Sum_probs=213.4
Q ss_pred ceeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccch-------hhhHHHHHHHHHc-CCCCeeeeceEEEecCCCce
Q 016184 81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQML-DHPNIVALKHCFFSTTDKEE 152 (394)
Q Consensus 81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~ 152 (394)
..+|+++++||+|+||.||+|+++.+++.||||++.+.. .....|..++..+ .|++|+.+++++ ...
T Consensus 340 ~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~-----~~~ 414 (674)
T 3pfq_A 340 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCF-----QTM 414 (674)
T ss_dssp CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEEC-----BCS
T ss_pred ccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEE-----EeC
Confidence 346999999999999999999999999999999986432 2334688888877 799999999887 344
Q ss_pred eEEEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecC
Q 016184 153 LYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS 231 (394)
Q Consensus 153 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~ 231 (394)
..+|+||||+.+ +|..++.. ...+++..++.++.||+.||+|||+ +||+||||||+||||+.++ .+||+|||+
T Consensus 415 ~~~~lV~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~-~gIiHrDLKp~NILl~~~g-~ikL~DFGl 488 (674)
T 3pfq_A 415 DRLYFVMEYVNGGDLMYHIQQ----VGRFKEPHAVFYAAEIAIGLFFLQS-KGIIYRDLKLDNVMLDSEG-HIKIADFGM 488 (674)
T ss_dssp SEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TSEECCCCCSTTEEECSSS-CEEECCCTT
T ss_pred CEEEEEEeCcCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeEeccCChhhEEEcCCC-cEEEeecce
Confidence 458899999985 77666654 3679999999999999999999999 8999999999999999988 699999999
Q ss_pred ccccc-cCCCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhh
Q 016184 232 AKVLV-KGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 310 (394)
Q Consensus 232 a~~~~-~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 310 (394)
++... .........||+.|+|||++.+. .++.++|||||||++|||++|+.||.+.+..+.+..+....
T Consensus 489 a~~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~--------- 558 (674)
T 3pfq_A 489 CKENIWDGVTTKTFCGTPDYIAPEIIAYQ-PYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHN--------- 558 (674)
T ss_dssp CEECCCTTCCBCCCCSCSSSCCHHHHTCC-CBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSC---------
T ss_pred eeccccCCcccccccCCCcccCHhhhcCC-CCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCC---------
Confidence 98643 23344567899999999999654 48999999999999999999999999888777777665411
Q ss_pred ccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCH-----HHHhcCCCCCCCCCCC
Q 016184 311 CMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTA-----LEACVHPFFDELRDPN 375 (394)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~-----~ell~hp~f~~~~~~~ 375 (394)
.. ++..+++++.+||++||+.||.+||++ +||++||||+.+....
T Consensus 559 --------~~------------~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~i~w~~ 608 (674)
T 3pfq_A 559 --------VA------------YPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEK 608 (674)
T ss_dssp --------CC------------CCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSSGGGSSCCHHH
T ss_pred --------CC------------CCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcCccccCCCHHH
Confidence 11 224689999999999999999999997 9999999999875433
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-47 Score=356.27 Aligned_cols=280 Identities=26% Similarity=0.473 Sum_probs=218.9
Q ss_pred eeEEEeeEEeecCceEEEEEEE-CCCCcEEEEEEeccch---hhhHHHHHHHHHcCCC------CeeeeceEEEecCCCc
Q 016184 82 VSYIAEHVVGTGSFGVVFQAKC-RETGEIVAIKKVLQDK---RYKNRELQIMQMLDHP------NIVALKHCFFSTTDKE 151 (394)
Q Consensus 82 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~h~------~iv~~~~~~~~~~~~~ 151 (394)
.+|++.+.||+|+||.||+|.+ ..+++.||||++.... ....+|+.+++.++|+ +++++++++..
T Consensus 14 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~----- 88 (339)
T 1z57_A 14 ARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEH----- 88 (339)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEE-----
T ss_pred CceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCCchhHHHHHHHHHHHHhhhcCCCCceeeEeeeccccc-----
Confidence 3599999999999999999998 5678999999986543 3456799999988665 48899888733
Q ss_pred eeEEEEEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeC------------
Q 016184 152 ELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNP------------ 219 (394)
Q Consensus 152 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~------------ 219 (394)
....++||||+++++.+++.... ...+++..++.++.||+.||+|||+ +||+||||||+|||++.
T Consensus 89 ~~~~~lv~e~~~~~l~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~ 165 (339)
T 1z57_A 89 HGHICIVFELLGLSTYDFIKENG--FLPFRLDHIRKMAYQICKSVNFLHS-NKLTHTDLKPENILFVQSDYTEAYNPKIK 165 (339)
T ss_dssp TTEEEEEEECCCCBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEESCCCEEEEEC----
T ss_pred CCcEEEEEcCCCCCHHHHHHhcC--CCCCcHHHHHHHHHHHHHHHHHHHH-CCCcCCCCCHHHEEEeccccccccCCccc
Confidence 33588999999989988776532 2468999999999999999999999 89999999999999986
Q ss_pred -------CCCcEEEEeecCccccccCCCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHH
Q 016184 220 -------HTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVD 292 (394)
Q Consensus 220 -------~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~ 292 (394)
++ .+||+|||++..... ......+|+.|+|||++.+. .++.++|||||||++|+|++|..||...+..+
T Consensus 166 ~~~~~~~~~-~~kl~Dfg~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~pf~~~~~~~ 241 (339)
T 1z57_A 166 RDERTLINP-DIKVVDFGSATYDDE--HHSTLVSTRHYRAPEVILAL-GWSQPCDVWSIGCILIEYYLGFTVFPTHDSKE 241 (339)
T ss_dssp CEEEEESCC-CEEECCCSSCEETTS--CCCSSCSCGGGCCHHHHTTS-CCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHH
T ss_pred cccccccCC-CceEeeCcccccCcc--ccccccCCccccChHHhhCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCChHH
Confidence 34 699999999976432 33456789999999999654 48999999999999999999999999988888
Q ss_pred HHHHHHHHhCCCChhhhhccCCCCcc----cCCCCCC---------CCCcch--hccccCChHHHHHHHHhcccCCCCCC
Q 016184 293 QLVEIIKVLGTPTREEIKCMNPNYTE----FKFPQIK---------PHPWHK--VFQKRLPPEAVDLVCRFFQYSPNLRC 357 (394)
Q Consensus 293 ~~~~i~~~~~~~~~~~~~~~~~~~~~----~~~~~~~---------~~~~~~--~~~~~~~~~~~~li~~~L~~dP~~Rp 357 (394)
.+..+....+..+...+......... ....... ..++.. ......++++.+||.+||+.||.+||
T Consensus 242 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp 321 (339)
T 1z57_A 242 HLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRI 321 (339)
T ss_dssp HHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSC
T ss_pred HHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCccccc
Confidence 88888888888777665432211000 0000000 000000 01123357799999999999999999
Q ss_pred CHHHHhcCCCCCCCCC
Q 016184 358 TALEACVHPFFDELRD 373 (394)
Q Consensus 358 t~~ell~hp~f~~~~~ 373 (394)
|+.|+|+||||+++++
T Consensus 322 t~~ell~hp~f~~~~~ 337 (339)
T 1z57_A 322 TLREALKHPFFDLLKK 337 (339)
T ss_dssp CHHHHTTSGGGGGGGC
T ss_pred CHHHHhcCHHHHHHhc
Confidence 9999999999998765
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-47 Score=347.49 Aligned_cols=252 Identities=28% Similarity=0.414 Sum_probs=201.7
Q ss_pred ceeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccch-------hhhHHHHHHHHHcCCCCeeeeceEEEecCCCcee
Q 016184 81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL 153 (394)
Q Consensus 81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 153 (394)
.++|++.+.||+|+||.||+|++..+|+.||||++.... ....+|+.+++.++||||+++++++.. ..
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~ 84 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVIST-----PT 84 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-----SS
T ss_pred eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEec-----CC
Confidence 346999999999999999999999999999999985432 245679999999999999999998833 34
Q ss_pred EEEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCc
Q 016184 154 YLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA 232 (394)
Q Consensus 154 ~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a 232 (394)
..++||||+.+ +|.+++.. ...+++..++.++.|++.||.|||+ +||+|+||||+||+++.++ .+||+|||++
T Consensus 85 ~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~p~Nil~~~~~-~~~l~dfg~~ 158 (276)
T 2h6d_A 85 DFFMVMEYVSGGELFDYICK----HGRVEEMEARRLFQQILSAVDYCHR-HMVVHRDLKPENVLLDAHM-NAKIADFGLS 158 (276)
T ss_dssp EEEEEEECCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHH-HCSSCCCCCGGGEEECTTS-CEEECCCCGG
T ss_pred eEEEEEeccCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHH-CCCccCCCChhhEEECCCC-CEEEeecccc
Confidence 57899999974 88777654 3578999999999999999999999 8999999999999999888 6999999999
Q ss_pred cccccCCCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhcc
Q 016184 233 KVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 312 (394)
Q Consensus 233 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 312 (394)
.............+++.|+|||.+.+....+.++||||||+++|+|++|+.||...........+....
T Consensus 159 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~----------- 227 (276)
T 2h6d_A 159 NMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGV----------- 227 (276)
T ss_dssp GCCCC-------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-----------
T ss_pred cccCCCcceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCc-----------
Confidence 876554444556789999999999765545789999999999999999999998776555554443311
Q ss_pred CCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 016184 313 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR 372 (394)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 372 (394)
.. ++..++..+.+||.+||+.||.+|||+.++++||||++..
T Consensus 228 ------~~------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h~~~~~~~ 269 (276)
T 2h6d_A 228 ------FY------------IPEYLNRSVATLLMHMLQVDPLKRATIKDIREHEWFKQDL 269 (276)
T ss_dssp ------CC------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHTTC
T ss_pred ------cc------------CchhcCHHHHHHHHHHccCChhhCCCHHHHHhChhhccCc
Confidence 00 1245788999999999999999999999999999998753
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-47 Score=345.52 Aligned_cols=254 Identities=23% Similarity=0.331 Sum_probs=206.7
Q ss_pred eeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccch------hhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEE
Q 016184 82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL 155 (394)
Q Consensus 82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 155 (394)
..|.+.+.||+|+||.||+|.+..++..||+|++.... ....+|+.+++.++||||+++++++.... ....++
T Consensus 26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~~~~ 104 (290)
T 1t4h_A 26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV-KGKKCI 104 (290)
T ss_dssp CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEES-SSCEEE
T ss_pred eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecccc-CCCceE
Confidence 35999999999999999999999999999999885432 33457999999999999999999875443 345667
Q ss_pred EEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCC--ceeccCCCCceEEe-CCCCcEEEEeecC
Q 016184 156 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG--ICHRDIKPQNLLVN-PHTHQLKLCDFGS 231 (394)
Q Consensus 156 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~g--ivH~Dlkp~Nil~~-~~~~~vkl~Dfg~ 231 (394)
++||||+++ +|.+++.. ...+++..++.++.||+.||.|||+ .| |+||||||+|||++ .++ .+||+|||+
T Consensus 105 ~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~-~~~~i~H~dikp~Nil~~~~~~-~~kl~Dfg~ 178 (290)
T 1t4h_A 105 VLVTELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLHT-RTPPIIHRDLKCDNIFITGPTG-SVKIGDLGL 178 (290)
T ss_dssp EEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHT-SSSCCCCSCCCGGGEEESSTTS-CEEECCTTG
T ss_pred EEEEEecCCCCHHHHHHH----ccCCCHHHHHHHHHHHHHHHHHHHc-CCCCEEECCCCHHHEEEECCCC-CEEEeeCCC
Confidence 899999975 88777654 3679999999999999999999999 78 99999999999998 555 799999999
Q ss_pred ccccccCCCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhc
Q 016184 232 AKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 311 (394)
Q Consensus 232 a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 311 (394)
+..... .......+|+.|+|||++.+ .++.++||||||+++|+|++|+.||..................
T Consensus 179 ~~~~~~-~~~~~~~~t~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~-------- 247 (290)
T 1t4h_A 179 ATLKRA-SFAKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVK-------- 247 (290)
T ss_dssp GGGCCT-TSBEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCC--------
T ss_pred cccccc-cccccccCCcCcCCHHHHhc--cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCC--------
Confidence 965432 33345678999999998853 4899999999999999999999999886655544433321100
Q ss_pred cCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 016184 312 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL 371 (394)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 371 (394)
...+....++++.+||.+||+.||.+|||+.++|+||||++-
T Consensus 248 ------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~f~~~ 289 (290)
T 1t4h_A 248 ------------------PASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQEE 289 (290)
T ss_dssp ------------------CGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC--
T ss_pred ------------------ccccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhCcccccC
Confidence 011234578899999999999999999999999999999863
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-47 Score=347.36 Aligned_cols=254 Identities=20% Similarity=0.259 Sum_probs=203.4
Q ss_pred ccceeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccc------hhhhHHHHHHHHHc-CCCCeeeeceEEEecCCCc
Q 016184 79 KQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQML-DHPNIVALKHCFFSTTDKE 151 (394)
Q Consensus 79 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~ 151 (394)
+...+|++.+.||+|+||.||+|++..+++.||||++... .....+|+..+..+ +||||+++++++..
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~----- 82 (289)
T 1x8b_A 8 RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAE----- 82 (289)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEE-----
T ss_pred cccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeec-----
Confidence 3445799999999999999999999999999999998643 23345688888888 99999999998843
Q ss_pred eeEEEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCC---------
Q 016184 152 ELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHT--------- 221 (394)
Q Consensus 152 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~--------- 221 (394)
....++||||+++ +|.+++.........+++..++.++.||+.||+|||+ +||+||||||+|||++.++
T Consensus 83 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~-~~ivH~Dikp~NIl~~~~~~~~~~~~~~ 161 (289)
T 1x8b_A 83 DDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHS-MSLVHMDIKPSNIFISRTSIPNAASEEG 161 (289)
T ss_dssp TTEEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEC------------
T ss_pred CCeEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHh-CCEeecCCCHHHEEEcCCCCCccccccc
Confidence 3357899999975 9998888766666789999999999999999999999 8999999999999998432
Q ss_pred ---------CcEEEEeecCccccccCCCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHH
Q 016184 222 ---------HQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVD 292 (394)
Q Consensus 222 ---------~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~ 292 (394)
..+||+|||++...... ....+|+.|+|||++.+...++.++||||||+++|+|++|.+++.....
T Consensus 162 ~~~~~~~~~~~~kl~Dfg~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~-- 236 (289)
T 1x8b_A 162 DEDDWASNKVMFKIGDLGHVTRISSP---QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ-- 236 (289)
T ss_dssp --------CCCEEECCCTTCEETTCS---CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHH--
T ss_pred ccccccCCceEEEEcccccccccCCc---cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhH--
Confidence 26999999999765432 2345899999999997665577899999999999999999987754432
Q ss_pred HHHHHHHHhCCCChhhhhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 016184 293 QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR 372 (394)
Q Consensus 293 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 372 (394)
...+.... . ..++..+++++.+||.+||+.||++|||+.++++||||++..
T Consensus 237 -~~~~~~~~-------------------~---------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 287 (289)
T 1x8b_A 237 -WHEIRQGR-------------------L---------PRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSAS 287 (289)
T ss_dssp -HHHHHTTC-------------------C---------CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC----
T ss_pred -HHHHHcCC-------------------C---------CCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhhhhc
Confidence 22221100 0 012246799999999999999999999999999999998753
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-47 Score=347.64 Aligned_cols=252 Identities=28% Similarity=0.462 Sum_probs=184.7
Q ss_pred ceeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccch-------hhhHHHHHHHHHcCCCCeeeeceEEEecCCCcee
Q 016184 81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL 153 (394)
Q Consensus 81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 153 (394)
..+|++.+.||+|+||.||+|++..+|+.||||++.... ....+|+.+++.++||||+++++++. ...
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~ 84 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFE-----DSN 84 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEE-----CSS
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEc-----cCC
Confidence 346999999999999999999999999999999986432 34567999999999999999999883 334
Q ss_pred EEEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCc
Q 016184 154 YLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA 232 (394)
Q Consensus 154 ~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a 232 (394)
..++||||+++ +|.+++.. ....+++..++.++.|++.||.|||+ .||+||||||+||+++.++ .+||+|||++
T Consensus 85 ~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~p~Nili~~~~-~~kl~dfg~~ 159 (278)
T 3cok_A 85 YVYLVLEMCHNGEMNRYLKN---RVKPFSENEARHFMHQIITGMLYLHS-HGILHRDLTLSNLLLTRNM-NIKIADFGLA 159 (278)
T ss_dssp EEEEEEECCTTEEHHHHHHT---CSSCCCHHHHHHHHHHHHHHHHHHHH-TTEECSSCCGGGEEECTTC-CEEECCCTTC
T ss_pred eEEEEEecCCCCcHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEEcCCC-CEEEEeecce
Confidence 57899999975 77666653 23678999999999999999999999 8999999999999999887 6999999999
Q ss_pred cccccC-CCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhc
Q 016184 233 KVLVKG-EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 311 (394)
Q Consensus 233 ~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 311 (394)
...... .......+|+.|+|||.+.+. .++.++||||||+++|+|++|+.||........+..+..
T Consensus 160 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~------------ 226 (278)
T 3cok_A 160 TQLKMPHEKHYTLCGTPNYISPEIATRS-AHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVL------------ 226 (278)
T ss_dssp EECC-----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCS------------
T ss_pred eeccCCCCcceeccCCCCcCCcchhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhh------------
Confidence 765432 223345689999999998654 489999999999999999999999987553322221100
Q ss_pred cCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 016184 312 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR 372 (394)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 372 (394)
.... .+..++.++.+||.+||+.||++|||++++++||||++..
T Consensus 227 -----~~~~------------~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~ 270 (278)
T 3cok_A 227 -----ADYE------------MPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDHPFMSRNS 270 (278)
T ss_dssp -----SCCC------------CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSTTTC---
T ss_pred -----cccC------------CccccCHHHHHHHHHHcccCHhhCCCHHHHhcCccccCCC
Confidence 0000 1245789999999999999999999999999999998754
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-47 Score=346.36 Aligned_cols=251 Identities=27% Similarity=0.459 Sum_probs=209.8
Q ss_pred ceeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccc-------hhhhHHHHHHHHHcCCCCeeeeceEEEecCCCcee
Q 016184 81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL 153 (394)
Q Consensus 81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 153 (394)
.++|++.+.||+|+||.||+|++..+++.||||++... .....+|+++++.++||||+++++++. ...
T Consensus 13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~ 87 (284)
T 2vgo_A 13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFH-----DRK 87 (284)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEE-----CSS
T ss_pred hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEE-----cCC
Confidence 45699999999999999999999999999999998543 234568999999999999999999883 334
Q ss_pred EEEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCc
Q 016184 154 YLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA 232 (394)
Q Consensus 154 ~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a 232 (394)
..++||||+++ +|.+.+.. ...+++..++.++.|++.||.|||+ .||+||||||+||+++.++ .+||+|||++
T Consensus 88 ~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~p~Nil~~~~~-~~kl~Dfg~~ 161 (284)
T 2vgo_A 88 RIYLMLEFAPRGELYKELQK----HGRFDEQRSATFMEELADALHYCHE-RKVIHRDIKPENLLMGYKG-ELKIADFGWS 161 (284)
T ss_dssp EEEEEECCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHT-TTEECCCCSGGGEEECTTC-CEEECCCTTC
T ss_pred EEEEEEEeCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCHHHEEEcCCC-CEEEeccccc
Confidence 57899999975 77776654 3579999999999999999999999 8999999999999999888 6999999998
Q ss_pred cccccCCCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhcc
Q 016184 233 KVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 312 (394)
Q Consensus 233 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 312 (394)
...... ......+++.|+|||.+.+. .++.++||||||+++|+|++|..||......+....+....
T Consensus 162 ~~~~~~-~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~----------- 228 (284)
T 2vgo_A 162 VHAPSL-RRRTMCGTLDYLPPEMIEGK-THDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVD----------- 228 (284)
T ss_dssp EECSSS-CBCCCCSCGGGCCHHHHTTC-CBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTC-----------
T ss_pred ccCccc-ccccccCCCCcCCHHHhccC-CCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhccc-----------
Confidence 655332 23456789999999999654 48999999999999999999999998877665554443310
Q ss_pred CCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q 016184 313 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD 373 (394)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~ 373 (394)
.. ++..++.++.+||.+||+.||.+|||++++++||||+....
T Consensus 229 ------~~------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~~~~~ 271 (284)
T 2vgo_A 229 ------LK------------FPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKANSR 271 (284)
T ss_dssp ------CC------------CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHHHHHCC
T ss_pred ------cC------------CCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHHHhhcc
Confidence 00 12457899999999999999999999999999999987543
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-47 Score=344.06 Aligned_cols=256 Identities=26% Similarity=0.341 Sum_probs=205.7
Q ss_pred eeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccch-----hhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEEE
Q 016184 82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN 156 (394)
Q Consensus 82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 156 (394)
.+|++.+.||+|+||.||+|++..+++.||||++.... ....+|+.+++.++||||+++++++.. ....+
T Consensus 7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~ 81 (276)
T 2yex_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRRE-----GNIQY 81 (276)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEE-----TTEEE
T ss_pred cceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEc-----CCEEE
Confidence 46999999999999999999999999999999985432 345689999999999999999998843 34478
Q ss_pred EEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCcccc
Q 016184 157 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL 235 (394)
Q Consensus 157 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~ 235 (394)
+||||+++ +|.+.+ .....+++..++.++.|++.||.|||+ .||+|+||||+||+++.++ .+||+|||++...
T Consensus 82 lv~e~~~~~~L~~~l----~~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dl~p~Nil~~~~~-~~kl~dfg~~~~~ 155 (276)
T 2yex_A 82 LFLEYCSGGELFDRI----EPDIGMPEPDAQRFFHQLMAGVVYLHG-IGITHRDIKPENLLLDERD-NLKISDFGLATVF 155 (276)
T ss_dssp EEEECCTTEEGGGGS----BTTTBCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECTTC-CEEECCCTTCEEC
T ss_pred EEEEecCCCcHHHHH----hhccCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCChHHEEEccCC-CEEEeeCCCcccc
Confidence 99999985 665443 234579999999999999999999999 8999999999999999887 6999999999765
Q ss_pred ccCC---CcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHH-HHHHHHHhCCCChhhhhc
Q 016184 236 VKGE---PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQ-LVEIIKVLGTPTREEIKC 311 (394)
Q Consensus 236 ~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~~ 311 (394)
.... ......+++.|+|||.+.+...++.++||||||+++|+|++|+.||........ +..+......
T Consensus 156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-------- 227 (276)
T 2yex_A 156 RYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTY-------- 227 (276)
T ss_dssp EETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTT--------
T ss_pred CCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccc--------
Confidence 3322 233456899999999997655457899999999999999999999987654322 2222210000
Q ss_pred cCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCC
Q 016184 312 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 375 (394)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~ 375 (394)
. . ....+++.+.+||.+||+.||.+|||+.++++||||++.....
T Consensus 228 ---------~-----~-----~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~~ 272 (276)
T 2yex_A 228 ---------L-----N-----PWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKKG 272 (276)
T ss_dssp ---------S-----T-----TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCCC--
T ss_pred ---------c-----C-----chhhcCHHHHHHHHHHCCCCchhCCCHHHHhcCccccChhhcc
Confidence 0 0 0145789999999999999999999999999999998875443
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-47 Score=357.05 Aligned_cols=287 Identities=30% Similarity=0.462 Sum_probs=221.3
Q ss_pred ceeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccch---hhhHHHHHHHHHcC-----------CCCeeeeceEEEe
Q 016184 81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---RYKNRELQIMQMLD-----------HPNIVALKHCFFS 146 (394)
Q Consensus 81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~-----------h~~iv~~~~~~~~ 146 (394)
..+|++.+.||+|+||.||+|++..+++.||||++.... ....+|+.+++.+. |+||+++++++..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~ 97 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 97 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhc
Confidence 346999999999999999999999999999999987543 34457888888876 8999999998854
Q ss_pred cCCCceeEEEEEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC-CceeccCCCCceEEeCCC----
Q 016184 147 TTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI-GICHRDIKPQNLLVNPHT---- 221 (394)
Q Consensus 147 ~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~-givH~Dlkp~Nil~~~~~---- 221 (394)
.. ....+++++||+++++|.+++.... ...+++..++.++.||+.||+|||+ + ||+||||||+|||++.++
T Consensus 98 ~~-~~~~~~~lv~e~~~~~L~~~~~~~~--~~~~~~~~~~~i~~qi~~aL~~lH~-~~~ivH~Dikp~NIll~~~~~~~~ 173 (373)
T 1q8y_A 98 KG-PNGVHVVMVFEVLGENLLALIKKYE--HRGIPLIYVKQISKQLLLGLDYMHR-RCGIIHTDIKPENVLMEIVDSPEN 173 (373)
T ss_dssp EE-TTEEEEEEEECCCCEEHHHHHHHTT--TSCCCHHHHHHHHHHHHHHHHHHHH-TTCEECSCCSGGGEEEEEEETTTT
T ss_pred cC-CCCceEEEEEecCCCCHHHHHHHhh--ccCCcHHHHHHHHHHHHHHHHHHHh-cCCEEecCCChHHeEEeccCCCcC
Confidence 33 3445788999999889988877643 2569999999999999999999999 8 999999999999995322
Q ss_pred -CcEEEEeecCccccccCCCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCC------cHHHH
Q 016184 222 -HQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGES------GVDQL 294 (394)
Q Consensus 222 -~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~------~~~~~ 294 (394)
..+||+|||++..... ......+|+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.. ....+
T Consensus 174 ~~~~kl~Dfg~a~~~~~--~~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~ 250 (373)
T 1q8y_A 174 LIQIKIADLGNACWYDE--HYTNSIQTREYRSPEVLLGAP-WGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHI 250 (373)
T ss_dssp EEEEEECCCTTCEETTB--CCCSCCSCGGGCCHHHHHTCC-CCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHH
T ss_pred cceEEEcccccccccCC--CCCCCCCCccccCcHHHhCCC-CCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHH
Confidence 2699999999976543 234457899999999997654 8999999999999999999999998654 45677
Q ss_pred HHHHHHhCCCChhhhhccCC-------CCcccCCCCCCCCCcchh------ccccCChHHHHHHHHhcccCCCCCCCHHH
Q 016184 295 VEIIKVLGTPTREEIKCMNP-------NYTEFKFPQIKPHPWHKV------FQKRLPPEAVDLVCRFFQYSPNLRCTALE 361 (394)
Q Consensus 295 ~~i~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~li~~~L~~dP~~Rpt~~e 361 (394)
..+...++..+...+..... ......+......+.... ++..++.++.+||.+||+.||.+|||+.|
T Consensus 251 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e 330 (373)
T 1q8y_A 251 AQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGG 330 (373)
T ss_dssp HHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHH
T ss_pred HHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHHH
Confidence 78888888888765532211 000011111111111111 22345678999999999999999999999
Q ss_pred HhcCCCCCCCCCC
Q 016184 362 ACVHPFFDELRDP 374 (394)
Q Consensus 362 ll~hp~f~~~~~~ 374 (394)
+|+||||++....
T Consensus 331 ll~hp~f~~~~~~ 343 (373)
T 1q8y_A 331 LVNHPWLKDTLGM 343 (373)
T ss_dssp HHTCGGGTTCTTC
T ss_pred HhhChhhhcccCc
Confidence 9999999986443
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-47 Score=363.02 Aligned_cols=266 Identities=16% Similarity=0.140 Sum_probs=189.9
Q ss_pred ceeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccch-------hhhHHHHHHHHHc--CCCCeeeec-------eEE
Q 016184 81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQML--DHPNIVALK-------HCF 144 (394)
Q Consensus 81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l--~h~~iv~~~-------~~~ 144 (394)
...|++.+.||+|+||.||+|++..+|+.||||++.... ..+.+|+.+++.+ +||||++++ +++
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence 445999999999999999999999999999999987632 2334675555555 699988755 333
Q ss_pred EecCC------------CceeEEEEEEecccccHHHHHHHhhhhcCCCCHHHH------HHHHHHHHHHHHHHHhCCCce
Q 016184 145 FSTTD------------KEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYV------KLYTYQICRALAYIHNCIGIC 206 (394)
Q Consensus 145 ~~~~~------------~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~------~~~~~qi~~al~~LH~~~giv 206 (394)
..... .....+++||||++++|.+++.... ..+..... ..++.||+.||+|||+ +||+
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~---~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~-~~iv 216 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLD---FVYVFRGDEGILALHILTAQLIRLAANLQS-KGLV 216 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCSEEHHHHHHHHH---HSCCCCHHHHHHHHHHHHHHHHHHHHHHHH-TTEE
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCCCCHHHHHHHhc---cccchhhhhhhhhHHHHHHHHHHHHHHHHH-CCCc
Confidence 22111 0114578999999999998887653 23444444 5677999999999999 8999
Q ss_pred eccCCCCceEEeCCCCcEEEEeecCccccccCCCcccccccccccccccccCC-CCCCChhhHHHHHHHHHHHHhCCCCC
Q 016184 207 HRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGA-TEYTTAIDIWSTGCVMAELLLGQPLF 285 (394)
Q Consensus 207 H~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~lltg~~pf 285 (394)
||||||+|||++.++ .+||+|||+++... .......+|+.|+|||++.+. ..++.++|||||||++|+|++|+.||
T Consensus 217 HrDikp~NIll~~~~-~~kL~DFG~a~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf 293 (371)
T 3q60_A 217 HGHFTPDNLFIMPDG-RLMLGDVSALWKVG--TRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPF 293 (371)
T ss_dssp ETTCSGGGEEECTTS-CEEECCGGGEEETT--CEEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCST
T ss_pred cCcCCHHHEEECCCC-CEEEEecceeeecC--CCccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCC
Confidence 999999999999888 69999999998653 222255677999999999641 35899999999999999999999999
Q ss_pred CCCCcHHHHHHHHHHhCCCChhhhhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 016184 286 PGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH 365 (394)
Q Consensus 286 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 365 (394)
.+...... ..+............+.......+++.+.+||.+||+.||++|||+.++|+|
T Consensus 294 ~~~~~~~~--------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 353 (371)
T 3q60_A 294 GLVTPGIK--------------------GSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMET 353 (371)
T ss_dssp TBCCTTCT--------------------TCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTS
T ss_pred CCcCcccc--------------------cchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 87542100 0000000000000111111124689999999999999999999999999999
Q ss_pred CCCCCCCC
Q 016184 366 PFFDELRD 373 (394)
Q Consensus 366 p~f~~~~~ 373 (394)
|||+++.+
T Consensus 354 p~f~~~~~ 361 (371)
T 3q60_A 354 PEFLQLQN 361 (371)
T ss_dssp HHHHHHHH
T ss_pred HHHHHHHH
Confidence 99987643
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-48 Score=356.75 Aligned_cols=276 Identities=21% Similarity=0.309 Sum_probs=207.6
Q ss_pred ceeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccch-----hhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEE
Q 016184 81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL 155 (394)
Q Consensus 81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 155 (394)
..+|++.++||+|+||.||+|++..+|+.||||++.... ....+|+++++.++||||+++++++.... ....
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~---~~~~ 84 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETT---TRHK 84 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTT---TCCE
T ss_pred CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCC---CceE
Confidence 346999999999999999999999999999999986432 34458999999999999999999874332 2347
Q ss_pred EEEEeccc-ccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEE----eCCCCcEEEEeec
Q 016184 156 NLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLV----NPHTHQLKLCDFG 230 (394)
Q Consensus 156 ~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~----~~~~~~vkl~Dfg 230 (394)
++||||+. ++|.+++..... ...+++..++.++.||+.||+|||+ .||+||||||+|||+ +.++ .+||+|||
T Consensus 85 ~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~~L~~LH~-~~ivH~Dlkp~NIll~~~~~~~~-~~kL~Dfg 161 (319)
T 4euu_A 85 VLIMEFCPCGSLYTVLEEPSN-AYGLPESEFLIVLRDVVGGMNHLRE-NGIVHRNIKPGNIMRVIGEDGQS-VYKLTDFG 161 (319)
T ss_dssp EEEEECCTTCBHHHHHHSGGG-TTCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEEECTTSCE-EEEECCCT
T ss_pred EEEEeCCCCCCHHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHH-CCEecCCCCHHHEEEeccCCCCc-eEEEccCC
Confidence 89999997 588777765332 2349999999999999999999999 899999999999998 5555 69999999
Q ss_pred CccccccCCCcccccccccccccccccC-------CCCCCChhhHHHHHHHHHHHHhCCCCCCCCCc----HHHHHHHHH
Q 016184 231 SAKVLVKGEPNVSYICSRYYRAPELIFG-------ATEYTTAIDIWSTGCVMAELLLGQPLFPGESG----VDQLVEIIK 299 (394)
Q Consensus 231 ~a~~~~~~~~~~~~~~t~~y~aPE~~~~-------~~~~~~~~DiwslG~il~~lltg~~pf~~~~~----~~~~~~i~~ 299 (394)
+++............+|+.|+|||++.. ...++.++|||||||++|+|++|+.||..... .+.+..+..
T Consensus 162 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~ 241 (319)
T 4euu_A 162 AARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT 241 (319)
T ss_dssp TCEECCTTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHH
T ss_pred CceecCCCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhc
Confidence 9987766666666789999999999852 34589999999999999999999999975443 233333333
Q ss_pred HhCCCChhhhhccCC-CCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCC
Q 016184 300 VLGTPTREEIKCMNP-NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 367 (394)
Q Consensus 300 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~ 367 (394)
. .+...+..... ....+.... ..+....+...++..+.+||++||+.||++|||++|+|+||-
T Consensus 242 ~---~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~ 305 (319)
T 4euu_A 242 G---KPSGAISGVQKAENGPIDWSG--DMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETS 305 (319)
T ss_dssp H---CCTTCCEEEECSTTCCEEEES--SCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHH
T ss_pred C---CCcccchhhhcccCCccccCc--cCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccH
Confidence 2 22111110000 000000000 000111223456678999999999999999999999999973
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-47 Score=353.21 Aligned_cols=256 Identities=30% Similarity=0.474 Sum_probs=204.0
Q ss_pred ceeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccch------------hhhHHHHHHHHHcCCCCeeeeceEEEecC
Q 016184 81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------------RYKNRELQIMQMLDHPNIVALKHCFFSTT 148 (394)
Q Consensus 81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 148 (394)
.++|++.+.||+|+||.||+|++..+++.||||++.... ..+.+|+++++.++||||+++++++..
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-- 86 (322)
T 2ycf_A 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA-- 86 (322)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEES--
T ss_pred hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcC--
Confidence 346999999999999999999999999999999885432 235689999999999999999998732
Q ss_pred CCceeEEEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCC--cEE
Q 016184 149 DKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTH--QLK 225 (394)
Q Consensus 149 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~--~vk 225 (394)
.. .++||||+.+ +|.+.+.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++.++. .+|
T Consensus 87 --~~--~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~dlkp~NIl~~~~~~~~~~k 157 (322)
T 2ycf_A 87 --ED--YYIVLELMEGGELFDKVVG----NKRLKEATCKLYFYQMLLAVQYLHE-NGIIHRDLKPENVLLSSQEEDCLIK 157 (322)
T ss_dssp --SS--EEEEEECCTTEETHHHHST----TCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEESSSSSSCCEE
T ss_pred --Cc--eEEEEecCCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCCHHHEEEecCCCCCeEE
Confidence 11 6799999975 77655432 4679999999999999999999999 89999999999999986552 499
Q ss_pred EEeecCccccccCCCccccccccccccccccc--CCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCC
Q 016184 226 LCDFGSAKVLVKGEPNVSYICSRYYRAPELIF--GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGT 303 (394)
Q Consensus 226 l~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~--~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~ 303 (394)
|+|||++.............+|+.|+|||++. +...++.++|||||||++|+|++|..||........+.........
T Consensus 158 l~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 237 (322)
T 2ycf_A 158 ITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKY 237 (322)
T ss_dssp ECCCTTCEECCCCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCC
T ss_pred EccCccceecccccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCcc
Confidence 99999998764433334456899999999973 3445899999999999999999999999876544333332221111
Q ss_pred CChhhhhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 016184 304 PTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL 371 (394)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 371 (394)
. +.......++..+.+||.+||+.||.+|||+.++|+||||++.
T Consensus 238 ~------------------------~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~~ 281 (322)
T 2ycf_A 238 N------------------------FIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDE 281 (322)
T ss_dssp C------------------------CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCCH
T ss_pred c------------------------cCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCCH
Confidence 0 0011124578999999999999999999999999999999863
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-47 Score=354.57 Aligned_cols=281 Identities=25% Similarity=0.447 Sum_probs=217.9
Q ss_pred eeEEEeeEEeecCceEEEEEEECCCC-cEEEEEEeccc---hhhhHHHHHHHHHcCCCC------eeeeceEEEecCCCc
Q 016184 82 VSYIAEHVVGTGSFGVVFQAKCRETG-EIVAIKKVLQD---KRYKNRELQIMQMLDHPN------IVALKHCFFSTTDKE 151 (394)
Q Consensus 82 ~~y~~~~~lg~G~~g~V~~~~~~~~~-~~vaiK~~~~~---~~~~~~E~~~l~~l~h~~------iv~~~~~~~~~~~~~ 151 (394)
.+|++.+.||+|+||.||+|++..++ +.||||++... .....+|+.+++.+.|++ ++.+.+++..
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~----- 93 (355)
T 2eu9_A 19 ERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNF----- 93 (355)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEE-----
T ss_pred ccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeee-----
Confidence 46999999999999999999998777 68999998653 234557999999987655 7787777732
Q ss_pred eeEEEEEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEE--------------
Q 016184 152 ELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLV-------------- 217 (394)
Q Consensus 152 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~-------------- 217 (394)
....++||||+++++.+.+.... ...+++..++.++.||+.||+|||+ +||+||||||+|||+
T Consensus 94 ~~~~~lv~e~~~~~l~~~l~~~~--~~~~~~~~~~~i~~qi~~~L~~lH~-~~ivH~Dlkp~NIll~~~~~~~~~~~~~~ 170 (355)
T 2eu9_A 94 HGHMCIAFELLGKNTFEFLKENN--FQPYPLPHVRHMAYQLCHALRFLHE-NQLTHTDLKPENILFVNSEFETLYNEHKS 170 (355)
T ss_dssp TTEEEEEEECCCCBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHT-TTEECCCCCGGGEEESCCCEEEEECCC-C
T ss_pred CCeEEEEEeccCCChHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEEeccccccccccccc
Confidence 33588999999988877665422 2569999999999999999999999 899999999999999
Q ss_pred -----eCCCCcEEEEeecCccccccCCCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHH
Q 016184 218 -----NPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVD 292 (394)
Q Consensus 218 -----~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~ 292 (394)
+.++ .+||+|||++..... ......+|+.|+|||++.+. .++.++|||||||++|+|++|+.||.+....+
T Consensus 171 ~~~~~~~~~-~~kl~Dfg~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~pf~~~~~~~ 246 (355)
T 2eu9_A 171 CEEKSVKNT-SIRVADFGSATFDHE--HHTTIVATRHYRPPEVILEL-GWAQPCDVWSIGCILFEYYRGFTLFQTHENRE 246 (355)
T ss_dssp CCEEEESCC-CEEECCCTTCEETTS--CCCSSCSCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred ccccccCCC-cEEEeecCccccccc--cccCCcCCCcccCCeeeecC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 4455 799999999976432 33456789999999999654 48999999999999999999999999988888
Q ss_pred HHHHHHHHhCCCChhhhhccCCCCccc----CCCCCC---------CCCcch--hccccCChHHHHHHHHhcccCCCCCC
Q 016184 293 QLVEIIKVLGTPTREEIKCMNPNYTEF----KFPQIK---------PHPWHK--VFQKRLPPEAVDLVCRFFQYSPNLRC 357 (394)
Q Consensus 293 ~~~~i~~~~~~~~~~~~~~~~~~~~~~----~~~~~~---------~~~~~~--~~~~~~~~~~~~li~~~L~~dP~~Rp 357 (394)
.+..+....+..+...+.......... ..+... ..++.. ......+.++.+||++||+.||++||
T Consensus 247 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp 326 (355)
T 2eu9_A 247 HLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRI 326 (355)
T ss_dssp HHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSC
T ss_pred HHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCc
Confidence 888888888888776654322110000 000000 000000 00112345799999999999999999
Q ss_pred CHHHHhcCCCCCCCCCC
Q 016184 358 TALEACVHPFFDELRDP 374 (394)
Q Consensus 358 t~~ell~hp~f~~~~~~ 374 (394)
|+.++|+||||+++...
T Consensus 327 t~~e~l~hp~f~~~~~~ 343 (355)
T 2eu9_A 327 TLAEALLHPFFAGLTPE 343 (355)
T ss_dssp CHHHHTTSGGGGGCCHH
T ss_pred CHHHHhcChhhcCCChh
Confidence 99999999999987654
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-47 Score=354.35 Aligned_cols=254 Identities=25% Similarity=0.358 Sum_probs=198.7
Q ss_pred eeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccch------hhhHHHHHHHHHcCC--CCeeeeceEEEecCCCcee
Q 016184 82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDH--PNIVALKHCFFSTTDKEEL 153 (394)
Q Consensus 82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h--~~iv~~~~~~~~~~~~~~~ 153 (394)
.+|++.+.||+|+||.||+|.+ .+++.||||++.... ..+.+|+.+++.+.| +||+++++++. ...
T Consensus 9 ~~y~i~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~-----~~~ 82 (343)
T 3dbq_A 9 RIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEI-----TDQ 82 (343)
T ss_dssp CEEEEEEEESCCSSEEEEEEEC-TTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEE-----CSS
T ss_pred CEEEEEEEEecCCCeEEEEEEe-CCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEe-----eCC
Confidence 4699999999999999999998 468999999885432 344679999999987 99999999883 334
Q ss_pred EEEEEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCcc
Q 016184 154 YLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK 233 (394)
Q Consensus 154 ~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~ 233 (394)
+.++|||+.+++|.+++.. ...+++..++.++.||+.||.|||+ .||+||||||+|||++ ++ .+||+|||+++
T Consensus 83 ~~~lv~e~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~-~~iiHrDikp~NIll~-~~-~~kl~DFG~a~ 155 (343)
T 3dbq_A 83 YIYMVMECGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQ-HGIVHSDLKPANFLIV-DG-MLKLIDFGIAN 155 (343)
T ss_dssp EEEEEECCCSEEHHHHHHH----SCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEEE-TT-EEEECCCSSSC
T ss_pred EEEEEEeCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCcceEEEE-CC-cEEEeeccccc
Confidence 6889999888888887764 3679999999999999999999999 8999999999999998 45 69999999998
Q ss_pred ccccCCC---cccccccccccccccccC----------CCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcH-HHHHHHHH
Q 016184 234 VLVKGEP---NVSYICSRYYRAPELIFG----------ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGV-DQLVEIIK 299 (394)
Q Consensus 234 ~~~~~~~---~~~~~~t~~y~aPE~~~~----------~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~-~~~~~i~~ 299 (394)
....... .....||+.|+|||++.+ ...++.++|||||||++|+|++|+.||...... ..+..+..
T Consensus 156 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~ 235 (343)
T 3dbq_A 156 QMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIID 235 (343)
T ss_dssp CC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHC
T ss_pred ccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhc
Confidence 6643322 234578999999999853 245889999999999999999999999865433 22222221
Q ss_pred HhCCCChhhhhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCC
Q 016184 300 VLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 375 (394)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~ 375 (394)
... . ..++...+.++.+||.+||+.||.+|||+.++|+||||+....+.
T Consensus 236 ---~~~------------~------------~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~~~ 284 (343)
T 3dbq_A 236 ---PNH------------E------------IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPV 284 (343)
T ss_dssp ---TTS------------C------------CCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCCC--
T ss_pred ---CCc------------c------------cCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCccccccCCcc
Confidence 000 0 012234678899999999999999999999999999998765543
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-47 Score=348.08 Aligned_cols=254 Identities=28% Similarity=0.426 Sum_probs=209.2
Q ss_pred ceeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccch----hhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEEE
Q 016184 81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN 156 (394)
Q Consensus 81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 156 (394)
..+|.+.+.||+|+||.||+|++..+|+.||+|++.... ....+|+.+++.++||||+++++++. .....+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~ 82 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYE-----STTHYY 82 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEE-----CSSEEE
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcc-----cCCEEE
Confidence 346999999999999999999999999999999986532 34568999999999999999999883 334578
Q ss_pred EEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEE---eCCCCcEEEEeecCc
Q 016184 157 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLV---NPHTHQLKLCDFGSA 232 (394)
Q Consensus 157 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~---~~~~~~vkl~Dfg~a 232 (394)
+||||+++ +|.+.+.. ...+++..++.++.|++.||.|||+ .||+||||||+|||+ +.++ .+||+|||++
T Consensus 83 lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dikp~NIl~~~~~~~~-~~kl~Dfg~~ 156 (304)
T 2jam_A 83 LVMQLVSGGELFDRILE----RGVYTEKDASLVIQQVLSAVKYLHE-NGIVHRDLKPENLLYLTPEENS-KIMITDFGLS 156 (304)
T ss_dssp EEECCCCSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCSCCGGGCEESSSSTTC-CEEBCSCSTT
T ss_pred EEEEcCCCccHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCHHHEEEecCCCCC-CEEEccCCcc
Confidence 99999974 77666643 3678999999999999999999999 899999999999999 5555 7999999998
Q ss_pred cccccCCCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhcc
Q 016184 233 KVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 312 (394)
Q Consensus 233 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 312 (394)
..... .......+|+.|+|||++.+. .++.++||||||+++|+|++|..||.+.........+.......+
T Consensus 157 ~~~~~-~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~------- 227 (304)
T 2jam_A 157 KMEQN-GIMSTACGTPGYVAPEVLAQK-PYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFE------- 227 (304)
T ss_dssp CCCCC-BTTHHHHSCCCBCCTTTBSSC-SCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCC-------
T ss_pred eecCC-CccccccCCCCccChHHhccC-CCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCC-------
Confidence 75432 233445689999999998654 489999999999999999999999988777666665554211100
Q ss_pred CCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 016184 313 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR 372 (394)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 372 (394)
..+...+++++.+||.+||+.||.+|||+.++|+||||++..
T Consensus 228 ------------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~ 269 (304)
T 2jam_A 228 ------------------SPFWDDISESAKDFICHLLEKDPNERYTCEKALSHPWIDGNT 269 (304)
T ss_dssp ------------------TTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHSSC
T ss_pred ------------------ccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCccccCCC
Confidence 111246789999999999999999999999999999998754
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-47 Score=358.81 Aligned_cols=254 Identities=25% Similarity=0.357 Sum_probs=199.0
Q ss_pred eeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccch------hhhHHHHHHHHHcC--CCCeeeeceEEEecCCCcee
Q 016184 82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLD--HPNIVALKHCFFSTTDKEEL 153 (394)
Q Consensus 82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~--h~~iv~~~~~~~~~~~~~~~ 153 (394)
.+|++.+.||+|+||.||+|.+.. ++.||||++.... ..+.+|+.+++.+. |+||+++++++.. ..
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~-----~~ 129 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT-----DQ 129 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC-----SS
T ss_pred CceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEec-----CC
Confidence 359999999999999999999865 8999999985432 34568999999996 5999999998843 33
Q ss_pred EEEEEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCcc
Q 016184 154 YLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK 233 (394)
Q Consensus 154 ~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~ 233 (394)
++++|||+.+++|.+++.. ...+++..++.++.||+.||.|||+ .||+||||||+|||++ ++ .+||+|||+++
T Consensus 130 ~~~lv~E~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~lH~-~~ivHrDlkp~NIll~-~~-~~kl~DFG~a~ 202 (390)
T 2zmd_A 130 YIYMVMECGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQ-HGIVHSDLKPANFLIV-DG-MLKLIDFGIAN 202 (390)
T ss_dssp EEEEEEECCSEEHHHHHHH----CSSCCHHHHHHHHHHHHHHHHHHHT-TTCCCCCCCGGGEEES-SS-CEEECCCSSSC
T ss_pred EEEEEEecCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCCHHHEEEE-CC-eEEEEecCccc
Confidence 4889999877888877764 3578999999999999999999999 8999999999999996 45 69999999998
Q ss_pred ccccCCC---cccccccccccccccccCC----------CCCCChhhHHHHHHHHHHHHhCCCCCCCCCcH-HHHHHHHH
Q 016184 234 VLVKGEP---NVSYICSRYYRAPELIFGA----------TEYTTAIDIWSTGCVMAELLLGQPLFPGESGV-DQLVEIIK 299 (394)
Q Consensus 234 ~~~~~~~---~~~~~~t~~y~aPE~~~~~----------~~~~~~~DiwslG~il~~lltg~~pf~~~~~~-~~~~~i~~ 299 (394)
....... .....||+.|+|||++.+. ..++.++|||||||++|+|++|+.||...... ..+..+..
T Consensus 203 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~ 282 (390)
T 2zmd_A 203 QMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIID 282 (390)
T ss_dssp CC---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHC
T ss_pred cccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhC
Confidence 6643322 2345789999999998641 34889999999999999999999999875433 33332221
Q ss_pred HhCCCChhhhhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCC
Q 016184 300 VLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 375 (394)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~ 375 (394)
.. .... ++...+.++.+||.+||+.||.+|||+.++|+||||+....+.
T Consensus 283 ~~---------------~~~~------------~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~~~~~ 331 (390)
T 2zmd_A 283 PN---------------HEIE------------FPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPV 331 (390)
T ss_dssp TT---------------SCCC------------CCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCC---
T ss_pred cc---------------ccCC------------CCccchHHHHHHHHHHcccChhhCCCHHHHhhCcCccccCccc
Confidence 00 0000 1234578899999999999999999999999999998765543
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-47 Score=352.58 Aligned_cols=263 Identities=25% Similarity=0.346 Sum_probs=208.7
Q ss_pred ceeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccch-------hhhHHHHHHHHHcCCCCeeeeceEEEecCCCcee
Q 016184 81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL 153 (394)
Q Consensus 81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 153 (394)
.++|++.+.||+|+||.||+|++..+++.||||++.... ..+.+|+.+++.++||||+++++++.... ....
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~~ 89 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAET-PAGP 89 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEE-TTEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccC-CCCc
Confidence 346999999999999999999999999999999986532 23457888999999999999999875443 2334
Q ss_pred EEEEEEeccc-ccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCc
Q 016184 154 YLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA 232 (394)
Q Consensus 154 ~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a 232 (394)
+.++||||++ ++|.+++.. ...+++..++.++.|++.||+|||+ +||+||||||+|||++.++ .+||+|||++
T Consensus 90 ~~~lv~e~~~g~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~dlkp~Nil~~~~~-~~kl~Dfg~a 163 (311)
T 3ork_A 90 LPYIVMEYVDGVTLRDIVHT----EGPMTPKRAIEVIADACQALNFSHQ-NGIIHRDVKPANIMISATN-AVKVMDFGIA 163 (311)
T ss_dssp EEEEEEECCCEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEEETTS-CEEECCCSCC
T ss_pred ccEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCCCcCCCCHHHEEEcCCC-CEEEeeccCc
Confidence 5689999997 588777654 3679999999999999999999999 8999999999999999888 6999999999
Q ss_pred cccccCCC----cccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhh
Q 016184 233 KVLVKGEP----NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 308 (394)
Q Consensus 233 ~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~ 308 (394)
........ .....||+.|+|||++.+. .++.++||||||+++|+|++|+.||.+.........+......++.
T Consensus 164 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~-- 240 (311)
T 3ork_A 164 RAIADSGNSVTQTAAVIGTAQYLSPEQARGD-SVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPS-- 240 (311)
T ss_dssp ------------------CCTTCCHHHHHTC-CCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCHH--
T ss_pred ccccccccccccccccCcCcccCCHHHhcCC-CCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCcc--
Confidence 76543321 2235689999999999765 4899999999999999999999999888776666555542211111
Q ss_pred hhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCC
Q 016184 309 IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNT 376 (394)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~ 376 (394)
.....+++++.+||.+||+.||.+||++.+++.|+|++.......
T Consensus 241 -----------------------~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~~~~ 285 (311)
T 3ork_A 241 -----------------------ARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHNGEPP 285 (311)
T ss_dssp -----------------------HHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHTTCCC
T ss_pred -----------------------cccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhcCCCC
Confidence 112458999999999999999999999999999999987654433
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-49 Score=373.08 Aligned_cols=254 Identities=17% Similarity=0.230 Sum_probs=193.6
Q ss_pred ceeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccc-------hhhhHHHHH---HHHHcCCCCeeeec-------eE
Q 016184 81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQ---IMQMLDHPNIVALK-------HC 143 (394)
Q Consensus 81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~---~l~~l~h~~iv~~~-------~~ 143 (394)
..+|++.+.||+|+||.||+|++..+|+.||||++... ...+.+|+. +++.++||||++++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 45799999999999999999999999999999998532 234567884 45555899999998 44
Q ss_pred EEecC---------CCcee---EEEEEEecccccHHHHHHHhhhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCCceec
Q 016184 144 FFSTT---------DKEEL---YLNLVLEYVPETVNRIARNYSRIH---QRMPLIYVKLYTYQICRALAYIHNCIGICHR 208 (394)
Q Consensus 144 ~~~~~---------~~~~~---~~~lv~e~~~~~l~~~~~~~~~~~---~~l~~~~~~~~~~qi~~al~~LH~~~givH~ 208 (394)
+.... +.... ..+++|||++++|.+++....... ..+++..++.++.||+.||+|||+ +||+||
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivHr 230 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH-YGLVHT 230 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECCSEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHH-TTEECS
T ss_pred hhccCCccccccccCCCceEEEEEEEEEeccCCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHh-CCeecC
Confidence 32221 11111 267999999999988887643211 123457888899999999999999 899999
Q ss_pred cCCCCceEEeCCCCcEEEEeecCccccccCCCcccccccccccccccccCC----------CCCCChhhHHHHHHHHHHH
Q 016184 209 DIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGA----------TEYTTAIDIWSTGCVMAEL 278 (394)
Q Consensus 209 Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~----------~~~~~~~DiwslG~il~~l 278 (394)
||||+|||++.++ .+||+|||+++... .......| +.|+|||++.+. ..++.++|||||||++|+|
T Consensus 231 Dikp~NIll~~~~-~~kL~DFG~a~~~~--~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~el 306 (377)
T 3byv_A 231 YLRPVDIVLDQRG-GVFLTGFEHLVRDG--ARVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWI 306 (377)
T ss_dssp CCCGGGEEECTTC-CEEECCGGGCEETT--CEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHH
T ss_pred CCCHHHEEEcCCC-CEEEEechhheecC--CcccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHHH
Confidence 9999999999888 79999999997532 23334566 999999999654 2489999999999999999
Q ss_pred HhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCC
Q 016184 279 LLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCT 358 (394)
Q Consensus 279 ltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt 358 (394)
++|+.||.+.........+.. ....+++++.+||.+||+.||++|||
T Consensus 307 ltg~~Pf~~~~~~~~~~~~~~---------------------------------~~~~~~~~~~~li~~~L~~dp~~Rpt 353 (377)
T 3byv_A 307 WCADLPITKDAALGGSEWIFR---------------------------------SCKNIPQPVRALLEGFLRYPKEDRLL 353 (377)
T ss_dssp HHSSCCC------CCSGGGGS---------------------------------SCCCCCHHHHHHHHHHTCSSGGGCCC
T ss_pred HHCCCCCcccccccchhhhhh---------------------------------hccCCCHHHHHHHHHHcCCCchhCCC
Confidence 999999976442211110000 01467999999999999999999999
Q ss_pred HHHHhcCCCCCCCC
Q 016184 359 ALEACVHPFFDELR 372 (394)
Q Consensus 359 ~~ell~hp~f~~~~ 372 (394)
+.++++||||+++.
T Consensus 354 ~~e~l~hp~f~~~~ 367 (377)
T 3byv_A 354 PLQAMETPEYEQLR 367 (377)
T ss_dssp HHHHHTSHHHHHHH
T ss_pred HHHHhhChHHHHHH
Confidence 99999999998764
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-47 Score=344.96 Aligned_cols=255 Identities=27% Similarity=0.431 Sum_probs=210.1
Q ss_pred eeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccc------hhhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEE
Q 016184 82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL 155 (394)
Q Consensus 82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 155 (394)
.+|++.+.||+|+||.||+|++..+++.||||++... ...+.+|+++++.++||||+++++++. .....
T Consensus 22 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~ 96 (287)
T 2wei_A 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILE-----DSSSF 96 (287)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEE-----CSSEE
T ss_pred hcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEe-----CCCeE
Confidence 4699999999999999999999999999999998543 234568999999999999999999883 23457
Q ss_pred EEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCC--CcEEEEeecCc
Q 016184 156 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHT--HQLKLCDFGSA 232 (394)
Q Consensus 156 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~--~~vkl~Dfg~a 232 (394)
++||||+.+ ++.+.+.. ...+++..++.++.||+.||.|||+ .||+|+||||+||+++.++ ..+||+|||++
T Consensus 97 ~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~-~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~ 171 (287)
T 2wei_A 97 YIVGELYTGGELFDEIIK----RKRFSEHDAARIIKQVFSGITYMHK-HNIVHRDLKPENILLESKEKDCDIKIIDFGLS 171 (287)
T ss_dssp EEEECCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEESCSSTTCCEEECSTTGG
T ss_pred EEEEEccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCChhhEEEecCCCcccEEEeccCcc
Confidence 899999974 67665543 3579999999999999999999999 8999999999999997643 26999999999
Q ss_pred cccccCCCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhcc
Q 016184 233 KVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 312 (394)
Q Consensus 233 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 312 (394)
.............+++.|+|||.+.+ .++.++||||||+++|+|++|..||.+.+..+....+.......+.
T Consensus 172 ~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~------ 243 (287)
T 2wei_A 172 TCFQQNTKMKDRIGTAYYIAPEVLRG--TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDL------ 243 (287)
T ss_dssp GTBCCCSSCSCHHHHHTTCCHHHHTT--CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCS------
T ss_pred eeecCCCccccccCcccccChHHhcC--CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCc------
Confidence 87655554555678999999999854 3899999999999999999999999887766655555442111000
Q ss_pred CCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q 016184 313 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD 373 (394)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~ 373 (394)
.....+++++.+||++||+.||.+|||+.++|+||||++...
T Consensus 244 -------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~~~~~~~ 285 (287)
T 2wei_A 244 -------------------PQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSS 285 (287)
T ss_dssp -------------------GGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHHHCC
T ss_pred -------------------hhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcCHHHhcccc
Confidence 011357899999999999999999999999999999987654
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-47 Score=358.22 Aligned_cols=257 Identities=28% Similarity=0.452 Sum_probs=203.4
Q ss_pred ceeEEEeeEEeecCceEEEEEEEC---CCCcEEEEEEeccc--------hhhhHHHHHHHHHc-CCCCeeeeceEEEecC
Q 016184 81 KVSYIAEHVVGTGSFGVVFQAKCR---ETGEIVAIKKVLQD--------KRYKNRELQIMQML-DHPNIVALKHCFFSTT 148 (394)
Q Consensus 81 ~~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~--------~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~ 148 (394)
..+|++.+.||+|+||.||+|++. .+|+.||||++... .....+|+++++.+ .|+||+++++++..
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~-- 130 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT-- 130 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE--
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEee--
Confidence 357999999999999999999984 57999999988542 23345799999999 69999999998833
Q ss_pred CCceeEEEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEE
Q 016184 149 DKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLC 227 (394)
Q Consensus 149 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~ 227 (394)
....++||||+.+ +|.+++.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+
T Consensus 131 ---~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivH~Dlkp~NIll~~~~-~~kl~ 201 (355)
T 1vzo_A 131 ---ETKLHLILDYINGGELFTHLSQ----RERFTEHEVQIYVGEIVLALEHLHK-LGIIYRDIKLENILLDSNG-HVVLT 201 (355)
T ss_dssp ---TTEEEEEECCCCSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECTTS-CEEES
T ss_pred ---CceEEEEeecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEECCCC-cEEEe
Confidence 3347899999985 77776654 3579999999999999999999999 8999999999999999888 69999
Q ss_pred eecCccccccCC--CcccccccccccccccccCC-CCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCC
Q 016184 228 DFGSAKVLVKGE--PNVSYICSRYYRAPELIFGA-TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTP 304 (394)
Q Consensus 228 Dfg~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~ 304 (394)
|||+++...... ......||+.|+|||++.+. ..++.++|||||||++|+|++|+.||...........+.+.....
T Consensus 202 DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~ 281 (355)
T 1vzo_A 202 DFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKS 281 (355)
T ss_dssp CSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHC
T ss_pred eCCCCeecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhcc
Confidence 999997653322 22345789999999999653 347899999999999999999999997643322222222111000
Q ss_pred ChhhhhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCC-----CHHHHhcCCCCCCCCC
Q 016184 305 TREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-----TALEACVHPFFDELRD 373 (394)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----t~~ell~hp~f~~~~~ 373 (394)
. ..++..++..+.+||.+||+.||.+|| |++++++||||+++..
T Consensus 282 -------------~------------~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~~~ 330 (355)
T 1vzo_A 282 -------------E------------PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINW 330 (355)
T ss_dssp -------------C------------CCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCH
T ss_pred -------------C------------CCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhcCCh
Confidence 0 001245789999999999999999999 9999999999998754
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-46 Score=347.33 Aligned_cols=260 Identities=23% Similarity=0.382 Sum_probs=205.9
Q ss_pred eeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccc---hhhhHHHHHHHHHc-CCCCeeeeceEEEecCCC-ceeEEE
Q 016184 82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD---KRYKNRELQIMQML-DHPNIVALKHCFFSTTDK-EELYLN 156 (394)
Q Consensus 82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~-~~~~~~ 156 (394)
++|++.+.||+|+||.||+|++..+|+.||||++... .....+|+.+++.+ .||||+++++++...... .....+
T Consensus 24 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~~ 103 (326)
T 2x7f_A 24 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLW 103 (326)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCEEE
T ss_pred CcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccceEE
Confidence 4599999999999999999999999999999998543 34566899999998 899999999998654321 134678
Q ss_pred EEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCcccc
Q 016184 157 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL 235 (394)
Q Consensus 157 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~ 235 (394)
+||||+++ +|.+++.... ...+++..++.++.||+.||.|||+ .||+|+||||+|||++.++ .+||+|||++...
T Consensus 104 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~-~~ivH~dlkp~NIl~~~~~-~~kl~Dfg~~~~~ 179 (326)
T 2x7f_A 104 LVMEFCGAGSVTDLIKNTK--GNTLKEEWIAYICREILRGLSHLHQ-HKVIHRDIKGQNVLLTENA-EVKLVDFGVSAQL 179 (326)
T ss_dssp EEEECCTTEEHHHHHHHSG--GGCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCSGGGEEECTTC-CEEECCCTTTC--
T ss_pred EEEEcCCCCcHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCcHHHEEEcCCC-CEEEeeCcCceec
Confidence 99999986 8888777543 3678999999999999999999999 8999999999999999887 6999999998765
Q ss_pred ccCC-CcccccccccccccccccC----CCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhh
Q 016184 236 VKGE-PNVSYICSRYYRAPELIFG----ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 310 (394)
Q Consensus 236 ~~~~-~~~~~~~t~~y~aPE~~~~----~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 310 (394)
.... ......+|+.|+|||++.. ...++.++|||||||++|+|++|..||.+......+..+..... +
T Consensus 180 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~------ 252 (326)
T 2x7f_A 180 DRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPA-P------ 252 (326)
T ss_dssp -----------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC-C------
T ss_pred CcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcc-c------
Confidence 4322 2334578999999999852 34488999999999999999999999988776655544433110 0
Q ss_pred ccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 016184 311 CMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR 372 (394)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 372 (394)
......++..+.+||.+||+.||.+|||+.++++||||++..
T Consensus 253 --------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~ 294 (326)
T 2x7f_A 253 --------------------RLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQP 294 (326)
T ss_dssp --------------------CCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHCCT
T ss_pred --------------------cCCccccCHHHHHHHHHHhccChhhCCCHHHHhhChHHhhCc
Confidence 001245789999999999999999999999999999998753
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-46 Score=343.25 Aligned_cols=256 Identities=26% Similarity=0.414 Sum_probs=205.4
Q ss_pred eeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccc----hhhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEEEE
Q 016184 82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL 157 (394)
Q Consensus 82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 157 (394)
.+|++.+.||+|+||.||+|++..+++.||+|++... .....+|+.+++.++||||+++++++... ...++
T Consensus 19 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~l 93 (302)
T 2j7t_A 19 EVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHD-----GKLWI 93 (302)
T ss_dssp GTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC------CEEE
T ss_pred cceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeC-----CeEEE
Confidence 4599999999999999999999999999999988543 23456799999999999999999988432 34789
Q ss_pred EEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCccccc
Q 016184 158 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV 236 (394)
Q Consensus 158 v~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~ 236 (394)
||||+++ ++..++.. ....+++..++.++.|++.||.|||+ .|++||||||+|||++.++ .+||+|||++....
T Consensus 94 v~e~~~~~~l~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dlkp~Nil~~~~~-~~kl~Dfg~~~~~~ 168 (302)
T 2j7t_A 94 MIEFCPGGAVDAIMLE---LDRGLTEPQIQVVCRQMLEALNFLHS-KRIIHRDLKAGNVLMTLEG-DIRLADFGVSAKNL 168 (302)
T ss_dssp EEECCTTEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCSGGGEEECTTS-CEEECCCHHHHHHH
T ss_pred EEEeCCCCcHHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHhc-CCcccCCCCHHHEEECCCC-CEEEEECCCCcccc
Confidence 9999986 66655543 23679999999999999999999999 8999999999999999887 69999999875432
Q ss_pred cC-CCccccccccccccccccc----CCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhc
Q 016184 237 KG-EPNVSYICSRYYRAPELIF----GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 311 (394)
Q Consensus 237 ~~-~~~~~~~~t~~y~aPE~~~----~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 311 (394)
.. .......+|+.|+|||++. ....++.++||||||+++|+|++|..||...+....+..+.......
T Consensus 169 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~------- 241 (302)
T 2j7t_A 169 KTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPT------- 241 (302)
T ss_dssp HHHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCC-------
T ss_pred ccccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCcc-------
Confidence 11 1223456899999999984 34458999999999999999999999998877666655544421000
Q ss_pred cCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q 016184 312 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD 373 (394)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~ 373 (394)
...+..++..+.+||.+||+.||.+|||+.++++||||+....
T Consensus 242 -------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~ 284 (302)
T 2j7t_A 242 -------------------LLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSITS 284 (302)
T ss_dssp -------------------CSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTSTTTTTCCC
T ss_pred -------------------cCCccccCHHHHHHHHHHcccChhhCCCHHHHhcChHHhhhcc
Confidence 0112457899999999999999999999999999999998754
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-46 Score=339.93 Aligned_cols=258 Identities=25% Similarity=0.373 Sum_probs=211.4
Q ss_pred ceeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccc------hhhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeE
Q 016184 81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY 154 (394)
Q Consensus 81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 154 (394)
..+|++.+.||+|+||.||+|++..+|+.||+|++... ...+.+|+.+++.++||||+++++++... ....
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~~~~ 81 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDR---TNTT 81 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEG---GGTE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecC---CCce
Confidence 34699999999999999999999999999999998542 23456799999999999999999987543 2345
Q ss_pred EEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCC-----ceeccCCCCceEEeCCCCcEEEEe
Q 016184 155 LNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG-----ICHRDIKPQNLLVNPHTHQLKLCD 228 (394)
Q Consensus 155 ~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~g-----ivH~Dlkp~Nil~~~~~~~vkl~D 228 (394)
.++||||+++ +|.+++.........+++..++.++.|++.||+|||+ .| |+||||||+|||++.++ .+||+|
T Consensus 82 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~-~~~~~~~ivH~dl~p~NIl~~~~~-~~kl~d 159 (279)
T 2w5a_A 82 LYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHR-RSDGGHTVLHRDLKPANVFLDGKQ-NVKLGD 159 (279)
T ss_dssp EEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH-HC------CCCCCSGGGEEECSSS-CEEECC
T ss_pred EEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhc-ccCCCCeeEEeccchhhEEEcCCC-CEEEec
Confidence 7899999975 8988887765555679999999999999999999999 78 99999999999999887 699999
Q ss_pred ecCccccccCCC-cccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChh
Q 016184 229 FGSAKVLVKGEP-NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 307 (394)
Q Consensus 229 fg~a~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~ 307 (394)
||++........ .....+++.|+|||++.+. .++.++||||||+++|+|++|+.||...+..+....+......
T Consensus 160 fg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~---- 234 (279)
T 2w5a_A 160 FGLARILNHDTSFAKTFVGTPYYMSPEQMNRM-SYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFR---- 234 (279)
T ss_dssp CCHHHHC---CHHHHHHHSCCTTCCHHHHHCC--CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC----
T ss_pred CchheeeccccccccccCCCccccChHHhccC-CCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhcccc----
Confidence 999976543322 1234679999999999655 4899999999999999999999999887765555554432100
Q ss_pred hhhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 016184 308 EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR 372 (394)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 372 (394)
.++..++.++.+||.+||+.||.+|||+.++++|+|+.+-.
T Consensus 235 ------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~ 275 (279)
T 2w5a_A 235 ------------------------RIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILEHH 275 (279)
T ss_dssp ------------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGGG
T ss_pred ------------------------cCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhhc
Confidence 01245789999999999999999999999999999997653
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-47 Score=357.60 Aligned_cols=283 Identities=24% Similarity=0.416 Sum_probs=207.6
Q ss_pred ceeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccc-----hhhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEE
Q 016184 81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL 155 (394)
Q Consensus 81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 155 (394)
..+|++.+.||+|+||.||+|++..+++.||+|++... .....+|+.+++.++||||+++++++.. ....
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~ 106 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS-----DGEI 106 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEE-----TTEE
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEE-----CCEE
Confidence 34699999999999999999999999999999998643 2345679999999999999999998843 3347
Q ss_pred EEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC-CceeccCCCCceEEeCCCCcEEEEeecCcc
Q 016184 156 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI-GICHRDIKPQNLLVNPHTHQLKLCDFGSAK 233 (394)
Q Consensus 156 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~-givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~ 233 (394)
++||||+++ +|.+++.. ...+++..++.++.|++.||.|||+ . ||+||||||+|||++.++ .+||+|||++.
T Consensus 107 ~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~~i~~~l~~lh~-~~~i~H~dlkp~Nil~~~~~-~~kl~Dfg~~~ 180 (360)
T 3eqc_A 107 SICMEHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLRE-KHKIMHRDVKPSNILVNSRG-EIKLCDFGVSG 180 (360)
T ss_dssp EEEECCCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-HHCCCCSCCSGGGEEECTTC-CEEECCCCCCH
T ss_pred EEEEECCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-hCCEEcCCccHHHEEECCCC-CEEEEECCCCc
Confidence 899999975 88777654 3579999999999999999999998 5 999999999999999888 69999999987
Q ss_pred ccccCCCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHh-CCCChhhhhcc
Q 016184 234 VLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVL-GTPTREEIKCM 312 (394)
Q Consensus 234 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~ 312 (394)
..... ......+|+.|+|||++.+. .++.++|||||||++|+|++|+.||...+..+....+.... +..........
T Consensus 181 ~~~~~-~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (360)
T 3eqc_A 181 QLIDS-MANSFVGTRSYMSPERLQGT-HYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPR 258 (360)
T ss_dssp HHHHH-C----CCCCTTCCHHHHTTC-CCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC---------------
T ss_pred ccccc-cccCCCCCCCeECHHHHcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcc
Confidence 55322 23345789999999999654 48999999999999999999999998766544332221111 10000000000
Q ss_pred C--CCCcccCCCCCCC------------CCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCC
Q 016184 313 N--PNYTEFKFPQIKP------------HPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNT 376 (394)
Q Consensus 313 ~--~~~~~~~~~~~~~------------~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~ 376 (394)
. .....+....... ..........++.++.+||++||+.||++|||++++|+||||++......
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~~ 336 (360)
T 3eqc_A 259 TPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDAEEV 336 (360)
T ss_dssp ---------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHHHHSCC
T ss_pred cCCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcchHhhh
Confidence 0 0000000000000 00000112347889999999999999999999999999999998655444
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-46 Score=343.23 Aligned_cols=252 Identities=25% Similarity=0.385 Sum_probs=209.4
Q ss_pred eeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccc-----hhhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEEE
Q 016184 82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN 156 (394)
Q Consensus 82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 156 (394)
..|++.+.||+|+||.||+|++..+++.||||++... .....+|+.+++.++||||+++++++.. ....+
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~ 96 (303)
T 3a7i_A 22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLK-----DTKLW 96 (303)
T ss_dssp GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEE-----TTEEE
T ss_pred HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEec-----CCeEE
Confidence 3599999999999999999999999999999998543 2445689999999999999999998843 23478
Q ss_pred EEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCcccc
Q 016184 157 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL 235 (394)
Q Consensus 157 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~ 235 (394)
+||||+++ +|.+++.. ..+++..++.++.|++.||.|||+ .||+|+||||+||+++.++ .+||+|||++...
T Consensus 97 lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~p~Nil~~~~~-~~kl~Dfg~~~~~ 169 (303)
T 3a7i_A 97 IIMEYLGGGSALDLLEP-----GPLDETQIATILREILKGLDYLHS-EKKIHRDIKAANVLLSEHG-EVKLADFGVAGQL 169 (303)
T ss_dssp EEEECCTTEEHHHHHTT-----SCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECTTS-CEEECCCTTCEEC
T ss_pred EEEEeCCCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH-CCCccCCCChheEEECCCC-CEEEeecccceec
Confidence 99999986 77666543 679999999999999999999999 8999999999999999888 6999999999765
Q ss_pred ccCC-CcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCC
Q 016184 236 VKGE-PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 314 (394)
Q Consensus 236 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 314 (394)
.... ......+++.|+|||++.+. .++.++||||||+++|+|++|+.||...........+.... +
T Consensus 170 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--~---------- 236 (303)
T 3a7i_A 170 TDTQIKRNTFVGTPFWMAPEVIKQS-AYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNN--P---------- 236 (303)
T ss_dssp BTTBCCBCCCCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSC--C----------
T ss_pred CccccccCccCCCcCccCHHHHhcC-CCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcCC--C----------
Confidence 4332 22345789999999999654 48999999999999999999999998776655544443310 0
Q ss_pred CCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCC
Q 016184 315 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP 374 (394)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~ 374 (394)
..+...++..+.+||.+||+.||.+|||+.++++||||.+....
T Consensus 237 ----------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~ 280 (303)
T 3a7i_A 237 ----------------PTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILRNAKK 280 (303)
T ss_dssp ----------------CCCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHHHHHHCCC
T ss_pred ----------------CCCccccCHHHHHHHHHHcCCChhhCcCHHHHhhChhhhcCCCc
Confidence 01124678999999999999999999999999999999775443
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-46 Score=342.01 Aligned_cols=255 Identities=29% Similarity=0.430 Sum_probs=206.2
Q ss_pred eeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccch--hhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEEEEEE
Q 016184 82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK--RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVL 159 (394)
Q Consensus 82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~ 159 (394)
.+|++.+.||+|+||.||+|++..+|+.||||++.... ....+|+.+++.++||||+++++++... ...++||
T Consensus 29 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~ 103 (314)
T 3com_A 29 EVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIMQQCDSPHVVKYYGSYFKN-----TDLWIVM 103 (314)
T ss_dssp -CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSCCHHHHHHHHHHHTCCCTTBCCEEEEEEET-----TEEEEEE
T ss_pred hhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeC-----CEEEEEe
Confidence 45999999999999999999999999999999986543 4556899999999999999999988442 3478999
Q ss_pred ecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCccccccC
Q 016184 160 EYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG 238 (394)
Q Consensus 160 e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~~ 238 (394)
||+++ +|.+++.. ....+++..++.++.|++.||.|||+ .||+|+||||+||+++.++ .+||+|||++......
T Consensus 104 e~~~~~~L~~~~~~---~~~~~~~~~~~~i~~~i~~~l~~lH~-~~i~H~dl~p~Nil~~~~~-~~kl~dfg~~~~~~~~ 178 (314)
T 3com_A 104 EYCGAGSVSDIIRL---RNKTLTEDEIATILQSTLKGLEYLHF-MRKIHRDIKAGNILLNTEG-HAKLADFGVAGQLTDT 178 (314)
T ss_dssp ECCTTEEHHHHHHH---HTCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECTTC-CEEECCCTTCEECBTT
T ss_pred ecCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHh-CCCcCCCcCHHHEEECCCC-CEEEeecccchhhhhh
Confidence 99986 78777653 24679999999999999999999999 8999999999999999888 6999999999765433
Q ss_pred C-CcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCCCc
Q 016184 239 E-PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 317 (394)
Q Consensus 239 ~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 317 (394)
. ......+++.|+|||.+.+. .++.++||||||+++|+|++|..||...........+..... +
T Consensus 179 ~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~------------- 243 (314)
T 3com_A 179 MAKRNTVIGTPFWMAPEVIQEI-GYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPP-P------------- 243 (314)
T ss_dssp BSCBCCCCSCGGGCCHHHHSSS-CBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC-C-------------
T ss_pred ccccCccCCCCCccChhhcCCC-CCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCC-c-------------
Confidence 2 23345789999999998654 489999999999999999999999987766554443332110 0
Q ss_pred ccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q 016184 318 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD 373 (394)
Q Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~ 373 (394)
.+ ..+..++..+.+||.+||+.||.+|||+.++++||||+....
T Consensus 244 ~~------------~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~~~~~~~~~ 287 (314)
T 3com_A 244 TF------------RKPELWSDNFTDFVKQCLVKSPEQRATATQLLQHPFVRSAKG 287 (314)
T ss_dssp CC------------SSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHTCCC
T ss_pred cc------------CCcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhcCCc
Confidence 00 012457899999999999999999999999999999998653
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-46 Score=349.99 Aligned_cols=264 Identities=24% Similarity=0.363 Sum_probs=184.9
Q ss_pred ceeEEEee-EEeecCceEEEEEEECCCCcEEEEEEeccchhhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEEEEEE
Q 016184 81 KVSYIAEH-VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVL 159 (394)
Q Consensus 81 ~~~y~~~~-~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~ 159 (394)
.++|.+.+ +||+|+||.||+|+++.+|+.||||++........+....++.++|+||+++++++.... ....+.++||
T Consensus 27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~-~~~~~~~lv~ 105 (336)
T 3fhr_A 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQEVDHHWQASGGPHIVCILDVYENMH-HGKRCLLIIM 105 (336)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSHHHHHHHHHHHHHTTSTTBCCEEEEEEEEE-TTEEEEEEEE
T ss_pred cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcHHHHHHHHHHHHhcCCCChHHHHHHHhhcc-CCCceEEEEE
Confidence 45699955 699999999999999999999999998776655555556678889999999999885433 3355678999
Q ss_pred ecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCC--CcEEEEeecCccccc
Q 016184 160 EYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHT--HQLKLCDFGSAKVLV 236 (394)
Q Consensus 160 e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~--~~vkl~Dfg~a~~~~ 236 (394)
||+.+ +|.+++.... ...+++..++.++.||+.||.|||+ +||+||||||+|||++.++ ..+||+|||++....
T Consensus 106 e~~~gg~L~~~l~~~~--~~~l~~~~~~~i~~ql~~~l~~LH~-~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~ 182 (336)
T 3fhr_A 106 ECMEGGELFSRIQERG--DQAFTEREAAEIMRDIGTAIQFLHS-HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETT 182 (336)
T ss_dssp ECCTTEEHHHHHHTC---CCCCBHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC-
T ss_pred eccCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEEecCCCceEEEeccccceecc
Confidence 99986 8877776432 2579999999999999999999999 8999999999999998633 259999999997654
Q ss_pred cCCCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCCC
Q 016184 237 KGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 316 (394)
Q Consensus 237 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 316 (394)
. .......+|+.|+|||++.+. .++.++||||||+++|+|++|+.||.+.........+......
T Consensus 183 ~-~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~------------- 247 (336)
T 3fhr_A 183 Q-NALQTPCYTPYYVAPEVLGPE-KYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRL------------- 247 (336)
T ss_dssp ----------------------C-HHHHHHHHHHHHHHHHHHHHSSCCC-------------------------------
T ss_pred c-cccccCCCCcCccChhhhCCC-CCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhc-------------
Confidence 3 233455779999999998544 4889999999999999999999999766543322211111000
Q ss_pred cccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 016184 317 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL 371 (394)
Q Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 371 (394)
....++ ......+++++.+||++||+.||.+|||+.++|+||||++.
T Consensus 248 ~~~~~~--------~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 294 (336)
T 3fhr_A 248 GQYGFP--------NPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQS 294 (336)
T ss_dssp ---CCC--------TTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTG
T ss_pred cccccC--------chhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcccccc
Confidence 000000 00114579999999999999999999999999999999875
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-47 Score=346.68 Aligned_cols=268 Identities=25% Similarity=0.358 Sum_probs=191.1
Q ss_pred ceeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccc-----hhhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEE
Q 016184 81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL 155 (394)
Q Consensus 81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 155 (394)
..+|++.+.||+|+||.||+|++..+++.||||++... .....+|+.+++.++||||+++++++.... ..
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~ 88 (303)
T 2vwi_A 14 RDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKD-----EL 88 (303)
T ss_dssp CCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSS-----CE
T ss_pred hhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecC-----Cc
Confidence 34699999999999999999999889999999987543 233457888999999999999999884433 37
Q ss_pred EEEEeccc-ccHHHHHHHhhh----hcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeec
Q 016184 156 NLVLEYVP-ETVNRIARNYSR----IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFG 230 (394)
Q Consensus 156 ~lv~e~~~-~~l~~~~~~~~~----~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg 230 (394)
++||||++ ++|.+++..... ....+++..++.++.||+.||.|||+ .||+||||||+||+++.++ .+||+|||
T Consensus 89 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dl~p~Nil~~~~~-~~kl~dfg 166 (303)
T 2vwi_A 89 WLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHK-NGQIHRDVKAGNILLGEDG-SVQIADFG 166 (303)
T ss_dssp EEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCSGGGEEECTTC-CEEECCCH
T ss_pred EEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCCCCChhhEEEcCCC-CEEEEecc
Confidence 89999996 488877765332 23568999999999999999999999 8999999999999999888 69999999
Q ss_pred CccccccCC------CcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCC
Q 016184 231 SAKVLVKGE------PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTP 304 (394)
Q Consensus 231 ~a~~~~~~~------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~ 304 (394)
++....... ......+|+.|+|||.+.+...++.++||||||+++|+|++|+.||...................
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 246 (303)
T 2vwi_A 167 VSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPS 246 (303)
T ss_dssp HHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCCC
T ss_pred chheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCCc
Confidence 987654321 12345689999999998653458999999999999999999999998877665544332211000
Q ss_pred ChhhhhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCC
Q 016184 305 TREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP 374 (394)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~ 374 (394)
.. ...........++.++.+||.+||+.||.+|||+.++++||||++....
T Consensus 247 ~~-------------------~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~ 297 (303)
T 2vwi_A 247 LE-------------------TGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAKNK 297 (303)
T ss_dssp TT-------------------C-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC------
T ss_pred cc-------------------cccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcCCCC
Confidence 00 0000011224678999999999999999999999999999999987654
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-45 Score=337.85 Aligned_cols=258 Identities=24% Similarity=0.327 Sum_probs=198.9
Q ss_pred ceeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccch---hhhHHHHHHHHHcCCCCeeeeceEEEecCC--------
Q 016184 81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---RYKNRELQIMQMLDHPNIVALKHCFFSTTD-------- 149 (394)
Q Consensus 81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-------- 149 (394)
..+|++.+.||+|+||.||+|++..+|+.||||++.... ....+|+.+++.++||||+++++++.....
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 84 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAV 84 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC-----
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhccc
Confidence 346999999999999999999999999999999986543 334579999999999999999998754321
Q ss_pred CceeEEEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEe
Q 016184 150 KEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCD 228 (394)
Q Consensus 150 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~D 228 (394)
......++||||+++ +|.+++... ...+++..++.++.|++.||+|||+ +||+||||||+|||++.++ .+||+|
T Consensus 85 ~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~LH~-~~i~H~dlkp~Nil~~~~~-~~kl~d 159 (303)
T 1zy4_A 85 KKKSTLFIQMEYCENGTLYDLIHSE---NLNQQRDEYWRLFRQILEALSYIHS-QGIIHRDLKPMNIFIDESR-NVKIGD 159 (303)
T ss_dssp -CEEEEEEEEECCCSCBHHHHHHHS---CGGGCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECTTS-CEEECC
T ss_pred ccCCceEEEEecCCCCCHHHhhhcc---ccccchHHHHHHHHHHHHHHHHHHh-CCeecccCCHHhEEEcCCC-CEEEee
Confidence 235678899999975 888877642 3567889999999999999999999 8999999999999999888 699999
Q ss_pred ecCccccccC---------------CCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcH-H
Q 016184 229 FGSAKVLVKG---------------EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGV-D 292 (394)
Q Consensus 229 fg~a~~~~~~---------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~-~ 292 (394)
||++...... .......+|+.|+|||++.+...++.++|||||||++|+|++ ||...... .
T Consensus 160 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~ 236 (303)
T 1zy4_A 160 FGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVN 236 (303)
T ss_dssp CCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHH
T ss_pred CcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHHH
Confidence 9998765321 122345679999999999766568999999999999999998 55432222 2
Q ss_pred HHHHHHHHhCCCChhhhhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 016184 293 QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL 371 (394)
Q Consensus 293 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 371 (394)
....+..... . +...+....+..+.+||++||+.||.+|||+.++++||||+..
T Consensus 237 ~~~~~~~~~~-----------------~--------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 290 (303)
T 1zy4_A 237 ILKKLRSVSI-----------------E--------FPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVK 290 (303)
T ss_dssp HHHHHHSTTC-----------------C--------CCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCCC
T ss_pred HHHhcccccc-----------------c--------cCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCCC
Confidence 2222211000 0 0111234567889999999999999999999999999999764
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-46 Score=343.57 Aligned_cols=257 Identities=23% Similarity=0.371 Sum_probs=189.2
Q ss_pred cceeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccch------hhhHHHHHHHHHcCCCCeeeeceEEEecCCCcee
Q 016184 80 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL 153 (394)
Q Consensus 80 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 153 (394)
...+|++.+.||+|+||.||+|++..+|+.||||++.... ....++..+++.++||||+++++++.. ..
T Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~-----~~ 97 (318)
T 2dyl_A 23 EINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFIT-----NT 97 (318)
T ss_dssp CGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC-----SS
T ss_pred hhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEec-----CC
Confidence 3457999999999999999999999999999999986432 122234456788899999999998843 33
Q ss_pred EEEEEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC-CceeccCCCCceEEeCCCCcEEEEeecCc
Q 016184 154 YLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI-GICHRDIKPQNLLVNPHTHQLKLCDFGSA 232 (394)
Q Consensus 154 ~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~-givH~Dlkp~Nil~~~~~~~vkl~Dfg~a 232 (394)
..++||||+++.+..+... ....+++..++.++.|++.||.|||+ . ||+|+||||+|||++.++ .+||+|||++
T Consensus 98 ~~~lv~e~~~~~~~~l~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~-~~~i~H~dlkp~Nil~~~~~-~~kl~dfg~~ 172 (318)
T 2dyl_A 98 DVFIAMELMGTCAEKLKKR---MQGPIPERILGKMTVAIVKALYYLKE-KHGVIHRDVKPSNILLDERG-QIKLCDFGIS 172 (318)
T ss_dssp EEEEEECCCSEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHH-HHCCCCCCCCGGGEEECTTS-CEEECCCTTC
T ss_pred cEEEEEeccCCcHHHHHHH---hccCCCHHHHHHHHHHHHHHHHHHHh-hCCEEeCCCCHHHEEECCCC-CEEEEECCCc
Confidence 5789999997666554432 24679999999999999999999998 6 999999999999999888 6999999999
Q ss_pred cccccCCCccccccccccccccccc----CCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCc-HHHHHHHHHHhCCCChh
Q 016184 233 KVLVKGEPNVSYICSRYYRAPELIF----GATEYTTAIDIWSTGCVMAELLLGQPLFPGESG-VDQLVEIIKVLGTPTRE 307 (394)
Q Consensus 233 ~~~~~~~~~~~~~~t~~y~aPE~~~----~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~-~~~~~~i~~~~~~~~~~ 307 (394)
.............+|+.|+|||++. ....++.++||||||+++|+|++|+.||..... .+.+..+..... +
T Consensus 173 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~-~--- 248 (318)
T 2dyl_A 173 GRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEP-P--- 248 (318)
T ss_dssp --------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCC-C---
T ss_pred hhccCCccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCC-C---
Confidence 7765554455567899999999985 234478999999999999999999999987443 344444433110 0
Q ss_pred hhhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 016184 308 EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR 372 (394)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 372 (394)
.++ ....+++++.+||.+||+.||.+|||+.++++||||++..
T Consensus 249 ------------~~~----------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 291 (318)
T 2dyl_A 249 ------------LLP----------GHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRYE 291 (318)
T ss_dssp ------------CCC----------SSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHHHH
T ss_pred ------------CCC----------ccCCCCHHHHHHHHHHccCChhHCcCHHHHhhCHHHHhcc
Confidence 000 0135789999999999999999999999999999998754
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=338.54 Aligned_cols=254 Identities=27% Similarity=0.393 Sum_probs=199.6
Q ss_pred eeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccc-------hhhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeE
Q 016184 82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY 154 (394)
Q Consensus 82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 154 (394)
.+|++.+.||+|+||.||+|++..+++.||+|++... ...+.+|+.+++.++||||+++++++ .....
T Consensus 11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~-----~~~~~ 85 (294)
T 4eqm_A 11 ERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVD-----EEDDC 85 (294)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEE-----ECSSE
T ss_pred ccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEee-----eeCCe
Confidence 4599999999999999999999999999999987432 13456799999999999999999987 33445
Q ss_pred EEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCcc
Q 016184 155 LNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK 233 (394)
Q Consensus 155 ~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~ 233 (394)
.++||||+++ +|.+++.. ...+++..++.++.|++.||+|||+ +||+||||||+|||++.++ .+||+|||++.
T Consensus 86 ~~lv~e~~~g~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~Dlkp~Nil~~~~~-~~kl~Dfg~~~ 159 (294)
T 4eqm_A 86 YYLVMEYIEGPTLSEYIES----HGPLSVDTAINFTNQILDGIKHAHD-MRIVHRDIKPQNILIDSNK-TLKIFDFGIAK 159 (294)
T ss_dssp EEEEEECCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECTTS-CEEECCCSSST
T ss_pred EEEEEeCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEECCCC-CEEEEeCCCcc
Confidence 7899999976 88777654 3579999999999999999999999 8999999999999999888 69999999997
Q ss_pred ccccCC--CcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhc
Q 016184 234 VLVKGE--PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 311 (394)
Q Consensus 234 ~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 311 (394)
...... ......||+.|+|||++.+.. ++.++||||||+++|+|++|+.||.+.............. .+.
T Consensus 160 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~-~~~------ 231 (294)
T 4eqm_A 160 ALSETSLTQTNHVLGTVQYFSPEQAKGEA-TDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDS-VPN------ 231 (294)
T ss_dssp TC-------------CCSSCCHHHHHTCC-CCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSC-CCC------
T ss_pred ccccccccccCccccCccccCHhHhcCCC-CCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcc-CCC------
Confidence 654332 223456899999999997654 8999999999999999999999998877655544433211 000
Q ss_pred cCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 016184 312 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL 371 (394)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 371 (394)
........+++.+.++|.+||+.||.+||+..+.+.+.|.+-+
T Consensus 232 -----------------~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~ 274 (294)
T 4eqm_A 232 -----------------VTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVL 274 (294)
T ss_dssp -----------------HHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSS
T ss_pred -----------------cchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHH
Confidence 1111235689999999999999999999965656556555443
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-45 Score=336.49 Aligned_cols=257 Identities=26% Similarity=0.419 Sum_probs=197.9
Q ss_pred eeEEeecCceEEEEEEECCCCcEEEEEEeccc----hhhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEEEEEEecc
Q 016184 87 EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYV 162 (394)
Q Consensus 87 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~ 162 (394)
..+||+|+||.||+|++..+++.||||++... .....+|+.+++.++||||+++++++.. ....++||||+
T Consensus 27 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~~~~~lv~e~~ 101 (295)
T 2clq_A 27 RVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSE-----NGFIKIFMEQV 101 (295)
T ss_dssp BCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEE-----TTEEEEEEECC
T ss_pred cEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEe-----CCcEEEEEEeC
Confidence 34899999999999999999999999988643 2345689999999999999999998843 33578999999
Q ss_pred c-ccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCccccccCC-C
Q 016184 163 P-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE-P 240 (394)
Q Consensus 163 ~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~~~-~ 240 (394)
+ ++|.+++.... ....+++..++.++.|++.||.|||+ .||+|+||||+|||++.....+||+|||++....... .
T Consensus 102 ~~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~ 179 (295)
T 2clq_A 102 PGGSLSALLRSKW-GPLKDNEQTIGFYTKQILEGLKYLHD-NQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPC 179 (295)
T ss_dssp SEEEHHHHHHHTT-CCCTTCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC----
T ss_pred CCCCHHHHHHhhc-cCCCccHHHHHHHHHHHHHHHHHHHh-CCEEccCCChhhEEEECCCCCEEEeecccccccCCCCCc
Confidence 6 57877776522 22456788999999999999999999 8999999999999999733379999999997654322 2
Q ss_pred cccccccccccccccccCC-CCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCCCccc
Q 016184 241 NVSYICSRYYRAPELIFGA-TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 319 (394)
Q Consensus 241 ~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 319 (394)
.....+++.|+|||++.+. ..++.++||||||+++|+|++|+.||...................
T Consensus 180 ~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~--------------- 244 (295)
T 2clq_A 180 TETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVH--------------- 244 (295)
T ss_dssp -CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCC---------------
T ss_pred ccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhcccccc---------------
Confidence 3345689999999998543 237899999999999999999999997654433222111111100
Q ss_pred CCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCC
Q 016184 320 KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNT 376 (394)
Q Consensus 320 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~ 376 (394)
..++..+++++.+||.+||+.||++|||+.++|+||||+.......
T Consensus 245 -----------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~~~ 290 (295)
T 2clq_A 245 -----------PEIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKVSSKKKK 290 (295)
T ss_dssp -----------CCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTSGGGCC------
T ss_pred -----------ccccccCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhhccccCC
Confidence 0122467899999999999999999999999999999998765544
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-46 Score=347.96 Aligned_cols=248 Identities=25% Similarity=0.394 Sum_probs=203.6
Q ss_pred ceeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccch----------hhhHHHHHHHHHcC--CCCeeeeceEEEecC
Q 016184 81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK----------RYKNRELQIMQMLD--HPNIVALKHCFFSTT 148 (394)
Q Consensus 81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----------~~~~~E~~~l~~l~--h~~iv~~~~~~~~~~ 148 (394)
..+|++.+.||+|+||.||+|++..+++.||||++.... ....+|+.+++.+. |+||+++++++.
T Consensus 42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~--- 118 (320)
T 3a99_A 42 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFE--- 118 (320)
T ss_dssp TTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEE---
T ss_pred cCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEe---
Confidence 345999999999999999999999999999999986432 33457999999996 599999999883
Q ss_pred CCceeEEEEEEeccc--ccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEE
Q 016184 149 DKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKL 226 (394)
Q Consensus 149 ~~~~~~~~lv~e~~~--~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl 226 (394)
.....+++||++. ++|.+++.. ...+++..++.++.||+.||+|||+ .||+||||||+|||++.+...+||
T Consensus 119 --~~~~~~lv~e~~~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~~LH~-~~ivH~Dlkp~NIll~~~~~~~kL 191 (320)
T 3a99_A 119 --RPDSFVLILERPEPVQDLFDFITE----RGALQEELARSFFWQVLEAVRHCHN-CGVLHRDIKDENILIDLNRGELKL 191 (320)
T ss_dssp --CSSEEEEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEEETTTTEEEE
T ss_pred --cCCcEEEEEEcCCCCccHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHH-CCcEeCCCCHHHEEEeCCCCCEEE
Confidence 3334789999987 577776654 3679999999999999999999999 899999999999999943337999
Q ss_pred EeecCccccccCCCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCh
Q 016184 227 CDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTR 306 (394)
Q Consensus 227 ~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~ 306 (394)
+|||++...... ......+|+.|+|||++.+...++.++||||||+++|+|++|+.||.... .+... .
T Consensus 192 ~Dfg~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~------~~~~~--~--- 259 (320)
T 3a99_A 192 IDFGSGALLKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRG--Q--- 259 (320)
T ss_dssp CCCTTCEECCSS-CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHC--C---
T ss_pred eeCccccccccc-cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh------hhhcc--c---
Confidence 999999866432 33456789999999998766545789999999999999999999996532 11110 0
Q ss_pred hhhhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCC
Q 016184 307 EEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP 374 (394)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~ 374 (394)
. .+...+++++.+||.+||+.||.+|||++++++||||++...+
T Consensus 260 ------------~------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~~~ 303 (320)
T 3a99_A 260 ------------V------------FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLP 303 (320)
T ss_dssp ------------C------------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCCCH
T ss_pred ------------c------------cccccCCHHHHHHHHHHccCChhhCcCHHHHhcCHhhcCccCc
Confidence 0 0124678999999999999999999999999999999987654
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=346.37 Aligned_cols=273 Identities=20% Similarity=0.324 Sum_probs=206.7
Q ss_pred ceeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccch---------------------hhhHHHHHHHHHcCCCCeee
Q 016184 81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---------------------RYKNRELQIMQMLDHPNIVA 139 (394)
Q Consensus 81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---------------------~~~~~E~~~l~~l~h~~iv~ 139 (394)
.++|++.+.||+|+||.||+|++ +|+.||||++.... ....+|+.+++.++||||++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~ 107 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLT 107 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcce
Confidence 34699999999999999999999 79999999985432 55678999999999999999
Q ss_pred eceEEEecCCCceeEEEEEEecccc-cHHHHHHH----hhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCc
Q 016184 140 LKHCFFSTTDKEELYLNLVLEYVPE-TVNRIARN----YSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQN 214 (394)
Q Consensus 140 ~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~----~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~N 214 (394)
+++++.. ....++||||+++ +|.+++.. .......+++..++.++.|++.||.|||+..||+||||||+|
T Consensus 108 ~~~~~~~-----~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~N 182 (348)
T 2pml_X 108 CEGIITN-----YDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSN 182 (348)
T ss_dssp CSEEEES-----SSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGG
T ss_pred EEEEEee-----CCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHh
Confidence 9998843 3457899999986 66544111 011146799999999999999999999963599999999999
Q ss_pred eEEeCCCCcEEEEeecCccccccCCCcccccccccccccccccCCCCCCC-hhhHHHHHHHHHHHHhCCCCCCCCCc-HH
Q 016184 215 LLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTT-AIDIWSTGCVMAELLLGQPLFPGESG-VD 292 (394)
Q Consensus 215 il~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~~DiwslG~il~~lltg~~pf~~~~~-~~ 292 (394)
||++.++ .+||+|||++...... ......+++.|+|||++.+...++. ++||||||+++|+|++|..||..... .+
T Consensus 183 il~~~~~-~~kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~ 260 (348)
T 2pml_X 183 ILMDKNG-RVKLSDFGESEYMVDK-KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVE 260 (348)
T ss_dssp EEECTTS-CEEECCCTTCEECBTT-EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHH
T ss_pred EEEcCCC-cEEEeccccccccccc-cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHH
Confidence 9999888 6999999999765433 3345678999999999976534555 99999999999999999999988766 44
Q ss_pred HHHHHHHHhCCCChhhhhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 016184 293 QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR 372 (394)
Q Consensus 293 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 372 (394)
....+.......+.. ...+..+ . ...........++.++.+||.+||+.||.+|||+.++++||||++..
T Consensus 261 ~~~~i~~~~~~~~~~--------~~~~~~~-~-~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~~~ 330 (348)
T 2pml_X 261 LFNNIRTKNIEYPLD--------RNHFLYP-L-TNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADTN 330 (348)
T ss_dssp HHHHHTSCCCCCCCS--------SSSSTTT-T-CC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTTCC
T ss_pred HHHHHhccCcCCccc--------hhhhhcc-c-cccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccccCCC
Confidence 443332211100000 0000000 0 00001112256899999999999999999999999999999999865
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=342.78 Aligned_cols=265 Identities=24% Similarity=0.353 Sum_probs=186.3
Q ss_pred ceeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccch-----hhhHHHHH-HHHHcCCCCeeeeceEEEecCCCceeE
Q 016184 81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQ-IMQMLDHPNIVALKHCFFSTTDKEELY 154 (394)
Q Consensus 81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~-~l~~l~h~~iv~~~~~~~~~~~~~~~~ 154 (394)
..+|++.+.||+|+||.||+|.+..+|+.||||++.... ....+|+. +++.++||||+++++++.. ...
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~-----~~~ 95 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFR-----EGD 95 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEEC-----SSE
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEe-----CCc
Confidence 356999999999999999999999999999999986432 12223444 6677899999999998843 234
Q ss_pred EEEEEecccccHHHHHHHhhh-hcCCCCHHHHHHHHHHHHHHHHHHHhCC-CceeccCCCCceEEeCCCCcEEEEeecCc
Q 016184 155 LNLVLEYVPETVNRIARNYSR-IHQRMPLIYVKLYTYQICRALAYIHNCI-GICHRDIKPQNLLVNPHTHQLKLCDFGSA 232 (394)
Q Consensus 155 ~~lv~e~~~~~l~~~~~~~~~-~~~~l~~~~~~~~~~qi~~al~~LH~~~-givH~Dlkp~Nil~~~~~~~vkl~Dfg~a 232 (394)
.++||||+.+++.+++..... ....+++..++.++.|++.||.|||+ . ||+||||||+|||++.++ .+||+|||++
T Consensus 96 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~-~~~ivH~dlkp~NIll~~~~-~~kl~Dfg~~ 173 (327)
T 3aln_A 96 CWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKE-NLKIIHRDIKPSNILLDRSG-NIKLCDFGIS 173 (327)
T ss_dssp EEEEECCCSEEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHH-HHSCCCSCCCGGGEEEETTT-EEEECCCSSS
T ss_pred eEEEEeecCCChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhc-cCCEeECCCCHHHEEEcCCC-CEEEccCCCc
Confidence 789999999988777764332 25779999999999999999999999 8 999999999999999887 7999999999
Q ss_pred cccccCCCccccccccccccccccc---CCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhh
Q 016184 233 KVLVKGEPNVSYICSRYYRAPELIF---GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI 309 (394)
Q Consensus 233 ~~~~~~~~~~~~~~t~~y~aPE~~~---~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 309 (394)
.............+|+.|+|||++. ....++.++||||||+++|+|++|+.||.+..... ..+.....
T Consensus 174 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~~~~~~~------- 244 (327)
T 3aln_A 174 GQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVF--DQLTQVVK------- 244 (327)
T ss_dssp CC------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC---------CCCCC-------
T ss_pred eecccccccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHH--HHHHHHhc-------
Confidence 8765544444557899999999983 23348999999999999999999999997643211 00000000
Q ss_pred hccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCC
Q 016184 310 KCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 375 (394)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~ 375 (394)
. ....+.......+++.+.+||.+||+.||.+|||+.++++||||++.....
T Consensus 245 ---------~-----~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~~~~~ 296 (327)
T 3aln_A 245 ---------G-----DPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMYEERA 296 (327)
T ss_dssp ---------S-----CCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHHHSC
T ss_pred ---------C-----CCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHHhHhhH
Confidence 0 000011111245789999999999999999999999999999998765443
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-45 Score=340.92 Aligned_cols=246 Identities=19% Similarity=0.198 Sum_probs=199.1
Q ss_pred eEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccc--hhhhHHHHHHHHHc-CCCCeeeeceEEEecCCCceeEEEEEE
Q 016184 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD--KRYKNRELQIMQML-DHPNIVALKHCFFSTTDKEELYLNLVL 159 (394)
Q Consensus 83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~lv~ 159 (394)
+|++.+.||+|+||.||+|++..+|+.||||++... .....+|+.+++.+ +|+||+++++++.. ..+.++||
T Consensus 10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~-----~~~~~lv~ 84 (330)
T 2izr_A 10 NFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGDGIPQVYYFGPC-----GKYNAMVL 84 (330)
T ss_dssp TEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSSCCHHHHHHHHHHHCSCTTSCCEEEEEEE-----TTEEEEEE
T ss_pred CeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHhhCCCCCCEEEEEEec-----CCccEEEE
Confidence 599999999999999999999999999999988543 34567899999999 99999999998743 34578999
Q ss_pred ecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCc-----EEEEeecCccc
Q 016184 160 EYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQ-----LKLCDFGSAKV 234 (394)
Q Consensus 160 e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~-----vkl~Dfg~a~~ 234 (394)
||++++|.+++... ...+++..++.++.|++.||+|||+ .||+||||||+|||++.++ . +||+|||+++.
T Consensus 85 e~~~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~-~~iiHrDlkp~Nill~~~~-~~~~~~~kl~DFg~a~~ 159 (330)
T 2izr_A 85 ELLGPSLEDLFDLC---DRTFSLKTVLMIAIQLISRMEYVHS-KNLIYRDVKPENFLIGRPG-NKTQQVIHIIDFALAKE 159 (330)
T ss_dssp ECCCCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECCGG-GTCTTSEEECCCTTCEE
T ss_pred EeCCCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCHHHeeeccCC-CCCCceEEEEEccccee
Confidence 99988998887753 3679999999999999999999999 8999999999999999776 4 99999999986
Q ss_pred cccCCC--------cccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHH---HHHHHHHHhCC
Q 016184 235 LVKGEP--------NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVD---QLVEIIKVLGT 303 (394)
Q Consensus 235 ~~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~---~~~~i~~~~~~ 303 (394)
...... .....||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+....+ .+..+......
T Consensus 160 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~ 238 (330)
T 2izr_A 160 YIDPETKKHIPYREHKSLTGTARYMSINTHLGK-EQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRA 238 (330)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHH
T ss_pred eecCCCCccccccccCCcCCCccccChHHHcCC-CCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhcc
Confidence 644322 2356789999999999664 48999999999999999999999998754332 23333221111
Q ss_pred CChhhhhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 016184 304 PTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV 364 (394)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 364 (394)
.+... ....++ ++.+||..||+.||.+||+++++++
T Consensus 239 ~~~~~------------------------~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~ 274 (330)
T 2izr_A 239 TPIEV------------------------LCENFP-EMATYLRYVRRLDFFEKPDYDYLRK 274 (330)
T ss_dssp SCHHH------------------------HTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred CCHHH------------------------HhccCh-HHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 11110 112345 9999999999999999999988875
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-45 Score=336.87 Aligned_cols=252 Identities=23% Similarity=0.347 Sum_probs=194.5
Q ss_pred ceeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccch------hhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeE
Q 016184 81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY 154 (394)
Q Consensus 81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 154 (394)
..+|++.+.||+|+||+||+|++ +|+.||||++.... ..+.+|+++++.++||||+++++++.. ...
T Consensus 36 ~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-----~~~ 108 (309)
T 3p86_A 36 WCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQ-----PPN 108 (309)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-----TTC
T ss_pred hhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE-----CCc
Confidence 34699999999999999999987 48899999985432 234579999999999999999998832 233
Q ss_pred EEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCC--ceeccCCCCceEEeCCCCcEEEEeecC
Q 016184 155 LNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG--ICHRDIKPQNLLVNPHTHQLKLCDFGS 231 (394)
Q Consensus 155 ~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~g--ivH~Dlkp~Nil~~~~~~~vkl~Dfg~ 231 (394)
.++||||+.+ +|.+++.... ....+++..++.++.|++.||+|||+ .| |+||||||+|||++.++ .+||+|||+
T Consensus 109 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~aL~~LH~-~~~~ivH~Dikp~NIll~~~~-~~kL~Dfg~ 185 (309)
T 3p86_A 109 LSIVTEYLSRGSLYRLLHKSG-AREQLDERRRLSMAYDVAKGMNYLHN-RNPPIVHRNLKSPNLLVDKKY-TVKVCDFGL 185 (309)
T ss_dssp CEEEEECCTTCBHHHHHHSTT-HHHHSCHHHHHHHHHHHHHHHHHHHT-SSSCCCCTTCCGGGEEECTTC-CEEECCCC-
T ss_pred eEEEEecCCCCcHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCEECCCCChhhEEEeCCC-cEEECCCCC
Confidence 6799999975 8877776422 12348999999999999999999999 89 99999999999999887 799999999
Q ss_pred ccccccCC-CcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhh
Q 016184 232 AKVLVKGE-PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 310 (394)
Q Consensus 232 a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 310 (394)
++...... ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+....+.......
T Consensus 186 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~------ 258 (309)
T 3p86_A 186 SRLKASTFLSSKSAAGTPEWMAPEVLRDE-PSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRL------ 258 (309)
T ss_dssp ----------------CCTTSCHHHHTTC-CCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCCC------
T ss_pred CccccccccccccCCCCccccChhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC------
Confidence 97543332 23346789999999999655 48999999999999999999999998877666555443211110
Q ss_pred ccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhc--CCCCCC
Q 016184 311 CMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV--HPFFDE 370 (394)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~--hp~f~~ 370 (394)
.++..+++++.+||.+||+.||.+|||+.++++ ++|++.
T Consensus 259 ---------------------~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~ 299 (309)
T 3p86_A 259 ---------------------EIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKS 299 (309)
T ss_dssp ---------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-
T ss_pred ---------------------CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 122568999999999999999999999999987 455544
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-45 Score=339.83 Aligned_cols=264 Identities=19% Similarity=0.253 Sum_probs=189.6
Q ss_pred eeEEEeeEEeecCceEEEEEEECCCCc---EEEEEEeccc------hhhhHHHHHHHHHcCCCCeeeeceEEEecCCCc-
Q 016184 82 VSYIAEHVVGTGSFGVVFQAKCRETGE---IVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKE- 151 (394)
Q Consensus 82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~---~vaiK~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~- 151 (394)
.+|++.+.||+|+||.||+|++..++. .||||++... .....+|+++++.++||||+++++++.......
T Consensus 23 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 102 (323)
T 3qup_A 23 QQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGR 102 (323)
T ss_dssp --CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-----
T ss_pred hHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccccC
Confidence 469999999999999999999887765 8999988543 234568999999999999999999885543321
Q ss_pred eeEEEEEEecccc-cHHHHHHHhhhh--cCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEe
Q 016184 152 ELYLNLVLEYVPE-TVNRIARNYSRI--HQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCD 228 (394)
Q Consensus 152 ~~~~~lv~e~~~~-~l~~~~~~~~~~--~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~D 228 (394)
....++||||+.+ +|.+++...... ...+++..++.++.|++.||+|||+ .||+||||||+|||++.++ .+||+|
T Consensus 103 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~-~~ivH~Dikp~NIli~~~~-~~kl~D 180 (323)
T 3qup_A 103 LPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSS-RNFIHRDLAARNCMLAEDM-TVCVAD 180 (323)
T ss_dssp --CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECTTS-CEEECC
T ss_pred CCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHc-CCcccCCCCcceEEEcCCC-CEEEee
Confidence 1234799999986 887777654321 2268999999999999999999999 8999999999999999887 799999
Q ss_pred ecCccccccCCC---cccccccccccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCC
Q 016184 229 FGSAKVLVKGEP---NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTP 304 (394)
Q Consensus 229 fg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~ 304 (394)
||++........ .....+++.|+|||.+.+. .++.++|||||||++|+|++ |..||.+....+....+......
T Consensus 181 fg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~- 258 (323)
T 3qup_A 181 FGLSRKIYSGDYYRQGCASKLPVKWLALESLADN-LYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGNRL- 258 (323)
T ss_dssp CCC-----------------CCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCC-
T ss_pred ccccccccccccccccccccCcccccCchhhcCC-CCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhcCCCC-
Confidence 999976543322 2234457789999998654 48999999999999999999 99999988776666555432100
Q ss_pred ChhhhhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCC-------HHHHhcCCCCCCCCCCCC
Q 016184 305 TREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCT-------ALEACVHPFFDELRDPNT 376 (394)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt-------~~ell~hp~f~~~~~~~~ 376 (394)
..+..+++++.+||.+||+.||.+||| ++++++|||+......-.
T Consensus 259 ---------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~~~~pl 310 (323)
T 3qup_A 259 ---------------------------KQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLSTSQDPL 310 (323)
T ss_dssp ---------------------------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-----------
T ss_pred ---------------------------CCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCCCCCCC
Confidence 012457899999999999999999999 788999999988655443
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-45 Score=336.64 Aligned_cols=247 Identities=25% Similarity=0.482 Sum_probs=199.3
Q ss_pred ceeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccc----hhhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEEE
Q 016184 81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN 156 (394)
Q Consensus 81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 156 (394)
..+|++.++||+|+||+||+|++..+++.||+|++... ...+.+|+++++.++||||+++++++.. ....+
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-----~~~~~ 83 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYK-----DKRLN 83 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE-----TTEEE
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEec-----CCeeE
Confidence 34699999999999999999999999999999987542 3345689999999999999999999843 33478
Q ss_pred EEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCcccc
Q 016184 157 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL 235 (394)
Q Consensus 157 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~ 235 (394)
+||||+.+ +|.+++... ...+++..++.++.|++.||+|||+ .||+||||||+|||++.++ .+||+|||++...
T Consensus 84 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~-~~ivH~dlkp~Nil~~~~~-~~kl~Dfg~~~~~ 158 (310)
T 3s95_A 84 FITEYIKGGTLRGIIKSM---DSQYPWSQRVSFAKDIASGMAYLHS-MNIIHRDLNSHNCLVRENK-NVVVADFGLARLM 158 (310)
T ss_dssp EEEECCTTCBHHHHHHHC---CTTSCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSTTSEEECTTS-CEEECCCTTCEEC
T ss_pred EEEEecCCCcHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHh-CCccCCCCCcCeEEECCCC-CEEEeecccceec
Confidence 99999975 887777642 3679999999999999999999999 8999999999999999887 6999999999765
Q ss_pred ccCCCc---------------ccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHH-----HHH
Q 016184 236 VKGEPN---------------VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVD-----QLV 295 (394)
Q Consensus 236 ~~~~~~---------------~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~-----~~~ 295 (394)
...... ....||+.|+|||++.+. .++.++||||||+++|+|++|..||....... ...
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~ 237 (310)
T 3s95_A 159 VDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGR-SYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVR 237 (310)
T ss_dssp C--------------------CCCCSCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHH
T ss_pred ccccccccccccccccccccccccCCCcceeCHHHhcCC-CCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhh
Confidence 433221 145789999999999654 48999999999999999999999987542211 001
Q ss_pred HHHHHhCCCChhhhhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 016184 296 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL 371 (394)
Q Consensus 296 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 371 (394)
.... ...+..+++.+.+||.+||+.||++|||+.++++ |++.+
T Consensus 238 ~~~~-------------------------------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~--~L~~l 280 (310)
T 3s95_A 238 GFLD-------------------------------RYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH--WLETL 280 (310)
T ss_dssp HHHH-------------------------------HTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHH--HHHHH
T ss_pred cccc-------------------------------ccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH--HHHHH
Confidence 1100 1123567899999999999999999999999987 55544
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=330.92 Aligned_cols=248 Identities=19% Similarity=0.189 Sum_probs=201.7
Q ss_pred eEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccc--hhhhHHHHHHHHHc-CCCCeeeeceEEEecCCCceeEEEEEE
Q 016184 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD--KRYKNRELQIMQML-DHPNIVALKHCFFSTTDKEELYLNLVL 159 (394)
Q Consensus 83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~lv~ 159 (394)
+|++.+.||+|+||.||+|++..+|+.||||++... .....+|+.+++.+ .|+|++++++++ ......++||
T Consensus 11 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~-----~~~~~~~lv~ 85 (298)
T 1csn_A 11 HYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFG-----QEGLHNVLVI 85 (298)
T ss_dssp TEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEE-----EETTEEEEEE
T ss_pred ceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCccHHHHHHHHHHHHHhcCCCCCeEEeec-----CCCceeEEEE
Confidence 599999999999999999999999999999988543 34567899999999 899999999887 3334578999
Q ss_pred ecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCC----cEEEEeecCcccc
Q 016184 160 EYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTH----QLKLCDFGSAKVL 235 (394)
Q Consensus 160 e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~----~vkl~Dfg~a~~~ 235 (394)
||++++|.+++... ...+++..++.++.||+.||+|||+ +||+||||||+|||++.++. .+||+|||++...
T Consensus 86 e~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~-~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~ 161 (298)
T 1csn_A 86 DLLGPSLEDLLDLC---GRKFSVKTVAMAAKQMLARVQSIHE-KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY 161 (298)
T ss_dssp ECCCCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHT-TTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred EecCCCHHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHh-CCEecCCCCHHHEEeccCCCCCCCeEEEEECcccccc
Confidence 99988998887653 3569999999999999999999999 89999999999999987652 3999999999866
Q ss_pred ccCCC--------cccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCc---HHHHHHHHHHhCCC
Q 016184 236 VKGEP--------NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESG---VDQLVEIIKVLGTP 304 (394)
Q Consensus 236 ~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~---~~~~~~i~~~~~~~ 304 (394)
..... .....||+.|+|||++.+. .++.++||||||+++|+|++|+.||.+... ...+..+......+
T Consensus 162 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 240 (298)
T 1csn_A 162 RDPVTKQHIPYREKKNLSGTARYMSINTHLGR-EQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST 240 (298)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHS
T ss_pred ccccccccccccCccCCCCCcccCCchhhcCC-CCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCc
Confidence 44322 2345689999999998654 489999999999999999999999987532 33333333322111
Q ss_pred ChhhhhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 016184 305 TREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV 364 (394)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 364 (394)
+.. .+...+++++.+||.+||+.||++|||++++++
T Consensus 241 ~~~------------------------~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~ 276 (298)
T 1csn_A 241 PLR------------------------ELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 276 (298)
T ss_dssp CHH------------------------HHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred cHH------------------------HHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHH
Confidence 111 112457999999999999999999999999875
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-45 Score=338.80 Aligned_cols=246 Identities=24% Similarity=0.346 Sum_probs=198.8
Q ss_pred cceeEEEeeEEeecCceEEEEEEECCCCc---EEEEEEeccc-----hhhhHHHHHHHHHcCCCCeeeeceEEEecCCCc
Q 016184 80 QKVSYIAEHVVGTGSFGVVFQAKCRETGE---IVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKE 151 (394)
Q Consensus 80 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~---~vaiK~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 151 (394)
...+|++.+.||+|+||.||+|++..+++ .||||++... ...+.+|+.+++.++||||+++++++ ..
T Consensus 47 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~ 121 (325)
T 3kul_A 47 EASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVV-----TR 121 (325)
T ss_dssp CGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-----CG
T ss_pred ChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEE-----Ee
Confidence 34579999999999999999999986554 4999998643 23456799999999999999999988 33
Q ss_pred eeEEEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeec
Q 016184 152 ELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFG 230 (394)
Q Consensus 152 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg 230 (394)
....++||||+.+ +|.+++... ...+++..++.++.||+.||+|||+ .||+||||||+|||++.++ .+||+|||
T Consensus 122 ~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~L~~LH~-~~ivH~Dlkp~NIll~~~~-~~kl~Dfg 196 (325)
T 3kul_A 122 GRLAMIVTEYMENGSLDTFLRTH---DGQFTIMQLVGMLRGVGAGMRYLSD-LGYVHRDLAARNVLVDSNL-VCKVSDFG 196 (325)
T ss_dssp GGCCEEEEECCTTCBHHHHHHTT---TTCSCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECTTC-CEEECCCS
T ss_pred CCccEEEeeCCCCCcHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHH-CCeeCCCCCcceEEECCCC-CEEECCCC
Confidence 3447799999975 887776542 3579999999999999999999999 8999999999999999887 79999999
Q ss_pred CccccccCCCc----ccccccccccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCC
Q 016184 231 SAKVLVKGEPN----VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPT 305 (394)
Q Consensus 231 ~a~~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~ 305 (394)
+++........ ....+|+.|+|||++.+. .++.++||||||+++|+|++ |..||.+....+....+......+
T Consensus 197 ~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~- 274 (325)
T 3kul_A 197 LSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFR-TFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLP- 274 (325)
T ss_dssp SCEECC----CCEECC---CCGGGSCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCC-
T ss_pred cccccccCccceeeccCCCCcccccCHhHhcCC-CCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCCCC-
Confidence 99876443221 123346789999999654 48999999999999999999 999998887766665554421111
Q ss_pred hhhhhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 016184 306 REEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV 364 (394)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 364 (394)
.+..+++.+.+||.+||+.||.+|||+.++++
T Consensus 275 ---------------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~ 306 (325)
T 3kul_A 275 ---------------------------APMGCPHALHQLMLDCWHKDRAQRPRFSQIVS 306 (325)
T ss_dssp ---------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---------------------------CCCCcCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 12467899999999999999999999999986
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=348.44 Aligned_cols=255 Identities=19% Similarity=0.228 Sum_probs=203.0
Q ss_pred ceeEEEeeEEeecCceEEEEEE-----ECCCCcEEEEEEeccc-----hhhhHHHHHHHHHcCCCCeeeeceEEEecCCC
Q 016184 81 KVSYIAEHVVGTGSFGVVFQAK-----CRETGEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDK 150 (394)
Q Consensus 81 ~~~y~~~~~lg~G~~g~V~~~~-----~~~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 150 (394)
..+|++.+.||+|+||.||+|+ +..+++.||||++... .....+|+.+++.++||||+++++++..
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~---- 145 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQ---- 145 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS----
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEec----
Confidence 4569999999999999999999 4456789999998532 2334579999999999999999998833
Q ss_pred ceeEEEEEEecccc-cHHHHHHHhhhh---cCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCC--CcE
Q 016184 151 EELYLNLVLEYVPE-TVNRIARNYSRI---HQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHT--HQL 224 (394)
Q Consensus 151 ~~~~~~lv~e~~~~-~l~~~~~~~~~~---~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~--~~v 224 (394)
....++||||+.+ +|.+++...... ...+++..++.++.||+.||+|||+ +||+||||||+|||++.++ ..+
T Consensus 146 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlkp~NIll~~~~~~~~~ 223 (367)
T 3l9p_A 146 -SLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE-NHFIHRDIAARNCLLTCPGPGRVA 223 (367)
T ss_dssp -SSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEESCSSTTCCE
T ss_pred -CCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHh-CCeeCCCCChhhEEEecCCCCceE
Confidence 2235799999965 888887764421 2458999999999999999999999 8999999999999998544 259
Q ss_pred EEEeecCccccccC---CCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHH
Q 016184 225 KLCDFGSAKVLVKG---EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKV 300 (394)
Q Consensus 225 kl~Dfg~a~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~ 300 (394)
||+|||+++..... .......+|+.|+|||++.+. .++.++|||||||++|+|++ |..||.+....+.+..+...
T Consensus 224 kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~~ 302 (367)
T 3l9p_A 224 KIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEG-IFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSG 302 (367)
T ss_dssp EECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTT
T ss_pred EECCCccccccccccccccCCCcCCcccEECHHHhcCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC
Confidence 99999999754322 223345678999999998654 48999999999999999998 99999887766655554432
Q ss_pred hCCCChhhhhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 016184 301 LGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE 370 (394)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~ 370 (394)
.... .+..++..+.+||.+||+.||.+|||+.++++|.|+-.
T Consensus 303 ~~~~----------------------------~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~ 344 (367)
T 3l9p_A 303 GRMD----------------------------PPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT 344 (367)
T ss_dssp CCCC----------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCC----------------------------CCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence 1100 12457899999999999999999999999999877643
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-45 Score=342.84 Aligned_cols=250 Identities=23% Similarity=0.327 Sum_probs=200.9
Q ss_pred cceeEEEeeEEeecCceEEEEEEEC-------CCCcEEEEEEeccch-----hhhHHHHHHHHHc-CCCCeeeeceEEEe
Q 016184 80 QKVSYIAEHVVGTGSFGVVFQAKCR-------ETGEIVAIKKVLQDK-----RYKNRELQIMQML-DHPNIVALKHCFFS 146 (394)
Q Consensus 80 ~~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l-~h~~iv~~~~~~~~ 146 (394)
...+|++.+.||+|+||.||+|++. .++..||||++.... ..+.+|+.+++.+ +||||+++++++..
T Consensus 79 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 158 (370)
T 2psq_A 79 PRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 158 (370)
T ss_dssp CGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECS
T ss_pred cHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEcc
Confidence 3457999999999999999999974 345679999986432 3456799999999 89999999998832
Q ss_pred cCCCceeEEEEEEecccc-cHHHHHHHhhh------------hcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCC
Q 016184 147 TTDKEELYLNLVLEYVPE-TVNRIARNYSR------------IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQ 213 (394)
Q Consensus 147 ~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~------------~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~ 213 (394)
...+++||||+.+ +|.+++..... ....+++..++.++.||+.||+|||+ +||+||||||+
T Consensus 159 -----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlkp~ 232 (370)
T 2psq_A 159 -----DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS-QKCIHRDLAAR 232 (370)
T ss_dssp -----SSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGG
T ss_pred -----CCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh-CCeeccccchh
Confidence 2337799999985 88888775431 12458999999999999999999999 89999999999
Q ss_pred ceEEeCCCCcEEEEeecCccccccCCC---cccccccccccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCC
Q 016184 214 NLLVNPHTHQLKLCDFGSAKVLVKGEP---NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGES 289 (394)
Q Consensus 214 Nil~~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~ 289 (394)
|||++.++ .+||+|||+++....... .....+|+.|+|||++.+. .++.++|||||||++|+|++ |..||.+..
T Consensus 233 NIll~~~~-~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DvwslG~il~ellt~g~~p~~~~~ 310 (370)
T 2psq_A 233 NVLVTENN-VMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDR-VYTHQSDVWSFGVLMWEIFTLGGSPYPGIP 310 (370)
T ss_dssp GEEECTTC-CEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred hEEECCCC-CEEEccccCCcccCcccceecccCCCcccceECHhHhcCC-CCCcHHHHHHHHHHHHHHHcCCCCCCCCCC
Confidence 99999888 699999999986543322 2234567889999999765 48999999999999999999 999998877
Q ss_pred cHHHHHHHHHHhCCCChhhhhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 016184 290 GVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH 365 (394)
Q Consensus 290 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 365 (394)
..+....+..... ...+..++.++.+||.+||+.||.+|||+.+++++
T Consensus 311 ~~~~~~~~~~~~~----------------------------~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~ 358 (370)
T 2psq_A 311 VEELFKLLKEGHR----------------------------MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 358 (370)
T ss_dssp GGGHHHHHHTTCC----------------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHhcCCC----------------------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 6555544432110 00124578999999999999999999999999863
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-45 Score=333.88 Aligned_cols=252 Identities=23% Similarity=0.351 Sum_probs=209.1
Q ss_pred ceeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccchhhhHHHHHHHHHcCCCCeeeeceEEEecC-----------C
Q 016184 81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTT-----------D 149 (394)
Q Consensus 81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-----------~ 149 (394)
..+|++.+.||+|+||.||+|++..+|+.||+|++........+|+++++.++||||+++++++.... .
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~ 89 (284)
T 2a19_B 10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSR 89 (284)
T ss_dssp HHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCSGGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC---------C
T ss_pred ccccceeeeeccCCceEEEEEEEcCCCeEEEEEEeccccHHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccccccc
Confidence 34699999999999999999999999999999999887778889999999999999999999874311 1
Q ss_pred CceeEEEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEe
Q 016184 150 KEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCD 228 (394)
Q Consensus 150 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~D 228 (394)
......++||||+++ +|.+++.... ...+++..++.++.||+.||.|||+ +||+|+||||+|||++.++ .+||+|
T Consensus 90 ~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dlkp~Nil~~~~~-~~kl~D 165 (284)
T 2a19_B 90 SKTKCLFIQMEFCDKGTLEQWIEKRR--GEKLDKVLALELFEQITKGVDYIHS-KKLINRDLKPSNIFLVDTK-QVKIGD 165 (284)
T ss_dssp CEEEEEEEEECCCCSCBHHHHHHHGG--GSCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEEETT-EEEECC
T ss_pred cCcceEEEEEeccCCCCHHHHHhhcc--CCCCCHHHHHHHHHHHHHHHHHHHh-CCeeeccCCHHHEEEcCCC-CEEECc
Confidence 235568899999996 8888876533 3679999999999999999999999 8999999999999999887 799999
Q ss_pred ecCccccccCCCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhh
Q 016184 229 FGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 308 (394)
Q Consensus 229 fg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~ 308 (394)
||++.............+++.|+|||.+.+. .++.++||||||+++|+|++|..||.... .....+..
T Consensus 166 fg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~~~~~~~~~--~~~~~~~~--------- 233 (284)
T 2a19_B 166 FGLVTSLKNDGKRTRSKGTLRYMSPEQISSQ-DYGKEVDLYALGLILAELLHVCDTAFETS--KFFTDLRD--------- 233 (284)
T ss_dssp CTTCEESSCCSCCCCCCSCCTTSCHHHHHCS-CCCTHHHHHHHHHHHHHHHSCCSSHHHHH--HHHHHHHT---------
T ss_pred chhheeccccccccccCCcccccChhhhccC-CCcchhhhHHHHHHHHHHHhcCCcchhHH--HHHHHhhc---------
Confidence 9999877655555566789999999999654 48999999999999999999998874211 11111110
Q ss_pred hhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 016184 309 IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE 370 (394)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~ 370 (394)
..++..++..+.+||.+||+.||.+|||+.++++|.|.-.
T Consensus 234 ----------------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~ 273 (284)
T 2a19_B 234 ----------------------GIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWK 273 (284)
T ss_dssp ----------------------TCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHT
T ss_pred ----------------------ccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence 0012357889999999999999999999999999977644
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-45 Score=341.03 Aligned_cols=268 Identities=21% Similarity=0.235 Sum_probs=197.0
Q ss_pred ceeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccchh---hhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEEEE
Q 016184 81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR---YKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL 157 (394)
Q Consensus 81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 157 (394)
..+|++.++||+|+||.||+|++. ++.||||++..... ...+|+.+++.++||||+++++++..... ....+++
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~-~~~~~~l 99 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTS-VDVDLWL 99 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECS-SSEEEEE
T ss_pred hhhchhhheecccCceEEEEEEEC--CCEEEEEEeecCchHHHHHHHHHHHHhcCCCCCchhhcceeccCCC-CCceEEE
Confidence 457999999999999999999986 78999999865432 23457888999999999999999865432 2345789
Q ss_pred EEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC----------CceeccCCCCceEEeCCCCcEEE
Q 016184 158 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI----------GICHRDIKPQNLLVNPHTHQLKL 226 (394)
Q Consensus 158 v~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~----------givH~Dlkp~Nil~~~~~~~vkl 226 (394)
||||+++ +|.+++.. ..+++..++.++.|++.||.|||+ . ||+||||||+|||++.++ .+||
T Consensus 100 v~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~qi~~al~~LH~-~~~~l~~~~~~~ivH~Dlkp~Nill~~~~-~~kL 172 (322)
T 3soc_A 100 ITAFHEKGSLSDFLKA-----NVVSWNELCHIAETMARGLAYLHE-DIPGLKDGHKPAISHRDIKSKNVLLKNNL-TACI 172 (322)
T ss_dssp EEECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHTC-CEEEETTEEECEEECSCCSGGGEEECTTC-CEEE
T ss_pred EEecCCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHh-hccccccccCCCEEeCCCChHhEEECCCC-eEEE
Confidence 9999975 88887764 569999999999999999999998 8 999999999999999887 7999
Q ss_pred EeecCccccccCCC---cccccccccccccccccCC----CCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHH
Q 016184 227 CDFGSAKVLVKGEP---NVSYICSRYYRAPELIFGA----TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIK 299 (394)
Q Consensus 227 ~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~----~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~ 299 (394)
+|||+++....... .....||+.|+|||++.+. ..++.++|||||||++|+|++|+.||.+............
T Consensus 173 ~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~ 252 (322)
T 3soc_A 173 ADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEE 252 (322)
T ss_dssp CCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHH
T ss_pred ccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhh
Confidence 99999976544322 2335789999999999653 2356688999999999999999999987543221111111
Q ss_pred HhCCCChhhhhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 016184 300 VLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV 364 (394)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 364 (394)
....+....+...... ................++++.+||.+||+.||++|||+.++++
T Consensus 253 ~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~ 311 (322)
T 3soc_A 253 IGQHPSLEDMQEVVVH------KKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGE 311 (322)
T ss_dssp HCSSCCHHHHHHHHTT------SCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hccCCchhhhhhhhhc------ccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 1122222111100000 0000000000011223466999999999999999999999985
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=333.92 Aligned_cols=256 Identities=25% Similarity=0.337 Sum_probs=196.3
Q ss_pred ceeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccc------hhhhHHHHHHHHHcC--CCCeeeeceEEEecCCCce
Q 016184 81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLD--HPNIVALKHCFFSTTDKEE 152 (394)
Q Consensus 81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~--h~~iv~~~~~~~~~~~~~~ 152 (394)
..+|++.+.||+|+||.||+|.+. +++.||||++... .....+|+++++.+. |+||+++++++. ..
T Consensus 27 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~-----~~ 100 (313)
T 3cek_A 27 GRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEI-----TD 100 (313)
T ss_dssp TEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEE-----CS
T ss_pred cceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEee-----cC
Confidence 346999999999999999999985 5899999998542 234467999999997 599999999883 33
Q ss_pred eEEEEEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCc
Q 016184 153 LYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA 232 (394)
Q Consensus 153 ~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a 232 (394)
.+.+++||+.+++|.+++.. ...+++..++.++.|++.||.|||+ .||+||||||+|||++. + .+||+|||++
T Consensus 101 ~~~~lv~e~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~dlkp~NIl~~~-~-~~kL~Dfg~~ 173 (313)
T 3cek_A 101 QYIYMVMECGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQ-HGIVHSDLKPANFLIVD-G-MLKLIDFGIA 173 (313)
T ss_dssp SEEEEEECCCSEEHHHHHHH----CSSCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEEET-T-EEEECCCSSS
T ss_pred CEEEEEEecCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCcccEEEEC-C-eEEEeecccc
Confidence 45889999888888887764 3578999999999999999999999 89999999999999974 5 7999999999
Q ss_pred cccccCCC---cccccccccccccccccCC----------CCCCChhhHHHHHHHHHHHHhCCCCCCCCCcH-HHHHHHH
Q 016184 233 KVLVKGEP---NVSYICSRYYRAPELIFGA----------TEYTTAIDIWSTGCVMAELLLGQPLFPGESGV-DQLVEII 298 (394)
Q Consensus 233 ~~~~~~~~---~~~~~~t~~y~aPE~~~~~----------~~~~~~~DiwslG~il~~lltg~~pf~~~~~~-~~~~~i~ 298 (394)
........ .....+|+.|+|||.+.+. ..++.++||||||+++|+|++|+.||...... ..+..+.
T Consensus 174 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~ 253 (313)
T 3cek_A 174 NQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAII 253 (313)
T ss_dssp CC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHH
T ss_pred ccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHH
Confidence 76543322 2245689999999998541 35788999999999999999999999765433 2222221
Q ss_pred HHhCCCChhhhhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCC
Q 016184 299 KVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNT 376 (394)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~ 376 (394)
... .. ..++...+.++.+||.+||+.||.+|||+.++|+||||+....+..
T Consensus 254 ~~~---------------~~------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~~~~ 304 (313)
T 3cek_A 254 DPN---------------HE------------IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVN 304 (313)
T ss_dssp CTT---------------SC------------CCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC-----
T ss_pred hcc---------------cc------------cCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCccccCCCCchh
Confidence 100 00 0112345789999999999999999999999999999987655544
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=327.13 Aligned_cols=245 Identities=19% Similarity=0.322 Sum_probs=200.3
Q ss_pred ceeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccc---hhhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEEEE
Q 016184 81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD---KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL 157 (394)
Q Consensus 81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 157 (394)
..+|++.+.||+|+||.||+|++. +++.||+|++... .....+|+++++.++||||+++++++.. ....++
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----~~~~~l 82 (269)
T 4hcu_A 9 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE-----QAPICL 82 (269)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECS-----SSSEEE
T ss_pred hhhceeeheecCCCccEEEEEEec-CCCeEEEEEecccccCHHHHHHHHHHHHhCCCCCEeeEEEEEec-----CCceEE
Confidence 346999999999999999999986 5778999998653 3456789999999999999999998832 333789
Q ss_pred EEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCccccc
Q 016184 158 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV 236 (394)
Q Consensus 158 v~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~ 236 (394)
||||+++ +|.+++... ...+++..++.++.|++.||+|||+ .||+||||||+||+++.++ .+||+|||++....
T Consensus 83 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~lH~-~~i~H~dikp~Nil~~~~~-~~kl~Dfg~~~~~~ 157 (269)
T 4hcu_A 83 VFEFMEHGCLSDYLRTQ---RGLFAAETLLGMCLDVCEGMAYLEE-ACVIHRDLAARNCLVGENQ-VIKVSDFGMTRFVL 157 (269)
T ss_dssp EEECCTTCBHHHHHHTT---TTCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECGGG-CEEECCTTGGGGBC
T ss_pred EEEeCCCCcHHHHHHhc---CcccCHHHHHHHHHHHHHHHHHHHh-CCeecCCcchheEEEcCCC-CEEecccccccccc
Confidence 9999975 777766542 3568999999999999999999999 8999999999999999887 69999999997653
Q ss_pred cCC--CcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCChhhhhccC
Q 016184 237 KGE--PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 313 (394)
Q Consensus 237 ~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 313 (394)
... ......+++.|+|||.+.+. .++.++||||||+++|+|++ |+.||......+....+......
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~~~---------- 226 (269)
T 4hcu_A 158 DDQYTSSTGTKFPVKWASPEVFSFS-RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRL---------- 226 (269)
T ss_dssp CHHHHSTTSTTCCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCC----------
T ss_pred ccccccccCcccccccCCHHHhcCC-CCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCccC----------
Confidence 321 22234557789999999654 48999999999999999999 99999887776666555432110
Q ss_pred CCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 016184 314 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH 365 (394)
Q Consensus 314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 365 (394)
..+..+++.+.+||.+||+.||.+|||+.++++|
T Consensus 227 ------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 260 (269)
T 4hcu_A 227 ------------------YKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQ 260 (269)
T ss_dssp ------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ------------------CCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 0124568999999999999999999999999875
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-45 Score=341.73 Aligned_cols=251 Identities=24% Similarity=0.347 Sum_probs=201.3
Q ss_pred ceeEEEeeEEeecCceEEEEEE-----ECCCCcEEEEEEeccch-----hhhHHHHHHHHHc-CCCCeeeeceEEEecCC
Q 016184 81 KVSYIAEHVVGTGSFGVVFQAK-----CRETGEIVAIKKVLQDK-----RYKNRELQIMQML-DHPNIVALKHCFFSTTD 149 (394)
Q Consensus 81 ~~~y~~~~~lg~G~~g~V~~~~-----~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~ 149 (394)
.++|++.+.||+|+||.||+|+ +..+++.||||++.... ....+|+++++.+ .||||+++++++...
T Consensus 21 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~-- 98 (359)
T 3vhe_A 21 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP-- 98 (359)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST--
T ss_pred ccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecC--
Confidence 4569999999999999999999 55677999999986532 3356799999999 789999999988432
Q ss_pred CceeEEEEEEecccc-cHHHHHHHhhhh----------------------------------------------------
Q 016184 150 KEELYLNLVLEYVPE-TVNRIARNYSRI---------------------------------------------------- 176 (394)
Q Consensus 150 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~---------------------------------------------------- 176 (394)
....++||||+.+ +|.+++......
T Consensus 99 --~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 176 (359)
T 3vhe_A 99 --GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDV 176 (359)
T ss_dssp --TSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-----------------------------------------------
T ss_pred --CCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchh
Confidence 2236789999985 888887754321
Q ss_pred ----------cCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCccccccCCC---ccc
Q 016184 177 ----------HQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP---NVS 243 (394)
Q Consensus 177 ----------~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~~~~---~~~ 243 (394)
...+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||++........ ...
T Consensus 177 ~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~-~~ivH~Dikp~NIll~~~~-~~kl~Dfg~a~~~~~~~~~~~~~~ 254 (359)
T 3vhe_A 177 EEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS-RKCIHRDLAARNILLSEKN-VVKICDFGLARDIYKDPDYVRKGD 254 (359)
T ss_dssp -------CTTTTCBCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECGGG-CEEECCCGGGSCTTSCTTCEEC--
T ss_pred hhcccccchhccccCHHHHHHHHHHHHHHHHHHHH-CCcccCCCChhhEEEcCCC-cEEEEeccceeeecccccchhccc
Confidence 1228999999999999999999999 8999999999999999887 699999999976543322 223
Q ss_pred ccccccccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCCCcccCCC
Q 016184 244 YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 322 (394)
Q Consensus 244 ~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (394)
..+|+.|+|||++.+. .++.++|||||||++|+|++ |..||.+......+...........
T Consensus 255 ~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~----------------- 316 (359)
T 3vhe_A 255 ARLPLKWMAPETIFDR-VYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMR----------------- 316 (359)
T ss_dssp CEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCC-----------------
T ss_pred cCCCceeEChhhhcCC-CCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCCC-----------------
Confidence 5678899999998654 48999999999999999998 9999988776555554444221111
Q ss_pred CCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 016184 323 QIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH 365 (394)
Q Consensus 323 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 365 (394)
.+..+++++.+||.+||+.||.+|||+.++++|
T Consensus 317 ----------~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 349 (359)
T 3vhe_A 317 ----------APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 349 (359)
T ss_dssp ----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ----------CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHH
Confidence 124578999999999999999999999999975
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-44 Score=339.41 Aligned_cols=256 Identities=16% Similarity=0.146 Sum_probs=195.5
Q ss_pred eeEEEeeEEeecCceEEEEEEECCC-----CcEEEEEEeccchhhhHHHHH---------------HHHHcCCCCeeeec
Q 016184 82 VSYIAEHVVGTGSFGVVFQAKCRET-----GEIVAIKKVLQDKRYKNRELQ---------------IMQMLDHPNIVALK 141 (394)
Q Consensus 82 ~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~vaiK~~~~~~~~~~~E~~---------------~l~~l~h~~iv~~~ 141 (394)
.+|++.+.||+|+||.||+|.+..+ ++.||||++........+|++ .++.++|+||++++
T Consensus 35 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~ 114 (364)
T 3op5_A 35 AAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYW 114 (364)
T ss_dssp CEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCEE
T ss_pred CeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeEE
Confidence 3699999999999999999998764 588999998765544444444 44556799999999
Q ss_pred eEEEecCCCceeEEEEEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEe--C
Q 016184 142 HCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVN--P 219 (394)
Q Consensus 142 ~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~--~ 219 (394)
+++.... ....+.++||||++++|.+++... ...+++..++.++.||+.||+|||+ +||+||||||+|||++ .
T Consensus 115 ~~~~~~~-~~~~~~~lv~e~~g~~L~~~~~~~---~~~l~~~~~~~i~~qi~~~l~~lH~-~~iiHrDlkp~Nill~~~~ 189 (364)
T 3op5_A 115 GSGLHDK-NGKSYRFMIMDRFGSDLQKIYEAN---AKRFSRKTVLQLSLRILDILEYIHE-HEYVHGDIKASNLLLNYKN 189 (364)
T ss_dssp EEEEEEE-TTEEEEEEEEECEEEEHHHHHHHT---TSCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEEESSC
T ss_pred eeeeecc-CCcceEEEEEeCCCCCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHH-CCeEEecCCHHHEEEecCC
Confidence 9886543 334678899999988888877652 3679999999999999999999999 8999999999999998 6
Q ss_pred CCCcEEEEeecCccccccCCC--------cccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcH
Q 016184 220 HTHQLKLCDFGSAKVLVKGEP--------NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGV 291 (394)
Q Consensus 220 ~~~~vkl~Dfg~a~~~~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~ 291 (394)
++ .+||+|||+++....... .....||+.|+|||++.+.. ++.++|||||||++|+|+||+.||.+....
T Consensus 190 ~~-~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~g~~Pf~~~~~~ 267 (364)
T 3op5_A 190 PD-QVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVA-PSRRGDLEILGYCMIQWLTGHLPWEDNLKD 267 (364)
T ss_dssp TT-CEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSCCTTGGGTTC
T ss_pred CC-eEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCC-CCchhhHHHHHHHHHHHHhCCCCccccccC
Confidence 66 799999999976543221 12345899999999996554 899999999999999999999999864333
Q ss_pred HHHHH-HHHHhCCCChhhhh-ccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 016184 292 DQLVE-IIKVLGTPTREEIK-CMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV 364 (394)
Q Consensus 292 ~~~~~-i~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 364 (394)
..... .............. ++ ....++.++.+||..||+.||.+||++.+|++
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~--------------------~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~ 322 (364)
T 3op5_A 268 PKYVRDSKIRYRENIASLMDKCF--------------------PAANAPGEIAKYMETVKLLDYTEKPLYENLRD 322 (364)
T ss_dssp HHHHHHHHHHHHHCHHHHHHHHS--------------------CTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HHHHHHHHHHhhhhHHHHHHHhc--------------------ccccCHHHHHHHHHHHhcCCCCCCCCHHHHHH
Confidence 22222 21111111111110 10 01457899999999999999999999998874
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-44 Score=323.93 Aligned_cols=245 Identities=20% Similarity=0.299 Sum_probs=199.7
Q ss_pred ceeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccc---hhhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEEEE
Q 016184 81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD---KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL 157 (394)
Q Consensus 81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 157 (394)
..+|++.+.||+|+||.||+|.+. ++..||+|++... .....+|+++++.++||||+++++++ ......++
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~~~~l 80 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVC-----SKEYPIYI 80 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTBCHHHHHHHHHHHHHCCCTTBCCEEEEE-----CSSSSEEE
T ss_pred hhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCCcHHHHHHHHHHHHhCCCCCEeeEEEEE-----ccCCceEE
Confidence 456999999999999999999885 5778999998653 34456899999999999999999988 33334789
Q ss_pred EEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCccccc
Q 016184 158 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV 236 (394)
Q Consensus 158 v~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~ 236 (394)
||||+++ +|.+++... ...+++..++.++.|++.||.|||+ .||+||||||+|||++.++ .+||+|||++....
T Consensus 81 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dikp~Nil~~~~~-~~~l~Dfg~~~~~~ 155 (268)
T 3sxs_A 81 VTEYISNGCLLNYLRSH---GKGLEPSQLLEMCYDVCEGMAFLES-HQFIHRDLAARNCLVDRDL-CVKVSDFGMTRYVL 155 (268)
T ss_dssp EEECCTTCBHHHHHHHH---GGGCCHHHHHHHHHHHHHHHHHHHH-TTEEESSCSGGGEEECTTC-CEEECCTTCEEECC
T ss_pred EEEccCCCcHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCcCcceEEECCCC-CEEEccCccceecc
Confidence 9999974 687776543 3569999999999999999999999 8999999999999999888 69999999997654
Q ss_pred cCCCc--ccccccccccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCChhhhhccC
Q 016184 237 KGEPN--VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 313 (394)
Q Consensus 237 ~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 313 (394)
..... ....+|+.|+|||.+.+. .++.++||||||+++|+|++ |..||...........+......
T Consensus 156 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~---------- 224 (268)
T 3sxs_A 156 DDQYVSSVGTKFPVKWSAPEVFHYF-KYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRL---------- 224 (268)
T ss_dssp TTCEEECCSCCCCGGGCCHHHHHHS-EEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCC----------
T ss_pred hhhhhcccCCCcCcccCCHHHHhcc-CCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCCC----------
Confidence 33221 233456789999998654 48999999999999999999 99999887766655554331100
Q ss_pred CCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 016184 314 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH 365 (394)
Q Consensus 314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 365 (394)
..+..+++.+.+||.+||+.||.+|||+.++++|
T Consensus 225 ------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 258 (268)
T 3sxs_A 225 ------------------YRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSS 258 (268)
T ss_dssp ------------------CCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred ------------------CCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 0123468899999999999999999999999975
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-45 Score=339.72 Aligned_cols=248 Identities=25% Similarity=0.404 Sum_probs=196.4
Q ss_pred ceeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccch----------hhhHHHHHHHHHc----CCCCeeeeceEEEe
Q 016184 81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK----------RYKNRELQIMQML----DHPNIVALKHCFFS 146 (394)
Q Consensus 81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----------~~~~~E~~~l~~l----~h~~iv~~~~~~~~ 146 (394)
.++|++.+.||+|+||.||+|++..+++.||||++.... ....+|+.+++.+ +|+||+++++++..
T Consensus 30 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~~ 109 (312)
T 2iwi_A 30 EAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFET 109 (312)
T ss_dssp ---CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC--
T ss_pred hhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEec
Confidence 346999999999999999999999999999999985432 2334699999998 89999999998732
Q ss_pred cCCCceeEEEEEEec-cc-ccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEe-CCCCc
Q 016184 147 TTDKEELYLNLVLEY-VP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVN-PHTHQ 223 (394)
Q Consensus 147 ~~~~~~~~~~lv~e~-~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~-~~~~~ 223 (394)
....++|||+ +. ++|.+++.. ...+++..++.++.||+.||+|||+ .||+||||||+||+++ .++ .
T Consensus 110 -----~~~~~~v~e~~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~Nil~~~~~~-~ 178 (312)
T 2iwi_A 110 -----QEGFMLVLERPLPAQDLFDYITE----KGPLGEGPSRCFFGQVVAAIQHCHS-RGVVHRDIKDENILIDLRRG-C 178 (312)
T ss_dssp --------CEEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHH-HTEECCCCSGGGEEEETTTT-E
T ss_pred -----CCeEEEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCChhhEEEeCCCC-e
Confidence 3346789998 44 578777654 3579999999999999999999999 8999999999999999 555 7
Q ss_pred EEEEeecCccccccCCCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCC
Q 016184 224 LKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGT 303 (394)
Q Consensus 224 vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~ 303 (394)
+||+|||++...... ......+++.|+|||++.+....+.++||||||+++|+|++|+.||.... .+...
T Consensus 179 ~kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~------~~~~~--- 248 (312)
T 2iwi_A 179 AKLIDFGSGALLHDE-PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ------EILEA--- 248 (312)
T ss_dssp EEECCCSSCEECCSS-CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHT---
T ss_pred EEEEEcchhhhcccC-cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH------HHhhh---
Confidence 999999999866433 33456789999999998665544569999999999999999999996531 11110
Q ss_pred CChhhhhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCC
Q 016184 304 PTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 375 (394)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~ 375 (394)
... ++..++..+.+||.+||+.||++|||++++++||||+...+..
T Consensus 249 --------------~~~------------~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~~~~~ 294 (312)
T 2iwi_A 249 --------------ELH------------FPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPAEDV 294 (312)
T ss_dssp --------------CCC------------CCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC-----
T ss_pred --------------ccC------------CcccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhcCchhcc
Confidence 000 1245789999999999999999999999999999999876543
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=348.99 Aligned_cols=257 Identities=28% Similarity=0.414 Sum_probs=189.6
Q ss_pred eEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccch-hhhHHHHHHHHHc-CCCCeeeeceEEEecCCCceeEEEEEEe
Q 016184 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-RYKNRELQIMQML-DHPNIVALKHCFFSTTDKEELYLNLVLE 160 (394)
Q Consensus 83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~lv~e 160 (394)
.|.+.+.||+|+||+||.+. ..+|+.||||++.... ....+|+.+++.+ +||||+++++++ ....+.++|||
T Consensus 16 ~~~~~~~LG~G~~g~V~~~~-~~~g~~vAvK~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~-----~~~~~~~lv~E 89 (434)
T 2rio_A 16 LVVSEKILGYGSSGTVVFQG-SFQGRPVAVKRMLIDFCDIALMEIKLLTESDDHPNVIRYYCSE-----TTDRFLYIALE 89 (434)
T ss_dssp CEEEEEEEEECSTTCEEEEE-ESSSSEEEEEEEEGGGHHHHHHHHHHHHHHTTSTTBCCEEEEE-----ECSSEEEEEEC
T ss_pred eeeccCeEeeCCCeEEEEEE-EECCeEEEEEEEcHHHHHHHHHHHHHHHhccCCCCcCeEEEEE-----ecCCeEEEEEe
Confidence 48888999999999998764 4679999999886543 3446799999876 899999998887 33455889999
Q ss_pred cccccHHHHHHHhhhhcCC---CCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCC------------CcEE
Q 016184 161 YVPETVNRIARNYSRIHQR---MPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHT------------HQLK 225 (394)
Q Consensus 161 ~~~~~l~~~~~~~~~~~~~---l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~------------~~vk 225 (394)
|++++|.+++......... ..+..++.++.||+.||+|||+ +||+||||||+|||++.++ ..+|
T Consensus 90 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~k 168 (434)
T 2rio_A 90 LCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS-LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRIL 168 (434)
T ss_dssp CCSEEHHHHHHTC------------CCHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEE
T ss_pred cCCCCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHH-CCccccCCChHhEEEecCcccccccccCCCceEEE
Confidence 9999998888754322111 1333457799999999999999 8999999999999997532 2699
Q ss_pred EEeecCccccccCCC-----cccccccccccccccccC------CCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHH
Q 016184 226 LCDFGSAKVLVKGEP-----NVSYICSRYYRAPELIFG------ATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQ 293 (394)
Q Consensus 226 l~Dfg~a~~~~~~~~-----~~~~~~t~~y~aPE~~~~------~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~ 293 (394)
|+|||++........ .....||+.|+|||++.+ ...++.++|||||||++|+|++ |..||.+.....
T Consensus 169 L~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~- 247 (434)
T 2rio_A 169 ISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE- 247 (434)
T ss_dssp ECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH-
T ss_pred EcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH-
Confidence 999999987654322 123578999999999864 2458999999999999999999 999997654332
Q ss_pred HHHHHHHhCCCChhhhhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 016184 294 LVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE 370 (394)
Q Consensus 294 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~ 370 (394)
..+.... ...+.. .......+++++.+||.+||+.||.+|||+.++++||||..
T Consensus 248 -~~i~~~~-----------------~~~~~~-----~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f~~ 301 (434)
T 2rio_A 248 -SNIIRGI-----------------FSLDEM-----KCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWP 301 (434)
T ss_dssp -HHHHHTC-----------------CCCCCC-----TTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSC
T ss_pred -HHHhcCC-----------------CCcccc-----cccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCccCC
Confidence 2222211 000000 00011345688999999999999999999999999999964
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-45 Score=349.92 Aligned_cols=254 Identities=24% Similarity=0.356 Sum_probs=189.9
Q ss_pred eeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccc-hhhhHHHHHHHHHc-CCCCeeeeceEEEecCCCceeEEEEEE
Q 016184 82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-KRYKNRELQIMQML-DHPNIVALKHCFFSTTDKEELYLNLVL 159 (394)
Q Consensus 82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~lv~ 159 (394)
.+|.+.++||+|+||+||.. ...+|+.||||++... .....+|+++++.+ +||||+++++++ ....+.++||
T Consensus 24 ~~y~~~~~LG~G~~G~V~~~-~~~~~~~vAvK~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~-----~~~~~~~lv~ 97 (432)
T 3p23_A 24 ISFCPKDVLGHGAEGTIVYR-GMFDNRDVAVKRILPECFSFADREVQLLRESDEHPNVIRYFCTE-----KDRQFQYIAI 97 (432)
T ss_dssp EEEEEEEEEEECGGGCEEEE-EESSSSEEEEEEECTTTEEECHHHHHHHHHSCCCTTBCCEEEEE-----EETTEEEEEE
T ss_pred EEEecCCeeecCcCEEEEEE-EEeCCeEEEEEEECHHHHHHHHHHHHHHHhccCCCCcCeEEEEE-----ecCCEEEEEE
Confidence 35999999999999997643 3467899999998653 24457899999999 899999999887 3344578999
Q ss_pred ecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCC----CcEEEEeecCcccc
Q 016184 160 EYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHT----HQLKLCDFGSAKVL 235 (394)
Q Consensus 160 e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~----~~vkl~Dfg~a~~~ 235 (394)
||++++|.+++.... ..+.+..++.++.||+.||+|||+ +||+||||||+|||++.++ ..+||+|||+++..
T Consensus 98 E~~~g~L~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~ 173 (432)
T 3p23_A 98 ELCAATLQEYVEQKD---FAHLGLEPITLLQQTTSGLAHLHS-LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKL 173 (432)
T ss_dssp ECCSEEHHHHHHSSS---CCCCSSCHHHHHHHHHHHHHHHHH-TTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC
T ss_pred ECCCCCHHHHHHhcC---CCccchhHHHHHHHHHHHHHHHHH-CcCEeCCCCHHHEEEecCCCCCceeEEEecccceeec
Confidence 999999888776432 334555667899999999999999 8999999999999995322 15889999999876
Q ss_pred ccCC----CcccccccccccccccccC--CCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCChhh
Q 016184 236 VKGE----PNVSYICSRYYRAPELIFG--ATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREE 308 (394)
Q Consensus 236 ~~~~----~~~~~~~t~~y~aPE~~~~--~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 308 (394)
.... ......||+.|+|||++.+ ...++.++|||||||++|+|++ |..||........ ..+. +....
T Consensus 174 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~-~~~~---~~~~~-- 247 (432)
T 3p23_A 174 AVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQA-NILL---GACSL-- 247 (432)
T ss_dssp ------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHH-HHHT---TCCCC--
T ss_pred cCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHH-HHHh---ccCCc--
Confidence 4332 2234578999999999864 3347889999999999999999 8999965443221 1111 11000
Q ss_pred hhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 016184 309 IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL 371 (394)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 371 (394)
.... .....+..+.+||.+||+.||.+|||+.++++||||..+
T Consensus 248 -------------~~~~-------~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~~ 290 (432)
T 3p23_A 248 -------------DCLH-------PEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSL 290 (432)
T ss_dssp -------------TTSC-------TTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCCH
T ss_pred -------------cccC-------ccccccHHHHHHHHHHHhCCHhhCCCHHHHHhCccccCh
Confidence 0000 002235668999999999999999999999999999764
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=338.48 Aligned_cols=248 Identities=24% Similarity=0.319 Sum_probs=200.3
Q ss_pred ceeEEEeeEEeecCceEEEEEEEC-----CCCcEEEEEEeccc-----hhhhHHHHHHHHHcCCCCeeeeceEEEecCCC
Q 016184 81 KVSYIAEHVVGTGSFGVVFQAKCR-----ETGEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDK 150 (394)
Q Consensus 81 ~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 150 (394)
..+|++.+.||+|+||.||+|++. .+++.||||++... ...+.+|+.+++.++||||+++++++..
T Consensus 46 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~---- 121 (343)
T 1luf_A 46 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAV---- 121 (343)
T ss_dssp GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS----
T ss_pred HHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcc----
Confidence 456999999999999999999997 34589999998653 2345679999999999999999998833
Q ss_pred ceeEEEEEEecccc-cHHHHHHHhhhh--------------------cCCCCHHHHHHHHHHHHHHHHHHHhCCCceecc
Q 016184 151 EELYLNLVLEYVPE-TVNRIARNYSRI--------------------HQRMPLIYVKLYTYQICRALAYIHNCIGICHRD 209 (394)
Q Consensus 151 ~~~~~~lv~e~~~~-~l~~~~~~~~~~--------------------~~~l~~~~~~~~~~qi~~al~~LH~~~givH~D 209 (394)
....++||||+++ +|.+++...... ...+++..++.++.||+.||.|||+ +||+|||
T Consensus 122 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~-~~ivH~D 199 (343)
T 1luf_A 122 -GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE-RKFVHRD 199 (343)
T ss_dssp -SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSC
T ss_pred -CCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCC
Confidence 3337799999985 888887763221 2578999999999999999999999 8999999
Q ss_pred CCCCceEEeCCCCcEEEEeecCccccccCC---CcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCC
Q 016184 210 IKPQNLLVNPHTHQLKLCDFGSAKVLVKGE---PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLF 285 (394)
Q Consensus 210 lkp~Nil~~~~~~~vkl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf 285 (394)
|||+|||++.++ .+||+|||++....... ......+|+.|+|||++.+.. ++.++||||||+++|+|++ |..||
T Consensus 200 lkp~NIl~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~el~t~g~~p~ 277 (343)
T 1luf_A 200 LATRNCLVGENM-VVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNR-YTTESDVWAYGVVLWEIFSYGLQPY 277 (343)
T ss_dssp CSGGGEEECGGG-CEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred CCcceEEECCCC-eEEEeecCCCcccccCccccccCCCcccceecChhhhccCC-cCcccccHHHHHHHHHHHhcCCCcC
Confidence 999999999887 79999999997653321 223456788999999986544 8999999999999999999 99999
Q ss_pred CCCCcHHHHHHHHHHhCCCChhhhhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 016184 286 PGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV 364 (394)
Q Consensus 286 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 364 (394)
.+....+....+...... .++..++.++.+||++||+.||.+|||+.++++
T Consensus 278 ~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~ 328 (343)
T 1luf_A 278 YGMAHEEVIYYVRDGNIL----------------------------ACPENCPLELYNLMRLCWSKLPADRPSFCSIHR 328 (343)
T ss_dssp TTSCHHHHHHHHHTTCCC----------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCChHHHHHHHhCCCcC----------------------------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 887766555544331100 012467899999999999999999999999986
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-44 Score=338.63 Aligned_cols=251 Identities=21% Similarity=0.305 Sum_probs=202.0
Q ss_pred ccceeEEEeeEEeecCceEEEEEEECCC-------CcEEEEEEeccch-----hhhHHHHHHHHHc-CCCCeeeeceEEE
Q 016184 79 KQKVSYIAEHVVGTGSFGVVFQAKCRET-------GEIVAIKKVLQDK-----RYKNRELQIMQML-DHPNIVALKHCFF 145 (394)
Q Consensus 79 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~-------~~~vaiK~~~~~~-----~~~~~E~~~l~~l-~h~~iv~~~~~~~ 145 (394)
....+|.+.+.||+|+||.||+|++..+ +..||||++.... ....+|+++++.+ +||||+++++++.
T Consensus 66 i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~ 145 (382)
T 3tt0_A 66 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT 145 (382)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeec
Confidence 3445799999999999999999997543 3579999986432 3345799999999 9999999999883
Q ss_pred ecCCCceeEEEEEEecccc-cHHHHHHHhhhh------------cCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCC
Q 016184 146 STTDKEELYLNLVLEYVPE-TVNRIARNYSRI------------HQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKP 212 (394)
Q Consensus 146 ~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~------------~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp 212 (394)
. ....++||||+.+ +|.+++...... ...+++..++.++.||+.||+|||+ .||+||||||
T Consensus 146 ~-----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dlkp 219 (382)
T 3tt0_A 146 Q-----DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS-KKCIHRDLAA 219 (382)
T ss_dssp S-----SSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCG
T ss_pred c-----CCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh-CCEecCCCCc
Confidence 3 2336799999975 888887764321 2459999999999999999999999 8999999999
Q ss_pred CceEEeCCCCcEEEEeecCccccccCC---CcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCC
Q 016184 213 QNLLVNPHTHQLKLCDFGSAKVLVKGE---PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGE 288 (394)
Q Consensus 213 ~Nil~~~~~~~vkl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~ 288 (394)
+|||++.++ .+||+|||+++...... ......+|+.|+|||++.+. .++.++|||||||++|+|++ |..||.+.
T Consensus 220 ~NIll~~~~-~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwslG~il~ellt~g~~p~~~~ 297 (382)
T 3tt0_A 220 RNVLVTEDN-VMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDR-IYTHQSDVWSFGVLLWEIFTLGGSPYPGV 297 (382)
T ss_dssp GGEEECTTC-CEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred ceEEEcCCC-cEEEcccCcccccccccccccccCCCCCcceeCHHHhcCC-CCCchhHHHHHHHHHHHHHhCCCCCCCCC
Confidence 999999888 79999999998654332 22334568889999999764 48999999999999999999 99999887
Q ss_pred CcHHHHHHHHHHhCCCChhhhhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 016184 289 SGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH 365 (394)
Q Consensus 289 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 365 (394)
...+....+...... ..+..+++++.+||.+||+.||++|||+.+++++
T Consensus 298 ~~~~~~~~~~~~~~~----------------------------~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 346 (382)
T 3tt0_A 298 PVEELFKLLKEGHRM----------------------------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 346 (382)
T ss_dssp CHHHHHHHHHTTCCC----------------------------CCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CHHHHHHHHHcCCCC----------------------------CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 765554444331100 0124578999999999999999999999999975
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-44 Score=332.09 Aligned_cols=250 Identities=20% Similarity=0.336 Sum_probs=200.6
Q ss_pred cceeEEEeeEEeecCceEEEEEEEC-----CCCcEEEEEEeccch-----hhhHHHHHHHHHcCCCCeeeeceEEEecCC
Q 016184 80 QKVSYIAEHVVGTGSFGVVFQAKCR-----ETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTD 149 (394)
Q Consensus 80 ~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 149 (394)
...+|++.+.||+|+||.||+|.+. .+++.||||++.... ....+|+++++.++||||+++++++..
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--- 97 (314)
T 2ivs_A 21 PRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQ--- 97 (314)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS---
T ss_pred chhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEec---
Confidence 3456999999999999999999983 456899999986432 344579999999999999999998832
Q ss_pred CceeEEEEEEeccc-ccHHHHHHHhhh--------------------hcCCCCHHHHHHHHHHHHHHHHHHHhCCCceec
Q 016184 150 KEELYLNLVLEYVP-ETVNRIARNYSR--------------------IHQRMPLIYVKLYTYQICRALAYIHNCIGICHR 208 (394)
Q Consensus 150 ~~~~~~~lv~e~~~-~~l~~~~~~~~~--------------------~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~ 208 (394)
....++||||+. ++|.+++..... ....+++..++.++.||+.||.|||+ +||+||
T Consensus 98 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~ivH~ 174 (314)
T 2ivs_A 98 --DGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAE-MKLVHR 174 (314)
T ss_dssp --SSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHH-TTEECC
T ss_pred --CCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHH-CCCccc
Confidence 233779999998 588888776432 12348999999999999999999999 899999
Q ss_pred cCCCCceEEeCCCCcEEEEeecCccccccCCC---cccccccccccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCC
Q 016184 209 DIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP---NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPL 284 (394)
Q Consensus 209 Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~p 284 (394)
||||+|||++.++ .+||+|||++........ .....+++.|+|||++.+. .++.++||||||+++|+|++ |..|
T Consensus 175 dikp~NIli~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~t~g~~p 252 (314)
T 2ivs_A 175 DLAARNILVAEGR-KMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDH-IYTTQSDVWSFGVLLWEIVTLGGNP 252 (314)
T ss_dssp CCSGGGEEEETTT-EEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCS
T ss_pred ccchheEEEcCCC-CEEEccccccccccccccceeccCCCCcccccChhhhcCC-CcCchhhHHHHHHHHHHHHhCCCCC
Confidence 9999999999887 799999999976543322 1234557889999998654 48999999999999999999 9999
Q ss_pred CCCCCcHHHHHHHHHHhCCCChhhhhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 016184 285 FPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV 364 (394)
Q Consensus 285 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 364 (394)
|.+.........+..... ...+..+++++.+||.+||+.||.+|||+.++++
T Consensus 253 ~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~ 304 (314)
T 2ivs_A 253 YPGIPPERLFNLLKTGHR----------------------------MERPDNCSEEMYRLMLQCWKQEPDKRPVFADISK 304 (314)
T ss_dssp STTCCGGGHHHHHHTTCC----------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCHHHHHHHhhcCCc----------------------------CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 988776555444332110 0012467899999999999999999999999986
Q ss_pred C
Q 016184 365 H 365 (394)
Q Consensus 365 h 365 (394)
+
T Consensus 305 ~ 305 (314)
T 2ivs_A 305 D 305 (314)
T ss_dssp H
T ss_pred H
Confidence 4
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-44 Score=324.62 Aligned_cols=241 Identities=28% Similarity=0.445 Sum_probs=188.0
Q ss_pred eeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccc--------hhhhHHHHHHHHHcCCCCeeeeceEEEecCCCcee
Q 016184 82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD--------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL 153 (394)
Q Consensus 82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 153 (394)
.+|++.+.||+|+||.||+|++. |+.||||++... .....+|+++++.++||||+++++++. ...
T Consensus 7 ~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~ 79 (271)
T 3dtc_A 7 AELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCL-----KEP 79 (271)
T ss_dssp TSEEEEEEEEEETTEEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEEC-----CC-
T ss_pred hheeeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEe-----cCC
Confidence 45999999999999999999985 889999987543 234567999999999999999999883 334
Q ss_pred EEEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCC---ceeccCCCCceEEeC--------CC
Q 016184 154 YLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG---ICHRDIKPQNLLVNP--------HT 221 (394)
Q Consensus 154 ~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~g---ivH~Dlkp~Nil~~~--------~~ 221 (394)
..++||||+.+ ++.+++. ...+++..++.++.|++.||.|||+ .| |+||||||+|||++. ++
T Consensus 80 ~~~lv~e~~~~~~L~~~~~-----~~~~~~~~~~~i~~~l~~~l~~lH~-~~~~~i~H~dikp~Nil~~~~~~~~~~~~~ 153 (271)
T 3dtc_A 80 NLCLVMEFARGGPLNRVLS-----GKRIPPDILVNWAVQIARGMNYLHD-EAIVPIIHRDLKSSNILILQKVENGDLSNK 153 (271)
T ss_dssp -CEEEEECCTTEEHHHHHT-----SSCCCHHHHHHHHHHHHHHHHHHHH-SSSSCCCCSCCSGGGEEESSCCSSSCCSSC
T ss_pred ceEEEEEcCCCCCHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceeecCCchHHEEEecccccccccCc
Confidence 47899999974 6666553 3689999999999999999999999 78 899999999999986 34
Q ss_pred CcEEEEeecCccccccCCCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHh
Q 016184 222 HQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVL 301 (394)
Q Consensus 222 ~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~ 301 (394)
.+||+|||++....... .....+|+.|+|||.+.+. .++.++||||||+++|+|++|+.||.+.+.......+....
T Consensus 154 -~~kl~Dfg~~~~~~~~~-~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~ 230 (271)
T 3dtc_A 154 -ILKITDFGLAREWHRTT-KMSAAGAYAWMAPEVIRAS-MFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNK 230 (271)
T ss_dssp -CEEECCCCC--------------CCGGGSCHHHHHHC-CCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSC
T ss_pred -ceEEccCCccccccccc-ccCCCCccceeCHHHhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCC
Confidence 69999999997654332 3355789999999998654 48999999999999999999999998877655544433211
Q ss_pred CCCChhhhhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 016184 302 GTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH 365 (394)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 365 (394)
. ...++..+++.+.+||.+||+.||.+|||+.++++|
T Consensus 231 ~---------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 267 (271)
T 3dtc_A 231 L---------------------------ALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQ 267 (271)
T ss_dssp C---------------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred C---------------------------CCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence 0 001224678999999999999999999999999874
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-44 Score=341.71 Aligned_cols=246 Identities=22% Similarity=0.306 Sum_probs=198.9
Q ss_pred cceeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccc-----hhhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeE
Q 016184 80 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY 154 (394)
Q Consensus 80 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 154 (394)
...+|++.+.||+|+||.||+|++..+++.||||++... ...+.+|+++++.++||||+++++++.. ...
T Consensus 112 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-----~~~ 186 (377)
T 3cbl_A 112 NHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQ-----KQP 186 (377)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECS-----SSS
T ss_pred chHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEec-----CCC
Confidence 445799999999999999999999989999999998643 1345579999999999999999998832 233
Q ss_pred EEEEEeccc-ccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCcc
Q 016184 155 LNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK 233 (394)
Q Consensus 155 ~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~ 233 (394)
.++||||++ ++|.+++... ...+++..++.++.|++.||+|||+ +||+||||||+|||++.++ .+||+|||+++
T Consensus 187 ~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~LH~-~~ivHrDlkp~Nil~~~~~-~~kl~DfG~s~ 261 (377)
T 3cbl_A 187 IYIVMELVQGGDFLTFLRTE---GARLRVKTLLQMVGDAAAGMEYLES-KCCIHRDLAARNCLVTEKN-VLKISDFGMSR 261 (377)
T ss_dssp CEEEEECCTTCBHHHHHHHH---GGGCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECTTC-CEEECCGGGCE
T ss_pred cEEEEEcCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHH-CCcCCcccCHHHEEEcCCC-cEEECcCCCce
Confidence 679999997 5787776642 3568999999999999999999999 8999999999999999887 79999999997
Q ss_pred ccccCCCc---ccccccccccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCChhhh
Q 016184 234 VLVKGEPN---VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEI 309 (394)
Q Consensus 234 ~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 309 (394)
........ ....+++.|+|||++.+. .++.++|||||||++|||++ |..||.+....+....+.... ..
T Consensus 262 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~~-~~----- 334 (377)
T 3cbl_A 262 EEADGVYAASGGLRQVPVKWTAPEALNYG-RYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGG-RL----- 334 (377)
T ss_dssp ECTTSEEECCSSCCEEEGGGSCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTC-CC-----
T ss_pred ecCCCceeecCCCCCCCcCcCCHhHhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-CC-----
Confidence 54322111 122346789999998654 48999999999999999998 999998877655444332211 00
Q ss_pred hccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 016184 310 KCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV 364 (394)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 364 (394)
..+..+++++.+||.+||+.||++|||+.++++
T Consensus 335 ----------------------~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~ 367 (377)
T 3cbl_A 335 ----------------------PCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQ 367 (377)
T ss_dssp ----------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ----------------------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 012457899999999999999999999999875
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=325.25 Aligned_cols=249 Identities=22% Similarity=0.227 Sum_probs=199.6
Q ss_pred eeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccc--hhhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEEEEEE
Q 016184 82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD--KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVL 159 (394)
Q Consensus 82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~ 159 (394)
++|++.+.||+|+||.||+|++..+|+.||||++... .....+|+.+++.+.|++++..+..+.. ...+.++||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~----~~~~~~lv~ 84 (296)
T 3uzp_A 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGA----EGDYNVMVM 84 (296)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSCCHHHHHHHHHHHHTTSTTCCCEEEEEE----ETTEEEEEE
T ss_pred cEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcchhHHHHHHHHHHHhhcCCCCCccccccC----CCCceEEEE
Confidence 3599999999999999999999999999999987543 3456789999999999887777666533 233578999
Q ss_pred ecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEe---CCCCcEEEEeecCccccc
Q 016184 160 EYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVN---PHTHQLKLCDFGSAKVLV 236 (394)
Q Consensus 160 e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~---~~~~~vkl~Dfg~a~~~~ 236 (394)
||++++|.+++... ...+++..++.++.|++.||+|||+ +||+||||||+|||++ .++ .+||+|||++....
T Consensus 85 e~~~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~-~~ivH~dlkp~NIl~~~~~~~~-~~kl~Dfg~~~~~~ 159 (296)
T 3uzp_A 85 ELLGPSLEDLFNFC---SRKFSLKTVLLLADQMISRIEYIHS-KNFIHRDVKPDNFLMGLGKKGN-LVYIIDFGLAKKYR 159 (296)
T ss_dssp ECCCCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEECCGGGTT-CEEECCCTTCEECB
T ss_pred EecCCCHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHh-CCeeeCCCCHHHeEEecCCCCC-eEEEeeCCCccccc
Confidence 99988998877642 3579999999999999999999999 8999999999999994 555 79999999998665
Q ss_pred cCCC--------cccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCc---HHHHHHHHHHhCCCC
Q 016184 237 KGEP--------NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESG---VDQLVEIIKVLGTPT 305 (394)
Q Consensus 237 ~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~---~~~~~~i~~~~~~~~ 305 (394)
.... .....+|+.|+|||.+.+.. ++.++|||||||++|+|++|+.||.+... ...+..+.......+
T Consensus 160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 238 (296)
T 3uzp_A 160 DARTHQHIPYRENKNLTGTARYASINTHLGIE-QSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP 238 (296)
T ss_dssp CTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC
T ss_pred ccccccccccccccccccccccCChhhhcCCC-CCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCc
Confidence 4332 23557899999999996544 89999999999999999999999987432 233333333211111
Q ss_pred hhhhhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 016184 306 REEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV 364 (394)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 364 (394)
.. .+...+++++.+||.+||+.||.+|||+.++++
T Consensus 239 ~~------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 273 (296)
T 3uzp_A 239 IE------------------------VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp HH------------------------HHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred hH------------------------HHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHH
Confidence 11 112457899999999999999999999999886
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-44 Score=334.62 Aligned_cols=250 Identities=24% Similarity=0.366 Sum_probs=184.6
Q ss_pred eeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccch----hhhHHHHHHHHHcC-CCCeeeeceEEEecCC---Ccee
Q 016184 82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK----RYKNRELQIMQMLD-HPNIVALKHCFFSTTD---KEEL 153 (394)
Q Consensus 82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~---~~~~ 153 (394)
.+|++.++||+|+||.||+|++..+++.||||++.... ....+|+.+++.+. ||||+++++++..... ....
T Consensus 28 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~ 107 (337)
T 3ll6_A 28 LRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQA 107 (337)
T ss_dssp EEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSE
T ss_pred ceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCCc
Confidence 36999999999999999999999999999999885432 33457899999995 9999999998854332 4456
Q ss_pred EEEEEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCC--ceeccCCCCceEEeCCCCcEEEEeecC
Q 016184 154 YLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG--ICHRDIKPQNLLVNPHTHQLKLCDFGS 231 (394)
Q Consensus 154 ~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~g--ivH~Dlkp~Nil~~~~~~~vkl~Dfg~ 231 (394)
.++++|||+.++|.+++..... ...+++..++.++.||+.||.|||+ .| |+||||||+|||++.++ .+||+|||+
T Consensus 108 ~~~lv~e~~~g~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~-~~~~ivH~Dikp~NIl~~~~~-~~kl~Dfg~ 184 (337)
T 3ll6_A 108 EFLLLTELCKGQLVEFLKKMES-RGPLSCDTVLKIFYQTCRAVQHMHR-QKPPIIHRDLKVENLLLSNQG-TIKLCDFGS 184 (337)
T ss_dssp EEEEEEECCSEEHHHHHHHHHT-TCSCCHHHHHHHHHHHHHHHHHHHT-SSSCCBCCCCCGGGCEECTTS-CEEBCCCTT
T ss_pred eEEEEEEecCCCHHHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHh-CCCCEEEccCCcccEEECCCC-CEEEecCcc
Confidence 6889999999999887765332 4579999999999999999999999 89 99999999999999888 699999999
Q ss_pred ccccccCCCc-------------cccccccccccccccc--CCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHH
Q 016184 232 AKVLVKGEPN-------------VSYICSRYYRAPELIF--GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVE 296 (394)
Q Consensus 232 a~~~~~~~~~-------------~~~~~t~~y~aPE~~~--~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~ 296 (394)
+......... ....+|+.|+|||++. ....++.++||||||+++|+|++|+.||...........
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~ 264 (337)
T 3ll6_A 185 ATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIVNG 264 (337)
T ss_dssp CBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-----------
T ss_pred ceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHhhcC
Confidence 9766433221 1345899999999983 234478899999999999999999999975443221110
Q ss_pred HHHHhCCCChhhhhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 016184 297 IIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH 365 (394)
Q Consensus 297 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 365 (394)
. ... ......+..+.+||++||+.||.+|||+.++++|
T Consensus 265 ~---------------------~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 302 (337)
T 3ll6_A 265 K---------------------YSI----------PPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQ 302 (337)
T ss_dssp ----------------------CCC----------CTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred c---------------------ccC----------CcccccchHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 0 000 0113467789999999999999999999999986
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-44 Score=328.68 Aligned_cols=252 Identities=22% Similarity=0.306 Sum_probs=193.5
Q ss_pred eeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccch-hhhHHHHHHHHH--cCCCCeeeeceEEEecCCCceeEEEEE
Q 016184 82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-RYKNRELQIMQM--LDHPNIVALKHCFFSTTDKEELYLNLV 158 (394)
Q Consensus 82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~E~~~l~~--l~h~~iv~~~~~~~~~~~~~~~~~~lv 158 (394)
++|++.+.||+|+||+||+|++ +|+.||||++.... ....+|.+++.. ++||||+++++++.... ......++|
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~-~~~~~~~lv 84 (301)
T 3q4u_A 8 RDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMTSR-HSSTQLWLI 84 (301)
T ss_dssp GGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEE-TTEEEEEEE
T ss_pred CcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEeccccchhhHHHHHHHHHhhccCcCeeeEEEeecccc-CCCceeEEe
Confidence 4699999999999999999998 58999999986543 334467777777 79999999999875533 334567899
Q ss_pred Eecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHH--------hCCCceeccCCCCceEEeCCCCcEEEEee
Q 016184 159 LEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH--------NCIGICHRDIKPQNLLVNPHTHQLKLCDF 229 (394)
Q Consensus 159 ~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH--------~~~givH~Dlkp~Nil~~~~~~~vkl~Df 229 (394)
|||+++ +|.+++.. ..+++..++.++.|++.||+||| + .||+||||||+|||++.++ .+||+||
T Consensus 85 ~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~-~~ivH~Dlkp~Nill~~~~-~~kl~Df 157 (301)
T 3q4u_A 85 THYHEMGSLYDYLQL-----TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGK-PAIAHRDLKSKNILVKKNG-QCCIADL 157 (301)
T ss_dssp ECCCTTCBHHHHHTT-----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCB-CEEECSCCCGGGEEECTTS-CEEECCC
T ss_pred hhhccCCCHHHHHhh-----cccCHHHHHHHHHHHHHHHHHHHHhhhhccCC-CCeecCCCChHhEEEcCCC-CEEEeeC
Confidence 999985 88777743 67999999999999999999999 8 8999999999999999888 7999999
Q ss_pred cCccccccCCCc-----ccccccccccccccccCCC-----CCCChhhHHHHHHHHHHHHhC----------CCCCCCCC
Q 016184 230 GSAKVLVKGEPN-----VSYICSRYYRAPELIFGAT-----EYTTAIDIWSTGCVMAELLLG----------QPLFPGES 289 (394)
Q Consensus 230 g~a~~~~~~~~~-----~~~~~t~~y~aPE~~~~~~-----~~~~~~DiwslG~il~~lltg----------~~pf~~~~ 289 (394)
|++......... ....||+.|+|||++.+.. .++.++|||||||++|+|++| ..||....
T Consensus 158 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~ 237 (301)
T 3q4u_A 158 GLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVV 237 (301)
T ss_dssp TTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTS
T ss_pred CCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccC
Confidence 999765433322 2347899999999996543 234689999999999999999 88886542
Q ss_pred c----HHHHHHHHHHhCCCChhhhhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 016184 290 G----VDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV 364 (394)
Q Consensus 290 ~----~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 364 (394)
. ...+.......... .......+....++++.+||.+||+.||.+|||+.++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~---------------------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~ 295 (301)
T 3q4u_A 238 PNDPSFEDMRKVVCVDQQR---------------------PNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK 295 (301)
T ss_dssp CSSCCHHHHHHHHTTSCCC---------------------CCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred CCCcchhhhhHHHhccCCC---------------------CCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHH
Confidence 2 22222221111000 001111122345678999999999999999999999985
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=324.93 Aligned_cols=249 Identities=21% Similarity=0.226 Sum_probs=198.3
Q ss_pred eeEEEeeEEeecCceEEEEEEECCCCcEEEEEEecc--chhhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEEEEEE
Q 016184 82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQ--DKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVL 159 (394)
Q Consensus 82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~ 159 (394)
++|++.+.||+|+||.||+|++..+++.||||++.. ......+|+.+++.+.|++++..+..+... ..+.++||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~----~~~~~lv~ 84 (296)
T 4hgt_A 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAE----GDYNVMVM 84 (296)
T ss_dssp --CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---CCCHHHHHHHHHHHTTSTTCCCEEEEEEE----TTEEEEEE
T ss_pred CceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccchHHHHHHHHHHHhcCCCCCCeeeeecCC----CCceEEEE
Confidence 459999999999999999999999999999998643 334567899999999999888777766432 33478999
Q ss_pred ecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEE---eCCCCcEEEEeecCccccc
Q 016184 160 EYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLV 236 (394)
Q Consensus 160 e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~---~~~~~~vkl~Dfg~a~~~~ 236 (394)
||++++|.+++... ...+++..++.++.||+.||.|||+ +||+||||||+|||+ +.++ .+||+|||++....
T Consensus 85 e~~~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~-~~ivH~Dlkp~NIl~~~~~~~~-~~kL~Dfg~a~~~~ 159 (296)
T 4hgt_A 85 ELLGPSLEDLFNFC---SRKFSLKTVLLLADQMISRIEYIHS-KNFIHRDVKPDNFLMGLGKKGN-LVYIIDFGLAKKYR 159 (296)
T ss_dssp ECCCCBHHHHHHHT---TSCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECCGGGTT-CEEECCCTTCEECB
T ss_pred EccCCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHeeeeccCCCC-eEEEecCccceecc
Confidence 99988998877642 3579999999999999999999999 899999999999999 5566 79999999998664
Q ss_pred cCCC--------cccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcH---HHHHHHHHHhCCCC
Q 016184 237 KGEP--------NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGV---DQLVEIIKVLGTPT 305 (394)
Q Consensus 237 ~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~---~~~~~i~~~~~~~~ 305 (394)
.... .....+|+.|+|||.+.+.. ++.++|||||||++|+|++|+.||.+.... ..+..+.......+
T Consensus 160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 238 (296)
T 4hgt_A 160 DARTHQHIPYRENKNLTGTARYASINTHLGIE-QSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP 238 (296)
T ss_dssp CTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC
T ss_pred CcccCccCCCCcccccCCCccccchHHhcCCC-CCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccch
Confidence 4322 23457899999999996554 899999999999999999999999875432 22333322211111
Q ss_pred hhhhhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 016184 306 REEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV 364 (394)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 364 (394)
.. .....+++++.+||.+||+.||++|||+.++++
T Consensus 239 ~~------------------------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~ 273 (296)
T 4hgt_A 239 IE------------------------VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp HH------------------------HHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred hh------------------------hhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHH
Confidence 11 112457899999999999999999999999886
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-44 Score=325.34 Aligned_cols=245 Identities=21% Similarity=0.293 Sum_probs=197.9
Q ss_pred ceeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccc---hhhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEEEE
Q 016184 81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD---KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL 157 (394)
Q Consensus 81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 157 (394)
..+|++.+.||+|+||.||+|.+. ++..||||++... .....+|+++++.++|+||+++++++. .....++
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~~~~~l 96 (283)
T 3gen_A 23 PKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCT-----KQRPIFI 96 (283)
T ss_dssp GGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEEC-----SSSSEEE
T ss_pred HHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCCCHHHHHHHHHHHhcCCCCCEeeEEEEEe-----cCCCeEE
Confidence 446999999999999999999886 5778999998653 345668999999999999999999883 3333789
Q ss_pred EEeccc-ccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCccccc
Q 016184 158 VLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV 236 (394)
Q Consensus 158 v~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~ 236 (394)
||||+. ++|.+++... ...+++..++.++.|++.||.|||+ +||+||||||+|||++.++ .+||+|||++....
T Consensus 97 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dikp~Nili~~~~-~~kl~Dfg~~~~~~ 171 (283)
T 3gen_A 97 ITEYMANGCLLNYLREM---RHRFQTQQLLEMCKDVCEAMEYLES-KQFLHRDLAARNCLVNDQG-VVKVSDFGLSRYVL 171 (283)
T ss_dssp EECCCTTCBHHHHHHCG---GGCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSSCSGGGEEECTTS-CEEECSTTGGGGBC
T ss_pred EEeccCCCcHHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHH-CCccCCCCccceEEEcCCC-CEEEcccccccccc
Confidence 999996 5787776542 3569999999999999999999999 8999999999999999888 69999999997653
Q ss_pred cCC--CcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCChhhhhccC
Q 016184 237 KGE--PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 313 (394)
Q Consensus 237 ~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 313 (394)
... ......+|+.|+|||++.+.. ++.++||||||+++|+|++ |+.||......+....+.......
T Consensus 172 ~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~--------- 241 (283)
T 3gen_A 172 DDEYTSSVGSKFPVRWSPPEVLMYSK-FSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLY--------- 241 (283)
T ss_dssp CHHHHSTTSTTSCGGGCCHHHHHHCC-CSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCC---------
T ss_pred ccccccccCCccCcccCCHHHhccCC-CCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccCCC---------
Confidence 321 122344577899999996544 8999999999999999998 999998887766666554421110
Q ss_pred CCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 016184 314 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH 365 (394)
Q Consensus 314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 365 (394)
.+..+++.+.+||.+||+.||.+|||+.++++|
T Consensus 242 -------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 274 (283)
T 3gen_A 242 -------------------RPHLASEKVYTIMYSCWHEKADERPTFKILLSN 274 (283)
T ss_dssp -------------------CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred -------------------CCCcCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence 123568899999999999999999999999875
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-45 Score=350.04 Aligned_cols=273 Identities=21% Similarity=0.309 Sum_probs=201.8
Q ss_pred ceeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccch-----hhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEE
Q 016184 81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL 155 (394)
Q Consensus 81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 155 (394)
..+|++.++||+|+||.||+|++..+|+.||||++.... ....+|+++++.++||||+++++++.... ....
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~---~~~~ 84 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETT---TRHK 84 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTT---TCCE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCC---CCee
Confidence 346999999999999999999999999999999986432 34458999999999999999999874332 2346
Q ss_pred EEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEE----eCCCCcEEEEeec
Q 016184 156 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLV----NPHTHQLKLCDFG 230 (394)
Q Consensus 156 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~----~~~~~~vkl~Dfg 230 (394)
++||||+.+ +|.+++..... ...+++..++.++.||+.||+|||+ .||+||||||+|||+ +.++ .+||+|||
T Consensus 85 ~lv~e~~~~g~L~~~l~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dlkp~NIll~~~~~~~~-~~kL~DFG 161 (396)
T 4eut_A 85 VLIMEFCPCGSLYTVLEEPSN-AYGLPESEFLIVLRDVVGGMNHLRE-NGIVHRNIKPGNIMRVIGEDGQS-VYKLTDFG 161 (396)
T ss_dssp EEEECCCTTEEHHHHTTSGGG-TTCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEEEECTTSCE-EEEECCGG
T ss_pred EEEEecCCCCCHHHHHHhhhc-ccCCCHHHHHHHHHHHHHHHHHHHH-CCEEECCcCHHHEEEeecCCCce-eEEEecCC
Confidence 799999974 77776654322 2349999999999999999999999 899999999999998 5454 69999999
Q ss_pred CccccccCCCcccccccccccccccccCC-------CCCCChhhHHHHHHHHHHHHhCCCCCCCCC----cHHHHHHHHH
Q 016184 231 SAKVLVKGEPNVSYICSRYYRAPELIFGA-------TEYTTAIDIWSTGCVMAELLLGQPLFPGES----GVDQLVEIIK 299 (394)
Q Consensus 231 ~a~~~~~~~~~~~~~~t~~y~aPE~~~~~-------~~~~~~~DiwslG~il~~lltg~~pf~~~~----~~~~~~~i~~ 299 (394)
+++............||+.|+|||++.+. ..++.++|||||||++|+|++|+.||.... ..+.+..+..
T Consensus 162 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~ 241 (396)
T 4eut_A 162 AARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT 241 (396)
T ss_dssp GCEECCCGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHH
T ss_pred CceEccCCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhc
Confidence 99877555555567789999999998531 346789999999999999999999997533 2233333332
Q ss_pred HhCCCChhhhhccCCC-CcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 016184 300 VLGTPTREEIKCMNPN-YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV 364 (394)
Q Consensus 300 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 364 (394)
..+...+...... ...+.... ..+....+...++..+.+||++||+.||++|||+.++++
T Consensus 242 ---~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~ 302 (396)
T 4eut_A 242 ---GKPSGAISGVQKAENGPIDWSG--DMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFA 302 (396)
T ss_dssp ---SCCTTCCEEEECSTTCCEEEES--SCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHH
T ss_pred ---CCCcccchhheeccCCCcccCc--cCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHH
Confidence 2222211111000 00000000 000111122445678999999999999999999998854
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-44 Score=329.44 Aligned_cols=250 Identities=24% Similarity=0.330 Sum_probs=201.7
Q ss_pred ceeEEEeeEEeecCceEEEEEEE-----CCCCcEEEEEEeccc-----hhhhHHHHHHHHHc-CCCCeeeeceEEEecCC
Q 016184 81 KVSYIAEHVVGTGSFGVVFQAKC-----RETGEIVAIKKVLQD-----KRYKNRELQIMQML-DHPNIVALKHCFFSTTD 149 (394)
Q Consensus 81 ~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~ 149 (394)
..+|++.+.||+|+||.||+|++ ..+++.||||++... .....+|+.+++.+ +||||+++++++..
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~--- 98 (313)
T 1t46_A 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTI--- 98 (313)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS---
T ss_pred hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEec---
Confidence 45699999999999999999985 456789999998643 23456899999999 99999999998833
Q ss_pred CceeEEEEEEecccc-cHHHHHHHhhh--------------hcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCc
Q 016184 150 KEELYLNLVLEYVPE-TVNRIARNYSR--------------IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQN 214 (394)
Q Consensus 150 ~~~~~~~lv~e~~~~-~l~~~~~~~~~--------------~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~N 214 (394)
....++||||+++ +|.+++..... ....+++..++.++.||+.||.|||+ +||+||||||+|
T Consensus 99 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~N 175 (313)
T 1t46_A 99 --GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS-KNCIHRDLAARN 175 (313)
T ss_dssp --SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGG
T ss_pred --CCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCccce
Confidence 2236799999975 88888775432 12358999999999999999999999 899999999999
Q ss_pred eEEeCCCCcEEEEeecCccccccCCC---cccccccccccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCc
Q 016184 215 LLVNPHTHQLKLCDFGSAKVLVKGEP---NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESG 290 (394)
Q Consensus 215 il~~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~ 290 (394)
||++.++ .+||+|||++........ .....+|+.|+|||++.+. .++.++||||||+++|+|++ |..||.+...
T Consensus 176 il~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p~~~~~~ 253 (313)
T 1t46_A 176 ILLTHGR-ITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNC-VYTFESDVWSYGIFLWELFSLGSSPYPGMPV 253 (313)
T ss_dssp EEEETTT-EEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCSSTTCCS
T ss_pred EEEcCCC-CEEEccccccccccccccceeccCCCCcceeeChHHhcCC-CCChHHHHHHHHHHHHHHHhCCCCCCCcccc
Confidence 9999887 799999999976644432 1234567889999998654 48999999999999999999 9999988776
Q ss_pred HHHHHHHHHHhCCCChhhhhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 016184 291 VDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH 365 (394)
Q Consensus 291 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 365 (394)
...+.......... ..+..++..+.+||.+||+.||.+|||+.+++++
T Consensus 254 ~~~~~~~~~~~~~~---------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 301 (313)
T 1t46_A 254 DSKFYKMIKEGFRM---------------------------LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL 301 (313)
T ss_dssp SHHHHHHHHHTCCC---------------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hhHHHHHhccCCCC---------------------------CCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence 55555544421111 0124578999999999999999999999999874
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-44 Score=329.69 Aligned_cols=257 Identities=26% Similarity=0.425 Sum_probs=192.5
Q ss_pred ceeEEEeeEEeecCceEEEEEE----ECCCCcEEEEEEeccch----hhhHHHHHHHHHcCCCCeeeeceEEEecCCCce
Q 016184 81 KVSYIAEHVVGTGSFGVVFQAK----CRETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE 152 (394)
Q Consensus 81 ~~~y~~~~~lg~G~~g~V~~~~----~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 152 (394)
..+|++.+.||+|+||.||+|+ +..+++.||||++.... ..+.+|+++++.++||||+++++++.... .
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~---~ 85 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG---R 85 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHH---H
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC---C
Confidence 4469999999999999999999 56789999999986533 34568999999999999999999874322 2
Q ss_pred eEEEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecC
Q 016184 153 LYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS 231 (394)
Q Consensus 153 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~ 231 (394)
..+++||||+++ +|.+++... ...+++..++.++.|++.||+|||+ .||+||||||+|||++.++ .+||+|||+
T Consensus 86 ~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~Dikp~Nil~~~~~-~~kl~Dfg~ 160 (295)
T 3ugc_A 86 RNLKLIMEYLPYGSLRDYLQKH---KERIDHIKLLQYTSQICKGMEYLGT-KRYIHRDLATRNILVENEN-RVKIGDFGL 160 (295)
T ss_dssp TSCEEEEECCTTCBHHHHHHHC---GGGCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEEEETT-EEEECCCCS
T ss_pred CceEEEEEeCCCCCHHHHHHhc---ccccCHHHHHHHHHHHHHHHHHHhc-CCcccCCCCHhhEEEcCCC-eEEEccCcc
Confidence 236799999964 888877653 2458999999999999999999999 8999999999999999887 799999999
Q ss_pred ccccccCCC----cccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChh
Q 016184 232 AKVLVKGEP----NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 307 (394)
Q Consensus 232 a~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~ 307 (394)
+........ .....++..|+|||++.+. .++.++||||||+++|+|++|..||...... . ....+.....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~--~---~~~~~~~~~~ 234 (295)
T 3ugc_A 161 TKVLPQDKEFFKVKEPGESPIFWYAPESLTES-KFSVASDVWSFGVVLYELFTYIEKSKSPPAE--F---MRMIGNDKQG 234 (295)
T ss_dssp CC-------------CTTCGGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHHTTCTTCSHHHH--H---HHHHCTTCCT
T ss_pred cccccCCcceeeeccCCCCccceeCcHHhcCC-CCChHHHHHHHHHHHHHHHhcccccCCChHH--H---HhhhcCcccc
Confidence 986643321 2234467789999999655 4899999999999999999999988643211 1 1111111000
Q ss_pred h------hhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 016184 308 E------IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV 364 (394)
Q Consensus 308 ~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 364 (394)
. ....... .....+..+++++.+||.+||+.||++|||+.++++
T Consensus 235 ~~~~~~~~~~~~~~-------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~ 284 (295)
T 3ugc_A 235 QMIVFHLIELLKNN-------------GRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 284 (295)
T ss_dssp HHHHHHHHHHHHTT-------------CCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred chhHHHHHHHHhcc-------------CcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 0 0000000 000112468899999999999999999999999975
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=323.50 Aligned_cols=244 Identities=23% Similarity=0.337 Sum_probs=195.0
Q ss_pred eeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccch-----------hhhHHHHHHHHHcCCCCeeeeceEEEecCCC
Q 016184 82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----------RYKNRELQIMQMLDHPNIVALKHCFFSTTDK 150 (394)
Q Consensus 82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 150 (394)
.+|++.+.||+|+||.||+|++..+++.||||++.... ....+|+.+++.++||||+++++++ .
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~ 93 (287)
T 4f0f_A 19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLM-----H 93 (287)
T ss_dssp TTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEE-----T
T ss_pred ccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheee-----c
Confidence 46999999999999999999999999999999885321 3456899999999999999999987 2
Q ss_pred ceeEEEEEEeccc-ccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCC--ceeccCCCCceEEeCCCC----c
Q 016184 151 EELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG--ICHRDIKPQNLLVNPHTH----Q 223 (394)
Q Consensus 151 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~g--ivH~Dlkp~Nil~~~~~~----~ 223 (394)
... ++||||+. ++|.+.+.. ....+++..++.++.|++.||+|||+ .| |+||||||+|||++.++. .
T Consensus 94 ~~~--~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~l~~~l~~lH~-~~~~ivH~dikp~Nil~~~~~~~~~~~ 167 (287)
T 4f0f_A 94 NPP--RMVMEFVPCGDLYHRLLD---KAHPIKWSVKLRLMLDIALGIEYMQN-QNPPIVHRDLRSPNIFLQSLDENAPVC 167 (287)
T ss_dssp TTT--EEEEECCTTCBHHHHHHC---TTSCCCHHHHHHHHHHHHHHHHHHHT-SSSCCBCSCCSGGGEEESCCCTTCSCC
T ss_pred CCC--eEEEEecCCCCHHHHHhc---ccCCccHHHHHHHHHHHHHHHHHHHh-CCCCeecCCCCcceEEEeccCCCCcee
Confidence 222 48999998 577665543 23679999999999999999999999 89 999999999999987662 2
Q ss_pred EEEEeecCccccccCCCcccccccccccccccccC-CCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHH-HHHHHHHh
Q 016184 224 LKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFG-ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQ-LVEIIKVL 301 (394)
Q Consensus 224 vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~-~~~i~~~~ 301 (394)
+||+|||++.... .......+|+.|+|||++.. ...++.++|||||||++|+|++|+.||........ ........
T Consensus 168 ~kl~Dfg~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~ 245 (287)
T 4f0f_A 168 AKVADFGLSQQSV--HSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREE 245 (287)
T ss_dssp EEECCCTTCBCCS--SCEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHS
T ss_pred EEeCCCCcccccc--ccccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhcc
Confidence 9999999997543 23445678999999999842 33478899999999999999999999987654332 12222211
Q ss_pred CCCChhhhhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 016184 302 GTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV 364 (394)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 364 (394)
+. ...++..+++++.+||.+||+.||.+|||+.++++
T Consensus 246 ~~--------------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 282 (287)
T 4f0f_A 246 GL--------------------------RPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVK 282 (287)
T ss_dssp CC--------------------------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CC--------------------------CCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 11 01123567899999999999999999999999985
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-44 Score=326.78 Aligned_cols=247 Identities=21% Similarity=0.346 Sum_probs=202.9
Q ss_pred cceeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccch---hhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEEE
Q 016184 80 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN 156 (394)
Q Consensus 80 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 156 (394)
...+|++.+.||+|+||.||+|++..+++.||+|++.... ....+|+.+++.++||||+++++++. .....+
T Consensus 11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~~~~~ 85 (288)
T 3kfa_A 11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT-----REPPFY 85 (288)
T ss_dssp CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCSTHHHHHHHHHHHHHHCCCTTBCCEEEEEC-----SSSSEE
T ss_pred cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEc-----cCCCEE
Confidence 4456999999999999999999999999999999986543 34568999999999999999999883 233378
Q ss_pred EEEeccc-ccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCcccc
Q 016184 157 LVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL 235 (394)
Q Consensus 157 lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~ 235 (394)
+||||+. ++|.+++.... ...+++..++.++.|++.||.|||+ .||+||||||+||+++.++ .+||+|||++...
T Consensus 86 ~v~e~~~~~~L~~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~-~~i~H~dikp~Nil~~~~~-~~~l~Dfg~~~~~ 161 (288)
T 3kfa_A 86 IITEFMTYGNLLDYLRECN--RQEVSAVVLLYMATQISSAMEYLEK-KNFIHRDLAARNCLVGENH-LVKVADFGLSRLM 161 (288)
T ss_dssp EEEECCTTEEHHHHHHHCC--TTTSCHHHHHHHHHHHHHHHHHHHH-HTCCCSCCSGGGEEECGGG-CEEECCCCGGGTS
T ss_pred EEEEcCCCCcHHHHHHhcc--cCCccHhHHHHHHHHHHHHHHHHHH-CCccCCCCCcceEEEcCCC-CEEEccCccceec
Confidence 9999998 58887776532 3568999999999999999999999 8999999999999999887 6999999999765
Q ss_pred ccCCC--cccccccccccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCChhhhhcc
Q 016184 236 VKGEP--NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 312 (394)
Q Consensus 236 ~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 312 (394)
..... .....+|+.|+|||.+.+. .++.++||||||+++|+|++ |..||.+.+.......+......
T Consensus 162 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~~~--------- 231 (288)
T 3kfa_A 162 TGDTYTAHAGAKFPIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRM--------- 231 (288)
T ss_dssp CSSSSEEETTEEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCC---------
T ss_pred cCCccccccCCccccCcCChhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccCCC---------
Confidence 43322 1234457889999999655 48999999999999999999 99999887765554444331100
Q ss_pred CCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 016184 313 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV 364 (394)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 364 (394)
..+..+++.+.+||++||+.||.+|||+.++++
T Consensus 232 -------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~ 264 (288)
T 3kfa_A 232 -------------------ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 264 (288)
T ss_dssp -------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -------------------CCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHH
Confidence 112457899999999999999999999999975
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-44 Score=332.33 Aligned_cols=260 Identities=21% Similarity=0.272 Sum_probs=207.9
Q ss_pred ceeEEEeeEEeecCceEEEEEEEC-----CCCcEEEEEEeccch-----hhhHHHHHHHHHcCCCCeeeeceEEEecCCC
Q 016184 81 KVSYIAEHVVGTGSFGVVFQAKCR-----ETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDK 150 (394)
Q Consensus 81 ~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 150 (394)
..+|++.+.||+|+||.||+|++. .+++.||||++.... ..+.+|+.+++.++||||+++++++..
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---- 99 (322)
T 1p4o_A 24 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ---- 99 (322)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECS----
T ss_pred hhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEcc----
Confidence 456999999999999999999886 357889999986432 234579999999999999999998832
Q ss_pred ceeEEEEEEecccc-cHHHHHHHhhhh------cCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCc
Q 016184 151 EELYLNLVLEYVPE-TVNRIARNYSRI------HQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQ 223 (394)
Q Consensus 151 ~~~~~~lv~e~~~~-~l~~~~~~~~~~------~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~ 223 (394)
....++||||+.+ +|.+++...... ...+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .
T Consensus 100 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dikp~NIli~~~~-~ 176 (322)
T 1p4o_A 100 -GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA-NKFVHRDLAARNCMVAEDF-T 176 (322)
T ss_dssp -SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH-TTCBCSCCSGGGEEECTTC-C
T ss_pred -CCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHH-CCCccCCCccceEEEcCCC-e
Confidence 2336799999975 888887764332 2467899999999999999999999 8999999999999999887 6
Q ss_pred EEEEeecCccccccCCC---cccccccccccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHH
Q 016184 224 LKLCDFGSAKVLVKGEP---NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIK 299 (394)
Q Consensus 224 vkl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~ 299 (394)
+||+|||++........ .....+|+.|+|||++.+. .++.++||||||+++|+|++ |..||.+.+..+....+..
T Consensus 177 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~ 255 (322)
T 1p4o_A 177 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDG-VFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVME 255 (322)
T ss_dssp EEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHT
T ss_pred EEECcCccccccccccccccccCCCCCCCccChhhhccC-CCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHHHc
Confidence 99999999976533321 1234568889999998654 48999999999999999999 8999988776555544433
Q ss_pred HhCCCChhhhhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcC------CCCCCCCC
Q 016184 300 VLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH------PFFDELRD 373 (394)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h------p~f~~~~~ 373 (394)
... + ..+..++..+.+||.+||+.||.+|||+.++++| |||+++..
T Consensus 256 ~~~-~---------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~~~~~~~~~ 307 (322)
T 1p4o_A 256 GGL-L---------------------------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREVSF 307 (322)
T ss_dssp TCC-C---------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTHHHHCS
T ss_pred CCc-C---------------------------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhccCCccccc
Confidence 110 0 0124578999999999999999999999999976 88887765
Q ss_pred CCC
Q 016184 374 PNT 376 (394)
Q Consensus 374 ~~~ 376 (394)
...
T Consensus 308 ~~~ 310 (322)
T 1p4o_A 308 YYS 310 (322)
T ss_dssp TTS
T ss_pred ccc
Confidence 544
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-44 Score=333.53 Aligned_cols=250 Identities=22% Similarity=0.301 Sum_probs=200.0
Q ss_pred ceeEEEeeEEeecCceEEEEEEE-----CCCCcEEEEEEeccc-----hhhhHHHHHHHHHc-CCCCeeeeceEEEecCC
Q 016184 81 KVSYIAEHVVGTGSFGVVFQAKC-----RETGEIVAIKKVLQD-----KRYKNRELQIMQML-DHPNIVALKHCFFSTTD 149 (394)
Q Consensus 81 ~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~ 149 (394)
..+|++.+.||+|+||.||+|++ ..++..||||++... .....+|+.+++.+ +||||+++++++..
T Consensus 44 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~--- 120 (344)
T 1rjb_A 44 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTL--- 120 (344)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECS---
T ss_pred HHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEee---
Confidence 35699999999999999999997 345678999998643 23456899999999 99999999998833
Q ss_pred CceeEEEEEEecccc-cHHHHHHHhhhh-------------------cCCCCHHHHHHHHHHHHHHHHHHHhCCCceecc
Q 016184 150 KEELYLNLVLEYVPE-TVNRIARNYSRI-------------------HQRMPLIYVKLYTYQICRALAYIHNCIGICHRD 209 (394)
Q Consensus 150 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~-------------------~~~l~~~~~~~~~~qi~~al~~LH~~~givH~D 209 (394)
....++||||+++ +|.+++...... ...+++..++.++.||+.||+|||+ .||+|||
T Consensus 121 --~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivH~D 197 (344)
T 1rjb_A 121 --SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF-KSCVHRD 197 (344)
T ss_dssp --SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH-TTEEETT
T ss_pred --CCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHh-CCcccCC
Confidence 2237799999975 888887653321 1347999999999999999999999 8999999
Q ss_pred CCCCceEEeCCCCcEEEEeecCccccccCCCc---ccccccccccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCC
Q 016184 210 IKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN---VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLF 285 (394)
Q Consensus 210 lkp~Nil~~~~~~~vkl~Dfg~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf 285 (394)
|||+|||++.++ .+||+|||++......... ....+|+.|+|||++.+. .++.++||||||+++|+|+| |..||
T Consensus 198 ikp~NIll~~~~-~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~el~t~g~~p~ 275 (344)
T 1rjb_A 198 LAARNVLVTHGK-VVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEG-IYTIKSDVWSYGILLWEIFSLGVNPY 275 (344)
T ss_dssp CSGGGEEEETTT-EEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHTTTSCCSS
T ss_pred CChhhEEEcCCC-cEEeCCCccCcccccCccceeccCccCccCccCHHHhccC-CCChhHhHHHHHHHHHHHHcCCCCCc
Confidence 999999999887 7999999999766443322 234567889999998654 48999999999999999998 99999
Q ss_pred CCCCcHHHHHHHHHHhCCCChhhhhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 016184 286 PGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH 365 (394)
Q Consensus 286 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 365 (394)
.+......+..+......+ ..+..+++++.+||.+||+.||.+|||+.++++|
T Consensus 276 ~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 328 (344)
T 1rjb_A 276 PGIPVDANFYKLIQNGFKM---------------------------DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 328 (344)
T ss_dssp TTCCCSHHHHHHHHTTCCC---------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ccCCcHHHHHHHHhcCCCC---------------------------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence 8877655555544421100 0123578999999999999999999999999985
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-44 Score=330.40 Aligned_cols=254 Identities=23% Similarity=0.340 Sum_probs=198.8
Q ss_pred eeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccc----hhhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEEEE
Q 016184 82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL 157 (394)
Q Consensus 82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 157 (394)
.+|++.+.||+|+||.||+|++..+|+.||||++... .....+|+++++.++||||+++++++.... ......++
T Consensus 29 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~~~~~l 107 (317)
T 2buj_A 29 KHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRER-GAKHEAWL 107 (317)
T ss_dssp EEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEE-TTEEEEEE
T ss_pred eEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEecc-CCCceeEE
Confidence 4699999999999999999999999999999987542 234567999999999999999999885432 23455789
Q ss_pred EEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCccccc
Q 016184 158 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV 236 (394)
Q Consensus 158 v~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~ 236 (394)
||||+.+ +|.+++.........+++..++.++.||+.||.|||+ .||+||||||+|||++.++ .+||+|||++....
T Consensus 108 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~-~~ivH~dlkp~NIl~~~~~-~~kl~dfg~~~~~~ 185 (317)
T 2buj_A 108 LLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHA-KGYAHRDLKPTNILLGDEG-QPVLMDLGSMNQAC 185 (317)
T ss_dssp EEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECTTS-CEEECCCSSCEESC
T ss_pred EEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHHEEEcCCC-CEEEEecCcchhcc
Confidence 9999986 8888888766666889999999999999999999999 8999999999999999888 69999999987543
Q ss_pred cCCC----------cccccccccccccccccCCC--CCCChhhHHHHHHHHHHHHhCCCCCCCCCcH-HHHHHHHHHhCC
Q 016184 237 KGEP----------NVSYICSRYYRAPELIFGAT--EYTTAIDIWSTGCVMAELLLGQPLFPGESGV-DQLVEIIKVLGT 303 (394)
Q Consensus 237 ~~~~----------~~~~~~t~~y~aPE~~~~~~--~~~~~~DiwslG~il~~lltg~~pf~~~~~~-~~~~~i~~~~~~ 303 (394)
.... .....||+.|+|||++.+.. .++.++||||||+++|+|++|+.||...... ..+......
T Consensus 186 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~--- 262 (317)
T 2buj_A 186 IHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQN--- 262 (317)
T ss_dssp EEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHHC---
T ss_pred cccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhhc---
Confidence 2111 11234689999999985433 2688999999999999999999999531100 001111110
Q ss_pred CChhhhhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 016184 304 PTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH 365 (394)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 365 (394)
....+ ....++.++.+||.+||+.||.+|||+.++++|
T Consensus 263 --------------~~~~~----------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 300 (317)
T 2buj_A 263 --------------QLSIP----------QSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQ 300 (317)
T ss_dssp --------------C--CC----------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred --------------cCCCC----------ccccCCHHHHHHHHHHhhcChhhCCCHHHHHHH
Confidence 00000 113578999999999999999999999999985
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-44 Score=325.67 Aligned_cols=253 Identities=17% Similarity=0.238 Sum_probs=195.9
Q ss_pred ceeEEEeeEEeecCceEEEEEEECCCC-------cEEEEEEeccch----hhhHHHHHHHHHcCCCCeeeeceEEEecCC
Q 016184 81 KVSYIAEHVVGTGSFGVVFQAKCRETG-------EIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVALKHCFFSTTD 149 (394)
Q Consensus 81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~-------~~vaiK~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 149 (394)
..+|++.+.||+|+||.||+|++..++ ..||+|++.... ....+|+.+++.++||||+++++++...
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-- 84 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCG-- 84 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCT--
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeC--
Confidence 346999999999999999999998777 469999985433 3456799999999999999999988432
Q ss_pred CceeEEEEEEeccc-ccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCc-----
Q 016184 150 KEELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQ----- 223 (394)
Q Consensus 150 ~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~----- 223 (394)
...++||||+. ++|.+++... ...+++..++.++.||+.||.|||+ +||+||||||+|||++.++..
T Consensus 85 ---~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~L~~LH~-~~ivH~Dlkp~NIll~~~~~~~~~~~ 157 (289)
T 4fvq_A 85 ---DENILVQEFVKFGSLDTYLKKN---KNCINILWKLEVAKQLAAAMHFLEE-NTLIHGNVCAKNILLIREEDRKTGNP 157 (289)
T ss_dssp ---TCCEEEEECCTTCBHHHHHHHT---GGGCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEEEECCBGGGTBC
T ss_pred ---CCCEEEEECCCCCCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHhh-CCeECCCcCcceEEEecCCccccccc
Confidence 23578999998 5888877652 2448999999999999999999999 899999999999999977621
Q ss_pred --EEEEeecCccccccCCCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCC-CCCCCCCcHHHHHHHHHH
Q 016184 224 --LKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQ-PLFPGESGVDQLVEIIKV 300 (394)
Q Consensus 224 --vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~-~pf~~~~~~~~~~~i~~~ 300 (394)
+||+|||++..... .....+|+.|+|||++.+...++.++||||||+++|+|++|. +||..... .........
T Consensus 158 ~~~kl~Dfg~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~-~~~~~~~~~ 233 (289)
T 4fvq_A 158 PFIKLSDPGISITVLP---KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDS-QRKLQFYED 233 (289)
T ss_dssp CEEEECCCCSCTTTSC---HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH-HHHHHHHHT
T ss_pred ceeeeccCcccccccC---ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccch-HHHHHHhhc
Confidence 99999999865422 234567889999999976466899999999999999999965 55544443 333332221
Q ss_pred hCCCChhhhhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCCC
Q 016184 301 LGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTR 377 (394)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~~ 377 (394)
.. .++...++++.+||.+||+.||.+|||+.++++| |+++..+...
T Consensus 234 ~~-----------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~--l~~l~~p~~~ 279 (289)
T 4fvq_A 234 RH-----------------------------QLPAPKAAELANLINNCMDYEPDHRPSFRAIIRD--LNSLFTPDLV 279 (289)
T ss_dssp TC-----------------------------CCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHH--HHTCC-----
T ss_pred cC-----------------------------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH--HHHhcCCCCC
Confidence 10 0113457889999999999999999999999984 5555444443
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-44 Score=333.63 Aligned_cols=256 Identities=16% Similarity=0.147 Sum_probs=192.0
Q ss_pred eeEEEeeEEeecCceEEEEEEECC---CCcEEEEEEeccchhh---------------hHHHHHHHHHcCCCCeeeeceE
Q 016184 82 VSYIAEHVVGTGSFGVVFQAKCRE---TGEIVAIKKVLQDKRY---------------KNRELQIMQMLDHPNIVALKHC 143 (394)
Q Consensus 82 ~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~~---------------~~~E~~~l~~l~h~~iv~~~~~ 143 (394)
.+|++.+.||+|+||.||+|++.. ++..||||++...... ..+|+.+++.++||||++++++
T Consensus 37 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~ 116 (345)
T 2v62_A 37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGS 116 (345)
T ss_dssp CEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEE
T ss_pred ceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecc
Confidence 469999999999999999999987 7889999988654322 2246677788899999999998
Q ss_pred EEecCCCceeEEEEEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCC-C
Q 016184 144 FFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHT-H 222 (394)
Q Consensus 144 ~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~-~ 222 (394)
+.... ....+.++||||++++|.+++.. ...+++..++.++.||+.||+|||+ .||+||||||+|||++.++ .
T Consensus 117 ~~~~~-~~~~~~~lv~e~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dlkp~NIll~~~~~~ 190 (345)
T 2v62_A 117 GLTEF-KGRSYRFMVMERLGIDLQKISGQ----NGTFKKSTVLQLGIRMLDVLEYIHE-NEYVHGDIKAANLLLGYKNPD 190 (345)
T ss_dssp EEEES-SSCEEEEEEEECEEEEHHHHCBG----GGBCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEESSSTT
T ss_pred ccccc-CCCcEEEEEEeccCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeeCCCcCHHHEEEccCCCC
Confidence 86533 23556889999997788776543 2479999999999999999999999 8999999999999998764 2
Q ss_pred cEEEEeecCccccccCC--------CcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCC-CcHHH
Q 016184 223 QLKLCDFGSAKVLVKGE--------PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGE-SGVDQ 293 (394)
Q Consensus 223 ~vkl~Dfg~a~~~~~~~--------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~-~~~~~ 293 (394)
.+||+|||+++...... ......+|+.|+|||++.+. .++.++|||||||++|+|++|+.||.+. .....
T Consensus 191 ~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~ 269 (345)
T 2v62_A 191 QVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGV-ALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVA 269 (345)
T ss_dssp SEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTC-CCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHH
T ss_pred cEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCC-CCCchhhHHHHHHHHHHHHhCCCCccccccccHH
Confidence 69999999997653221 11345789999999999765 4899999999999999999999999653 22232
Q ss_pred HHHHHH-HhCCCChhhhhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 016184 294 LVEIIK-VLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV 364 (394)
Q Consensus 294 ~~~i~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 364 (394)
...... .....+....... -...+++++.+||.+||+.||++|||++++++
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~--------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 321 (345)
T 2v62_A 270 VQTAKTNLLDELPQSVLKWA--------------------PSGSSCCEIAQFLVCAHSLAYDEKPNYQALKK 321 (345)
T ss_dssp HHHHHHHHHHTTTHHHHHHS--------------------CTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HHHHHHhhcccccHHHHhhc--------------------cccccHHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence 322222 2212221111110 00267899999999999999999999999986
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=323.16 Aligned_cols=246 Identities=26% Similarity=0.356 Sum_probs=188.8
Q ss_pred cceeEEEeeEEeecCceEEEEEEECCC---CcEEEEEEeccc-----hhhhHHHHHHHHHcCCCCeeeeceEEEecCCCc
Q 016184 80 QKVSYIAEHVVGTGSFGVVFQAKCRET---GEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKE 151 (394)
Q Consensus 80 ~~~~y~~~~~lg~G~~g~V~~~~~~~~---~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 151 (394)
...+|++.+.||+|+||.||+|++..+ +..||+|++... ...+.+|+.+++.++||||+++++++. .+
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~----~~ 88 (281)
T 1mp8_A 13 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT----EN 88 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC----SS
T ss_pred ehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc----cC
Confidence 345699999999999999999998654 457999987542 234557999999999999999999872 11
Q ss_pred eeEEEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeec
Q 016184 152 ELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFG 230 (394)
Q Consensus 152 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg 230 (394)
..++||||+.+ +|.+++... ...+++..++.++.|++.||.|||+ .||+||||||+|||++.++ .+||+|||
T Consensus 89 --~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~Nil~~~~~-~~kl~Dfg 161 (281)
T 1mp8_A 89 --PVWIIMELCTLGELRSFLQVR---KYSLDLASLILYAYQLSTALAYLES-KRFVHRDIAARNVLVSSND-CVKLGDFG 161 (281)
T ss_dssp --SCEEEEECCTTEEHHHHHHHT---TTTSCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEEEETT-EEEECC--
T ss_pred --ccEEEEecCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHh-CCeecccccHHHEEECCCC-CEEECccc
Confidence 25689999985 787776542 2468999999999999999999999 8999999999999999887 79999999
Q ss_pred CccccccCCC--cccccccccccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCChh
Q 016184 231 SAKVLVKGEP--NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTRE 307 (394)
Q Consensus 231 ~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~ 307 (394)
++........ .....+++.|+|||++.+. .++.++||||||+++|+|++ |..||.+....+....+......
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~~~---- 236 (281)
T 1mp8_A 162 LSRYMEDSTYYKASKGKLPIKWMAPESINFR-RFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERL---- 236 (281)
T ss_dssp -----------------CCGGGCCHHHHHHC-CCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCC----
T ss_pred cccccCcccccccccCCCcccccChhhcccC-CCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCCCC----
Confidence 9976643322 2233457889999998654 48999999999999999996 99999887776665554431100
Q ss_pred hhhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 016184 308 EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH 365 (394)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 365 (394)
.++..+++.+.+||.+||+.||.+|||+.+++++
T Consensus 237 ------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 270 (281)
T 1mp8_A 237 ------------------------PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 270 (281)
T ss_dssp ------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ------------------------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 0124679999999999999999999999999863
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-44 Score=333.57 Aligned_cols=249 Identities=23% Similarity=0.308 Sum_probs=199.4
Q ss_pred ceeEEEeeEEeecCceEEEEEEECCCCcEE--EEEEeccc-----hhhhHHHHHHHHHc-CCCCeeeeceEEEecCCCce
Q 016184 81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIV--AIKKVLQD-----KRYKNRELQIMQML-DHPNIVALKHCFFSTTDKEE 152 (394)
Q Consensus 81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~v--aiK~~~~~-----~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~ 152 (394)
.++|++.+.||+|+||.||+|++..++..+ |+|.+... .....+|+++++.+ +||||+++++++.. .
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~-----~ 98 (327)
T 1fvr_A 24 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH-----R 98 (327)
T ss_dssp GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEE-----T
T ss_pred HHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeee-----C
Confidence 356999999999999999999998888865 99987542 23456799999999 99999999998833 3
Q ss_pred eEEEEEEecccc-cHHHHHHHhh------------hhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeC
Q 016184 153 LYLNLVLEYVPE-TVNRIARNYS------------RIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNP 219 (394)
Q Consensus 153 ~~~~lv~e~~~~-~l~~~~~~~~------------~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~ 219 (394)
...++||||+++ +|.+++.... .....+++..++.++.||+.||.|||+ +||+||||||+|||++.
T Consensus 99 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~dlkp~NIl~~~ 177 (327)
T 1fvr_A 99 GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ-KQFIHRDLAARNILVGE 177 (327)
T ss_dssp TEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECG
T ss_pred CceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh-CCccCCCCccceEEEcC
Confidence 357899999975 8888876543 123579999999999999999999999 89999999999999998
Q ss_pred CCCcEEEEeecCccccccCCCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHH
Q 016184 220 HTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEII 298 (394)
Q Consensus 220 ~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~ 298 (394)
++ .+||+|||++.............+++.|+|||++.+. .++.++||||||+++|+|++ |+.||.+....+....+.
T Consensus 178 ~~-~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~ 255 (327)
T 1fvr_A 178 NY-VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYS-VYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP 255 (327)
T ss_dssp GG-CEEECCTTCEESSCEECCC----CCTTTCCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGG
T ss_pred CC-eEEEcccCcCccccccccccCCCCCccccChhhhccc-cCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHhh
Confidence 87 6999999998754433333445568889999998654 48999999999999999998 999998877655444332
Q ss_pred HHhCCCChhhhhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 016184 299 KVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH 365 (394)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 365 (394)
.... ...+..+++.+.+||.+||+.||.+|||+.++++|
T Consensus 256 ~~~~----------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 294 (327)
T 1fvr_A 256 QGYR----------------------------LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 294 (327)
T ss_dssp GTCC----------------------------CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cCCC----------------------------CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 2100 00123578999999999999999999999999875
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=327.33 Aligned_cols=254 Identities=19% Similarity=0.268 Sum_probs=193.4
Q ss_pred ceeEEEeeEEeecCceEEEEEEECC---CCcEEEEEEeccch------hhhHHHHHHHHHcCCCCeeeeceEEEecCCCc
Q 016184 81 KVSYIAEHVVGTGSFGVVFQAKCRE---TGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKE 151 (394)
Q Consensus 81 ~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 151 (394)
..+|.+.+.||+|+||.||+|++.. +++.||+|++.... ....+|+.+++.++||||+++++++.......
T Consensus 33 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 112 (313)
T 3brb_A 33 RNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQG 112 (313)
T ss_dssp GGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-----
T ss_pred HHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccccC
Confidence 3469999999999999999998865 45689999986431 33567999999999999999999986554443
Q ss_pred eeEEEEEEecccc-cHHHHHHHhh--hhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEe
Q 016184 152 ELYLNLVLEYVPE-TVNRIARNYS--RIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCD 228 (394)
Q Consensus 152 ~~~~~lv~e~~~~-~l~~~~~~~~--~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~D 228 (394)
....++||||+.+ +|..++.... .....+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+|
T Consensus 113 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~dikp~NIli~~~~-~~kl~D 190 (313)
T 3brb_A 113 IPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSN-RNFLHRDLAARNCMLRDDM-TVCVAD 190 (313)
T ss_dssp --CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHT-TTCCCCCCSGGGEEECTTS-CEEECS
T ss_pred CcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCcceEEEcCCC-cEEEee
Confidence 4456899999985 8877765432 234669999999999999999999999 8999999999999999887 699999
Q ss_pred ecCccccccCC---CcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCC
Q 016184 229 FGSAKVLVKGE---PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTP 304 (394)
Q Consensus 229 fg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~ 304 (394)
||++....... ......+++.|+|||.+.+. .++.++||||||+++|+|++ |..||.+.........+......
T Consensus 191 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~- 268 (313)
T 3brb_A 191 FGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADR-VYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGHRL- 268 (313)
T ss_dssp CSCC----------------CCGGGSCHHHHHSS-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCC-
T ss_pred cCcceecccccccCcccccCCCccccCchhhcCC-CccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHcCCCC-
Confidence 99997654332 12234567889999999654 48999999999999999999 89999887766655554431100
Q ss_pred ChhhhhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 016184 305 TREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH 365 (394)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 365 (394)
..+..+++.+.+||.+||+.||.+|||+.+++++
T Consensus 269 ---------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 302 (313)
T 3brb_A 269 ---------------------------KQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQ 302 (313)
T ss_dssp ---------------------------CCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred ---------------------------CCCccccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 1124678999999999999999999999999864
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-44 Score=332.12 Aligned_cols=245 Identities=22% Similarity=0.296 Sum_probs=194.0
Q ss_pred ceeEEEeeEEeecCceEEEEEEECCCCcE----EEEEEeccc-----hhhhHHHHHHHHHcCCCCeeeeceEEEecCCCc
Q 016184 81 KVSYIAEHVVGTGSFGVVFQAKCRETGEI----VAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKE 151 (394)
Q Consensus 81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~----vaiK~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 151 (394)
..+|++.+.||+|+||.||+|++..+++. ||+|.+... .....+|+.+++.++||||+++++++. .
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~ 86 (325)
T 3kex_A 12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-----G 86 (325)
T ss_dssp TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-----B
T ss_pred HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-----C
Confidence 34699999999999999999999888876 677765432 133457999999999999999999772 1
Q ss_pred eeEEEEEEeccc-ccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeec
Q 016184 152 ELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFG 230 (394)
Q Consensus 152 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg 230 (394)
...++||||+. ++|.+.+... ...+++..++.++.||+.||+|||+ .||+||||||+|||++.++ .+||+|||
T Consensus 87 -~~~~~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~Dikp~Nil~~~~~-~~kl~Dfg 160 (325)
T 3kex_A 87 -SSLQLVTQYLPLGSLLDHVRQH---RGALGPQLLLNWGVQIAKGMYYLEE-HGMVHRNLAARNVLLKSPS-QVQVADFG 160 (325)
T ss_dssp -SSEEEEEECCTTCBSHHHHHSS---GGGSCTTHHHHHHHHHHHHHHHHHH-TTCCCSCCSSTTEEESSSS-CEEECSCS
T ss_pred -CccEEEEEeCCCCCHHHHHHHc---cccCCHHHHHHHHHHHHHHHHHHHh-CCCCCCccchheEEECCCC-eEEECCCC
Confidence 12668999998 5777666542 3578999999999999999999999 8999999999999999888 69999999
Q ss_pred CccccccCCC---cccccccccccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCh
Q 016184 231 SAKVLVKGEP---NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTR 306 (394)
Q Consensus 231 ~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~ 306 (394)
+++....... .....+++.|+|||++.+.. ++.++||||||+++|+|++ |..||.+....+....+.....
T Consensus 161 ~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~---- 235 (325)
T 3kex_A 161 VADLLPPDDKQLLYSEAKTPIKWMALESIHFGK-YTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGER---- 235 (325)
T ss_dssp GGGGSCCCTTCCC-----CCTTTSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTCB----
T ss_pred cccccCcccccccccCCCCcccccChHHhccCC-CChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCCC----
Confidence 9987644332 23345677899999996544 8999999999999999999 9999988765554444332100
Q ss_pred hhhhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 016184 307 EEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH 365 (394)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 365 (394)
. ..+..++.++.+||.+||+.||.+|||+.++++|
T Consensus 236 ------------~------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~ 270 (325)
T 3kex_A 236 ------------L------------AQPQICTIDVYMVMVKCWMIDENIRPTFKELANE 270 (325)
T ss_dssp ------------C------------CCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHH
T ss_pred ------------C------------CCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 0 0123467889999999999999999999999876
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-44 Score=330.88 Aligned_cols=245 Identities=22% Similarity=0.345 Sum_probs=191.0
Q ss_pred ceeEEEeeEEeecCceEEEEEEECCCCcEE----EEEEecc-----chhhhHHHHHHHHHcCCCCeeeeceEEEecCCCc
Q 016184 81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIV----AIKKVLQ-----DKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKE 151 (394)
Q Consensus 81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~v----aiK~~~~-----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 151 (394)
..+|++.+.||+|+||+||+|++..+++.+ |+|.+.. ....+.+|+.+++.++||||+++++++...
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~---- 89 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS---- 89 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS----
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC----
Confidence 346999999999999999999998887654 7776642 224456799999999999999999988432
Q ss_pred eeEEEEEEeccc-ccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeec
Q 016184 152 ELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFG 230 (394)
Q Consensus 152 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg 230 (394)
. .+++++|+. ++|.+.+... ...+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||
T Consensus 90 -~-~~~v~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~LH~-~~ivH~Dikp~NIll~~~~-~~kl~Dfg 162 (327)
T 3poz_A 90 -T-VQLITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLED-RRLVHRDLAARNVLVKTPQ-HVKITDFG 162 (327)
T ss_dssp -S-EEEEEECCTTCBHHHHHHHS---TTSCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEEEETT-EEEECCTT
T ss_pred -C-eEEEEEecCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHhh-CCeeCCCCChheEEECCCC-CEEEccCc
Confidence 1 457788877 4777666542 3679999999999999999999999 8999999999999999888 79999999
Q ss_pred CccccccCCCc---ccccccccccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCh
Q 016184 231 SAKVLVKGEPN---VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTR 306 (394)
Q Consensus 231 ~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~ 306 (394)
+++........ ....+|+.|+|||++.+. .++.++|||||||++|+|++ |+.||.+.........+......+
T Consensus 163 ~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~-- 239 (327)
T 3poz_A 163 LAKLLGAEEKEYHAEGGKVPIKWMALESILHR-IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLP-- 239 (327)
T ss_dssp HHHHHTTTCC-------CCCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCC--
T ss_pred ceeEccCCcccccccCCCccccccChHHhccC-CCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCCCCC--
Confidence 99866443322 233457789999999754 48999999999999999999 999998776655443333211000
Q ss_pred hhhhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 016184 307 EEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH 365 (394)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 365 (394)
.+..++.++.+|+.+||+.||.+|||+.+++++
T Consensus 240 --------------------------~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 272 (327)
T 3poz_A 240 --------------------------QPPICTIDVYMIMVKCWMIDADSRPKFRELIIE 272 (327)
T ss_dssp --------------------------CCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHH
T ss_pred --------------------------CCccCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 124578899999999999999999999999875
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=329.68 Aligned_cols=249 Identities=24% Similarity=0.325 Sum_probs=201.3
Q ss_pred ceeEEEeeEEeecCceEEEEEEECCCCc-----EEEEEEeccc-----hhhhHHHHHHHHHc-CCCCeeeeceEEEecCC
Q 016184 81 KVSYIAEHVVGTGSFGVVFQAKCRETGE-----IVAIKKVLQD-----KRYKNRELQIMQML-DHPNIVALKHCFFSTTD 149 (394)
Q Consensus 81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~-----~vaiK~~~~~-----~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~ 149 (394)
..+|++.+.||+|+||.||+|.+..+++ .||+|++... .....+|+.+++.+ +||||+++++++..
T Consensus 45 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~--- 121 (333)
T 2i1m_A 45 RNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTH--- 121 (333)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS---
T ss_pred HHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEec---
Confidence 3569999999999999999999977664 7999988653 23456899999999 89999999998832
Q ss_pred CceeEEEEEEecccc-cHHHHHHHhhhh----------cCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEe
Q 016184 150 KEELYLNLVLEYVPE-TVNRIARNYSRI----------HQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVN 218 (394)
Q Consensus 150 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~----------~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~ 218 (394)
....++||||+++ +|.+++...... ...+++..++.++.|++.||+|||+ .||+||||||+|||++
T Consensus 122 --~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~Dlkp~NIl~~ 198 (333)
T 2i1m_A 122 --GGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLAS-KNCIHRDVAARNVLLT 198 (333)
T ss_dssp --SSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGCEEE
T ss_pred --CCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhc-CCcccCCcccceEEEC
Confidence 2337799999975 888887764332 3568999999999999999999999 8999999999999999
Q ss_pred CCCCcEEEEeecCccccccCCCc---ccccccccccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHH
Q 016184 219 PHTHQLKLCDFGSAKVLVKGEPN---VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQL 294 (394)
Q Consensus 219 ~~~~~vkl~Dfg~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~ 294 (394)
.++ .+||+|||++......... ....+|+.|+|||++.+. .++.++||||||+++|+|++ |..||.+......+
T Consensus 199 ~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~ 276 (333)
T 2i1m_A 199 NGH-VAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDC-VYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKF 276 (333)
T ss_dssp GGG-EEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHH
T ss_pred CCC-eEEECccccccccccccceeecCCCCCCccccCHHHhccC-CCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHH
Confidence 887 7999999999765443321 234557889999998654 48999999999999999998 99999887665555
Q ss_pred HHHHHHhCCCChhhhhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 016184 295 VEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV 364 (394)
Q Consensus 295 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 364 (394)
..+......+. .+..+++.+.+||.+||+.||.+|||+.++++
T Consensus 277 ~~~~~~~~~~~---------------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 319 (333)
T 2i1m_A 277 YKLVKDGYQMA---------------------------QPAFAPKNIYSIMQACWALEPTHRPTFQQICS 319 (333)
T ss_dssp HHHHHHTCCCC---------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHhcCCCCC---------------------------CCCCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 55544221110 12346889999999999999999999999986
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-44 Score=335.16 Aligned_cols=255 Identities=13% Similarity=0.098 Sum_probs=197.2
Q ss_pred eeEEEeeEEeecCceEEEEEEECCC--------CcEEEEEEeccchhhhHHHHHHHHHcCCCCeee--------------
Q 016184 82 VSYIAEHVVGTGSFGVVFQAKCRET--------GEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVA-------------- 139 (394)
Q Consensus 82 ~~y~~~~~lg~G~~g~V~~~~~~~~--------~~~vaiK~~~~~~~~~~~E~~~l~~l~h~~iv~-------------- 139 (394)
.+|++.+.||+|+||.||+|++..+ ++.||||++... ....+|+++++.++||||++
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~i~ 120 (352)
T 2jii_A 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-GRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAIP 120 (352)
T ss_dssp CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-STHHHHHHHHHHHCCHHHHHHHHHHTTCTTCSCC
T ss_pred CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-chHHHHHHHHHHhcccchhhhhhhhccCCccCcc
Confidence 4699999999999999999999874 889999988754 45678999999999999987
Q ss_pred -eceEEEecCCCceeEEEEEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEe
Q 016184 140 -LKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVN 218 (394)
Q Consensus 140 -~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~ 218 (394)
+++++.. ...+.++||||++++|.+++.... ...+++..++.++.||+.||+|||+ +||+||||||+|||++
T Consensus 121 ~~~~~~~~----~~~~~~lv~e~~~~~L~~~l~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~-~~ivH~Dikp~NIl~~ 193 (352)
T 2jii_A 121 TCMGFGVH----QDKYRFLVLPSLGRSLQSALDVSP--KHVLSERSVLQVACRLLDALEFLHE-NEYVHGNVTAENIFVD 193 (352)
T ss_dssp CCCEEEEE----TTTEEEEEEECCCEEHHHHHHHSG--GGCCCHHHHHHHHHHHHHHHHHHHH-TTCBCSCCCGGGEEEE
T ss_pred chhhcccc----CCcEEEEEecCCCcCHHHHHHhCC--cCCCCHHHHHHHHHHHHHHHHHHHh-CCccCCCCCHHHEEEc
Confidence 3444422 234578999999889988887532 3679999999999999999999999 8999999999999999
Q ss_pred CCCC-cEEEEeecCccccccCC--------CcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCC
Q 016184 219 PHTH-QLKLCDFGSAKVLVKGE--------PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGES 289 (394)
Q Consensus 219 ~~~~-~vkl~Dfg~a~~~~~~~--------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~ 289 (394)
.++. .+||+|||+++...... ......+|+.|+|||++.+. .++.++|||||||++|+|++|+.||....
T Consensus 194 ~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~pf~~~~ 272 (352)
T 2jii_A 194 PEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGC-GPSRRSDLQSLGYCMLKWLYGFLPWTNCL 272 (352)
T ss_dssp TTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSCCTTGGGT
T ss_pred CCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccC-CCCchhhHHHHHHHHHHHHhCCCCcccCC
Confidence 7751 59999999997654322 11334789999999999654 48999999999999999999999998764
Q ss_pred -cHHHHHHHHHHhCCCChhhhhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 016184 290 -GVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV 364 (394)
Q Consensus 290 -~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 364 (394)
....+..........+..... .......+++++.+||.+||+.||.+|||++++++
T Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~-------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 329 (352)
T 2jii_A 273 PNTEDIMKQKQKFVDKPGPFVG-------------------PCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRN 329 (352)
T ss_dssp TCHHHHHHHHHHHHHSCCCEEC-------------------TTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred cCHHHHHHHHHhccCChhhhhh-------------------hccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHH
Confidence 333333333221110000000 00011357899999999999999999999999976
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-45 Score=349.79 Aligned_cols=254 Identities=19% Similarity=0.208 Sum_probs=192.7
Q ss_pred ceeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccc-------hhhhHHHHHHHHHcCC-CCeee---------eceE
Q 016184 81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDH-PNIVA---------LKHC 143 (394)
Q Consensus 81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h-~~iv~---------~~~~ 143 (394)
...|.+.++||+|+||.||+|++..+|+.||||++... ...+.+|+.+++.+.| +|... ....
T Consensus 77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 156 (413)
T 3dzo_A 77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 156 (413)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEE
T ss_pred ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhh
Confidence 34699999999999999999999999999999988622 2345689999998877 22111 1111
Q ss_pred EE------------ecCCCceeEEEEEEecccccHHHHHHHhh---hhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceec
Q 016184 144 FF------------STTDKEELYLNLVLEYVPETVNRIARNYS---RIHQRMPLIYVKLYTYQICRALAYIHNCIGICHR 208 (394)
Q Consensus 144 ~~------------~~~~~~~~~~~lv~e~~~~~l~~~~~~~~---~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~ 208 (394)
+. ..........+++|+++.++|.+++.... .....+++..++.++.||+.||+|||+ +||+||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~iiHr 235 (413)
T 3dzo_A 157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH-YGLVHT 235 (413)
T ss_dssp EECCC---------------CCSEEEEEECCSEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHH-TTEECS
T ss_pred cccCCCCccccccCCCccccccceEEEeehhcCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccC
Confidence 10 00001122367889999899988876432 223557788899999999999999999 899999
Q ss_pred cCCCCceEEeCCCCcEEEEeecCccccccCCCccccccccccccccccc---------CCCCCCChhhHHHHHHHHHHHH
Q 016184 209 DIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIF---------GATEYTTAIDIWSTGCVMAELL 279 (394)
Q Consensus 209 Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~---------~~~~~~~~~DiwslG~il~~ll 279 (394)
||||+|||++.++ .+||+|||+++..... .....| +.|+|||++. ....++.++|||||||++|+|+
T Consensus 236 DiKp~NILl~~~~-~~kL~DFG~a~~~~~~--~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~ell 311 (413)
T 3dzo_A 236 YLRPVDIVLDQRG-GVFLTGFEHLVRDGAS--AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIW 311 (413)
T ss_dssp CCCGGGEEECTTC-CEEECCGGGCEETTEE--ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHH
T ss_pred CcccceEEEecCC-eEEEEeccceeecCCc--cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHH
Confidence 9999999999988 6999999998765332 334566 9999999983 3344788999999999999999
Q ss_pred hCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCH
Q 016184 280 LGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTA 359 (394)
Q Consensus 280 tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~ 359 (394)
+|+.||.+.........+ +. ....+++++.+||.+||+.||.+|||+
T Consensus 312 tg~~Pf~~~~~~~~~~~~-----------------------~~----------~~~~~~~~~~~li~~~l~~dP~~Rpt~ 358 (413)
T 3dzo_A 312 CADLPNTDDAALGGSEWI-----------------------FR----------SCKNIPQPVRALLEGFLRYPKEDRLLP 358 (413)
T ss_dssp HSSCCCCTTGGGSCSGGG-----------------------GS----------SCCCCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred HCCCCCCCcchhhhHHHH-----------------------Hh----------hcccCCHHHHHHHHHHccCChhhCcCH
Confidence 999999765432111100 00 013578999999999999999999999
Q ss_pred HHHhcCCCCCCCC
Q 016184 360 LEACVHPFFDELR 372 (394)
Q Consensus 360 ~ell~hp~f~~~~ 372 (394)
.++++||||+++.
T Consensus 359 ~~~l~~~~~~~~~ 371 (413)
T 3dzo_A 359 LQAMETPEYEQLR 371 (413)
T ss_dssp HHHTTSHHHHHHH
T ss_pred HHHHhCHHHHHHH
Confidence 9999999998764
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-43 Score=323.84 Aligned_cols=250 Identities=28% Similarity=0.440 Sum_probs=190.4
Q ss_pred ceeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccc-------hhhhHHHHHHHHHcCCCCeeeeceEEEecCCCcee
Q 016184 81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL 153 (394)
Q Consensus 81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 153 (394)
..+|++.+.||+|+||.||+|.+..+|+.||||++... .....+|+.+++.++||||+++++++... .
T Consensus 31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-----~ 105 (310)
T 2wqm_A 31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIED-----N 105 (310)
T ss_dssp GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEET-----T
T ss_pred ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcC-----C
Confidence 34699999999999999999999999999999988632 23345799999999999999999988542 3
Q ss_pred EEEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCc
Q 016184 154 YLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA 232 (394)
Q Consensus 154 ~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a 232 (394)
..++||||+.+ +|.+++.........+++..++.++.|++.||.|||+ .||+|+||||+|||++.++ .+||+|||++
T Consensus 106 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~i~H~dl~p~NIl~~~~~-~~kl~Dfg~~ 183 (310)
T 2wqm_A 106 ELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHS-RRVMHRDIKPANVFITATG-VVKLGDLGLG 183 (310)
T ss_dssp EEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECTTS-CEEECCC---
T ss_pred cEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhh-CCeeCCCCcHHHEEEcCCC-CEEEEeccce
Confidence 47899999986 8888888766666789999999999999999999999 8999999999999999887 7999999998
Q ss_pred cccccCCC-cccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCc-HHHHHHHHHHhCCCChhhhh
Q 016184 233 KVLVKGEP-NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESG-VDQLVEIIKVLGTPTREEIK 310 (394)
Q Consensus 233 ~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~ 310 (394)
........ .....+++.|+|||++.+. .++.++||||||+++|+|++|..||.+... ...+.........++
T Consensus 184 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~----- 257 (310)
T 2wqm_A 184 RFFSSKTTAAHSLVGTPYYMSPERIHEN-GYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPP----- 257 (310)
T ss_dssp ---------------CCSSCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCSCC-----
T ss_pred eeecCCCccccccCCCeeEeChHHhCCC-CCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccCCC-----
Confidence 76543322 2345689999999998654 489999999999999999999999976432 222222222111000
Q ss_pred ccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 016184 311 CMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV 364 (394)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 364 (394)
.....+++++.+||.+||+.||.+|||+.++++
T Consensus 258 ---------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~ 290 (310)
T 2wqm_A 258 ---------------------LPSDHYSEELRQLVNMCINPDPEKRPDVTYVYD 290 (310)
T ss_dssp ---------------------CCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---------------------CcccccCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 011457899999999999999999999999986
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-44 Score=333.97 Aligned_cols=271 Identities=21% Similarity=0.293 Sum_probs=204.0
Q ss_pred eeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccch-----hhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEEE
Q 016184 82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN 156 (394)
Q Consensus 82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 156 (394)
++|++.+.||+|+||.||+|++ .+|+.||||++.... ..+.+|+++++.++||||+++++++... ...+
T Consensus 30 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~~~ 103 (326)
T 3uim_A 30 DNFSNKNILGRGGFGKVYKGRL-ADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTP-----TERL 103 (326)
T ss_dssp TSSCSTTEEECCSSSEEEEECC-SSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEECCS-----SCCE
T ss_pred hccccceeEecCCCcEEEEEEe-cCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEEecC-----CceE
Confidence 4599999999999999999986 468999999986432 2457899999999999999999988432 2367
Q ss_pred EEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC---CceeccCCCCceEEeCCCCcEEEEeecCc
Q 016184 157 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI---GICHRDIKPQNLLVNPHTHQLKLCDFGSA 232 (394)
Q Consensus 157 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---givH~Dlkp~Nil~~~~~~~vkl~Dfg~a 232 (394)
+||||+.+ +|.+++.........+++..++.++.|++.||+|||+ . ||+||||||+|||++.++ .+||+|||++
T Consensus 104 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~-~~~~~ivH~Dlkp~Nil~~~~~-~~kl~Dfg~~ 181 (326)
T 3uim_A 104 LVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHD-HCDPKIIHRDVKAANILLDEEF-EAVVGDFGLA 181 (326)
T ss_dssp EEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHH-SSSSCEECCCCSGGGEEECTTC-CEEECCCSSC
T ss_pred EEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEeCCCchhhEEECCCC-CEEeccCccc
Confidence 99999975 8888887765555679999999999999999999999 8 999999999999999887 6999999999
Q ss_pred cccccCCC--cccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCC----CcHHHHHHHHHHhCCCCh
Q 016184 233 KVLVKGEP--NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGE----SGVDQLVEIIKVLGTPTR 306 (394)
Q Consensus 233 ~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~----~~~~~~~~i~~~~~~~~~ 306 (394)
........ .....||+.|+|||++.+.. ++.++||||||+++|+|++|+.||... .............
T Consensus 182 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~----- 255 (326)
T 3uim_A 182 KLMDYKDTHVTTAVRGTIGHIAPEYLSTGK-SSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGL----- 255 (326)
T ss_dssp EECCSSSSCEECCCCSCGGGCCHHHHHHSE-ECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTT-----
T ss_pred cccCcccccccccccCCcCccCHHHhccCC-CCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHH-----
Confidence 86643322 23345899999999986544 899999999999999999999999521 1111111111100
Q ss_pred hhhhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCC
Q 016184 307 EEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 375 (394)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~ 375 (394)
.................+....+..+.+|+.+||+.||.+|||+.++++|-+-..+.+..
T Consensus 256 ---------~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~~~~~ 315 (326)
T 3uim_A 256 ---------LKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGLAERW 315 (326)
T ss_dssp ---------TSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSSCSSSC
T ss_pred ---------hhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcchhhhh
Confidence 000011111111111122234457899999999999999999999999986655554443
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-43 Score=339.01 Aligned_cols=245 Identities=23% Similarity=0.322 Sum_probs=198.6
Q ss_pred ccceeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccch--hhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEEE
Q 016184 79 KQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK--RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN 156 (394)
Q Consensus 79 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 156 (394)
....+|++.+.||+|+||.||+|.+. |+.||||++.... ..+.+|+.+++.++||||+++++++.... ..++
T Consensus 190 i~~~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----~~~~ 263 (450)
T 1k9a_A 190 LNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEK----GGLY 263 (450)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCTTSHHHHHHHHHHHTCCCTTBCCEEEEEECTT----SCEE
T ss_pred cChHHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCchHHHHHHHHHHHHHhccCCCEEEEEEEEEcCC----CceE
Confidence 34457999999999999999999985 7899999987543 44568999999999999999999875432 2377
Q ss_pred EEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCcccc
Q 016184 157 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL 235 (394)
Q Consensus 157 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~ 235 (394)
+||||+.+ +|.+++.... ...+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+++..
T Consensus 264 iv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~-~~ivHrDlkp~Nill~~~~-~~kl~DfG~a~~~ 339 (450)
T 1k9a_A 264 IVTEYMAKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEG-NNFVHRDLAARNVLVSEDN-VAKVSDFGLTKEA 339 (450)
T ss_dssp EEEECCTTCBHHHHHHHHC--TTTCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEECTTS-CEEECCCTTCEEC
T ss_pred EEEEecCCCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHh-CCeeCCCCCHhhEEECCCC-CEEEeeCCCcccc
Confidence 99999975 8888776532 2347999999999999999999999 8999999999999999887 7999999999754
Q ss_pred ccCCCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCC
Q 016184 236 VKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 314 (394)
Q Consensus 236 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 314 (394)
... .....+++.|+|||++.+. .++.++||||||+++|+|++ |+.||.+....+....+......
T Consensus 340 ~~~--~~~~~~~~~y~aPE~~~~~-~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~----------- 405 (450)
T 1k9a_A 340 SST--QDTGKLPVKWTAPEALREK-KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKM----------- 405 (450)
T ss_dssp C--------CCCTTTSCHHHHHSS-CCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTCCC-----------
T ss_pred ccc--ccCCCCCcceeCHHHhcCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC-----------
Confidence 322 2233567889999999654 48999999999999999998 99999887766555544331100
Q ss_pred CCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 016184 315 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV 364 (394)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 364 (394)
..+..+++++.+||.+||+.||.+|||+.++++
T Consensus 406 -----------------~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~ 438 (450)
T 1k9a_A 406 -----------------DAPDGCPPAVYDVMKNCWHLDAATRPTFLQLRE 438 (450)
T ss_dssp -----------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -----------------CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 112468999999999999999999999999875
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-43 Score=323.36 Aligned_cols=246 Identities=24% Similarity=0.303 Sum_probs=189.8
Q ss_pred ceeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccch-------hhhHHHHHHHHHcCCCCeeeeceEEEecCCCcee
Q 016184 81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL 153 (394)
Q Consensus 81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 153 (394)
.++|++.+.||+|+||.||+|++..+++.||||++.... ..+.+|+.+++.++||||+++++++.. ..
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~-----~~ 107 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEI-----DG 107 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE-----TT
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEee-----CC
Confidence 346999999999999999999999999999999986432 345579999999999999999998843 33
Q ss_pred EEEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCc
Q 016184 154 YLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA 232 (394)
Q Consensus 154 ~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a 232 (394)
..+++|||+++ +|.+++.. ...+++..++.++.|++.||.|||+ .||+||||||+|||++.++ .+||+|||++
T Consensus 108 ~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dlkp~NIl~~~~~-~~kl~Dfg~~ 181 (309)
T 2h34_A 108 QLYVDMRLINGVDLAAMLRR----QGPLAPPRAVAIVRQIGSALDAAHA-AGATHRDVKPENILVSADD-FAYLVDFGIA 181 (309)
T ss_dssp EEEEEEECCCCEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECTTS-CEEECSCCC-
T ss_pred eEEEEEEecCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CcCCcCCCChHHEEEcCCC-CEEEecCccC
Confidence 47899999986 88777664 3579999999999999999999999 8999999999999999887 7999999998
Q ss_pred cccccCC--CcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhh
Q 016184 233 KVLVKGE--PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 310 (394)
Q Consensus 233 ~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 310 (394)
....... ......+++.|+|||++.+. .++.++||||||+++|+|++|+.||.+.... .+........ +
T Consensus 182 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-~~~~~~~~~~-~------ 252 (309)
T 2h34_A 182 SATTDEKLTQLGNTVGTLYYMAPERFSES-HATYRADIYALTCVLYECLTGSPPYQGDQLS-VMGAHINQAI-P------ 252 (309)
T ss_dssp ---------------CCGGGCCGGGTCC-----CCCHHHHHHHHHHHHHHSSCSSCSCHHH-HHHHHHHSCC-C------
T ss_pred ccccccccccccccCCCcCccCHHHHcCC-CCCchHhHHHHHHHHHHHHHCCCCCCCchHH-HHHHHhccCC-C------
Confidence 7654332 22345689999999998654 4899999999999999999999999875543 2222222110 0
Q ss_pred ccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCC-CHHHHhc
Q 016184 311 CMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-TALEACV 364 (394)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-t~~ell~ 364 (394)
........++.++.+||.+||+.||.+|| |++++++
T Consensus 253 ------------------~~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~ 289 (309)
T 2h34_A 253 ------------------RPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSA 289 (309)
T ss_dssp ------------------CGGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred ------------------CccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHH
Confidence 01112356899999999999999999999 8888775
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-43 Score=327.20 Aligned_cols=249 Identities=23% Similarity=0.331 Sum_probs=198.3
Q ss_pred ceeEEEeeEEeecCceEEEEEEEC-------CCCcEEEEEEeccch-----hhhHHHHHHHHHc-CCCCeeeeceEEEec
Q 016184 81 KVSYIAEHVVGTGSFGVVFQAKCR-------ETGEIVAIKKVLQDK-----RYKNRELQIMQML-DHPNIVALKHCFFST 147 (394)
Q Consensus 81 ~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l-~h~~iv~~~~~~~~~ 147 (394)
..+|++.+.||+|+||.||+|++. .++..||||++.... ....+|+++++.+ +||||+++++++..
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~- 112 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ- 112 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEcc-
Confidence 456999999999999999999985 456789999986432 3345799999999 99999999998832
Q ss_pred CCCceeEEEEEEecccc-cHHHHHHHhhh------------hcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCc
Q 016184 148 TDKEELYLNLVLEYVPE-TVNRIARNYSR------------IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQN 214 (394)
Q Consensus 148 ~~~~~~~~~lv~e~~~~-~l~~~~~~~~~------------~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~N 214 (394)
....++||||+.+ +|.+++..... ....+++..++.++.||+.||.|||+ .||+||||||+|
T Consensus 113 ----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dlkp~N 187 (334)
T 2pvf_A 113 ----DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS-QKCIHRDLAARN 187 (334)
T ss_dssp ----SSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGG
T ss_pred ----CCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh-CCeeCCCCccce
Confidence 3347799999975 88888775332 12358999999999999999999999 899999999999
Q ss_pred eEEeCCCCcEEEEeecCccccccCCC---cccccccccccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCc
Q 016184 215 LLVNPHTHQLKLCDFGSAKVLVKGEP---NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESG 290 (394)
Q Consensus 215 il~~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~ 290 (394)
||++.++ .+||+|||++........ .....+++.|+|||++.+. .++.++||||||+++|+|++ |..||.+...
T Consensus 188 Ill~~~~-~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p~~~~~~ 265 (334)
T 2pvf_A 188 VLVTENN-VMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDR-VYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV 265 (334)
T ss_dssp EEECTTC-CEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCSSTTCCH
T ss_pred EEEcCCC-CEEEccccccccccccccccccCCCCcccceeChHHhcCC-CcChHHHHHHHHHHHHHHHhCCCCCcCcCCH
Confidence 9999887 699999999976544322 2234557889999998654 48999999999999999999 9999988776
Q ss_pred HHHHHHHHHHhCCCChhhhhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 016184 291 VDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH 365 (394)
Q Consensus 291 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 365 (394)
.+....+...... ..+..++.++.+||.+||+.||.+|||+.+++++
T Consensus 266 ~~~~~~~~~~~~~----------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 312 (334)
T 2pvf_A 266 EELFKLLKEGHRM----------------------------DKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 312 (334)
T ss_dssp HHHHHHHHHTCCC----------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHhcCCCC----------------------------CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 5555444432100 0124578999999999999999999999999864
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=328.62 Aligned_cols=262 Identities=23% Similarity=0.324 Sum_probs=198.2
Q ss_pred cceeEEEeeEEeecCceEEEEEE----ECCCCcEEEEEEeccch----hhhHHHHHHHHHcCCCCeeeeceEEEecCCCc
Q 016184 80 QKVSYIAEHVVGTGSFGVVFQAK----CRETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKE 151 (394)
Q Consensus 80 ~~~~y~~~~~lg~G~~g~V~~~~----~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 151 (394)
...+|++.+.||+|+||.||+|+ +..+++.||||++.... ..+.+|+++++.++|+||+++++++.. ..
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~ 97 (327)
T 3lxl_A 21 EERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYG---PG 97 (327)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEC---SS
T ss_pred chhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEec---CC
Confidence 34579999999999999999999 46788999999986542 335689999999999999999998753 23
Q ss_pred eeEEEEEEeccc-ccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeec
Q 016184 152 ELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFG 230 (394)
Q Consensus 152 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg 230 (394)
....++||||++ ++|.+++.... ..+++..++.++.|++.||+|||+ .||+||||||+|||++.++ .+||+|||
T Consensus 98 ~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~al~~lH~-~~ivH~Dikp~NIl~~~~~-~~kl~Dfg 172 (327)
T 3lxl_A 98 RQSLRLVMEYLPSGCLRDFLQRHR---ARLDASRLLLYSSQICKGMEYLGS-RRCVHRDLAARNILVESEA-HVKIADFG 172 (327)
T ss_dssp SCEEEEEEECCTTCBHHHHHHHHG---GGCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEEETT-EEEECCGG
T ss_pred CceEEEEEeecCCCCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHh-CCccCCCCChhhEEECCCC-CEEEcccc
Confidence 445789999996 58877776532 469999999999999999999999 8999999999999999887 79999999
Q ss_pred CccccccCCC----cccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCC-
Q 016184 231 SAKVLVKGEP----NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPT- 305 (394)
Q Consensus 231 ~a~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~- 305 (394)
++........ .....+|+.|+|||++.+. .++.++||||||+++|+|++|..||......... ........+
T Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~--~~~~~~~~~~ 249 (327)
T 3lxl_A 173 LAKLLPLDKDYYVVREPGQSPIFWYAPESLSDN-IFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLR--MMGCERDVPA 249 (327)
T ss_dssp GCEECCTTCSEEECSSCCCSCGGGSCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHH--HCC----CCH
T ss_pred cceecccCCccceeeccCCccccccCHHHhccC-CCChHHhHHHHHHHHHHHHhCCCCCccccchhhh--hccccccccc
Confidence 9986644332 2234568889999998654 4799999999999999999999998653321100 000000000
Q ss_pred hh-hhhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 016184 306 RE-EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH 365 (394)
Q Consensus 306 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 365 (394)
.. ........ .....+..+++++.+||.+||+.||.+|||+.++++|
T Consensus 250 ~~~~~~~~~~~-------------~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 297 (327)
T 3lxl_A 250 LSRLLELLEEG-------------QRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQ 297 (327)
T ss_dssp HHHHHHHHHTT-------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHhhcc-------------cCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 00 00000000 0001124689999999999999999999999999653
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-43 Score=318.84 Aligned_cols=246 Identities=28% Similarity=0.385 Sum_probs=195.4
Q ss_pred cceeEEEeeEEeecCceEEEEEEECC---CCcEEEEEEeccc-----hhhhHHHHHHHHHcCCCCeeeeceEEEecCCCc
Q 016184 80 QKVSYIAEHVVGTGSFGVVFQAKCRE---TGEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKE 151 (394)
Q Consensus 80 ~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 151 (394)
...+|++.+.||+|+||.||+|++.. ++..||+|++... ...+.+|+.+++.++||||+++++++.. .
T Consensus 10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~----~ 85 (281)
T 3cc6_A 10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE----E 85 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS----S
T ss_pred cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC----C
Confidence 34569999999999999999998753 3456999998653 3345679999999999999999998721 1
Q ss_pred eeEEEEEEeccc-ccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeec
Q 016184 152 ELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFG 230 (394)
Q Consensus 152 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg 230 (394)
. .++||||+. ++|.+++... ...+++..++.++.|++.||.|||+ +||+||||||+|||++.++ .+||+|||
T Consensus 86 ~--~~~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dlkp~Nil~~~~~-~~kl~Dfg 158 (281)
T 3cc6_A 86 P--TWIIMELYPYGELGHYLERN---KNSLKVLTLVLYSLQICKAMAYLES-INCVHRDIAVRNILVASPE-CVKLGDFG 158 (281)
T ss_dssp S--CEEEEECCTTCBHHHHHHHH---TTTCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCSGGGEEEEETT-EEEECCCC
T ss_pred C--CEEEEecCCCCCHHHHHHhc---cccCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCccceEEECCCC-cEEeCccC
Confidence 1 468999998 4787776542 3568999999999999999999999 8999999999999999887 79999999
Q ss_pred CccccccCCC--cccccccccccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCChh
Q 016184 231 SAKVLVKGEP--NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTRE 307 (394)
Q Consensus 231 ~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~ 307 (394)
++........ .....+++.|+|||++.+. .++.++||||||+++|+|++ |+.||......+....+......+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~~~--- 234 (281)
T 3cc6_A 159 LSRYIEDEDYYKASVTRLPIKWMSPESINFR-RFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLP--- 234 (281)
T ss_dssp GGGCC---------CCCCCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCCCC---
T ss_pred CCcccccccccccccCCCCcceeCchhhccC-CCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCCCC---
Confidence 9976543321 2234557889999998654 48999999999999999998 999998777666555444321100
Q ss_pred hhhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 016184 308 EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH 365 (394)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 365 (394)
.+..+++.+.+||.+||+.||.+|||+.+++++
T Consensus 235 -------------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~ 267 (281)
T 3cc6_A 235 -------------------------KPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCS 267 (281)
T ss_dssp -------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -------------------------CCCCCCHHHHHHHHHHccCCchhCcCHHHHHHH
Confidence 124578999999999999999999999999864
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-43 Score=326.61 Aligned_cols=251 Identities=24% Similarity=0.349 Sum_probs=199.8
Q ss_pred ceeEEEeeEEeecCceEEEEEEE-----CCCCcEEEEEEeccch-----hhhHHHHHHHHHc-CCCCeeeeceEEEecCC
Q 016184 81 KVSYIAEHVVGTGSFGVVFQAKC-----RETGEIVAIKKVLQDK-----RYKNRELQIMQML-DHPNIVALKHCFFSTTD 149 (394)
Q Consensus 81 ~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~ 149 (394)
..+|++.+.||+|+||.||+|++ ..+++.||||++.... ....+|+.+++.+ +||||+++++++...
T Consensus 26 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~-- 103 (316)
T 2xir_A 26 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP-- 103 (316)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCT--
T ss_pred hhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecC--
Confidence 45699999999999999999985 4567899999986532 3455799999999 789999999987432
Q ss_pred CceeEEEEEEecccc-cHHHHHHHhhhh------------cCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceE
Q 016184 150 KEELYLNLVLEYVPE-TVNRIARNYSRI------------HQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLL 216 (394)
Q Consensus 150 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~------------~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil 216 (394)
...+++||||+.+ +|.+++...... ...+++..++.++.|++.||.|||+ .||+||||||+|||
T Consensus 104 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~-~~i~H~dikp~Nil 180 (316)
T 2xir_A 104 --GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS-RKCIHRDLAARNIL 180 (316)
T ss_dssp --TSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEE
T ss_pred --CCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHh-CCcccccCccceEE
Confidence 2336789999985 888877653321 1238899999999999999999999 89999999999999
Q ss_pred EeCCCCcEEEEeecCccccccCCCc---ccccccccccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHH
Q 016184 217 VNPHTHQLKLCDFGSAKVLVKGEPN---VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVD 292 (394)
Q Consensus 217 ~~~~~~~vkl~Dfg~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~ 292 (394)
++.++ .+||+|||++......... ....+|+.|+|||++.+. .++.++||||||+++|+|++ |..||.+.....
T Consensus 181 ~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~ 258 (316)
T 2xir_A 181 LSEKN-VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDR-VYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE 258 (316)
T ss_dssp ECGGG-CEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSH
T ss_pred ECCCC-CEEECCCccccccccCccceeccCCCcceeecCchhhccc-cccchhHHHHHHHHHHHHHhCCCCCCcccchhH
Confidence 99887 6999999999765443322 234568899999998654 48999999999999999998 999998876554
Q ss_pred HHHHHHHHhCCCChhhhhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 016184 293 QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH 365 (394)
Q Consensus 293 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 365 (394)
.+........... .+..+++.+.++|.+||+.||.+|||+.++++|
T Consensus 259 ~~~~~~~~~~~~~---------------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 304 (316)
T 2xir_A 259 EFCRRLKEGTRMR---------------------------APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304 (316)
T ss_dssp HHHHHHHHTCCCC---------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHhccCccCC---------------------------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 4444333211100 123578999999999999999999999999976
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-43 Score=319.75 Aligned_cols=243 Identities=26% Similarity=0.351 Sum_probs=187.5
Q ss_pred ceeEEEe-eEEeecCceEEEEEEECCCCcEEEEEEeccchhhhHHHHHHH-HHcCCCCeeeeceEEEecCCCceeEEEEE
Q 016184 81 KVSYIAE-HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIM-QMLDHPNIVALKHCFFSTTDKEELYLNLV 158 (394)
Q Consensus 81 ~~~y~~~-~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~E~~~l-~~l~h~~iv~~~~~~~~~~~~~~~~~~lv 158 (394)
..+|.+. +.||+|+||.||+|.+..+++.||||++... ....+|++++ +.++||||+++++++.... ....+.++|
T Consensus 16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~-~~~~~~~lv 93 (299)
T 3m2w_A 16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-PKARREVELHWRASQCPHIVRIVDVYENLY-AGRKCLLIV 93 (299)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-HHHHHHHHHHHHHTTSTTBCCEEEEEEEEE-TTEEEEEEE
T ss_pred ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-HHHHHHHHHHHHhccCCCchhHHhhhhhhc-CCCceEEEE
Confidence 3458877 7899999999999999999999999998653 4456788887 6679999999999884322 235568899
Q ss_pred Eecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeC---CCCcEEEEeecCccc
Q 016184 159 LEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNP---HTHQLKLCDFGSAKV 234 (394)
Q Consensus 159 ~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~---~~~~vkl~Dfg~a~~ 234 (394)
|||+.+ +|.+++.... ...+++..++.++.|++.||+|||+ .||+||||||+|||++. ++ .+||+|||++..
T Consensus 94 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dlkp~Nil~~~~~~~~-~~kl~Dfg~a~~ 169 (299)
T 3m2w_A 94 MECLDGGELFSRIQDRG--DQAFTEREASEIMKSIGEAIQYLHS-INIAHRDVKPENLLYTSKRPNA-ILKLTDFGFAKE 169 (299)
T ss_dssp ECCCCSCBHHHHHHHCT--TCCCBHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEESSSSTTC-CEEECCCTTCEE
T ss_pred EeecCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHHEEEecCCCCC-cEEEeccccccc
Confidence 999975 8888777532 2469999999999999999999999 89999999999999997 45 799999999864
Q ss_pred cccCCCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCC
Q 016184 235 LVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 314 (394)
Q Consensus 235 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 314 (394)
.. ...++.++|||||||++|+|++|+.||.+.........+..
T Consensus 170 ~~----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~--------------- 212 (299)
T 3m2w_A 170 TT----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKT--------------- 212 (299)
T ss_dssp CT----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCC---------------
T ss_pred cc----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHH---------------
Confidence 31 12378899999999999999999999976543221110000
Q ss_pred CCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 016184 315 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR 372 (394)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 372 (394)
.. ......+.......+++++.+||.+||+.||.+|||+.++|+||||++..
T Consensus 213 ---~~---~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~ 264 (299)
T 3m2w_A 213 ---RI---RMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 264 (299)
T ss_dssp ---SS---CTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGG
T ss_pred ---HH---hhccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhcccc
Confidence 00 00000111112246799999999999999999999999999999998764
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=346.56 Aligned_cols=247 Identities=20% Similarity=0.338 Sum_probs=202.3
Q ss_pred cceeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccc---hhhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEEE
Q 016184 80 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD---KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN 156 (394)
Q Consensus 80 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 156 (394)
...+|++.+.||+|+||.||+|++..++..||||++... ...+.+|+.+++.++||||+++++++.. ...++
T Consensus 218 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-----~~~~~ 292 (495)
T 1opk_A 218 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR-----EPPFY 292 (495)
T ss_dssp CGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-----SSSCE
T ss_pred CHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccchHHHHHHHHHHHhcCCCCEeeEEEEEec-----CCcEE
Confidence 455799999999999999999999988999999998654 3445689999999999999999998832 23367
Q ss_pred EEEeccc-ccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCcccc
Q 016184 157 LVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL 235 (394)
Q Consensus 157 lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~ 235 (394)
+||||+. ++|.+++.... ...+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+++..
T Consensus 293 lv~E~~~~g~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~L~~LH~-~~ivHrDlkp~NIll~~~~-~~kl~DFG~a~~~ 368 (495)
T 1opk_A 293 IITEFMTYGNLLDYLRECN--RQEVSAVVLLYMATQISSAMEYLEK-KNFIHRNLAARNCLVGENH-LVKVADFGLSRLM 368 (495)
T ss_dssp EEEECCTTCBHHHHHHHSC--TTTSCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECGGG-CEEECCTTCEECC
T ss_pred EEEEccCCCCHHHHHHhcC--cCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCChhhEEECCCC-cEEEeecccceec
Confidence 9999998 58888776532 2568999999999999999999999 8999999999999999887 7999999999865
Q ss_pred ccCCC--cccccccccccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCChhhhhcc
Q 016184 236 VKGEP--NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 312 (394)
Q Consensus 236 ~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 312 (394)
..... .....+++.|+|||++... .++.++|||||||++|+|++ |..||.+.+..+....+.....
T Consensus 369 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~---------- 437 (495)
T 1opk_A 369 TGDTYTAHAGAKFPIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYR---------- 437 (495)
T ss_dssp TTCCEECCTTCCCCGGGCCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCC----------
T ss_pred cCCceeecCCCcCCcceeCHhHHhcC-CCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC----------
Confidence 43221 1223456789999998654 48999999999999999999 9999988776555444332110
Q ss_pred CCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 016184 313 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV 364 (394)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 364 (394)
...+..+++.+.+||.+||+.||.+|||+.++++
T Consensus 438 ------------------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~ 471 (495)
T 1opk_A 438 ------------------MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 471 (495)
T ss_dssp ------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ------------------CCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHH
Confidence 0112467899999999999999999999999986
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-43 Score=316.66 Aligned_cols=244 Identities=19% Similarity=0.320 Sum_probs=198.7
Q ss_pred eeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccc---hhhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEEEEE
Q 016184 82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD---KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLV 158 (394)
Q Consensus 82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv 158 (394)
.+|++.+.||+|+||.||+|.+. +++.||+|++... .....+|+++++.++||||+++++++.. ....+++
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~lv 81 (267)
T 3t9t_A 8 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE-----QAPICLV 81 (267)
T ss_dssp GGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTBCHHHHHHHHHHHHTCCCTTBCCEEEEECS-----SSSCEEE
T ss_pred hheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCCCHHHHHHHHHHHHhCCCCCEeeEEEEEcc-----CCCeEEE
Confidence 46999999999999999999996 6788999998654 3456689999999999999999998833 2336799
Q ss_pred Eecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCcccccc
Q 016184 159 LEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK 237 (394)
Q Consensus 159 ~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~ 237 (394)
|||+++ +|.+++... ...+++..++.++.|++.||.|||+ +|++||||||+||+++.++ .+||+|||++.....
T Consensus 82 ~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dl~p~Nili~~~~-~~kl~dfg~~~~~~~ 156 (267)
T 3t9t_A 82 TEFMEHGCLSDYLRTQ---RGLFAAETLLGMCLDVCEGMAYLEE-ACVIHRDLAARNCLVGENQ-VIKVSDFGMTRFVLD 156 (267)
T ss_dssp ECCCTTCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSSCCGGGEEECGGG-CEEECCTTGGGGBCC
T ss_pred EeCCCCCcHHHHHhhC---cccCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCchheEEECCCC-CEEEccccccccccc
Confidence 999974 787777542 2568999999999999999999999 8999999999999999887 699999999876532
Q ss_pred CC--CcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCC
Q 016184 238 GE--PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 314 (394)
Q Consensus 238 ~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 314 (394)
.. ......+++.|+|||++.+. .++.++||||||+++|+|++ |+.||......+....+......
T Consensus 157 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~~~----------- 224 (267)
T 3t9t_A 157 DQYTSSTGTKFPVKWASPEVFSFS-RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRL----------- 224 (267)
T ss_dssp HHHHSTTSTTCCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCC-----------
T ss_pred ccccccccccccccccChhhhcCC-CccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCcC-----------
Confidence 21 12234567789999998654 48999999999999999999 89999887766655554331100
Q ss_pred CCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 016184 315 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH 365 (394)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 365 (394)
..+..++..+.+||.+||+.||.+|||+.+++++
T Consensus 225 -----------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 258 (267)
T 3t9t_A 225 -----------------YKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQ 258 (267)
T ss_dssp -----------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -----------------CCCccCcHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 0123568899999999999999999999999864
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-43 Score=327.76 Aligned_cols=243 Identities=23% Similarity=0.339 Sum_probs=188.8
Q ss_pred eeEEEeeEEeecCceEEEEEEECCCCcEE----EEEEecc-----chhhhHHHHHHHHHcCCCCeeeeceEEEecCCCce
Q 016184 82 VSYIAEHVVGTGSFGVVFQAKCRETGEIV----AIKKVLQ-----DKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE 152 (394)
Q Consensus 82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~v----aiK~~~~-----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 152 (394)
.+|++.++||+|+||.||+|++..+++.| |+|.+.. ....+.+|+.+++.++||||+++++++...
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~----- 89 (327)
T 3lzb_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS----- 89 (327)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESS-----
T ss_pred hHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecC-----
Confidence 45999999999999999999998888765 5555532 234556899999999999999999988432
Q ss_pred eEEEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecC
Q 016184 153 LYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS 231 (394)
Q Consensus 153 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~ 231 (394)
. .+++++++.+ ++.+++... ...+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||+
T Consensus 90 ~-~~~v~~~~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dikp~NIl~~~~~-~~kL~DfG~ 163 (327)
T 3lzb_A 90 T-VQLITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLED-RRLVHRDLAARNVLVKTPQ-HVKITDFGL 163 (327)
T ss_dssp S-EEEEECCCSSCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEEEETT-EEEECCTTC
T ss_pred C-ceEEEEecCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHhh-CCCcCCCCCHHHEEEcCCC-CEEEccCcc
Confidence 1 4577888774 777666542 3579999999999999999999999 8999999999999999887 799999999
Q ss_pred ccccccCCCc---ccccccccccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCChh
Q 016184 232 AKVLVKGEPN---VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTRE 307 (394)
Q Consensus 232 a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~ 307 (394)
++........ ....+|+.|+|||++.+. .++.++|||||||++|+|++ |..||.+....+....+......+
T Consensus 164 a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~--- 239 (327)
T 3lzb_A 164 AKLLGAEEKEYHAEGGKVPIKWMALESILHR-IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLP--- 239 (327)
T ss_dssp ----------------CCCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCC---
T ss_pred eeEccCccccccccCCCccccccCHHHHcCC-CCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCC---
Confidence 9765433222 233457789999999754 48999999999999999999 999998877665544433211000
Q ss_pred hhhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 016184 308 EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV 364 (394)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 364 (394)
.+..++.++.+||++||+.||.+|||+.++++
T Consensus 240 -------------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 271 (327)
T 3lzb_A 240 -------------------------QPPICTIDVYMIMRKCWMIDADSRPKFRELII 271 (327)
T ss_dssp -------------------------CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -------------------------CCccCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 12457889999999999999999999999986
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-43 Score=321.61 Aligned_cols=257 Identities=23% Similarity=0.362 Sum_probs=194.5
Q ss_pred ceeEEEeeEEeecCceEEEEEE----ECCCCcEEEEEEeccch-----hhhHHHHHHHHHcCCCCeeeeceEEEecCCCc
Q 016184 81 KVSYIAEHVVGTGSFGVVFQAK----CRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKE 151 (394)
Q Consensus 81 ~~~y~~~~~lg~G~~g~V~~~~----~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 151 (394)
...|++.+.||+|+||.||+|+ +..+++.||||++.... ....+|+++++.++||||+++++++... .
T Consensus 20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~---~ 96 (302)
T 4e5w_A 20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTED---G 96 (302)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-----
T ss_pred hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecC---C
Confidence 3459999999999999999999 56789999999986432 4456899999999999999999988532 2
Q ss_pred eeEEEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeec
Q 016184 152 ELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFG 230 (394)
Q Consensus 152 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg 230 (394)
...+++||||+++ +|.+++... ...+++..++.++.|++.||+|||+ .||+||||||+|||++.++ .+||+|||
T Consensus 97 ~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dikp~Nil~~~~~-~~kl~Dfg 171 (302)
T 4e5w_A 97 GNGIKLIMEFLPSGSLKEYLPKN---KNKINLKQQLKYAVQICKGMDYLGS-RQYVHRDLAARNVLVESEH-QVKIGDFG 171 (302)
T ss_dssp -CCEEEEEECCTTCBHHHHHHHH---TTTCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEEETT-EEEECCCT
T ss_pred CceEEEEEEeCCCCcHHHHHHhc---cccCCHHHHHHHHHHHHHHHHHhhc-CCcccCCCchheEEEcCCC-CEEECccc
Confidence 2347799999975 887777542 3569999999999999999999999 8999999999999999887 79999999
Q ss_pred CccccccCCC----cccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCh
Q 016184 231 SAKVLVKGEP----NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTR 306 (394)
Q Consensus 231 ~a~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~ 306 (394)
++........ .....+|..|+|||++.+.. ++.++||||||+++|+|++|..|+.... .......+....
T Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~-----~~~~~~~~~~~~ 245 (302)
T 4e5w_A 172 LTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSK-FYIASDVWSFGVTLHELLTYCDSDSSPM-----ALFLKMIGPTHG 245 (302)
T ss_dssp TCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTTCGGGSHH-----HHHHHHHCSCCG
T ss_pred ccccccCCCcceeccCCCCCCccccCCeeecCCC-CCcchhHHHHHHHHHHHHHccCCCcchh-----hHHhhccCCccc
Confidence 9987654432 22345688899999986544 7899999999999999999998864221 111111111110
Q ss_pred hhh-----hccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 016184 307 EEI-----KCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV 364 (394)
Q Consensus 307 ~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 364 (394)
... ...... .....+..+++++.+||.+||+.||.+|||+.++++
T Consensus 246 ~~~~~~~~~~~~~~-------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 295 (302)
T 4e5w_A 246 QMTVTRLVNTLKEG-------------KRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE 295 (302)
T ss_dssp GGHHHHHHHHHHTT-------------CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred ccCHHHHHHHHhcc-------------CCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence 000 000000 000122468899999999999999999999999985
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=335.27 Aligned_cols=245 Identities=25% Similarity=0.351 Sum_probs=187.0
Q ss_pred ceeEEEeeEEeecCceEEEEEEEC---CCCcEEEEEEeccc-----hhhhHHHHHHHHHcCCCCeeeeceEEEecCCCce
Q 016184 81 KVSYIAEHVVGTGSFGVVFQAKCR---ETGEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE 152 (394)
Q Consensus 81 ~~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 152 (394)
..+|.+.+.||+|+||.||+|++. .++..||||++... ...+.+|+.+++.++||||+++++++.. .
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-----~ 118 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTK-----S 118 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-----S
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEee-----C
Confidence 346999999999999999999986 45778999998643 2345679999999999999999998832 3
Q ss_pred eEEEEEEeccc-ccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecC
Q 016184 153 LYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS 231 (394)
Q Consensus 153 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~ 231 (394)
...++||||++ ++|.+++... ...+++..++.++.||+.||+|||+ .||+||||||+|||++.++ .+||+|||+
T Consensus 119 ~~~~lv~e~~~~~sL~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dlkp~NIll~~~~-~~kl~Dfg~ 193 (373)
T 2qol_A 119 KPVMIVTEYMENGSLDSFLRKH---DAQFTVIQLVGMLRGIASGMKYLSD-MGYVHRDLAARNILINSNL-VCKVSDFGL 193 (373)
T ss_dssp SSCEEEEECCTTCBHHHHHHTT---TTCSCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECTTC-CEEECCC--
T ss_pred CceEEEEeCCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHH-CCeeCCCCCcceEEEcCCC-CEEECcCcc
Confidence 34679999996 5888777642 3579999999999999999999999 8999999999999999888 699999999
Q ss_pred ccccccCCCc----ccccccccccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCh
Q 016184 232 AKVLVKGEPN----VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTR 306 (394)
Q Consensus 232 a~~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~ 306 (394)
++........ ....+++.|+|||++.+. .++.++||||||+++|+|++ |+.||......+....+......+
T Consensus 194 a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~~~~-- 270 (373)
T 2qol_A 194 GRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYR-KFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLP-- 270 (373)
T ss_dssp --------------------CTTSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTEECC--
T ss_pred ccccccCCccceeccCCCcCCCccChhhhccC-CcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC--
Confidence 9866433211 122346789999999654 48999999999999999998 999998877665554443311100
Q ss_pred hhhhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 016184 307 EEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV 364 (394)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 364 (394)
.+..++..+.+||.+||+.||.+|||+.++++
T Consensus 271 --------------------------~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~ 302 (373)
T 2qol_A 271 --------------------------PPMDCPAALYQLMLDCWQKDRNNRPKFEQIVS 302 (373)
T ss_dssp --------------------------CCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --------------------------CCccccHHHHHHHHHHhCcChhhCcCHHHHHH
Confidence 11357889999999999999999999998875
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=330.20 Aligned_cols=255 Identities=18% Similarity=0.221 Sum_probs=197.6
Q ss_pred ceeEEEeeEEeecCceEEEEEE-----ECCCCcEEEEEEeccc-----hhhhHHHHHHHHHcCCCCeeeeceEEEecCCC
Q 016184 81 KVSYIAEHVVGTGSFGVVFQAK-----CRETGEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDK 150 (394)
Q Consensus 81 ~~~y~~~~~lg~G~~g~V~~~~-----~~~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 150 (394)
..+|++.+.||+|+||.||+|+ +..+++.||||++... .....+|+.+++.++||||+++++++..
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~---- 104 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQ---- 104 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS----
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcC----
Confidence 3469999999999999999999 5567889999998532 2344579999999999999999998833
Q ss_pred ceeEEEEEEeccc-ccHHHHHHHhhhh---cCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCC--CcE
Q 016184 151 EELYLNLVLEYVP-ETVNRIARNYSRI---HQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHT--HQL 224 (394)
Q Consensus 151 ~~~~~~lv~e~~~-~~l~~~~~~~~~~---~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~--~~v 224 (394)
....++||||++ ++|.+++...... ...+++..++.++.|++.||.|||+ .||+||||||+|||++.++ ..+
T Consensus 105 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~-~~i~H~dlkp~NIli~~~~~~~~~ 182 (327)
T 2yfx_A 105 -SLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE-NHFIHRDIAARNCLLTCPGPGRVA 182 (327)
T ss_dssp -SSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEESCSSTTCCE
T ss_pred -CCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhh-CCeecCcCCHhHEEEecCCCcceE
Confidence 223679999995 5888887764321 1458999999999999999999999 8999999999999998433 269
Q ss_pred EEEeecCccccccCC---CcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHH
Q 016184 225 KLCDFGSAKVLVKGE---PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKV 300 (394)
Q Consensus 225 kl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~ 300 (394)
||+|||++....... ......+++.|+|||++.+. .++.++||||||+++|+|++ |..||......+....+...
T Consensus 183 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~ 261 (327)
T 2yfx_A 183 KIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEG-IFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSG 261 (327)
T ss_dssp EECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTT
T ss_pred EECccccccccccccccccCCCcCCCcceeCHhHhcCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHhcC
Confidence 999999987543322 22344668899999998654 48999999999999999998 99999887665554444331
Q ss_pred hCCCChhhhhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 016184 301 LGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE 370 (394)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~ 370 (394)
.. + ..+..++..+.+||.+||+.||.+|||+.++++|.|+-.
T Consensus 262 ~~-~---------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~ 303 (327)
T 2yfx_A 262 GR-M---------------------------DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT 303 (327)
T ss_dssp CC-C---------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CC-C---------------------------CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHh
Confidence 10 0 012457899999999999999999999999999988643
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-43 Score=316.56 Aligned_cols=244 Identities=13% Similarity=0.198 Sum_probs=197.3
Q ss_pred ceeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccc------hhhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeE
Q 016184 81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY 154 (394)
Q Consensus 81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 154 (394)
..+|++.+.||+|+||.||+|++. ++.||||++... ...+.+|+.+++.++||||+++++++... ....
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~---~~~~ 83 (271)
T 3kmu_A 9 FKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSP---PAPH 83 (271)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTT---TSSS
T ss_pred HHHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccC---CCCC
Confidence 346999999999999999999985 889999998643 23456799999999999999999988432 1234
Q ss_pred EEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCC--ceeccCCCCceEEeCCCCcEEEEeecC
Q 016184 155 LNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG--ICHRDIKPQNLLVNPHTHQLKLCDFGS 231 (394)
Q Consensus 155 ~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~g--ivH~Dlkp~Nil~~~~~~~vkl~Dfg~ 231 (394)
.++||||+++ +|.+++.... ...+++..++.++.|++.||.|||+ .| |+||||||+|||++.++ .++|+|||+
T Consensus 84 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~-~~~~i~H~dikp~Nil~~~~~-~~~l~~~~~ 159 (271)
T 3kmu_A 84 PTLITHWMPYGSLYNVLHEGT--NFVVDQSQAVKFALDMARGMAFLHT-LEPLIPRHALNSRSVMIDEDM-TARISMADV 159 (271)
T ss_dssp CEEEEECCTTCBHHHHHHSCS--SCCCCHHHHHHHHHHHHHHHHHHTT-SSSCCTTCCCSGGGEEECTTS-CEEEEGGGS
T ss_pred eEeeecccCCCcHHHHHhhcc--cCCCCHHHHHHHHHHHHHHHHHHhc-CCCceecCCCccceEEEcCCc-ceeEEeccc
Confidence 6799999985 8888776421 2358999999999999999999999 89 99999999999999887 699999998
Q ss_pred ccccccCCCcccccccccccccccccCCCC--CCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhh
Q 016184 232 AKVLVKGEPNVSYICSRYYRAPELIFGATE--YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI 309 (394)
Q Consensus 232 a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~--~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 309 (394)
+... ......+|+.|+|||.+.+... ++.++||||||+++|+|++|+.||.+.........+......+
T Consensus 160 ~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~----- 230 (271)
T 3kmu_A 160 KFSF----QSPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRP----- 230 (271)
T ss_dssp CCTT----SCTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCC-----
T ss_pred eeee----cccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCC-----
Confidence 7543 2234567999999999965432 2338999999999999999999998877766655554421111
Q ss_pred hccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 016184 310 KCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV 364 (394)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 364 (394)
.++..+++++.+||.+||+.||.+|||+.++++
T Consensus 231 ----------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (271)
T 3kmu_A 231 ----------------------TIPPGISPHVSKLMKICMNEDPAKRPKFDMIVP 263 (271)
T ss_dssp ----------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ----------------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 122467999999999999999999999999986
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=334.44 Aligned_cols=260 Identities=20% Similarity=0.240 Sum_probs=195.8
Q ss_pred eeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccch----hhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEEEE
Q 016184 82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL 157 (394)
Q Consensus 82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 157 (394)
++|++.+.||+|+||.||+|++ .+|+.||||++.... ....+|+.+++.++||||+++++++.. ....++
T Consensus 39 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~~l 112 (321)
T 2qkw_B 39 NNFDHKFLIGHGVFGKVYKGVL-RDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDE-----RNEMIL 112 (321)
T ss_dssp CCCSCCCCSCBCSSSEEEEEEC-TTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCC-----TTCCEE
T ss_pred hccCccceeecCCCeeEEEEEE-CCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcC-----CCeEEE
Confidence 4599999999999999999997 468999999876432 345689999999999999999998732 233679
Q ss_pred EEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCccccc
Q 016184 158 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV 236 (394)
Q Consensus 158 v~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~ 236 (394)
||||+.+ +|.+++.........+++..++.++.|++.||+|||+ +||+||||||+|||++.++ .+||+|||++....
T Consensus 113 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~-~~ivH~dlkp~Nil~~~~~-~~kl~Dfg~~~~~~ 190 (321)
T 2qkw_B 113 IYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHT-RAIIHRDVKSINILLDENF-VPKITDFGISKKGT 190 (321)
T ss_dssp EEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCSTTEEECTTC-CEEECCCTTCEECS
T ss_pred EEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcC-CCeecCCCCHHHEEECCCC-CEEEeecccccccc
Confidence 9999975 7766554333223468999999999999999999999 8999999999999999887 79999999997643
Q ss_pred cCC---CcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHH--HH-HHHhCCCChhhhh
Q 016184 237 KGE---PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLV--EI-IKVLGTPTREEIK 310 (394)
Q Consensus 237 ~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~--~i-~~~~~~~~~~~~~ 310 (394)
... ......||+.|+|||++.+. .++.++||||||+++|+|++|+.||.+....+... .. .....
T Consensus 191 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~-------- 261 (321)
T 2qkw_B 191 ELDQTHLSTVVKGTLGYIDPEYFIKG-RLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHN-------- 261 (321)
T ss_dssp SSSCCCCBCCCEEETTTCCHHHHHHC-BCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHT--------
T ss_pred cccccccccccCCCccccCHHHhcCC-CCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccc--------
Confidence 221 12334589999999998654 48999999999999999999999997654322111 00 00000
Q ss_pred ccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 016184 311 CMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH 365 (394)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 365 (394)
... +...........+....+..+.+|+.+||+.||++|||+.++++|
T Consensus 262 --~~~-----~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 309 (321)
T 2qkw_B 262 --NGQ-----LEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWK 309 (321)
T ss_dssp --TTC-----CCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred --ccc-----HHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 000 000000111112224456789999999999999999999999975
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=337.62 Aligned_cols=246 Identities=24% Similarity=0.369 Sum_probs=200.4
Q ss_pred ccceeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccc---hhhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEE
Q 016184 79 KQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD---KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL 155 (394)
Q Consensus 79 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 155 (394)
....+|++.+.||+|+||.||+|.+. .+..||||++... ...+.+|+.+++.++||||+++++++. .+ ..
T Consensus 185 i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~----~~--~~ 257 (454)
T 1qcf_A 185 IPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVT----KE--PI 257 (454)
T ss_dssp CCGGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHTTCCCTTBCCEEEEEC----SS--SC
T ss_pred echHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCCccHHHHHHHHHHHhhCCCCCEeeEEEEEe----CC--cc
Confidence 34557999999999999999999985 4678999998653 345568999999999999999998872 11 26
Q ss_pred EEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCccc
Q 016184 156 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV 234 (394)
Q Consensus 156 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~ 234 (394)
++||||+.+ +|.+++.... ...+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+++.
T Consensus 258 ~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~-~~ivHrDlkp~Nill~~~~-~~kl~DFG~a~~ 333 (454)
T 1qcf_A 258 YIITEFMAKGSLLDFLKSDE--GSKQPLPKLIDFSAQIAEGMAFIEQ-RNYIHRDLRAANILVSASL-VCKIADFGLARV 333 (454)
T ss_dssp EEEECCCTTCBHHHHHHSHH--HHTCCHHHHHHHHHHHHHHHHHHHH-TTCCCSSCSGGGEEECTTC-CEEECSTTGGGG
T ss_pred EEEEeecCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHh-CCccCCCCCHHHEEECCCC-cEEEeeCCCceE
Confidence 789999974 8888776432 2468899999999999999999999 8999999999999999887 799999999986
Q ss_pred cccCC--CcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCChhhhhc
Q 016184 235 LVKGE--PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKC 311 (394)
Q Consensus 235 ~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 311 (394)
..... ......+++.|+|||++... .++.++|||||||++|+|++ |+.||.+.+..+.+..+......+
T Consensus 334 ~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~------- 405 (454)
T 1qcf_A 334 IEDNEYTAREGAKFPIKWTAPEAINFG-SFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMP------- 405 (454)
T ss_dssp BCCHHHHTTCSSSSCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCCC-------
T ss_pred cCCCceeccCCCcccccccCHHHhccC-CCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC-------
Confidence 53221 11223457789999999654 48999999999999999999 999999887776666555421111
Q ss_pred cCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 016184 312 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV 364 (394)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 364 (394)
.+..+++++.+||.+||+.||.+|||++++++
T Consensus 406 ---------------------~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~ 437 (454)
T 1qcf_A 406 ---------------------RPENCPEELYNIMMRCWKNRPEERPTFEYIQS 437 (454)
T ss_dssp ---------------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---------------------CCCCCCHHHHHHHHHHccCChhHCcCHHHHHH
Confidence 12457899999999999999999999999975
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-43 Score=324.70 Aligned_cols=246 Identities=23% Similarity=0.329 Sum_probs=191.4
Q ss_pred ceeEEEeeEEeecCceEEEEEEECCCC----cEEEEEEeccc-----hhhhHHHHHHHHHcCCCCeeeeceEEEecCCCc
Q 016184 81 KVSYIAEHVVGTGSFGVVFQAKCRETG----EIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKE 151 (394)
Q Consensus 81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~----~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 151 (394)
..+|++.+.||+|+||.||+|++..++ ..||||++... ...+.+|+.+++.++||||+++++++. .
T Consensus 43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~ 117 (333)
T 1mqb_A 43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVIS-----K 117 (333)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-----S
T ss_pred hHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEe-----c
Confidence 346999999999999999999987553 45999998643 223457999999999999999999883 2
Q ss_pred eeEEEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeec
Q 016184 152 ELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFG 230 (394)
Q Consensus 152 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg 230 (394)
....++||||+.+ +|.+++... ...+++..++.++.||+.||+|||+ .||+||||||+|||++.++ .+||+|||
T Consensus 118 ~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dikp~NIl~~~~~-~~kl~Dfg 192 (333)
T 1mqb_A 118 YKPMMIITEYMENGALDKFLREK---DGEFSVLQLVGMLRGIAAGMKYLAN-MNYVHRDLAARNILVNSNL-VCKVSDFG 192 (333)
T ss_dssp SSSEEEEEECCTTEEHHHHHHHT---TTCSCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECTTC-CEEECCCC
T ss_pred CCCcEEEEeCCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHh-CCeeCCCCChheEEECCCC-cEEECCCC
Confidence 3347899999986 887776542 3579999999999999999999999 8999999999999999887 79999999
Q ss_pred CccccccCCC----cccccccccccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCC
Q 016184 231 SAKVLVKGEP----NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPT 305 (394)
Q Consensus 231 ~a~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~ 305 (394)
++........ .....+|+.|+|||++.+. .++.++||||||+++|+|++ |+.||.+....+....+......+
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~- 270 (333)
T 1mqb_A 193 LSRVLEDDPEATYTTSGGKIPIRWTAPEAISYR-KFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLP- 270 (333)
T ss_dssp C-----------------CCCGGGSCHHHHHSC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCC-
T ss_pred cchhhccccccccccCCCCccccccCchhcccC-CCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCCcCC-
Confidence 9976543321 1123457789999999654 48999999999999999999 999998877655554443311000
Q ss_pred hhhhhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 016184 306 REEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH 365 (394)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 365 (394)
.+..++..+.+||.+||+.||.+||++.+++++
T Consensus 271 ---------------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 303 (333)
T 1mqb_A 271 ---------------------------TPMDCPSAIYQLMMQCWQQERARRPKFADIVSI 303 (333)
T ss_dssp ---------------------------CCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred ---------------------------CcccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 113578899999999999999999999998864
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-43 Score=318.86 Aligned_cols=247 Identities=20% Similarity=0.285 Sum_probs=186.4
Q ss_pred ceeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccc------hhhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeE
Q 016184 81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY 154 (394)
Q Consensus 81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 154 (394)
.++|++.+.||+|+||.||+|++. ..||+|++... ...+.+|+.+++.++|+||++++++.. . ..
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~---~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~----~--~~ 93 (289)
T 3og7_A 23 DGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST----A--PQ 93 (289)
T ss_dssp TTSCEEEEEEEECSSEEEEEEESS---SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC----S--SS
T ss_pred ccceeeeeEecCCCCeEEEEEEEc---CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeecc----C--Cc
Confidence 345999999999999999999874 35999988532 234567999999999999999988541 1 12
Q ss_pred EEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCcc
Q 016184 155 LNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK 233 (394)
Q Consensus 155 ~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~ 233 (394)
.++||||+.+ +|.+.+.. ....+++..++.++.|++.||.|||+ .||+||||||+|||++.++ .+||+|||++.
T Consensus 94 ~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~L~~lH~-~~i~H~Dlkp~Nil~~~~~-~~kl~Dfg~~~ 168 (289)
T 3og7_A 94 LAIVTQWCEGSSLYHHLHA---SETKFEMKKLIDIARQTARGMDYLHA-KSIIHRDLKSNNIFLHEDN-TVKIGDFGLAT 168 (289)
T ss_dssp CEEEEECCCEEEHHHHHTT---C---CCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEEETTT-EEEECCCC---
T ss_pred cEEEEEecCCCcHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHh-CCcccccCccceEEECCCC-CEEEccceecc
Confidence 5689999984 66665532 23679999999999999999999999 8999999999999999887 79999999987
Q ss_pred ccccC---CCccccccccccccccccc--CCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhh
Q 016184 234 VLVKG---EPNVSYICSRYYRAPELIF--GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 308 (394)
Q Consensus 234 ~~~~~---~~~~~~~~t~~y~aPE~~~--~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~ 308 (394)
..... .......+|+.|+|||++. ....++.++||||||+++|+|++|+.||.+....+.+..+.......+.
T Consensus 169 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~-- 246 (289)
T 3og7_A 169 EKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPD-- 246 (289)
T ss_dssp ---------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCC--
T ss_pred ccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcc--
Confidence 55321 2223456899999999985 2344788999999999999999999999987777666665543221110
Q ss_pred hhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 016184 309 IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV 364 (394)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 364 (394)
...+...+++.+.+||.+||+.||.+|||+.++++
T Consensus 247 ---------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 281 (289)
T 3og7_A 247 ---------------------LSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILA 281 (289)
T ss_dssp ---------------------TTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---------------------hhhccccCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 00112467899999999999999999999999986
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-43 Score=317.62 Aligned_cols=244 Identities=23% Similarity=0.336 Sum_probs=191.9
Q ss_pred cceeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccch--hhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEEEE
Q 016184 80 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK--RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL 157 (394)
Q Consensus 80 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 157 (394)
...+|++.+.||+|+||.||+|.+. |+.||||++.... ....+|+.+++.++||||+++++++... ....++
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~----~~~~~l 92 (278)
T 1byg_A 19 NMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEE----KGGLYI 92 (278)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCCC--HHHHHTHHHHTTCCCTTBCCEEEEECCC------CCEE
T ss_pred ChhhceEEeEEecCCCceEEEEEEc--CCEEEEEEecchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEcC----CCceEE
Confidence 3456999999999999999999885 8899999986543 4456899999999999999999987432 223679
Q ss_pred EEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCccccc
Q 016184 158 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV 236 (394)
Q Consensus 158 v~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~ 236 (394)
||||+++ +|.+++..... ..+++..++.++.|++.||+|||+ +||+||||||+||+++.++ .+||+|||++....
T Consensus 93 v~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dlkp~Nil~~~~~-~~~l~Dfg~~~~~~ 168 (278)
T 1byg_A 93 VTEYMAKGSLVDYLRSRGR--SVLGGDCLLKFSLDVCEAMEYLEG-NNFVHRDLAARNVLVSEDN-VAKVSDFGLTKEAS 168 (278)
T ss_dssp EECCCTTEEHHHHHHHHHH--HHCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECTTS-CEEECCCCC-----
T ss_pred EEecCCCCCHHHHHHhccc--ccCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCcceEEEeCCC-cEEEeecccccccc
Confidence 9999986 88887765322 348899999999999999999999 8999999999999999887 79999999987543
Q ss_pred cCCCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCC
Q 016184 237 KGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 315 (394)
Q Consensus 237 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 315 (394)
.. .....+++.|+|||.+.+. .++.++||||||+++|+|++ |+.||......+....+....
T Consensus 169 ~~--~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~-------------- 231 (278)
T 1byg_A 169 ST--QDTGKLPVKWTAPEALREK-KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGY-------------- 231 (278)
T ss_dssp ---------CCTTTSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTC--------------
T ss_pred cc--ccCCCccccccCHHHhCCC-CCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCC--------------
Confidence 32 2234568889999998654 48999999999999999998 999998776555444332210
Q ss_pred CcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 016184 316 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV 364 (394)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 364 (394)
....+..+++.+.+||.+||+.||.+|||+.++++
T Consensus 232 --------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 266 (278)
T 1byg_A 232 --------------KMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLRE 266 (278)
T ss_dssp --------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --------------CCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHH
Confidence 00112467899999999999999999999999875
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=317.38 Aligned_cols=245 Identities=26% Similarity=0.326 Sum_probs=196.6
Q ss_pred ceeEEEee-EEeecCceEEEEEEEC--CCCcEEEEEEeccc-----hhhhHHHHHHHHHcCCCCeeeeceEEEecCCCce
Q 016184 81 KVSYIAEH-VVGTGSFGVVFQAKCR--ETGEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE 152 (394)
Q Consensus 81 ~~~y~~~~-~lg~G~~g~V~~~~~~--~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 152 (394)
..+|.+.+ .||+|+||.||+|.+. .++..||||++... .....+|+++++.++||||+++++++ ...
T Consensus 8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~---- 82 (287)
T 1u59_A 8 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAE---- 82 (287)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESS----
T ss_pred HHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCC----
Confidence 34577776 9999999999999864 46788999998653 23455799999999999999999987 211
Q ss_pred eEEEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecC
Q 016184 153 LYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS 231 (394)
Q Consensus 153 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~ 231 (394)
..++||||+++ +|.+++.. ....+++..++.++.|++.||.|||+ .||+||||||+|||++.++ .+||+|||+
T Consensus 83 -~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~Nili~~~~-~~kl~Dfg~ 156 (287)
T 1u59_A 83 -ALMLVMEMAGGGPLHKFLVG---KREEIPVSNVAELLHQVSMGMKYLEE-KNFVHRDLAARNVLLVNRH-YAKISDFGL 156 (287)
T ss_dssp -SEEEEEECCTTEEHHHHHTT---CTTTSCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEEEETT-EEEECCCTT
T ss_pred -CcEEEEEeCCCCCHHHHHHh---CCccCCHHHHHHHHHHHHHHHHHHHH-CCEeeCCCchheEEEcCCC-CEEECcccc
Confidence 16799999986 77666542 23569999999999999999999999 8999999999999999887 799999999
Q ss_pred ccccccCCC----cccccccccccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCh
Q 016184 232 AKVLVKGEP----NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTR 306 (394)
Q Consensus 232 a~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~ 306 (394)
+........ .....+|+.|+|||++.+. .++.++||||||+++|+|++ |+.||.+....+....+.... .
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~-~--- 231 (287)
T 1u59_A 157 SKALGADDSYYTARSAGKWPLKWYAPECINFR-KFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGK-R--- 231 (287)
T ss_dssp CEECTTCSCEECCCCSSCCCGGGCCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTC-C---
T ss_pred eeeeccCcceeeccccccccccccCHHHhccC-CCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCC-c---
Confidence 986643322 1223457889999998644 48999999999999999998 999998877665554443310 0
Q ss_pred hhhhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 016184 307 EEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH 365 (394)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 365 (394)
..++..+++++.+||.+||+.||.+|||+.++++|
T Consensus 232 ------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 266 (287)
T 1u59_A 232 ------------------------MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQR 266 (287)
T ss_dssp ------------------------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred ------------------------CCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 01224679999999999999999999999999976
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-43 Score=325.76 Aligned_cols=252 Identities=21% Similarity=0.283 Sum_probs=188.7
Q ss_pred eeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccch-hhhHHHHHHHHHc--CCCCeeeeceEEEecCCCceeEEEEE
Q 016184 82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-RYKNRELQIMQML--DHPNIVALKHCFFSTTDKEELYLNLV 158 (394)
Q Consensus 82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~E~~~l~~l--~h~~iv~~~~~~~~~~~~~~~~~~lv 158 (394)
++|++.+.||+|+||.||+|++. |+.||||++.... ....+|.+++..+ +||||+++++++.... ......++|
T Consensus 37 ~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~-~~~~~~~lv 113 (337)
T 3mdy_A 37 KQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTEEASWFRETEIYQTVLMRHENILGFIAADIKGT-GSWTQLYLI 113 (337)
T ss_dssp HHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESC-GGGCEEEEE
T ss_pred cceEEEeEeecCCCeEEEEEEEC--CceEEEEEEeccccchhhhHHHHHHHHhhcCCCeeeEEEEEccCC-CCCCceEEE
Confidence 46999999999999999999985 8999999986543 2334566665554 9999999999885543 223557899
Q ss_pred Eecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC--------CceeccCCCCceEEeCCCCcEEEEee
Q 016184 159 LEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI--------GICHRDIKPQNLLVNPHTHQLKLCDF 229 (394)
Q Consensus 159 ~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~--------givH~Dlkp~Nil~~~~~~~vkl~Df 229 (394)
|||+.+ +|.+++.. ..+++..++.++.|++.||.|||+ . ||+||||||+|||++.++ .+||+||
T Consensus 114 ~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~-~~~~~~~~~~ivH~Dikp~Nill~~~~-~~kl~Df 186 (337)
T 3mdy_A 114 TDYHENGSLYDYLKS-----TTLDAKSMLKLAYSSVSGLCHLHT-EIFSTQGKPAIAHRDLKSKNILVKKNG-TCCIADL 186 (337)
T ss_dssp ECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHS-CBCSTTCBCCEECSCCCGGGEEECTTS-CEEECCC
T ss_pred EeccCCCcHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHH-hhhhhccCCCEEecccchHHEEECCCC-CEEEEeC
Confidence 999975 88887754 579999999999999999999998 7 999999999999999888 7999999
Q ss_pred cCccccccCCCc-----ccccccccccccccccCCCCCCC------hhhHHHHHHHHHHHHhC----------CCCCCCC
Q 016184 230 GSAKVLVKGEPN-----VSYICSRYYRAPELIFGATEYTT------AIDIWSTGCVMAELLLG----------QPLFPGE 288 (394)
Q Consensus 230 g~a~~~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~------~~DiwslG~il~~lltg----------~~pf~~~ 288 (394)
|++......... ....||+.|+|||++.+.. ... ++|||||||++|+|++| ..||...
T Consensus 187 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~ 265 (337)
T 3mdy_A 187 GLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESL-NRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDL 265 (337)
T ss_dssp TTCEECC---------CCSSCSCGGGCCHHHHTTCC-CTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTT
T ss_pred CCceeeccccccccCCCCCCccCcceeChhhccccc-CCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhh
Confidence 999765433222 2457899999999996544 333 49999999999999999 6677543
Q ss_pred Cc----HHHHHHHHHHhCCCChhhhhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 016184 289 SG----VDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV 364 (394)
Q Consensus 289 ~~----~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 364 (394)
.. ............ .............+++++.+||.+||+.||.+|||+.++++
T Consensus 266 ~~~~~~~~~~~~~~~~~~---------------------~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (337)
T 3mdy_A 266 VPSDPSYEDMREIVCIKK---------------------LRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKK 324 (337)
T ss_dssp SCSSCCHHHHHHHHTTSC---------------------CCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred cCCCCchhhhHHHHhhhc---------------------cCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHH
Confidence 22 122222211100 00000011112346778999999999999999999999987
Q ss_pred C
Q 016184 365 H 365 (394)
Q Consensus 365 h 365 (394)
|
T Consensus 325 ~ 325 (337)
T 3mdy_A 325 T 325 (337)
T ss_dssp H
T ss_pred H
Confidence 5
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-45 Score=361.25 Aligned_cols=284 Identities=25% Similarity=0.334 Sum_probs=206.0
Q ss_pred eeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccc-----hhhhHHHHHHHHHcCCCCeeeeceEEEecCC-CceeEE
Q 016184 82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTD-KEELYL 155 (394)
Q Consensus 82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~~~~~~ 155 (394)
++|++.+.||+|+||.||+|.+..+|+.||||++... .....+|+++++.++||||+++++++..... ......
T Consensus 14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~ 93 (676)
T 3qa8_A 14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLP 93 (676)
T ss_dssp ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSC
T ss_pred CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeE
Confidence 4699999999999999999999999999999987643 2345579999999999999999887632111 123446
Q ss_pred EEEEeccc-ccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCC--cEEEEeecCc
Q 016184 156 NLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTH--QLKLCDFGSA 232 (394)
Q Consensus 156 ~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~--~vkl~Dfg~a 232 (394)
++||||++ ++|.+++.... ....+++..++.++.|++.||+|||+ .||+||||||+|||++.++. .+||+|||++
T Consensus 94 ~LVmEy~~ggsL~~~L~~~~-~~~~lse~~i~~I~~QLl~aL~yLHs-~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a 171 (676)
T 3qa8_A 94 LLAMEYCEGGDLRKYLNQFE-NCCGLKEGPIRTLLSDISSALRYLHE-NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYA 171 (676)
T ss_dssp CCEEECCSSCBHHHHHHSSS-CTTCCCSSHHHHHHHHHHHHHHHHHH-TTBCCCCCCSTTEEEECCSSSCEEEECSCCCC
T ss_pred EEEEEeCCCCCHHHHHHhcc-cCCCCCHHHHHHHHHHHHHHHHHHHH-CCCccCCCCHHHeEeecCCCceeEEEcccccc
Confidence 79999996 48877776532 22368999999999999999999999 89999999999999997653 3899999999
Q ss_pred cccccCCCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhcc
Q 016184 233 KVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 312 (394)
Q Consensus 233 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 312 (394)
.............+|+.|+|||++.+. .++.++||||||+++|+|++|..||.+.......... ............
T Consensus 172 ~~~~~~~~~~~~~gt~~Y~APE~l~~~-~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~---i~~~~~~~~~~~ 247 (676)
T 3qa8_A 172 KELDQGELCTEFVGTLQYLAPELLEQK-KYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGK---VREKSNEHIVVY 247 (676)
T ss_dssp CBTTSCCCCCCCCSCCTTCSSCSSCCS-CCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTT---CC------CCSC
T ss_pred cccccccccccccCCcccCChHHhccC-CCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhh---hhcccchhhhhh
Confidence 877666555667889999999998654 5899999999999999999999999775433211100 000000000000
Q ss_pred CCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q 016184 313 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD 373 (394)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~ 373 (394)
........+... .+....+...+++.+.+||.+||++||++|||+.++++||||+.+.+
T Consensus 248 ~~l~g~~~~~~~--lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~ 306 (676)
T 3qa8_A 248 DDLTGAVKFSSV--LPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDS 306 (676)
T ss_dssp CCCSSSCCCCSS--SCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHH
T ss_pred hhhccccccccc--cCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHH
Confidence 000011111111 11112233457789999999999999999999999999999988543
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=317.50 Aligned_cols=242 Identities=24% Similarity=0.298 Sum_probs=194.0
Q ss_pred eeEEEee-EEeecCceEEEEEEE--CCCCcEEEEEEeccc------hhhhHHHHHHHHHcCCCCeeeeceEEEecCCCce
Q 016184 82 VSYIAEH-VVGTGSFGVVFQAKC--RETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE 152 (394)
Q Consensus 82 ~~y~~~~-~lg~G~~g~V~~~~~--~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 152 (394)
.+|++.+ .||+|+||.||+|.+ ..+++.||||++... ...+.+|+.+++.++||||+++++++ ...
T Consensus 16 ~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~---- 90 (291)
T 1xbb_A 16 KLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAE---- 90 (291)
T ss_dssp GGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESS----
T ss_pred hhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCC----
Confidence 4699988 999999999999954 566789999998643 23456799999999999999999987 211
Q ss_pred eEEEEEEeccc-ccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecC
Q 016184 153 LYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS 231 (394)
Q Consensus 153 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~ 231 (394)
..++||||+. ++|.+++.. ...+++..++.++.|++.||+|||+ .||+||||||+|||++.++ .+||+|||+
T Consensus 91 -~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~-~~i~H~dikp~Nil~~~~~-~~kl~Dfg~ 163 (291)
T 1xbb_A 91 -SWMLVMEMAELGPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEE-SNFVHRDLAARNVLLVTQH-YAKISDFGL 163 (291)
T ss_dssp -SEEEEEECCTTEEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEEETT-EEEECCCTT
T ss_pred -CcEEEEEeCCCCCHHHHHHh----CcCCCHHHHHHHHHHHHHHHHHHHh-CCeEcCCCCcceEEEeCCC-cEEEccCCc
Confidence 2679999998 477777654 3569999999999999999999999 8999999999999999887 799999999
Q ss_pred ccccccCCCc----ccccccccccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCh
Q 016184 232 AKVLVKGEPN----VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTR 306 (394)
Q Consensus 232 a~~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~ 306 (394)
+......... ....+++.|+|||.+.+.. ++.++||||||+++|+|++ |+.||.+....+....+.... .+
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~-~~-- 239 (291)
T 1xbb_A 164 SKALRADENYYKAQTHGKWPVKWYAPECINYYK-FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGE-RM-- 239 (291)
T ss_dssp CEECCTTCSEEEC----CCCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC-CC--
T ss_pred ceeeccCCCcccccccCCCCceeeChHHhccCC-CChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC-CC--
Confidence 9766443321 1233468899999986544 7899999999999999999 999998877655444433210 00
Q ss_pred hhhhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 016184 307 EEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV 364 (394)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 364 (394)
.++..+++.+.+||.+||+.||.+|||+.++++
T Consensus 240 -------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 272 (291)
T 1xbb_A 240 -------------------------GCPAGCPREMYDLMNLCWTYDVENRPGFAAVEL 272 (291)
T ss_dssp -------------------------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred -------------------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 012467899999999999999999999999875
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-43 Score=329.13 Aligned_cols=282 Identities=21% Similarity=0.288 Sum_probs=193.2
Q ss_pred ceeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccchh-hhHHHHHH--HHHcCCCCeeeeceEEEecCCCceeEEEE
Q 016184 81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-YKNRELQI--MQMLDHPNIVALKHCFFSTTDKEELYLNL 157 (394)
Q Consensus 81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~E~~~--l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 157 (394)
.++|++.+.||+|+||.||+|++ +++.||||++..... ....|.++ +..++|+||+++++.+..........+++
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~l 89 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFANRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLL 89 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEEE
T ss_pred hHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccchhhHHHHHHHHHHHhccCcchhhheecccccccCCCceEEE
Confidence 34699999999999999999987 589999999864432 22334444 44589999999998775555555666789
Q ss_pred EEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC---------CceeccCCCCceEEeCCCCcEEEE
Q 016184 158 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI---------GICHRDIKPQNLLVNPHTHQLKLC 227 (394)
Q Consensus 158 v~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---------givH~Dlkp~Nil~~~~~~~vkl~ 227 (394)
||||+++ +|.+++.. ...++..++.++.||+.||.|||+ . ||+||||||+|||++.++ .+||+
T Consensus 90 v~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~qi~~~L~~LH~-~~~~~~~~~~~ivH~Dikp~Nill~~~~-~~kL~ 162 (336)
T 3g2f_A 90 VMEYYPNGSLXKYLSL-----HTSDWVSSCRLAHSVTRGLAYLHT-ELPRGDHYKPAISHRDLNSRNVLVKNDG-TCVIS 162 (336)
T ss_dssp EECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHC-CBCCGGGCBCCEECSSCSGGGEEECTTS-CEEEC
T ss_pred EEecCCCCcHHHHHhh-----cccchhHHHHHHHHHHHHHHHHHh-hhccccccccceeecccccceEEEcCCC-cEEEe
Confidence 9999964 88887764 556899999999999999999998 8 999999999999999887 79999
Q ss_pred eecCccccccCC---------CcccccccccccccccccCC------CCCCChhhHHHHHHHHHHHHhCCCCCCCCCc-H
Q 016184 228 DFGSAKVLVKGE---------PNVSYICSRYYRAPELIFGA------TEYTTAIDIWSTGCVMAELLLGQPLFPGESG-V 291 (394)
Q Consensus 228 Dfg~a~~~~~~~---------~~~~~~~t~~y~aPE~~~~~------~~~~~~~DiwslG~il~~lltg~~pf~~~~~-~ 291 (394)
|||++....... ......||+.|+|||++.+. ..++.++|||||||++|+|++|..||..... .
T Consensus 163 DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~ 242 (336)
T 3g2f_A 163 DFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVP 242 (336)
T ss_dssp CCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCC
T ss_pred eccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchh
Confidence 999997654321 12245689999999998652 2356789999999999999999766543221 1
Q ss_pred HHHHHHHH-HhCCCChhhhhcc-CCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHH------h
Q 016184 292 DQLVEIIK-VLGTPTREEIKCM-NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEA------C 363 (394)
Q Consensus 292 ~~~~~i~~-~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~el------l 363 (394)
.....+.. ....+....+... ........++. .+.. ...+++++.+||.+||+.||++|||+.|+ +
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~--~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~l 316 (336)
T 3g2f_A 243 EYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPE----AWKE--NSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAEL 316 (336)
T ss_dssp CCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCT----TCCC--CSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHhhhcccCCCchHHHHHhhhcccccCCCCCc----cccc--ccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHH
Confidence 11000111 1111111111100 00000000110 0000 01245679999999999999999999999 4
Q ss_pred cCCCCCCCCCCCCC
Q 016184 364 VHPFFDELRDPNTR 377 (394)
Q Consensus 364 ~hp~f~~~~~~~~~ 377 (394)
.++|-++....-.+
T Consensus 317 l~~~~~~~~~~~~~ 330 (336)
T 3g2f_A 317 MMIWERNKSVSPTA 330 (336)
T ss_dssp HHCCCC--------
T ss_pred HHHHHhcccCCCcc
Confidence 57888776554443
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-43 Score=340.01 Aligned_cols=249 Identities=20% Similarity=0.223 Sum_probs=197.1
Q ss_pred eeEEEeeEEeecCceEEEEEEECCCCcEEEEEEecc--chhhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEEEEEE
Q 016184 82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQ--DKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVL 159 (394)
Q Consensus 82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~ 159 (394)
++|++.++||+|+||.||+|++..+++.||||++.. ......+|+++++.+.|.+.+..+..+.. ...+.++||
T Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~il~~L~~~~~i~~i~~~~~----~~~~~~lvm 82 (483)
T 3sv0_A 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQGGTGIPNVRWFGV----EGDYNVLVM 82 (483)
T ss_dssp TTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSSCCHHHHHHHHHHTTTSTTCCCEEEEEE----ETTEEEEEE
T ss_pred CcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccccHHHHHHHHHHHHhcCCCCCCeEEEEEe----eCCEEEEEE
Confidence 359999999999999999999999999999998753 33456789999999988665555444432 233578999
Q ss_pred ecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEE---eCCCCcEEEEeecCccccc
Q 016184 160 EYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLV 236 (394)
Q Consensus 160 e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~---~~~~~~vkl~Dfg~a~~~~ 236 (394)
||++++|.+++... ...+++..++.++.||+.||+|||+ +||+||||||+|||| +.++ .+||+|||+++...
T Consensus 83 e~~g~sL~~ll~~~---~~~l~~~~~~~i~~qi~~aL~yLH~-~gIvHrDIKP~NILl~~~~~~~-~vkL~DFGla~~~~ 157 (483)
T 3sv0_A 83 DLLGPSLEDLFNFC---SRKLSLKTVLMLADQMINRVEFVHS-KSFLHRDIKPDNFLMGLGRRAN-QVYIIDFGLAKKYR 157 (483)
T ss_dssp ECCCCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECCGGGTT-CEEECCCTTCEECB
T ss_pred ECCCCCHHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHH-CCEeecccCcceEEEecCCCCC-eEEEEeCCcceecc
Confidence 99988998887642 3679999999999999999999999 899999999999999 4555 79999999998765
Q ss_pred cCCC--------cccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcH---HHHHHHHHHhCCCC
Q 016184 237 KGEP--------NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGV---DQLVEIIKVLGTPT 305 (394)
Q Consensus 237 ~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~---~~~~~i~~~~~~~~ 305 (394)
.... .....||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.... ..+..+........
T Consensus 158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 236 (483)
T 3sv0_A 158 DTSTHQHIPYRENKNLTGTARYASVNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATS 236 (483)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSC
T ss_pred CCccccccccccccccCCCccccCHHHhcCC-CCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhcccccc
Confidence 4332 1256789999999999655 4899999999999999999999999876543 23333322111111
Q ss_pred hhhhhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 016184 306 REEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV 364 (394)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 364 (394)
. ..+...++.++.+||..||+.||.+||++.+|++
T Consensus 237 ~------------------------~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~ 271 (483)
T 3sv0_A 237 I------------------------EALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKR 271 (483)
T ss_dssp H------------------------HHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred H------------------------HHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 1 1122467999999999999999999999987763
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=314.15 Aligned_cols=244 Identities=23% Similarity=0.313 Sum_probs=197.3
Q ss_pred ceeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccc---hhhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEEEE
Q 016184 81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD---KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL 157 (394)
Q Consensus 81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 157 (394)
..+|++.+.||+|+||.||+|.+. ++..||||++... .....+|+++++.++||||+++++++.. + ..++
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~----~--~~~~ 84 (279)
T 1qpc_A 12 RETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ----E--PIYI 84 (279)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS----S--SCEE
T ss_pred HHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCcccHHHHHHHHHHHHhCCCcCcceEEEEEcC----C--CcEE
Confidence 456999999999999999999985 5678999998653 3455689999999999999999988721 1 1568
Q ss_pred EEeccc-ccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCccccc
Q 016184 158 VLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV 236 (394)
Q Consensus 158 v~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~ 236 (394)
||||+. ++|.+++.... ...+++..++.++.|++.||+|||+ +||+||||||+|||++.++ .+||+|||++....
T Consensus 85 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dikp~Nil~~~~~-~~kl~Dfg~~~~~~ 160 (279)
T 1qpc_A 85 ITEYMENGSLVDFLKTPS--GIKLTINKLLDMAAQIAEGMAFIEE-RNYIHRDLRAANILVSDTL-SCKIADFGLARLIE 160 (279)
T ss_dssp EEECCTTCBHHHHTTSHH--HHTCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECTTS-CEEECCCTTCEECS
T ss_pred EEecCCCCCHHHHHhcCC--CCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCCHhhEEEcCCC-CEEECCCccccccc
Confidence 999996 58877665422 2479999999999999999999999 8999999999999999887 69999999998664
Q ss_pred cCCC--cccccccccccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCChhhhhccC
Q 016184 237 KGEP--NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 313 (394)
Q Consensus 237 ~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 313 (394)
.... .....+++.|+|||.+.+. .++.++||||||+++|+|++ |+.||.+....+....+.....
T Consensus 161 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~----------- 228 (279)
T 1qpc_A 161 DNEYTAREGAKFPIKWTAPEAINYG-TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYR----------- 228 (279)
T ss_dssp SSCEECCTTCCCCTTTSCHHHHHHC-EECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC-----------
T ss_pred CcccccccCCCCccCccChhhhccC-CCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcccC-----------
Confidence 3321 1233457789999998644 48999999999999999999 9999988776665554433110
Q ss_pred CCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 016184 314 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV 364 (394)
Q Consensus 314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 364 (394)
...+..+++++.+||.+||+.||++|||+.++++
T Consensus 229 -----------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 262 (279)
T 1qpc_A 229 -----------------MVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRS 262 (279)
T ss_dssp -----------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -----------------CCCcccccHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 0112457899999999999999999999999886
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=317.47 Aligned_cols=246 Identities=20% Similarity=0.311 Sum_probs=193.1
Q ss_pred ceeEEEeeEEeecCceEEEEEEECCCC---cEEEEEEeccch-----hhhHHHHHHHHHcCCCCeeeeceEEEecCCCce
Q 016184 81 KVSYIAEHVVGTGSFGVVFQAKCRETG---EIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE 152 (394)
Q Consensus 81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~---~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 152 (394)
..+|++.++||+|+||.||+|++..++ ..||+|.+.... ....+|+.+++.++||||+++++++....
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~---- 99 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSE---- 99 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSS----
T ss_pred ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCC----
Confidence 456999999999999999999975433 468999876422 33457999999999999999999864322
Q ss_pred eEEEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecC
Q 016184 153 LYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS 231 (394)
Q Consensus 153 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~ 231 (394)
...+++|||+++ +|.+++.. ....+++..++.++.|++.||+|||+ +||+||||||+|||++.++ .+||+|||+
T Consensus 100 ~~~~~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~ql~~~l~~lH~-~~i~H~dikp~Nil~~~~~-~~kl~Dfg~ 174 (298)
T 3f66_A 100 GSPLVVLPYMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKYLAS-KKFVHRDLAARNCMLDEKF-TVKVADFGL 174 (298)
T ss_dssp SCCEEEEECCTTCBHHHHHHC---TTCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECTTC-CEEECSCGG
T ss_pred CceEEEEeCCCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHh-CCccCCCCchheEEECCCC-CEEECcccc
Confidence 236789999986 88777753 23668999999999999999999999 8999999999999999887 799999999
Q ss_pred ccccccCC-----CcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCC
Q 016184 232 AKVLVKGE-----PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPT 305 (394)
Q Consensus 232 a~~~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~ 305 (394)
+....... ......+|+.|+|||.+.+. .++.++||||||+++|+|++ |.+||.+....+....+......
T Consensus 175 a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~~-- 251 (298)
T 3f66_A 175 ARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQ-KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRL-- 251 (298)
T ss_dssp GCCCSCGGGCBC-----CCBCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCCC--
T ss_pred cccccccchhccccccCCCCCccccChHHhcCC-CCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCCC--
Confidence 97653322 12334567889999999654 48999999999999999999 66777776655555444331110
Q ss_pred hhhhhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 016184 306 REEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV 364 (394)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 364 (394)
..+..++..+.+||.+||+.||.+|||+.++++
T Consensus 252 --------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 284 (298)
T 3f66_A 252 --------------------------LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVS 284 (298)
T ss_dssp --------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --------------------------CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 012457889999999999999999999999986
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=336.22 Aligned_cols=251 Identities=24% Similarity=0.352 Sum_probs=198.0
Q ss_pred cceeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccc---hhhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEEE
Q 016184 80 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD---KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN 156 (394)
Q Consensus 80 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 156 (394)
...+|++.+.||+|+||.||+|.+.. +..||||++... ...+.+|+++++.++||||+++++++.. ...+
T Consensus 182 ~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~------~~~~ 254 (452)
T 1fmk_A 182 PRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE------EPIY 254 (452)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS------SSCE
T ss_pred ChhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEcC------CceE
Confidence 44579999999999999999999964 467999998653 3456789999999999999999998732 1267
Q ss_pred EEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCcccc
Q 016184 157 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL 235 (394)
Q Consensus 157 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~ 235 (394)
+||||+.+ +|.+++.... ...+++..+..++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+++..
T Consensus 255 iv~e~~~~gsL~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~-~~ivHrDlkp~Nill~~~~-~~kl~DfG~a~~~ 330 (452)
T 1fmk_A 255 IVTEYMSKGSLLDFLKGET--GKYLRLPQLVDMAAQIASGMAYVER-MNYVHRDLRAANILVGENL-VCKVADFGLARLI 330 (452)
T ss_dssp EEECCCTTCBHHHHHSHHH--HTTCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECGGG-CEEECCCCTTC--
T ss_pred EEehhhcCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHh-CCeeCCCCChhhEEECCCC-CEEECCCccceec
Confidence 89999975 8888775422 3568999999999999999999999 8999999999999999887 7999999999765
Q ss_pred ccCCC--cccccccccccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCChhhhhcc
Q 016184 236 VKGEP--NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 312 (394)
Q Consensus 236 ~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 312 (394)
..... .....+++.|+|||++... .++.++||||||+++|+|++ |+.||.+....+.+..+......
T Consensus 331 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~--------- 400 (452)
T 1fmk_A 331 EDNEYTARQGAKFPIKWTAPEAALYG-RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM--------- 400 (452)
T ss_dssp ------------CCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC---------
T ss_pred CCCceecccCCcccccccCHhHHhcC-CCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC---------
Confidence 43221 1233457889999998654 48999999999999999999 99999988766655554332110
Q ss_pred CCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhc--CCCCCC
Q 016184 313 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV--HPFFDE 370 (394)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~--hp~f~~ 370 (394)
..+..+++.+.+||.+||+.||++|||++++++ ..++..
T Consensus 401 -------------------~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~ 441 (452)
T 1fmk_A 401 -------------------PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 441 (452)
T ss_dssp -------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred -------------------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhcc
Confidence 012457899999999999999999999999987 345543
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-42 Score=313.48 Aligned_cols=248 Identities=21% Similarity=0.306 Sum_probs=193.9
Q ss_pred ccceeEEEeeEEeecCceEEEEEEECCCCc---EEEEEEeccch-----hhhHHHHHHHHHcCCCCeeeeceEEEecCCC
Q 016184 79 KQKVSYIAEHVVGTGSFGVVFQAKCRETGE---IVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDK 150 (394)
Q Consensus 79 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~---~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 150 (394)
.....|.+.++||+|+||.||+|++..+++ .||+|++.... ....+|+.+++.++||||+++++++....
T Consensus 18 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-- 95 (298)
T 3pls_A 18 HERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPE-- 95 (298)
T ss_dssp GGGEEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSS--
T ss_pred ccceEEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCC--
Confidence 344569999999999999999999765544 79999886422 34457999999999999999999884322
Q ss_pred ceeEEEEEEeccc-ccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEee
Q 016184 151 EELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDF 229 (394)
Q Consensus 151 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Df 229 (394)
...+++|||+. ++|.+++.. ....+++..++.++.|++.||+|||+ .||+||||||+|||++.++ .+||+||
T Consensus 96 --~~~~~v~e~~~~~~L~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~-~~i~H~dikp~Nili~~~~-~~kl~Df 168 (298)
T 3pls_A 96 --GLPHVLLPYMCHGDLLQFIRS---PQRNPTVKDLISFGLQVARGMEYLAE-QKFVHRDLAARNCMLDESF-TVKVADF 168 (298)
T ss_dssp --SCCEEEECCCTTCBHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECTTC-CEEECCT
T ss_pred --CCcEEEEecccCCCHHHHHhc---cccCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCcceEEEcCCC-cEEeCcC
Confidence 22468999986 577776654 23678999999999999999999999 8999999999999999887 6999999
Q ss_pred cCccccccC-----CCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCC-CCCCCCCcHHHHHHHHHHhCC
Q 016184 230 GSAKVLVKG-----EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQ-PLFPGESGVDQLVEIIKVLGT 303 (394)
Q Consensus 230 g~a~~~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~-~pf~~~~~~~~~~~i~~~~~~ 303 (394)
|++...... .......+++.|+|||.+.+. .++.++||||||+++|+|++|. +||...+..+....+......
T Consensus 169 g~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~ 247 (298)
T 3pls_A 169 GLARDILDREYYSVQQHRHARLPVKWTALESLQTY-RFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRL 247 (298)
T ss_dssp TSSCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTC-CCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCCC
T ss_pred CCcccccCCcccccccCcCCCCCccccChhhhccC-CCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCCC
Confidence 999754322 222345668899999999654 4899999999999999999955 555555544444433321100
Q ss_pred CChhhhhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 016184 304 PTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV 364 (394)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 364 (394)
..+..+++.+.+||.+||+.||.+|||+.++++
T Consensus 248 ----------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 280 (298)
T 3pls_A 248 ----------------------------PQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVG 280 (298)
T ss_dssp ----------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ----------------------------CCCccchHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 012457899999999999999999999999886
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-43 Score=329.53 Aligned_cols=248 Identities=20% Similarity=0.299 Sum_probs=187.7
Q ss_pred cceeEEEeeEEeecCceEEEEEEECCCC---cEEEEEEeccc-----hhhhHHHHHHHHHcCCCCeeeeceEEEecCCCc
Q 016184 80 QKVSYIAEHVVGTGSFGVVFQAKCRETG---EIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKE 151 (394)
Q Consensus 80 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~---~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 151 (394)
....|.+.+.||+|+||.||+|++..++ ..||+|.+... ...+.+|+.+++.++||||+++++++....
T Consensus 87 ~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~--- 163 (373)
T 3c1x_A 87 SSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSE--- 163 (373)
T ss_dssp TTEEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCS---
T ss_pred hhceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCC---
Confidence 3456999999999999999999975432 46899987542 234567999999999999999999874322
Q ss_pred eeEEEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeec
Q 016184 152 ELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFG 230 (394)
Q Consensus 152 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg 230 (394)
...++||||+.+ +|.+++.. ....+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||
T Consensus 164 -~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlkp~NIll~~~~-~~kL~DFG 237 (373)
T 3c1x_A 164 -GSPLVVLPYMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKFLAS-KKFVHRDLAARNCMLDEKF-TVKVADFG 237 (373)
T ss_dssp -SCCEEEEECCTTCBHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECTTC-CEEECCC-
T ss_pred -CCeEEEEECCCCCCHHHHHhh---cccCCCHHHHHHHHHHHHHHHHHHHH-CCEecCccchheEEECCCC-CEEEeecc
Confidence 235689999985 88777653 23568899999999999999999999 8999999999999999887 79999999
Q ss_pred CccccccCCC-----cccccccccccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCC
Q 016184 231 SAKVLVKGEP-----NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTP 304 (394)
Q Consensus 231 ~a~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~ 304 (394)
+++....... .....+++.|+|||++.+. .++.++|||||||++|+|++ |.+||.+.+..+....+.....
T Consensus 238 ~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~~-- 314 (373)
T 3c1x_A 238 LARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQ-KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRR-- 314 (373)
T ss_dssp --------------------CCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTCC--
T ss_pred ccccccccccccccccCCCCCcccccChHHhcCC-CCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCCC--
Confidence 9976533221 1234567889999998654 48999999999999999999 7788887665554444332110
Q ss_pred ChhhhhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 016184 305 TREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH 365 (394)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 365 (394)
...+..++..+.+||.+||+.||.+|||+.+++++
T Consensus 315 --------------------------~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 349 (373)
T 3c1x_A 315 --------------------------LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 349 (373)
T ss_dssp --------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred --------------------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 00124578999999999999999999999999864
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-42 Score=314.84 Aligned_cols=254 Identities=28% Similarity=0.410 Sum_probs=192.2
Q ss_pred eeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccch--hhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEEEEEE
Q 016184 82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK--RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVL 159 (394)
Q Consensus 82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~ 159 (394)
.+|++.+.||+|+||.||+|++. ++.||||++.... ..+.+|+++++.++||||+++++++. +. .++||
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-----~~--~~lv~ 78 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIESESERKAFIVELRQLSRVNHPNIVKLYGACL-----NP--VCLVM 78 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET--TEEEEEEECSSTTHHHHHHHHHHHHHHCCCTTBCCEEEBCT-----TT--TEEEE
T ss_pred hHeeeeeEeecCCCceEEEEEEC--CeeEEEEEecChhHHHHHHHHHHHHhcCCCCCcCeEEEEEc-----CC--cEEEE
Confidence 46999999999999999999985 7889999986543 34568999999999999999998762 22 56899
Q ss_pred ecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhC--CCceeccCCCCceEEeCCCCcEEEEeecCccccc
Q 016184 160 EYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC--IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV 236 (394)
Q Consensus 160 e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~--~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~ 236 (394)
||+++ +|.+++.... ....+++..++.++.|++.||+|||+. +||+||||||+|||++.++..+||+|||++....
T Consensus 79 e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~ 157 (307)
T 2eva_A 79 EYAEGGSLYNVLHGAE-PLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQ 157 (307)
T ss_dssp ECCTTCBHHHHHHCSS-SEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC-----
T ss_pred EcCCCCCHHHHHhccC-CCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccc
Confidence 99975 8877776422 123578899999999999999999972 4899999999999999887558999999997543
Q ss_pred cCCCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHH-HHHHHHHhCCCChhhhhccCCC
Q 016184 237 KGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQ-LVEIIKVLGTPTREEIKCMNPN 315 (394)
Q Consensus 237 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~~~~ 315 (394)
.. .....||+.|+|||++.+. .++.++||||||+++|+|++|+.||........ +..... .+..
T Consensus 158 ~~--~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~-~~~~----------- 222 (307)
T 2eva_A 158 TH--MTNNKGSAAWMAPEVFEGS-NYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVH-NGTR----------- 222 (307)
T ss_dssp ---------CCTTSSCHHHHTCC-CCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHH-TTCC-----------
T ss_pred cc--cccCCCCCceEChhhhCCC-CCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHh-cCCC-----------
Confidence 22 2345689999999999654 489999999999999999999999976443221 111111 0000
Q ss_pred CcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhc-----CCCCCCCCCCC
Q 016184 316 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV-----HPFFDELRDPN 375 (394)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~-----hp~f~~~~~~~ 375 (394)
..+...++..+.+||.+||+.||.+|||+.++++ ..++.....+.
T Consensus 223 ---------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~~~~~ 272 (307)
T 2eva_A 223 ---------------PPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPL 272 (307)
T ss_dssp ---------------CCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCCCTTSCC
T ss_pred ---------------CCcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhccCCCCcc
Confidence 0012467899999999999999999999999987 35665554443
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-42 Score=339.87 Aligned_cols=250 Identities=24% Similarity=0.357 Sum_probs=201.2
Q ss_pred cceeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccc---hhhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEEE
Q 016184 80 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD---KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN 156 (394)
Q Consensus 80 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 156 (394)
...+|++.+.||+|+||.||+|++.. +..||||++... ...+.+|+++|+.++|+||+++++++.. ..++
T Consensus 265 ~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~------~~~~ 337 (535)
T 2h8h_A 265 PRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE------EPIY 337 (535)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS------SSCE
T ss_pred chhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEee------ccce
Confidence 34579999999999999999999964 567999998653 2456789999999999999999998732 1267
Q ss_pred EEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCcccc
Q 016184 157 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL 235 (394)
Q Consensus 157 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~ 235 (394)
+||||+.+ +|.+++.... ...+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+++..
T Consensus 338 lv~e~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~-~~ivHrDlkp~NIll~~~~-~~kl~DFG~a~~~ 413 (535)
T 2h8h_A 338 IVTEYMSKGSLLDFLKGET--GKYLRLPQLVDMAAQIASGMAYVER-MNYVHRDLRAANILVGENL-VCKVADFGLARLI 413 (535)
T ss_dssp EEECCCTTEEHHHHHSHHH--HTTCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECGGG-CEEECCTTSTTTC
T ss_pred EeeehhcCCcHHHHHhhcC--CCCCCHHHHHHHHHHHHHHHHHHHh-CCeeCCCCCHhhEEEcCCC-cEEEcccccceec
Confidence 99999985 8887775422 3568999999999999999999999 8999999999999999887 7999999999765
Q ss_pred ccCC--CcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCChhhhhcc
Q 016184 236 VKGE--PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 312 (394)
Q Consensus 236 ~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 312 (394)
.... ......++..|+|||++... .++.++|||||||++|+|++ |+.||.+....+.+..+......
T Consensus 414 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~--------- 483 (535)
T 2h8h_A 414 EDNEYTARQGAKFPIKWTAPEAALYG-RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM--------- 483 (535)
T ss_dssp CCHHHHTTCSTTSCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTCCC---------
T ss_pred CCCceecccCCcCcccccCHHHhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC---------
Confidence 3221 11233457789999998654 48999999999999999999 99999887766655554331100
Q ss_pred CCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcC--CCCC
Q 016184 313 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH--PFFD 369 (394)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h--p~f~ 369 (394)
..+..++..+.+||.+||+.||++|||+++|++. .+|.
T Consensus 484 -------------------~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~ 523 (535)
T 2h8h_A 484 -------------------PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 523 (535)
T ss_dssp -------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSC
T ss_pred -------------------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhh
Confidence 0124578999999999999999999999999873 4443
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=318.50 Aligned_cols=256 Identities=21% Similarity=0.273 Sum_probs=194.5
Q ss_pred EEEeeEEeecCceEEEEEEECCCCcEEEEEEeccc--------hhhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEE
Q 016184 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD--------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL 155 (394)
Q Consensus 84 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 155 (394)
|...+.||+|+||.||+|.+ +++.||||++... ...+.+|+.+++.++||||+++++++.. ....
T Consensus 33 ~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----~~~~ 105 (307)
T 2nru_A 33 SVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSD-----GDDL 105 (307)
T ss_dssp TTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECS-----SSSC
T ss_pred cccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEec-----CCce
Confidence 56678999999999999987 4889999988542 2345689999999999999999998833 2336
Q ss_pred EEEEeccc-ccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCccc
Q 016184 156 NLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV 234 (394)
Q Consensus 156 ~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~ 234 (394)
+++|||++ ++|.+++.... ....+++..++.++.|++.||+|||+ .||+||||||+|||++.++ .+||+|||++..
T Consensus 106 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~-~~i~H~dlkp~Nili~~~~-~~kl~Dfg~~~~ 182 (307)
T 2nru_A 106 CLVYVYMPNGSLLDRLSCLD-GTPPLSWHMRCKIAQGAANGINFLHE-NHHIHRDIKSANILLDEAF-TAKISDFGLARA 182 (307)
T ss_dssp EEEEECCTTCBHHHHHHTGG-GCCCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEECTTC-CEEECCCTTCEE
T ss_pred EEEEEecCCCcHHHHHHhcc-CCCCCCHHHHHHHHHHHHHHHHHHhc-CCeecCCCCHHHEEEcCCC-cEEEeecccccc
Confidence 79999996 58877776432 24569999999999999999999999 8999999999999999887 799999999876
Q ss_pred cccCCC---cccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhc
Q 016184 235 LVKGEP---NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 311 (394)
Q Consensus 235 ~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 311 (394)
...... .....||+.|+|||.+.+ .++.++||||||+++|+|++|..||........+..+..............
T Consensus 183 ~~~~~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (307)
T 2nru_A 183 SEKFAQTVMTSRIVGTTAYMAPEALRG--EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDY 260 (307)
T ss_dssp CCSCSSCEECSSCCSCGGGCCHHHHTT--EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHH
T ss_pred cccccccccccccCCCcCcCChHHhcC--CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhh
Confidence 543222 223568999999999854 479999999999999999999999987654433333332221111100000
Q ss_pred cCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 016184 312 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH 365 (394)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 365 (394)
..... .......+..+.+||.+||+.||.+|||+.+++++
T Consensus 261 ~~~~~--------------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~ 300 (307)
T 2nru_A 261 IDKKM--------------NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL 300 (307)
T ss_dssp SCSSC--------------SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred ccccc--------------cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 00000 00113346789999999999999999999999863
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-42 Score=320.41 Aligned_cols=253 Identities=21% Similarity=0.231 Sum_probs=193.4
Q ss_pred eeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccc-hhhhHHHHHHHHH--cCCCCeeeeceEEEecCCCceeEEEEE
Q 016184 82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-KRYKNRELQIMQM--LDHPNIVALKHCFFSTTDKEELYLNLV 158 (394)
Q Consensus 82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~E~~~l~~--l~h~~iv~~~~~~~~~~~~~~~~~~lv 158 (394)
.+|++.+.||+|+||.||+|++ +|+.||||++... .....+|.+++.. ++||||+++++++.... ......++|
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~-~~~~~~~lv 118 (342)
T 1b6c_B 42 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDN-GTWTQLWLV 118 (342)
T ss_dssp HHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCC-SSCCCEEEE
T ss_pred ccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCchhHHHHHHHHHHHHHhhcCCCcEEEEEeeecccC-CccceeEEE
Confidence 4699999999999999999998 4899999998654 3344578888888 79999999999885433 122357899
Q ss_pred Eecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHH--------hCCCceeccCCCCceEEeCCCCcEEEEee
Q 016184 159 LEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH--------NCIGICHRDIKPQNLLVNPHTHQLKLCDF 229 (394)
Q Consensus 159 ~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH--------~~~givH~Dlkp~Nil~~~~~~~vkl~Df 229 (394)
|||+++ +|.+++.. ..+++..++.++.|++.||.||| + .||+||||||+|||++.++ .+||+||
T Consensus 119 ~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~-~~ivH~Dlkp~NIll~~~~-~~kL~Df 191 (342)
T 1b6c_B 119 SDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGK-PAIAHRDLKSKNILVKKNG-TCCIADL 191 (342)
T ss_dssp ECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCB-CEEECSCCSGGGEEECTTS-CEEECCC
T ss_pred EeecCCCcHHHHHhc-----cCccHHHHHHHHHHHHHHHHHHHHHHhhhccc-CCeeeCCCCHHHEEECCCC-CEEEEEC
Confidence 999986 88887764 57999999999999999999999 8 8999999999999999888 7999999
Q ss_pred cCccccccCCC-----cccccccccccccccccCCCC-----CCChhhHHHHHHHHHHHHhC----------CCCCCCCC
Q 016184 230 GSAKVLVKGEP-----NVSYICSRYYRAPELIFGATE-----YTTAIDIWSTGCVMAELLLG----------QPLFPGES 289 (394)
Q Consensus 230 g~a~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~-----~~~~~DiwslG~il~~lltg----------~~pf~~~~ 289 (394)
|++........ .....+|+.|+|||++.+... ++.++||||||+++|+|++| ..||....
T Consensus 192 g~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~ 271 (342)
T 1b6c_B 192 GLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLV 271 (342)
T ss_dssp TTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTS
T ss_pred CCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccC
Confidence 99976654432 234578999999999865432 23689999999999999999 77886643
Q ss_pred c----HHHHHHHHHHhCCCChhhhhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 016184 290 G----VDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH 365 (394)
Q Consensus 290 ~----~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 365 (394)
. ...+......... ............++..+.+||.+||+.||++|||+.++++|
T Consensus 272 ~~~~~~~~~~~~~~~~~~---------------------~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~ 330 (342)
T 1b6c_B 272 PSDPSVEEMRKVVCEQKL---------------------RPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 330 (342)
T ss_dssp CSSCCHHHHHHHHTTSCC---------------------CCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred cCcccHHHHHHHHHHHHh---------------------CCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence 2 1222221110000 00000001112345689999999999999999999999875
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-42 Score=320.00 Aligned_cols=246 Identities=26% Similarity=0.367 Sum_probs=191.1
Q ss_pred EEEeeEEeecCceEEEEEEE----CCCCcEEEEEEeccch-----hhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeE
Q 016184 84 YIAEHVVGTGSFGVVFQAKC----RETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY 154 (394)
Q Consensus 84 y~~~~~lg~G~~g~V~~~~~----~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 154 (394)
|++.+.||+|+||.||++.+ ..+++.||||++.... ..+.+|+++++.++||||+++++++.... ...
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~---~~~ 109 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAG---AAS 109 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT---TTE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCC---Cce
Confidence 59999999999999988764 4578999999986542 34568999999999999999999885432 345
Q ss_pred EEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCcc
Q 016184 155 LNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK 233 (394)
Q Consensus 155 ~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~ 233 (394)
+++||||+++ +|.+++.. ..+++..++.++.||+.||+|||+ .||+||||||+|||++.++ .+||+|||++.
T Consensus 110 ~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~i~~~l~~~l~~LH~-~~ivH~Dikp~Nil~~~~~-~~kl~Dfg~a~ 182 (318)
T 3lxp_A 110 LQLVMEYVPLGSLRDYLPR-----HSIGLAQLLLFAQQICEGMAYLHA-QHYIHRDLAARNVLLDNDR-LVKIGDFGLAK 182 (318)
T ss_dssp EEEEECCCTTCBHHHHGGG-----SCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECTTC-CEEECCGGGCE
T ss_pred EEEEEecccCCcHHHHHhh-----CCCCHHHHHHHHHHHHHHHHHHHh-CCccCCCCchheEEEcCCC-CEEECCccccc
Confidence 7899999975 77776643 569999999999999999999999 8999999999999999887 79999999998
Q ss_pred ccccCCC----cccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHH-----------HHHHHH
Q 016184 234 VLVKGEP----NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVD-----------QLVEII 298 (394)
Q Consensus 234 ~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~-----------~~~~i~ 298 (394)
....... .....+|+.|+|||++.+.. ++.++||||||+++|+|++|..||....... ....+.
T Consensus 183 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (318)
T 3lxp_A 183 AVPEGHEYYRVREDGDSPVFWYAPECLKEYK-FYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLT 261 (318)
T ss_dssp ECCTTCSEEEC---CCCCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHH
T ss_pred cccccccccccccCCCCCceeeChHHhcCCC-CCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHH
Confidence 7654332 22345688899999996544 7899999999999999999999996532110 011111
Q ss_pred HHhCCCChhhhhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 016184 299 KVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV 364 (394)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 364 (394)
..+.. . .....+..+++++.+||++||+.||.+|||+.++++
T Consensus 262 ~~~~~-----------~-------------~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 303 (318)
T 3lxp_A 262 ELLER-----------G-------------ERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIP 303 (318)
T ss_dssp HHHHT-----------T-------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHhc-----------c-------------cCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 10000 0 000112467899999999999999999999999985
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-42 Score=314.70 Aligned_cols=244 Identities=24% Similarity=0.336 Sum_probs=188.1
Q ss_pred eeEEEeeEEeecCceEEEEEEECC-CCc--EEEEEEeccc-------hhhhHHHHHHHHHcCCCCeeeeceEEEecCCCc
Q 016184 82 VSYIAEHVVGTGSFGVVFQAKCRE-TGE--IVAIKKVLQD-------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKE 151 (394)
Q Consensus 82 ~~y~~~~~lg~G~~g~V~~~~~~~-~~~--~vaiK~~~~~-------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 151 (394)
.+|++.+.||+|+||.||+|++.. +++ .||||++... .....+|+.+++.++||||+++++++...
T Consensus 18 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---- 93 (291)
T 1u46_A 18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP---- 93 (291)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS----
T ss_pred hHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccC----
Confidence 469999999999999999998643 333 6899987542 23445799999999999999999988422
Q ss_pred eeEEEEEEeccc-ccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeec
Q 016184 152 ELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFG 230 (394)
Q Consensus 152 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg 230 (394)
. .++||||+. ++|.+.+... ...+++..++.++.|++.||.|||+ +||+|+||||+|||++.++ .+||+|||
T Consensus 94 ~--~~~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dikp~Nili~~~~-~~kl~Dfg 166 (291)
T 1u46_A 94 P--MKMVTELAPLGSLLDRLRKH---QGHFLLGTLSRYAVQVAEGMGYLES-KRFIHRDLAARNLLLATRD-LVKIGDFG 166 (291)
T ss_dssp S--CEEEEECCTTCBHHHHHHHH---GGGSCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEEEETT-EEEECCCT
T ss_pred C--ceeeEecccCCCHHHHHHhc---cCCcCHHHHHHHHHHHHHHHHHHHh-CCcccCCCchheEEEcCCC-CEEEcccc
Confidence 1 568999998 4787766543 3568999999999999999999999 8999999999999999887 79999999
Q ss_pred CccccccCCCc----ccccccccccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCC
Q 016184 231 SAKVLVKGEPN----VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPT 305 (394)
Q Consensus 231 ~a~~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~ 305 (394)
++......... ....+|+.|+|||++.+. .++.++||||||+++|+|++ |+.||.+.+..+.+..+.......
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~- 244 (291)
T 1u46_A 167 LMRALPQNDDHYVMQEHRKVPFAWCAPESLKTR-TFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERL- 244 (291)
T ss_dssp TCEECCC-CCEEEC-----CCGGGCCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCC-
T ss_pred ccccccccccchhhhccCCCCceeeCchhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCCC-
Confidence 99776443321 233457789999998654 47899999999999999999 999998887666555543311100
Q ss_pred hhhhhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 016184 306 REEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV 364 (394)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 364 (394)
.....++.++.++|.+||+.||.+|||+.++++
T Consensus 245 --------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 277 (291)
T 1u46_A 245 --------------------------PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRD 277 (291)
T ss_dssp --------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --------------------------CCCcCcCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 012457899999999999999999999999987
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-42 Score=324.02 Aligned_cols=243 Identities=16% Similarity=0.174 Sum_probs=188.3
Q ss_pred ceeEEEeeEEeecCceEEEEE-----EECCCCcEEEEEEeccc-hhhhHHHHHHHHHcC---CCCeeeeceEEEecCCCc
Q 016184 81 KVSYIAEHVVGTGSFGVVFQA-----KCRETGEIVAIKKVLQD-KRYKNRELQIMQMLD---HPNIVALKHCFFSTTDKE 151 (394)
Q Consensus 81 ~~~y~~~~~lg~G~~g~V~~~-----~~~~~~~~vaiK~~~~~-~~~~~~E~~~l~~l~---h~~iv~~~~~~~~~~~~~ 151 (394)
..+|.+.+.||+|+||.||+| .+..+++.||||++... .....+|+++++.+. |+||+.+++++....
T Consensus 64 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~--- 140 (365)
T 3e7e_A 64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQN--- 140 (365)
T ss_dssp SSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCCHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSS---
T ss_pred CEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCChhHHHHHHHHHHHhhhhhhhhhhhhheeeecCC---
Confidence 346999999999999999999 46778999999998654 344567888888887 899999999885433
Q ss_pred eeEEEEEEeccc-ccHHHHHHHhhh-hcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeC----------
Q 016184 152 ELYLNLVLEYVP-ETVNRIARNYSR-IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNP---------- 219 (394)
Q Consensus 152 ~~~~~lv~e~~~-~~l~~~~~~~~~-~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~---------- 219 (394)
..++||||++ ++|.+++..... ....+++..++.++.||+.||+|||+ +||+||||||+|||++.
T Consensus 141 --~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~-~~ivHrDiKp~NIll~~~~~~~~~~~~ 217 (365)
T 3e7e_A 141 --GSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHD-CEIIHGDIKPDNFILGNGFLEQDDEDD 217 (365)
T ss_dssp --CEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHT-TTEECCCCSGGGEEECGGGTCC-----
T ss_pred --CcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhh-CCeecCCCCHHHEEecccccCcccccc
Confidence 3679999998 588888876544 24679999999999999999999999 89999999999999987
Q ss_pred -CCCcEEEEeecCcccccc---CCCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHH
Q 016184 220 -HTHQLKLCDFGSAKVLVK---GEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLV 295 (394)
Q Consensus 220 -~~~~vkl~Dfg~a~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~ 295 (394)
++ .+||+|||+|+.... ........||+.|+|||++.+.. ++.++|||||||++|+|+||+.||.......
T Consensus 218 ~~~-~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~elltg~~pf~~~~~~~--- 292 (365)
T 3e7e_A 218 LSA-GLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKP-WNYQIDYFGVAATVYCMLFGTYMKVKNEGGE--- 292 (365)
T ss_dssp -CT-TEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCC-BSTHHHHHHHHHHHHHHHHSSCCCEEEETTE---
T ss_pred ccC-CEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCC-CCccccHHHHHHHHHHHHhCCCccccCCCCc---
Confidence 56 799999999965432 22334567899999999997654 8999999999999999999999996432210
Q ss_pred HHHHHhCCCChhhhhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 016184 296 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV 364 (394)
Q Consensus 296 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 364 (394)
+........ ...++.+.+++..||+.+|.+|++..+.+.
T Consensus 293 -----------------------~~~~~~~~~-------~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~ 331 (365)
T 3e7e_A 293 -----------------------CKPEGLFRR-------LPHLDMWNEFFHVMLNIPDCHHLPSLDLLR 331 (365)
T ss_dssp -----------------------EEECSCCTT-------CSSHHHHHHHHHHHHCCCCTTCCCCHHHHH
T ss_pred -----------------------eeechhccc-------cCcHHHHHHHHHHHcCCCCCCcchHHHHHH
Confidence 000000000 123567889999999999999965444433
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-42 Score=316.94 Aligned_cols=258 Identities=26% Similarity=0.434 Sum_probs=194.6
Q ss_pred cceeEEEeeEEeecCceEEEEEE----ECCCCcEEEEEEeccch----hhhHHHHHHHHHcCCCCeeeeceEEEecCCCc
Q 016184 80 QKVSYIAEHVVGTGSFGVVFQAK----CRETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKE 151 (394)
Q Consensus 80 ~~~~y~~~~~lg~G~~g~V~~~~----~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 151 (394)
...+|++.+.||+|+||.||+|+ +..+|+.||||++.... ..+.+|+++++.++||||+++++++... .
T Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~---~ 115 (326)
T 2w1i_A 39 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSA---G 115 (326)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC-----
T ss_pred CHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEec---C
Confidence 34569999999999999999999 45689999999986532 3456899999999999999999987432 2
Q ss_pred eeEEEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeec
Q 016184 152 ELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFG 230 (394)
Q Consensus 152 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg 230 (394)
....++||||+++ +|.+++... ...+++..++.++.|++.||.|||+ .||+||||||+|||++.++ .+||+|||
T Consensus 116 ~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~dikp~NIli~~~~-~~kL~Dfg 190 (326)
T 2w1i_A 116 RRNLKLIMEYLPYGSLRDYLQKH---KERIDHIKLLQYTSQICKGMEYLGT-KRYIHRDLATRNILVENEN-RVKIGDFG 190 (326)
T ss_dssp --CCEEEECCCTTCBHHHHHHHS---TTSSCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEEEETT-EEEECCCT
T ss_pred CCceEEEEECCCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHh-CCEeccCCCcceEEEcCCC-cEEEecCc
Confidence 2346799999975 888777652 2568999999999999999999999 8999999999999999887 79999999
Q ss_pred CccccccCCC----cccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCh
Q 016184 231 SAKVLVKGEP----NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTR 306 (394)
Q Consensus 231 ~a~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~ 306 (394)
++........ .....++..|+|||.+.+.. ++.++||||||+++|+|++|..||.... ..+ .+..+....
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~tg~~~~~~~~--~~~---~~~~~~~~~ 264 (326)
T 2w1i_A 191 LTKVLPQDKEYYKVKEPGESPIFWYAPESLTESK-FSVASDVWSFGVVLYELFTYIEKSKSPP--AEF---MRMIGNDKQ 264 (326)
T ss_dssp TCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHHTTCGGGSHH--HHH---HHHHCTTCC
T ss_pred chhhccccccccccccCCCCceeEECchhhcCCC-CCchhhHHHHHHHHHHHHhcCCCCCCCH--HHH---HHhhccccc
Confidence 9987644332 12334577899999986544 7899999999999999999998885421 111 111111110
Q ss_pred hh------hhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 016184 307 EE------IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV 364 (394)
Q Consensus 307 ~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 364 (394)
.. ....... . . ...+..++.++.+||.+||+.||++|||+.++++
T Consensus 265 ~~~~~~~~~~~~~~~-~--~----------~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~ 315 (326)
T 2w1i_A 265 GQMIVFHLIELLKNN-G--R----------LPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 315 (326)
T ss_dssp THHHHHHHHHHHHTT-C--C----------CCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred hhhhHHHHHHHhhcC-C--C----------CCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 00 0000000 0 0 0012467899999999999999999999999975
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=339.92 Aligned_cols=240 Identities=23% Similarity=0.302 Sum_probs=191.1
Q ss_pred EEE-eeEEeecCceEEEEEEE--CCCCcEEEEEEeccch------hhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeE
Q 016184 84 YIA-EHVVGTGSFGVVFQAKC--RETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY 154 (394)
Q Consensus 84 y~~-~~~lg~G~~g~V~~~~~--~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 154 (394)
+.+ .+.||+|+||.||+|.+ ..+++.||||++.... ..+.+|+++++.++||||+++++++. . ..
T Consensus 370 ~~l~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-~----~~- 443 (635)
T 4fl3_A 370 LTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-A----ES- 443 (635)
T ss_dssp EEEEEEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEE-S----SS-
T ss_pred ccccCCEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-c----CC-
Confidence 444 35899999999999955 4567899999986432 34568999999999999999999872 1 11
Q ss_pred EEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCcc
Q 016184 155 LNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK 233 (394)
Q Consensus 155 ~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~ 233 (394)
.++||||+.+ +|.+++.. ...+++..++.++.||+.||+|||+ +||+||||||+||||+.++ .+||+|||+++
T Consensus 444 ~~lv~E~~~~g~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~yLH~-~~iiHrDLkp~NILl~~~~-~~kL~DFGla~ 517 (635)
T 4fl3_A 444 WMLVMEMAELGPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEE-SNFVHRDLAARNVLLVTQH-YAKISDFGLSK 517 (635)
T ss_dssp EEEEEECCTTEEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEEEETT-EEEECCTTHHH
T ss_pred EEEEEEccCCCCHHHHHhh----CCCCCHHHHHHHHHHHHHHHHHHHH-CCEeCCCCChHhEEEeCCC-CEEEEEcCCcc
Confidence 5699999985 77776653 4679999999999999999999999 8999999999999999887 79999999998
Q ss_pred ccccCCC----cccccccccccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCChhh
Q 016184 234 VLVKGEP----NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREE 308 (394)
Q Consensus 234 ~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 308 (394)
....... .....+|+.|+|||++.+. .++.++|||||||++|+|++ |+.||.+.+..+....+......
T Consensus 518 ~~~~~~~~~~~~~~~~~t~~y~APE~~~~~-~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~----- 591 (635)
T 4fl3_A 518 ALRADENYYKAQTHGKWPVKWYAPECINYY-KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERM----- 591 (635)
T ss_dssp HTTC-------------CGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC-----
T ss_pred ccccCccccccccCCCCceeeeChhhhcCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC-----
Confidence 6643322 1223457889999999654 48999999999999999998 99999988776655554432100
Q ss_pred hhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 016184 309 IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV 364 (394)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 364 (394)
..+..+++++.+||.+||+.||++|||+.+|++
T Consensus 592 -----------------------~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~ 624 (635)
T 4fl3_A 592 -----------------------GCPAGCPREMYDLMNLCWTYDVENRPGFAAVEL 624 (635)
T ss_dssp -----------------------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred -----------------------CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 012467899999999999999999999999875
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=338.93 Aligned_cols=242 Identities=26% Similarity=0.320 Sum_probs=191.8
Q ss_pred eEEEee-EEeecCceEEEEEEEC--CCCcEEEEEEeccc-----hhhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeE
Q 016184 83 SYIAEH-VVGTGSFGVVFQAKCR--ETGEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY 154 (394)
Q Consensus 83 ~y~~~~-~lg~G~~g~V~~~~~~--~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 154 (394)
++.+.+ .||+|+||.||+|.++ .++..||||++... ...+.+|+++++.++||||+++++++.. . .
T Consensus 336 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~-----~ 409 (613)
T 2ozo_A 336 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-E-----A 409 (613)
T ss_dssp SEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-S-----S
T ss_pred ceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-C-----C
Confidence 455655 8999999999999875 34667999998653 3445689999999999999999998732 1 1
Q ss_pred EEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCcc
Q 016184 155 LNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK 233 (394)
Q Consensus 155 ~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~ 233 (394)
+++||||+.+ +|.+++.. ....+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+++
T Consensus 410 ~~lv~E~~~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~~L~~LH~-~~iiHrDlkp~NILl~~~~-~vkL~DFGla~ 484 (613)
T 2ozo_A 410 LMLVMEMAGGGPLHKFLVG---KREEIPVSNVAELLHQVSMGMKYLEE-KNFVHRNLAARNVLLVNRH-YAKISDFGLSK 484 (613)
T ss_dssp EEEEEECCTTCBHHHHHTT---CTTTSCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEEEETT-EEEECCCSTTT
T ss_pred eEEEEEeCCCCcHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHH-CCEEcCcCCHHHEEEcCCC-cEEEeeccCcc
Confidence 6799999985 67666543 23569999999999999999999999 8999999999999999887 79999999998
Q ss_pred ccccCCCc----ccccccccccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCChhh
Q 016184 234 VLVKGEPN----VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREE 308 (394)
Q Consensus 234 ~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 308 (394)
........ ....+++.|+|||++.+. .++.++|||||||++|||++ |+.||.+.+..+....+.....
T Consensus 485 ~~~~~~~~~~~~~~~~~~~~y~APE~~~~~-~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~------ 557 (613)
T 2ozo_A 485 ALGADDSYYTARSAGKWPLKWYAPECINFR-KFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKR------ 557 (613)
T ss_dssp TCC--------------CCTTSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTCC------
T ss_pred cccCCCceeeeccCCCCccceeCHhhhcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCC------
Confidence 65433221 122346789999999654 48999999999999999998 9999998887766655543110
Q ss_pred hhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 016184 309 IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV 364 (394)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 364 (394)
..++..+++++.+||.+||+.||.+|||+.++++
T Consensus 558 ----------------------~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~ 591 (613)
T 2ozo_A 558 ----------------------MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQ 591 (613)
T ss_dssp ----------------------CCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHH
T ss_pred ----------------------CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 0122468999999999999999999999998853
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=331.52 Aligned_cols=247 Identities=17% Similarity=0.151 Sum_probs=183.5
Q ss_pred eeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccch------------hhhHHHHHHHHHcC---------CCCeeee
Q 016184 82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------------RYKNRELQIMQMLD---------HPNIVAL 140 (394)
Q Consensus 82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------------~~~~~E~~~l~~l~---------h~~iv~~ 140 (394)
.+|++.+.||+|+||+||+|++ +|+.||||++.... ....+|+.+++.++ |+||+++
T Consensus 20 ~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 20 EKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp HHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred ccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 4699999999999999999998 58999999986542 45568999999885 7777777
Q ss_pred ceEEEecC-------------------------CCceeEEEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHH
Q 016184 141 KHCFFSTT-------------------------DKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICR 194 (394)
Q Consensus 141 ~~~~~~~~-------------------------~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~ 194 (394)
.+++.... .......++||||+.+ ++.+.+. ...+++..++.++.||+.
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~-----~~~~~~~~~~~i~~qi~~ 172 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMR-----TKLSSLATAKSILHQLTA 172 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGT-----TTCCCHHHHHHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHH-----hcCCCHHHHHHHHHHHHH
Confidence 66543211 0013457899999865 3433221 267899999999999999
Q ss_pred HHHHHH-hCCCceeccCCCCceEEeCCC-------------------CcEEEEeecCccccccCCCcccccccccccccc
Q 016184 195 ALAYIH-NCIGICHRDIKPQNLLVNPHT-------------------HQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPE 254 (394)
Q Consensus 195 al~~LH-~~~givH~Dlkp~Nil~~~~~-------------------~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE 254 (394)
||+||| + +||+||||||+|||++.++ ..+||+|||+|+.... ....||+.|+|||
T Consensus 173 aL~~lH~~-~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~----~~~~gt~~y~aPE 247 (336)
T 2vuw_A 173 SLAVAEAS-LRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD----GIVVFCDVSMDED 247 (336)
T ss_dssp HHHHHHHH-HCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET----TEEECCCCTTCSG
T ss_pred HHHHHHHh-CCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC----CcEEEeecccChh
Confidence 999999 8 8999999999999999775 1699999999986643 2457899999999
Q ss_pred cccCCCCCCChhhHHHHHHH-HHHHHhCCCCCCCCCcHH-HHHHHHHHhCCCChhhhhccCCCCcccCCCCCCCCCcchh
Q 016184 255 LIFGATEYTTAIDIWSTGCV-MAELLLGQPLFPGESGVD-QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKV 332 (394)
Q Consensus 255 ~~~~~~~~~~~~DiwslG~i-l~~lltg~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 332 (394)
++.+.. +.++|||||+++ .+++++|..||.+..... ....+....... . .....
T Consensus 248 ~~~g~~--~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~------------------~----~~~~~ 303 (336)
T 2vuw_A 248 LFTGDG--DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFK------------------T----KCNTP 303 (336)
T ss_dssp GGCCCS--SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCS------------------S----CCCSH
T ss_pred hhcCCC--ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccC------------------c----ccchh
Confidence 996543 889999998777 777888999984321111 111222110000 0 00011
Q ss_pred ccccCChHHHHHHHHhcccCCCCCCCHHHHh-cCCCCC
Q 016184 333 FQKRLPPEAVDLVCRFFQYSPNLRCTALEAC-VHPFFD 369 (394)
Q Consensus 333 ~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell-~hp~f~ 369 (394)
....+++++++||++||++| |++|+| +||||+
T Consensus 304 ~~~~~s~~~~dli~~~L~~d-----sa~e~l~~Hp~f~ 336 (336)
T 2vuw_A 304 AMKQIKRKIQEFHRTMLNFS-----SATDLLCQHSLFK 336 (336)
T ss_dssp HHHHHHHHHHHHHHHGGGSS-----SHHHHHHHCGGGC
T ss_pred hhhhcCHHHHHHHHHHhccC-----CHHHHHhcCCCcC
Confidence 22457889999999999987 999999 999996
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=314.15 Aligned_cols=252 Identities=18% Similarity=0.253 Sum_probs=193.0
Q ss_pred eeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccc------hhhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEE
Q 016184 82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL 155 (394)
Q Consensus 82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 155 (394)
.+|++.+.||+|+||.||+|++.. .||+|++... ...+.+|+.+++.++|+||+++++++.... ..
T Consensus 33 ~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-----~~ 104 (319)
T 2y4i_B 33 EQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPP-----HL 104 (319)
T ss_dssp SCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSS-----CE
T ss_pred HHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCC-----ce
Confidence 459999999999999999999853 4999988542 233457999999999999999999884332 37
Q ss_pred EEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCccc
Q 016184 156 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV 234 (394)
Q Consensus 156 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~ 234 (394)
+++|||+.+ +|.+++.. ....+++..++.++.||+.||+|||+ .||+||||||+|||++ ++ .+||+|||++..
T Consensus 105 ~iv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~-~~i~H~dlkp~NIl~~-~~-~~~l~Dfg~~~~ 178 (319)
T 2y4i_B 105 AIITSLCKGRTLYSVVRD---AKIVLDVNKTRQIAQEIVKGMGYLHA-KGILHKDLKSKNVFYD-NG-KVVITDFGLFSI 178 (319)
T ss_dssp EEECBCCCSEEHHHHTTS---SCCCCCSHHHHHHHHHHHHHHHHHHH-TTCCCCCCCSTTEEEC----CCEECCCSCCC-
T ss_pred EEEeecccCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCChhhEEEe-CC-CEEEeecCCccc
Confidence 899999974 77666543 23468999999999999999999999 8999999999999998 55 699999999865
Q ss_pred ccc------CCCcccccccccccccccccC--------CCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHH
Q 016184 235 LVK------GEPNVSYICSRYYRAPELIFG--------ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV 300 (394)
Q Consensus 235 ~~~------~~~~~~~~~t~~y~aPE~~~~--------~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~ 300 (394)
... ........+++.|+|||++.+ ...++.++||||||+++|+|++|+.||...........+...
T Consensus 179 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~ 258 (319)
T 2y4i_B 179 SGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTG 258 (319)
T ss_dssp ---------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHTT
T ss_pred cccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccC
Confidence 421 122233458999999999864 234788999999999999999999999887765555444331
Q ss_pred hCCCChhhhhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCC
Q 016184 301 LGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNT 376 (394)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~ 376 (394)
.... .....++.++.+||.+||+.||.+|||+.++++ .|+++.....
T Consensus 259 ~~~~---------------------------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~--~l~~l~~~~~ 305 (319)
T 2y4i_B 259 MKPN---------------------------LSQIGMGKEISDILLFCWAFEQEERPTFTKLMD--MLEKLPKRNR 305 (319)
T ss_dssp CCCC---------------------------CCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHH--HHTTC-----
T ss_pred CCCC---------------------------CCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHH--HHHHHHHhhc
Confidence 1000 011347889999999999999999999999997 5665554433
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=335.31 Aligned_cols=245 Identities=27% Similarity=0.366 Sum_probs=196.4
Q ss_pred cceeEEEeeEEeecCceEEEEEEECCC---CcEEEEEEeccch-----hhhHHHHHHHHHcCCCCeeeeceEEEecCCCc
Q 016184 80 QKVSYIAEHVVGTGSFGVVFQAKCRET---GEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKE 151 (394)
Q Consensus 80 ~~~~y~~~~~lg~G~~g~V~~~~~~~~---~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 151 (394)
...+|++.+.||+|+||.||+|++..+ +..||||++.... ..+.+|+.+++.++||||+++++++. .+
T Consensus 388 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~----~~ 463 (656)
T 2j0j_A 388 QRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT----EN 463 (656)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC----SS
T ss_pred ccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe----cC
Confidence 345799999999999999999998653 4679999875432 34567999999999999999999872 11
Q ss_pred eeEEEEEEeccc-ccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeec
Q 016184 152 ELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFG 230 (394)
Q Consensus 152 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg 230 (394)
..++||||+. ++|.+++... ...+++..++.++.|++.||+|||+ +||+||||||+|||++.++ .+||+|||
T Consensus 464 --~~~lv~E~~~~g~L~~~l~~~---~~~l~~~~~~~i~~qi~~aL~~LH~-~givHrDikp~NILl~~~~-~vkL~DFG 536 (656)
T 2j0j_A 464 --PVWIIMELCTLGELRSFLQVR---KFSLDLASLILYAYQLSTALAYLES-KRFVHRDIAARNVLVSSND-CVKLGDFG 536 (656)
T ss_dssp --SCEEEEECCTTCBHHHHHHHT---TTTCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEEEETT-EEEECCCC
T ss_pred --ceEEEEEcCCCCcHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHh-CCccccccchHhEEEeCCC-CEEEEecC
Confidence 1578999998 5887776542 2468999999999999999999999 8999999999999999887 79999999
Q ss_pred CccccccCCCc--ccccccccccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCChh
Q 016184 231 SAKVLVKGEPN--VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTRE 307 (394)
Q Consensus 231 ~a~~~~~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~ 307 (394)
+++........ ....+|+.|+|||++.+. .++.++|||||||++|+|++ |..||.+....+.+..+......+
T Consensus 537 ~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~--- 612 (656)
T 2j0j_A 537 LSRYMEDSTYYKASKGKLPIKWMAPESINFR-RFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLP--- 612 (656)
T ss_dssp CCCSCCC----------CCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCCCC---
T ss_pred CCeecCCCcceeccCCCCCcceeCHHHhcCC-CCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCC---
Confidence 99866433221 223457889999999654 48999999999999999997 999999887776666654421100
Q ss_pred hhhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 016184 308 EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV 364 (394)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 364 (394)
++..+++.+.+||.+||+.||.+|||+.++++
T Consensus 613 -------------------------~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~ 644 (656)
T 2j0j_A 613 -------------------------MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKA 644 (656)
T ss_dssp -------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -------------------------CCccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 12467899999999999999999999999975
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=343.53 Aligned_cols=241 Identities=25% Similarity=0.341 Sum_probs=194.4
Q ss_pred eeEEEeeEEeecCceEEEEEEECC-CCcEEEEEEeccch-----hhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEE
Q 016184 82 VSYIAEHVVGTGSFGVVFQAKCRE-TGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL 155 (394)
Q Consensus 82 ~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 155 (394)
++|++.+.||+|+||.||+|++.. +|+.||||++.... ....+|+.+++.++||||+++++++.........+.
T Consensus 80 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~ 159 (681)
T 2pzi_A 80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVG 159 (681)
T ss_dssp TTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred CceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCcee
Confidence 579999999999999999999976 78999999885432 234579999999999999999999876655455567
Q ss_pred EEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCccc
Q 016184 156 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV 234 (394)
Q Consensus 156 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~ 234 (394)
|+||||+++ +|.+.+. ..+++..++.++.||+.||.|||+ +||+||||||+|||++.+ .+||+|||+++.
T Consensus 160 ~lv~E~~~g~~L~~~~~------~~l~~~~~~~~~~qi~~aL~~lH~-~giiHrDlkp~NIll~~~--~~kl~DFG~a~~ 230 (681)
T 2pzi_A 160 YIVMEYVGGQSLKRSKG------QKLPVAEAIAYLLEILPALSYLHS-IGLVYNDLKPENIMLTEE--QLKLIDLGAVSR 230 (681)
T ss_dssp EEEEECCCCEECC----------CCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECSS--CEEECCCTTCEE
T ss_pred EEEEEeCCCCcHHHHHh------CCCCHHHHHHHHHHHHHHHHHHHH-CCCeecccChHHeEEeCC--cEEEEecccchh
Confidence 899999985 5544332 479999999999999999999999 899999999999999964 699999999986
Q ss_pred cccCCCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCC
Q 016184 235 LVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 314 (394)
Q Consensus 235 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 314 (394)
.... ....||+.|+|||++.+. ++.++|||||||++|+|++|..||.+.....
T Consensus 231 ~~~~---~~~~gt~~y~aPE~~~~~--~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~---------------------- 283 (681)
T 2pzi_A 231 INSF---GYLYGTPGFQAPEIVRTG--PTVATDIYTVGRTLAALTLDLPTRNGRYVDG---------------------- 283 (681)
T ss_dssp TTCC---SCCCCCTTTSCTTHHHHC--SCHHHHHHHHHHHHHHHHSCCCEETTEECSS----------------------
T ss_pred cccC---CccCCCccccCHHHHcCC--CCCceehhhhHHHHHHHHhCCCCCccccccc----------------------
Confidence 5433 456789999999998643 4889999999999999999998886421100
Q ss_pred CCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 016184 315 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL 371 (394)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 371 (394)
++. . ......++.+.+||.+||+.||.+||+..+.+.|+|+.-+
T Consensus 284 ------~~~-----~--~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~ 327 (681)
T 2pzi_A 284 ------LPE-----D--DPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVL 327 (681)
T ss_dssp ------CCT-----T--CHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred ------ccc-----c--ccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHH
Confidence 000 0 0001246789999999999999999999999999888643
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-39 Score=293.10 Aligned_cols=225 Identities=13% Similarity=0.059 Sum_probs=175.2
Q ss_pred eeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccch-------hhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeE
Q 016184 82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY 154 (394)
Q Consensus 82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 154 (394)
++|++.+.||+|+||.||+|++..+|+.||||++.... ..+.+|+.+++.++||||+++++++.. ...
T Consensus 31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~-----~~~ 105 (286)
T 3uqc_A 31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHT-----RAG 105 (286)
T ss_dssp TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEE-----TTE
T ss_pred CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEE-----CCc
Confidence 35999999999999999999999999999999986532 345679999999999999999998843 334
Q ss_pred EEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCcc
Q 016184 155 LNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK 233 (394)
Q Consensus 155 ~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~ 233 (394)
.|+||||+.+ +|.+++.. ......+..++.|++.||+|||+ +||+||||||+|||++.++ .+||++++
T Consensus 106 ~~lv~e~~~g~~L~~~l~~------~~~~~~~~~i~~ql~~aL~~lH~-~givH~Dikp~NIll~~~g-~~kl~~~~--- 174 (286)
T 3uqc_A 106 GLVVAEWIRGGSLQEVADT------SPSPVGAIRAMQSLAAAADAAHR-AGVALSIDHPSRVRVSIDG-DVVLAYPA--- 174 (286)
T ss_dssp EEEEEECCCEEEHHHHHTT------CCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCSGGGEEEETTS-CEEECSCC---
T ss_pred EEEEEEecCCCCHHHHHhc------CCChHHHHHHHHHHHHHHHHHHH-CCCccCCCCcccEEEcCCC-CEEEEecc---
Confidence 7899999975 77776632 24556788899999999999999 8999999999999999888 69987443
Q ss_pred ccccCCCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccC
Q 016184 234 VLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 313 (394)
Q Consensus 234 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 313 (394)
|++ .++.++|||||||++|+|+||+.||.+.+....+....
T Consensus 175 ----------------~~~--------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~--------------- 215 (286)
T 3uqc_A 175 ----------------TMP--------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAE--------------- 215 (286)
T ss_dssp ----------------CCT--------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECC---------------
T ss_pred ----------------ccC--------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHH---------------
Confidence 332 27899999999999999999999998765322110000
Q ss_pred CCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 016184 314 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL 371 (394)
Q Consensus 314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 371 (394)
.... ........+...+++++.+||.+||+.||.+| |+.++++ .++++
T Consensus 216 ------~~~~-~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~--~L~~~ 263 (286)
T 3uqc_A 216 ------RDTA-GQPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLN--LMQQA 263 (286)
T ss_dssp ------BCTT-SCBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHH--HHHHH
T ss_pred ------HHhc-cCCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHH--HHHHH
Confidence 0000 00011112335689999999999999999999 9999987 44443
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.6e-32 Score=270.52 Aligned_cols=178 Identities=17% Similarity=0.077 Sum_probs=123.2
Q ss_pred EEeecCceEEEEEEECCCCcEEEEEEeccc--------------hhhhHHHHHHHHHc-CCCCeeeeceEEEecCCCcee
Q 016184 89 VVGTGSFGVVFQAKCRETGEIVAIKKVLQD--------------KRYKNRELQIMQML-DHPNIVALKHCFFSTTDKEEL 153 (394)
Q Consensus 89 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--------------~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~ 153 (394)
..+.|+.|.+..++....|+.||+|++.+. ...+.+|+++|+++ .|+||+++++++ .+..
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~-----ed~~ 315 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHG-----ENAQ 315 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEE-----ECSS
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEE-----EECC
Confidence 367788888888888888999999998542 13356799999999 799999999988 4445
Q ss_pred EEEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCc
Q 016184 154 YLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA 232 (394)
Q Consensus 154 ~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a 232 (394)
..||||||++| +|.+++.. ...+++. .|+.||+.||+|||+ +|||||||||+|||++.++ .+||+|||+|
T Consensus 316 ~~yLVMEyv~G~~L~d~i~~----~~~l~~~---~I~~QIl~AL~ylH~-~GIIHRDIKPeNILL~~dg-~vKL~DFGlA 386 (569)
T 4azs_A 316 SGWLVMEKLPGRLLSDMLAA----GEEIDRE---KILGSLLRSLAALEK-QGFWHDDVRPWNVMVDARQ-HARLIDFGSI 386 (569)
T ss_dssp EEEEEEECCCSEEHHHHHHT----TCCCCHH---HHHHHHHHHHHHHHH-TTCEESCCCGGGEEECTTS-CEEECCCTTE
T ss_pred EEEEEEecCCCCcHHHHHHh----CCCCCHH---HHHHHHHHHHHHHHH-CCceeccCchHhEEECCCC-CEEEeecccC
Confidence 58899999997 77777754 3556654 478899999999999 8999999999999999988 6999999999
Q ss_pred cccccC-CCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCC
Q 016184 233 KVLVKG-EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQ 282 (394)
Q Consensus 233 ~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~ 282 (394)
+..... ....+.+||+.|+|||++.+ .+..++|+||+|++++++.++.
T Consensus 387 r~~~~~~~~~~t~vGTp~YmAPE~l~g--~~~~~~d~~s~g~~~~~l~~~~ 435 (569)
T 4azs_A 387 VTTPQDCSWPTNLVQSFFVFVNELFAE--NKSWNGFWRSAPVHPFNLPQPW 435 (569)
T ss_dssp ESCC---CCSHHHHHHHHHHHHHHC-------------------CCCCTTH
T ss_pred eeCCCCCccccCceechhhccHHHhCC--CCCCcccccccccchhhhcccc
Confidence 866443 23445689999999999965 3678899999999988776554
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=3.1e-27 Score=232.78 Aligned_cols=179 Identities=17% Similarity=0.249 Sum_probs=132.3
Q ss_pred EEeeEEeecCceEEEEEEECCCCcEEEEEEeccc------------hhhhHHHHHHHHHcCCCCeeeeceEEEecCCCce
Q 016184 85 IAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE 152 (394)
Q Consensus 85 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 152 (394)
...++||+|+||.||+|.. .++.+++|+.... ...+.+|+++++.++||||+++..++.....
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~--~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~--- 413 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSY--LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDN--- 413 (540)
T ss_dssp ---------CCEEEEEEEC--SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTT---
T ss_pred CCCCEEeeCCCEEEEEEEE--CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCc---
Confidence 4567899999999999954 4788999975321 1224689999999999999955544443222
Q ss_pred eEEEEEEeccc-ccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecC
Q 016184 153 LYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS 231 (394)
Q Consensus 153 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~ 231 (394)
.++||||++ ++|.+++.. +..++.|++.||+|||+ +||+||||||+|||++. .+||+|||+
T Consensus 414 --~~lVmE~~~ggsL~~~l~~------------~~~i~~qi~~aL~~LH~-~gIiHrDiKp~NILl~~---~~kL~DFGl 475 (540)
T 3en9_A 414 --KRIMMSYINGKLAKDVIED------------NLDIAYKIGEIVGKLHK-NDVIHNDLTTSNFIFDK---DLYIIDFGL 475 (540)
T ss_dssp --TEEEEECCCSEEHHHHSTT------------CTHHHHHHHHHHHHHHH-TTEECTTCCTTSEEESS---SEEECCCTT
T ss_pred --cEEEEECCCCCCHHHHHHH------------HHHHHHHHHHHHHHHHH-CcCccCCCCHHHEEECC---eEEEEECcc
Confidence 479999997 577665543 45789999999999999 89999999999999997 599999999
Q ss_pred ccccccCCCc--------ccccccccccccccccCC-CCCCChhhHHHHHHHHHHHHhCCCCCC
Q 016184 232 AKVLVKGEPN--------VSYICSRYYRAPELIFGA-TEYTTAIDIWSTGCVMAELLLGQPLFP 286 (394)
Q Consensus 232 a~~~~~~~~~--------~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~lltg~~pf~ 286 (394)
++........ ....||+.|+|||++... ..|+..+|+|+..+-..+.+.++.+|.
T Consensus 476 a~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 476 GKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp CEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred CEECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 9876443221 246789999999998541 237788899999998888888776663
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=3.6e-24 Score=193.96 Aligned_cols=137 Identities=18% Similarity=0.170 Sum_probs=108.5
Q ss_pred EEEeeEEeecCceEEEEEEECCCCcEEEEEEeccc----------------------hhhhHHHHHHHHHcCCCCeeeec
Q 016184 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD----------------------KRYKNRELQIMQMLDHPNIVALK 141 (394)
Q Consensus 84 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----------------------~~~~~~E~~~l~~l~h~~iv~~~ 141 (394)
|.+.+.||+|+||.||+|++ .+|+.||||++... .....+|+++++.++ | +++.
T Consensus 92 ~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~ 167 (282)
T 1zar_A 92 DAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVP 167 (282)
T ss_dssp SEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSC
T ss_pred EEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcC
Confidence 55669999999999999999 88999999998532 223568999999999 5 6666
Q ss_pred eEEEecCCCceeEEEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCC
Q 016184 142 HCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPH 220 (394)
Q Consensus 142 ~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~ 220 (394)
+++.. ...++||||+++ +|.+ + .......++.|++.||.|||+ .||+||||||+|||++ +
T Consensus 168 ~~~~~------~~~~lvmE~~~g~~L~~-l----------~~~~~~~i~~qi~~~l~~lH~-~giiHrDlkp~NILl~-~ 228 (282)
T 1zar_A 168 KVYAW------EGNAVLMELIDAKELYR-V----------RVENPDEVLDMILEEVAKFYH-RGIVHGDLSQYNVLVS-E 228 (282)
T ss_dssp CEEEE------ETTEEEEECCCCEEGGG-C----------CCSCHHHHHHHHHHHHHHHHH-TTEECSCCSTTSEEEE-T
T ss_pred eEEec------cceEEEEEecCCCcHHH-c----------chhhHHHHHHHHHHHHHHHHH-CCCEeCCCCHHHEEEE-C
Confidence 65521 124799999986 6643 1 123345689999999999999 8999999999999999 7
Q ss_pred CCcEEEEeecCccccccCCCcccccccccccccccc
Q 016184 221 THQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELI 256 (394)
Q Consensus 221 ~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~ 256 (394)
+ .+||+|||+|+. +..++|||.+
T Consensus 229 ~-~vkl~DFG~a~~------------~~~~~a~e~l 251 (282)
T 1zar_A 229 E-GIWIIDFPQSVE------------VGEEGWREIL 251 (282)
T ss_dssp T-EEEECCCTTCEE------------TTSTTHHHHH
T ss_pred C-cEEEEECCCCeE------------CCCCCHHHHH
Confidence 6 799999999964 3347888877
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.85 E-value=3.7e-21 Score=172.05 Aligned_cols=135 Identities=17% Similarity=0.230 Sum_probs=102.5
Q ss_pred eEEEeeEEeecCceEEEEEEECCCCcE--EEEEEeccch----------------------------hhhHHHHHHHHHc
Q 016184 83 SYIAEHVVGTGSFGVVFQAKCRETGEI--VAIKKVLQDK----------------------------RYKNRELQIMQML 132 (394)
Q Consensus 83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~--vaiK~~~~~~----------------------------~~~~~E~~~l~~l 132 (394)
-|.+.+.||+|+||.||+|.+..+|+. ||||++.... ....+|+.+++.+
T Consensus 48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 127 (258)
T 1zth_A 48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA 127 (258)
T ss_dssp EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence 388999999999999999999778999 9999864321 1356799999999
Q ss_pred CCCCeeeeceEEEecCCCceeEEEEEEecccc------cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHH-hCCCc
Q 016184 133 DHPNIVALKHCFFSTTDKEELYLNLVLEYVPE------TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH-NCIGI 205 (394)
Q Consensus 133 ~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~~------~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH-~~~gi 205 (394)
.|+++... ..+.. . ..++||||+++ .+.+... ..++..+..++.|++.||.||| + .||
T Consensus 128 ~~~~i~~p-~~~~~-~-----~~~lVmE~~g~~g~~~~~L~~~~~-------~~~~~~~~~i~~qi~~~l~~lH~~-~gi 192 (258)
T 1zth_A 128 KEAGVSVP-QPYTY-M-----KNVLLMEFIGEDELPAPTLVELGR-------ELKELDVEGIFNDVVENVKRLYQE-AEL 192 (258)
T ss_dssp HHTTCCCC-CEEEE-E-----TTEEEEECCEETTEECCBHHHHGG-------GGGGSCHHHHHHHHHHHHHHHHHT-SCE
T ss_pred HhCCCCCC-eEEEc-C-----CCEEEEEecCCCCCccccHHHHhh-------ccChHHHHHHHHHHHHHHHHHHHH-CCE
Confidence 88764221 11111 1 14689999953 4443321 1234567788999999999999 8 899
Q ss_pred eeccCCCCceEEeCCCCcEEEEeecCcccc
Q 016184 206 CHRDIKPQNLLVNPHTHQLKLCDFGSAKVL 235 (394)
Q Consensus 206 vH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~ 235 (394)
+||||||+|||++. .++|+|||+|...
T Consensus 193 vHrDlkp~NILl~~---~~~liDFG~a~~~ 219 (258)
T 1zth_A 193 VHADLSEYNIMYID---KVYFIDMGQAVTL 219 (258)
T ss_dssp ECSSCSTTSEEESS---SEEECCCTTCEET
T ss_pred EeCCCCHHHEEEcC---cEEEEECcccccC
Confidence 99999999999996 5999999999653
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.73 E-value=9.3e-18 Score=156.13 Aligned_cols=132 Identities=12% Similarity=0.141 Sum_probs=91.8
Q ss_pred EEEeeEEeecCceEEEEEEECCCCcEEEEEEeccchh--------------------------hhHHHHHHHHHcCCCCe
Q 016184 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR--------------------------YKNRELQIMQMLDHPNI 137 (394)
Q Consensus 84 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--------------------------~~~~E~~~l~~l~h~~i 137 (394)
|.+.+.||.|++|.||+|.+. +|+.||||+++.... ...+|...|.++.+.++
T Consensus 97 Y~I~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv 175 (397)
T 4gyi_A 97 YSVGSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF 175 (397)
T ss_dssp SEEEEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred EEecCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence 899999999999999999984 699999998642110 01235555666644333
Q ss_pred eeeceEEEecCCCceeEEEEEEeccccc-HHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceE
Q 016184 138 VALKHCFFSTTDKEELYLNLVLEYVPET-VNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLL 216 (394)
Q Consensus 138 v~~~~~~~~~~~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil 216 (394)
.. ...+... . .++||||++|. +.+ .........++.||+.+|.+||+ .|||||||||.|||
T Consensus 176 ~v-p~p~~~~--~----~~LVME~i~G~~L~~----------l~~~~~~~~l~~qll~~l~~lH~-~gIVHrDLKp~NIL 237 (397)
T 4gyi_A 176 PV-PEPIAQS--R----HTIVMSLVDALPMRQ----------VSSVPDPASLYADLIALILRLAK-HGLIHGDFNEFNIL 237 (397)
T ss_dssp SC-CCEEEEE--T----TEEEEECCSCEEGGG----------CCCCSCHHHHHHHHHHHHHHHHH-TTEECSCCSTTSEE
T ss_pred CC-Ceeeecc--C----ceEEEEecCCccHhh----------hcccHHHHHHHHHHHHHHHHHHH-CCCcCCCCCHHHEE
Confidence 21 1111110 1 25899999873 311 11122345678899999999999 89999999999999
Q ss_pred EeCCCC---------cEEEEeecCccc
Q 016184 217 VNPHTH---------QLKLCDFGSAKV 234 (394)
Q Consensus 217 ~~~~~~---------~vkl~Dfg~a~~ 234 (394)
++.++. .+.|+||+-+-.
T Consensus 238 l~~dgd~~d~~~~~~~~~iID~~Q~V~ 264 (397)
T 4gyi_A 238 IREEKDAEDPSSITLTPIIIXFPQMVS 264 (397)
T ss_dssp EEEEECSSCTTSEEEEEEECCCTTCEE
T ss_pred EeCCCCcccccccccceEEEEeCCccc
Confidence 987652 289999997743
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.30 E-value=1.4e-11 Score=109.82 Aligned_cols=134 Identities=14% Similarity=0.095 Sum_probs=98.7
Q ss_pred eEEEeeEEeecCceEEEEEEECCCCcEEEEEEecc----chhhhHHHHHHHHHcC-CCCeeeeceEEEecCCCceeEEEE
Q 016184 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQ----DKRYKNRELQIMQMLD-HPNIVALKHCFFSTTDKEELYLNL 157 (394)
Q Consensus 83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~----~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~~l 157 (394)
.|++...++.|+.+.||++... ++.+++|+... ......+|+++++.+. +..+.++++++. .....++
T Consensus 15 ~~~~~~~~~g~s~~~v~~~~~~--~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~-----~~~~~~l 87 (263)
T 3tm0_A 15 KYRCVKDTEGMSPAKVYKLVGE--NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFER-----HDGWSNL 87 (263)
T ss_dssp TSEEEECCSCCSSSEEEEEECS--SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEE-----ETTEEEE
T ss_pred cceeEeeccCCCCCeEEEEECC--CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEe-----cCCceEE
Confidence 4888999999999999999753 67899998753 3345788999999985 556667777652 2234679
Q ss_pred EEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhC----------------------------------
Q 016184 158 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC---------------------------------- 202 (394)
Q Consensus 158 v~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---------------------------------- 202 (394)
|||+++| ++.... .+......++.+++.+|..||+.
T Consensus 88 v~e~i~G~~l~~~~---------~~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (263)
T 3tm0_A 88 LMSEADGVLCSEEY---------EDEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENW 158 (263)
T ss_dssp EEECCSSEEHHHHC---------CTTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGG
T ss_pred EEEecCCeehhhcc---------CCcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccc
Confidence 9999998 443220 01122335677899999999970
Q ss_pred ------------------------CCceeccCCCCceEEeCCCCcEEEEeecCcc
Q 016184 203 ------------------------IGICHRDIKPQNLLVNPHTHQLKLCDFGSAK 233 (394)
Q Consensus 203 ------------------------~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~ 233 (394)
..++|+|++|.|||++.+. .+.|+||+.+.
T Consensus 159 ~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~-~~~lIDwe~a~ 212 (263)
T 3tm0_A 159 EEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGK-VSGFIDLGRSG 212 (263)
T ss_dssp STTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTE-EEEECCCTTCE
T ss_pred cccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCc-EEEEEEchhcc
Confidence 2489999999999998543 56799999874
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.16 E-value=7e-11 Score=104.96 Aligned_cols=131 Identities=16% Similarity=0.097 Sum_probs=87.8
Q ss_pred EEEeeEEeecCceEEEEEEECCCCcEEEEEEeccc-hhhhHHHHHHHHHcCCCC--eeeeceEEEecCCCceeEEEEEEe
Q 016184 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-KRYKNRELQIMQMLDHPN--IVALKHCFFSTTDKEELYLNLVLE 160 (394)
Q Consensus 84 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~E~~~l~~l~h~~--iv~~~~~~~~~~~~~~~~~~lv~e 160 (394)
|.+..+.+.|..+.||++.. .+|..+++|+.... .....+|+++++.+.+.+ +.+++.+... ....++|||
T Consensus 22 ~~~~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~-----~~~~~~v~e 95 (264)
T 1nd4_A 22 YDWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSGALNELQDEAARLSWLATTGVPCAAVLDVVTE-----AGRDWLLLG 95 (264)
T ss_dssp CEEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSCTTSCHHHHHHHHHHHHTTTCCBCCEEEEEEC-----SSCEEEEEE
T ss_pred CceEecccCCCCceEEEEec-CCCCeEEEEeCCcccchhhhHHHHHHHHHHhCCCCCCeEEEeccC-----CCCCEEEEE
Confidence 55544445666799999965 56778999986543 244678999999986544 3456655421 122678999
Q ss_pred cccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCC------------------------------------
Q 016184 161 YVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG------------------------------------ 204 (394)
Q Consensus 161 ~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~g------------------------------------ 204 (394)
|++|.... . ..... ..++.+++.+|..||+ ..
T Consensus 96 ~i~G~~l~-~-------~~~~~---~~~~~~l~~~l~~lh~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (264)
T 1nd4_A 96 EVPGQDLL-S-------SHLAP---AEKVSIMADAMRRLHT-LDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQ 163 (264)
T ss_dssp CCSSEETT-T-------SCCCH---HHHHHHHHHHHHHHTT-SCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGT
T ss_pred ecCCcccC-c-------CcCCH---hHHHHHHHHHHHHHhC-CCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhcc
Confidence 99973211 0 11111 2345667777777775 33
Q ss_pred ----------------------ceeccCCCCceEEeCCCCcEEEEeecCcc
Q 016184 205 ----------------------ICHRDIKPQNLLVNPHTHQLKLCDFGSAK 233 (394)
Q Consensus 205 ----------------------ivH~Dlkp~Nil~~~~~~~vkl~Dfg~a~ 233 (394)
++|+|++|.|||++.++ .+.|+||+.+.
T Consensus 164 ~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~-~~~liD~~~a~ 213 (264)
T 1nd4_A 164 GLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGR-FSGFIDCGRLG 213 (264)
T ss_dssp TCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTE-EEEECCCTTCE
T ss_pred CccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCc-EEEEEcchhcc
Confidence 99999999999998654 56799999874
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.04 E-value=7.3e-10 Score=103.46 Aligned_cols=139 Identities=16% Similarity=0.180 Sum_probs=97.3
Q ss_pred eeEEeecCceEEEEEEECCCCcEEEEEEec--c-----chhhhHHHHHHHHHcCC--CCeeeeceEEEecCCCceeEEEE
Q 016184 87 EHVVGTGSFGVVFQAKCRETGEIVAIKKVL--Q-----DKRYKNRELQIMQMLDH--PNIVALKHCFFSTTDKEELYLNL 157 (394)
Q Consensus 87 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~--~-----~~~~~~~E~~~l~~l~h--~~iv~~~~~~~~~~~~~~~~~~l 157 (394)
.+.|+.|.++.||++... +..+++|+.. . ......+|+.+++.+.. ..+++++.++... ......++
T Consensus 43 ~~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~--~~~g~~~~ 118 (359)
T 3dxp_A 43 VEQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDE--SVIGRAFY 118 (359)
T ss_dssp EEECCC-CCSCEEEEECS--SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCT--TTTSSCEE
T ss_pred EEEcCCcccceEEEEEEC--CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCC--CccCCeEE
Confidence 566899999999998864 4678899765 2 23456789999999974 3456666654221 11123458
Q ss_pred EEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhC-----------------------------------
Q 016184 158 VLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC----------------------------------- 202 (394)
Q Consensus 158 v~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~----------------------------------- 202 (394)
||||++|... .. .....++......++.+++.+|..||+.
T Consensus 119 vme~v~G~~l---~~--~~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (359)
T 3dxp_A 119 IMEFVSGRVL---WD--QSLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETES 193 (359)
T ss_dssp EEECCCCBCC---CC--TTCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSC
T ss_pred EEEecCCeec---CC--CccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcC
Confidence 9999997321 00 1123467777888899999999999961
Q ss_pred ----------------------CCceeccCCCCceEEeCCCC-cEEEEeecCccc
Q 016184 203 ----------------------IGICHRDIKPQNLLVNPHTH-QLKLCDFGSAKV 234 (394)
Q Consensus 203 ----------------------~givH~Dlkp~Nil~~~~~~-~vkl~Dfg~a~~ 234 (394)
..++|+|+++.|||++.++. .+.|+||+.+..
T Consensus 194 ~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 194 IPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp CHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred ChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 36999999999999997652 368999999864
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.01 E-value=4.3e-10 Score=102.51 Aligned_cols=186 Identities=12% Similarity=0.158 Sum_probs=110.0
Q ss_pred eEEeecCceEEEEEEECCCCcEEEEEEeccc--hhhhHHHHHHHHHcC-CCCeeeeceEEEecCC-CceeEEEEEEeccc
Q 016184 88 HVVGTGSFGVVFQAKCRETGEIVAIKKVLQD--KRYKNRELQIMQMLD-HPNIVALKHCFFSTTD-KEELYLNLVLEYVP 163 (394)
Q Consensus 88 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~-~~~~~~~lv~e~~~ 163 (394)
+.++.|....||++. ..+++|+.... .....+|+++++.+. +..+. +-..+..... ......++||++++
T Consensus 26 ~~~~~G~~n~v~~v~-----~~~vlR~~~~~~~~~~~~~E~~~l~~l~~~~~v~-vP~~~~~~~~~~~~~~~~~vm~~i~ 99 (304)
T 3sg8_A 26 EISGEGNDCIAYEIN-----RDFIFKFPKHSRGSTNLFNEVNILKRIHNKLPLP-IPEVVFTGMPSETYQMSFAGFTKIK 99 (304)
T ss_dssp CEEEECSSEEEEEST-----TSEEEEEESSHHHHHHHHHHHHHHHHHTTSSSSC-CCCEEEECCCCSSCSCSCEEEECCC
T ss_pred EecCCCCcceEEEEC-----CEEEEEecCCcchHHHHHHHHHHHHHHHhcCCCC-CCceEeecCCCCCCCcceEEEcccC
Confidence 458999999999863 45889976543 345678999998884 33322 2222222111 11223467899999
Q ss_pred cc-HHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhC----------------------------------------
Q 016184 164 ET-VNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC---------------------------------------- 202 (394)
Q Consensus 164 ~~-l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---------------------------------------- 202 (394)
|. +..... ..++......++.+++..|..||+.
T Consensus 100 G~~l~~~~~------~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 173 (304)
T 3sg8_A 100 GVPLTPLLL------NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKV 173 (304)
T ss_dssp CEECCHHHH------HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHH
T ss_pred CeECCcccc------ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHH
Confidence 73 321111 3455666666677777777777740
Q ss_pred -----------------CCceeccCCCCceEEeCC-CCcEEEEeecCccccccCCCccccccccccccccccc------C
Q 016184 203 -----------------IGICHRDIKPQNLLVNPH-THQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIF------G 258 (394)
Q Consensus 203 -----------------~givH~Dlkp~Nil~~~~-~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~------~ 258 (394)
..++|+|++|.||+++.+ +..+.|+||+.+.................-..|+... +
T Consensus 174 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~ 253 (304)
T 3sg8_A 174 DDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYK 253 (304)
T ss_dssp HHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHT
T ss_pred HHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcC
Confidence 247999999999999974 4368899999986432111000000000001222110 0
Q ss_pred CC-------CCCChhhHHHHHHHHHHHHhCCCCC
Q 016184 259 AT-------EYTTAIDIWSTGCVMAELLLGQPLF 285 (394)
Q Consensus 259 ~~-------~~~~~~DiwslG~il~~lltg~~pf 285 (394)
.. ......+.|+++.++|.+.+|..+|
T Consensus 254 ~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 254 HKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp CSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred CCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 00 0122368999999999999998766
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.61 E-value=4.6e-07 Score=82.38 Aligned_cols=68 Identities=12% Similarity=-0.047 Sum_probs=44.7
Q ss_pred eEEeecCceEEEEEEECCCCcEEEEEEeccc--hhhhHHHHHHHHHcCCCC---eeeeceEEEecCCCceeEEEEEEecc
Q 016184 88 HVVGTGSFGVVFQAKCRETGEIVAIKKVLQD--KRYKNRELQIMQMLDHPN---IVALKHCFFSTTDKEELYLNLVLEYV 162 (394)
Q Consensus 88 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~E~~~l~~l~h~~---iv~~~~~~~~~~~~~~~~~~lv~e~~ 162 (394)
+.++.|....||+. |..+++|+.... .....+|.++|+.+.+.. +.+++.+.. . . ....+++|+++
T Consensus 25 ~~l~~G~~n~v~~v-----g~~~VlR~~~~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~--~-~-~g~~~~v~e~i 95 (306)
T 3tdw_A 25 ESLGEGFRNYAILV-----NGDWVFRFPKSQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGK--R-S-DGNPFVGYRKV 95 (306)
T ss_dssp EEEEECSSEEEEEE-----TTTEEEEEESSHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEE--C-T-TSCEEEEEECC
T ss_pred eecCCCcceeEEEE-----CCEEEEEecCCchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecc--c-C-CCceEEEEecc
Confidence 45788998999988 466889975432 245668999999997532 334333331 1 1 12245899999
Q ss_pred cc
Q 016184 163 PE 164 (394)
Q Consensus 163 ~~ 164 (394)
+|
T Consensus 96 ~G 97 (306)
T 3tdw_A 96 QG 97 (306)
T ss_dssp CS
T ss_pred CC
Confidence 97
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.43 E-value=3.3e-06 Score=75.05 Aligned_cols=130 Identities=15% Similarity=0.144 Sum_probs=81.0
Q ss_pred EeecCce-EEEEEEECCCCcEEEEEEeccc-hhhhHHHHHHHHHcCC-CCeeeeceEEEecCCCceeEEEEEEecccc-c
Q 016184 90 VGTGSFG-VVFQAKCRETGEIVAIKKVLQD-KRYKNRELQIMQMLDH-PNIVALKHCFFSTTDKEELYLNLVLEYVPE-T 165 (394)
Q Consensus 90 lg~G~~g-~V~~~~~~~~~~~vaiK~~~~~-~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~~~~~~~~lv~e~~~~-~ 165 (394)
+..|..+ .||+......+..+++|+-... .....+|...|+.+.. -.+.+++.++.. ....++|||+++| .
T Consensus 32 ~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~-----~~~~~lvme~l~G~~ 106 (272)
T 4gkh_A 32 DNVGQSGATIYRLYGKPNAPELFLKHGKGSVANDVTDEMVRLNWLTAFMPLPTIKHFIRT-----PDDAWLLTTAIPGKT 106 (272)
T ss_dssp EECSSSSCEEEEEECCTTCCCEEEEEEETHHHHHHHHHHHHHHHHTTTSCCCCEEEEEEE-----TTEEEEEEECCCSEE
T ss_pred ccCCCcCCeEEEEEecCCCeEEEEEECCCCCHhHHHHHHHHHHHhccCCCcCeEEEEEEE-----CCeEEEEEEeeCCcc
Confidence 3445444 7999888777788999976543 3445689999998843 224455554422 1235689999987 3
Q ss_pred HHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhC-------------------------------------------
Q 016184 166 VNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC------------------------------------------- 202 (394)
Q Consensus 166 l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~------------------------------------------- 202 (394)
+.+..... ......+..++...|..||..
T Consensus 107 ~~~~~~~~--------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 178 (272)
T 4gkh_A 107 AFQVLEEY--------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQ 178 (272)
T ss_dssp HHHHHHHC--------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHH
T ss_pred ccccccCC--------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHH
Confidence 33322110 111223344555555555530
Q ss_pred --------------CCceeccCCCCceEEeCCCCcEEEEeecCcc
Q 016184 203 --------------IGICHRDIKPQNLLVNPHTHQLKLCDFGSAK 233 (394)
Q Consensus 203 --------------~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~ 233 (394)
..++|+|+.+.|||++.++ .+-|+||+.+.
T Consensus 179 ~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~-~~~viDwe~a~ 222 (272)
T 4gkh_A 179 VWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGK-LIGCIDVGRVG 222 (272)
T ss_dssp HHHHHHTTCCCCCCEEEECSCCCTTSEEEETTE-EEEECCCTTCE
T ss_pred HHHHHHhcccccCCcEEEcCCCCCCeEEEECCe-EEEEEECcccc
Confidence 0179999999999999654 56799999875
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.21 E-value=6.8e-06 Score=75.60 Aligned_cols=30 Identities=23% Similarity=0.469 Sum_probs=26.6
Q ss_pred CCceeccCCCCceEEeCCCCcEEEEeecCcc
Q 016184 203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAK 233 (394)
Q Consensus 203 ~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~ 233 (394)
..++|+|+++.|||++.++ .+.|+||+.+.
T Consensus 222 ~~l~HgD~~~~Nil~~~~~-~~~lIDfe~a~ 251 (346)
T 2q83_A 222 PNLCHQDYGTGNTLLGENE-QIWVIDLDTVS 251 (346)
T ss_dssp CCEECSSCSTTSEEECGGG-CEEECCCTTCE
T ss_pred CceecCCCCcccEEEeCCC-cEEEEehhhcc
Confidence 6899999999999997665 69999999874
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.12 E-value=1.3e-05 Score=75.54 Aligned_cols=71 Identities=18% Similarity=0.195 Sum_probs=44.1
Q ss_pred eeEEeecCceEEEEEEECCCCcEEEEEEeccc-----------hhhhHHHHHHHHHcCC--CC-eeeeceEEEecCCCce
Q 016184 87 EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-----------KRYKNRELQIMQMLDH--PN-IVALKHCFFSTTDKEE 152 (394)
Q Consensus 87 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----------~~~~~~E~~~l~~l~h--~~-iv~~~~~~~~~~~~~~ 152 (394)
.+.||.|..+.||++....+++.++||..... ......|.++++.+.. +. +.+++.+ .. +.
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~---~~ 109 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DT---EM 109 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ET---TT
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cC---Cc
Confidence 45789999999999977656788999975321 1223578888888743 32 3344332 11 11
Q ss_pred eEEEEEEecccc
Q 016184 153 LYLNLVLEYVPE 164 (394)
Q Consensus 153 ~~~~lv~e~~~~ 164 (394)
.++|||++++
T Consensus 110 --~~lvmE~l~g 119 (397)
T 2olc_A 110 --AVTVMEDLSH 119 (397)
T ss_dssp --TEEEECCCTT
T ss_pred --cEEEEEeCCC
Confidence 3589999975
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.03 E-value=1.3e-05 Score=74.24 Aligned_cols=78 Identities=9% Similarity=0.101 Sum_probs=48.7
Q ss_pred EEeeEE-eecCceEEEEEEEC--C----CCcEEEEEEeccch-------hhhHHHHHHHHHcCC---CCeeeeceEEEec
Q 016184 85 IAEHVV-GTGSFGVVFQAKCR--E----TGEIVAIKKVLQDK-------RYKNRELQIMQMLDH---PNIVALKHCFFST 147 (394)
Q Consensus 85 ~~~~~l-g~G~~g~V~~~~~~--~----~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h---~~iv~~~~~~~~~ 147 (394)
...+.| +.|....+|+.... . ++..+++|+..... ....+|+.+++.+.. -.+.+++.+....
T Consensus 23 ~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~ 102 (357)
T 3ats_A 23 TVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTG 102 (357)
T ss_dssp EEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSS
T ss_pred EEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCC
Confidence 345677 88888999988753 0 15678899765432 356789999988843 2355555543111
Q ss_pred CCCceeEEEEEEecccc
Q 016184 148 TDKEELYLNLVLEYVPE 164 (394)
Q Consensus 148 ~~~~~~~~~lv~e~~~~ 164 (394)
......++|||+++|
T Consensus 103 --~~~g~~~~v~e~l~G 117 (357)
T 3ats_A 103 --DVLGTPFFLMDYVEG 117 (357)
T ss_dssp --TTTSSCEEEEECCCC
T ss_pred --CccCCceEEEEecCC
Confidence 101123579999986
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.78 E-value=0.00064 Score=57.28 Aligned_cols=98 Identities=18% Similarity=0.111 Sum_probs=63.9
Q ss_pred cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCccccccCCCcccc
Q 016184 165 TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY 244 (394)
Q Consensus 165 ~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~~~~~~~~ 244 (394)
+|.+++..+. .++++.++|.++.|.+.+|.-+-....-..+=+.|..|++..+| .|.+.+ ..+.
T Consensus 34 SL~eIL~~~~---~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG-~V~f~~-~~s~----------- 97 (229)
T 2yle_A 34 SLEEILRLYN---QPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDG-AVTLAP-AADD----------- 97 (229)
T ss_dssp EHHHHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTS-CEEECC-C--------------
T ss_pred cHHHHHHHcC---CCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCC-ceeccc-cccc-----------
Confidence 6778777654 89999999999999999988762211212333557889999998 466543 1110
Q ss_pred cccccccccccccCCCCCCChhhHHHHHHHHHHHHh
Q 016184 245 ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL 280 (394)
Q Consensus 245 ~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt 280 (394)
.....+.|||... ...+.+.-|||||+++|..+-
T Consensus 98 ~~~~~~~~pe~~~--~~~te~~~IysLG~tLY~ALD 131 (229)
T 2yle_A 98 AGEPPPVAGKLGY--SQCMETEVIESLGIIIYKALD 131 (229)
T ss_dssp ---------CCSS--SSSCHHHHHHHHHHHHHHHHT
T ss_pred ccccCCCChhhcc--ccchHHHHHHHHHHHHHHHhh
Confidence 1123467888762 336789999999999999984
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.77 E-value=0.00052 Score=61.38 Aligned_cols=70 Identities=14% Similarity=0.117 Sum_probs=48.6
Q ss_pred EEEeeEEeecCceEEEEEEECCCCcEEEEEEeccc----hhhhHHHHHHHHHcCCC---CeeeeceEEEecCCCceeEEE
Q 016184 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD----KRYKNRELQIMQMLDHP---NIVALKHCFFSTTDKEELYLN 156 (394)
Q Consensus 84 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~E~~~l~~l~h~---~iv~~~~~~~~~~~~~~~~~~ 156 (394)
..-...+|.|..+.||+.+. .+|+.|.+|+.... ...+..|++.|+.|... .+++++.+. . -+
T Consensus 17 v~~v~~~g~G~~~~vyrv~l-~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~---~------~~ 86 (288)
T 3f7w_A 17 VAAVAERGHSHRWHLYRVEL-ADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD---D------RT 86 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEE-TTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE---T------TE
T ss_pred eEEEEecCCCCCeEEEEEEE-CCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc---C------ce
Confidence 45567899999999999987 57899999975432 23467899999988532 223333221 1 24
Q ss_pred EEEeccc
Q 016184 157 LVLEYVP 163 (394)
Q Consensus 157 lv~e~~~ 163 (394)
+|||++.
T Consensus 87 lv~e~l~ 93 (288)
T 3f7w_A 87 LAMEWVD 93 (288)
T ss_dssp EEEECCC
T ss_pred EEEEeec
Confidence 7899886
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.68 E-value=0.0002 Score=64.62 Aligned_cols=65 Identities=12% Similarity=0.063 Sum_probs=40.2
Q ss_pred eeEEeecCceEEEEEEECCCCcEEEEEEeccch---hhhHHHHHHHHHcCCCCee-eeceEEEecCCCceeEEEEEEecc
Q 016184 87 EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---RYKNRELQIMQMLDHPNIV-ALKHCFFSTTDKEELYLNLVLEYV 162 (394)
Q Consensus 87 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~h~~iv-~~~~~~~~~~~~~~~~~~lv~e~~ 162 (394)
.+.|+.|....+|++ ..+++|+..... ....+|+.+++.+...++. +++... .+. -++++||+
T Consensus 23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~~~~~-----~~~--~~~v~e~i 89 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA------GDLCLRIPGKGTEEYINRANEAVAAREAAKAGVSPEVLHVD-----PAT--GVMVTRYI 89 (301)
T ss_dssp CEEEESCSSEEEEEE------TTEEEEEECC----CCCHHHHHHHHHHHHHTTSSCCEEEEC-----TTT--CCEEEECC
T ss_pred eeEcCCcccccccee------eeEEEECCCCCccceeCHHHHHHHHHHHHHcCCCCceEEEE-----CCC--CEEEEeec
Confidence 567889999999998 458889765432 2335788888877433333 333321 111 13689999
Q ss_pred -cc
Q 016184 163 -PE 164 (394)
Q Consensus 163 -~~ 164 (394)
++
T Consensus 90 ~~g 92 (301)
T 3dxq_A 90 AGA 92 (301)
T ss_dssp TTC
T ss_pred CCC
Confidence 64
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.53 E-value=0.00029 Score=66.81 Aligned_cols=77 Identities=13% Similarity=-0.037 Sum_probs=46.7
Q ss_pred CCceeccCCCCceEEeCCCCcEEEEeecCccccccCCCcccccc--cccccccccccCCC--CCCChhhHHHHHHHHHHH
Q 016184 203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYIC--SRYYRAPELIFGAT--EYTTAIDIWSTGCVMAEL 278 (394)
Q Consensus 203 ~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~--t~~y~aPE~~~~~~--~~~~~~DiwslG~il~~l 278 (394)
..++|+|++|.|||++.++ ++|+||+.+..-...-....... ...|++|+...... ......++..+...+|..
T Consensus 232 ~~liHGDl~~~Nil~~~~~--~~lID~e~a~~G~p~~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (420)
T 2pyw_A 232 QALIHGDLHTGSVMVTQDS--TQVIDPEFSFYGPMGFDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWNL 309 (420)
T ss_dssp CEEECSCCSGGGEEECSSC--EEECCCTTCEEECHHHHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHHH
T ss_pred CeEEecCCCCCcEEEeCCC--CEEEeCcccccCchHHHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHHH
Confidence 6899999999999998654 99999998864321111111111 23466666542111 012234555777777777
Q ss_pred HhC
Q 016184 279 LLG 281 (394)
Q Consensus 279 ltg 281 (394)
+++
T Consensus 310 y~~ 312 (420)
T 2pyw_A 310 FNK 312 (420)
T ss_dssp HHH
T ss_pred HHH
Confidence 754
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.51 E-value=0.00098 Score=60.29 Aligned_cols=71 Identities=14% Similarity=0.065 Sum_probs=49.6
Q ss_pred eeEEeecCceEEEEEEECCCCcEEEEEEeccc-hhhhHHHHHHHHHcCC---CCeeeeceEEEecCCCceeEEEEEEecc
Q 016184 87 EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-KRYKNRELQIMQMLDH---PNIVALKHCFFSTTDKEELYLNLVLEYV 162 (394)
Q Consensus 87 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~E~~~l~~l~h---~~iv~~~~~~~~~~~~~~~~~~lv~e~~ 162 (394)
.+.|+.|....+|+... ++..+++|+.... ...+..|++.|+.|.. ..+++++.+... ....++|||++
T Consensus 41 ~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~-----~g~~~lvme~l 113 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLIND--EVQTVFVKINERSYRSMFRAEADQLALLAKTNSINVPLVYGIGNS-----QGHSFLLLEAL 113 (312)
T ss_dssp EEEECCSSSSEEEEEES--SSCEEEEEEEEGGGHHHHHHHHHHHHHHHHTTSSBCCCEEEEEEC-----SSEEEEEEECC
T ss_pred eEEeCCccceeeeEEEE--CCCeEEEEeCCcccHHHHHHHHHHHHHHHhhCCCCcceEEEEeec-----CCceEEEEEec
Confidence 46689999999999875 4677889976543 3456789998888842 445566554421 12367899999
Q ss_pred cc
Q 016184 163 PE 164 (394)
Q Consensus 163 ~~ 164 (394)
++
T Consensus 114 ~G 115 (312)
T 3jr1_A 114 NK 115 (312)
T ss_dssp CC
T ss_pred cC
Confidence 85
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.47 E-value=0.00047 Score=65.46 Aligned_cols=69 Identities=17% Similarity=0.254 Sum_probs=46.0
Q ss_pred eeEEeecCceEEEEEEECC-------CCcEEEEEEecc-ch-hhhHHHHHHHHHcCCCCe-eeeceEEEecCCCceeEEE
Q 016184 87 EHVVGTGSFGVVFQAKCRE-------TGEIVAIKKVLQ-DK-RYKNRELQIMQMLDHPNI-VALKHCFFSTTDKEELYLN 156 (394)
Q Consensus 87 ~~~lg~G~~g~V~~~~~~~-------~~~~vaiK~~~~-~~-~~~~~E~~~l~~l~h~~i-v~~~~~~~~~~~~~~~~~~ 156 (394)
.+.|+.|....||++.... .+..+++|+... .. ....+|..+++.|...++ +++++.+ .+ .
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~~~~~li~E~~~l~~L~~~g~~P~l~~~~-----~~----g 148 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPETESHLVAESVIFTLLSERHLGPKLYGIF-----SG----G 148 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCCHHHHHHHHHHHHHHHHTTSSSCEEEEE-----TT----E
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCCcHHHHHHHHHHHHHHHhCCCCCcEEEEe-----CC----C
Confidence 4568888899999998743 257899998744 22 344579888888854444 4555443 22 1
Q ss_pred EEEecccc
Q 016184 157 LVLEYVPE 164 (394)
Q Consensus 157 lv~e~~~~ 164 (394)
+|+||++|
T Consensus 149 ~v~e~l~G 156 (429)
T 1nw1_A 149 RLEEYIPS 156 (429)
T ss_dssp EEECCCCE
T ss_pred EEEEEeCC
Confidence 68898875
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.35 E-value=0.0013 Score=59.68 Aligned_cols=142 Identities=13% Similarity=0.054 Sum_probs=74.8
Q ss_pred EeeEEeecCceEEEEEEECCCCcEEEEEEecc--chhhhHHHHHHHHHcCCCCe--eeeceEEEecCCC----ceeEEEE
Q 016184 86 AEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQ--DKRYKNRELQIMQMLDHPNI--VALKHCFFSTTDK----EELYLNL 157 (394)
Q Consensus 86 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~--~~~~~~~E~~~l~~l~h~~i--v~~~~~~~~~~~~----~~~~~~l 157 (394)
-.+.|+.|....+|++... +| .+++|+... .......|..+++.+...++ .+++.. ..+. .....++
T Consensus 26 ~~~~i~~G~~n~~~~v~~~-~g-~~vlk~~~~~~~~~~l~~e~~~l~~L~~~g~~vP~~~~~---~~g~~~~~~~g~~~~ 100 (322)
T 2ppq_A 26 SYKGIAEGVENSNFLLHTT-KD-PLILTLYEKRVEKNDLPFFLGLMQHLAAKGLSCPLPLPR---KDGELLGELSGRPAA 100 (322)
T ss_dssp EEEEECC---EEEEEEEES-SC-CEEEEEECC---CCHHHHHHHHHHHHHHTTCCCCCBCCB---TTCCSCEEETTEEEE
T ss_pred EeeccCCCcccceEEEEeC-Cc-cEEEEEeCCCCCHHHHHHHHHHHHHHHHCCCCCCcccCC---CCCCEEEEECCEEEE
Confidence 3456788888999999763 33 688998765 34456678888887743232 233211 0000 0123568
Q ss_pred EEecccccH---------HH---HHHHhhhhcCC--------CCHHHHHHH---------------HHHHHHHHHHHHh-
Q 016184 158 VLEYVPETV---------NR---IARNYSRIHQR--------MPLIYVKLY---------------TYQICRALAYIHN- 201 (394)
Q Consensus 158 v~e~~~~~l---------~~---~~~~~~~~~~~--------l~~~~~~~~---------------~~qi~~al~~LH~- 201 (394)
++++++|.. .. .+...-..... ......... ...+...++.+..
T Consensus 101 l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~ 180 (322)
T 2ppq_A 101 LISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAH 180 (322)
T ss_dssp EEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHH
T ss_pred EEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhh
Confidence 999988621 01 11110000000 011100000 0113344555542
Q ss_pred -----CCCceeccCCCCceEEeCCCCcEEEEeecCcc
Q 016184 202 -----CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK 233 (394)
Q Consensus 202 -----~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~ 233 (394)
..+++|+|+++.|||++.++ .+.|+||+.+.
T Consensus 181 ~~~~~~~~liHgDl~~~Nil~~~~~-~~~lIDf~~a~ 216 (322)
T 2ppq_A 181 WPKDLPAGVIHADLFQDNVFFLGDE-LSGLIDFYFAC 216 (322)
T ss_dssp CCCSSCEEEECSCCCGGGEEEETTE-EEEECCCTTCE
T ss_pred CcccCCcccCCCCCCccCEEEeCCc-eEEEecchhcc
Confidence 14799999999999999654 45799999875
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.34 E-value=0.00074 Score=62.84 Aligned_cols=138 Identities=20% Similarity=0.267 Sum_probs=75.9
Q ss_pred eEEeecCceEEEEEEECC-------CCcEEEEEEecc---chhhhHHHHHHHHHcCCCCe-eeeceEEEecCCCceeEEE
Q 016184 88 HVVGTGSFGVVFQAKCRE-------TGEIVAIKKVLQ---DKRYKNRELQIMQMLDHPNI-VALKHCFFSTTDKEELYLN 156 (394)
Q Consensus 88 ~~lg~G~~g~V~~~~~~~-------~~~~vaiK~~~~---~~~~~~~E~~~l~~l~h~~i-v~~~~~~~~~~~~~~~~~~ 156 (394)
+.|..|-...+|++.... +++.+++|+.-. ......+|.++++.|...++ .++++.+ .++
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~-----~~g---- 126 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAILQGVDSLVLESVMFAILAERSLGPQLYGVF-----PEG---- 126 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---CCHHHHHHHHHHHHHHHHTTSSCCEEEEE-----TTE----
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCccchHHHHHHHHHHHHHHHhcCCCCeEEEEc-----CCc----
Confidence 346667778888887642 356788997532 23344579999888843333 3454443 221
Q ss_pred EEEeccccc------------HHHHHHHhhhhcC-------CCC--HHHHHHHHHHHHH-------------------HH
Q 016184 157 LVLEYVPET------------VNRIARNYSRIHQ-------RMP--LIYVKLYTYQICR-------------------AL 196 (394)
Q Consensus 157 lv~e~~~~~------------l~~~~~~~~~~~~-------~l~--~~~~~~~~~qi~~-------------------al 196 (394)
+||||++|. ...+.....+.+. ... ...+..+..++.. .+
T Consensus 127 ~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~ 206 (379)
T 3feg_A 127 RLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEM 206 (379)
T ss_dssp EEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHH
T ss_pred cEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHH
Confidence 789998751 1122222222111 111 2344555444321 22
Q ss_pred HHHH----h---CCCceeccCCCCceEEeCC---CCcEEEEeecCccc
Q 016184 197 AYIH----N---CIGICHRDIKPQNLLVNPH---THQLKLCDFGSAKV 234 (394)
Q Consensus 197 ~~LH----~---~~givH~Dlkp~Nil~~~~---~~~vkl~Dfg~a~~ 234 (394)
..|. . ...++|+|+.+.|||++.+ ...+.|+||..+..
T Consensus 207 ~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 207 GNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 3332 1 1359999999999999876 23699999998853
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.26 E-value=0.0015 Score=59.55 Aligned_cols=32 Identities=38% Similarity=0.561 Sum_probs=26.8
Q ss_pred CCceeccCCCCceEEeCC---CCcEEEEeecCccc
Q 016184 203 IGICHRDIKPQNLLVNPH---THQLKLCDFGSAKV 234 (394)
Q Consensus 203 ~givH~Dlkp~Nil~~~~---~~~vkl~Dfg~a~~ 234 (394)
..++|+|+.+.|||++.+ ...+.|+||+.+..
T Consensus 183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 579999999999999864 13699999998864
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.23 E-value=0.0036 Score=59.76 Aligned_cols=69 Identities=16% Similarity=0.193 Sum_probs=45.2
Q ss_pred eeEEeecCceEEEEEEECCCCcEEEEEEeccchh---hhHHHHHHHHHcCCCCee-eeceEEEecCCCceeEEEEEEecc
Q 016184 87 EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR---YKNRELQIMQMLDHPNIV-ALKHCFFSTTDKEELYLNLVLEYV 162 (394)
Q Consensus 87 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~E~~~l~~l~h~~iv-~~~~~~~~~~~~~~~~~~lv~e~~ 162 (394)
.+.|+.|-...+|++.....+..+++|+...... ...+|..+++.|...++. ++++.+ .+. +||||+
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~idR~~E~~vl~~L~~~gl~P~ll~~~-----~~G----~v~e~I 183 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEIINREREKKISCILYNKNIAKKIYVFF-----TNG----RIEEFM 183 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCSCHHHHHHHHHHHTTSSSBCCEEEEE-----TTE----EEEECC
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhcCHHHHHHHHHHHHhcCCCCCEEEEe-----CCe----EEEEee
Confidence 4568889999999998754457888997643221 236899999999765553 555544 221 489998
Q ss_pred cc
Q 016184 163 PE 164 (394)
Q Consensus 163 ~~ 164 (394)
+|
T Consensus 184 ~G 185 (458)
T 2qg7_A 184 DG 185 (458)
T ss_dssp CS
T ss_pred CC
Confidence 75
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.15 E-value=0.0021 Score=58.47 Aligned_cols=72 Identities=14% Similarity=0.009 Sum_probs=42.8
Q ss_pred EEeecCceEEEEEEECCCCcEEEEEEecc---chhhhHHHHHHHHHcCCCC--eeeeceEEEecCC--CceeEEEEEEec
Q 016184 89 VVGTGSFGVVFQAKCRETGEIVAIKKVLQ---DKRYKNRELQIMQMLDHPN--IVALKHCFFSTTD--KEELYLNLVLEY 161 (394)
Q Consensus 89 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~---~~~~~~~E~~~l~~l~h~~--iv~~~~~~~~~~~--~~~~~~~lv~e~ 161 (394)
.|+ |....||++.. .+|+.+++|+... .......|..+++.+.... +++++.. .... ......+++|++
T Consensus 33 ~l~-g~~n~~y~v~~-~~g~~~vlK~~~~~~~~~~~~~~E~~~~~~L~~~g~~vp~~~~~--~g~~~~~~~g~~~~l~~~ 108 (328)
T 1zyl_A 33 PLN-SYENRVYQFQD-EDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAF--NGQTLLNHQGFYFAVFPS 108 (328)
T ss_dssp EEC-CSSSEEEEECC-TTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCB--TTBSCEEETTEEEEEEEC
T ss_pred eec-CcccceEEEEc-CCCCEEEEEEcCCCCCCHHHHHHHHHHHHHHHHcCCeecceeec--CCcEEEEECCEEEEEEEe
Confidence 355 77788998765 3466799998763 2345567888888874322 3333332 0000 011235679999
Q ss_pred ccc
Q 016184 162 VPE 164 (394)
Q Consensus 162 ~~~ 164 (394)
++|
T Consensus 109 i~G 111 (328)
T 1zyl_A 109 VGG 111 (328)
T ss_dssp CCC
T ss_pred cCC
Confidence 986
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.12 E-value=0.0014 Score=60.85 Aligned_cols=68 Identities=13% Similarity=0.164 Sum_probs=40.1
Q ss_pred eEEeecCceEEEEEEECC--------CCcEEEEEEeccchh---hhHHHHHHHHHcCCCCe-eeeceEEEecCCCceeEE
Q 016184 88 HVVGTGSFGVVFQAKCRE--------TGEIVAIKKVLQDKR---YKNRELQIMQMLDHPNI-VALKHCFFSTTDKEELYL 155 (394)
Q Consensus 88 ~~lg~G~~g~V~~~~~~~--------~~~~vaiK~~~~~~~---~~~~E~~~l~~l~h~~i-v~~~~~~~~~~~~~~~~~ 155 (394)
..|+.|....+|++.... .+..+++|+...... ....|.++++.+...++ .++++.. .+
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~~~~~~~E~~~l~~L~~~g~~P~~~~~~-----~~---- 109 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDELYNTISEFEVYKTMSKYKIAPQLLNTF-----NG---- 109 (369)
T ss_dssp EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGGTSCHHHHHHHHHHHHHTTSSCCEEEEE-----TT----
T ss_pred EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccceecHHHHHHHHHHHHhcCCCCceEEec-----CC----
Confidence 457788888999998643 126788998654322 23678888888854443 3444332 11
Q ss_pred EEEEecccc
Q 016184 156 NLVLEYVPE 164 (394)
Q Consensus 156 ~lv~e~~~~ 164 (394)
++||+|++|
T Consensus 110 ~~v~e~i~G 118 (369)
T 3c5i_A 110 GRIEEWLYG 118 (369)
T ss_dssp EEEEECCCS
T ss_pred cEEEEEecC
Confidence 368999875
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.79 E-value=0.0032 Score=57.69 Aligned_cols=31 Identities=26% Similarity=0.532 Sum_probs=26.7
Q ss_pred CCceeccCCCCceEEeCCCCcEEEEeecCccc
Q 016184 203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV 234 (394)
Q Consensus 203 ~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~ 234 (394)
..++|+|+.+.||+++.++ .+.|+||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~~~~~-~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEE-SIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEECGGG-CEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEeCCC-eEEEEECCCCee
Confidence 4699999999999998765 699999988754
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=95.28 E-value=0.14 Score=48.22 Aligned_cols=69 Identities=14% Similarity=0.147 Sum_probs=44.0
Q ss_pred eeEEeecCceEEEEEEECCC-------CcEEEEEEeccch---hhhHHHHHHHHHcCCCCe-eeeceEEEecCCCceeEE
Q 016184 87 EHVVGTGSFGVVFQAKCRET-------GEIVAIKKVLQDK---RYKNRELQIMQMLDHPNI-VALKHCFFSTTDKEELYL 155 (394)
Q Consensus 87 ~~~lg~G~~g~V~~~~~~~~-------~~~vaiK~~~~~~---~~~~~E~~~l~~l~h~~i-v~~~~~~~~~~~~~~~~~ 155 (394)
++.|..|-...+|++..... ++.+++|+..... ....+|..+++.+...++ .++++.+ .+
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~idR~~E~~~l~~L~~~gi~P~l~~~~-----~~---- 145 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKFYDSKVELDVFRYLSNINIAPNIIADF-----PE---- 145 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CCCCHHHHHHHHHHHHHTTSSCCEEEEE-----TT----
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchhcCHHHHHHHHHHHHhcCCCCCEEEEc-----CC----
Confidence 34567788889999987521 5778999764322 223579999888853333 3444322 11
Q ss_pred EEEEecccc
Q 016184 156 NLVLEYVPE 164 (394)
Q Consensus 156 ~lv~e~~~~ 164 (394)
++||+|++|
T Consensus 146 ~~I~efI~G 154 (424)
T 3mes_A 146 GRIEEFIDG 154 (424)
T ss_dssp EEEEECCCS
T ss_pred CEEEEEeCC
Confidence 368999886
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=94.22 E-value=0.22 Score=46.44 Aligned_cols=30 Identities=30% Similarity=0.546 Sum_probs=24.4
Q ss_pred ceeccCCCCceEEeC-----CCCcEEEEeecCccc
Q 016184 205 ICHRDIKPQNLLVNP-----HTHQLKLCDFGSAKV 234 (394)
Q Consensus 205 ivH~Dlkp~Nil~~~-----~~~~vkl~Dfg~a~~ 234 (394)
++|+|+.+.|||+.. +...+.++||..|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 689999999999942 233699999999864
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 394 | ||||
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 1e-120 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 2e-71 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 2e-71 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 8e-71 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 7e-68 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 4e-67 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 9e-67 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 1e-66 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 2e-66 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 2e-66 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 5e-65 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 1e-64 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 2e-63 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 4e-63 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 4e-62 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 5e-62 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 1e-60 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 1e-60 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 2e-60 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 7e-60 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 7e-60 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 9e-60 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 1e-59 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 1e-59 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 7e-58 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 1e-57 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 2e-57 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 6e-57 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 9e-53 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 2e-52 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 2e-52 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 1e-51 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 2e-51 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 3e-49 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 7e-49 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 3e-47 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 2e-46 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 6e-45 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 1e-44 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 5e-44 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 1e-42 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 7e-42 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 7e-41 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 1e-40 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 1e-39 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 1e-39 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 3e-39 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 7e-39 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 1e-38 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 1e-38 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 2e-38 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 4e-38 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 1e-37 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 5e-36 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 5e-35 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 6e-35 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 7e-35 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 2e-34 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 3e-34 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 2e-33 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 4e-33 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 3e-31 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 2e-20 |
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 350 bits (899), Expect = e-120
Identities = 227/321 (70%), Positives = 268/321 (83%), Gaps = 2/321 (0%)
Query: 73 GRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQML 132
G+ + Q+VSY V+G GSFGVV+QAK ++GE+VAIKKVLQDKR+KNRELQIM+ L
Sbjct: 11 GQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKL 70
Query: 133 DHPNIVALKHCFFST-TDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQ 191
DH NIV L++ F+S+ K+E+YLNLVL+YVPETV R+AR+YSR Q +P+IYVKLY YQ
Sbjct: 71 DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ 130
Query: 192 ICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR 251
+ R+LAYIH+ GICHRDIKPQNLL++P T LKLCDFGSAK LV+GEPNVSYICSRYYR
Sbjct: 131 LFRSLAYIHSF-GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYR 189
Query: 252 APELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 311
APELIFGAT+YT++ID+WS GCV+AELLLGQP+FPG+SGVDQLVEIIKVLGTPTRE+I+
Sbjct: 190 APELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE 249
Query: 312 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL 371
MNPNYTEFKFPQIK HPW KVF+ R PPEA+ L R +Y+P R T LEAC H FFDEL
Sbjct: 250 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 309
Query: 372 RDPNTRLPNGRPLPPLFNFKP 392
RDPN +LPNGR P LFNF
Sbjct: 310 RDPNVKLPNGRDTPALFNFTT 330
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 225 bits (574), Expect = 2e-71
Identities = 95/320 (29%), Positives = 164/320 (51%), Gaps = 20/320 (6%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV--LQDKRYKN---RELQIMQMLDHPNIV 138
Y +G G++G+V A VAIKK+ + + Y RE++I+ H NI+
Sbjct: 10 YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 69
Query: 139 ALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
+ + T ++ + LV + + ++ + Q + ++ + YQI R L Y
Sbjct: 70 GINDIIRAPTIEQMKDVYLVTHLMGADLYKLLK-----TQHLSNDHICYFLYQILRGLKY 124
Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNV----SYICSRYYRAPE 254
IH+ + HRD+KP NLL+N T LK+CDFG A+V + Y+ +R+YRAPE
Sbjct: 125 IHSA-NVLHRDLKPSNLLLN-TTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 182
Query: 255 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM-- 312
++ + YT +IDIWS GC++AE+L +P+FPG+ +DQL I+ +LG+P++E++ C+
Sbjct: 183 IMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN 242
Query: 313 -NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL 371
P PW+++F +A+DL+ + ++P+ R +A HP+ ++
Sbjct: 243 LKARNYLLSLPHKNKVPWNRLF-PNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY 301
Query: 372 RDPNTRLPNGRPLPPLFNFK 391
DP+ P
Sbjct: 302 YDPSDEPIAEAPFKFDMELD 321
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 223 bits (570), Expect = 2e-71
Identities = 99/303 (32%), Positives = 149/303 (49%), Gaps = 23/303 (7%)
Query: 89 VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---------RELQIMQMLDHPNIVA 139
+G G F V++A+ + T +IVAIKK+ R + RE++++Q L HPNI+
Sbjct: 5 FLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIG 64
Query: 140 LKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 199
L F K + L V +++ + + ++K Y + L Y+
Sbjct: 65 LLDAF---GHKSNISL--VFDFME---TDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYL 116
Query: 200 HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYIC-SRYYRAPELIFG 258
H I HRD+KP NLL++ + LKL DFG AK ++ +R+YRAPEL+FG
Sbjct: 117 HQHW-ILHRDLKPNNLLLDEN-GVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFG 174
Query: 259 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 318
A Y +D+W+ GC++AELLL P PG+S +DQL I + LGTPT E+ M
Sbjct: 175 ARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDY 234
Query: 319 FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP--NT 376
F P H +F + +DL+ F ++P R TA +A +F P
Sbjct: 235 VTFKSFPGIPLHHIF-SAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPTPGC 293
Query: 377 RLP 379
+LP
Sbjct: 294 QLP 296
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 223 bits (568), Expect = 8e-71
Identities = 72/305 (23%), Positives = 122/305 (40%), Gaps = 31/305 (10%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-----RELQIMQMLDHPNIV 138
+ +G G+ GVVF+ + +G ++A K + + + RELQ++ + P IV
Sbjct: 8 FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 67
Query: 139 ALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
F E+ + +E++ + R+P + + + + L Y
Sbjct: 68 GFYGAF---YSDGEISI--CMEHMD---GGSLDQVLKKAGRIPEQILGKVSIAVIKGLTY 119
Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFG 258
+ I HRD+KP N+LVN +KLCDFG + L+ N S++ +R Y +PE + G
Sbjct: 120 LREKHKIMHRDVKPSNILVNSRGE-IKLCDFGVSGQLIDSMAN-SFVGTRSYMSPERLQG 177
Query: 259 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESG-VDQLVEIIKVLGTPTREEIKCMNPNYT 317
T Y+ DIWS G + E+ +G+ P +L+ +V G + P
Sbjct: 178 -THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRP 236
Query: 318 EFKF--------------PQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEAC 363
+ I P K+ E D V + +P R +
Sbjct: 237 LSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLM 296
Query: 364 VHPFF 368
VH F
Sbjct: 297 VHAFI 301
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 214 bits (546), Expect = 7e-68
Identities = 102/307 (33%), Positives = 165/307 (53%), Gaps = 21/307 (6%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNI 137
+ +G G++GVV++A+ + TGE+VA+KK+ D + RE+ +++ L+HPNI
Sbjct: 4 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 138 VALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALA 197
V L + +LYL V E++ + + + + +PL +K Y +Q+ + LA
Sbjct: 64 VKLLDVI---HTENKLYL--VFEFLHQDLKKFMD--ASALTGIPLPLIKSYLFQLLQGLA 116
Query: 198 YIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL-VKGEPNVSYICSRYYRAPELI 256
+ H+ + HRD+KPQNLL+N +KL DFG A+ V + + +YRAPE++
Sbjct: 117 FCHSHR-VLHRDLKPQNLLINTE-GAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEIL 174
Query: 257 FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK-CMNPN 315
G Y+TA+DIWS GC+ AE++ + LFPG+S +DQL I + LGTP +
Sbjct: 175 LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMP 234
Query: 316 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 375
+ FP+ + KV L + L+ + Y PN R +A A HPFF ++ P
Sbjct: 235 DYKPSFPKWARQDFSKVV-PPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP- 292
Query: 376 TRLPNGR 382
+P+ R
Sbjct: 293 --VPHLR 297
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 213 bits (544), Expect = 4e-67
Identities = 89/300 (29%), Positives = 147/300 (49%), Gaps = 21/300 (7%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-NRELQIMQML-DHPNIVALK 141
Y +G G + VF+A E V +K + K+ K RE++I++ L PNI+ L
Sbjct: 37 YQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLA 96
Query: 142 HCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
D LV E+V T ++ +++Q + ++ Y Y+I +AL Y H+
Sbjct: 97 DIV---KDPVSRTPALVFEHVNNT------DFKQLYQTLTDYDIRFYMYEILKALDYCHS 147
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 261
GI HRD+KP N++++ +L+L D+G A+ G+ + SRY++ PEL+
Sbjct: 148 M-GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQM 206
Query: 262 YTTAIDIWSTGCVMAELLLGQ-PLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 320
Y ++D+WS GC++A ++ + P F G DQLV I KVLGT + + +
Sbjct: 207 YDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPR 266
Query: 321 FPQIKPHPWHKVFQKRLP--------PEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR 372
F I K +++ + PEA+D + + +Y R TA EA HP+F +
Sbjct: 267 FNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVV 326
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 212 bits (541), Expect = 9e-67
Identities = 86/309 (27%), Positives = 144/309 (46%), Gaps = 22/309 (7%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNI 137
Y +G G+FG VF+A+ R+TG+ VA+KKVL + + RE++I+Q+L H N+
Sbjct: 12 YEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENV 71
Query: 138 VALKHCFFSTT---DKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICR 194
V L + ++ + + LV ++ + +A S + + L +K +
Sbjct: 72 VNLIEICRTKASPYNRCKGSIYLVFDFCE---HDLAGLLSNVLVKFTLSEIKRVMQMLLN 128
Query: 195 ALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNV-----SYICSRY 249
L YIH I HRD+K N+L+ LKL DFG A+ + + + + + +
Sbjct: 129 GLYYIHRN-KILHRDMKAANVLITRDGV-LKLADFGLARAFSLAKNSQPNRYTNRVVTLW 186
Query: 250 YRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI 309
YR PEL+ G +Y ID+W GC+MAE+ P+ G + QL I ++ G+ T E
Sbjct: 187 YRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVW 246
Query: 310 KCMNPNYTEFKFPQIKPHP---WHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHP 366
++ K +K ++ P A+DL+ + P R + +A H
Sbjct: 247 PNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHD 306
Query: 367 FFDELRDPN 375
FF P+
Sbjct: 307 FFWSDPMPS 315
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 213 bits (542), Expect = 1e-66
Identities = 97/316 (30%), Positives = 158/316 (50%), Gaps = 21/316 (6%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNI 137
Y VG+G++G V A TG VAIKK+ + + + REL++++ + H N+
Sbjct: 20 YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENV 79
Query: 138 VALKHCFFSTTDKEELY-LNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
+ L F ++ LV+ ++ + ++ + H+++ ++ YQ+ + L
Sbjct: 80 IGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMK-----HEKLGEDRIQFLVYQMLKGL 134
Query: 197 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELI 256
YIH GI HRD+KP NL VN K+ DFG A+ Y+ +R+YRAPE+I
Sbjct: 135 RYIHAA-GIIHRDLKPGNLAVNEDCEL-KILDFGLARQA--DSEMTGYVVTRWYRAPEVI 190
Query: 257 FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 316
YT +DIWS GC+MAE++ G+ LF G +DQL EI+KV GTP E ++ + +
Sbjct: 191 LNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDE 250
Query: 317 TEF---KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD 373
+ P+++ + + P AV+L+ + R TA EA HP+F+ L D
Sbjct: 251 AKNYMKGLPELEKKDFASIL-TNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHD 309
Query: 374 PNTRLPNGRPLPPLFN 389
P + F+
Sbjct: 310 TE-DEPQVQKYDDSFD 324
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 213 bits (542), Expect = 2e-66
Identities = 73/309 (23%), Positives = 120/309 (38%), Gaps = 41/309 (13%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVL----QDKRYKNRELQIMQMLDHPNIVA 139
Y +GTG+FGVV + R TG A K V+ DK +E+Q M +L HP +V
Sbjct: 28 YDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVN 87
Query: 140 LKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 199
L F D E+ + + E++ + + H +M Y Q+C+ L ++
Sbjct: 88 LHDAF---EDDNEMVM--IYEFMSG--GELFEKVADEHNKMSEDEAVEYMRQVCKGLCHM 140
Query: 200 HNCIGICHRDIKPQNLLVNPH-THQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFG 258
H H D+KP+N++ +++LKL DFG L + + + APE+ G
Sbjct: 141 HEN-NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEG 199
Query: 259 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 318
D+WS G + LL G F GE+ + L +
Sbjct: 200 -KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAF--------- 249
Query: 319 FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP--NT 376
+ + D + + PN R T +A HP+ P ++
Sbjct: 250 ----------------SGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDS 293
Query: 377 RLPNGRPLP 385
++P+ R
Sbjct: 294 QIPSSRYTK 302
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 212 bits (541), Expect = 2e-66
Identities = 98/316 (31%), Positives = 154/316 (48%), Gaps = 23/316 (7%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV------LQDKRYKNRELQIMQMLDHPNI 137
Y VG+G++G V A +TG VA+KK+ + + REL++++ + H N+
Sbjct: 20 YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 79
Query: 138 VALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALA 197
+ L F EE ++ ++ N Q++ +V+ YQI R L
Sbjct: 80 IGLLDVFTPARSLEEFNDVYLVTHLMGADL----NNIVKCQKLTDDHVQFLIYQILRGLK 135
Query: 198 YIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIF 257
YIH+ I HRD+KP NL VN K+ DFG A+ + Y+ +R+YRAPE++
Sbjct: 136 YIHSA-DIIHRDLKPSNLAVNEDCEL-KILDFGLARHT--DDEMTGYVATRWYRAPEIML 191
Query: 258 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 317
Y +DIWS GC+MAELL G+ LFPG +DQL I++++GTP E +K ++
Sbjct: 192 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESA 251
Query: 318 EF---KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP 374
Q+ + VF P AVDL+ + + R TA +A H +F + DP
Sbjct: 252 RNYIQSLTQMPKMNFANVF-IGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDP 310
Query: 375 NTRLPNGRPLPPLFNF 390
+ P+ ++
Sbjct: 311 DD-----EPVADPYDQ 321
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 207 bits (526), Expect = 5e-65
Identities = 96/299 (32%), Positives = 150/299 (50%), Gaps = 18/299 (6%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNI 137
Y +G G++G VF+AK RET EIVA+K+V D + RE+ +++ L H NI
Sbjct: 4 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNI 63
Query: 138 VALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALA 197
V L + L LV E+ + + + + + VK + +Q+ + L
Sbjct: 64 VRLHDVL-----HSDKKLTLVFEFCD---QDLKKYFDSCNGDLDPEIVKSFLFQLLKGLG 115
Query: 198 YIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL-VKGEPNVSYICSRYYRAPELI 256
+ H+ + HRD+KPQNLL+N + KL +FG A+ + + + + +YR P+++
Sbjct: 116 FCHSR-NVLHRDLKPQNLLINRNGEL-KLANFGLARAFGIPVRCYSAEVVTLWYRPPDVL 173
Query: 257 FGATEYTTAIDIWSTGCVMAELLLG-QPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 315
FGA Y+T+ID+WS GC+ AEL +PLFPG DQL I ++LGTPT E+ M
Sbjct: 174 FGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKL 233
Query: 316 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP 374
+P +L DL+ + +P R +A EA HP+F + P
Sbjct: 234 PDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCPP 292
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 206 bits (525), Expect = 1e-64
Identities = 90/299 (30%), Positives = 147/299 (49%), Gaps = 17/299 (5%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRET-GEIVAIKKVLQDKRYKN------RELQIMQML---D 133
Y +G G++G VF+A+ + G VA+K+V + RE+ +++ L +
Sbjct: 9 YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFE 68
Query: 134 HPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQIC 193
HPN+V L + E L LV E+V + + +P +K +Q+
Sbjct: 69 HPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ--DLTTYLDKVPEPGVPTETIKDMMFQLL 126
Query: 194 RALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAP 253
R L ++H+ + HRD+KPQN+LV + Q+KL DFG A++ S + + +YRAP
Sbjct: 127 RGLDFLHSH-RVVHRDLKPQNILVT-SSGQIKLADFGLARIYSFQMALTSVVVTLWYRAP 184
Query: 254 ELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 313
E++ + Y T +D+WS GC+ AE+ +PLF G S VDQL +I+ V+G P E+ +
Sbjct: 185 EVLLQ-SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP-RD 242
Query: 314 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR 372
F P K + DL+ + ++P R +A A HP+F +L
Sbjct: 243 VALPRQAFHSKSAQPIEKFV-TDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLE 300
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 203 bits (516), Expect = 2e-63
Identities = 96/295 (32%), Positives = 151/295 (51%), Gaps = 20/295 (6%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNI 137
Y +G G++GVV++A+ GE A+KK+ +K + RE+ I++ L H NI
Sbjct: 4 YHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNI 62
Query: 138 VALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALA 197
V L + L LV E++ + + + + K + Q+ +A
Sbjct: 63 VKLYDVIH-----TKKRLVLVFEHLD---QDLKKLLDVCEGGLESVTAKSFLLQLLNGIA 114
Query: 198 YIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL-VKGEPNVSYICSRYYRAPELI 256
Y H+ + HRD+KPQNLL+N +LK+ DFG A+ + I + +YRAP+++
Sbjct: 115 YCHDR-RVLHRDLKPQNLLIN-REGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVL 172
Query: 257 FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN- 315
G+ +Y+T IDIWS GC+ AE++ G PLFPG S DQL+ I ++LGTP + +
Sbjct: 173 MGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELP 232
Query: 316 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE 370
+ F +P PW K L +DL+ + + PN R TA +A H +F E
Sbjct: 233 KYDPNFTVYEPLPWESFL-KGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 203 bits (518), Expect = 4e-63
Identities = 79/309 (25%), Positives = 122/309 (39%), Gaps = 34/309 (11%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIM-QMLDHPNIVALKH 142
+ V+G G G V Q + T E A+ K+LQD RE+++ + P+IV +
Sbjct: 14 KVTSQVLGLGINGKVLQIFNKRTQEKFAL-KMLQDCPKARREVELHWRASQCPHIVRIVD 72
Query: 143 CFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 200
+ + + L +V+E + E +RI R Q I A+ Y+H
Sbjct: 73 VYENLYAGRK-CLLIVMECLDGGELFSRIQD---RGDQAFTEREASEIMKSIGEAIQYLH 128
Query: 201 NCIGICHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFG 258
+ I HRD+KP+NLL LKL DFG AK + + YY APE++
Sbjct: 129 SI-NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGP 187
Query: 259 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 318
+Y + D+WS G +M LL G P F G+ + + +
Sbjct: 188 -EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMG-------------Q 233
Query: 319 FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF-DELRDPNTR 377
++FP + + E L+ + P R T E HP+ + P T
Sbjct: 234 YEFPNPEW--------SEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTP 285
Query: 378 LPNGRPLPP 386
L R L
Sbjct: 286 LHTSRVLKE 294
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 201 bits (513), Expect = 4e-62
Identities = 77/302 (25%), Positives = 121/302 (40%), Gaps = 44/302 (14%)
Query: 89 VVGTGSFGVVFQAKCRETGEIVAIKKV----LQDKRYKNRELQIMQMLDHPNIVALKHCF 144
+G+G+FGVV + + TG + K + DK E+ IM L HP ++ L F
Sbjct: 36 ELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF 95
Query: 145 FSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
DK E+ L +LE++ E +RIA +M V Y Q C L ++H
Sbjct: 96 ---EDKYEMVL--ILEFLSGGELFDRIAAE----DYKMSEAEVINYMRQACEGLKHMHEH 146
Query: 203 IGICHRDIKPQNLLV-NPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 261
I H DIKP+N++ +K+ DFG A L E + + APE++
Sbjct: 147 -SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDR-EP 204
Query: 262 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF 321
D+W+ G + LL G F GE ++ L + + +
Sbjct: 205 VGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAF------------ 252
Query: 322 PQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF-DELRDPNTRLPN 380
+ PEA D + Q P R T +A HP+ + + +R+P+
Sbjct: 253 -------------SSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNLTSRIPS 299
Query: 381 GR 382
R
Sbjct: 300 SR 301
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (505), Expect = 5e-62
Identities = 68/295 (23%), Positives = 113/295 (38%), Gaps = 44/295 (14%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-----RELQIMQMLDHPNIV 138
+ +G G++G V A R T E VA+K V + +E+ I +ML+H N+V
Sbjct: 7 WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 66
Query: 139 ALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
L LEY + MP + + +Q+ + Y
Sbjct: 67 KFYGHRREGN-----IQYLFLEYCS---GGELFDRIEPDIGMPEPDAQRFFHQLMAGVVY 118
Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNV---SYICSRYYRAPEL 255
+H GI HRDIKP+NLL++ + LK+ DFG A V + Y APEL
Sbjct: 119 LHGI-GITHRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 176
Query: 256 IFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 315
+ + +D+WS G V+ +L G+ + S Q
Sbjct: 177 LKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDW----------------- 219
Query: 316 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE 370
K + +PW K+ + L+ + +P+ R T + ++++
Sbjct: 220 ----KEKKTYLNPWKKI-----DSAPLALLHKILVENPSARITIPDIKKDRWYNK 265
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 196 bits (500), Expect = 1e-60
Identities = 72/305 (23%), Positives = 123/305 (40%), Gaps = 49/305 (16%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-------RELQIMQMLDHPN 136
+ +G GSFG V+ A+ E+VAIKK+ + N +E++ +Q L HPN
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 137 IVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
+ + C+ + + LV+EY + + + + + T+ + L
Sbjct: 77 TIQYRGCY---LREHTAW--LVMEYCL---GSASDLLEVHKKPLQEVEIAAVTHGALQGL 128
Query: 197 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELI 256
AY+H+ + HRD+K N+L++ +KL DFGSA ++ P S++ + Y+ APE+I
Sbjct: 129 AYLHSH-NMIHRDVKAGNILLS-EPGLVKLGDFGSASIM---APANSFVGTPYWMAPEVI 183
Query: 257 FGATE--YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 314
E Y +D+WS G EL +P + + L I +
Sbjct: 184 LAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ--------------- 228
Query: 315 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP 374
+ P ++ W + V Q P R T+ H F R P
Sbjct: 229 ----NESPALQSGHW--------SEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPP 276
Query: 375 NTRLP 379
+
Sbjct: 277 TVIMD 281
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (502), Expect = 1e-60
Identities = 95/328 (28%), Positives = 152/328 (46%), Gaps = 32/328 (9%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNI 137
Y +G+G+ G+V A VAIKK+ + + + REL +M+ ++H NI
Sbjct: 19 YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 78
Query: 138 VALKHCFFSTTDKEEL-YLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
++L + F EE + LV+E + A I + + YQ+ +
Sbjct: 79 ISLLNVFTPQKTLEEFQDVYLVMELMD------ANLCQVIQMELDHERMSYLLYQMLCGI 132
Query: 197 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELI 256
++H+ GI HRD+KP N++V K+ DFG A+ Y+ +RYYRAPE+I
Sbjct: 133 KHLHSA-GIIHRDLKPSNIVVKSDCTL-KILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 190
Query: 257 FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM---- 312
G Y +DIWS GC+M E++ + LFPG +DQ ++I+ LGTP E +K +
Sbjct: 191 LG-MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 249
Query: 313 ------NPNYTEFKFPQIKP---HPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEAC 363
P Y FP++ P P K +A DL+ + P R + +A
Sbjct: 250 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDAL 309
Query: 364 VHPFFDELRDPNTRLPNGRPLPPLFNFK 391
HP+ + DP P P +++ +
Sbjct: 310 QHPYINVWYDPAEVEA---PPPQIYDKQ 334
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (495), Expect = 2e-60
Identities = 60/289 (20%), Positives = 117/289 (40%), Gaps = 40/289 (13%)
Query: 87 EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVAL 140
+ +G GSF V++ ET VA ++ K K+ E ++++ L HPNIV
Sbjct: 14 DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 73
Query: 141 KHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 200
+ + +T K + + LV E + + + Y + + M + ++ + QI + L ++H
Sbjct: 74 -YDSWESTVKGKKCIVLVTELMT---SGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLH 129
Query: 201 -NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGA 259
I HRD+K N+ + T +K+ D G A L + + I + + APE+
Sbjct: 130 TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT-LKRASFAKAVIGTPEFMAPEMYEE- 187
Query: 260 TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 319
+Y ++D+++ G M E+ + + Q+ + P
Sbjct: 188 -KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPAS------------- 233
Query: 320 KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368
F K PE +++ + + + R + + H FF
Sbjct: 234 -------------FDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFF 269
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (492), Expect = 7e-60
Identities = 64/294 (21%), Positives = 117/294 (39%), Gaps = 44/294 (14%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV----LQDKRYKNRELQIMQMLDHPNIVA 139
+ +G G+FG V++A+ +ET + A K + ++ E+ I+ DHPNIV
Sbjct: 14 WEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVK 73
Query: 140 LKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 199
L F + L++ ++E+ + + + + +++ Q AL Y+
Sbjct: 74 LLDAF---YYENNLWI--LIEFCAG--GAVDAVMLELERPLTESQIQVVCKQTLDALNYL 126
Query: 200 HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-EPNVSYICSRYYRAPELIFG 258
H+ I HRD+K N+L +KL DFG + + + S+I + Y+ APE++
Sbjct: 127 HDN-KIIHRDLKAGNILFTLDGD-IKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMC 184
Query: 259 AT----EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 314
T Y D+WS G + E+ +P + + L++I K
Sbjct: 185 ETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKS-------------- 230
Query: 315 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368
P R D + + + + + R T + HPF
Sbjct: 231 EPPTLAQP------------SRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFV 272
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 196 bits (497), Expect = 7e-60
Identities = 95/349 (27%), Positives = 150/349 (42%), Gaps = 49/349 (14%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPNIVAL 140
YI +G G F V+ AK VA+K V DK Y E++++Q ++ +
Sbjct: 15 YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKE 74
Query: 141 KH----------CFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTY 190
F+ +++ +V E + E + + + Y H+ +PLIYVK +
Sbjct: 75 DSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYE--HRGIPLIYVKQISK 132
Query: 191 QICRALAYIHNCIGICHRDIKPQNLLVNPHTH-----QLKLCDFGSAKVLVKGEPNVSYI 245
Q+ L Y+H GI H DIKP+N+L+ Q+K+ D G+A E + I
Sbjct: 133 QLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYD--EHYTNSI 190
Query: 246 CSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESG------VDQLVEIIK 299
+R YR+PE++ GA + DIWST C++ EL+ G LF + G D + +II+
Sbjct: 191 QTREYRSPEVLLGA-PWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIE 249
Query: 300 VLGTPTREEIKCMNPNYTEF-------KFPQIKPHPWHKV------FQKRLPPEAVDLVC 346
+LG ++ T F ++K P V F K E D +
Sbjct: 250 LLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLS 309
Query: 347 RFFQYSPNLRCTALEACVHPFF------DELRDPNTRL-PNGRPLPPLF 388
Q P R A HP+ +E+R P+ L +G +P F
Sbjct: 310 PMLQLDPRKRADAGGLVNHPWLKDTLGMEEIRVPDRELYGSGSDIPGWF 358
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (490), Expect = 9e-60
Identities = 67/296 (22%), Positives = 118/296 (39%), Gaps = 45/296 (15%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVL------QDKRYKNRELQIMQMLDHPNI 137
Y + +GTGS+G + + + G+I+ K++ +K+ E+ +++ L HPNI
Sbjct: 6 YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNI 65
Query: 138 VALKHCFFSTTDKEELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
V T+ L +V+EY + + ++ Q + +V Q+ AL
Sbjct: 66 VRYYDRIIDRTNT---TLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 122
Query: 197 AYIH----NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNV-SYICSRYYR 251
H + HRD+KP N+ ++ + +KL DFG A++L +++ + YY
Sbjct: 123 KECHRRSDGGHTVLHRDLKPANVFLDGKQN-VKLGDFGLARILNHDTSFAKAFVGTPYYM 181
Query: 252 APELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 311
+PE + Y DIWS GC++ EL P F S + +I
Sbjct: 182 SPEQMNR-MSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIR------------- 227
Query: 312 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 367
E KF +I E +++ R R + E +P
Sbjct: 228 ------EGKFRRIPYR---------YSDELNEIITRMLNLKDYHRPSVEEILENPL 268
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (489), Expect = 1e-59
Identities = 75/292 (25%), Positives = 122/292 (41%), Gaps = 48/292 (16%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-------RELQIMQMLDHPN 136
+ +G G FG V+ A+ +++ I+A+K + + + K RE++I L HPN
Sbjct: 8 FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 67
Query: 137 IVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
I+ L F D +YL +LEY P + + Y ++ AL
Sbjct: 68 ILRLYGYF---HDATRVYL--ILEYAP---LGTVYRELQKLSKFDEQRTATYITELANAL 119
Query: 197 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELI 256
+Y H+ + HRDIKP+NLL+ LK+ DFG + + + Y PE+I
Sbjct: 120 SYCHSK-RVIHRDIKPENLLLGSAGE-LKIADFGWSV-HAPSSRRTTLCGTLDYLPPEMI 176
Query: 257 FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 316
G + +D+WS G + E L+G+P F + + I +V
Sbjct: 177 EG-RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV---------------- 219
Query: 317 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368
EF FP + A DL+ R +++P+ R E HP+
Sbjct: 220 -EFTFP------------DFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 258
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (493), Expect = 1e-59
Identities = 72/293 (24%), Positives = 122/293 (41%), Gaps = 42/293 (14%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKNRELQIMQMLDHPNIVAL 140
Y+ +G G FG+V + + + K V D+ +E+ I+ + H NI+ L
Sbjct: 7 YMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHL 66
Query: 141 KHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
F EEL + + E++ + RI + +++R + Y +Q+C AL +
Sbjct: 67 HESF---ESMEELVM--IFEFISGLDIFERINTSAFELNERE----IVSYVHQVCEALQF 117
Query: 199 IHNCIGICHRDIKPQNLLV-NPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIF 257
+H+ I H DI+P+N++ + +K+ +FG A+ L G+ + Y APE+
Sbjct: 118 LHSH-NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQ 176
Query: 258 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 317
+TA D+WS G ++ LL G F E+ + I+ T E
Sbjct: 177 H-DVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAF-------- 227
Query: 318 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE 370
K + EA+D V R R TA EA HP+ +
Sbjct: 228 -----------------KEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQ 263
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (479), Expect = 7e-58
Identities = 73/309 (23%), Positives = 125/309 (40%), Gaps = 45/309 (14%)
Query: 76 GNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV----LQDKRYKNRELQIMQM 131
G+ K+K Y +G G+ G V+ A TG+ VAI+++ K E+ +M+
Sbjct: 16 GDPKKK--YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRE 73
Query: 132 LDHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQ 191
+PNIV + +EL++ V+EY+ M + +
Sbjct: 74 NKNPNIVNYLDSY---LVGDELWV--VMEYLAGGSLT----DVVTETCMDEGQIAAVCRE 124
Query: 192 ICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYIC-SRYY 250
+AL ++H+ + HRDIK N+L+ +KL DFG + + S + + Y+
Sbjct: 125 CLQALEFLHSN-QVIHRDIKSDNILLGMDGS-VKLTDFGFCAQITPEQSKRSTMVGTPYW 182
Query: 251 RAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 310
APE++ Y +DIWS G + E++ G+P + E+ + L I GTP
Sbjct: 183 MAPEVVTR-KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIAT-NGTP------ 234
Query: 311 CMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE 370
E + P ++L D + R R +A E H F
Sbjct: 235 -------ELQNP------------EKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKI 275
Query: 371 LRDPNTRLP 379
+ ++ P
Sbjct: 276 AKPLSSLTP 284
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 188 bits (479), Expect = 1e-57
Identities = 69/303 (22%), Positives = 116/303 (38%), Gaps = 42/303 (13%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-----RELQIMQMLDHPNIV 138
Y V+GTG+F V A+ + T ++VAIK + + E+ ++ + HPNIV
Sbjct: 11 YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIV 70
Query: 139 ALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
AL + LYL +++ V + +Q+ A+ Y
Sbjct: 71 ALDDIY---ESGGHLYL--IMQLVS---GGELFDRIVEKGFYTERDASRLIFQVLDAVKY 122
Query: 199 IHNCIGICHRDIKPQNLLVNPHTH--QLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELI 256
+H+ I HRD+KP+NLL ++ + DFG +K+ G + + Y APE++
Sbjct: 123 LHDLG-IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVL 181
Query: 257 FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 316
Y+ A+D WS G + LL G P F E+ +I+K
Sbjct: 182 AQ-KPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSP--------- 231
Query: 317 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNT 376
+ + A D + + P R T +A HP+ +
Sbjct: 232 ----------------YWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGDTALDK 275
Query: 377 RLP 379
+
Sbjct: 276 NIH 278
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 186 bits (474), Expect = 2e-57
Identities = 75/306 (24%), Positives = 121/306 (39%), Gaps = 54/306 (17%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV-------------LQDKRYKNRELQIMQ 130
Y + ++G G VV + + T + A+K + + + +E+ I++
Sbjct: 5 YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILR 64
Query: 131 ML-DHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYT 189
+ HPNI+ LK + + + LV + + +Y + +
Sbjct: 65 KVSGHPNIIQLKDTY-----ETNTFFFLVFDLMK---KGELFDYLTEKVTLSEKETRKIM 116
Query: 190 YQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY 249
+ + +H I HRD+KP+N+L++ + +KL DFG + L GE +
Sbjct: 117 RALLEVICALHKL-NIVHRDLKPENILLDDDMN-IKLTDFGFSCQLDPGEKLREVCGTPS 174
Query: 250 YRAPELIFGATE-----YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTP 304
Y APE+I + Y +D+WSTG +M LL G P F + L I
Sbjct: 175 YLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMI------- 227
Query: 305 TREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV 364
M+ NY +F P+ DLV RF P R TA EA
Sbjct: 228 -------MSGNY-QFGSPEW----------DDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269
Query: 365 HPFFDE 370
HPFF +
Sbjct: 270 HPFFQQ 275
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (473), Expect = 6e-57
Identities = 84/304 (27%), Positives = 125/304 (41%), Gaps = 56/304 (18%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------NRELQIMQMLDHPN 136
+ ++G GSF V A+ T AIK + + K RE +M LDHP
Sbjct: 10 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 69
Query: 137 IVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
V L F D E+LY L Y N Y R + YT +I AL
Sbjct: 70 FVKLYFTF---QDDEKLYF--GLSYAK---NGELLKYIRKIGSFDETCTRFYTAEIVSAL 121
Query: 197 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNV---SYICSRYYRAP 253
Y+H I HRD+KP+N+L+N H +++ DFG+AKVL S++ + Y +P
Sbjct: 122 EYLHGKG-IIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANSFVGTAQYVSP 179
Query: 254 ELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 313
EL+ + D+W+ GC++ +L+ G P F + +IIK+
Sbjct: 180 ELLTE-KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKL------------- 225
Query: 314 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV------HPF 367
E+ FP+ + P+A DLV + R E HPF
Sbjct: 226 ----EYDFPE------------KFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPF 269
Query: 368 FDEL 371
F+ +
Sbjct: 270 FESV 273
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (444), Expect = 9e-53
Identities = 65/317 (20%), Positives = 120/317 (37%), Gaps = 49/317 (15%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN----------RELQIMQMLD 133
Y +G+G F VV + + + TG A K + + + + RE+ I++ +
Sbjct: 12 YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 71
Query: 134 HPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQIC 193
HPN++ L + +K ++ L +LE V ++ + + + QI
Sbjct: 72 HPNVITLHEVY---ENKTDVIL--ILELVA---GGELFDFLAEKESLTEEEATEFLKQIL 123
Query: 194 RALAYIHNCIGICHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYY 250
+ Y+H+ I H D+KP+N+++ N ++K+ DFG A + G + + +
Sbjct: 124 NGVYYLHSLQ-IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEF 182
Query: 251 RAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 310
APE++ D+WS G + LL G F G++ + L + V E
Sbjct: 183 VAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDE--- 238
Query: 311 CMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE 370
+ A D + R P R T ++ HP+
Sbjct: 239 ----------------------YFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKP 276
Query: 371 LRDPNTRLPNGRPLPPL 387
+D L + P
Sbjct: 277 -KDTQQALSSAWSHPQF 292
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (445), Expect = 2e-52
Identities = 79/319 (24%), Positives = 133/319 (41%), Gaps = 55/319 (17%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ--------IMQMLDHP 135
+I ++G GSFG VF A+ ++T + AIK + +D + +++ + +HP
Sbjct: 4 FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHP 63
Query: 136 NIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRA 195
+ + F KE L+ + EY+ + + + L Y +I
Sbjct: 64 FLTHMFCTF---QTKENLFFVM--EYLN---GGDLMYHIQSCHKFDLSRATFYAAEIILG 115
Query: 196 LAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYIC-SRYYRAPE 254
L ++H+ GI +RD+K N+L++ H K+ DFG K + G+ + C + Y APE
Sbjct: 116 LQFLHSK-GIVYRDLKLDNILLDKDGHI-KIADFGMCKENMLGDAKTNTFCGTPDYIAPE 173
Query: 255 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 314
++ G +Y ++D WS G ++ E+L+GQ F G+ + I+ NP
Sbjct: 174 ILLGQ-KYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELF------------HSIRMDNP 220
Query: 315 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV-HPFFDELRD 373
Y + L EA DL+ + F P R HP F E+
Sbjct: 221 FYPRW-----------------LEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREIN- 262
Query: 374 PNTRLPNGRPLPPLFNFKP 392
L PP F+P
Sbjct: 263 -WEELERKEIDPP---FRP 277
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (441), Expect = 2e-52
Identities = 64/303 (21%), Positives = 116/303 (38%), Gaps = 56/303 (18%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN----------RELQIMQMLD 133
Y ++G+G FG V+ VAIK V +D+ E+ +++ +
Sbjct: 6 YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 65
Query: 134 --HPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQ 191
++ L F L+LE + ++ + + + +Q
Sbjct: 66 SGFSGVIRLLDWFE-----RPDSFVLILERPEP--VQDLFDFITERGALQEELARSFFWQ 118
Query: 192 ICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR 251
+ A+ + HNC G+ HRDIK +N+L++ + +LKL DFGS L+K + +R Y
Sbjct: 119 VLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSGA-LLKDTVYTDFDGTRVYS 176
Query: 252 APELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 311
PE I + + +WS G ++ +++ G F + EII+
Sbjct: 177 PPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIR------------ 218
Query: 312 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL 371
F++R+ E L+ P+ R T E HP+ ++
Sbjct: 219 -----------------GQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 261
Query: 372 RDP 374
P
Sbjct: 262 LLP 264
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 174 bits (442), Expect = 1e-51
Identities = 69/325 (21%), Positives = 122/325 (37%), Gaps = 57/325 (17%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK----------RYKNRELQIMQMLD 133
+ ++G G FG V+ + +TG++ A+K + + + + L ++ D
Sbjct: 6 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 65
Query: 134 HPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQIC 193
P IV + + F ++L +L+ + + H ++ Y +I
Sbjct: 66 CPFIVCMSYAF---HTPDKLSF--ILDLMN---GGDLHYHLSQHGVFSEADMRFYAAEII 117
Query: 194 RALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAP 253
L ++HN + +RD+KP N+L++ H H +++ D G A K +P+ S + Y AP
Sbjct: 118 LGLEHMHNR-FVVYRDLKPANILLDEHGH-VRISDLGLACDFSKKKPHASV-GTHGYMAP 174
Query: 254 ELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 313
E++ Y ++ D +S GC++ +LL G F D+ EI +
Sbjct: 175 EVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH-EIDR-------------- 219
Query: 314 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCT-----ALEACVHPFF 368
PE L+ Q N R A E PFF
Sbjct: 220 -----------MTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFF 268
Query: 369 DELRDPNTRLPNGRPLPPLFNFKPP 393
L + + PP PP
Sbjct: 269 RSL--DWQMVFLQKYPPP---LIPP 288
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 172 bits (437), Expect = 2e-51
Identities = 74/322 (22%), Positives = 134/322 (41%), Gaps = 59/322 (18%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV-------LQDKRYKNRELQIMQMLDHPN 136
+ +GTGSFG V + R G A+K + L+ + N E ++ ++ HP
Sbjct: 6 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPF 65
Query: 137 IVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
I+ + F ++ + ++++Y+ + R QR P K Y ++C AL
Sbjct: 66 IIRMWGTF-----QDAQQIFMIMDYIE---GGELFSLLRKSQRFPNPVAKFYAAEVCLAL 117
Query: 197 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELI 256
Y+H+ I +RD+KP+N+L++ + H +K+ DFG AK + + + + Y APE++
Sbjct: 118 EYLHSK-DIIYRDLKPENILLDKNGH-IKITDFGFAKYV--PDVTYTLCGTPDYIAPEVV 173
Query: 257 FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 316
Y +ID WS G ++ E+L G F + + +I+
Sbjct: 174 ST-KPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILN----------------- 215
Query: 317 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-----TALEACVHPFFDEL 371
E +FP + DL+ R + R + HP+F E+
Sbjct: 216 AELRFP------------PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEV 263
Query: 372 RDPNTRLPNGRPLPPLFNFKPP 393
+L + P ++PP
Sbjct: 264 -VWE-KLLSRNIETP---YEPP 280
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 165 bits (419), Expect = 3e-49
Identities = 65/295 (22%), Positives = 106/295 (35%), Gaps = 43/295 (14%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-------RELQIMQMLDHPN 136
Y ++G G V A+ VA+K + D RE Q L+HP
Sbjct: 9 YELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPA 68
Query: 137 IVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
IVA+ + +V+EYV R+ M C+AL
Sbjct: 69 IVAV-YDTGEAETPAGPLPYIVMEYVD---GVTLRDIVHTEGPMTPKRAIEVIADACQAL 124
Query: 197 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNV----SYICSRYYRA 252
+ H GI HRD+KP N++++ + +K+ DFG A+ + +V + I + Y +
Sbjct: 125 NFSHQN-GIIHRDVKPANIMISAT-NAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLS 182
Query: 253 PELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 312
PE G D++S GCV+ E+L G+P F G+S V + ++ P
Sbjct: 183 PEQARGD-SVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSA----- 236
Query: 313 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 367
+ L + +V + +P R
Sbjct: 237 --------------------RHEGLSADLDAVVLKALAKNPENRYQTAAEMRADL 271
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (421), Expect = 7e-49
Identities = 71/328 (21%), Positives = 120/328 (36%), Gaps = 59/328 (17%)
Query: 81 KVS---YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-------RELQIMQ 130
KV+ + ++G G+FG V + + TG A+K + ++ E +++Q
Sbjct: 1 KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 60
Query: 131 MLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTY 190
HP + ALK+ F + L + + + + Y
Sbjct: 61 NTRHPFLTALKYAF---QTHDRLCF-----VMEYANGGELFFHLSRERVFTEERARFYGA 112
Query: 191 QICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYY 250
+I AL Y+H+ + +RDIK +NL+++ H +K+ DFG K + + C
Sbjct: 113 EIVSALEYLHSR-DVVYRDIKLENLMLDKDGH-IKITDFGLCKEGISDGATMKTFCGTPE 170
Query: 251 RAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 310
+ +Y A+D W G VM E++ G+ F + I+
Sbjct: 171 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILM----------- 219
Query: 311 CMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLR-----CTALEACVH 365
E +FP + L PEA L+ + P R A E H
Sbjct: 220 ------EEIRFP------------RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261
Query: 366 PFFDELRDPNTRLPNGRPLPPLFNFKPP 393
FF + + + LPP FKP
Sbjct: 262 RFFLSIN--WQDVVQKKLLPP---FKPQ 284
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (406), Expect = 3e-47
Identities = 52/294 (17%), Positives = 106/294 (36%), Gaps = 47/294 (15%)
Query: 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPN 136
+G+GSFG V++ K VA+K + E+ +++ H N
Sbjct: 9 QITVGQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 65
Query: 137 IVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
I+ L +V ++ + + + I + +I + Q + +
Sbjct: 66 ILLFMGYS------TAPQLAIVTQWCEGS--SLYHHLHIIETKFEMIKLIDIARQTAQGM 117
Query: 197 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSRYYRAP 253
Y+H I HRD+K N+ ++ +K+ DFG A V + + + S + AP
Sbjct: 118 DYLH-AKSIIHRDLKSNNIFLHEDLT-VKIGDFGLATVKSRWSGSHQFEQLSGSILWMAP 175
Query: 254 ELIFG--ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 311
E+I Y+ D+++ G V+ EL+ GQ + + DQ++ ++
Sbjct: 176 EVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGR----------- 224
Query: 312 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH 365
Y +++ + P L+ + + R +
Sbjct: 225 ---GYLSPDLSKVRSN---------CPKAMKRLMAECLKKKRDERPLFPQILAS 266
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 158 bits (401), Expect = 2e-46
Identities = 56/315 (17%), Positives = 103/315 (32%), Gaps = 54/315 (17%)
Query: 71 IGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN--RELQI 128
+G R Y +G+GSFG ++ GE VAIK ++ E +I
Sbjct: 5 VGNR---------YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKI 55
Query: 129 MQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLY 188
+M+ + + D Y +V+E + ++ + ++ ++ L V L
Sbjct: 56 YKMMQGGVGIPTIRWCGAEGD----YNVMVMELLGPSLEDL---FNFCSRKFSLKTVLLL 108
Query: 189 TYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLC--DFGSAKVLVKGEPNV---- 242
Q+ + YIH+ HRD+KP N L+ + DFG AK +
Sbjct: 109 ADQMISRIEYIHSK-NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPY 167
Query: 243 ----SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEII 298
+ + Y + G E + D+ S G V+ LG + G + +
Sbjct: 168 RENKNLTGTARYASINTHLG-IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKY- 225
Query: 299 KVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCT 358
+ + K +V K P E + + +
Sbjct: 226 --------------------ERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPD 265
Query: 359 A---LEACVHPFFDE 370
+ + F +
Sbjct: 266 YSYLRQLFRNLFHRQ 280
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 154 bits (391), Expect = 6e-45
Identities = 48/280 (17%), Positives = 96/280 (34%), Gaps = 33/280 (11%)
Query: 71 IGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN--RELQI 128
+G Y +G GSFGV+F+ + VAIK + E +
Sbjct: 3 VGVH---------YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRT 53
Query: 129 MQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLY 188
++L + + F E L+ LV++ + ++ + R + + V +
Sbjct: 54 YKLLAGCTGIPNVYYFGQ----EGLHNVLVIDLLGPSLEDLLDLCGR---KFSVKTVAMA 106
Query: 189 TYQICRALAYIHNCIGICHRDIKPQNLLVN----PHTHQLKLCDFGSAKVLVKGEPNV-- 242
Q+ + IH + +RDIKP N L+ + + + + DFG K
Sbjct: 107 AKQMLARVQSIHEK-SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHI 165
Query: 243 ------SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVE 296
+ + Y + G E + D+ + G V L G + G +
Sbjct: 166 PYREKKNLSGTARYMSINTHLG-REQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQK 224
Query: 297 IIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKR 336
++ ++ + + E +F + + + F
Sbjct: 225 YERIGEKKQSTPLRELCAGFPE-EFYKYMHYARNLAFDAT 263
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (387), Expect = 1e-44
Identities = 54/281 (19%), Positives = 99/281 (35%), Gaps = 43/281 (15%)
Query: 88 HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN--RELQIMQMLDHPNIVALKHCFF 145
+G G FG V G VA+K + D + E +M L H N+V L
Sbjct: 13 QTIGKGEFGDVM--LGDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIV 70
Query: 146 STTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGI 205
L +V EY+ + + + SR + + ++ +C A+ Y+
Sbjct: 71 EEKG----GLYIVTEYMAKG-SLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN-NF 124
Query: 206 CHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTA 265
HRD+ +N+LV+ K+ DFG K + + APE + +++T
Sbjct: 125 VHRDLAARNVLVSEDNV-AKVSDFGLTKEA--SSTQDTGKLPVKWTAPEALRE-KKFSTK 180
Query: 266 IDIWSTGCVMAELL-LGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQI 324
D+WS G ++ E+ G+ +P D + + K
Sbjct: 181 SDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK------------------------- 215
Query: 325 KPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH 365
+ PP +++ + +R + L+
Sbjct: 216 ---GYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQ 253
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 154 bits (389), Expect = 5e-44
Identities = 64/312 (20%), Positives = 114/312 (36%), Gaps = 57/312 (18%)
Query: 89 VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-------RELQIMQMLDHPNIVALK 141
+GTGSFG V K +E+G A+K + + K K E +I+Q ++ P +V L+
Sbjct: 48 TLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 142 HCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
F ++ + + + + R R + + Y QI Y+H+
Sbjct: 108 FSFKDNSNLYMVMEYVAGGEMFSHLRR--------IGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 261
+ +RD+KP+NLL++ + +++ DFG AK + + APE+I
Sbjct: 160 L-DLIYRDLKPENLLIDQQGY-IQVTDFGFAK--RVKGRTWTLCGTPEALAPEIILS-KG 214
Query: 262 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF 321
Y A+D W+ G ++ E+ G P F + + +I
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI------------------------ 250
Query: 322 PQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSP-----NLRCTALEACVHPFFDELRDPNT 376
F + DL+ Q NL+ + H +F +
Sbjct: 251 -----VSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWF---ATTDW 302
Query: 377 RLPNGRPLPPLF 388
R + F
Sbjct: 303 IAIYQRKVEAPF 314
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (377), Expect = 1e-42
Identities = 76/337 (22%), Positives = 132/337 (39%), Gaps = 61/337 (18%)
Query: 79 KQKVS---YIAEHVVGTGSFGVVFQAKC---RETGEIVAIKKV--------LQDKRYKNR 124
+KV + V+GTG++G VF + +TG++ A+K + + +
Sbjct: 18 AEKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRT 77
Query: 125 ELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIY 184
E Q+++ + + H F + +L+L L E +++ +R
Sbjct: 78 ERQVLEHIRQSPFLVTLHYAF--QTETKLHLILDYINGGELFTHLSQ-----RERFTEHE 130
Query: 185 VKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY 244
V++Y +I AL ++H GI +RDIK +N+L++ + H + L DFG +K V E +Y
Sbjct: 131 VQIYVGEIVLALEHLHKL-GIIYRDIKLENILLDSNGH-VVLTDFGLSKEFVADETERAY 188
Query: 245 IC---SRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVL 301
Y + G + + A+D WS G +M ELL G F + + EI +
Sbjct: 189 DFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISR-- 246
Query: 302 GTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLR----- 356
+ + + + A DL+ R P R
Sbjct: 247 -----------------------RILKSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGP 283
Query: 357 CTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKPP 393
A E H FF ++ + L + P FKP
Sbjct: 284 RDADEIKEHLFFQKINWDD--LAAKKVPAP---FKPV 315
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (371), Expect = 7e-42
Identities = 58/299 (19%), Positives = 110/299 (36%), Gaps = 35/299 (11%)
Query: 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR---YKNRELQIMQMLDHPNIVA 139
+ + + +G G FG V+ + + GE VA+K + ++ E+ ML H NI+
Sbjct: 4 TIVLQESIGKGRFGEVW--RGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILG 61
Query: 140 LKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 199
+ + L LV +Y + +Y + + + LA++
Sbjct: 62 F-IAADNKDNGTWTQLWLVSDYHE---HGSLFDYLN-RYTVTVEGMIKLALSTASGLAHL 116
Query: 200 HNCI-------GICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVS-----YICS 247
H I I HRD+K +N+LV + D G A + + +
Sbjct: 117 HMEIVGTQGKPAIAHRDLKSKNILVK-KNGTCCIADLGLAVRHDSATDTIDIAPNHRVGT 175
Query: 248 RYYRAPELIFGA-----TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLG 302
+ Y APE++ + E DI++ G V E+ + G QL V
Sbjct: 176 KRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIG-GIHEDYQLPYYDLVPS 234
Query: 303 TPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALE 361
P+ EE++ + +++P+ ++ ++ + + R TAL
Sbjct: 235 DPSVEEMRKV------VCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALR 287
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (363), Expect = 7e-41
Identities = 67/300 (22%), Positives = 110/300 (36%), Gaps = 47/300 (15%)
Query: 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPNIVA 139
S E +G G FG V+ T VAIK + +E Q+M+ L H +V
Sbjct: 18 SLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQ 76
Query: 140 LKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 199
L +E +Y+ V EY+ + + + L + QI +AY+
Sbjct: 77 LYAVV----SEEPIYI--VTEYMSKGSLLD-FLKGETGKYLRLPQLVDMAAQIASGMAYV 129
Query: 200 HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE--PNVSYICSRYYRAPELIF 257
HRD++ N+LV + K+ DFG A+++ E + APE
Sbjct: 130 ERM-NYVHRDLRAANILVGENLV-CKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAAL 187
Query: 258 GATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 316
+T D+WS G ++ EL G+ +PG + L ++ + P E
Sbjct: 188 Y-GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPEC------- 239
Query: 317 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTA--LEACVHPFFDELRDP 374
P DL+C+ ++ P R T L+A + +F
Sbjct: 240 ---------------------PESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQ 278
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (360), Expect = 1e-40
Identities = 57/293 (19%), Positives = 107/293 (36%), Gaps = 47/293 (16%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPNIVAL 140
+G G FG V+ VA+K + Q + E +M+ L H +V L
Sbjct: 15 LKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRL 73
Query: 141 KHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 200
+E +Y+ + EY+ + + + ++ + + QI +A+I
Sbjct: 74 YAVV----TQEPIYI--ITEYMENG-SLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE 126
Query: 201 NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYIC--SRYYRAPELIFG 258
HRD++ N+LV+ K+ DFG A+++ E + APE I
Sbjct: 127 ER-NYIHRDLRAANILVSDTLSC-KIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINY 184
Query: 259 ATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 317
+T D+WS G ++ E++ G+ +PG + + + + +
Sbjct: 185 G-TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER------------------ 225
Query: 318 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALE--ACVHPFF 368
+ V P E L+ ++ P R T + + FF
Sbjct: 226 ----------GYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 141 bits (356), Expect = 1e-39
Identities = 65/309 (21%), Positives = 117/309 (37%), Gaps = 54/309 (17%)
Query: 83 SYIAEHVVGTGSFGVVFQAKCRETGE---IVAIKKVL-----QDKRYKNRELQIMQMLDH 134
E V+G G FG V + G+ VAIK + + +R E IM DH
Sbjct: 27 CVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDH 86
Query: 135 PNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICR 194
PN++ L+ T + ++ E++ + + + +I + I
Sbjct: 87 PNVIHLEGVV---TKSTPVM--IITEFMEN--GSLDSFLRQNDGQFTVIQLVGMLRGIAA 139
Query: 195 ALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR------ 248
+ Y+ + HRD+ +N+LVN + K+ DFG ++ L + +Y +
Sbjct: 140 GMKYLA-DMNYVHRDLAARNILVNSNLV-CKVSDFGLSRFLEDDTSDPTYTSALGGKIPI 197
Query: 249 YYRAPELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQLVEIIKVLGTPTRE 307
+ APE I ++T+A D+WS G VM E++ G+ + + D + I + P
Sbjct: 198 RWTAPEAIQY-RKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPPM 256
Query: 308 EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 367
+ P L+ +Q N R + V+
Sbjct: 257 DC----------------------------PSALHQLMLDCWQKDRNHRPKFGQ-IVNTL 287
Query: 368 FDELRDPNT 376
+R+PN+
Sbjct: 288 DKMIRNPNS 296
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 140 bits (354), Expect = 1e-39
Identities = 53/293 (18%), Positives = 114/293 (38%), Gaps = 43/293 (14%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPNIVAL 140
+H +G G +G V++ ++ VA+K + +D +E +M+ + HPN+V L
Sbjct: 19 ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQL 78
Query: 141 KHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 200
T + Y+ E++ Q + + + QI A+ Y+
Sbjct: 79 LGVC---TREPPFYIIT--EFMTYGNLLDYLRECN-RQEVSAVVLLYMATQISSAMEYLE 132
Query: 201 NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR--YYRAPELIFG 258
HRD+ +N LV + H +K+ DFG ++++ + APE +
Sbjct: 133 KK-NFIHRDLAARNCLVGEN-HLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY 190
Query: 259 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 318
+++ D+W+ G ++ E+ + Q+ E+++
Sbjct: 191 -NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE---------------KDYR 234
Query: 319 FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL 371
+ P + P + +L+ +Q++P+ R + E +H F+ +
Sbjct: 235 MERP------------EGCPEKVYELMRACWQWNPSDRPSFAE--IHQAFETM 273
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (351), Expect = 3e-39
Identities = 57/298 (19%), Positives = 103/298 (34%), Gaps = 53/298 (17%)
Query: 89 VVGTGSFGVVFQAKCRET---GEIVAIKKVLQDKRYKN-------RELQIMQMLDHPNIV 138
+G GSFGVV + + VA+K + D + RE+ M LDH N++
Sbjct: 15 KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 74
Query: 139 ALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
L + +V E P + + L + Y Q+ + Y
Sbjct: 75 RLYGVV------LTPPMKMVTELAPL--GSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGY 126
Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNV---SYICSRYYRAPEL 255
+ + HRD+ +NLL+ +K+ DFG + L + + + + +
Sbjct: 127 LESK-RFIHRDLAARNLLLA-TRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPE 184
Query: 256 IFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 314
++ A D W G + E+ GQ + G +G L +I K R E
Sbjct: 185 SLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPE------ 238
Query: 315 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR 372
P + +++ + + + P R T + + F E +
Sbjct: 239 ---------------------DCPQDIYNVMVQCWAHKPEDRPTFVA--LRDFLLEAQ 273
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (347), Expect = 7e-39
Identities = 47/282 (16%), Positives = 96/282 (34%), Gaps = 43/282 (15%)
Query: 89 VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPNIVALKHCFF 145
+G+G FG+V + VAIK + + + E ++M L HP +V L
Sbjct: 12 EIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVC- 69
Query: 146 STTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGI 205
++ + LV E++ ++ + +C +AY+ +
Sbjct: 70 --LEQAPIC--LVFEFMEH--GCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA-CV 122
Query: 206 CHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYIC--SRYYRAPELIFGATEYT 263
HRD+ +N LV + +K+ DFG + ++ + S + +PE+ + Y+
Sbjct: 123 IHRDLAARNCLVGENQV-IKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSF-SRYS 180
Query: 264 TAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQ 323
+ D+WS G +M E+ + ++VE I
Sbjct: 181 SKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIS------------------------ 216
Query: 324 IKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH 365
+ + ++ ++ P R
Sbjct: 217 ---TGFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQ 255
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (347), Expect = 1e-38
Identities = 68/300 (22%), Positives = 111/300 (37%), Gaps = 54/300 (18%)
Query: 85 IAEHVVGTGSFGVVFQAKCRETGE--IVAIKKVLQDKRYKN-----RELQIMQMLDHPNI 137
IA+ +G G+FG V Q R + VAIK + Q + RE QIM LD+P I
Sbjct: 12 IADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYI 71
Query: 138 VALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALA 197
V L + L LV+E + + + +P+ V +Q+ +
Sbjct: 72 VRLIGVC------QAEALMLVMEMAGGGP--LHKFLVGKREEIPVSNVAELLHQVSMGMK 123
Query: 198 YIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR----YYRAP 253
Y+ HRD+ +N+L+ + K+ DFG +K L + + + + AP
Sbjct: 124 YLE-EKNFVHRDLAARNVLLVNRHY-AKISDFGLSKALGADDSYYTARSAGKWPLKWYAP 181
Query: 254 ELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 312
E I ++++ D+WS G M E L GQ + G + + I +
Sbjct: 182 ECINF-RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQG------------ 228
Query: 313 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV---HPFFD 369
K + P PPE L+ + Y R L ++
Sbjct: 229 -------KRMECPPE---------CPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 272
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (347), Expect = 1e-38
Identities = 58/301 (19%), Positives = 106/301 (35%), Gaps = 56/301 (18%)
Query: 85 IAEHVVGTGSFGVVFQAKCR--ETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPN 136
+ + +G+G+FG V + + + + VA+K + + E +MQ LD+P
Sbjct: 10 LEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPY 69
Query: 137 IVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
IV + + E L V+E Y + ++ + + +Q+ +
Sbjct: 70 IVRMIGIC----EAESWML--VMEMAE---LGPLNKYLQQNRHVKDKNIIELVHQVSMGM 120
Query: 197 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP----NVSYICSRYYRA 252
Y+ HRD+ +N+L+ H K+ DFG +K L E + A
Sbjct: 121 KYLEES-NFVHRDLAARNVLLVTQ-HYAKISDFGLSKALRADENYYKAQTHGKWPVKWYA 178
Query: 253 PELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 311
PE I ++++ D+WS G +M E GQ + G G + + K
Sbjct: 179 PECINY-YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGC-- 235
Query: 312 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV---HPFF 368
P E DL+ + Y R + + ++
Sbjct: 236 --------------------------PREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY 269
Query: 369 D 369
D
Sbjct: 270 D 270
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (348), Expect = 2e-38
Identities = 62/317 (19%), Positives = 107/317 (33%), Gaps = 70/317 (22%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGE-----IVAIKKVLQDKRYKN-----RELQIMQML- 132
V+G+G+FG V A + VA+K + + EL++M L
Sbjct: 39 LEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLG 98
Query: 133 DHPNIVALKHCFFSTTDKEELYLNLVLEYVP--------------------ETVNRIARN 172
H NIV L T +Y L+ EY E N+
Sbjct: 99 SHENIVNLLGAC---TLSGPIY--LIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLE 153
Query: 173 YSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA 232
+ + + YQ+ + + ++ HRD+ +N+LV +K+CDFG A
Sbjct: 154 EEEDLNVLTFEDLLCFAYQVAKGMEFLEFK-SCVHRDLAARNVLVTHGKV-VKICDFGLA 211
Query: 233 KVLVKGEPNVSYICSR---YYRAPELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGE 288
+ ++ V +R + APE +F YT D+WS G ++ E+ LG +PG
Sbjct: 212 RDIMSDSNYVVRGNARLPVKWMAPESLFE-GIYTIKSDVWSYGILLWEIFSLGVNPYPGI 270
Query: 289 SGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRF 348
++I+ N + P E ++
Sbjct: 271 PVDANFYKLIQ---------------NGFKMDQP------------FYATEEIYIIMQSC 303
Query: 349 FQYSPNLRCTALEACVH 365
+ + R +
Sbjct: 304 WAFDSRKRPSFPNLTSF 320
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (342), Expect = 4e-38
Identities = 54/288 (18%), Positives = 105/288 (36%), Gaps = 45/288 (15%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPNIVAL 140
+GTG FGVV K R VAIK + + ++ E ++M L H +V L
Sbjct: 6 LTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQL 64
Query: 141 KHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 200
T + ++ ++ EY+ + + R + +C A+ Y+
Sbjct: 65 YGVC---TKQRPIF--IITEYMAN--GCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE 117
Query: 201 NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVS--YICSRYYRAPELIFG 258
HRD+ +N LVN +K+ DFG ++ ++ E S + PE++
Sbjct: 118 -SKQFLHRDLAARNCLVNDQGV-VKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMY 175
Query: 259 ATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 317
+++++ DIW+ G +M E+ LG+ + + + I + L
Sbjct: 176 -SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGL---------------- 218
Query: 318 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH 365
P + + ++ + + R T +
Sbjct: 219 RLYRPHL------------ASEKVYTIMYSCWHEKADERPTFKILLSN 254
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (343), Expect = 1e-37
Identities = 62/303 (20%), Positives = 114/303 (37%), Gaps = 53/303 (17%)
Query: 89 VVGTGSFGVVFQAKCRETGE----IVAIKKVLQDKRYKN-----RELQIMQMLDHPNIVA 139
V+G+G+FG V++ GE VAIK++ + K E +M +D+P++
Sbjct: 16 VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 75
Query: 140 LKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 199
L ++T + L+ + +P + + Y+ + QI + + Y+
Sbjct: 76 LLGICLTST------VQLITQLMPF--GCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 127
Query: 200 HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR---YYRAPELI 256
+ + HRD+ +N+LV H +K+ DFG AK+L E + + A E I
Sbjct: 128 EDR-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 185
Query: 257 FGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 315
YT D+WS G + EL+ G + G ++ I++ + I
Sbjct: 186 LH-RIYTHQSDVWSYGVTVWELMTFGSKPYDGIP-ASEISSILEKGERLPQPPI------ 237
Query: 316 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 375
+ ++ + + + R E + F RDP
Sbjct: 238 ---------------------CTIDVYMIMVKCWMIDADSRPKFRELIIE-FSKMARDPQ 275
Query: 376 TRL 378
L
Sbjct: 276 RYL 278
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (331), Expect = 5e-36
Identities = 62/308 (20%), Positives = 106/308 (34%), Gaps = 65/308 (21%)
Query: 84 YIAEHVVGTGSFGVVFQAKCR-----ETGEIVAIKKVLQDKRYKN-----RELQIMQML- 132
+G G+FG V +A + VA+K + EL+++ L
Sbjct: 25 LSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLG 84
Query: 133 DHPNIVALKHCFFSTTDKEELYLNLVLEYVP---------------ETVNRIARNYSRIH 177
+H NIV L T ++ EY
Sbjct: 85 NHMNIVNLLGAC---TIGGPTL--VITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDE 139
Query: 178 QRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK 237
+ L + ++YQ+ + +A++ + HRD+ +N+L+ K+CDFG A+ +
Sbjct: 140 LALDLEDLLSFSYQVAKGMAFLASK-NCIHRDLAARNILLTHGRIT-KICDFGLARDIKN 197
Query: 238 GEPNVSYICSR---YYRAPELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQ 293
V +R + APE IF YT D+WS G + EL LG +PG +
Sbjct: 198 DSNYVVKGNARLPVKWMAPESIFN-CVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK 256
Query: 294 LVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSP 353
++IK + + + P E D++ + P
Sbjct: 257 FYKMIK---------------------------EGFRMLSPEHAPAEMYDIMKTCWDADP 289
Query: 354 NLRCTALE 361
R T +
Sbjct: 290 LKRPTFKQ 297
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 128 bits (323), Expect = 5e-35
Identities = 61/318 (19%), Positives = 108/318 (33%), Gaps = 73/318 (22%)
Query: 89 VVGTGSFGVVFQAKCR-----ETGEIVAIKKVLQDKRYKN-----RELQIMQMLDHPNIV 138
+G G+FG VFQA+ E +VA+K + ++ RE +M D+PNIV
Sbjct: 20 DIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIV 79
Query: 139 ALKHCFFSTTDKEELYLNLVLEYVP---------------------ETVNRIARNYSRIH 177
+ + L + EY+ ++ AR S
Sbjct: 80 ---KLLGVCAVGKPMCL--LFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGP 134
Query: 178 QRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK 237
+ Q+ +AY+ HRD+ +N LV + +K+ DFG ++ +
Sbjct: 135 PPLSCAEQLCIARQVAAGMAYLSER-KFVHRDLATRNCLVGENMV-VKIADFGLSRNIYS 192
Query: 238 GEPNV---SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQ 293
+ + + PE IF YTT D+W+ G V+ E+ G + G + +
Sbjct: 193 ADYYKADGNDAIPIRWMPPESIFY-NRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEV 251
Query: 294 LVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSP 353
+ + I P + P E +L+ + P
Sbjct: 252 IYYVRD----------------------GNILACP------ENCPLELYNLMRLCWSKLP 283
Query: 354 NLRCTALEACVHPFFDEL 371
R + +H +
Sbjct: 284 ADRPSFCS--IHRILQRM 299
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (323), Expect = 6e-35
Identities = 52/304 (17%), Positives = 106/304 (34%), Gaps = 57/304 (18%)
Query: 87 EHVVGTGSFGVVFQAKCRE---TGEIVAIKKVLQDKRYKN-----RELQIMQMLDHPNIV 138
V+G G FG V+ + A+K + + E IM+ HPN++
Sbjct: 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 91
Query: 139 ALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
+L + E +VL Y+ R + + + Q+ + + +
Sbjct: 92 SLLGICLRS----EGSPLVVLPYMKHGDLRNFIRNET--HNPTVKDLIGFGLQVAKGMKF 145
Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY-----YRAP 253
+ HRD+ +N +++ +K+ DFG A+ + E + + + + A
Sbjct: 146 LA-SKKFVHRDLAARNCMLDEK-FTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMAL 203
Query: 254 ELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 312
E + ++TT D+WS G ++ EL+ G P +P + D V +++ E
Sbjct: 204 ESLQT-QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYC--- 259
Query: 313 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTA------LEACVHP 366
P +++ + + +R + + A
Sbjct: 260 -------------------------PDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 294
Query: 367 FFDE 370
F E
Sbjct: 295 FIGE 298
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (321), Expect = 7e-35
Identities = 66/293 (22%), Positives = 100/293 (34%), Gaps = 50/293 (17%)
Query: 84 YIAEHVVGTGSFGVVFQAKCR---ETGEIVAIKKVLQDKRYKN-----RELQIMQMLDHP 135
+G G FG V Q VAIK +E M+ DHP
Sbjct: 9 IELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHP 68
Query: 136 NIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRA 195
+IV L E + +++E + + L + LY YQ+ A
Sbjct: 69 HIVKLIGVI------TENPVWIIMELCTL--GELRSFLQVRKYSLDLASLILYAYQLSTA 120
Query: 196 LAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYIC--SRYYRAP 253
LAY+ + HRDI +N+LV+ + +KL DFG ++ + + + AP
Sbjct: 121 LAYLESK-RFVHRDIAARNVLVSSNDC-VKLGDFGLSRYMEDSTYYKASKGKLPIKWMAP 178
Query: 254 ELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 312
E I +T+A D+W G M E+L+ G F G D + I P
Sbjct: 179 ESINF-RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNC--- 234
Query: 313 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH 365
PP L+ + + Y P+ R E
Sbjct: 235 -------------------------PPTLYSLMTKCWAYDPSRRPRFTELKAQ 262
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (317), Expect = 2e-34
Identities = 55/292 (18%), Positives = 98/292 (33%), Gaps = 50/292 (17%)
Query: 83 SYIAEHVVGTGSFGVVFQAKCRETGE----IVAIKKVLQDKRYKN-----RELQIMQMLD 133
+ V+G G FG V++ + + VAIK + K E IM
Sbjct: 8 CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFS 67
Query: 134 HPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQIC 193
H NI+ L+ + + ++ EY+ + ++ + I
Sbjct: 68 HHNIIRLEGVIS-----KYKPMMIITEYMENGALD--KFLREKDGEFSVLQLVGMLRGIA 120
Query: 194 RALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYIC----SRY 249
+ Y+ N HRD+ +N+LVN + K+ DFG ++VL
Sbjct: 121 AGMKYLANM-NYVHRDLAARNILVNSNLV-CKVSDFGLSRVLEDDPEATYTTSGGKIPIR 178
Query: 250 YRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI 309
+ APE I ++T+A D+WS G VM E++ E ++++ I
Sbjct: 179 WTAPEAISY-RKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIN---------- 227
Query: 310 KCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALE 361
+ P L+ + +Q R +
Sbjct: 228 -----------------DGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFAD 262
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (318), Expect = 3e-34
Identities = 58/300 (19%), Positives = 105/300 (35%), Gaps = 56/300 (18%)
Query: 87 EHVVGTGSFGVVFQAKCRETGEI--VAIKKV-----LQDKRYKNRELQIMQML-DHPNIV 138
+ V+G G+FG V +A+ ++ G AIK++ D R EL+++ L HPNI+
Sbjct: 15 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 74
Query: 139 ALKHCFFSTTDKEELYLNLVLEYVP-------------ETVNRIARNYSRIHQRMPLIYV 185
L YL L +EY P + + + +
Sbjct: 75 NLLGACEHRG-----YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129
Query: 186 KLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYI 245
+ + R + Y+ HRD+ +N+LV + + K+ DFG ++
Sbjct: 130 LHFAADVARGMDYLSQK-QFIHRDLAARNILVGEN-YVAKIADFGLSRGQEVYVKKTMGR 187
Query: 246 CSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPT 305
+ A E + + YTT D+WS G ++ E++ +L E +
Sbjct: 188 LPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP------ 240
Query: 306 REEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH 365
+ P E DL+ + ++ P R + + V
Sbjct: 241 ---------QGYRLEKP------------LNCDDEVYDLMRQCWREKPYERPSFAQILVS 279
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (312), Expect = 2e-33
Identities = 61/309 (19%), Positives = 114/309 (36%), Gaps = 66/309 (21%)
Query: 84 YIAEHVVGTGSFGVVFQAKCRETGE-------IVAIKKVLQDKRYKN-----RELQIMQM 131
+ +G G+FG V A+ + VA+K + D K+ E+++M+M
Sbjct: 15 LVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKM 74
Query: 132 L-DHPNIVALKHCFFSTTDKEELYLNLVLEYV-------------PETVNRIARNYSRIH 177
+ H NI+ + + T LY+ ++EY P +
Sbjct: 75 IGKHKNII---NLLGACTQDGPLYV--IVEYASKGNLREYLQARRPPGLEYSYNPSHNPE 129
Query: 178 QRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK 237
+++ + YQ+ R + Y+ + HRD+ +N+LV K+ DFG A+ +
Sbjct: 130 EQLSSKDLVSCAYQVARGMEYLASK-KCIHRDLAARNVLVTEDNVM-KIADFGLARDIHH 187
Query: 238 GEPNVS---YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQ 293
+ + APE +F YT D+WS G ++ E+ LG +PG V++
Sbjct: 188 IDYYKKTTNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP-VEE 245
Query: 294 LVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSP 353
L +++K E + E ++ + P
Sbjct: 246 LFKLLK------------------EGHRMDKPSN---------CTNELYMMMRDCWHAVP 278
Query: 354 NLRCTALEA 362
+ R T +
Sbjct: 279 SQRPTFKQL 287
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (310), Expect = 4e-33
Identities = 58/310 (18%), Positives = 107/310 (34%), Gaps = 62/310 (20%)
Query: 84 YIAEHVVGTGSFGVVFQAKCR-----ETGEIVAIKKVLQD------KRYKNRELQIMQML 132
+G G+FG V +A T VA+K + + + + ++ +
Sbjct: 15 LKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIG 74
Query: 133 DHPNIVALKHCFFSTTDKEELYLNLVLEYVP-------------ETVNRIARNYSRIHQR 179
H N+V L L +++E+ E V
Sbjct: 75 HHLNVVNLLGACTKPGG----PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDF 130
Query: 180 MPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE 239
+ L ++ Y++Q+ + + ++ + HRD+ +N+L++ +K+CDFG A+ + K
Sbjct: 131 LTLEHLICYSFQVAKGMEFLASR-KCIHRDLAARNILLSEKNV-VKICDFGLARDIYKDP 188
Query: 240 PNV---SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLG-QPLFPGESGVDQLV 295
V + APE IF YT D+WS G ++ E+ +PG ++
Sbjct: 189 DYVRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC 247
Query: 296 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNL 355
+K T + P PE + + P+
Sbjct: 248 RRLK---------------EGTRMRAPDY------------TTPEMYQTMLDCWHGEPSQ 280
Query: 356 RCTALEACVH 365
R T E H
Sbjct: 281 RPTFSELVEH 290
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (297), Expect = 3e-31
Identities = 55/315 (17%), Positives = 114/315 (36%), Gaps = 63/315 (20%)
Query: 84 YIAEHVVGTGSFGVVFQAKCR-----ETGEIVAIKKV-----LQDKRYKNRELQIMQMLD 133
+G GSFG+V++ + E VAIK V ++++ E +M+ +
Sbjct: 22 ITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFN 81
Query: 134 HPNIVALKHCFFSTTDKEELYLNLVLEYVPE-------TVNRIARNYSRIHQRMPLIYVK 186
++V + + +++E + R A + + L +
Sbjct: 82 CHHVV---RLLGVVSQGQPTL--VIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMI 136
Query: 187 LYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYIC 246
+I +AY++ HRD+ +N +V +K+ DFG + + + +
Sbjct: 137 QMAGEIADGMAYLNAN-KFVHRDLAARNCMVAEDFT-VKIGDFGMTRDIYETDYYRKGGK 194
Query: 247 ---SRYYRAPELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQLVEIIKVLG 302
+ +PE + +TT D+WS G V+ E+ L + + G S L +++
Sbjct: 195 GLLPVRWMSPESLKDGV-FTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVME--- 250
Query: 303 TPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTA--- 359
+ P P +L+ +QY+P +R +
Sbjct: 251 -------------------GGLLDKP------DNCPDMLFELMRMCWQYNPKMRPSFLEI 285
Query: 360 ---LEACVHPFFDEL 371
++ + P F E+
Sbjct: 286 ISSIKEEMEPGFREV 300
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 86.0 bits (212), Expect = 2e-20
Identities = 31/204 (15%), Positives = 57/204 (27%), Gaps = 34/204 (16%)
Query: 89 VVGTGSFGVVFQAKCRETGEIVAIKKV--------------LQDKRYKNRELQIMQMLDH 134
++G G VF E +K + + +
Sbjct: 7 LMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 135 PNIVALKHCFFSTT-DKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQIC 193
+ L+ E + ++E ++ R+ + I
Sbjct: 66 RALQKLQGLAVPKVYAWEGNAV--LMEL----------IDAKELYRVRVENPDEVLDMIL 113
Query: 194 RALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAP 253
+A ++ I H D+ N+LV + + DF + + GE I R R
Sbjct: 114 EEVAKFYHRG-IVHGDLSQYNVLV--SEEGIWIIDFPQSVEV--GEEGWREILERDVRNI 168
Query: 254 ELIFGATEYTTAIDIWSTGCVMAE 277
F Y T DI S + +
Sbjct: 169 ITYFS-RTYRTEKDINSAIDRILQ 191
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 394 | |||
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.92 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.33 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.01 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.9 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.02 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.92 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.41 |
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-63 Score=464.44 Aligned_cols=310 Identities=73% Similarity=1.248 Sum_probs=280.3
Q ss_pred ceeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccchhhhHHHHHHHHHcCCCCeeeeceEEEecCC-CceeEEEEEE
Q 016184 81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTD-KEELYLNLVL 159 (394)
Q Consensus 81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~~~~~~~lv~ 159 (394)
..+|+.+++||+|+||+||+|+++.+|+.||||++........+|+++|+.++|+||++++++|..... .+..++++||
T Consensus 19 ~~~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~ 98 (350)
T d1q5ka_ 19 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVL 98 (350)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSSCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEEE
T ss_pred cCCcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchHHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEEE
Confidence 346999999999999999999999999999999998877777899999999999999999999866543 4567889999
Q ss_pred ecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCccccccCC
Q 016184 160 EYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE 239 (394)
Q Consensus 160 e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~~~ 239 (394)
||+++++...+.........+++..++.++.||+.||+|||+ +||+||||||+|||++.++..+||+|||+++......
T Consensus 99 Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~-~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~~~ 177 (350)
T d1q5ka_ 99 DYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS-FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 177 (350)
T ss_dssp ECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT-TTEECCCCCGGGEEECTTTCCEEECCCTTCEECCTTS
T ss_pred eccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHh-cCCcccCCCcceEEEecCCCceeEecccchhhccCCc
Confidence 999998877777766667889999999999999999999999 8999999999999999887679999999998876666
Q ss_pred CcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCCCccc
Q 016184 240 PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 319 (394)
Q Consensus 240 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 319 (394)
......||+.|+|||.+.+...++.++||||+||++|+|++|+.||...+..+.+..+.+.+|.+..+.+....+.+...
T Consensus 178 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~ 257 (350)
T d1q5ka_ 178 PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEF 257 (350)
T ss_dssp CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC---CC
T ss_pred ccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhccchhhc
Confidence 66778899999999998777779999999999999999999999999999999999999999999999999888888888
Q ss_pred CCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCCCCCCCCCCCCCCCCC
Q 016184 320 KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFK 391 (394)
Q Consensus 320 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~~~~~~~~~~~~~~~~ 391 (394)
.++.....++.......+++++.+||.+||++||.+||||.|+|+||||+++.++..++++...++..++|+
T Consensus 258 ~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~~~~~~~~~~~~~~~~~~ 329 (350)
T d1q5ka_ 258 KFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVKLPNGRDTPALFNFT 329 (350)
T ss_dssp CCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGCTTCCCTTSCCCCCCCCCC
T ss_pred cccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccccCCCCCCCCCCCCCccCCCC
Confidence 888888888888888889999999999999999999999999999999999999999999999999888874
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-59 Score=427.83 Aligned_cols=280 Identities=35% Similarity=0.600 Sum_probs=228.6
Q ss_pred EeeEEeecCceEEEEEEECCCCcEEEEEEeccch---------hhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEEE
Q 016184 86 AEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN 156 (394)
Q Consensus 86 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 156 (394)
.+++||+|+||+||+|+++.+|+.||||++.... ....+|+.+++.++||||+++++++.. ..+++
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~-----~~~~~ 76 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGH-----KSNIS 76 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECC-----TTCCE
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeecc-----CCcee
Confidence 4688999999999999999999999999985432 234589999999999999999999833 33478
Q ss_pred EEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCccccc
Q 016184 157 LVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV 236 (394)
Q Consensus 157 lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~ 236 (394)
+||||+.+++...+ ......+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+|+...
T Consensus 77 ivmE~~~~~~~~~~---~~~~~~l~~~~~~~~~~qil~aL~~lH~-~~iiHrDiKp~NIli~~~~-~~KL~DFG~a~~~~ 151 (299)
T d1ua2a_ 77 LVFDFMETDLEVII---KDNSLVLTPSHIKAYMLMTLQGLEYLHQ-HWILHRDLKPNNLLLDENG-VLKLADFGLAKSFG 151 (299)
T ss_dssp EEEECCSEEHHHHH---TTCCSSCCSSHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECTTC-CEEECCCGGGSTTT
T ss_pred ehhhhhcchHHhhh---hhcccCCCHHHHHHHHHHHHHHHHHhhc-cceecccCCcceEEecCCC-ccccccCccccccC
Confidence 99999998764433 3335779999999999999999999999 8999999999999999888 79999999997664
Q ss_pred cCC-CcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCC
Q 016184 237 KGE-PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 315 (394)
Q Consensus 237 ~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 315 (394)
... ......||+.|+|||++.....++.++|||||||++|+|+||.+||.+.+..+.+..+.+.++.+..+.+......
T Consensus 152 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~ 231 (299)
T d1ua2a_ 152 SPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSL 231 (299)
T ss_dssp SCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSS
T ss_pred CCcccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhcc
Confidence 433 3345678999999999976666899999999999999999999999999999999999999998887766544333
Q ss_pred CcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCC
Q 016184 316 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNT 376 (394)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~ 376 (394)
.....+......++...+ ..+++++.+||++||+.||++||||+|+|+||||++...+..
T Consensus 232 ~~~~~~~~~~~~~~~~~~-~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~p~p~~ 291 (299)
T d1ua2a_ 232 PDYVTFKSFPGIPLHHIF-SAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPTP 291 (299)
T ss_dssp TTCCCCCCCCCCCHHHHC-TTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSCCCC
T ss_pred chhhhhccCCCCChHHhc-ccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCCCCCCC
Confidence 222233333333333332 467999999999999999999999999999999998655444
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-59 Score=422.35 Aligned_cols=253 Identities=27% Similarity=0.333 Sum_probs=207.7
Q ss_pred eeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccc-----hhhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEEE
Q 016184 82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN 156 (394)
Q Consensus 82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 156 (394)
++|++.+.||+|+||+||+|+++.+|+.||||++... ...+.+|+++++.++||||+++++++.. ...++
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~-----~~~~~ 79 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRRE-----GNIQY 79 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEE-----TTEEE
T ss_pred cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeecc-----CceeE
Confidence 4699999999999999999999999999999998543 2345689999999999999999999843 34588
Q ss_pred EEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCcccc
Q 016184 157 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL 235 (394)
Q Consensus 157 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~ 235 (394)
+||||+.+ +|.+++. ....+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+|+..
T Consensus 80 ivmEy~~gg~L~~~l~----~~~~l~e~~~~~i~~qi~~al~ylH~-~~IiHrDiKp~NILl~~~~-~~KL~DFG~a~~~ 153 (271)
T d1nvra_ 80 LFLEYCSGGELFDRIE----PDIGMPEPDAQRFFHQLMAGVVYLHG-IGITHRDIKPENLLLDERD-NLKISDFGLATVF 153 (271)
T ss_dssp EEEECCTTEEGGGGSB----TTTBCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEECTTC-CEEECCCTTCEEC
T ss_pred EEEeccCCCcHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHH-cCCccCcccHHHEEECCCC-CEEEccchhheee
Confidence 99999985 6655443 34679999999999999999999999 8999999999999999888 6999999999876
Q ss_pred ccCC---CcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhcc
Q 016184 236 VKGE---PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 312 (394)
Q Consensus 236 ~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 312 (394)
.... ......||+.|+|||++.+...++.++|||||||++|+|+||+.||....................
T Consensus 154 ~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~~------- 226 (271)
T d1nvra_ 154 RYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYL------- 226 (271)
T ss_dssp EETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTTS-------
T ss_pred ccCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC-------
Confidence 4332 234567999999999997766567889999999999999999999987654433333222110000
Q ss_pred CCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 016184 313 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL 371 (394)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 371 (394)
. ....+++++.+||.+||+.||++|||++|+|+||||++.
T Consensus 227 --------------~-----~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~~ 266 (271)
T d1nvra_ 227 --------------N-----PWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKP 266 (271)
T ss_dssp --------------T-----TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCC
T ss_pred --------------C-----ccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCcC
Confidence 0 114579999999999999999999999999999999753
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-59 Score=424.84 Aligned_cols=250 Identities=25% Similarity=0.375 Sum_probs=212.4
Q ss_pred eEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccc----hhhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEEEEE
Q 016184 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLV 158 (394)
Q Consensus 83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv 158 (394)
+|++.+.||+|+||+||+|+++.+|+.||||++... .....+|+++++.++||||+++++++.. ..++++|
T Consensus 21 ~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~-----~~~~~iv 95 (293)
T d1yhwa1 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLV-----GDELWVV 95 (293)
T ss_dssp TBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEE-----TTEEEEE
T ss_pred ccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEE-----CCEEEEE
Confidence 599999999999999999999999999999998643 2345689999999999999999999843 3348899
Q ss_pred Eecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCcccccc
Q 016184 159 LEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK 237 (394)
Q Consensus 159 ~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~ 237 (394)
|||+++ +|..++.. ..+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+|+....
T Consensus 96 mEy~~gg~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~yLH~-~~iiHrDiKp~NILl~~~~-~vkl~DFG~a~~~~~ 168 (293)
T d1yhwa1 96 MEYLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHS-NQVIHRDIKSDNILLGMDG-SVKLTDFGFCAQITP 168 (293)
T ss_dssp EECCTTCBHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECTTC-CEEECCCTTCEECCS
T ss_pred EEecCCCcHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHH-CCCcccCCcHHHeEECCCC-cEeeccchhheeecc
Confidence 999985 66665443 679999999999999999999999 8999999999999999888 699999999987644
Q ss_pred CC-CcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCCC
Q 016184 238 GE-PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 316 (394)
Q Consensus 238 ~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 316 (394)
.. ......||+.|+|||++.+. .++.++|||||||++|+|+||+.||.+.+..+.+..+........
T Consensus 169 ~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~----------- 236 (293)
T d1yhwa1 169 EQSKRSTMVGTPYWMAPEVVTRK-AYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPEL----------- 236 (293)
T ss_dssp TTCCBCCCCSCGGGCCHHHHSSS-CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCC-----------
T ss_pred ccccccccccCCCccChhhhcCC-CCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCC-----------
Confidence 33 34556799999999999764 489999999999999999999999998887777666655321100
Q ss_pred cccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 016184 317 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL 371 (394)
Q Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 371 (394)
..+..+++++++||.+||+.||.+|||++|+|+||||+..
T Consensus 237 ---------------~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~Hp~~~~~ 276 (293)
T d1yhwa1 237 ---------------QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIA 276 (293)
T ss_dssp ---------------SSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTCGGGGGC
T ss_pred ---------------CCcccCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCC
Confidence 0125689999999999999999999999999999999753
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-59 Score=417.10 Aligned_cols=247 Identities=30% Similarity=0.497 Sum_probs=211.1
Q ss_pred eeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccc-------hhhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeE
Q 016184 82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY 154 (394)
Q Consensus 82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 154 (394)
++|++.+.||+|+||+||+|+++.+|+.||+|++.+. .....+|+++++.++||||+++++++. +...
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~-----~~~~ 80 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFH-----DATR 80 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEE-----CSSE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEE-----ECCE
Confidence 4699999999999999999999999999999998542 234467999999999999999999983 3345
Q ss_pred EEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCcc
Q 016184 155 LNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK 233 (394)
Q Consensus 155 ~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~ 233 (394)
+++||||+++ +|.+++.. ...+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+|.
T Consensus 81 ~~ivmEy~~~g~L~~~l~~----~~~l~e~~~~~i~~qi~~al~~lH~-~~ivHrDiKp~Nill~~~~-~~kl~DFG~a~ 154 (263)
T d2j4za1 81 VYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELANALSYCHS-KRVIHRDIKPENLLLGSAG-ELKIADFGWSV 154 (263)
T ss_dssp EEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECTTS-CEEECCCCSCS
T ss_pred EEEEEeecCCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeeeeccccceecCCC-CEeecccceee
Confidence 8899999985 77666654 3679999999999999999999999 8999999999999999888 69999999997
Q ss_pred ccccCCCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccC
Q 016184 234 VLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 313 (394)
Q Consensus 234 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 313 (394)
..... ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+.+..+.+.
T Consensus 155 ~~~~~-~~~~~~Gt~~Y~APE~~~~~-~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~------------- 219 (263)
T d2j4za1 155 HAPSS-RRTTLCGTLDYLPPEMIEGR-MHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV------------- 219 (263)
T ss_dssp CCCCC-CCEETTEEGGGCCHHHHTTC-CCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTT-------------
T ss_pred ecCCC-cccccCCCCcccCHHHHcCC-CCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcC-------------
Confidence 65433 34466899999999999765 4899999999999999999999999887766666655431
Q ss_pred CCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 016184 314 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE 370 (394)
Q Consensus 314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~ 370 (394)
... +++.+|+++++||.+||+.||.+|||++|+|+||||+.
T Consensus 220 ----~~~------------~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~hp~~~~ 260 (263)
T d2j4za1 220 ----EFT------------FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 260 (263)
T ss_dssp ----CCC------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTCHHHHH
T ss_pred ----CCC------------CCccCCHHHHHHHHHHccCCHhHCcCHHHHHcCcCcCC
Confidence 111 22457999999999999999999999999999999974
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8e-59 Score=420.15 Aligned_cols=254 Identities=31% Similarity=0.522 Sum_probs=212.4
Q ss_pred eeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccch-------hhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeE
Q 016184 82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY 154 (394)
Q Consensus 82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 154 (394)
++|++++.||+|+||+||+|+++.+|+.||||++.+.. ....+|++++++++||||+++++++. ....
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~-----~~~~ 82 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQ-----DDEK 82 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEE-----CSSE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEE-----ECCE
Confidence 46999999999999999999999999999999986422 34568999999999999999999883 3345
Q ss_pred EEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCcc
Q 016184 155 LNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK 233 (394)
Q Consensus 155 ~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~ 233 (394)
+|+||||+++ +|.+++.. .+.+++..++.++.|++.||+|||+ +||+||||||+|||++.++ .+||+|||+|+
T Consensus 83 ~~ivmEy~~gg~L~~~~~~----~~~l~e~~~~~~~~qi~~al~ylH~-~~iiHrDiKp~NIll~~~~-~vkl~DFG~a~ 156 (288)
T d1uu3a_ 83 LYFGLSYAKNGELLKYIRK----IGSFDETCTRFYTAEIVSALEYLHG-KGIIHRDLKPENILLNEDM-HIQITDFGTAK 156 (288)
T ss_dssp EEEEECCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECTTS-CEEECCCTTCE
T ss_pred EEEEEEccCCCCHHHhhhc----cCCCCHHHHHHHHHHHHHHHHhhcc-ccEEcCcCCccccccCCCc-eEEecccccce
Confidence 7899999985 77665543 3789999999999999999999999 8999999999999999888 69999999998
Q ss_pred ccccCC---CcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhh
Q 016184 234 VLVKGE---PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 310 (394)
Q Consensus 234 ~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 310 (394)
...... ......||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+..+.+..+.+.
T Consensus 157 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~-~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~---------- 225 (288)
T d1uu3a_ 157 VLSPESKQARANSFVGTAQYVSPELLTEKS-ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKL---------- 225 (288)
T ss_dssp ECC----------CCCCGGGCCHHHHHTCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTT----------
T ss_pred ecccCCcccccccccCCccccCceeeccCC-CCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcC----------
Confidence 764332 223467999999999997654 899999999999999999999999988777766665441
Q ss_pred ccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHH------HhcCCCCCCCCCCCC
Q 016184 311 CMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALE------ACVHPFFDELRDPNT 376 (394)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e------ll~hp~f~~~~~~~~ 376 (394)
... ++..+++++++||++||+.||++|||++| +++||||+++.....
T Consensus 226 -------~~~------------~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i~w~~l 278 (288)
T d1uu3a_ 226 -------EYD------------FPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENL 278 (288)
T ss_dssp -------CCC------------CCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCTTG
T ss_pred -------CCC------------CCccCCHHHHHHHHHHccCCHhHCcCHHHHcCCHHHHcCCccCCCCHHHh
Confidence 111 22468999999999999999999999987 589999999865554
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-58 Score=419.80 Aligned_cols=269 Identities=23% Similarity=0.351 Sum_probs=218.8
Q ss_pred eeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccc----------hhhhHHHHHHHHHcCCCCeeeeceEEEecCCCc
Q 016184 82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD----------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKE 151 (394)
Q Consensus 82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 151 (394)
++|++++.||+|+||+||+|+++.+|+.||||++.+. ...+.+|+.+|+.++||||+++++++. +
T Consensus 10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~-----~ 84 (293)
T d1jksa_ 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYE-----N 84 (293)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEE-----C
T ss_pred cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEE-----E
Confidence 4599999999999999999999999999999998532 234568999999999999999999983 3
Q ss_pred eeEEEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCC---cEEEE
Q 016184 152 ELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTH---QLKLC 227 (394)
Q Consensus 152 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~---~vkl~ 227 (394)
...+++|||||++ +|.+++.. ...+++..++.++.|++.||+|||+ .||+||||||+|||++.++. .+||+
T Consensus 85 ~~~~~iv~E~~~gg~L~~~i~~----~~~l~~~~~~~~~~qi~~al~yLH~-~~ivHrDiKp~Nill~~~~~~~~~vkl~ 159 (293)
T d1jksa_ 85 KTDVILILELVAGGELFDFLAE----KESLTEEEATEFLKQILNGVYYLHS-LQIAHFDLKPENIMLLDRNVPKPRIKII 159 (293)
T ss_dssp SSEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEESCSSSSSCCEEEC
T ss_pred CCEEEEEEEcCCCccccchhcc----ccccchhHHHHHHHHHHHHHHhhhh-cceeecccccceEEEecCCCcccceEec
Confidence 4458899999985 78777654 3679999999999999999999999 89999999999999987653 49999
Q ss_pred eecCccccccCCCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChh
Q 016184 228 DFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 307 (394)
Q Consensus 228 Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~ 307 (394)
|||+|.............+|+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+.+..+.......+
T Consensus 160 DfG~a~~~~~~~~~~~~~~t~~y~APE~~~~~-~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~-- 236 (293)
T d1jksa_ 160 DFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYE-PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFE-- 236 (293)
T ss_dssp CCTTCEECTTSCBCSCCCCCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCC--
T ss_pred chhhhhhcCCCccccccCCCCcccCHHHHcCC-CCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCC--
Confidence 99999887666666677899999999999654 489999999999999999999999998887777776655322111
Q ss_pred hhhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCCCCCCCCCCCCC
Q 016184 308 EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPNGRPLPPL 387 (394)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~~~~~~~~~~~~ 387 (394)
..+...+|+++++||++||+.||.+|||++|+|+||||+..... ........||.
T Consensus 237 -----------------------~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~~~--~~l~~~~~~P~ 291 (293)
T d1jksa_ 237 -----------------------DEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQ--QALSSAWSHPQ 291 (293)
T ss_dssp -----------------------HHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC---------------CC
T ss_pred -----------------------chhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCChh--HhhccCCCCcC
Confidence 12235689999999999999999999999999999999876432 22334455566
Q ss_pred C
Q 016184 388 F 388 (394)
Q Consensus 388 ~ 388 (394)
|
T Consensus 292 f 292 (293)
T d1jksa_ 292 F 292 (293)
T ss_dssp C
T ss_pred C
Confidence 5
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-58 Score=420.15 Aligned_cols=282 Identities=35% Similarity=0.645 Sum_probs=230.4
Q ss_pred eEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccc------hhhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEEE
Q 016184 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN 156 (394)
Q Consensus 83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 156 (394)
+|++++.||+|+||+||+|+++.+|+.||||++... .....+|++++++++||||+++++++.. ...+|
T Consensus 3 ~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~-----~~~~~ 77 (298)
T d1gz8a_ 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHT-----ENKLY 77 (298)
T ss_dssp TEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEE-----TTEEE
T ss_pred CCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEecccccc-----cccee
Confidence 599999999999999999999999999999998543 2345679999999999999999999943 33488
Q ss_pred EEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCccccc
Q 016184 157 LVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV 236 (394)
Q Consensus 157 lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~ 236 (394)
+||||+.+++...+... ....+++..++.++.||+.||+|||+ +|||||||||+|||++.++ .+||+|||.|+...
T Consensus 78 iv~e~~~~~~~~~~~~~--~~~~l~e~~~~~~~~qil~~L~yLH~-~~IiHrDiKpeNIl~~~~~-~~kl~DFG~a~~~~ 153 (298)
T d1gz8a_ 78 LVFEFLHQDLKKFMDAS--ALTGIPLPLIKSYLFQLLQGLAFCHS-HRVLHRDLKPQNLLINTEG-AIKLADFGLARAFG 153 (298)
T ss_dssp EEEECCSEEHHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECTTS-CEEECSTTHHHHHC
T ss_pred EEEeecCCchhhhhhhh--cccCCCHHHHHHHHHHHHHHHHHhhc-CCEEccccCchheeecccC-cceeccCCcceecc
Confidence 99999998776655432 24679999999999999999999999 8999999999999999888 79999999998764
Q ss_pred cC-CCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCC
Q 016184 237 KG-EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 315 (394)
Q Consensus 237 ~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 315 (394)
.. .......||+.|+|||.+.....++.++|||||||++|+|++|+.||.+.+..+.+..+....+.+....+......
T Consensus 154 ~~~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 233 (298)
T d1gz8a_ 154 VPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM 233 (298)
T ss_dssp CCSBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGS
T ss_pred CCcccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhccccccc
Confidence 43 23345678999999999877776789999999999999999999999999988999999888887776554422111
Q ss_pred C-cccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCC
Q 016184 316 Y-TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP 374 (394)
Q Consensus 316 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~ 374 (394)
. ....++......+.. ....+++++.+||++||+.||.+|||++|+|+||||+++.+|
T Consensus 234 ~~~~~~~~~~~~~~~~~-~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~~p 292 (298)
T d1gz8a_ 234 PDYKPSFPKWARQDFSK-VVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 292 (298)
T ss_dssp TTCCTTSCCCCCCCHHH-HSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCCCC
T ss_pred cccccccccccccchhh-hccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccCCCC
Confidence 0 111122222222222 234678999999999999999999999999999999999776
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.7e-59 Score=416.29 Aligned_cols=253 Identities=25% Similarity=0.378 Sum_probs=203.7
Q ss_pred eeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccch------hhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEE
Q 016184 82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL 155 (394)
Q Consensus 82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 155 (394)
++|++.+.||+|+||+||+|+++.+|+.||||++.... ..+.+|+++++.++||||+++++++... ....+
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~---~~~~~ 80 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDR---TNTTL 80 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC-------CE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeC---CCCEE
Confidence 46999999999999999999999999999999985432 2345799999999999999999988532 23347
Q ss_pred EEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCC-----ceeccCCCCceEEeCCCCcEEEEee
Q 016184 156 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG-----ICHRDIKPQNLLVNPHTHQLKLCDF 229 (394)
Q Consensus 156 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~g-----ivH~Dlkp~Nil~~~~~~~vkl~Df 229 (394)
++||||+++ +|.+++.........+++..++.++.||+.||+|||+ .| |+||||||+|||++.++ .+||+||
T Consensus 81 ~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~-~~~~~~~IiHrDiKp~NIll~~~~-~vkl~DF 158 (269)
T d2java1 81 YIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHR-RSDGGHTVLHRDLKPANVFLDGKQ-NVKLGDF 158 (269)
T ss_dssp EEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH-HCC---------CCGGGEEECTTS-CEEECCH
T ss_pred EEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHH-hcCCCCCEEeCcCchhhcCcCCCC-cEEEeec
Confidence 899999985 8988888777667889999999999999999999998 56 99999999999999888 6999999
Q ss_pred cCccccccCCC-cccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhh
Q 016184 230 GSAKVLVKGEP-NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 308 (394)
Q Consensus 230 g~a~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~ 308 (394)
|+|+....... .....||+.|+|||++.+. .++.++|||||||++|+|+||+.||.+.+..+....+....-.
T Consensus 159 G~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~-~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~~~----- 232 (269)
T d2java1 159 GLARILNHDTSFAKAFVGTPYYMSPEQMNRM-SYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFR----- 232 (269)
T ss_dssp HHHHHC-----------CCCSCCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCC-----
T ss_pred cceeecccCCCccccCCCCcccCCHHHHcCC-CCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCC-----
Confidence 99987654332 3456789999999999654 4899999999999999999999999988776666665542100
Q ss_pred hhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 016184 309 IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368 (394)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f 368 (394)
.++..+|+++.+||.+||+.||.+|||++|+|+|||+
T Consensus 233 -----------------------~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~hp~i 269 (269)
T d2java1 233 -----------------------RIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 269 (269)
T ss_dssp -----------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred -----------------------CCCcccCHHHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence 0124679999999999999999999999999999996
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-57 Score=416.28 Aligned_cols=286 Identities=31% Similarity=0.548 Sum_probs=233.4
Q ss_pred ceeEEEeeEEeecCceEEEEEEECCC-CcEEEEEEeccc------hhhhHHHHHHHHHc---CCCCeeeeceEEEecCCC
Q 016184 81 KVSYIAEHVVGTGSFGVVFQAKCRET-GEIVAIKKVLQD------KRYKNRELQIMQML---DHPNIVALKHCFFSTTDK 150 (394)
Q Consensus 81 ~~~y~~~~~lg~G~~g~V~~~~~~~~-~~~vaiK~~~~~------~~~~~~E~~~l~~l---~h~~iv~~~~~~~~~~~~ 150 (394)
.++|++++.||+|+||+||+|++..+ ++.||||++... .....+|+.+++.| +||||++++++|......
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 35699999999999999999999765 677999998542 22345788887766 799999999998766656
Q ss_pred ceeEEEEEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeec
Q 016184 151 EELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFG 230 (394)
Q Consensus 151 ~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg 230 (394)
...+++++|||+.+++..+... .....+++..++.++.|++.||+|||+ +||+||||||+|||++.++ .+||+|||
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~--~~~~~~~~~~~~~~~~qi~~aL~yLH~-~~ivHrDiKp~NILi~~~~-~~kl~dfg 161 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDK--VPEPGVPTETIKDMMFQLLRGLDFLHS-HRVVHRDLKPQNILVTSSG-QIKLADFG 161 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHH--SCTTCSCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECTTC-CEEECSCC
T ss_pred cCceEEEEEEeccCCchhhhhh--ccCCCCCHHHHHHHHHHHHHHHHHHHh-CCEEecCCCccEEEEcCCC-Ceeecchh
Confidence 6778899999999876554443 234779999999999999999999999 8999999999999999888 69999999
Q ss_pred CccccccCCCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhh
Q 016184 231 SAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 310 (394)
Q Consensus 231 ~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 310 (394)
+++............||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+.+..+....+.+....+.
T Consensus 162 ~~~~~~~~~~~~~~~gT~~Y~APE~~~~~-~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 240 (305)
T d1blxa_ 162 LARIYSFQMALTSVVVTLWYRAPEVLLQS-SYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP 240 (305)
T ss_dssp SCCCCCGGGGGCCCCCCCTTCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSC
T ss_pred hhhhhcccccCCCcccChhhcCcchhcCC-CCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhccc
Confidence 99876655556677899999999999665 48999999999999999999999999999999999999999988776654
Q ss_pred ccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q 016184 311 CMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD 373 (394)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~ 373 (394)
...... ...+......+ ...+...+++++.+||++||++||++|||++|+|+||||+++..
T Consensus 241 ~~~~~~-~~~~~~~~~~~-~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i~~ 301 (305)
T d1blxa_ 241 RDVALP-RQAFHSKSAQP-IEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLER 301 (305)
T ss_dssp TTCSSC-GGGSCCCCCCC-GGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCC
T ss_pred ccccch-hhhhccccccc-hhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCchh
Confidence 322111 11111111112 22234678999999999999999999999999999999999854
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=5.2e-58 Score=425.89 Aligned_cols=260 Identities=26% Similarity=0.395 Sum_probs=219.7
Q ss_pred eeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccch----hhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEEEE
Q 016184 82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL 157 (394)
Q Consensus 82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 157 (394)
++|++.+.||+|+||.||+|+++.+|+.||||++.... ..+.+|+.+|+.++||||+++++++.. ...+++
T Consensus 26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~-----~~~~~i 100 (350)
T d1koaa2 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFED-----DNEMVM 100 (350)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEE-----TTEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEE-----CCEEEE
Confidence 36999999999999999999999999999999986532 344679999999999999999999843 345889
Q ss_pred EEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCC-CCcEEEEeecCcccc
Q 016184 158 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPH-THQLKLCDFGSAKVL 235 (394)
Q Consensus 158 v~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~-~~~vkl~Dfg~a~~~ 235 (394)
|||||++ +|.+++.. ....+++..++.++.||+.||+|||+ +||+||||||+|||++.+ .+.+||+|||+|+..
T Consensus 101 vmE~~~gg~L~~~l~~---~~~~l~e~~~~~i~~qi~~aL~ylH~-~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~ 176 (350)
T d1koaa2 101 IYEFMSGGELFEKVAD---EHNKMSEDEAVEYMRQVCKGLCHMHE-NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL 176 (350)
T ss_dssp EECCCCSCBHHHHHTC---TTSCBCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEESSTTSCCEEECCCTTCEEC
T ss_pred EEEcCCCCCHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHh-cCCeeeeechhHeeeccCCCCeEEEeecchheec
Confidence 9999985 77665532 23679999999999999999999999 899999999999999643 237999999999887
Q ss_pred ccCCCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCC
Q 016184 236 VKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 315 (394)
Q Consensus 236 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 315 (394)
..........||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+..+.+..+.......+..
T Consensus 177 ~~~~~~~~~~gT~~Y~aPEv~~~~~-~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~-------- 247 (350)
T d1koaa2 177 DPKQSVKVTTGTAEFAAPEVAEGKP-VGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDS-------- 247 (350)
T ss_dssp CTTSCEEEECSCTTTCCHHHHHTCC-BCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCG--------
T ss_pred ccccccceecCcccccCHHHHcCCC-CChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcc--------
Confidence 6666666788999999999997654 8999999999999999999999999888877777776632221111
Q ss_pred CcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCC
Q 016184 316 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNT 376 (394)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~ 376 (394)
....+|+++++||++||+.||++|||++|+|+||||++...+..
T Consensus 248 -----------------~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~~~~~~~~~~ 291 (350)
T d1koaa2 248 -----------------AFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGR 291 (350)
T ss_dssp -----------------GGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHSTTTSCTTCCSC
T ss_pred -----------------cccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCCCCCc
Confidence 12468999999999999999999999999999999998765543
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.1e-58 Score=409.63 Aligned_cols=250 Identities=23% Similarity=0.336 Sum_probs=206.0
Q ss_pred EEEeeEEeecCceEEEEEEECCCCcEEEEEEeccch------hhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEEEE
Q 016184 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL 157 (394)
Q Consensus 84 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 157 (394)
|++.++||+|+||+||+|++..+++.||+|++.... ..+.+|+++++.++||||+++++++.... .....+++
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~-~~~~~~~i 89 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV-KGKKCIVL 89 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEES-SSCEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeecc-ccCCEEEE
Confidence 578889999999999999999999999999885432 33568999999999999999999885543 33456789
Q ss_pred EEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCC--ceeccCCCCceEEeC-CCCcEEEEeecCcc
Q 016184 158 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG--ICHRDIKPQNLLVNP-HTHQLKLCDFGSAK 233 (394)
Q Consensus 158 v~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~g--ivH~Dlkp~Nil~~~-~~~~vkl~Dfg~a~ 233 (394)
||||+++ +|.+++.. ...+++..++.++.||+.||+|||+ ++ |+||||||+|||++. ++ .+||+|||+|+
T Consensus 90 vmE~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~gl~yLH~-~~~~IiHrDiKp~NILl~~~~~-~~Kl~DFGla~ 163 (270)
T d1t4ha_ 90 VTELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLHT-RTPPIIHRDLKCDNIFITGPTG-SVKIGDLGLAT 163 (270)
T ss_dssp EEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHT-SSSCCCCSCCCGGGEEESSTTS-CEEECCTTGGG
T ss_pred EEeCCCCCcHHHHHhc----cccccHHHHHHHHHHHHHHHHHHHH-CCCCEEeCCcChhhceeeCCCC-CEEEeecCcce
Confidence 9999985 77776654 3679999999999999999999999 78 999999999999975 55 79999999997
Q ss_pred ccccCCCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccC
Q 016184 234 VLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 313 (394)
Q Consensus 234 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 313 (394)
... ........||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+......+...+... ..+
T Consensus 164 ~~~-~~~~~~~~GT~~Y~aPE~~~~--~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~-~~~-------- 231 (270)
T d1t4ha_ 164 LKR-ASFAKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSG-VKP-------- 231 (270)
T ss_dssp GCC-TTSBEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTT-CCC--------
T ss_pred ecc-CCccCCcccCccccCHHHhCC--CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcC-CCC--------
Confidence 543 333446789999999999854 48999999999999999999999998766555444333211 111
Q ss_pred CCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCC
Q 016184 314 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFD 369 (394)
Q Consensus 314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~ 369 (394)
..++...++++.+||.+||+.||++|||++|+|+|||||
T Consensus 232 -----------------~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~Hp~fk 270 (270)
T d1t4ha_ 232 -----------------ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 270 (270)
T ss_dssp -----------------GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred -----------------cccCccCCHHHHHHHHHHccCCHhHCcCHHHHhCCcccC
Confidence 112356789999999999999999999999999999996
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-58 Score=415.44 Aligned_cols=252 Identities=25% Similarity=0.388 Sum_probs=210.7
Q ss_pred eEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccc----hhhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEEEEE
Q 016184 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLV 158 (394)
Q Consensus 83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv 158 (394)
.|++++.||+|+||+||+|+++.+|+.||||++... ...+.+|+++++.++||||+++++++.. ...+++|
T Consensus 13 ~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~-----~~~~~lv 87 (288)
T d2jfla1 13 FWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYY-----ENNLWIL 87 (288)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEE-----TTEEEEE
T ss_pred CeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEee-----CCeEEEE
Confidence 499999999999999999999999999999998542 2455689999999999999999999843 3347899
Q ss_pred Eecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCcccccc
Q 016184 159 LEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK 237 (394)
Q Consensus 159 ~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~ 237 (394)
|||+++ +|..++.. ....+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||+|+....
T Consensus 88 mEy~~~g~L~~~~~~---~~~~l~e~~~~~i~~qi~~gL~ylH~-~~ivHrDiKp~NIll~~~~-~~Kl~DFG~a~~~~~ 162 (288)
T d2jfla1 88 IEFCAGGAVDAVMLE---LERPLTESQIQVVCKQTLDALNYLHD-NKIIHRDLKAGNILFTLDG-DIKLADFGVSAKNTR 162 (288)
T ss_dssp EECCTTEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECTTS-CEEECCCTTCEECHH
T ss_pred EecCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCEEEeecChhheeECCCC-CEEEEechhhhccCC
Confidence 999985 66665443 23679999999999999999999999 8999999999999999988 699999999975533
Q ss_pred CC-CcccccccccccccccccC----CCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhcc
Q 016184 238 GE-PNVSYICSRYYRAPELIFG----ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 312 (394)
Q Consensus 238 ~~-~~~~~~~t~~y~aPE~~~~----~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 312 (394)
.. ......||+.|+|||++.. ...++.++|||||||++|+|+||+.||.+.+..+.+..+.......
T Consensus 163 ~~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~-------- 234 (288)
T d2jfla1 163 TIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPT-------- 234 (288)
T ss_dssp HHHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCC--------
T ss_pred CcccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCC--------
Confidence 21 2235678999999999842 3447899999999999999999999999888877777666521000
Q ss_pred CCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 016184 313 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE 370 (394)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~ 370 (394)
...+..+++++++||++||+.||.+|||++|+|+||||+.
T Consensus 235 ------------------~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~hp~~~~ 274 (288)
T d2jfla1 235 ------------------LAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTV 274 (288)
T ss_dssp ------------------CSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGCC
T ss_pred ------------------CCccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCC
Confidence 0012468999999999999999999999999999999974
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.9e-58 Score=420.57 Aligned_cols=253 Identities=27% Similarity=0.419 Sum_probs=198.6
Q ss_pred eeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccch-----hhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEEE
Q 016184 82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN 156 (394)
Q Consensus 82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 156 (394)
+.|++.+.||+|+||+||+|+++.+|+.||||++.+.. ....+|+.+++.++||||+++++++ .....++
T Consensus 9 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~-----~~~~~~~ 83 (307)
T d1a06a_ 9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIY-----ESGGHLY 83 (307)
T ss_dssp GTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEE-----ECSSEEE
T ss_pred cceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEE-----EECCEEE
Confidence 45999999999999999999999999999999986432 2345799999999999999999988 3344588
Q ss_pred EEEeccc-ccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeC---CCCcEEEEeecCc
Q 016184 157 LVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNP---HTHQLKLCDFGSA 232 (394)
Q Consensus 157 lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~---~~~~vkl~Dfg~a 232 (394)
+|||||+ ++|.+++.. ...+++..++.++.||+.||+|||+ +||+||||||+|||+.. ++ .+||+|||+|
T Consensus 84 lvmE~~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~al~ylH~-~~iiHrDiKp~Nil~~~~~~~~-~vkl~DFG~a 157 (307)
T d1a06a_ 84 LIMQLVSGGELFDRIVE----KGFYTERDASRLIFQVLDAVKYLHD-LGIVHRDLKPENLLYYSLDEDS-KIMISDFGLS 157 (307)
T ss_dssp EEECCCCSCBHHHHHHT----CSCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEESSSSTTC-CEEECCC---
T ss_pred EEEeccCCCcHHHhhhc----ccCCCHHHHHHHHHHHHHHHHhhhh-ceeeeEEecccceeecccCCCc-eEEEecccee
Confidence 9999998 588777653 4679999999999999999999999 89999999999999953 45 6999999999
Q ss_pred cccccCCCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhcc
Q 016184 233 KVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 312 (394)
Q Consensus 233 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 312 (394)
+............||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+....+....+.+.....+
T Consensus 158 ~~~~~~~~~~~~~GT~~y~APE~~~~~-~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~------- 229 (307)
T d1a06a_ 158 KMEDPGSVLSTACGTPGYVAPEVLAQK-PYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFD------- 229 (307)
T ss_dssp ---------------CTTSCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCC-------
T ss_pred EEccCCCeeeeeeeCccccCcHHHcCC-CCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCC-------
Confidence 877666556677899999999999665 489999999999999999999999998877666666554211111
Q ss_pred CCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 016184 313 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL 371 (394)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 371 (394)
......+|+++++||.+||+.||.+|||++|+|+||||++.
T Consensus 230 ------------------~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 270 (307)
T d1a06a_ 230 ------------------SPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGD 270 (307)
T ss_dssp ------------------TTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTTSS
T ss_pred ------------------CccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence 01224689999999999999999999999999999999864
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.6e-58 Score=419.34 Aligned_cols=251 Identities=27% Similarity=0.405 Sum_probs=210.4
Q ss_pred eEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccch-------hhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEE
Q 016184 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL 155 (394)
Q Consensus 83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 155 (394)
.|++++.||+|+||+||+|++..+|+.||||++.... ..+.+|+++++.++||||+++++++.. ...+
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~-----~~~~ 90 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR-----EHTA 90 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE-----TTEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEE-----CCEE
Confidence 4999999999999999999999999999999986432 234579999999999999999999843 3348
Q ss_pred EEEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCcccc
Q 016184 156 NLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL 235 (394)
Q Consensus 156 ~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~ 235 (394)
++|||||.++...... .....+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||+|...
T Consensus 91 ~iv~E~~~~g~l~~~~---~~~~~l~e~~~~~i~~qi~~aL~yLH~-~~iiHrDiKp~NILl~~~~-~~Kl~DFG~a~~~ 165 (309)
T d1u5ra_ 91 WLVMEYCLGSASDLLE---VHKKPLQEVEIAAVTHGALQGLAYLHS-HNMIHRDVKAGNILLSEPG-LVKLGDFGSASIM 165 (309)
T ss_dssp EEEEECCSEEHHHHHH---HHTSCCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCSGGGEEEETTT-EEEECCCTTCBSS
T ss_pred EEEEEecCCCchHHHH---HhCCCCCHHHHHHHHHHHHHHHHHHHh-CCEeccCCCcceEEECCCC-CEEEeeccccccc
Confidence 8999999976544332 234789999999999999999999999 8999999999999999887 7999999999865
Q ss_pred ccCCCcccccccccccccccccCC--CCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccC
Q 016184 236 VKGEPNVSYICSRYYRAPELIFGA--TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 313 (394)
Q Consensus 236 ~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 313 (394)
.. .....||+.|+|||++.+. ..|+.++|||||||++|+|++|+.||.+....+.+..+.......
T Consensus 166 ~~---~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~--------- 233 (309)
T d1u5ra_ 166 AP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPA--------- 233 (309)
T ss_dssp SS---BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCC---------
T ss_pred CC---CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCC---------
Confidence 33 3456799999999998642 348999999999999999999999999888777766665521100
Q ss_pred CCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q 016184 314 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD 373 (394)
Q Consensus 314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~ 373 (394)
.....+|+++.+||.+||+.||.+|||++|+|+||||++...
T Consensus 234 ------------------~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~Hp~~~~~~~ 275 (309)
T d1u5ra_ 234 ------------------LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERP 275 (309)
T ss_dssp ------------------CSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSCCC
T ss_pred ------------------CCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHhCHHhcCCCC
Confidence 012457899999999999999999999999999999987543
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=7.3e-58 Score=425.22 Aligned_cols=255 Identities=26% Similarity=0.385 Sum_probs=216.0
Q ss_pred eeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccc----hhhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEEEE
Q 016184 82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL 157 (394)
Q Consensus 82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 157 (394)
+.|++++.||+|+||+||+|+++.+|+.||||++... .....+|+++|+.++||||++++++|. ....+++
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~-----~~~~~~i 103 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFE-----DKYEMVL 103 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEE-----CSSEEEE
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEE-----ECCEEEE
Confidence 3599999999999999999999999999999998643 234467999999999999999999983 3445789
Q ss_pred EEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEe--CCCCcEEEEeecCccc
Q 016184 158 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVN--PHTHQLKLCDFGSAKV 234 (394)
Q Consensus 158 v~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~--~~~~~vkl~Dfg~a~~ 234 (394)
|||||++ +|.+.+. .....+++..++.++.||+.||+|||+ +||+||||||+|||++ .++ .+||+|||+|+.
T Consensus 104 vmE~~~gg~L~~~~~---~~~~~l~e~~~~~i~~qi~~aL~ylH~-~~iiHRDiKp~NILl~~~~~~-~vkL~DFGla~~ 178 (352)
T d1koba_ 104 ILEFLSGGELFDRIA---AEDYKMSEAEVINYMRQACEGLKHMHE-HSIVHLDIKPENIMCETKKAS-SVKIIDFGLATK 178 (352)
T ss_dssp EEECCCCCBHHHHTT---CTTCCBCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEESSTTCC-CEEECCCTTCEE
T ss_pred EEEcCCCChHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecccccccccccccCCC-eEEEeeccccee
Confidence 9999985 6644332 234579999999999999999999999 8999999999999998 345 799999999998
Q ss_pred cccCCCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCC
Q 016184 235 LVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 314 (394)
Q Consensus 235 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 314 (394)
...........+|+.|+|||++.+. .++.++|||||||++|+|+||+.||.+.+..+.+..+.......+.
T Consensus 179 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~-------- 249 (352)
T d1koba_ 179 LNPDEIVKVTTATAEFAAPEIVDRE-PVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDE-------- 249 (352)
T ss_dssp CCTTSCEEEECSSGGGCCHHHHTTC-CBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCS--------
T ss_pred cCCCCceeeccCcccccCHHHHcCC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCc--------
Confidence 7766666677899999999999655 4899999999999999999999999998888877777663222111
Q ss_pred CCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 016184 315 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR 372 (394)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 372 (394)
.....+++++.+||.+||+.||.+|||++|+|+||||++..
T Consensus 250 -----------------~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~~ 290 (352)
T d1koba_ 250 -----------------DAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDH 290 (352)
T ss_dssp -----------------STTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCC
T ss_pred -----------------ccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCCc
Confidence 11246899999999999999999999999999999998753
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-57 Score=417.31 Aligned_cols=250 Identities=27% Similarity=0.431 Sum_probs=213.7
Q ss_pred eeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccc-------hhhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeE
Q 016184 82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY 154 (394)
Q Consensus 82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 154 (394)
++|++++.||+|+||+||+|+++.+|+.||||++.+. .....+|+.+|+.++||||+++++++ .+..+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~-----~~~~~ 79 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAF-----QTHDR 79 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEE-----ECSSE
T ss_pred HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeee-----ccccc
Confidence 4699999999999999999999999999999998643 23345799999999999999999998 44455
Q ss_pred EEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCcc
Q 016184 155 LNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK 233 (394)
Q Consensus 155 ~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~ 233 (394)
+|+||||+++ +|..++.. ...+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+|+
T Consensus 80 ~~iv~ey~~gg~L~~~~~~----~~~~~e~~~~~~~~qil~al~ylH~-~~iiHRDlKP~NILl~~~g-~vkl~DFG~a~ 153 (337)
T d1o6la_ 80 LCFVMEYANGGELFFHLSR----ERVFTEERARFYGAEIVSALEYLHS-RDVVYRDIKLENLMLDKDG-HIKITDFGLCK 153 (337)
T ss_dssp EEEEEECCTTCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCCGGGEEECTTS-CEEECCCTTCB
T ss_pred cccceeccCCCchhhhhhc----ccCCcHHHHHHHHHHHhhhhhhhhh-cCccccccCHHHeEecCCC-CEEEeeccccc
Confidence 8899999996 66555443 4789999999999999999999999 8999999999999999988 69999999998
Q ss_pred cccc-CCCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhcc
Q 016184 234 VLVK-GEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 312 (394)
Q Consensus 234 ~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 312 (394)
.... .......+||+.|+|||++.+.. ++.++|||||||++|+|++|++||.+.+..+.+..+...
T Consensus 154 ~~~~~~~~~~~~~GT~~Y~aPE~~~~~~-y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~------------ 220 (337)
T d1o6la_ 154 EGISDGATMKTFCGTPEYLAPEVLEDND-YGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME------------ 220 (337)
T ss_dssp CSCCTTCCBCCCEECGGGCCGGGGSSSC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC------------
T ss_pred ccccCCcccccceeCHHHhhhhhccCCC-CChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcC------------
Confidence 7644 33445678999999999997654 899999999999999999999999998877766665541
Q ss_pred CCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCC-----CHHHHhcCCCCCCCC
Q 016184 313 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-----TALEACVHPFFDELR 372 (394)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----t~~ell~hp~f~~~~ 372 (394)
... ++..+|+++++||++||++||.+|+ +++|+++||||+++.
T Consensus 221 -----~~~------------~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~i~ 268 (337)
T d1o6la_ 221 -----EIR------------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSIN 268 (337)
T ss_dssp -----CCC------------CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCC
T ss_pred -----CCC------------CCccCCHHHHHHHHhhccCCchhhcccccccHHHHHcCcccccCC
Confidence 111 2256899999999999999999999 499999999998863
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=7.7e-57 Score=405.08 Aligned_cols=254 Identities=27% Similarity=0.400 Sum_probs=216.0
Q ss_pred eeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccch-------------hhhHHHHHHHHHcC-CCCeeeeceEEEec
Q 016184 82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------------RYKNRELQIMQMLD-HPNIVALKHCFFST 147 (394)
Q Consensus 82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------------~~~~~E~~~l~~l~-h~~iv~~~~~~~~~ 147 (394)
++|++.+.||+|+||+||+|+++.+|+.||||++.+.. ....+|+.+++.++ ||||+++++++
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~--- 79 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY--- 79 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE---
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeec---
Confidence 35999999999999999999999999999999985431 13457999999997 99999999998
Q ss_pred CCCceeEEEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEE
Q 016184 148 TDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKL 226 (394)
Q Consensus 148 ~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl 226 (394)
.+...+|+||||+++ +|.+++.. ...+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||
T Consensus 80 --~~~~~~~ivmE~~~~g~L~~~l~~----~~~l~e~~~~~~~~qi~~al~~lH~-~~ivHrDlkp~Nill~~~~-~~kl 151 (277)
T d1phka_ 80 --ETNTFFFLVFDLMKKGELFDYLTE----KVTLSEKETRKIMRALLEVICALHK-LNIVHRDLKPENILLDDDM-NIKL 151 (277)
T ss_dssp --ECSSEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECTTC-CEEE
T ss_pred --ccCcceEEEEEcCCCchHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-cCCcccccccceEEEcCCC-CeEE
Confidence 344558899999985 88877754 4689999999999999999999999 8999999999999999888 6999
Q ss_pred EeecCccccccCCCcccccccccccccccccC-----CCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHh
Q 016184 227 CDFGSAKVLVKGEPNVSYICSRYYRAPELIFG-----ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVL 301 (394)
Q Consensus 227 ~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~-----~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~ 301 (394)
+|||+++............||+.|+|||.+.+ ...++.++||||+||++|+|++|+.||.+.+.......+....
T Consensus 152 ~DFG~a~~~~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~ 231 (277)
T d1phka_ 152 TDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGN 231 (277)
T ss_dssp CCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC
T ss_pred ccchheeEccCCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCC
Confidence 99999988766666666789999999999852 3347889999999999999999999999888777776666521
Q ss_pred CCCChhhhhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 016184 302 GTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL 371 (394)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 371 (394)
-..+. .....+|+++++||.+||+.||.+|||++|+|+||||++.
T Consensus 232 ~~~~~-------------------------~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~~ 276 (277)
T d1phka_ 232 YQFGS-------------------------PEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQY 276 (277)
T ss_dssp CCCCT-------------------------TTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTT
T ss_pred CCCCC-------------------------cccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHHh
Confidence 11110 0124689999999999999999999999999999999875
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=5.7e-57 Score=413.62 Aligned_cols=249 Identities=27% Similarity=0.470 Sum_probs=212.3
Q ss_pred eeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccc-------hhhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeE
Q 016184 82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY 154 (394)
Q Consensus 82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 154 (394)
.+|++++.||+|+||+||+|+++.+|+.||||++.+. .....+|+.+++.++||||+++++++. ....
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~-----~~~~ 78 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQ-----DAQQ 78 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEE-----CSSE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEe-----eCCe
Confidence 3599999999999999999999999999999998643 234567999999999999999999983 3445
Q ss_pred EEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCcc
Q 016184 155 LNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK 233 (394)
Q Consensus 155 ~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~ 233 (394)
+++||||+.+ ++..++. ....+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+|+
T Consensus 79 ~~ivmE~~~gg~l~~~~~----~~~~~~~~~~~~~~~qi~~al~~lH~-~~iiHrDiKp~NILl~~~g-~vkL~DFG~a~ 152 (316)
T d1fota_ 79 IFMIMDYIEGGELFSLLR----KSQRFPNPVAKFYAAEVCLALEYLHS-KDIIYRDLKPENILLDKNG-HIKITDFGFAK 152 (316)
T ss_dssp EEEEECCCCSCBHHHHHH----HTSSCCHHHHHHHHHHHHHHHHHHHT-TTEECCCCCGGGEEECTTS-CEEECCCSSCE
T ss_pred eeeEeeecCCcccccccc----ccccccccHHHHHHHHHHHhhhhhcc-CcEEccccCchheeEcCCC-CEEEecCccce
Confidence 8899999986 4444433 35778999999999999999999999 8999999999999999988 69999999998
Q ss_pred ccccCCCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccC
Q 016184 234 VLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 313 (394)
Q Consensus 234 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 313 (394)
.... ......||+.|+|||++.+. .++.++|||||||++|+|+||+.||.+.+..+.+..+....
T Consensus 153 ~~~~--~~~~~~Gt~~Y~APE~l~~~-~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~------------ 217 (316)
T d1fota_ 153 YVPD--VTYTLCGTPDYIAPEVVSTK-PYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAE------------ 217 (316)
T ss_dssp ECSS--CBCCCCSCTTTCCHHHHTTC-CBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCC------------
T ss_pred Eecc--ccccccCcccccCHHHHcCC-CCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCC------------
Confidence 7643 33467899999999999654 48999999999999999999999999888777777766521
Q ss_pred CCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCC-----CHHHHhcCCCCCCCCC
Q 016184 314 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-----TALEACVHPFFDELRD 373 (394)
Q Consensus 314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----t~~ell~hp~f~~~~~ 373 (394)
.. ++..+++++.++|.+||+.||.+|+ |++++|+||||+++..
T Consensus 218 -----~~------------~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~Hp~f~~i~~ 265 (316)
T d1fota_ 218 -----LR------------FPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVW 265 (316)
T ss_dssp -----CC------------CCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCCH
T ss_pred -----CC------------CCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcCcccccCCH
Confidence 11 1245799999999999999999996 9999999999999753
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1.6e-56 Score=406.65 Aligned_cols=277 Identities=35% Similarity=0.630 Sum_probs=223.0
Q ss_pred eeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccc------hhhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEE
Q 016184 82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL 155 (394)
Q Consensus 82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 155 (394)
++|+++++||+|+||+||+|+++ +|+.||||++... .....+|+.+|+.++||||+++++++.... ..
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~-----~~ 75 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKK-----RL 75 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSS-----CE
T ss_pred CCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCC-----ce
Confidence 36999999999999999999995 7899999998543 234568999999999999999999984433 37
Q ss_pred EEEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCcccc
Q 016184 156 NLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL 235 (394)
Q Consensus 156 ~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~ 235 (394)
+++||++.+++...+. .....+++..++.++.||+.||+|||+ .|||||||||+|||++.++ .+||+|||.+...
T Consensus 76 ~i~~e~~~~~~~~~~~---~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~IvHrDiKp~NIll~~~~-~~kl~DfG~a~~~ 150 (286)
T d1ob3a_ 76 VLVFEHLDQDLKKLLD---VCEGGLESVTAKSFLLQLLNGIAYCHD-RRVLHRDLKPQNLLINREG-ELKIADFGLARAF 150 (286)
T ss_dssp EEEEECCSEEHHHHHH---TSTTCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECTTS-CEEECCTTHHHHH
T ss_pred eEEEEeehhhhHHHHH---hhcCCcchhhhHHHHHHHHHHHHHhcc-CcEEecCCCCceeeEcCCC-CEEecccccceec
Confidence 8999999987755443 334789999999999999999999999 8999999999999999988 6999999999776
Q ss_pred ccCCC-cccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCC
Q 016184 236 VKGEP-NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 314 (394)
Q Consensus 236 ~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 314 (394)
..... .....+++.|+|||.+.+...++.++|||||||++|+|++|+.||.+.+..+.+..+....+.+....+.....
T Consensus 151 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 230 (286)
T d1ob3a_ 151 GIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTE 230 (286)
T ss_dssp CC---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGG
T ss_pred ccCccccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhh
Confidence 44322 34456899999999998777789999999999999999999999999988899999999888877665543221
Q ss_pred CCc-ccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 016184 315 NYT-EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE 370 (394)
Q Consensus 315 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~ 370 (394)
... ..........++. .+...+++++++||++||++||++|||++|+|+||||++
T Consensus 231 ~~~~~~~~~~~~~~~~~-~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~ 286 (286)
T d1ob3a_ 231 LPKYDPNFTVYEPLPWE-SFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286 (286)
T ss_dssp STTCCTTCCCCCCCCGG-GTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred hhhcccccccccCcchh-hhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCc
Confidence 111 1111111222222 234678999999999999999999999999999999985
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-58 Score=422.32 Aligned_cols=281 Identities=25% Similarity=0.432 Sum_probs=206.5
Q ss_pred ceeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccc-----hhhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEE
Q 016184 81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL 155 (394)
Q Consensus 81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 155 (394)
.++|++++.||+|+||+||+|+++.+|+.||+|++... .....+|+.+|+.++||||++++++|.. ...+
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~-----~~~~ 79 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS-----DGEI 79 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEEC-----SSEE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE-----CCEE
Confidence 34699999999999999999999999999999998643 2345689999999999999999999943 3448
Q ss_pred EEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCccc
Q 016184 156 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV 234 (394)
Q Consensus 156 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~ 234 (394)
++||||+.+ +|.+++.. ...+++..++.++.|++.||.|||+.+||+||||||+|||++.++ .+||+|||+|+.
T Consensus 80 ~iVmEy~~gg~L~~~l~~----~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~-~vkl~DFGla~~ 154 (322)
T d1s9ja_ 80 SICMEHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRG-EIKLCDFGVSGQ 154 (322)
T ss_dssp EEEEECCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTC-CEEECCCCCCHH
T ss_pred EEEEEcCCCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCC-CEEEeeCCCccc
Confidence 899999995 77776654 367999999999999999999999614999999999999999888 699999999986
Q ss_pred cccCCCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHH-HHHHHHHhCCCChhhhhccC
Q 016184 235 LVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQ-LVEIIKVLGTPTREEIKCMN 313 (394)
Q Consensus 235 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~~ 313 (394)
.... ...+..||+.|+|||++.+. .|+.++||||+||++|||++|+.||.+.+..+. ........+...........
T Consensus 155 ~~~~-~~~~~~GT~~Y~APEvl~~~-~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (322)
T d1s9ja_ 155 LIDS-MANSFVGTRSYMSPERLQGT-HYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRT 232 (322)
T ss_dssp HHHH-TC---CCSSCCCCHHHHHCS-CCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-----------------
T ss_pred cCCC-ccccccCCccccCchHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccc
Confidence 5432 23456899999999999765 499999999999999999999999987654322 21112212211110000000
Q ss_pred CC--Cccc---CCCCC---------CCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q 016184 314 PN--YTEF---KFPQI---------KPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD 373 (394)
Q Consensus 314 ~~--~~~~---~~~~~---------~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~ 373 (394)
.. .... ..+.. ............+|.++++||.+||+.||.+|||++|+|+||||++...
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~~~ 306 (322)
T d1s9ja_ 233 PGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDA 306 (322)
T ss_dssp -------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHHHH
T ss_pred ccccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcCCc
Confidence 00 0000 00000 0000001111346889999999999999999999999999999987543
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-56 Score=413.60 Aligned_cols=285 Identities=33% Similarity=0.606 Sum_probs=228.1
Q ss_pred eeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccch------hhhHHHHHHHHHcCCCCeeeeceEEEecCC-CceeE
Q 016184 82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTD-KEELY 154 (394)
Q Consensus 82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~~~~~ 154 (394)
.+|++++.||+|+||+||+|+++.+|+.||||++.+.. ....+|+++|+.++||||++++++|..... .....
T Consensus 18 ~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~ 97 (346)
T d1cm8a_ 18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTD 97 (346)
T ss_dssp SSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCC
T ss_pred CcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccce
Confidence 46999999999999999999999999999999986432 234579999999999999999999854432 22345
Q ss_pred EEEEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCccc
Q 016184 155 LNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV 234 (394)
Q Consensus 155 ~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~ 234 (394)
+|+||||++.++..+... ..+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+|+.
T Consensus 98 ~~lv~e~~~~~l~~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~-~~IiHrDiKp~NIL~~~~~-~~kl~Dfg~a~~ 170 (346)
T d1cm8a_ 98 FYLVMPFMGTDLGKLMKH-----EKLGEDRIQFLVYQMLKGLRYIHA-AGIIHRDLKPGNLAVNEDC-ELKILDFGLARQ 170 (346)
T ss_dssp CEEEEECCSEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECTTC-CEEECCCTTCEE
T ss_pred EEEEEecccccHHHHHHh-----ccccHHHHHHHHHHHHHHHHHHHh-CCCcccccCcchhhccccc-ccccccccceec
Confidence 789999998887776653 679999999999999999999999 8999999999999999988 699999999986
Q ss_pred cccCCCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCC
Q 016184 235 LVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 314 (394)
Q Consensus 235 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 314 (394)
.. .......+|+.|+|||++.+...++.++||||+||++|+|++|+.||.+.+....+..+....+.++...+.....
T Consensus 171 ~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (346)
T d1cm8a_ 171 AD--SEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQS 248 (346)
T ss_dssp CC--SSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSC
T ss_pred cC--CccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcc
Confidence 53 3345678899999999998777789999999999999999999999999999999999999999988876654332
Q ss_pred CCcc---cCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCC
Q 016184 315 NYTE---FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNT 376 (394)
Q Consensus 315 ~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~ 376 (394)
.... ...+......+... ...+++++.+||++||+.||.+|||++|+|+||||+++.+...
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~-~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~~~~~ 312 (346)
T d1cm8a_ 249 DEAKNYMKGLPELEKKDFASI-LTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTED 312 (346)
T ss_dssp HHHHHHHHHSCCCCCCCGGGT-CTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC----
T ss_pred hhhhhhhccCCcccccchHHh-ccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCCCccc
Confidence 1110 11222223333332 2568999999999999999999999999999999999876554
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-56 Score=412.81 Aligned_cols=255 Identities=26% Similarity=0.383 Sum_probs=216.6
Q ss_pred eeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccch---hhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEEEEE
Q 016184 82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLV 158 (394)
Q Consensus 82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv 158 (394)
++|++++.||+|+||+||+|+++.+|+.||||++.... ....+|+++|+.++||||+++++++.. ...+|+|
T Consensus 5 ~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~-----~~~~~lv 79 (321)
T d1tkia_ 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFES-----MEELVMI 79 (321)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEE-----TTEEEEE
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcccHHHHHHHHHHHHhCCCCCCCeEEEEEEE-----CCEEEEE
Confidence 35999999999999999999999999999999987543 335689999999999999999999843 3458899
Q ss_pred Eecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCC-CcEEEEeecCccccc
Q 016184 159 LEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHT-HQLKLCDFGSAKVLV 236 (394)
Q Consensus 159 ~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~-~~vkl~Dfg~a~~~~ 236 (394)
||||.+ +|.+.+.. ....+++..++.++.||+.||+|||+ +||+||||||+|||++.++ ..+||+|||+++...
T Consensus 80 mE~~~gg~L~~~i~~---~~~~l~e~~~~~i~~qi~~al~yLH~-~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~ 155 (321)
T d1tkia_ 80 FEFISGLDIFERINT---SAFELNEREIVSYVHQVCEALQFLHS-HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK 155 (321)
T ss_dssp ECCCCCCBHHHHHTS---SSCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEESSSSCCCEEECCCTTCEECC
T ss_pred EecCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH-cCCCcccccccceeecCCCceEEEEcccchhhccc
Confidence 999985 77665543 23479999999999999999999999 8999999999999998543 369999999998776
Q ss_pred cCCCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCCC
Q 016184 237 KGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 316 (394)
Q Consensus 237 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 316 (394)
.........+|+.|+|||.+.+. .++.++|||||||++|+|++|..||.+.+..+.+..+.+.....+..
T Consensus 156 ~~~~~~~~~~t~~y~ape~~~~~-~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~--------- 225 (321)
T d1tkia_ 156 PGDNFRLLFTAPEYYAPEVHQHD-VVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEE--------- 225 (321)
T ss_dssp TTCEEEEEESCGGGSCHHHHTTC-EECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHH---------
T ss_pred cCCcccccccccccccchhccCC-CCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChh---------
Confidence 65556667889999999998654 48999999999999999999999999988888887777643222222
Q ss_pred cccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 016184 317 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL 371 (394)
Q Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 371 (394)
....+|+++++||.+||+.||.+|||++|+|+||||++.
T Consensus 226 ----------------~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~ 264 (321)
T d1tkia_ 226 ----------------AFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQK 264 (321)
T ss_dssp ----------------HHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred ----------------hccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccC
Confidence 124589999999999999999999999999999999764
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=3.6e-56 Score=415.93 Aligned_cols=253 Identities=25% Similarity=0.382 Sum_probs=206.1
Q ss_pred eeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccch-------hhhHHH---HHHHHHcCCCCeeeeceEEEecCCCc
Q 016184 82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRE---LQIMQMLDHPNIVALKHCFFSTTDKE 151 (394)
Q Consensus 82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E---~~~l~~l~h~~iv~~~~~~~~~~~~~ 151 (394)
++|++.++||+|+||.||+|+++.+|+.||||++.+.. ....+| +.+++.++||||+++++++. .
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~-----~ 78 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFH-----T 78 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEE-----C
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEE-----E
Confidence 35999999999999999999999999999999985432 112233 55666678999999999883 3
Q ss_pred eeEEEEEEeccc-ccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeec
Q 016184 152 ELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFG 230 (394)
Q Consensus 152 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg 230 (394)
...+|+||||++ ++|..++.. ...+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||
T Consensus 79 ~~~~~ivmE~~~gg~L~~~l~~----~~~~~e~~~~~~~~qi~~aL~ylH~-~~iiHrDlKP~NILl~~~g-~iKl~DFG 152 (364)
T d1omwa3 79 PDKLSFILDLMNGGDLHYHLSQ----HGVFSEADMRFYAAEIILGLEHMHN-RFVVYRDLKPANILLDEHG-HVRISDLG 152 (364)
T ss_dssp SSEEEEEECCCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECSSS-CEEECCCT
T ss_pred CCEEEEEEEecCCCcHHHHHHh----cccccHHHHHHHHHHHHHHHHHHHH-CCccceeeccceeEEcCCC-cEEEeeec
Confidence 344789999998 477776654 4678999999999999999999999 8999999999999999888 69999999
Q ss_pred CccccccCCCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhh
Q 016184 231 SAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 310 (394)
Q Consensus 231 ~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 310 (394)
+|+..... ......||+.|+|||++.....++.++|||||||++|+|+||+.||.+....+...........+
T Consensus 153 la~~~~~~-~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~------ 225 (364)
T d1omwa3 153 LACDFSKK-KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMA------ 225 (364)
T ss_dssp TCEECSSS-CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSCC------
T ss_pred eeeecCCC-cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCC------
Confidence 99866443 34456899999999999765668999999999999999999999998765443332222211110
Q ss_pred ccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCC-----HHHHhcCCCCCCCC
Q 016184 311 CMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCT-----ALEACVHPFFDELR 372 (394)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt-----~~ell~hp~f~~~~ 372 (394)
..++..+++++++||.+||+.||.+||| |+|+++||||+++.
T Consensus 226 --------------------~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i~ 272 (364)
T d1omwa3 226 --------------------VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLD 272 (364)
T ss_dssp --------------------CCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTTCC
T ss_pred --------------------CCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcCccccCCC
Confidence 0122468999999999999999999999 89999999999874
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=5.4e-56 Score=412.58 Aligned_cols=249 Identities=26% Similarity=0.411 Sum_probs=211.8
Q ss_pred eeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccch-------hhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeE
Q 016184 82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY 154 (394)
Q Consensus 82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 154 (394)
++|++++.||+|+||.||+|+++.+|+.||||++.+.. ....+|+.+|+.++||||+++++++. ....
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~-----~~~~ 115 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK-----DNSN 115 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEE-----CSSE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccc-----cccc
Confidence 46999999999999999999999999999999986432 23457999999999999999999883 3445
Q ss_pred EEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCcc
Q 016184 155 LNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK 233 (394)
Q Consensus 155 ~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~ 233 (394)
.++||||+.+ ++...+.. ...+++..++.++.||+.||.|||+ +|||||||||+|||++.++ .+||+|||+|+
T Consensus 116 ~~~v~e~~~~g~l~~~l~~----~~~l~e~~~~~i~~qi~~aL~yLH~-~~iiHRDIKP~NILl~~~g-~ikL~DFG~a~ 189 (350)
T d1rdqe_ 116 LYMVMEYVAGGEMFSHLRR----IGRFSEPHARFYAAQIVLTFEYLHS-LDLIYRDLKPENLLIDQQG-YIQVTDFGFAK 189 (350)
T ss_dssp EEEEEECCTTCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECTTS-CEEECCCTTCE
T ss_pred cccccccccccchhhhHhh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCEecCcCCHHHcccCCCC-CEEeeeceeee
Confidence 7899999985 55555443 3679999999999999999999999 8999999999999999888 69999999998
Q ss_pred ccccCCCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccC
Q 016184 234 VLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 313 (394)
Q Consensus 234 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 313 (394)
.... ......||+.|||||++.+. .++.++|||||||++|+|+||+.||.+.+....+..+.....
T Consensus 190 ~~~~--~~~~~~Gt~~Y~APE~~~~~-~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~----------- 255 (350)
T d1rdqe_ 190 RVKG--RTWTLCGTPEALAPEIILSK-GYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV----------- 255 (350)
T ss_dssp ECSS--CBCCCEECGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC-----------
T ss_pred eccc--ccccccCccccCCHHHHcCC-CCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCC-----------
Confidence 7643 33457899999999999765 489999999999999999999999998887777776655211
Q ss_pred CCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCC-----CHHHHhcCCCCCCCCC
Q 016184 314 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-----TALEACVHPFFDELRD 373 (394)
Q Consensus 314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----t~~ell~hp~f~~~~~ 373 (394)
. ++..+++++.+||++||+.||.+|+ |++++++||||+++..
T Consensus 256 ------~------------~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp~f~~~~~ 302 (350)
T d1rdqe_ 256 ------R------------FPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDW 302 (350)
T ss_dssp ------C------------CCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCCH
T ss_pred ------C------------CCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcCccccCCCH
Confidence 1 1246899999999999999999995 9999999999998753
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-56 Score=404.15 Aligned_cols=245 Identities=25% Similarity=0.393 Sum_probs=203.1
Q ss_pred eeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccch----------hhhHHHHHHHHHcC--CCCeeeeceEEEecCC
Q 016184 82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK----------RYKNRELQIMQMLD--HPNIVALKHCFFSTTD 149 (394)
Q Consensus 82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----------~~~~~E~~~l~~l~--h~~iv~~~~~~~~~~~ 149 (394)
++|++.++||+|+||+||+|++..+|+.||||++.+.. ....+|+.+++.++ ||||+++++++.
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~---- 79 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFE---- 79 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEE----
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEe----
Confidence 35999999999999999999999999999999986432 22458999999996 899999999883
Q ss_pred CceeEEEEEEecccc--cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEE
Q 016184 150 KEELYLNLVLEYVPE--TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLC 227 (394)
Q Consensus 150 ~~~~~~~lv~e~~~~--~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~ 227 (394)
.....++||||+.+ ++..++.. ...+++..++.++.||+.||+|||+ +||+||||||+|||++.+...+||+
T Consensus 80 -~~~~~~lv~e~~~~~~~l~~~~~~----~~~l~e~~~~~~~~qi~~al~~lH~-~~iiHrDiKp~NIll~~~~~~vkl~ 153 (273)
T d1xwsa_ 80 -RPDSFVLILERPEPVQDLFDFITE----RGALQEELARSFFWQVLEAVRHCHN-CGVLHRDIKDENILIDLNRGELKLI 153 (273)
T ss_dssp -CSSEEEEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEETTTTEEEEC
T ss_pred -eCCeEEEEEEeccCcchHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHH-CCCccccCcccceEEecCCCeEEEC
Confidence 33447899999974 45444433 4789999999999999999999999 8999999999999999765579999
Q ss_pred eecCccccccCCCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChh
Q 016184 228 DFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 307 (394)
Q Consensus 228 Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~ 307 (394)
|||+|+.... .......||+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+ .+.+.
T Consensus 154 DFG~a~~~~~-~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~------~i~~~------- 219 (273)
T d1xwsa_ 154 DFGSGALLKD-TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRG------- 219 (273)
T ss_dssp CCTTCEECCS-SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHC-------
T ss_pred ccccceeccc-ccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch------HHhhc-------
Confidence 9999976533 334467899999999999766656788999999999999999999997532 12221
Q ss_pred hhhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 016184 308 EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR 372 (394)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 372 (394)
.. .++..+|+++++||++||+.||++|||++|+|+||||+++.
T Consensus 220 ----------~~------------~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~~ 262 (273)
T d1xwsa_ 220 ----------QV------------FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL 262 (273)
T ss_dssp ----------CC------------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCC
T ss_pred ----------cc------------CCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCCC
Confidence 00 12256899999999999999999999999999999999864
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-55 Score=404.93 Aligned_cols=250 Identities=28% Similarity=0.516 Sum_probs=209.3
Q ss_pred eeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccch-------hhhHHHHHHH-HHcCCCCeeeeceEEEecCCCcee
Q 016184 82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIM-QMLDHPNIVALKHCFFSTTDKEEL 153 (394)
Q Consensus 82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l-~~l~h~~iv~~~~~~~~~~~~~~~ 153 (394)
++|++++.||+|+||+||+|+++.+|+.||||++.+.. ....+|..++ +.++||||+++++++ ....
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~-----~~~~ 76 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTF-----QTKE 76 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEE-----ECSS
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEE-----ccCC
Confidence 35999999999999999999999999999999986432 1233455555 468999999999998 3344
Q ss_pred EEEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCc
Q 016184 154 YLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA 232 (394)
Q Consensus 154 ~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a 232 (394)
.+|+||||+++ +|..++.. ...+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||++
T Consensus 77 ~~yivmEy~~~g~L~~~i~~----~~~~~e~~~~~~~~qi~~al~ylH~-~~iiHrDikp~NiL~~~~~-~~kl~DFG~a 150 (320)
T d1xjda_ 77 NLFFVMEYLNGGDLMYHIQS----CHKFDLSRATFYAAEIILGLQFLHS-KGIVYRDLKLDNILLDKDG-HIKIADFGMC 150 (320)
T ss_dssp EEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCCGGGEEECTTS-CEEECCCTTC
T ss_pred ceeEEEeecCCCcHHHHhhc----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeeeccCcccceeecCCC-ceeccccchh
Confidence 58899999985 77766654 4679999999999999999999999 8999999999999999888 6999999999
Q ss_pred cccccCC-CcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhc
Q 016184 233 KVLVKGE-PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 311 (394)
Q Consensus 233 ~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 311 (394)
+...... ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+.+..+... .+
T Consensus 151 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~--~~------- 220 (320)
T d1xjda_ 151 KENMLGDAKTNTFCGTPDYIAPEILLGQ-KYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMD--NP------- 220 (320)
T ss_dssp BCCCCTTCCBCCCCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--CC-------
T ss_pred hhcccccccccccCCCCCcCCHHHHcCC-CCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcC--CC-------
Confidence 8654433 33446789999999999765 4899999999999999999999999988877766666441 11
Q ss_pred cCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHH-HHhcCCCCCCCC
Q 016184 312 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTAL-EACVHPFFDELR 372 (394)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~-ell~hp~f~~~~ 372 (394)
. ++..+|+++.+||++||+.||.+|||+. ++++||||+++.
T Consensus 221 --------~------------~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~hpff~~~~ 262 (320)
T d1xjda_ 221 --------F------------YPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREIN 262 (320)
T ss_dssp --------C------------CCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTCC
T ss_pred --------C------------CCccCCHHHHHHHHHhcccCCCCCcCHHHHHHhCchhccCC
Confidence 1 2246899999999999999999999996 899999999874
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.6e-55 Score=396.53 Aligned_cols=282 Identities=33% Similarity=0.557 Sum_probs=224.4
Q ss_pred eEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccc------hhhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEEE
Q 016184 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN 156 (394)
Q Consensus 83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 156 (394)
+|++++.||+|+||+||+|++..+|+.||||++... .....+|+.+++.++||||+++++++. .....+
T Consensus 3 ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~-----~~~~~~ 77 (292)
T d1unla_ 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLH-----SDKKLT 77 (292)
T ss_dssp SEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEE-----CSSEEE
T ss_pred CCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccc-----ccccee
Confidence 699999999999999999999999999999998543 234468999999999999999999883 334478
Q ss_pred EEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCccccc
Q 016184 157 LVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV 236 (394)
Q Consensus 157 lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~ 236 (394)
++++++.+.....+ ....+.+++..++.++.|++.||+|||+ +||+||||||+|||++.++ .+||+|||.++...
T Consensus 78 iv~~~~~~~~l~~~---~~~~~~~~~~~~~~~~~q~~~aL~~lH~-~~IvHrDiKP~NIli~~~~-~~kl~DFG~a~~~~ 152 (292)
T d1unla_ 78 LVFEFCDQDLKKYF---DSCNGDLDPEIVKSFLFQLLKGLGFCHS-RNVLHRDLKPQNLLINRNG-ELKLANFGLARAFG 152 (292)
T ss_dssp EEEECCSEEHHHHH---HHTTTCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECTTC-CEEECCCTTCEECC
T ss_pred EEeeeccccccccc---cccccccchhHHHHHHHHHHHHHHHhhc-CCEeeecccCcccccccCC-ceeeeecchhhccc
Confidence 89999987653333 2345789999999999999999999999 8999999999999999887 69999999998765
Q ss_pred cCCC-cccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCC-CCCCcHHHHHHHHHHhCCCChhhhhccCC
Q 016184 237 KGEP-NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLF-PGESGVDQLVEIIKVLGTPTREEIKCMNP 314 (394)
Q Consensus 237 ~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf-~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 314 (394)
.... .....+++.|+|||.+.+...++.++|||||||++|+|++|+.|| .+.+..+.+..+....+.+....+.....
T Consensus 153 ~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (292)
T d1unla_ 153 IPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTK 232 (292)
T ss_dssp SCCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGG
T ss_pred CCCccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhh
Confidence 4432 334456888999999877666899999999999999999999885 44555677777777777776655443322
Q ss_pred CCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCC
Q 016184 315 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP 374 (394)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~ 374 (394)
.......+..............+++.+.+||++||+.||.+||||+|+|+||||+++.+|
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~~~~~ 292 (292)
T d1unla_ 233 LPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCPP 292 (292)
T ss_dssp STTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSSCSCC
T ss_pred cccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcCCCCC
Confidence 211222222222222333446789999999999999999999999999999999987654
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-55 Score=406.01 Aligned_cols=286 Identities=32% Similarity=0.627 Sum_probs=231.0
Q ss_pred eEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccch-----hhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEEEE
Q 016184 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL 157 (394)
Q Consensus 83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 157 (394)
+|++++.||+|+||+||+|+++.+|+.||||++.+.. ....+|+++|+.++||||+++++++.........++++
T Consensus 9 rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~l 88 (345)
T d1pmea_ 9 RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYL 88 (345)
T ss_dssp TEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEE
T ss_pred CeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEEE
Confidence 4999999999999999999999999999999986432 23457999999999999999999986655445556778
Q ss_pred EEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCcccccc
Q 016184 158 VLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK 237 (394)
Q Consensus 158 v~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~ 237 (394)
++++++++|.+++.. ..+++..++.++.||+.||+|||+ +|||||||||+|||++.++ .+||+|||+|.....
T Consensus 89 ~~~~~~g~L~~~l~~-----~~l~~~~i~~i~~qil~al~yLH~-~~iiHRDIKp~NILl~~~~-~~kl~DfG~a~~~~~ 161 (345)
T d1pmea_ 89 VTHLMGADLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHS-ANVLHRDLKPSNLLLNTTC-DLKICDFGLARVADP 161 (345)
T ss_dssp EEECCCEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECTTC-CEEECCCTTCEECCG
T ss_pred EEeecCCchhhhhhc-----CCCCHHHHHHHHHHHHHHHHHHHH-CCCcCCCCCcceEEECCCC-CEEEcccCceeeccC
Confidence 888888899888764 579999999999999999999999 8999999999999999888 699999999976533
Q ss_pred CC----CcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccC
Q 016184 238 GE----PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 313 (394)
Q Consensus 238 ~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 313 (394)
.. ......||+.|+|||++.....++.++||||+||++|+|++|+.||.+.+..+....+......+.........
T Consensus 162 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (345)
T d1pmea_ 162 DHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCII 241 (345)
T ss_dssp GGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCC
T ss_pred CCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhh
Confidence 22 23445689999999998666668999999999999999999999999988888888888887777765443221
Q ss_pred CC---CcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCC
Q 016184 314 PN---YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNT 376 (394)
Q Consensus 314 ~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~ 376 (394)
.. ......+.....++...+ ..+++++++||.+||+.||.+|||++|+|+||||+....+..
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~-~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~~~~~ 306 (345)
T d1pmea_ 242 NLKARNYLLSLPHKNKVPWNRLF-PNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSD 306 (345)
T ss_dssp CHHHHHHHHTSCCCCCCCHHHHC-TTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTCCGGG
T ss_pred hhhhhcccccCCccCCCCHHHhC-CCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCCCCcc
Confidence 10 011123333344444433 467899999999999999999999999999999998877654
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=2.8e-55 Score=406.14 Aligned_cols=282 Identities=29% Similarity=0.492 Sum_probs=221.2
Q ss_pred ceeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccc-hhhhHHHHHHHHHcC-CCCeeeeceEEEecCCCceeEEEEE
Q 016184 81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-KRYKNRELQIMQMLD-HPNIVALKHCFFSTTDKEELYLNLV 158 (394)
Q Consensus 81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~~lv 158 (394)
.++|+++++||+|+||+||+|+++.+|+.||||++... .....+|+++|+.+. ||||++++++|... ...++++|
T Consensus 34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~---~~~~~~~v 110 (328)
T d3bqca1 34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDP---VSRTPALV 110 (328)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSCHHHHHHHHHHHHHHTTSTTBCCEEEEEECT---TTCSEEEE
T ss_pred CcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHHHHHHHHHHHHHHhccCCCCCcEEEEEEEec---CCCceeEE
Confidence 35699999999999999999999999999999998754 345678999999995 99999999988432 23347889
Q ss_pred Eecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCcccccc
Q 016184 159 LEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK 237 (394)
Q Consensus 159 ~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~ 237 (394)
|||+.+ +|.. ..+.+++..++.++.||+.||+|||+ +||+||||||+|||++.+++.+||+|||+|+....
T Consensus 111 ~e~~~~~~L~~-------~~~~l~e~~i~~i~~qil~aL~~LH~-~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~ 182 (328)
T d3bqca1 111 FEHVNNTDFKQ-------LYQTLTDYDIRFYMYEILKALDYCHS-MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 182 (328)
T ss_dssp EECCCSCBGGG-------TTTSCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEEETTTTEEEECCGGGCEECCT
T ss_pred EeecCCCcHHH-------HhcCCCHHHHHHHHHHHHHHHHHHhh-cccccccccccceEEcCCCCeeeecccccceeccC
Confidence 999996 4322 23679999999999999999999999 89999999999999998776799999999988776
Q ss_pred CCCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCC-cHHHHHHHHHHhCCCChhhhhccCCCC
Q 016184 238 GEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGES-GVDQLVEIIKVLGTPTREEIKCMNPNY 316 (394)
Q Consensus 238 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~~~~~ 316 (394)
........+|+.|+|||.+.+...++.++||||+||++|+|++|+.||.... ..+....+...++.+....+.......
T Consensus 183 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~ 262 (328)
T d3bqca1 183 GQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE 262 (328)
T ss_dssp TCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCC
T ss_pred CCcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccc
Confidence 6666777889999999999777778999999999999999999999997654 445566666666544332221111000
Q ss_pred ccc----CCCCCCCCCcch----hccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q 016184 317 TEF----KFPQIKPHPWHK----VFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD 373 (394)
Q Consensus 317 ~~~----~~~~~~~~~~~~----~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~ 373 (394)
... .........+.. .....+++++++||++||++||.+|||++|+|+||||+.+.+
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~v~~ 327 (328)
T d3bqca1 263 LDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVK 327 (328)
T ss_dssp CCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTSCC
T ss_pred cCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCCC
Confidence 000 000111111111 122457899999999999999999999999999999998764
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-54 Score=398.95 Aligned_cols=286 Identities=29% Similarity=0.467 Sum_probs=222.3
Q ss_pred ceeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccch------hhhHHHHHHHHHcCCCCeeeeceEEEecCC---Cc
Q 016184 81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTD---KE 151 (394)
Q Consensus 81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~---~~ 151 (394)
.++|++++.||+|+||+||+|+++.+|+.||||++.... ....+|+++|+.++|+||+++++++..... ..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 457999999999999999999999999999999875432 234589999999999999999998854322 12
Q ss_pred eeEEEEEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecC
Q 016184 152 ELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS 231 (394)
Q Consensus 152 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~ 231 (394)
...++++|||+.+++.... ......+++..++.++.|++.||.|||+ +||+||||||+|||++.++ .+||+|||+
T Consensus 89 ~~~~~iv~e~~~~~~~~~~---~~~~~~~~~~~~~~i~~qil~~l~~lH~-~~ivHrDlKp~NILl~~~~-~~kl~dfg~ 163 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLL---SNVLVKFTLSEIKRVMQMLLNGLYYIHR-NKILHRDMKAANVLITRDG-VLKLADFGL 163 (318)
T ss_dssp --CEEEEEECCCEEHHHHH---TCTTCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECTTS-CEEECCCTT
T ss_pred CceEEEEEeccCCCccchh---hhcccccccHHHHHHHHHHHHHHHHhcc-CCEEecCcCchheeecCCC-cEEeeecce
Confidence 3457899999998764433 3345789999999999999999999999 8999999999999999988 699999999
Q ss_pred ccccccC-----CCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCh
Q 016184 232 AKVLVKG-----EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTR 306 (394)
Q Consensus 232 a~~~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~ 306 (394)
++..... .......||+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+....+..+.+..+.+..
T Consensus 164 ~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~ 243 (318)
T d3blha1 164 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITP 243 (318)
T ss_dssp CEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCT
T ss_pred eeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCCh
Confidence 9765422 22334578999999999987767999999999999999999999999999999999999998888776
Q ss_pred hhhhccCCCCcccCCCCCC--CCCcc-hhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 016184 307 EEIKCMNPNYTEFKFPQIK--PHPWH-KVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL 371 (394)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~--~~~~~-~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 371 (394)
+.............+.... ..... .......++++.+||.+||++||++||||+|+|+||||+..
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~~ 311 (318)
T d3blha1 244 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSD 311 (318)
T ss_dssp TTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSSS
T ss_pred hhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhccC
Confidence 6554433221111111111 11111 11122357889999999999999999999999999999854
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-55 Score=406.60 Aligned_cols=263 Identities=26% Similarity=0.355 Sum_probs=208.8
Q ss_pred eeEEEee-EEeecCceEEEEEEECCCCcEEEEEEeccchhhhHHHHHHHHH-cCCCCeeeeceEEEecCCCceeEEEEEE
Q 016184 82 VSYIAEH-VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQM-LDHPNIVALKHCFFSTTDKEELYLNLVL 159 (394)
Q Consensus 82 ~~y~~~~-~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~E~~~l~~-l~h~~iv~~~~~~~~~~~~~~~~~~lv~ 159 (394)
++|.+.. .||+|+||+||+|+++.+|+.||||++... ....+|++++.+ .+||||++++++|.... ....++|+||
T Consensus 11 ~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~-~~~~~~~ivm 88 (335)
T d2ozaa1 11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-PKARREVELHWRASQCPHIVRIVDVYENLY-AGRKCLLIVM 88 (335)
T ss_dssp GTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-HHHHHHHHHHHHHTTSTTBCCEEEEEEEEE-TTEEEEEEEE
T ss_pred cCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-HHHHHHHHHHHHhcCCCCCCeEEEEEeecc-cCCCEEEEEE
Confidence 3598875 699999999999999999999999998654 456689988654 58999999999884322 3356688999
Q ss_pred ecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCC--CcEEEEeecCccccc
Q 016184 160 EYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHT--HQLKLCDFGSAKVLV 236 (394)
Q Consensus 160 e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~--~~vkl~Dfg~a~~~~ 236 (394)
|||++ +|.+++... ....+++..++.++.||+.||+|||+ +||+||||||+|||++.+. ..+||+|||+|+...
T Consensus 89 Ey~~gg~L~~~i~~~--~~~~l~e~~~~~i~~qi~~al~ylH~-~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~ 165 (335)
T d2ozaa1 89 ECLDGGELFSRIQDR--GDQAFTEREASEIMKSIGEAIQYLHS-INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT 165 (335)
T ss_dssp ECCCSEEHHHHHHSC--SCCCEEHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEESCSSTTCCEEECCCTTCEECC
T ss_pred ECCCCCcHHHHHHhc--CCCCcCHHHHHHHHHHHHHHHHHHHH-cCCccccccccccccccccccccccccccceeeecc
Confidence 99984 888877642 23579999999999999999999999 8999999999999998632 269999999998877
Q ss_pred cCCCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCCC
Q 016184 237 KGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 316 (394)
Q Consensus 237 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 316 (394)
.........||+.|+|||++.+. .++.++|||||||++|+|+||+.||.+.+.......+......
T Consensus 166 ~~~~~~~~~gt~~y~aPE~~~~~-~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~------------- 231 (335)
T d2ozaa1 166 SHNSLTTPCYTPYYVAPEVLGPE-KYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRM------------- 231 (335)
T ss_dssp CCCCCCCCSCCCSSCCCCCCCGG-GGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCS-------------
T ss_pred CCCccccccCCcccCCcHHHcCC-CCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhc-------------
Confidence 76666778899999999998654 4899999999999999999999999877655444433321100
Q ss_pred cccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 016184 317 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL 371 (394)
Q Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 371 (394)
..+.++ ......+|+++.+||++||+.||++|||+.|+|+||||++.
T Consensus 232 ~~~~~~--------~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 278 (335)
T d2ozaa1 232 GQYEFP--------NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 278 (335)
T ss_dssp CSSSCC--------TTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTT
T ss_pred CCCCCC--------CcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhCC
Confidence 011111 11124589999999999999999999999999999999764
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-54 Score=403.57 Aligned_cols=284 Identities=31% Similarity=0.521 Sum_probs=218.9
Q ss_pred eEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccch------hhhHHHHHHHHHcCCCCeeeeceEEEecCC-CceeEE
Q 016184 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTD-KEELYL 155 (394)
Q Consensus 83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~~~~~~ 155 (394)
+|+++++||+|+||+||+|+++.+|+.||||++.+.. ....+|+.+++.++||||++++++|..... ....++
T Consensus 18 ~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~~ 97 (355)
T d2b1pa1 18 RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDV 97 (355)
T ss_dssp TEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEE
T ss_pred CeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCcee
Confidence 5999999999999999999999999999999986431 234589999999999999999999854332 245678
Q ss_pred EEEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCcccc
Q 016184 156 NLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL 235 (394)
Q Consensus 156 ~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~ 235 (394)
|+||||+.+++...+ ...+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+|++|||+++..
T Consensus 98 ~iv~Ey~~~~l~~~~------~~~~~~~~i~~~~~qil~gl~~LH~-~giiHrDlKP~Nil~~~~~-~~kl~df~~~~~~ 169 (355)
T d2b1pa1 98 YLVMELMDANLCQVI------QMELDHERMSYLLYQMLCGIKHLHS-AGIIHRDLKPSNIVVKSDC-TLKILDFGLARTA 169 (355)
T ss_dssp EEEEECCSEEHHHHH------TSCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECTTC-CEEECCCCC----
T ss_pred EEEEeccchHHHHhh------hcCCCHHHHHHHHHHHHHHHHHhhh-cccccccCCcccccccccc-ceeeechhhhhcc
Confidence 999999998875543 3678999999999999999999999 8999999999999999988 6999999998877
Q ss_pred ccCCCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCC
Q 016184 236 VKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 315 (394)
Q Consensus 236 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 315 (394)
..........+|+.|+|||++.+. .++.++||||+||++|+|++|+.||.+.+.......+....+.+..+.+......
T Consensus 170 ~~~~~~~~~~~t~~y~aPE~l~~~-~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 248 (355)
T d2b1pa1 170 GTSFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPT 248 (355)
T ss_dssp -----------CCTTCCHHHHTTC-CCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHH
T ss_pred ccccccccccccccccChhhhcCC-CCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhh
Confidence 666666677889999999999765 5899999999999999999999999999999999999998888888776544322
Q ss_pred CcccC--CCCCCCCCcc-----------hhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCC
Q 016184 316 YTEFK--FPQIKPHPWH-----------KVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 375 (394)
Q Consensus 316 ~~~~~--~~~~~~~~~~-----------~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~ 375 (394)
..... .+......+. .......++++.+||++||++||++||||+|+|+||||++..++.
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~~~~~~ 321 (355)
T d2b1pa1 249 VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDPA 321 (355)
T ss_dssp HHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGCCHH
T ss_pred HHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCCCCcc
Confidence 11100 0000011111 111223577899999999999999999999999999999865533
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-54 Score=400.71 Aligned_cols=285 Identities=35% Similarity=0.581 Sum_probs=227.7
Q ss_pred eEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccch------hhhHHHHHHHHHcCCCCeeeeceEEEecCC-CceeEE
Q 016184 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTD-KEELYL 155 (394)
Q Consensus 83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~~~~~~ 155 (394)
+|++++.||+|+||+||+|+++.+|+.||||++.+.. ....+|+++|+.++||||+++++++..... .+..+.
T Consensus 19 rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~~ 98 (348)
T d2gfsa1 19 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV 98 (348)
T ss_dssp TEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCCC
T ss_pred CeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCceE
Confidence 5999999999999999999999999999999986432 234579999999999999999998854432 233345
Q ss_pred EEEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCcccc
Q 016184 156 NLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL 235 (394)
Q Consensus 156 ~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~ 235 (394)
++++++.+++|.+++.. +++++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+|++|||++...
T Consensus 99 ~i~~~~~gg~L~~~~~~-----~~l~e~~~~~i~~qil~aL~~LH~-~giiHrDiKp~NILi~~~~-~~kl~dfg~a~~~ 171 (348)
T d2gfsa1 99 YLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS-ADIIHRDLKPSNLAVNEDC-ELKILDFGLARHT 171 (348)
T ss_dssp EEEEECCSEEHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECTTC-CEEECCC----CC
T ss_pred EEEEeecCCchhhhccc-----ccccHHHHHHHHHHHHHHHHHHHh-CCCcccccCCccccccccc-cccccccchhccc
Confidence 56666666788777643 679999999999999999999999 8999999999999999988 6999999998654
Q ss_pred ccCCCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCC
Q 016184 236 VKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 315 (394)
Q Consensus 236 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 315 (394)
. .......||+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+.......+....+.+..+........
T Consensus 172 ~--~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 249 (348)
T d2gfsa1 172 D--DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 249 (348)
T ss_dssp T--GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCH
T ss_pred C--cccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccch
Confidence 2 33445678999999999877777899999999999999999999999999999999999998888877665433221
Q ss_pred Ccc---cCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCCC
Q 016184 316 YTE---FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTR 377 (394)
Q Consensus 316 ~~~---~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~~ 377 (394)
... ..........+... ...+++++++||++||+.||.+|||++|+|+||||+++.++...
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~-~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~~~~~~ 313 (348)
T d2gfsa1 250 SARNYIQSLTQMPKMNFANV-FIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE 313 (348)
T ss_dssp HHHHHHTTSCCCCCCCHHHH-STTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCTTSC
T ss_pred hhhhhhhhcccCCCcchhhh-cCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCCCCccC
Confidence 110 11122222223222 24689999999999999999999999999999999998776543
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=3.7e-53 Score=382.34 Aligned_cols=255 Identities=27% Similarity=0.374 Sum_probs=200.6
Q ss_pred ceeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccch-------hhhHHHHHHHHHcCCCCeeeeceEEEecCCCcee
Q 016184 81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL 153 (394)
Q Consensus 81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 153 (394)
.++|++.+.||+|+||+||+|++..+|+.||||++.... ..+.+|+++++.++||||+++++++.... ....
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~-~~~~ 84 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAET-PAGP 84 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEC-SSSE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeecc-CCCc
Confidence 345999999999999999999999999999999985432 23567999999999999999999886543 3345
Q ss_pred EEEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCc
Q 016184 154 YLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA 232 (394)
Q Consensus 154 ~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a 232 (394)
..|+||||+++ +|...+.. ...+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .++|+|||.+
T Consensus 85 ~~~lvmE~~~g~~L~~~~~~----~~~l~~~~~~~i~~qi~~al~~lH~-~~iiHrDiKP~NIll~~~~-~~~l~d~~~~ 158 (277)
T d1o6ya_ 85 LPYIVMEYVDGVTLRDIVHT----EGPMTPKRAIEVIADACQALNFSHQ-NGIIHRDVKPANIMISATN-AVKVMDFGIA 158 (277)
T ss_dssp EEEEEEECCCEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEEETTS-CEEECCCTTC
T ss_pred eEEEEEECCCCCEehhhhcc----cCCCCHHHHHHHHHHHHHHHHHHHh-CCccCccccCcccccCccc-cceeehhhhh
Confidence 57899999996 56554433 4689999999999999999999999 8999999999999999888 6999999998
Q ss_pred cccccCC----CcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhh
Q 016184 233 KVLVKGE----PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 308 (394)
Q Consensus 233 ~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~ 308 (394)
....... ......||+.|+|||++.+. .++.++|||||||++|+|+||+.||.+.+..+.+..+......++.
T Consensus 159 ~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~~-- 235 (277)
T d1o6ya_ 159 RAIADSGNSVTQTAAVIGTAQYLSPEQARGD-SVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPS-- 235 (277)
T ss_dssp EECC----------------TTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCGG--
T ss_pred hhhccccccccccccccCcccccCHHHHcCC-CCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCCc--
Confidence 6543322 23456789999999999654 4899999999999999999999999988877776666553211111
Q ss_pred hhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCC-CHHHHhcCCCCC
Q 016184 309 IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-TALEACVHPFFD 369 (394)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-t~~ell~hp~f~ 369 (394)
.....+|+++.+||.+||+.||.+|| |++++ .|+|.+
T Consensus 236 -----------------------~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l-~~~l~r 273 (277)
T d1o6ya_ 236 -----------------------ARHEGLSADLDAVVLKALAKNPENRYQTAAEM-RADLVR 273 (277)
T ss_dssp -----------------------GTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHH-HHHHHH
T ss_pred -----------------------hhccCCCHHHHHHHHHHccCCHhHCHhHHHHH-HHHHHH
Confidence 12256899999999999999999999 55554 466553
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=8.3e-53 Score=381.05 Aligned_cols=247 Identities=19% Similarity=0.295 Sum_probs=201.2
Q ss_pred ceeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccc---hhhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEEEE
Q 016184 81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD---KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL 157 (394)
Q Consensus 81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 157 (394)
..+|++.+.||+|+||+||+|+++.+|+.||||++..+ ...+.+|+++++.++||||+++++++... ..+++
T Consensus 16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~-----~~~~i 90 (287)
T d1opja_ 16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE-----PPFYI 90 (287)
T ss_dssp GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSCHHHHHHHHHHHHHCCCTTBCCEEEEECSS-----SSCEE
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccchHHHHHHHHHHHHhCCCCCEecCCccEeeC-----CeeEE
Confidence 34699999999999999999999999999999998654 34456899999999999999999998432 33679
Q ss_pred EEeccc-ccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCccccc
Q 016184 158 VLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV 236 (394)
Q Consensus 158 v~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~ 236 (394)
||||++ |++..++... ....+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+|+...
T Consensus 91 v~E~~~~g~l~~~l~~~--~~~~~~~~~~~~i~~qi~~gL~yLH~-~~iiHrDlKp~NILl~~~~-~~Kl~DFG~a~~~~ 166 (287)
T d1opja_ 91 ITEFMTYGNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLEK-KNFIHRDLAARNCLVGENH-LVKVADFGLSRLMT 166 (287)
T ss_dssp EEECCTTCBHHHHHHHS--CTTTSCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECGGG-CEEECCCCCTTTCC
T ss_pred EeecccCcchHHHhhhc--cccchHHHHHHHHHHHHHHHHHHHHH-CCcccCccccCeEEECCCC-cEEEccccceeecC
Confidence 999998 4777766542 23678999999999999999999999 8999999999999999888 79999999998764
Q ss_pred cCCCc--ccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCC
Q 016184 237 KGEPN--VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 314 (394)
Q Consensus 237 ~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 314 (394)
..... ....+++.|+|||++.+. .++.++|||||||++|||++|..||........+..++.....+
T Consensus 167 ~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~~~---------- 235 (287)
T d1opja_ 167 GDTYTAHAGAKFPIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRM---------- 235 (287)
T ss_dssp SSSSEEETTEEECGGGCCHHHHHHC-CCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCC----------
T ss_pred CCCceeeccccccccccChHHHcCC-CCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcCCCC----------
Confidence 43322 234578899999998655 48999999999999999999776665555555444444321100
Q ss_pred CCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 016184 315 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV 364 (394)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 364 (394)
.++..+++++.+||.+||+.||.+|||++++++
T Consensus 236 -----------------~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~ 268 (287)
T d1opja_ 236 -----------------ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 268 (287)
T ss_dssp -----------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -----------------CCCccchHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 123568999999999999999999999999976
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-52 Score=376.94 Aligned_cols=247 Identities=21% Similarity=0.277 Sum_probs=196.2
Q ss_pred eeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccc------hhhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEE
Q 016184 82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL 155 (394)
Q Consensus 82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 155 (394)
++|++.+.||+|+||+||+|+++ ..||||++... ...+.+|++++++++||||+++++++.. . .+
T Consensus 8 ~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~----~--~~ 78 (276)
T d1uwha_ 8 GQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA----P--QL 78 (276)
T ss_dssp TCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS----S--SC
T ss_pred ccEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec----c--EE
Confidence 45999999999999999999864 35999998532 2345689999999999999999987621 1 25
Q ss_pred EEEEeccc-ccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCccc
Q 016184 156 NLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV 234 (394)
Q Consensus 156 ~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~ 234 (394)
++||||++ |+|.+++.. ....+++..+..++.||+.||+|||+ +|||||||||+|||++.++ .+||+|||+|+.
T Consensus 79 ~lv~Ey~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~gl~yLH~-~~ivHrDlKp~NiLl~~~~-~~Kl~DFGla~~ 153 (276)
T d1uwha_ 79 AIVTQWCEGSSLYHHLHI---IETKFEMIKLIDIARQTAQGMDYLHA-KSIIHRDLKSNNIFLHEDL-TVKIGDFGLATV 153 (276)
T ss_dssp EEEEECCCEEEHHHHHHT---SCCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEEETTS-SEEECCCCCSCC
T ss_pred EEEEecCCCCCHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHhc-CCEeccccCHHHEEEcCCC-CEEEccccceee
Confidence 79999998 588776653 23569999999999999999999999 8999999999999999888 699999999976
Q ss_pred cccCC---CcccccccccccccccccCC--CCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhh
Q 016184 235 LVKGE---PNVSYICSRYYRAPELIFGA--TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI 309 (394)
Q Consensus 235 ~~~~~---~~~~~~~t~~y~aPE~~~~~--~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 309 (394)
..... ......||+.|+|||++.+. ..++.++|||||||++|||+||+.||.+.+....+.........++.
T Consensus 154 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~--- 230 (276)
T d1uwha_ 154 KSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPD--- 230 (276)
T ss_dssp ------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCC---
T ss_pred ccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCc---
Confidence 54322 22345789999999998643 34799999999999999999999999988777666555543211111
Q ss_pred hccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 016184 310 KCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH 365 (394)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 365 (394)
...+...+++++.+||.+||+.||.+|||+.++++|
T Consensus 231 --------------------~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~ 266 (276)
T d1uwha_ 231 --------------------LSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILAS 266 (276)
T ss_dssp --------------------GGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred --------------------chhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 011235689999999999999999999999999976
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-52 Score=375.93 Aligned_cols=248 Identities=22% Similarity=0.309 Sum_probs=199.4
Q ss_pred eeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccc---hhhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEEEEE
Q 016184 82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD---KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLV 158 (394)
Q Consensus 82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv 158 (394)
.+|++.+.||+|+||.||+|+++ +++.||||++... ...+.+|++++++++||||+++++++.. +. .++|
T Consensus 13 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~----~~--~~iv 85 (272)
T d1qpca_ 13 ETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ----EP--IYII 85 (272)
T ss_dssp GGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS----SS--CEEE
T ss_pred HHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCcCCHHHHHHHHHHHHhCCCCCEeEEEeeecc----CC--eEEE
Confidence 46999999999999999999985 5788999998653 3446789999999999999999997621 11 4689
Q ss_pred Eecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCcccccc
Q 016184 159 LEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK 237 (394)
Q Consensus 159 ~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~ 237 (394)
|||+++ +|.+++... ....+++..+..++.||+.||.|||+ +||+||||||+||||+.++ .+||+|||+|+....
T Consensus 86 ~Ey~~~g~L~~~~~~~--~~~~l~~~~~~~i~~qi~~gl~~lH~-~~ivHrDiKp~NIll~~~~-~~Kl~DFGla~~~~~ 161 (272)
T d1qpca_ 86 TEYMENGSLVDFLKTP--SGIKLTINKLLDMAAQIAEGMAFIEE-RNYIHRDLRAANILVSDTL-SCKIADFGLARLIED 161 (272)
T ss_dssp EECCTTCBHHHHTTSH--HHHTCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECTTS-CEEECCCTTCEECSS
T ss_pred EEeCCCCcHHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCccchhheeeeccc-ceeeccccceEEccC
Confidence 999985 666554332 23569999999999999999999999 8999999999999999888 699999999987654
Q ss_pred CCC--cccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCC-CCCCCCCcHHHHHHHHHHhCCCChhhhhccCC
Q 016184 238 GEP--NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQ-PLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 314 (394)
Q Consensus 238 ~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~-~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 314 (394)
... .....+|+.|+|||++.+. .++.++|||||||++|||+||. +||......+.+..+.... .+
T Consensus 162 ~~~~~~~~~~gt~~y~APE~~~~~-~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~-~~---------- 229 (272)
T d1qpca_ 162 NEYTAREGAKFPIKWTAPEAINYG-TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGY-RM---------- 229 (272)
T ss_dssp SCEECCTTCCCCTTTSCHHHHHHC-EECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC-CC----------
T ss_pred CccccccccCCcccccChHHHhCC-CCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcC-CC----------
Confidence 332 2345678999999998654 4899999999999999999954 5555555555444443311 00
Q ss_pred CCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhc--CCCCC
Q 016184 315 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV--HPFFD 369 (394)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~--hp~f~ 369 (394)
..+..+++++.+||.+||+.||++|||++++++ |+||.
T Consensus 230 -----------------~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ft 269 (272)
T d1qpca_ 230 -----------------VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269 (272)
T ss_dssp -----------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -----------------CCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhh
Confidence 122468999999999999999999999999998 78875
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-52 Score=373.17 Aligned_cols=243 Identities=19% Similarity=0.322 Sum_probs=189.8
Q ss_pred eEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccc---hhhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEEEEEE
Q 016184 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD---KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVL 159 (394)
Q Consensus 83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~ 159 (394)
+|++.+.||+|+||+||+|++. +++.||||++... ...+.+|+++++.++||||+++++++.... ..++||
T Consensus 6 ~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~-----~~~lv~ 79 (263)
T d1sm2a_ 6 ELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQA-----PICLVF 79 (263)
T ss_dssp CEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-----SCEEEE
T ss_pred HcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCcCcHHHHHHHHHHHHhcCCCCcccccceeccCC-----ceEEEE
Confidence 5999999999999999999985 5778999998653 344568999999999999999999984332 367999
Q ss_pred ecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCccccccC
Q 016184 160 EYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG 238 (394)
Q Consensus 160 e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~~ 238 (394)
||+++ +|.+++.. ....+++..+..++.|++.||+|||+ ++|+||||||+|||++.++ .+||+|||+++.....
T Consensus 80 E~~~~g~L~~~l~~---~~~~~~~~~~~~i~~qia~gl~~lH~-~~iiHrDlKp~Nill~~~~-~~Kl~DFGla~~~~~~ 154 (263)
T d1sm2a_ 80 EFMEHGCLSDYLRT---QRGLFAAETLLGMCLDVCEGMAYLEE-ACVIHRDLAARNCLVGENQ-VIKVSDFGMTRFVLDD 154 (263)
T ss_dssp ECCTTCBHHHHHHT---TTTCCCHHHHHHHHHHHHHHHHHHHH-TTCCCTTCSGGGEEECGGG-CEEECSCC--------
T ss_pred EecCCCcHHHHhhc---cccCCCHHHHHHHHHHHHHHHHhhhc-cceeecccchhheeecCCC-CeEecccchheeccCC
Confidence 99984 77666554 23668899999999999999999999 8999999999999999888 6999999999866443
Q ss_pred CCc--ccccccccccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCC
Q 016184 239 EPN--VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 315 (394)
Q Consensus 239 ~~~--~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 315 (394)
... ....||+.|+|||++.+. .++.++|||||||++|||+| |.+||...+..+.+..+......
T Consensus 155 ~~~~~~~~~gt~~y~aPE~l~~~-~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~------------ 221 (263)
T d1sm2a_ 155 QYTSSTGTKFPVKWASPEVFSFS-RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRL------------ 221 (263)
T ss_dssp ----------CTTSCCHHHHTTC-CCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCC------------
T ss_pred CceeecceecCcccCChHHhcCC-CCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCCC------------
Confidence 322 235678999999999655 48999999999999999999 56666666655555555442110
Q ss_pred CcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 016184 316 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH 365 (394)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 365 (394)
..+..+++++.+||.+||+.||++|||++++++|
T Consensus 222 ----------------~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~ 255 (263)
T d1sm2a_ 222 ----------------YKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQ 255 (263)
T ss_dssp ----------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ----------------CCccccCHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence 1124578999999999999999999999999986
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-52 Score=384.31 Aligned_cols=249 Identities=22% Similarity=0.298 Sum_probs=201.6
Q ss_pred eeEEEeeEEeecCceEEEEEEECCCCc-----EEEEEEeccc-----hhhhHHHHHHHHHc-CCCCeeeeceEEEecCCC
Q 016184 82 VSYIAEHVVGTGSFGVVFQAKCRETGE-----IVAIKKVLQD-----KRYKNRELQIMQML-DHPNIVALKHCFFSTTDK 150 (394)
Q Consensus 82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~-----~vaiK~~~~~-----~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~ 150 (394)
++|++.++||+|+||+||+|++..+++ .||+|.+... ...+.+|+.+++++ +|||||++++++..
T Consensus 37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~---- 112 (325)
T d1rjba_ 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTL---- 112 (325)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECS----
T ss_pred HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEee----
Confidence 469999999999999999999876543 6999987542 23456799999988 89999999999843
Q ss_pred ceeEEEEEEecccc-cHHHHHHHhhh-------------------hcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccC
Q 016184 151 EELYLNLVLEYVPE-TVNRIARNYSR-------------------IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDI 210 (394)
Q Consensus 151 ~~~~~~lv~e~~~~-~l~~~~~~~~~-------------------~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dl 210 (394)
...+++|||||++ +|.+++..... ....+++..++.++.||+.||+|||+ +||+||||
T Consensus 113 -~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~-~~IiHRDl 190 (325)
T d1rjba_ 113 -SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF-KSCVHRDL 190 (325)
T ss_dssp -SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH-TTEEETTC
T ss_pred -CCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh-CCeeeccC
Confidence 2337899999984 88888765321 12458999999999999999999999 89999999
Q ss_pred CCCceEEeCCCCcEEEEeecCccccccCCCc---ccccccccccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCC
Q 016184 211 KPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN---VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFP 286 (394)
Q Consensus 211 kp~Nil~~~~~~~vkl~Dfg~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~ 286 (394)
||+|||++.++ .+||+|||+|+........ ....+|+.|+|||++.+. .++.++|||||||++|||+| |+.||.
T Consensus 191 Kp~Nill~~~~-~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~DiwS~Gvil~emlt~g~~Pf~ 268 (325)
T d1rjba_ 191 AARNVLVTHGK-VVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEG-IYTIKSDVWSYGILLWEIFSLGVNPYP 268 (325)
T ss_dssp SGGGEEEETTT-EEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred chhccccccCC-eEEEeeccccccccCCCceeeeccccCCCccCChHHHcCC-CCCcceeccchhHHHHHHHhCCCCCCC
Confidence 99999999888 7999999999876554432 245679999999998655 48999999999999999997 899999
Q ss_pred CCCcHHHHHHHHHHhCCCChhhhhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 016184 287 GESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH 365 (394)
Q Consensus 287 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 365 (394)
+.+....+..++.....+ .++..+|+++++||.+||+.||++|||++||++|
T Consensus 269 ~~~~~~~~~~~~~~~~~~---------------------------~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 320 (325)
T d1rjba_ 269 GIPVDANFYKLIQNGFKM---------------------------DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320 (325)
T ss_dssp TCCCSHHHHHHHHTTCCC---------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCHHHHHHHHHhcCCCC---------------------------CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 877766666665522111 1224679999999999999999999999999975
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.2e-52 Score=379.37 Aligned_cols=245 Identities=24% Similarity=0.362 Sum_probs=188.5
Q ss_pred eeEEEeeEEeecCceEEEEEEECCCCc---EEEEEEeccc-----hhhhHHHHHHHHHcCCCCeeeeceEEEecCCCcee
Q 016184 82 VSYIAEHVVGTGSFGVVFQAKCRETGE---IVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL 153 (394)
Q Consensus 82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~---~vaiK~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 153 (394)
..|++.++||+|+||+||+|+++.+++ .||||.+... ...+.+|+++|+.++|||||++++++... .
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-----~ 100 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKS-----T 100 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS-----S
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeC-----C
Confidence 459999999999999999999987664 5899987532 23456899999999999999999998332 2
Q ss_pred EEEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCc
Q 016184 154 YLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA 232 (394)
Q Consensus 154 ~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a 232 (394)
.+++|||||++ +|.+++.. ....+++..+..++.||+.||+|||+ +||+||||||+||||+.++ .+||+|||+|
T Consensus 101 ~~~iv~Ey~~~g~L~~~~~~---~~~~l~~~~~~~i~~qia~gl~yLH~-~~iiHrDlKp~NILl~~~~-~~Kl~DFGla 175 (299)
T d1jpaa_ 101 PVMIITEFMENGSLDSFLRQ---NDGQFTVIQLVGMLRGIAAGMKYLAD-MNYVHRDLAARNILVNSNL-VCKVSDFGLS 175 (299)
T ss_dssp SCEEEEECCTTEEHHHHHHT---TTTCSCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECTTC-CEEECCC---
T ss_pred EEEEEEEecCCCcceeeecc---ccCCCCHHHHHHHHHHHHHHHHHHhh-CCCccCccccceEEECCCC-cEEECCcccc
Confidence 37799999986 66665543 23579999999999999999999999 8999999999999999888 7999999999
Q ss_pred cccccCCCc------ccccccccccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCC
Q 016184 233 KVLVKGEPN------VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPT 305 (394)
Q Consensus 233 ~~~~~~~~~------~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~ 305 (394)
+........ ....+|+.|+|||.+.+. .++.++|||||||++|||+| |+.||.+....+.+..+.+....+
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~- 253 (299)
T d1jpaa_ 176 RFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYR-KFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLP- 253 (299)
T ss_dssp --------------------CGGGSCHHHHHSC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCC-
T ss_pred eEccCCCCcceeeecccccCCccccCHHHHhcC-CCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC-
Confidence 876443221 123568899999999654 48999999999999999998 899999887766665554321111
Q ss_pred hhhhhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 016184 306 REEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH 365 (394)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 365 (394)
.+..+++++.+||.+||+.||++|||+.|++++
T Consensus 254 ---------------------------~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~ 286 (299)
T d1jpaa_ 254 ---------------------------PPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNT 286 (299)
T ss_dssp ---------------------------CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred ---------------------------CCccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 124578999999999999999999999988764
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-52 Score=369.09 Aligned_cols=243 Identities=21% Similarity=0.300 Sum_probs=201.1
Q ss_pred eEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccc---hhhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEEEEEE
Q 016184 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD---KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVL 159 (394)
Q Consensus 83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~ 159 (394)
+|++.++||+|+||+||+|+++ +++.||||++.+. ...+.+|+.++++++||||+++++++... ..+++||
T Consensus 5 ~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~-----~~~~iv~ 78 (258)
T d1k2pa_ 5 DLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQ-----RPIFIIT 78 (258)
T ss_dssp CCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSSCHHHHHHHHHHHHTCCCTTBCCEEEEECCS-----SSEEEEE
T ss_pred HCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcCCHHHHHHHHHHHHhcCCCceeeEEEEEeeC-----CceEEEE
Confidence 5889999999999999999985 7889999998653 35567899999999999999999988432 2378999
Q ss_pred ecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCccccccC
Q 016184 160 EYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG 238 (394)
Q Consensus 160 e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~~ 238 (394)
||+.+ ++..++.. ....+++..++.++.|++.||+|||+ +||+||||||+|||++.++ .+||+|||+++.....
T Consensus 79 Ey~~~g~l~~~~~~---~~~~~~~~~~~~i~~qi~~gl~~LH~-~~iiH~dlk~~Nill~~~~-~~kl~DfG~a~~~~~~ 153 (258)
T d1k2pa_ 79 EYMANGCLLNYLRE---MRHRFQTQQLLEMCKDVCEAMEYLES-KQFLHRDLAARNCLVNDQG-VVKVSDFGLSRYVLDD 153 (258)
T ss_dssp ECCTTEEHHHHHHS---GGGCCCHHHHHHHHHHHHHHHHHHHH-TTBCCSCCSGGGEEECTTC-CEEECCCSSCCBCSSS
T ss_pred EccCCCcHHHhhhc---cccCCcHHHHHHHHHHHHHHHHHHhh-cCcccccccceeEEEcCCC-cEEECcchhheeccCC
Confidence 99984 66555433 23678999999999999999999999 8999999999999999887 6999999999765443
Q ss_pred CC--cccccccccccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCC
Q 016184 239 EP--NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 315 (394)
Q Consensus 239 ~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 315 (394)
.. .....+|+.|+|||.+.+. .++.++|||||||++|||+| |+.||.+.+..+....+.+....
T Consensus 154 ~~~~~~~~~~t~~y~aPE~~~~~-~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~~------------ 220 (258)
T d1k2pa_ 154 EYTSSVGSKFPVRWSPPEVLMYS-KFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRL------------ 220 (258)
T ss_dssp SCCCCCCSCCCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCC------------
T ss_pred CceeecccCCCCCcCCcHHhcCC-CCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCCC------------
Confidence 32 2235679999999999754 48999999999999999998 89999988877666555432110
Q ss_pred CcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 016184 316 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH 365 (394)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 365 (394)
..+..+++++.+||.+||+.||++|||++++++|
T Consensus 221 ----------------~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 254 (258)
T d1k2pa_ 221 ----------------YRPHLASEKVYTIMYSCWHEKADERPTFKILLSN 254 (258)
T ss_dssp ----------------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred ----------------CCcccccHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence 1124578999999999999999999999999987
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-52 Score=374.61 Aligned_cols=249 Identities=26% Similarity=0.332 Sum_probs=200.4
Q ss_pred ceeEEEeeE-EeecCceEEEEEEECC--CCcEEEEEEeccc-----hhhhHHHHHHHHHcCCCCeeeeceEEEecCCCce
Q 016184 81 KVSYIAEHV-VGTGSFGVVFQAKCRE--TGEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE 152 (394)
Q Consensus 81 ~~~y~~~~~-lg~G~~g~V~~~~~~~--~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 152 (394)
+++|.+.+. ||+|+||+||+|.++. ++..||||++... ...+.+|++++++++||||+++++++.. . .
T Consensus 7 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~---~ 82 (285)
T d1u59a_ 7 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-E---A 82 (285)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-S---S
T ss_pred ccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-C---e
Confidence 346888885 9999999999998764 3457999998542 2345679999999999999999998732 1 1
Q ss_pred eEEEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecC
Q 016184 153 LYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS 231 (394)
Q Consensus 153 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~ 231 (394)
+++||||+++ +|.+++.. ....+++..+..++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+
T Consensus 83 --~~lvmE~~~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~gL~ylH~-~~iiHrDlKp~Nill~~~~-~~Kl~DFGl 155 (285)
T d1u59a_ 83 --LMLVMEMAGGGPLHKFLVG---KREEIPVSNVAELLHQVSMGMKYLEE-KNFVHRDLAARNVLLVNRH-YAKISDFGL 155 (285)
T ss_dssp --EEEEEECCTTEEHHHHHTT---CTTTSCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEEEETT-EEEECCCTT
T ss_pred --EEEEEEeCCCCcHHHHhhc---cccCCCHHHHHHHHHHHHHHHHHHHh-CCeecCcCchhheeeccCC-ceeeccchh
Confidence 6799999995 77665432 23679999999999999999999999 8999999999999999888 799999999
Q ss_pred ccccccCCC----cccccccccccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCh
Q 016184 232 AKVLVKGEP----NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTR 306 (394)
Q Consensus 232 a~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~ 306 (394)
|+....... .....+|+.|+|||++.+. .++.++|||||||++|||+| |+.||.+.+..+.+..+.+.. .+
T Consensus 156 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~-~~-- 231 (285)
T d1u59a_ 156 SKALGADDSYYTARSAGKWPLKWYAPECINFR-KFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGK-RM-- 231 (285)
T ss_dssp CEECTTCSCEECCCCSSCCCGGGCCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTC-CC--
T ss_pred hhcccccccccccccccccCccccChHHHhCC-CCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-CC--
Confidence 987644332 2234578999999999655 48999999999999999998 999999887766655544311 00
Q ss_pred hhhhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHH---hcCCCCC
Q 016184 307 EEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEA---CVHPFFD 369 (394)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~el---l~hp~f~ 369 (394)
.++..+|+++.+||.+||+.||++|||+.++ |+|+|+.
T Consensus 232 -------------------------~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~ 272 (285)
T d1u59a_ 232 -------------------------ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 272 (285)
T ss_dssp -------------------------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -------------------------CCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 1235689999999999999999999999877 6788774
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-52 Score=383.35 Aligned_cols=257 Identities=28% Similarity=0.443 Sum_probs=206.3
Q ss_pred ceeEEEeeEEeecCceEEEEEEE---CCCCcEEEEEEeccc--------hhhhHHHHHHHHHcCC-CCeeeeceEEEecC
Q 016184 81 KVSYIAEHVVGTGSFGVVFQAKC---RETGEIVAIKKVLQD--------KRYKNRELQIMQMLDH-PNIVALKHCFFSTT 148 (394)
Q Consensus 81 ~~~y~~~~~lg~G~~g~V~~~~~---~~~~~~vaiK~~~~~--------~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~ 148 (394)
.++|++++.||+|+||+||+|++ +.+|+.||||++.+. .....+|++++++++| |||+++++++.
T Consensus 23 l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~--- 99 (322)
T d1vzoa_ 23 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQ--- 99 (322)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEE---
T ss_pred hhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeec---
Confidence 35699999999999999999987 446899999988542 2334579999999977 79999998883
Q ss_pred CCceeEEEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEE
Q 016184 149 DKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLC 227 (394)
Q Consensus 149 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~ 227 (394)
.....+++|||+.+ +|...+.. ...+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+
T Consensus 100 --~~~~~~~v~e~~~~~~L~~~i~~----~~~~~e~~~~~~~~Qi~~al~~lH~-~~ivHrDiKp~Nill~~~~-~vkL~ 171 (322)
T d1vzoa_ 100 --TETKLHLILDYINGGELFTHLSQ----RERFTEHEVQIYVGEIVLALEHLHK-LGIIYRDIKLENILLDSNG-HVVLT 171 (322)
T ss_dssp --ETTEEEEEECCCCSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECTTS-CEEES
T ss_pred --cCCceeeeeecccccHHHHHHHh----cccccHHHHHHHHHHHHHHHHHhhc-CCEEeccCCccceeecCCC-CEEEe
Confidence 33458899999985 66665543 4678899999999999999999999 8999999999999999988 69999
Q ss_pred eecCccccccCC--CcccccccccccccccccCCC-CCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCC
Q 016184 228 DFGSAKVLVKGE--PNVSYICSRYYRAPELIFGAT-EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTP 304 (394)
Q Consensus 228 Dfg~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~-~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~ 304 (394)
|||+++...... ......|++.|+|||.+.+.. .++.++|||||||++|+|++|+.||.+....+....+.+.....
T Consensus 172 DFG~a~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~ 251 (322)
T d1vzoa_ 172 DFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKS 251 (322)
T ss_dssp CSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHC
T ss_pred eccchhhhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccC
Confidence 999997654322 234567899999999996543 47889999999999999999999998876555544444321100
Q ss_pred ChhhhhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCC-----CHHHHhcCCCCCCCCC
Q 016184 305 TREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-----TALEACVHPFFDELRD 373 (394)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----t~~ell~hp~f~~~~~ 373 (394)
. . .++..+++++++||.+||+.||.+|| |++|+|+||||+++..
T Consensus 252 ~-------------~------------~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i~~ 300 (322)
T d1vzoa_ 252 E-------------P------------PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINW 300 (322)
T ss_dssp C-------------C------------CCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCH
T ss_pred C-------------C------------CCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcCCCH
Confidence 0 0 02246899999999999999999999 5899999999998753
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.6e-52 Score=372.42 Aligned_cols=245 Identities=24% Similarity=0.309 Sum_probs=194.5
Q ss_pred EEEe-eEEeecCceEEEEEEEC--CCCcEEEEEEeccc------hhhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeE
Q 016184 84 YIAE-HVVGTGSFGVVFQAKCR--ETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY 154 (394)
Q Consensus 84 y~~~-~~lg~G~~g~V~~~~~~--~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 154 (394)
+.+. ++||+|+||+||+|.+. .+++.||||++... ...+.+|++++++++||||+++++++.. . .
T Consensus 8 ~~le~k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~---~-- 81 (277)
T d1xbba_ 8 LTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-E---S-- 81 (277)
T ss_dssp EEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-S---S--
T ss_pred CeecCCCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-C---C--
Confidence 4444 57999999999999864 45678999998542 2345689999999999999999998721 1 1
Q ss_pred EEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCcc
Q 016184 155 LNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK 233 (394)
Q Consensus 155 ~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~ 233 (394)
.++||||+++ +|.+++.. ...+++..+..++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+++
T Consensus 82 ~~lvmE~~~~g~L~~~l~~----~~~l~~~~~~~i~~qi~~gl~ylH~-~~iiHrDlKp~Nill~~~~-~~kl~DFGla~ 155 (277)
T d1xbba_ 82 WMLVMEMAELGPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEE-SNFVHRDLAARNVLLVTQH-YAKISDFGLSK 155 (277)
T ss_dssp EEEEEECCTTEEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEEETT-EEEECCCTTCE
T ss_pred EEEEEEcCCCCcHHHHHhh----ccCCCHHHHHHHHHHHHHHHhhHHh-CCcccCCCcchhhcccccC-cccccchhhhh
Confidence 4689999985 77666553 4679999999999999999999999 8999999999999999888 79999999998
Q ss_pred ccccCCCc----ccccccccccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCChhh
Q 016184 234 VLVKGEPN----VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREE 308 (394)
Q Consensus 234 ~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 308 (394)
........ ....||+.|+|||++.+. .++.++|||||||++|||+| |+.||.+.+..+....+.+.. .+
T Consensus 156 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~-~~---- 229 (277)
T d1xbba_ 156 ALRADENYYKAQTHGKWPVKWYAPECINYY-KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGE-RM---- 229 (277)
T ss_dssp ECCTTCSEEEC----CCCGGGCCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC-CC----
T ss_pred hccccccccccccccCCCceecCchhhcCC-CCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcCC-CC----
Confidence 66443322 234678999999999654 48999999999999999998 899999877665554443311 00
Q ss_pred hhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHH---hcCCCCC
Q 016184 309 IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEA---CVHPFFD 369 (394)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~el---l~hp~f~ 369 (394)
.++..+|+++.+||.+||+.||++|||++++ |+|+|++
T Consensus 230 -----------------------~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~ 270 (277)
T d1xbba_ 230 -----------------------GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 270 (277)
T ss_dssp -----------------------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred -----------------------CCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHhh
Confidence 1224689999999999999999999999988 4676654
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-50 Score=366.17 Aligned_cols=250 Identities=24% Similarity=0.353 Sum_probs=195.2
Q ss_pred eeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccc---hhhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEEEEE
Q 016184 82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD---KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLV 158 (394)
Q Consensus 82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv 158 (394)
.+|++.+.||+|+||+||+|+++.+ +.||||++... ...+.+|+.++++++|+|||++++++.. +. +++|
T Consensus 17 ~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~----~~--~~lv 89 (285)
T d1fmka3 17 ESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE----EP--IYIV 89 (285)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS----SS--CEEE
T ss_pred HHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECcccCCHHHHHHHHHHHHhcccCCEeEEEEEEec----CC--eEEE
Confidence 4699999999999999999999654 67999998643 3456789999999999999999998721 11 5689
Q ss_pred Eecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCcccccc
Q 016184 159 LEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK 237 (394)
Q Consensus 159 ~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~ 237 (394)
|||+.+ ++..++... ....+++..++.++.||+.||+|||+ .||+||||||+||||+.++ .+||+|||+++....
T Consensus 90 ~Ey~~~g~l~~~~~~~--~~~~l~~~~~~~i~~~i~~gl~~LH~-~~ivH~DlKp~NIll~~~~-~~kl~DfGla~~~~~ 165 (285)
T d1fmka3 90 TEYMSKGSLLDFLKGE--TGKYLRLPQLVDMAAQIASGMAYVER-MNYVHRDLRAANILVGENL-VCKVADFGLARLIED 165 (285)
T ss_dssp ECCCTTCBHHHHHSHH--HHTTCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECGGG-CEEECCCCTTC----
T ss_pred EEecCCCchhhhhhhc--ccccchHHHHHHHHHHHHHHHHHHhh-hheecccccceEEEECCCC-cEEEcccchhhhccC
Confidence 999995 565554432 23679999999999999999999999 8999999999999999887 799999999986543
Q ss_pred CCC--cccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCC-CCCCCcHHHHHHHHHHhCCCChhhhhccCC
Q 016184 238 GEP--NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPL-FPGESGVDQLVEIIKVLGTPTREEIKCMNP 314 (394)
Q Consensus 238 ~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~p-f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 314 (394)
... .....+|+.|+|||++... .++.++|||||||++|||+||..| |.+....+.+..+..... +
T Consensus 166 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~-~---------- 233 (285)
T d1fmka3 166 NEYTARQGAKFPIKWTAPEAALYG-RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR-M---------- 233 (285)
T ss_dssp ----------CCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC-C----------
T ss_pred CCceeeccccccccccChHHHhCC-CCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCC-C----------
Confidence 322 2335679999999999654 489999999999999999996555 555554444444433111 0
Q ss_pred CCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhc--CCCCCCC
Q 016184 315 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV--HPFFDEL 371 (394)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~--hp~f~~~ 371 (394)
.++..+++++.+||.+||+.||++|||++++++ |+||+..
T Consensus 234 -----------------~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~ 275 (285)
T d1fmka3 234 -----------------PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 275 (285)
T ss_dssp -----------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred -----------------CCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCC
Confidence 022467999999999999999999999999988 8899764
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-50 Score=363.59 Aligned_cols=243 Identities=23% Similarity=0.285 Sum_probs=184.7
Q ss_pred eEEEeeEEeecCceEEEEEEECCCC----cEEEEEEeccc-----hhhhHHHHHHHHHcCCCCeeeeceEEEecCCCcee
Q 016184 83 SYIAEHVVGTGSFGVVFQAKCRETG----EIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL 153 (394)
Q Consensus 83 ~y~~~~~lg~G~~g~V~~~~~~~~~----~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 153 (394)
.|++.++||+|+||.||+|.++.++ ..||||++... ...+.+|+++++.++|||||++++++... .
T Consensus 8 ~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~-----~ 82 (283)
T d1mqba_ 8 CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKY-----K 82 (283)
T ss_dssp TEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS-----S
T ss_pred HeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecC-----C
Confidence 4999999999999999999987654 46999998542 22456899999999999999999988432 2
Q ss_pred EEEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCc
Q 016184 154 YLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA 232 (394)
Q Consensus 154 ~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a 232 (394)
..++||||+.+ ++...+.. ....+++..+..++.||+.||+|||+ ++|+||||||+||||+.++ .+||+|||++
T Consensus 83 ~~~~v~e~~~~~~l~~~~~~---~~~~~~~~~~~~i~~~i~~gl~~lH~-~~iiHrDlKp~NILl~~~~-~~Kl~DFGla 157 (283)
T d1mqba_ 83 PMMIITEYMENGALDKFLRE---KDGEFSVLQLVGMLRGIAAGMKYLAN-MNYVHRDLAARNILVNSNL-VCKVSDFGLS 157 (283)
T ss_dssp SEEEEEECCTTEEHHHHHHH---TTTCSCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECTTC-CEEECCCCC-
T ss_pred ceEEEEEecccCcchhhhhc---ccccccHHHHHHHHHHHHHhhhhccc-cccccCccccceEEECCCC-eEEEcccchh
Confidence 37789999986 44443332 33679999999999999999999999 8999999999999999988 7999999999
Q ss_pred cccccCCC----cccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCC-CCCCcHHHHHHHHHHhCCCChh
Q 016184 233 KVLVKGEP----NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLF-PGESGVDQLVEIIKVLGTPTRE 307 (394)
Q Consensus 233 ~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf-~~~~~~~~~~~i~~~~~~~~~~ 307 (394)
+....... .....||+.|+|||++.+. .++.++|||||||++|||++|..|| ......+.+..+... ..+
T Consensus 158 ~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~-~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~-~~~--- 232 (283)
T d1mqba_ 158 RVLEDDPEATYTTSGGKIPIRWTAPEAISYR-KFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDG-FRL--- 232 (283)
T ss_dssp ----------------CCCGGGSCHHHHHSC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTT-CCC---
T ss_pred hcccCCCccceEeccCCCCccccCHHHHccC-CCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhcc-CCC---
Confidence 87644322 2234578999999999655 5899999999999999999965554 444444433333221 111
Q ss_pred hhhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 016184 308 EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV 364 (394)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 364 (394)
..+..++.++.+||.+||+.||++|||+.++++
T Consensus 233 ------------------------~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~ 265 (283)
T d1mqba_ 233 ------------------------PTPMDCPSAIYQLMMQCWQQERARRPKFADIVS 265 (283)
T ss_dssp ------------------------CCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred ------------------------CCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHH
Confidence 122457899999999999999999999999976
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-50 Score=370.00 Aligned_cols=243 Identities=22% Similarity=0.335 Sum_probs=192.2
Q ss_pred eEEEeeEEeecCceEEEEEEECCCCc----EEEEEEeccc-----hhhhHHHHHHHHHcCCCCeeeeceEEEecCCCcee
Q 016184 83 SYIAEHVVGTGSFGVVFQAKCRETGE----IVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL 153 (394)
Q Consensus 83 ~y~~~~~lg~G~~g~V~~~~~~~~~~----~vaiK~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 153 (394)
+|+++++||+|+||+||+|++..+|+ .||+|.+... ...+.+|+++++.++||||+++++++... .
T Consensus 10 dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-----~ 84 (317)
T d1xkka_ 10 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-----T 84 (317)
T ss_dssp TEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-----S
T ss_pred HCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-----C
Confidence 49999999999999999999988876 4788876432 23456899999999999999999988432 1
Q ss_pred EEEEEEeccc-ccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCc
Q 016184 154 YLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA 232 (394)
Q Consensus 154 ~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a 232 (394)
.+++++++. +++.+.+.. ....+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+|
T Consensus 85 -~~~v~e~~~~~~l~~~~~~---~~~~~~~~~~~~i~~qi~~gl~yLH~-~~iiHrDlKp~NIll~~~~-~~kl~DFGla 158 (317)
T d1xkka_ 85 -VQLITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLED-RRLVHRDLAARNVLVKTPQ-HVKITDFGLA 158 (317)
T ss_dssp -EEEEEECCTTCBHHHHHHH---TSSSCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEEEETT-EEEECCCSHH
T ss_pred -eeEEEEeccCCcccccccc---cccCCCHHHHHHHHHHHHHHHHHHHH-cCcccCcchhhcceeCCCC-CeEeeccccc
Confidence 345666665 567555443 34789999999999999999999999 8999999999999999888 7999999999
Q ss_pred cccccCCCc---ccccccccccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCChhh
Q 016184 233 KVLVKGEPN---VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREE 308 (394)
Q Consensus 233 ~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 308 (394)
+........ ....||+.|+|||++.+. .++.++|||||||++|||+| |..||.+.+..+....+.+.. .++
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~-~~~--- 233 (317)
T d1xkka_ 159 KLLGAEEKEYHAEGGKVPIKWMALESILHR-IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE-RLP--- 233 (317)
T ss_dssp HHTTTTCC--------CCTTTSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTC-CCC---
T ss_pred eecccccccccccccccCccccChHHHhcC-CCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCC-CCC---
Confidence 876443322 234579999999999765 48999999999999999998 789998877665554443321 111
Q ss_pred hhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 016184 309 IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH 365 (394)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 365 (394)
.+..+++++.+||.+||+.||.+|||+.++++|
T Consensus 234 ------------------------~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 266 (317)
T d1xkka_ 234 ------------------------QPPICTIDVYMIMVKCWMIDADSRPKFRELIIE 266 (317)
T ss_dssp ------------------------CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ------------------------CCcccCHHHHHHHHHhCCCChhhCcCHHHHHHH
Confidence 124578999999999999999999999999987
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-50 Score=362.78 Aligned_cols=244 Identities=26% Similarity=0.342 Sum_probs=188.8
Q ss_pred eeEEEeeEEeecCceEEEEEEECCCC---cEEEEEEeccc-----hhhhHHHHHHHHHcCCCCeeeeceEEEecCCCcee
Q 016184 82 VSYIAEHVVGTGSFGVVFQAKCRETG---EIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL 153 (394)
Q Consensus 82 ~~y~~~~~lg~G~~g~V~~~~~~~~~---~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 153 (394)
.+|++.+.||+|+||.||+|++..++ ..||||.+... ...+.+|+.+++.++||||+++++++.. .
T Consensus 7 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~------~ 80 (273)
T d1mp8a_ 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE------N 80 (273)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS------S
T ss_pred HHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec------C
Confidence 46999999999999999999986543 56899987532 2335679999999999999999998721 1
Q ss_pred EEEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCc
Q 016184 154 YLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA 232 (394)
Q Consensus 154 ~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a 232 (394)
.+++||||+.+ ++..++.. ....+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+|
T Consensus 81 ~~~iv~E~~~~g~l~~~~~~---~~~~l~~~~~~~~~~qi~~gl~ylH~-~~iiHrDlKp~NIll~~~~-~~Kl~DfG~a 155 (273)
T d1mp8a_ 81 PVWIIMELCTLGELRSFLQV---RKYSLDLASLILYAYQLSTALAYLES-KRFVHRDIAARNVLVSSND-CVKLGDFGLS 155 (273)
T ss_dssp SCEEEEECCTTEEHHHHHHH---TTTTSCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEEEETT-EEEECC----
T ss_pred eEEEEEEeccCCcHHhhhhc---cCCCCCHHHHHHHHHHHHHHhhhhcc-cCeeccccchhheeecCCC-cEEEccchhh
Confidence 26799999985 55554433 23678999999999999999999999 8999999999999999888 7999999999
Q ss_pred cccccCCC--cccccccccccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCChhhh
Q 016184 233 KVLVKGEP--NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEI 309 (394)
Q Consensus 233 ~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 309 (394)
+....... .....+|+.|+|||++.+. .++.++|||||||++|||+| |.+||.+.+..+.+..+......
T Consensus 156 ~~~~~~~~~~~~~~~gt~~y~apE~l~~~-~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~~~------ 228 (273)
T d1mp8a_ 156 RYMEDSTYYKASKGKLPIKWMAPESINFR-RFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERL------ 228 (273)
T ss_dssp ---------------CCGGGCCHHHHHHC-CCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCC------
T ss_pred eeccCCcceeccceecCcccchhhHhccC-CCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC------
Confidence 86543322 2344678999999999654 48999999999999999998 89999988877766665442100
Q ss_pred hccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 016184 310 KCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH 365 (394)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 365 (394)
.++..+|+++.+||.+||+.||++|||+.||++|
T Consensus 229 ----------------------~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~ 262 (273)
T d1mp8a_ 229 ----------------------PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 262 (273)
T ss_dssp ----------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ----------------------CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 1235689999999999999999999999999875
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-49 Score=363.73 Aligned_cols=250 Identities=23% Similarity=0.336 Sum_probs=190.0
Q ss_pred eeEEEeeEEeecCceEEEEEEECC-----CCcEEEEEEeccch-----hhhHHHHHHHHHc-CCCCeeeeceEEEecCCC
Q 016184 82 VSYIAEHVVGTGSFGVVFQAKCRE-----TGEIVAIKKVLQDK-----RYKNRELQIMQML-DHPNIVALKHCFFSTTDK 150 (394)
Q Consensus 82 ~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~-----~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~ 150 (394)
++|++.++||+|+||.||+|++.. +++.||||++.... ....+|..++.++ .|+||+.+++++....
T Consensus 13 ~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~-- 90 (299)
T d1ywna1 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG-- 90 (299)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTT--
T ss_pred HHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCC--
Confidence 469999999999999999999754 45789999986432 2334566666666 6889999988774322
Q ss_pred ceeEEEEEEeccc-ccHHHHHHHhhh------------hcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEE
Q 016184 151 EELYLNLVLEYVP-ETVNRIARNYSR------------IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLV 217 (394)
Q Consensus 151 ~~~~~~lv~e~~~-~~l~~~~~~~~~------------~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~ 217 (394)
..+++|||||+ |+|.+++..... ....+++..++.++.||+.||+|||+ +||+||||||+||||
T Consensus 91 --~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~-~~ivHrDlKp~NILl 167 (299)
T d1ywna1 91 --GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS-RKCIHRDLAARNILL 167 (299)
T ss_dssp --SCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEE
T ss_pred --CeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHh-CCCcCCcCCccceeE
Confidence 23679999998 588888765432 13458999999999999999999999 899999999999999
Q ss_pred eCCCCcEEEEeecCccccccCCC---cccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhC-CCCCCCCCcHHH
Q 016184 218 NPHTHQLKLCDFGSAKVLVKGEP---NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLG-QPLFPGESGVDQ 293 (394)
Q Consensus 218 ~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg-~~pf~~~~~~~~ 293 (394)
+.++ .+||+|||+|+....... .....||+.|+|||++.+. .++.++|||||||++|||+|| .+||.+....+.
T Consensus 168 ~~~~-~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~ 245 (299)
T d1ywna1 168 SEKN-VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDR-VYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE 245 (299)
T ss_dssp CGGG-CEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHH
T ss_pred CCCC-cEEEccCcchhhccccccccccCceeeCccccchhHhhcC-CCCcccceeehHHHHHHHHhCCCCCCCCCCHHHH
Confidence 9888 699999999986543332 2345789999999999765 489999999999999999986 568887766665
Q ss_pred HHHHHHHhCCCChhhhhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 016184 294 LVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH 365 (394)
Q Consensus 294 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 365 (394)
+.........+. ++..+++++.+||.+||+.||++|||++|+++|
T Consensus 246 ~~~~~~~~~~~~---------------------------~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~ 290 (299)
T d1ywna1 246 FCRRLKEGTRMR---------------------------APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290 (299)
T ss_dssp HHHHHHHTCCCC---------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHhcCCCCC---------------------------CCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 555544321111 124578999999999999999999999999987
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.1e-50 Score=356.54 Aligned_cols=244 Identities=22% Similarity=0.330 Sum_probs=193.8
Q ss_pred ceeEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccc--hhhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEEEEE
Q 016184 81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD--KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLV 158 (394)
Q Consensus 81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv 158 (394)
..+|++.+.||+|+||.||+|+++ |+.||||++..+ ...+.+|++++++++||||+++++++.... ..+++|
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~i~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~----~~~~lv 79 (262)
T d1byga_ 6 MKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEK----GGLYIV 79 (262)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCCC--HHHHHTHHHHTTCCCTTBCCEEEEECCC------CCEEE
T ss_pred HHHeEEeEEEecCCCeEEEEEEEC--CeEEEEEEECcHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEecC----CcEEEE
Confidence 346999999999999999999985 788999998654 345678999999999999999999874322 226799
Q ss_pred Eecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCcccccc
Q 016184 159 LEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK 237 (394)
Q Consensus 159 ~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~ 237 (394)
|||+++ +|.+++.... ...+++..+..++.||+.||.|||+ .+|+||||||+|||++.++ .+||+|||+++....
T Consensus 80 ~ey~~~g~L~~~l~~~~--~~~l~~~~~~~i~~~i~~al~ylH~-~~ivH~dlkp~Nil~~~~~-~~kl~dfg~s~~~~~ 155 (262)
T d1byga_ 80 TEYMAKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEG-NNFVHRDLAARNVLVSEDN-VAKVSDFGLTKEASS 155 (262)
T ss_dssp ECCCTTEEHHHHHHHHH--HHHCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECTTS-CEEECCCCC------
T ss_pred EeccCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHhhcccccc-CceeccccchHhheecCCC-CEeecccccceecCC
Confidence 999985 7887776532 2468999999999999999999999 8999999999999999988 699999999976533
Q ss_pred CCCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCCC
Q 016184 238 GEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 316 (394)
Q Consensus 238 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 316 (394)
. .....+++.|+|||++.+. .++.++|||||||++|||+| |++||...+..+.+..+....
T Consensus 156 ~--~~~~~~~~~y~aPE~l~~~-~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~~--------------- 217 (262)
T d1byga_ 156 T--QDTGKLPVKWTAPEALREK-KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGY--------------- 217 (262)
T ss_dssp --------CCTTTSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTC---------------
T ss_pred C--CccccccccCCChHHHhCC-CCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCC---------------
Confidence 2 3345678899999999755 48999999999999999998 788888776666555543210
Q ss_pred cccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 016184 317 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH 365 (394)
Q Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 365 (394)
...++..+++++.+||.+||+.||.+|||+.+++++
T Consensus 218 -------------~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 253 (262)
T d1byga_ 218 -------------KMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQ 253 (262)
T ss_dssp -------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -------------CCCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 011235678999999999999999999999999873
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.1e-49 Score=360.60 Aligned_cols=248 Identities=23% Similarity=0.310 Sum_probs=198.6
Q ss_pred ceeEEEeeEEeecCceEEEEEEEC-----CCCcEEEEEEeccc-----hhhhHHHHHHHHHcCCCCeeeeceEEEecCCC
Q 016184 81 KVSYIAEHVVGTGSFGVVFQAKCR-----ETGEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDK 150 (394)
Q Consensus 81 ~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 150 (394)
.++|++.+.||+|+||+||+|+++ .+++.||||++... ...+.+|+++++.++||||+++++++...
T Consensus 12 ~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~--- 88 (301)
T d1lufa_ 12 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVG--- 88 (301)
T ss_dssp GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS---
T ss_pred HHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccC---
Confidence 446999999999999999999975 35678999998643 23456899999999999999999988433
Q ss_pred ceeEEEEEEeccc-ccHHHHHHHhh--------------------hhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceecc
Q 016184 151 EELYLNLVLEYVP-ETVNRIARNYS--------------------RIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRD 209 (394)
Q Consensus 151 ~~~~~~lv~e~~~-~~l~~~~~~~~--------------------~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~D 209 (394)
...+++|||++ ++|.+++.... .....+++..+..++.|++.||+|||+ ++|||||
T Consensus 89 --~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~-~~ivHrD 165 (301)
T d1lufa_ 89 --KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE-RKFVHRD 165 (301)
T ss_dssp --SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSC
T ss_pred --CceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhccc-CCeEeeE
Confidence 23678999998 57887775421 122458899999999999999999999 8999999
Q ss_pred CCCCceEEeCCCCcEEEEeecCccccccCC---CcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCC-CCC
Q 016184 210 IKPQNLLVNPHTHQLKLCDFGSAKVLVKGE---PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQ-PLF 285 (394)
Q Consensus 210 lkp~Nil~~~~~~~vkl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~-~pf 285 (394)
|||+|||++.++ .+||+|||+|+...... ......+|+.|+|||.+.+. .++.++|||||||++|||++|. +||
T Consensus 166 lKp~NILld~~~-~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~t~ksDVwS~Gvvl~ell~~~~~p~ 243 (301)
T d1lufa_ 166 LATRNCLVGENM-VVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYN-RYTTESDVWAYGVVLWEIFSYGLQPY 243 (301)
T ss_dssp CSGGGEEECGGG-CEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred EcccceEECCCC-cEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccC-CCChhhhhccchhhHHHHHccCCCCC
Confidence 999999999888 69999999997653332 22345678999999999755 4899999999999999999985 678
Q ss_pred CCCCcHHHHHHHHHHhCCCChhhhhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 016184 286 PGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV 364 (394)
Q Consensus 286 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 364 (394)
.+.+..+.+..+.+.. .+ .++..+++++.+||.+||+.||++|||+.||++
T Consensus 244 ~~~~~~e~~~~v~~~~-~~---------------------------~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~ 294 (301)
T d1lufa_ 244 YGMAHEEVIYYVRDGN-IL---------------------------ACPENCPLELYNLMRLCWSKLPADRPSFCSIHR 294 (301)
T ss_dssp TTSCHHHHHHHHHTTC-CC---------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCHHHHHHHHHcCC-CC---------------------------CCCccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 8777766666554311 00 022568999999999999999999999999965
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-49 Score=355.12 Aligned_cols=244 Identities=24% Similarity=0.323 Sum_probs=189.3
Q ss_pred eeEEEeeEEeecCceEEEEEEECCC-C--cEEEEEEeccc-------hhhhHHHHHHHHHcCCCCeeeeceEEEecCCCc
Q 016184 82 VSYIAEHVVGTGSFGVVFQAKCRET-G--EIVAIKKVLQD-------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKE 151 (394)
Q Consensus 82 ~~y~~~~~lg~G~~g~V~~~~~~~~-~--~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 151 (394)
.+|++.+.||+|+||.||+|++..+ + ..||||++.+. ...+.+|+.+++.++||||+++++++...
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~---- 83 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP---- 83 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS----
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeec----
Confidence 3599999999999999999987533 3 36899987532 23456899999999999999999988321
Q ss_pred eeEEEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeec
Q 016184 152 ELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFG 230 (394)
Q Consensus 152 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg 230 (394)
..++||||+.+ ++.+.+.. ....+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||
T Consensus 84 --~~~lv~e~~~~~~l~~~~~~---~~~~l~~~~~~~~~~qi~~gl~ylH~-~~iiHrDikp~NIll~~~~-~vkl~DfG 156 (273)
T d1u46a_ 84 --PMKMVTELAPLGSLLDRLRK---HQGHFLLGTLSRYAVQVAEGMGYLES-KRFIHRDLAARNLLLATRD-LVKIGDFG 156 (273)
T ss_dssp --SCEEEEECCTTCBHHHHHHH---HGGGSCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEEEETT-EEEECCCT
T ss_pred --chheeeeeecCcchhhhhhc---ccCCCCHHHHHHHHHHHHHHHHHhhh-CCEeeeeecHHHhcccccc-ceeeccch
Confidence 15689999985 66554443 23679999999999999999999999 8999999999999999887 79999999
Q ss_pred CccccccCCCc----ccccccccccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCC
Q 016184 231 SAKVLVKGEPN----VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPT 305 (394)
Q Consensus 231 ~a~~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~ 305 (394)
+++........ ....++..|+|||++.+. .++.++|||||||++|||+| |+.||.+.+..+.+..+.+....+
T Consensus 157 l~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~- 234 (273)
T d1u46a_ 157 LMRALPQNDDHYVMQEHRKVPFAWCAPESLKTR-TFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERL- 234 (273)
T ss_dssp TCEECCC-CCEEEC-----CCGGGCCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCC-
T ss_pred hhhhcccCCCcceecCccccCcccCCHHHHhCC-CCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCCC-
Confidence 99876444332 223467889999999754 48999999999999999998 899999888777776665421111
Q ss_pred hhhhhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 016184 306 REEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV 364 (394)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 364 (394)
..+..+|+++.+||.+||+.||++|||+.+|++
T Consensus 235 --------------------------~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~ 267 (273)
T d1u46a_ 235 --------------------------PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRD 267 (273)
T ss_dssp --------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --------------------------CCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 112568899999999999999999999999864
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-49 Score=362.90 Aligned_cols=248 Identities=23% Similarity=0.306 Sum_probs=199.6
Q ss_pred eeEEEeeEEeecCceEEEEEEECCCCcE--EEEEEecc-----chhhhHHHHHHHHHc-CCCCeeeeceEEEecCCCcee
Q 016184 82 VSYIAEHVVGTGSFGVVFQAKCRETGEI--VAIKKVLQ-----DKRYKNRELQIMQML-DHPNIVALKHCFFSTTDKEEL 153 (394)
Q Consensus 82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~--vaiK~~~~-----~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~ 153 (394)
++|++.++||+|+||.||+|+++.+|.. ||||.+.. ....+.+|+++|+++ +||||+++++++... .
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~-----~ 84 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR-----G 84 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEET-----T
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecC-----C
Confidence 4699999999999999999999888764 67777643 223467899999998 799999999998543 3
Q ss_pred EEEEEEeccc-ccHHHHHHHhh------------hhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCC
Q 016184 154 YLNLVLEYVP-ETVNRIARNYS------------RIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPH 220 (394)
Q Consensus 154 ~~~lv~e~~~-~~l~~~~~~~~------------~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~ 220 (394)
..++||||++ |+|.+++.... .....+++..+..++.||+.||.|||+ ++|+||||||+|||++.+
T Consensus 85 ~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~-~~iiHrDlkp~NIL~~~~ 163 (309)
T d1fvra_ 85 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ-KQFIHRDLAARNILVGEN 163 (309)
T ss_dssp EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECGG
T ss_pred eeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhc-CCccccccccceEEEcCC
Confidence 4789999999 58888776431 234679999999999999999999999 899999999999999988
Q ss_pred CCcEEEEeecCccccccCCCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCC-CCCCCCCcHHHHHHHHH
Q 016184 221 THQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQ-PLFPGESGVDQLVEIIK 299 (394)
Q Consensus 221 ~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~-~pf~~~~~~~~~~~i~~ 299 (394)
+ .+||+|||+++............+|..|+|||.+.+. .++.++|||||||++|||++|. +||.+.+..+.+..+.+
T Consensus 164 ~-~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~~ 241 (309)
T d1fvra_ 164 Y-VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYS-VYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ 241 (309)
T ss_dssp G-CEEECCTTCEESSCEECCC----CCTTTCCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGG
T ss_pred C-ceEEccccccccccccccccceecCCcccchHHhccC-CCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHHh
Confidence 8 7999999999866555555566789999999999755 4899999999999999999975 57877665555444332
Q ss_pred HhCCCChhhhhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 016184 300 VLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH 365 (394)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 365 (394)
.. . ..++..+++++.+||.+||+.||++|||+.++++|
T Consensus 242 ~~-~---------------------------~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 279 (309)
T d1fvra_ 242 GY-R---------------------------LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 279 (309)
T ss_dssp TC-C---------------------------CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cC-C---------------------------CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 10 0 01224678999999999999999999999999987
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=5.3e-48 Score=362.16 Aligned_cols=284 Identities=30% Similarity=0.458 Sum_probs=210.1
Q ss_pred eEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccch---hhhHHHHHHHHHcC-----------CCCeeeeceEEEecC
Q 016184 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---RYKNRELQIMQMLD-----------HPNIVALKHCFFSTT 148 (394)
Q Consensus 83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~-----------h~~iv~~~~~~~~~~ 148 (394)
+|+++++||+|+||+||+|+++.+|+.||||++.++. ....+|+.+++.+. |+||+++++++....
T Consensus 14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~~ 93 (362)
T d1q8ya_ 14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKG 93 (362)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEE
T ss_pred cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeecc
Confidence 4999999999999999999999999999999997653 33457888888775 578999988874322
Q ss_pred CCceeEEEEEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCC-----c
Q 016184 149 DKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTH-----Q 223 (394)
Q Consensus 149 ~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~-----~ 223 (394)
....+.++.+++..++...... ......+++..++.++.||+.||+|||+..||+||||||+|||++.++. .
T Consensus 94 -~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~~~ 170 (362)
T d1q8ya_ 94 -PNGVHVVMVFEVLGENLLALIK--KYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQ 170 (362)
T ss_dssp -TTEEEEEEEECCCCEEHHHHHH--HTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEE
T ss_pred -ccceeeeeeecccccccccccc--cccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCcccccce
Confidence 2233333444444444433333 3345789999999999999999999996579999999999999986542 4
Q ss_pred EEEEeecCccccccCCCcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCC------cHHHHHHH
Q 016184 224 LKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGES------GVDQLVEI 297 (394)
Q Consensus 224 vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~------~~~~~~~i 297 (394)
++++|||.+.... .......+|+.|+|||++.... ++.++||||+||++++|++|+.||.... ..+.+...
T Consensus 171 ~kl~dfg~s~~~~--~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~~ 247 (362)
T d1q8ya_ 171 IKIADLGNACWYD--EHYTNSIQTREYRSPEVLLGAP-WGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQI 247 (362)
T ss_dssp EEECCCTTCEETT--BCCCSCCSCGGGCCHHHHHTCC-CCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHH
T ss_pred eeEeecccccccc--cccccccccccccChhhccccC-CCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHHH
Confidence 9999999997553 2345677899999999997654 8999999999999999999999997543 34566777
Q ss_pred HHHhCCCChhhhhccCC-------CCcccCCCCCCCCCcchh------ccccCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 016184 298 IKVLGTPTREEIKCMNP-------NYTEFKFPQIKPHPWHKV------FQKRLPPEAVDLVCRFFQYSPNLRCTALEACV 364 (394)
Q Consensus 298 ~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 364 (394)
...+|..+...+..... ......+......++... +....++++.+||.+||++||.+||||+|+|+
T Consensus 248 ~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L~ 327 (362)
T d1q8ya_ 248 IELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVN 327 (362)
T ss_dssp HHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHT
T ss_pred HHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 78888877766543211 111112222222222221 12345678999999999999999999999999
Q ss_pred CCCCCCCC
Q 016184 365 HPFFDELR 372 (394)
Q Consensus 365 hp~f~~~~ 372 (394)
||||++..
T Consensus 328 Hp~f~~~~ 335 (362)
T d1q8ya_ 328 HPWLKDTL 335 (362)
T ss_dssp CGGGTTCT
T ss_pred CcccCCCC
Confidence 99999763
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.6e-49 Score=357.14 Aligned_cols=248 Identities=21% Similarity=0.312 Sum_probs=193.3
Q ss_pred ceeEEEeeEEeecCceEEEEEEECCCC-------cEEEEEEeccch-----hhhHHHHHHHHHc-CCCCeeeeceEEEec
Q 016184 81 KVSYIAEHVVGTGSFGVVFQAKCRETG-------EIVAIKKVLQDK-----RYKNRELQIMQML-DHPNIVALKHCFFST 147 (394)
Q Consensus 81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~-------~~vaiK~~~~~~-----~~~~~E~~~l~~l-~h~~iv~~~~~~~~~ 147 (394)
.++|++.+.||+|+||.||+|++..++ ..||||++..+. ....+|+..+.++ +||||+++++++..
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~- 90 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ- 90 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEeccccccc-
Confidence 346999999999999999999986554 479999885432 2334577888777 89999999999843
Q ss_pred CCCceeEEEEEEecccc-cHHHHHHHhhh------------hcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCc
Q 016184 148 TDKEELYLNLVLEYVPE-TVNRIARNYSR------------IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQN 214 (394)
Q Consensus 148 ~~~~~~~~~lv~e~~~~-~l~~~~~~~~~------------~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~N 214 (394)
...+++||||+.+ ++.+++..... ....+++..++.++.||+.||+|||+ .|||||||||+|
T Consensus 91 ----~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~-~~ivHrDiKp~N 165 (299)
T d1fgka_ 91 ----DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS-KKCIHRDLAARN 165 (299)
T ss_dssp ----SSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGG
T ss_pred ----CCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhh-CCEEeeeecccc
Confidence 3347799999984 78777764321 23568999999999999999999999 899999999999
Q ss_pred eEEeCCCCcEEEEeecCccccccCCC---cccccccccccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCc
Q 016184 215 LLVNPHTHQLKLCDFGSAKVLVKGEP---NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESG 290 (394)
Q Consensus 215 il~~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~ 290 (394)
||++.++ .+||+|||+++....... .....+|+.|+|||.+.+. .++.++|||||||++|+|++ |.+||.+.+.
T Consensus 166 iLl~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~-~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~ 243 (299)
T d1fgka_ 166 VLVTEDN-VMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDR-IYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV 243 (299)
T ss_dssp EEECTTC-CEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH
T ss_pred eeecCCC-CeEeccchhhccccccccccccccCCCChhhhhhhHhcCC-CCCchhhhHHhHHHHHHhccCCCCCCCCCCH
Confidence 9999988 699999999986654332 2345679999999999665 49999999999999999998 7889987776
Q ss_pred HHHHHHHHHHhCCCChhhhhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 016184 291 VDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV 364 (394)
Q Consensus 291 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 364 (394)
......+... ..+ .++..+++++.+||.+||+.||++|||+.|+++
T Consensus 244 ~~~~~~i~~~-~~~---------------------------~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 289 (299)
T d1fgka_ 244 EELFKLLKEG-HRM---------------------------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 289 (299)
T ss_dssp HHHHHHHHTT-CCC---------------------------CCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHcC-CCC---------------------------CCCccchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence 5544433321 111 122468999999999999999999999999986
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.5e-48 Score=354.64 Aligned_cols=255 Identities=21% Similarity=0.239 Sum_probs=197.8
Q ss_pred eEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccc--hhhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEEEEEEe
Q 016184 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD--KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLE 160 (394)
Q Consensus 83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e 160 (394)
+|++.+.||+|+||+||+|++..+|+.||||++... .....+|+++++.++|++++..+..+... ....++|||
T Consensus 8 rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~----~~~~~ivme 83 (299)
T d1ckia_ 8 RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAE----GDYNVMVME 83 (299)
T ss_dssp TEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTSCCHHHHHHHHHHSTTSTTCCCEEEEEEE----TTEEEEEEE
T ss_pred EEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccCHHHHHHHHHHHHccCCCcccEEEEEEec----CCEEEEEEE
Confidence 499999999999999999999999999999987543 34567899999999988776665555332 234778999
Q ss_pred cccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCC--CCcEEEEeecCccccccC
Q 016184 161 YVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPH--THQLKLCDFGSAKVLVKG 238 (394)
Q Consensus 161 ~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~--~~~vkl~Dfg~a~~~~~~ 238 (394)
|+++++...+.. ....+++..+..++.|++.||+|||+ +||+||||||+|||++.. ...+||+|||+|+.....
T Consensus 84 ~~~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~-~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~ 159 (299)
T d1ckia_ 84 LLGPSLEDLFNF---CSRKFSLKTVLLLADQMISRIEYIHS-KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA 159 (299)
T ss_dssp CCCCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCT
T ss_pred EcCCchhhhhhh---ccCCCcHHHHHHHHHHHHHHHHHHHH-CCeeeccCCHhhccccccCCCceeeeeccCcceecccc
Confidence 999887665443 34679999999999999999999999 899999999999998642 236999999999876543
Q ss_pred CC--------cccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhC---CCChh
Q 016184 239 EP--------NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLG---TPTRE 307 (394)
Q Consensus 239 ~~--------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~---~~~~~ 307 (394)
.. .....||+.|+|||++.+. .++.++|||||||++|||+||+.||...........+..... ..+.
T Consensus 160 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~- 237 (299)
T d1ckia_ 160 RTHQHIPYRENKNLTGTARYASINTHLGI-EQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI- 237 (299)
T ss_dssp TTCCBCCCCBCCSCCCCSSSCCHHHHTTB-CCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCH-
T ss_pred ccccceeccccCCcCCCccccCHHHHhCC-CCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCCh-
Confidence 22 2345789999999999654 489999999999999999999999987665544333322110 0111
Q ss_pred hhhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHH---HHhcCCCCCC
Q 016184 308 EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTAL---EACVHPFFDE 370 (394)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~---ell~hp~f~~ 370 (394)
..+...+|+++.+||..||+.||++||++. ++|+|+|.+.
T Consensus 238 -----------------------~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~ 280 (299)
T d1ckia_ 238 -----------------------EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ 280 (299)
T ss_dssp -----------------------HHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHH
T ss_pred -----------------------hHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHc
Confidence 112246899999999999999999999987 5577877644
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-48 Score=357.73 Aligned_cols=254 Identities=21% Similarity=0.279 Sum_probs=204.1
Q ss_pred eeEEEeeEEeecCceEEEEEEECC-----CCcEEEEEEeccch-----hhhHHHHHHHHHcCCCCeeeeceEEEecCCCc
Q 016184 82 VSYIAEHVVGTGSFGVVFQAKCRE-----TGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKE 151 (394)
Q Consensus 82 ~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 151 (394)
++|++.+.||+|+||+||+|+++. ++..||||++.... ..+.+|++++++++||||+++++++...
T Consensus 20 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~---- 95 (308)
T d1p4oa_ 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG---- 95 (308)
T ss_dssp GGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSS----
T ss_pred HHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecC----
Confidence 469999999999999999998853 35789999986432 2345899999999999999999988332
Q ss_pred eeEEEEEEeccc-ccHHHHHHHhhh------hcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcE
Q 016184 152 ELYLNLVLEYVP-ETVNRIARNYSR------IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQL 224 (394)
Q Consensus 152 ~~~~~lv~e~~~-~~l~~~~~~~~~------~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~v 224 (394)
...++||||+. |++..++..... ....+++..+..++.|++.||.|||+ ++|+||||||+|||++.++ .+
T Consensus 96 -~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~-~~ivHrDlk~~NiLld~~~-~~ 172 (308)
T d1p4oa_ 96 -QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA-NKFVHRDLAARNCMVAEDF-TV 172 (308)
T ss_dssp -SSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH-TTCBCSCCSGGGEEECTTC-CE
T ss_pred -CceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhh-CCeeeceEcCCceeecCCc-eE
Confidence 23679999998 477777654332 12346888999999999999999999 8999999999999999888 79
Q ss_pred EEEeecCccccccCCC---cccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhC-CCCCCCCCcHHHHHHHHHH
Q 016184 225 KLCDFGSAKVLVKGEP---NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLG-QPLFPGESGVDQLVEIIKV 300 (394)
Q Consensus 225 kl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg-~~pf~~~~~~~~~~~i~~~ 300 (394)
||+|||+|+....... .....+|+.|+|||.+.+.. ++.++||||||+++|||+|| .+||.+.+..+.+..+.+.
T Consensus 173 Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~-~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~~ 251 (308)
T d1p4oa_ 173 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGV-FTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEG 251 (308)
T ss_dssp EECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTT
T ss_pred EEeecccceeccCCcceeeccceecccccCCHHHHccCC-CCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhC
Confidence 9999999986644332 23346799999999997554 89999999999999999998 4888877776666655431
Q ss_pred hCCCChhhhhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhc------CCCCCCC
Q 016184 301 LGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV------HPFFDEL 371 (394)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~------hp~f~~~ 371 (394)
.. + ..+..+++.+.+||.+||+.||++|||+.++++ +|+|+++
T Consensus 252 ~~-~---------------------------~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~~~~~~ 300 (308)
T d1p4oa_ 252 GL-L---------------------------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREV 300 (308)
T ss_dssp CC-C---------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTHHHH
T ss_pred CC-C---------------------------CCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCCcCC
Confidence 10 0 012467899999999999999999999999997 7887654
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7e-48 Score=353.05 Aligned_cols=249 Identities=24% Similarity=0.321 Sum_probs=201.1
Q ss_pred ceeEEEeeEEeecCceEEEEEEEC-----CCCcEEEEEEeccch-----hhhHHHHHHHHHc-CCCCeeeeceEEEecCC
Q 016184 81 KVSYIAEHVVGTGSFGVVFQAKCR-----ETGEIVAIKKVLQDK-----RYKNRELQIMQML-DHPNIVALKHCFFSTTD 149 (394)
Q Consensus 81 ~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~ 149 (394)
.++|++.++||+|+||.||+|++. .+++.||||++.... ..+.+|+.+++.+ +||||+++++++..
T Consensus 22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~--- 98 (311)
T d1t46a_ 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTI--- 98 (311)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS---
T ss_pred HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEee---
Confidence 457999999999999999999863 456789999986432 2345799999998 69999999999833
Q ss_pred CceeEEEEEEecccc-cHHHHHHHhhh--------------hcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCc
Q 016184 150 KEELYLNLVLEYVPE-TVNRIARNYSR--------------IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQN 214 (394)
Q Consensus 150 ~~~~~~~lv~e~~~~-~l~~~~~~~~~--------------~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~N 214 (394)
....+++||||++ ++..++..... ....+++..+..++.||+.||+|||+ +|++||||||+|
T Consensus 99 --~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~-~~ivHrDLKp~N 175 (311)
T d1t46a_ 99 --GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS-KNCIHRDLAARN 175 (311)
T ss_dssp --SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGG
T ss_pred --CCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh-CCeeeccccccc
Confidence 2337799999985 77777664321 23468999999999999999999999 899999999999
Q ss_pred eEEeCCCCcEEEEeecCccccccCCCc---ccccccccccccccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCc
Q 016184 215 LLVNPHTHQLKLCDFGSAKVLVKGEPN---VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESG 290 (394)
Q Consensus 215 il~~~~~~~vkl~Dfg~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~ 290 (394)
||++.++ .+||+|||.++........ ....+|+.|+|||.+.+. .++.++|||||||++|||+| |.+||.+...
T Consensus 176 Il~~~~~-~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~ 253 (311)
T d1t46a_ 176 ILLTHGR-ITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNC-VYTFESDVWSYGIFLWELFSLGSSPYPGMPV 253 (311)
T ss_dssp EEEETTT-EEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCSSTTCCS
T ss_pred ccccccC-cccccccchheeccCCCcceEeeecccChHHcCHHHhcCC-CCCCcccccchHHHHHHHHhCCCCCCCCCCH
Confidence 9999887 7999999999876543322 235679999999999654 48999999999999999998 6677777777
Q ss_pred HHHHHHHHHHhCCCChhhhhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 016184 291 VDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV 364 (394)
Q Consensus 291 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 364 (394)
.+.+..++.....+. .+..+++++.+||.+||+.||.+|||++++++
T Consensus 254 ~~~~~~~i~~~~~~~---------------------------~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~ 300 (311)
T d1t46a_ 254 DSKFYKMIKEGFRML---------------------------SPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300 (311)
T ss_dssp SHHHHHHHHHTCCCC---------------------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHhcCCCCC---------------------------CcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 677766665321111 12457899999999999999999999999985
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-47 Score=348.86 Aligned_cols=244 Identities=19% Similarity=0.261 Sum_probs=188.6
Q ss_pred EEEeeEEeecCceEEEEEEECCCC---cEEEEEEeccc-----hhhhHHHHHHHHHcCCCCeeeeceEEEecCCCceeEE
Q 016184 84 YIAEHVVGTGSFGVVFQAKCRETG---EIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL 155 (394)
Q Consensus 84 y~~~~~lg~G~~g~V~~~~~~~~~---~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 155 (394)
+...++||+|+||+||+|++..++ ..||||++... ...+.+|++++++++||||+++++++.... ...
T Consensus 29 ~~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~----~~~ 104 (311)
T d1r0pa_ 29 VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSE----GSP 104 (311)
T ss_dssp EEEEEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETT----TEE
T ss_pred eccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecC----Cce
Confidence 344688999999999999986543 36899988532 234568999999999999999999875432 247
Q ss_pred EEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCCCcEEEEeecCccc
Q 016184 156 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV 234 (394)
Q Consensus 156 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~ 234 (394)
++||||+++ ++.+++.. ....+++..+..++.|++.||.|||+ .+|+||||||+|||++.++ .+||+|||+++.
T Consensus 105 ~lv~E~~~~g~l~~~~~~---~~~~~~~~~~~~i~~qia~gL~~lH~-~~iiHrDLK~~NILl~~~~-~~kL~DFG~~~~ 179 (311)
T d1r0pa_ 105 LVVLPYMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKFLAS-KKFVHRDLAARNCMLDEKF-TVKVADFGLARD 179 (311)
T ss_dssp EEEEECCTTCBHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECTTC-CEEECSSGGGCC
T ss_pred EEEEEEeecCchhhhhcc---ccccchHHHHHHHHHHHHHhhhhhcc-cCcccCCccHHhEeECCCC-CEEEecccchhh
Confidence 799999995 66555443 33567788899999999999999999 8999999999999999887 799999999986
Q ss_pred cccCCC-----cccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcH-HHHHHHHHHhCCCChhh
Q 016184 235 LVKGEP-----NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGV-DQLVEIIKVLGTPTREE 308 (394)
Q Consensus 235 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~-~~~~~i~~~~~~~~~~~ 308 (394)
...... .....||+.|+|||.+... .++.++||||||+++|||+||..||...... +....+... ..+
T Consensus 180 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g-~~~---- 253 (311)
T d1r0pa_ 180 MYDKEFDSVHNKTGAKLPVKWMALESLQTQ-KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQG-RRL---- 253 (311)
T ss_dssp TTTTTCCCTTCTTCSSCCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTT-CCC----
T ss_pred ccccccccceecccccccccccChHHHhcC-CCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcC-CCC----
Confidence 643322 2234678999999998654 4899999999999999999987777654332 222222221 000
Q ss_pred hhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 016184 309 IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH 365 (394)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 365 (394)
..+..+++++.+||.+||+.||++|||+.|+++|
T Consensus 254 -----------------------~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~ 287 (311)
T d1r0pa_ 254 -----------------------LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 287 (311)
T ss_dssp -----------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -----------------------CCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 1124578999999999999999999999999988
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=1.3e-46 Score=341.58 Aligned_cols=248 Identities=19% Similarity=0.190 Sum_probs=197.2
Q ss_pred eEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccc--hhhhHHHHHHHHHcCC-CCeeeeceEEEecCCCceeEEEEEE
Q 016184 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD--KRYKNRELQIMQMLDH-PNIVALKHCFFSTTDKEELYLNLVL 159 (394)
Q Consensus 83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~~~~~~~~lv~ 159 (394)
+|+++++||+|+||+||+|++..+|+.||||++... .....+|+++++.+.| +|++.+++++ ......++||
T Consensus 6 ~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~-----~~~~~~~~vm 80 (293)
T d1csna_ 6 HYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFG-----QEGLHNVLVI 80 (293)
T ss_dssp TEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEE-----EETTEEEEEE
T ss_pred ceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCcHHHHHHHHHHHHhcCCCCCCEEEEEe-----ecCCccEEEE
Confidence 499999999999999999999999999999987543 3456789999999976 8998888877 3334578999
Q ss_pred ecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCC----CCcEEEEeecCcccc
Q 016184 160 EYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPH----THQLKLCDFGSAKVL 235 (394)
Q Consensus 160 e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~----~~~vkl~Dfg~a~~~ 235 (394)
||++++|..++... ...+++..+..++.|++.||+|||+ +||+||||||+|||++.+ .+.+||+|||+|+..
T Consensus 81 e~~~~~l~~~~~~~---~~~~~~~~~~~i~~q~~~~l~~lH~-~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~ 156 (293)
T d1csna_ 81 DLLGPSLEDLLDLC---GRKFSVKTVAMAAKQMLARVQSIHE-KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY 156 (293)
T ss_dssp ECCCCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHT-TTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred EecCCCHHHHHHhh---ccchhhHHHHHHHHHHHHHHHHHHH-CCceeccCCccceeecCcccccCCceEEcccceeEEc
Confidence 99999987766542 3579999999999999999999999 899999999999999742 236999999999876
Q ss_pred ccCC--------CcccccccccccccccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHH---HHHHHHHhCCC
Q 016184 236 VKGE--------PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQ---LVEIIKVLGTP 304 (394)
Q Consensus 236 ~~~~--------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~---~~~i~~~~~~~ 304 (394)
.... ......||+.|+|||++.+. .++.++|||||||++|+|+||..||.+...... ...+.......
T Consensus 157 ~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~-~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~ 235 (293)
T d1csna_ 157 RDPVTKQHIPYREKKNLSGTARYMSINTHLGR-EQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST 235 (293)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHS
T ss_pred ccCccccceeecccCceEEchhhcCHHHhcCC-CCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCC
Confidence 4321 22345789999999999754 489999999999999999999999986544322 22232211111
Q ss_pred ChhhhhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 016184 305 TREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV 364 (394)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 364 (394)
+.. .+...+|+++.+++..|+..+|++||+.+.+.+
T Consensus 236 ~~~------------------------~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~ 271 (293)
T d1csna_ 236 PLR------------------------ELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 271 (293)
T ss_dssp CHH------------------------HHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred ChH------------------------HhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence 111 112467899999999999999999998776644
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-47 Score=346.02 Aligned_cols=255 Identities=21% Similarity=0.218 Sum_probs=187.5
Q ss_pred eEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccchhh-hHH--HHHHHHHcCCCCeeeeceEEEecCCCceeEEEEEE
Q 016184 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRY-KNR--ELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVL 159 (394)
Q Consensus 83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~--E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~ 159 (394)
+|.+.+.||+|+||.||+|++ +|+.||||++...... ..+ |+..+..++||||+++++++.... .....+++||
T Consensus 4 ~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~-~~~~~~~lv~ 80 (303)
T d1vjya_ 4 TIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDN-GTWTQLWLVS 80 (303)
T ss_dssp GEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEEC-SSSEEEEEEE
T ss_pred EEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccchhHHHHHHHHHHHhhCCCCcCcceEEEEEeCC-CcceEEEEEE
Confidence 599999999999999999997 4899999998654322 223 444456789999999999986554 3334578999
Q ss_pred ecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhC-------CCceeccCCCCceEEeCCCCcEEEEeecC
Q 016184 160 EYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC-------IGICHRDIKPQNLLVNPHTHQLKLCDFGS 231 (394)
Q Consensus 160 e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~-------~givH~Dlkp~Nil~~~~~~~vkl~Dfg~ 231 (394)
||+.+ +|..++.. ..+++.....++.|++.||+|||.. +||+||||||+||||+.++ .+||+|||+
T Consensus 81 Ey~~~g~L~~~l~~-----~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~-~~Kl~DFGl 154 (303)
T d1vjya_ 81 DYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG-TCCIADLGL 154 (303)
T ss_dssp ECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTS-CEEECCCTT
T ss_pred ecccCCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCC-CeEEEecCc
Confidence 99975 88888764 5799999999999999999999961 5999999999999999888 799999999
Q ss_pred ccccccCCC-----cccccccccccccccccCCC-----CCCChhhHHHHHHHHHHHHhCCCCCCCCCcHH---------
Q 016184 232 AKVLVKGEP-----NVSYICSRYYRAPELIFGAT-----EYTTAIDIWSTGCVMAELLLGQPLFPGESGVD--------- 292 (394)
Q Consensus 232 a~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~-----~~~~~~DiwslG~il~~lltg~~pf~~~~~~~--------- 292 (394)
++....... .....||+.|+|||++.+.. .++.++|||||||++|||+||..||.......
T Consensus 155 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~ 234 (303)
T d1vjya_ 155 AVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPS 234 (303)
T ss_dssp CEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCS
T ss_pred cccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccc
Confidence 987654332 23457899999999985432 25678999999999999999998775322110
Q ss_pred --HHHHHHHHhCCCChhhhhccCCCCcccCCCCCCCCCcchhccccCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 016184 293 --QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV 364 (394)
Q Consensus 293 --~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 364 (394)
....+.+.... ....+..............+.+|+.+||+.||++|||+.|+++
T Consensus 235 ~~~~~~~~~~~~~------------------~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~ 290 (303)
T d1vjya_ 235 DPSVEEMRKVVCE------------------QKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 290 (303)
T ss_dssp SCCHHHHHHHHTT------------------SCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHH
T ss_pred cchHHHHHHHHhc------------------cccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHH
Confidence 01111111000 0000000111111223456899999999999999999999976
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.92 E-value=7.3e-26 Score=191.26 Aligned_cols=165 Identities=16% Similarity=0.113 Sum_probs=117.1
Q ss_pred EEEeeEEeecCceEEEEEEECCCCcEEEEEEeccch----------------------hhhHHHHHHHHHcCCCCeeeec
Q 016184 84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK----------------------RYKNRELQIMQMLDHPNIVALK 141 (394)
Q Consensus 84 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----------------------~~~~~E~~~l~~l~h~~iv~~~ 141 (394)
|.+.+.||+|+||+||+|++. +|+.||||++.... ....+|...+.++.|.+++..+
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~ 80 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY 80 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred chhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEE
Confidence 568899999999999999984 68999999864211 1113578889999999988876
Q ss_pred eEEEecCCCceeEEEEEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccCCCCceEEeCCC
Q 016184 142 HCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHT 221 (394)
Q Consensus 142 ~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~ 221 (394)
++. . .+++|||+++.. ...++...+..++.|++.||.|||+ +||+||||||+|||++.+
T Consensus 81 ~~~-----~----~~lvme~~~~~~----------~~~l~~~~~~~i~~ql~~~l~~lH~-~giiHrDiKP~NILv~~~- 139 (191)
T d1zara2 81 AWE-----G----NAVLMELIDAKE----------LYRVRVENPDEVLDMILEEVAKFYH-RGIVHGDLSQYNVLVSEE- 139 (191)
T ss_dssp EEE-----T----TEEEEECCCCEE----------GGGCCCSCHHHHHHHHHHHHHHHHH-TTEECSCCSTTSEEEETT-
T ss_pred Eec-----C----CEEEEEeecccc----------ccchhhHHHHHHHHHHHHHHHHHhh-CCEEEccCChhheeeeCC-
Confidence 543 1 258999999732 1335556677889999999999999 899999999999999964
Q ss_pred CcEEEEeecCccccccCCCcccccc-cccccccccccCCCCCCChhhHHHHHHHH
Q 016184 222 HQLKLCDFGSAKVLVKGEPNVSYIC-SRYYRAPELIFGATEYTTAIDIWSTGCVM 275 (394)
Q Consensus 222 ~~vkl~Dfg~a~~~~~~~~~~~~~~-t~~y~aPE~~~~~~~~~~~~DiwslG~il 275 (394)
.++|+|||.|......... .... ... .-.+.+ ...|+.++|+||+.--+
T Consensus 140 -~~~liDFG~a~~~~~~~~~-~~l~rd~~-~~~~~f--~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 140 -GIWIIDFPQSVEVGEEGWR-EILERDVR-NIITYF--SRTYRTEKDINSAIDRI 189 (191)
T ss_dssp -EEEECCCTTCEETTSTTHH-HHHHHHHH-HHHHHH--HHHHCCCCCHHHHHHHH
T ss_pred -CEEEEECCCcccCCCCCcH-HHHHHHHH-HHHHHH--cCCCCCcccHHHHHHHH
Confidence 4999999998754322111 0000 000 001222 13478899999976443
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.33 E-value=1.6e-06 Score=74.56 Aligned_cols=76 Identities=16% Similarity=0.112 Sum_probs=48.6
Q ss_pred eEEEeeEEeecCceEEEEEEECCCCcEEEEEEeccc----hhhhHHHHHHHHHcC-CCCeeeeceEEEecCCCceeEEEE
Q 016184 83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD----KRYKNRELQIMQMLD-HPNIVALKHCFFSTTDKEELYLNL 157 (394)
Q Consensus 83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~~l 157 (394)
.|++.+..+.++.+.||+.. .+++.+.||+.... .....+|...++.+. +--+.+++.+. ......++
T Consensus 15 ~~~~~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~-----~~~~~~~l 87 (263)
T d1j7la_ 15 KYRCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFE-----RHDGWSNL 87 (263)
T ss_dssp TSEEEECSCCCSSSEEEEEE--CSSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEE-----EETTEEEE
T ss_pred ceEEEEcCCCCCCCcEEEEE--eCCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEE-----ecCCceEE
Confidence 36777766666667999876 34667888977543 234568898888774 22244554443 12234678
Q ss_pred EEeccccc
Q 016184 158 VLEYVPET 165 (394)
Q Consensus 158 v~e~~~~~ 165 (394)
||++++|.
T Consensus 88 v~~~l~G~ 95 (263)
T d1j7la_ 88 LMSEADGV 95 (263)
T ss_dssp EEECCSSE
T ss_pred EEEecccc
Confidence 99999873
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.01 E-value=1.1e-05 Score=68.89 Aligned_cols=68 Identities=18% Similarity=0.125 Sum_probs=42.7
Q ss_pred eecC-ceEEEEEEECCCCcEEEEEEeccch-hhhHHHHHHHHHcCCCC--eeeeceEEEecCCCceeEEEEEEecccc
Q 016184 91 GTGS-FGVVFQAKCRETGEIVAIKKVLQDK-RYKNRELQIMQMLDHPN--IVALKHCFFSTTDKEELYLNLVLEYVPE 164 (394)
Q Consensus 91 g~G~-~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~E~~~l~~l~h~~--iv~~~~~~~~~~~~~~~~~~lv~e~~~~ 164 (394)
..|. -+.||+... .++..+++|...... ....+|...++.+.... +.+++.+... . ...++||++++|
T Consensus 19 ~~G~s~~~v~r~~~-~~~~~~vlK~~~~~~~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~---~--~~~~~v~~~i~G 90 (255)
T d1nd4a_ 19 TIGCSDAAVFRLSA-QGRPVLFVKTDLSGALNELQDEAARLSWLATTGVPCAAVLDVVTE---A--GRDWLLLGEVPG 90 (255)
T ss_dssp SCTTSSCEEEEEEC-TTSCCEEEEEECSCTTSCHHHHHHHHHHHHTTTCCBCCEEEEEEC---S--SCEEEEEECCSS
T ss_pred CCcccCCeEEEEEe-CCCCEEEEEeCCccCHhHHHHHHHHHHHHHhcCCCCCceeeeccc---c--cceEEEEEeeec
Confidence 3444 468898876 456678899765443 34678999988875433 3444444321 1 235689999975
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.90 E-value=3.3e-05 Score=70.31 Aligned_cols=71 Identities=18% Similarity=0.174 Sum_probs=42.4
Q ss_pred eeEEeecCceEEEEEEECCCCcEEEEEEecc-----------chhhhHHHHHHHHHcC-C--CCeeeeceEEEecCCCce
Q 016184 87 EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQ-----------DKRYKNRELQIMQMLD-H--PNIVALKHCFFSTTDKEE 152 (394)
Q Consensus 87 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-----------~~~~~~~E~~~l~~l~-h--~~iv~~~~~~~~~~~~~~ 152 (394)
.+.||.|....||++....+++.|+||.-.. .......|.+.|+.+. + ..+++++.+ .. ..
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~---~~ 105 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DT---EM 105 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ET---TT
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cC---CC
Confidence 3468999999999999877788899996421 1122345888887763 2 234444332 21 11
Q ss_pred eEEEEEEecccc
Q 016184 153 LYLNLVLEYVPE 164 (394)
Q Consensus 153 ~~~~lv~e~~~~ 164 (394)
.++|||++++
T Consensus 106 --~~lvmE~L~~ 115 (392)
T d2pula1 106 --AVTVMEDLSH 115 (392)
T ss_dssp --TEEEECCCTT
T ss_pred --CEEEEeccCC
Confidence 2479999874
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.02 E-value=0.0011 Score=58.25 Aligned_cols=39 Identities=18% Similarity=0.019 Sum_probs=28.9
Q ss_pred ceEEEEEEECCCCcEEEEEEeccc---hhhhHHHHHHHHHcCC
Q 016184 95 FGVVFQAKCRETGEIVAIKKVLQD---KRYKNRELQIMQMLDH 134 (394)
Q Consensus 95 ~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~E~~~l~~l~h 134 (394)
--.||+++. .+|+.|++|+.+.. ...+..|...+..|..
T Consensus 35 EN~vy~v~~-~dg~~~VlK~~rp~~~s~~~i~~E~~~l~~L~~ 76 (325)
T d1zyla1 35 ENRVYQFQD-EDRRRFVVKFYRPERWTADQILEEHQFALQLVN 76 (325)
T ss_dssp SSEEEEECC-TTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHH
T ss_pred cceeEEEEc-CCCCEEEEEEeCCCCCCHHHHHHHHHHHHHHHh
Confidence 368999987 56888999987653 3456678888887743
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.92 E-value=0.0027 Score=57.22 Aligned_cols=69 Identities=17% Similarity=0.236 Sum_probs=44.7
Q ss_pred eeEEeecCceEEEEEEECC-------CCcEEEEEEeccc--hhhhHHHHHHHHHcCCCCee-eeceEEEecCCCceeEEE
Q 016184 87 EHVVGTGSFGVVFQAKCRE-------TGEIVAIKKVLQD--KRYKNRELQIMQMLDHPNIV-ALKHCFFSTTDKEELYLN 156 (394)
Q Consensus 87 ~~~lg~G~~g~V~~~~~~~-------~~~~vaiK~~~~~--~~~~~~E~~~l~~l~h~~iv-~~~~~~~~~~~~~~~~~~ 156 (394)
++.|+.|-.-.+|++.... ..+.|.+++.-.. .....+|..+++.+.-.++. ++++++ .+ .
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~~~idr~~E~~i~~~ls~~gl~Pkll~~~-----~~----g 117 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPETESHLVAESVIFTLLSERHLGPKLYGIF-----SG----G 117 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCCHHHHHHHHHHHHHHHHTTSSSCEEEEE-----TT----E
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcchhhHHHHHHHHHHHHHhCCCCCeEEEEc-----CC----c
Confidence 3568889999999998743 2356777765422 23345788888888544443 555554 22 3
Q ss_pred EEEecccc
Q 016184 157 LVLEYVPE 164 (394)
Q Consensus 157 lv~e~~~~ 164 (394)
+|+||++|
T Consensus 118 ~I~efi~g 125 (395)
T d1nw1a_ 118 RLEEYIPS 125 (395)
T ss_dssp EEECCCCE
T ss_pred eEEEEecc
Confidence 68888874
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.41 E-value=0.0092 Score=51.67 Aligned_cols=30 Identities=27% Similarity=0.269 Sum_probs=26.2
Q ss_pred CCceeccCCCCceEEeCCCCcEEEEeecCcc
Q 016184 203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAK 233 (394)
Q Consensus 203 ~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~ 233 (394)
.|+||+|+.++||+++.+. ..-|+||+.+.
T Consensus 183 ~giIHgDl~~dNvl~~~~~-v~gvIDF~~~~ 212 (316)
T d2ppqa1 183 AGVIHADLFQDNVFFLGDE-LSGLIDFYFAC 212 (316)
T ss_dssp EEEECSCCCGGGEEEETTE-EEEECCCTTCE
T ss_pred cccccCCcchhhhhccccc-ceeEecccccc
Confidence 5799999999999999765 56899999885
|